<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33007077</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2473-9537</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>19</Issue><PubDate><Year>2020</Year><Month>Oct</Month><Day>13</Day></PubDate></JournalIssue><Title>Blood advances</Title><ISOAbbreviation>Blood Adv</ISOAbbreviation></Journal><ArticleTitle>American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism.</ArticleTitle><Pagination><StartPage>4693</StartPage><EndPage>4738</EndPage><MedlinePgn>4693-4738</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1182/bloodadvances.2020001830</ELocationID><Abstract><AbstractText Label="BACKGROUND">Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE), occurs in &#x223c;1 to 2 individuals per 1000 each year, corresponding to &#x223c;300&#x2009;000 to 600&#x2009;000 events in the United States annually.</AbstractText><AbstractText Label="OBJECTIVE">These evidence-based guidelines from the American Society of Hematology (ASH) intend to support patients, clinicians, and others in decisions about treatment of VTE.</AbstractText><AbstractText Label="METHODS">ASH formed a multidisciplinary guideline panel balanced to minimize potential bias from conflicts of interest. The McMaster University GRADE Centre supported the guideline development process, including updating or performing systematic evidence reviews. The panel prioritized clinical questions and outcomes according to their importance for clinicians and adult patients. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach was used to assess evidence and make recommendations, which were subject to public comment.</AbstractText><AbstractText Label="RESULTS">The panel agreed on 28 recommendations for the initial management of VTE, primary treatment, secondary prevention, and treatment of recurrent VTE events.</AbstractText><AbstractText Label="CONCLUSIONS">Strong recommendations include the use of thrombolytic therapy for patients with PE and hemodynamic compromise, use of an international normalized ratio (INR) range of 2.0 to 3.0 over a lower INR range for patients with VTE who use a vitamin K antagonist (VKA) for secondary prevention, and use of indefinite anticoagulation for patients with recurrent unprovoked VTE. Conditional recommendations include the preference for home treatment over hospital-based treatment for uncomplicated DVT and PE at low risk for complications and a preference for direct oral anticoagulants over VKA for primary treatment of VTE.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ortel</LastName><ForeName>Thomas L</ForeName><Initials>TL</Initials><AffiliationInfo><Affiliation>Division of Hematology, Department of Medicine, Duke University, Durham NC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neumann</LastName><ForeName>Ignacio</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Pontificia Universidad Catolica de Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ageno</LastName><ForeName>Walter</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Medicine and Surgery, University of Insurbria, Varese, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beyth</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine, Department of Medicine, University of Florida, Gainesville, FL.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Malcolm Randall Veterans Affairs Medical Center, Gainesville, FL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clark</LastName><ForeName>Nathan P</ForeName><Initials>NP</Initials><AffiliationInfo><Affiliation>Clinical Pharmacy Anticoagulation Service, Kaiser Permanente, Aurora, CO.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cuker</LastName><ForeName>Adam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hutten</LastName><ForeName>Barbara A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jaff</LastName><ForeName>Michael R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manja</LastName><ForeName>Veena</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>University of California Davis, Sacramento, CA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Veterans Affairs Northern California Health Care System, Mather, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schulman</LastName><ForeName>Sam</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, I.M. Sechenov First Moscow State Medical University, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thurston</LastName><ForeName>Caitlin</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>May-Thurner Syndrome Resource Network.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vedantham</LastName><ForeName>Suresh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Diagnostic Radiology, Washington University School of Medicine in St. Louis, St. Louis, MO.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verhamme</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Witt</LastName><ForeName>Daniel M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D Florez</LastName><ForeName>Ivan</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Antioquia, Medellin, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Izcovich</LastName><ForeName>Ariel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Internal Medicine Department, German Hospital, Buenos Aires, Argentina; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nieuwlaat</LastName><ForeName>Robby</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ross</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>J Sch&#xfc;nemann</LastName><ForeName>Holger</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiercioch</LastName><ForeName>Wojtek</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yuqing</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017065">Practice Guideline</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Blood Adv</MedlineTA><NlmUniqueID>101698425</NlmUniqueID><ISSNLinking>2473-9529</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Am Fam Physician. 2021 Oct 1;104(4):429-431.</RefSource><PMID Version="1">34652096</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D019317" MajorTopicYN="N">Evidence-Based Medicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006405" MajorTopicYN="Y">Hematology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="Y">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="Y">Venous Thrombosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Conflict-of-interest disclosure: All authors were members of the guideline panel, the systematic review team, or both. They completed disclosure-of interest-forms, which were reviewed by ASH and are available as Supplements 2 and 3. The following disclosure was added after the finalization of the guideline panel&#x2019;s disclosure of interest forms: In January 2020, M.R.J. became part-time chief medical officer for Boston Scientific, for which he receives salary and equity. Embolitech was sold to Surmodics, for which M.R.J. received equity.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>7</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>2</Day><Hour>17</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>10</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33007077</ArticleId><ArticleId IdType="pmc">PMC7556153</ArticleId><ArticleId IdType="doi">10.1182/bloodadvances.2020001830</ArticleId><ArticleId IdType="pii">S2473-9529(20)31203-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aujesky D, Obrosky DS, Stone RA, et al. . Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med. 2005;172(8):1041-1046.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2718410</ArticleId><ArticleId IdType="pubmed">16020800</ArticleId></ArticleIdList></Reference><Reference><Citation>Jim&#xe9;nez D, Aujesky D, Moores L, et al. ; RIETE Investigators. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med. 2010;170(15):1383-1389.</Citation><ArticleIdList><ArticleId IdType="pubmed">20696966</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldwin MJ, Moore HM, Rudarakanchana N, Gohel M, Davies AH. Post-thrombotic syndrome: a clinical review. J Thromb Haemost. 2013;11(5):795-805.</Citation><ArticleIdList><ArticleId IdType="pubmed">23433231</ArticleId></ArticleIdList></Reference><Reference><Citation>Heit JA. Epidemiology of venous thromboembolism. Nat Rev Cardiol. 2015;12(8):464-474.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4624298</ArticleId><ArticleId IdType="pubmed">26076949</ArticleId></ArticleIdList></Reference><Reference><Citation>Delluc A, Le Mao R, Tromeur C, et al. . Incidence of upper-extremity deep vein thrombosis in western France: a community-based study. Haematologica. 2019;104(1):e29-e31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6312028</ArticleId><ArticleId IdType="pubmed">30076179</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant JD, Stevens SM, Woller SC, et al. . Diagnosis and management of upper extremity deep-vein thrombosis in adults. Thromb Haemost. 2012;108(6):1097-1108.</Citation><ArticleIdList><ArticleId IdType="pubmed">23093319</ArticleId></ArticleIdList></Reference><Reference><Citation>Cushman M, Tsai AW, White RH, et al. . Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med. 2004;117(1):19-25.</Citation><ArticleIdList><ArticleId IdType="pubmed">15210384</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang W, Goldberg RJ, Anderson FA, Kiefe CI, Spencer FA. Secular trends in occurrence of acute venous thromboembolism: the Worcester VTE study (1985-2009). Am J Med. 2014;127(9):829-839.e5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4161646</ArticleId><ArticleId IdType="pubmed">24813864</ArticleId></ArticleIdList></Reference><Reference><Citation>Tagalakis V, Patenaude V, Kahn SR, Suissa S. Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE Study Cohort. Am J Med. 2013;126(9):832.e13-832.e21.</Citation><ArticleIdList><ArticleId IdType="pubmed">23830539</ArticleId></ArticleIdList></Reference><Reference><Citation>Baglin T, Luddington R, Brown K, Baglin C. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet. 2003;362(9383):523-526.</Citation><ArticleIdList><ArticleId IdType="pubmed">12932383</ArticleId></ArticleIdList></Reference><Reference><Citation>Boutitie F, Pinede L, Schulman S, et al. . Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants&#x2019; data from seven trials. BMJ. 2011;342:d3036.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3100759</ArticleId><ArticleId IdType="pubmed">21610040</ArticleId></ArticleIdList></Reference><Reference><Citation>Prandoni P, Noventa F, Ghirarduzzi A, et al. . The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients. Haematologica. 2007;92(2):199-205.</Citation><ArticleIdList><ArticleId IdType="pubmed">17296569</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabinovich A, Kahn SR. How I treat the postthrombotic syndrome. Blood. 2018;131(20):2215-2222.</Citation><ArticleIdList><ArticleId IdType="pubmed">29545327</ArticleId></ArticleIdList></Reference><Reference><Citation>Pengo V, Lensing AW, Prins MH, et al. ; Thromboembolic Pulmonary Hypertension Study Group. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med. 2004;350(22):2257-2264.</Citation><ArticleIdList><ArticleId IdType="pubmed">15163775</ArticleId></ArticleIdList></Reference><Reference><Citation>Piran S, Schulman S. Treatment of bleeding complications in patients on anticoagulant therapy. Blood. 2019;133(5):425-435.</Citation><ArticleIdList><ArticleId IdType="pubmed">30559261</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverstein MD, Heit JA, Mohr DN, Petterson TM, O&#x2019;Fallon WM, Melton LJ III. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998;158(6):585-593.</Citation><ArticleIdList><ArticleId IdType="pubmed">9521222</ArticleId></ArticleIdList></Reference><Reference><Citation>Zakai NA, McClure LA, Judd SE, et al. . Racial and regional differences in venous thromboembolism in the United States in 3 cohorts. Circulation. 2014;129(14):1502-1509.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4098668</ArticleId><ArticleId IdType="pubmed">24508826</ArticleId></ArticleIdList></Reference><Reference><Citation>White RH, Zhou H, Romano PS. Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California. Ann Intern Med. 1998;128(9):737-740.</Citation><ArticleIdList><ArticleId IdType="pubmed">9556467</ArticleId></ArticleIdList></Reference><Reference><Citation>Klatsky AL, Armstrong MA, Poggi J. Risk of pulmonary embolism and/or deep venous thrombosis in Asian-Americans. Am J Cardiol. 2000;85(11):1334-1337.</Citation><ArticleIdList><ArticleId IdType="pubmed">10831950</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso-Coello P, Oxman AD, Moberg J, et al. ; GRADE Working Group. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines. BMJ. 2016;353:i2089.</Citation><ArticleIdList><ArticleId IdType="pubmed">27365494</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso-Coello P, Sch&#xfc;nemann HJ, Moberg J, et al. ; GRADE Working Group. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction. BMJ. 2016;353:i2016.</Citation><ArticleIdList><ArticleId IdType="pubmed">27353417</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt G, Oxman AD, Akl EA, et al. . GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383-394.</Citation><ArticleIdList><ArticleId IdType="pubmed">21195583</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, et al. ; GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924-926.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xfc;nemann HJ, Mustafa R, Brozek J, et al. ; GRADE Working Group. GRADE Guidelines: 16. GRADE evidence to decision frameworks for tests in clinical practice and public health. J Clin Epidemiol. 2016;76:89-98.</Citation><ArticleIdList><ArticleId IdType="pubmed">26931285</ArticleId></ArticleIdList></Reference><Reference><Citation>Qaseem A, Forland F, Macbeth F, Ollenschl&#xe4;ger G, Phillips S, van der Wees P; Board of Trustees of the Guidelines International Network. Guidelines International Network: toward international standards for clinical practice guidelines. Ann Intern Med. 2012;156(7):525-531.</Citation><ArticleIdList><ArticleId IdType="pubmed">22473437</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xfc;nemann H. Principles for Disclosure of Interests and Management of Conflicts in Guidelines: Desirable and Undesirable Action and Consequences. Ann Intern Med. 2016;164(10):702.</Citation><ArticleIdList><ArticleId IdType="pubmed">27182911</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham RMM, Wolman DM, Greenfield S, Steinberg E, eds. Clinical Practice Guidelines We Can Trust. Washington, DC: National Academies Press; 2012</Citation><ArticleIdList><ArticleId IdType="pubmed">24983061</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Kunz R, et al. . GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol. 2011;64(4):395-400.</Citation><ArticleIdList><ArticleId IdType="pubmed">21194891</ArticleId></ArticleIdList></Reference><Reference><Citation>Othieno R, Okpo E, Forster R. Home versus in-patient treatment for deep vein thrombosis. Cochrane Database Syst Rev. 2018;1:CD003076.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6491318</ArticleId><ArticleId IdType="pubmed">29315455</ArticleId></ArticleIdList></Reference><Reference><Citation>Boccalon H, Elias A, Chal&#xe9; JJ, Cad&#xe8;ne A, Gabriel S. Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with a low-molecular-weight heparin: the Vascular Midi-Pyrenees study. Arch Intern Med. 2000;160(12):1769-1773.</Citation><ArticleIdList><ArticleId IdType="pubmed">10871969</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong BH, Brighton TA, Baker RI, Thurlow P, Lee CH; ASTH DVT Study Group. Once-daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep-vein thrombosis. J Thromb Thrombolysis. 2005;19(3):173-181.</Citation><ArticleIdList><ArticleId IdType="pubmed">16082604</ArticleId></ArticleIdList></Reference><Reference><Citation>Daskalopoulos ME, Daskalopoulou SS, Tzortzis E, et al. . Long-term treatment of deep venous thrombosis with a low molecular weight heparin (tinzaparin): a prospective randomized trial. Eur J Vasc Endovasc Surg. 2005;29(6):638-650.</Citation><ArticleIdList><ArticleId IdType="pubmed">15878544</ArticleId></ArticleIdList></Reference><Reference><Citation>Koopman MM, Prandoni P, Piovella F, et al. ; The Tasman Study Group. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. N Engl J Med. 1996;334(11):682-687.</Citation><ArticleIdList><ArticleId IdType="pubmed">8594426</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine M, Gent M, Hirsh J, et al. . A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med. 1996;334(11):677-681.</Citation><ArticleIdList><ArticleId IdType="pubmed">8594425</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramacciotti E, Ara&#xfa;jo GR, Lastoria S, et al. ; CLETRAT Investigators. An open-label, comparative study of the efficacy and safety of once-daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep-vein thrombosis. Thromb Res. 2004;114(3):149-153.</Citation><ArticleIdList><ArticleId IdType="pubmed">15342210</ArticleId></ArticleIdList></Reference><Reference><Citation>Romera-Villegas A, Cairols-Castellote MA, Vila-Coll R, et al. . Early mobilisation in patients with acute deep vein thrombosis does not increase the risk of a symptomatic pulmonary embolism. Int Angiol. 2008;27(6):494-499.</Citation><ArticleIdList><ArticleId IdType="pubmed">19078912</ArticleId></ArticleIdList></Reference><Reference><Citation>Lozano F, Trujillo-Santos J, Barr&#xf3;n M, et al. ; RIETE Investigators. Home versus in-hospital treatment of outpatients with acute deep venous thrombosis of the lower limbs. J Vasc Surg. 2014;59(5):1362-1367.e1.</Citation><ArticleIdList><ArticleId IdType="pubmed">24439322</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodger MA, Gagn&#xe9;-Rodger C, Howley HE, Carrier M, Coyle D, Wells PS. The outpatient treatment of deep vein thrombosis delivers cost savings to patients and their families, compared to inpatient therapy. Thromb Res. 2003;112(1-2):13-18.</Citation><ArticleIdList><ArticleId IdType="pubmed">15013267</ArticleId></ArticleIdList></Reference><Reference><Citation>Spyropoulos AC, Frost FJ, Hurley JS, Roberts M. Costs and clinical outcomes associated with low-molecular-weight heparin vs unfractionated heparin for perioperative bridging in patients receiving long-term oral anticoagulant therapy. Chest. 2004;125(5):1642-1650.</Citation><ArticleIdList><ArticleId IdType="pubmed">15136371</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Belt AG, Bossuyt PM, Prins MH, Gallus AS, B&#xfc;ller HR; TASMAN Study Group. Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis&#x2013;an economic evaluation. Thromb Haemost. 1998;79(2):259-263.</Citation><ArticleIdList><ArticleId IdType="pubmed">9493572</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodger M, Bredeson C, Wells PS, Beck J, Kearns B, Huebsch LB. Cost-effectiveness of low-molecular-weight heparin and unfractionated heparin in treatment of deep vein thrombosis. CMAJ. 1998;159(8):931-938.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1229738</ArticleId><ArticleId IdType="pubmed">9834718</ArticleId></ArticleIdList></Reference><Reference><Citation>Frank D, Bl&#xe4;ttler W. Comparison of ambulatory and inpatient treatment of acute deep venous thrombosis of the leg: subjective and economic aspects [in German]. Schweiz Med Wochenschr. 1998;128(36):1328-1333.</Citation><ArticleIdList><ArticleId IdType="pubmed">9784675</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Brien B, Levine M, Willan A, et al. . Economic evaluation of outpatient treatment with low-molecular-weight heparin for proximal vein thrombosis. Arch Intern Med. 1999;159(19):2298-2304.</Citation><ArticleIdList><ArticleId IdType="pubmed">10547169</ArticleId></ArticleIdList></Reference><Reference><Citation>Santamar&#xed;a A, Ju&#xe1;rez S, Reche A, G&#xf3;mez-Outes A, Mart&#xed;nez-Gonz&#xe1;lez J, Fontcuberta J; ESFERA Investigators. Low-molecular-weight heparin, bemiparin, in the outpatient treatment and secondary prophylaxis of venous thromboembolism in standard clinical practice: the ESFERA Study. Int J Clin Pract. 2006;60(5):518-525.</Citation><ArticleIdList><ArticleId IdType="pubmed">16700847</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith BJ, Weekley JS, Pilotto L, Howe T, Beven R. Cost comparison of at-home treatment of deep venous thrombosis with low molecular weight heparin to inpatient treatment with unfractionated heparin. Intern Med J. 2002;32(1-2):29-34.</Citation><ArticleIdList><ArticleId IdType="pubmed">11783670</ArticleId></ArticleIdList></Reference><Reference><Citation>Misky GJ, Manheim JC, Zehnder N, et al. . Health care disparities in the acute management of venous thromboembolism based on insurance status in the U.S. J Thromb Thrombolysis. 2011;32(4):393-398.</Citation><ArticleIdList><ArticleId IdType="pubmed">21877234</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider D, Lilienfeld DE, Im W. The epidemiology of pulmonary embolism: racial contrasts in incidence and in-hospital case fatality. J Natl Med Assoc. 2006;98(12):1967-1972.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2569672</ArticleId><ArticleId IdType="pubmed">17225843</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal S, Clark D III, Sud K, Jaber WA, Cho L, Menon V. Gender disparities in outcomes and resource utilization for acute pulmonary embolism hospitalizations in the United States. Am J Cardiol. 2015;116(8):1270-1276.</Citation><ArticleIdList><ArticleId IdType="pubmed">26341183</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanemaaijer S, Sodihardjo F, Horikx A, et al. . Trends in antithrombotic drug use and adherence to non-vitamin K oral anticoagulants in the Netherlands. Int J Clin Pharm. 2015;37(6):1128-1135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4619456</ArticleId><ArticleId IdType="pubmed">26243531</ArticleId></ArticleIdList></Reference><Reference><Citation>Douketis JD. Treatment of deep vein thrombosis: what factors determine appropriate treatment? Can Fam Physician. 2005;51:217-223.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1472974</ArticleId><ArticleId IdType="pubmed">15751565</ArticleId></ArticleIdList></Reference><Reference><Citation>Zondag W, Kooiman J, Klok FA, Dekkers OM, Huisman MV. Outpatient versus inpatient treatment in patients with pulmonary embolism: a meta-analysis. Eur Respir J. 2013;42(1):134-144.</Citation><ArticleIdList><ArticleId IdType="pubmed">23100493</ArticleId></ArticleIdList></Reference><Reference><Citation>Piran S, Le Gal G, Wells PS, et al. . Outpatient treatment of symptomatic pulmonary embolism: a systematic review and meta-analysis. Thromb Res. 2013;132(5):515-519.</Citation><ArticleIdList><ArticleId IdType="pubmed">24035045</ArticleId></ArticleIdList></Reference><Reference><Citation>Squizzato A, Galli M, Dentali F, Ageno W. Outpatient treatment and early discharge of symptomatic pulmonary embolism: a systematic review. Eur Respir J. 2009;33(5):1148-1155.</Citation><ArticleIdList><ArticleId IdType="pubmed">19407049</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinson DR, Zehtabchi S, Yealy DM. Can selected patients with newly diagnosed pulmonary embolism be safely treated without hospitalization? A systematic review. Ann Emerg Med. 2012;60(5):651-662.e4.</Citation><ArticleIdList><ArticleId IdType="pubmed">22944455</ArticleId></ArticleIdList></Reference><Reference><Citation>Janjua M, Badshah A, Matta F, Danescu LG, Yaekoub AY, Stein PD. Treatment of acute pulmonary embolism as outpatients or following early discharge. A systematic review. Thromb Haemost. 2008;100(5):756-761.</Citation><ArticleIdList><ArticleId IdType="pubmed">18989517</ArticleId></ArticleIdList></Reference><Reference><Citation>Aujesky D, Roy PM, Verschuren F, et al. . Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial. Lancet. 2011;378(9785):41-48.</Citation><ArticleIdList><ArticleId IdType="pubmed">21703676</ArticleId></ArticleIdList></Reference><Reference><Citation>Peacock WF, Coleman CI, Diercks DB, et al. . Emergency department discharge of pulmonary embolus patients. Acad Emerg Med. 2018;25(9):995-1003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6175358</ArticleId><ArticleId IdType="pubmed">29757489</ArticleId></ArticleIdList></Reference><Reference><Citation>Beer JH, Burger M, Gretener S, Bernard-Bagattini S, Bounameaux H. Outpatient treatment of pulmonary embolism is feasible and safe in a substantial proportion of patients. J Thromb Haemost. 2003;1(1):186-187.</Citation><ArticleIdList><ArticleId IdType="pubmed">12871557</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez-Cerrillo M, Alvarez-Arcaya A, Fern&#xe1;ndez-D&#xed;az E, Fern&#xe1;ndez-Cruz A. A prospective study of the management of non-massive pulmonary embolism in the home. Eur J Intern Med. 2009;20(6):598-600.</Citation><ArticleIdList><ArticleId IdType="pubmed">19782920</ArticleId></ArticleIdList></Reference><Reference><Citation>Siragusa S, Arcara C, Malato A, et al. . Home therapy for deep vein thrombosis and pulmonary embolism in cancer patients. Ann Oncol. 2005;16(Suppl 4):iv136-iv139.</Citation><ArticleIdList><ArticleId IdType="pubmed">15923414</ArticleId></ArticleIdList></Reference><Reference><Citation>Peacock WF, Singer AJ. Reducing the hospital burden associated with the treatment of pulmonary embolism. J Thromb Haemost. 2019;17(5):720-736.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6849869</ArticleId><ArticleId IdType="pubmed">30851227</ArticleId></ArticleIdList></Reference><Reference><Citation>Adam SS, McDuffie JR, Ortel TL, Williams JW Jr. Comparative effectiveness of warfarin and new oral anticoagulants for the management of atrial fibrillation and venous thromboembolism: a systematic review. Ann Intern Med. 2012;157(11):796-807.</Citation><ArticleIdList><ArticleId IdType="pubmed">22928173</ArticleId></ArticleIdList></Reference><Reference><Citation>Almutairi AR, Zhou L, Gellad WF, et al. . Effectiveness and safety of non-vitamin K antagonist oral anticoagulants for atrial fibrillation and venous thromboembolism: a systematic review and meta-analyses. Clin Ther. 2017;39(7):1456-1478.e36.</Citation><ArticleIdList><ArticleId IdType="pubmed">28668628</ArticleId></ArticleIdList></Reference><Reference><Citation>Canadian Agency for Drugs and Technologies in Health. Rivaroxaban (Xarelto): treatment of venous thromboembolic events (deep vein thrombosis [DVT], pulmonary embolism [PE]) and prevention of recurrent DVT and PE. Available at: https://www.ncbi.nlm.nih.gov/books/NBK344331/. Accessed 15 July 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">26913324</ArticleId></ArticleIdList></Reference><Reference><Citation>Castellucci LA, Cameron C, Le Gal G, et al. . Clinical and safety outcomes associated with treatment of acute venous thromboembolism: a systematic review and meta-analysis. JAMA. 2014;312(11):1122-1135.</Citation><ArticleIdList><ArticleId IdType="pubmed">25226478</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen AT, Hamilton M, Mitchell SA, et al. . Comparison of the novel oral anticoagulants apixaban, dabigatran, edoxaban, and rivaroxaban in the initial and long-term treatment and prevention of venous thromboembolism: systematic review and network meta-analysis. PLoS One. 2015;10(12):e0144856.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4696796</ArticleId><ArticleId IdType="pubmed">26716830</ArticleId></ArticleIdList></Reference><Reference><Citation>Dentali F, Di Minno MN, Gianni M, Ambrosino P, Squizzato A, Ageno W. Non-vitamin K oral anticoagulants in patients with pulmonary embolism: a systematic review and meta-analysis of the literature. Intern Emerg Med. 2015;10(4):507-514.</Citation><ArticleIdList><ArticleId IdType="pubmed">25982918</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Minno MN, Ambrosino P, Lupoli R, Di Minno A, Dentali F. Direct oral anticoagulants for the treatment of unprovoked venous thromboembolism: a meta-analysis of randomised controlled trials. Blood Transfus. 2015;13(3):391-395.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4614289</ArticleId><ArticleId IdType="pubmed">25545875</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox BD, Kahn SR, Langleben D, Eisenberg MJ, Shimony A. Efficacy and safety of novel oral anticoagulants for treatment of acute venous thromboembolism: direct and adjusted indirect meta-analysis of randomised controlled trials. BMJ. 2012;345(7884):e7498.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3496553</ArticleId><ArticleId IdType="pubmed">23150473</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganji R, Ala S, Aarabi M, Baghery B, Salehifar E. Comparison of dabigatran vs. warfarin in acute venous thromboemboly: systematic review. Iran J Pharm Res. 2016;15(2):611-617.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5018290</ArticleId><ArticleId IdType="pubmed">27642333</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez-Outes A, Su&#xe1;rez-Gea ML, Lecumberri R, Terleira-Fern&#xe1;ndez AI, Vargas-Castrill&#xf3;n E. Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: an evidence-based review. Vasc Health Risk Manag. 2014;10:627-639.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4230169</ArticleId><ArticleId IdType="pubmed">25404858</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez-Outes A, Terleira-Fern&#xe1;ndez AI, Lecumberri R, Su&#xe1;rez-Gea ML, Vargas-Castrill&#xf3;n E. Direct oral anticoagulants in the treatment of acute venous thromboembolism: a systematic review and meta-analysis. Thromb Res. 2014;134(4):774-782.</Citation><ArticleIdList><ArticleId IdType="pubmed">25037495</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirschl M, Kundi M. New oral anticoagulants in the treatment of acute venous thromboembolism - a systematic review with indirect comparisons [published correction appears in Vasa. 2014;43(6):477]. Vasa. 2014;43(5):353-364.</Citation><ArticleIdList><ArticleId IdType="pubmed">25147012</ArticleId></ArticleIdList></Reference><Reference><Citation>Kakkos SK, Kirkilesis GI, Tsolakis IA. Editor's Choice - efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials. Eur J Vasc Endovasc Surg. 2014;48(5):565-575.</Citation><ArticleIdList><ArticleId IdType="pubmed">24951377</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang N, Sobieraj DM. Indirect treatment comparison of new oral anticoagulants for the treatment of acute venous thromboembolism. Thromb Res. 2014;133(6):1145-1151.</Citation><ArticleIdList><ArticleId IdType="pubmed">24713109</ArticleId></ArticleIdList></Reference><Reference><Citation>Loffredo L, Perri L, Del Ben M, Angelico F, Violi F. New oral anticoagulants for the treatment of acute venous thromboembolism: are they safer than vitamin K antagonists? A meta-analysis of the interventional trials. Intern Emerg Med. 2015;10(4):499-506.</Citation><ArticleIdList><ArticleId IdType="pubmed">25539954</ArticleId></ArticleIdList></Reference><Reference><Citation>Mumoli N, Cei M, Pesavento R, Campanini M, Dentali F. Are direct oral anticoagulants equally effective in reducing deep vein thrombosis and pulmonary embolism? Int J Cardiol. 2015;187:645-647.</Citation><ArticleIdList><ArticleId IdType="pubmed">25863742</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrov VI, Shatalova OV, Gorbatenko VS, Smuseva ON, Maslakov AS. Efficacy and safety of the new oral anticoagulants in the treatment of venous thromboembolic complications: meta-analysis. Rational Pharmacotherapy in Cardiology. 2016;12(1):31-39.</Citation></Reference><Reference><Citation>Robertson L, Kesteven P, McCaslin JE. Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of deep vein thrombosis. Cochrane Database Syst Rev. 2015;(6):CD010956.</Citation><ArticleIdList><ArticleId IdType="pubmed">26123214</ArticleId></ArticleIdList></Reference><Reference><Citation>Robertson L, Kesteven P, McCaslin JE. Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of pulmonary embolism. Cochrane Database Syst Rev. 2015;(12):CD010957.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6463831</ArticleId><ArticleId IdType="pubmed">26636644</ArticleId></ArticleIdList></Reference><Reference><Citation>Senoo K, Kondo Y, Miyazawa K, Isogai T, Chun YH, Kobayashi Y. Safety and efficacy of direct oral anticoagulants over warfarin in Japanese patients with acute venous thromboembolism: A meta-analysis. J Cardiol. 2017;69(5):763-768.</Citation><ArticleIdList><ArticleId IdType="pubmed">27502316</ArticleId></ArticleIdList></Reference><Reference><Citation>Tahir F, Riaz H, Riaz T, et al. . The new oral anti-coagulants and the phase 3 clinical trials - a systematic review of the literature. Thromb J. 2013;11(1):18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3766654</ArticleId><ArticleId IdType="pubmed">24007323</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Hulle T, Kooiman J, den Exter PL, Dekkers OM, Klok FA, Huisman MV. Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis. J Thromb Haemost. 2014;12(3):320-328.</Citation><ArticleIdList><ArticleId IdType="pubmed">24330006</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es N, Coppens M, Schulman S, Middeldorp S, B&#xfc;ller HR. Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials. Blood. 2014;124(12):1968-1975.</Citation><ArticleIdList><ArticleId IdType="pubmed">24963045</ArticleId></ArticleIdList></Reference><Reference><Citation>Vedovati MC, Becattini C, Germini F, Agnelli G. Efficacy and safety of direct oral anticoagulants after pulmonary embolism: a meta-analysis. Int J Cardiol. 2014;177(2):601-603.</Citation><ArticleIdList><ArticleId IdType="pubmed">25217215</ArticleId></ArticleIdList></Reference><Reference><Citation>Agnelli G, Buller HR, Cohen A, et al. ; AMPLIFY Investigators. Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med. 2013;369(9):799-808.</Citation><ArticleIdList><ArticleId IdType="pubmed">23808982</ArticleId></ArticleIdList></Reference><Reference><Citation>Agnelli G, Gallus A, Goldhaber SZ, et al. ; ODIXa-DVT Study Investigators. Treatment of proximal deep-vein thrombosis with the oral direct factor Xa inhibitor rivaroxaban (BAY 59-7939): the ODIXa-DVT (Oral Direct Factor Xa Inhibitor BAY 59-7939 in Patients With Acute Symptomatic Deep-Vein Thrombosis) study. Circulation. 2007;116(2):180-187.</Citation><ArticleIdList><ArticleId IdType="pubmed">17576867</ArticleId></ArticleIdList></Reference><Reference><Citation>EINSTEIN Investigators; Bauersachs R, Berkowitz SD, Brenner B, et al. . Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med. 2010;363(26):2499-2510.</Citation><ArticleIdList><ArticleId IdType="pubmed">21128814</ArticleId></ArticleIdList></Reference><Reference><Citation>Botticelli Investigators, Writing Committee; Buller H, Deitchman D, Prins M, Segers A. Efficacy and safety of the oral direct factor Xa inhibitor apixaban for symptomatic deep vein thrombosis. The Botticelli DVT dose-ranging study. J Thromb Haemost. 2008;6(8):1313-1318.</Citation><ArticleIdList><ArticleId IdType="pubmed">18541000</ArticleId></ArticleIdList></Reference><Reference><Citation>Hokusai-VTE Investigators; B&#xfc;ller HR, D&#xe9;cousus H, Grosso MA, et al. . Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. N Engl J Med. 2013;369(15):1406-1415.</Citation><ArticleIdList><ArticleId IdType="pubmed">23991658</ArticleId></ArticleIdList></Reference><Reference><Citation>Buller HR, Lensing AW, Prins MH, et al. ; Einstein-DVT Dose-Ranging Study Investigators. A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging Study. Blood. 2008;112(6):2242-2247.</Citation><ArticleIdList><ArticleId IdType="pubmed">18621928</ArticleId></ArticleIdList></Reference><Reference><Citation>EINSTEIN&#x2013;PE Investigators; B&#xfc;ller HR, Prins MH, Lensin AW, et al. ; Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med. 2012;366(14):1287-1297.</Citation><ArticleIdList><ArticleId IdType="pubmed">22449293</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura M, Nishikawa M, Komuro I, et al. . Apixaban for the treatment of Japanese subjects with acute venous thromboembolism (AMPLIFY-J Study). Circ J. 2015;79(6):1230-1236.</Citation><ArticleIdList><ArticleId IdType="pubmed">25912695</ArticleId></ArticleIdList></Reference><Reference><Citation>Piazza G, Mani V, Goldhaber SZ, et al. Magnetic resonance venography to assess thrombus resolution with edoxaban monotherapy versus parenteral anticoagulation/warfarin for symptomatic deep vein thrombosis: a multicenter feasibility study. Vasc Med. 2016;21(4):361-368.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4963800</ArticleId><ArticleId IdType="pubmed">27165711</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulman S, Kakkar AK, Goldhaber SZ, et al. ; RE-COVER II Trial Investigators. Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis. Circulation. 2014;129(7):764-772.</Citation><ArticleIdList><ArticleId IdType="pubmed">24344086</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulman S, Kearon C, Kakkar AK, et al. ; RE-COVER Study Group. Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med. 2009;361(24):2342-2352.</Citation><ArticleIdList><ArticleId IdType="pubmed">19966341</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada N, Hirayama A, Maeda H, et al. . Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism - the J-EINSTEIN DVT and PE program [published correction appears in Thromb J. 2016;214:11]. Thromb J. 2015;13(1):2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4339301</ArticleId><ArticleId IdType="pubmed">25717286</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrier M, Le Gal G, Wells PS, Rodger MA. Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism. Ann Intern Med. 2010;152(9):578-589.</Citation><ArticleIdList><ArticleId IdType="pubmed">20439576</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin A, Bruno A, Trocio J, Lin J, Lingohr-Smith M. Real-world medical cost avoidance when new oral anticoagulants are used versus warfarin for venous thromboembolism in the United States. Clin Appl Thromb Hemost. 2016;22(1):5-11.</Citation><ArticleIdList><ArticleId IdType="pubmed">25993994</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin A, Jing Y, Trocio J, Lin J, Lingohr-Smith M, Graham J. Evaluation of medical costs associated with use of new oral anticoagulants compared with standard therapy among venous thromboembolism patients. J Med Econ. 2014;17(11):763-770.</Citation><ArticleIdList><ArticleId IdType="pubmed">25078794</ArticleId></ArticleIdList></Reference><Reference><Citation>Margolis JM, Deitelzweig S, Kline J, et al. . Pulmonary embolism inpatients treated with rivaroxaban had shorter hospital stays and lower costs compared with warfarin. Clin Ther. 2016;38(11):2496-2503.</Citation><ArticleIdList><ArticleId IdType="pubmed">27751675</ArticleId></ArticleIdList></Reference><Reference><Citation>Weeda ER, Kohn CG, Peacock WF, et al. . Rivaroxaban versus heparin bridging to warfarin therapy: impact on hospital length of stay and treatment costs for low-risk patients with pulmonary embolism. Pharmacotherapy. 2016;36(10):1109-1115.</Citation><ArticleIdList><ArticleId IdType="pubmed">27548074</ArticleId></ArticleIdList></Reference><Reference><Citation>Courtney W, Groarke E, Conway J, et al. . A direct oral anticoagulant as a cost effective alternative to warfarin for treatment of provoked venous thrombosis. Ir Med J. 2016;109(9):466.</Citation><ArticleIdList><ArticleId IdType="pubmed">28125180</ArticleId></ArticleIdList></Reference><Reference><Citation>Bamber L, Muston D, McLeod E, Guillermin A, Lowin J, Patel R. Cost-effectiveness analysis of treatment of venous thromboembolism with rivaroxaban compared with combined low molecular weight heparin/vitamin K antagonist. Thromb J. 2015;13(1):20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4464718</ArticleId><ArticleId IdType="pubmed">26074735</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimenez D, Jimenez S, Martinez-Lopez I, et al. . Cost-effectiveness of rivaroxaban in the treatment of venous thromboembolism in Spain. Pharmacoeconomics - Spanish Research Articles. 2015;12(4):147-156.</Citation></Reference><Reference><Citation>Jugrin AV, Ustyugova A, Urbich M, Lamotte M, Sunderland T. The cost-utility of dabigatran etexilate compared with warfarin in treatment and extended anticoagulation of acute VTE in the UK. Thromb Haemost. 2015;114(4):778-792.</Citation><ArticleIdList><ArticleId IdType="pubmed">26272227</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanitis T, Leipold R, Hamilton M, et al. . Cost-effectiveness of apixaban versus other oral anticoagulants for the initial treatment of venous thromboembolism and prevention of recurrence. Clin Ther. 2016;38(3):478-493.e1-16.</Citation><ArticleIdList><ArticleId IdType="pubmed">26922297</ArticleId></ArticleIdList></Reference><Reference><Citation>Law S, Ghag D, Grafstein E, Stenstrom R, Harris D. A pharmacoeconomic study of traditional anticoagulation versus direct oral anticoagulation for the treatment of venous thromboembolism in the emergency department. CJEM. 2016;18(5):340-348.</Citation><ArticleIdList><ArticleId IdType="pubmed">27618975</ArticleId></ArticleIdList></Reference><Reference><Citation>Lefebvre P, Coleman CI, Bookhart BK, et al. . Cost-effectiveness of rivaroxaban compared with enoxaparin plus a vitamin K antagonist for the treatment of venous thromboembolism. J Med Econ. 2014;17(1):52-64.</Citation><ArticleIdList><ArticleId IdType="pubmed">24156243</ArticleId></ArticleIdList></Reference><Reference><Citation>Maervoet J, Verhamme P, Hainaut P, et al. . Cost effectiveness of rivaroxaban versus low molecular weight heparin and vitamin K antagonists for the treatment of deep-vein thrombosis in the Belgian healthcare setting. Eur J Cardiovasc Med. 2015;3(1):452-461.</Citation></Reference><Reference><Citation>Preblick R, Kwong WJ, White RH, Goldhaber SZ. Cost-effectiveness of edoxaban for the treatment of venous thromboembolism based on the Hokusai-VTE study. Hosp Prac (1995). 2015;43(5):249-257.</Citation><ArticleIdList><ArticleId IdType="pubmed">26549305</ArticleId></ArticleIdList></Reference><Reference><Citation>Quon P, Le HH, Raymond V, Mtibaa M, Moshyk A. Clinical and economic benefits of extended treatment with apixaban for the treatment and prevention of recurrent venous thromboembolism in Canada. J Med Econ. 2016;19(6):557-567.</Citation><ArticleIdList><ArticleId IdType="pubmed">26761644</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudakova AV. Cost-effectiveness of new oral anticoagulants in the treatment and secondary prevention of venous thromboembolism. Rational Pharmacotherapy in Cardiology. 2015;11(5):496-503.</Citation></Reference><Reference><Citation>Santos IF, Pereira S, McLeod E, Guillermin AL, Chatzitheofilou I. Economic analysis of rivaroxaban for the treatment and long-term prevention of venous thromboembolism in Portugal. Acta Med Port. 2014;27(5):615-624.</Citation><ArticleIdList><ArticleId IdType="pubmed">25409218</ArticleId></ArticleIdList></Reference><Reference><Citation>Seaman CD, Smith KJ, Ragni MV. Cost-effectiveness of rivaroxaban versus warfarin anticoagulation for the prevention of recurrent venous thromboembolism: a U.S. perspective. Thromb Res. 2013;132(6):647-651.</Citation><ArticleIdList><ArticleId IdType="pubmed">24139508</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevanovic J, De Jong LA, Kappelhoff BS, Dvortsin EP, Voorhaar M, Postma MJ. Dabigatran for the treatment and secondary prevention of venous thromboembolism; a cost-effectiveness analysis for the Netherlands. PLoS ONE. 2016;11(10):e0163550.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5077099</ArticleId><ArticleId IdType="pubmed">27776137</ArticleId></ArticleIdList></Reference><Reference><Citation>Witt DM, Nieuwlaat R, Clark NP, et al. . American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy. Blood Adv. 2018;2(22):3257-3291.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6258922</ArticleId><ArticleId IdType="pubmed">30482765</ArticleId></ArticleIdList></Reference><Reference><Citation>Millar CM, Laffan MA. Drug therapy in anticoagulation: which drug for which patient [published correction appears in Clin Med (Lond). 2017;17(4):347-349]? Clin Med (Lond). 2017;17(3):233-244.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6297571</ArticleId><ArticleId IdType="pubmed">28572224</ArticleId></ArticleIdList></Reference><Reference><Citation>Alesh I, Kayali F, Stein PD. Catheter-directed thrombolysis (intrathrombus injection) in treatment of deep venous thrombosis: a systematic review. Catheter Cardiovasc Interv. 2007;70(1):143-148.</Citation><ArticleIdList><ArticleId IdType="pubmed">17377992</ArticleId></ArticleIdList></Reference><Reference><Citation>Broholm R, Panduro Jensen L, Baekgaard N.. Catheter-directed thrombolysis in the treatment of iliofemoral venous thrombosis. A review. Int Angiol. 2010;29(4):292-302.</Citation><ArticleIdList><ArticleId IdType="pubmed">20671646</ArticleId></ArticleIdList></Reference><Reference><Citation>Casey ET, Murad MH, Zumaeta-Garcia M, et al. . Treatment of acute iliofemoral deep vein thrombosis. J Vasc Surg. 2012;55(5):1463-1473.</Citation><ArticleIdList><ArticleId IdType="pubmed">22440631</ArticleId></ArticleIdList></Reference><Reference><Citation>Du GC, Zhang MC, Zhao JC. Catheter-directed thrombolysis plus anticoagulation versus anticoagulation alone in the treatment of proximal deep vein thrombosis - a meta-analysis. Vasa. 2015;44(3):195-202.</Citation><ArticleIdList><ArticleId IdType="pubmed">26098323</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldhaber SZ, Buring JE, Lipnick RJ, Hennekens CH. Pooled analyses of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosis. Am J Med. 1984;76(3):393-397.</Citation><ArticleIdList><ArticleId IdType="pubmed">6367454</ArticleId></ArticleIdList></Reference><Reference><Citation>Karthikesalingam A, Young EL, Hinchliffe RJ, Loftus IM, Thompson MM, Holt PJ. A systematic review of percutaneous mechanical thrombectomy in the treatment of deep venous thrombosis. Eur J Vasc Endovasc Surg. 2011;41(4):554-565.</Citation><ArticleIdList><ArticleId IdType="pubmed">21288745</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng CM, Rivera JO. Meta-analysis of streptokinase and heparin in deep vein thrombosis. Am J Health Syst Pharm. 1998;55(19):1995-2001.</Citation><ArticleIdList><ArticleId IdType="pubmed">9784786</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson L, Broderick C, Armon MP. Thrombolysis for acute deep vein thrombosis. Cochrane Database Syst Rev. 2016;(11):CD002783.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6464997</ArticleId><ArticleId IdType="pubmed">27830895</ArticleId></ArticleIdList></Reference><Reference><Citation>Elbasty A, Metcalf J.. Safety and efficacy of catheter direct thrombolysis in management of acute iliofemoral deep vein thrombosis: a systematic review. Vasc Specialist Int. 2017;33(4):121-134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5754069</ArticleId><ArticleId IdType="pubmed">29354622</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Chuanlin Z, Shaoyu M, Yeh CH, Liqun C, Zeju Z. Catheter-directed thrombolysis for patients with acute lower extremity deep vein thrombosis: a meta-analysis. Rev Lat Am Enfermagem. 2018;26:e2990.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6047892</ArticleId><ArticleId IdType="pubmed">29947719</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas M, Hollingsworth A, Mofidi R.. Endovascular management of acute lower limb deep vein thrombosis: a systematic review and meta-analysis. Ann Vasc Surg. 2019;58:363-370.</Citation><ArticleIdList><ArticleId IdType="pubmed">30769054</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnesen H, Heilo A, Jakobsen E, Ly B, Skaga E. A prospective study of streptokinase and heparin in the treatment of deep vein thrombosis. Acta Med Scand. 1978;203(6):457-463.</Citation><ArticleIdList><ArticleId IdType="pubmed">352099</ArticleId></ArticleIdList></Reference><Reference><Citation>Common HH, Seaman AJ, R&#xf6;sch J, Porter JM, Dotter CT. Deep vein thrombosis treated with streptokinase or heparin. Follow-up of a randomized study. Angiology. 1976;27(11):645-654.</Citation><ArticleIdList><ArticleId IdType="pubmed">802925</ArticleId></ArticleIdList></Reference><Reference><Citation>Elliot MS, Immelman EJ, Jeffery P, et al. . A comparative randomized trial of heparin versus streptokinase in the treatment of acute proximal venous thrombosis: an interim report of a prospective trial. Br J Surg. 1979;66(12):838-843.</Citation><ArticleIdList><ArticleId IdType="pubmed">389338</ArticleId></ArticleIdList></Reference><Reference><Citation>Elsharawy M, Elzayat E. Early results of thrombolysis vs anticoagulation in iliofemoral venous thrombosis. A randomised clinical trial. Eur J Vasc Endovasc Surg. 2002;24(3):209-214.</Citation><ArticleIdList><ArticleId IdType="pubmed">12217281</ArticleId></ArticleIdList></Reference><Reference><Citation>Enden T, Haig Y, Kl&#xf8;w NE, et al. ; CaVenT Study Group. Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. Lancet. 2012;379(9810):31-38.</Citation><ArticleIdList><ArticleId IdType="pubmed">22172244</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldhaber SZ, Hirsch DR, MacDougall RC, Polak JF, Creager MA. Bolus recombinant urokinase versus heparin in deep venous thrombosis: a randomized controlled trial. Am Heart J. 1996;132(2 Pt 1):314-318.</Citation><ArticleIdList><ArticleId IdType="pubmed">8701892</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldhaber SZ, Meyerovitz MF, Green D, et al. . Randomized controlled trial of tissue plasminogen activator in proximal deep venous thrombosis. Am J Med. 1990;88(3):235-240.</Citation><ArticleIdList><ArticleId IdType="pubmed">2106783</ArticleId></ArticleIdList></Reference><Reference><Citation>Kakkar VV, Flanc C, Howe CT, O&#x2019;Shea M, Flute PT. Treatment of deep vein thrombosis. A trial of heparin, streptokinase, and arvin. BMJ. 1969;1(5647):806-810.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1982504</ArticleId><ArticleId IdType="pubmed">4886628</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiil J, Carvalho A, Saks&#xf8; P, Nielsen HO. Urokinase or heparin in the management of patients with deep vein thrombosis? Acta Chir Scand. 1981;147(7):529-532.</Citation><ArticleIdList><ArticleId IdType="pubmed">7048826</ArticleId></ArticleIdList></Reference><Reference><Citation>Marder VJ, Soulen RL, Atichartakarn V, et al. . Quantitative venographic assessment of deep vein thrombosis in the evaluation of streptokinase and heparin therapy. J Lab Clin Med. 1977;89(5):1018-1029.</Citation><ArticleIdList><ArticleId IdType="pubmed">323387</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulman S, Granqvist S, Juhlin-Dannfelt A, Lockner D. Long-term sequelae of calf vein thrombosis treated with heparin or low-dose streptokinase. Acta Med Scand. 1986;219(4):349-357.</Citation><ArticleIdList><ArticleId IdType="pubmed">3521207</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweizer J, Elix H, Altmann E, Hellner G, Forkmann L. Comparative results of thrombolysis treatment with rt-PA and urokinase: a pilot study. Vasa. 1998;27(3):167-171.</Citation><ArticleIdList><ArticleId IdType="pubmed">9747153</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweizer J, Kirch W, Koch R, et al. . Short- and long-term results after thrombolytic treatment of deep venous thrombosis. J Am Coll Cardiol. 2000;36(4):1336-1343.</Citation><ArticleIdList><ArticleId IdType="pubmed">11028492</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsapogas MJ, Peabody RA, Wu KT, Karmody AM, Devaraj KT, Eckert C. Controlled study of thrombolytic therapy in deep vein thrombosis. Surgery. 1973;74(6):973-984.</Citation><ArticleIdList><ArticleId IdType="pubmed">4749637</ArticleId></ArticleIdList></Reference><Reference><Citation>Turpie AG, Levine MN, Hirsh J, et al. . Tissue plasminogen activator (rt-PA) vs heparin in deep vein thrombosis. Results of a randomized trial. Chest. 1990;97(4 suppl):172S-175S.</Citation><ArticleIdList><ArticleId IdType="pubmed">2108855</ArticleId></ArticleIdList></Reference><Reference><Citation>Ugurlu B, Kazaz H, Oto O, Hazan E, Sariosmano&#x11f;lu N. Low dose systemic thrombolytic therapy for treatment of deep venous thrombosis. J Cardiovasc Surg (Torino). 2002;43(6):881-885.</Citation><ArticleIdList><ArticleId IdType="pubmed">12483184</ArticleId></ArticleIdList></Reference><Reference><Citation>Vedantham S, Goldhaber SZ, Julian JA, et al. ; ATTRACT Trial Investigators. Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis. N Engl J Med. 2017;377(23):2240-2252.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5763501</ArticleId><ArticleId IdType="pubmed">29211671</ArticleId></ArticleIdList></Reference><Reference><Citation>Verhaeghe R, Besse P, Bounameaux H, Marbet GA. Multicenter pilot study of the efficacy and safety of systemic rt-PA administration in the treatment of deep vein thrombosis of the lower extremities and/or pelvis. Thromb Res. 1989;55(1):5-11.</Citation><ArticleIdList><ArticleId IdType="pubmed">2506661</ArticleId></ArticleIdList></Reference><Reference><Citation>Su SF, Tian YF, Chen LB, Yan B. Comparison of therapeutic efficacy of anticoagulation and its combination with catheter-directed thrombolysis for deep venous thrombosis of lower extremities [in Chinese]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017;25(5):1509-1513.</Citation><ArticleIdList><ArticleId IdType="pubmed">29070134</ArticleId></ArticleIdList></Reference><Reference><Citation>Roumen-Klappe EM, den Heijer M, Janssen MC, van der Vleuten C, Thien T, Wollersheim H. The post-thrombotic syndrome: incidence and prognostic value of non-invasive venous examinations in a six-year follow-up study. Thromb Haemost. 2005;94(4):825-830.</Citation><ArticleIdList><ArticleId IdType="pubmed">16270638</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn SR, Kearon C, Julian JA, et al. ; Extended Low-intensity Anticoagulation for Thrombo-embolism (ELATE) Investigators. Predictors of the post-thrombotic syndrome during long-term treatment of proximal deep vein thrombosis. J Thromb Haemost. 2005;3(4):718-723.</Citation><ArticleIdList><ArticleId IdType="pubmed">15733061</ArticleId></ArticleIdList></Reference><Reference><Citation>Agnelli G, Becattini C, Kirschstein T. Thrombolysis vs heparin in the treatment of pulmonary embolism: a clinical outcome-based meta-analysis. Arch Intern Med. 2002;162(22):2537-2541.</Citation><ArticleIdList><ArticleId IdType="pubmed">12456225</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson DR, Levine MN. Thrombolytic therapy for the treatment of acute pulmonary embolism. CMAJ. 1992;146(8):1317-1324.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1488554</ArticleId><ArticleId IdType="pubmed">1555162</ArticleId></ArticleIdList></Reference><Reference><Citation>Arcasoy SM, Kreit JW. Thrombolytic therapy of pulmonary embolism: a comprehensive review of current evidence. Chest. 1999;115(6):1695-1707.</Citation><ArticleIdList><ArticleId IdType="pubmed">10378570</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloomer TL, El-Hayek GE, McDaniel MC, et al. . Safety of catheter-directed thrombolysis for massive and submassive pulmonary embolism: results of a multicenter registry and meta-analysis. Catheter Cardiovasc Interv. 2017;89(4):754-760.</Citation><ArticleIdList><ArticleId IdType="pubmed">28145042</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y, Zhao H, Gao W, Wang Y, Cao J. Systematic review and meta-analysis for thrombolysis treatment in patients with acute submassive pulmonary embolism. Patient Prefer Adherence. 2014;8:275-282.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3945048</ArticleId><ArticleId IdType="pubmed">24611003</ArticleId></ArticleIdList></Reference><Reference><Citation>Capstick T, Henry MT. Efficacy of thrombolytic agents in the treatment of pulmonary embolism. Eur Resp J. 2005;26(5):864-874.</Citation><ArticleIdList><ArticleId IdType="pubmed">16264048</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee S, Chakraborty A, Weinberg I, et al. . Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis. JAMA. 2014;311(23):2414-2421.</Citation><ArticleIdList><ArticleId IdType="pubmed">24938564</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H, Ren C, Chen H. Thrombolysis versus anticoagulation for the initial treatment of moderate pulmonary embolism: a meta-analysis of randomized controlled trials. Respir Care. 2014;59(12):1880-1887.</Citation><ArticleIdList><ArticleId IdType="pubmed">25269681</ArticleId></ArticleIdList></Reference><Reference><Citation>Doomernik DE, Schrijver AM, Zeebregts CJ, de Vries JP, Reijnen MM. Advancements in catheter-directed ultrasound-accelerated thrombolysis. J Endovasc Ther. 2011;18(3):418-434.</Citation><ArticleIdList><ArticleId IdType="pubmed">21679085</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao GY, Yang P, Liu M, et al. . Thrombolysis for acute intermediate-risk pulmonary embolism: a meta-analysis. Thromb Res. 2015;136(5):932-937.</Citation><ArticleIdList><ArticleId IdType="pubmed">26384442</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao Q, Dong BR, Yue J, Wu T, Liu GJ. Thrombolytic therapy for pulmonary embolism. Cochrane Database Syst Rev. 2018;(12):CD004437.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6516871</ArticleId><ArticleId IdType="pubmed">30560579</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris T, Meek S. When should we thrombolyse patients with pulmonary embolism? A systematic review of the literature. Emerg Med J. 2005;22(11):766-771.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1726594</ArticleId><ArticleId IdType="pubmed">16244331</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Lu Y, Song J, et al. . Recombinant tissue plasminogen activator for hemodynamically stable patients experiencing an acute pulmonary embolism: a meta-analysis. Thromb Res. 2014;134(1):50-56.</Citation><ArticleIdList><ArticleId IdType="pubmed">24824292</ArticleId></ArticleIdList></Reference><Reference><Citation>Marti C, John G, Konstantinides S, et al. . Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis. Eur Heart J. 2015;36(10):605-614.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4352209</ArticleId><ArticleId IdType="pubmed">24917641</ArticleId></ArticleIdList></Reference><Reference><Citation>Mostafa A, Briasoulis A, Shokr M, Briasouli AA, Panaich S, Grines C. Ultrasound accelerated thrombolysis in patients with acute pulmonary embolism: a systematic review and proportion meta-analysis. Int J Cardiol. 2016;211:27-30.</Citation><ArticleIdList><ArticleId IdType="pubmed">26970962</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura S, Takano H, Kubota Y, Asai K, Shimizu W. Impact of the efficacy of thrombolytic therapy on the mortality of patients with acute submassive pulmonary embolism: a meta-analysis. J Thromb Haemost. 2014;12(7):1086-1095.</Citation><ArticleIdList><ArticleId IdType="pubmed">24829097</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramakrishnan N. Thrombolysis is not warranted in submassive pulmonary embolism: a systematic review and meta-analysis. Crit Care Resusc. 2007;9(4):357-363.</Citation><ArticleIdList><ArticleId IdType="pubmed">18052901</ArticleId></ArticleIdList></Reference><Reference><Citation>Riera-Mestre A, Becattini C, Giustozzi M, Agnelli G. Thrombolysis in hemodynamically stable patients with acute pulmonary embolism: a meta-analysis. Thromb Res. 2014;134(6):1265-1271.</Citation><ArticleIdList><ArticleId IdType="pubmed">25457585</ArticleId></ArticleIdList></Reference><Reference><Citation>Serra-Prat M, Jovell AJ, Aymerich M. Efficacy and safety of thrombolytic therapy in pulmonary embolism: meta-analysis of randomized controlled trials [in Spanish]. Med Clin (Barc). 1999;112(18):685-689.</Citation><ArticleIdList><ArticleId IdType="pubmed">10374198</ArticleId></ArticleIdList></Reference><Reference><Citation>Tafur AJ, Shamoun FE, Patel SI, Tafur D, Donna F, Murad MH. Catheter-directed treatment of pulmonary embolism: a systematic review and meta-analysis of modern literature. Clin Appl Thromb Hemost. 2017;23(7):821-829.</Citation><ArticleIdList><ArticleId IdType="pubmed">27481877</ArticleId></ArticleIdList></Reference><Reference><Citation>Tardy B, Venet C, Zeni F, Coudrot M, Guyomarc&#x2019;h S, Mismetti P. Short term effect of recombinant tissue plasminogen activator in patients with hemodynamically stable acute pulmonary embolism: results of a meta-analysis involving 464 patients. Thromb Res. 2009;124(6):672-677.</Citation><ArticleIdList><ArticleId IdType="pubmed">19493561</ArticleId></ArticleIdList></Reference><Reference><Citation>Thabut G, Thabut D, Myers RP, et al. . Thrombolytic therapy of pulmonary embolism: a meta-analysis. J Am Coll Cardiol. 2002;40(9):1660-1667.</Citation><ArticleIdList><ArticleId IdType="pubmed">12427420</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan S, Quinlan DJ, Agnelli G, Eikelboom JW. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials. Circulation. 2004;110(6):744-749.</Citation><ArticleIdList><ArticleId IdType="pubmed">15262836</ArticleId></ArticleIdList></Reference><Reference><Citation>Worster A, Smith C, Silver S, Brown MD. Evidence-based emergency medicine/critically appraised topic. Thrombolytic therapy for submassive pulmonary embolism? Ann Emerg Med. 2007;50(1):78-84.</Citation><ArticleIdList><ArticleId IdType="pubmed">17449142</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Q, Huang K, Zhai Z, Yang Y, Wang J, Wang C. Initial thrombolysis treatment compared with anticoagulation for acute intermediate-risk pulmonary embolism: a meta-analysis. J Thorac Dis. 2015;7(5):810-821.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4454855</ArticleId><ArticleId IdType="pubmed">26101636</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Zhai ZG, Liang LR, Liu FF, Yang YH, Wang C. Lower dosage of recombinant tissue-type plasminogen activator (rt-PA) in the treatment of acute pulmonary embolism: a systematic review and meta-analysis. Thromb Res. 2014;133(3):357-363.</Citation><ArticleIdList><ArticleId IdType="pubmed">24412030</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimenez D, Barbero E, Chiluiza D, et al. . Efficacy of thrombolytic therapy in patients with massive pulmonary embolism: systematic review and meta-analysis [abstract]. Am J Respir Crit Care Med. 2020;201:A3783.</Citation></Reference><Reference><Citation>Lou BH, Wang LH, Chen Y. A meta-analysis of efficacy and safety of catheter-directed interventions in submassive pulmonary embolism. Eur Rev Med Pharmacol Sci. 2017;21(1):184-198.</Citation><ArticleIdList><ArticleId IdType="pubmed">28121338</ArticleId></ArticleIdList></Reference><Reference><Citation>Quezada CA, Bikdeli B, Barrios D, et al. . Meta-analysis of prevalence and short-term prognosis of hemodynamically unstable patients with symptomatic acute pulmonary embolism. Am J Cardiol. 2019;123(4):684-689.</Citation><ArticleIdList><ArticleId IdType="pubmed">30528278</ArticleId></ArticleIdList></Reference><Reference><Citation>Becattini C, Agnelli G, Salvi A, et al. ; TIPES Study Group. Bolus tenecteplase for right ventricle dysfunction in hemodynamically stable patients with pulmonary embolism. Thromb Res. 2010;125(3):e82-e86.</Citation><ArticleIdList><ArticleId IdType="pubmed">19833379</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalla-Volta S, Palla A, Santolicandro A, et al. . PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2. J Am Coll Cardiol. 1992;20(3):520-526.</Citation><ArticleIdList><ArticleId IdType="pubmed">1512328</ArticleId></ArticleIdList></Reference><Reference><Citation>Dotter CT, Seaman AJ, R&#xf6;sch J, Porter JM. Streptokinase and heparin in the treatment of pulmonary embolism: a randomized comparison. Vasc Endovascular Surg. 1979;13(1):42-52.</Citation></Reference><Reference><Citation>Fasullo S, Scalzo S, Maringhini G, et al. . Six-month echocardiographic study in patients with submassive pulmonary embolism and right ventricle dysfunction: comparison of thrombolysis with heparin. Am J Med Sci. 2011;341(1):33-39.</Citation><ArticleIdList><ArticleId IdType="pubmed">20890176</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldhaber SZ, Haire WD, Feldstein ML, et al. . Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet. 1993;341(8844):507-511.</Citation><ArticleIdList><ArticleId IdType="pubmed">8094768</ArticleId></ArticleIdList></Reference><Reference><Citation>Urokinase pulmonary embolism trial. Phase 1 results: a cooperative study. JAMA. 1970;214(12):2163-2172.</Citation><ArticleIdList><ArticleId IdType="pubmed">5536580</ArticleId></ArticleIdList></Reference><Reference><Citation>Tissue plasminogen activator for the treatment of acute pulmonary embolism. A collaborative study by the PIOPED Investigators. Chest. 1990;97(3):528-533.</Citation><ArticleIdList><ArticleId IdType="pubmed">2106408</ArticleId></ArticleIdList></Reference><Reference><Citation>Jerjes-Sanchez C, Ram&#xed;rez-Rivera A, de Lourdes Garc&#xed;a M, et al. . Streptokinase and heparin versus heparin alone in massive pulmonary embolism: a randomized controlled trial. J Thromb Thrombolysis. 1995;2(3):227-229.</Citation><ArticleIdList><ArticleId IdType="pubmed">10608028</ArticleId></ArticleIdList></Reference><Reference><Citation>Kline JA, Nordenholz KE, Courtney DM, et al. . Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double-blind, placebo-controlled randomized trial. J Thromb Haemost. 2014;12(4):459-468.</Citation><ArticleIdList><ArticleId IdType="pubmed">24484241</ArticleId></ArticleIdList></Reference><Reference><Citation>Konstantinides SV, Vicaut E, Danays T, et al. . Impact of thrombolytic therapy on the long-term outcome of intermediate-risk pulmonary embolism. J Am Coll Cardiol. 2017;69(12):1536-1544.</Citation><ArticleIdList><ArticleId IdType="pubmed">28335835</ArticleId></ArticleIdList></Reference><Reference><Citation>Kucher N, Boekstegers P, M&#xfc;ller OJ, et al. . Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism. Circulation. 2014;129(4):479-486.</Citation><ArticleIdList><ArticleId IdType="pubmed">24226805</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine M, Hirsh J, Weitz J, et al. . A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism. Chest. 1990;98(6):1473-1479.</Citation><ArticleIdList><ArticleId IdType="pubmed">2123152</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu LH, Lu SJ, Liu Z The effect of thrombolysis and anticoagulation therapy in patients with sub-massive pulmonary embolism [in Chinese]. Chongqing Med J. 2013;42(11):1288-1290.</Citation></Reference><Reference><Citation>Lu WH, Tang ZZ, Ma Y, Zh Y. The effectiveness and long-term prognosis of thrombolysis plus anticoagulation therapy versus anticoagulation therapy alone in patients with sub-massive pulmonary embolism [in Chinese]. Clin J Medical Officer. 2008;36(3):340-342.</Citation></Reference><Reference><Citation>Marini C, Di Ricco G, Rossi G, Rindi M, Palla R, Giuntini C. Fibrinolytic effects of urokinase and heparin in acute pulmonary embolism: a randomized clinical trial. Respiration. 1989;54(3):162-173.</Citation><ArticleIdList><ArticleId IdType="pubmed">3073463</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer G, Vicaut E, Danays T, et al. ; PEITHO Investigators. Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med. 2014;370(15):1402-1411.</Citation><ArticleIdList><ArticleId IdType="pubmed">24716681</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou YQ. Analysis of the therapeutic effect of urokinase plus sequential anticoagulation for the treatment of sub-massive pulmonary embolism [in Chinese]. J Hainan Medical College. 2012;18(7):897-898.</Citation></Reference><Reference><Citation>Sharifi M, Bay C, Skrocki L, Rahimi F, Mehdipour M; &#x201c;MOPETT&#x201d; Investigators. Moderate pulmonary embolism treated with thrombolysis (from the &#x201c;MOPETT&#x201d; Trial). Am J Cardiol. 2013;111(2):273-277.</Citation><ArticleIdList><ArticleId IdType="pubmed">23102885</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun RQ. Efficacy of urokinase combined with low molecular weight heparin and warfarin for the treatment of sub-massive pulmonary embolism [in Chinese]. Strait Pharmaceutical J. 2012;24(5):130-131.</Citation></Reference><Reference><Citation>Taherkhani M, Taherkhani A, Hashemi SR, Faghihi Langroodi T, Sadeghi R, Beyranvand M. Thrombolytic-plus-anticoagulant therapy versus anticoagulant-alone therapy in submassive pulmonary thromboembolism (TVASPE Study): a randomized clinical trial. J. Tehran Heart Center. 2014;9(3):104-108.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4393831</ArticleId><ArticleId IdType="pubmed">25870626</ArticleId></ArticleIdList></Reference><Reference><Citation>Tibbutt DA, Davies JA, Anderson JA, et al. . Comparison by controlled clinical trial of streptokinase and heparin in treatment of life-threatening pulmonay embolism. BMJ. 1974;1(5904):343-347.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1633603</ArticleId><ArticleId IdType="pubmed">4594580</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei L, Sun FC. Curative effect of thrombolysis and anticoagulant therapy on submassive pulmonary embolism patients. Int J Respir. 2012;32(19):1471-1473.</Citation></Reference><Reference><Citation>Zhang XL, Jiang SH, Jiang LN, Shan FL, Li Z, Qin MH. The effectiveness of low-dose rt-PA thrombolysis in 26 elderly patients with acute sub-massive pulmonary embolism [in Chinese]. Shandong Yiyao. 2012;52(3):69-70.</Citation></Reference><Reference><Citation>Ahmed MA, Abdelsalam SI, Elmorsy RA. Value of thrombolytic therapy for submassive pulmonary embolism patients. Egypt J Chest Dis Tuberc. 2018;67(4):413-418.</Citation></Reference><Reference><Citation>Zhang LY, Gao BA, Jin Z, et al. . Clinical efficacy of low dose recombinant tissue-type plasminogen activator for the treatment of acute intermediate-risk pulmonary embolism. Saudi Med J. 2018;39(11):1090-1095.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6274653</ArticleId><ArticleId IdType="pubmed">30397707</ArticleId></ArticleIdList></Reference><Reference><Citation>Kucher N, Rossi E, De Rosa M, Goldhaber SZ. Massive pulmonary embolism. Circulation. 2006;113(4):577-582.</Citation><ArticleIdList><ArticleId IdType="pubmed">16432055</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin BW, Schreiber DH, Liu G, et al. . Therapy and outcomes in massive pulmonary embolism from the Emergency Medicine Pulmonary Embolism in the Real World Registry. Am J Emerg Med. 2012;30(9):1774-1781.</Citation><ArticleIdList><ArticleId IdType="pubmed">22633723</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabrhel C, Rosovsky R, Channick R, et al. . A multidisciplinary pulmonary embolism response team: initial 30-month experience with a novel approach to delivery of care to patients with submassive and massive pulmonary embolism. Chest. 2016;150(2):384-393.</Citation><ArticleIdList><ArticleId IdType="pubmed">27006156</ArticleId></ArticleIdList></Reference><Reference><Citation>Xenos ES, Davis GA, He Q, Green A, Smyth SS. The implementation of a pulmonary embolism response team in the management of intermediate- or high-risk pulmonary embolism. J Vasc Surg Venous Lymphat Disord. 2019;7(4):493-500.</Citation><ArticleIdList><ArticleId IdType="pubmed">30930079</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosovsky R, Chang Y, Rosenfield K, et al. . Changes in treatment and outcomes after creation of a pulmonary embolism response team (PERT), a 10-year analysis [published correction appears in J Thromb Thrombolysis. 2019;47(1):41]. J Thromb Thrombolysis. 2019;47(1):31-40.</Citation><ArticleIdList><ArticleId IdType="pubmed">30242551</ArticleId></ArticleIdList></Reference><Reference><Citation>Laporte S, Mismetti P, D&#xe9;cousus H, et al. ; RIETE Investigators. Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry. Circulation. 2008;117(13):1711-1716.</Citation><ArticleIdList><ArticleId IdType="pubmed">18347212</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999;353(9162):1386-1389.</Citation><ArticleIdList><ArticleId IdType="pubmed">10227218</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng JJ, Zhang ZH, Shan Z, et al. . Catheter-directed thrombolysis in the treatment of acute deep venous thrombosis: a meta-analysis. Genet Mol Res. 2014;13(3):5241-5249.</Citation><ArticleIdList><ArticleId IdType="pubmed">25078578</ArticleId></ArticleIdList></Reference><Reference><Citation>Robertson L, McBride O, Burdess A. Pharmacomechanical thrombectomy for iliofemoral deep vein thrombosis. Cochrane Database Syst Rev. 2016;(11):CD011536.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6464782</ArticleId><ArticleId IdType="pubmed">27814432</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong Y, Gu Y, Chen Z, Yu Z, Lv J.. Thrombolysis for the treatment of lower extremities deep vein thrombosis [in Chinese]. J. Chinese Physician. 2005;7(8):1101.</Citation></Reference><Reference><Citation>Yu X, Zhou C, Chen X.. Using interventional urokinase thrombolysis for the treatment of low extremities deep vein thrombosis [in Chinese]. J Southern Medical University. 2009;9:1930-1931.</Citation></Reference><Reference><Citation>Zhang X, Ren Q, Jiang X, et al. . A prospective randomized trial of catheter-directed thrombolysis with additional balloon dilatation for iliofemoral deep venous thrombosis: a single-center experience. Cardiovasc Intervent Radiol. 2014;37(4):958-968.</Citation><ArticleIdList><ArticleId IdType="pubmed">24091759</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Q, Zeng Q. Clinical study of venous filter implantation combined with catheterization thrombolytic therapy for deep vein thrombosis [in Chinese]. Jiangxi Med J. 2011;46(4):303-306.</Citation></Reference><Reference><Citation>Kuo WT, Gould MK, Louie JD, Rosenberg JK, Sze DY, Hofmann LV. Catheter-directed therapy for the treatment of massive pulmonary embolism: systematic review and meta-analysis of modern techniques. J Vasc Interv Radiol. 2009;20(11):1431-1440.</Citation><ArticleIdList><ArticleId IdType="pubmed">19875060</ArticleId></ArticleIdList></Reference><Reference><Citation>Macovei L, Presura RM, Arsenescu Georgescu C. Systemic or local thrombolysis in high-risk pulmonary embolism. Cardiol J. 2015;22(4):467-474.</Citation><ArticleIdList><ArticleId IdType="pubmed">25563712</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang NL, Avgerinos ED, Singh MJ, Makaroun MS, Chaer RA. Systemic thrombolysis increases hemorrhagic stroke risk without survival benefit compared with catheter-directed intervention for the treatment of acute pulmonary embolism. J Vasc Surg Venous Lymphat Disord. 2017;5(2):171-176.e1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5324829</ArticleId><ArticleId IdType="pubmed">28214483</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel P, Arora S, Lahewala S, et al. . Thrombolysis (catheter directed/systemic) in pulmonary embolism: predictors and etiologies of readmissions. Circulation. 2016;134(suppl 1). Abstract 15283.</Citation></Reference><Reference><Citation>Geller Bram J, Adusumalli S, Yang L, Groeneveld Peter W, Giri J.. Catheter directed thrombolysis versus systemic thrombolysis for the treatment of pulmonary embolism. Circulation. 2017;136(suppl 1). Abstract 18461.</Citation></Reference><Reference><Citation>Chung J, Owen RJ. Using inferior vena cava filters to prevent pulmonary embolism. Can Fam Physician. 2008;54(1):49-55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2293317</ArticleId><ArticleId IdType="pubmed">18208955</ArticleId></ArticleIdList></Reference><Reference><Citation>Deso SE, Idakoji IA, Kuo WT. Evidence-based evaluation of inferior vena cava filter complications based on filter type. Semin Intervent Radiol. 2016;33(2):93-100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4862854</ArticleId><ArticleId IdType="pubmed">27247477</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox MA, Kahn SR. Postthrombotic syndrome in relation to vena cava filter placement: a systematic review. J Vasc Interv Radiol. 2008;19(7):981-985.</Citation><ArticleIdList><ArticleId IdType="pubmed">18589311</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia D, Ansari M, Cardoso R, et al. . Clinical outcomes of retrievable inferior vena cava filter plus anticoagulation versus anticoagulation alone on high-risk patients: a meta-analysis. J Am Coll Cardiol. 2016;67(13 suppl):2267.</Citation></Reference><Reference><Citation>Jiang J, Jiao Y, Zhang X. The short-term efficacy of vena cava filters for the prevention of pulmonary embolism in patients with venous thromboembolism receiving anticoagulation: meta-analysis of randomized controlled trials. Phlebology. 2017;32(9):620-627.</Citation><ArticleIdList><ArticleId IdType="pubmed">27913756</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SL, Lloyd AJ. Clinical review: inferior vena cava filters in the age of patient-centered outcomes. Ann Med. 2013;45(7):474-481.</Citation><ArticleIdList><ArticleId IdType="pubmed">24099038</ArticleId></ArticleIdList></Reference><Reference><Citation>Young T, Tang H, Hughes R. Vena caval filters for the prevention of pulmonary embolism. Cochrane Database Syst Rev. 2010;(2):CD006212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7387443</ArticleId><ArticleId IdType="pubmed">20166079</ArticleId></ArticleIdList></Reference><Reference><Citation>Decousus H, Leizorovicz A, Parent F, et al. ; Pr&#xe9;vention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N Engl J Med. 1998;338(7):409-415.</Citation><ArticleIdList><ArticleId IdType="pubmed">9459643</ArticleId></ArticleIdList></Reference><Reference><Citation>Mismetti P, Laporte S, Pellerin O, et al. ; PREPIC2 Study Group. Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial. JAMA. 2015;313(16):1627-1635.</Citation><ArticleIdList><ArticleId IdType="pubmed">25919526</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertoletti L, Quenet S, Laporte S, et al. ; RIETE Investigators. Pulmonary embolism and 3-month outcomes in 4036 patients with venous thromboembolism and chronic obstructive pulmonary disease: data from the RIETE registry. Respir Res. 2013;14(1):75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3728047</ArticleId><ArticleId IdType="pubmed">23865769</ArticleId></ArticleIdList></Reference><Reference><Citation>Otero R, Trujillo-Santos J, Cayuela A, et al. ; Registro Informatizado de la Enfermedad Tromboemb&#xf3;lica (RIETE) Investigators. Haemodynamically unstable pulmonary embolism in the RIETE Registry: systolic blood pressure or shock index? Eur Respir J. 2007;30(6):1111-1116.</Citation><ArticleIdList><ArticleId IdType="pubmed">17804446</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown PP, Peyton MD, Elkins RC, Greenfield LJ. Experimental comparison of a new intracaval filter with the Mobin-Uddin umbrella device. Circulation. 1974;50(2 suppl):II272-II276.</Citation><ArticleIdList><ArticleId IdType="pubmed">4846125</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulman S, Rhedin AS, Lindmarker P, et al. ; Duration of Anticoagulation Trial Study Group. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. N Engl J Med. 1995;332(25):1661-1665.</Citation><ArticleIdList><ArticleId IdType="pubmed">7760866</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine MN, Hirsh J, Gent M, et al. . Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Thromb Haemost. 1995;74(2):606-611.</Citation><ArticleIdList><ArticleId IdType="pubmed">8584992</ArticleId></ArticleIdList></Reference><Reference><Citation>Kearon C, Ageno W, Cannegieter SC, Cosmi B, Geersing GJ, Kyrle PA; Subcommittees on Control of Anticoagulation, and Predictive and Diagnostic Variables in Thrombotic Disease. Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH. J Thromb Haemost. 2016;14(7):1480-1483.</Citation><ArticleIdList><ArticleId IdType="pubmed">27428935</ArticleId></ArticleIdList></Reference><Reference><Citation>Konstantinides SV, Meyer G, Becattini C, et al. ; ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020;41(4):543-603.</Citation><ArticleIdList><ArticleId IdType="pubmed">31504429</ArticleId></ArticleIdList></Reference><Reference><Citation>Rollins BM, Silva MA, Donovan JL, Kanaan AO. Evaluation of oral anticoagulants for the extended treatment of venous thromboembolism using a mixed-treatment comparison, meta-analytic approach. Clin Ther. 2014;36(10):1454-64.e3.</Citation><ArticleIdList><ArticleId IdType="pubmed">25092394</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez-Outes A, Lecumberri R, Su&#xe1;rez-Gea ML, Terleira-Fern&#xe1;ndez AI, Monreal M, Vargas-Castrill&#xf3;n E. Case fatality rates of recurrent thromboembolism and bleeding in patients receiving direct oral anticoagulants for the initial and extended treatment of venous thromboembolism: a systematic review. J Cardiovasc Pharmacol Ther. 2015;20(5):490-500.</Citation><ArticleIdList><ArticleId IdType="pubmed">25802423</ArticleId></ArticleIdList></Reference><Reference><Citation>Cundiff DK. Clinical evidence for rebound hypercoagulability after discontinuing oral anticoagulants for venous thromboembolism. Medscape J Med. 2008;10(11):258.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2605115</ArticleId><ArticleId IdType="pubmed">19099008</ArticleId></ArticleIdList></Reference><Reference><Citation>Simes J, Becattini C, Agnelli G, et al. ; INSPIRE Study Investigators (International Collaboration of Aspirin Trials for Recurrent Venous Thromboembolism). Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration. Circulation. 2014;130(13):1062-1071.</Citation><ArticleIdList><ArticleId IdType="pubmed">25156992</ArticleId></ArticleIdList></Reference><Reference><Citation>Streiff MB, Segal JB, Tamariz LJ, et al. . Duration of vitamin K antagonist therapy for venous thromboembolism: a systematic review of the literature. Am J Hematol. 2006;81(9):684-691.</Citation><ArticleIdList><ArticleId IdType="pubmed">16838335</ArticleId></ArticleIdList></Reference><Reference><Citation>Sindet-Pedersen C, Pallisgaard JL, Olesen JB, Gislason GH, Arevalo LC. Safety and efficacy of direct oral anticoagulants compared to warfarin for extended treatment of venous thromboembolism -a systematic review and meta-analysis. Thromb Res. 2015;136(4):732-738.</Citation><ArticleIdList><ArticleId IdType="pubmed">26277682</ArticleId></ArticleIdList></Reference><Reference><Citation>Middeldorp S, Prins MH, Hutten BA. Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism. Cochrane Database Syst Rev. 2014;(8):CD001367.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7074008</ArticleId><ArticleId IdType="pubmed">25092359</ArticleId></ArticleIdList></Reference><Reference><Citation>Marik PE, Cavallazzi R. Extended anticoagulant and aspirin treatment for the secondary prevention of thromboembolic disease: a systematic review and meta-analysis. PLoS One. 2015;10(11):e0143252.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4654552</ArticleId><ArticleId IdType="pubmed">26587983</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinede L, Duhaut P, Cucherat M, Ninet J, Pasquier J, Boissel JP. Comparison of long versus short duration of anticoagulant therapy after a first episode of venous thromboembolism: a meta-analysis of randomized, controlled trials. J Intern Med. 2000;247(5):553-562.</Citation><ArticleIdList><ArticleId IdType="pubmed">10809994</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobieraj DM, Coleman CI, Pasupuleti V, Deshpande A, Kaw R, Hernandez AV. Comparative efficacy and safety of anticoagulants and aspirin for extended treatment of venous thromboembolism: A network meta-analysis. Thromb Res. 2015;135(5):888-896.</Citation><ArticleIdList><ArticleId IdType="pubmed">25795564</ArticleId></ArticleIdList></Reference><Reference><Citation>Ost D, Tepper J, Mihara H, Lander O, Heinzer R, Fein A. Duration of anticoagulation following venous thromboembolism: a meta-analysis. JAMA. 2005;294(6):706-715.</Citation><ArticleIdList><ArticleId IdType="pubmed">16091573</ArticleId></ArticleIdList></Reference><Reference><Citation>Castellucci LA, Le Gal G, Rodger MA, Carrier M. Major bleeding during secondary prevention of venous thromboembolism in patients who have completed anticoagulation: a systematic review and meta-analysis. J Thromb Haemost. 2014;12(3):344-348.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4230389</ArticleId><ArticleId IdType="pubmed">24405519</ArticleId></ArticleIdList></Reference><Reference><Citation>Bova C, Bianco A, Mascaro V, Nobile CG. Extended anticoagulation and mortality in venous thromboembolism. A meta-analysis of six randomized trials. Thromb Res. 2016;139:22-28.</Citation><ArticleIdList><ArticleId IdType="pubmed">26916292</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen AT, Hamilton M, Bird A, et al. . Comparison of the non-VKA oral anticoagulants apixaban, dabigatran, and rivaroxaban in the extended treatment and prevention of venous thromboembolism: systematic review and network meta-analysis [published correction appears in PLoS One. 2016;11(9):e0168836]. PLoS One. 2016;11(8):e0160064.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4972314</ArticleId><ArticleId IdType="pubmed">27487187</ArticleId></ArticleIdList></Reference><Reference><Citation>Castellucci LA, Cameron C, Le Gal G, et al. . Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis. BMJ. 2013;347:f5133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3758108</ArticleId><ArticleId IdType="pubmed">23996149</ArticleId></ArticleIdList></Reference><Reference><Citation>Sardar P, Chatterjee S, Mukherjee D. Efficacy and safety of new oral anticoagulants for extended treatment of venous thromboembolism: systematic review and meta-analyses of randomized controlled trials. Drugs. 2013;73(11):1171-1182.</Citation><ArticleIdList><ArticleId IdType="pubmed">23812923</ArticleId></ArticleIdList></Reference><Reference><Citation>Kakkos SK, Kirkilesis GI, Tsolakis IA. Editor&#x2019;s Choice - efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials. Eur J Vasc Endovasc Surg. 2014;48(5):565-575.</Citation><ArticleIdList><ArticleId IdType="pubmed">24951377</ArticleId></ArticleIdList></Reference><Reference><Citation>Alotaibi G, Alsaleh K, Wu C, Mcmurtry MS. Dabigatran, rivaroxaban and apixaban for extended venous thromboembolism treatment: network meta-analysis. Int Angiol. 2014;33(4):301-308.</Citation><ArticleIdList><ArticleId IdType="pubmed">25056161</ArticleId></ArticleIdList></Reference><Reference><Citation>Holley AB, King CS, Jackson JL, Moores LK. Different finite durations of anticoagulation and outcomes following idiopathic venous thromboembolism: a meta-analysis. Thrombosis. 2010;2010:540386.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3211079</ArticleId><ArticleId IdType="pubmed">22084660</ArticleId></ArticleIdList></Reference><Reference><Citation>Agnelli G, Prandoni P, Becattini C, et al. ; Warfarin Optimal Duration Italian Trial Investigators. Extended oral anticoagulant therapy after a first episode of pulmonary embolism. Ann Intern Med. 2003;139(1):19-25.</Citation><ArticleIdList><ArticleId IdType="pubmed">12834314</ArticleId></ArticleIdList></Reference><Reference><Citation>Agnelli G, Prandoni P, Santamaria MG, et al. ; Warfarin Optimal Duration Italian Trial Investigators. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. N Engl J Med. 2001;345(3):165-169.</Citation><ArticleIdList><ArticleId IdType="pubmed">11463010</ArticleId></ArticleIdList></Reference><Reference><Citation>Belcaro G, Laurora G, Cesarone MR, De Sanctis MT. Prophylaxis of recurrent deep venous thrombosis. A randomized, prospective study using indobufen and graduated elastic compression stockings. Angiology. 1993;44(9):695-699.</Citation><ArticleIdList><ArticleId IdType="pubmed">8357095</ArticleId></ArticleIdList></Reference><Reference><Citation>Couturaud F, Sanchez O, Pernod G, et al. ; PADIS-PE Investigators. Six months vs extended oral anticoagulation after a first episode of pulmonary embolism: the PADIS-PE Randomized Clinical Trial. JAMA. 2015;314(1):31-40.</Citation><ArticleIdList><ArticleId IdType="pubmed">26151264</ArticleId></ArticleIdList></Reference><Reference><Citation>Eischer L, Gartner V, Schulman S, Kyrle PA, Eichinger S; AUREC-FVIII investigators. 6 versus 30 months anticoagulation for recurrent venous thrombosis in patients with high factor VIII. Ann Hematol. 2009;88(5):485-490.</Citation><ArticleIdList><ArticleId IdType="pubmed">18931845</ArticleId></ArticleIdList></Reference><Reference><Citation>Farraj RS. Anticoagulation period in idiopathic venous thromboembolism. How long is enough? Saudi Med J. 2004;25(7):848-851.</Citation><ArticleIdList><ArticleId IdType="pubmed">15235686</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulman S, Lockner D, Juhlin-Dannfelt A. The duration of oral anticoagulation after deep vein thrombosis. A randomized study. Acta Med Scand. 1985;217(5):547-552.</Citation><ArticleIdList><ArticleId IdType="pubmed">3895828</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulman S, W&#xe5;hlander K, Lundstr&#xf6;m T, Clason SB, Eriksson H; THRIVE III Investigators. Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximelagatran. N Engl J Med. 2003;349(18):1713-1721.</Citation><ArticleIdList><ArticleId IdType="pubmed">14585939</ArticleId></ArticleIdList></Reference><Reference><Citation>Siragusa S, Malato A, Anastasio R, et al. . Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression UltraSonography (DACUS) study. Blood. 2008;112(3):511-515.</Citation><ArticleIdList><ArticleId IdType="pubmed">18497320</ArticleId></ArticleIdList></Reference><Reference><Citation>V&#xed;tovec M, Gol&#xe1;n L, Roztocil K, Linhart A. The development of persistent thrombotic masses in patients with deep venous thrombosis randomized to long-term anticoagulation treatment. Vasa. 2009;38(3):238-244.</Citation><ArticleIdList><ArticleId IdType="pubmed">19736635</ArticleId></ArticleIdList></Reference><Reference><Citation>Iorio A, Kearon C, Filippucci E, et al. . Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review. Arch Intern Med. 2010;170(19):1710-1716.</Citation><ArticleIdList><ArticleId IdType="pubmed">20975016</ArticleId></ArticleIdList></Reference><Reference><Citation>Lecumberri R, Alfonso A, Jim&#xe9;nez D, et al. ; RIETE investigators. Dynamics of case-fatalilty rates of recurrent thromboembolism and major bleeding in patients treated for venous thromboembolism. Thromb Haemost. 2013;110(4):834-843.</Citation><ArticleIdList><ArticleId IdType="pubmed">23846721</ArticleId></ArticleIdList></Reference><Reference><Citation>Coleman CI, Limone BL, Bookhart BK, Mody SH, Nutescu EA. Cost-effectiveness analysis of extended duration anticoagulation with rivaroxaban to prevent recurrent venous thromboembolism. Thromb Res. 2014;133(5):743-749.</Citation><ArticleIdList><ArticleId IdType="pubmed">24582461</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen GC, Bernstein CN. Duration of anticoagulation for the management of venous thromboembolism in inflammatory bowel disease: a decision analysis. Am J Gastroenterol. 2013;108(9):1486-1495.</Citation><ArticleIdList><ArticleId IdType="pubmed">23857476</ArticleId></ArticleIdList></Reference><Reference><Citation>Aujesky D, Smith KJ, Roberts MS. Oral anticoagulation strategies after a first idiopathic venous thromboembolic event. Am J Med. 2005;118(6):625-635.</Citation><ArticleIdList><ArticleId IdType="pubmed">15922694</ArticleId></ArticleIdList></Reference><Reference><Citation>Bamber L, Wang MY, Prins MH, et al. . Patient-reported treatment satisfaction with oral rivaroxaban versus standard therapy in the treatment of acute symptomatic deep-vein thrombosis. Thromb Haemost. 2013;110(4):732-741.</Citation><ArticleIdList><ArticleId IdType="pubmed">23846019</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodger MA, Kahn SR, Wells PS, et al. . Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy. CMAJ. 2008;179(5):417-426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2518177</ArticleId><ArticleId IdType="pubmed">18725614</ArticleId></ArticleIdList></Reference><Reference><Citation>Ensor J, Riley RD, Moore D, Snell KI, Bayliss S, Fitzmaurice D. Systematic review of prognostic models for recurrent venous thromboembolism (VTE) post-treatment of first unprovoked VTE. BMJ Open. 2016;6(5):e011190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4861103</ArticleId><ArticleId IdType="pubmed">27154483</ArticleId></ArticleIdList></Reference><Reference><Citation>Eichinger S, Heinze G, Jandeck LM, Kyrle PA. Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna Prediction Model. Circulation. 2010;121(14):1630-1636.</Citation><ArticleIdList><ArticleId IdType="pubmed">20351233</ArticleId></ArticleIdList></Reference><Reference><Citation>Eichinger S, Heinze G, Kyrle PA. Risk assessment model to predict recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism [abstract]. Blood. 2009;114(22). Abstract 452.</Citation><ArticleIdList><ArticleId IdType="pubmed">20351233</ArticleId></ArticleIdList></Reference><Reference><Citation>Eichinger S, Heinze G, Kyrle PA. D-dimer levels over time and the risk of recurrent venous thromboembolism: an update of the Vienna prediction model. J Thromb Haemost. 2013;11:115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3959721</ArticleId><ArticleId IdType="pubmed">24385451</ArticleId></ArticleIdList></Reference><Reference><Citation>Eichinger S, Heinze G, Kyrle PA. D-dimer levels over time and the risk of recurrent venous thromboembolism: an update of the Vienna prediction model. J Am Heart Assoc. 2014;3(1):e000467.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3959721</ArticleId><ArticleId IdType="pubmed">24385451</ArticleId></ArticleIdList></Reference><Reference><Citation>Ensor J, Riley RD, Jowett S, et al. ; PIT-STOP collaborative group. Prediction of risk of recurrence of venous thromboembolism following treatment for a first unprovoked venous thromboembolism: systematic review, prognostic model and clinical decision rule, and economic evaluation. Health Technol Assess. 2016;20(12):i-xxxiii, 1-190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4781504</ArticleId><ArticleId IdType="pubmed">26879848</ArticleId></ArticleIdList></Reference><Reference><Citation>Eichinger S, Heinze G, Kyrle PA. D-dimer levels over time and the risk of recurrent venous thromboembolism: an update of the Vienna Prediction Model. Blood. 2013;122(21):462.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3959721</ArticleId><ArticleId IdType="pubmed">24385451</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazo-Langner A, Abdulrehman J, Taylor EJ, Sharma S, Kovacs MJ. The use of the REVERSE study clinical prediction rule for risk stratification after initial anticoagulation results in decreased recurrences in patients with idiopathic venous thromboembolism. J Thromb Haemost. 2013;11:879.</Citation></Reference><Reference><Citation>Marcucci M, Eichinger S, Iorio A, et al. . External validation and updating of the Vienna Prediction Model for recurrent venous thromboembolism using a pooled individual patient data database. J Thromb Haemost. 2013;11:879-880.</Citation><ArticleIdList><ArticleId IdType="pubmed">25660555</ArticleId></ArticleIdList></Reference><Reference><Citation>ClinicalTrials.gov. Clinical decision rule validation study to predict low recurrent risk in patients with unprovoked venous thromboembolism (REVERSEII). Identifier NCT00967304. https://clinicaltrials.gov/ct2/show/NCT00967304. Accessed 15 July 2020.</Citation></Reference><Reference><Citation>Raskob GE, Anthonie LWA, Prins MH, Schellong S, Buller HR. Risk assessment for recurrent venous thromboembolism (VTE) after 6-14 months of anticoagulant treatment. J Thromb Haemost. 2011;9:857-858.</Citation></Reference><Reference><Citation>Rodger M, Kovacs M, Le Gal G, Anderson D, Righini M, Beaudoin T. The REVERSE I and II studies: impact of using. Men continue and HERDOO2 clinical decision rule to guide anticoagulant therapy in patients with first unprovoked venous thromboembolism. J Thromb Haemost. 2013;11:114.</Citation></Reference><Reference><Citation>Rodger M, Kovacs MJ, Kahn S, et al. . Extended follow-up of the multi-center multi-national prospective cohort study that derived the &#x201c;Men Continue and HERDOO2&#x201d; clinical decision rule which identifies low risk patients who may be able to discontinue oral anticoagulants (Oac) 5-7 months after treatment for unprovoked venous thromboembolism (VTE) [abstract]. Blood. 2009;114(22). Abstract 451.</Citation></Reference><Reference><Citation>Rodger MA, Rodger M, Kovacs M. Extended follow-up of the multi-center prospective cohort that derived the &#x2018;men continue and HERDOO2&#x2019; clinical decision rule identifying low risk unprovoked patients. J ThrombHaemost. 2011;9:39-40.</Citation></Reference><Reference><Citation>Tosetto A, Iorio A, Marcucci M. Clinical prediction of VTE recurrence in patients with previous unprovoked venous thromboembolism. Results from an individual-level meta-analysis. Pathophysiol Haemost Thromb. 2010.</Citation></Reference><Reference><Citation>Tosetto A, Iorio A, Marcucci M, et al. . Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: the DASH prediction score. Blood. 2011;118(21):544.</Citation><ArticleIdList><ArticleId IdType="pubmed">22489957</ArticleId></ArticleIdList></Reference><Reference><Citation>Tosetto A, Iorio A, Marcucci M, et al. . Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH). J Thromb Haemost. 2012;10(6):1019-1025.</Citation><ArticleIdList><ArticleId IdType="pubmed">22489957</ArticleId></ArticleIdList></Reference><Reference><Citation>Tosetto A, Lorio A, Marcucci M, Baglin T, Cushman M, Eichinger S. Clinical prediction guide to predict thrombosis recurrence after a first unprovoked venous thromboembolism. J Thromb Haemost. 2009.</Citation><ArticleIdList><ArticleId IdType="pubmed">25660555</ArticleId></ArticleIdList></Reference><Reference><Citation>Nederlands Trial Register. Cost-effectiveness of tailoring anticoagulant therapy by a VTE recurrence prediction model in patients with venous thrombo-embolism as compared to care-as-usual: The VISTA study. Trial NL2562 (NTR2680). https://www.trialregister.nl/trial/2562. Accessed 15 July 2020.</Citation></Reference><Reference><Citation>Bruinstroop E, Klok FA, Van De Ree MA, Oosterwijk FL, Huisman MV. Elevated D-dimer levels predict recurrence in patients with idiopathic venous thromboembolism: a meta-analysis. J Thromb Haemost. 2009;7(4):611-618.</Citation><ArticleIdList><ArticleId IdType="pubmed">19175498</ArticleId></ArticleIdList></Reference><Reference><Citation>Douketis J, Tosetto A, Marcucci M, et al. . Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis. BMJ. 2011;342:d813.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3044449</ArticleId><ArticleId IdType="pubmed">21349898</ArticleId></ArticleIdList></Reference><Reference><Citation>Douketis J, Tosetto A, Marcucci M, et al. . Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism. Ann Intern Med. 2010;153(8):523-531.</Citation><ArticleIdList><ArticleId IdType="pubmed">20956709</ArticleId></ArticleIdList></Reference><Reference><Citation>Verhovsek M, Douketis JD, Yi Q, et al. . Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism. Ann Intern Med. 2008;149(7):481-490, W494.</Citation><ArticleIdList><ArticleId IdType="pubmed">18838728</ArticleId></ArticleIdList></Reference><Reference><Citation>Palareti G, Cosmi B, Legnani C, et al. ; PROLONG Investigators. D-dimer testing to determine the duration of anticoagulation therapy. N Engl J Med. 2006;355(17):1780-1789.</Citation><ArticleIdList><ArticleId IdType="pubmed">17065639</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrier M, Rodger MA, Wells PS, Righini M, LE Gal G. Residual vein obstruction to predict the risk of recurrent venous thromboembolism in patients with deep vein thrombosis: a systematic review and meta-analysis. J Thromb Haemost. 2011;9(6):1119-1125.</Citation><ArticleIdList><ArticleId IdType="pubmed">21382171</ArticleId></ArticleIdList></Reference><Reference><Citation>Donadini MP, Ageno W, Antonucci E, et al. . Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis: a patient-level meta-analysis. Thromb Haemost. 2014;111(1):172-179.</Citation><ArticleIdList><ArticleId IdType="pubmed">24154729</ArticleId></ArticleIdList></Reference><Reference><Citation>Janakiram M, Sullivan M, Shcherba M, Guo S, Billett HH. A systematic review of the utility of residual vein obstruction studies in primary and secondary venous thrombosis. Thrombosis. 2013;2013:247913.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3853333</ArticleId><ArticleId IdType="pubmed">24349773</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson EJ, Liem TK. Duplex imaging of residual venous obstruction to guide duration of therapy for lower extremity deep venous thrombosis. J Vasc Surg Venous Lymphat Disord. 2015;3(3):326-332.</Citation><ArticleIdList><ArticleId IdType="pubmed">26992315</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan M, Mos IC, Klok FA, Huisman MV. Residual venous thrombosis as predictive factor for recurrent venous thromboembolim in patients with proximal deep vein thrombosis: a sytematic review. Br J Haematol. 2011;153(2):168-178.</Citation><ArticleIdList><ArticleId IdType="pubmed">21375522</ArticleId></ArticleIdList></Reference><Reference><Citation>Prandoni P, Prins MH, Lensing AW, et al. ; AESOPUS Investigators. Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis: a randomized trial. Ann Intern Med. 2009;150(9):577-585.</Citation><ArticleIdList><ArticleId IdType="pubmed">19414836</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodger MA, Le Gal G, Anderson DR, et al. ; REVERSE II Study Investigators. Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study. BMJ. 2017;356:j1065.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6287588</ArticleId><ArticleId IdType="pubmed">28314711</ArticleId></ArticleIdList></Reference><Reference><Citation>Agnelli G, Buller HR, Cohen A, et al. ; AMPLIFY-EXT Investigators. Apixaban for extended treatment of venous thromboembolism. N Engl J Med. 2013;368(8):699-708.</Citation><ArticleIdList><ArticleId IdType="pubmed">23216615</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridker PM, Goldhaber SZ, Danielson E, et al. ; PREVENT Investigators. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med. 2003;348(15):1425-1434.</Citation><ArticleIdList><ArticleId IdType="pubmed">12601075</ArticleId></ArticleIdList></Reference><Reference><Citation>Kearon C, Gent M, Hirsh J, et al. . A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med. 1999;340(12):901-907.</Citation><ArticleIdList><ArticleId IdType="pubmed">10089183</ArticleId></ArticleIdList></Reference><Reference><Citation>Becattini C, Agnelli G, Schenone A, et al. ; WARFASA Investigators. Aspirin for preventing the recurrence of venous thromboembolism. N Engl J Med. 2012;366(21):1959-1967.</Citation><ArticleIdList><ArticleId IdType="pubmed">22621626</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulman S, Kearon C, Kakkar AK, et al. ; RE-SONATE Trial Investigators. Extended use of dabigatran, warfarin, or placebo in venous thromboembolism. N Engl J Med. 2013;368(8):709-718.</Citation><ArticleIdList><ArticleId IdType="pubmed">23425163</ArticleId></ArticleIdList></Reference><Reference><Citation>Locadia M, Bossuyt PM, Stalmeier PF, et al. . Treatment of venous thromboembolism with vitamin K antagonists: patients&#x2019; health state valuations and treatment preferences. Thromb Haemost. 2004;92(6):1336-1341.</Citation><ArticleIdList><ArticleId IdType="pubmed">15583742</ArticleId></ArticleIdList></Reference><Reference><Citation>Kearon C, Akl EA, Comerota AJ, et al. . Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 suppl):e419S-e496S.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3278049</ArticleId><ArticleId IdType="pubmed">22315268</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansson PO, S&#xf6;rbo J, Eriksson H. Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors. Arch Intern Med. 2000;160(6):769-774.</Citation><ArticleIdList><ArticleId IdType="pubmed">10737276</ArticleId></ArticleIdList></Reference><Reference><Citation>Weitz JI, Lensing AWA, Prins MH, et al. ; EINSTEIN CHOICE Investigators. Rivaroxaban or aspirin for extended treatment of venous thromboembolism. N Engl J Med. 2017;376(13):1211-1222.</Citation><ArticleIdList><ArticleId IdType="pubmed">28316279</ArticleId></ArticleIdList></Reference><Reference><Citation>Brighton TA, Eikelboom JW, Mann K, et al. ; ASPIRE Investigators. Low-dose aspirin for preventing recurrent venous thromboembolism. N Engl J Med. 2012;367(21):1979-1987.</Citation><ArticleIdList><ArticleId IdType="pubmed">23121403</ArticleId></ArticleIdList></Reference><Reference><Citation>Kearon C, Ginsberg JS, Kovacs MJ, et al. ; Extended Low-Intensity Anticoagulation for Thrombo-Embolism Investigators. Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. N Engl J Med. 2003;349(7):631-639.</Citation><ArticleIdList><ArticleId IdType="pubmed">12917299</ArticleId></ArticleIdList></Reference><Reference><Citation>Eriksson BI, Borris LC, Friedman RJ, et al. ; RECORD1 Study Group. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. N Engl J Med. 2008;358(26):2765-2775.</Citation><ArticleIdList><ArticleId IdType="pubmed">18579811</ArticleId></ArticleIdList></Reference><Reference><Citation>Lassen MR, Gallus A, Raskob GE, Pineo G, Chen D, Ramirez LM; ADVANCE-3 Investigators. Apixaban versus enoxaparin for thromboprophylaxis after hip replacement. N Engl J Med. 2010;363(26):2487-2498.</Citation><ArticleIdList><ArticleId IdType="pubmed">21175312</ArticleId></ArticleIdList></Reference><Reference><Citation>Lassen MR, Ageno W, Borris LC, et al. ; RECORD3 Investigators. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. N Engl J Med. 2008;358(26):2776-2786.</Citation><ArticleIdList><ArticleId IdType="pubmed">18579812</ArticleId></ArticleIdList></Reference><Reference><Citation>Lassen MR, Raskob GE, Gallus A, Pineo G, Chen D, Hornick P; ADVANCE-2 investigators. Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial. Lancet. 2010;375(9717):807-815.</Citation><ArticleIdList><ArticleId IdType="pubmed">20206776</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann I, Rada G, Claro JC, et al. . Oral direct factor Xa inhibitors versus low-molecular-weight heparin to prevent venous thromboembolism in patients undergoing total hip or knee replacement: a systematic review and meta-analysis. Ann Intern Med. 2012;156(10):710-719.</Citation><ArticleIdList><ArticleId IdType="pubmed">22412038</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulman S. How I treat recurrent venous thromboembolism in patients receiving anticoagulant therapy. Blood. 2017;129(25):3285-3293.</Citation><ArticleIdList><ArticleId IdType="pubmed">28483766</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuker A, Arepally GM, Chong BH, et al. . American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia. Blood Adv. 2018;2(22):3360-3392.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6258919</ArticleId><ArticleId IdType="pubmed">30482768</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Hulle T, Tan M, den Exter PL, et al. . Recurrence risk after anticoagulant treatment of limited duration for late, second venous thromboembolism. Haematologica. 2015;100(2):188-193.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4803121</ArticleId><ArticleId IdType="pubmed">25261098</ArticleId></ArticleIdList></Reference><Reference><Citation>Altman R, Boullon F, Rouvier J, Raca R, de la Fuente L, Favaloro R. Aspirin and prophylaxis of thromboembolic complications in patients with substitute heart valves. J Thorac Cardiovasc Surg. 1976;72(1):127-129.</Citation><ArticleIdList><ArticleId IdType="pubmed">1084448</ArticleId></ArticleIdList></Reference><Reference><Citation>Casais P, Meschengieser SS, Sanchez Luceros AG, Bermejo EI, Lazzari MA. Effect of low-dose aspirin on the international normalized ratio variability in patients with mechanical heart valve prostheses. Pathophysiol Haemost Thromb. 2002;32(4):155-157.</Citation><ArticleIdList><ArticleId IdType="pubmed">12759515</ArticleId></ArticleIdList></Reference><Reference><Citation>Dale J, Myhre E, Storstein O, Stormorken H, Efskind L. Prevention of arterial thromboembolism with acetylsalicylic acid. A controlled clinical study in patients with aortic ball valves. Am Heart J. 1977;94(1):101-111.</Citation><ArticleIdList><ArticleId IdType="pubmed">326013</ArticleId></ArticleIdList></Reference><Reference><Citation>Farah E, Cadhilac M, Boubaker A, Starkman C, Acar J. Thromboembolic risk in prosthetic valve carriers. Prevention trial. Scand J Haematol Suppl. 1981;38:97-119.</Citation><ArticleIdList><ArticleId IdType="pubmed">6950503</ArticleId></ArticleIdList></Reference><Reference><Citation>Gull&#xf8;v AL, Koefoed BG, Petersen P. Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: the AFASAK 2 study. Atrial Fibrillation Aspirin and Anticoagulation. Arch Intern Med. 1999;159(12):1322-1328.</Citation><ArticleIdList><ArticleId IdType="pubmed">10386508</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurlen M, Abdelnoor M, Smith P, Erikssen J, Arnesen H. Warfarin, aspirin, or both after myocardial infarction. N Engl J Med. 2002;347(13):969-974.</Citation><ArticleIdList><ArticleId IdType="pubmed">12324552</ArticleId></ArticleIdList></Reference><Reference><Citation>Huynh T, Th&#xe9;roux P, Bogaty P, Nasmith J, Solymoss S. Aspirin, warfarin, or the combination for secondary prevention of coronary events in patients with acute coronary syndromes and prior coronary artery bypass surgery. Circulation. 2001;103(25):3069-3074.</Citation><ArticleIdList><ArticleId IdType="pubmed">11425770</ArticleId></ArticleIdList></Reference><Reference><Citation>Laffort P, Roudaut R, Roques X, et al. . Early and long-term (one-year) effects of the association of aspirin and oral anticoagulant on thrombi and morbidity after replacement of the mitral valve with the St. Jude medical prosthesis: a clinical and transesophageal echocardiographic study. J Am Coll Cardiol. 2000;35(3):739-746.</Citation><ArticleIdList><ArticleId IdType="pubmed">10716478</ArticleId></ArticleIdList></Reference><Reference><Citation>Meschengieser SS, Fondevila CG, Frontroth J, Santarelli MT, Lazzari MA. Low-intensity oral anticoagulation plus low-dose aspirin versus high-intensity oral anticoagulation alone: a randomized trial in patients with mechanical prosthetic heart valves. J Thorac Cardiovasc Surg. 1997;113(5):910-916.</Citation><ArticleIdList><ArticleId IdType="pubmed">9159625</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirhosseini SJ, Forouzannia SK, Mostafavi Pour Manshadi SM, Ali-Hasan-Al-Saegh S, Naderi N, Sanatkar M. Comparison of aspirin plus heparin with heparin alone on asymptomatic perioperative deep vein thrombosis in candidates for elective off-pump coronary artery bypass graft: a randomized clinical trial. Cardiol J. 2013;20(2):139-143.</Citation><ArticleIdList><ArticleId IdType="pubmed">23558871</ArticleId></ArticleIdList></Reference><Reference><Citation>Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council&#x2019;s General Practice Research Framework. Lancet. 1998;351(9098):233-241.</Citation><ArticleIdList><ArticleId IdType="pubmed">9457092</ArticleId></ArticleIdList></Reference><Reference><Citation>Turpie AG, Gent M, Laupacis A, et al. . A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. N Engl J Med. 1993;329(8):524-529.</Citation><ArticleIdList><ArticleId IdType="pubmed">8336751</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es RF, Jonker JJ, Verheugt FW, Deckers JW, Grobbee DE; Antithrombotics in the Secondary Preventionof Events in Coronary Thrombosis-2 (ASPECT-2) Research Group. Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial. Lancet. 2002;360(9327):109-113.</Citation><ArticleIdList><ArticleId IdType="pubmed">12126819</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SR, Rhee TM, Kang DY, Choi EK, Oh S, Lip GYH. Meta-analysis of oral anticoagulant monotherapy as an antithrombotic strategy in patients with stable coronary artery disease and nonvalvular atrial fibrillation. Am J Cardiol. 2019;124(6):879-885.</Citation><ArticleIdList><ArticleId IdType="pubmed">31311662</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirchhof P, Benussi S, Kotecha D, et al. . 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur J Cardiothorac Surg. 2016;50(5):e1-e88.</Citation><ArticleIdList><ArticleId IdType="pubmed">27663299</ArticleId></ArticleIdList></Reference><Reference><Citation>Berntsen CF, Kristiansen A, Akl EA, et al. . Compression stockings for preventing the postthrombotic syndrome in patients with deep vein thrombosis. Am J Med. 2016;129(4):447.e1-447.e20.</Citation><ArticleIdList><ArticleId IdType="pubmed">26747198</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgstaller JM, Steurer J, Held U, Amann-Vesti B. Efficacy of compression stockings in preventing post-thrombotic syndrome in patients with deep venous thrombosis: a systematic review and metaanalysis. Vasa. 2016;45(2):141-147.</Citation><ArticleIdList><ArticleId IdType="pubmed">27058800</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannoukas AD, Labropoulos N, Michaels JA. Compression with or without early ambulation in the prevention of post-thrombotic syndrome: a systematic review. Eur J Vasc Endovasc Surg. 2006;32(2):217-221.</Citation><ArticleIdList><ArticleId IdType="pubmed">16546415</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin YW, Ye H, Li FY, Xiong XZ, Cheng NS. Compression stockings for prevention of postthrombotic syndrome: a systematic review and meta-analysis. Vasc Endovascular Surg. 2016;50(5):328-334.</Citation><ArticleIdList><ArticleId IdType="pubmed">27260750</ArticleId></ArticleIdList></Reference><Reference><Citation>Kakkos SK, Daskalopoulou SS, Daskalopoulos ME, Nicolaides AN, Geroulakos G. Review on the value of graduated elastic compression stockings after deep vein thrombosis. Thromb Haemost. 2006;96(4):441-445.</Citation><ArticleIdList><ArticleId IdType="pubmed">17003920</ArticleId></ArticleIdList></Reference><Reference><Citation>Musani MH, Matta F, Yaekoub AY, Liang J, Hull RD, Stein PD. Venous compression for prevention of postthrombotic syndrome: a meta-analysis. Am J Med. 2010;123(8):735-740.</Citation><ArticleIdList><ArticleId IdType="pubmed">20670728</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrin M, Ekl&#xf6;f B. Does prescription of medical compression prevent development of post-thrombotic syndrome after proximal deep venous thrombosis? Phlebology. 2016;31(3):160-169.</Citation><ArticleIdList><ArticleId IdType="pubmed">25944460</ArticleId></ArticleIdList></Reference><Reference><Citation>Skervin AL, Thapar A, Franchini AJ, Prandoni P, Shalhoub J, Davies AH. Systematic review and meta-analysis of utility of graduated compression stockings in prevention of post-thrombotic syndrome. Eur J Vasc Endovasc Surg. 2016;51(6):838-845.</Citation><ArticleIdList><ArticleId IdType="pubmed">27026391</ArticleId></ArticleIdList></Reference><Reference><Citation>Subbiah R, Aggarwal V, Bashir R.. Compression stockings use to prevent post thrombotic syndrome in DVT patients: a meta-analysis of randomized control studies. J Am Coll Cardiol. 2015;65(10 suppl):A2054.</Citation></Reference><Reference><Citation>Tie HT, Luo MZ, Luo MJ, Li K, Li Q, Wu QC. Compression therapy in the prevention of postthrombotic syndrome: a systematic review and meta-analysis. Medicine (Baltimore). 2015;94(31):e1318.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4616586</ArticleId><ArticleId IdType="pubmed">26252318</ArticleId></ArticleIdList></Reference><Reference><Citation>Aschwanden M, Jeanneret C, Koller MT, Thalhammer C, Bucher HC, Jaeger KA. Effect of prolonged treatment with compression stockings to prevent post-thrombotic sequelae: a randomized controlled trial. J Vasc Surg. 2008;47(5):1015-1021.</Citation><ArticleIdList><ArticleId IdType="pubmed">18372153</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandjes DP, B&#xfc;ller HR, Heijboer H, et al. . Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet. 1997;349(9054):759-762.</Citation><ArticleIdList><ArticleId IdType="pubmed">9074574</ArticleId></ArticleIdList></Reference><Reference><Citation>Ginsberg JS, Hirsh J, Julian J, et al. . Prevention and treatment of postphlebitic syndrome: results of a 3-part study. Arch Intern Med. 2001;161(17):2105-2109.</Citation><ArticleIdList><ArticleId IdType="pubmed">11570939</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn SR, Shapiro S, Wells PS, et al. ; SOX trial investigators. Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial. Lancet. 2014;383(9920):880-888.</Citation><ArticleIdList><ArticleId IdType="pubmed">24315521</ArticleId></ArticleIdList></Reference><Reference><Citation>Prandoni P, Lensing AW, Prins MH, et al. . Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial. Ann Intern Med. 2004;141(4):249-256.</Citation><ArticleIdList><ArticleId IdType="pubmed">15313740</ArticleId></ArticleIdList></Reference><Reference><Citation>Villalta SBP, Piccioli A, Lensing A, Prins M, Prandoni P. Assessment of validity and reproducibility of a clinical scale for the post-thrombotic syndrome [abstract]. Haemostasis. 1994;24:158a.</Citation></Reference><Reference><Citation>Kearon C, Akl EA, Ornelas J, et al. . Antithrombotic therapy for VTE disease: CHEST Guideline and Expert Panel Report [published correction appears in Chest 2016;150(4):988]. Chest. 2016;149(2):315-352.</Citation><ArticleIdList><ArticleId IdType="pubmed">26867832</ArticleId></ArticleIdList></Reference><Reference><Citation>Streiff MB, Agnelli G, Connors JM, et al. . Guidance for the treatment of deep vein thrombosis and pulmonary embolism [published correction appears in J Thromb Thrombolysis 2016;41(3):548]. J Thromb Thrombolysis. 2016;41(1):32-67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4715858</ArticleId><ArticleId IdType="pubmed">26780738</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzolai L, Aboyans V, Ageno W, et al. . Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European Society of Cardiology working groups of aorta and peripheral vascular diseases and pulmonary circulation and right ventricular function. Eur Heart J. 2018;39(47):4208-4218.</Citation><ArticleIdList><ArticleId IdType="pubmed">28329262</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xfc;nemann HJ, Wiercioch W, Brozek J, et al. . GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT. J Clin Epidemiol. 2017;81:101-110.</Citation><ArticleIdList><ArticleId IdType="pubmed">27713072</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiercioch W, Nieuwlaat R, Akl EA, et al. . Methodology for the American Society of Hematology VTE guidelines: current best practice, innovations, and experiences. Blood Adv. 2020;4(10):2351-2365.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7252554</ArticleId><ArticleId IdType="pubmed">32453843</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">31783013</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>11</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1678-4782</ISSN><JournalIssue CitedMedium="Internet"><Volume>96 Suppl 1</Volume><Issue>Suppl 1</Issue><PubDate><Year>2020</Year><Season>Mar-Apr</Season></PubDate></JournalIssue><Title>Jornal de pediatria</Title><ISOAbbreviation>J Pediatr (Rio J)</ISOAbbreviation></Journal><ArticleTitle>Osteoarticular infections in pediatrics.</ArticleTitle><Pagination><StartPage>58</StartPage><EndPage>64</EndPage><MedlinePgn>58-64</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jped.2019.10.005</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0021-7557(19)30424-3</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To collect the most up-to-date information regarding pediatric osteoarticular infections, including the epidemiological and microbiological profiles, diagnosis, and treatment.</AbstractText><AbstractText Label="SOURCE OF DATA" NlmCategory="METHODS">A non-systematic review was performed on the search engines PubMed, SciELO, LILACS, and Google Scholar, using the keywords "bone and joint infection", "children", "pediatric", "osteomyelitis", "septic arthritis" and "spondylodiscitis" over the last ten years. The most relevant articles were selected by the authors to constitute the database.</AbstractText><AbstractText Label="SYNTHESIS OF DATA" NlmCategory="METHODS">Osteoarticular infections are still a major cause of morbidity in pediatrics. Their main etiology is Staphylococcus aureus, but there has been an increase in the detection of Kingella kingae, especially through molecular methods. Microbiological identification allows treatment direction, while evidence of inflammatory activity assists in treatment follow-up. Imaging tests are especially useful in the initial diagnosis of infections. Empirical treatment should include coverage for the main microorganisms according to the age and clinical conditions of the patient, while considering the local resistance profile. Surgical procedures can be indicated for diagnosis, focus control, and function preservation. Acute complications include sepsis, deep venous thrombosis, and pulmonary embolism. Deaths are rare. Late complications are uncommon but may lead to deformities that compromise motor development.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">A correct and early diagnosis, prompt implementation of adequate antimicrobial therapy, and focus control, when indicated, are critical to a better prognosis.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019. Published by Elsevier Editora Ltda.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alvares</LastName><ForeName>Paula Andrade</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Santa Casa de S&#xe3;o Paulo, Departamento de Pediatria, S&#xe3;o Paulo, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mimica</LastName><ForeName>Marcelo Jenn&#xe9;</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Santa Casa de S&#xe3;o Paulo, Departamento de Pediatria, Setor de Infectologia Pedi&#xe1;trica, S&#xe3;o Paulo, SP, Brazil; Faculdade de Ci&#xea;ncias M&#xe9;dicas da Santa Casa de S&#xe3;o Paulo, Departamento de Ci&#xea;ncias Patol&#xf3;gicas, Disciplina de Microbiologia, S&#xe3;o Paulo, SP, Brazil. Electronic address: marcelo.mimica@fcmsantacasasp.edu.br.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>11</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>J Pediatr (Rio J)</MedlineTA><NlmUniqueID>2985188R</NlmUniqueID><ISSNLinking>0021-7557</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001170" MajorTopicYN="Y">Arthritis, Infectious</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017882" MajorTopicYN="Y">Kingella kingae</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010019" MajorTopicYN="Y">Osteomyelitis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010372" MajorTopicYN="N">Pediatrics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013203" MajorTopicYN="N">Staphylococcal Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013211" MajorTopicYN="N">Staphylococcus aureus</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="por"><AbstractText Label="OBJETIVO">Compilar as informa&#xe7;&#xf5;es mais atuais referentes &#xe0;s infec&#xe7;&#xf5;es ostoarticulares em pediatria, inclusive perfil epidemiol&#xf3;gico e microbiol&#xf3;gico, diagn&#xf3;stico e tratamento.</AbstractText><AbstractText Label="FONTE DOS DADOS">Feita revis&#xe3;o n&#xe3;o sistem&#xe1;tica nos mecanismos de busca Pubmed, Scielo, Lilacs e Google Scholar, com as palavras-chave <i>bone and joint infection, children, pediatric, osteomyelitis, septic arthritis e espondylodiscitis</i> nos &#xfa;ltimos 10 anos. Os artigos mais relevantes foram selecionados pelos autores para compor a base de dados.</AbstractText><AbstractText Label="S&#xcd;NTESE DOS DADOS">As infec&#xe7;&#xf5;es osteoarticulares ainda s&#xe3;o causa importante de morbidade na pediatria. A sua principal etiologia &#xe9; o <i>Staphylococcus aureus</i>, por&#xe9;m h&#xe1; um aumento na detec&#xe7;&#xe3;o de <i>Kingella kingae,</i> especialmente atrav&#xe9;s de m&#xe9;todos moleculares. A identifica&#xe7;&#xe3;o microbiol&#xf3;gica possibilita direcionamento de tratamento, enquanto que as provas de atividade inflamat&#xf3;ria auxiliam no acompanhamento do tratamento. Exames de imagem s&#xe3;o especialmente &#xfa;teis no diagn&#xf3;stico inicial das infec&#xe7;&#xf5;es. O tratamento emp&#xed;rico deve incluir cobertura para os principais microrganismos, de acordo com a faixa et&#xe1;ria e as condi&#xe7;&#xf5;es cl&#xed;nicas do paciente, considerando o perfil de resist&#xea;ncia local. Procedimentos cir&#xfa;rgicos podem ser indicados para diagn&#xf3;stico, controle do foco e preserva&#xe7;&#xe3;o da fun&#xe7;&#xe3;o. As complica&#xe7;&#xf5;es agudas incluem sepse, trombose venosa profunda e embolia pulmonar. &#xd3;bitos s&#xe3;o raros. As complica&#xe7;&#xf5;es tardias s&#xe3;o incomuns, mas podem levar a deformidades que comprometem o desenvolvimento motor.</AbstractText><AbstractText Label="CONCLUS&#xc3;O">O diagn&#xf3;stico correto e precoce, com pronta institui&#xe7;&#xe3;o de terapia antimicrobiana adequada e controle do foco, quando indicado, &#xe9; fundamental para um melhor progn&#xf3;stico.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019. Published by Elsevier Editora Ltda.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Children</Keyword><Keyword MajorTopicYN="N">Crian&#xe7;as</Keyword><Keyword MajorTopicYN="N">Infections</Keyword><Keyword MajorTopicYN="N">Infec&#xe7;&#xf5;es</Keyword><Keyword MajorTopicYN="N">Osteoarticular</Keyword><Keyword MajorTopicYN="N">S. aureus</Keyword><Keyword MajorTopicYN="N">S. pyogenes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>7</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>10</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>10</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>11</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31783013</ArticleId><ArticleId IdType="pmc">PMC9432004</ArticleId><ArticleId IdType="doi">10.1016/j.jped.2019.10.005</ArticleId><ArticleId IdType="pii">S0021-7557(19)30424-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Akinkugbe O., Stewart C., McKenna C. Presentation and investigation of pediatric bone and joint infections in the pediatric emergency department. Pediatr Emerg Care. 2019;35:700&#x2013;704.</Citation><ArticleIdList><ArticleId IdType="pubmed">29509649</ArticleId></ArticleIdList></Reference><Reference><Citation>Saavedra-Lozano J., Falup-Pecurariu O., Faust S.N., Girschick H., Hartwig N., Kaplan S., et al. Bone and joint infections. Pediatr Infect Dis J. 2017;36:788&#x2013;799.</Citation><ArticleIdList><ArticleId IdType="pubmed">28708801</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell C.D., Ramaesh R., Kalima P., Murray A., Gaston M.S. Microbiological characteristics of acute osteoarticular infections in children. J Med Microbiol. 2015;64:446&#x2013;453.</Citation><ArticleIdList><ArticleId IdType="pubmed">25596125</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold J.C., Bradley J.S. Osteoarticular infections in children. Infect Dis Clin N Am. 2015;29:557&#x2013;574.</Citation><ArticleIdList><ArticleId IdType="pubmed">26311358</ArticleId></ArticleIdList></Reference><Reference><Citation>Iliadis A.D., Ramachandran M. Paediatric bone and joint infection. EFORT Open Rev. 2017;2:7&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5444236</ArticleId><ArticleId IdType="pubmed">28607765</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe4;&#xe4;kk&#xf6;nen M., Kallio M.J., Lankinen P., Peltola H., Kallio P.E. Preceding trauma in childhood hematogenous bone and joint infection. J Pediatr Orthop B. 2014;23:196&#x2013;199.</Citation><ArticleIdList><ArticleId IdType="pubmed">24157569</ArticleId></ArticleIdList></Reference><Reference><Citation>Dartnell J., Ramachandrean M., Katchburian M. Haematogenous acute and subacute paediatric osteomielytis: a systematic review of the literature. J Bone Joint Surg Br. 2012;94:584&#x2013;595.</Citation><ArticleIdList><ArticleId IdType="pubmed">22529075</ArticleId></ArticleIdList></Reference><Reference><Citation>Gafur O.A., Copley L.A., Hollmig S.T., Browne R.H., Thornton L.A., Crawford S.E. The impact of the current epidemiology of pediatric musculoskeletal infection on evaluation and treatment guidelines. J Pediatr Orthop. 2008;28:777&#x2013;785.</Citation><ArticleIdList><ArticleId IdType="pubmed">18812907</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitha A., Boutry N., Nectoux E., Petyt C., Lagr&#xe9;e M., Happiette L., et al. Community-acquired bone and joint infections in children: a 1-year prospective epidemiological study. Arch Dis Child. 2015;100:126&#x2013;129.</Citation><ArticleIdList><ArticleId IdType="pubmed">25187492</ArticleId></ArticleIdList></Reference><Reference><Citation>Riise O.R., Handeland K.S., Cvancaroca M., Wathne K.P., Nakstad B., Abrahamsen T.G., et al. Incidence and characteristics of arthritis in Norwegian children: a population-based study. Pediatrics. 2008;121:299&#x2013;306.</Citation><ArticleIdList><ArticleId IdType="pubmed">18227193</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavy C.B., Peek A.C., Manjolo G. The incidence of septic arthritis in Malawian children. Int Orthop. 2005;29:195&#x2013;196.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3456879</ArticleId><ArticleId IdType="pubmed">15806359</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold S.R., Elias D., Buckingham S., Thomas E.D., Novais E., Arkader A., et al. Changing patterns of acute hematogenous osteomyelitis and sepstic arthritis. J Pediatr Orthop. 2006;26:703&#x2013;708.</Citation><ArticleIdList><ArticleId IdType="pubmed">17065930</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkissian E.J., Gans I., Gunderson M.A., Myers S.H., Spiegel D.A., Flynn J.M. Community-acquired methicillin-resistant Staphylococcus aureus musculoskeletal infections: emerging trends over the past decade. J Pediatr Orthop. 2016;36:323&#x2013;327.</Citation><ArticleIdList><ArticleId IdType="pubmed">25785593</ArticleId></ArticleIdList></Reference><Reference><Citation>Ensinck G., Ernst A., Lazarte G., Romagnoli A., Sguassero Y., Miguez N., et al. Community-acquired methicillin-resistant Staphylococcus aureus infections: 10-years experience in a children&#x2019;s hospital in the city of Rosario, Argentina. Arch Argent Pediatr. 2018;116:119&#x2013;125.</Citation><ArticleIdList><ArticleId IdType="pubmed">29557598</ArticleId></ArticleIdList></Reference><Reference><Citation>Zun&#xed;no C., Vomero A., Pandolfo S., Guti&#xe9;rrez C., Algorta G., P&#xed;rez M.C., et al. Etiolog&#xed;a y evoluci&#xf3;n de las infecciones osteo-articulares 2009-2015. Hospital Pedi&#xe1;trico del Centro Hospitalario Pereiro Rossell, Uruguay. Rev Chilena Infectol. 2017;34:235&#x2013;242.</Citation><ArticleIdList><ArticleId IdType="pubmed">28991319</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosanova M.T., Beber&#xed;an G., Bologna R., Gim&#xe9;nez S., Sarkis C., Buchovsky A., et al. Estudio descriptivo de infecciones osteo-articulares en ni&#xf1;os en tempos de Staphylococcus aureus resistente a meticilina de la counidad (SARM-Co) Rev Chilena Infectol. 2015;32:321&#x2013;325.</Citation><ArticleIdList><ArticleId IdType="pubmed">26230439</ArticleId></ArticleIdList></Reference><Reference><Citation>Osei L., El Houmami N., Minodier P., Sika A., Basset T., Seligmann H., et al. Paediatric bon&#xe9; and joint infections in French Guiana: a 6 year retrospective review. J Trop Pediatr. 2017;63:380&#x2013;388.</Citation><ArticleIdList><ArticleId IdType="pubmed">28204806</ArticleId></ArticleIdList></Reference><Reference><Citation>Neto F.C.J., Ortega C.S., Goiano E.O. Epidemiological study of osteoarticular infections in children. Acta Ortop Bras. 2018;26:201&#x2013;205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6053965</ArticleId><ArticleId IdType="pubmed">30038548</ArticleId></ArticleIdList></Reference><Reference><Citation>Paternina-de la Ossa R., do Prado S.I., Cervi M.C., Lima D.A.F.S., Martinez R., Bellissimo-Rodrigues F. Is community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) an emerging pathogen among children in Brazil? Braz J Infect Dis. 2018;22:371&#x2013;376.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9428034</ArticleId><ArticleId IdType="pubmed">30389351</ArticleId></ArticleIdList></Reference><Reference><Citation>Chometon S., Benito Y., Chaker M., Boisset S., Ploton C., B&#xe9;rard J., et al. Specific real-time polymerase chain reaction places Kingella kingae as the most common cause of osteoarticular infections in young children. Pediatr Infect Dis J. 2007;26:377&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pubmed">17468645</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceroni D., Cherkaoui A., Ferey S., Kaelin Am Schrenzel J. Kingella kingae osteoarticular infections in Young children: clinical features and contribution of a new specific real-time PCR assay to the diagnosis. J Pediatr Orthop. 2010;30:301&#x2013;304.</Citation><ArticleIdList><ArticleId IdType="pubmed">20357599</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceroni D., Cherkaoui A., Combercure C., Fran&#xe7;ois P., Kaelin A., Schrenzel J. Differentiating osteoarticular infections caused by Kingella kingae from those due to typical pathogens in young children. Pediatr Infect Dis J. 2011;30:906&#x2013;909.</Citation><ArticleIdList><ArticleId IdType="pubmed">21494171</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvo C., N&#xfa;&#xf1;ez E., Camacho M., Clemente D., Fern&#xe1;ndez-Cooke E., Alcobendas R., et al. Epidemiology and management of acute, uncomplicated septic arthritis and osteomyelitis: Spanish multicenter study. Pediatr Infect Dis J. 2016;35:1288&#x2013;1293.</Citation><ArticleIdList><ArticleId IdType="pubmed">27455444</ArticleId></ArticleIdList></Reference><Reference><Citation>Peltola H., P&#xe4;&#xe4;kk&#xf6;nen M., Kallio P., Kallio M.J.T., Osteomyelitis-Septic Arthritis Study Group Short-versus long-term antimicrobial treatment for acute hematogenous osteomyelitis of childhood: prospective, randomized trial on 131 culture-positive cases. Pediatr Infect Dis J. 2010;29:1123&#x2013;1128.</Citation><ArticleIdList><ArticleId IdType="pubmed">20842069</ArticleId></ArticleIdList></Reference><Reference><Citation>Dayer R., Alzahrani M.M., Saran N., Ouellet J.A., Journeau P., Tabard-Foug&#xe8;re A., et al. Spinal infections in children. Bone Joint J. 2018;100-B:542&#x2013;548.</Citation><ArticleIdList><ArticleId IdType="pubmed">29629576</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima A.L., Oliveira P.R., Carvalho V.C., Cimerman S., Savio E., Diretrizes Panamericanas para el Tratamiento de las Osteomielitis e Infecciones de Tejidos Blandos Group Recommendations for the treatment of osteomyelitis. Braz J Infect Dis. 2014;18:526&#x2013;534.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9428226</ArticleId><ArticleId IdType="pubmed">24698709</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodwell E.R. Osteomyelitis and septic arthritis in children: current concepts. Curr Opin Pediatr. 2013;25:58&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">23283291</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorrot M., Gillet Y., Gras Le Guen C., Launay E., et al. Antibiotic therapy of bone and joint infections in children: proposals of the French Pediatric Infectious Diseases Group. Arch Pediatr. 2017;24:S36&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">29290233</ArticleId></ArticleIdList></Reference><Reference><Citation>Prado S.M.A., Lizama C.M., Pe&#xf1;a D.A., Valenzuela M.C., Viviani S.T. Tratamiento intravenoso inicial abreviado en 70 pacientes pedi&#xe1;tricos con infecciones osteo-articulares. Rev Chil Infectol. 2008;25:30&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">18273522</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H.K., Rombach I., Zambellas R., Walker A.S., McNally M.A., Atkins B.L., et al. Oral versus intravenous antibiotics for bon&#xe9; and joint infection. N Engl J Med. 2019;380:425&#x2013;436.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6522347</ArticleId><ArticleId IdType="pubmed">30699315</ArticleId></ArticleIdList></Reference><Reference><Citation>Jagodzinski N.A., Kanwar R., Graham K., Bache C.E. Prospective evaluation of a shortened regimen of treatment for acute osteomyelitis and septic arthritis in children. J Pediatr Orthop. 2009;29:518&#x2013;525.</Citation><ArticleIdList><ArticleId IdType="pubmed">19568027</ArticleId></ArticleIdList></Reference><Reference><Citation>Principi N., Esposito S. Infectious discitis and spondylodiscitis in children. Int J Mol Sci. 2016;17:539.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4848995</ArticleId><ArticleId IdType="pubmed">27070599</ArticleId></ArticleIdList></Reference><Reference><Citation>Pendleton A., Kocher M.S. Methicillin-resistant Staphylococcus aureus bone and joint infections in children. J Am Acad Orthop Surg. 2015;23:29&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">25538128</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35938605</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>09</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1469-493X</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>8</Issue><PubDate><Year>2022</Year><Month>Aug</Month><Day>08</Day></PubDate></JournalIssue><Title>The Cochrane database of systematic reviews</Title><ISOAbbreviation>Cochrane Database Syst Rev</ISOAbbreviation></Journal><ArticleTitle>Catheter-directed therapies for the treatment of high risk (massive) and intermediate risk (submassive) acute pulmonary embolism.</ArticleTitle><Pagination><StartPage>CD013083</StartPage><MedlinePgn>CD013083</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">CD013083</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/14651858.CD013083.pub2</ELocationID><Abstract><AbstractText Label="BACKGROUND">Acute pulmonary embolism (APE) is a major cause of acute morbidity and mortality. APE results in long-term morbidity in up to 50% of survivors, known as post-pulmonary embolism (post-PE) syndrome.&#xa0; APE can be classified according to the short-term (30-day) risk of mortality, based on a variety of clinical, imaging and laboratory findings. Most mortality and morbidity is concentrated in high-risk (massive) and intermediate-risk (submassive) APE. The first-line treatment for APE is systemic anticoagulation.&#xa0; High-risk (massive) APE accounts for less than 10% of APE cases and is a life-threatening medical emergency, requiring immediate reperfusion treatment to prevent death. Systemic thrombolysis is the recommended treatment for high-risk (massive) APE. However, only a minority of the people affected receive systemic thrombolysis, due to comorbidities or the 10% risk of major haemorrhagic side effects. Of those who do receive systemic thrombolysis, 8% do not respond in a timely manner. Surgical pulmonary embolectomy is an alternative reperfusion treatment, but is not widely available.&#xa0; Intermediate-risk (submassive) APE represents 45% to 65% of APE cases, with a short-term mortality rate of around 3%. Systemic thrombolysis is not recommended for this group, as major haemorrhagic complications outweigh the benefit. However, the people at higher risk within this group have a short-term mortality of around 12%, suggesting that anticoagulation alone is not an adequate treatment. Identification and more aggressive treatment of people at intermediate to high risk, who have a more favourable risk profile for reperfusion treatments, could reduce short-term mortality and potentially reduce post-PE syndrome. Catheter-directed treatments (catheter-directed thrombolysis and catheter embolectomy) are minimally invasive reperfusion treatments for high- and intermediate-risk APE. Catheter-directed treatments can be used either as the primary treatment or as salvage treatment after failure of systemic thrombolysis. Catheter-directed&#xa0;thrombolysis administers 10% to 20% of the systemic thrombolysis dose directly into the thrombus in the lungs, potentially reducing the risks of haemorrhagic side effects. Catheter embolectomy mechanically removes the thrombus without the need for thrombolysis, and may be useful for people with contraindications for thrombolysis.&#xa0; Currently, the benefits of catheter-based APE treatments compared with existing medical and surgical treatment are unclear despite increasing adoption of catheter treatments by PE response teams. This review examines the evidence for the use of catheter-directed treatments in high- and intermediate-risk APE. This evidence could help guide the optimal treatment strategy for people affected by this common and life-threatening condition.</AbstractText><AbstractText Label="OBJECTIVES">To assess the effects of catheter-directed therapies versus alternative treatments for high-risk (massive) and intermediate-risk (submassive) APE.</AbstractText><AbstractText Label="SEARCH METHODS">We used standard, extensive Cochrane search methods. The latest search was 15 March 2022.</AbstractText><AbstractText Label="SELECTION CRITERIA">We included randomised controlled trials (RCTs) of catheter-directed therapies for the treatment of high-risk (massive) and intermediate-risk (submassive) APE. We excluded catheter-directed treatments for non-PE. We applied no restrictions on participant age or on the date, language or publication status of RCTs.</AbstractText><AbstractText Label="DATA COLLECTION AND ANALYSIS">We used standard Cochrane methods. The main outcomes were all-cause mortality, treatment-associated major and minor haemorrhage rates based on two established clinical definitions, recurrent APE requiring retreatment or change to a different APE treatment, length of hospital stay, and quality of life. We used GRADE to assess certainty of evidence for each outcome.</AbstractText><AbstractText Label="MAIN RESULTS">We identified one RCT (59 participants) of (ultrasound-augmented) catheter-directed thrombolysis for intermediate-risk (submassive) APE. We found no trials of any catheter-directed treatments (thrombectomy or thrombolysis) in people with high-risk (massive) APE or of catheter-based embolectomy in people with intermediate-risk (submassive) APE. The included trial compared ultrasound-augmented catheter-directed thrombolysis with alteplase and systemic heparinisation versus systemic heparinisation alone. In the treatment group, each participant received an infusion of alteplase 10 mg or 20 mg over 15 hours. We identified a high risk of selection and performance bias, low risk of detection and reporting bias, and unclear risk of attrition and other bias. Certainty of evidence was very low because of risk of bias and imprecision.&#xa0; By 90 days, there was no clear difference in all-cause mortality between the treatment group and control group. A single death occurred in the control group at 20 days after randomisation, but it was unrelated to the treatment or to APE (odds ratio (OR) 0.31, 95% confidence interval (CI) 0.01 to 7.96; 59 participants). By 90 days, there were no episodes of treatment-associated major haemorrhage in either the treatment or control group. There was no clear difference in treatment-associated minor haemorrhage between the treatment and control group by 90 days (OR 3.11, 95% CI 0.30 to 31.79; 59 participants). By 90 days, there were no episodes of recurrent APE requiring retreatment or change to a different APE treatment in the treatment or control group. There was no clear difference in the length of mean total hospital stay between the treatment and control groups. Mean stay was 8.9 (standard deviation (SD) 3.4) days in the treatment group versus 8.6 (SD 3.9) days in the control group (mean difference 0.30, 95% CI -1.57 to 2.17; 59 participants). The included trial did not investigate quality of life measures.&#xa0; AUTHORS' CONCLUSIONS: There is a lack of evidence to support widespread adoption of catheter-based interventional therapies for APE. We identified one small trial showing no clear differences between ultrasound-augmented catheter-directed thrombolysis with alteplase plus systemic heparinisation versus systemic heparinisation alone in all-cause mortality, major and minor haemorrhage rates, recurrent APE and length of hospital stay. Quality of life was not assessed.&#xa0; Multiple small retrospective case series, prospective patient registries and single-arm studies suggest potential benefits of catheter-based treatments, but they provide insufficient evidence to recommend this approach over other evidence-based treatments. Researchers should consider clinically relevant primary outcomes (e.g. mortality and exercise tolerance), rather than surrogate markers (e.g. right ventricular to left ventricular (RV:LV) ratio or thrombus burden), which have limited clinical utility. Trials must include a control group to determine if the effects are specific to the treatment.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Harvey</LastName><ForeName>John J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Trinity College, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiology, Royal Children's Hospital Melbourne, Parkville, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Shiwei</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Radiology, St George Hospital, Kogarah, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uberoi</LastName><ForeName>Raman</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Radiology, John Radcliffe NHS Trust Hospital, Oxford, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>CSO_</Acronym><Agency>Chief Scientist Office</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cochrane Database Syst Rev</MedlineTA><NlmUniqueID>100909747</NlmUniqueID><ISSNLinking>1361-6137</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.21.68</RegistryNumber><NameOfSubstance UI="D010959">Tissue Plasminogen Activator</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>doi: 10.1002/14651858.CD013083</RefSource></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015912" MajorTopicYN="N">Thrombolytic Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010959" MajorTopicYN="Y">Tissue Plasminogen Activator</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>JJH: none&#x2028;SH: none&#x2028;RU: none</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>8</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35938605</ArticleId><ArticleId IdType="pmc">PMC9358724</ArticleId><ArticleId IdType="doi">10.1002/14651858.CD013083.pub2</ArticleId></ArticleIdList><ReferenceList><Title>References to studies included in this review</Title><ReferenceList><Title>Kucher 2014 {published data only}</Title><Reference><Citation>Kucher N, Boekstegers P, Muller OJ, Kupatt C, Beyer-Westendorf J, Heitzer T, et al. Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism. Circulation 2014;129(4):479-86. [DOI: 10.1161/CIRCULATIONAHA.113.005544]</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.113.005544</ArticleId><ArticleId IdType="pubmed">24226805</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to studies excluded from this review</Title><ReferenceList><Title>Avgerinos 2018 {published data only}</Title><Reference><Citation>Avgerinos ED, Mohapatra A, Rivera-Lebron B, Toma, C, Kabrhel C, Fish L, et al. Design and rationale of a randomized trial comparing standard versus ultrasound-assisted thrombolysis for submassive pulmonary embolism. Journal of Vascular Surgery 2018;6(1):126-32. [DOI: 10.1016/j.jvsv.2017.09.004]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvsv.2017.09.004</ArticleId><ArticleId IdType="pmc">PMC6394224</ArticleId><ArticleId IdType="pubmed">29248101</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Edla 2016 {published data only}</Title><Reference><Citation>Edla S, Boshara A, Neupane S, Mehta RH, Rosman H, Attallah A. Safety and efficacy of ultrasound-assisted catheter-directed thrombolysis in treatment of submassive pulmonary embolism. Circulation 2016;134(Suppl 1):A19993.</Citation></Reference></ReferenceList><ReferenceList><Title>FLARE 2019 {published data only}</Title><Reference><Citation>Tu T, Toma C, Tapson VF, Adams C, Jaber WA, Silver M, et al. A prospective, single-arm, multicenter trial of catheter-directed mechanical thrombectomy for intermediate-risk acute pulmonary embolism: the FLARE study. JACC: Cardiovascular Interventions 2019;12(9):859-69. [DOI: 10.1016/j.jcin.2018.12.022]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2018.12.022</ArticleId><ArticleId IdType="pubmed">31072507</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Jaber 2020 {published data only}</Title><Reference><Citation>Jaber WA, Kabrhel C, Rosenfield K, Tu T, Ouriel K, Tapson VF. Percutaneous thrombectomy in emergency department patients with pulmonary embolism: the FLARE ED sub-study. Journal of Emergency Medicine 2020;58(2):175-82. [DOI: 10.1016/j.jemermed.2019.11.044]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jemermed.2019.11.044</ArticleId><ArticleId IdType="pubmed">32220546</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>NCT03086317 {published data only}</Title><Reference><Citation>NCT03086317. Standard vs ultrasound-assisted catheter thrombolysis for submassive pulmonary embolism. clinicaltrials.gov/show/NCT03086317 (first received 22 March 2017).</Citation></Reference></ReferenceList><ReferenceList><Title>NCT03218410 {published data only}</Title><Reference><Citation>NCT03218410. Surgical pulmonary embolectomy versus catheter-directed thrombolysis in the treatment of pulmonary embolism: a non-inferiority study (Lungembolism). clinicaltrials.gov/ct2/show/NCT03218410 (first received 14 July 2017).</Citation></Reference></ReferenceList><ReferenceList><Title>NCT04430569 {published data only}</Title><Reference><Citation>NCT04430569. Pulmonary Embolism International THrOmbolysis Study-3 (PEITHO-3). clinicaltrials.gov/ct2/show/NCT04430569 (first received 12 June 2020).</Citation></Reference></ReferenceList><ReferenceList><Title>NCT05111613 {published data only}</Title><Reference><Citation>NCT05111613. The PEERLESS Study (PEERLESS). clinicaltrials.gov/ct2/show/NCT05111613 (first received 8 November 2021). [CLINICALTRIALS.GOV IDENTIFIER: NCT05111613]</Citation></Reference></ReferenceList><ReferenceList><Title>OPTALYSE&#x2010;PE 2018 {published data only}</Title><Reference><Citation>Sterling K, Jones N, Piazza G, Goldhaber S, Tapson V. Optimum duration and dose of rTPA with the acoustic pulse thrombolysisis procedure for intermediate-risk (submassive) pulmonary embolism: OPTALYSE PE. Journal of Vascular and Interventional Radiology 2018;29(4 Suppl 1):S96.</Citation></Reference><Reference><Citation>Sterling KM, Jones N, Piazza G, Goldhaber S, Tapson V. Optimum duration and dose of r-TPA with the acoustic pulse thrombolysis procedure for intermediate-risk (submassive) pulmonary embolism (OPTALYSE PE). Cardiovascular and Interventional Radiology 2017;40(2 Suppl 1):S142. [DOI: 10.1007/s00270-017-1725-y]</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00270-017-1725-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Tapson VF, Piazza G, Goldhaber SZ, Sterling K, Ouriel K, Liu PY. Optimum duration and dose of r-tpa with the acoustic pulse thrombolysis procedure for intermediate-risk (submassive) pulmonary embolism: OPTALYSE-PE. American Journal of Respiratory and Critical Care Medicine 2017;195:A2835. [DOI: 10.1164/ajrccm-conference.2017.A108]</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm-conference.2017.A108</ArticleId></ArticleIdList></Reference><Reference><Citation>Tapson VF, Sterling K, Jones N, Elder M, Tripathy U, Brower J, et al. A randomized trial of the optimum duration of acoustic pulse thrombolysis procedure in acute intermediate-risk pulmonary embolism: the OPTALYSE PE trial. JACC: Cardiovascular Interventions 2018;11(14):1401-10. [DOI: 10.1016/j.jcin.2018.04.008]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2018.04.008</ArticleId><ArticleId IdType="pubmed">30025734</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to ongoing studies</Title><ReferenceList><Title>NCT03854266 {published data only}</Title><Reference><Citation>NCT03854266. Low dose catheter directed thrombolysis for acute pulmonary embolism (BETULA). clinicaltrials.gov/ct2/show/NCT03854266 (first received 26 February 2019).</Citation></Reference></ReferenceList><ReferenceList><Title>NCT04088292 {unpublished data only}</Title><Reference><Citation>NCT04088292. Low dose thrombolysis, ultrasound assisted thrombolysis or heparin for intermediate high risk pulmonary embolism (STRATIFY). clinicaltrials.gov/ct2/show/NCT04088292 (first received 12 September 2019). [CLINICALTRIALS.GOV ID: NCT04088292]</Citation></Reference></ReferenceList><ReferenceList><Title>NCT04790370 {published data only}</Title><Reference><Citation>NCT04790370. Ultrasound-facilitated, catheter-directed thrombolysis in intermediate-high risk pulmonary embolism (HI-PEITHO). clinicaltrials.gov/ct2/show/NCT04790370 (first received 3 November 2021).</Citation></Reference></ReferenceList></ReferenceList><ReferenceList><Title>Additional references</Title><ReferenceList><Title>ACCP 2016</Title><Reference><Citation>Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest 2016;149(2):315-52. [DOI: 10.1016/j.chest.2015.11.026]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2015.11.026</ArticleId><ArticleId IdType="pubmed">26867832</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>ACCP 2021</Title><Reference><Citation>Stevens SM, Woller SC, Baumann Kreuziger L, Bounameaux H, Doerschug K, Geersing GJ, et al. Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report &#x2013; executive summary. Chest 2021;160(6):e545-608. [DOI: 10.1016/j.chest.2021.07.056]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.07.056</ArticleId><ArticleId IdType="pubmed">34352278</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>AHA 2011</Title><Reference><Citation>Jaff MR, McMurty MS, Archer SL, Cushman M, Goldenberg N, Goldhaber SZ, et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation 2011;123(16):1788-830. [DOI: 10.1161/CIR.0b013e318214914f]</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0b013e318214914f</ArticleId><ArticleId IdType="pubmed">21422387</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>AHA 2019</Title><Reference><Citation>Giri J, Sista AK, Weinberg I, Kearon C, Kumbhani DJ, Desai ND, et al. Interventional therapies for acute pulmonary embolism: current status and principles for the development of novel evidence: a scientific statement from the American Heart Association. Circulation 2019;140(20):e774-e801. [DOI: 10.1161/CIR.0000000000000707]</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000707</ArticleId><ArticleId IdType="pubmed">31585051</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Alkinj 2017</Title><Reference><Citation>Alkinj B, Pannu BS, Apala DR, Kotecha A, Kashyap R, Iyer VN. Saddle vs nonsaddle pulmonary embolism: clinical presentation, hemodynamics, management, and outcomes. Mayo Clinic Proceedings 2017;92(10):1511-8. [DOI: 10.1016/j.mayocp.2017.07.014]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2017.07.014</ArticleId><ArticleId IdType="pubmed">28890217</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>ASH 2020</Title><Reference><Citation>Ortel TL, Neumann I, Ageno W, Beyth R, Clark NP, Cuker A, et al. American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Advances 2020;4(19):4693-738. [DOI: 10.1182/bloodadvances.2020001830]</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2020001830</ArticleId><ArticleId IdType="pmc">PMC7556153</ArticleId><ArticleId IdType="pubmed">33007077</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Atkins 2004</Title><Reference><Citation>Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al. Grading quality of evidence and strength of recommendations. BMJ 2004;328(7454):1490-4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC428525</ArticleId><ArticleId IdType="pubmed">15205295</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>ATTRACT 2017</Title><Reference><Citation>Vedantham S, Goldhaber SZ, Julian JA, Kahn SR, Jaff MR, Cohen DJ, et al, on behalf of the ATTRACT Trial Investigators. Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis. New England Journal of Medicine 2017;377(23):2240-52. [DOI: 10.1056/NEJMoa1615066]</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1615066</ArticleId><ArticleId IdType="pmc">PMC5763501</ArticleId><ArticleId IdType="pubmed">29211671</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Barco 2021</Title><Reference><Citation>Barco S, Valerio L, Gallo A, Turatti G, Mahmoudpour SH, Ageno W, et al. Global reporting of pulmonary embolism-related deaths in the World Health Organization mortality database: vital registration data from 123 countries. Research and Practice in Thrombosis and Haemostasis 2021;5(5):e12520. [DOI: 10.1002/rth2.12520]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rth2.12520</ArticleId><ArticleId IdType="pmc">PMC8268665</ArticleId><ArticleId IdType="pubmed">34263098</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Barnes 2020</Title><Reference><Citation>Barnes GD, Muzikansky A, Cameron S, Giri J, Heresi GA, Jaber W, et al. Comparison of 4 acute pulmonary embolism mortality risk scores in patients evaluated by pulmonary embolism response teams. JAMA Network Open 2020;3(8):e2010779. [DOI: 10.1001/jamanetworkopen.2020.10779]</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.10779</ArticleId><ArticleId IdType="pmc">PMC7450352</ArticleId><ArticleId IdType="pubmed">32845326</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Becattini 2016</Title><Reference><Citation>Becattini C, Agnelli G, Lankeit M, Masotti L, Pruszczyk P, Casazza F, et al. Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model. European Respiratory Journal 2016;48(3):780-6. [DOI: 10.1183/13993003.00024-2016]</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00024-2016</ArticleId><ArticleId IdType="pubmed">27174887</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Beyer 2020</Title><Reference><Citation>Beyer SE, Shanafelt C, Pinto DS, Weinstein JL, Aronow HD, Weinberg I, et al. Utilization and outcomes of thrombolytic therapy for acute pulmonary embolism: a nationwide cohort study. Chest 2020;157(3):645-53. [DOI: 10.1016/j.chest.2019.10.049]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2019.10.049</ArticleId><ArticleId IdType="pubmed">31783016</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bloomer 2017</Title><Reference><Citation>Bloomer TL, El-Hayek GE, McDaniel MC, Sandvall BC, Liberman HA, Devireddy CM, et al. Safety of catheter-directed thrombolysis for massive and submassive pulmonary embolism: results of a multicenter registry and meta-analysis. Catheterization and Cardiovascular Interventions 2017;89(4):754-60. [DOI: 10.1002/ccd.26900]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccd.26900</ArticleId><ArticleId IdType="pubmed">28145042</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Boon 2020</Title><Reference><Citation>Boon GJ, Bogaard HJ, Klok FA. Essential aspects of the follow-up after acute pulmonary embolism: an illustrated review. Research and Practice in Thrombosis and Haemostasis 2020;4(6):958-68. [DOI: 10.1002/rth2.12404]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rth2.12404</ArticleId><ArticleId IdType="pmc">PMC7443426</ArticleId><ArticleId IdType="pubmed">32864549</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Brailovsky 2019</Title><Reference><Citation>Brailovsky Y, Lakhter V, Weinberg I, Porcaro K, Haines J, Morris S, et al. Right ventricular outflow Doppler predicts low cardiac index in intermediate risk pulmonary embolism. Clinical and Applied Thrombosis/Hemostasis 2019;25:1076029619886062. [DOI: 10.1177/1076029619886062]</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1076029619886062</ArticleId><ArticleId IdType="pmc">PMC7019409</ArticleId><ArticleId IdType="pubmed">31722539</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Brailovsky 2021</Title><Reference><Citation>Brailovsky Y, Masic D, Allen S, Lakhter V, Bashir R, Forfia P, et al. Novel CT-derived parameter is associated with low cardiac index in acute pulmonary embolism. Thrombosis Research 2021;202:105-7. [DOI: 10.1016/j.thromres.2021.03.014]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2021.03.014</ArticleId><ArticleId IdType="pubmed">33812279</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Caron 2019</Title><Reference><Citation>Caron A, Depas N, Chazard E, Yelnik C, Jeanpierre E, Paris C, et al. Risk of pulmonary embolism more than 6 weeks after surgery among cancer-free middle-aged patients. JAMA Surgery 2019;154(12):1126-32. [DOI: 10.1001/jamasurg.2019.3742]</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2019.3742</ArticleId><ArticleId IdType="pmc">PMC6802263</ArticleId><ArticleId IdType="pubmed">31596449</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Cherfan 2021</Title><Reference><Citation>Cherfan P, Abou Ali AN, Zaghloul MS, Yuo TH, Phillips DP, Chaer RA, et al. Propofol administration during catheter-directed interventions for intermediate-risk pulmonary embolism is associated with major adverse events. Journal of Vascular Surgery: Venous and Lymphatic Disorders 2021;9(3):621-6. [DOI: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">32858244</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Clark 2013</Title><Reference><Citation>Clark D, McGriffin DC, Dell'Italia LJ, Ahmed MI. Submassive pulmonary embolism: where's the tipping point? Circulation 2013;127(24):2458-64. [DOI: 10.1161/CIRCULATIONAHA.112.000859]</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.112.000859</ArticleId><ArticleId IdType="pubmed">23775195</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>COMMAND VTE Registry 2021</Title><Reference><Citation>Yamashita&#xa0;Y, &#xa0;Morimoto&#xa0;T, &#xa0;Kadota&#xa0;K, Takase T, Hiramori S, Kim K, et al, on behalf of the COMMAND VTE Registry Investigators. Severity of pulmonary embolism at initial diagnosis and long-term clinical outcomes: from the COMMAND VTE registry. International Journal of Cardiology 2021;343:107-13. [DOI: 10.1016/j.ijcard.2021.08.052]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2021.08.052</ArticleId><ArticleId IdType="pubmed">34499975</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Covidence [Computer program]</Title><Reference><Citation>Covidence. Melbourne, Australia: Veritas Health Innovation, accessed 5 April 2020. Available at covidence.org.</Citation></Reference></ReferenceList><ReferenceList><Title>Dhruva 2022</Title><Reference><Citation>Dhruva SS, Redberg RF. Coverage of transvenous pulmonary embolectomy &#x2013; Medicare's missed opportunity for evidence generation. New England Journal of Medicine 2022;386:904-6. [DOI: 10.1056/NEJMp2114960]</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp2114960</ArticleId><ArticleId IdType="pubmed">34788505</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Dotter 1972</Title><Reference><Citation>Dotter CT, Rosch J, Seaman AJ, Dennis D, Massey WH. Streptokinase treatment of thromboembolic disease. Radiology 1972;102:283-90. [DOI: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">5009927</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>ESC 2014</Title><Reference><Citation>Konstrantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Nazzareno G, et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. European Heart Journal 2014;35(43):3033-69. [DOI: 10.1093/eurheartj/ehu283]</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehu283</ArticleId><ArticleId IdType="pubmed">25173341</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>ESC 2019</Title><Reference><Citation>Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, et al. 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). European Heart Journal 2020;41(4):543-603. [DOI: 10.1093/eurheartj/ehz405]</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehz405</ArticleId><ArticleId IdType="pubmed">31504429</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>EXTRACT&#x2010;PE 2021</Title><Reference><Citation>Sista AK, Horowitz JM, Tapson VF, Rosenberg M, Elder MD, Schiro BJ, et al. Indigo aspiration system for treatment of pulmonary embolism: results of the EXTRACT-PE trial. JACC: Cardiovascular Interventions 2021;14(3):319-29. [DOI: 10.1016/j.jcin.2020.09.053]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2020.09.053</ArticleId><ArticleId IdType="pubmed">33454291</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Furlan 2012</Title><Reference><Citation>Furlan A, Aghayev A, Chang C-CH, Patil A, Jeon KN, Park B, et al. Short-term mortality in acute pulmonary embolism: clot burden and signs of right heart dysfunction at CT pulmonary angiography. Radiology 2012;265(1):283-93. [DOI: 10.1148/radiol.12110802]</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.12110802</ArticleId><ArticleId IdType="pmc">PMC3447174</ArticleId><ArticleId IdType="pubmed">22993221</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Goldhaber 2013</Title><Reference><Citation>Goldhaber SZ. Surgical pulmonary embolectomy: the resurrection of an almost discarded operation. Texas Heart Institute Journal 2013;40(1):5-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3568292</ArticleId><ArticleId IdType="pubmed">23468580</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>GRADEpro GDT 2015 [Computer program]</Title><Reference><Citation>GRADEpro GDT. Version accessed 20 April 2018. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015. Available at gradepro.org.</Citation></Reference></ReferenceList><ReferenceList><Title>Guyatt 2011a</Title><Reference><Citation>Guyatt GH, Oxman AD, Vist G, Kunz R, Brozek J, Alonso-Coello P, et al. GRADE guidelines: 4. Rating the quality of evidence &#x2013; study limitations (risk of bias). Journal of Clinical Epidemiology 2011;64(4):407-15. [DOI: 10.1016/j.jclinepi.2010.07.017]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2010.07.017</ArticleId><ArticleId IdType="pubmed">21247734</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Guyatt 2011b</Title><Reference><Citation>Guyatt GH, Oxman AD, Montorid V, Vistc G, Kunze R, Brozek J, et al. GRADE guidelines: 5. Rating the quality of evidence &#x2013; publication bias. Journal of Clinical Epidemiology 2011;64(12):1277-82. [DOI: 10.1016/j.jclinepi.2011.01.011]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2011.01.011</ArticleId><ArticleId IdType="pubmed">21802904</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Guyatt 2011c</Title><Reference><Citation>Guyatt GH, Oxman AD, Kunz R, Brozek J, Alonso-Coello P, Rind D, et al. GRADE guidelines 6. Rating the quality of evidence &#x2013; imprecision. Journal of Clinical Epidemiology 2011;64(12):1283-93. [DOI: 10.1016/j.jclinepi.2011.01.012]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2011.01.012</ArticleId><ArticleId IdType="pubmed">21839614</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Guyatt 2011d</Title><Reference><Citation>Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. GRADE guidelines: 7. Rating the quality of evidence &#x2013; inconsistency. Journal of Clinical Epidemiology 2011;64(12):1294-302. [DOI: 10.1016/j.jclinepi.2011.03.017]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2011.03.017</ArticleId><ArticleId IdType="pubmed">21803546</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Guyatt 2011e</Title><Reference><Citation>Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. GRADE guidelines: 8. Rating the quality of evidence &#x2013; indirectness. Journal of Clinical Epidemiology 2011;64(12):1303-10. [DOI: 10.1016/j.jclinepi.2011.04.014]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2011.04.014</ArticleId><ArticleId IdType="pubmed">21802903</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Higgins 2017</Title><Reference><Citation>Higgins JP, Altman DG, Sterne JA, editor(s). Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017), Cochrane, 2017. Available from training.cochrane.org/handbook/archive/v5.2.</Citation></Reference></ReferenceList><ReferenceList><Title>Higgins 2021</Title><Reference><Citation>Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.</Citation></Reference></ReferenceList><ReferenceList><Title>Ho 2019</Title><Reference><Citation>Ho KM, Rao S, Honeybul S, Zellweger R, Wibrow B, Lipman J, et al. A multicenter trial of vena cava filters in severely injured patients. New England Journal of Medicine 2019;381:328-37. [DOI: 10.1056/NEJMoa1806515]</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1806515</ArticleId><ArticleId IdType="pubmed">31259488</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Hobohm 2020</Title><Reference><Citation>Hobohm L, Becattini C, Konstantinides SV, Casazza F, Lankeit M. Validation of a fast prognostic score for risk stratification of normotensive patients with acute pulmonary embolism. Clinical Research in Cardiology 2020;109(8):1008-17. [DOI: 10.1007/s00392-019-01593-w]</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-019-01593-w</ArticleId><ArticleId IdType="pmc">PMC7376081</ArticleId><ArticleId IdType="pubmed">32025793</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kaatz 2015</Title><Reference><Citation>Kaatz S, Ahmad D, Spyropoulos AC, Schulman S, Subcommittee on Control of Anticoagulation. Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH. Journal of Thrombosis and Haemostasis 2015;13(11):2119-26. [DOI: 10.1111/jth.13140]</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.13140</ArticleId><ArticleId IdType="pubmed">26764429</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kadakia 2022</Title><Reference><Citation>Kadakia KT, Beckman AL, Ross JS, Krumholz HM. Renewing the call for reforms to medical device safety &#x2013; the case of Penumbra. JAMA Internal Medicine 2022;182(1):59-65. [PMID: 10.1001/jamainternmed.2021.6626]</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2021.6626</ArticleId><ArticleId IdType="pubmed">34842892</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kahn 2017</Title><Reference><Citation>Kahn SR, Hirsch AM, Akaberi A, Hernandez P, Anderson DR, Wells PS, et al. Functional and exercise limitations after a first episode of pulmonary embolism: results of the ELOPE prospective cohort study. Chest 2017;151(5):1058-68. [DOI: 10.1016/j.chest.2016.11.030]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2016.11.030</ArticleId><ArticleId IdType="pubmed">27932051</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kalra 2017</Title><Reference><Citation>Kalra R, Bajaj NS, Arora P, Arora G, Crosland WA, McGiffin DC. Surgical embolectomy for acute pulmonary embolism: systematic review and comprehensive meta-analyses. Annals of Thoracic Surgery 2017;103(3):982-90. [DOI: 10.1016/j.athoracsur.2016.11.016]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2016.11.016</ArticleId><ArticleId IdType="pubmed">28159170</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Keller 2020</Title><Reference><Citation>Keller K, Hobohm L, Ebner M, Kresoja K-P, M&#xfc;nzel T, Konstantinides SV, et al. Trends in thrombolytic treatment and outcomes of acute pulmonary embolism in Germany. European Heart Journal 2020;41(4):522-9. [DOI: 10.1093/eurheartj/ehz236]</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehz236</ArticleId><ArticleId IdType="pubmed">31102407</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Klok 2014</Title><Reference><Citation>Klok FA, Hulle T, den Exter PL, Lankeit M. The post-PE syndrome: a new concept for chronic complications of pulmonary embolism. Blood Reviews 2014;28(6):221-26. [DOI: 10.1016/j.blre.2014.07.003]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.blre.2014.07.003</ArticleId><ArticleId IdType="pubmed">25168205</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kucher 2006</Title><Reference><Citation>Kucher N, Rossi E, De Rosa M, Goldhaber SZ. Massive pulmonary embolism. Circulation 2006;113(4):577-82. [DOI: 10.1161/CIRCULATIONAHA.105.592592]</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.105.592592</ArticleId><ArticleId IdType="pubmed">16432055</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kuo 2008</Title><Reference><Citation>Kuo WT, den Bosch MA, Hofmann LV, Louie JD, Kothary N, Sze DY. Catheter-directed embolectomy, fragmentation, and thrombolysis for the treatment of massive pulmonary embolism after failure of systemic thrombolysis. Chest 2008;134(2):250-4.</Citation><ArticleIdList><ArticleId IdType="pubmed">18682455</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kuo 2009</Title><Reference><Citation>Kuo WT, Gould MK, Louie JD, Rosenberg JK, Sze DY, Hoffmann LV. Catheter-directed therapy for the treatment of massive pulmonary embolism: systematic review and meta-analysis of modern techniques. Journal of Vascular and Interventional Radiology 2009;20(11):1431-40. [DOI: 10.1016/j.jvir.2009.08.002]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvir.2009.08.002</ArticleId><ArticleId IdType="pubmed">19875060</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kuo 2010</Title><Reference><Citation>Kuo WT, Hofmann LV. Drs. Kuo and Hofmann respond. Journal of Vascular and Interventional Radiology 2010;21(11):1776-7. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">20884234</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lang 2014</Title><Reference><Citation>Lange IM, Madani M. Update on chronic thromboembolic pulmonary hypertension. Circulation 2014;130(6):508-13. [DOI: 10.1161/CIRCULATIONAHA.114.009309]</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.114.009309</ArticleId><ArticleId IdType="pubmed">25092279</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lefebvre 2021</Title><Reference><Citation>Lefebvre C, Glanville J, Briscoe S, Littlewood A, Marshall C, Metzendorf M-I, et al. Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.</Citation></Reference></ReferenceList><ReferenceList><Title>Madani 2016</Title><Reference><Citation>Madani M, Mayer E, Fadel E, Jenkins DP. Pulmonary endarterectomy. Annals of the American Thoracic Society 2016;13(3):S240-7. [DOI: 10.1513/AnnalsATS.201601-014AS]</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.201601-014AS</ArticleId><ArticleId IdType="pubmed">27571005</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Manchec 2019</Title><Reference><Citation>Manchec B, Liu B, Tran T, Zuchowski C, Guruvadoo K, Parente R, et al. Sedation with propofol during catheter-directed thrombolysis for acute submassive pulmonary embolism is associated with increased mortality. Journal of Vascular and Interventional Radiology 2019;30:1719-24. [DOI: 10.1016/j.jvir.2019.08.009]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvir.2019.08.009</ArticleId><ArticleId IdType="pubmed">31587943</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Marti 2014</Title><Reference><Citation>Marti C, John G, Konstantinides S, Combescure C, Sanchez O, Lankeit M, et al. Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis. European Heart Journal June 2014;36(10):605-14. [DOI: 10.1093/eurheartj/ehu218]</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehu218</ArticleId><ArticleId IdType="pmc">PMC4352209</ArticleId><ArticleId IdType="pubmed">24917641</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mathai 2016</Title><Reference><Citation>Mathai SC, Ghofrani H-A, Mayer E, Pepke-Zaba J, Nikkho S, Simmonneau G. Quality of life in patients with chronic thromboembolic pulmonary hypertension. European Respiratory Journal 2016;48(6):1-12. [DOI: 10.1183/13993003.01626-2015]</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01626-2015</ArticleId><ArticleId IdType="pmc">PMC4967564</ArticleId><ArticleId IdType="pubmed">27076580</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>McFadden 2010</Title><Reference><Citation>McFadden PM, Ochsner JL. Aggressive approach to pulmonary embolectomy for massive acute pulmonary embolism: a historical and contemporary perspective. Mayo Clinic Proceedings 2010;85(9):782-4. [DOI: 10.4065/mcp.2010.0481]</Citation><ArticleIdList><ArticleId IdType="doi">10.4065/mcp.2010.0481</ArticleId><ArticleId IdType="pmc">PMC2931612</ArticleId><ArticleId IdType="pubmed">20810791</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mehran 2011</Title><Reference><Citation>Mehran R, Rao SV, Bhatt DL, Gibson M, Caixeta A, Eikelboom J, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium. Circulation 2011;123:2736-47. [DOI: 10.1161/CIRCULATIONAHA.110.009449]</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.110.009449</ArticleId><ArticleId IdType="pubmed">21670242</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Meinel 2015</Title><Reference><Citation>Meinel FG, Nance Jr JW, Schoepf UJ, Hoffmann VS, Thierfelder KM, Costello P, et al. Predictive value of computed tomography in acute pulmonary embolism: systematic review and meta-analysis. American Journal of Medicine 2015;128(7):747-59. [EMBASE: 10.1016/j.amjmed.2015.01.023]</Citation><ArticleIdList><ArticleId IdType="pubmed">25680885</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Meyer 2014</Title><Reference><Citation>Meyer G, Vicaut E, Danays MD, Agnelli G, Becattini C, Beyer-Westendorf J, et al. Fibrinolysis for patients with intermediate-risk pulmonary embolism. New England Journal of Medicine 2014;370(15):1402-11. [DOI: 10.1056/NEJMoa1302097]</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1302097</ArticleId><ArticleId IdType="pubmed">24716681</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mir&#xf3; 2021</Title><Reference><Citation>Mir&#xf3; &#xd2;, Jim&#xe9;nez S, Mebazaa A, Freund Y, Burillo-Putze G, Mart&#xed;n A, et al. Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome. European Heart Journal 2021;42(33):3127-42. [DOI: 10.1093/eurheartj/ehab314]</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab314</ArticleId><ArticleId IdType="pmc">PMC8344714</ArticleId><ArticleId IdType="pubmed">34164664</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>NCT03426124</Title><Reference><Citation>NCT03426124. An international pulmonary embolism registry using EKOS (KNOCOUT PE). clinicaltrials.gov/ct2/show/NCT03426124 (first received 8 February 2018). [CLINICALTRIALS.GOV: NCT03426124]</Citation></Reference></ReferenceList><ReferenceList><Title>NCT03761173</Title><Reference><Citation>NCT03761173. FlowTriever All-Comer Registry for patient safety and hemodynamics (FLASH). clinicaltrials.gov/ct2/show/NCT03761173 (first received 3 December 2018). [CLINICALTRIALS.GOV IDENTIFIER: NCT03761173]</Citation></Reference></ReferenceList><ReferenceList><Title>NCT04248868</Title><Reference><Citation>NCT04248868. tPA by endovascular administration for the treatment of submassive PE using CDT for the reduction of thrombus burden (RESCUE). clinicaltrials.gov/ct2/show/NCT04248868 (first received 30 January 2020). [CLINICALTRIALS.GOV IDENTIFIER: NCT04248868]</Citation></Reference></ReferenceList><ReferenceList><Title>NCT04795167</Title><Reference><Citation>NCT04795167. FLowTriever for acute massive pulmonary embolism (FLAME). clinicaltrials.gov/ct2/show/NCT04795167 (first received 12 March 2021). [CLINICALTRIALS.GOV IDENTIFIER: NCT04795167]</Citation></Reference></ReferenceList><ReferenceList><Title>NCT04798261</Title><Reference><Citation>NCT04798261. Study of the long-term safety and outcomes of treating pulmonary embolism with the Indigo Aspiration System. clinicaltrials.gov/ct2/show/NCT04798261 (first received 15 March 21).</Citation></Reference></ReferenceList><ReferenceList><Title>PEITHO 2014</Title><Reference><Citation>Meyer G, Vicaut E, Danays T, Agnelli G, Becattini C, Beyer-Westendorf J, et al, on behalf of the PEITHO investigators. Fibrinolysis for patients with intermediate-risk pulmonary embolism. New England Journal of Medicine 2014;370(15):1402-11. [DOI: 10.1056/NEJMoa1302097]</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1302097</ArticleId><ArticleId IdType="pubmed">24716681</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>PERFECT 2015</Title><Reference><Citation>Kuo WT, Banerjee A, Kim PS, DeMarco FJ Jr, Levy JR, Facchini FR, et al. Pulmonary embolism response to fragmentation, embolectomy, and catheter thrombolysis (PERFECT): initial results from a prospective multicenter registry. Chest 2015;148(3):66773. [CLINICALTRIAL.GOV: NCT01097928] [DOI: 10.1378/chest.15-0119]</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.15-0119</ArticleId><ArticleId IdType="pubmed">25856269</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Pesavento 2017</Title><Reference><Citation>Pesavento R, Filippi L, Palla A, Vison&#xe0; A, Bova C, Marzolo M, et al. Impact of residual pulmonary obstruction on the long-term outcome of patients with pulmonary embolism. European Respiratory Journal 2017;49:1601980. [DOI: 10.1183/13993003.01980-2016]</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01980-2016</ArticleId><ArticleId IdType="pubmed">28546279</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Piazza 2010</Title><Reference><Citation>Piazza G, Goldhaber SZ. Management of submassive pulmonary embolism. Circulation 2010;122(11):1124-9. [DOI: 10.1161/CIRCULATIONAHA.110.961136]</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.110.961136</ArticleId><ArticleId IdType="pmc">PMC2941210</ArticleId><ArticleId IdType="pubmed">20837937</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>PREPIC2 2015</Title><Reference><Citation>Mismetti P, Laporte S, Pellerin O, Ennezat PV, Couturaud F, Elias A, et al, on behalf of the PREPIC2 study group. Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial. JAMA 2015;313(16):1627-35. [DOI: 10.1001/jama.2015.3780]</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2015.3780</ArticleId><ArticleId IdType="pubmed">25919526</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Review Manager 2020 [Computer program]</Title><Reference><Citation>Review Manager 5 (RevMan 5). Version 5.4. Copenhagen: Nordic Cochrane Centre, the Cochrane Collaboration, 2020.</Citation></Reference></ReferenceList><ReferenceList><Title>Samuels 2019</Title><Reference><Citation>Samuels J, Lawson PJ, Morton AP, Hansen KC, Sauaia A, Schoen JA, et al. Prospective assessment of fibrinolysis in morbid obesity: tissue plasminogen activator resistance improves after bariatric surgery. Surgery for Obesity and Related Diseases 2019;15(7):1153-9. [DOI: 10.1016/j.soard.2019.03.048]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.soard.2019.03.048</ArticleId><ArticleId IdType="pmc">PMC6719338</ArticleId><ArticleId IdType="pubmed">31128997</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Sardar 2020</Title><Reference><Citation>Sardar P, Piazza G, Goldhaber SZ, Liu P-Y, Prabhu W, Soukas P, et al. Predictors of treatment response following ultrasound-facilitated catheter-directed thrombolysis for submassive and massive pulmonary embolism: a SEATTLE II substudy. Circulation: Cardiovascular Interventions 2020;13(6):1-6. [DOI: 10.1161/CIRCINTERVENTIONS.119.008747]</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCINTERVENTIONS.119.008747</ArticleId><ArticleId IdType="pubmed">32519884</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Schmitz&#x2010;Rode 1998</Title><Reference><Citation>Schmitz-Rode T, Kilbinger M, Gunther RW. Simulated flow pattern in massive pulmonary embolism: significance for selective intrapulmonary thrombolysis. Cardiovascular and Interventional Radiology 1998;21(3):199-204. [DOI: 10.1007/s002709900244]</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s002709900244</ArticleId><ArticleId IdType="pubmed">9626434</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Schulman 2005</Title><Reference><Citation>Schulman S, Kearon C, Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. Journal of Thrombosis and Haemostasis 2005;3(4):692-4. [DOI: 10.1111/j.1538-7836.2005.01204.x]</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2005.01204.x</ArticleId><ArticleId IdType="pubmed">15842354</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>SEATTLE II 2015</Title><Reference><Citation>Piazza G, Hohlfelder B, Jaff MR, Ouriel K, Engelhardt TC, Sterling KM, et al. A prospective, single-arm, multicenter trial of ultrasound-facilitated, catheter-directed, low-dose fibrinolysis for acute massive and submassive pulmonary embolism: the SEATTLE II Study. JACC: Cardiovascular Interventions 2015;8(10):1382-92. [DOI: 10.1016/j.jcin.2015.04.020]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2015.04.020</ArticleId><ArticleId IdType="pubmed">26315743</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Secemsky 2018</Title><Reference><Citation>Secemsky E, Chang Y, Jain CC, Beckman&#xa0;JA, &#xa0;Giri&#xa0;J, &#xa0;Jaff MR, &#xa0;et al. Contemporary management and outcomes of patients with massive and submassive pulmonary embolism. American Journal of Medicine 2018;131(12):1506-14. [DOI: 10.1016/j.amjmed.2018.07.035]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2018.07.035</ArticleId><ArticleId IdType="pubmed">30102908</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>SUNSET sPE 2021</Title><Reference><Citation>Avgerinos ED, Jaber W, Lacomis J, Markel K, McDaniel M, Rivera-Lebron BN, et al, on behalf of SUNSET sPE Collaborators. Randomized trial comparing standard versus ultrasound-assisted thrombolysis for submassive pulmonary embolism: the SUNSET sPE trial. JACC: Cardiovascular Interventions 2021;14(12):1364-73. [DOI: 10.1016/j.jcin.2021.04.049]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2021.04.049</ArticleId><ArticleId IdType="pmc">PMC9057455</ArticleId><ArticleId IdType="pubmed">34167677</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>TIPES 2010</Title><Reference><Citation>Becattini C, Agnelli G, Salvi A, Grifoni S, Pancaldi LG, Enea I, et al, on behalf of the TIPES Study Group. Bolus tenecteplase for right ventricle dysfunction in hemodynamically stable patients with pulmonary embolism. Thrombosis Research 2010;125(3):e82-6. [DOI: 10.1016/j.thromres.2009.09.017]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2009.09.017</ArticleId><ArticleId IdType="pubmed">19833379</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Todoran 2018</Title><Reference><Citation>Todoran&#xa0;TM, Giri&#xa0;J, Barnes&#xa0;GD, Rosovsky RP, Chang Y, Jaff MR, et al, on behalf of the PERT Consortium. Treatment of submassive and massive pulmonary embolism: a clinical practice survey from the second annual meeting of the Pulmonary Embolism Response Team Consortium. Journal of Thrombosis and Thrombolysis 2018;46(1):39-49. [DOI: 10.1007/s11239-018-1659-5]</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-018-1659-5</ArticleId><ArticleId IdType="pubmed">29667126</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Virani 2021</Title><Reference><Citation>Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, et al. Heart disease and stroke statistics &#x2013; 2021 update: a report from the American Heart Association. Circulation 2021;143(8):e254-743. [DOI: 10.1161/CIR.0000000000000950]</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000950</ArticleId><ArticleId IdType="pubmed">33501848</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Wood 2002</Title><Reference><Citation>Wood K. Major pulmonary embolism: review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism. Chest 2002;121(3):877-905.</Citation><ArticleIdList><ArticleId IdType="pubmed">11888976</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Young 2020</Title><Reference><Citation>Young T, Srinam KB. Vena caval filters for the prevention of pulmonary embolism. Cochrane Database of Systematic Reviews 2020, Issue 10. Art. No: CD006212. [DOI: 10.1002/14651858.CD006212.pub5]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD006212.pub5</ArticleId><ArticleId IdType="pmc">PMC8971091</ArticleId><ArticleId IdType="pubmed">33027844</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Yuriditsky 2020</Title><Reference><Citation>Yuriditsky E, Mitchell OJ, Sista AK, Xia Y, Sibley RA, Zhong J, et al. Right ventricular stroke distance predicts death and clinical deterioration in patients with pulmonary embolism. Thrombosis Research 2020;195:29-34. [DOI: 10.1016/j.thromres.2020.06.049]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.06.049</ArticleId><ArticleId IdType="pubmed">32652350</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Zuo 2021</Title><Reference><Citation>Zuo Z, Yue J, Dong BR, Wu T, Liu GJ, Hao Q. Thrombolytic therapy for pulmonary embolism. Cochrane Database of Systematic Reviews 2021, Issue 4. Art. No: CD004437. [DOI: 10.1002/14651858.CD004437.pub6]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD004437.pub6</ArticleId><ArticleId IdType="pmc">PMC8092433</ArticleId><ArticleId IdType="pubmed">33857326</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to other published versions of this review</Title><ReferenceList><Title>Harvey 2018</Title><Reference><Citation>Harvey JJ, Makris GC, Uberoi R. Catheter-directed therapies for the treatment of massive and submassive acute pulmonary embolism. Cochrane Database of Systematic Reviews 2018, Issue 7. Art. No: CD013083. [DOI: 10.1002/14651858.CD013083]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD013083</ArticleId><ArticleId IdType="pmc">PMC9358724</ArticleId><ArticleId IdType="pubmed">35938605</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37827272</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-6868</ISSN><JournalIssue CitedMedium="Internet"><Volume>230</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Apr</Month></PubDate></JournalIssue><Title>American journal of obstetrics and gynecology</Title><ISOAbbreviation>Am J Obstet Gynecol</ISOAbbreviation></Journal><ArticleTitle>Risk of thrombosis and bleeding in gynecologic cancer surgery: systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>403</StartPage><EndPage>416</EndPage><MedlinePgn>403-416</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajog.2023.10.006</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0002-9378(23)00735-4</ELocationID><Abstract><AbstractText Label="OBJECTIVE">This study aimed to provide procedure-specific estimates of the risk of symptomatic venous thromboembolism and major bleeding in the absence of thromboprophylaxis, following gynecologic cancer surgery.</AbstractText><AbstractText Label="DATA SOURCES">We conducted comprehensive searches on Embase, MEDLINE, Web of Science, and Google Scholar for observational studies. We also reviewed reference lists of eligible studies and review articles. We performed separate searches for randomized trials addressing effects of thromboprophylaxis and conducted a web-based survey on thromboprophylaxis practice.</AbstractText><AbstractText Label="STUDY ELIGIBILITY CRITERIA">Observational studies enrolling &#x2265;50 adult patients undergoing gynecologic cancer surgery procedures reporting absolute incidence for at least 1 of the following were included: symptomatic pulmonary embolism, symptomatic deep vein thrombosis, symptomatic venous thromboembolism, bleeding requiring reintervention (including reexploration and angioembolization), bleeding leading to transfusion, or postoperative hemoglobin &lt;70 g/L.</AbstractText><AbstractText Label="METHODS">Two reviewers independently assessed eligibility, performed data extraction, and evaluated risk of bias of eligible articles. We adjusted the reported estimates for thromboprophylaxis and length of follow-up and used the median value from studies to determine cumulative incidence at 4 weeks postsurgery stratified by patient venous thromboembolism risk factors. The GRADE approach was applied to rate evidence certainty.</AbstractText><AbstractText Label="RESULTS">We included 188 studies (398,167 patients) reporting on 37 gynecologic cancer surgery procedures. The evidence certainty was generally low to very low. Median symptomatic venous thromboembolism risk (in the absence of prophylaxis) was &lt;1% in 13 of 37 (35%) procedures, 1% to 2% in 11 of 37 (30%), and &gt;2.0% in 13 of 37 (35%). The risks of venous thromboembolism varied from 0.1% in low venous thromboembolism risk patients undergoing cervical conization to 33.5% in high venous thromboembolism risk patients undergoing pelvic exenteration. Estimates of bleeding requiring reintervention varied from &lt;0.1% to 1.3%. Median risks of bleeding requiring reintervention were &lt;1% in 22 of 29 (76%) and 1% to 2% in 7 of 29 (24%) procedures.</AbstractText><AbstractText Label="CONCLUSION">Venous thromboembolism reduction with thromboprophylaxis likely outweighs the increase in bleeding requiring reintervention in many gynecologic cancer procedures (eg, open surgery for ovarian cancer and pelvic exenteration). In some procedures (eg, laparoscopic total hysterectomy without lymphadenectomy), thromboembolism and bleeding risks are similar, and decisions depend on individual risk prediction and values and preferences regarding venous thromboembolism and bleeding.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lavikainen</LastName><ForeName>Lauri I</ForeName><Initials>LI</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Helsinki, Helsinki, Finland. Electronic address: lauri.lavikainen@helsinki.fi.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guyatt</LastName><ForeName>Gordon H</ForeName><Initials>GH</Initials><AffiliationInfo><Affiliation>Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Canada; Department of Medicine, McMaster University, Hamilton, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luomaranta</LastName><ForeName>Anna L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cartwright</LastName><ForeName>Rufus</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Gender Affirmation Surgery, Chelsea and Westminster NHS Foundation Trust, London, United Kingdom; Department of Epidemiology and Biostatistics, Imperial College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalliala</LastName><ForeName>Ilkka E J</ForeName><Initials>IEJ</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Couban</LastName><ForeName>Rachel J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, McMaster University, Hamilton, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aaltonen</LastName><ForeName>Riikka L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, Turku University Hospital and University of Turku, Turku, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aro</LastName><ForeName>Karoliina M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>C&#xe1;rdenas</LastName><ForeName>Jovita L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Direction of Health Technology Assessment, National Center for Health Technology Excellence (CENETEC), Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Devereaux</LastName><ForeName>P J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Canada; Department of Medicine, McMaster University, Hamilton, Canada; Population Health Research Institute, Hamilton, Canada; Outcomes Research Consortium, Cleveland, OH.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galambosi</LastName><ForeName>P&#xe4;ivi J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ge</LastName><ForeName>Fang Zhou</ForeName><Initials>FZ</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halme</LastName><ForeName>Alex L E</ForeName><Initials>ALE</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Helsinki, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haukka</LastName><ForeName>Jari</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland; Clinicum/Department of Public Health, University of Helsinki, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Izett-Kay</LastName><ForeName>Matthew L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Urogynaecology Department, John Radcliffe Hospital, Oxford University Hospitals, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joronen</LastName><ForeName>Kirsi M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, Turku University Hospital and University of Turku, Turku, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karjalainen</LastName><ForeName>P&#xe4;ivi K</ForeName><Initials>PK</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Central Finland Central Hospital, Jyv&#xe4;skyl&#xe4;, Finland; Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khamani</LastName><ForeName>Nadina</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Institute of Children's Health, I.M. Sechenov First Moscow State Medical University, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oksjoki</LastName><ForeName>Sanna M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Felicitas Mehil&#xe4;inen Turku, Turku, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pourjamal</LastName><ForeName>Negar</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>ROTBIGGS Investigators</CollectiveName></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Tino</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>T&#xe4;htinen</LastName><ForeName>Riikka M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Tampere University and Tampere University Hospital, Tampere, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vernooij</LastName><ForeName>Robin W M</ForeName><Initials>RWM</Initials><AffiliationInfo><Affiliation>Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands; Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tikkinen</LastName><ForeName>Kari A O</ForeName><Initials>KAO</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Helsinki, Helsinki, Finland; Department of Urology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Department of Surgery, South Karelia Central Hospital, Lappeenranta, Finland. Electronic address: kari.tikkinen@helsinki.fi.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Obstet Gynecol</MedlineTA><NlmUniqueID>0370476</NlmUniqueID><ISSNLinking>0002-9378</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005833" MajorTopicYN="Y">Genital Neoplasms, Female</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="Y">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="Y">Venous Thrombosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013509" MajorTopicYN="Y">Gynecologic Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019106" MajorTopicYN="N">Postoperative Hemorrhage</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">baseline risk</Keyword><Keyword MajorTopicYN="N">bleeding</Keyword><Keyword MajorTopicYN="N">gynecologic surgery</Keyword><Keyword MajorTopicYN="N">modeling</Keyword><Keyword MajorTopicYN="N">reporting</Keyword><Keyword MajorTopicYN="N">risk of bias</Keyword><Keyword MajorTopicYN="N">thromboprophylaxis</Keyword><Keyword MajorTopicYN="N">venous thromboembolism</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>Ahopelto</LastName><ForeName>Kaisa</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aoki</LastName><ForeName>Yoshitaka</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Beilmann-Lehtonen</LastName><ForeName>Ines</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Blanker</LastName><ForeName>Marco H</ForeName><Initials>MH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Craigie</LastName><ForeName>Samantha</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Elberkennou</LastName><ForeName>Jaana</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Garcia-Perdomo</LastName><ForeName>Herney A</ForeName><Initials>HA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gomaa</LastName><ForeName>Huda A</ForeName><Initials>HA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gross</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hajebrahimi</LastName><ForeName>Sakineh</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Karanicolas</LastName><ForeName>Paul J</ForeName><Initials>PJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kilpel&#xe4;inen</LastName><ForeName>Tuomas P</ForeName><Initials>TP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kivel&#xe4;</LastName><ForeName>Antti J</ForeName><Initials>AJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Korhonen</LastName><ForeName>Tapio</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lampela</LastName><ForeName>Hanna</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lee</LastName><ForeName>Yung</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mattila</LastName><ForeName>Anne K</ForeName><Initials>AK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Najafabadi</LastName><ForeName>Borna Tadayon</ForeName><Initials>BT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nyk&#xe4;nen</LastName><ForeName>Taina P</ForeName><Initials>TP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nyst&#xe9;n</LastName><ForeName>Carolina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pandanaboyana</LastName><ForeName>Sanjay</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ratnayake</LastName><ForeName>Chathura B B</ForeName><Initials>CBB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Raudasoja</LastName><ForeName>Aleksi R</ForeName><Initials>AR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sallinen</LastName><ForeName>Ville J</ForeName><Initials>VJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Violette</LastName><ForeName>Philippe D</ForeName><Initials>PD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Xiao</LastName><ForeName>Yingqi</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yao</LastName><ForeName>Liang</ForeName><Initials>L</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>13</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>12</Day><Hour>19</Hour><Minute>25</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37827272</ArticleId><ArticleId IdType="doi">10.1016/j.ajog.2023.10.006</ArticleId><ArticleId IdType="pii">S0002-9378(23)00735-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37452732</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1522-9645</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>32</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>22</Day></PubDate></JournalIssue><Title>European heart journal</Title><ISOAbbreviation>Eur Heart J</ISOAbbreviation></Journal><ArticleTitle>Diagnostic management of acute pulmonary embolism: a prediction model based on a patient data meta-analysis.</ArticleTitle><Pagination><StartPage>3073</StartPage><EndPage>3081</EndPage><MedlinePgn>3073-3081</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/eurheartj/ehad417</ELocationID><Abstract><AbstractText Label="AIMS">Risk stratification is used for decisions regarding need for imaging in patients with clinically suspected acute pulmonary embolism (PE). The aim was to develop a clinical prediction model that provides an individualized, accurate probability estimate for the presence of acute PE in patients with suspected disease based on readily available clinical items and D-dimer concentrations.</AbstractText><AbstractText Label="METHODS AND RESULTS">An individual patient data meta-analysis was performed based on sixteen cross-sectional or prospective studies with data from 28 305 adult patients with clinically suspected PE from various clinical settings, including primary care, emergency care, hospitalized and nursing home patients. A multilevel logistic regression model was built and validated including ten a priori defined objective candidate predictors to predict objectively confirmed PE at baseline or venous thromboembolism (VTE) during follow-up of 30 to 90 days. Multiple imputation was used for missing data. Backward elimination was performed with a P-value &lt;0.10. Discrimination (c-statistic with 95% confidence intervals [CI] and prediction intervals [PI]) and calibration (outcome:expected [O:E] ratio and calibration plot) were evaluated based on internal-external cross-validation. The accuracy of the model was subsequently compared with algorithms based on the Wells score and D-dimer testing. The final model included age (in years), sex, previous VTE, recent surgery or immobilization, haemoptysis, cancer, clinical signs of deep vein thrombosis, inpatient status, D-dimer (in &#xb5;g/L), and an interaction term between age and D-dimer. The pooled c-statistic was 0.87 (95% CI, 0.85-0.89; 95% PI, 0.77-0.93) and overall calibration was very good (pooled O:E ratio, 0.99; 95% CI, 0.87-1.14; 95% PI, 0.55-1.79). The model slightly overestimated VTE probability in the lower range of estimated probabilities. Discrimination of the current model in the validation data sets was better than that of the Wells score combined with a D-dimer threshold based on age (c-statistic 0.73; 95% CI, 0.70-0.75) or structured clinical pretest probability (c-statistic 0.79; 95% CI, 0.76-0.81).</AbstractText><AbstractText Label="CONCLUSION">The present model provides an absolute, individualized probability of PE presence in a broad population of patients with suspected PE, with very good discrimination and calibration. Its clinical utility needs to be evaluated in a prospective management or impact study.</AbstractText><AbstractText Label="REGISTRATION">PROSPERO ID 89366.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>van Es</LastName><ForeName>Nick</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-5256-6346</Identifier><AffiliationInfo><Affiliation>Amsterdam University Medical Center, Department of Vascular Medicine, University of Amsterdam, Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Cardiovascular Sciences, Pulmonary Hypertension &amp; Thrombosis, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takada</LastName><ForeName>Toshihiko</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, 3584 CG, Utrecht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of General Medicine, Shirakawa Satellite for Teaching And Research (STAR), Fukushima Medical University, 1 Hikarigaoka, Fukushima, 960-1247, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kraaijpoel</LastName><ForeName>No&#xe9;mie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Amsterdam University Medical Center, Department of Vascular Medicine, University of Amsterdam, Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Cardiovascular Sciences, Pulmonary Hypertension &amp; Thrombosis, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klok</LastName><ForeName>Frederikus A</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Department of Medicine, Thrombosis and Hemostasis, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, Zuid-Holland, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stals</LastName><ForeName>Milou A M</ForeName><Initials>MAM</Initials><AffiliationInfo><Affiliation>Department of Medicine, Thrombosis and Hemostasis, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, Zuid-Holland, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>B&#xfc;ller</LastName><ForeName>Harry R</ForeName><Initials>HR</Initials><AffiliationInfo><Affiliation>Amsterdam University Medical Center, Department of Vascular Medicine, University of Amsterdam, Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Cardiovascular Sciences, Pulmonary Hypertension &amp; Thrombosis, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Courtney</LastName><ForeName>D Mark</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freund</LastName><ForeName>Yonathan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Emergency Department, Sorbonne University, H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Assistance Publique-H&#xf4;pitaux de Paris, 47-83 Bd de l'H&#xf4;pital, 75013 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galipienzo</LastName><ForeName>Javier</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Service of Anesthesiology, MD Anderson Cancer Center Madrid, C. de Arturo Soria, 270, 28033 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le Gal</LastName><ForeName>Gr&#xe9;goire</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Ottawa, and the Ottawa Hospital Research Institute, 725 Parkdale Ave, Ottawa, ON K1Y 4E9, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghanima</LastName><ForeName>Waleed</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Departments of Hemato-oncology and Research, &#xd8;stfold hospital, Kalnesveien 300, 1714 Gr&#xe5;lum, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Clinical Medicine, University of Oslo, Klaus Torg&#xe5;rds vei 3, 0372 Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huisman</LastName><ForeName>Menno V</ForeName><Initials>MV</Initials><AffiliationInfo><Affiliation>Department of Medicine, Thrombosis and Hemostasis, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, Zuid-Holland, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kline</LastName><ForeName>Jeffrey A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Wayne State University School of Medicine, 540 E Canfield St, Detroit, MI 4820, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moons</LastName><ForeName>Karel G M</ForeName><Initials>KGM</Initials><AffiliationInfo><Affiliation>Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, 3584 CG, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parpia</LastName><ForeName>Sameer</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Health Research Methods, Evidence, &amp; Impact, McMaster University, 1200 Main St W, Hamilton, ON L8N 3Z5, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Oncology, McMaster University, Juravinski Cancer Centre, 699 Concession St. Suite 4-204, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perrier</LastName><ForeName>Arnaud</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Angiology and Hemostasis, Geneva University Hospitals and Faculty of Medicine, Rue Michel-Servet 1, 1206 Gen&#xe8;ve, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Righini</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Angiology and Hemostasis, Geneva University Hospitals and Faculty of Medicine, Rue Michel-Servet 1, 1206 Gen&#xe8;ve, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robert-Ebadi</LastName><ForeName>Helia</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Angiology and Hemostasis, Geneva University Hospitals and Faculty of Medicine, Rue Michel-Servet 1, 1206 Gen&#xe8;ve, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roy</LastName><ForeName>Pierre-Marie</ForeName><Initials>PM</Initials><Identifier Source="ORCID">0000-0003-4811-6793</Identifier><AffiliationInfo><Affiliation>Emergency Department, CHU Angers, UNIV Angers, 4 Rue Larrey, 49100 Angers, Maine-et-Loire, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wells</LastName><ForeName>Phil S</ForeName><Initials>PS</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Ottawa, and the Ottawa Hospital Research Institute, 725 Parkdale Ave, Ottawa, ON K1Y 4E9, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Wit</LastName><ForeName>Kerstin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Queen's University, 76 Stuart Street, Kingston ON K7L 2V7, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, McMaster Children's Hospital, 1200 Main Street West, Hamilton, L8N 3Z5 Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Evidence and Impact, McMaster University, 1200 Main St W, Hamilton, ON L8N 3Z5, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Smeden</LastName><ForeName>Maarten</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5529-1541</Identifier><AffiliationInfo><Affiliation>Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, 3584 CG, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geersing</LastName><ForeName>Geert-Jan</ForeName><Initials>GJ</Initials><AffiliationInfo><Affiliation>Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, 3584 CG, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur Heart J</MedlineTA><NlmUniqueID>8006263</NlmUniqueID><ISSNLinking>0195-668X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005338">Fibrin Fibrinogen Degradation Products</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Eur Heart J. 2023 Aug 22;44(32):3082-3084. doi: 10.1093/eurheartj/ehad392.</RefSource><PMID Version="1">37475706</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="Y">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="N">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005338" MajorTopicYN="N">Fibrin Fibrinogen Degradation Products</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">D-dimer</Keyword><Keyword MajorTopicYN="N">Pulmonary embolism</Keyword><Keyword MajorTopicYN="N">diagnosis</Keyword><Keyword MajorTopicYN="N">prediction model</Keyword><Keyword MajorTopicYN="N">venous thromboembolism</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>15</Day><Hour>21</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>15</Day><Hour>8</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37452732</ArticleId><ArticleId IdType="pmc">PMC10917087</ArticleId><ArticleId IdType="doi">10.1093/eurheartj/ehad417</ArticleId><ArticleId IdType="pii">7224694</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Huisman &#xa0;MV, Barco &#xa0;S, Cannegieter &#xa0;SC, Le Gal &#xa0;G, Konstantinides &#xa0;SV, Reitsma &#xa0;PH, et al. &#xa0;Pulmonary embolism. Nat Rev Dis Primers &#xa0;2018;4:18028. 10.1038/nrdp.2018.28</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2018.28</ArticleId><ArticleId IdType="pubmed">29770793</ArticleId></ArticleIdList></Reference><Reference><Citation>Konstantinides &#xa0;SV, Meyer &#xa0;G, Becattini &#xa0;C, Bueno &#xa0;H, Geersing &#xa0;GJ, Harjola &#xa0;VP, et al. &#xa0;2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European respiratory society (ERS). Eur Heart J &#xa0;2020;41:543&#x2013;603. 10.1093/eurheartj/ehz405</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehz405</ArticleId><ArticleId IdType="pubmed">31504429</ArticleId></ArticleIdList></Reference><Reference><Citation>Righini &#xa0;M, Van Es &#xa0;J, Den Exter &#xa0;PL, Roy &#xa0;PM, Verschuren &#xa0;F, Ghuysen &#xa0;A, et al. &#xa0;Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study. JAMA &#xa0;2014;311:1117&#x2013;1124. 10.1001/jama.2014.2135</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2014.2135</ArticleId><ArticleId IdType="pubmed">24643601</ArticleId></ArticleIdList></Reference><Reference><Citation>Kearon &#xa0;C, de Wit &#xa0;K, Parpia &#xa0;S, Schulman &#xa0;S, Afilalo &#xa0;M, Hirsch &#xa0;A, et al. &#xa0;Diagnosis of pulmonary embolism with d-dimer adjusted to clinical probability. N Engl J Med &#xa0;2019;381:2125&#x2013;2134. 10.1056/NEJMoa1909159</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1909159</ArticleId><ArticleId IdType="pubmed">31774957</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Hulle &#xa0;T, Cheung &#xa0;WY, Kooij &#xa0;S, Beenen &#xa0;LFM, van Bemmel &#xa0;T, van Es &#xa0;J, et al. &#xa0;Simplified diagnostic management of suspected pulmonary embolism (the YEARS study): a prospective, multicentre, cohort study. Lancet &#xa0;2017;390:289&#x2013;297. 10.1016/S0140-6736(17)30885-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)30885-1</ArticleId><ArticleId IdType="pubmed">28549662</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es &#xa0;N, van der Hulle &#xa0;T, van Es &#xa0;J, den Exter &#xa0;PL, Douma &#xa0;RA, Goekoop &#xa0;RJ, et al. &#xa0;Wells rule and d-dimer testing to rule out pulmonary embolism a systematic review and individual-patient data meta- analysis. Ann Intern Med &#xa0;2016;165:253&#x2013;261. 10.7326/M16-0031</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M16-0031</ArticleId><ArticleId IdType="pubmed">27182696</ArticleId></ArticleIdList></Reference><Reference><Citation>van Belle &#xa0;A, B&#xfc;ller &#xa0;HR, Huisman &#xa0;MV, Huisman &#xa0;PM, Kaasjager &#xa0;K, Kamphuisen &#xa0;PW, et al. &#xa0;Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. JAMA &#xa0;2006;295:172&#x2013;179. 10.1001/jama.295.2.172</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.295.2.172</ArticleId><ArticleId IdType="pubmed">16403929</ArticleId></ArticleIdList></Reference><Reference><Citation>Geersing &#xa0;GJ, Takada &#xa0;T, Klok &#xa0;FA, B&#xfc;ller &#xa0;HR, Courtney &#xa0;DM, Freund &#xa0;Y, et al. &#xa0;Ruling out pulmonary embolism across different healthcare settings: a systematic review and individual patient data meta-analysis. PLoS Med &#xa0;2022;19:e1003905. 10.1371/journal.pmed.1003905</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003905</ArticleId><ArticleId IdType="pmc">PMC8824365</ArticleId><ArticleId IdType="pubmed">35077453</ArticleId></ArticleIdList></Reference><Reference><Citation>Stals &#xa0;MAM, Takada &#xa0;T, Kraaijpoel &#xa0;N, van Es &#xa0;N, B&#xfc;ller &#xa0;HR, Courtney &#xa0;DM, et al. &#xa0;Safety and efficiency of diagnostic strategies for ruling out pulmonary embolism in clinically relevant patient subgroups. Ann Intern Med &#xa0;2022;175:244&#x2013;255. 10.7326/M21-2625</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M21-2625</ArticleId><ArticleId IdType="pubmed">34904857</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells &#xa0;P, Anderson &#xa0;DR, Rodger &#xa0;M, Ginsberg &#xa0;JS, Kearon &#xa0;C, Gent &#xa0;M, et al. &#xa0;Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost &#xa0;2000;83:416&#x2013;420. 10.1055/s-0037-1613830</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0037-1613830</ArticleId><ArticleId IdType="pubmed">10744147</ArticleId></ArticleIdList></Reference><Reference><Citation>Glober &#xa0;N, Tainter &#xa0;CR, Brennan &#xa0;J, Darocki &#xa0;M, Klingfus &#xa0;M, Choi &#xa0;M, et al. &#xa0;The DAGMAR score: D-dimer assay-guided moderation of adjusted risk. Improving specificity of the D-dimer for pulmonary embolism. Am J Emerg Med &#xa0;2019;37:895&#x2013;901. 10.1016/j.ajem.2018.08.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2018.08.018</ArticleId><ArticleId IdType="pubmed">30104092</ArticleId></ArticleIdList></Reference><Reference><Citation>Wicki &#xa0;J, Perneger &#xa0;TV, Junod &#xa0;AF, Bounameaux &#xa0;H, Perrier &#xa0;A. Assessing clinical probability of pulmonary embolism in the emergency ward: a simple score. Arch Intern Med &#xa0;2001;161:92&#x2013;97. 10.1001/archinte.161.1.92</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.161.1.92</ArticleId><ArticleId IdType="pubmed">11146703</ArticleId></ArticleIdList></Reference><Reference><Citation>Moons &#xa0;KGM, Wolff &#xa0;RF, Riley &#xa0;RD, Whiting &#xa0;PF, Westwood &#xa0;M, Collins &#xa0;GS, et al. &#xa0;PROBAST: a tool to assess risk of bias and applicability of prediction model studies: explanation and elaboration. Ann Intern Med &#xa0;2019;170:W1. 10.7326/M18-1377</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M18-1377</ArticleId><ArticleId IdType="pubmed">30596876</ArticleId></ArticleIdList></Reference><Reference><Citation>Geersing &#xa0;GJ, Kraaijpoel &#xa0;N, B&#xfc;ller &#xa0;HR, van Doorn &#xa0;S, van Es &#xa0;N, Le Gal &#xa0;G, et al. &#xa0;Ruling out pulmonary embolism across different subgroups of patients and healthcare settings: protocol for a systematic review and individual patient data meta-analysis (IPDMA). Diagn Progn Res &#xa0;2018;2:10. 10.1186/s41512-018-0032-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41512-018-0032-7</ArticleId><ArticleId IdType="pmc">PMC6460525</ArticleId><ArticleId IdType="pubmed">31093560</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins &#xa0;GS, Reitsma &#xa0;JB, Altman &#xa0;DG, Moons &#xa0;KGM. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. Ann Intern Med &#xa0;2015;162:55&#x2013;63. 10.7326/M14-0697</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M14-0697</ArticleId><ArticleId IdType="pubmed">25560714</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiting &#xa0;PF, Rutjes &#xa0;AWS, Westwood &#xa0;ME, Mallett &#xa0;S, Deeks &#xa0;JJ, Reitsma &#xa0;JB, et al. &#xa0;QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med &#xa0;2011;155:529&#x2013;536. 10.7326/0003-4819-155-8-201110180-00009</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-155-8-201110180-00009</ArticleId><ArticleId IdType="pubmed">22007046</ArticleId></ArticleIdList></Reference><Reference><Citation>Schouten &#xa0;HJ, Geersing &#xa0;GJ, Koek &#xa0;HL, Zuithoff &#xa0;NPA, Janssen &#xa0;KJM, Douma &#xa0;RA, et al. &#xa0;Diagnostic accuracy of conventional or age adjusted D-dimer cut-off values in older patients with suspected venous thromboembolism: systematic review and meta-analysis. BMJ &#xa0;2013;346:f2492. 10.1136/bmj.f2492</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.f2492</ArticleId><ArticleId IdType="pmc">PMC3643284</ArticleId><ArticleId IdType="pubmed">23645857</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Gal &#xa0;G, Righini &#xa0;M, Roy &#xa0;PM, Sanchez &#xa0;O, Aujesky &#xa0;D, Bounameaux &#xa0;H, et al. &#xa0;Prediction of pulmonary embolism in the emergency department: the revised Geneva score. Ann Intern Med &#xa0;2006;144:165&#x2013;171. 10.7326/0003-4819-144-3-200602070-00004</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-144-3-200602070-00004</ArticleId><ArticleId IdType="pubmed">16461960</ArticleId></ArticleIdList></Reference><Reference><Citation>Riley &#xa0;RD, Ensor &#xa0;J, Snell &#xa0;KIE, Harrell &#xa0;FE, Martin &#xa0;GP, Reitsma &#xa0;JB, et al. &#xa0;Calculating the sample size required for developing a clinical prediction model. BMJ &#xa0;2020;368:m441. 10.1136/bmj.m441</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m441</ArticleId><ArticleId IdType="pubmed">32188600</ArticleId></ArticleIdList></Reference><Reference><Citation>Janssen &#xa0;KJM, Donders &#xa0;ART, Harrell &#xa0;FE, Vergouwe &#xa0;Y, Chen &#xa0;Q, Grobbee &#xa0;DE, et al. &#xa0;Missing covariate data in medical research: to impute is better than to ignore. J Clin Epidemiol &#xa0;2010;63:721&#x2013;727. 10.1016/j.jclinepi.2009.12.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2009.12.008</ArticleId><ArticleId IdType="pubmed">20338724</ArticleId></ArticleIdList></Reference><Reference><Citation>Moons &#xa0;KGM, Donders &#xa0;RART, Stijnen &#xa0;T, Harrell &#xa0;FE. Using the outcome for imputation of missing predictor values was preferred. J Clin Epidemiol &#xa0;2006;59:1092&#x2013;1101. 10.1016/j.jclinepi.2006.01.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2006.01.009</ArticleId><ArticleId IdType="pubmed">16980150</ArticleId></ArticleIdList></Reference><Reference><Citation>Madley-Dowd &#xa0;P, Hughes &#xa0;R, Tilling &#xa0;K, Heron &#xa0;J. The proportion of missing data should not be used to guide decisions on multiple imputation. J Clin Epidemiol &#xa0;2019;110:63&#x2013;73. 10.1016/j.jclinepi.2019.02.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2019.02.016</ArticleId><ArticleId IdType="pmc">PMC6547017</ArticleId><ArticleId IdType="pubmed">30878639</ArticleId></ArticleIdList></Reference><Reference><Citation>Audigier &#xa0;V, White &#xa0;IR, Jolani &#xa0;S, Debray &#xa0;TPA, Quartagno &#xa0;M, Carpenter &#xa0;J, et al. &#xa0;Multiple imputation for multilevel data with continuous and binary variables. Stat Sci &#xa0;2018;33:160&#x2013;183. 10.1214/18-STS646</Citation><ArticleIdList><ArticleId IdType="doi">10.1214/18-STS646</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynants &#xa0;L, Vergouwe &#xa0;Y, van Huffel &#xa0;S, Timmerman &#xa0;D, van Calster &#xa0;B. Does ignoring clustering in multicenter data influence the performance of prediction models? A simulation study. Stat Methods Med Res &#xa0;2018;27:1723&#x2013;1736. 10.1177/0962280216668555</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0962280216668555</ArticleId><ArticleId IdType="pubmed">27647815</ArticleId></ArticleIdList></Reference><Reference><Citation>Debray &#xa0;TPA, Collins &#xa0;GS, Riley &#xa0;RD, Snell &#xa0;KIE, Van Calster &#xa0;B, Reitsma &#xa0;JB, et al. &#xa0;Transparent reporting of multivariable prediction models developed or validated using clustered data: tRIPOD-cluster checklist. BMJ &#xa0;2023;380:e071018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9903175</ArticleId><ArticleId IdType="pubmed">36750242</ArticleId></ArticleIdList></Reference><Reference><Citation>Royston &#xa0;P. A smooth covariate rank transformation for use in regression models with a sigmoid dose-response function. Stata J &#xa0;2014;14:329&#x2013;341. 10.1177/1536867X1401400206</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1536867X1401400206</ArticleId><ArticleId IdType="pmc">PMC5663339</ArticleId><ArticleId IdType="pubmed">29097908</ArticleId></ArticleIdList></Reference><Reference><Citation>Moons &#xa0;KGM, Altman &#xa0;DG, Reitsma &#xa0;JB, Ioannidis &#xa0;JPA, Macaskill &#xa0;P, Steyerberg &#xa0;EW, et al. &#xa0;Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med &#xa0;2015;162:W1&#x2013;73. 10.7326/M14-0698</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M14-0698</ArticleId><ArticleId IdType="pubmed">25560730</ArticleId></ArticleIdList></Reference><Reference><Citation>Riley &#xa0;RD &#xa0;van der Windt &#xa0;D &#xa0;Croft &#xa0;P, Moons &#xa0;KGM (eds). Prognosis research in health care. Oxford University Press; 2019.</Citation></Reference><Reference><Citation>Jong &#xa0;VMT, Moons &#xa0;KGM, Eijkemans &#xa0;MJC, Riley &#xa0;RD, Debray &#xa0;TPA. Developing more generalizable prediction models from pooled studies and large clustered data sets. Stat Med &#xa0;2021;40:3533&#x2013;3559. 10.1002/sim.8981</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.8981</ArticleId><ArticleId IdType="pmc">PMC8252590</ArticleId><ArticleId IdType="pubmed">33948970</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyerberg &#xa0;EW, Harrell &#xa0;FE. Prediction models need appropriate internal, internal&#x2013;external, and external validation. J Clin Epidemiol &#xa0;2016;69:245&#x2013;247. 10.1016/j.jclinepi.2015.04.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2015.04.005</ArticleId><ArticleId IdType="pmc">PMC5578404</ArticleId><ArticleId IdType="pubmed">25981519</ArticleId></ArticleIdList></Reference><Reference><Citation>Dronkers &#xa0;CEA, van der Hulle &#xa0;T, Le Gal &#xa0;G, Kyrle &#xa0;PA, Huisman &#xa0;MV, Cannegieter &#xa0;SC, et al. &#xa0;Towards a tailored diagnostic standard for future diagnostic studies in pulmonary embolism: communication from the SSC of the ISTH. J Thromb Haemost &#xa0;2017;15:1040&#x2013;1043. 10.1111/jth.13654</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.13654</ArticleId><ArticleId IdType="pubmed">28296048</ArticleId></ArticleIdList></Reference><Reference><Citation>Geersing &#xa0;G-J, Erkens &#xa0;PMG, Lucassen &#xa0;WAM, Buller &#xa0;HR, Cate &#xa0;HT, Hoes &#xa0;AW, et al. &#xa0;Safe exclusion of pulmonary embolism using the wells rule and qualitative D-dimer testing in primary care: prospective cohort study. BMJ &#xa0;2012;345:e6564. 10.1136/bmj.e6564</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.e6564</ArticleId><ArticleId IdType="pmc">PMC3464185</ArticleId><ArticleId IdType="pubmed">23036917</ArticleId></ArticleIdList></Reference><Reference><Citation>Kline &#xa0;JA, Nelson &#xa0;RD, Jackson &#xa0;RE, Courtney &#xa0;DM. Criteria for the safe use of D -dimer testing in emergency department patients with suspected pulmonary embolism: a multicenter US study. Ann Emerg Med &#xa0;2002;39:144&#x2013;152. 10.1067/mem.2002.121398</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mem.2002.121398</ArticleId><ArticleId IdType="pubmed">11823768</ArticleId></ArticleIdList></Reference><Reference><Citation>Runyon &#xa0;MS, Beam &#xa0;DM, King &#xa0;MC, Lipford &#xa0;EH, Kline &#xa0;JA. Comparison of the simplify D-dimer assay performed at the bedside with a laboratory-based quantitative D-dimer assay for the diagnosis of pulmonary embolism in a low prevalence emergency department population. Emerg Med J &#xa0;2008;25:70&#x2013;75. 10.1136/emj.2007.048918</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/emj.2007.048918</ArticleId><ArticleId IdType="pubmed">18212136</ArticleId></ArticleIdList></Reference><Reference><Citation>Kline &#xa0;JA, Runyon &#xa0;MS, Webb &#xa0;WB, Jones &#xa0;AE, Mitchell &#xa0;AM. Prospective study of the diagnostic accuracy of the simplify D-dimer assay for pulmonary embolism in emergency department patients. Chest &#xa0;2006;129:1417&#x2013;1423. 10.1378/chest.129.6.1417</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.129.6.1417</ArticleId><ArticleId IdType="pubmed">16778257</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanson &#xa0;BJ, Lijmer &#xa0;JG, Mac Gillavry &#xa0;MR, Turkstra &#xa0;F, Prins &#xa0;MH, B&#xfc;ller &#xa0;HR. Comparison of a clinical probability estimate and two clinical models in patients with suspected pulmonary embolism. ANTELOPE-study group. Thromb Haemost &#xa0;2000;83:199&#x2013;203. 10.1055/s-0037-1613785</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0037-1613785</ArticleId><ArticleId IdType="pubmed">10739372</ArticleId></ArticleIdList></Reference><Reference><Citation>Kearon &#xa0;C, Ginsberg &#xa0;JS, Douketis &#xa0;J, Turpie &#xa0;AG, Bates &#xa0;SM, Lee &#xa0;AY, et al. &#xa0;An evaluation of D-dimer in the diagnosis of pulmonary embolism: a randomized trial. Ann Intern Med &#xa0;2006;144:812&#x2013;821. 10.7326/0003-4819-144-11-200606060-00007</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-144-11-200606060-00007</ArticleId><ArticleId IdType="pubmed">16754923</ArticleId></ArticleIdList></Reference><Reference><Citation>Mos &#xa0;ICM, Douma &#xa0;RA, Erkens &#xa0;PMG, Kruip &#xa0;MJHA, Hovens &#xa0;MM, van Houten &#xa0;AA, et al. &#xa0;Diagnostic outcome management study in patients with clinically suspected recurrent acute pulmonary embolism with a structured algorithm. Thromb Res &#xa0;2014;133:1039&#x2013;1044. 10.1016/j.thromres.2014.03.050</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2014.03.050</ArticleId><ArticleId IdType="pubmed">24735976</ArticleId></ArticleIdList></Reference><Reference><Citation>Galipienzo &#xa0;J, de Tena J &#xa0;G, Flores &#xa0;J, Alvarez &#xa0;C, Garcia-Avello &#xa0;A, Arribas &#xa0;I. Effectiveness of a diagnostic algorithm combining clinical probability, D-dimer testing, and computed tomography in patients with suspected pulmonary embolism in an emergency department. Rom J Intern Med &#xa0;2012;50:195&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pubmed">23330286</ArticleId></ArticleIdList></Reference><Reference><Citation>Goekoop &#xa0;RJ, Steeghs &#xa0;N, Niessen &#xa0;RWLM, Jonkers &#xa0;GJPM, Dik &#xa0;H, Castel &#xa0;Ad, et al. &#xa0;Simple and safe exclusion of pulmonary embolism in outpatients using quantitative D-dimer and wells&#x2019; simplified decision rule. Thromb Haemost &#xa0;2007;97:146&#x2013;150. 10.1160/TH06-09-0529</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH06-09-0529</ArticleId><ArticleId IdType="pubmed">17200782</ArticleId></ArticleIdList></Reference><Reference><Citation>Schouten &#xa0;HJ, Geersing &#xa0;G-J, Oudega &#xa0;R, van Delden &#xa0;JJM, Moons &#xa0;KGM, Koek &#xa0;HL. Accuracy of the wells clinical prediction rule for pulmonary embolism in older ambulatory adults. J Am Geriatr Soc &#xa0;2014;62:2136&#x2013;2141. 10.1111/jgs.13080</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.13080</ArticleId><ArticleId IdType="pubmed">25366538</ArticleId></ArticleIdList></Reference><Reference><Citation>Douma &#xa0;RA, Mos &#xa0;ICM, Erkens &#xa0;PMG, Nizet &#xa0;TAC, Durian &#xa0;MF, Hovens &#xa0;MM, et al. &#xa0;Performance of 4 clinical decision rules in the diagnostic management of acute pulmonary embolism: a prospective cohort study. Ann Intern Med &#xa0;2011;154:709&#x2013;718. 10.7326/0003-4819-154-11-201106070-00002</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-154-11-201106070-00002</ArticleId><ArticleId IdType="pubmed">21646554</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghanima &#xa0;W, Almaas &#xa0;V, Aballi &#xa0;S, D&#xf6;rje &#xa0;C, Nielssen &#xa0;BE, Holmen &#xa0;LO, et al. &#xa0;Management of suspected pulmonary embolism (PE) by D-dimer and multi-slice computed tomography in outpatients: an outcome study. J Thromb Haemost &#xa0;2005;3:1926&#x2013;1932. 10.1111/j.1538-7836.2005.01544.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2005.01544.x</ArticleId><ArticleId IdType="pubmed">16102097</ArticleId></ArticleIdList></Reference><Reference><Citation>Kline &#xa0;JA, Hogg &#xa0;MM, Courtney &#xa0;DM, Miller &#xa0;CD, Jones &#xa0;AE, Smithline &#xa0;HA. D-dimer threshold increase with pretest probability unlikely for pulmonary embolism to decrease unnecessary computerized tomographic pulmonary angiography. J Thromb Haemost &#xa0;2012;10:572&#x2013;581. 10.1111/j.1538-7836.2012.04647.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2012.04647.x</ArticleId><ArticleId IdType="pmc">PMC3319270</ArticleId><ArticleId IdType="pubmed">22284935</ArticleId></ArticleIdList></Reference><Reference><Citation>Kline &#xa0;JA, Courtney &#xa0;DM, Kabrhel &#xa0;C, Moore &#xa0;CL, Smithline &#xa0;HA, Plewa &#xa0;MC, et al. &#xa0;Prospective multicenter evaluation of the pulmonary embolism rule-out criteria. J Thromb Haemost &#xa0;2008;6:772&#x2013;780. 10.1111/j.1538-7836.2008.02944.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2008.02944.x</ArticleId><ArticleId IdType="pubmed">18318689</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrier &#xa0;A, Roy &#xa0;PMM, Aujesky &#xa0;D, Chagnon &#xa0;I, Howarth &#xa0;N, Gourdier &#xa0;ALL, et al. &#xa0;Diagnosing pulmonary embolism in outpatients with clinical assessment, D-dimer measurement, venous ultrasound, and helical computed tomography: a multicenter management study. Am J Med &#xa0;2004;116:291&#x2013;299. 10.1016/j.amjmed.2003.09.041</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2003.09.041</ArticleId><ArticleId IdType="pubmed">14984813</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrier &#xa0;A, Roy &#xa0;PM, Sanchez &#xa0;O, Meyer &#xa0;G, Gourdier &#xa0;A-L, Furber &#xa0;A, et al. &#xa0;Multidetector-Row computed tomography in suspected pulmonary embolism. N Engl J Med &#xa0;2005;352:1760&#x2013;1768. 10.1056/NEJMoa042905</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa042905</ArticleId><ArticleId IdType="pubmed">15858185</ArticleId></ArticleIdList></Reference><Reference><Citation>Penaloza &#xa0;A, Souli&#xe9; &#xa0;C, Moumneh &#xa0;T, Delmez &#xa0;Q, Ghuysen &#xa0;A, el Kouri &#xa0;D, et al. &#xa0;Pulmonary embolism rule-out criteria (PERC) rule in European patients with low implicit clinical probability (PERCEPIC): a multicentre, prospective, observational study. Lancet Haematol &#xa0;2017;4:e615&#x2013;e621. 10.1016/S2352-3026(17)30210-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(17)30210-7</ArticleId><ArticleId IdType="pubmed">29150390</ArticleId></ArticleIdList></Reference><Reference><Citation>Righini &#xa0;M, Le Gal &#xa0;G, Aujesky &#xa0;D, Roy &#xa0;PM, Sanchez &#xa0;O, Verschuren &#xa0;F, et al. &#xa0;Diagnosis of pulmonary embolism by multidetector CT alone or combined with venous ultrasonography of the leg: a randomised non-inferiority trial. Lancet &#xa0;2008;371:1343&#x2013;1352. 10.1016/S0140-6736(08)60594-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(08)60594-2</ArticleId><ArticleId IdType="pubmed">18424324</ArticleId></ArticleIdList></Reference><Reference><Citation>Schouten &#xa0;HJ, Koek &#xa0;HL, Kruisman-Ebbers &#xa0;M, Geersing &#xa0;GJ, Oudega &#xa0;R, Kars &#xa0;MC, et al. &#xa0;Decisions to withhold diagnostic investigations in nursing home patients with a clinical suspicion of venous thromboembolism. PLoS One &#xa0;2014;9:e90395. 10.1371/journal.pone.0090395</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0090395</ArticleId><ArticleId IdType="pmc">PMC3948630</ArticleId><ArticleId IdType="pubmed">24614754</ArticleId></ArticleIdList></Reference><Reference><Citation>Kline &#xa0;JA, Mitchell &#xa0;AM, Kabrhel &#xa0;C, Richman &#xa0;PB, Courtney &#xa0;DM. Clinical criteria to prevent unnecessary diagnostic testing in emergency department patients with suspected pulmonary embolism. J Thromb Haemost &#xa0;2004;2:1247&#x2013;1255. 10.1111/j.1538-7836.2004.00790.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2004.00790.x</ArticleId><ArticleId IdType="pubmed">15304025</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy &#xa0;PM, Friou &#xa0;E, Germeau &#xa0;B, Douillet &#xa0;D, Kline &#xa0;JA, Righini &#xa0;M, et al. &#xa0;Derivation and validation of a 4-level clinical pretest probability score for suspected pulmonary embolism to safely decrease imaging testing. JAMA Cardiol &#xa0;2021;6:669&#x2013;677. 10.1001/jamacardio.2021.0064</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2021.0064</ArticleId><ArticleId IdType="pmc">PMC7931139</ArticleId><ArticleId IdType="pubmed">33656522</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38681292</PMID><DateRevised><Year>2024</Year><Month>04</Month><Day>30</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Treatment Efficacy of Plasmapheresis Versus Intravenous Immunoglobulin in Guillain-Barr&#xe9; Syndrome Management: A Systematic Review.</ArticleTitle><Pagination><StartPage>e57066</StartPage><MedlinePgn>e57066</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e57066</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.57066</ELocationID><Abstract><AbstractText>Guillain-Barr&#xe9; syndrome (GBS) is a rare and debilitating autoimmune disorder that affects the peripheral nervous system. Although the exact etiology of GBS is still unknown, it is thought to be triggered by a preceding gastrointestinal infection in most of the cases. Clinical manifestations include limb weakness, areflexia, and sensory loss that can further progress to neuromuscular paralysis affecting the respiratory, facial, and bulbar functions. Both plasmapheresis (PE) and intravenous immunoglobulin (IVIG) have shown effectiveness in the treatment of GBS, but it is still unclear which treatment approach is superior in terms of therapeutic efficacy. This systematic review acts per Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) 2020 guidelines. For appropriate studies and research, we searched PubMed, PubMed Central (PMC), Medical Literature Analysis and Retrieval System Online (MEDLINE), Science Direct, and Google Scholar. Screening of articles was performed based on relevance and inclusion and exclusion criteria. To check for bias, we used relevant quality appraisal tools. Initially, we found 2454 articles. After removing duplicates and irrelevant papers, we finalized 31 studies based on titles, abstracts, and reading entire articles. We excluded 14 studies because of poor quality; the remaining 17 papers were included in this review. IVIG is equally efficacious as PE in improving primary outcomes and secondary outcomes. IVIG showed a slight advantage over PE in reducing the need for mechanical ventilation (MV) and hospital stay duration. However, in children, PE demonstrated a slight edge in improving secondary outcomes. PE was associated with a slightly higher risk of adverse events and post-treatment worsening symptoms compared to IVIG. IVIG is considered more user-friendly with a significantly lower patient discontinuation rate than PE. IVIG treatment was found to be significantly more expensive than PE.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024, Savithri Nandeesha et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Savithri Nandeesha</LastName><ForeName>Sanath</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Internal Medicine, California Institute of Behavioral Neurosciences &amp; Psychology, Fairfield, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kasagga</LastName><ForeName>Alousious</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Pathology, California Institute of Behavioral Neurosciences &amp; Psychology, Fairfield, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hawrami</LastName><ForeName>Chnoor</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Pediatric Surgery, California Institute of Behavioral Neurosciences &amp; Psychology, Fairfield, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ricci</LastName><ForeName>Erica</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Anesthesiology, California Institute of Behavioral Neurosciences &amp; Psychology, Fairfield, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hailu</LastName><ForeName>Kirubel T</ForeName><Initials>KT</Initials><AffiliationInfo><Affiliation>Internal Medicine, California Institute of Behavioral Neurosciences &amp; Psychology, Fairfield, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Internal Medicine, Afet Speciality Clinic, Addis Ababa, ETH.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salib</LastName><ForeName>Korlos</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Internal Medicine, St. Mary El Zaytoun, Cairo, EGY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butt</LastName><ForeName>Samia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Research, California Institute of Behavioral Neurosciences &amp; Psychology, Fairfield, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">guillain-barre syndrome (gbs)</Keyword><Keyword MajorTopicYN="N">guillain-barr&#xe9; syndrome (gbs)</Keyword><Keyword MajorTopicYN="N">intravenous immunoglobulins (ivig)</Keyword><Keyword MajorTopicYN="N">ivig treatment</Keyword><Keyword MajorTopicYN="N">therapeutic plasma exchange (tpe)</Keyword><Keyword MajorTopicYN="N">therapeutic plasmapheresis</Keyword></KeywordList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>29</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>29</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>29</Day><Hour>4</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38681292</ArticleId><ArticleId IdType="pmc">PMC11052558</ArticleId><ArticleId IdType="doi">10.7759/cureus.57066</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Population incidence of Guillain-Barr&#xe9; syndrome: a systematic review and meta-analysis. Sejvar JJ, Baughman AL, Wise M, Morgan OW. https://doi.org/10.1159/000324710. Neuroepidemiology. 2011;36:123&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5703046</ArticleId><ArticleId IdType="pubmed">21422765</ArticleId></ArticleIdList></Reference><Reference><Citation>Guillain-Barr&#xe9; syndrome. Yuki N, Hartung HP. N Engl J Med. 2012;366:2294&#x2013;2304.</Citation><ArticleIdList><ArticleId IdType="pubmed">22694000</ArticleId></ArticleIdList></Reference><Reference><Citation>Guillain-Barr&#xe9; syndrome: causes, immunopathogenic mechanisms and treatment. Jasti AK, Selmi C, Sarmiento-Monroy JC, Vega DA, Anaya JM, Gershwin ME. https://doi.org/10.1080/1744666X.2016.1193006. Expert Rev Clin Immunol. 2016;12:1175&#x2013;1189.</Citation><ArticleIdList><ArticleId IdType="pubmed">27292311</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical features, pathogenesis, and treatment of Guillain-Barr&#xe9; syndrome. Van Doorn PA, Ruts L, Jacobs BC. https://doi.org/10.1016/S1474-4422(08)70215-1. Lancet Neurol. 2008;7:939&#x2013;950.</Citation><ArticleIdList><ArticleId IdType="pubmed">18848313</ArticleId></ArticleIdList></Reference><Reference><Citation>Guillain-Barr&#xe9; syndrome: pathogenesis, diagnosis, treatment and prognosis. van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA. https://doi.org/10.1038/nrneurol.2014.121. Nat Rev Neurol. 2014;10:469&#x2013;482.</Citation><ArticleIdList><ArticleId IdType="pubmed">25023340</ArticleId></ArticleIdList></Reference><Reference><Citation>Assessment of current diagnostic criteria for Guillain-Barr&#xe9; syndrome. Asbury AK, Cornblath DR. https://doi.org/10.1002/ana.410270707 Ann Neurol. 1990;27 Suppl:0&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">2194422</ArticleId></ArticleIdList></Reference><Reference><Citation>Motor recovery after Guillain-Barr&#xe9; syndrome in childhood. Ortiz-Corredor F, Pe&#xf1;a-Preciado M, D&#xed;az-Ru&#xed;z J. https://doi.org/10.1080/09638280701240326. Disabil Rehabil. 2007;29:883&#x2013;889.</Citation><ArticleIdList><ArticleId IdType="pubmed">17577723</ArticleId></ArticleIdList></Reference><Reference><Citation>IVIG treatment and prognosis in Guillain-Barr&#xe9; syndrome. van Doorn PA, Kuitwaard K, Walgaard C, van Koningsveld R, Ruts L, Jacobs BC. J Clin Immunol. 2010;30 Suppl 1:0&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2883091</ArticleId><ArticleId IdType="pubmed">20396937</ArticleId></ArticleIdList></Reference><Reference><Citation>A clinical picture of Guillain-Barr&#xe9; syndrome in children in the United States. Hicks CW, Kay B, Worley SE, Moodley M. https://doi.org/10.1177/0883073810370481. J Child Neurol. 2010;25:1504&#x2013;1510.</Citation><ArticleIdList><ArticleId IdType="pubmed">20823034</ArticleId></ArticleIdList></Reference><Reference><Citation>The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Page MJ, McKenzie JE, Bossuyt PM, et al. BMJ. 2021;372:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8008539</ArticleId><ArticleId IdType="pubmed">33781348</ArticleId></ArticleIdList></Reference><Reference><Citation>The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses.  [
Jan;
2012 
];Peterson J, Welch V, Losos M, et al.  http://www.evidencebasedpublichealth.de/download/Newcastle_Ottowa_Scale_Pope_Bruce.pdf Ottawa Hospital Research Institute. 2011 2:1&#x2013;2.</Citation></Reference><Reference><Citation>Joanna Briggs Institute. Joanna Briggs Institute-Checklist for systematic reviews and research syntheses.  [
Jan;
2012 
]. 2017. https://joannabriggs.org/ebp/critical_appraisal_tools https://joannabriggs.org/ebp/critical_appraisal_tools</Citation></Reference><Reference><Citation>Critical Appraisal Skills Programme (2023). CASP (Randomised Controlled Trial ) Checklist.  [
Jan;
2012 
]. 2023. https://casp-uk.net/checklists/casp-rct-randomised-controlled-trial-checklist.docx https://casp-uk.net/checklists/casp-rct-randomised-controlled-trial-checklist.docx</Citation></Reference><Reference><Citation>Intravenous immunoglobulin vs plasma exchange in treatment of mechanically ventilated adults with Guillain-Barr&#xe9; syndrome. Charra B, Hachimi A, Benslama A, Motaouakkil S. https://doi.org/10.11604/pamj.2014.18.35.2911. Pan Afr Med J. 2014;18:35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4215378</ArticleId><ArticleId IdType="pubmed">25368724</ArticleId></ArticleIdList></Reference><Reference><Citation>Comparison of effectiveness and unit cost of intravenous immunoglobulin (IVIG) and plasma exchange (PE) in therapy for Guillain-Barr&#xe9; syndrome in Ratchaburi hospital. Rodprasert K.  https://he02.tci-thaijo.org/index.php/reg45/article/view/125943 Reg 4-5 Med J. 2018;33:157&#x2013;163.</Citation></Reference><Reference><Citation>A comparison between plasmapheresis and intravenous immunoglobulin in children with Guillain-Barr&#xe9; syndrome in Upper Egypt. Saad K, Mohamad IL, Abd El-Hamed MA, et al.  https://doi.org/10.1177/1756285615610471. Ther Adv Neurol Disord. 2016;9:3&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4710103</ArticleId><ArticleId IdType="pubmed">26788127</ArticleId></ArticleIdList></Reference><Reference><Citation>Comparison of intravenous immunoglobulin and plasma exchange in treatment of mechanically ventilated children with Guillain Barr&#xe9; syndrome: a randomized study. El-Bayoumi MA, El-Refaey AM, Abdelkader AM, El-Assmy MM, Alwakeel AA, El-Tahan HM. https://doi.org/10.1186/cc10305 Crit Care. 2011;15:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3387601</ArticleId><ArticleId IdType="pubmed">21745374</ArticleId></ArticleIdList></Reference><Reference><Citation>Comparison of ICU outcomes between intravenous immunoglobulin and plasma exchange in treatment of mechanically ventilated patients with GuillainBarr&#xe9; syndrome in a neuro-intensive care unit in a Govt. Hospital of Bangladesh: a observational cohort study. Mallick UK, Chowdhury MSJH, Hussain ME, et al.  http://dx.doi.org/10.3329/jninb.v5i2.43015 J Natl Inst Neurosci Bangladesh. 2019;5:118&#x2013;122.</Citation></Reference><Reference><Citation>Nationwide study of therapeutic plasma exchange vs intravenous immunoglobulin in Guillain-Barr&#xe9; syndrome. Beydoun HA, Beydoun MA, Hossain S, Zonderman AB, Eid SM. https://doi.org/10.1002/mus.26831. Muscle Nerve. 2020;61:608&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11008558</ArticleId><ArticleId IdType="pubmed">32052454</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashalatha R. Intravenous immune globulin vs plasma exchange in Guillain barre syndrome a 5-year retrospective study. Trivandrum: Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST); 2002. Intravenous immune globulin vs plasma exchange in Guillain barre syndrome a 5-year retrospective study.</Citation></Reference><Reference><Citation>Management of Guillain-Barr&#xe9; syndrome with plasmapheresis or immunoglobulin: our experience from a tertiary care institute in South India. Kishore CK, Vijayabhaskar J, Vishnu Vardhan R, et al.  https://doi.org/10.3109/0886022X.2014.890859. Ren Fail. 2014;36:732&#x2013;736.</Citation><ArticleIdList><ArticleId IdType="pubmed">24593239</ArticleId></ArticleIdList></Reference><Reference><Citation>High dose intravenous immune globulins and plasma exchange in Guillain-Barr&#xe9; syndrome. Emilia-Romagna Study Group on Clinical and Epidemiological Problems in Neurology Italy, Participating Centers, Ravasio A, et al.   https://doi.org/10.1007/BF02229327. Ital J Neurol Sci. 1995;16:487&#x2013;492.</Citation><ArticleIdList><ArticleId IdType="pubmed">8749707</ArticleId></ArticleIdList></Reference><Reference><Citation>Guillain-Barr&#xe9; syndrome: clinical profile and management. Sudulagunta SR, Sodalagunta MB, Sepehrar M, et al. Ger Med Sci. 2015;13:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4576316</ArticleId><ArticleId IdType="pubmed">26421004</ArticleId></ArticleIdList></Reference><Reference><Citation>Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barr&#xe9; syndrome. Sandoglobulin Guillain-Barr&#xe9; Syndrome Trial Group. https://doi.org/10.1016/S0140-6736(96)09095-2. Lancet. 1997;349:225&#x2013;230.</Citation><ArticleIdList><ArticleId IdType="pubmed">9014908</ArticleId></ArticleIdList></Reference><Reference><Citation>Outcome of various treatments in Guillain-Barr&#xe9; Syndrome in Children. Anwer J, Khalid S, Haq R, Iqbal R, Mahmood Z, Tayyab H. https://pjmhsonline.com/2020/jan_march/pdf/296.pdf Pak J Med Sci . 2020;14:296&#x2013;298.</Citation></Reference><Reference><Citation>Intravenous immunoglobulin therapy for Guillain-Barr&#xe9; syndrome with IgG anti-GM1 antibody. Kuwabara S, Mori M, Ogawara K, et al.  https://doi.org/10.1002/1097-4598(200101)24:1%3C54::AID-MUS6%3E3.0.CO;2-9. Muscle Nerve. 2001;24:54&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">11150966</ArticleId></ArticleIdList></Reference><Reference><Citation>Comparison on therapeutic effect of plasma exchange and intravenous immunoglobulin for Guillian-Barre syndrome. Ye Y, Li SL, Li YJ. https://doi.org/10.1111/tme.12169. Transfus Med. 2015;25:79&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">25515056</ArticleId></ArticleIdList></Reference><Reference><Citation>Plasma exchange versus intravenous immunoglobulin in children with Guillain Barr&#xe9; syndrome. Elahi E, Ashfaq M, Nisa BU, Chachar S. https://doi.org/10.36570/jduhs.2019.3.693 J Dow Univ Health Sci. 2019;13:133&#x2013;137.</Citation></Reference><Reference><Citation>Plasmapheresis versus intravenous immunoglobulins in guillain barre syndrome, the therapeutic outcomes. Asghar SP, Mubarik H, Shams N, Cheema MB, Shah S. https://www.pafmj.org/PAFMJ/article/view/1004 Pak Armed Forces Med J. 2015;65:524&#x2013;529.</Citation></Reference><Reference><Citation>A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barr&#xe9; syndrome. van der Mech&#xe9; FG, Schmitz PI, the Dutch Guillain-Barr&#xe9; Study Group. N Engl J Med. 1992;326:1123&#x2013;1129.</Citation><ArticleIdList><ArticleId IdType="pubmed">1552913</ArticleId></ArticleIdList></Reference><Reference><Citation>Plasmapheresis and acute Guillain&#x2010;Barr&#xe9; syndrome. The Guillain-Barr&#xe9; Syndrome Study Group. https://doi.org/10.1212/WNL.35.8.1096. Neurology. 1985;35:1096.</Citation><ArticleIdList><ArticleId IdType="pubmed">4022342</ArticleId></ArticleIdList></Reference><Reference><Citation>Treatment of Guillain-Barr&#xe9; syndrome with high-dose gammaglobulin. Kleyweg RP, van der Mech&#xe9; FG, Meulstee J. https://doi.org/10.1212/WNL.38.10.1639. Neurology. 1988;38:1639&#x2013;1641.</Citation><ArticleIdList><ArticleId IdType="pubmed">2458549</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunotherapy for Guillain-Barr&#xe9; syndrome: a systematic review. Hughes RA, Swan AV, Rapha&#xeb;l JC, Annane D, van Koningsveld R, van Doorn PA. https://doi.org/10.1093/brain/awm004. Brain. 2007;130:2245&#x2013;2257.</Citation><ArticleIdList><ArticleId IdType="pubmed">17337484</ArticleId></ArticleIdList></Reference><Reference><Citation>Controlled trial of prednisolone in acute polyneuropathy. Hughes RA, Newsom-Davis JM, Perkin GD, Pierce JM. https://doi.org/10.1016/S0140-6736(78)92644-2 Lancet. 1978;7:750&#x2013;753.</Citation><ArticleIdList><ArticleId IdType="pubmed">80682</ArticleId></ArticleIdList></Reference><Reference><Citation>Intravenous immunoglobulin for Guillain-Barr&#xe9; syndrome. Hughes RA, Swan AV, van Doorn PA. https://doi.org/10.1002/14651858.CD002063.pub6 Cochrane Database Syst Rev. 2014;2014:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6781841</ArticleId><ArticleId IdType="pubmed">25238327</ArticleId></ArticleIdList></Reference><Reference><Citation>Current therapeutic options in severe Guillain-Barre syndrome. Shahar E. https://journals.lww.com/clinicalneuropharm/Fulltext/2006/01000/Current_Therapeutic_Options_in_Severe.00011.aspx Clin Neuropharmacol. 2001;29:45&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">16518134</ArticleId></ArticleIdList></Reference><Reference><Citation>Cost-minimization analysis of the direct costs of TPE and IVIg in the treatment of Guillain-Barr&#xe9; syndrome. Winters JL, Brown D, Hazard E, Chainani A, Andrzejewski C Jr. https://doi.org/10.1186/1472-6963-11-101. BMC Health Serv Res. 2011;11:101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3121582</ArticleId><ArticleId IdType="pubmed">21575219</ArticleId></ArticleIdList></Reference><Reference><Citation>Plasma exchange (PE) versus intravenous immunoglobulin (IVIG) for the treatment of Guillain-Barr&#xe9; syndrome (GBS) in patients with severe symptoms: a systematic review and meta-analysis. Zaki HA, Iftikhar H, Najam M, et al.  https://doi.org/10.1016/j.ensci.2023.100468. eNeurologicalSci. 2023;31:100468.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10242495</ArticleId><ArticleId IdType="pubmed">37288440</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36342116</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>15</Day></DateCompleted><DateRevised><Year>2025</Year><Month>04</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1533-4406</ISSN><JournalIssue CitedMedium="Internet"><Volume>387</Volume><Issue>23</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>08</Day></PubDate></JournalIssue><Title>The New England journal of medicine</Title><ISOAbbreviation>N Engl J Med</ISOAbbreviation></Journal><ArticleTitle>Methylprednisolone for Heart Surgery in Infants - A Randomized, Controlled Trial.</ArticleTitle><Pagination><StartPage>2138</StartPage><EndPage>2149</EndPage><MedlinePgn>2138-2149</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1056/NEJMoa2212667</ELocationID><Abstract><AbstractText Label="BACKGROUND">Although perioperative prophylactic glucocorticoids have been used for decades, whether they improve outcomes in infants after heart surgery with cardiopulmonary bypass is unknown.</AbstractText><AbstractText Label="METHODS">We conducted a multicenter, prospective, randomized, placebo-controlled, registry-based trial involving infants (&lt;1 year of age) undergoing heart surgery with cardiopulmonary bypass at 24 sites participating in the Society of Thoracic Surgeons Congenital Heart Surgery Database. Registry data were used in the evaluation of outcomes. The infants were randomly assigned to receive prophylactic methylprednisolone (30 mg per kilogram of body weight) or placebo, which was administered into the cardiopulmonary-bypass pump-priming fluid. The primary end point was a ranked composite of death, heart transplantation, or any of 13 major complications. Patients without any of these events were assigned a ranked outcome based on postoperative length of stay. In the primary analysis, the ranked outcomes were compared between the trial groups with the use of odds ratios adjusted for prespecified risk factors. Secondary analyses included an unadjusted odds ratio, a win ratio, and safety outcomes.</AbstractText><AbstractText Label="RESULTS">A total of 1263 infants underwent randomization, of whom 1200 received either methylprednisolone (599 infants) or placebo (601 infants). The likelihood of a worse outcome did not differ significantly between the methylprednisolone group and the placebo group (adjusted odds ratio, 0.86; 95% confidence interval [CI], 0.71 to 1.05; P&#x2009;=&#x2009;0.14). Secondary analyses (unadjusted for risk factors) showed an odds ratio for a worse outcome of 0.82 (95% CI, 0.67 to 1.00) and a win ratio of 1.15 (95% CI, 1.00 to 1.32) in the methylprednisolone group as compared with the placebo group, findings suggestive of a benefit with methylprednisolone; however, patients in the methylprednisolone group were more likely than those in the placebo group to receive postoperative insulin for hyperglycemia (19.0% vs. 6.7%, P&lt;0.001).</AbstractText><AbstractText Label="CONCLUSIONS">Among infants undergoing surgery with cardiopulmonary bypass, prophylactic use of methylprednisolone did not significantly reduce the likelihood of a worse outcome in an adjusted analysis and was associated with postoperative development of hyperglycemia warranting insulin in a higher percentage of infants than placebo. (Funded by the National Center for Advancing Translational Sciences and others; STRESS ClinicalTrials.gov number, NCT03229538.).</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Massachusetts Medical Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hill</LastName><ForeName>Kevin D</ForeName><Initials>KD</Initials><Identifier Source="ORCID">0000-0003-4451-3580</Identifier><AffiliationInfo><Affiliation>From the Duke Pediatric and Congenital Heart Center (K.D.H., J.W.T., J.S.L.) and the Duke Clinical Research Institute (K.D.H., S.M.O., J.L.K., D.S.G., J.S.L.) - both in Durham, NC; Vanderbilt University Medical Center, Nashville (P.J.K., H.S.B., D.P.B.); the University of Florida Congenital Heart Center, Gainesville (J.P.J., M.B.); Johns Hopkins University School of Medicine, Baltimore (M.L.J., B.M.); the Medical University of South Carolina, Charleston (E.M.G.); the UPMC Children's Hospital of Pittsburgh, Pittsburgh (B.B.); the Section of Pediatric Cardiac Anesthesiology, Texas Children's Hospital, Department of Anesthesiology, Baylor College of Medicine, Houston (A.R., D.F.V.), and the Division of Cardiology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas (R.B.); the University of Utah-Primary Children's Hospital, Salt Lake City (A.S.H.); the University of Southern California and the Heart Institute, Children's Hospital of Los Angeles - both in Los Angeles (S.R.K.); the University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati (A.B.), the Division of Pediatric Cardiac Surgery, Heart Vascular and Thoracic Institute, Cleveland Clinic Children's, Cleveland (T.K.), and the Department of Cardiothoracic Surgery, Nationwide Children's Hospital, and Ohio State University, Columbus (P.I.M.) - all in Ohio; the Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago (E.W.), and the Advocate Children's Heart Institute, Advocate Children's Hospital, Division of Pediatric Cardiac Critical Care, Oak Lawn (A.H.V.B.) - both in Illinois; the Division of Cardiovascular Surgery, Children's Minnesota, Minneapolis (D.O.); the Section of Pediatric Cardiothoracic Surgery, Washington University School of Medicine, St. Louis (P.E.); the Division of Cardiology, Department of Pediatrics, Heart Institute, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora (J.S.K.); Children's Wisconsin, Medical College of Wisconsin, Milwaukee (J.P.S.); and the Division of Pediatric Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York (B.R.A.), and the University of Rochester Medical Center, Rochester (M.F.S.) - both in New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kannankeril</LastName><ForeName>Prince J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>From the Duke Pediatric and Congenital Heart Center (K.D.H., J.W.T., J.S.L.) and the Duke Clinical Research Institute (K.D.H., S.M.O., J.L.K., D.S.G., J.S.L.) - both in Durham, NC; Vanderbilt University Medical Center, Nashville (P.J.K., H.S.B., D.P.B.); the University of Florida Congenital Heart Center, Gainesville (J.P.J., M.B.); Johns Hopkins University School of Medicine, Baltimore (M.L.J., B.M.); the Medical University of South Carolina, Charleston (E.M.G.); the UPMC Children's Hospital of Pittsburgh, Pittsburgh (B.B.); the Section of Pediatric Cardiac Anesthesiology, Texas Children's Hospital, Department of Anesthesiology, Baylor College of Medicine, Houston (A.R., D.F.V.), and the Division of Cardiology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas (R.B.); the University of Utah-Primary Children's Hospital, Salt Lake City (A.S.H.); the University of Southern California and the Heart Institute, Children's Hospital of Los Angeles - both in Los Angeles (S.R.K.); the University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati (A.B.), the Division of Pediatric Cardiac Surgery, Heart Vascular and Thoracic Institute, Cleveland Clinic Children's, Cleveland (T.K.), and the Department of Cardiothoracic Surgery, Nationwide Children's Hospital, and Ohio State University, Columbus (P.I.M.) - all in Ohio; the Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago (E.W.), and the Advocate Children's Heart Institute, Advocate Children's Hospital, Division of Pediatric Cardiac Critical Care, Oak Lawn (A.H.V.B.) - both in Illinois; the Division of Cardiovascular Surgery, Children's Minnesota, Minneapolis (D.O.); the Section of Pediatric Cardiothoracic Surgery, Washington University School of Medicine, St. Louis (P.E.); the Division of Cardiology, Department of Pediatrics, Heart Institute, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora (J.S.K.); Children's Wisconsin, Medical College of Wisconsin, Milwaukee (J.P.S.); and the Division of Pediatric Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York (B.R.A.), and the University of Rochester Medical Center, Rochester (M.F.S.) - both in New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacobs</LastName><ForeName>Jeffrey P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>From the Duke Pediatric and Congenital Heart Center (K.D.H., J.W.T., J.S.L.) and the Duke Clinical Research Institute (K.D.H., S.M.O., J.L.K., D.S.G., J.S.L.) - both in Durham, NC; Vanderbilt University Medical Center, Nashville (P.J.K., H.S.B., D.P.B.); the University of Florida Congenital Heart Center, Gainesville (J.P.J., M.B.); Johns Hopkins University School of Medicine, Baltimore (M.L.J., B.M.); the Medical University of South Carolina, Charleston (E.M.G.); the UPMC Children's Hospital of Pittsburgh, Pittsburgh (B.B.); the Section of Pediatric Cardiac Anesthesiology, Texas Children's Hospital, Department of Anesthesiology, Baylor College of Medicine, Houston (A.R., D.F.V.), and the Division of Cardiology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas (R.B.); the University of Utah-Primary Children's Hospital, Salt Lake City (A.S.H.); the University of Southern California and the Heart Institute, Children's Hospital of Los Angeles - both in Los Angeles (S.R.K.); the University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati (A.B.), the Division of Pediatric Cardiac Surgery, Heart Vascular and Thoracic Institute, Cleveland Clinic Children's, Cleveland (T.K.), and the Department of Cardiothoracic Surgery, Nationwide Children's Hospital, and Ohio State University, Columbus (P.I.M.) - all in Ohio; the Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago (E.W.), and the Advocate Children's Heart Institute, Advocate Children's Hospital, Division of Pediatric Cardiac Critical Care, Oak Lawn (A.H.V.B.) - both in Illinois; the Division of Cardiovascular Surgery, Children's Minnesota, Minneapolis (D.O.); the Section of Pediatric Cardiothoracic Surgery, Washington University School of Medicine, St. Louis (P.E.); the Division of Cardiology, Department of Pediatrics, Heart Institute, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora (J.S.K.); Children's Wisconsin, Medical College of Wisconsin, Milwaukee (J.P.S.); and the Division of Pediatric Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York (B.R.A.), and the University of Rochester Medical Center, Rochester (M.F.S.) - both in New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baldwin</LastName><ForeName>H Scott</ForeName><Initials>HS</Initials><AffiliationInfo><Affiliation>From the Duke Pediatric and Congenital Heart Center (K.D.H., J.W.T., J.S.L.) and the Duke Clinical Research Institute (K.D.H., S.M.O., J.L.K., D.S.G., J.S.L.) - both in Durham, NC; Vanderbilt University Medical Center, Nashville (P.J.K., H.S.B., D.P.B.); the University of Florida Congenital Heart Center, Gainesville (J.P.J., M.B.); Johns Hopkins University School of Medicine, Baltimore (M.L.J., B.M.); the Medical University of South Carolina, Charleston (E.M.G.); the UPMC Children's Hospital of Pittsburgh, Pittsburgh (B.B.); the Section of Pediatric Cardiac Anesthesiology, Texas Children's Hospital, Department of Anesthesiology, Baylor College of Medicine, Houston (A.R., D.F.V.), and the Division of Cardiology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas (R.B.); the University of Utah-Primary Children's Hospital, Salt Lake City (A.S.H.); the University of Southern California and the Heart Institute, Children's Hospital of Los Angeles - both in Los Angeles (S.R.K.); the University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati (A.B.), the Division of Pediatric Cardiac Surgery, Heart Vascular and Thoracic Institute, Cleveland Clinic Children's, Cleveland (T.K.), and the Department of Cardiothoracic Surgery, Nationwide Children's Hospital, and Ohio State University, Columbus (P.I.M.) - all in Ohio; the Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago (E.W.), and the Advocate Children's Heart Institute, Advocate Children's Hospital, Division of Pediatric Cardiac Critical Care, Oak Lawn (A.H.V.B.) - both in Illinois; the Division of Cardiovascular Surgery, Children's Minnesota, Minneapolis (D.O.); the Section of Pediatric Cardiothoracic Surgery, Washington University School of Medicine, St. Louis (P.E.); the Division of Cardiology, Department of Pediatrics, Heart Institute, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora (J.S.K.); Children's Wisconsin, Medical College of Wisconsin, Milwaukee (J.P.S.); and the Division of Pediatric Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York (B.R.A.), and the University of Rochester Medical Center, Rochester (M.F.S.) - both in New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacobs</LastName><ForeName>Marshall L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>From the Duke Pediatric and Congenital Heart Center (K.D.H., J.W.T., J.S.L.) and the Duke Clinical Research Institute (K.D.H., S.M.O., J.L.K., D.S.G., J.S.L.) - both in Durham, NC; Vanderbilt University Medical Center, Nashville (P.J.K., H.S.B., D.P.B.); the University of Florida Congenital Heart Center, Gainesville (J.P.J., M.B.); Johns Hopkins University School of Medicine, Baltimore (M.L.J., B.M.); the Medical University of South Carolina, Charleston (E.M.G.); the UPMC Children's Hospital of Pittsburgh, Pittsburgh (B.B.); the Section of Pediatric Cardiac Anesthesiology, Texas Children's Hospital, Department of Anesthesiology, Baylor College of Medicine, Houston (A.R., D.F.V.), and the Division of Cardiology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas (R.B.); the University of Utah-Primary Children's Hospital, Salt Lake City (A.S.H.); the University of Southern California and the Heart Institute, Children's Hospital of Los Angeles - both in Los Angeles (S.R.K.); the University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati (A.B.), the Division of Pediatric Cardiac Surgery, Heart Vascular and Thoracic Institute, Cleveland Clinic Children's, Cleveland (T.K.), and the Department of Cardiothoracic Surgery, Nationwide Children's Hospital, and Ohio State University, Columbus (P.I.M.) - all in Ohio; the Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago (E.W.), and the Advocate Children's Heart Institute, Advocate Children's Hospital, Division of Pediatric Cardiac Critical Care, Oak Lawn (A.H.V.B.) - both in Illinois; the Division of Cardiovascular Surgery, Children's Minnesota, Minneapolis (D.O.); the Section of Pediatric Cardiothoracic Surgery, Washington University School of Medicine, St. Louis (P.E.); the Division of Cardiology, Department of Pediatrics, Heart Institute, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora (J.S.K.); Children's Wisconsin, Medical College of Wisconsin, Milwaukee (J.P.S.); and the Division of Pediatric Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York (B.R.A.), and the University of Rochester Medical Center, Rochester (M.F.S.) - both in New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Brien</LastName><ForeName>Sean M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>From the Duke Pediatric and Congenital Heart Center (K.D.H., J.W.T., J.S.L.) and the Duke Clinical Research Institute (K.D.H., S.M.O., J.L.K., D.S.G., J.S.L.) - both in Durham, NC; Vanderbilt University Medical Center, Nashville (P.J.K., H.S.B., D.P.B.); the University of Florida Congenital Heart Center, Gainesville (J.P.J., M.B.); Johns Hopkins University School of Medicine, Baltimore (M.L.J., B.M.); the Medical University of South Carolina, Charleston (E.M.G.); the UPMC Children's Hospital of Pittsburgh, Pittsburgh (B.B.); the Section of Pediatric Cardiac Anesthesiology, Texas Children's Hospital, Department of Anesthesiology, Baylor College of Medicine, Houston (A.R., D.F.V.), and the Division of Cardiology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas (R.B.); the University of Utah-Primary Children's Hospital, Salt Lake City (A.S.H.); the University of Southern California and the Heart Institute, Children's Hospital of Los Angeles - both in Los Angeles (S.R.K.); the University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati (A.B.), the Division of Pediatric Cardiac Surgery, Heart Vascular and Thoracic Institute, Cleveland Clinic Children's, Cleveland (T.K.), and the Department of Cardiothoracic Surgery, Nationwide Children's Hospital, and Ohio State University, Columbus (P.I.M.) - all in Ohio; the Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago (E.W.), and the Advocate Children's Heart Institute, Advocate Children's Hospital, Division of Pediatric Cardiac Critical Care, Oak Lawn (A.H.V.B.) - both in Illinois; the Division of Cardiovascular Surgery, Children's Minnesota, Minneapolis (D.O.); the Section of Pediatric Cardiothoracic Surgery, Washington University School of Medicine, St. Louis (P.E.); the Division of Cardiology, Department of Pediatrics, Heart Institute, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora (J.S.K.); Children's Wisconsin, Medical College of Wisconsin, Milwaukee (J.P.S.); and the Division of Pediatric Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York (B.R.A.), and the University of Rochester Medical Center, Rochester (M.F.S.) - both in New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bichel</LastName><ForeName>David P</ForeName><Initials>DP</Initials><AffiliationInfo><Affiliation>From the Duke Pediatric and Congenital Heart Center (K.D.H., J.W.T., J.S.L.) and the Duke Clinical Research Institute (K.D.H., S.M.O., J.L.K., D.S.G., J.S.L.) - both in Durham, NC; Vanderbilt University Medical Center, Nashville (P.J.K., H.S.B., D.P.B.); the University of Florida Congenital Heart Center, Gainesville (J.P.J., M.B.); Johns Hopkins University School of Medicine, Baltimore (M.L.J., B.M.); the Medical University of South Carolina, Charleston (E.M.G.); the UPMC Children's Hospital of Pittsburgh, Pittsburgh (B.B.); the Section of Pediatric Cardiac Anesthesiology, Texas Children's Hospital, Department of Anesthesiology, Baylor College of Medicine, Houston (A.R., D.F.V.), and the Division of Cardiology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas (R.B.); the University of Utah-Primary Children's Hospital, Salt Lake City (A.S.H.); the University of Southern California and the Heart Institute, Children's Hospital of Los Angeles - both in Los Angeles (S.R.K.); the University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati (A.B.), the Division of Pediatric Cardiac Surgery, Heart Vascular and Thoracic Institute, Cleveland Clinic Children's, Cleveland (T.K.), and the Department of Cardiothoracic Surgery, Nationwide Children's Hospital, and Ohio State University, Columbus (P.I.M.) - all in Ohio; the Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago (E.W.), and the Advocate Children's Heart Institute, Advocate Children's Hospital, Division of Pediatric Cardiac Critical Care, Oak Lawn (A.H.V.B.) - both in Illinois; the Division of Cardiovascular Surgery, Children's Minnesota, Minneapolis (D.O.); the Section of Pediatric Cardiothoracic Surgery, Washington University School of Medicine, St. Louis (P.E.); the Division of Cardiology, Department of Pediatrics, Heart Institute, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora (J.S.K.); Children's Wisconsin, Medical College of Wisconsin, Milwaukee (J.P.S.); and the Division of Pediatric Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York (B.R.A.), and the University of Rochester Medical Center, Rochester (M.F.S.) - both in New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Graham</LastName><ForeName>Eric M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>From the Duke Pediatric and Congenital Heart Center (K.D.H., J.W.T., J.S.L.) and the Duke Clinical Research Institute (K.D.H., S.M.O., J.L.K., D.S.G., J.S.L.) - both in Durham, NC; Vanderbilt University Medical Center, Nashville (P.J.K., H.S.B., D.P.B.); the University of Florida Congenital Heart Center, Gainesville (J.P.J., M.B.); Johns Hopkins University School of Medicine, Baltimore (M.L.J., B.M.); the Medical University of South Carolina, Charleston (E.M.G.); the UPMC Children's Hospital of Pittsburgh, Pittsburgh (B.B.); the Section of Pediatric Cardiac Anesthesiology, Texas Children's Hospital, Department of Anesthesiology, Baylor College of Medicine, Houston (A.R., D.F.V.), and the Division of Cardiology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas (R.B.); the University of Utah-Primary Children's Hospital, Salt Lake City (A.S.H.); the University of Southern California and the Heart Institute, Children's Hospital of Los Angeles - both in Los Angeles (S.R.K.); the University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati (A.B.), the Division of Pediatric Cardiac Surgery, Heart Vascular and Thoracic Institute, Cleveland Clinic Children's, Cleveland (T.K.), and the Department of Cardiothoracic Surgery, Nationwide Children's Hospital, and Ohio State University, Columbus (P.I.M.) - all in Ohio; the Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago (E.W.), and the Advocate Children's Heart Institute, Advocate Children's Hospital, Division of Pediatric Cardiac Critical Care, Oak Lawn (A.H.V.B.) - both in Illinois; the Division of Cardiovascular Surgery, Children's Minnesota, Minneapolis (D.O.); the Section of Pediatric Cardiothoracic Surgery, Washington University School of Medicine, St. Louis (P.E.); the Division of Cardiology, Department of Pediatrics, Heart Institute, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora (J.S.K.); Children's Wisconsin, Medical College of Wisconsin, Milwaukee (J.P.S.); and the Division of Pediatric Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York (B.R.A.), and the University of Rochester Medical Center, Rochester (M.F.S.) - both in New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blasiole</LastName><ForeName>Brian</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>From the Duke Pediatric and Congenital Heart Center (K.D.H., J.W.T., J.S.L.) and the Duke Clinical Research Institute (K.D.H., S.M.O., J.L.K., D.S.G., J.S.L.) - both in Durham, NC; Vanderbilt University Medical Center, Nashville (P.J.K., H.S.B., D.P.B.); the University of Florida Congenital Heart Center, Gainesville (J.P.J., M.B.); Johns Hopkins University School of Medicine, Baltimore (M.L.J., B.M.); the Medical University of South Carolina, Charleston (E.M.G.); the UPMC Children's Hospital of Pittsburgh, Pittsburgh (B.B.); the Section of Pediatric Cardiac Anesthesiology, Texas Children's Hospital, Department of Anesthesiology, Baylor College of Medicine, Houston (A.R., D.F.V.), and the Division of Cardiology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas (R.B.); the University of Utah-Primary Children's Hospital, Salt Lake City (A.S.H.); the University of Southern California and the Heart Institute, Children's Hospital of Los Angeles - both in Los Angeles (S.R.K.); the University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati (A.B.), the Division of Pediatric Cardiac Surgery, Heart Vascular and Thoracic Institute, Cleveland Clinic Children's, Cleveland (T.K.), and the Department of Cardiothoracic Surgery, Nationwide Children's Hospital, and Ohio State University, Columbus (P.I.M.) - all in Ohio; the Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago (E.W.), and the Advocate Children's Heart Institute, Advocate Children's Hospital, Division of Pediatric Cardiac Critical Care, Oak Lawn (A.H.V.B.) - both in Illinois; the Division of Cardiovascular Surgery, Children's Minnesota, Minneapolis (D.O.); the Section of Pediatric Cardiothoracic Surgery, Washington University School of Medicine, St. Louis (P.E.); the Division of Cardiology, Department of Pediatrics, Heart Institute, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora (J.S.K.); Children's Wisconsin, Medical College of Wisconsin, Milwaukee (J.P.S.); and the Division of Pediatric Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York (B.R.A.), and the University of Rochester Medical Center, Rochester (M.F.S.) - both in New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Resheidat</LastName><ForeName>Ashraf</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the Duke Pediatric and Congenital Heart Center (K.D.H., J.W.T., J.S.L.) and the Duke Clinical Research Institute (K.D.H., S.M.O., J.L.K., D.S.G., J.S.L.) - both in Durham, NC; Vanderbilt University Medical Center, Nashville (P.J.K., H.S.B., D.P.B.); the University of Florida Congenital Heart Center, Gainesville (J.P.J., M.B.); Johns Hopkins University School of Medicine, Baltimore (M.L.J., B.M.); the Medical University of South Carolina, Charleston (E.M.G.); the UPMC Children's Hospital of Pittsburgh, Pittsburgh (B.B.); the Section of Pediatric Cardiac Anesthesiology, Texas Children's Hospital, Department of Anesthesiology, Baylor College of Medicine, Houston (A.R., D.F.V.), and the Division of Cardiology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas (R.B.); the University of Utah-Primary Children's Hospital, Salt Lake City (A.S.H.); the University of Southern California and the Heart Institute, Children's Hospital of Los Angeles - both in Los Angeles (S.R.K.); the University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati (A.B.), the Division of Pediatric Cardiac Surgery, Heart Vascular and Thoracic Institute, Cleveland Clinic Children's, Cleveland (T.K.), and the Department of Cardiothoracic Surgery, Nationwide Children's Hospital, and Ohio State University, Columbus (P.I.M.) - all in Ohio; the Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago (E.W.), and the Advocate Children's Heart Institute, Advocate Children's Hospital, Division of Pediatric Cardiac Critical Care, Oak Lawn (A.H.V.B.) - both in Illinois; the Division of Cardiovascular Surgery, Children's Minnesota, Minneapolis (D.O.); the Section of Pediatric Cardiothoracic Surgery, Washington University School of Medicine, St. Louis (P.E.); the Division of Cardiology, Department of Pediatrics, Heart Institute, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora (J.S.K.); Children's Wisconsin, Medical College of Wisconsin, Milwaukee (J.P.S.); and the Division of Pediatric Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York (B.R.A.), and the University of Rochester Medical Center, Rochester (M.F.S.) - both in New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Husain</LastName><ForeName>Adil S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>From the Duke Pediatric and Congenital Heart Center (K.D.H., J.W.T., J.S.L.) and the Duke Clinical Research Institute (K.D.H., S.M.O., J.L.K., D.S.G., J.S.L.) - both in Durham, NC; Vanderbilt University Medical Center, Nashville (P.J.K., H.S.B., D.P.B.); the University of Florida Congenital Heart Center, Gainesville (J.P.J., M.B.); Johns Hopkins University School of Medicine, Baltimore (M.L.J., B.M.); the Medical University of South Carolina, Charleston (E.M.G.); the UPMC Children's Hospital of Pittsburgh, Pittsburgh (B.B.); the Section of Pediatric Cardiac Anesthesiology, Texas Children's Hospital, Department of Anesthesiology, Baylor College of Medicine, Houston (A.R., D.F.V.), and the Division of Cardiology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas (R.B.); the University of Utah-Primary Children's Hospital, Salt Lake City (A.S.H.); the University of Southern California and the Heart Institute, Children's Hospital of Los Angeles - both in Los Angeles (S.R.K.); the University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati (A.B.), the Division of Pediatric Cardiac Surgery, Heart Vascular and Thoracic Institute, Cleveland Clinic Children's, Cleveland (T.K.), and the Department of Cardiothoracic Surgery, Nationwide Children's Hospital, and Ohio State University, Columbus (P.I.M.) - all in Ohio; the Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago (E.W.), and the Advocate Children's Heart Institute, Advocate Children's Hospital, Division of Pediatric Cardiac Critical Care, Oak Lawn (A.H.V.B.) - both in Illinois; the Division of Cardiovascular Surgery, Children's Minnesota, Minneapolis (D.O.); the Section of Pediatric Cardiothoracic Surgery, Washington University School of Medicine, St. Louis (P.E.); the Division of Cardiology, Department of Pediatrics, Heart Institute, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora (J.S.K.); Children's Wisconsin, Medical College of Wisconsin, Milwaukee (J.P.S.); and the Division of Pediatric Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York (B.R.A.), and the University of Rochester Medical Center, Rochester (M.F.S.) - both in New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>S Ram</ForeName><Initials>SR</Initials><Identifier Source="ORCID">0000-0003-1487-4203</Identifier><AffiliationInfo><Affiliation>From the Duke Pediatric and Congenital Heart Center (K.D.H., J.W.T., J.S.L.) and the Duke Clinical Research Institute (K.D.H., S.M.O., J.L.K., D.S.G., J.S.L.) - both in Durham, NC; Vanderbilt University Medical Center, Nashville (P.J.K., H.S.B., D.P.B.); the University of Florida Congenital Heart Center, Gainesville (J.P.J., M.B.); Johns Hopkins University School of Medicine, Baltimore (M.L.J., B.M.); the Medical University of South Carolina, Charleston (E.M.G.); the UPMC Children's Hospital of Pittsburgh, Pittsburgh (B.B.); the Section of Pediatric Cardiac Anesthesiology, Texas Children's Hospital, Department of Anesthesiology, Baylor College of Medicine, Houston (A.R., D.F.V.), and the Division of Cardiology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas (R.B.); the University of Utah-Primary Children's Hospital, Salt Lake City (A.S.H.); the University of Southern California and the Heart Institute, Children's Hospital of Los Angeles - both in Los Angeles (S.R.K.); the University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati (A.B.), the Division of Pediatric Cardiac Surgery, Heart Vascular and Thoracic Institute, Cleveland Clinic Children's, Cleveland (T.K.), and the Department of Cardiothoracic Surgery, Nationwide Children's Hospital, and Ohio State University, Columbus (P.I.M.) - all in Ohio; the Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago (E.W.), and the Advocate Children's Heart Institute, Advocate Children's Hospital, Division of Pediatric Cardiac Critical Care, Oak Lawn (A.H.V.B.) - both in Illinois; the Division of Cardiovascular Surgery, Children's Minnesota, Minneapolis (D.O.); the Section of Pediatric Cardiothoracic Surgery, Washington University School of Medicine, St. Louis (P.E.); the Division of Cardiology, Department of Pediatrics, Heart Institute, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora (J.S.K.); Children's Wisconsin, Medical College of Wisconsin, Milwaukee (J.P.S.); and the Division of Pediatric Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York (B.R.A.), and the University of Rochester Medical Center, Rochester (M.F.S.) - both in New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirchner</LastName><ForeName>Jerry L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>From the Duke Pediatric and Congenital Heart Center (K.D.H., J.W.T., J.S.L.) and the Duke Clinical Research Institute (K.D.H., S.M.O., J.L.K., D.S.G., J.S.L.) - both in Durham, NC; Vanderbilt University Medical Center, Nashville (P.J.K., H.S.B., D.P.B.); the University of Florida Congenital Heart Center, Gainesville (J.P.J., M.B.); Johns Hopkins University School of Medicine, Baltimore (M.L.J., B.M.); the Medical University of South Carolina, Charleston (E.M.G.); the UPMC Children's Hospital of Pittsburgh, Pittsburgh (B.B.); the Section of Pediatric Cardiac Anesthesiology, Texas Children's Hospital, Department of Anesthesiology, Baylor College of Medicine, Houston (A.R., D.F.V.), and the Division of Cardiology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas (R.B.); the University of Utah-Primary Children's Hospital, Salt Lake City (A.S.H.); the University of Southern California and the Heart Institute, Children's Hospital of Los Angeles - both in Los Angeles (S.R.K.); the University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati (A.B.), the Division of Pediatric Cardiac Surgery, Heart Vascular and Thoracic Institute, Cleveland Clinic Children's, Cleveland (T.K.), and the Department of Cardiothoracic Surgery, Nationwide Children's Hospital, and Ohio State University, Columbus (P.I.M.) - all in Ohio; the Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago (E.W.), and the Advocate Children's Heart Institute, Advocate Children's Hospital, Division of Pediatric Cardiac Critical Care, Oak Lawn (A.H.V.B.) - both in Illinois; the Division of Cardiovascular Surgery, Children's Minnesota, Minneapolis (D.O.); the Section of Pediatric Cardiothoracic Surgery, Washington University School of Medicine, St. Louis (P.E.); the Division of Cardiology, Department of Pediatrics, Heart Institute, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora (J.S.K.); Children's Wisconsin, Medical College of Wisconsin, Milwaukee (J.P.S.); and the Division of Pediatric Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York (B.R.A.), and the University of Rochester Medical Center, Rochester (M.F.S.) - both in New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gallup</LastName><ForeName>Dianne S</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>From the Duke Pediatric and Congenital Heart Center (K.D.H., J.W.T., J.S.L.) and the Duke Clinical Research Institute (K.D.H., S.M.O., J.L.K., D.S.G., J.S.L.) - both in Durham, NC; Vanderbilt University Medical Center, Nashville (P.J.K., H.S.B., D.P.B.); the University of Florida Congenital Heart Center, Gainesville (J.P.J., M.B.); Johns Hopkins University School of Medicine, Baltimore (M.L.J., B.M.); the Medical University of South Carolina, Charleston (E.M.G.); the UPMC Children's Hospital of Pittsburgh, Pittsburgh (B.B.); the Section of Pediatric Cardiac Anesthesiology, Texas Children's Hospital, Department of Anesthesiology, Baylor College of Medicine, Houston (A.R., D.F.V.), and the Division of Cardiology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas (R.B.); the University of Utah-Primary Children's Hospital, Salt Lake City (A.S.H.); the University of Southern California and the Heart Institute, Children's Hospital of Los Angeles - both in Los Angeles (S.R.K.); the University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati (A.B.), the Division of Pediatric Cardiac Surgery, Heart Vascular and Thoracic Institute, Cleveland Clinic Children's, Cleveland (T.K.), and the Department of Cardiothoracic Surgery, Nationwide Children's Hospital, and Ohio State University, Columbus (P.I.M.) - all in Ohio; the Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago (E.W.), and the Advocate Children's Heart Institute, Advocate Children's Hospital, Division of Pediatric Cardiac Critical Care, Oak Lawn (A.H.V.B.) - both in Illinois; the Division of Cardiovascular Surgery, Children's Minnesota, Minneapolis (D.O.); the Section of Pediatric Cardiothoracic Surgery, Washington University School of Medicine, St. Louis (P.E.); the Division of Cardiology, Department of Pediatrics, Heart Institute, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora (J.S.K.); Children's Wisconsin, Medical College of Wisconsin, Milwaukee (J.P.S.); and the Division of Pediatric Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York (B.R.A.), and the University of Rochester Medical Center, Rochester (M.F.S.) - both in New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turek</LastName><ForeName>Joseph W</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>From the Duke Pediatric and Congenital Heart Center (K.D.H., J.W.T., J.S.L.) and the Duke Clinical Research Institute (K.D.H., S.M.O., J.L.K., D.S.G., J.S.L.) - both in Durham, NC; Vanderbilt University Medical Center, Nashville (P.J.K., H.S.B., D.P.B.); the University of Florida Congenital Heart Center, Gainesville (J.P.J., M.B.); Johns Hopkins University School of Medicine, Baltimore (M.L.J., B.M.); the Medical University of South Carolina, Charleston (E.M.G.); the UPMC Children's Hospital of Pittsburgh, Pittsburgh (B.B.); the Section of Pediatric Cardiac Anesthesiology, Texas Children's Hospital, Department of Anesthesiology, Baylor College of Medicine, Houston (A.R., D.F.V.), and the Division of Cardiology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas (R.B.); the University of Utah-Primary Children's Hospital, Salt Lake City (A.S.H.); the University of Southern California and the Heart Institute, Children's Hospital of Los Angeles - both in Los Angeles (S.R.K.); the University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati (A.B.), the Division of Pediatric Cardiac Surgery, Heart Vascular and Thoracic Institute, Cleveland Clinic Children's, Cleveland (T.K.), and the Department of Cardiothoracic Surgery, Nationwide Children's Hospital, and Ohio State University, Columbus (P.I.M.) - all in Ohio; the Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago (E.W.), and the Advocate Children's Heart Institute, Advocate Children's Hospital, Division of Pediatric Cardiac Critical Care, Oak Lawn (A.H.V.B.) - both in Illinois; the Division of Cardiovascular Surgery, Children's Minnesota, Minneapolis (D.O.); the Section of Pediatric Cardiothoracic Surgery, Washington University School of Medicine, St. Louis (P.E.); the Division of Cardiology, Department of Pediatrics, Heart Institute, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora (J.S.K.); Children's Wisconsin, Medical College of Wisconsin, Milwaukee (J.P.S.); and the Division of Pediatric Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York (B.R.A.), and the University of Rochester Medical Center, Rochester (M.F.S.) - both in New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bleiweis</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the Duke Pediatric and Congenital Heart Center (K.D.H., J.W.T., J.S.L.) and the Duke Clinical Research Institute (K.D.H., S.M.O., J.L.K., D.S.G., J.S.L.) - both in Durham, NC; Vanderbilt University Medical Center, Nashville (P.J.K., H.S.B., D.P.B.); the University of Florida Congenital Heart Center, Gainesville (J.P.J., M.B.); Johns Hopkins University School of Medicine, Baltimore (M.L.J., B.M.); the Medical University of South Carolina, Charleston (E.M.G.); the UPMC Children's Hospital of Pittsburgh, Pittsburgh (B.B.); the Section of Pediatric Cardiac Anesthesiology, Texas Children's Hospital, Department of Anesthesiology, Baylor College of Medicine, Houston (A.R., D.F.V.), and the Division of Cardiology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas (R.B.); the University of Utah-Primary Children's Hospital, Salt Lake City (A.S.H.); the University of Southern California and the Heart Institute, Children's Hospital of Los Angeles - both in Los Angeles (S.R.K.); the University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati (A.B.), the Division of Pediatric Cardiac Surgery, Heart Vascular and Thoracic Institute, Cleveland Clinic Children's, Cleveland (T.K.), and the Department of Cardiothoracic Surgery, Nationwide Children's Hospital, and Ohio State University, Columbus (P.I.M.) - all in Ohio; the Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago (E.W.), and the Advocate Children's Heart Institute, Advocate Children's Hospital, Division of Pediatric Cardiac Critical Care, Oak Lawn (A.H.V.B.) - both in Illinois; the Division of Cardiovascular Surgery, Children's Minnesota, Minneapolis (D.O.); the Section of Pediatric Cardiothoracic Surgery, Washington University School of Medicine, St. Louis (P.E.); the Division of Cardiology, Department of Pediatrics, Heart Institute, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora (J.S.K.); Children's Wisconsin, Medical College of Wisconsin, Milwaukee (J.P.S.); and the Division of Pediatric Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York (B.R.A.), and the University of Rochester Medical Center, Rochester (M.F.S.) - both in New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mettler</LastName><ForeName>Bret</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>From the Duke Pediatric and Congenital Heart Center (K.D.H., J.W.T., J.S.L.) and the Duke Clinical Research Institute (K.D.H., S.M.O., J.L.K., D.S.G., J.S.L.) - both in Durham, NC; Vanderbilt University Medical Center, Nashville (P.J.K., H.S.B., D.P.B.); the University of Florida Congenital Heart Center, Gainesville (J.P.J., M.B.); Johns Hopkins University School of Medicine, Baltimore (M.L.J., B.M.); the Medical University of South Carolina, Charleston (E.M.G.); the UPMC Children's Hospital of Pittsburgh, Pittsburgh (B.B.); the Section of Pediatric Cardiac Anesthesiology, Texas Children's Hospital, Department of Anesthesiology, Baylor College of Medicine, Houston (A.R., D.F.V.), and the Division of Cardiology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas (R.B.); the University of Utah-Primary Children's Hospital, Salt Lake City (A.S.H.); the University of Southern California and the Heart Institute, Children's Hospital of Los Angeles - both in Los Angeles (S.R.K.); the University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati (A.B.), the Division of Pediatric Cardiac Surgery, Heart Vascular and Thoracic Institute, Cleveland Clinic Children's, Cleveland (T.K.), and the Department of Cardiothoracic Surgery, Nationwide Children's Hospital, and Ohio State University, Columbus (P.I.M.) - all in Ohio; the Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago (E.W.), and the Advocate Children's Heart Institute, Advocate Children's Hospital, Division of Pediatric Cardiac Critical Care, Oak Lawn (A.H.V.B.) - both in Illinois; the Division of Cardiovascular Surgery, Children's Minnesota, Minneapolis (D.O.); the Section of Pediatric Cardiothoracic Surgery, Washington University School of Medicine, St. Louis (P.E.); the Division of Cardiology, Department of Pediatrics, Heart Institute, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora (J.S.K.); Children's Wisconsin, Medical College of Wisconsin, Milwaukee (J.P.S.); and the Division of Pediatric Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York (B.R.A.), and the University of Rochester Medical Center, Rochester (M.F.S.) - both in New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benscoter</LastName><ForeName>Alexis</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the Duke Pediatric and Congenital Heart Center (K.D.H., J.W.T., J.S.L.) and the Duke Clinical Research Institute (K.D.H., S.M.O., J.L.K., D.S.G., J.S.L.) - both in Durham, NC; Vanderbilt University Medical Center, Nashville (P.J.K., H.S.B., D.P.B.); the University of Florida Congenital Heart Center, Gainesville (J.P.J., M.B.); Johns Hopkins University School of Medicine, Baltimore (M.L.J., B.M.); the Medical University of South Carolina, Charleston (E.M.G.); the UPMC Children's Hospital of Pittsburgh, Pittsburgh (B.B.); the Section of Pediatric Cardiac Anesthesiology, Texas Children's Hospital, Department of Anesthesiology, Baylor College of Medicine, Houston (A.R., D.F.V.), and the Division of Cardiology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas (R.B.); the University of Utah-Primary Children's Hospital, Salt Lake City (A.S.H.); the University of Southern California and the Heart Institute, Children's Hospital of Los Angeles - both in Los Angeles (S.R.K.); the University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati (A.B.), the Division of Pediatric Cardiac Surgery, Heart Vascular and Thoracic Institute, Cleveland Clinic Children's, Cleveland (T.K.), and the Department of Cardiothoracic Surgery, Nationwide Children's Hospital, and Ohio State University, Columbus (P.I.M.) - all in Ohio; the Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago (E.W.), and the Advocate Children's Heart Institute, Advocate Children's Hospital, Division of Pediatric Cardiac Critical Care, Oak Lawn (A.H.V.B.) - both in Illinois; the Division of Cardiovascular Surgery, Children's Minnesota, Minneapolis (D.O.); the Section of Pediatric Cardiothoracic Surgery, Washington University School of Medicine, St. Louis (P.E.); the Division of Cardiology, Department of Pediatrics, Heart Institute, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora (J.S.K.); Children's Wisconsin, Medical College of Wisconsin, Milwaukee (J.P.S.); and the Division of Pediatric Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York (B.R.A.), and the University of Rochester Medical Center, Rochester (M.F.S.) - both in New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wald</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>From the Duke Pediatric and Congenital Heart Center (K.D.H., J.W.T., J.S.L.) and the Duke Clinical Research Institute (K.D.H., S.M.O., J.L.K., D.S.G., J.S.L.) - both in Durham, NC; Vanderbilt University Medical Center, Nashville (P.J.K., H.S.B., D.P.B.); the University of Florida Congenital Heart Center, Gainesville (J.P.J., M.B.); Johns Hopkins University School of Medicine, Baltimore (M.L.J., B.M.); the Medical University of South Carolina, Charleston (E.M.G.); the UPMC Children's Hospital of Pittsburgh, Pittsburgh (B.B.); the Section of Pediatric Cardiac Anesthesiology, Texas Children's Hospital, Department of Anesthesiology, Baylor College of Medicine, Houston (A.R., D.F.V.), and the Division of Cardiology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas (R.B.); the University of Utah-Primary Children's Hospital, Salt Lake City (A.S.H.); the University of Southern California and the Heart Institute, Children's Hospital of Los Angeles - both in Los Angeles (S.R.K.); the University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati (A.B.), the Division of Pediatric Cardiac Surgery, Heart Vascular and Thoracic Institute, Cleveland Clinic Children's, Cleveland (T.K.), and the Department of Cardiothoracic Surgery, Nationwide Children's Hospital, and Ohio State University, Columbus (P.I.M.) - all in Ohio; the Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago (E.W.), and the Advocate Children's Heart Institute, Advocate Children's Hospital, Division of Pediatric Cardiac Critical Care, Oak Lawn (A.H.V.B.) - both in Illinois; the Division of Cardiovascular Surgery, Children's Minnesota, Minneapolis (D.O.); the Section of Pediatric Cardiothoracic Surgery, Washington University School of Medicine, St. Louis (P.E.); the Division of Cardiology, Department of Pediatrics, Heart Institute, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora (J.S.K.); Children's Wisconsin, Medical College of Wisconsin, Milwaukee (J.P.S.); and the Division of Pediatric Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York (B.R.A.), and the University of Rochester Medical Center, Rochester (M.F.S.) - both in New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karamlou</LastName><ForeName>Tara</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>From the Duke Pediatric and Congenital Heart Center (K.D.H., J.W.T., J.S.L.) and the Duke Clinical Research Institute (K.D.H., S.M.O., J.L.K., D.S.G., J.S.L.) - both in Durham, NC; Vanderbilt University Medical Center, Nashville (P.J.K., H.S.B., D.P.B.); the University of Florida Congenital Heart Center, Gainesville (J.P.J., M.B.); Johns Hopkins University School of Medicine, Baltimore (M.L.J., B.M.); the Medical University of South Carolina, Charleston (E.M.G.); the UPMC Children's Hospital of Pittsburgh, Pittsburgh (B.B.); the Section of Pediatric Cardiac Anesthesiology, Texas Children's Hospital, Department of Anesthesiology, Baylor College of Medicine, Houston (A.R., D.F.V.), and the Division of Cardiology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas (R.B.); the University of Utah-Primary Children's Hospital, Salt Lake City (A.S.H.); the University of Southern California and the Heart Institute, Children's Hospital of Los Angeles - both in Los Angeles (S.R.K.); the University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati (A.B.), the Division of Pediatric Cardiac Surgery, Heart Vascular and Thoracic Institute, Cleveland Clinic Children's, Cleveland (T.K.), and the Department of Cardiothoracic Surgery, Nationwide Children's Hospital, and Ohio State University, Columbus (P.I.M.) - all in Ohio; the Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago (E.W.), and the Advocate Children's Heart Institute, Advocate Children's Hospital, Division of Pediatric Cardiac Critical Care, Oak Lawn (A.H.V.B.) - both in Illinois; the Division of Cardiovascular Surgery, Children's Minnesota, Minneapolis (D.O.); the Section of Pediatric Cardiothoracic Surgery, Washington University School of Medicine, St. Louis (P.E.); the Division of Cardiology, Department of Pediatrics, Heart Institute, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora (J.S.K.); Children's Wisconsin, Medical College of Wisconsin, Milwaukee (J.P.S.); and the Division of Pediatric Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York (B.R.A.), and the University of Rochester Medical Center, Rochester (M.F.S.) - both in New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Bergen</LastName><ForeName>Andrew H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>From the Duke Pediatric and Congenital Heart Center (K.D.H., J.W.T., J.S.L.) and the Duke Clinical Research Institute (K.D.H., S.M.O., J.L.K., D.S.G., J.S.L.) - both in Durham, NC; Vanderbilt University Medical Center, Nashville (P.J.K., H.S.B., D.P.B.); the University of Florida Congenital Heart Center, Gainesville (J.P.J., M.B.); Johns Hopkins University School of Medicine, Baltimore (M.L.J., B.M.); the Medical University of South Carolina, Charleston (E.M.G.); the UPMC Children's Hospital of Pittsburgh, Pittsburgh (B.B.); the Section of Pediatric Cardiac Anesthesiology, Texas Children's Hospital, Department of Anesthesiology, Baylor College of Medicine, Houston (A.R., D.F.V.), and the Division of Cardiology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas (R.B.); the University of Utah-Primary Children's Hospital, Salt Lake City (A.S.H.); the University of Southern California and the Heart Institute, Children's Hospital of Los Angeles - both in Los Angeles (S.R.K.); the University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati (A.B.), the Division of Pediatric Cardiac Surgery, Heart Vascular and Thoracic Institute, Cleveland Clinic Children's, Cleveland (T.K.), and the Department of Cardiothoracic Surgery, Nationwide Children's Hospital, and Ohio State University, Columbus (P.I.M.) - all in Ohio; the Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago (E.W.), and the Advocate Children's Heart Institute, Advocate Children's Hospital, Division of Pediatric Cardiac Critical Care, Oak Lawn (A.H.V.B.) - both in Illinois; the Division of Cardiovascular Surgery, Children's Minnesota, Minneapolis (D.O.); the Section of Pediatric Cardiothoracic Surgery, Washington University School of Medicine, St. Louis (P.E.); the Division of Cardiology, Department of Pediatrics, Heart Institute, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora (J.S.K.); Children's Wisconsin, Medical College of Wisconsin, Milwaukee (J.P.S.); and the Division of Pediatric Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York (B.R.A.), and the University of Rochester Medical Center, Rochester (M.F.S.) - both in New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Overman</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>From the Duke Pediatric and Congenital Heart Center (K.D.H., J.W.T., J.S.L.) and the Duke Clinical Research Institute (K.D.H., S.M.O., J.L.K., D.S.G., J.S.L.) - both in Durham, NC; Vanderbilt University Medical Center, Nashville (P.J.K., H.S.B., D.P.B.); the University of Florida Congenital Heart Center, Gainesville (J.P.J., M.B.); Johns Hopkins University School of Medicine, Baltimore (M.L.J., B.M.); the Medical University of South Carolina, Charleston (E.M.G.); the UPMC Children's Hospital of Pittsburgh, Pittsburgh (B.B.); the Section of Pediatric Cardiac Anesthesiology, Texas Children's Hospital, Department of Anesthesiology, Baylor College of Medicine, Houston (A.R., D.F.V.), and the Division of Cardiology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas (R.B.); the University of Utah-Primary Children's Hospital, Salt Lake City (A.S.H.); the University of Southern California and the Heart Institute, Children's Hospital of Los Angeles - both in Los Angeles (S.R.K.); the University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati (A.B.), the Division of Pediatric Cardiac Surgery, Heart Vascular and Thoracic Institute, Cleveland Clinic Children's, Cleveland (T.K.), and the Department of Cardiothoracic Surgery, Nationwide Children's Hospital, and Ohio State University, Columbus (P.I.M.) - all in Ohio; the Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago (E.W.), and the Advocate Children's Heart Institute, Advocate Children's Hospital, Division of Pediatric Cardiac Critical Care, Oak Lawn (A.H.V.B.) - both in Illinois; the Division of Cardiovascular Surgery, Children's Minnesota, Minneapolis (D.O.); the Section of Pediatric Cardiothoracic Surgery, Washington University School of Medicine, St. Louis (P.E.); the Division of Cardiology, Department of Pediatrics, Heart Institute, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora (J.S.K.); Children's Wisconsin, Medical College of Wisconsin, Milwaukee (J.P.S.); and the Division of Pediatric Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York (B.R.A.), and the University of Rochester Medical Center, Rochester (M.F.S.) - both in New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eghtesady</LastName><ForeName>Pirooz</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>From the Duke Pediatric and Congenital Heart Center (K.D.H., J.W.T., J.S.L.) and the Duke Clinical Research Institute (K.D.H., S.M.O., J.L.K., D.S.G., J.S.L.) - both in Durham, NC; Vanderbilt University Medical Center, Nashville (P.J.K., H.S.B., D.P.B.); the University of Florida Congenital Heart Center, Gainesville (J.P.J., M.B.); Johns Hopkins University School of Medicine, Baltimore (M.L.J., B.M.); the Medical University of South Carolina, Charleston (E.M.G.); the UPMC Children's Hospital of Pittsburgh, Pittsburgh (B.B.); the Section of Pediatric Cardiac Anesthesiology, Texas Children's Hospital, Department of Anesthesiology, Baylor College of Medicine, Houston (A.R., D.F.V.), and the Division of Cardiology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas (R.B.); the University of Utah-Primary Children's Hospital, Salt Lake City (A.S.H.); the University of Southern California and the Heart Institute, Children's Hospital of Los Angeles - both in Los Angeles (S.R.K.); the University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati (A.B.), the Division of Pediatric Cardiac Surgery, Heart Vascular and Thoracic Institute, Cleveland Clinic Children's, Cleveland (T.K.), and the Department of Cardiothoracic Surgery, Nationwide Children's Hospital, and Ohio State University, Columbus (P.I.M.) - all in Ohio; the Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago (E.W.), and the Advocate Children's Heart Institute, Advocate Children's Hospital, Division of Pediatric Cardiac Critical Care, Oak Lawn (A.H.V.B.) - both in Illinois; the Division of Cardiovascular Surgery, Children's Minnesota, Minneapolis (D.O.); the Section of Pediatric Cardiothoracic Surgery, Washington University School of Medicine, St. Louis (P.E.); the Division of Cardiology, Department of Pediatrics, Heart Institute, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora (J.S.K.); Children's Wisconsin, Medical College of Wisconsin, Milwaukee (J.P.S.); and the Division of Pediatric Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York (B.R.A.), and the University of Rochester Medical Center, Rochester (M.F.S.) - both in New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butts</LastName><ForeName>Ryan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>From the Duke Pediatric and Congenital Heart Center (K.D.H., J.W.T., J.S.L.) and the Duke Clinical Research Institute (K.D.H., S.M.O., J.L.K., D.S.G., J.S.L.) - both in Durham, NC; Vanderbilt University Medical Center, Nashville (P.J.K., H.S.B., D.P.B.); the University of Florida Congenital Heart Center, Gainesville (J.P.J., M.B.); Johns Hopkins University School of Medicine, Baltimore (M.L.J., B.M.); the Medical University of South Carolina, Charleston (E.M.G.); the UPMC Children's Hospital of Pittsburgh, Pittsburgh (B.B.); the Section of Pediatric Cardiac Anesthesiology, Texas Children's Hospital, Department of Anesthesiology, Baylor College of Medicine, Houston (A.R., D.F.V.), and the Division of Cardiology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas (R.B.); the University of Utah-Primary Children's Hospital, Salt Lake City (A.S.H.); the University of Southern California and the Heart Institute, Children's Hospital of Los Angeles - both in Los Angeles (S.R.K.); the University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati (A.B.), the Division of Pediatric Cardiac Surgery, Heart Vascular and Thoracic Institute, Cleveland Clinic Children's, Cleveland (T.K.), and the Department of Cardiothoracic Surgery, Nationwide Children's Hospital, and Ohio State University, Columbus (P.I.M.) - all in Ohio; the Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago (E.W.), and the Advocate Children's Heart Institute, Advocate Children's Hospital, Division of Pediatric Cardiac Critical Care, Oak Lawn (A.H.V.B.) - both in Illinois; the Division of Cardiovascular Surgery, Children's Minnesota, Minneapolis (D.O.); the Section of Pediatric Cardiothoracic Surgery, Washington University School of Medicine, St. Louis (P.E.); the Division of Cardiology, Department of Pediatrics, Heart Institute, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora (J.S.K.); Children's Wisconsin, Medical College of Wisconsin, Milwaukee (J.P.S.); and the Division of Pediatric Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York (B.R.A.), and the University of Rochester Medical Center, Rochester (M.F.S.) - both in New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>John S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>From the Duke Pediatric and Congenital Heart Center (K.D.H., J.W.T., J.S.L.) and the Duke Clinical Research Institute (K.D.H., S.M.O., J.L.K., D.S.G., J.S.L.) - both in Durham, NC; Vanderbilt University Medical Center, Nashville (P.J.K., H.S.B., D.P.B.); the University of Florida Congenital Heart Center, Gainesville (J.P.J., M.B.); Johns Hopkins University School of Medicine, Baltimore (M.L.J., B.M.); the Medical University of South Carolina, Charleston (E.M.G.); the UPMC Children's Hospital of Pittsburgh, Pittsburgh (B.B.); the Section of Pediatric Cardiac Anesthesiology, Texas Children's Hospital, Department of Anesthesiology, Baylor College of Medicine, Houston (A.R., D.F.V.), and the Division of Cardiology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas (R.B.); the University of Utah-Primary Children's Hospital, Salt Lake City (A.S.H.); the University of Southern California and the Heart Institute, Children's Hospital of Los Angeles - both in Los Angeles (S.R.K.); the University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati (A.B.), the Division of Pediatric Cardiac Surgery, Heart Vascular and Thoracic Institute, Cleveland Clinic Children's, Cleveland (T.K.), and the Department of Cardiothoracic Surgery, Nationwide Children's Hospital, and Ohio State University, Columbus (P.I.M.) - all in Ohio; the Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago (E.W.), and the Advocate Children's Heart Institute, Advocate Children's Hospital, Division of Pediatric Cardiac Critical Care, Oak Lawn (A.H.V.B.) - both in Illinois; the Division of Cardiovascular Surgery, Children's Minnesota, Minneapolis (D.O.); the Section of Pediatric Cardiothoracic Surgery, Washington University School of Medicine, St. Louis (P.E.); the Division of Cardiology, Department of Pediatrics, Heart Institute, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora (J.S.K.); Children's Wisconsin, Medical College of Wisconsin, Milwaukee (J.P.S.); and the Division of Pediatric Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York (B.R.A.), and the University of Rochester Medical Center, Rochester (M.F.S.) - both in New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scott</LastName><ForeName>John P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>From the Duke Pediatric and Congenital Heart Center (K.D.H., J.W.T., J.S.L.) and the Duke Clinical Research Institute (K.D.H., S.M.O., J.L.K., D.S.G., J.S.L.) - both in Durham, NC; Vanderbilt University Medical Center, Nashville (P.J.K., H.S.B., D.P.B.); the University of Florida Congenital Heart Center, Gainesville (J.P.J., M.B.); Johns Hopkins University School of Medicine, Baltimore (M.L.J., B.M.); the Medical University of South Carolina, Charleston (E.M.G.); the UPMC Children's Hospital of Pittsburgh, Pittsburgh (B.B.); the Section of Pediatric Cardiac Anesthesiology, Texas Children's Hospital, Department of Anesthesiology, Baylor College of Medicine, Houston (A.R., D.F.V.), and the Division of Cardiology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas (R.B.); the University of Utah-Primary Children's Hospital, Salt Lake City (A.S.H.); the University of Southern California and the Heart Institute, Children's Hospital of Los Angeles - both in Los Angeles (S.R.K.); the University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati (A.B.), the Division of Pediatric Cardiac Surgery, Heart Vascular and Thoracic Institute, Cleveland Clinic Children's, Cleveland (T.K.), and the Department of Cardiothoracic Surgery, Nationwide Children's Hospital, and Ohio State University, Columbus (P.I.M.) - all in Ohio; the Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago (E.W.), and the Advocate Children's Heart Institute, Advocate Children's Hospital, Division of Pediatric Cardiac Critical Care, Oak Lawn (A.H.V.B.) - both in Illinois; the Division of Cardiovascular Surgery, Children's Minnesota, Minneapolis (D.O.); the Section of Pediatric Cardiothoracic Surgery, Washington University School of Medicine, St. Louis (P.E.); the Division of Cardiology, Department of Pediatrics, Heart Institute, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora (J.S.K.); Children's Wisconsin, Medical College of Wisconsin, Milwaukee (J.P.S.); and the Division of Pediatric Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York (B.R.A.), and the University of Rochester Medical Center, Rochester (M.F.S.) - both in New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anderson</LastName><ForeName>Brett R</ForeName><Initials>BR</Initials><Identifier Source="ORCID">0000-0002-0450-9387</Identifier><AffiliationInfo><Affiliation>From the Duke Pediatric and Congenital Heart Center (K.D.H., J.W.T., J.S.L.) and the Duke Clinical Research Institute (K.D.H., S.M.O., J.L.K., D.S.G., J.S.L.) - both in Durham, NC; Vanderbilt University Medical Center, Nashville (P.J.K., H.S.B., D.P.B.); the University of Florida Congenital Heart Center, Gainesville (J.P.J., M.B.); Johns Hopkins University School of Medicine, Baltimore (M.L.J., B.M.); the Medical University of South Carolina, Charleston (E.M.G.); the UPMC Children's Hospital of Pittsburgh, Pittsburgh (B.B.); the Section of Pediatric Cardiac Anesthesiology, Texas Children's Hospital, Department of Anesthesiology, Baylor College of Medicine, Houston (A.R., D.F.V.), and the Division of Cardiology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas (R.B.); the University of Utah-Primary Children's Hospital, Salt Lake City (A.S.H.); the University of Southern California and the Heart Institute, Children's Hospital of Los Angeles - both in Los Angeles (S.R.K.); the University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati (A.B.), the Division of Pediatric Cardiac Surgery, Heart Vascular and Thoracic Institute, Cleveland Clinic Children's, Cleveland (T.K.), and the Department of Cardiothoracic Surgery, Nationwide Children's Hospital, and Ohio State University, Columbus (P.I.M.) - all in Ohio; the Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago (E.W.), and the Advocate Children's Heart Institute, Advocate Children's Hospital, Division of Pediatric Cardiac Critical Care, Oak Lawn (A.H.V.B.) - both in Illinois; the Division of Cardiovascular Surgery, Children's Minnesota, Minneapolis (D.O.); the Section of Pediatric Cardiothoracic Surgery, Washington University School of Medicine, St. Louis (P.E.); the Division of Cardiology, Department of Pediatrics, Heart Institute, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora (J.S.K.); Children's Wisconsin, Medical College of Wisconsin, Milwaukee (J.P.S.); and the Division of Pediatric Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York (B.R.A.), and the University of Rochester Medical Center, Rochester (M.F.S.) - both in New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Swartz</LastName><ForeName>Michael F</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>From the Duke Pediatric and Congenital Heart Center (K.D.H., J.W.T., J.S.L.) and the Duke Clinical Research Institute (K.D.H., S.M.O., J.L.K., D.S.G., J.S.L.) - both in Durham, NC; Vanderbilt University Medical Center, Nashville (P.J.K., H.S.B., D.P.B.); the University of Florida Congenital Heart Center, Gainesville (J.P.J., M.B.); Johns Hopkins University School of Medicine, Baltimore (M.L.J., B.M.); the Medical University of South Carolina, Charleston (E.M.G.); the UPMC Children's Hospital of Pittsburgh, Pittsburgh (B.B.); the Section of Pediatric Cardiac Anesthesiology, Texas Children's Hospital, Department of Anesthesiology, Baylor College of Medicine, Houston (A.R., D.F.V.), and the Division of Cardiology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas (R.B.); the University of Utah-Primary Children's Hospital, Salt Lake City (A.S.H.); the University of Southern California and the Heart Institute, Children's Hospital of Los Angeles - both in Los Angeles (S.R.K.); the University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati (A.B.), the Division of Pediatric Cardiac Surgery, Heart Vascular and Thoracic Institute, Cleveland Clinic Children's, Cleveland (T.K.), and the Department of Cardiothoracic Surgery, Nationwide Children's Hospital, and Ohio State University, Columbus (P.I.M.) - all in Ohio; the Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago (E.W.), and the Advocate Children's Heart Institute, Advocate Children's Hospital, Division of Pediatric Cardiac Critical Care, Oak Lawn (A.H.V.B.) - both in Illinois; the Division of Cardiovascular Surgery, Children's Minnesota, Minneapolis (D.O.); the Section of Pediatric Cardiothoracic Surgery, Washington University School of Medicine, St. Louis (P.E.); the Division of Cardiology, Department of Pediatrics, Heart Institute, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora (J.S.K.); Children's Wisconsin, Medical College of Wisconsin, Milwaukee (J.P.S.); and the Division of Pediatric Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York (B.R.A.), and the University of Rochester Medical Center, Rochester (M.F.S.) - both in New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McConnell</LastName><ForeName>Patrick I</ForeName><Initials>PI</Initials><AffiliationInfo><Affiliation>From the Duke Pediatric and Congenital Heart Center (K.D.H., J.W.T., J.S.L.) and the Duke Clinical Research Institute (K.D.H., S.M.O., J.L.K., D.S.G., J.S.L.) - both in Durham, NC; Vanderbilt University Medical Center, Nashville (P.J.K., H.S.B., D.P.B.); the University of Florida Congenital Heart Center, Gainesville (J.P.J., M.B.); Johns Hopkins University School of Medicine, Baltimore (M.L.J., B.M.); the Medical University of South Carolina, Charleston (E.M.G.); the UPMC Children's Hospital of Pittsburgh, Pittsburgh (B.B.); the Section of Pediatric Cardiac Anesthesiology, Texas Children's Hospital, Department of Anesthesiology, Baylor College of Medicine, Houston (A.R., D.F.V.), and the Division of Cardiology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas (R.B.); the University of Utah-Primary Children's Hospital, Salt Lake City (A.S.H.); the University of Southern California and the Heart Institute, Children's Hospital of Los Angeles - both in Los Angeles (S.R.K.); the University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati (A.B.), the Division of Pediatric Cardiac Surgery, Heart Vascular and Thoracic Institute, Cleveland Clinic Children's, Cleveland (T.K.), and the Department of Cardiothoracic Surgery, Nationwide Children's Hospital, and Ohio State University, Columbus (P.I.M.) - all in Ohio; the Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago (E.W.), and the Advocate Children's Heart Institute, Advocate Children's Hospital, Division of Pediatric Cardiac Critical Care, Oak Lawn (A.H.V.B.) - both in Illinois; the Division of Cardiovascular Surgery, Children's Minnesota, Minneapolis (D.O.); the Section of Pediatric Cardiothoracic Surgery, Washington University School of Medicine, St. Louis (P.E.); the Division of Cardiology, Department of Pediatrics, Heart Institute, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora (J.S.K.); Children's Wisconsin, Medical College of Wisconsin, Milwaukee (J.P.S.); and the Division of Pediatric Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York (B.R.A.), and the University of Rochester Medical Center, Rochester (M.F.S.) - both in New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vener</LastName><ForeName>David F</ForeName><Initials>DF</Initials><AffiliationInfo><Affiliation>From the Duke Pediatric and Congenital Heart Center (K.D.H., J.W.T., J.S.L.) and the Duke Clinical Research Institute (K.D.H., S.M.O., J.L.K., D.S.G., J.S.L.) - both in Durham, NC; Vanderbilt University Medical Center, Nashville (P.J.K., H.S.B., D.P.B.); the University of Florida Congenital Heart Center, Gainesville (J.P.J., M.B.); Johns Hopkins University School of Medicine, Baltimore (M.L.J., B.M.); the Medical University of South Carolina, Charleston (E.M.G.); the UPMC Children's Hospital of Pittsburgh, Pittsburgh (B.B.); the Section of Pediatric Cardiac Anesthesiology, Texas Children's Hospital, Department of Anesthesiology, Baylor College of Medicine, Houston (A.R., D.F.V.), and the Division of Cardiology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas (R.B.); the University of Utah-Primary Children's Hospital, Salt Lake City (A.S.H.); the University of Southern California and the Heart Institute, Children's Hospital of Los Angeles - both in Los Angeles (S.R.K.); the University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati (A.B.), the Division of Pediatric Cardiac Surgery, Heart Vascular and Thoracic Institute, Cleveland Clinic Children's, Cleveland (T.K.), and the Department of Cardiothoracic Surgery, Nationwide Children's Hospital, and Ohio State University, Columbus (P.I.M.) - all in Ohio; the Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago (E.W.), and the Advocate Children's Heart Institute, Advocate Children's Hospital, Division of Pediatric Cardiac Critical Care, Oak Lawn (A.H.V.B.) - both in Illinois; the Division of Cardiovascular Surgery, Children's Minnesota, Minneapolis (D.O.); the Section of Pediatric Cardiothoracic Surgery, Washington University School of Medicine, St. Louis (P.E.); the Division of Cardiology, Department of Pediatrics, Heart Institute, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora (J.S.K.); Children's Wisconsin, Medical College of Wisconsin, Milwaukee (J.P.S.); and the Division of Pediatric Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York (B.R.A.), and the University of Rochester Medical Center, Rochester (M.F.S.) - both in New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jennifer S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>From the Duke Pediatric and Congenital Heart Center (K.D.H., J.W.T., J.S.L.) and the Duke Clinical Research Institute (K.D.H., S.M.O., J.L.K., D.S.G., J.S.L.) - both in Durham, NC; Vanderbilt University Medical Center, Nashville (P.J.K., H.S.B., D.P.B.); the University of Florida Congenital Heart Center, Gainesville (J.P.J., M.B.); Johns Hopkins University School of Medicine, Baltimore (M.L.J., B.M.); the Medical University of South Carolina, Charleston (E.M.G.); the UPMC Children's Hospital of Pittsburgh, Pittsburgh (B.B.); the Section of Pediatric Cardiac Anesthesiology, Texas Children's Hospital, Department of Anesthesiology, Baylor College of Medicine, Houston (A.R., D.F.V.), and the Division of Cardiology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas (R.B.); the University of Utah-Primary Children's Hospital, Salt Lake City (A.S.H.); the University of Southern California and the Heart Institute, Children's Hospital of Los Angeles - both in Los Angeles (S.R.K.); the University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati (A.B.), the Division of Pediatric Cardiac Surgery, Heart Vascular and Thoracic Institute, Cleveland Clinic Children's, Cleveland (T.K.), and the Department of Cardiothoracic Surgery, Nationwide Children's Hospital, and Ohio State University, Columbus (P.I.M.) - all in Ohio; the Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago (E.W.), and the Advocate Children's Heart Institute, Advocate Children's Hospital, Division of Pediatric Cardiac Critical Care, Oak Lawn (A.H.V.B.) - both in Illinois; the Division of Cardiovascular Surgery, Children's Minnesota, Minneapolis (D.O.); the Section of Pediatric Cardiothoracic Surgery, Washington University School of Medicine, St. Louis (P.E.); the Division of Cardiology, Department of Pediatrics, Heart Institute, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora (J.S.K.); Children's Wisconsin, Medical College of Wisconsin, Milwaukee (J.P.S.); and the Division of Pediatric Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York (B.R.A.), and the University of Rochester Medical Center, Rochester (M.F.S.) - both in New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>STRESS Network Investigators</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT03229538</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>U24TR-001608-03</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RC1 HL099941</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>1U01TR001803-01</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 TR001608</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 HD061601</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K08 HL116639</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18 FD006298</GrantID><Acronym>FD</Acronym><Agency>FDA HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 TR001803</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K01 AI073729</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HHSN267200700051C</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>N Engl J Med</MedlineTA><NlmUniqueID>0255562</NlmUniqueID><ISSNLinking>0028-4793</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>X4W7ZR7023</RegistryNumber><NameOfSubstance UI="D008775">Methylprednisolone</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Nat Rev Cardiol. 2023 Jan;20(1):6. doi: 10.1038/s41569-022-00812-8.</RefSource><PMID Version="1">36376436</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Cardiothorac Vasc Anesth. 2023 Jun;37(6):860-862. doi: 10.1053/j.jvca.2023.02.002.</RefSource><PMID Version="1">36863987</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>N Engl J Med. 2023 Mar 9;388(10):958. doi: 10.1056/NEJMc2300127.</RefSource><PMID Version="1">36884336</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>N Engl J Med. 2023 Mar 9;388(10):958-959. doi: 10.1056/NEJMc2300127.</RefSource><PMID Version="1">36884337</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>N Engl J Med. 2023 Mar 9;388(10):959. doi: 10.1056/NEJMc2300127.</RefSource><PMID Version="1">36884338</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008775" MajorTopicYN="Y">Methylprednisolone</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName></MeshHeading></MeshHeadingList><InvestigatorList><Investigator ValidYN="Y"><LastName>Amula</LastName><ForeName>Venugopal</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Andersen</LastName><ForeName>Nick</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ballweg</LastName><ForeName>Jean</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bradley</LastName><ForeName>Scott M</ForeName><Initials>SM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Buckley</LastName><ForeName>Jason R</ForeName><Initials>JR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chamberlain</LastName><ForeName>Reid C</ForeName><Initials>RC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Christian</LastName><ForeName>Karla G</ForeName><Initials>KG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cleveland</LastName><ForeName>John D</ForeName><Initials>JD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Do</LastName><ForeName>Nhue</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gibson</LastName><ForeName>Will</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hornik</LastName><ForeName>Christoph P</ForeName><Initials>CP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jaggers</LastName><ForeName>James</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kavarana</LastName><ForeName>Minoo N</ForeName><Initials>MN</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ravekes</LastName><ForeName>William</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schuette</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tabutt</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Williams</LastName><ForeName>Richard V</ForeName><Initials>RV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zyblewski</LastName><ForeName>Sinai C</ForeName><Initials>SC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Feltes</LastName><ForeName>Timothy F</ForeName><Initials>TF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Laughon</LastName><ForeName>Matthew</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gauvreau</LastName><ForeName>Kimberlee</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Newburger</LastName><ForeName>Jane</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Graham</LastName><ForeName>Eric</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tweddel</LastName><ForeName>James</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smoot</LastName><ForeName>Lori</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chang</LastName><ForeName>Soju</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Avdiushko</LastName><ForeName>Sergei</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bartone</LastName><ForeName>Susan</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Beaulieu</LastName><ForeName>Gail</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chavez</LastName><ForeName>Darwin</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Decker</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Drosdick</LastName><ForeName>Deborah</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Edwards</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Elliott</LastName><ForeName>Carrie</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ellis</LastName><ForeName>Alicia</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Evans</LastName><ForeName>Claire</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fly</LastName><ForeName>Julie</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gallup</LastName><ForeName>Dianne</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Green</LastName><ForeName>Cindy</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hickerson</LastName><ForeName>Jesse</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jackson</LastName><ForeName>Valerie</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jasion</LastName><ForeName>Theresa</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jensen</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kirchner</LastName><ForeName>Jerry</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mayton</LastName><ForeName>Cheryl</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>McDaniel</LastName><ForeName>Annette</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Metry</LastName><ForeName>Rania</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pereira</LastName><ForeName>Carol</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Phillips</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tasissa</LastName><ForeName>Gudaye</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Turner</LastName><ForeName>Tinisha</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wells</LastName><ForeName>Kadie</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fountain</LastName><ForeName>Darlene</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Madell</LastName><ForeName>Sarita</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Crum</LastName><ForeName>Kimberly</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Galligy</LastName><ForeName>Kate</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Van'tHof</LastName><ForeName>Kathleen</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Burgardt</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Otto</LastName><ForeName>Michelle</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sanchez</LastName><ForeName>Chantal</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Al Sarraf</LastName><ForeName>Layla</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Boyle</LastName><ForeName>Lucey</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Woodly</LastName><ForeName>Shalayna</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Swann</LastName><ForeName>Taylor</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Molony</LastName><ForeName>Kathleen</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Anguiano</LastName><ForeName>William</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Martinez</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mobley</LastName><ForeName>Bianca</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mohazabnia</LastName><ForeName>Parvin</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brown</LastName><ForeName>Molly</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Taylor</LastName><ForeName>Amy</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gawad</LastName><ForeName>Mike</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nelson</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marshall</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Monroe</LastName><ForeName>Amy</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Price</LastName><ForeName>Reality</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Richey</LastName><ForeName>Susan</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lopez Colon</LastName><ForeName>Dalia</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Breault</LastName><ForeName>Leah</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lambert</LastName><ForeName>Linda</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goel</LastName><ForeName>Disha</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kwiatkowski</LastName><ForeName>Pawel</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mannie</LastName><ForeName>Chelsea</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pourney</LastName><ForeName>Annie</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hansen</LastName><ForeName>Gabriel</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chamberlain</LastName><ForeName>Carolyn</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Murphy</LastName><ForeName>Luke</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harman</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Challman</LastName><ForeName>Melissa</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lee</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Malivers</LastName><ForeName>Martine</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Menard</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hughes</LastName><ForeName>Bonnie</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>O'Grady</LastName><ForeName>Katrin</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>LoGalbo</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bizjak</LastName><ForeName>Deborah</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hunter</LastName><ForeName>Fejeania</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Koepp</LastName><ForeName>Sidney</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kost</LastName><ForeName>Lukas</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Teknipp</LastName><ForeName>Kimberly</ForeName><Initials>K</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>7</Day><Hour>7</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36342116</ArticleId><ArticleId IdType="mid">NIHMS1861125</ArticleId><ArticleId IdType="pmc">PMC9843240</ArticleId><ArticleId IdType="doi">10.1056/NEJMoa2212667</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jacobs JP, Mayer JE Jr, Pasquali SK, et al. The Society of Thoracic Surgeons Congenital Heart Surgery Database: 2019 update on outcomes and quality. Ann Thorac Surg 2019;107:691&#x2013;704.</Citation><ArticleIdList><ArticleId IdType="pubmed">30641069</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson BR, Fieldston ES, Newburger JW, Bacha EA, Glied SA. Disparities in outcomes and resource use after hospitalization for cardiac surgery by neighborhood income. Pediatrics 2018;141(3):e20172432.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5847092</ArticleId><ArticleId IdType="pubmed">29472494</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashraf SS, Tian Y, Zacharrias S, Cowan D, Martin P, Watterson K. Effects of cardiopulmonary bypass on neonatal and paediatric inflammatory profiles. Eur J Cardiothorac Surg 1997;12:862&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">9489870</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman TM, Wernovsky G, Atz AM, et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 2003;107:996&#x2013;1002.</Citation><ArticleIdList><ArticleId IdType="pubmed">12600913</ArticleId></ArticleIdList></Reference><Reference><Citation>Asimakopoulos G Systemic inflammation and cardiac surgery: an update. Perfusion 2001;16:353&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">11565890</ArticleId></ArticleIdList></Reference><Reference><Citation>Moat NE, Shore DF, Evans TW. Organ dysfunction and cardiopulmonary bypass: the role of complement and complement regulatory proteins. Eur J Cardiothorac Surg 1993;7:563&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">8297608</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan S, LeClerc JL, Vincent JL. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest 1997;112:676&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">9315800</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitlock RP, Devereaux PJ, Teoh KH, et al. Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): a randomised, double-blind, placebo-controlled trial. Lancet 2015;386:1243&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">26460660</ArticleId></ArticleIdList></Reference><Reference><Citation>Dieleman JM, Nierich AP, Rosseel PM, et al. Intraoperative high-dose dexamethasone for cardiac surgery: a randomized controlled trial. JAMA 2012;308:1761&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">23117776</ArticleId></ArticleIdList></Reference><Reference><Citation>Wernovsky G, Wypij D, Jonas RA, et al. Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants: a comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation 1995;92:2226&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">7554206</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs JP, He X, Mayer JE Jr, et al. Mortality trends in pediatric and congenital heart surgery: an analysis of the Society of Thoracic Surgeons Congenital Heart Surgery Database. Ann Thorac Surg 2016;102:1345&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">27590683</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs ML, O&#x2019;Brien SM, Jacobs JP, et al. An empirically based tool for analyzing morbidity associated with operations for congenital heart disease. J Thorac Cardiovasc Surg 2013;145(4):1046.e1&#x2013;1057.e1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3824389</ArticleId><ArticleId IdType="pubmed">22835225</ArticleId></ArticleIdList></Reference><Reference><Citation>Scrascia G, Rotunno C, Guida P, et al. Perioperative steroids administration in pediatric cardiac surgery: a meta-analysis of randomized controlled trials. Pediatr Crit Care Med 2014;15:435&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">24717907</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Luo Q, Wu X, Jia Y, Yan F. Perioperative corticosteroid therapy in children undergoing cardiac surgery: a systematic review and meta-analysis. Front Pediatr 2020;8:350.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7396528</ArticleId><ArticleId IdType="pubmed">32903325</ArticleId></ArticleIdList></Reference><Reference><Citation>Bronicki RA, Flores S, Loomba RS, et al. Impact of corticosteroids on cardiopulmonary bypass induced inflammation in children: a meta-analysis. Ann Thorac Surg 2021;112:1363&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">33309732</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauer MS, D&#x2019;Agostino RB Sr. The randomized registry trial &#x2014; the next disruptive technology in clinical research? N Engl J Med 2013;369:1579&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">23991657</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill KD, Baldwin HS, Bichel DP, et al. Rationale and design of the STeroids to REduce Systemic inflammation after infant heart Surgery (STRESS) trial. Am Heart J 2020;220:192&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7008076</ArticleId><ArticleId IdType="pubmed">31855716</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs JP, Mavroudis C, Jacobs ML, et al. What is operative mortality? Defining death in a surgical registry database: a report of the STS Congenital Database Taskforce and the Joint EACTS-STS Congenital Database Committee. Ann Thorac Surg 2006;81:1937&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">16631716</ArticleId></ArticleIdList></Reference><Reference><Citation>Overman DM, Jacobs JP, Prager RL, et al. Report from the Society of Thoracic Surgeons National Database Workforce: clarifying the definition of operative mortality. World J Pediatr Congenit Heart Surg 2013;4:10&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3828200</ArticleId><ArticleId IdType="pubmed">23799748</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahan BC, Jairath V, Dor&#xe9; CJ, Morris TP. The risks and rewards of covariate adjustment in randomized trials: an assessment of 12 outcomes from 8 studies. Trials 2014;15:139.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4022337</ArticleId><ArticleId IdType="pubmed">24755011</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Brien SM, Jacobs JP, Pasquali SK, et al. The Society of Thoracic Surgeons Congenital Heart Surgery Database mortality risk model: part 1 &#x2014; statistical methodology. Ann Thorac Surg 2015;100:1054&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4728716</ArticleId><ArticleId IdType="pubmed">26245502</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill KD, Baldwin HS, Bichel DP, et al. Overcoming underpowering: trial simulations and a global rank end point to optimize clinical trials in children with heart disease. Am Heart J 2020;226:188&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7442685</ArticleId><ArticleId IdType="pubmed">32599259</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs ML, Jacobs JP, Thibault D, et al. Updating an empirically based tool for analyzing congenital heart surgery mortality. World J Pediatr Congenit Heart Surg 2021;12:246&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">33683997</ArticleId></ArticleIdList></Reference><Reference><Citation>Pocock SJ, Ariti CA, Collier TJ, Wang D. The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities. Eur Heart J 2012;33:176&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">21900289</ArticleId></ArticleIdList></Reference><Reference><Citation>Agresti A Generalized odds ratios for ordinal data. Biometrics 1980;36:59&#x2013;67.</Citation></Reference><Reference><Citation>Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999;94:496&#x2013;509.</Citation></Reference><Reference><Citation>Whitlock RP, Dieleman JM, Belley-Cote E, et al. The effect of steroids in patients undergoing cardiopulmonary bypass: an individual patient meta-analysis of two randomized trials. J Cardiothorac Vasc Anesth 2020;34:99&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pubmed">31401207</ArticleId></ArticleIdList></Reference><Reference><Citation>Lomivorotov V, Kornilov I, Boboshko V, et al. Effect of intraoperative dexamethasone on major complications and mortality among infants undergoing cardiac surgery: the DECISION randomized clinical trial. JAMA 2020;323:2485&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7312411</ArticleId><ArticleId IdType="pubmed">32573670</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham EM, Martin RH, Buckley JR, et al. Corticosteroid therapy in neonates undergoing cardiopulmonary bypass: randomized controlled trial. J Am Coll Cardiol 2019;74:659&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6684326</ArticleId><ArticleId IdType="pubmed">31370958</ArticleId></ArticleIdList></Reference><Reference><Citation>Polito A, Thiagarajan RR, Laussen PC, et al. Association between intraoperative and early postoperative glucose levels and adverse outcomes after complex congenital heart surgery. Circulation 2008;118:2235&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2892105</ArticleId><ArticleId IdType="pubmed">19001022</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballweg JA, Wernovsky G, Ittenbach RF, et al. Hyperglycemia after infant cardiac surgery does not adversely impact neurodevelopmental outcome. Ann Thorac Surg 2007;84:2052&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">18036934</ArticleId></ArticleIdList></Reference><Reference><Citation>DeCampli WM, Olsen MC, Munro HM, Felix DE. Perioperative hyperglycemia: effect on outcome after infant congenital heart surgery. Ann Thorac Surg 2010;89:181&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">20103231</ArticleId></ArticleIdList></Reference><Reference><Citation>Agus MSD, Steil GM, Wypij D, et al. Tight glycemic control versus standard care after pediatric cardiac surgery. N Engl J Med 2012;367:1208&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3501680</ArticleId><ArticleId IdType="pubmed">22957521</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlasselaers D, Milants I, Desmet L, et al. Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study. Lancet 2009;373:547&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">19176240</ArticleId></ArticleIdList></Reference><Reference><Citation>Fr&#xf6;bert O, Lagerqvist B, Olivecrona GK, et al. Thrombus aspiration during ST-segment elevation myocardial infarction. N Engl J Med 2013;369:1587&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">23991656</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao SV, Hess CN, Barham B, et al. A registry-based randomized trial comparing radial and femoral approaches in women undergoing percutaneous coronary intervention: the SAFE-PCI for Women (Study of Access Site for Enhancement of PCI for Women) trial. JACC Cardiovasc Interv 2014;7:857&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">25147030</ArticleId></ArticleIdList></Reference><Reference><Citation>Torok RD, Li JS, Kannankeril PJ, et al. Recommendations to enhance pediatric cardiovascular drug development: report of a multi-stakeholder think tank. J Am Heart Assoc 2018;7(4):e007283.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5850184</ArticleId><ArticleId IdType="pubmed">29440007</ArticleId></ArticleIdList></Reference><Reference><Citation>Nathan M, Jacobs ML, Gaynor JW, et al. Completeness and accuracy of local clinical registry data for children undergoing heart surgery. Ann Thorac Surg 2017;103:629&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5253303</ArticleId><ArticleId IdType="pubmed">27726857</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36520715</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1756-1833</ISSN><JournalIssue CitedMedium="Internet"><Volume>379</Volume><PubDate><Year>2022</Year><Month>Nov</Month><Day>23</Day></PubDate></JournalIssue><Title>BMJ (Clinical research ed.)</Title><ISOAbbreviation>BMJ</ISOAbbreviation></Journal><ArticleTitle>Rivaroxaban treatment for six weeks versus three months in patients with symptomatic isolated distal deep vein thrombosis: randomised controlled trial.</ArticleTitle><Pagination><StartPage>e072623</StartPage><MedlinePgn>e072623</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e072623</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmj-2022-072623</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To compare two different treatment durations of rivaroxaban in patients with symptomatic isolated distal deep vein thrombosis (DVT).</AbstractText><AbstractText Label="DESIGN">Randomised, double blind, placebo controlled clinical trial.</AbstractText><AbstractText Label="SETTING">28 outpatient clinics specialising in venous thromboembolism.</AbstractText><AbstractText Label="PARTICIPANTS">402 adults (&#x2265;18 years) with symptomatic isolated distal DVT.</AbstractText><AbstractText Label="INTERVENTIONS">After receiving standard dose rivaroxaban for six weeks, participants were randomly assigned to receive rivaroxaban 20 mg or placebo once daily for an additional six weeks. Follow-up was for 24 months from study inclusion.</AbstractText><AbstractText Label="MAIN OUTCOMES MEASURES">The primary efficacy outcome was recurrent venous thromboembolism during follow-up after randomisation, defined as the composite of progression of isolated distal DVT, recurrent isolated distal DVT, proximal DVT, symptomatic pulmonary embolism, or fatal pulmonary embolism. The primary safety outcome was major bleeding after randomisation until two days from the last dose of rivaroxaban or placebo. An independent committee adjudicated the outcomes.</AbstractText><AbstractText Label="RESULTS">200 adults were randomised to receive additional rivaroxaban treatment and 202 to receive placebo. Isolated distal DVT was unprovoked in 81 (40%) and 86 (43%) patients, respectively. The primary efficacy outcome occurred in 23 (11%) patients in the rivaroxaban arm and 39 (19%) in the placebo arm (relative risk 0.59, 95% confidence interval 0.36 to 0.95; P=0.03, number needed to treat 13, 95% confidence interval 7 to 126). Recurrent isolated distal DVT occurred in 16 (8%) patients in the rivaroxaban arm and 31 (15%) in the placebo arm (P=0.02). Proximal DVT or pulmonary embolism occurred in seven (3%) patients in the rivaroxaban arm and eight (4%) in the placebo arm (P=0.80). No major bleeding events occurred.</AbstractText><AbstractText Label="CONCLUSIONS">Rivaroxaban administered for six additional weeks in patients with isolated distal DVT who had an uneventful six week treatment course reduces the risk of recurrent venous thromboembolism, mainly recurrent isolated distal DVT, over a two year follow-up without increasing the risk of haemorrhage.</AbstractText><AbstractText Label="TRIAL REGISTRATION">EudraCT 2016-000958-36; ClinicalTrials.gov NCT02722447.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ageno</LastName><ForeName>Walter</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-1922-8879</Identifier><AffiliationInfo><Affiliation>Department of Medicine and Surgery, University of Insubria, 21100 Varese, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bert&#xf9;</LastName><ForeName>Lorenza</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medicine and Surgery, University of Insubria, 21100 Varese, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bucherini</LastName><ForeName>Eugenio</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Vascular Medicine, AUSL Romagna, Faenza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camporese</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Unit of Angiology, Department of Cardiac, Thoracic and Vascular Sciences, University of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dentali</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Medicine and Surgery, University of Insubria, 21100 Varese, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iotti</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiovascular Medicine Unit - AUSL-IRCCS, Reggio Emilia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lessiani</LastName><ForeName>Gianfranco</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Angiology Unit, Department of Internal Medicine, Villa Serena Hospital, Citt&#xe0; Sant'Angelo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parisi</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Medicine, SS Giovanni e Paolo Hospital, Venice, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prandoni</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Arianna Anticoagulazione Foundation, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sartori</LastName><ForeName>Michelangelo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Angiology and Blood Coagulation, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vison&#xe0;</LastName><ForeName>Adriana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Angiology Unit, Azienda ULSS 2 Marca Trevigiana, Castelfranco Veneto, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bigagli</LastName><ForeName>Elisabetta</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Psychology, Drug Research and Child Health, Section of Pharmacology and Toxicology, University of Florence, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palareti</LastName><ForeName>Gualtiero</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Arianna Anticoagulazione Foundation, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>RIDTS study group</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02722447</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ</MedlineTA><NlmUniqueID>8900488</NlmUniqueID><ISSNLinking>0959-8138</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9NDF7JZ4M3</RegistryNumber><NameOfSubstance UI="D000069552">Rivaroxaban</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Ann Intern Med. 2023 Apr;176(4):JC42. doi: 10.7326/J23-0014.</RefSource><PMID Version="1">37011394</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069552" MajorTopicYN="N">Rivaroxaban</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="Y">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="Y">Venous Thrombosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Competing interests: All authors have completed the ICMJE uniform disclosure for at www.icmje.org/disclosure-of-interest/ and declare: support from Bayer Italy. WA has received payment or honorariums for lectures from Aspen, Bayer, Bristol Myers Squibb, Leo Pharma, Norgine, Pfizer, Sanofi, and Werfen, and has participated on advisory boards for Bayer, Leo Pharma, Norgine, Sanofi, and Viatris; GP has received consulting fees from Alfa Sigma. All other authors have no financial relationships or other relationships or activities to disclose.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Galgano</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zingaretti</LastName><ForeName>Oriana</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Amitrano</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mastroiacovo</LastName><ForeName>Daniela</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pinelli</LastName><ForeName>Mauro</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cosmi</LastName><ForeName>Benilde</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Silingardi</LastName><ForeName>Mauro</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bigolin</LastName><ForeName>Paola</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zalunardo</LastName><ForeName>Beniamino</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Porreca</LastName><ForeName>Ettore</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Di Nisio</LastName><ForeName>Marcello</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pomero</LastName><ForeName>Fulvio</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mumoli</LastName><ForeName>Nicola</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Avruscio</LastName><ForeName>Giampiero</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tonello</LastName><ForeName>Chiara</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Imberti</LastName><ForeName>Davide</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Benedetti</LastName><ForeName>Raffaella</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zanatta</LastName><ForeName>Nello</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Veropalumbo</LastName><ForeName>Maria Rosaria</ForeName><Initials>MR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ghirarduzzi</LastName><ForeName>Angelo</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pola</LastName><ForeName>Roberto</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Porfidia</LastName><ForeName>Angelo</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marzolo</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cuppini</LastName><ForeName>Stefano</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lodigiani</LastName><ForeName>Corrado</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Banfi</LastName><ForeName>Elena</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gnerre</LastName><ForeName>Paola</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cappelli</LastName><ForeName>Roberto</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Girardi</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Conte</LastName><ForeName>Giulia</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pegoraro</LastName><ForeName>Samuela</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hong</LastName><ForeName>Ngog Vo</ForeName><Initials>NV</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>15</Day><Hour>13</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36520715</ArticleId><ArticleId IdType="pmc">PMC9682494</ArticleId><ArticleId IdType="doi">10.1136/bmj-2022-072623</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Palareti G. How I treat isolated distal deep vein thrombosis (IDDVT). Blood 2014;123:1802-9. 10.1182/blood-2013-10-512616&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2013-10-512616</ArticleId><ArticleId IdType="pubmed">24472834</ArticleId></ArticleIdList></Reference><Reference><Citation>Franco L, Giustozzi M, Agnelli G, Becattini C. Anticoagulation in patients with isolated distal deep vein thrombosis: a meta-analysis. J Thromb Haemost 2017;15:1142-54. 10.1111/jth.13677&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.13677</ArticleId><ArticleId IdType="pubmed">28316124</ArticleId></ArticleIdList></Reference><Reference><Citation>Donadini MP, Dentali F, Pegoraro S, et al. . Long-term recurrence of venous thromboembolism after short-term treatment of symptomatic isolated distal deep vein thrombosis: A cohort study. Vasc Med 2017;22:518-24. 10.1177/1358863X17720531&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1358863X17720531</ArticleId><ArticleId IdType="pubmed">28732457</ArticleId></ArticleIdList></Reference><Reference><Citation>Galanaud JP, Sevestre MA, Genty C, et al. OPTIMEV-SFMV investigators . Incidence and predictors of venous thromboembolism recurrence after a first isolated distal deep vein thrombosis. J Thromb Haemost 2014;12:436-43. 10.1111/jth.12512&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.12512</ArticleId><ArticleId IdType="pubmed">24450376</ArticleId></ArticleIdList></Reference><Reference><Citation>Sartori M, Migliaccio L, Favaretto E, Palareti G, Cosmi B. Two years outcome of isolated distal deep vein thrombosis. Thromb Res 2014;134:36-40. 10.1016/j.thromres.2014.03.033&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2014.03.033</ArticleId><ArticleId IdType="pubmed">24713107</ArticleId></ArticleIdList></Reference><Reference><Citation>Kearon C, Akl EA, Comerota AJ, et al. . Antithrombotic therapy for VTE disease. Chest 2012;141(Suppl):e419S-96S. 10.1378/chest.11-2301.&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.11-2301</ArticleId><ArticleId IdType="pmc">PMC3278049</ArticleId><ArticleId IdType="pubmed">22315268</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens SM, Woller SC, Baumann Kreuziger L, et al. . Antithrombotic therapy for VTE disease: second update of the CHEST Guideline and Expert Panel Report. Chest 2021;160:2247-59. 10.1016/j.chest.2021.07.056&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.07.056</ArticleId><ArticleId IdType="pubmed">34352279</ArticleId></ArticleIdList></Reference><Reference><Citation>Schellong S, Ageno W, Casella IB, et al. . Profile of Patients with Isolated Distal Deep Vein Thrombosis versus Proximal Deep Vein Thrombosis or Pulmonary Embolism: RE-COVERY DVT/PE Study. Semin Thromb Hemost 2022;48:446-58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9246482</ArticleId><ArticleId IdType="pubmed">33971682</ArticleId></ArticleIdList></Reference><Reference><Citation>Schellong SM, Goldhaber SZ, Weitz JI, et al. . Isolated Distal Deep Vein Thrombosis: Perspectives from the GARFIELD-VTE Registry. Thromb Haemost 2019;119:1675-85. 10.1055/s-0039-1693461&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0039-1693461</ArticleId><ArticleId IdType="pubmed">31370075</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulman S, Kearon C, Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis . Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 2005;3:692-4. 10.1111/j.1538-7836.2005.01204.x&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2005.01204.x</ArticleId><ArticleId IdType="pubmed">15842354</ArticleId></ArticleIdList></Reference><Reference><Citation>Barco S, Corti M, Trinchero A, et al. . Survival and recurrent venous thromboembolism in patients with first proximal or isolated distal deep vein thrombosis and no pulmonary embolism. J Thromb Haemost 2017;15:1436-42. 10.1111/jth.13713&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.13713</ArticleId><ArticleId IdType="pubmed">28439954</ArticleId></ArticleIdList></Reference><Reference><Citation>Galanaud JP, Quenet S, Rivron-Guillot K, et al. RIETE INVESTIGATORS . Comparison of the clinical history of symptomatic isolated distal deep-vein thrombosis vs. proximal deep vein thrombosis in 11 086 patients. J Thromb Haemost 2009;7:2028-34. 10.1111/j.1538-7836.2009.03629.x&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2009.03629.x</ArticleId><ArticleId IdType="pubmed">19793188</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuczmik W, Wysokinski WE, Macedo T, et al. . Calf vein thrombosis outcomes comparing anticoagulation and serial ultrasound imaging management strategies. Mayo Clin Proc 2021;96:1184-92. 10.1016/j.mayocp.2021.01.024&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.01.024</ArticleId><ArticleId IdType="pubmed">33840522</ArticleId></ArticleIdList></Reference><Reference><Citation>Astermark J, Bj&#xf6;rgell O, Lind&#xe9;n E, Lethagen S, Nilsson P, Berntorp E. Low recurrence rate after deep calf-vein thrombosis with 6 weeks of oral anticoagulation. J Intern Med 1998;244:79-82. 10.1046/j.1365-2796.1998.00318.x&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2796.1998.00318.x</ArticleId><ArticleId IdType="pubmed">9698028</ArticleId></ArticleIdList></Reference><Reference><Citation>Ageno W, Mantovani LG, Haas S, et al. . Patient management strategies and long-term outcomes in isolated distal deep vein thrombosis versus proximal deep vein thrombosis: findings from XALIA. TH Open 2019;3:e85-93. 10.1055/s-0039-1683968&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0039-1683968</ArticleId><ArticleId IdType="pmc">PMC6524913</ArticleId><ArticleId IdType="pubmed">31249987</ArticleId></ArticleIdList></Reference><Reference><Citation>Righini M, Galanaud JP, Guenneguez H, et al. . Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double-blind, placebo-controlled trial. Lancet Haematol 2016;3:e556-62. 10.1016/S2352-3026(16)30131-4&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(16)30131-4</ArticleId><ArticleId IdType="pubmed">27836513</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinede L, Ninet J, Duhaut P, et al. Investigators of the &#x201c;Dur&#xe9;e Optimale du Traitement AntiVitamines K&#x201d; (DOTAVK) Study . Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation 2001;103:2453-60. 10.1161/01.CIR.103.20.2453&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.103.20.2453</ArticleId><ArticleId IdType="pubmed">11369685</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrara F, Meli F, Amato C, et al. . Optimal duration of treatment in surgical patients with calf venous thrombosis involving one or more veins. Angiology 2006;57:418-23. 10.1177/0003319706290745&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0003319706290745</ArticleId><ArticleId IdType="pubmed">17022376</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulman S, Rhedin AS, Lindmarker P, et al. Duration of Anticoagulation Trial Study Group . A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. N Engl J Med 1995;332:1661-5. 10.1056/NEJM199506223322501&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199506223322501</ArticleId><ArticleId IdType="pubmed">7760866</ArticleId></ArticleIdList></Reference><Reference><Citation>Li AY, Woulfe T, Rolfe-Vyson V, Rowland V, Simpson D, Merriman E. Management and outcomes of axial isolated distal deep vein thrombosis at North Shore Hospital, New Zealand: a retrospective audit. Intern Med J 2015;45:177-82. 10.1111/imj.12664&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imj.12664</ArticleId><ArticleId IdType="pubmed">25521797</ArticleId></ArticleIdList></Reference><Reference><Citation>Valerio L, Ambaglio C, Barone M, et al. . Recurrence risk after first symptomatic distal versus proximal deep vein thrombosis according to baseline risk factors. TH Open 2019;3:e58-63. 10.1055/s-0039-1683374&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0039-1683374</ArticleId><ArticleId IdType="pmc">PMC6524909</ArticleId><ArticleId IdType="pubmed">31249983</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzolai L, Ageno W, Alatri A, et al. . Second consensus document on diagnosis and management of acute deep vein thrombosis: updated document elaborated by the ESC Working Group on aorta and peripheral vascular diseases and the ESC Working Group on pulmonary circulation and right ventricular function. Eur J Prev Cardiol 2022;29:1248-63. 10.1093/eurjpc/zwab088&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurjpc/zwab088</ArticleId><ArticleId IdType="pubmed">34254133</ArticleId></ArticleIdList></Reference><Reference><Citation>Ageno W, Camporese G, Riva N, et al. PALLADIO Study Investigators . Analysis of an algorithm incorporating limited and whole-leg assessment of the deep venous system in symptomatic outpatients with suspected deep-vein thrombosis (PALLADIO): a prospective, multicentre, cohort study. Lancet Haematol 2015;2:e474-80. 10.1016/S2352-3026(15)00190-8&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(15)00190-8</ArticleId><ArticleId IdType="pubmed">26686257</ArticleId></ArticleIdList></Reference><Reference><Citation>Prandoni P, Lensing AW, Prins MH, et al. . The impact of residual thrombosis on the long-term outcome of patients with deep venous thrombosis treated with conventional anticoagulation. Semin Thromb Hemost 2015;41:133-40. 10.1055/s-0035-1544161&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0035-1544161</ArticleId><ArticleId IdType="pubmed">25682083</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">30822776</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>07</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1524-4040</ISSN><JournalIssue CitedMedium="Internet"><Volume>84</Volume><Issue>6</Issue><PubDate><Year>2019</Year><Month>Jun</Month><Day>01</Day></PubDate></JournalIssue><Title>Neurosurgery</Title><ISOAbbreviation>Neurosurgery</ISOAbbreviation></Journal><ArticleTitle>Guidelines for the Management of Pediatric Severe Traumatic Brain Injury, Third Edition: Update of the Brain Trauma Foundation Guidelines, Executive Summary.</ArticleTitle><Pagination><StartPage>1169</StartPage><EndPage>1178</EndPage><MedlinePgn>1169-1178</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/neuros/nyz051</ELocationID><Abstract><AbstractText>The purpose of this work is to identify and synthesize research produced since the second edition of these Guidelines was published and incorporate new results into revised evidence-based recommendations for the treatment of severe traumatic brain injury in pediatric patients. This document provides an overview of our process, lists the new research added, and includes the revised recommendations. Recommendations are only provided when there is supporting evidence. This update includes 22 recommendations, 9 are new or revised from previous editions. New recommendations on neuroimaging, hyperosmolar therapy, analgesics and sedatives, seizure prophylaxis, temperature control/hypothermia, and nutrition are provided. None are level I, 3 are level II, and 19 are level III. The Clinical Investigators responsible for these Guidelines also created a companion algorithm that supplements the recommendations with expert consensus where evidence is not available and organizes possible interventions into first and second tier utilization. The complete guideline document and supplemental appendices are available electronically (https://doi.org/10.1097/PCC.0000000000001735). The online documents contain summaries and evaluations of all the studies considered, including those from prior editions, and more detailed information on our methodology. New level II and level III evidence-based recommendations and an algorithm provide additional guidance for the development of local protocols to treat pediatric patients with severe traumatic brain injury. Our intention is to identify and institute a sustainable process to update these Guidelines as new evidence becomes available.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kochanek</LastName><ForeName>Patrick M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Department of Anesthesiology, Pe-diatrics, Bioengineering, and Clinical and Translational Science, Safar Center for Resuscitation Research, University of Pittsburgh School of Medicine, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tasker</LastName><ForeName>Robert C</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Department of Neurology, Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital; Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carney</LastName><ForeName>Nancy</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Pacific Northwest Evidence-based Practice Center, Department of Medical Informatics and Clinical Epidemiology, Oregon Health &amp; Science University, Portland, Oregon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Totten</LastName><ForeName>Annette M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Pacific Northwest Evidence-based Practice Center, Department of Medical Informatics and Clinical Epidemiology, Oregon Health &amp; Science University, Portland, Oregon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adelson</LastName><ForeName>P David</ForeName><Initials>PD</Initials><AffiliationInfo><Affiliation>Deptartment of Pediatric Neurosurgery, BARROW Neurological Institute at Phoenix Children's Hospital, Phoenix, Arizona.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Selden</LastName><ForeName>Nathan R</ForeName><Initials>NR</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, Oregon Health &amp; Science University, Portland, Oregon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davis-O'Reilly</LastName><ForeName>Cynthia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Pacific Northwest Evidence-based Practice Center, Department of Medical Informatics and Clinical Epidemiology, Oregon Health &amp; Science University, Portland, Oregon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hart</LastName><ForeName>Erica L</ForeName><Initials>EL</Initials><AffiliationInfo><Affiliation>Pacific Northwest Evidence-based Practice Center, Department of Medical Informatics and Clinical Epidemiology, Oregon Health &amp; Science University, Portland, Oregon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bell</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department Critical Care Medicine, Children's National Medical Center, Washington, District of Columbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bratton</LastName><ForeName>Susan L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Utah, Salt Lake City, Utah.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grant</LastName><ForeName>Gerald A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Stanford University, Stanford, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kissoon</LastName><ForeName>Niranjan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, British Columbia's Children's Hospital, Child and Family Research Institute, University of British Columbia, Vancouver, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reuter-Rice</LastName><ForeName>Karin E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>School of Nursing/School of Medicine, Department of Pediatrics, Division of Pediatric Critical Care Medicine, Duke University, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vavilala</LastName><ForeName>Monica S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology &amp; Pain Medicine, Department of Pediatrics, Harborview Injury Prevention and Research Center (HIPRC), University of Washington, Seattle, Washington.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wainwright</LastName><ForeName>Mark S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Division of Pediatric Neurology, University of Washington, Seattle Children's Hospital, Seattle, Washington.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017065">Practice Guideline</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurosurgery</MedlineTA><NlmUniqueID>7802914</NlmUniqueID><ISSNLinking>0148-396X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Neurosurgery. 2019 Aug 1;85(2):E384-E385. doi: 10.1093/neuros/nyz192.</RefSource><PMID Version="1">31173145</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Neurosurgery. 2019 Aug 1;85(2):E386-E387. doi: 10.1093/neuros/nyz208.</RefSource><PMID Version="1">31215623</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Neurosurgery. 2019 Aug 1;85(2):E388-E389. doi: 10.1093/neuros/nyz209.</RefSource><PMID Version="1">31215626</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000070642" MajorTopicYN="N">Brain Injuries, Traumatic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007427" MajorTopicYN="N">Intracranial Pressure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059906" MajorTopicYN="N">Neuroimaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064926" MajorTopicYN="N">Neurophysiological Monitoring</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017410" MajorTopicYN="N">Practice Guidelines as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Critical care</Keyword><Keyword MajorTopicYN="N">Evidence-based medicine</Keyword><Keyword MajorTopicYN="N">Guidelines</Keyword><Keyword MajorTopicYN="N">Head injury</Keyword><Keyword MajorTopicYN="N">Pediatrics</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword><Keyword MajorTopicYN="N">Traumatic brain injury</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>1</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>2</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30822776</ArticleId><ArticleId IdType="doi">10.1093/neuros/nyz051</ArticleId><ArticleId IdType="pii">5367430</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39016117</PMID><DateCompleted><Year>2024</Year><Month>12</Month><Day>13</Day></DateCompleted><DateRevised><Year>2024</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1552-4876</ISSN><JournalIssue CitedMedium="Internet"><Volume>196</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>American journal of medical genetics. Part C, Seminars in medical genetics</Title><ISOAbbreviation>Am J Med Genet C Semin Med Genet</ISOAbbreviation></Journal><ArticleTitle>Multiorgan manifestations of COL4A1 and COL4A2 variants and proposal for a clinical management protocol.</ArticleTitle><Pagination><StartPage>e32099</StartPage><MedlinePgn>e32099</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/ajmg.c.32099</ELocationID><Abstract><AbstractText>COL4A1/2 variants are associated with highly variable multiorgan manifestations. Depicting the whole clinical spectrum of COL4A1/2-related manifestations is challenging, and there is no consensus on management and preventative strategies. Based on a systematic review of current evidence on COL4A1/2-related disease, we developed a clinical questionnaire that we administered to 43 individuals from 23 distinct families carrying pathogenic variants. In this cohort, we extended ophthalmological and cardiological examinations to asymptomatic individuals and those with only limited or mild, often nonspecific, clinical signs commonly occurring in the general population (i.e., oligosymptomatic). The most frequent clinical findings emerging from both the literature review and the questionnaire included stroke (203/685, 29.6%), seizures or epilepsy (199/685, 29.0%), intellectual disability or developmental delay (168/685, 24.5%), porencephaly/schizencephaly (168/685, 24.5%), motor impairment (162/685, 23.6%), cataract (124/685, 18.1%), hematuria (63/685, 9.2%), and retinal arterial tortuosity (58/685, 8.5%). In oligosymptomatic and asymptomatic carriers, ophthalmological investigations detected retinal vascular tortuosity (5/13, 38.5%), dysgenesis of the anterior segment (4/13, 30.8%), and cataract (2/13, 15.4%), while cardiological investigations were unremarkable except for mild ascending aortic ectasia in 1/8 (12.5%). Our multimodal approach confirms highly variable penetrance and expressivity in COL4A1/2-related conditions, even at the intrafamilial level with neurological involvement being the most frequent and severe finding in both children and adults. We propose a protocol for prevention and management based on individualized risk estimation and periodic multiorgan evaluations.</AbstractText><CopyrightInformation>&#xa9; 2024 The Author(s). American Journal of Medical Genetics Part C: Seminars in Medical Genetics published by Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gasparini</LastName><ForeName>Simone</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Neuroscience and Human Genetics Department, Meyer Children's Hospital IRCCS (full member of the European Reference Network EpiCARE), Florence, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Florence, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balestrini</LastName><ForeName>Simona</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-5639-1969</Identifier><AffiliationInfo><Affiliation>Neuroscience and Human Genetics Department, Meyer Children's Hospital IRCCS (full member of the European Reference Network EpiCARE), Florence, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Florence, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saccaro</LastName><ForeName>Luigi Francesco</ForeName><Initials>LF</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Geneva University and Geneva University Hospitals, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bacci</LastName><ForeName>Giacomo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Pediatric Ophthalmology Unit, Meyer Children's Hospital IRCCS, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Panichella</LastName><ForeName>Giorgia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>University of Florence, Florence, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical and Experimental Medicine, University Hospital Careggi, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montomoli</LastName><ForeName>Martino</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neuroscience and Human Genetics Department, Meyer Children's Hospital IRCCS (full member of the European Reference Network EpiCARE), Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cantalupo</LastName><ForeName>Gaetano</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Child Neuropsychiatry Unit, University Hospital of Verona (full member of the European Reference Network EpiCARE), Verona, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Engineering for Innovation Medicine, Innovation Biomedicine Section, University of Verona, Verona, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Research on Epilepsy in Pediatric Age (CREP), University Hospital of Verona, Verona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bigoni</LastName><ForeName>Stefania</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Medical Genetics Unit, Ferrara University Hospital, Ferrara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mancano</LastName><ForeName>Giorgia</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-6528-1841</Identifier><AffiliationInfo><Affiliation>Neuroscience and Human Genetics Department, Meyer Children's Hospital IRCCS (full member of the European Reference Network EpiCARE), Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pellacani</LastName><ForeName>Simona</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Neuroscience and Human Genetics Department, Meyer Children's Hospital IRCCS (full member of the European Reference Network EpiCARE), Florence, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Florence, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leuzzi</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-2314-6139</Identifier><AffiliationInfo><Affiliation>Unit of Child Neurology and Psychiatry, Department of Human Neuroscience, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Volpi</LastName><ForeName>Nila</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Neurology and Clinical Neurophysiology Unit, Department of Medical, Surgical and Neurological Sciences, University of Siena, Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mari</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Child and Adolescent Epilepsy and Clinical Neurophysiology Departmental Unit, USL Centro Toscana, Prato, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melani</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Neuroscience and Human Genetics Department, Meyer Children's Hospital IRCCS (full member of the European Reference Network EpiCARE), Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cavallin</LastName><ForeName>Mara</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neuroscience and Human Genetics Department, Meyer Children's Hospital IRCCS (full member of the European Reference Network EpiCARE), Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pisano</LastName><ForeName>Tiziana</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Neuroscience and Human Genetics Department, Meyer Children's Hospital IRCCS (full member of the European Reference Network EpiCARE), Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Porcedda</LastName><ForeName>Giulio</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Paediatric Cardiology, Meyer Children's Hospital IRCCS, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vaglio</LastName><ForeName>Augusto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Nephrology and Dialysis Unit, Meyer Children's Hospital IRCCS, Florence, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical, Experimental and Clinical Sciences "Mario Serio", University of Florence, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mei</LastName><ForeName>Davide</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Neuroscience and Human Genetics Department, Meyer Children's Hospital IRCCS (full member of the European Reference Network EpiCARE), Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barba</LastName><ForeName>Carmen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Neuroscience and Human Genetics Department, Meyer Children's Hospital IRCCS (full member of the European Reference Network EpiCARE), Florence, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Florence, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parrini</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Neuroscience and Human Genetics Department, Meyer Children's Hospital IRCCS (full member of the European Reference Network EpiCARE), Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guerrini</LastName><ForeName>Renzo</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-7272-7079</Identifier><AffiliationInfo><Affiliation>Neuroscience and Human Genetics Department, Meyer Children's Hospital IRCCS (full member of the European Reference Network EpiCARE), Florence, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Florence, Florence, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Current Research 2023 of the Italian Ministry of Health</Agency><Country/></Grant><Grant><Agency>Ministry of University and Research (MUR)</Agency><Country/></Grant><Grant><Agency>National Recovery and Resilience Plan (NRRP)</Agency><Country/></Grant><Grant><GrantID>PE0000006</GrantID><Agency>project MNESYS</Agency><Country/></Grant><Grant><Agency>Brain Optical Mapping by Fondazione CARIFI</Agency><Country/></Grant><Grant><Agency>DECODEE, Call Health 2018 of the Tuscany Region</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Med Genet C Semin Med Genet</MedlineTA><NlmUniqueID>101235745</NlmUniqueID><ISSNLinking>1552-4868</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C547475">COL4A1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C502625">COL4A2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D024141">Collagen Type IV</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D024141" MajorTopicYN="Y">Collagen Type IV</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004827" MajorTopicYN="N">Epilepsy</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008607" MajorTopicYN="N">Intellectual Disability</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012640" MajorTopicYN="N">Seizures</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002386" MajorTopicYN="N">Cataract</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006417" MajorTopicYN="N">Hematuria</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D065708" MajorTopicYN="N">Porencephaly</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002658" MajorTopicYN="N">Developmental Disabilities</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COL4A1</Keyword><Keyword MajorTopicYN="N">COL4A2</Keyword><Keyword MajorTopicYN="N">collagen</Keyword><Keyword MajorTopicYN="N">genotype&#x2013;phenotype correlation</Keyword><Keyword MajorTopicYN="N">multiorgan</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>6</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>12</Month><Day>13</Day><Hour>11</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>17</Day><Hour>12</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39016117</ArticleId><ArticleId IdType="doi">10.1002/ajmg.c.32099</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Abe, Y., Matsuduka, A., Okanari, K., Miyahara, H., Kato, M., Miyatake, S., Saitsu, H., Matsumoto, N., Tomoki, M., &amp; Ihara, K. (2017). A severe pulmonary complication in a patient with COL4A1&#x2010;related disorder: A case report. European Journal of Medical Genetics, 60(3), 169&#x2013;171. https://doi.org/10.1016/j.ejmg.2016.12.008</Citation></Reference><Reference><Citation>Amir&#x2010;Behghadami, M., &amp; Janati, A. (2020). Population, Intervention, Comparison, Outcomes and Study (PICOS) design as a framework to formulate eligibility criteria in systematic reviews. Emergency Medicine Journal: EMJ, 37(6), 387. https://doi.org/10.1136/emermed-2020-209567</Citation></Reference><Reference><Citation>Aubart, M., Gazal, S., Arnaud, P., Benarroch, L., Gross, M. S., Buratti, J., Boland, A., Meyer, V., Zouali, H., Hanna, N., Milleron, O., Stheneur, C., Bourgeron, T., Desguerre, I., Jacob, M. P., Gouya, L., G&#xe9;nin, E., Deleuze, J. F., Jondeau, G., &amp; Boileau, C. (2018). Association of modifiers and other genetic factors explain Marfan syndrome clinical variability. European Journal of Human Genetics: EJHG, 26(12), 1759&#x2013;1772. https://doi.org/10.1038/s41431-018-0164-9</Citation></Reference><Reference><Citation>Breedveld, G., de Coo, I. F., Lequin, M. H., Arts, W. F., Heutink, P., Gould, D. B., John, S. W., Oostra, B., &amp; Mancini, G. M. (2006). Novel mutations in three families confirm a major role of COL4A1 in hereditary porencephaly. Journal of Medical Genetics, 43(6), 490&#x2013;495. https://doi.org/10.1136/jmg.2005.035584</Citation></Reference><Reference><Citation>Campo&#x2010;Caballero, D., Rodriguez&#x2010;Antig&#xfc;edad, J., Ekiza&#x2010;Bazan, J., Iruzubieta&#x2010;Agudo, P., Fern&#xe1;ndez&#x2010;Eulate, G., Mu&#xf1;oz&#x2010;Lopetegui, A., Mart&#xed;nez&#x2010;Zabaleta, M., de la Riva, P., Urtasun&#x2010;Ocariz, M., L&#xf3;pez de Munain, A., &amp; de Arce, A. (2020). COL4A1 mutation as a cause of familial recurrent intracerebral hemorrhage. Journal of Stroke and Cerebrovascular Diseases: The Official Journal of National Stroke Association, 29(4), 104652. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.104652</Citation></Reference><Reference><Citation>Cavallin, M., Mine, M., Philbert, M., Boddaert, N., Lepage, J. M., Coste, T., Lopez&#x2010;Gonzalez, V., Sanchez&#x2010;Soler, M. J., Ballesta&#x2010;Mart&#xed;nez, M. J., Remerand, G., Pasquier, L., Gu&#xeb;t, A., Chelly, J., Lascelles, K., Prieto&#x2010;Morin, C., Kossorotoff, M., Tournier Lasserve, E., &amp; Bahi&#x2010;Buisson, N. (2018). Further refinement of COL4A1 and COL4A2 related cortical malformations. European Journal of Medical Genetics, 61(12), 765&#x2013;772. https://doi.org/10.1016/j.ejmg.2018.10.004</Citation></Reference><Reference><Citation>Chen, Z., Migeon, T., Verpont, M. C., Zaidan, M., Sado, Y., Kerjaschki, D., Ronco, P., &amp; Plaisier, E. (2016). HANAC syndrome Col4a1 mutation causes neonate glomerular hyperpermeability and adult glomerulocystic kidney disease. Journal of the American Society of Nephrology: JASN, 27(4), 1042&#x2013;1054. https://doi.org/10.1681/ASN.2014121217</Citation></Reference><Reference><Citation>Cho, B. P. H., Harshfield, E. L., Al&#x2010;Thani, M., Tozer, D. J., Bell, S., &amp; Markus, H. S. (2022). Association of vascular risk factors and genetic factors with penetrance of variants causing monogenic stroke. JAMA Neurology, 79(12), 1303&#x2013;1311. https://doi.org/10.1001/jamaneurol.2022.3832</Citation></Reference><Reference><Citation>Coupry, I., Sibon, I., Mortemousque, B., Rouanet, F., Mine, M., &amp; Goizet, C. (2010). Ophthalmological features associated with COL4A1 mutations. Archives of Ophthalmology, 128(4), 483&#x2013;489. https://doi.org/10.1001/archophthalmol.2010.42</Citation></Reference><Reference><Citation>Dahl, S., Pettersson, M., Eisfeldt, J., Schr&#xf6;der, A. K., Wickstr&#xf6;m, R., Te&#xe4;r Fahnehjelm, K., Anderlid, B. M., &amp; Lindstrand, A. (2020). Whole genome sequencing unveils genetic heterogeneity in optic nerve hypoplasia. PLoS One, 15(2), e0228622. https://doi.org/10.1371/journal.pone.0228622</Citation></Reference><Reference><Citation>Deciphering Developmental Disorders Study. (2017). Prevalence and architecture of de novo mutations in developmental disorders. Nature, 542(7642), 433&#x2013;438. https://doi.org/10.1038/nature21062</Citation></Reference><Reference><Citation>Deml, B., Reis, L. M., Maheshwari, M., Griffis, C., Bick, D., &amp; Semina, E. V. (2014). Whole exome analysis identifies dominant COL4A1 mutations in patients with complex ocular phenotypes involving microphthalmia. Clinical Genetics, 86(5), 475&#x2013;481. https://doi.org/10.1111/cge.12379</Citation></Reference><Reference><Citation>Desai, D. S., &amp; Hajouli, S. (2023). Arrhythmias. In StatPearls. StatPearls Publishing.</Citation></Reference><Reference><Citation>Donner, I., Sipil&#xe4;, L. J., Plaketti, R. M., Kuosmanen, A., Forsstr&#xf6;m, L., Katainen, R., Kuismin, O., Aavikko, M., Romsi, P., Kariniemi, J., &amp; Aaltonen, L. A. (2022). Next&#x2010;generation sequencing in a large pedigree segregating visceral artery aneurysms suggests potential role of COL4A1/COL4A2 in disease etiology. Vascular, 30(5), 842&#x2013;847. https://doi.org/10.1177/17085381211033157</Citation></Reference><Reference><Citation>Ellard, S., Baple, E. L., Berry, I., Forrester, N., Turnbull, C., Owens, M., Eccles, D. M., Abbs, S., Scott, R., Deans, Z., Lester, T., Campbell, J., Newman, W., &amp; McMullan, D. (2020). ACGS best practice guidelines for variant classification 2020: association for clinical genetics science (ACGS), 2020. Retrieved from: https://www.acgs.uk.com/quality/best-practice-guidelines/#VariantGuidelines</Citation></Reference><Reference><Citation>Gale, D. P., Oygar, D. D., Lin, F., Oygar, P. D., Khan, N., Connor, T. M., Lapsley, M., Maxwell, P. H., &amp; Neild, G. H. (2016). A novel COL4A1 frameshift mutation in familial kidney disease: The importance of the C&#x2010;terminal NC1 domain of type IV collagen. Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association &#x2010; European Renal Association, 31(11), 1908&#x2013;1914. https://doi.org/10.1093/ndt/gfw051</Citation></Reference><Reference><Citation>George, E., Vassar, R., Mogga, A., Li, Y., Norton, M. E., Gano, D., &amp; Glenn, O. A. (2023). Spectrum of fetal intraparenchymal hemorrhage in COL4A1/A2&#x2010;related disorders. Pediatric Neurology, 147, 63&#x2013;67. https://doi.org/10.1016/j.pediatrneurol.2023.07.008</Citation></Reference><Reference><Citation>Giorgio, E., Vaula, G., Bosco, G., Giacone, S., Mancini, C., Calcia, A., Cavalieri, S., Di Gregorio, E., Rigault De Longrais, R., Leombruni, S., Pinessi, L., Cerrato, P., Brusco, A., &amp; Brussino, A. (2015). Two families with novel missense mutations in COL4A1: When diagnosis can be missed. Journal of the Neurological Sciences, 352(1&#x2013;2), 99&#x2013;104. https://doi.org/10.1016/j.jns.2015.03.042</Citation></Reference><Reference><Citation>Gould, D. B., Phalan, F. C., Breedveld, G. J., van Mil, S. E., Smith, R. S., Schimenti, J. C., Aguglia, U., van der Knaap, M. S., Heutink, P., &amp; John, S. W. (2005). Mutations in Col4a1 cause perinatal cerebral hemorrhage and porencephaly. Science (New York, N.Y.), 308(5725), 1167&#x2013;1171. https://doi.org/10.1126/science.1109418</Citation></Reference><Reference><Citation>Gould, D. B., Phalan, F. C., van Mil, S. E., Sundberg, J. P., Vahedi, K., Massin, P., Bousser, M. G., Heutink, P., Miner, J. H., Tournier&#x2010;Lasserve, E., &amp; John, S. W. (2006). Role of COL4A1 in small&#x2010;vessel disease and hemorrhagic stroke. The New England Journal of Medicine, 354(14), 1489&#x2013;1496. https://doi.org/10.1056/NEJMoa053727</Citation></Reference><Reference><Citation>Greenberg, S. M., Ziai, W. C., Cordonnier, C., Dowlatshahi, D., Francis, B., Goldstein, J. N., Hemphill, J. C., Johnson, R., Keigher, K. M., Mack, W. J., Mocco, J., Newton, E. J., Ruff, I. M., Sansing, L. H., Schulman, S., Selim, M. H., Sheth, K. N., Sprigg, N., Sunnerhagen, K. S., &amp; American Heart Association/American Stroke Association. (2022). 2022 guideline for the management of patients with spontaneous intracerebral hemorrhage: A guideline from the American Heart Association/American Stroke Association. Stroke, 53(7), e282&#x2013;e361. https://doi.org/10.1161/STR.0000000000000407</Citation></Reference><Reference><Citation>Gunda, B., Mine, M., Kov&#xe1;cs, T., Horny&#xe1;k, C., Bereczki, D., V&#xe1;rallyay, G., Rudas, G., Audrezet, M. P., &amp; Tournier&#x2010;Lasserve, E. (2014). COL4A2 mutation causing adult onset recurrent intracerebral hemorrhage and leukoencephalopathy. Journal of Neurology, 261(3), 500&#x2013;503. https://doi.org/10.1007/s00415-013-7224-4</Citation></Reference><Reference><Citation>Haga, S., Takeguchi, R., Tanaka, R., Satake, A., Makita, Y., Yanagi, K., Kaname, T., &amp; Takahashi, S. (2023). Clinical characteristics of muscle cramps in hereditary angiopathy with nephropathy, aneurysms, and muscle cramps syndrome associated with a novel COL4A1 pathogenic variant: A family case study. Brain &amp; Development, 45(7), 390&#x2013;394. https://doi.org/10.1016/j.braindev.2023.02.008</Citation></Reference><Reference><Citation>Hirono, K., Hata, Y., Miyao, N., Okabe, M., Takarada, S., Nakaoka, H., Ibuki, K., Ozawa, S., Origasa, H., Nishida, N., Ichida, F., &amp; LVNC study collaborates*. (2020). Increased burden of ion channel gene variants is related to distinct phenotypes in pediatric patients with left ventricular noncompaction. Circulation: Genomic and Precision Medicine, 13(4), e002940. https://doi.org/10.1161/CIRCGEN.119.002940</Citation></Reference><Reference><Citation>Huang, X., Xiao, X., Jia, X., Li, S., Li, M., Guo, X., Liu, X., &amp; Zhang, Q. (2015). Mutation analysis of the genes associated with anterior segment dysgenesis, microcornea and microphthalmia in 257 patients with glaucoma. International Journal of Molecular Medicine, 36(4), 1111&#x2013;1117. https://doi.org/10.3892/ijmm.2015.2325</Citation></Reference><Reference><Citation>Itai, T., Miyatake, S., Taguri, M., Nozaki, F., Ohta, M., Osaka, H., Morimoto, M., Tandou, T., Nohara, F., Takami, Y., Yoshioka, F., Shimokawa, S., Okuno&#x2010;Yuguchi, J., Motobayashi, M., Takei, Y., Fukuyama, T., Kumada, S., Miyata, Y., Ogawa, C., &#x2026; Matsumoto, N. (2021). Prenatal clinical manifestations in individuals with COL4A1/2 variants. Journal of Medical Genetics, 58(8), 505&#x2013;513. https://doi.org/10.1136/jmedgenet-2020-106896</Citation></Reference><Reference><Citation>Jeanne, M., &amp; Gould, D. B. (2017). Genotype&#x2010;phenotype correlations in pathology caused by collagen type IV alpha 1 and 2 mutations. Matrix Biology: Journal of the International Society for Matrix Biology, 57&#x2010;58, 29&#x2013;44. https://doi.org/10.1016/j.matbio.2016.10.003</Citation></Reference><Reference><Citation>Jeanne, M., Labelle&#x2010;Dumais, C., Jorgensen, J., Kauffman, W. B., Mancini, G. M., Favor, J., Valant, V., Greenberg, S. M., Rosand, J., &amp; Gould, D. B. (2012). COL4A2 mutations impair COL4A1 and COL4A2 secretion and cause hemorrhagic stroke. American Journal of Human Genetics, 90(1), 91&#x2013;101. https://doi.org/10.1016/j.ajhg.2011.11.022</Citation></Reference><Reference><Citation>John, S., Jehi, L., Manno, E. M., Conway, D. S., &amp; Uchino, K. (2015). COL4A1 gene mutation&#x2014;Beyond a vascular syndrome. Seizure, 31, 19&#x2013;21. https://doi.org/10.1016/j.seizure.2015.06.014</Citation></Reference><Reference><Citation>Kessel, L., Bach&#x2010;Holm, D., Al&#x2010;Bakri, M., Roos, L., Lund, A., &amp; Gr&#xf8;nskov, K. (2021). Genetic disease is a common cause of bilateral childhood cataract in Denmark. Ophthalmic Genetics, 42(6), 650&#x2013;658. https://doi.org/10.1080/13816810.2021.1941128</Citation></Reference><Reference><Citation>Kikumoto, M., Kurashige, T., Ohshita, T., Kume, K., Kikumoto, O., Nezu, T., Aoki, S., Ochi, K., Morino, H., Nomura, E., Yamashita, H., Kaneko, M., Maruyama, H., &amp; Kawakami, H. (2023). 'Raisin bread sign' feature of pontine autosomal dominant microangiopathy and leukoencephalopathy. Brain Communications, 5(6), fcad281. https://doi.org/10.1093/braincomms/fcad281</Citation></Reference><Reference><Citation>Kirkham, F. J., Zafeiriou, D., Howe, D., Czarpran, P., Harris, A., Gunny, R., &amp; Vollmer, B. (2018). Fetal stroke and cerebrovascular disease: Advances in understanding from lenticulostriate and venous imaging, alloimmune thrombocytopaenia and monochorionic twins. European Journal of Paediatric Neurology: EJPN: Official Journal of the European Paediatric Neurology Society, 22(6), 989&#x2013;1005. https://doi.org/10.1016/j.ejpn.2018.08.008</Citation></Reference><Reference><Citation>Kitzler, T. M., Schneider, R., Kohl, S., Kolvenbach, C. M., Connaughton, D. M., Dai, R., Mann, N., Nakayama, M., Majmundar, A. J., Wu, C. W., Kari, J. A., El Desoky, S. M., Senguttuvan, P., Bogdanovic, R., Stajic, N., Valivullah, Z., Lek, M., Mane, S., Lifton, R. P., &#x2026; Hildebrandt, F. (2019). COL4A1 mutations as a potential novel cause of autosomal dominant CAKUT in humans. Human Genetics, 138(10), 1105&#x2013;1115. https://doi.org/10.1007/s00439-019-02042-4</Citation></Reference><Reference><Citation>Kuo, D. S., Labelle&#x2010;Dumais, C., &amp; Gould, D. B. (2012). COL4A1 and COL4A2 mutations and disease: Insights into pathogenic mechanisms and potential therapeutic targets. Human Molecular Genetics, 21(R1), R97&#x2013;R110. https://doi.org/10.1093/hmg/dds346</Citation></Reference><Reference><Citation>Kylat, R. I. (2022). Peter's anomaly&#x2010;a homeotic gene disorder. Acta Paediatrica (Oslo, Norway: 1992), 111(5), 948&#x2013;951. https://doi.org/10.1111/apa.16260</Citation></Reference><Reference><Citation>Labelle&#x2010;Dumais, C., Dilworth, D. J., Harrington, E. P., de Leau, M., Lyons, D., Kabaeva, Z., Manzini, M. C., Dobyns, W. B., Walsh, C. A., Michele, D. E., &amp; Gould, D. B. (2011). COL4A1 mutations cause ocular dysgenesis, neuronal localization defects, and myopathy in mice and Walker&#x2010;Warburg syndrome in humans. PLoS Genetics, 7(5), e1002062. https://doi.org/10.1371/journal.pgen.1002062</Citation></Reference><Reference><Citation>Labelle&#x2010;Dumais, C., Schuitema, V., Hayashi, G., Hoff, K., Gong, W., Dao, D. Q., Ullian, E. M., Oishi, P., Margeta, M., &amp; Gould, D. B. (2019). COL4A1 mutations cause neuromuscular disease with tissue&#x2010;specific mechanistic heterogeneity. American Journal of Human Genetics, 104(5), 847&#x2013;860. https://doi.org/10.1016/j.ajhg.2019.03.007</Citation></Reference><Reference><Citation>Lemmens, R., Maugeri, A., Niessen, H. W., Goris, A., Tousseyn, T., Demaerel, P., Corveleyn, A., Robberecht, W., van der Knaap, M. S., Thijs, V. N., &amp; Zwijnenburg, P. J. (2013). Novel COL4A1 mutations cause cerebral small vessel disease by haploinsufficiency. Human Molecular Genetics, 22(2), 391&#x2013;397. https://doi.org/10.1093/hmg/dds436</Citation></Reference><Reference><Citation>Li, Q., Wang, C., Li, W., Zhang, Z., Wang, S., Wupuer, A., Hu, X., Wumaier, K., Zhu, Y., Li, H., &amp; Yu, W. (2022). A novel mutation in COL4A1 gene in a Chinese family with pontine autosomal dominant microangiopathy and leukoencephalopathy. Translational Stroke Research, 13(2), 238&#x2013;244. https://doi.org/10.1007/s12975-021-00926-0</Citation></Reference><Reference><Citation>Livingston, J., Doherty, D., Orcesi, S., Tonduti, D., Piechiecchio, A., La Piana, R., Tournier&#x2010;Lasserve, E., Majumdar, A., Tomkins, S., Rice, G., Kneen, R., van der Knaap, M., &amp; Crow, Y. (2011). COL4A1 mutations associated with a characteristic pattern of intracranial calcification. Neuropediatrics, 42(6), 227&#x2013;233. https://doi.org/10.1055/s-0031-1295493</Citation></Reference><Reference><Citation>Mancuso, M., Arnold, M., Bersano, A., Burlina, A., Chabriat, H., Debette, S., Enzinger, C., Federico, A., Filla, A., Finsterer, J., Hunt, D., Lesnik Oberstein, S., Tournier&#x2010;Lasserve, E., &amp; Markus, H. S. (2020). Monogenic cerebral small&#x2010;vessel diseases: Diagnosis and therapy. Consensus Recommendations of the European Academy of Neurology. European Journal of Neurology, 27(6), 909&#x2013;927. https://doi.org/10.1111/ene.14183</Citation></Reference><Reference><Citation>Mao, M., Labelle&#x2010;Dumais, C., Tufa, S. F., Keene, D. R., &amp; Gould, D. B. (2022). Elevated TGF&#x3b2; signaling contributes to ocular anterior segment dysgenesis in Col4a1 mutant mice. Matrix Biology: Journal of the International Society for Matrix Biology, 110, 151&#x2013;173. https://doi.org/10.1016/j.matbio.2022.05.001</Citation></Reference><Reference><Citation>Maurice, P., Guilbaud, L., Garel, J., Mine, M., Dugas, A., Friszer, S., Maisonneuve, E., Moutard, M. L., Coste, T., H&#xe9;ron, D., Tournier&#x2010;Lasserve, E., Garel, C., &amp; Jouannic, J. M. (2021). Prevalence of COL4A1 and COL4A2 mutations in severe fetal multifocal hemorrhagic and/or ischemic cerebral lesions. Ultrasound in Obstetrics &amp; Gynecology: The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology, 57(5), 783&#x2013;789. https://doi.org/10.1002/uog.22106</Citation></Reference><Reference><Citation>McHugh, D. C., &amp; Esenwa, C. (2020). A novel COL4A2 mutation associated with recurrent strokes. Journal of Stroke and Cerebrovascular Diseases: The Official Journal of National Stroke Association, 29(10), 105156. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105156</Citation></Reference><Reference><Citation>Meschia, J. F., Worrall, B. B., Elahi, F. M., Ross, O. A., Wang, M. M., Goldstein, E. D., Rost, N. S., Majersik, J. J., Gutierrez, J., &amp; American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; and Council on Hypertension. (2023). Management of inherited CNS small vessel diseases: The CADASIL example: A scientific statement from the American Heart Association. Stroke, 54(10), e452&#x2013;e464. https://doi.org/10.1161/STR.0000000000000444</Citation></Reference><Reference><Citation>Meuwissen, M. E., Halley, D. J., Smit, L. S., Lequin, M. H., Cobben, J. M., de Coo, R., van Harssel, J., Sallevelt, S., Woldringh, G., van der Knaap, M. S., de Vries, L. S., &amp; Mancini, G. M. (2015). The expanding phenotype of COL4A1 and COL4A2 mutations: Clinical data on 13 newly identified families and a review of the literature. Genetics in Medicine: Official Journal of the American College of Medical Genetics, 17(11), 843&#x2013;853. https://doi.org/10.1038/gim.2014.210</Citation></Reference><Reference><Citation>Murray, L. S., Lu, Y., Taggart, A., Van Regemorter, N., Vilain, C., Abramowicz, M., Kadler, K. E., &amp; Van Agtmael, T. (2014). Chemical chaperone treatment reduces intracellular accumulation of mutant collagen IV and ameliorates the cellular phenotype of a COL4A2 mutation that causes haemorrhagic stroke. Human Molecular Genetics, 23(2), 283&#x2013;292. https://doi.org/10.1093/hmg/ddt418</Citation></Reference><Reference><Citation>Myllyharju, J., &amp; Kivirikko, K. I. (2004). Collagens, modifying enzymes and their mutations in humans, flies and worms. Trends in Genetics: TIG, 20(1), 33&#x2013;43. https://doi.org/10.1016/j.tig.2003.11.004</Citation></Reference><Reference><Citation>Nadkarni, S. K., Bouma, B. E., de Boer, J., &amp; Tearney, G. J. (2009). Evaluation of collagen in atherosclerotic plaques: The use of two coherent laser&#x2010;based imaging methods. Lasers in Medical Science, 24(3), 439&#x2013;445. https://doi.org/10.1007/s10103-007-0535-x</Citation></Reference><Reference><Citation>Oohashi, T., Sugimoto, M., Mattei, M. G., &amp; Ninomiya, Y. (1994). Identification of a new collagen IV chain, alpha 6(IV), by cDNA isolation and assignment of the gene to chromosome Xq22, which is the same locus for COL4A5. The Journal of Biological Chemistry, 269(10), 7520&#x2013;7526.</Citation></Reference><Reference><Citation>Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hr&#xf3;bjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo&#x2010;Wilson, E., McDonald, S., &#x2026; Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ (Clinical Research Ed.), 372, n71. https://doi.org/10.1136/bmj.n71</Citation></Reference><Reference><Citation>Petrovski, S., Aggarwal, V., Giordano, J. L., Stosic, M., Wou, K., Bier, L., Spiegel, E., Brennan, K., Stong, N., Jobanputra, V., Ren, Z., Zhu, X., Mebane, C., Nahum, O., Wang, Q., Kamalakaran, S., Malone, C., Anyane&#x2010;Yeboa, K., Miller, R., &#x2026; Wapner, R. J. (2019). Whole&#x2010;exome sequencing in the evaluation of fetal structural anomalies: A prospective cohort study. Lancet (London, England), 393(10173), 758&#x2013;767. https://doi.org/10.1016/S0140-6736(18)32042-7</Citation></Reference><Reference><Citation>Plaisier, E., Chen, Z., Gekeler, F., Benhassine, S., Dahan, K., Marro, B., Alamowitch, S., Paques, M., &amp; Ronco, P. (2010). Novel COL4A1 mutations associated with HANAC syndrome: A role for the triple helical CB3[IV] domain. American Journal of Medical Genetics. Part A, 152A(10), 2550&#x2013;2555. https://doi.org/10.1002/ajmg.a.33659</Citation></Reference><Reference><Citation>Plaisier, E., Gribouval, O., Alamowitch, S., Mougenot, B., Prost, C., Verpont, M. C., Marro, B., Desmettre, T., Cohen, S. Y., Roullet, E., Dracon, M., Fardeau, M., Van Agtmael, T., Kerjaschki, D., Antignac, C., &amp; Ronco, P. (2007). COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps. The New England Journal of Medicine, 357(26), 2687&#x2013;2695. https://doi.org/10.1056/NEJMoa071906</Citation></Reference><Reference><Citation>Plaisier, E., Ronco, P., &amp; COL4A1&#x2010;Related Disorders. (2009 [Updated 2016 Jul 7]). In M. P. Adam, J. Feldman, G. M. Mirzaa, et al. (Eds.), GeneReviews&#xae; [Internet] (pp. 1993&#x2013;2024). University of Washington, Seattle. Available from: https://www.ncbi.nlm.nih.gov/books/NBK7046/</Citation></Reference><Reference><Citation>Ratelade, J., Mezouar, N., Domenga&#x2010;Denier, V., Rochey, A., Plaisier, E., &amp; Joutel, A. (2018). Severity of arterial defects in the retina correlates with the burden of intracerebral haemorrhage in COL4A1&#x2010;related stroke. The Journal of Pathology, 244(4), 408&#x2013;420. https://doi.org/10.1002/path.5023</Citation></Reference><Reference><Citation>Rechsteiner, D., Issler, L., Koller, S., Lang, E., B&#xe4;hr, L., Feil, S., R&#xfc;egger, C. M., Kottke, R., Toelle, S. P., Zweifel, N., Steindl, K., Joset, P., Zweier, M., Suter, A. A., Gogoll, L., Haas, C., Berger, W., &amp; Gerth&#x2010;Kahlert, C. (2021). Genetic analysis in a Swiss cohort of bilateral congenital cataract. JAMA Ophthalmology, 139(7), 691&#x2013;700. https://doi.org/10.1001/jamaophthalmol.2021.0385</Citation></Reference><Reference><Citation>Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier&#x2010;Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., Voelkerding, K., Rehm, H. L., &amp; ACMG Laboratory Quality Assurance Committee. (2015). Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in Medicine: Official Journal of the American College of Medical Genetics, 17(5), 405&#x2013;424. https://doi.org/10.1038/gim.2015.30</Citation></Reference><Reference><Citation>Ruigrok, Y. M., Rinkel, G. J., van't Slot, R., Wolfs, M., Tang, S., &amp; Wijmenga, C. (2006). Evidence in favor of the contribution of genes involved in the maintenance of the extracellular matrix of the arterial wall to the development of intracranial aneurysms. Human Molecular Genetics, 15(22), 3361&#x2013;3368. https://doi.org/10.1093/hmg/ddl412</Citation></Reference><Reference><Citation>Saskin, A., Sillon, G., Palfreeman, N., &amp; Buhas, D. (2018). COL4A1/2 CNVs and cerebral small vessel disease: Narrowing in on the critical chromosomal region. Neurology, 90(22), 1026&#x2013;1028. https://doi.org/10.1212/WNL.0000000000005601</Citation></Reference><Reference><Citation>Shields, M. B., Buckley, E., Klintworth, G. K., &amp; Thresher, R. (1985). Axenfeld&#x2010;Rieger syndrome. A spectrum of developmental disorders. Survey of Ophthalmology, 29(6), 387&#x2013;409. https://doi.org/10.1016/0039-6257(85)90205-x</Citation></Reference><Reference><Citation>Sibon, I., Coupry, I., Menegon, P., Bouchet, J. P., Gorry, P., Burgelin, I., Calvas, P., Orignac, I., Dousset, V., Lacombe, D., Orgogozo, J. M., Arveiler, B., &amp; Goizet, C. (2007). COL4A1 mutation in Axenfeld&#x2010;Rieger anomaly with leukoencephalopathy and stroke. Annals of Neurology, 62(2), 177&#x2013;184. https://doi.org/10.1002/ana.21191</Citation></Reference><Reference><Citation>Siitonen, M., B&#xf6;rjesson&#x2010;Hanson, A., P&#xf6;yh&#xf6;nen, M., Ora, A., Pasanen, P., Bras, J., Kern, S., Kern, J., Andersen, O., Stanescu, H., Kleta, R., Baumann, M., Kalaria, R., Kalimo, H., Singleton, A., Hardy, J., Viitanen, M., Myllykangas, L., &amp; Guerreiro, R. (2017). Multi&#x2010;infarct dementia of Swedish type is caused by a 3'UTR mutation of COL4A1. Brain: A Journal of Neurology, 140(5), e29. https://doi.org/10.1093/brain/awx062</Citation></Reference><Reference><Citation>Slavotinek, A. M., Garcia, S. T., Chandratillake, G., Bardakjian, T., Ullah, E., Wu, D., Umeda, K., Lao, R., Tang, P. L., Wan, E., Madireddy, L., Lyalina, S., Mendelsohn, B. A., Dugan, S., Tirch, J., Tischler, R., Harris, J., Clark, M. J., Chervitz, S., &#x2026; Chen, R. O. (2015). Exome sequencing in 32 patients with anophthalmia/microphthalmia and developmental eye defects. Clinical Genetics, 88(5), 468&#x2013;473. https://doi.org/10.1111/cge.12543</Citation></Reference><Reference><Citation>Smit, L. M., Barth, P. G., Valk, J., &amp; Njiokiktjien, C. (1984). Familial porencephalic white matter disease in two generations. Brain &amp; Development, 6(1), 54&#x2013;58. https://doi.org/10.1016/s0387-7604(84)80010-8</Citation></Reference><Reference><Citation>Steffensen, L. B., &amp; Rasmussen, L. M. (2018). A role for collagen type IV in cardiovascular disease? American Journal of Physiology. Heart and Circulatory Physiology, 315(3), H610&#x2013;H625. https://doi.org/10.1152/ajpheart.00070.2018</Citation></Reference><Reference><Citation>Stenson, P. D., Ball, E. V., Mort, M., Phillips, A. D., Shiel, J. A., Thomas, N. S., Abeysinghe, S., Krawczak, M., &amp; Cooper, D. N. (2003). Human Gene Mutation Database (HGMD): 2003 update. Human Mutation, 21(6), 577&#x2013;581. https://doi.org/10.1002/humu.10212</Citation></Reference><Reference><Citation>Sugimoto, M., Oohashi, T., &amp; Ninomiya, Y. (1994). The genes COL4A5 and COL4A6, coding for basement membrane collagen chains alpha 5(IV) and alpha 6(IV), are located head&#x2010;to&#x2010;head in close proximity on human chromosome Xq22 and COL4A6 is transcribed from two alternative promoters. Proceedings of the National Academy of Sciences of the United States of America, 91(24), 11679&#x2013;11683. https://doi.org/10.1073/pnas.91.24.11679</Citation></Reference><Reference><Citation>Tarr, I., Hesselson, S., Iismaa, S. E., Rath, E., Monger, S., Troup, M., Mishra, K., Wong, C. M. Y., Hsu, P. C., Junday, K., Humphreys, D. T., Adlam, D., Webb, T. R., Baranowska&#x2010;Clarke, A. A., Hamby, S. E., Carss, K. J., Samani, N. J., Bax, M., McGrath&#x2010;Cadell, L., &#x2026; Giannoulatou, E. (2022). Exploring the genetic architecture of spontaneous coronary artery dissection using whole&#x2010;genome sequencing. Circulation: Genomic and Precision Medicine, 15(4), e003527. https://doi.org/10.1161/CIRCGEN.121.003527</Citation></Reference><Reference><Citation>Tonduti, D., Pichiecchio, A., La Piana, R., Livingston, J. H., Doherty, D. A., Majumdar, A., Tomkins, S., Mine, M., Ceroni, M., Ricca, I., Balottin, U., &amp; Orcesi, S. (2012). COL4A1&#x2010;related disease: Raised creatine kinase and cerebral calcification as useful pointers. Neuropediatrics, 43(5), 283&#x2013;288. https://doi.org/10.1055/s-0032-1325116</Citation></Reference><Reference><Citation>Turner, T. N., Wilfert, A. B., Bakken, T. E., Bernier, R. A., Pepper, M. R., Zhang, Z., Torene, R. I., Retterer, K., &amp; Eichler, E. E. (2019). Sex&#x2010;based analysis of de novo variants in neurodevelopmental disorders. American Journal of Human Genetics, 105(6), 1274&#x2013;1285. https://doi.org/10.1016/j.ajhg.2019.11.003</Citation></Reference><Reference><Citation>Vahedi, K., Kubis, N., Boukobza, M., Arnoult, M., Massin, P., Tournier&#x2010;Lasserve, E., &amp; Bousser, M. G. (2007). COL4A1 mutation in a patient with sporadic, recurrent intracerebral hemorrhage. Stroke, 38(5), 1461&#x2013;1464. https://doi.org/10.1161/STROKEAHA.106.475194</Citation></Reference><Reference><Citation>van Eyk, C. L., Fahey, M. C., &amp; Gecz, J. (2023). Redefining cerebral palsies as a diverse group of neurodevelopmental disorders with genetic aetiology. Nature Reviews. Neurology, 19(9), 542&#x2013;555. https://doi.org/10.1038/s41582-023-00847-6</Citation></Reference><Reference><Citation>Veit, G., Kobbe, B., Keene, D. R., Paulsson, M., Koch, M., &amp; Wagener, R. (2006). Collagen XXVIII, a novel von Willebrand factor A domain&#x2010;containing protein with many imperfections in the collagenous domain. The Journal of Biological Chemistry, 281(6), 3494&#x2013;3504. https://doi.org/10.1074/jbc.M509333200</Citation></Reference><Reference><Citation>Verbeek, E., Meuwissen, M. E., Verheijen, F. W., Govaert, P. P., Licht, D. J., Kuo, D. S., Poulton, C. J., Schot, R., Lequin, M. H., Dudink, J., Halley, D. J., de Coo, R. I., den Hollander, J. C., Oegema, R., Gould, D. B., &amp; Mancini, G. M. (2012). COL4A2 mutation associated with familial porencephaly and small&#x2010;vessel disease. European Journal of Human Genetics: EJHG, 20(8), 844&#x2013;851. https://doi.org/10.1038/ejhg.2012.20</Citation></Reference><Reference><Citation>Verdura, E., Herv&#xe9;, D., Bergametti, F., Jacquet, C., Morvan, T., Prieto&#x2010;Morin, C., Mackowiak, A., Manchon, E., Hosseini, H., Cordonnier, C., Girard&#x2010;Buttaz, I., Rosenstingl, S., Hagel, C., Kuhlenba&#xfc;mer, G., Leca&#x2010;Radu, E., Goux, D., Fleming, L., Van Agtmael, T., Chabriat, H., &#x2026; Tournier&#x2010;Lasserve, E. (2016). Disruption of a miR&#x2010;29 binding site leading to COL4A1 upregulation causes pontine autosomal dominant microangiopathy with leukoencephalopathy. Annals of Neurology, 80(5), 741&#x2013;753. https://doi.org/10.1002/ana.24782</Citation></Reference><Reference><Citation>Wang, Q. H., Zou, L. P., Zhang, M. N., Wang, Y. Y., Lu, Q., Shen, Y. W., He, W., Chen, H. M., Luo, X. M., Wang, J., &amp; Zhang, T. T. (2020). Phenotypic characterization of COL4A1&#x2010;related West syndrome. Epilepsy Research, 164, 106349. https://doi.org/10.1016/j.eplepsyres.2020.106349</Citation></Reference><Reference><Citation>Weng, Y. C., Sonni, A., Labelle&#x2010;Dumais, C., de Leau, M., Kauffman, W. B., Jeanne, M., Biffi, A., Greenberg, S. M., Rosand, J., &amp; Gould, D. B. (2012). COL4A1 mutations in patients with sporadic late&#x2010;onset intracerebral hemorrhage. Annals of Neurology, 71(4), 470&#x2013;477. https://doi.org/10.1002/ana.22682</Citation></Reference><Reference><Citation>Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Jr., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., MacLaughlin, E. J., Muntner, P., Ovbiagele, B., Smith, S. C., Jr., Spencer, C. C., Stafford, R. S., Taler, S. J., Thomas, R. J., Williams, K. A., Sr., &#x2026; Wright, J. T., Jr. (2018). 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Hypertension (Dallas, TX: 1979), 71(6), e13&#x2013;e115. https://doi.org/10.1161/HYP.0000000000000065</Citation></Reference><Reference><Citation>Wu, W., He, J., &amp; Shao, X. (2020). Incidence and mortality trend of congenital heart disease at the global, regional, and national level, 1990&#x2010;2017. Medicine, 99(23), e20593. https://doi.org/10.1097/MD.0000000000020593</Citation></Reference><Reference><Citation>Xia, X. Y., Li, N., Cao, X., Wu, Q. Y., Li, T. F., Zhang, C., Li, W. W., Cui, Y. X., Li, X. J., &amp; Xue, C. Y. (2014). A novel COL4A1 gene mutation results in autosomal dominant non&#x2010;syndromic congenital cataract in a Chinese family. BMC Medical Genetics, 15, 97. https://doi.org/10.1186/s12881-014-0097-2</Citation></Reference><Reference><Citation>Yamasaki, E., Thakore, P., Ali, S., Sanchez Solano, A., Wang, X., Gao, X., Labelle&#x2010;Dumais, C., Chaumeil, M. M., Gould, D. B., &amp; Earley, S. (2023). Impaired intracellular Ca2+ signaling contributes to age&#x2010;related cerebral small vessel disease in Col4a1 mutant mice. Science Signaling, 16(811), eadi3966. https://doi.org/10.1126/scisignal.adi3966</Citation></Reference><Reference><Citation>Yang, W., Ng, F. L., Chan, K., Pu, X., Poston, R. N., Ren, M., An, W., Zhang, R., Wu, J., Yan, S., Situ, H., He, X., Chen, Y., Tan, X., Xiao, Q., Tucker, A. T., Caulfield, M. J., &amp; Ye, S. (2016). Coronary&#x2010;heart&#x2010;disease&#x2010;associated genetic variant at the COL4A1/COL4A2 locus affects COL4A1/COL4A2 expression, vascular cell survival, atherosclerotic plaque stability and risk of myocardial infarction. PLoS Genetics, 12(7), e1006127. https://doi.org/10.1371/journal.pgen.1006127</Citation></Reference><Reference><Citation>Yoneda, Y., Haginoya, K., Arai, H., Yamaoka, S., Tsurusaki, Y., Doi, H., Miyake, N., Yokochi, K., Osaka, H., Kato, M., Matsumoto, N., &amp; Saitsu, H. (2012). De novo and inherited mutations in COL4A2, encoding the type IV collagen &#x3b1;2 chain cause porencephaly. American Journal of Human Genetics, 90(1), 86&#x2013;90. https://doi.org/10.1016/j.ajhg.2011.11.016</Citation></Reference><Reference><Citation>Yoneda, Y., Haginoya, K., Kato, M., Osaka, H., Yokochi, K., Arai, H., Kakita, A., Yamamoto, T., Otsuki, Y., Shimizu, S., Wada, T., Koyama, N., Mino, Y., Kondo, N., Takahashi, S., Hirabayashi, S., Takanashi, J., Okumura, A., Kumagai, T., &#x2026; Saitsu, H. (2013). Phenotypic spectrum of COL4A1 mutations: Porencephaly to schizencephaly. Annals of Neurology, 73(1), 48&#x2013;57. https://doi.org/10.1002/ana.23736</Citation></Reference><Reference><Citation>Yu, X., Jiang, D. S., Wang, J., Wang, R., Chen, T., Wang, K., Cao, S., &amp; Wei, X. (2019). Fluoroquinolone use and the risk of collagen&#x2010;associated adverse events: A systematic review and meta&#x2010;analysis. Drug Safety, 42(9), 1025&#x2013;1033. https://doi.org/10.1007/s40264-019-00828-z</Citation></Reference><Reference><Citation>Zagaglia, S., Selch, C., Nisevic, J. R., Mei, D., Michalak, Z., Hernandez&#x2010;Hernandez, L., Krithika, S., Vezyroglou, K., Varadkar, S. M., Pepler, A., Biskup, S., Le&#xe3;o, M., G&#xe4;rtner, J., Merkenschlager, A., Jaksch, M., M&#xf8;ller, R. S., Gardella, E., Kristiansen, B. S., Hansen, L. K., &#x2026; Sisodiya, S. M. (2018). Neurologic phenotypes associated with COL4A1/2 mutations: Expanding the spectrum of disease. Neurology, 91(22), e2078&#x2013;e2088. https://doi.org/10.1212/WNL.0000000000006567</Citation></Reference><Reference><Citation>Zekavat, S. M., Chou, E. L., Zekavat, M., Pampana, A., Paruchuri, K., Lino Cardenas, C. L., Koyama, S., Ghazzawi, Y., Kii, E., Uddin, M. M., Pirruccello, J., Zhao, H., Wood, M., Natarajan, P., &amp; Lindsay, M. E. (2022). Fibrillar collagen variants in spontaneous coronary artery dissection. JAMA Cardiology, 7(4), 396&#x2013;406. https://doi.org/10.1001/jamacardio.2022.0001</Citation></Reference><Reference><Citation>Zenteno, J. C., Cresp&#xed;, J., Buentello&#x2010;Volante, B., Buil, J. A., Bassaganyas, F., Vela&#x2010;Segarra, J. I., Diaz&#x2010;Cascajosa, J., &amp; Marieges, M. T. (2014). Next generation sequencing uncovers a missense mutation in COL4A1 as the cause of familial retinal arteriolar tortuosity. Graefe's Archive for Clinical and Experimental Ophthalmology (Albrecht von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie), 252(11), 1789&#x2013;1794. https://doi.org/10.1007/s00417-014-2800-6</Citation></Reference><Reference><Citation>Zhao, Y. Y., Duan, R. N., Ji, L., Liu, Q. J., &amp; Yan, C. Z. (2019). Cervical spinal involvement in a Chinese pedigree with pontine autosomal dominant microangiopathy and leukoencephalopathy caused by a 3' untranslated region mutation of COL4A1 gene. Stroke, 50(9), 2307&#x2013;2313. https://doi.org/10.1161/STROKEAHA.119.024875</Citation></Reference><Reference><Citation>Zhou, J., Mochizuki, T., Smeets, H., Antignac, C., Laurila, P., de Paepe, A., Tryggvason, K., &amp; Reeders, S. T. (1993). Deletion of the paired alpha 5(IV) and alpha 6(IV) collagen genes in inherited smooth muscle tumors. Science (New York, NY), 261(5125), 1167&#x2013;1169. https://doi.org/10.1126/science.8356449</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36328157</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>22</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1558-3597</ISSN><JournalIssue CitedMedium="Internet"><Volume>80</Volume><Issue>24</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>13</Day></PubDate></JournalIssue><Title>Journal of the American College of Cardiology</Title><ISOAbbreviation>J Am Coll Cardiol</ISOAbbreviation></Journal><ArticleTitle>Edoxaban for Thromboembolism Prevention in Pediatric Patients With Cardiac Disease.</ArticleTitle><Pagination><StartPage>2301</StartPage><EndPage>2310</EndPage><MedlinePgn>2301-2310</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacc.2022.09.031</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0735-1097(22)06970-4</ELocationID><Abstract><AbstractText Label="BACKGROUND">Standard of care (SOC) anticoagulation for thromboembolism (TE) prevention in children with cardiac disease includes low molecular weight heparins or vitamin K antagonists. Limited data exists for alternate use of direct oral anticoagulants in children.</AbstractText><AbstractText Label="OBJECTIVES">The investigators aimed to obtain safety and efficacy data for edoxaban in children.</AbstractText><AbstractText Label="METHODS">We performed a phase 3, multinational, prospective, randomized, open-label, blinded-endpoint trial in patients&#xa0;&lt;18 years of age with cardiac disease (ENNOBLE-ATE [Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease] trial). Patients were randomized 2:1 to age- and weight-based oral edoxaban once daily vs SOC for 3&#xa0;months (main study period), stratified by cardiac diagnosis. Both groups could continue in an open-label edoxaban extension arm through 1 year. The primary endpoint was adjudicated clinically relevant bleeding (CRB). The main secondary endpoint was symptomatic TE or asymptomatic intracardiac thrombosis.</AbstractText><AbstractText Label="RESULTS">The modified intention-to-treat cohort included 167 children. One patient per group experienced a nonmajor CRB in the main period. Treatment-emergent adverse events occurred in 46.8% (51 of 109) with edoxaban and 41.4% (24 of 58) with SOC. One SOC patient experienced 2 TE events (DVT with PE). Among 147 children in the extension, 1 CRB event (0.7%) and 4 TEs occurred (2.8%; 2 strokes and 2 of 33 Kawasaki disease patients with coronary artery thromboses and/or myocardial infarctions).</AbstractText><AbstractText Label="CONCLUSIONS">Edoxaban is a potential alternative mode of thromboprophylaxis in children with cardiac disease showing low rates of CRB and TEs with advantages of once daily dosing and infrequent monitoring requirement. (ENNOBLE-ATE [Edoxaban for Prevention of Blood Vessels Being Blocked by Clots] (Thrombotic Events) in Children&#xa0;at&#xa0;Risk Because of Cardiac Disease trial; NCT03395639).</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Portman</LastName><ForeName>Michael A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Seattle Children's Research Institute, and Division of Cardiology, Department of Pediatrics, University of Washington, Seattle, Washington, USA. Electronic address: michael.portman@seattle.childrens.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacobs</LastName><ForeName>Jeffrey P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Congenital Heart Center, Division of Cardiovascular Surgery, Departments of Surgery and Pediatrics, University of Florida, Gainesville, Florida, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Newburger</LastName><ForeName>Jane W</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Boston Children's Hospital, and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berger</LastName><ForeName>Felix</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Congenital Heart Disease/Pediatric Cardiology, German Heart Institute Berlin, and Department of Pediatric Cardiology, Charit&#xe9; Universit&#xe4;tmedizin Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grosso</LastName><ForeName>Michael A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Daiichi-Sankyo, Inc, Basking Ridge, New Jersey, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duggal</LastName><ForeName>Anil</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Daiichi-Sankyo, Inc, Basking Ridge, New Jersey, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tao</LastName><ForeName>Ben</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Daiichi-Sankyo, Inc, Basking Ridge, New Jersey, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldenberg</LastName><ForeName>Neil A</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Johns Hopkins All Children's Institute for Clinical and Translational Research, Heart Institute, Institute for Brain Protection Sciences, and Cancer and Blood Disorders Institute, Johns Hopkins All Children's Hospital, St. Petersburg, Florida, USA; Divisions of Hematology, Departments of Pediatrics and Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>ENNOBLE-ATE Trial Investigators</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT03395639</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D017428">Clinical Trial, Phase III</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Am Coll Cardiol</MedlineTA><NlmUniqueID>8301365</NlmUniqueID><ISSNLinking>0735-1097</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Am Coll Cardiol. 2022 Dec 13;80(24):2311-2313. doi: 10.1016/j.jacc.2022.10.006.</RefSource><PMID Version="1">36480973</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006331" MajorTopicYN="Y">Heart Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="Y">Venous Thromboembolism</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Fontan</Keyword><Keyword MajorTopicYN="N">Kawasaki disease</Keyword><Keyword MajorTopicYN="N">anticoagulation</Keyword><Keyword MajorTopicYN="N">children</Keyword><Keyword MajorTopicYN="N">thromboembolism</Keyword></KeywordList><CoiStatement>Funding Support and Author Disclosures This trial was funded solely by Daiichi-Sankyo, Inc. Drs Portman, Jacobs, Newburger, Berger, and Goldenberg serve for Daiichi-Sankyo on the Steering Committee for this study. Drs Grosso and Dugal and Ben Tao are employees of Daiichi-Sankyo.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Brothers</LastName><ForeName>Matthew</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marino</LastName><ForeName>Bradley</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Canter</LastName><ForeName>Charles</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Law</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Nguyenvu</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sang</LastName><ForeName>Charlie</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shimano</LastName><ForeName>Kristin</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gupta</LastName><ForeName>Dipankar</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Portman</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Williams</LastName><ForeName>Derek</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Glass</LastName><ForeName>Lauren</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sperrazza</LastName><ForeName>Charles</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Herold</LastName><ForeName>Steven</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Garg</LastName><ForeName>Ruchira</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vranicar</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Awad</LastName><ForeName>Sawsan</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Asante-Korang</LastName><ForeName>Alfred</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Druzgal</LastName><ForeName>Colleen</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ozment</LastName><ForeName>Caroline</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Del Toro</LastName><ForeName>Kamill</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Roses</LastName><ForeName>Ferran</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jux</LastName><ForeName>Christian</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gravenhorst</LastName><ForeName>Verena</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schweigmann</LastName><ForeName>Ulrich</ForeName><Initials>U</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bhatt</LastName><ForeName>Mihir</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sabapathy</LastName><ForeName>Christine</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dahdah</LastName><ForeName>Nagib</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bartonicek</LastName><ForeName>Dototea</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tulzer</LastName><ForeName>Gerald</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Basargina</LastName><ForeName>Elena</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zvereva</LastName><ForeName>Tatiana</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pertels</LastName><ForeName>Tatiana</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Plotnikova</LastName><ForeName>Irina</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pierre-Emmanuel</LastName><ForeName>S E G U E L A</ForeName><Initials>SEGUELA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Amedro</LastName><ForeName>Pascal</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yves</LastName><ForeName>Dulac</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bonnet</LastName><ForeName>Damien</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Saraco</LastName><ForeName>Paola</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rimini</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Digtiar</LastName><ForeName>Valerii</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gonchar</LastName><ForeName>Margaryta</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kryuchko</LastName><ForeName>Tetyana</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yablon</LastName><ForeName>Olga</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bedi</LastName><ForeName>Varinder Singh</ForeName><Initials>VS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Patel</LastName><ForeName>Jashvant</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mitra</LastName><ForeName>Monjori</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kusa</LastName><ForeName>Jacek</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Domagala</LastName><ForeName>Kowalczyk</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>K&#xf6;rnyei</LastName><ForeName>L&#xe1;szl&#xf3;</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bereczki</LastName><ForeName>Csaba</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ablonczy</LastName><ForeName>L&#xe1;szl&#xf3;</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Levitas</LastName><ForeName>Vivianne Aviva</ForeName><Initials>VA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mishali</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Revel-Vilk</LastName><ForeName>Shoshana</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harlev</LastName><ForeName>Dan</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sasmaz</LastName><ForeName>Hatice Ilgen</ForeName><Initials>HI</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ozbek</LastName><ForeName>Namik Yasar</ForeName><Initials>NY</Initials></Investigator><Investigator ValidYN="Y"><LastName>Unal</LastName><ForeName>Sule</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pat&#x131;roglu</LastName><ForeName>T&#xfc;rkan</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Malbora</LastName><ForeName>Baris</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Agin</LastName><ForeName>Hasan</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Karakas</LastName><ForeName>Zeynep</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kavakli</LastName><ForeName>Ramazan Kaan</ForeName><Initials>RK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chalmers</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bu'Lock</LastName><ForeName>Frances</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Daubeney</LastName><ForeName>Piers</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hamza</LastName><ForeName>Hala</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Badr</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Elalfy</LastName><ForeName>Mohsen</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mansour</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hassab</LastName><ForeName>Hoda</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sabry</LastName><ForeName>Ayman</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Daou</LastName><ForeName>Linda</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bitar</LastName><ForeName>Fadi</ForeName><Initials>F</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>3</Day><Hour>20</Hour><Minute>25</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36328157</ArticleId><ArticleId IdType="doi">10.1016/j.jacc.2022.09.031</ArticleId><ArticleId IdType="pii">S0735-1097(22)06970-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33785517</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2154-1671</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Hospital pediatrics</Title><ISOAbbreviation>Hosp Pediatr</ISOAbbreviation></Journal><ArticleTitle>COVID-19-Associated Pulmonary Embolism in Pediatric Patients.</ArticleTitle><Pagination><StartPage>e90</StartPage><EndPage>e94</EndPage><MedlinePgn>e90-e94</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1542/hpeds.2021-005866</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVES">Coronavirus disease 2019 (COVID-19) is associated with pulmonary embolism in adults, but the clinical circumstances surrounding its presence are unknown in children. The objectives of this study are to determine the prevalence of pulmonary embolism in pediatric subjects with COVID-19, evaluate patient characteristics, and describe treatments applied.</AbstractText><AbstractText Label="METHODS">We performed a retrospective cohort study using TriNetX electronic health record data of subjects aged &lt;18 years who were diagnosed with COVID-19 infection (<i>International Classification of Diseases, 10th Revision</i>, code U07.1). Pulmonary embolism was identified by using <i>International Classification of Diseases, 10th Revision</i>, code I26. We additionally collected data on age, sex, race, ethnicity, all diagnostic codes, medications, procedures, laboratory results, comorbidities, and outcomes.</AbstractText><AbstractText Label="RESULTS">During the study period, 24&#x2009;723 pediatric subjects were reported to have a COVID-19 infection diagnosis among 41 health care organizations, of which 693 (2.8%) were hospitalized. Eight subjects (0.03% overall and 1.2% of hospitalized patients) were diagnosed with pulmonary embolism. The median age (25th to 75th percentile) of patients diagnosed with pulmonary embolism was 16.5 years, and median (25th to 75th percentile) BMI was 22.1 (19.6-47.9). Three (37.5%) received critical care services, and 1 (12.5%) underwent mechanical ventilation. Five (62.5%) subjects had potentially significant risk factors (obesity, malignancy, recent surgery, and oral contraceptive use). All patients received anticoagulation, but none underwent thrombolysis. There were no reported deaths.</AbstractText><AbstractText Label="CONCLUSIONS">Although pulmonary embolism is diagnosed less commonly in children than in adults, its occurrence appears to be more frequent in children hospitalized with COVID-19, as compared with previous reports in hospitalized children in general. All patients survived, with only 1 requiring mechanical ventilation.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 by the American Academy of Pediatrics.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chima</LastName><ForeName>Melissa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>College of Medicine and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Duane</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Pediatric Critical Care, Department of Pediatrics, College of Medicine, Penn State Health Children's Hospital, Hershey, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Neal J</ForeName><Initials>NJ</Initials><AffiliationInfo><Affiliation>Pediatric Critical Care, Department of Pediatrics, College of Medicine, Penn State Health Children's Hospital, Hershey, Pennsylvania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Public Health Sciences Pennsylvania State University, Hershey, Pennsylvania; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krawiec</LastName><ForeName>Conrad</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Pediatric Critical Care, Department of Pediatrics, College of Medicine, Penn State Health Children's Hospital, Hershey, Pennsylvania ckrawiec@pennstatehealth.psu.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR002014</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Hosp Pediatr</MedlineTA><NlmUniqueID>101585349</NlmUniqueID><ISSNLinking>2154-1671</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015984" MajorTopicYN="N">Causality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>6</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33785517</ArticleId><ArticleId IdType="pmc">PMC10472622</ArticleId><ArticleId IdType="doi">10.1542/hpeds.2021-005866</ArticleId><ArticleId IdType="pii">hpeds.2021-005866</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lu R, Zhao X, Li J, et al. . Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565&#x2013;574</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159086</ArticleId><ArticleId IdType="pubmed">32007145</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight TE. Severe acute respiratory syndrome coronavirus 2 and coronavirus disease 2019: a clinical overview and primer. Biopreserv Biobank. 2020;18(6):492&#x2013;502</Citation><ArticleIdList><ArticleId IdType="pubmed">32726140</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilaloglu S, Aphinyanaphongs Y, Jones S, Iturrate E, Hochman J, Berger JS. Thrombosis in hospitalized patients with COVID-19 in a New York city health System. JAMA. 2020;324(8):799&#x2013;801</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7372509</ArticleId><ArticleId IdType="pubmed">32702090</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Samkari H, Karp Leaf RS, Dzik WH, et al. . COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood. 2020;136(4):489&#x2013;500</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7378457</ArticleId><ArticleId IdType="pubmed">32492712</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai R, Gandhi Z, Singh S, et al. . Prevalence of pulmonary embolism in COVID-19: a pooled analysis [published online ahead of print October 28, 2020]. SN Compr Clin Med. doi:10.1007/s42399-020-00605-5</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7594943</ArticleId><ArticleId IdType="pubmed">33145478</ArticleId></ArticleIdList></Reference><Reference><Citation>Aronoff SC, Hall A, Del Vecchio MT. The natural history of SARS-Cov-2 related Multisystem Inflammatory Syndrome in Children (MIS-C): a systematic review. J Pediatric Infect Dis Soc. 2020;9(6):746&#x2013;751</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7797745</ArticleId><ArticleId IdType="pubmed">32924059</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpenter SL, Richardson T, Hall M. Increasing rate of pulmonary embolism diagnosed in hospitalized children in the United States from 2001 to 2014. Blood Adv. 2018;2(12):1403&#x2013;1408</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6020809</ArticleId><ArticleId IdType="pubmed">29907635</ArticleId></ArticleIdList></Reference><Reference><Citation>Navanandan N, Stein J, Mistry RD. Pulmonary embolism in children. Pediatr Emerg Care. 2019;35(2):143&#x2013;151</Citation><ArticleIdList><ArticleId IdType="pubmed">30702542</ArticleId></ArticleIdList></Reference><Reference><Citation>Alsohime F, Temsah MH, Al-Nemri AM, Somily AM, Al-Subaie S. COVID-19 infection prevalence in pediatric population: etiology, clinical presentation, and outcome. J Infect Public Health. 2020;13(12):1791&#x2013;1796</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7574780</ArticleId><ArticleId IdType="pubmed">33127335</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Luciano S, Geddes JR, Harrison PJ. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62&#x2008;354 COVID-19 cases in the USA. Lancet Psychiatry. 2021;8(2):130&#x2013;140</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7820108</ArticleId><ArticleId IdType="pubmed">33181098</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson MR, Geleris J, Anderson DR, et al. . Body mass index and risk for intubation or death in SARS-CoV-2 infection: a retrospective cohort study. Ann Intern Med. 2020;173(10):782&#x2013;790</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7397550</ArticleId><ArticleId IdType="pubmed">32726151</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggio S, L&#x2019;Huillier AG, Yerly S, et al. . SARS-CoV-2 viral load in the upper respiratory tract of children and adults with early acute COVID-19 [published online ahead of print August 6, 2020]. Clin Infect Dis. doi:10.1093/cid/ciaa1157</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454380</ArticleId><ArticleId IdType="pubmed">32761228</ArticleId></ArticleIdList></Reference><Reference><Citation>Liguoro I, Pilotto C, Bonanni M, et al. . SARS-COV-2 infection in children and newborns: a systematic review. Eur J Pediatr. 2020;179(7):1029&#x2013;1046</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7234446</ArticleId><ArticleId IdType="pubmed">32424745</ArticleId></ArticleIdList></Reference><Reference><Citation>Bikdeli B, Madhavan MV, Jimenez D, et al. ; Global COVID-19 Thrombosis Collaborative Group, Endorsed by the ISTH, NATF, ESVM, and the IUA, Supported by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. J Am Coll Cardiol. 2020;75(23):2950&#x2013;2973</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7164881</ArticleId><ArticleId IdType="pubmed">32311448</ArticleId></ArticleIdList></Reference><Reference><Citation>Yonker LM, Shen K, Kinane TB. Lessons unfolding from pediatric cases of COVID-19 disease caused by SARS-CoV-2 infection. Pediatr Pulmonol. 2020;55(5):1085&#x2013;1086</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7167841</ArticleId><ArticleId IdType="pubmed">32243722</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakr Y, Giovini M, Leone M, et al. . Pulmonary embolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: a narrative review. Ann Intensive Care. 2020;10:124.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7492788</ArticleId><ArticleId IdType="pubmed">32953201</ArticleId></ArticleIdList></Reference><Reference><Citation>Poyiadji N, Cormier P, Patel PY, et al. . Acute pulmonary embolism and COVID-19. Radiology. 2020;297(3):E335&#x2013;E338</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7706099</ArticleId><ArticleId IdType="pubmed">32407256</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim L, Whitaker M, O&#x2019;Halloran A, et al. ; COVID-NET Surveillance Team. Hospitalization rates and characteristics of children aged &lt;18 years hospitalized with laboratory-confirmed COVID-19 - COVID-NET, 14 states, March 1-July 25, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(32):1081&#x2013;1088</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7440125</ArticleId><ArticleId IdType="pubmed">32790664</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29860923</PMID><DateCompleted><Year>2019</Year><Month>06</Month><Day>17</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1758-1125</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>3</Issue><PubDate><Year>2019</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Phlebology</Title><ISOAbbreviation>Phlebology</ISOAbbreviation></Journal><ArticleTitle>A systematic review of paediatric deep venous thrombolysis.</ArticleTitle><Pagination><StartPage>179</StartPage><EndPage>190</EndPage><MedlinePgn>179-190</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/0268355518778660</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The aim was to assess the effectiveness and safety of catheter-directed thrombolysis in children with deep venous thrombosis and to evaluate its long-term effect.</AbstractText><AbstractText Label="METHOD AND RESULTS" NlmCategory="RESULTS">EMBASE, Medline and Cochrane databases were searched to identify studies in which paediatric acute deep venous thrombosis patients received thrombolysis. Following title and abstract screening, seven cohort studies with a total of 183 patients were identified. Technical success was 82% and superior in regional rather than systemic thrombolysis (p&#x2009;&lt;&#x2009;0.00001). One cohort study identified significant difference in thrombus resolution at one year between thrombolytic and anticoagulant groups (p&#x2009;=&#x2009;0.01). The complication rate was low, with incidence rates of major bleeding, pulmonary embolism and others at 2.8%, 1.8% and 8.4%, respectively. The overall post-thrombotic syndrome rate was 12.7%. The incidence of re-thrombosis ranged from 12.3% to 27%.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Thrombolysis for paediatric deep venous thrombosis is an effective and relatively safe therapeutic option, lowering the incidence of post-thrombotic syndrome and deep venous thrombosis recurrence.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Taha</LastName><ForeName>Mohamed Ah</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0003-0419-3527</Identifier><AffiliationInfo><Affiliation>1 Academic Section of Vascular Surgery, Department of Surgery and Cancer, Imperial College London, Charing Cross Hospital, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>2 Department of Vascular and Endovascular Surgery, Assiut University Hospitals, Assiut, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Busuttil</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>1 Academic Section of Vascular Surgery, Department of Surgery and Cancer, Imperial College London, Charing Cross Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bootun</LastName><ForeName>Roshan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>1 Academic Section of Vascular Surgery, Department of Surgery and Cancer, Imperial College London, Charing Cross Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davies</LastName><ForeName>Alun H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>1 Academic Section of Vascular Surgery, Department of Surgery and Cancer, Imperial College London, Charing Cross Hospital, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>06</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Phlebology</MedlineTA><NlmUniqueID>9012921</NlmUniqueID><ISSNLinking>0268-3555</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015912" MajorTopicYN="N">Thrombolytic Therapy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Thrombolysis</Keyword><Keyword MajorTopicYN="N">children</Keyword><Keyword MajorTopicYN="N">deep venous thrombosis</Keyword><Keyword MajorTopicYN="N">paediatric</Keyword><Keyword MajorTopicYN="N">post-thrombotic syndrome</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>6</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>6</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29860923</ArticleId><ArticleId IdType="doi">10.1177/0268355518778660</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33263653</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>18</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1809-4546</ISSN><JournalIssue CitedMedium="Internet"><Volume>47</Volume><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>Revista do Colegio Brasileiro de Cirurgioes</Title><ISOAbbreviation>Rev Col Bras Cir</ISOAbbreviation></Journal><ArticleTitle>Adult primary liver sarcoma: systematic review.</ArticleTitle><Pagination><StartPage>e20202647</StartPage><MedlinePgn>e20202647</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1590/0100-6991e-20202647</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0100-69912020000100208</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">primary liver sarcoma is a rare type of tumor, more common in children. Among adults, it represents a spectrum of neoplasms with reserved prognosis. There is no consensus on the treatment of choice of these lesions, justifying a systematic review of the literature on treatment options, prognostic factors, and survival.</AbstractText><AbstractText Label="MATERIAL/METHODS" NlmCategory="METHODS">a systematic review of articles published in Pubmed, Medline, LiLacs e SciElo, from 1966 to March/2019, presenting the keywords: primary-liver-sarcoma and primary-hepatic-sarcoma was undertaken. Studies including patients older than 18 years, and published in English, Portuguese and Spanish were included. Case reports, metastatic tumors and multiple oncologic diagnosis were excluded. The initial search listed 1,318 articles. 1,206 did not meet the inclusion criteria. After reviewing 112 eligible articles, 15 were selected (14 case series and 1 retrospective-cohort).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">proposed treatment modalities for primary liver sarcoma included surgery and/or chemotherapy and/or radiotherapy or liver transplantation. The most common histological types were angiosarcoma (32%), leiomyosarcoma (29%), epithelioid hemangioendothelioma (15%) and embryonal sarcoma (7%). Histology, degree of differentiation and R0 resection were mentioned positive prognostic factors. Median survival ranged from two to 23 months. Five-year survival rate varied from 0% to 64%, on average 21%.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">surgical resection (R0 resection) is the main treatment for primary liver sarcomas. Development of effective systemic therapies are required to improve prognosis of patients harboring this type of tumor.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Martins</LastName><ForeName>Antonio Cavalcanti DE Albuquerque</ForeName><Initials>ACA</Initials><Identifier Source="ORCID">0000-0002-1249-8622</Identifier><AffiliationInfo><Affiliation>- Instituto de Medicina Integral Prof. Fernando Figueira, Departamento de Cirurgia Geral - Recife - PE - Brasil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>- Faculdade Pernambucana de Sa&#xfa;de - FPS/IMIP, Curso de Medicina - Recife - PE - Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costa Neto</LastName><ForeName>Du&#xcd;lio Cabral DA</ForeName><Initials>DCD</Initials><AffiliationInfo><Affiliation>- Faculdade Pernambucana de Sa&#xfa;de - FPS/IMIP, Curso de Medicina - Recife - PE - Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva</LastName><ForeName>J&#xda;lio Dourado DE-Matos E</ForeName><Initials>JDDE</Initials><AffiliationInfo><Affiliation>- Faculdade Pernambucana de Sa&#xfa;de - FPS/IMIP, Curso de Medicina - Recife - PE - Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moraes</LastName><ForeName>Ygor Monteiro</ForeName><Initials>YM</Initials><AffiliationInfo><Affiliation>- Faculdade Pernambucana de Sa&#xfa;de - FPS/IMIP, Curso de Medicina - Recife - PE - Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le&#xc3;o</LastName><ForeName>Cristiano Souza</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>- Instituto de Medicina Integral Prof. Fernando Figueira, Departamento de Cirurgia Geral - Recife - PE - Brasil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>- Faculdade Pernambucana de Sa&#xfa;de - FPS/IMIP, Curso de Medicina - Recife - PE - Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martins</LastName><ForeName>Carolina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>- Hospital Metropolitano Oeste Pel&#xf3;pidas Silveira (HPS) - SUS-PE/IMIP, Diretoria de Ensino e Pesquisa - Recife - PE - Brasil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>- Universidade Federal de Pernambuco - UFPE, Coordena&#xe7;&#xe3;o de Pequisa - Centro de Ci&#xea;ncias M&#xe9;dicas - Recife - PE - Brasil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>por</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Rev Col Bras Cir</MedlineTA><NlmUniqueID>7809515</NlmUniqueID><ISSNLinking>0100-6991</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008113" MajorTopicYN="N">Liver Neoplasms</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012509" MajorTopicYN="N">Sarcoma</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>6</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>2</Day><Hour>12</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33263653</ArticleId><ArticleId IdType="doi">10.1590/0100-6991e-20202647</ArticleId><ArticleId IdType="pii">S0100-69912020000100208</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28338596</PMID><DateCompleted><Year>2017</Year><Month>08</Month><Day>01</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2163-0763</ISSN><JournalIssue CitedMedium="Internet"><Volume>82</Volume><Issue>6</Issue><PubDate><Year>2017</Year><Month>Jun</Month></PubDate></JournalIssue><Title>The journal of trauma and acute care surgery</Title><ISOAbbreviation>J Trauma Acute Care Surg</ISOAbbreviation></Journal><ArticleTitle>Operation versus antibiotics--The "appendicitis conundrum" continues: A meta-analysis.</ArticleTitle><Pagination><StartPage>1129</StartPage><EndPage>1137</EndPage><MedlinePgn>1129-1137</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/TA.0000000000001450</ELocationID><Abstract><AbstractText Label="BACKGROUND">Acute appendicitis continues to constitute a diagnostic and therapeutic challenge. The aim of this study was to synthesize evidence from randomized controlled trials (RCTs) comparing nonoperative versus surgical management of uncomplicated acute appendicitis in adult patients.</AbstractText><AbstractText Label="METHODS">A systematic literature search of the PubMed, Cochrane, and Scopus databases was performed with respect to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) statement (end-of-search date: January 29, 2017). Data on the study design, interventions, participants, and outcomes were extracted by two independent reviewers. The random-effects model (DerSimonian-Laird) was used to calculate pooled effect estimates when substantial heterogeneity was encountered; otherwise, the fixed-effects (Mantel-Haenszel) model was implemented. Quality assessment of included RCTs was performed using the modified Jadad scale.</AbstractText><AbstractText Label="RESULTS">Five RCTs were included in this review. Overall, 1,430 adult patients with uncomplicated acute appendicitis underwent either nonoperative (n = 727) or operative management (n = 703). Treatment efficacy at 1-year follow-up was significantly lower (63.8%) for antibiotics compared with the surgery group (93%) (risk ratio [RR], 0.68; 95% confidence interval [CI], 0.60-0.77; p &lt; 0.001). Overall complications were significantly higher in the surgery group (166/703 [23.6%]) compared with the antibiotics group (56/727 [7.7%]) (RR, 0.32; 95% CI, 0.24-0.43; p &lt; 0.001). No difference was found between the two treatment modalities in terms of perforated appendicitis rates (RR, 0.52; 95% CI, 0.14-1.92), length of hospital stay (weighted mean difference [WMD], 0.20; 95% CI, -0.16 to 0.56), duration of pain (WMD, 0.22; 95% CI, -5.30 to -5.73), and sick leave (WMD, -2; 95% CI, -5.2 to 1.1).</AbstractText><AbstractText Label="CONCLUSIONS">Conservative management of uncomplicated appendicitis in adults warrants further study. Addressing patients' expectations via a shared decision-making process is a crucial step in optimizing nonoperative outcomes.</AbstractText><AbstractText Label="LEVEL OF EVIDENCE">Systematic review, level II.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sakran</LastName><ForeName>Joseph V</ForeName><Initials>JV</Initials><AffiliationInfo><Affiliation>From the Department of Surgery (J.V.S.), Johns Hopkins University, Baltimore, Maryland; Surgery Working Group (K.S.M., K.P.E.), Society of Junior Doctors, Athens, Greece; Division of Pediatric Surgery, Department of Surgery (K.S.M.), Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Institute of Preventive Medicine, Environmental &amp; Occupational Health (A.G.), Prolepsis, Athens, Greece; Department of Hygiene, Epidemiology and Medical Statistics (A.G.), Medical School, National and Kapodistrian University of Athens, Athens, Greece; Department of Research &amp; Innovation (S.P.S.), St Luke's University Health Network, Bethlehem, Pennsylvania; Department of Surgery (C.J.B.), Brigham &amp; Women's Hospital, Harvard Medical School, Boston, Massachusetts; Department of Surgery (M.M.M.), Medical University of South Carolina, Charleston, South Carolina; and Department of Surgery (K.P.E.), Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mylonas</LastName><ForeName>Konstantinos S</ForeName><Initials>KS</Initials></Author><Author ValidYN="Y"><LastName>Gryparis</LastName><ForeName>Alexandros</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Stawicki</LastName><ForeName>Stanislaw P</ForeName><Initials>SP</Initials></Author><Author ValidYN="Y"><LastName>Burns</LastName><ForeName>Christopher J</ForeName><Initials>CJ</Initials></Author><Author ValidYN="Y"><LastName>Matar</LastName><ForeName>Maher M</ForeName><Initials>MM</Initials></Author><Author ValidYN="Y"><LastName>Economopoulos</LastName><ForeName>Konstantinos P</ForeName><Initials>KP</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Trauma Acute Care Surg</MedlineTA><NlmUniqueID>101570622</NlmUniqueID><ISSNLinking>2163-0755</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001062" MajorTopicYN="Y">Appendectomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001064" MajorTopicYN="N">Appendicitis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28338596</ArticleId><ArticleId IdType="doi">10.1097/TA.0000000000001450</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38182827</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>07</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1496-8975</ISSN><JournalIssue CitedMedium="Internet"><Volume>71</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Canadian journal of anaesthesia = Journal canadien d'anesthesie</Title><ISOAbbreviation>Can J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Perioperative clinical practice recommendations for pediatric tonsillectomy: a systematic review.</ArticleTitle><Pagination><StartPage>187</StartPage><EndPage>200</EndPage><MedlinePgn>187-200</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12630-023-02668-z</ELocationID><Abstract><AbstractText Label="PURPOSE">Tonsillectomy is one of the most common surgical procedures performed in children. Since most clinical practice guidelines (CPGs) are designed to support surgical decisions, none are specifically designed for the perioperative management of children undergoing tonsillectomy. We aimed to identify and analyze the existing CPGs with recommendations for the perioperative management of children undergoing tonsillectomy by conducting a systematic review.</AbstractText><AbstractText Label="SOURCE">We searched Embase, MEDLINE, MEDLINE ePub Ahead of Print, and CINAHL for relevant articles published from inception to 3 August 2022. The inclusion criteria were: 1) CPG of perioperative recommendations for tonsillectomy under general anesthesia in children, 2) CPG that include at least one evidence-based recommendation, 3) peer-reviewed CPG published in English after 2000. We extracted data on baseline characteristics of each CPG and general recommendations for perioperative interventions or complications.</AbstractText><AbstractText Label="PRINCIPAL FINDINGS">Out of five eligible CPGs, AGREE II and REX confirmed that two CPGs were high quality while only one of the two was recommended for implementation without modifications. Most of the recommendations were for pain management. Acetaminophen was the only medication recommended in all five CPG. Except for the oldest CPG, the CPG all supported of the use of nonsteroidal anti-inflammatory drugs and steroids as a pain adjunct.</AbstractText><AbstractText Label="CONCLUSIONS">Acetaminophen, nonsteroidal anti-inflammatory drugs, and steroids are recommended in the perioperative management of pediatric tonsillectomy. Future CPG should further clarify the safe use of opioids based on severity of obstructive sleep apnea and in the context of opioid-sparing techniques, such as dexmedetomidine, high-dose dexamethasone, and gabapentinoids.</AbstractText><AbstractText Label="STUDY REGISTRATION">PROSPERO (CRD42021253374); first submitted 18 June 2021.</AbstractText><CopyrightInformation>&#xa9; 2024. Canadian Anesthesiologists' Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Albornoz</LastName><ForeName>Alfonso E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Medicine, The Hospital for Sick Children, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rana</LastName><ForeName>Mehwish</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hayes</LastName><ForeName>Jason</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Medicine, The Hospital for Sick Children, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Englesakis</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Library and Information Services, University Health Network, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsang</LastName><ForeName>Maisie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Medicine, The Hospital for Sick Children, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amin</LastName><ForeName>Reshma</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Respiratory Medicine, The Hospital for Sick Children, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Child Health Evaluative Sciences, SickKids Research Institute, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gilfoyle</LastName><ForeName>Elaine</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Child Health Evaluative Sciences, SickKids Research Institute, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care Medicine, The Hospital for Sick Children, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petre</LastName><ForeName>Maria-Alexandra</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Montreal Children's Hospital, Montreal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campisi</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology - Head and Neck Surgery, The Hospital for Sick Children, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aoyama</LastName><ForeName>Kazuyoshi</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-7502-0896</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, ON, Canada. kazu.aoyama@utoronto.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Child Health Evaluative Sciences, SickKids Research Institute, Toronto, ON, Canada. kazu.aoyama@utoronto.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Medicine, The Hospital for Sick Children, 555 University Ave, #2211, Toronto, ON, M5G 1X8, Canada. kazu.aoyama@utoronto.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Perioperative Services Summer Studentship Program 2021</GrantID><Agency>Hospital for Sick Children</Agency><Country/></Grant><Grant><GrantID>Outcomes Research Award 2020-2021</GrantID><Agency>Hospital for Sick Children</Agency><Country/></Grant><Grant><GrantID>Department of Anesthesia</GrantID><Agency>Hospital for Sick Children</Agency><Country/></Grant><Grant><GrantID>Pain Medicine</GrantID><Agency>Hospital for Sick Children</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Directives de pratique clinique p&#xe9;riop&#xe9;ratoires pour l&#x2019;amygdalectomie p&#xe9;diatrique : une revue syst&#xe9;matique.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Can J Anaesth</MedlineTA><NlmUniqueID>8701709</NlmUniqueID><ISSNLinking>0832-610X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>362O9ITL9D</RegistryNumber><NameOfSubstance UI="D000082">Acetaminophen</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000894">Anti-Inflammatory Agents, Non-Steroidal</NameOfSubstance></Chemical></ChemicalList><MeshHeadingList><MeshHeading><DescriptorName UI="D014068" MajorTopicYN="Y">Tonsillectomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="Y">Perioperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017410" MajorTopicYN="Y">Practice Guidelines as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010149" MajorTopicYN="N">Pain, Postoperative</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000082" MajorTopicYN="N">Acetaminophen</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059408" MajorTopicYN="N">Pain Management</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000894" MajorTopicYN="N">Anti-Inflammatory Agents, Non-Steroidal</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="fre"><AbstractText Label="UNLABELLED">R&#xe9;SUM&#xe9;: OBJECTIF: L&#x2019;amygdalectomie est l&#x2019;une des interventions chirurgicales les plus courantes pratiqu&#xe9;es chez les enfants. &#xc9;tant donn&#xe9; que la plupart des lignes directrices de pratique clinique sont con&#xe7;ues pour soutenir les d&#xe9;cisions chirurgicales, aucune n&#x2019;est sp&#xe9;cifiquement con&#xe7;ue pour la prise en charge p&#xe9;riop&#xe9;ratoire des enfants b&#xe9;n&#xe9;ficiant d&#x2019;une amygdalectomie. Notre objectif &#xe9;tait d&#x2019;identifier et d&#x2019;analyser les lignes directrices de pratique clinique existantes comportant des recommandations pour la prise en charge p&#xe9;riop&#xe9;ratoire des enfants b&#xe9;n&#xe9;ficiant d&#x2019;une amygdalectomie en r&#xe9;alisant une revue syst&#xe9;matique.</AbstractText><AbstractText Label="SOURCES">Nous avons recherch&#xe9; des articles pertinents dans Embase, MEDLINE, MEDLINE ePub Ahead of Print et CINAHL, publi&#xe9;s depuis la cr&#xe9;ation de ces bases de donn&#xe9;es jusqu&#x2019;au 3 ao&#xfb;t 2022. Les crit&#xe8;res d&#x2019;inclusion &#xe9;taient les suivants : 1) lignes directrices de pratique clinique comportant des recommandations p&#xe9;riop&#xe9;ratoires pour l&#x2019;amygdalectomie sous anesth&#xe9;sie g&#xe9;n&#xe9;rale chez les enfants, 2) lignes directrices de pratique clinique incluant au moins une recommandation fond&#xe9;e sur des donn&#xe9;es probantes, et 3) lignes directrices de pratique clinique &#xe9;valu&#xe9;es par des pairs et publi&#xe9;es en anglais apr&#xe8;s 2000. Nous avons extrait des donn&#xe9;es sur les caract&#xe9;ristiques de base de chacune des lignes directrices de pratique clinique et des recommandations g&#xe9;n&#xe9;rales pour les interventions p&#xe9;riop&#xe9;ratoires ou les complications.</AbstractText><AbstractText Label="CONSTATATIONS PRINCIPALES">Sur les cinq lignes directrices de pratique clinique admissibles, AGREE II et REX ont confirm&#xe9; que deux lignes directrices de pratique clinique &#xe9;taient de haute qualit&#xe9;, tandis qu&#x2019;une seule des deux a &#xe9;t&#xe9; recommand&#xe9;e pour une mise en &#x153;uvre sans modifications. La plupart des recommandations portaient sur la prise en charge de la douleur. L&#x2019;ac&#xe9;taminoph&#xe8;ne &#xe9;tait le seul m&#xe9;dicament recommand&#xe9; dans les cinq lignes directrices de pratique clinique. &#xc0; l&#x2019;exception des lignes directrices de pratique clinique les plus anciennes, les autres ont toutes soutenu l&#x2019;utilisation d&#x2019;agents anti-inflammatoires non st&#xe9;ro&#xef;diens et de st&#xe9;ro&#xef;des comme adjuvants pour la douleur.</AbstractText><AbstractText Label="CONCLUSION">L&#x2019;ac&#xe9;taminoph&#xe8;ne, les agents anti-inflammatoires non st&#xe9;ro&#xef;diens et les st&#xe9;ro&#xef;des sont recommand&#xe9;s pour la prise en charge p&#xe9;riop&#xe9;ratoire de l&#x2019;amygdalectomie p&#xe9;diatrique. &#xc0; l&#x2019;avenir, les lignes directrices de pratique clinique devraient clarifier davantage l&#x2019;utilisation s&#xe9;curitaire des opio&#xef;des en fonction de la gravit&#xe9; de l&#x2019;apn&#xe9;e obstructive du sommeil et dans le contexte des techniques d&#x2019;&#xe9;pargne des opio&#xef;des, telles que la dexm&#xe9;d&#xe9;tomidine, la dexam&#xe9;thasone &#xe0; forte dose et les gabapentino&#xef;des. ENREGISTREMENT DE L&#x2019;&#xe9;TUDE: PROSPERO (CRD42021253374); soumise pour la premi&#xe8;re fois le 18 juin 2021.</AbstractText><CopyrightInformation>&#xa9; 2024. Canadian Anesthesiologists' Society.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">clinical practice guidelines</Keyword><Keyword MajorTopicYN="N">general anesthesia</Keyword><Keyword MajorTopicYN="N">pediatric tonsillectomy</Keyword><Keyword MajorTopicYN="N">perioperative care</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>6</Day><Hour>10</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>5</Day><Hour>23</Hour><Minute>36</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38182827</ArticleId><ArticleId IdType="doi">10.1007/s12630-023-02668-z</ArticleId><ArticleId IdType="pii">10.1007/s12630-023-02668-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hall MJ, Schwartzman A, Zhang J, Liu X. Ambulatory surgery data from hospitals and ambulatory surgery centers: United States, 2010; 2017. Available from URL: https://www.cdc.gov/nchs/data/nhsr/nhsr102.pdf (accessed October 2023).</Citation></Reference><Reference><Citation>Patel HH, Straight CE, Lehman EB, Tanner M, Carr MM. Indications for tonsillectomy: a 10 year retrospective review. Int J Pediatr Otorhinolaryngol 2014; 78: 2151&#x2013;5. https://doi.org/10.1016/j.ijporl.2014.09.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijporl.2014.09.030</ArticleId><ArticleId IdType="pubmed">25447951</ArticleId></ArticleIdList></Reference><Reference><Citation>Belyea J, Chang Y, Rigby MH, Corsten G, Hong P. Post-tonsillectomy complications in children less than three years of age: a case&#x2013;control study. Int J Pediatr Otorhinolaryngol 2014; 78: 871&#x2013;4. https://doi.org/10.1016/j.ijporl.2014.02.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijporl.2014.02.029</ArticleId><ArticleId IdType="pubmed">24680134</ArticleId></ArticleIdList></Reference><Reference><Citation>Steward DL, Grisel J, Meinzen-Derr J. Steroids for improving recovery following tonsillectomy in children. Cochrane Database Syst Rev 2011; 2011: CD003997. https://doi.org/10.1002/14651858.cd003997.pub2</Citation></Reference><Reference><Citation>Lescanne E, Chiron B, Constant I, et al. Pediatric tonsillectomy: clinical practice guidelines. Eur Ann Otorhinolaryngol Head Neck Dis 2012; 129: 264&#x2013;71. https://doi.org/10.1016/j.anorl.2012.03.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anorl.2012.03.003</ArticleId><ArticleId IdType="pubmed">23078979</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell RB, Archer SM, Ishman SL, et al. Clinical practice guideline: tonsillectomy in children (update)&#x2014;executive summary. Otolaryngol Head Neck Surg 2019; 160: 187&#x2013;205. https://doi.org/10.1177/0194599818807917</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0194599818807917</ArticleId><ArticleId IdType="pubmed">30921525</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, Mckenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372: n71. https://doi.org/10.1136/bmj.n71</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId><ArticleId IdType="pmc">8005924</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston A, Kelly SE, Hsieh SC, Skidmore B, Wells GA. Systematic reviews of clinical practice guidelines: a methodological guide. J Clin Epidemiol 2019; 108: 64&#x2013;76. https://doi.org/10.1016/j.jclinepi.2018.11.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2018.11.030</ArticleId><ArticleId IdType="pubmed">30529647</ArticleId></ArticleIdList></Reference><Reference><Citation>Brouwers MC, Kho ME, Browman GP, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ 2010; 182: E839&#x2013;42. https://doi.org/10.1503/cmaj.090449</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.090449</ArticleId><ArticleId IdType="pubmed">20603348</ArticleId><ArticleId IdType="pmc">3001530</ArticleId></ArticleIdList></Reference><Reference><Citation>Brouwers MC, Spithoff K, Kerkvliet K, et al. Development and validation of a tool to assess the quality of clinical practice guideline recommendations. JAMA Netw Open 2020; 3: e205535. https://doi.org/10.1001/jamanetworkopen.2020.5535</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.5535</ArticleId><ArticleId IdType="pubmed">32459354</ArticleId><ArticleId IdType="pmc">7254179</ArticleId></ArticleIdList></Reference><Reference><Citation>Aldamluji N, Burgess A, Pogatzki-Zahn E, Raeder J, Beloeil H. PROSPECT guideline for tonsillectomy: systematic review and procedure-specific postoperative pain management recommendations. Anaesthesia 2021; 76: 947&#x2013;61. https://doi.org/10.1111/anae.15299</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.15299</ArticleId><ArticleId IdType="pubmed">33201518</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell RB, Archer SM, Ishman SL, et al. Clinical practice guideline: tonsillectomy in children (update). Otolaryngol Head Neck Surg 2019; 160: S1&#x2013;42. https://doi.org/10.1177/0194599818801757</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0194599818801757</ArticleId><ArticleId IdType="pubmed">30798778</ArticleId></ArticleIdList></Reference><Reference><Citation>Ericsson E, Brattwall M, Lundeberg S. Swedish guidelines for the treatment of pain in tonsil surgery in pediatric patients up to 18 years. Int J Pediatr Otorhinolaryngol 2015; 79: 443&#x2013;50. https://doi.org/10.1016/j.ijporl.2015.01.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijporl.2015.01.016</ArticleId><ArticleId IdType="pubmed">25677565</ArticleId></ArticleIdList></Reference><Reference><Citation>Constant I, Ayari Khalfallah S, Brunaud A, et al. How to replace codeine after tonsillectomy in children under 12 years of age? Guidelines of the French Oto-Rhino-Laryngology-Head and Neck Surgery Society (SFORL). Eur Ann Otorhinolaryngol Head Neck Dis 2014; 131: 233&#x2013;8. https://doi.org/10.1016/j.anorl.2014.06.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anorl.2014.06.001</ArticleId><ArticleId IdType="pubmed">25106698</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabbani CC, Pflum ZE, Ye MJ, et al. Intraoperative ketorolac for pediatric tonsillectomy: Effect on post-tonsillectomy hemorrhage and perioperative analgesia. Int J Pediatr Otorhinolaryngol 2020; 138: 110341. https://doi.org/10.1016/j.ijporl.2020.110341</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijporl.2020.110341</ArticleId><ArticleId IdType="pubmed">32891944</ArticleId></ArticleIdList></Reference><Reference><Citation>Lammers CR, Schwinghammer AJ, Hall B, et al. Comparison of oral loading dose to intravenous acetaminophen in children for analgesia after tonsillectomy and adenoidectomy: a randomized clinical trial. Anesth Analg 2021; 133: 1568&#x2013;76. https://doi.org/10.1213/ane.0000000000005678</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0000000000005678</ArticleId><ArticleId IdType="pubmed">34304234</ArticleId></ArticleIdList></Reference><Reference><Citation>Hii J, von Ungern-Sternberg BS, Sommerfield A, Sommerfield D. Perioperative pediatric tonsillectomy analgesia: a single-center review of practice and cost-effectiveness analysis. Paediatr Anaesth 2021; 31: 497&#x2013;8. https://doi.org/10.1111/pan.14134</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pan.14134</ArticleId><ArticleId IdType="pubmed">33484060</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann GE, Flamer SZ, Nair S, et al. Opioid-free anesthesia for adenotonsillectomy in children. Int J Pediatr Otorhinolaryngol 2021; 140: 110501. https://doi.org/10.1016/j.ijporl.2020.110501</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijporl.2020.110501</ArticleId><ArticleId IdType="pubmed">33290925</ArticleId></ArticleIdList></Reference><Reference><Citation>Franz AM, Dahl JP, Huang H, et al. The development of an opioid sparing anesthesia protocol for pediatric ambulatory tonsillectomy and adenotonsillectomy surgery&#x2014;a quality improvement project. Paediatr Anaesth 2019; 29: 682&#x2013;9. https://doi.org/10.1111/pan.13662</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pan.13662</ArticleId><ArticleId IdType="pubmed">31077491</ArticleId></ArticleIdList></Reference><Reference><Citation>Adler AC, Daszkowski A, Tan JC, et al. The association of dexmedetomidine on perioperative opioid consumption in children undergoing adenotonsillectomy with and without obstructive sleep apnea. Anesth Analg 2021; 133: 1260&#x2013;8. https://doi.org/10.1213/ane.0000000000005410</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0000000000005410</ArticleId><ArticleId IdType="pubmed">33591119</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi M, Miao S, Gu T, Wang D, Zhang H, Liu J. Dexmedetomidine for the prevention of emergence delirium and postoperative behavioral changes in pediatric patients with sevoflurane anesthesia: a double-blind, randomized trial. Drug Des Devel Ther 2019; 13: 897&#x2013;905. https://doi.org/10.2147/dddt.s196075</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/dddt.s196075</ArticleId><ArticleId IdType="pubmed">30936683</ArticleId><ArticleId IdType="pmc">6421876</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YZ, Wang X, Wu JM, Song CY, Cui XG. Optimal dexmedetomidine dose to prevent emergence agitation under sevoflurane and remifentanil anesthesia during pediatric tonsillectomy and adenoidectomy. Front Pharmacol 2019; 10: 1091. https://doi.org/10.3389/fphar.2019.01091</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2019.01091</ArticleId><ArticleId IdType="pubmed">31607927</ArticleId><ArticleId IdType="pmc">6761387</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsiotou AG, Malisiova A, Kouptsova E, Mavri M, Anagnostopoulou M, Kalliardou E. Dexmedetomidine for the reduction of emergence delirium in children undergoing tonsillectomy with propofol anesthesia: a double-blind, randomized study. Paediatr Anaesth 2018; 28: 632&#x2013;8. https://doi.org/10.1111/pan.13397</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pan.13397</ArticleId><ArticleId IdType="pubmed">29752853</ArticleId></ArticleIdList></Reference><Reference><Citation>Teunkens A, Vermeulen K, Peters M, Fieuws S, Van de Velde M, Rex S. Bupivacaine infiltration in children for postoperative analgesia after tonsillectomy: a randomised controlled trial. Eur J Anaesthesiol 2019; 36: 206&#x2013;14. https://doi.org/10.1097/eja.0000000000000950</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/eja.0000000000000950</ArticleId><ArticleId IdType="pubmed">30640245</ArticleId></ArticleIdList></Reference><Reference><Citation>Loy KA, Lam AS, Franz AM, et al. Impact of eliminating local anesthesia on immediate postoperative analgesia in pediatric ambulatory adenotonsillectomy. Pediatr Qual Saf 2021; 6: e405. https://doi.org/10.1097/pq9.0000000000000405</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/pq9.0000000000000405</ArticleId><ArticleId IdType="pubmed">33977193</ArticleId><ArticleId IdType="pmc">8104218</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrette LX, Harris J, De Ravin E, Balar E, Moreira AG, Rajasekaran K. Clinical practice guidelines for pain management after tonsillectomy: systematic quality appraisal using the AGREE II instrument. Int J Pediatr Otorhinolaryngol 2022; 156: 111091. https://doi.org/10.1016/j.ijporl.2022.111091</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijporl.2022.111091</ArticleId><ArticleId IdType="pubmed">35240561</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih MC, Long BD, Pecha PP, et al. A scoping review of randomized clinical trials for pain management in pediatric tonsillectomy and adenotonsillectomy. World J Otorhinolaryngol Head Neck Surg 2022; 9: 9&#x2013;26. https://doi.org/10.1002/wjo2.54</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wjo2.54</ArticleId><ArticleId IdType="pubmed">37006744</ArticleId><ArticleId IdType="pmc">10050970</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes J, Zuercher M, Gai N, Roy Chowdhury A, Kazuyoshi Aoyama D. The Fragility Index of randomized controlled trials in pediatric anesthesiology. Can J Anesth 2023; 70: 1449&#x2013;60. https://doi.org/10.1007/s12630-023-02513-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12630-023-02513-3</ArticleId><ArticleId IdType="pubmed">37286747</ArticleId></ArticleIdList></Reference><Reference><Citation>Peker K, Polat R. Effects of intravenous and mask induction on post-operative emergence delirium in pediatric patients undergoing tonsillectomy with or without adenoidectomy. Ir J Med Sci 2020; 189: 1061&#x2013;8. https://doi.org/10.1007/s11845-020-02197-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11845-020-02197-4</ArticleId><ArticleId IdType="pubmed">32048203</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng A, Dodson KM, Thacker LR, Kierce J, Shapiro J, Baldassari CM. Use of laryngeal mask airway in pediatric adenotonsillectomy. Arch Otolaryngol Head Neck Surg 2011; 137: 42&#x2013;6. https://doi.org/10.1001/archoto.2010.230</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archoto.2010.230</ArticleId><ArticleId IdType="pubmed">21242545</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalwani K, Richins S, Aliason I, Milczuk H, Fu R. The laryngeal mask airway for pediatric adenotonsillectomy: predictors of failure and complications. Int J Pediatr Otorhinolaryngol 2013; 77: 25&#x2013;8. https://doi.org/10.1016/j.ijporl.2012.09.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijporl.2012.09.021</ArticleId><ArticleId IdType="pubmed">23063385</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranieri D, Neubauer AG, Ranieri DM, do Nascimento P Jr. The use of disposable laryngeal mask airway for adenotonsillectomies. Rev Bras Anestesiol 2012; 62: 788&#x2013;98. https://doi.org/10.1016/s0034-7094(12)70179-4</Citation></Reference><Reference><Citation>Nghiem J, Brown SC, Aoyama K. Is there a role for pregabalin as premedication in pediatric anesthesia? J Anesth 2021; 35: 775&#x2013;7. https://doi.org/10.1007/s00540-021-02929-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-021-02929-5</ArticleId><ArticleId IdType="pubmed">33837480</ArticleId></ArticleIdList></Reference><Reference><Citation>Petre MA, Levin DN, Englesakis M, Maynes JT, Pechlivanoglou P, Aoyama K. Dexmedetomidine vs. total intravenous anaesthesia in paediatric emergence delirium: a network meta-analysis. Eur J Anaesthesiol 2021; 38: 1111&#x2013;23. https://doi.org/10.1097/eja.0000000000001490</Citation></Reference><Reference><Citation>Gan TJ, Belani KG, Bergese S, et al. Fourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting. Anesth Analg 2020; 131: 411&#x2013;48. https://doi.org/10.1213/ane.0000000000004833</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0000000000004833</ArticleId><ArticleId IdType="pubmed">32467512</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28331932</PMID><DateCompleted><Year>2018</Year><Month>05</Month><Day>18</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2567-689X</ISSN><JournalIssue CitedMedium="Internet"><Volume>117</Volume><Issue>6</Issue><PubDate><Year>2017</Year><Month>Jun</Month><Day>02</Day></PubDate></JournalIssue><Title>Thrombosis and haemostasis</Title><ISOAbbreviation>Thromb Haemost</ISOAbbreviation></Journal><ArticleTitle>Pulmonary embolism and in situ pulmonary artery thrombosis in paediatrics. A systematic review.</ArticleTitle><Pagination><StartPage>1199</StartPage><EndPage>1207</EndPage><MedlinePgn>1199-1207</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1160/TH16-07-0529</ELocationID><Abstract><AbstractText>Data on paediatric pulmonary embolism (PE) are scarce. We sought to systematically review the current literature on childhood PE and conducted a search on paediatric PE via PubMed (1946-2013) and Embase (1980-2013). There was significant heterogeneity in reported data. Two patterns were noted: classic thromboembolic PE (TE-PE) and in situ pulmonary artery thrombosis (ISPAT). Mean age of presentation for TE-PE was 14.86 years, and 51&#x2009;% of cases were males. The commonest method for diagnosis of TE-PE was contrast CT with angiography (74&#x2009;% of patients). The diagnosis of TE-PE was often delayed. Although 85&#x2009;% of children with TE-PE had an elevated D-dimer at presentation, it was non-discriminatory for the diagnosis. In paediatric TE-PE, the prevalence of central venous catheters was 23&#x2009;%, immobilisation 38&#x2009;%, systemic infection 31&#x2009;% and obesity 13&#x2009;%, elevated Factor VIII or von Willebrand factor levels 27&#x2009;%, Protein C deficiency 17&#x2009;%, Factor V Leiden 14&#x2009;% and Protein S deficiency 7&#x2009;%. In patients with TE-PE, pharmacologic thrombolysis was used in 29&#x2009;%; unfractionated heparin was the most common initial anticoagulant treatment in 64&#x2009;% and low-molecular-weight heparins the most common follow-up treatment in 83&#x2009;%. Duration of anticoagulant therapy was variable and death was reported in 26&#x2009;% of TE-PE patients. In contrast to TE-PE, patients with ISPAT were not investigated systematically for presence of thrombophilia, had more surgical interventions as the initial management and were often treated with anti-platelet medications. This review summarises important data and identifies gaps in the knowledge of paediatric PE, which may help to design future studies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rajpurkar</LastName><ForeName>Madhvi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Madhvi Rajpurkar, 3901 Beaubien St, Detroit, MI, 48201, USA, Tel.: +1 313 745 551, E-mail: mrajpurk@med.wayne.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biss</LastName><ForeName>Tina</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Amankwah</LastName><ForeName>Ernest K</ForeName><Initials>EK</Initials></Author><Author ValidYN="Y"><LastName>Martinez</LastName><ForeName>Denise</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Suzan</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Van Ommen</LastName><ForeName>C Heleen</ForeName><Initials>CH</Initials></Author><Author ValidYN="Y"><LastName>Goldenberg</LastName><ForeName>Neil A</ForeName><Initials>NA</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>03</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Thromb Haemost</MedlineTA><NlmUniqueID>7608063</NlmUniqueID><ISSNLinking>0340-6245</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical><Chemical><RegistryNumber>9005-49-6</RegistryNumber><NameOfSubstance UI="D006493">Heparin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000792" MajorTopicYN="N">Angiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006493" MajorTopicYN="N">Heparin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011029" MajorTopicYN="N">Pneumoradiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011651" MajorTopicYN="N">Pulmonary Artery</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013923" MajorTopicYN="N">Thromboembolism</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013927" MajorTopicYN="N">Thrombosis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Pulmonary embolism</Keyword><Keyword MajorTopicYN="N">children</Keyword><Keyword MajorTopicYN="N">paediatrics</Keyword><Keyword MajorTopicYN="N">pulmonary artery thrombosis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>7</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>5</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28331932</ArticleId><ArticleId IdType="doi">10.1160/TH16-07-0529</ArticleId><ArticleId IdType="pii">16-07-0529</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30336908</PMID><DateCompleted><Year>2019</Year><Month>09</Month><Day>24</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2213-3348</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>6</Issue><PubDate><Year>2018</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of vascular surgery. Venous and lymphatic disorders</Title><ISOAbbreviation>J Vasc Surg Venous Lymphat Disord</ISOAbbreviation></Journal><ArticleTitle>Meta-analysis and systematic review of percutaneous mechanical thrombectomy for lower extremity deep vein thrombosis.</ArticleTitle><Pagination><StartPage>788</StartPage><EndPage>800</EndPage><MedlinePgn>788-800</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jvsv.2018.08.002</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2213-333X(18)30330-5</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The objective of this review was to evaluate the efficacy and safety of percutaneous mechanical thrombectomy (PMT) with or without catheter-directed thrombolysis (CDT) in the treatment of lower extremity deep venous thrombosis (DVT).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched PubMed for clinical trials and prospective or retrospective case series (comparative or single-arm studies) that focused on PMT&#xa0;&#xb1; CDT in the treatment of DVT, published before March 2, 2017. We meta-analyzed perioperative outcomes and complications and long-term outcomes of this procedure. We also compared the results between PMT&#xa0;&#xb1; CDT and CDT alone, using the data from comparative studies.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Overall, 1323 PMT&#xa0;&#xb1; CDT patients from 35 studies were included in our study. The rate of patients experiencing successful thrombolysis with a partial or complete lysis rate was 93.4% (95% confidence interval [CI], 90.1%-95.6%) or 67.0% (95% CI, 59.1%-76.4%), respectively. The pooled proportion of 30-day rethrombosis rate was 11.9% (95% CI, 6.7%-20.3%). The 30-day DVT-related mortality was 2.4% (95% CI, 1.6%-3.7%). The perioperative incidence of major bleeding and pulmonary embolism was 4.6% (95% CI, 2.9%-7.3%) and 3.8% (95% CI, 2.5%-6.7%), respectively. During the follow-up, the late rethrombosis rate was 10.7% (95% CI, 8.7%-13.0%; the average follow-up period ranged from 2.8 to 32.1&#xa0;months). About 15.1% (95% CI, 9.6%-22.9%) of patients developed post-thrombotic syndrome during follow-up (the average follow-up period varied from 3.8 to 29.6&#xa0;months). In comparing the results of PMT&#xa0;&#xb1; CDT with CDT alone, six studies were included (195 patients in the PMT&#xa0;&#xb1; CDT group and 193 patients in the CDT group). The partial thrombolysis rate was higher in the PMT&#xa0;&#xb1; CDT group (odds ratio [OR], 2.64; 95% CI, 1.34-5.21; P&#xa0;= .005), whereas the complete lysis rate was not (OR, 1.38; 95% CI, 0.87-2.18; P&#xa0;= .17). The difference between the Villalta scores of the two groups during follow-up had no statistical significance (OR,&#xa0;-0.50; 95% CI,&#xa0;-1.34 to 0.34; P&#xa0;= .24). The thrombolytic drug dose in the PMT&#xa0;&#xb1; CDT group was much lower than that in the CDT group (standard mean difference,&#xa0;-0.98; 95% CI,&#xa0;-1.59 to&#xa0;-0.38; P&#xa0;= .001), and the procedural time was shorter in the PMT&#xa0;&#xb1; CDT group (mean difference,&#xa0;-16.94; 95% CI,&#xa0;-22.38 to&#xa0;-11.50; P&#xa0;&lt; .00,001). There was no significant difference in major bleeding (OR, 1.20; 95% CI, 0.50-2.90; P&#xa0;= .24) or pulmonary embolism (OR, 1.18; 95% CI, 0.16-8.73; P&#xa0;= .87) between the two groups.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">PMT with or without CDT is a relatively effective and safe approach for lower extremity DVT patients because of the acceptable incidence of perioperative complications and satisfying short- or long-term outcomes.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Wenda</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Rui</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yuexin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China. Electronic address: cyuexin2007@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Changwei</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Vasc Surg Venous Lymphat Disord</MedlineTA><NlmUniqueID>101607771</NlmUniqueID><ISSNLinking>2213-333X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005343">Fibrinolytic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005343" MajorTopicYN="N">Fibrinolytic Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054070" MajorTopicYN="N">Postthrombotic Syndrome</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017131" MajorTopicYN="N">Thrombectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015912" MajorTopicYN="N">Thrombolytic Therapy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Catheter-directed thrombolysis (CDT)</Keyword><Keyword MajorTopicYN="N">Efficacy</Keyword><Keyword MajorTopicYN="N">Lower extremity deep venous thrombosis (DVT)</Keyword><Keyword MajorTopicYN="N">Percutaneous mechanical thrombectomy (PMT)</Keyword><Keyword MajorTopicYN="N">Safety</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>1</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>8</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>10</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>10</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30336908</ArticleId><ArticleId IdType="doi">10.1016/j.jvsv.2018.08.002</ArticleId><ArticleId IdType="pii">S2213-333X(18)30330-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38894740</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>19</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>25</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-2392</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in endocrinology</Title><ISOAbbreviation>Front Endocrinol (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>Recommendations for recognizing, risk stratifying, treating, and managing children and adolescents with hypoglycemia.</ArticleTitle><Pagination><StartPage>1387537</StartPage><MedlinePgn>1387537</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1387537</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fendo.2024.1387537</ELocationID><Abstract><AbstractText>There has been continuous progress in diabetes management over the last few decades, not least due to the widespread dissemination of continuous glucose monitoring (CGM) and automated insulin delivery systems. These technological advances have radically changed the daily lives of people living with diabetes, improving the quality of life of both children and their families. Despite this, hypoglycemia remains the primary side-effect of insulin therapy. Based on a systematic review of the available scientific evidence, this paper aims to provide evidence-based recommendations for recognizing, risk stratifying, treating, and managing patients with hypoglycemia. The objective of these recommendations is to unify the behavior of pediatric diabetologists with respect to the timely recognition and prevention of hypoglycemic episodes and the correct treatment of hypoglycemia, especially in patients using CGM or advanced hybrid closed-loop systems. All authors have long experience in the specialty and are members of the Italian Society of Pediatric Endocrinology and Diabetology. The goal of treating hypoglycemia is to raise blood glucose above 70 mg/dL (3.9 mmol/L) and to prevent further decreases. Oral glucose at a dose of 0.3 g/kg (0.1 g/kg for children using "smart pumps" or hybrid closed loop systems in automated mode) is the preferred treatment for the conscious individual with blood glucose &lt;70 mg/dL (3.9 mmol/L), although any form of carbohydrate (e.g., sucrose, which consists of glucose and fructose, or honey, sugary soft drinks, or fruit juice) containing glucose may be used. Using automatic insulin delivery systems, the oral glucose dose can be decreased to 0.1 g/kg. Practical flow charts are included to aid clinical decision-making. Although representing the official position of the Italian Society of Pediatric Endocrinology and Diabetology (ISPED), these guidelines are applicable to the global audience and are especially pertinent in the era of CGM and other advanced technologies.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Zucchini, Tumini, Scaramuzza, Bonfanti, Delvecchio, Franceschi, Iafusco, Lenzi, Mozzillo, Passanisi, Piona, Rabbone, Rapini, Rigamonti, Ripoli, Salzano, Savastio, Schiaffini, Zanfardino, Cherubini and Diabetes Study Group of the Italian Society for Pediatric Endocrinology and Diabetes.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zucchini</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Study Group of Diabetology of the Italian Society for Pediatric Endocrinology and Diabetes (I.S.P.E.D.,) University Hospital of Ferrara, Ferrara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tumini</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Maternal and Child Health, UOSD Regional Center of Pediatric Diabetology, Annunziata Hospital, Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scaramuzza</LastName><ForeName>Andrea Enzo</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Division of Pediatrics, Pediatric Diabetes, Endocrinology and Nutrition, Azienda Socio Sanitaria Territoriale (ASST) Cremona, Cremona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonfanti</LastName><ForeName>Riccardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>UO Pediatric Diabetes Research Institute, Ospedale San Raffaele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delvecchio</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franceschi</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, S. Chiara Hospital of Trento, APSS, Trento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iafusco</LastName><ForeName>Dario</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Woman, Child and General and Specialistic Surgery, Regional Center of Pediatric Diabetes, University of Campania 'L. Vanvitelli', Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lenzi</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Diabetology Unit, Pediatric Department, Anna Meyer Children's Hospital, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mozzillo</LastName><ForeName>Enza</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Section of Pediatrics, Regional Center of Pediatric Diabetes, University Federico II, Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Passanisi</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Human Pathology of Adulthood and Childhood G. Barresi, University of Messina, Messina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piona</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Pediatric Diabetes and Metabolic Disorders Unit, Regional Center for Pediatric Diabetes, Department of Surgery, Dentistry, Pediatrics, and Gynecology, University of Verona, Verona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rabbone</LastName><ForeName>Ivana</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Division of Pediatrics, Department of Health Sciences, University of Piemonte Orientale, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rapini</LastName><ForeName>Novella</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Diabetes Unit, Bambino Ges&#xfa; Childrens' Hospital, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rigamonti</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>UO Pediatric Diabetes Research Institute, Ospedale San Raffaele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ripoli</LastName><ForeName>Carlo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Pediatric Diabetology Unit, Department of Pediatrics, ASL 8 Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salzano</LastName><ForeName>Giuseppina</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Human Pathology of Adulthood and Childhood G. Barresi, University of Messina, Messina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Savastio</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Pediatrics, Department of Health Sciences, University of Piemonte Orientale, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schiaffini</LastName><ForeName>Riccardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Diabetes Unit, Bambino Ges&#xfa; Childrens' Hospital, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zanfardino</LastName><ForeName>Angela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Woman, Child and General and Specialistic Surgery, Regional Center of Pediatric Diabetes, University of Campania 'L. Vanvitelli', Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cherubini</LastName><ForeName>Valentino</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Women's and Children's Health, Azienda Ospedaliero-Universitaria, Ospedali Riuniti di Ancona, 'Salesi Hospital', Ancona, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Endocrinol (Lausanne)</MedlineTA><NlmUniqueID>101555782</NlmUniqueID><ISSNLinking>1664-2392</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007003" MajorTopicYN="Y">Hypoglycemia</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015190" MajorTopicYN="Y">Blood Glucose Self-Monitoring</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="Y">Insulin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007004" MajorTopicYN="Y">Hypoglycemic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007332" MajorTopicYN="N">Insulin Infusion Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017410" MajorTopicYN="N">Practice Guidelines as Topic</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019468" MajorTopicYN="N">Disease Management</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">adolescents</Keyword><Keyword MajorTopicYN="N">automated insulin delivery</Keyword><Keyword MajorTopicYN="N">children</Keyword><Keyword MajorTopicYN="N">glucagon</Keyword><Keyword MajorTopicYN="N">hypoglycemia</Keyword><Keyword MajorTopicYN="N">oral glucose</Keyword><Keyword MajorTopicYN="N">type 1 diabetes</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>19</Day><Hour>4</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38894740</ArticleId><ArticleId IdType="pmc">PMC11183505</ArticleId><ArticleId IdType="doi">10.3389/fendo.2024.1387537</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abraham MB, Karges B, Dovc K, Naranjo D, Arbelaez AM, Mbogo J, et al. . ISPAD Clinical Practice Consensus Guidelines 2022: Assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes. (2022) 23:1322&#x2013;40. doi:&#xa0;10.1111/PEDI.13443</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/PEDI.13443</ArticleId><ArticleId IdType="pmc">PMC10107518</ArticleId><ArticleId IdType="pubmed">36537534</ArticleId></ArticleIdList></Reference><Reference><Citation>International Hypoglycaemia Study Group . Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. (2017) 40:155&#x2013;7. doi:&#xa0;10.2337/dc16-2215</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc16-2215</ArticleId><ArticleId IdType="pubmed">27872155</ArticleId></ArticleIdList></Reference><Reference><Citation>Cryer PE. Mechanisms of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med. (2013) 369:362&#x2013;72. doi:&#xa0;10.1056/NEJMra1215228</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1215228</ArticleId><ArticleId IdType="pubmed">23883381</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitrakou A, Ryan C, Veneman T, Mokan M, Jenssen T, Kiss I, et al. . Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction. Am J Physiol Metab. (1991) 260:E67&#x2013;74. doi:&#xa0;10.1152/ajpendo.1991.260.1.E67</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpendo.1991.260.1.E67</ArticleId><ArticleId IdType="pubmed">1987794</ArticleId></ArticleIdList></Reference><Reference><Citation>Cryer PE . Hypoglycemia in type 1 diabetes mellitus. Endocrinol Metab Clin North Am. (2010) 39:641&#x2013;54. doi:&#xa0;10.1016/j.ecl.2010.05.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ecl.2010.05.003</ArticleId><ArticleId IdType="pmc">PMC2923455</ArticleId><ArticleId IdType="pubmed">20723825</ArticleId></ArticleIdList></Reference><Reference><Citation>Gubitosi-Klug RA, Braffett BH, White NH, Sherwin RS, Service FJ, Lachin JM, et al. . Risk of severe hypoglycemia in type 1 diabetes over 30 years of follow-up in the dcct/edic study. Diabetes Care. (2017) 40:1010&#x2013;6. doi:&#xa0;10.2337/dc16-2723</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc16-2723</ArticleId><ArticleId IdType="pmc">PMC5521975</ArticleId><ArticleId IdType="pubmed">28550194</ArticleId></ArticleIdList></Reference><Reference><Citation>Haynes A, Hermann JM, Miller KM, Hofer SE, Jones TW, Beck RW, et al. . Severe hypoglycemia rates are not associated with HbA1c: a cross-sectional analysis of 3 contemporary pediatric diabetes registry databases. Pediatr Diabetes. (2017) 18:643&#x2013;50. doi:&#xa0;10.1111/pedi.12477</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pedi.12477</ArticleId><ArticleId IdType="pmc">PMC7162500</ArticleId><ArticleId IdType="pubmed">27878914</ArticleId></ArticleIdList></Reference><Reference><Citation>Cherubini V, Pintaudi B, Rossi MC, Lucisano G, Pellegrini F, Chiumello G. Severe hypoglycemia and ketoacidosis over one year in Italian pediatric population with type 1 diabetes mellitus: a multicenter retrospective observational study. Nutr Metab Cardiovasc Dis. (2014) 24:538&#x2013;46. doi:&#xa0;10.1016/j.numecd.2013.11.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.numecd.2013.11.004</ArticleId><ArticleId IdType="pubmed">24418381</ArticleId></ArticleIdList></Reference><Reference><Citation>Cryer PE. Symptoms of hypoglycemia, thresholds for their occurrence, and hypoglycemia unawareness. Endocrinol Metab Clin North Am. (1999) 28:495&#x2013;500, v&#x2013;vi. doi:&#xa0;10.1016/s0889-8529(05)70084-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0889-8529(05)70084-0</ArticleId><ArticleId IdType="pubmed">10500927</ArticleId></ArticleIdList></Reference><Reference><Citation>Urakami T. Severe hypoglycemia: is it still a threat for children and adolescents with type 1 diabetes? Front Endocrinol (Lausanne). (2020) 11:609. doi:&#xa0;10.3389/fendo.2020.00609</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2020.00609</ArticleId><ArticleId IdType="pmc">PMC7523511</ArticleId><ArticleId IdType="pubmed">33042005</ArticleId></ArticleIdList></Reference><Reference><Citation>Verhulst CEM, Fabricius TW, Teerenstra S, Kristensen PL, Tack CJ, McCrimmon RJ, et al. . Glycaemic thresholds for counterregulatory hormone and symptom responses to hypoglycaemia in people with and without type 1 diabetes: a systematic review. Diabetologia. (2022) 65:1601&#x2013;12. doi:&#xa0;10.1007/s00125-022-05749-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-022-05749-8</ArticleId><ArticleId IdType="pmc">PMC9477942</ArticleId><ArticleId IdType="pubmed">35867127</ArticleId></ArticleIdList></Reference><Reference><Citation>Arbelaez AM, Xing D, Cryer PE, Kollman C, Beck RW, Sherr J, et al. . Blunted glucagon but not epinephrine responses to hypoglycemia occurs in youth with less than 1 yr duration of type 1 diabetes mellitus. Pediatr Diabetes. (2014) 15:127&#x2013;34. doi:&#xa0;10.1111/pedi.12070</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pedi.12070</ArticleId><ArticleId IdType="pmc">PMC3858506</ArticleId><ArticleId IdType="pubmed">23992543</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherr J, Xing D, Ruedy KJ, Beck RW, Kollman C, Buckingham B, et al. . Lack of association between residual insulin production and glucagon response to hypoglycemia in youth with short duration of type 1 diabetes. Diabetes Care. (2013) 36:1470&#x2013;6. doi:&#xa0;10.2337/dc12-1697</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc12-1697</ArticleId><ArticleId IdType="pmc">PMC3661789</ArticleId><ArticleId IdType="pubmed">23288858</ArticleId></ArticleIdList></Reference><Reference><Citation>McCrimmon RJ, Gold AE, Deary IJ, Kelnar CJ, Frier BM. Symptoms of hypoglycemia in children with IDDM. Diabetes Care. (1995) 18:858&#x2013;61. doi:&#xa0;10.2337/diacare.18.6.858</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diacare.18.6.858</ArticleId><ArticleId IdType="pubmed">7555514</ArticleId></ArticleIdList></Reference><Reference><Citation>Hepburn DA, Deary IJ, Frier BM. Classification of symptoms of hypoglycaemia in insulin-treated diabetic patients using factor analysis: relationship to hypoglycaemia unawareness. Diabetes Med. (1992) 9:70&#x2013;5. doi:&#xa0;10.1111/j.1464-5491.1992.tb01718.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1464-5491.1992.tb01718.x</ArticleId><ArticleId IdType="pubmed">1551313</ArticleId></ArticleIdList></Reference><Reference><Citation>Birkebaek N, Drivvoll A, Aakeson K, Bjarnason R, Johansen A, Samuelsson U, et al. . Incidence of severe hypoglycemia in children with type 1 diabetes in the Nordic countries in the period 2008&#x2013;2012: association with hemoglobin A 1c and treatment modality. BMJ Open Diabetes Res Care. (2017) 5:e000377. doi:&#xa0;10.1136/bmjdrc-2016-000377</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjdrc-2016-000377</ArticleId><ArticleId IdType="pmc">PMC5530237</ArticleId><ArticleId IdType="pubmed">28761652</ArticleId></ArticleIdList></Reference><Reference><Citation>Abraham MB, Jones TW, Naranjo D, Karges B, Oduwole A, Tauschmann M, et al. . ISPAD Clinical Practice Consensus Guidelines 2018: Assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes. (2018) 19:178&#x2013;92. doi:&#xa0;10.1111/pedi.12698</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pedi.12698</ArticleId><ArticleId IdType="pubmed">29869358</ArticleId></ArticleIdList></Reference><Reference><Citation>Piccini B, Pessina B, Casalini E, Lenzi L, Toni S. Long-term effectiveness of advanced hybrid closed loop in children and adolescents with type 1 diabetes. Pediatr Diabetes. (2022) 23:1647&#x2013;55. doi:&#xa0;10.1111/pedi.13440</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pedi.13440</ArticleId><ArticleId IdType="pubmed">36317539</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulkkinen MA, Varimo TJ, Hakonen ET, Harsunen MH, Hyv&#xf6;nen ME, Jan&#xe9;r JN, et al. . MiniMed 780G&#x2122; in 2- to 6-year-old children: safety and clinical outcomes after the first 12 weeks. Diabetes Technol Ther. (2023) 25:100&#x2013;7. doi:&#xa0;10.1089/dia.2022.0313</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/dia.2022.0313</ArticleId><ArticleId IdType="pubmed">36511831</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner BC, Jenkins E, Kerr D, Sherwin RS, Cavan DA. The effect of evening alcohol consumption on next-morning glucose control in type 1 diabetes. Diabetes Care. (2001) 24:1888&#x2013;93. doi:&#xa0;10.2337/diacare.24.11.1888</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diacare.24.11.1888</ArticleId><ArticleId IdType="pubmed">11679452</ArticleId></ArticleIdList></Reference><Reference><Citation>Valerio G, Mozzillo E, Zito E, De Nitto E, Maltoni G, Marigliano M, et al. . Alcohol consumption or cigarette smoking and cardiovascular disease risk in youth with type 1 diabetes. Acta Diabetol. (2019) 56:1315&#x2013;21. doi:&#xa0;10.1007/s00592-019-01415-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00592-019-01415-5</ArticleId><ArticleId IdType="pubmed">31493030</ArticleId></ArticleIdList></Reference><Reference><Citation>Hermann JM, Meusers M, Bachran R, Kuhnle-Krahl U, Jorch N, Hofer SE, et al. . Self-reported regular alcohol consumption in adolescents and emerging adults with type 1 diabetes: A neglected risk factor for diabetic ketoacidosis? Multicenter analysis of 29 630 patients from the DPV registry. Pediatr Diabetes. (2017) 18:817&#x2013;23. doi:&#xa0;10.1111/pedi.12496</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pedi.12496</ArticleId><ArticleId IdType="pubmed">28145026</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a A, Moscard&#xf3; V, Ramos-Prol A, D&#xed;az J, Boronat M, Bondia J, et al. . Effect of meal composition and alcohol consumption on postprandial glucose concentration in subjects with type 1 diabetes: a randomised crossover trial. BMJ Open Diabetes Res Care. (2021) 9:e002399. doi:&#xa0;10.1136/bmjdrc-2021-002399</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjdrc-2021-002399</ArticleId><ArticleId IdType="pmc">PMC8499260</ArticleId><ArticleId IdType="pubmed">34620620</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansen A, Kanijo B, Fredheim S, Olsen B, Hertz B, Lauridsen MH, et al. . Prevalence and predictors of severe hypoglycemia in Danish children and adolescents with diabetes. Pediatr Diabetes. (2015) 16:354&#x2013;60. doi:&#xa0;10.1111/pedi.12171</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pedi.12171</ArticleId><ArticleId IdType="pubmed">25039921</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper MN, O&#x2019;Connell SM, Davis EA, Jones TW. A population-based study of risk factors for severe hypoglycaemia in a contemporary cohort of childhood-onset type 1 diabetes. Diabetologia. (2013) 56:2164&#x2013;70. doi:&#xa0;10.1007/s00125-013-2982-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-013-2982-1</ArticleId><ArticleId IdType="pubmed">23832082</ArticleId></ArticleIdList></Reference><Reference><Citation>Maahs DM, Hermann JM, DuBose SN, Miller KM, Heidtmann B, DiMeglio LA, et al. . Contrasting the clinical care and outcomes of 2,622 children with type 1 diabetes less than 6 years of age in the United States T1D Exchange and German/Austrian DPV registries. Diabetologia. (2014) 57:1578&#x2013;85. doi:&#xa0;10.1007/s00125-014-3272-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-014-3272-2</ArticleId><ArticleId IdType="pubmed">24893863</ArticleId></ArticleIdList></Reference><Reference><Citation>Cherubini V, Rabbone I, Lombardo F, Mossetto G, Orsini Federici M, Nicolucci A. Incidence of severe hypoglycemia and possible associated factors in pediatric patients with type 1 diabetes mellitus in the real-life, post-DCCT setting: a systematic review. Pediatr Diabetes. (2019) 20(6):678-692. doi:&#xa0;10.1111/pedi.12876</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pedi.12876</ArticleId><ArticleId IdType="pubmed">31177592</ArticleId></ArticleIdList></Reference><Reference><Citation>Peacock S, Frizelle I, Hussain S. A systematic review of commercial hybrid closed-loop automated insulin delivery systems. Diabetes Ther. (2023) 14:839&#x2013;55. doi:&#xa0;10.1007/s13300-023-01394-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13300-023-01394-5</ArticleId><ArticleId IdType="pmc">PMC10126177</ArticleId><ArticleId IdType="pubmed">37017916</ArticleId></ArticleIdList></Reference><Reference><Citation>Tetzschner R, N&#xf8;rgaard K, Ranjan A. Effects of alcohol on plasma glucose and prevention of alcohol-induced hypoglycemia in type 1 diabetes-A systematic review with GRADE. Diabetes Metab Res Rev. (2018) 34:e2965. doi:&#xa0;10.1002/dmrr.2965</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dmrr.2965</ArticleId><ArticleId IdType="pubmed">29135074</ArticleId></ArticleIdList></Reference><Reference><Citation>Cockcroft EJ, Narendran P, Andrews RC. Exercise-induced hypoglycaemia in type 1 diabetes. Exp Physiol. (2020) 105:590&#x2013;9. doi:&#xa0;10.1113/EP088219</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/EP088219</ArticleId><ArticleId IdType="pubmed">31785115</ArticleId></ArticleIdList></Reference><Reference><Citation>Giblin S, Scully P, Dalton N, Connolly M, McCaffrey A, Sheikhi A, et al. . Parent and child perceptions of physical activity with type 1 diabetes. BMJ Open Diabetes Res Care. (2022) 10:e002977. doi:&#xa0;10.1136/bmjdrc-2022-002977</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjdrc-2022-002977</ArticleId><ArticleId IdType="pmc">PMC9685260</ArticleId><ArticleId IdType="pubmed">36414272</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe4;rnblad S, Ponsot E, Lepr&#xea;tre P, Kadi F. Acute effects of aerobic continuous, intermittent, and resistance exercise on glycemia in adolescents males with type 1 diabetes. Pediatr Diabetes. (2021) 22:610&#x2013;7. doi:&#xa0;10.1111/pedi.13194</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pedi.13194</ArticleId><ArticleId IdType="pubmed">33650298</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Garc&#xed;a F, Kumareswaran K, Hovorka R, Hernando ME. Quantifying the acute changes in glucose with exercise in type 1 diabetes: A systematic review and meta-analysis. Sport Med. (2015) 45:587&#x2013;99. doi:&#xa0;10.1007/s40279-015-0302-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40279-015-0302-2</ArticleId><ArticleId IdType="pubmed">25616852</ArticleId></ArticleIdList></Reference><Reference><Citation>Pitt JP, McCarthy OM, Hoeg-Jensen T, Wellman BM, Bracken RM. Factors influencing insulin absorption around exercise in type 1 diabetes. Front Endocrinol (Lausanne). (2020) 11:573275. doi:&#xa0;10.3389/fendo.2020.573275</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2020.573275</ArticleId><ArticleId IdType="pmc">PMC7609903</ArticleId><ArticleId IdType="pubmed">33193089</ArticleId></ArticleIdList></Reference><Reference><Citation>Riddell MC, Gallen IW, Smart CE, Taplin CE, Adolfsson P, Lumb AN, et al. . Exercise management in type 1 diabetes: a consensus statement. Lancet Diabetes Endocrinol. (2017) 5:377&#x2013;90. doi:&#xa0;10.1016/S2213-8587(17)30014-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(17)30014-1</ArticleId><ArticleId IdType="pubmed">28126459</ArticleId></ArticleIdList></Reference><Reference><Citation>MacDonald MJ. Postexercise late-onset hypoglycemia in insulin-dependent diabetic patients. Diabetes Care. (1987) 10:584&#x2013;8. doi:&#xa0;10.2337/diacare.10.5.584</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diacare.10.5.584</ArticleId><ArticleId IdType="pubmed">3677976</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee AS, Way KL, Johnson NA, Twigg SM. High-intensity interval exercise and hypoglycaemia minimisation in adults with type 1 diabetes: A randomised cross-over trial. J Diabetes Complications. (2020) 34:107514. doi:&#xa0;10.1016/j.jdiacomp.2019.107514</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jdiacomp.2019.107514</ArticleId><ArticleId IdType="pubmed">31918984</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson SR, Cooper MN, Davis EA, Jones TW. Hypoglycaemia, fear of hypoglycaemia and quality of life in children with Type 1 diabetes and their parents. Diabetes Med. (2013) 30:1126&#x2013;31. doi:&#xa0;10.1111/dme.12247</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dme.12247</ArticleId><ArticleId IdType="pubmed">23808967</ArticleId></ArticleIdList></Reference><Reference><Citation>Battelino T, Danne T, Edelman SV, Choudhary P, Renard E, Westerbacka J, et al. . Continuous glucose monitoring-based time-in-range using insulin glargine 300 units/ml versus insulin degludec 100 units/ml in type 1 diabetes: The head-to-head randomised controlled InRange trial. Diabetes Obes Metab. (2023) 25:545&#x2013;55. doi:&#xa0;10.1111/dom.14898</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dom.14898</ArticleId><ArticleId IdType="pmc">PMC10100006</ArticleId><ArticleId IdType="pubmed">36263928</ArticleId></ArticleIdList></Reference><Reference><Citation>Alotaibi A, Al Khalifah R, McAssey K. The efficacy and safety of insulin pump therapy with predictive low glucose suspend feature in decreasing hypoglycemia in children with type 1 diabetes mellitus: A systematic review and meta-analysis. Pediatr Diabetes. (2020) 21:1256&#x2013;67. doi:&#xa0;10.1111/pedi.13088</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pedi.13088</ArticleId><ArticleId IdType="pubmed">32738022</ArticleId></ArticleIdList></Reference><Reference><Citation>Verbeeten KC, Perez Trejo ME, Tang K, Chan J, Courtney JM, Bradley BJ, et al. . Fear of hypoglycemia in children with type 1 diabetes and their parents: Effect of pump therapy and continuous glucose monitoring with option of low glucose suspend in the CGM TIME trial. Pediatr Diabetes. (2021) 22:288&#x2013;93. doi:&#xa0;10.1111/pedi.13150</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pedi.13150</ArticleId><ArticleId IdType="pmc">PMC7983886</ArticleId><ArticleId IdType="pubmed">33179818</ArticleId></ArticleIdList></Reference><Reference><Citation>Monzani A, Savastio S, Manzo A, Scalogna A, Pozzi E, Sainaghi PP, et al. . Not only for caregivers: intranasal glucagon for severe hypoglycaemia in a simulation study. Acta Diabetol. (2022) 59:1479&#x2013;84. doi:&#xa0;10.1007/s00592-022-01952-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00592-022-01952-6</ArticleId><ArticleId IdType="pubmed">35951133</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoury N, Semenkovich K, Arbel&#xe1;ez AM. Coeliac disease presenting as severe hypoglycaemia in youth with type 1 diabetes. Diabetes Med. (2014) 31:e33&#x2013;6. doi:&#xa0;10.1111/dme.12488</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dme.12488</ArticleId><ArticleId IdType="pubmed">24805141</ArticleId></ArticleIdList></Reference><Reference><Citation>Mortimer B, Naganur VD, Satouris P, Greenfield JR, Torpy DJ, Rushworth RL. Acute illness in patients with concomitant Addison&#x2019;s disease and type 1 diabetes mellitus: Increased incidence of hypoglycaemia and adrenal crises. Clin Endocrinol (Oxf). (2020) 93:104&#x2013;10. doi:&#xa0;10.1111/cen.14219</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cen.14219</ArticleId><ArticleId IdType="pubmed">32396991</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohn A, Di Michele S, Di Luzio R, Tumini S, Chiarelli F. The effect of subclinical hypothyroidism on metabolic control in children and adolescents with Type 1 diabetes mellitus. Diabetic medicine: J Br Diabetic Assoc. (2002) 19:70&#x2013;3. doi:&#xa0;10.1046/j.1464-5491.2002.00635.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1464-5491.2002.00635.x</ArticleId><ArticleId IdType="pubmed">11869306</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood SP. Is D50 Too Much of a Good Thing?: A reappraisal of the safety of 50 percent dextrose administration in patients with hypoglycemia. JEMS J Emerg Med Serv. (2007) 32:as0197251007700906. doi:&#xa0;10.1016/S0197-2510(07)70090-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0197-2510(07)70090-6</ArticleId><ArticleId IdType="pubmed">17367650</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore C, Woollard M. Dextrose 10% or 50% in the treatment of hypoglycaemia out of hospital? A randomised controlled trial. Emerg Med J. (2005) 22:512&#x2013;5. doi:&#xa0;10.1136/emj.2004.020693</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/emj.2004.020693</ArticleId><ArticleId IdType="pmc">PMC1726850</ArticleId><ArticleId IdType="pubmed">15983093</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearson T. Glucagon as a treatment of severe hypoglycemia. Diabetes Educ. (2008) 34:128&#x2013;34. doi:&#xa0;10.1177/0145721707312400</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0145721707312400</ArticleId><ArticleId IdType="pubmed">18267999</ArticleId></ArticleIdList></Reference><Reference><Citation>Rickels MR, Ruedy KJ, Foster NC, Pich&#xe9; CA, Dulude H, Sherr JL, et al. . Intranasal glucagon for treatment of insulin-induced hypoglycemia in adults with type 1 diabetes: A randomised crossover noninferiority study. Diabetes Care. (2016) 39:264&#x2013;70. doi:&#xa0;10.2337/dc15-1498</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc15-1498</ArticleId><ArticleId IdType="pmc">PMC4722945</ArticleId><ArticleId IdType="pubmed">26681725</ArticleId></ArticleIdList></Reference><Reference><Citation>Deeb LC, Dulude H, Guzman CB, Zhang S, Reiner BJ, Pich&#xe9; CA, et al. . A phase 3 multicenter, open-label, prospective study designed to evaluate the effectiveness and ease of use of nasal glucagon in the treatment of moderate and severe hypoglycemia in children and adolescents with type 1 diabetes in the home or school setti. Pediatr Diabetes. (2018) 19:1007&#x2013;13. doi:&#xa0;10.1111/pedi.12668</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pedi.12668</ArticleId><ArticleId IdType="pubmed">29512902</ArticleId></ArticleIdList></Reference><Reference><Citation>Yale J-F, Dulude H, Egeth M, Pich&#xe9; CA, Lafontaine M, Carballo D, et al. . Faster use and fewer failures with needle-free nasal glucagon versus injectable glucagon in severe hypoglycemia rescue: A simulation study. Diabetes Technol Ther. (2017) 19:423&#x2013;32. doi:&#xa0;10.1089/dia.2016.0460</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/dia.2016.0460</ArticleId><ArticleId IdType="pmc">PMC5563859</ArticleId><ArticleId IdType="pubmed">28556672</ArticleId></ArticleIdList></Reference><Reference><Citation>Pontiroli AE, Tagliabue E. Intranasal versus injectable glucagon for hypoglycemia in type 1 diabetes: systematic review and meta-analysis. Acta Diabetol. (2020) 57:743&#x2013;9. doi:&#xa0;10.1007/s00592-020-01483-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00592-020-01483-y</ArticleId><ArticleId IdType="pubmed">32025860</ArticleId></ArticleIdList></Reference><Reference><Citation>Zucchini S, Ripoli C, Cherubini V, Coccioli MS, Delvecchio M, De Marco R, et al. . Nasal glucagon is safe and effective in children with type 1 diabetes: a real-life prospective cohort study. Diabetes Obes Metab. (2023). doi:&#xa0;10.1111/dom.15330</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dom.15330</ArticleId><ArticleId IdType="pubmed">37867226</ArticleId></ArticleIdList></Reference><Reference><Citation>McTavish L, Wiltshire E. Effective treatment of hypoglycemia in children with type 1 diabetes: a randomised controlled clinical trial. Pediatr Diabetes. (2011) 12:381&#x2013;7. doi:&#xa0;10.1111/pdi.2011.12.issue-4pt2</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pdi.2011.12.issue-4pt2</ArticleId><ArticleId IdType="pubmed">21443586</ArticleId></ArticleIdList></Reference><Reference><Citation>McTavish L, Corley B, Weatherall M, Wiltshire E, Krebs JD. Weight-based carbohydrate treatment of hypoglycaemia in people with Type 1 diabetes using insulin pump therapy: a randomised crossover clinical trial. Diabetes Med. (2018) 35:339&#x2013;46. doi:&#xa0;10.1111/dme.13576</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dme.13576</ArticleId><ArticleId IdType="pubmed">29285796</ArticleId></ArticleIdList></Reference><Reference><Citation>Husband AC, Crawford S, McCoy LA, Pacaud D. The effectiveness of glucose, sucrose, and fructose in treating hypoglycemia in children with type 1 diabetes. Pediatr Diabetes. (2009) 11:154&#x2013;8. doi:&#xa0;10.1111/pdi.2010.11.issue-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pdi.2010.11.issue-3</ArticleId><ArticleId IdType="pubmed">19663922</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlson JN, Schunder-Tatzber S, Neilson CJ, Hood N. Dietary sugars versus glucose tablets for first-aid treatment of symptomatic hypoglycaemia in awake patients with diabetes: a systematic review and meta-analysis. Emerg Med J. (2017) 34:100&#x2013;6. doi:&#xa0;10.1136/emermed-2015-205637</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/emermed-2015-205637</ArticleId><ArticleId IdType="pubmed">27644757</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodows RG, Williams C, Amatruda JM. Treatment of insulin reactions in diabetics. JAMA. (1984) 252:3378&#x2013;81. doi:&#xa0;10.1001/jama.252.24.3378</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.252.24.3378</ArticleId><ArticleId IdType="pubmed">6389915</ArticleId></ArticleIdList></Reference><Reference><Citation>Tinti D, Rabbone I. Mini-doses of glucagon to prevent hypoglycemia in children with type 1 diabetes refusing food: a case series. Acta Diabetol. (2020) 57:359&#x2013;65. doi:&#xa0;10.1007/s00592-019-01443-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00592-019-01443-1</ArticleId><ArticleId IdType="pubmed">31673895</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawrence SE, Albanese-O&#x2019;Neill A, Besan&#xe7;on S, Black T, Bratina N, Chaney D, et al. . ISPAD Clinical Practice Consensus Guidelines 2022: Management and support of children and adolescents with diabetes in school. Pediatr Diabetes. (2022) 23:1478&#x2013;95. doi:&#xa0;10.1111/pedi.13432</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pedi.13432</ArticleId><ArticleId IdType="pubmed">36537526</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinsker JE, Bartee A, Katz M, Lalonde A, Jones R, Dassau E, et al. . Predictive low-glucose suspend necessitates less carbohydrate supplementation to rescue hypoglycemia: need to revisit current hypoglycemia treatment guidelines. Diabetes Technol Ther. (2021). doi:&#xa0;10.1089/dia.2020.0619</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/dia.2020.0619</ArticleId><ArticleId IdType="pmc">PMC8252907</ArticleId><ArticleId IdType="pubmed">33535013</ArticleId></ArticleIdList></Reference><Reference><Citation>Messer LH, Berget C, Forlenza GP. A clinical guide to advanced diabetes devices and closed-loop systems using the CARES paradigm. Diabetes Technol Ther (2019) 21(8):462-469. doi:&#xa0;10.1089/dia.2019.0105</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/dia.2019.0105</ArticleId><ArticleId IdType="pmc">PMC6653788</ArticleId><ArticleId IdType="pubmed">31140878</ArticleId></ArticleIdList></Reference><Reference><Citation>Cacciatore M, Grasso EA, Tripodi R, Chiarelli F. Impact of glucose metabolism on the developing brain. Front Endocrinol (Lausanne). (2022) 13:1047545. doi:&#xa0;10.3389/fendo.2022.1047545</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2022.1047545</ArticleId><ArticleId IdType="pmc">PMC9816389</ArticleId><ArticleId IdType="pubmed">36619556</ArticleId></ArticleIdList></Reference><Reference><Citation>Cameron FJ, Northam EA, Ryan CM. The effect of type 1 diabetes on the developing brain. Lancet Child Adolesc Heal. (2019) 3:427&#x2013;36. doi:&#xa0;10.1016/S2352-4642(19)30055-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(19)30055-0</ArticleId><ArticleId IdType="pubmed">30987935</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauras N, Mazaika P, Buckingham B, Weinzimer S, White NH, Tsalikian E, et al. . Longitudinal assessment of neuroanatomical and cognitive differences in young children with type 1 diabetes: association with hyperglycemia. Diabetes. (2015) 64:1770&#x2013;9. doi:&#xa0;10.2337/db14-1445</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db14-1445</ArticleId><ArticleId IdType="pmc">PMC4407847</ArticleId><ArticleId IdType="pubmed">25488901</ArticleId></ArticleIdList></Reference><Reference><Citation>Strachan MW, Deary IJ, Ewing FM, Frier BM. Recovery of cognitive function and mood after severe hypoglycemia in adults with insulin-treated diabetes. Diabetes Care. (2000) 23:305&#x2013;12. doi:&#xa0;10.2337/diacare.23.3.305</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diacare.23.3.305</ArticleId><ArticleId IdType="pubmed">10868856</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu E, Twigg SM, Semsarian C. Sudden death in type 1 diabetes: the mystery of the &#x201c;dead in bed&#x201d; syndrome. Int J Cardiol. (2010) 138:91&#x2013;3. doi:&#xa0;10.1016/j.ijcard.2008.06.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2008.06.021</ArticleId><ArticleId IdType="pubmed">18676043</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagnum V, Stene LC, Jenssen TG, Berteussen LM, Sandvik L, Joner G, et al. . Causes of death in childhood-onset Type 1 diabetes: long-term follow-up. Diabetes Med. (2017) 34:56&#x2013;63. doi:&#xa0;10.1111/dme.13114</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dme.13114</ArticleId><ArticleId IdType="pubmed">26996105</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaccardi F, Dhalwani NN, Webb DR, Davies MJ, Khunti K. Global burden of hypoglycaemia-related mortality in 109 countries, from 2000 to 2014: an analysis of death certificates. Diabetologia. (2018) 61:1592&#x2013;602. doi:&#xa0;10.1007/s00125-018-4626-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-018-4626-y</ArticleId><ArticleId IdType="pmc">PMC6438613</ArticleId><ArticleId IdType="pubmed">29717336</ArticleId></ArticleIdList></Reference><Reference><Citation>Novodvorsky P, Bernjak A, Chow E, Iqbal A, Sellors L, Williams S, et al. . Diurnal differences in risk of cardiac arrhythmias during spontaneous hypoglycemia in young people with type 1 diabetes. Diabetes Care. (2017) 40:655&#x2013;62. doi:&#xa0;10.2337/dc16-2177</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc16-2177</ArticleId><ArticleId IdType="pubmed">28213374</ArticleId></ArticleIdList></Reference><Reference><Citation>Annuzzi G, Triggiani R, De Angelis R, Rainone C, Corrado A, Scid&#xe0; G, et al. . Delayed prandial insulin boluses are an important determinant of blood glucose control and relate to fear of hypoglycemia in people with type 1 diabetes on advanced technologies. J Diabetes Complications. (2024) 38:108689. doi:&#xa0;10.1016/j.jdiacomp.2024.108689</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jdiacomp.2024.108689</ArticleId><ArticleId IdType="pubmed">38244326</ArticleId></ArticleIdList></Reference><Reference><Citation>Donat Ergin B, Ergin I, G&#xf6;k&#x15f;en D. Fear of hypoglycemia and longer disease duration associated with physical activity avoidance in children and adolescents with type 1 diabetes mellitus. J Clin Res Pediatr Endocrinol. (2023) 15:238&#x2013;47. doi:&#xa0;10.4274/jcrpe.galenos.2023.2022-9-13</Citation><ArticleIdList><ArticleId IdType="doi">10.4274/jcrpe.galenos.2023.2022-9-13</ArticleId><ArticleId IdType="pmc">PMC10448549</ArticleId><ArticleId IdType="pubmed">36800682</ArticleId></ArticleIdList></Reference><Reference><Citation>Driscoll KA, Raymond J, Naranjo D, Patton SR. Fear of hypoglycemia in children and adolescents and their parents with type 1 diabetes. Curr Diabetes Rep. (2016) 16:1&#x2013;14. doi:&#xa0;10.1007/s11892-016-0762-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11892-016-0762-2</ArticleId><ArticleId IdType="pmc">PMC5371512</ArticleId><ArticleId IdType="pubmed">27370530</ArticleId></ArticleIdList></Reference><Reference><Citation>Majidi S, Driscoll KA, Raymond JK. Anxiety in children and adolescents with type 1 diabetes. Curr Diabetes Rep. (2015) 15:47. doi:&#xa0;10.1007/s11892-015-0619-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11892-015-0619-0</ArticleId><ArticleId IdType="pubmed">26071685</ArticleId></ArticleIdList></Reference><Reference><Citation>Patton SR, Dolan LM, Henry R, Powers SW. Parental fear of hypoglycemia: young children treated with continuous subcutaneous insulin infusion. Pediatr Diabetes. (2007) 8:362&#x2013;8. doi:&#xa0;10.1111/j.1399-5448.2007.00242.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-5448.2007.00242.x</ArticleId><ArticleId IdType="pubmed">18036061</ArticleId></ArticleIdList></Reference><Reference><Citation>Haugstvedt A, Wentzel-Larsen T, Graue M, S&#xf8;vik O, Rokne B. Fear of hypoglycaemia in mothers and fathers of children with Type 1 diabetes is associated with poor glycaemic control and parental emotional distress: a population-based study. Diabetes Med. (2010) 27:72&#x2013;8. doi:&#xa0;10.1111/j.1464-5491.2009.02867.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1464-5491.2009.02867.x</ArticleId><ArticleId IdType="pubmed">20121892</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacaud D, Hermann J, Karges B, Rosenbauer J, Danne T, D&#xfc;rr R, et al. . Risk of recurrent severe hypoglycemia remains associated with a past history of severe hypoglycemia up to 4 years: Results from a large prospective contemporary pediatric cohort of the DPV initiative. Pediatr Diabetes. (2018) 19:493&#x2013;500. doi:&#xa0;10.1111/pedi.12610</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pedi.12610</ArticleId><ArticleId IdType="pubmed">29218766</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke WL, Gonder-Frederick LA, Snyder AL, Cox DJ. Maternal fear of hypoglycemia in their children with insulin dependent diabetes mellitus. J Pediatr Endocrinol Metab. (2011) 11:189&#x2013;94. doi:&#xa0;10.1515/JPEM.1998.11.S1.189</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/JPEM.1998.11.S1.189</ArticleId><ArticleId IdType="pubmed">9642659</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonder-frederick LA, Fisher CD, Ritterband LM, Cox DJ, Hou L, DasGupta AA, et al. . Predictors of fear of hypoglycemia in adolescents with type 1 diabetes and their parents. Pediatr Diabetes. (2006) 7:215&#x2013;22. doi:&#xa0;10.1111/j.1399-5448.2006.00182.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-5448.2006.00182.x</ArticleId><ArticleId IdType="pubmed">16911009</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamps JL, Roberts MC, Varela RE. Development of a new fear of hypoglycemia scale: Preliminary results. J Pediatr Psychol. (2005) 30:287&#x2013;91. doi:&#xa0;10.1093/jpepsy/jsi038</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jpepsy/jsi038</ArticleId><ArticleId IdType="pubmed">15784924</ArticleId></ArticleIdList></Reference><Reference><Citation>Godoi A, Reis Marques I, Padr&#xe3;o EMH, Mahesh A, Hespanhol LC, Riceto Loyola J&#xfa;nior JE, et al. . Glucose control and psychosocial outcomes with use of automated insulin delivery for 12 to 96 weeks in type 1 diabetes: a meta-analysis of randomised controlled trials. Diabetol Metab Syndr. (2023) 15:190. doi:&#xa0;10.1186/s13098-023-01144-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13098-023-01144-4</ArticleId><ArticleId IdType="pmc">PMC10537468</ArticleId><ArticleId IdType="pubmed">37759290</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MA, Holmes-Walker DJ, Farrell K, Clark-Luccitti A. Impact of continuous glucose monitoring in youth with type 1 diabetes aged 15&#x2013;21 years. Intern Med J. (2023) 53:209&#x2013;15. doi:&#xa0;10.1111/imj.15347</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imj.15347</ArticleId><ArticleId IdType="pubmed">33949770</ArticleId></ArticleIdList></Reference><Reference><Citation>Rilstone S, Oliver N, Godsland I, Tanushi B, Thomas M, Hill N. A randomized controlled trial assessing the impact of continuous glucose monitoring with a predictive hypoglycemia alert function on hypoglycemia in physical activity for people with type 1 diabetes (PACE). Diabetes Technol Ther. (2024) 26:95&#x2013;102. doi:&#xa0;10.1089/dia.2023.0376</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/dia.2023.0376</ArticleId><ArticleId IdType="pubmed">37943579</ArticleId></ArticleIdList></Reference><Reference><Citation>Cobry EC, Pyle L, Karami AJ, Sakamoto C, Meltzer LJ, Jost E, et al. . Impact of 6-months of an advanced hybrid closed-loop system on sleep and psychosocial outcomes in youth with type 1 diabetes and their parents. Diabetes Res Clin Pract. (2024) 207:111087. doi:&#xa0;10.1016/j.diabres.2023.111087</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2023.111087</ArticleId><ArticleId IdType="pmc">PMC10942664</ArticleId><ArticleId IdType="pubmed">38181984</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong JJ, Hood KK, Hanes SJ, Lal RA, Naranjo D. Psychosocial effects of the loop open-source automated insulin delivery system. J Diabetes Sci Technol. (2022) 17:1440&#x2013;7. doi:&#xa0;10.1177/19322968221105288</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/19322968221105288</ArticleId><ArticleId IdType="pmc">PMC10658689</ArticleId><ArticleId IdType="pubmed">35771004</ArticleId></ArticleIdList></Reference><Reference><Citation>Franceschi R, Mozzillo E, Di Candia F, Maines E, Leonardi L, Girardi M, et al. . A systematic review on the impact of commercially available hybrid closed loop systems on psychological outcomes in youths with type 1 diabetes and their parents. Diabetes Med. (2023) 40:e15099. doi:&#xa0;10.1111/dme.15099</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dme.15099</ArticleId><ArticleId IdType="pubmed">37029751</ArticleId></ArticleIdList></Reference><Reference><Citation>Liakos A, Karagiannis T, Avgerinos I, Tsapas A, Bekiari E. Burden and coping strategies of hypoglycemia in people with diabetes. Curr Diabetes Rev. (2023) 20. doi:&#xa0;10.2174/0115733998271244231010100747</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0115733998271244231010100747</ArticleId><ArticleId IdType="pubmed">37867276</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeitoun MH, Abdel Reheem AA, Kharboush IF, Sheshtawy H, Assad DH, El Feky AY. Relationship between depressive and anxiety symptoms and fear of hypoglycemia among adolescents and adults with type 1 diabetes mellitus. Prim Care Diabetes. (2023) 17:255&#x2013;9. doi:&#xa0;10.1016/j.pcd.2023.03.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pcd.2023.03.002</ArticleId><ArticleId IdType="pubmed">36925404</ArticleId></ArticleIdList></Reference><Reference><Citation>Reid LA, Zheng S, Mendoza JA, Reboussin BA, Roberts AJ, Sauder KA, et al. . Household food insecurity and fear of hypoglycemia in adolescents and young adults with diabetes and parents of youth with diabetes. Diabetes Care. (2023) 46:262&#x2013;9. doi:&#xa0;10.2337/dc21-1807</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc21-1807</ArticleId><ArticleId IdType="pmc">PMC9887608</ArticleId><ArticleId IdType="pubmed">35771776</ArticleId></ArticleIdList></Reference><Reference><Citation>Orozco-Beltr&#xe1;n D, Pineda AL, Quesada JA, Artime E, D&#xed;az-Cerezo S, Redondo-Ant&#xf3;n J, et al. . Barriers and solutions for the management of severe hypoglycaemia in people with diabetes in Spain: A Delphi survey. Prim Care Diabetes. (2023). doi:&#xa0;10.1016/j.pcd.2023.11.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pcd.2023.11.007</ArticleId><ArticleId IdType="pubmed">38044201</ArticleId></ArticleIdList></Reference><Reference><Citation>Commissariat PV, DiMeglio LA, Kanapka LG, Laffel LM, Miller KM, Anderson BJ, et al. . Twelve-month psychosocial outcomes of continuous glucose monitoring with behavioural support in parents of young children with type 1 diabetes. Diabetes Med. (2023) 40. doi:&#xa0;10.1111/dme.15120</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dme.15120</ArticleId><ArticleId IdType="pmc">PMC10524740</ArticleId><ArticleId IdType="pubmed">37083018</ArticleId></ArticleIdList></Reference><Reference><Citation>Patton SR, Clements MA, Marker AM, Nelson EL. Intervention to reduce hypoglycemia fear in parents of young kids using video-based telehealth (REDCHiP). Pediatr Diabetes. (2020) 21:112&#x2013;9. doi:&#xa0;10.1111/pedi.12934</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pedi.12934</ArticleId><ArticleId IdType="pmc">PMC7393613</ArticleId><ArticleId IdType="pubmed">31610073</ArticleId></ArticleIdList></Reference><Reference><Citation>Cryer PE. The barrier of hypoglycemia in diabetes. Diabetes. (2008) 57:3169&#x2013;76. doi:&#xa0;10.2337/db08-1084</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db08-1084</ArticleId><ArticleId IdType="pmc">PMC2584119</ArticleId><ArticleId IdType="pubmed">19033403</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke WL, Cox DJ, Gonder-Frederick LA, Julian D, Schlundt D, Polonsky W. Reduced Awareness of Hypoglycemia in Adults With IDDM: A prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care. (1995) 18:517&#x2013;22. doi:&#xa0;10.2337/diacare.18.4.517</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diacare.18.4.517</ArticleId><ArticleId IdType="pubmed">7497862</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold AE, Macleod KM, Frier BM. Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia. Diabetes Care. (1994) 17:697&#x2013;703. doi:&#xa0;10.2337/diacare.17.7.697</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diacare.17.7.697</ArticleId><ArticleId IdType="pubmed">7924780</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen-Bjergaard U, Pramming S, Thorsteinsson B. Recall of severe hypoglycaemia and self-estimated state of awareness in type 1 diabetes. Diabetes Metab Res Rev. (2003) 19:232&#x2013;40. doi:&#xa0;10.1002/dmrr.377</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dmrr.377</ArticleId><ArticleId IdType="pubmed">12789657</ArticleId></ArticleIdList></Reference><Reference><Citation>Speight J, Barendse SM, Singh H, Little SA, Inkster B, Frier BM, et al. . Characterising problematic hypoglycaemia: iterative design and preliminary psychometric validation of the Hypoglycaemia Awareness Questionnaire (HypoA-Q). Diabetes Med. (2016) 33:376&#x2013;85. doi:&#xa0;10.1111/dme.12824</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dme.12824</ArticleId><ArticleId IdType="pubmed">26042777</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatle H, Bj&#xf8;rgaas MR, Skrivarhaug T, &#xc5;svold BO, Graveling AJ, Frier BM, et al. . Assessing awareness of hypoglycemia in children and adolescents with type 1 diabetes: Evaluation of established questionnaires. Pediatr Diabetes. (2020) 21:300&#x2013;9. doi:&#xa0;10.1111/pedi.12951</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pedi.12951</ArticleId><ArticleId IdType="pubmed">31788937</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubiak T, Hermanns N, Schreckling HJ, Kulzer B, Haak T. Assessment of hypoglycaemia awareness using continuous glucose monitoring. Diabetes Med. (2004) 21:487&#x2013;90. doi:&#xa0;10.1111/j.1464-5491.2004.1136.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1464-5491.2004.1136.x</ArticleId><ArticleId IdType="pubmed">15089796</ArticleId></ArticleIdList></Reference><Reference><Citation>Demir G, &#xd6;zen S, &#xc7;etin H, Darcan &#x15e;, G&#xf6;k&#x15f;en D. Effect of education on impaired hypoglycemia awareness and glycemic variability in children and adolescents with type 1 diabetes mellitus. J Clin Res Pediatr Endocrinol. (2019) 11:189&#x2013;95. doi:&#xa0;10.4274/jcrpe.galenos.2019.2019.0009</Citation><ArticleIdList><ArticleId IdType="doi">10.4274/jcrpe.galenos.2019.2019.0009</ArticleId><ArticleId IdType="pmc">PMC6571530</ArticleId><ArticleId IdType="pubmed">30701953</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghandi K, Pieri B, Dornhorst A, Hussain S. A comparison of validated methods used to assess impaired awareness of hypoglycaemia in type 1 diabetes: an observational study. Diabetes Ther. (2021) 12:441&#x2013;51. doi:&#xa0;10.1007/s13300-020-00965-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13300-020-00965-0</ArticleId><ArticleId IdType="pmc">PMC7843675</ArticleId><ArticleId IdType="pubmed">33219468</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkhatatbeh MJ, Abdalqader NA, Alqudah MAY. Impaired awareness of hypoglycemia in children and adolescents with type 1 diabetes mellitus in north of Jordan. BMC Endocr Disord. (2019) 19. doi:&#xa0;10.1186/s12902-019-0441-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12902-019-0441-9</ArticleId><ArticleId IdType="pmc">PMC6814051</ArticleId><ArticleId IdType="pubmed">31651281</ArticleId></ArticleIdList></Reference><Reference><Citation>Graveling AJ, Noyes KJ, Allerhand MH, Wright RJ, Bath LE, Deary IJ, et al. . Prevalence of impaired awareness of hypoglycemia and identification of predictive symptoms in children and adolescents with type 1 diabetes. Pediatr Diabetes. (2014) 15:206&#x2013;13. doi:&#xa0;10.1111/pedi.12077</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pedi.12077</ArticleId><ArticleId IdType="pubmed">24102825</ArticleId></ArticleIdList></Reference><Reference><Citation>Ly TT, Gallego PH, Davis EA, Jones TW. Impaired awareness of hypoglycemia in a population-based sample of children and adolescents with type 1 diabetes. Diabetes Care. (2009) 32:1802&#x2013;6. doi:&#xa0;10.2337/dc09-0541</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc09-0541</ArticleId><ArticleId IdType="pmc">PMC2752917</ArticleId><ArticleId IdType="pubmed">19587370</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunn JT, Cranston I, Marsden PK, Amiel SA, Reed LJ. Attenuation of amydgala and frontal cortical responses to low blood glucose concentration in asymptomatic hypoglycemia in type 1 diabetes: A new player in hypoglycemia unawareness? Diabetes. (2007) 56:2766&#x2013;73. doi:&#xa0;10.2337/db07-0666</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db07-0666</ArticleId><ArticleId IdType="pubmed">17660265</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan O, Cheng H, Herzog R, Czyzyk D, Zhu W, Wang A, et al. . Increased GABAergic tone in the ventromedial hypothalamus contributes to suppression of counterregulatory reponses after antecedent hypoglycemia. Diabetes. (2008) 57:1363&#x2013;70. doi:&#xa0;10.2337/db07-1559</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db07-1559</ArticleId><ArticleId IdType="pmc">PMC5518793</ArticleId><ArticleId IdType="pubmed">18375441</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan O, Paranjape S, Czyzyk D, Horblitt A, Zhu W, Ding Y, et al. . Increased GABAergic output in the ventromedial hypothalamus contributes to impaired hypoglycemic counterregulation in diabetic rats. Diabetes. (2011) 60:1582&#x2013;9. doi:&#xa0;10.2337/db10-1579</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db10-1579</ArticleId><ArticleId IdType="pmc">PMC3292334</ArticleId><ArticleId IdType="pubmed">21411513</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatle H, Skrivarhaug T, Bj&#xf8;rgaas MR, &#xc5;svold BO, R&#xf8; TB. Prevalence and associations of impaired awareness of hypoglycemia in a pediatric type 1 diabetes population &#x2013; The Norwegian Childhood Diabetes Registry. Diabetes Res Clin Pract. (2024) 209:111093. doi:&#xa0;10.1016/j.diabres.2024.111093</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2024.111093</ArticleId><ArticleId IdType="pubmed">38224875</ArticleId></ArticleIdList></Reference><Reference><Citation>Fritsche A, Stefan N, H&#xe4;ring H, Gerich J, Stumvoll M. Avoidance of hypoglycemia restores hypoglycemia awareness by increasing &#x3b2;-adrenergic sensitivity in type 1 diabetes. Ann Intern Med. (2001) 134:729. doi:&#xa0;10.7326/0003-4819-134-9_Part_1-200105010-00009</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-134-9_Part_1-200105010-00009</ArticleId><ArticleId IdType="pubmed">11329230</ArticleId></ArticleIdList></Reference><Reference><Citation>Ly TT, Jones TW, Griffiths A, Dart J, Davis EA, Stick S, et al. . Hypoglycemia does not change the threshold for arousal from sleep in adolescents with type 1 diabetes. Diabetes Technol Ther. (2011) 14:101&#x2013;4. doi:&#xa0;10.1089/dia.2011.0144</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/dia.2011.0144</ArticleId><ArticleId IdType="pubmed">21988312</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox D, Gonder-Frederick L, Polonsky W, Schlundt D, Julian D, Clarke W. A multicenter evaluation of blood glucose awareness training-II. Diabetes Care. (1995) 18:523&#x2013;8. doi:&#xa0;10.2337/diacare.18.4.523</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diacare.18.4.523</ArticleId><ArticleId IdType="pubmed">7497863</ArticleId></ArticleIdList></Reference><Reference><Citation>de Zoysa N, Rogers H, Stadler M, Gianfrancesco C, Beveridge S, Britneff E, et al. . A psychoeducational program to restore hypoglycemia awareness: the DAFNE-HART pilot study. Diabetes Care. (2014) 37:863&#x2013;6. doi:&#xa0;10.2337/dc13-1245</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc13-1245</ArticleId><ArticleId IdType="pubmed">24319119</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37798598</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1496-8975</ISSN><JournalIssue CitedMedium="Internet"><Volume>70</Volume><Issue>12</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Canadian journal of anaesthesia = Journal canadien d'anesthesie</Title><ISOAbbreviation>Can J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Prophylaxis for pediatric postoperative nausea and vomiting: a scoping review of clinical trials.</ArticleTitle><Pagination><StartPage>1978</StartPage><EndPage>1988</EndPage><MedlinePgn>1978-1988</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12630-023-02560-w</ELocationID><Abstract><AbstractText Label="PURPOSE">Postoperative nausea and vomiting (PONV) is common in pediatric patients undergoing general anesthesia, and clinicians seek prophylactic interventions to prevent its ill effects on patients as well as its ramifications on perioperative care. We sought to assess the body of evidence around prophylactic strategies, both pharmacologic and nonpharmacologic, targeting pediatric PONV.</AbstractText><AbstractText Label="SOURCE">We searched MEDLINE, MEDLINE ePubs Ahead of Print and In-Process Citations, Embase Classic+Embase, the Cochrane Database of Systematic Reviews, Cochrane CENTRAL (via the Ovid platform), Scopus (Elsevier), Web of Science (Clarivate Analytics), ClinicalTrials.gov, the WHO International Clinical Trials Registry Platform, and the International Standard Randomized Controlled Trial Number Registry, from their inception to 23 September 2022.</AbstractText><AbstractText Label="PRINCIPAL FINDINGS">Of 188 clinical trials, 157 (83%) investigated pharmacologic interventions, 25 (13%) investigated nonpharmacologic interventions, and six (3%) investigated mixed pharmacologic and nonpharmacologic interventions. The most common surgeries investigated for pediatric PONV were strabismus surgery (68 trials, 36%) and tonsillectomy or tympanoplasty (45 trials, 23%). Of four measurement tools used to assess PONV in the included trials, the most common was clinical judgement (170 trials, 90%).</AbstractText><AbstractText Label="CONCLUSION">The majority of data in pediatric PONV prophylaxis is based on pharmacologic interventions, with a paucity of research in nonpharmacologic or mixed interventions. Assessing and documenting PONV using tools such as the Baxter Animated Retching Faces Scale or PONV numeric scoring system may help standardize pediatric PONV prophylaxis research moving forward. Furthermore, concurrently assessing pain and adverse effects associated with PONV might further inform our understanding of this complex clinical entity.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pankiv</LastName><ForeName>Evelina</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Medicine, The Hospital for Sick Children (SickKids), Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albornoz</LastName><ForeName>Alfonso E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Medicine, The Hospital for Sick Children (SickKids), Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nghiem</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, The Children's Hospital at Westmead, Westmead, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petre</LastName><ForeName>Maria-Alexandra</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Montreal Children's Hospital, Montreal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Englesakis</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Library and Information Services, University Health Network, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rana</LastName><ForeName>Mehwish</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Medicine, The Hospital for Sick Children (SickKids), Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mc Donnell</LastName><ForeName>Conor</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Medicine, The Hospital for Sick Children (SickKids), Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hayes</LastName><ForeName>Jason</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Medicine, The Hospital for Sick Children (SickKids), Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aoyama</LastName><ForeName>Kazuyoshi</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-7502-0896</Identifier><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Medicine, The Hospital for Sick Children (SickKids), Toronto, ON, Canada. kazu.aoyama@utoronto.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Child Health Evaluative Sciences, SickKids Research Institute, Toronto, ON, Canada. kazu.aoyama@utoronto.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, University of Toronto, #2211-555 University Ave, Toronto, ON, M5G 1X8, Canada. kazu.aoyama@utoronto.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Perioperative Services Facilitator Grant Program 2019-2020</GrantID><Agency>Hospital for Sick Children</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000098583">Scoping Review</PublicationType></PublicationTypeList><VernacularTitle>Prophylaxie pour les naus&#xe9;es et vomissements postop&#xe9;ratoires p&#xe9;diatriques : une revue de port&#xe9;e des &#xe9;tudes cliniques.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Can J Anaesth</MedlineTA><NlmUniqueID>8701709</NlmUniqueID><ISSNLinking>0832-610X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000932">Antiemetics</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020250" MajorTopicYN="Y">Postoperative Nausea and Vomiting</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000932" MajorTopicYN="Y">Antiemetics</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010146" MajorTopicYN="N">Pain</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="fre"><AbstractText Label="UNLABELLED">R&#xe9;SUM&#xe9;: OBJECTIF: Les naus&#xe9;es et vomissements postop&#xe9;ratoires (NVPO) sont fr&#xe9;quents chez la patient&#xe8;le p&#xe9;diatrique b&#xe9;n&#xe9;ficiant d&#x2019;une anesth&#xe9;sie g&#xe9;n&#xe9;rale, et les &#xe9;quipes cliniques recherchent des interventions prophylactiques pour pr&#xe9;venir leurs effets n&#xe9;fastes sur les patient&#xb7;es ainsi que leurs ramifications sur les soins p&#xe9;riop&#xe9;ratoires. Nous avons cherch&#xe9; &#xe0; &#xe9;valuer l&#x2019;ensemble des donn&#xe9;es probantes entourant les strat&#xe9;gies prophylactiques pharmacologiques et non pharmacologiques ciblant les NVPO p&#xe9;diatriques.</AbstractText><AbstractText Label="SOURCES">Nous avons effectu&#xe9; des recherches dans les bases de donn&#xe9;es MEDLINE, MEDLINE ePubs Ahead of Print and In-Process Citations, Embase Classic+Embase, la base de donn&#xe9;es des revues syst&#xe9;matiques Cochrane, Cochrane CENTRAL (via la plateforme Ovid), Scopus (Elsevier), Web of Science (Clarivate Analytics), ClinicalTrials.gov, le syst&#xe8;me d&#x2019;enregistrement international des essais cliniques de l&#x2019;OMS et le registre international normalis&#xe9; des num&#xe9;ros d&#x2019;essais contr&#xf4;l&#xe9;s randomis&#xe9;s, depuis leur cr&#xe9;ation jusqu&#x2019;au 23 septembre 2022.</AbstractText><AbstractText Label="CONSTATATIONS PRINCIPALES">Sur 188 &#xe9;tudes cliniques, 157 (83 %) portaient sur des interventions pharmacologiques, 25 (13 %) sur des interventions non pharmacologiques et six (3 %) sur des interventions pharmacologiques et non pharmacologiques mixtes. Les chirurgies les plus fr&#xe9;quemment &#xe9;tudi&#xe9;es pour les NVPO p&#xe9;diatriques &#xe9;taient les chirurgies de strabisme (68 &#xe9;tudes, 36 %) et les amygdalectomies ou tympanoplasties (45 &#xe9;tudes, 23 %). Parmi les quatre outils de mesure utilis&#xe9;s pour &#xe9;valuer les NVPO dans les &#xe9;tudes incluses, le plus fr&#xe9;quemment utilis&#xe9; &#xe9;tait le jugement clinique (170 &#xe9;tudes, 90 %).</AbstractText><AbstractText Label="CONCLUSION">La majorit&#xe9; des donn&#xe9;es sur les prophylaxies p&#xe9;diatriques pour pr&#xe9;venir les NVPO sont bas&#xe9;es sur des interventions pharmacologiques, avec peu de recherche sur les interventions non pharmacologiques ou mixtes. L&#x2019;&#xe9;valuation et la documentation des NVPO &#xe0; l&#x2019;aide d&#x2019;outils tels que l&#x2019;&#xe9;chelle Baxter Animated Retching Faces Scale ou un syst&#xe8;me de notation num&#xe9;rique des NVPO peuvent aider &#xe0; normaliser la recherche sur la prophylaxie p&#xe9;diatrique des NVPO &#xe0; l&#x2019;avenir. De plus, l&#x2019;&#xe9;valuation simultan&#xe9;e de la douleur et des effets ind&#xe9;sirables associ&#xe9;s aux NVPO pourrait &#xe9;clairer davantage notre compr&#xe9;hension de cette entit&#xe9; clinique complexe.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">clinical trials</Keyword><Keyword MajorTopicYN="N">general anesthesia</Keyword><Keyword MajorTopicYN="N">pediatric anesthesia</Keyword><Keyword MajorTopicYN="N">postoperative nausea and vomiting</Keyword><Keyword MajorTopicYN="N">prophylaxis</Keyword><Keyword MajorTopicYN="N">scoping review</Keyword></KeywordList><CoiStatement>The authors declare that there is no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>17</Day><Hour>9</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>6</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>5</Day><Hour>23</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37798598</ArticleId><ArticleId IdType="pmc">PMC10709227</ArticleId><ArticleId IdType="doi">10.1007/s12630-023-02560-w</ArticleId><ArticleId IdType="pii">10.1007/s12630-023-02560-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>H&#xf6;hne C. Postoperative nausea and vomiting in pediatric anesthesia. Curr Opin Anaesthesiol. 2014;27:303&#x2013;308. doi: 10.1097/aco.0000000000000073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/aco.0000000000000073</ArticleId><ArticleId IdType="pubmed">24722005</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalil SN, Roth AG, Cohen IT, et al. A double-blind comparison of intravenous ondansetron and placebo for preventing postoperative emesis in 1- to 24-month-old pediatric patients after surgery under general anesthesia. Anesth Analg. 2005;101:356&#x2013;361. doi: 10.1213/01.ane.0000155261.27335.29.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ane.0000155261.27335.29</ArticleId><ArticleId IdType="pubmed">16037143</ArticleId></ArticleIdList></Reference><Reference><Citation>Apfel CC, L&#xe4;&#xe4;r&#xe4; E, Koivuranta M, Greim CA, Roewer N. A simplified risk score for predicting postoperative nausea and vomiting. Anesthesiology. 1999;91:693&#x2013;700. doi: 10.1097/00000542-199909000-00022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-199909000-00022</ArticleId><ArticleId IdType="pubmed">10485781</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Errico C, Voepel-Lewis TD, Siewert M, Malviya S. Prolonged recovery stay and unplanned admission of the pediatric surgical outpatient: an observational study. J Clin Anesth. 1998;10:482&#x2013;487. doi: 10.1016/s0952-8180(98)00075-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0952-8180(98)00075-0</ArticleId><ArticleId IdType="pubmed">9793812</ArticleId></ArticleIdList></Reference><Reference><Citation>Gan TJ, Belani KG, Bergese S, et al. Fourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting. Anesth Analg. 2020;131:411&#x2013;448. doi: 10.1213/ane.0000000000004833.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0000000000004833</ArticleId><ArticleId IdType="pubmed">32467512</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Nghiem J, Albornoz AE, Petre MA, et al</i>. A systematic review of evidence synthesis studies investigating interventions that reduce the incidence of post-operative nausea and vomiting in children. Anesth Analg 2021; 132: 786&#x2013;7. Available from URL: https://meetings.iars.org/wp-content/uploads/2021/08/Web_AA-AbstractSupp_Final.pdf (accessed May 2023).</Citation></Reference><Reference><Citation>Tricco AC, Lillie E, Zarin W, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169:467&#x2013;473. doi: 10.7326/m18-0850.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/m18-0850</ArticleId><ArticleId IdType="pubmed">30178033</ArticleId></ArticleIdList></Reference><Reference><Citation>Eberhart LH, Geldner G, Kranke P, et al. The development and validation of a risk score to predict the probability of postoperative vomiting in pediatric patients. Anesth Analg. 2004;99:1630&#x2013;1637. doi: 10.1213/01.ane.0000135639.57715.6c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ane.0000135639.57715.6c</ArticleId><ArticleId IdType="pubmed">15562045</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller DR. Retraction of articles written by Dr. Yoshitaka Fujii. Can J Anesth. 2012;59:1081&#x2013;1088. doi: 10.1007/s12630-012-9802-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12630-012-9802-9</ArticleId><ArticleId IdType="pubmed">23055039</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirota K. Retraction note: notice of formal retraction of articles by Dr. Yoshitaka Fujii. J Anesth. 2013;27:322. doi: 10.1007/s00540-013-1576-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-013-1576-x</ArticleId><ArticleId IdType="pubmed">23455701</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirota K. Retraction note: further notice of formal retraction of articles by Dr. Yoshitaka Fujii. J Anesth. 2013;27:485. doi: 10.1007/s00540-013-1620-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-013-1620-x</ArticleId><ArticleId IdType="pubmed">23666482</ArticleId></ArticleIdList></Reference><Reference><Citation>Gan TJ, Diemunsch P, Habib AS, et al. Consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg. 2014;118:85&#x2013;113. doi: 10.1213/ane.0000000000000002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0000000000000002</ArticleId><ArticleId IdType="pubmed">24356162</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Martin S, Baines D, Holtby H, Carr Autumn AS</i>. The Association of Paediatric Anaesthetists of Great Britain &amp; Ireland 2016 guidelines on the prevention of post-operative vomiting in children guidelines on the prevention of postoperative vomiting in children. Available from URL: https://www.apagbi.org.uk/sites/default/files/inline-files/2016%20APA%20POV%20Guideline-2.pdf (accessed May 2023).</Citation></Reference><Reference><Citation>Kranke P, Eberhart LH, Toker H, Roewer N, Wulf H, Kiefer P. A prospective evaluation of the POVOC score for the prediction of postoperative vomiting in children. Anesth Analg. 2007;105:1592&#x2013;1597. doi: 10.1213/01.ane.0000287816.44124.03.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ane.0000287816.44124.03</ArticleId><ArticleId IdType="pubmed">18042855</ArticleId></ArticleIdList></Reference><Reference><Citation>Gai N, Naser B, Hanley J, Peliowski A, Hayes J, Aoyama K. A practical guide to acute pain management in children. J Anesth. 2020;34:421&#x2013;433. doi: 10.1007/s00540-020-02767-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-020-02767-x</ArticleId><ArticleId IdType="pmc">PMC7256029</ArticleId><ArticleId IdType="pubmed">32236681</ArticleId></ArticleIdList></Reference><Reference><Citation>Odom-Forren J, Rayens MK, Gokun Y, et al. The relationship of pain and nausea in postoperative patients for 1 week after ambulatory surgery. Clin J Pain. 2015;31:845&#x2013;851. doi: 10.1097/ajp.0000000000000170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ajp.0000000000000170</ArticleId><ArticleId IdType="pubmed">25370136</ArticleId></ArticleIdList></Reference><Reference><Citation>Aubrun F, Ecoffey C, Benhamou D, et al. Perioperative pain and post-operative nausea and vomiting (PONV) management after day-case surgery: the SFAR-OPERA national study. Anaesth Crit Care Pain Med. 2019;38:223&#x2013;229. doi: 10.1016/j.accpm.2018.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.accpm.2018.08.004</ArticleId><ArticleId IdType="pubmed">30339892</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagrange C, Jepp C, Slevin L, et al. Impact of a revised postoperative care plan on pain and recovery trajectory following pediatric tonsillectomy. Pediatr Anesth. 2021;31:778&#x2013;786. doi: 10.1111/pan.14187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pan.14187</ArticleId><ArticleId IdType="pubmed">33788340</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40011940</PMID><DateCompleted><Year>2025</Year><Month>02</Month><Day>27</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1752-1947</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Feb</Month><Day>26</Day></PubDate></JournalIssue><Title>Journal of medical case reports</Title><ISOAbbreviation>J Med Case Rep</ISOAbbreviation></Journal><ArticleTitle>Systematic review of case series and case reports on pediatric pulmonary embolism.</ArticleTitle><Pagination><StartPage>76</StartPage><MedlinePgn>76</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">76</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13256-025-05084-7</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Pediatric pulmonary embolism is a rare yet potentially life-threatening condition, presenting significant diagnostic and therapeutic challenges owing to its nonspecific symptoms and diverse underlying risk factors. This systematic review aims to consolidate data from case series and case reports to provide a comprehensive overview of pediatric pulmonary embolism, focusing on clinical characteristics, diagnostic approaches, treatment strategies, and outcomes.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This systematic review was conducted in adherence to the Preferred Reporting Items for Systematic Reviews and Meta-analysis guidelines and the Cochrane Handbook for Systematic Reviews of Interventions, version 6.3. The study protocol was registered with PROSPERO (ID: CRD42024532471). We utilized the Covidence systematic review software for deduplication and screening of search results. The literature search was developed with a subject specialist and included Medical Subject Headings terms and free-text keywords such as "pulmonary embolism," "pediatric," and "case reports." Databases searched included PubMed, Scopus, Web of Science, and the Cochrane Library up to April 2024, limited to English-language publications. Reference lists of relevant articles were also reviewed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Pulmonary embolism affected males and females with age ranging from 1 to 18&#xa0;years. Common underlying conditions included malignancies (for example, Wilms tumor), chronic diseases (for example, nephrotic syndrome), and recent surgical interventions. Diagnostic practices primarily relied on computed tomography pulmonary angiography, supplemented by chest X-ray and ultrasound. Treatment typically involved anticoagulation therapy with unfractionated heparin and low-molecular-weight heparin, transitioning to oral anticoagulants for long-term management. Thrombolytic therapy was used in severe cases. Outcomes varied, with many patients recovering well, though complications such as recurrent embolism and pleural effusion were observed. Fatal cases underscored the critical need for early detection and prompt treatment.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This systemic review underscores the rarity and complexity of pediatric pulmonary embolism, highlighting the necessity for increased clinical vigilance given its nonspecific presentation and diverse underlying risk factors. Accurate diagnosis, primarily via computed tomography pulmonary angiography, with the prompt initiation of anticoagulation therapy are essential for optimal outcomes. Despite favorable recovery rates for most patients, the potential for severe complications and fatalities reinforces the value of timely diagnosis and personalized management approaches. Further research is essential to refine diagnostic protocols, optimize treatment approaches, establish evidence-based guidelines, and improve long-term outcomes for children with pulmonary embolism.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alsabri</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Emergency Department, Althawara Modern General Hospital, Sanaa, Yemen. Alsabri5000@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatric Emergency Department, St. Christopher'S Hospital for Children, Philadelphia, PA, USA. Alsabri5000@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Attalla</LastName><ForeName>Almoatazbellah</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Alexandria Faculty of Medicine, Alexandria, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdelrahman</LastName><ForeName>Salma Tamer</ForeName><Initials>ST</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Zagazig University, Zagazig, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elsnhory</LastName><ForeName>Ahmed Bostamy</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Al-Azhar University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abo-Elnour</LastName><ForeName>Dina Essam</ForeName><Initials>DE</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Zagazig University, Zagazig, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aderinto</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medicine, Ladoke Akintola University of Technology, Ogbomoso, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ukoaka</LastName><ForeName>Bonaventure Michael</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Asokoro District Hospital, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alqeeq</LastName><ForeName>Basel F</ForeName><Initials>BF</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Islamic University of Gaza, Gaza, Palestine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gamboa</LastName><ForeName>Luis L</ForeName><Initials>LL</Initials><AffiliationInfo><Affiliation>Assistant Professor of Pediatrics, Drexel University College of Medicine, Philadelphia, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Program Director, Pediatric Emergency Medicine Fellowship, St. Christopher'S Hospital for Children, Philadelphia, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>02</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Med Case Rep</MedlineTA><NlmUniqueID>101293382</NlmUniqueID><ISSNLinking>1752-1947</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="Y">Anticoagulants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Case reports</Keyword><Keyword MajorTopicYN="N">Pediatrics</Keyword><Keyword MajorTopicYN="N">Pulmonary embolism</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval and consent to participate: Not applicable. This article does not contain any studies with human participants or animals performed by any of the authors. Consent for publication: Not applicable. Competing interests: The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>10</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>1</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>2</Month><Day>27</Day><Hour>5</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>2</Month><Day>26</Day><Hour>23</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>2</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40011940</ArticleId><ArticleId IdType="pmc">PMC11866702</ArticleId><ArticleId IdType="doi">10.1186/s13256-025-05084-7</ArticleId><ArticleId IdType="pii">10.1186/s13256-025-05084-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Stein PD, Kayali F, Olson RE. Incidence of venous thromboembolism in infants and children: data from the national hospital discharge survey. J Pediatr. 2004;145(4):563&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">15480387</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein PD, Kayali F, Olson RE. Pulmonary thromboembolism in infants and children: a 40-year review of the literature. Prog Cardiovasc Dis. 2004;47(2):97&#x2013;117. 10.1016/j.pcad.2004.07.001.</Citation></Reference><Reference><Citation>Goldenberg NA, Bernard TJ. Venous thromboembolism in children. Hematol Oncol Clin North Am. 2010;24(1):151&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">20113900</ArticleId></ArticleIdList></Reference><Reference><Citation>Raffini L, Huang YS, Witmer C, Feudtner C. Dramatic increase in venous thromboembolism in children&#x2019;s hospitals in the United States from 2001 to 2007. Pediatrics. 2009;124(4):1001&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">19736261</ArticleId></ArticleIdList></Reference><Reference><Citation>Branchford BR, Carpenter SL. The role of inherited thrombophilia in venous thromboembolism in children. Front Pediatr. 2018;6:103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5974100</ArticleId><ArticleId IdType="pubmed">29876337</ArticleId></ArticleIdList></Reference><Reference><Citation>van Ommen CH, Heijboer H, Buller HR, Hirasing RA, Heijmans HS, Peters M. Venous thromboembolism in childhood: a prospective two-year registry in the Netherlands. J Pediatr Hematol Oncol. 2001;23(9):595&#x2013;600. 10.1097/00043426-200111000-00008.</Citation><ArticleIdList><ArticleId IdType="pubmed">11713446</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajpurkar M, Warrier I, Chitlur M. Pulmonary embolism in children. Pediatr Clin North Am. 2006;53(3):545&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">29803279</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhle S, Massicotte MP, Chan AK. Systematic review of the efficacy and safety of low molecular weight heparin in pediatric patients. Thromb Res. 2005;116(1):5&#x2013;15.</Citation></Reference><Reference><Citation>Biss TT, Brand&#xe3;o LR, Kahr WH, Chan AK, Williams S. Clinical probability score and D-dimer estimation lack utility in the diagnosis of childhood pulmonary embolism. J Thromb Haemost. 2009;7(10):1633&#x2013;8. 10.1111/j.1538-7836.2009.03572.x.</Citation><ArticleIdList><ArticleId IdType="pubmed">19682234</ArticleId></ArticleIdList></Reference><Reference><Citation>Hennelly KE, Baskin MN, Monuteuax MC, Hudgins J, Kua E, Commeree A, Kimia R, Lee EY, Kimia A, Neuman MI. Detection of pulmonary embolism in high-risk children. J Pediatr. 2016;178:214-218.e3. 10.1016/j.jpeds.2016.07.046.</Citation><ArticleIdList><ArticleId IdType="pubmed">27567411</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes C, Newall F, Ignjatovic V, Monagle P. Reduced dose anticoagulation with enoxaparin in children: a single center experience. Thromb Res. 2006;118(1):5&#x2013;11.</Citation></Reference><Reference><Citation>Goldenberg NA, Sochet A, O&#x2019;Brien SH, Bernard TJ, Male C, Kenet G, Monagle P, Kainth S, Jaffray J, Raffini LJ. Pediatric thrombosis and hemostasis: scientific evolution and future perspectives. Res Pract Thromb Haemost. 2018;2(1):11&#x2013;20.</Citation></Reference><Reference><Citation>Kerlin BA, Ayoob R, Smoyer WE. Epidemiology and pathophysiology of venous thromboembolism in critically ill children. Pediatr Crit Care Med. 2012;13(4):391&#x2013;9.</Citation></Reference><Reference><Citation>Monagle P, Cuello CA, Augustine C, Bonduel M, Brand&#xe3;o LR, Capman T, Chan AK, Hanson S, Male C, Meerpohl JJ, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism. Blood Adv. 2018;2(22):3292&#x2013;316.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6258911</ArticleId><ArticleId IdType="pubmed">30482766</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn SR, Lim W, Dunn AS, Cushman M, Dentali F, Akl EA, Cook DJ, Balekian AA, Klein R, Le H, et al. Prevention of VTE in nonsurgical patients. Chest. 2012;141(2):e195S.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3278052</ArticleId><ArticleId IdType="pubmed">22315261</ArticleId></ArticleIdList></Reference><Reference><Citation>Manco-Johnson MJ, Nuss R, Jacobson L, Young G, Shapiro AD, Abshire T, Manco-Johnson ML. Prevention of central venous catheter thrombosis with low-dose warfarin in children: a randomized, double-blind, placebo-controlled trial. Lancet. 2000;356(9232):1703&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldenberg NA, Bernard TJ. Venous thromboembolism in children. Pediatrics. 2010;125(5): e1115.</Citation><ArticleIdList><ArticleId IdType="pubmed">20113900</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;29:372.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Song S, Xu Y. A retrospective study of the clinical characteristics of 9 children with pulmonary embolism associated with Mycoplasmapneumoniae pneumonia. BMC Pediatr. 2023;23(1):370. 10.1186/s12887-023-04188-7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10360226</ArticleId><ArticleId IdType="pubmed">37474910</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheng CQ, Yang CF, Ao Y, Zhao ZY, Li YM. Mycoplasma pneumoniae pneumonia with pulmonary embolism: a study on pediatric cases in Jilin province of China. Exp Ther Med. 2021;21(3):201. 10.3892/etm.2021.9634.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7818525</ArticleId><ArticleId IdType="pubmed">33574906</ArticleId></ArticleIdList></Reference><Reference><Citation>Saharan S, Vettukattil J, Bhat A, Amula V, Bansal M, Chowdhury D, Dyamenahalli U, Gupta SK, Das B, Susheel Kumar TK, Muralidaran A, Trivedi K, Swaminathan S, Bansal N, Doshi U, Hoskoppal A, Balaji S. Patent foramen ovale in children: unique pediatric challenges and lessons learned from adult literature. Ann Pediatr Cardiol. 2022;15(1):44&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9280096</ArticleId><ArticleId IdType="pubmed">35847406</ArticleId></ArticleIdList></Reference><Reference><Citation>Baird JS, Killinger JS, Kalkbrenner KJ, Bye MR, Schleien CL. Massive pulmonary embolism in children. J Pediatr. 2010;156(1):148&#x2013;51. 10.1016/j.jpeds.2009.06.048.</Citation><ArticleIdList><ArticleId IdType="pubmed">20006766</ArticleId></ArticleIdList></Reference><Reference><Citation>Huiras EE, Barnes CJ, Eichenfield LF, Pelech AN, Drolet BA. Pulmonary thromboembolism associated with Klippel&#x2013;Trenaunay syndrome. Pediatrics. 2005;116(4):e596-600. 10.1542/peds.2004-1607.</Citation><ArticleIdList><ArticleId IdType="pubmed">16166386</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverstein MD, Heit JA, Mohr DN, Petterson TM, O&#x2019;Fallon WM, Melton LJ 3rd. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998;158(6):585&#x2013;93. 10.1001/archinte.158.6.585.</Citation><ArticleIdList><ArticleId IdType="pubmed">9521222</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrader MW, Ho AK, Notrica DM, Segal LS. Pulmonary embolism following an ankle fracture in a 9-year-old boy: a case report. Acta Orthop Belg. 2012;78(4):564&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">23019794</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown SM, Padley S, Bush A, Cummins D, Davidson S, Buchdahl R. Mycoplasma pneumonia and pulmonary embolism in a child due to acquired prothrombotic factors. Pediatr Pulmonol. 2008;43(2):200&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">18041082</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosch A, Junker R, Wermes C, Nowak-G&#xf6;ttl U. Recurrent pulmonary embolism in a 13-year-old male homozygous for the prothrombin G20210A mutation combined with protein S deficiency and increased lipoprotein (a). Thromb Res. 2002;105(1):49&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">11864707</ArticleId></ArticleIdList></Reference><Reference><Citation>Tetsuhara K, Tsuji S, Uematsu S, Kamei K. Pulmonary embolism mimicking infectious pleuritis. Pediatr Emerg Care. 2018;34(11):e201&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">28350720</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Cui Y, Liang P, Wang C, Zhou K, Ma F, Duan H. Case report: cerebral venous sinus thrombosis and pulmonary embolism as the initial presentation in a child with asymptomatic primary nephrotic syndrome. Front Pediatr. 2023;5(11):1169116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10196485</ArticleId><ArticleId IdType="pubmed">37215608</ArticleId></ArticleIdList></Reference><Reference><Citation>Profitlich L, Kirmse B, Wasserstein MP, Diaz G, Srivastava S. Resolution of cor pulmonale after medical management in a patient with cblC-type methylmalonic aciduria and homocystinuria: a case report. Cases J. 2009;2:1&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2740237</ArticleId><ArticleId IdType="pubmed">19830091</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu XT, Wang BH, Wang Q, et al. Idiopathic hypereosinophilic syndrome with hepatic sinusoidal obstruction syndrome: a case report and literature review. World J Gastrointest Surg. 2023;15(7):1532&#x2013;41. 10.4240/wjgs.v15.i7.1532.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10405125</ArticleId><ArticleId IdType="pubmed">37555104</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo H, Kim HJ, Chin AY, Cho YY, Joung JY, Jeong H, Jeon K. A case of acute pulmonary embolism associated with dysplasminogenemia. J Korean Med Sci. 2013;28(6):959&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3678018</ArticleId><ArticleId IdType="pubmed">23772166</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena A, Biss T, Monagle P, Newall F. Thrombolysis in children: a systematic review. Thromb Res. 2010;126(5):e311&#x2013;7. 10.1016/j.thromres.2010.08.008.</Citation></Reference><Reference><Citation>Monagle P, Chan AKC, Goldenberg NA, et al. Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2):e737S-e801S. 10.1378/chest.11-2308.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3278066</ArticleId><ArticleId IdType="pubmed">22315277</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaidi AU, Hutchins KK, Rajpurkar M. Pulmonary embolism in children. Front Pediatr. 2017;10(5):170. 10.3389/fped.2017.00170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5554122</ArticleId><ArticleId IdType="pubmed">28848725</ArticleId></ArticleIdList></Reference><Reference><Citation>Staser JA, Alam T, Applegate K. Calcified pulmonary thromboembolism in a child with sickle cell disease: value of multidetector CT in patients with acute chest syndrome. Pediatr Radiol. 2006;36:561&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">16708206</ArticleId></ArticleIdList></Reference><Reference><Citation>Biss TT, Brand&#xe3;o LR, Kahr WH, Chan AK, Williams S. Clinical features and outcome of pulmonary embolism in children. Br J Haematol. 2008;142(5):808&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">18564359</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerlin BA, Ayoob R, Smoyer WE. Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolism. Clin J Am Soc Nephrol. 2012;7(3):513&#x2013;20. 10.2215/CJN.10131011.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3302669</ArticleId><ArticleId IdType="pubmed">22344511</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Jiang H, Zhong Z, Ghoorun R, Xu L, Chen H, Liu J, Tang W. Case report B-acute lymphoblastic leukemia occurring in two pediatric patients with a history of prior Wilms tumors. Int J Clin Exp Med. 2016;9(11):22434&#x2013;43.</Citation></Reference><Reference><Citation>Stein PD, Kayali F, Olson RE. Pulmonary thromboembolism in infants and children: comparison of clinical presentation with adults. Am J Cardiol. 2004;93(9):1316&#x2013;9. 10.1016/j.amjcard.2004.01.055.</Citation><ArticleIdList><ArticleId IdType="pubmed">15135716</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhle S, Koloshuk B, Marzinotto V, et al. D-dimer concentrations in healthy children. J Thromb Haemost. 2003;1(5):1108&#x2013;12. 10.1046/j.1538-7836.2003.00224.x.</Citation></Reference><Reference><Citation>van Ommen CH, Peters M. Pediatric thromboembolism: epidemiology and optimal management. Blood Rev. 2010;24(3):101&#x2013;8. 10.1016/j.blre.2010.03.001.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3733544</ArticleId><ArticleId IdType="pubmed">20417588</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner DJ, Hall EJ. Computed tomography&#x2014;an increasing source of radiation exposure. N Engl J Med. 2007;357(22):2277&#x2013;84. 10.1056/NEJMra072149.</Citation><ArticleIdList><ArticleId IdType="pubmed">18046031</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnam M, Gutierrez FR, Weisman DS, Seidel FG, Samson R. Imaging in pediatric pulmonary embolism. Pediatr Radiol. 2005;35(3):258&#x2013;64. 10.1007/s00247-004-1346-3.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Monagle P, Newall F. Management of thrombosis in children and neonates: practical use of anticoagulants in children. Heart. 2010;96(12):977&#x2013;83. 10.1136/hrt.2009.186379.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6245972</ArticleId><ArticleId IdType="pubmed">30504338</ArticleId></ArticleIdList></Reference><Reference><Citation>Massicotte MP, Halton J, Mahoney K, et al. Low-molecular-weight heparin in pediatric patients with thrombotic disease: a dose-finding study. J Pediatr. 1998;133(3):293&#x2013;8. 10.1016/s0022-3476(98)70234-2.</Citation><ArticleIdList><ArticleId IdType="pubmed">8774496</ArticleId></ArticleIdList></Reference><Reference><Citation>Widlitz A, Barst RJ. Pulmonary arterial hypertension in children. Eur Respir J. 2003;21(1):155&#x2013;76. 10.1183/09031936.03.00286203.</Citation><ArticleIdList><ArticleId IdType="pubmed">12570125</ArticleId></ArticleIdList></Reference><Reference><Citation>Abman SH, Hansmann G, Archer SL, et al. Pediatric pulmonary hypertension: guidelines from the American Heart Association and American Thoracic Society. Circulation. 2015;132(21):2037&#x2013;99. 10.1161/CIR.0000000000000329.</Citation><ArticleIdList><ArticleId IdType="pubmed">26534956</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson RD, Kitterman N, Auerbach SR, et al. Chronic thromboembolic pulmonary hypertension in pediatric patients: a case series and review of the literature. Pediatr Cardiol. 2017;38(6):1247&#x2013;56. 10.1007/s00246-017-1647-6.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40881487</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>15</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2307-8960</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>26</Issue><PubDate><Year>2025</Year><Month>Sep</Month><Day>16</Day></PubDate></JournalIssue><Title>World journal of clinical cases</Title><ISOAbbreviation>World J Clin Cases</ISOAbbreviation></Journal><ArticleTitle>Clots in colitis: Thromboembolism and beyond.</ArticleTitle><Pagination><StartPage>102957</StartPage><MedlinePgn>102957</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">102957</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.12998/wjcc.v13.i26.102957</ELocationID><Abstract><AbstractText>Patients with ulcerative colitis (UC) have an increased risk of thromboembolic events, particularly venous thromboembolism (VTE), which encompasses deep vein thrombosis and pulmonary embolism. The incidence of VTE in patients with UC is significantly higher than that in the general population, and a retrospective cohort study found that patients undergoing colectomy had a notable risk of developing VTE, with rates reaching as high as 22% among patients exposed to tofacitinib within a month prior to surgery. The GETAID FOCUS study also reported a high prevalence of self-reported VTE in patients with UC, with a pooled prevalence of approximately 12% across various studies. The risk of thromboembolism in UC is multifactorial and influenced by chronic inflammation, a wide range of medications used, potential surgical interventions, and possibly genetic factors or associations that are yet to be fully defined. Recognizing the various contributing factors is crucial for developing effective preventive strategies and improving patient outcomes.</AbstractText><CopyrightInformation>&#xa9;The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rahmoune</LastName><ForeName>Hakim</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Medicine, LIRSSEI Research Laboratory, Faculty of Medicine, University of Setif-1, Setif 19000, Algeria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Setif University Hospital, University of Setif-1, Setif 19000, Algeria. rahmounehakim@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boutrid</LastName><ForeName>Nada</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>LIRSSEI Research Laboratory, Faculty of Medicine, University of Setif-1, Setif 19000, Algeria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>World J Clin Cases</MedlineTA><NlmUniqueID>101618806</NlmUniqueID><ISSNLinking>2307-8960</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Incidence</Keyword><Keyword MajorTopicYN="N">Risk</Keyword><Keyword MajorTopicYN="N">Surgery</Keyword><Keyword MajorTopicYN="N">Ulcerative colitis</Keyword><Keyword MajorTopicYN="N">Venous thromboembolism</Keyword></KeywordList><CoiStatement>Conflict-of-interest statement: All authors declare no conflict of interest in publishing the manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>11</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>4</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>29</Day><Hour>20</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>29</Day><Hour>20</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>29</Day><Hour>14</Hour><Minute>28</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40881487</ArticleId><ArticleId IdType="pmc">PMC12336842</ArticleId><ArticleId IdType="doi">10.12998/wjcc.v13.i26.102957</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ando K, Fujiya M, Nomura Y, Inaba Y, Sugiyama Y, Iwama T, Ijiri M, Takahashi K, Tanaka K, Sakatani A, Ueno N, Kashima S, Moriichi K, Mizukami Y, Okumura T. The incidence and risk factors of venous thromboembolism in Japanese inpatients with inflammatory bowel disease: a retrospective cohort study. Intest Res. 2018;16:416&#x2013;425.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6077312</ArticleId><ArticleId IdType="pubmed">30090041</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell TA, Banerjee S, Lipman JM, Holubar SD, Hull TL, Steele SR, Lightner AL. Tofacitinib Is Associated With Increased Risk of Postoperative Venous Thromboembolism in Patients With Ulcerative Colitis. Dis Colon Rectum. 2024;67:693&#x2013;699.</Citation><ArticleIdList><ArticleId IdType="pubmed">38231035</ArticleId></ArticleIdList></Reference><Reference><Citation>Guillo L, Amiot A, Serrero M, Altwegg R, Roblin X, Atanasiu C, Buisson A, Le Berre C, Reenaers C, Gornet JM, Laharie D, Abitbol V, Biron A, Caron B, Nancey S, Chupin A, Blain A, Vuitton L, Caillo L, Kirchgesner J, Nachury M, Peyrin-Biroulet L FOCUS Study Group. Prevalence of Self-Reported Venous Thromboembolism and Cardiovascular Risk Factors in Patients with Ulcerative Colitis: The GETAID FOCUS Study. Dig Dis Sci. 2022;67:4525&#x2013;4532.</Citation><ArticleIdList><ArticleId IdType="pubmed">35246801</ArticleId></ArticleIdList></Reference><Reference><Citation>Itabashi M, Ikeuchi H, Kimura H, Fukushima K, Fujii H, Nezu R, Futami K, Sugita A, Suzuki Y, Hisamatsu T. Perioperative Venous Thromboembolism in Ulcerative Colitis: A Multicenter Prospective Study in Japan. Crohns Colitis 360. 2021;3:otab024.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9802445</ArticleId><ArticleId IdType="pubmed">36776649</ArticleId></ArticleIdList></Reference><Reference><Citation>Karim MM, Shaikh H, Ismail FW. Spectrum of venous thromboembolism in adult patients with ulcerative colitis in Pakistan: A single center retrospective study. World J Clin Cases. 2025;13:99648.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11612674</ArticleId><ArticleId IdType="pubmed">40012826</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Wang X. Risk Factors of Venous Thromboembolism in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2021;8:693927.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8273255</ArticleId><ArticleId IdType="pubmed">34262920</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimada N, Ohge H, Kitagawa H, Yoshimura K, Shigemoto N, Uegami S, Watadani Y, Uemura K, Takahashi S. High incidence of postoperative silent venous thromboembolism in ulcerative colitis: a retrospective observational study. BMC Surg. 2021;21:247.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8132420</ArticleId><ArticleId IdType="pubmed">34011335</ArticleId></ArticleIdList></Reference><Reference><Citation>Kristensen LE, Danese S, Yndestad A, Wang C, Nagy E, Modesto I, Rivas J, Benda B. Identification of two tofacitinib subpopulations with different relative risk versus TNF inhibitors: an analysis of the open label, randomised controlled study ORAL Surveillance. Ann Rheum Dis. 2023;82:901&#x2013;910.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10314011</ArticleId><ArticleId IdType="pubmed">36931693</ArticleId></ArticleIdList></Reference><Reference><Citation>De Greef I, Bislenghi G, Terrasson I, Sabino J, Ferrante M, D'hoore A, Vermeire S, Verstockt B. P454 No increased postoperative risk of venous thromboembolism nor infectious complications after JAK inhibitor exposure in patients with ulcerative colitis undergoing colectomy. J Crohns Colitis. 2023;17:i583&#x2013;i584.</Citation></Reference><Reference><Citation>Gandhi J, Mages K, Kucine N, Chien K. Venous Thromboembolism in Pediatric Inflammatory Bowel Disease: A Scoping Review. J Pediatr Gastroenterol Nutr. 2023;77:491&#x2013;498.</Citation><ArticleIdList><ArticleId IdType="pubmed">37455339</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding Z, Sherlock M, Chan AKC, Zachos M. Venous thromboembolism in pediatric inflammatory bowel disease: an 11-year population-based nested case-control study in Canada. Blood Coagul Fibrinolysis. 2022;33:449&#x2013;456.</Citation><ArticleIdList><ArticleId IdType="pubmed">36409922</ArticleId></ArticleIdList></Reference><Reference><Citation>Naito T, Botwin GJ, Haritunians T, Li D, Yang S, Khrom M, Braun J NIDDK IBD Genetics Consortium, Abbou L, Mengesha E, Stevens C, Masamune A, Daly M, McGovern DPB. Prevalence and Effect of Genetic Risk of Thromboembolic Disease in Inflammatory Bowel Disease. Gastroenterology. 2021;160:771&#x2013;780.e4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11057914</ArticleId><ArticleId IdType="pubmed">33098885</ArticleId></ArticleIdList></Reference><Reference><Citation>Heo CM, Kim TJ, Kim ER, Hong SN, Chang DK, Yang M, Kim S, Kim YH. Risk of venous thromboembolism in Asian patients with inflammatory bowel disease: a nationwide cohort study. Sci Rep. 2021;11:2025.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7820465</ArticleId><ArticleId IdType="pubmed">33479464</ArticleId></ArticleIdList></Reference><Reference><Citation>Faye AS, Lee KE, Dodson J, Chodosh J, Hudesman D, Remzi F, Wright JD, Friedman AM, Shaukat A, Wen T. Increasing rates of venous thromboembolism among hospitalised patients with inflammatory bowel disease: a nationwide analysis. Aliment Pharmacol Ther. 2022;56:1157&#x2013;1167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC12371573</ArticleId><ArticleId IdType="pubmed">35879231</ArticleId></ArticleIdList></Reference><Reference><Citation>Lightner AL, Vaidya P, Holubar S, Warusavitarne J, Sahnan K, Carrano FM, Spinelli A, Zaghiyan K, Fleshner PR. Perioperative safety of tofacitinib in surgical ulcerative colitis patients. Colorectal Dis. 2021;23:2085&#x2013;2090.</Citation><ArticleIdList><ArticleId IdType="pubmed">33942470</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma N, Tewatia P, Harvey PR, Kumar A. Controversies in Venous Thromboembolism Risk Assessment in Inflammatory Bowel Disease: A Narrative Review. Diagnostics (Basel) 2024;14:2112.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11476391</ArticleId><ArticleId IdType="pubmed">39410515</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40951165</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>15</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>15</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>8</Issue><PubDate><Year>2025</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Therapeutic Vasopressor Use for Postspinal Hypotension in Low-Risk Elective Cesarean Deliveries: A Systematic Review, Network Meta-Analysis, and Trial Sequential Analysis.</ArticleTitle><Pagination><StartPage>e89934</StartPage><MedlinePgn>e89934</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e89934</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.89934</ELocationID><Abstract><AbstractText>Spinal anesthesia-induced hypotension (SAIH) is a common complication of cesarean delivery (CD), potentially leading to maternal discomfort and fetal compromise. Vasopressors such as norepinephrine (NE), phenylephrine (PE), and ephedrine (EP) are frequently used for treatment, yet their comparative efficacy and safety remain uncertain. This study aimed to assess and compare the effectiveness and tolerability of NE, PE, and EP for managing postspinal hypotension (PSH) in low-risk elective CD. Systematic searches were conducted in PubMed, Embase, Cochrane CENTRAL, ScienceDirect, and ClinicalTrials.gov through June 2025. The protocol was registered in the International Prospective Register of Systematic Reviews (PROSPERO) (CRD420251074831). We included randomized controlled trials (RCTs) involving parturients undergoing low-risk elective cesarean section who received NE, PE, or EP for the management of PSH. A systematic review, network meta-analysis (NMA), and trial sequential analysis (TSA) were performed. The primary outcome was the successful correction of PSH. Secondary outcomes included maternal bradycardia, nausea, vomiting, neonatal Apgar scores, and umbilical artery pH. Risk of bias was assessed using the Cochrane RoB 2 tool, and the certainty of evidence was graded with the GRADE (Grading of Recommendations Assessment, Development and Evaluation) methodology. A total of 16 RCTs encompassing 2,102 parturients were included. NE demonstrated superior efficacy in reversing PSH (odds ratio (OR): 0.23; 95% confidence interval (CI): 0.09-0.58) and was associated with fewer adverse maternal events, including bradycardia (OR: 0.28) and nausea/vomiting (OR: 0.36), compared to PE and EP. Neonatal outcomes were generally comparable across groups, though NE showed a favorable trend in reducing the risk of neonatal acidosis (umbilical artery pH OR: 1.25; 95% CI: 1.06-1.54). Surface under the cumulative ranking curve (SUCRA) rankings and TSA supported the robustness of these findings. NE appears to be the most effective and best-tolerated vasopressor for treating SAIH during elective CD, without compromising neonatal safety. These results support the preferential use of NE over PE and EP in this clinical setting.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025, Babul et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Babul</LastName><ForeName>Arya</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Biomedical Sciences, West Career &amp;amp; Technical Academy, Las Vegas, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Sciences, Society for Awareness of Neglected Diseases (SAND), Las Vegas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ashraf</LastName><ForeName>Sohi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Intensive Care, MountainView Hospital, Las Vegas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Free</LastName><ForeName>Leanne</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Gynecologic Surgery and Obstetrics, Kirk Kerkorian School of Medicine at University of Nevada, Las Vegas (UNLV), Las Vegas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Desai</LastName><ForeName>Jyoti</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Gynecologic Surgery and Obstetrics, Kirk Kerkorian School of Medicine at University of Nevada, Las Vegas (UNLV), Las Vegas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hussain</LastName><ForeName>Momina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Genomics, Chinese Academy of Tropical Agricultural Sciences, Sanya, CHN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Babul</LastName><ForeName>Najib</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Drug Development, Quadra Therapeutics, Las Vegas, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">low-risk elective cesarean delivery</Keyword><Keyword MajorTopicYN="N">network meta-analysis</Keyword><Keyword MajorTopicYN="N">norepinephrine</Keyword><Keyword MajorTopicYN="N">spinal anesthesia</Keyword><Keyword MajorTopicYN="N">vasopressors</Keyword></KeywordList><CoiStatement>Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>8</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>15</Day><Hour>12</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>9</Month><Day>15</Day><Hour>12</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>9</Month><Day>15</Day><Hour>8</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>8</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40951165</ArticleId><ArticleId IdType="pmc">PMC12431973</ArticleId><ArticleId IdType="doi">10.7759/cureus.89934</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Spinal versus epidural anaesthesia for caesarean section. Ng K, Parsons J, Cyna AM, Middleton P. Cochrane Database Syst Rev. 2004;2004:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8728877</ArticleId><ArticleId IdType="pubmed">15106218</ArticleId></ArticleIdList></Reference><Reference><Citation>Category I caesarean delivery and preferred mode of anaesthesia: dilemma persists. Gupta S, Chhabra A. Indian J Anaesth. 2018;62:835&#x2013;837.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6236784</ArticleId><ArticleId IdType="pubmed">30532317</ArticleId></ArticleIdList></Reference><Reference><Citation>Techniques for preventing hypotension during spinal anaesthesia for caesarean section. Chooi C, Cox JJ, Lumb RS, et al.  http://eng.https Cochrane Database Syst Rev. 2017;8:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6483677</ArticleId><ArticleId IdType="pubmed">28976555</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathophysiological basis of orthostatic hypotension in autonomic failure. Smit AA, Halliwill JR, Low PA, Wieling W. J Physiol. 1999;519 Pt 1:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2269496</ArticleId><ArticleId IdType="pubmed">10432334</ArticleId></ArticleIdList></Reference><Reference><Citation>The efficacy and safety of norepinephrine and its feasibility as a replacement for phenylephrine to manage maternal hypotension during elective cesarean delivery under spinal anesthesia. Wang X, Shen X, Liu S, Yang J, Xu S. Biomed Res Int. 2018;2018:1869189.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6330831</ArticleId><ArticleId IdType="pubmed">30687737</ArticleId></ArticleIdList></Reference><Reference><Citation>Sung S, Mikes BA, Martingano DJ, Mahdy H. StatPearls [Internet] Treasure Island (FL): StatPearls Publishing; 2025. Cesarean delivery.</Citation><ArticleIdList><ArticleId IdType="pubmed">31536313</ArticleId></ArticleIdList></Reference><Reference><Citation>Norepinephrine for the prevention of spinal-induced hypotension during caesarean delivery under combined spinal-epidural anaesthesia: randomised, double-blind, dose-finding study. Wei C, Qian J, Zhang Y, Chang X, Hu H, Xiao F. Eur J Anaesthesiol. 2020;37:309&#x2013;315.</Citation><ArticleIdList><ArticleId IdType="pubmed">31977628</ArticleId></ArticleIdList></Reference><Reference><Citation>Ephedrine versus phenylephrine as a vasopressor for spinal anaesthesia-induced hypotension in parturients undergoing high-risk caesarean section: meta-analysis, meta-regression and trial sequential analysis. Heesen M, Rijs K, Hilber N, Ngan Kee WD, Rossaint R, van der Marel C, Klimek M. Int J Obstet Anesth. 2019;37:16&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">30477997</ArticleId></ArticleIdList></Reference><Reference><Citation>Norepinephrine or phenylephrine for the prevention of post-spinal hypotension after caesarean section: a double-blinded, randomized, controlled study of fetal heart rate and fetal cardiac output. Sun L, Tang Y, Guo F, et al. J Clin Anesth. 2024;97:111533.</Citation><ArticleIdList><ArticleId IdType="pubmed">38880002</ArticleId></ArticleIdList></Reference><Reference><Citation>Comparison of prophylactic phenylephrine and norepinephrine infusion on umbilical arterial pH and maternal blood pressure during spinal anaesthesia for caesarean delivery. Singh J, Singh J, Mitra S, Anand LK, Goel B, Kaur M. Indian J Anaesth. 2022;66:0&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9116634</ArticleId><ArticleId IdType="pubmed">35601041</ArticleId></ArticleIdList></Reference><Reference><Citation>The effect of phenylephrine infusion on maternal hemodynamic changes during spinal anesthesia for cesarean delivery. Shafeinia A, Ghaed MA, Nikoubakht N. Anesth Pain Med. 2020;10:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7144416</ArticleId><ArticleId IdType="pubmed">32309198</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasopressors for managing maternal hypotension during cesarean section under spinal anesthesia: a systematic review and network meta-analysis. Ryu C, Choi GJ, Park YH, Cho YJ, Kang H. Signa Vitae. 2021;17:152&#x2013;168.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6344174</ArticleId><ArticleId IdType="pubmed">30608428</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasopressors for the management of maternal hypotension during cesarean section under spinal anesthesia: a systematic review and network meta-analysis protocol. Ryu C, Choi GJ, Park YH, Kang H. Medicine (Baltimore) 2019;98:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6344174</ArticleId><ArticleId IdType="pubmed">30608428</ArticleId></ArticleIdList></Reference><Reference><Citation>Epinephrine vs. phenylephrine infusion for prophylaxis against maternal hypotension after spinal anesthesia for cesarean delivery: a randomized controlled trial. Hassabelnaby YS, Hasanin AM, Shamardal M, Mostafa M, Zaki RM, Elsherbiny M, Refaat S. J Anesth. 2024;38:500&#x2013;507.</Citation><ArticleIdList><ArticleId IdType="pubmed">38789602</ArticleId></ArticleIdList></Reference><Reference><Citation>Use and misuse of corrections for multiple testing. Garc&#xed;a-P&#xe9;rez MA. Methods Psychol. 2023;8:100120.</Citation></Reference><Reference><Citation>Prioritizing GWAS results: a review of statistical methods and recommendations for their application. Cantor RM, Lange K, Sinsheimer JS. Am J Hum Genet. 2010;86:6&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2801749</ArticleId><ArticleId IdType="pubmed">20074509</ArticleId></ArticleIdList></Reference><Reference><Citation>A review of the impact of obstetric anesthesia on maternal and neonatal outcomes. Lim G, Facco FL, Nathan N, Waters JH, Wong CA, Eltzschig HK. Anesthesiology. 2018;129:192&#x2013;215.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6008182</ArticleId><ArticleId IdType="pubmed">29561267</ArticleId></ArticleIdList></Reference><Reference><Citation>Lack of reproducibility of trial sequential analyses: a meta-epidemiological study. Xing X, Wang Y, Wang Y, Murad MH, Lin L. Trials. 2025;26:93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11917100</ArticleId><ArticleId IdType="pubmed">40102921</ArticleId></ArticleIdList></Reference><Reference><Citation>Current practice in obstetric anesthesia: a 2012 European survey. Staikou C, Paraskeva A, Karmaniolou I, Mani A, Chondrogiannis K. https://pubmed.ncbi.nlm.nih.gov/24193179/ Minerva Anestesiol. 2014;80:347&#x2013;354.</Citation><ArticleIdList><ArticleId IdType="pubmed">24193179</ArticleId></ArticleIdList></Reference><Reference><Citation>The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Page MJ, McKenzie JE, Bossuyt PM, et al. BMJ. 2021;372:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8008539</ArticleId><ArticleId IdType="pubmed">33781348</ArticleId></ArticleIdList></Reference><Reference><Citation>JBI's systematic reviews: data extraction and synthesis. Munn Z, Tufanaru C, Aromataris E. Am J Nurs. 2014;114:49&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">25742352</ArticleId></ArticleIdList></Reference><Reference><Citation>RoB 2: a revised tool for assessing risk of bias in randomised trials. Sterne JA, Savovi&#x107; J, Page MJ, et al. BMJ. 2019;366:0.</Citation><ArticleIdList><ArticleId IdType="pubmed">31462531</ArticleId></ArticleIdList></Reference><Reference><Citation>GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Sch&#xfc;nemann HJ. BMJ. 2008;336:924&#x2013;926.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>The surface under the cumulative ranking curve. Yang S, Berdine G. The Southwest Journal of Medicine. 2025;13:35&#x2013;38.</Citation></Reference><Reference><Citation>Trial sequential analysis: novel approach for meta-analysis. Kang H. Anesth Pain Med (Seoul) 2021;16:138&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8107247</ArticleId><ArticleId IdType="pubmed">33940767</ArticleId></ArticleIdList></Reference><Reference><Citation>The effects of phenylephrine and ephedrine on maternal hemodynamic changes and neonatal acid-base Status during spinal anesthesia for cesarean delivery. Amiri HA, Banihashem N, Naziri F, Rabiee M, Ghasemi A, Shirkhani Z, ShaKohee M. https://jmums.mazums.ac.ir/article-1-2997-en.html J Mazandaran Univ Med Sci. 2013;23:117&#x2013;124.</Citation></Reference><Reference><Citation>The effect of epinephrine for the treatment of spinal-hypotension: comparison with norepinephrine and phenylephrine, clinical trial (Article in Portuguese) Biricik E, Karacaer F, &#xdc;nal &#x130;, Sucu M, &#xdc;nl&#xfc;gen&#xe7; H. Braz J Anesthesiol. 2020;70:500&#x2013;507.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9373668</ArticleId><ArticleId IdType="pubmed">32980142</ArticleId></ArticleIdList></Reference><Reference><Citation>Systemic hemodynamic effects of norepinephrine versus phenylephrine in intermittent bolus doses during spinal anesthesia for cesarean delivery. Cho WJ, Cho SY, Lee AR. Anesth Pain Med (Seoul) 2020;15:53&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7713867</ArticleId><ArticleId IdType="pubmed">33329790</ArticleId></ArticleIdList></Reference><Reference><Citation>Comparison of intermittent intravenous bolus of phenylephrine and noradrenaline in management of spinal anesthesia induced hypotension in elective cesarean section: a randomized controlled trial. Das S, Roy S, Hembrom BP, Bhattacharya D, Choudhury A. https://www.ijca.in/html-article/23911 Indian J Clin Anaesth. 2025;12:139&#x2013;144.</Citation></Reference><Reference><Citation>Incidence of bradycardia during noradrenaline or phenylephrine bolus treatment of postspinal hypotension in cesarean delivery: a randomized double-blinded controlled trial. de Queiroz DV, Velarde LG, Alves RL, Ver&#xe7;osa N, Cavalcanti IL. Acta Anaesthesiol Scand. 2023;67:797&#x2013;803.</Citation><ArticleIdList><ArticleId IdType="pubmed">36866963</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasopressor choice for hypotension in elective cesarean section: ephedrine or phenylephrine? Gunda CP, Malinowski J, Tegginmath A, Suryanarayana VG, Chandra SB. Arch Med Sci. 2010;6:257&#x2013;263.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3281349</ArticleId><ArticleId IdType="pubmed">22371756</ArticleId></ArticleIdList></Reference><Reference><Citation>Comparison of two norepinephrine rescue bolus for management of post-spinal hypotension during cesarean delivery: a randomized controlled trial. Hassabelnaby YS, Hasanin AM, Adly N, et al. BMC Anesthesiol. 2020;20:84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7164145</ArticleId><ArticleId IdType="pubmed">32303180</ArticleId></ArticleIdList></Reference><Reference><Citation>Randomised trial of intravenous infusion of ephedrine or mephentermine for management of hypotension during spinal anaesthesia for caesarean section. Kansal A, Mohta M, Sethi AK, Tyagi A, Kumar P. Anaesthesia. 2005;60:28&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">15601269</ArticleId></ArticleIdList></Reference><Reference><Citation>Randomised controlled trial of combined spinal epidural vs. spinal anaesthesia for elective caesarean section: vasopressor requirements and cardiovascular changes. Macfarlane AJ, Pryn A, Litchfield KN, Bryden F, Young S, Weir C, McGrady EM. Eur J Anaesthesiol. 2009;26:47&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">19122552</ArticleId></ArticleIdList></Reference><Reference><Citation>Effect of different phenylephrine bolus doses for treatment of hypotension during spinal anaesthesia in patients undergoing elective caesarean section. Mohta M, Harisinghani P, Sethi AK, Agarwal D. Anaesth Intensive Care. 2015;43:74&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">25579292</ArticleId></ArticleIdList></Reference><Reference><Citation>Comparison of the potency of phenylephrine and norepinephrine bolus doses used to treat post-spinal hypotension during elective caesarean section. Mohta M, Dubey M, Malhotra RK, Tyagi A. Int J Obstet Anesth. 2019;38:25&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">30685301</ArticleId></ArticleIdList></Reference><Reference><Citation>A randomised controlled trial of phenylephrine and noradrenaline boluses for treatment of postspinal hypotension during elective caesarean section. Mohta M, Garg A, Chilkoti GT, Malhotra RK. Anaesthesia. 2019;74:850&#x2013;855.</Citation><ArticleIdList><ArticleId IdType="pubmed">31044424</ArticleId></ArticleIdList></Reference><Reference><Citation>A random-allocation graded dose-response study of norepinephrine and phenylephrine for treating hypotension during spinal anesthesia for cesarean delivery. Ngan Kee WD. Anesthesiology. 2017;127:934&#x2013;941.</Citation><ArticleIdList><ArticleId IdType="pubmed">28872480</ArticleId></ArticleIdList></Reference><Reference><Citation>Norepinephrine or phenylephrine during spinal anaesthesia for caesarean delivery: a randomised double-blind pragmatic non-inferiority study of neonatal outcome. Ngan Kee WD, Lee SW, Ng FF, Lee A. Br J Anaesth. 2020;125:588&#x2013;595.</Citation><ArticleIdList><ArticleId IdType="pubmed">32682556</ArticleId></ArticleIdList></Reference><Reference><Citation>Maternal and neonatal effects of bolus administration of ephedrine and phenylephrine during spinal anaesthesia for caesarean delivery: a randomised study. Prakash S, Pramanik V, Chellani H, Salhan S, Gogia AR. Int J Obstet Anesth. 2010;19:24&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">19665364</ArticleId></ArticleIdList></Reference><Reference><Citation>Comparison of norepinephrine and phenylephrine boluses for the treatment of hypotension during spinal anaesthesia for caesarean section-a randomised controlled trial. Puthenveettil N, Sivachalam SN, Rajan S, Paul J, Kumar L. Indian J Anaesth. 2019;63:995&#x2013;1000.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6921314</ArticleId><ArticleId IdType="pubmed">31879423</ArticleId></ArticleIdList></Reference><Reference><Citation>Comparison of prophylactic infusion of phenylephrine with ephedrine for prevention of hypotension in elective cesarean section under spinal anesthesi: a randomized clinical trial. Moslemi F, Rasooli S. https://pubmed.ncbi.nlm.nih.gov/25649721/ Iran J Med Sci. 2015;40:19&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4300475</ArticleId><ArticleId IdType="pubmed">25649721</ArticleId></ArticleIdList></Reference><Reference><Citation>Efficacy and safety of norepinephrine versus phenylephrine for post-spinal hypotension in preeclamptic patients: a systematic review and meta-analysis. Ahmed S, Ahmad E, Fatima E, et al. Eur J Obstet Gynecol Reprod Biol. 2024;303:91&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">39437476</ArticleId></ArticleIdList></Reference><Reference><Citation>Prophylactic norepinephrine infusion to treat hypotension after spinal anaesthesia during caesarean section: a meta-analysis. Zhang C, Qiu J, Huang Y, Tan R. J Obstet Gynaecol. 2024;44:2393379.</Citation><ArticleIdList><ArticleId IdType="pubmed">39166780</ArticleId></ArticleIdList></Reference><Reference><Citation>Comparison of vasopressors for management of hypotension in high-risk caesarean section under neuraxial anesthesia: a systematic review and network meta-analysis. Zhao S, Chen Q, Qin P, Liu L, Wei K. BMC Anesthesiol. 2024;24:447.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11616188</ArticleId><ArticleId IdType="pubmed">39633265</ArticleId></ArticleIdList></Reference><Reference><Citation>Comparison of phenylephrine bolus and infusion regimens on maternal and fetal outcomes during cesarean delivery: a systematic review and meta-analysis. Garg H, Narayanan M R V, Khanna P, Yalla B. Anesth Analg. 2024;139:1144&#x2013;1155.</Citation><ArticleIdList><ArticleId IdType="pubmed">39715512</ArticleId></ArticleIdList></Reference><Reference><Citation>GRADE guidelines: 19. Assessing the certainty of evidence in the importance of outcomes or values and preferences-risk of bias and indirectness. Zhang Y, Alonso-Coello P, Guyatt GH, et al. J Clin Epidemiol. 2019;111:94&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pubmed">29452223</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35716205</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1436-3771</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>9</Issue><PubDate><Year>2022</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Clinical oral investigations</Title><ISOAbbreviation>Clin Oral Investig</ISOAbbreviation></Journal><ArticleTitle>Association between components of metabolic syndrome and periodontitis: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>5557</StartPage><EndPage>5574</EndPage><MedlinePgn>5557-5574</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00784-022-04583-x</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To evaluate the role of metabolic syndrome (MetS) components in the association with periodontitis (PE) (#CRD42020218310).</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">A systematic electronic search was performed in PUBMED, Scielo and Lilacs databases up to April 2022. Cross-sectional, case-control, and cohort studies presenting data on the association between MetS and PE in the adult and elderly populations were included. A random effect meta-analysis was performed to determine association effect estimates. Results interpretation followed the assessment of methodological quality (Joana Briggs Institute tool) together with the certainty of evidence (GRADE approach).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">This review included 52 studies, totalling 140,434 participants, and 38 studies were meta-analyzed. Association between PE and MetS was observed (OR<sub>adj</sub> from 1.27 to 1.90; PR<sub>ajd</sub>&#x2009;=&#x2009;1.19; RR<sub>adj</sub> from 1.10 to 1.37) (low and very low certainty of evidence). Hyperglycaemia (OR&#x2009;=&#x2009;1.18), HDL (OR&#x2009;=&#x2009;1.16), obesity (OR&#x2009;=&#x2009;1.08), and hypertension (OR&#x2009;=&#x2009;1.11) were associated with PE, except triglycerides (low and very low certainty of evidence). There was a dose-response gradient between the number of MetS components and PE, with a gradual increase in the effect magnitude for 1 (OR&#x2009;=&#x2009;1.14), 2 (OR&#x2009;=&#x2009;1.52), 3 or more (OR&#x2009;=&#x2009;1.79), and 4 or 5 components (OR&#x2009;=&#x2009;2.02) (low to high certainty of evidence).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">MetS was associated with PE, with a dose-response gradient between the number of MetS components and the occurrence of PE, with an increasing effect magnitude according to an increasing number of components.</AbstractText><AbstractText Label="CLINICAL RELEVANCE" NlmCategory="CONCLUSIONS">Periodontal examination should be part of a comprehensive propaedeutic approach of MetS patients, particularly those presenting a great number of components.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Campos</LastName><ForeName>Julya Ribeiro</ForeName><Initials>JR</Initials><Identifier Source="ORCID">0000-0002-1406-4166</Identifier><AffiliationInfo><Affiliation>Department of Dental Clinics, Oral Pathology, and Oral Surgery, School of Dentistry, Federal University of Minas Gerais, Ant&#xf4;nio Carlos Avenue 6627, Pampulha. PO Box 359, Belo Horizonte, Minas Gerais, 31270-901, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martins</LastName><ForeName>Carolina Castro</ForeName><Initials>CC</Initials><Identifier Source="ORCID">0000-0001-9072-3226</Identifier><AffiliationInfo><Affiliation>Department of Pediatric Dentistry, School of Dentistry, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faria</LastName><ForeName>Sandro Felipe Santos</ForeName><Initials>SFS</Initials><Identifier Source="ORCID">0000-0002-1602-0079</Identifier><AffiliationInfo><Affiliation>Department of Dental Clinics, Oral Pathology, and Oral Surgery, School of Dentistry, Federal University of Minas Gerais, Ant&#xf4;nio Carlos Avenue 6627, Pampulha. PO Box 359, Belo Horizonte, Minas Gerais, 31270-901, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carvalho</LastName><ForeName>Ana Paula</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Department of Dental Clinics, Oral Pathology, and Oral Surgery, School of Dentistry, Federal University of Minas Gerais, Ant&#xf4;nio Carlos Avenue 6627, Pampulha. PO Box 359, Belo Horizonte, Minas Gerais, 31270-901, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pereira</LastName><ForeName>Alexandre Godinho</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Department of Dental Clinics, Oral Pathology, and Oral Surgery, School of Dentistry, Federal University of Minas Gerais, Ant&#xf4;nio Carlos Avenue 6627, Pampulha. PO Box 359, Belo Horizonte, Minas Gerais, 31270-901, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costa</LastName><ForeName>Fernando Oliveira</ForeName><Initials>FO</Initials><Identifier Source="ORCID">0000-0002-7687-1238</Identifier><AffiliationInfo><Affiliation>Department of Dental Clinics, Oral Pathology, and Oral Surgery, School of Dentistry, Federal University of Minas Gerais, Ant&#xf4;nio Carlos Avenue 6627, Pampulha. PO Box 359, Belo Horizonte, Minas Gerais, 31270-901, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cota</LastName><ForeName>Lu&#xed;s Ot&#xe1;vio Miranda</ForeName><Initials>LOM</Initials><Identifier Source="ORCID">0000-0003-1517-5842</Identifier><AffiliationInfo><Affiliation>Department of Dental Clinics, Oral Pathology, and Oral Surgery, School of Dentistry, Federal University of Minas Gerais, Ant&#xf4;nio Carlos Avenue 6627, Pampulha. PO Box 359, Belo Horizonte, Minas Gerais, 31270-901, Brazil. luiscota@ufmg.br.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>#302251/2019-7</GrantID><Agency>Conselho Nacional de Desenvolvimento Cient&#xed;fico e Tecnol&#xf3;gico</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Clin Oral Investig</MedlineTA><NlmUniqueID>9707115</NlmUniqueID><ISSNLinking>1432-6981</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="Y">Hypertension</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D024821" MajorTopicYN="Y">Metabolic Syndrome</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010518" MajorTopicYN="Y">Periodontitis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Hyperglycemia</Keyword><Keyword MajorTopicYN="N">Hypertension</Keyword><Keyword MajorTopicYN="N">Metabolic syndrome</Keyword><Keyword MajorTopicYN="N">Obesity</Keyword><Keyword MajorTopicYN="N">Periodontal diseases</Keyword><Keyword MajorTopicYN="N">Periodontitis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>18</Day><Hour>11</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35716205</ArticleId><ArticleId IdType="doi">10.1007/s00784-022-04583-x</ArticleId><ArticleId IdType="pii">10.1007/s00784-022-04583-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Papapanou PN, Sanz M, Buduneli N, Dietrich T, Feres M, Fine DH, Flemmig TF, Garcia R, Giannobile WV, Graziani F, Greenwell H, Herrera D, Kao RT, Kebschull M, Kinane DF, Kirkwood KL, Kocher T, KennethKorman SKS, Kumar PS, Loos BG, Machtei E, Meng H, Mombelli A, Needleman I, Offenbacher S, Seymour GJ, Teles R, Tonetti MS (2018) Periodontitis: consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Clin Periodontol 45:162&#x2013;170. https://doi.org/10.1111/jcpe.12946</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcpe.12946</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapila YL (2000) (2021) Oral health&#x2019;s inextricable connection to systemic health: special populations bring to bear multimodal relationships and factors connecting periodontal disease to systemic diseases and conditions. Periodontol 87:11&#x2013;16. https://doi.org/10.1111/prd.12398</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/prd.12398</ArticleId></ArticleIdList></Reference><Reference><Citation>Pirih FQ, Monajemzadeh S, Singh N, Sinacola RS, Shin JM, Chen T, Fenno JC, Kamarajan P, Rickard AH, Travan S, Paster BJ (2000) Kapila Y (2021) Association between metabolic syndrome and periodontitis: the role of lipids, inflammatory cytokines, altered host response, and the microbiome. Periodontol 87:50&#x2013;75. https://doi.org/10.1111/prd.12379</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/prd.12379</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P, He L, Sha YQ, Luan QX (2009) Relationship of metabolic syndrome to chronic periodontitis. J Periodontol 80:541&#x2013;549. https://doi.org/10.1902/jop.2009.080387</Citation><ArticleIdList><ArticleId IdType="doi">10.1902/jop.2009.080387</ArticleId><ArticleId IdType="pubmed">19335073</ArticleId></ArticleIdList></Reference><Reference><Citation>Nesbitt MJ, Reynolds MA, Shiau H, Choe K, Simonsick EM, Ferrucci L (2010) Association of periodontitis and metabolic syndrome in the Baltimore longitudinal study of aging. Aging Clin Exp Res 22:238&#x2013;242. https://doi.org/10.1007/BF03324802</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03324802</ArticleId><ArticleId IdType="pubmed">20634647</ArticleId><ArticleId IdType="pmc">2929594</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhabashneh R, Khader Y, Herra Z, Asa&#x2019;ad F, Assad F (2015) The association between periodontal disease and metabolic syndrome among outpatients with diabetes in Jordan. J Diabetes Metab Disord 16:67. https://doi.org/10.1186/s40200-015-0192-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40200-015-0192-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes-Filho IS, das Merces MC, de Santana Passos-Soares J, Seixas da Cruz S, Teixeira Ladeia AM, Trindade SC, Cerqueira EMM, Coelho JMF, Monteiro FMM, Barreto ML, Vianna MIP, Costa MCN, Gregory John Seymour GJ, Scannapieco FA (2016) Severity of periodontitis and metabolic syndrome: is there an association? J Periodontol 87:357&#x2013;366. https://doi.org/10.1902/jop.2015.150367</Citation><ArticleIdList><ArticleId IdType="doi">10.1902/jop.2015.150367</ArticleId><ArticleId IdType="pubmed">26654349</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaye EK, Chen N, Cabral HJ, Vokonas P, Garcia RI (2016) Metabolic syndrome and periodontal disease progression in men. J Dent Res 95:822&#x2013;828. https://doi.org/10.1177/0022034516641053</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0022034516641053</ArticleId><ArticleId IdType="pubmed">27025874</ArticleId><ArticleId IdType="pmc">4914866</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaramillo A, Contreras A, Lafaurie GI, Duque A, Ardila CM, Duarte S, Osorio L (2017) Association of metabolic syndrome and chronic periodontitis in Colombians. Clin Oral Investig 21:1537&#x2013;1544. https://doi.org/10.1007/s00784-016-1942-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00784-016-1942-9</ArticleId><ArticleId IdType="pubmed">27535794</ArticleId></ArticleIdList></Reference><Reference><Citation>Musskopf ML, Daudt LD, Weidlich P, Gerchman F, Gross JL, Oppermann RV (2017) Metabolic syndrome as a risk indicator for periodontal disease and tooth loss. Clin Oral Investig 21:675&#x2013;683. https://doi.org/10.1007/s00784-016-1935-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00784-016-1935-8</ArticleId><ArticleId IdType="pubmed">27604232</ArticleId></ArticleIdList></Reference><Reference><Citation>Koo HS, Hong SM (2018) Prevalence and risk factors for periodontitis among patients with metabolic syndrome. Metab Syndr Relat Disord 16:375&#x2013;381. https://doi.org/10.1089/met.2018.0003</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/met.2018.0003</ArticleId><ArticleId IdType="pubmed">29893616</ArticleId></ArticleIdList></Reference><Reference><Citation>Pham T (2018) The association between periodontal disease severity and metabolic syndrome in Vietnamese patients. Int J Dent Hyg 16:484&#x2013;491. https://doi.org/10.1111/idh.12350</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/idh.12350</ArticleId><ArticleId IdType="pubmed">29900658</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdalla-Aslan R, Findler M, Levin L, Zini A, Shay B, Twig G, Almoznino G (2019) Where periodontitis meets metabolic syndrome-the role of common health-related risk factors. J Oral Rehab 46:647&#x2013;656. https://doi.org/10.1111/joor.12798</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joor.12798</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JS, Kim SY, Byon MJ, Lee JH, Jeong SH, Kim JB (2019) Association between periodontitis and metabolic syndrome in a Korean nationally representative sample of adults aged 35&#x2013;79 years. Int J Environ Res Public Health 15:16. https://doi.org/10.3390/ijerph16162930</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph16162930</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakurai SI, Yamada SI, Karasawa I, Sakurai A, Kurita H (2019) A longitudinal study on the relationship between dental health and metabolic syndrome in Japan. J Periodontol 90:728&#x2013;746. https://doi.org/10.1002/JPER.18-0523</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JPER.18-0523</ArticleId><ArticleId IdType="pubmed">30720212</ArticleId></ArticleIdList></Reference><Reference><Citation>Campos JR, Costa FO, Cota LOM (2020) Association between periodontitis and metabolic syndrome: a case-control study. J Periodontol 91:784&#x2013;791. https://doi.org/10.1002/JPER.19-0298</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JPER.19-0298</ArticleId><ArticleId IdType="pubmed">31691971</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberti K, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WPT, Loria CM, Smith SC Jr (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640&#x2013;1645. https://doi.org/10.1161/CIRCULATIONAHA.109.192644</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.109.192644</ArticleId><ArticleId IdType="pubmed">19805654</ArticleId></ArticleIdList></Reference><Reference><Citation>Albandar JM, Susin C, Hughes FJ (2018) Manifestations of systemic diseases and conditions that affect the periodontal attachment apparatus: case definitions and diagnostic considerations. J Periodontol 89:S183&#x2013;S203. https://doi.org/10.1002/JPER.16-0480</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JPER.16-0480</ArticleId><ArticleId IdType="pubmed">29926941</ArticleId></ArticleIdList></Reference><Reference><Citation>Teles F, Wang Y, Hajishengallis G, Hasturk H (2000) Marchesan JT (2021) Impact of systemic factors in shaping the periodontal microbiome. Periodontol 85:126&#x2013;160. https://doi.org/10.1111/prd.12356</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/prd.12356</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Aiuto F, Sabbah W, Netuveli G, Donos N, Hingorani AD, Deanfield J, Tsakos G (2008) Association of the metabolic syndrome with severe periodontitis in a large U.S. population-based survey. J Clin Endocrinol Metab 93:3989&#x2013;3994. https://doi.org/10.1210/jc.2007-2522</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2007-2522</ArticleId><ArticleId IdType="pubmed">18682518</ArticleId></ArticleIdList></Reference><Reference><Citation>Morita T, Ogawa Y, Takada K, Nishinoue N, Sasaki Y, Motohashi M, Maeno M (2009) Association between periodontal disease and metabolic syndrome. J Public Health Dent 69:248&#x2013;253. https://doi.org/10.1111/j.1752-7325.2009.00130.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1752-7325.2009.00130.x</ArticleId><ArticleId IdType="pubmed">19453864</ArticleId></ArticleIdList></Reference><Reference><Citation>Kushiyama M, Shimazaki Y, Yamashita Y (2009) Relationship between metabolic syndrome and periodontal disease in Japanese adults. J Periodontol 80:1610&#x2013;1615. https://doi.org/10.1902/jop.2009.090218</Citation><ArticleIdList><ArticleId IdType="doi">10.1902/jop.2009.090218</ArticleId><ArticleId IdType="pubmed">19792850</ArticleId></ArticleIdList></Reference><Reference><Citation>Adriankaja OM, Sreenivasa S, Dunford R, DeNardin E (2010) Association between metabolic syndrome and periodontal disease. Aust Dent J 55:252&#x2013;259</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1834-7819.2010.01231.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon YE, Ha JE, Paik DI, Jin BH, Bae KH (2011) The relationship between periodontitis and metabolic syndrome among a Korean nationally representative sample of adults. J Clin Periodontol 38:781&#x2013;786. https://doi.org/10.1111/j.1600-051X.2011.01756.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-051X.2011.01756.x</ArticleId><ArticleId IdType="pubmed">21722155</ArticleId></ArticleIdList></Reference><Reference><Citation>Han DH, Lim SY, Sun BC, Paek D, Kim HD (2010) The association of metabolic syndrome with periodontal disease is confounded by age and smoking in a Korean population: the Shiwha-Banwol Environmental Health Study. J Clin Periodontol 37:609&#x2013;616. https://doi.org/10.1111/j.1600-051X.2010.01580.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-051X.2010.01580.x</ArticleId><ArticleId IdType="pubmed">20492075</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu YK, D&#x2019;Aiuto F, Lin HJ, Chen YW, Chien KL (2013) Relationship between metabolic syndrome and diagnoses of periodontal diseases among participants in a large Taiwanese cohort. J Clin Periodontol 40:994&#x2013;1000. https://doi.org/10.1111/jcpe.12157</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcpe.12157</ArticleId><ArticleId IdType="pubmed">24007401</ArticleId></ArticleIdList></Reference><Reference><Citation>Thanakun S, Watanabe H, Thaweboon S, Izumi Y (2014) Association of untreated metabolic syndrome with moderate to severe periodontitis in Thai population. J Periodontol 85:1502&#x2013;1514. https://doi.org/10.1902/jop.2014.140105</Citation><ArticleIdList><ArticleId IdType="doi">10.1902/jop.2014.140105</ArticleId><ArticleId IdType="pubmed">24835416</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasaki M, Sato M, Minagawa K, Manz MC, Yoshihara A, Miyazaki H (2015) Longitudinal relationship between metabolic syndrome and periodontal disease among Japanese adults aged &#x2265;70 years: the Niigata Study. J Periodontol 86:491&#x2013;498. https://doi.org/10.1902/jop.2015.140398</Citation><ArticleIdList><ArticleId IdType="doi">10.1902/jop.2015.140398</ArticleId><ArticleId IdType="pubmed">25579498</ArticleId></ArticleIdList></Reference><Reference><Citation>Minagawa K, Iwasaki M, Ogawa H, Yoshihara A, Miyazaki H (2015) Relationship between metabolic syndrome and periodontitis in 80-year-old Japanese subjects. J Periodontal Res 50:173&#x2013;179. https://doi.org/10.1111/jre.12190</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jre.12190</ArticleId><ArticleId IdType="pubmed">24815529</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar N, Bhardwaj A, Negi PC, Jhingta PK, Sharma D, Bhardwaj VK (2016) Association of chronic periodontitis with metabolic syndrome: a cross-sectional study. J Indian Soc Periodontol 20:324&#x2013;329. https://doi.org/10.4103/0972-124X.183096</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0972-124X.183096</ArticleId><ArticleId IdType="pubmed">27563208</ArticleId><ArticleId IdType="pmc">4976555</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikui M, Kokubo Y, Ono T, Kida M, Kosaka T, Yamamoto M, Watanabe M, Maeda Y, Miyamoto Y (2017) Relationship between metabolic syndrome components and periodontal disease in a Japanese general population: the Suita study. J Atheroscler Thromb 24:495&#x2013;507. https://doi.org/10.5551/jat.33761</Citation><ArticleIdList><ArticleId IdType="doi">10.5551/jat.33761</ArticleId><ArticleId IdType="pubmed">27725400</ArticleId><ArticleId IdType="pmc">5429165</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuk A, Qui&#xf1;onez C, Lebenbaum M, Rosella LC (2017) The association between undiagnosed glycaemic abnormalities and cardiometabolic risk factors with periodontitis: results from 2007&#x2013;2009 Canadian Health Measures Survey. J Clin Periodontol 44:132&#x2013;141. https://doi.org/10.1111/jcpe.12684</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcpe.12684</ArticleId><ArticleId IdType="pubmed">28028834</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim OS, Shin MH, Kweon SS, Lee YH, Kim OJ, Kim YJ, Chung HJ (2018) The severity of periodontitis and metabolic syndrome in Korean population: the Dong-gu study. J Periodontal Res 53:362&#x2013;368. https://doi.org/10.1111/jre.12521</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jre.12521</ArticleId><ArticleId IdType="pubmed">29226321</ArticleId></ArticleIdList></Reference><Reference><Citation>Gobin R, Tian D, Liu Q, Wang J (2020) Periodontal disease and the risk of metabolic syndrome: an updated systematic review and metaanalysis. Front Endocrinol 9:336. https://doi.org/10.3389/fendo.2020.00336</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2020.00336</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamster IB, Pagan M (2017) Periodontal disease and the metabolic syndrome. Int Dent J 67:67&#x2013;77. https://doi.org/10.1111/idj.12264</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/idj.12264</ArticleId><ArticleId IdType="pubmed">27861820</ArticleId></ArticleIdList></Reference><Reference><Citation>Nibali L, Tatarakis N, Needleman I, Tu YK, D&#x2019;Aiuto F, Rizzo M, Donos N (2013) Clinical review: association between metabolic syndrome and periodontitis: a systematic review and meta-analysis. J Clin Endocrinol Metab 98:913&#x2013;920. https://doi.org/10.1210/jc.2012-3552</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2012-3552</ArticleId><ArticleId IdType="pubmed">23386648</ArticleId></ArticleIdList></Reference><Reference><Citation>Daudt LD, Musskopf ML, Mendez M, Remonti LLR, Leit&#xe3;o CB, Gross JL, Weidlich P, Oppermann RV (2018) Association between metabolic syndrome and periodontitis: a systematic review and meta-analysis. Braz Oral Res 24:e35. https://doi.org/10.1590/1807-3107bor-2018.vol32.0035</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1807-3107bor-2018.vol32.0035</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe K, Cho YD (2014) Periodontal disease and metabolic syndrome: a qualitative critical review of their association. Arch Oral Biol 59:855&#x2013;870. https://doi.org/10.1016/j.archoralbio.2014.05.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.archoralbio.2014.05.003</ArticleId><ArticleId IdType="pubmed">24880501</ArticleId><ArticleId IdType="pmc">4399819</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https://doi.org/10.1136/bmj.n71</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId><ArticleId IdType="pmc">8005924</ArticleId></ArticleIdList></Reference><Reference><Citation>Joanna Briggs Institute. Critical appraisal tools for use in JBI systematic reviews. [Internet]. [cited Apr 08 2021]. Available from: https://jbi.global/critical-appraisal-tools</Citation></Reference><Reference><Citation>Deeks JJ, Higgins JPT, Altan DG, on behalf of the Cochrane Statistical Methods Group (2019) Analysing data and undertaking meta-analyses. https://doi.org/10.1002/9781119536604.ch10</Citation></Reference><Reference><Citation>Egger M, Smith GD, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629&#x2013;634</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.315.7109.629</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coelho P, Schunemann HJ, GRADE Working Group (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336:924&#x2013;926. https://doi.org/10.1136/bmj.39489.470347.AD</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39489.470347.AD</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId><ArticleId IdType="pmc">2335261</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Akl EA, Schunemann HJ (2018) Using systematic reviews in guideline development: the GRADE approach. Res Synth Methods 14. https://doi.org/10.1002/jrsm.1313</Citation></Reference><Reference><Citation>Shimazaki Y, Saito T, Yonemoto K, Kiyohara Y, Iida M, Yamashita Y (2007) Relationship of metabolic syndrome to periodontal disease in Japanese women: the Hisayama study. J Dent R 86:271&#x2013;275. https://doi.org/10.1177/154405910708600314</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/154405910708600314</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel SP, Kalra N, Pradeep AR, Martande SS, Naik SB, Raju AP, Singh P (2014) Association of metabolic syndrome and periodontal disease in an Indian population. J Inter Acad Periodontol 16:98&#x2013;102</Citation></Reference><Reference><Citation>Morita T, Yamazaki Y, Fujiharu C, Ishii T, Seto M, Nishinoue N, Sasaki Y, Nakai K, Tanaka H, Kawato T (2016) Maeno M (2016) Association between the duration of periodontitis and increased cardiometabolic risk factors: a 9-year cohort study. Metab Syndr Relat Disord 14(10):475&#x2013;482. https://doi.org/10.1089/met.2016.0018</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/met.2016.0018</ArticleId><ArticleId IdType="pubmed">27740886</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandiwadekar AS, Shanbhag N, Madhuniranjanswamy MS, Khanagar SB, Naik S, Siddeeqh S (2020) Association of periodontitis with metabolic syndrome: a case-control study. J Int Soc Prev Community Dent 10:458&#x2013;465. https://doi.org/10.4103/jispcd.JISPCD_91_20</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jispcd.JISPCD_91_20</ArticleId><ArticleId IdType="pubmed">33042888</ArticleId><ArticleId IdType="pmc">7523929</ArticleId></ArticleIdList></Reference><Reference><Citation>Montero E, Molina A, Carasol M, Fern&#xe1;ndez-Meseguer A, Calvo-Bonacho E, Garc&#xed;a-Margallo MT, Sanz M, Herrera D (2021) The association between metabolic syndrome and periodontitis in Spain: results from the WORALTH (Workers&#x2019; ORAL healTH) Study. J Clin Periodontol 48:37&#x2013;49. https://doi.org/10.1111/jcpe.13391</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcpe.13391</ArticleId><ArticleId IdType="pubmed">33067816</ArticleId></ArticleIdList></Reference><Reference><Citation>Borges PK, Gimeno SG, Tomita NE, Ferreira SR (2007) Prevalence and characteristics associated with metabolic syndrome in Japanese-Brazilians with and without periodontal disease. Cad Saude Publica 23:657&#x2013;668. https://doi.org/10.1590/s0102-311x2007000300024</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/s0102-311x2007000300024</ArticleId><ArticleId IdType="pubmed">17334579</ArticleId></ArticleIdList></Reference><Reference><Citation>Han DH, Lim S, Paek D, Kim HD (2012) Periodontitis could be related factors on metabolic syndrome among Koreans: a case-control study. J Clin Periodontol 39:30&#x2013;37. https://doi.org/10.1111/j.1600-051X.2011.01806.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-051X.2011.01806.x</ArticleId><ArticleId IdType="pubmed">22092822</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Xie L, Liu Y, Chen D, Yu Q, Gan X, Yu H (2016) Metabolic syndrome and periodontal disease among civilian pilots. Aerosp Med Hum Perform 87:1016&#x2013;1020. https://doi.org/10.3357/AMHP.4654.2016</Citation><ArticleIdList><ArticleId IdType="doi">10.3357/AMHP.4654.2016</ArticleId><ArticleId IdType="pubmed">28323587</ArticleId></ArticleIdList></Reference><Reference><Citation>Adachi N, Kobayashi Y (2020) One-year follow-up study on associations between dental caries, periodontitis, and metabolic syndrome. J Oral Sci 62:52&#x2013;56. https://doi.org/10.2334/josnusd.18-0251</Citation><ArticleIdList><ArticleId IdType="doi">10.2334/josnusd.18-0251</ArticleId><ArticleId IdType="pubmed">31996523</ArticleId></ArticleIdList></Reference><Reference><Citation>Khader Y, Khassawneh B, Obeidat B, Hammad M, El-Salem K, Bawadi H, Al-akour N (2008) Periodontal status of patients with metabolic syndrome compared to those without metabolic syndrome. J Periodontol 79:2048&#x2013;2053. https://doi.org/10.1902/jop.2008.080022</Citation><ArticleIdList><ArticleId IdType="doi">10.1902/jop.2008.080022</ArticleId><ArticleId IdType="pubmed">18980512</ArticleId></ArticleIdList></Reference><Reference><Citation>Benguigui C, Bongard V, Ruidavets JB, Chamontin B, Sixou M, Ferri&#xe8;res J, Amar J (2010) Metabolic syndrome, insulin resistance, and periodontitis: a cross-sectional study in a middle-aged French population. J Clin Periodontol 37:601&#x2013;608. https://doi.org/10.1111/j.1600-051X.2010.01571.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-051X.2010.01571.x</ArticleId><ArticleId IdType="pubmed">20492076</ArticleId></ArticleIdList></Reference><Reference><Citation>Timonen P, Niskanen M, Suominen-Taipale L, Jula A, Knuuttila M, Yl&#xf6;stalo P (2010) Metabolic syndrome, periodontal infection, and dental caries. J Dent Res 89:1068&#x2013;1073. https://doi.org/10.1177/0022034510376542</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0022034510376542</ArticleId><ArticleId IdType="pubmed">20647498</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukui N, Shimazaki Y, Shinagawa T, Yamashita Y (2012) Periodontal status and metabolic syndrome in middle-aged Japanese. J Periodontol 83:1363&#x2013;1371. https://doi.org/10.1902/jop.2012.110605</Citation><ArticleIdList><ArticleId IdType="doi">10.1902/jop.2012.110605</ArticleId><ArticleId IdType="pubmed">22248226</ArticleId></ArticleIdList></Reference><Reference><Citation>Furuta M, Shimazaki Y, Takeshita T, Shibata Y, Akifusa S, Eshima N, Kiyohara Y, Ninomiya Y, Hirakawa Y, Mukai N, Nagata M, Yamashita Y (2013) Gender differences in the association between metabolic syndrome and periodontal disease: the Hisayama study. J Clin Periodontol 40:743&#x2013;752. https://doi.org/10.1111/jcpe.12119</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcpe.12119</ArticleId><ArticleId IdType="pubmed">23829196</ArticleId><ArticleId IdType="pmc">3807558</ArticleId></ArticleIdList></Reference><Reference><Citation>Goulart AC, Armani F, Arap AM, Nejm T, Andrade JB, Bufarah HB, Dezen DHS (2017) Relationship between periodontal disease and cardiovascular risk factors among young and middle-aged Brazilians. Cross-sectional study Sao Paulo Med J 135:226&#x2013;233. https://doi.org/10.1590/1516-3180.2016.0357300117</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1516-3180.2016.0357300117</ArticleId><ArticleId IdType="pubmed">28746658</ArticleId></ArticleIdList></Reference><Reference><Citation>Nascimento GG, Leite FRM, Peres KG, Demarco FF, Corr&#xea;a MB, Peres MA (2019) Metabolic syndrome and periodontitis: a structural equation modeling approach. J Periodontol 90:655&#x2013;662. https://doi.org/10.1002/JPER.18-0483</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JPER.18-0483</ArticleId><ArticleId IdType="pubmed">30447085</ArticleId></ArticleIdList></Reference><Reference><Citation>Tegelberg P, Tervonen T, Knuuttila M, Jokelainen J, Kein&#xe4;nen-Kiukaanniemi S, Auvinen J, Yl&#xf6;stalo P (2019) Long-term metabolic syndrome is associated with periodontal pockets and alveolar bone loss. J Clin Periodontol 46:799&#x2013;808. https://doi.org/10.1111/jcpe.13154</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcpe.13154</ArticleId><ArticleId IdType="pubmed">31141197</ArticleId></ArticleIdList></Reference><Reference><Citation>Nibali L, D&#x2019;Aiuto F, Griffiths G, Patel K, Suvan J, Tonetti MS (2007) Severe periodontitis is associated with systemic inflammation and a dysmetabolic status: a case-control study. J Clin Periodontol 34:931&#x2013;937. https://doi.org/10.1111/j.1600-051X.2007.01133.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-051X.2007.01133.x</ArticleId><ArticleId IdType="pubmed">17877746</ArticleId></ArticleIdList></Reference><Reference><Citation>Hlushchenko TA, Batig VM, Borysenko AV, Tokar OM, Batih IV, Vynogradova OM, Boychuk-Tovsta OG (2020) Prevalence and intensity of periodontal disease in individuals with metabolic syndrome. J Med Life 13:289&#x2013;292. https://doi.org/10.25122/jml-2020-0073</Citation></Reference><Reference><Citation>Teixeira FCF, Marin-Leon L, Gomes EP, Pedr&#xe3;o AMN, Pereira AC, Francisco PMSB (2020) Relationship between periodontitis and subclinical risk indicators for chronic non-communicable diseases. Braz Oral Res 34:e058. https://doi.org/10.1590/1807-3107bor-2020.vol34.0058.eCollection2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1807-3107bor-2020.vol34.0058.eCollection2020</ArticleId><ArticleId IdType="pubmed">32578801</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes-Filho IS, Balinha ISCE, da Cruz SS, Trindade SC, Cerqueira EMM, Passos-Soares JS, Coelho JMF, Ladeia AMT, Vianna MIP, Hintz AM, Santana TC, Santos PP, Figueiredo ANMG, Silva ICO, Scannapieco FA, Barreto ML, Loomer PM (2021) Moderate and severe periodontitis are positively associated with metabolic syndrome. Clin Oral Investig 25:3719&#x2013;3727. https://doi.org/10.1007/s00784-020-03699-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00784-020-03699-2</ArticleId><ArticleId IdType="pubmed">33226499</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotin J, Walther C, Wenzel U, Zyriax BC, Borof K, Schnabel RB, Seedorf U, Jagodzinski A, Heydecke G, Lamprecht R, Smeets R, Beikler T, Aarabi G (2021) Association between periodontitis and metabolic syndrome in the Hamburg city health study. J Periodontol. Online ahead of print. https://doi.org/10.1002/JPER.21-0464</Citation></Reference><Reference><Citation>Manzon L, Mandolesi S, Guerra F, Poli O, Niglio T (2021) Associations between bone retraction, lost teeth, and metabolic syndrome. A cross-sectional study in dentistry patients aged over 60 years. Clin Ter 172:442&#x2013;447. https://doi.org/10.7417/CT.2021.2356</Citation><ArticleIdList><ArticleId IdType="doi">10.7417/CT.2021.2356</ArticleId><ArticleId IdType="pubmed">34625777</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngoude JXE, Moor VJA, Nadia-Flore TT, Agoons BB, Marcelle GGC, MacBrain EE, Tcheutchoua DN, Nkeck JR (2021) Relationship between periodontal diseases and newly-diagnosed metabolic syndrome components in a sub-Saharan population: a cross sectional study. BMC Oral Health 21:326. https://doi.org/10.1186/s12903-021-01661-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12903-021-01661-6</ArticleId><ArticleId IdType="pubmed">34187434</ArticleId><ArticleId IdType="pmc">8244141</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai KG, Su FY, Cheng WC, Ruang RY, Lin YP, Lin GM (2021) Associations between metabolic biomarkers and localized stage II/III periodontitis in young adults: The CHIEF Oral Health study. J Clin Periodontol 48:1549&#x2013;1558. https://doi.org/10.1111/jcpe.13555</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcpe.13555</ArticleId><ArticleId IdType="pubmed">34605054</ArticleId></ArticleIdList></Reference><Reference><Citation>Suwanprasit W, Lertpimonchai A, Thienpramuk L, Vathesatogkit P, Sritara P, Tamsailom S (2021) Metabolic syndrome and severe periodontitis were associated in Thai adults: a cross-sectional study. J Periodontol 92:1420&#x2013;1429. https://doi.org/10.1002/JPER.20-0651</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JPER.20-0651</ArticleId><ArticleId IdType="pubmed">33590483</ArticleId></ArticleIdList></Reference><Reference><Citation>Bensley L, VanEenwyk J, Ossiander EM (2011) Associations of self-reported periodontal disease with metabolic syndrome and number of self-reported chronic conditions. Prev Chronic Di 8:A50</Citation></Reference><Reference><Citation>Jepsen S, Suvan J (2000) Deschner J (2020) The association of periodontal diseases with metabolic syndrome and obesity. Periodontol 83:125&#x2013;153. https://doi.org/10.1111/prd.12326</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/prd.12326</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong LB, Yap AU, Allen PF (2020) Periodontal disease and quality of life: umbrella review of systematic reviews. J Periodontal Res 56:1&#x2013;17. https://doi.org/10.1111/jre.12805</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jre.12805</ArticleId><ArticleId IdType="pubmed">32965050</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartold PM, Mariotti A (2017) The future of periodontal-systemic associations: raising the standards. Curr Oral Health Rep 4:258&#x2013;262. https://doi.org/10.1007/s40496-017-0150-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40496-017-0150-2</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">18005235</PMID><DateCompleted><Year>2008</Year><Month>05</Month><Day>01</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1538-7836</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>2</Issue><PubDate><Year>2008</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of thrombosis and haemostasis : JTH</Title><ISOAbbreviation>J Thromb Haemost</ISOAbbreviation></Journal><ArticleTitle>Intraoperative pulmonary embolism and intracardiac thrombosis complicating liver transplantation: a systematic review.</ArticleTitle><Pagination><StartPage>297</StartPage><EndPage>302</EndPage><MedlinePgn>297-302</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/j.1538-7836.2008.02831.x</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1538-7836(22)12939-9</ELocationID><Abstract><AbstractText Label="BACKGROUND">Pulmonary embolism (PE) and intracardiac thrombosis (ICT) are rare but potentially lethal complications during orthotopic liver transplantation (OLT).</AbstractText><AbstractText Label="METHODS">We aimed to review clinical and pathological correlates of PE and ICT in patients undergoing OLT. A systematic review of the literature was conducted using MEDLINE and ISI Web of Science.</AbstractText><AbstractText Label="RESULTS">Seventy-four cases of intraoperative PE and/or ICT were identified; PE alone in 32 patients (43%) and a combination of PE and ICT in 42 patients (57%). Most frequent clinical symptoms included systemic hypotension and concomitant rising pulmonary artery pressure, often leading to complete circulatory collapse. PE and ICT occurred in every stage of the operation and were reported equally in patients with or without the use of venovenous bypass or antifibrinolytics. A large variety of putative risk factors have been suggested in the literature, including the use of pulmonary artery catheters or certain blood products. Nineteen patients underwent urgent thrombectomy or thrombolysis. Overall mortality was 68% (50/74) and 41 patients (82%) died intraoperatively.</AbstractText><AbstractText Label="CONCLUSION">Mortality was significantly higher in patients with an isolated PE, compared to patients with a combination of PE and ICT (91% and 50%, respectively; P &lt; 0.001). Intraoperative PE and ICT during OLT appear to have multiple etiologies and may occur unexpectedly at any time during the procedure.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Warnaar</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Section Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molenaar</LastName><ForeName>I Q</ForeName><Initials>IQ</Initials></Author><Author ValidYN="Y"><LastName>Colquhoun</LastName><ForeName>S D</ForeName><Initials>SD</Initials></Author><Author ValidYN="Y"><LastName>Slooff</LastName><ForeName>M J H</ForeName><Initials>MJ</Initials></Author><Author ValidYN="Y"><LastName>Sherwani</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>de Wolf</LastName><ForeName>A M</ForeName><Initials>AM</Initials></Author><Author ValidYN="Y"><LastName>Porte</LastName><ForeName>R J</ForeName><Initials>RJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2007</Year><Month>11</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Thromb Haemost</MedlineTA><NlmUniqueID>101170508</NlmUniqueID><ISSNLinking>1538-7836</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Liver Transpl. 2008 Apr;14(4):575.</RefSource><PMID Version="1">18396486</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006331" MajorTopicYN="N">Heart Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006976" MajorTopicYN="N">Hypertension, Pulmonary</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="N">Hypotension</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="N">Intraoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016031" MajorTopicYN="Y">Liver Transplantation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012769" MajorTopicYN="N">Shock</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013916" MajorTopicYN="N">Thrombelastography</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013927" MajorTopicYN="N">Thrombosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>58</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>11</Month><Day>17</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>5</Month><Day>2</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2007</Year><Month>11</Month><Day>17</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18005235</ArticleId><ArticleId IdType="doi">10.1111/j.1538-7836.2008.02831.x</ArticleId><ArticleId IdType="pii">S1538-7836(22)12939-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">18948803</PMID><DateCompleted><Year>2008</Year><Month>11</Month><Day>18</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1528-1140</ISSN><JournalIssue CitedMedium="Internet"><Volume>248</Volume><Issue>5</Issue><PubDate><Year>2008</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Annals of surgery</Title><ISOAbbreviation>Ann Surg</ISOAbbreviation></Journal><ArticleTitle>Systematic review and meta-analysis of bariatric surgery for pediatric obesity.</ArticleTitle><Pagination><StartPage>763</StartPage><EndPage>776</EndPage><MedlinePgn>763-76</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/SLA.0b013e31818702f4</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The prevalence of morbid obesity has risen sharply in recent years, even among pediatric patients. Bariatric surgery is used increasingly in an effort to induce weight loss, improve medical comorbidities, enhance quality of life, and extend survival. We performed a systematic review and meta-analysis of all published evidence pertaining specifically to bariatric surgery in pediatric patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We systematically searched MEDLINE, EMBASE, 13 other databases, and article bibliographies to identify relevant evidence. Included studies must have reported outcome data for &gt; or =3 patients aged &lt; or =21, representing &gt; or =50% of pediatric patients enrolled at that center. We only included English language articles on currently performed procedures when data were separated by procedure, and there was a minimum 1-year follow-up for weight and body mass index (BMI).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Eight studies of laparoscopic adjustable gastric banding (LAGB) reported data on 352 patients (mean BMI 45.8); 6 studies of Roux-en-Y gastric bypass (RYGB) included 131 patients (mean BMI 51.8); 5 studies of other surgical procedures included 158 patients (mean BMI 48.8). Average patient age was 16.8 years (range, 9-21). Meta-analyses of BMI reductions at longest follow-up indicated sustained and clinically significant BMI reductions for both LAGB and RYGB. Comorbidity resolution was sparsely reported, but surgery did appear to resolve some medical conditions including diabetes and hypertension. For LAGB, band slippage and micronutrient deficiency were the most frequently reported complications, with sporadic cases of band erosion, port/tube dysfunction, hiatal hernia, wound infection, and pouch dilation. For RYGB, more severe complications have been documented, such as pulmonary embolism, shock, intestinal obstruction, postoperative bleeding, staple line leak, and severe malnutrition.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Bariatric surgery in pediatric patients results in sustained and clinically significant weight loss, but also has the potential for serious complications.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Treadwell</LastName><ForeName>Jonathan R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>ECRI Institute, Evidence-Based Practice Center and Health Technology Assessment Information Service, Plymouth Meeting, Pennsylvania, 19462, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Fang</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Schoelles</LastName><ForeName>Karen</ForeName><Initials>K</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Surg</MedlineTA><NlmUniqueID>0372354</NlmUniqueID><ISSNLinking>0003-4932</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D050110" MajorTopicYN="Y">Bariatric Surgery</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003625" MajorTopicYN="N">Data Collection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015391" MajorTopicYN="N">Gastroplasty</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="N">Laparoscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009767" MajorTopicYN="N">Obesity, Morbid</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>89</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2008</Year><Month>10</Month><Day>25</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>11</Month><Day>19</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>10</Month><Day>25</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18948803</ArticleId><ArticleId IdType="doi">10.1097/SLA.0b013e31818702f4</ArticleId><ArticleId IdType="pii">00000658-200811000-00011</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33422802</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>17</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-2472</ISSN><JournalIssue CitedMedium="Internet"><Volume>199</Volume><PubDate><Year>2021</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Thrombosis research</Title><ISOAbbreviation>Thromb Res</ISOAbbreviation></Journal><ArticleTitle>Thromboprophylaxis for orthopedic surgery; An updated meta-analysis.</ArticleTitle><Pagination><StartPage>43</StartPage><EndPage>53</EndPage><MedlinePgn>43-53</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.thromres.2020.12.007</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0049-3848(20)30654-X</ELocationID><Abstract><AbstractText Label="BACKGROUND">Venous thromboembolism (VTE) is a serious complication of orthopedic surgery. Low molecular weight heparin (LMWH) has been the standard of care for thromboprophylaxis in this population. However, direct oral anticoagulants (DOACs) are increasingly being used as alternatives.</AbstractText><AbstractText Label="OBJECTIVE">To assess the efficacy and safety of DOACs versus LMWH for thromboprophylaxis in orthopedic surgery.</AbstractText><AbstractText Label="METHODS">We searched MEDLINE, Embase, and the Cochrane Collaboration Central Register of Controlled Trials from inception until April 2020, for randomized controlled trials (RCTs) comparing DOACs with LMWH for thromboprophylaxis in orthopedic surgery.</AbstractText><AbstractText Label="RESULTS">Twenty-five RCTs met inclusion criteria, including 40,438 patients, with a mean age of 68&#xa0;years and 50% were males. Compared to LMWH, DOACs were associated with a significant reduction of major VTE; defined as the composite events of proximal deep vein thrombosis (DVT), pulmonary embolism (PE), and VTE-related mortality (RR 0.33; 95% CI: 0.20-0.53; P&lt;0.01), and total DVT (RR: 0.59; 95% CI: 0.48-0.73; P&lt;0.01), but not PE (RR 0.81; 95% CI: 0.49-1.34; P=0.42). There was no statistically significant difference between both groups on the incidence of major bleeding (RR 0.99; 95% CI: 0.77-1.27; P=0.92), clinically relevant non-major bleeding (RR 1.04; 95% CI: 0.92-1.17; P=0.52), all-cause mortality (RR 1.06; 95% CI: 0.64-1.76; P=0.83), VTE-related mortality (RR 0.84; 95% CI: 0.40-1.74; P=0.64) and bleeding-related mortality (RR 1.24; 95% CI: 0.30-5.18; P=0.77).</AbstractText><AbstractText Label="CONCLUSION">For patients undergoing orthopedic surgery, thromboprophylaxis with DOACs is associated with a significant reduction of major VTE and DVT, compared to LMWH. Safety outcomes were not significantly different between both treatment groups.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Haykal</LastName><ForeName>Tarek</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Duke University, Division of Hematology, Department of Medicine, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adam</LastName><ForeName>Soheir</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Duke University, Division of Hematology, Department of Medicine, Durham, NC, USA. Electronic address: soheir.adam@duke.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bala</LastName><ForeName>Areeg</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hurley Medical Center, Department of Internal Medicine, Flint, MI, USA; Michigan State University, College of Human Medicine, East Lansing, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zayed</LastName><ForeName>Yazan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Hurley Medical Center, Department of Internal Medicine, Flint, MI, USA; Michigan State University, College of Human Medicine, East Lansing, MI, USA; University of Florida, Department of Pulmonary and Critical Care Medicine, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deliwala</LastName><ForeName>Smit</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hurley Medical Center, Department of Internal Medicine, Flint, MI, USA; Michigan State University, College of Human Medicine, East Lansing, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kerbage</LastName><ForeName>Josiane</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Lebanese University, Department of Anesthesiology, Beirut, Lebanon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ponnapalli</LastName><ForeName>Anoosha</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hurley Medical Center, Department of Internal Medicine, Flint, MI, USA; Michigan State University, College of Human Medicine, East Lansing, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malladi</LastName><ForeName>Srikanth</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Michigan State University, College of Human Medicine, East Lansing, MI, USA; Hurley Medical Center, Department of combined Internal Medicine and Pediatrics, Flint, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Samji</LastName><ForeName>Varun</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Hurley Medical Center, Department of Internal Medicine, Flint, MI, USA; Michigan State University, College of Human Medicine, East Lansing, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ortel</LastName><ForeName>Thomas L</ForeName><Initials>TL</Initials><AffiliationInfo><Affiliation>Duke University, Division of Hematology, Department of Medicine, Durham, NC, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>12</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Thromb Res</MedlineTA><NlmUniqueID>0326377</NlmUniqueID><ISSNLinking>0049-3848</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006495">Heparin, Low-Molecular-Weight</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006495" MajorTopicYN="N">Heparin, Low-Molecular-Weight</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019637" MajorTopicYN="Y">Orthopedic Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="Y">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Direct oral anticoagulants</Keyword><Keyword MajorTopicYN="N">Low-molecular-weight heparin</Keyword><Keyword MajorTopicYN="N">Orthopedic surgery</Keyword><Keyword MajorTopicYN="N">Venous thromboembolism</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>12</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>10</Day><Hour>20</Hour><Minute>34</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33422802</ArticleId><ArticleId IdType="doi">10.1016/j.thromres.2020.12.007</ArticleId><ArticleId IdType="pii">S0049-3848(20)30654-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38072372</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-6868</ISSN><JournalIssue CitedMedium="Internet"><Volume>230</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Apr</Month></PubDate></JournalIssue><Title>American journal of obstetrics and gynecology</Title><ISOAbbreviation>Am J Obstet Gynecol</ISOAbbreviation></Journal><ArticleTitle>Risk of thrombosis and bleeding in gynecologic noncancer surgery: systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>390</StartPage><EndPage>402</EndPage><MedlinePgn>390-402</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajog.2023.11.1255</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0002-9378(23)02117-8</ELocationID><Abstract><AbstractText Label="OBJECTIVE">This study aimed to provide procedure-specific estimates of the risk for symptomatic venous thromboembolism and major bleeding in noncancer gynecologic surgeries.</AbstractText><AbstractText Label="DATA SOURCES">We conducted comprehensive searches on Embase, MEDLINE, Web of Science, and Google Scholar. Furthermore, we performed separate searches for randomized trials that addressed the effects of thromboprophylaxis.</AbstractText><AbstractText Label="STUDY ELIGIBILITY CRITERIA">Eligible studies were observational studies that enrolled &#x2265;50 adult patients who underwent noncancer gynecologic surgery procedures and that reported the absolute incidence of at least 1 of the following: symptomatic pulmonary embolism, symptomatic deep vein thrombosis, symptomatic venous thromboembolism, bleeding that required reintervention (including re-exploration and angioembolization), bleeding that led to transfusion, or postoperative hemoglobin level &lt;70 g/L.</AbstractText><AbstractText Label="METHODS">A teams of 2 reviewers independently assessed eligibility, performed data extraction, and evaluated the risk of bias of the eligible articles. We adjusted the reported estimates for thromboprophylaxis and length of follow-up and used the median value from studies to determine the cumulative incidence at 4 weeks postsurgery stratified by patient venous thromboembolism risk factors and used the Grading of Recommendations Assessment, Development and Evaluation approach to rate the evidence certainty.</AbstractText><AbstractText Label="RESULTS">We included 131 studies (1,741,519 patients) that reported venous thromboembolism risk estimates for 50 gynecologic noncancer procedures and bleeding requiring reintervention estimates for 35 procedures. The evidence certainty was generally moderate or low for venous thromboembolism and low or very low for bleeding requiring reintervention. The risk for symptomatic venous thromboembolism varied from a median of &lt;0.1% for several procedures (eg, transvaginal oocyte retrieval) to 1.5% for others (eg, minimally invasive sacrocolpopexy with hysterectomy, 1.2%-4.6% across patient venous thromboembolism risk groups). Venous thromboembolism risk was &lt;0.5% for 30 (60%) of the procedures; 0.5% to 1.0% for 10 (20%) procedures; and &gt;1.0% for 10 (20%) procedures. The risk for bleeding the require reintervention varied from &lt;0.1% (transvaginal oocyte retrieval) to 4.0% (open myomectomy). The bleeding requiring reintervention risk was &lt;0.5% in 17 (49%) procedures, 0.5% to 1.0% for 12 (34%) procedures, and &gt;1.0% in 6 (17%) procedures.</AbstractText><AbstractText Label="CONCLUSION">The risk for venous thromboembolism in gynecologic noncancer surgery varied between procedures and patients. Venous thromboembolism risks exceeded the bleeding risks only among selected patients and procedures. Although most of the evidence is of low certainty, the results nevertheless provide a compelling rationale for restricting pharmacologic thromboprophylaxis to a minority of patients who undergo gynecologic noncancer procedures.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lavikainen</LastName><ForeName>Lauri I</ForeName><Initials>LI</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Helsinki, Helsinki, Finland. Electronic address: lauri.lavikainen@helsinki.fi.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guyatt</LastName><ForeName>Gordon H</ForeName><Initials>GH</Initials><AffiliationInfo><Affiliation>Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalliala</LastName><ForeName>Ilkka E J</ForeName><Initials>IEJ</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cartwright</LastName><ForeName>Rufus</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Chelsea Centre for Gender Surgery, Chelsea and Westminster NHS Foundation Trust, London, United Kingdom; Department of Gynaecology, Chelsea and Westminster NHS Foundation Trust, London, United Kingdom; Department of Epidemiology &amp; Biostatistics, Imperial College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luomaranta</LastName><ForeName>Anna L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vernooij</LastName><ForeName>Robin W M</ForeName><Initials>RWM</Initials><AffiliationInfo><Affiliation>Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands; Department of Nephrology &amp; Hypertension, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>T&#xe4;htinen</LastName><ForeName>Riikka M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Tampere University and Tampere University Hospital, Tampere, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tadayon Najafabadi</LastName><ForeName>Borna</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Tino</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>ROTBIGGS Investigators</CollectiveName></Author><Author ValidYN="Y"><LastName>Pourjamal</LastName><ForeName>Negar</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Helsinki, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oksjoki</LastName><ForeName>Sanna M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Felicitas Mehil&#xe4;inen Turku, Turku, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khamani</LastName><ForeName>Nadina</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Institute of Childrens' Health, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karjalainen</LastName><ForeName>P&#xe4;ivi K</ForeName><Initials>PK</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Central Finland Central Hospital, Jyv&#xe4;skyl&#xe4;, Finland; Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joronen</LastName><ForeName>Kirsi M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Turku University Hospital and University of Turku, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Izett-Kay</LastName><ForeName>Matthew L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Urogynaecology Department, The John Radcliffe Hospital, Oxford University Hospitals, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haukka</LastName><ForeName>Jari</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland; Clinicum/Department of Public Health, University of Helsinki, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halme</LastName><ForeName>Alex L E</ForeName><Initials>ALE</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Helsinki, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ge</LastName><ForeName>Fang Zhou</ForeName><Initials>FZ</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galambosi</LastName><ForeName>P&#xe4;ivi J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Devereaux</LastName><ForeName>P J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada; Population Health Research Institute, Hamilton, Ontario, Canada; Outcomes Research Consortium, Cleveland, OH.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>C&#xe1;rdenas</LastName><ForeName>Jovita L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>National Center for Health Technology Excellence (CENETEC), Direction of Health Technologies assessment, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Couban</LastName><ForeName>Rachel J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aro</LastName><ForeName>Karoliina M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aaltonen</LastName><ForeName>Riikka L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Urogynaecology Department, The John Radcliffe Hospital, Oxford University Hospitals, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tikkinen</LastName><ForeName>Kari A O</ForeName><Initials>KAO</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Helsinki, Helsinki, Finland; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada; Department of Urology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Department of Surgery, South Karelian Central Hospital, Lappeenranta, Finland. Electronic address: kari.tikkinen@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Obstet Gynecol</MedlineTA><NlmUniqueID>0370476</NlmUniqueID><ISSNLinking>0002-9378</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013509" MajorTopicYN="Y">Gynecologic Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="Y">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="Y">Venous Thrombosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019106" MajorTopicYN="Y">Postoperative Hemorrhage</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001803" MajorTopicYN="N">Blood Transfusion</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">baseline risk</Keyword><Keyword MajorTopicYN="N">bleeding</Keyword><Keyword MajorTopicYN="N">gynecologic surgery</Keyword><Keyword MajorTopicYN="N">modeling</Keyword><Keyword MajorTopicYN="N">reporting</Keyword><Keyword MajorTopicYN="N">risk of bias</Keyword><Keyword MajorTopicYN="N">thromboprophylaxis</Keyword><Keyword MajorTopicYN="N">venous thromboembolism</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>Ahopelto</LastName><ForeName>Kaisa</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aoki</LastName><ForeName>Yoshitaka</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Beilmann-Lehtonen</LastName><ForeName>Ines</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Blanker</LastName><ForeName>Marco H</ForeName><Initials>MH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Craigie</LastName><ForeName>Samantha</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Elberkennou</LastName><ForeName>Jaana</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Garcia-Perdomo</LastName><ForeName>Herney A</ForeName><Initials>HA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gomaa</LastName><ForeName>Huda A</ForeName><Initials>HA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gross</LastName><ForeName>Bcps Peter</ForeName><Initials>BP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hajebrahimi</LastName><ForeName>Sakineh</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Huang</LastName><ForeName>Linglong</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Karanicolas</LastName><ForeName>Paul J</ForeName><Initials>PJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kilpel&#xe4;inen</LastName><ForeName>Tuomas P</ForeName><Initials>TP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kivel&#xe4;</LastName><ForeName>Antti J</ForeName><Initials>AJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Korhonen</LastName><ForeName>Tapio</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lampela</LastName><ForeName>Hanna</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lee</LastName><ForeName>Yung</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mattila</LastName><ForeName>Anne K</ForeName><Initials>AK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Najafabadi</LastName><ForeName>Borna Tadayon</ForeName><Initials>BT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nyk&#xe4;nen</LastName><ForeName>Taina P</ForeName><Initials>TP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nyst&#xe9;n</LastName><ForeName>Carolina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pandanaboyana</LastName><ForeName>Sanjay</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ratnayake</LastName><ForeName>Chathura B B</ForeName><Initials>CBB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Raudasoja</LastName><ForeName>Aleksi R</ForeName><Initials>AR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sallinen</LastName><ForeName>Ville J</ForeName><Initials>VJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Violette</LastName><ForeName>Philippe D</ForeName><Initials>PD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Xiao</LastName><ForeName>Yingqi</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yao</LastName><ForeName>Liang</ForeName><Initials>L</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>11</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>11</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>10</Day><Hour>19</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38072372</ArticleId><ArticleId IdType="doi">10.1016/j.ajog.2023.11.1255</ArticleId><ArticleId IdType="pii">S0002-9378(23)02117-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33707559</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>07</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Mar</Month><Day>11</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>A systematic review with network meta-analysis on mono strategy of anaesthesia for preeclampsia in caesarean section.</ArticleTitle><Pagination><StartPage>5630</StartPage><MedlinePgn>5630</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">5630</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-021-85179-5</ELocationID><Abstract><AbstractText>The aim of this study was to reveal the effects of anaesthesia strategies on maternal mean arterial pressure (MAP), heart rate, vasopressor consumption, adverse events, and neonatal resuscitation when women with preeclampsia (PE) undergo caesarean section (CS). Three major databases were searched for randomized controlled trials (RCTs) and prospective controlled studies (PCSs). Two authors independently screened, extracted, and checked eligibility and outcome data. Outcomes involved MAP, vasopressor use, maternal adverse events, APGAR scores, and neonatal resuscitation. Pooled estimates were carried out by contrast-based network meta-analysis, and pooled effect sizes were presented with 95% confidence interval (CI). Eleven RCTs and one PCS (n&#x2009;=&#x2009;782) formed three-node network meta-analysis, and non-significant differences were observed in MAP, 5-min APGAR score, and neonatal intubation rate among the three anaesthesia strategies. General anaesthesia had significantly lower vasopressor consumption than spinal anaesthesia did (standardised mean difference&#x2009;=&#x2009;&#x2009;-&#x2009;1.19, 95% confidence interval [CI]:&#x2009;-&#x2009;1.76 to&#x2009;-&#x2009;0.63), but it had higher maternal adverse event rate (risk ratio&#x2009;=&#x2009;2.00, 95% CI 1.16-3.47). Because no optimal anaesthesia strategy has been shown to achieve a balanced maternal and neonatal outcome, therefore a shared decision-making process may be required regarding the most suitable choice of anaesthetic strategy for individual preeclamptic mother undergoing CS. Future larger studies may need to focus on evaluating the role of vasopressors on maternal hemodynamic as well as factors affecting maternal outcomes for different anaesthetic techniques in preeclamptic women undergoing CS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Cheng</LastName><ForeName>Chu</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Liao</LastName><ForeName>Alan Hsi-Wen</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Taipei Medical University Hospital, No. 252, Wuxing Street, Taipei, 11031, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Chien-Yu</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Taipei Medical University Hospital, No. 252, Wuxing Street, Taipei, 11031, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Yu-Cih</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Taipei Medical University Hospital, No. 252, Wuxing Street, Taipei, 11031, Taiwan. y.c.lin.tracy@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Nursing, College of Nursing, Taipei Medical University, Taipei, Taiwan. y.c.lin.tracy@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Yi-No</ForeName><Initials>YN</Initials><AffiliationInfo><Affiliation>Evidence-Based Medicine Center, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan. academicnono@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Center of Big Data and Meta-Analysis, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan. academicnono@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cochrane Taiwan, Taipei Medical University, Taipei, Taiwan. academicnono@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Health Policy and Management, College of Public Health, National Taiwan University, Taipei, Taiwan. academicnono@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014662">Vasoconstrictor Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000758" MajorTopicYN="Y">Anesthesia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062186" MajorTopicYN="N">Arterial Pressure</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002585" MajorTopicYN="Y">Cesarean Section</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011225" MajorTopicYN="N">Pre-Eclampsia</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011256" MajorTopicYN="N">Pregnancy Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014662" MajorTopicYN="N">Vasoconstrictor Agents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>3</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33707559</ArticleId><ArticleId IdType="pmc">PMC7970950</ArticleId><ArticleId IdType="doi">10.1038/s41598-021-85179-5</ArticleId><ArticleId IdType="pii">10.1038/s41598-021-85179-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ramanathan J. Pathophysiology and anesthetic implications in preeclampsia. Clin. Obstet. Gynecol. 1992;35:414&#x2013;425. doi: 10.1097/00003081-199235020-00022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003081-199235020-00022</ArticleId><ArticleId IdType="pubmed">1638832</ArticleId></ArticleIdList></Reference><Reference><Citation>Hariharan N, Shoemaker A, Wagner S. Pathophysiology of hypertension in preeclampsia. Microvasc. Res. 2017;109:34&#x2013;37. doi: 10.1016/j.mvr.2016.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mvr.2016.10.002</ArticleId><ArticleId IdType="pubmed">27793558</ArticleId></ArticleIdList></Reference><Reference><Citation>Abalos E, Cuesta C, Grosso AL, Chou D, Say L. Global and regional estimates of preeclampsia and eclampsia: A systematic review. Eur. J. Obstet. Gynecol. Reprod. Biol. 2013;170:1&#x2013;7. doi: 10.1016/j.ejogrb.2013.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejogrb.2013.05.005</ArticleId><ArticleId IdType="pubmed">23746796</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim WH, et al. Comparison between general, spinal, epidural, and combined spinal-epidural anesthesia for cesarean delivery: A network meta-analysis. Int. J. Obstet. Anesth. 2019;37:5&#x2013;15. doi: 10.1016/j.ijoa.2018.09.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijoa.2018.09.012</ArticleId><ArticleId IdType="pubmed">30415797</ArticleId></ArticleIdList></Reference><Reference><Citation>Izci B, et al. The upper airway in pregnancy and pre-eclampsia. Am. J. Respir. Crit. Care Med. 2003;167:137&#x2013;140. doi: 10.1164/rccm.200206-590OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200206-590OC</ArticleId><ArticleId IdType="pubmed">12411285</ArticleId></ArticleIdList></Reference><Reference><Citation>Roopa S, et al. Anesthetic management of combined emergency cesarean section and craniotomy for intracerebral hemorrhage in a patient with severe pre-eclampsia. Curr. Anaesth. Crit. Care. 2010;21:292&#x2013;295. doi: 10.1016/j.cacc.2010.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cacc.2010.06.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Aya AGM, et al. Patients with severe preeclampsia experience less hypotension during spinal anesthesia for elective cesarean delivery than healthy parturients: A prospective cohort comparison. Anesth. Analg. 2003;97:867&#x2013;872. doi: 10.1213/01.ane.0000073610.23885.f2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ane.0000073610.23885.f2</ArticleId><ArticleId IdType="pubmed">12933418</ArticleId></ArticleIdList></Reference><Reference><Citation>Dyer RA, Piercy JL, Reed AR. The role of the anaesthetist in the management of the pre-eclamptic patient. Curr. Opin. Anaesthesiol. 2007;20:168&#x2013;174. doi: 10.1097/ACO.0b013e328136c1ac.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACO.0b013e328136c1ac</ArticleId><ArticleId IdType="pubmed">17479015</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones L, et al. Pain management for women in labour: An overview of systematic reviews. Cochrane Database Syst. Rev. 2012 doi: 10.1002/14651858.CD009234.pub2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD009234.pub2</ArticleId><ArticleId IdType="pmc">PMC7132546</ArticleId><ArticleId IdType="pubmed">22419342</ArticleId></ArticleIdList></Reference><Reference><Citation>Shnider SM, et al. Maternal catecholamines decrease during labor after lumbar epidural anesthesia. Am. J. Obstet. Gynecol. 1983;147:13&#x2013;15. doi: 10.1016/0002-9378(83)90076-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9378(83)90076-5</ArticleId><ArticleId IdType="pubmed">6614080</ArticleId></ArticleIdList></Reference><Reference><Citation>Lederman RP, Lederman E, Work B, Jr, McCann DS. Anxiety and epinephrine in multiparous women in labor: Relationship to duration of labor and fetal heart rate pattern. Am. J. Obstet. Gynecol. 1985;153:870&#x2013;877. doi: 10.1016/0002-9378(85)90692-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9378(85)90692-1</ArticleId><ArticleId IdType="pubmed">4073158</ArticleId></ArticleIdList></Reference><Reference><Citation>Jouppila R, Jouppila P, Hollm&#xe9;n A, Kuikka J. Effect of segmental extradural analgesia on placental blood flow during normal labour. Br. J. Anaesth. 1978;50:563&#x2013;567. doi: 10.1093/bja/50.6.563.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/50.6.563</ArticleId><ArticleId IdType="pubmed">666930</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramanathan J, Coleman P, Sibai B. Anesthetic modification of hemodynamic and neuroendocrine stress responses to cesarean delivery in women with severe preeclampsia. Anesth. Analg. 1991;73:772&#x2013;779. doi: 10.1213/00000539-199112000-00016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/00000539-199112000-00016</ArticleId><ArticleId IdType="pubmed">1659254</ArticleId></ArticleIdList></Reference><Reference><Citation>Hood DD, Curry R. Spinal versus epidural anesthesia for cesarean section in severely preeclamptic patients: A retrospective survey. Anesthesiology. 1999;90:1276&#x2013;1282. doi: 10.1097/00000542-199905000-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-199905000-00009</ArticleId><ArticleId IdType="pubmed">10319773</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark VA, Sharwood-Smith GH, Stewart AVG. Ephedrine requirements are reduced during spinal anaesthesia for caesarean section in preeclampsia. Int. J. Obstet. Anesth. 2005;14:9&#x2013;13. doi: 10.1016/j.ijoa.2004.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijoa.2004.08.002</ArticleId><ArticleId IdType="pubmed">15627532</ArticleId></ArticleIdList></Reference><Reference><Citation>Visalyaputra S, et al. Spinal versus epidural anesthesia for cesarean delivery in severe preeclampsia: A prospective randomized, multicenter study. Anesth. Analg. 2005;101:862. doi: 10.1213/01.ANE.0000160535.95678.34.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ANE.0000160535.95678.34</ArticleId><ArticleId IdType="pubmed">16116005</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu CL, Mansor M, Ng KP, Chan YK. Retrospective review of spinal versus epidural anaesthesia for caesarean section in preeclamptic patients. Int. J. Obstet. Anesth. 2003;12:23&#x2013;27. doi: 10.1016/s0959-289x(02)00137-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0959-289x(02)00137-1</ArticleId><ArticleId IdType="pubmed">15676316</ArticleId></ArticleIdList></Reference><Reference><Citation>Izak M, Bussel JB. Management of thrombocytopenia. F1000Prime Rep. 2014;6:45&#x2013;45. doi: 10.12703/P6-45.</Citation><ArticleIdList><ArticleId IdType="doi">10.12703/P6-45</ArticleId><ArticleId IdType="pmc">PMC4047949</ArticleId><ArticleId IdType="pubmed">24991422</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos AC, Birnbach DJ. Spinal anesthesia in the parturient with severe preeclampsia: Time for reconsideration. Anesth. Analg. 2003;97:621&#x2013;622. doi: 10.1213/01.ane.0000085017.03397.59.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ane.0000085017.03397.59</ArticleId><ArticleId IdType="pubmed">12933372</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos AC. Spinal anesthesia in severely preeclamptic women: When is it safe? Anesthesiology. 1999;90:1252&#x2013;1254. doi: 10.1097/00000542-199905000-00005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-199905000-00005</ArticleId><ArticleId IdType="pubmed">10319769</ArticleId></ArticleIdList></Reference><Reference><Citation>Chattopadhyay S, Das A, Pahari S. Fetomaternal outcome in severe preeclamptic women undergoing emergency cesarean section under either general or spinal anesthesia. J. Pregnan. 2014;325098&#x2013;325098:2014. doi: 10.1155/2014/325098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/325098</ArticleId><ArticleId IdType="pmc">PMC4016895</ArticleId><ArticleId IdType="pubmed">24864211</ArticleId></ArticleIdList></Reference><Reference><Citation>Dasgupta S, Chakraborty B, Saha D, Ghosh D. Comparison of neonatal outcome in women with severe pre-eclampsia undergoing caesarean section under spinal or general anaesthesia. J. Indian Med. Assoc. 2011;109:166&#x2013;170.</Citation><ArticleIdList><ArticleId IdType="pubmed">22010585</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinzhalova S, Makarov R, Davidova N. Comparison of general and spinal anaesthesia on haemodynamic parameters in severe preeclamptic pregnancy undergoing caesarean section. Eur. J. Anaesthesiol. 2013;30:178. doi: 10.1097/00003643-201306001-00555.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003643-201306001-00555</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinzhalova SD, Makarov R. Haemodynamic parameters of pregnant women with chronic arterial hypertension during Caesarean section: Comparison of general and spinal anaesthesia: 11AP3&#x2013;6. Eur. J. Anaesthesiol. 2012;29:167&#x2013;168.</Citation></Reference><Reference><Citation>Kinzhalova SV, Makarov RA, Davydova NS. Central haemodynamics parameters during different anaesthesia methods of surgical delivery in preeclampsia women. Anesteziol. Reanimatol. 2012;5:52&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">23662522</ArticleId></ArticleIdList></Reference><Reference><Citation>Moslemi F, Rasooli S. Comparison of spinal versus general anesthesia for cesarean delivery in patients with severe preeclampsia. J. Med. Sci. 2007;7:1044&#x2013;1048. doi: 10.3923/jms.2007.1044.1048.</Citation><ArticleIdList><ArticleId IdType="doi">10.3923/jms.2007.1044.1048</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharwood-Smith G, Clark V, Watson E. Regional anaesthesia for caesarean section in severe preeclampsia: Spinal anaesthesia is the preferred choice. Int. J. Obstet. Anesth. 1999;8:85&#x2013;89. doi: 10.1016/S0959-289X(99)80003-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0959-289X(99)80003-X</ArticleId><ArticleId IdType="pubmed">15321150</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivevski AG, Sholjakova MV, Kartalov AB, Kuzmanovska BK, Durnev VM. Comparison of low dose spinal anesthesia with general anesthesia in pre-eclamptic parturients undergoing emergency cesarean section. Anaesth. Pain Intens. Care. 2015;19:37&#x2013;43.</Citation></Reference><Reference><Citation>Hodgkinson R, Husain FJ, Hayashi RH. Systemic and pulmonary blood pressure during caesarean section in parturients with gestational hypertension. Can. Anaesth. Soc. J. 1980;27:389&#x2013;394. doi: 10.1007/BF03007461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03007461</ArticleId><ArticleId IdType="pubmed">7407669</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallace DH, et al. Randomized comparison of general and regional anesthesia for cesarean delivery in pregnancies complicated by severe preeclampsia. Obstet. Gynecol. 1995;86:193&#x2013;199. doi: 10.1016/0029-7844(95)00139-I.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0029-7844(95)00139-I</ArticleId><ArticleId IdType="pubmed">7617349</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallace DH, et al. Randomized study of general anesthesia vs epidural or spinal-epidural analgesia for Cesarean section in pregnancies complicated by severe preeclampsia. Am. J. Obstet. Gynecol. 1992;166:302.</Citation></Reference><Reference><Citation>Mathur V, Nagrath A, Saxena S, Maheshwari M. Study of the maternal and neonatal outcome in caesarean deliveries in pregnancies complicated by pre-eclampsia conducted under general anaesthesia and regional anaesthesia. J. Obstet. Gynaecol. India. 2002;52:28&#x2013;32.</Citation></Reference><Reference><Citation>Sayg&#x131; A&#x130;, et al. Comparison of maternal and fetal outcomes among patients undergoing cesarean section under general and spinal anesthesia: A randomized clinical trial. Sao Paulo Med. J. 2015;133:227&#x2013;234. doi: 10.1590/1516-3180.2014.8901012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1516-3180.2014.8901012</ArticleId><ArticleId IdType="pmc">PMC10876380</ArticleId><ArticleId IdType="pubmed">26176927</ArticleId></ArticleIdList></Reference><Reference><Citation>Chumpathong S, et al. Maternal and neonatal outcomes in women with severe pre-eclampsia undergoing cesarean section: A 10-year retrospective study from a single tertiary care center: Anesthetic point of view. J. Matern. Fetal Neona. 2016;29:4096&#x2013;4100. doi: 10.3109/14767058.2016.1159674.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/14767058.2016.1159674</ArticleId><ArticleId IdType="pubmed">26952582</ArticleId></ArticleIdList></Reference><Reference><Citation>Algert CS, et al. Regional block versus general anaesthesia for caesarean section and neonatal outcomes: A population-based study. BMC Med. 2009;7:20&#x2013;20. doi: 10.1186/1741-7015-7-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1741-7015-7-20</ArticleId><ArticleId IdType="pmc">PMC2683867</ArticleId><ArticleId IdType="pubmed">19402884</ArticleId></ArticleIdList></Reference><Reference><Citation>ACOG Practice Bulletin No 202: Gestational hypertension and preeclampsia. Obstet. Gynecol. 2019;133:e1&#x2013;e25. doi: 10.1097/AOG.0000000000003018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AOG.0000000000003018</ArticleId><ArticleId IdType="pubmed">30575675</ArticleId></ArticleIdList></Reference><Reference><Citation>Butalia S, et al. Hypertension Canada's 2018 guidelines for the management of hypertension in pregnancy. Can. J. Cardiol. 2018;34:526&#x2013;531. doi: 10.1016/j.cjca.2018.02.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2018.02.021</ArticleId><ArticleId IdType="pubmed">29731014</ArticleId></ArticleIdList></Reference><Reference><Citation>Regitz-Zagrosek V, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur. Heart J. 2018;39:3165&#x2013;3241. doi: 10.1093/eurheartj/ehy340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehy340</ArticleId><ArticleId IdType="pubmed">30165544</ArticleId></ArticleIdList></Reference><Reference><Citation>Magee LA, et al. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: Executive summary. J. Obstet. Gynaecol. Can. 2014;36:416&#x2013;441. doi: 10.1016/s1701-2163(15)30588-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1701-2163(15)30588-0</ArticleId><ArticleId IdType="pubmed">24927294</ArticleId></ArticleIdList></Reference><Reference><Citation>Tranquilli AL, et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP. Pregnan. Hypertens. 2014;4:97&#x2013;104. doi: 10.1016/j.preghy.2014.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.preghy.2014.02.001</ArticleId><ArticleId IdType="pubmed">26104417</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown MA, et al. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension. 2018;72:24&#x2013;43. doi: 10.1161/HYPERTENSIONAHA.117.10803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.117.10803</ArticleId><ArticleId IdType="pubmed">29899139</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowe SA, et al. SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014. Aust. N. Z. J. Obstet. Gynaecol. 2015;55:e1&#x2013;e29. doi: 10.1111/ajo.12399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajo.12399</ArticleId><ArticleId IdType="pubmed">26412014</ArticleId></ArticleIdList></Reference><Reference><Citation>Redman CWG. Hypertension in pregnancy: The NICE guidelines. Heart. 2011;97:1967&#x2013;1969. doi: 10.1136/heartjnl-2011-300949.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2011-300949</ArticleId><ArticleId IdType="pubmed">21990386</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner JA. Severe preeclampsia: Anesthetic implications of the disease and its management. Am. J .Ther. 2009;16:284&#x2013;288. doi: 10.1097/MJT.0b013e31816f6fd8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MJT.0b013e31816f6fd8</ArticleId><ArticleId IdType="pubmed">19546805</ArticleId></ArticleIdList></Reference><Reference><Citation>Aya AGM, et al. Spinal anesthesia-induced hypotension: A risk comparison between patients with severe preeclampsia and healthy women undergoing preterm cesarean delivery. Anesth. Analg. 2005;101:869. doi: 10.1213/01.ANE.0000175229.98493.2B.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ANE.0000175229.98493.2B</ArticleId><ArticleId IdType="pubmed">16116006</ArticleId></ArticleIdList></Reference><Reference><Citation>Soma-Pillay P, Nelson-Piercy C, Tolppanen H, Mebazaa A. Physiological changes in pregnancy. Cardiovasc. J. Afr. 2016;27:89&#x2013;94. doi: 10.5830/CVJA-2016-021.</Citation><ArticleIdList><ArticleId IdType="doi">10.5830/CVJA-2016-021</ArticleId><ArticleId IdType="pmc">PMC4928162</ArticleId><ArticleId IdType="pubmed">27213856</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindheimer MD, Katz AI. Preeclampsia: Pathophysiology, diagnosis, and management. Annu. Rev. Med. 1989;40:233&#x2013;250. doi: 10.1146/annurev.me.40.020189.001313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.me.40.020189.001313</ArticleId><ArticleId IdType="pubmed">2658750</ArticleId></ArticleIdList></Reference><Reference><Citation>Kee VR. Hemodynamic pharmacology of intravenous vasopressors. Crit. Care Nurse. 2003;23:79&#x2013;82. doi: 10.4037/ccn2003.23.4.79.</Citation><ArticleIdList><ArticleId IdType="doi">10.4037/ccn2003.23.4.79</ArticleId><ArticleId IdType="pubmed">12961786</ArticleId></ArticleIdList></Reference><Reference><Citation>Overgaard Christopher B, D&#x17e;av&#xed;k V. Inotropes and vasopressors. Circulation. 2008;118:1047&#x2013;1056. doi: 10.1161/CIRCULATIONAHA.107.728840.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.107.728840</ArticleId><ArticleId IdType="pubmed">18765387</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutton B, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: Checklist and explanations. Ann. Intern. Med. 2015;162:777&#x2013;784. doi: 10.7326/m14-2385.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/m14-2385</ArticleId><ArticleId IdType="pubmed">26030634</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, et al. Cochrane Handbook for Systematic Reviews of Interventions. John Wiley &amp; Sons; 2019.</Citation></Reference><Reference><Citation>Cipriani A, Higgins JP, Geddes JR, Salanti G. Conceptual and technical challenges in network meta-analysis. Ann. Intern. Med. 2013;159:130&#x2013;137. doi: 10.7326/0003-4819-159-2-201307160-00008.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-159-2-201307160-00008</ArticleId><ArticleId IdType="pubmed">23856683</ArticleId></ArticleIdList></Reference><Reference><Citation>Salanti G. Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: Many names, many benefits, many concerns for the next generation evidence synthesis tool. Res. Synth. Methods. 2012;3:80&#x2013;97. doi: 10.1002/jrsm.1037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrsm.1037</ArticleId><ArticleId IdType="pubmed">26062083</ArticleId></ArticleIdList></Reference><Reference><Citation>Tonin FS, Rotta I, Mendes AM, Pontarolo R. Network meta-analysis: A technique to gather evidence from direct and indirect comparisons. Pharmacy Pract. 2017;15:2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5386629</ArticleId><ArticleId IdType="pubmed">28503228</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu G, Ades A. Assessing evidence inconsistency in mixed treatment comparisons. J. Am. Stat. Assoc. 2006;101:447&#x2013;459. doi: 10.1198/016214505000001302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1198/016214505000001302</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J, et al. Consistency and inconsistency in network meta-analysis: Concepts and models for multi-arm studies. Res. Synth. Methods. 2012;3:98&#x2013;110. doi: 10.1002/jrsm.1044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrsm.1044</ArticleId><ArticleId IdType="pmc">PMC4433772</ArticleId><ArticleId IdType="pubmed">26062084</ArticleId></ArticleIdList></Reference><Reference><Citation>White IR. Network meta-analysis. Stata J. 2015;15:951&#x2013;985. doi: 10.1177/1536867X1501500403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1536867X1501500403</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris RJ, et al. Metan: Fixed-and random-effects meta-analysis. Stata J. 2008;8:3&#x2013;28. doi: 10.1177/1536867X0800800102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1536867X0800800102</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikolakopoulou A, et al. CINeMA: An approach for assessing confidence in the results of a network meta-analysis. PLoS Med. 2020;17:e1003082. doi: 10.1371/journal.pmed.1003082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003082</ArticleId><ArticleId IdType="pmc">PMC7122720</ArticleId><ArticleId IdType="pubmed">32243458</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35626045</PMID><DateRevised><Year>2024</Year><Month>08</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2072-6694</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>10</Issue><PubDate><Year>2022</Year><Month>May</Month><Day>15</Day></PubDate></JournalIssue><Title>Cancers</Title><ISOAbbreviation>Cancers (Basel)</ISOAbbreviation></Journal><ArticleTitle>A Systematic Review of the Guidelines on Venous Thromboembolism Prophylaxis in Gynecologic Oncology.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2439</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cancers14102439</ELocationID><Abstract><AbstractText>(1) Background: This review aimed to summarize the indications for venous thromboembolic (VTE) events' prophylaxis in a gynecological cancer population, according to the most recent guidelines. (2) Methods: A systematic review of the guidelines in PubMed, SCOPUS, Web of Science, EMBASE, and CINHAL regarding VTE prevention in gynecological cancer patients was conducted according to PRISMA criteria. We compared the recommendations given by oncological and hematological societies regarding VTE prevention in gynecological cancer patients published from January 2010 through March 2021. We searched for the following keywords: "venous thromboembolism prevention", "cancer", and "guidelines". The AGREE II checklist was used to critically analyze the guidelines' quality. (3) Results: There were 1003 documents available; 14 met the inclusion criteria, 5 were excluded and, eventually, the guidelines of 10 societies were evaluated. (4) Conclusions: The guidelines agree that low-molecular-weight heparin (LMWH) and fondaparinux achieve better results in VTE prevention in gynecological cancer patients. Direct oral anticoagulants (DOACs) can be used to prevent VTE in outpatients and high-risk medical patients after discharge. VTE risk scores should be applied to all oncological patients to identify those who would benefit from a prevention program. More attention should be paid to mechanical prophylactic methods due to the high bleeding risk of gynecological cancer patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Romano</LastName><ForeName>Federico</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-2157-8330</Identifier><AffiliationInfo><Affiliation>Institute for Maternal and Child Health, IRCCS Burlo Garofolo, Via dell' Istria 65/1, 34137 Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Lorenzo</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute for Maternal and Child Health, IRCCS Burlo Garofolo, Via dell' Istria 65/1, 34137 Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stabile</LastName><ForeName>Guglielmo</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-9266-3896</Identifier><AffiliationInfo><Affiliation>Institute for Maternal and Child Health, IRCCS Burlo Garofolo, Via dell' Istria 65/1, 34137 Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mirandola</LastName><ForeName>Mariateresa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, Surgery and Health Sciences, University of Trieste, Strada di Fiume 447, 34127 Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Restaino</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-7848-0329</Identifier><AffiliationInfo><Affiliation>Department of Maternal and Child Health, University-Hospital of Udine, P.le S. Maria della Misericordia 15, 33100 Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ianniello</LastName><ForeName>Patrizia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medicine, Surgery and Health Sciences, University of Trieste, Strada di Fiume 447, 34127 Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mirenda</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute for Maternal and Child Health, IRCCS Burlo Garofolo, Via dell' Istria 65/1, 34137 Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ricci</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-8031-1102</Identifier><AffiliationInfo><Affiliation>Institute for Maternal and Child Health, IRCCS Burlo Garofolo, Via dell' Istria 65/1, 34137 Trieste, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Surgery and Health Sciences, University of Trieste, Strada di Fiume 447, 34127 Trieste, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cancers (Basel)</MedlineTA><NlmUniqueID>101526829</NlmUniqueID><ISSNLinking>2072-6694</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">deep vein thrombosis</Keyword><Keyword MajorTopicYN="N">gynecological cancer</Keyword><Keyword MajorTopicYN="N">pulmonary embolism</Keyword><Keyword MajorTopicYN="N">thromboprophylaxis</Keyword><Keyword MajorTopicYN="N">venous thromboembolism prevention</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>5</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>28</Day><Hour>1</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>5</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35626045</ArticleId><ArticleId IdType="pmc">PMC9139174</ArticleId><ArticleId IdType="doi">10.3390/cancers14102439</ArticleId><ArticleId IdType="pii">cancers14102439</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Beckman M.G., Hooper W.C., Critchley S.E., Ortel T.L. Venous Thromboembolism: A Public Health Concern. Am. J. Prev. Med. 2010;38:S495&#x2013;S501. doi: 10.1016/j.amepre.2009.12.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amepre.2009.12.017</ArticleId><ArticleId IdType="pubmed">20331949</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung I., Lip G.Y. Virchow&#x2019;s Triad Revisited: Blood Constituents. Pathophysiol. Haemost. Thromb. 2003;33:449&#x2013;454. doi: 10.1159/000083844.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000083844</ArticleId><ArticleId IdType="pubmed">15692259</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackman N., Tilley R.E., Key N.S. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arterioscler. Thromb. Vasc. Biol. 2007;27:1687&#x2013;1693. doi: 10.1161/ATVBAHA.107.141911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.107.141911</ArticleId><ArticleId IdType="pubmed">17556654</ArticleId></ArticleIdList></Reference><Reference><Citation>Levitan N., Dowlati A., Remick S.C., Tahsildar H.I., Sivinski L.D., Beyth R., Rimm A.A. Rates of Initial and Recurrent Thromboembolic Disease Among Patients with Malignancy Versus Those without Malignancy: Risk Analysis Using Medicare Claims Data. Medicine. 1999;78:285&#x2013;291. doi: 10.1097/00005792-199909000-00001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005792-199909000-00001</ArticleId><ArticleId IdType="pubmed">10499070</ArticleId></ArticleIdList></Reference><Reference><Citation>Falanga A., Donati M.B. Pathogenesis of Thrombosis in Patients with Malignancy. Int. J. Hematol. 2001;73:137&#x2013;144. doi: 10.1007/BF02981929.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02981929</ArticleId><ArticleId IdType="pubmed">11372723</ArticleId></ArticleIdList></Reference><Reference><Citation>Rickles F.R., Falanga A. Molecular Basis for the Relationship Between Thrombosis and Cancer. Thromb. Res. 2001;102:V215&#x2013;V224. doi: 10.1016/S0049-3848(01)00285-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0049-3848(01)00285-7</ArticleId><ArticleId IdType="pubmed">11516455</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashrani A.A., Heit J.A., Noble S.I.R., Johnson M.J., Lee A.Y.Y. Epidemiology of venous thromboembolism. Adv. Dis. A Clin. Guid. 2008;12:464&#x2013;474. doi: 10.1093/acprof:oso/9780199232048.003.0002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/acprof:oso/9780199232048.003.0002</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Lip G.Y., Chin B.S., Blann A.D. Cancer and the prothrombotic state. Lancet Oncol. 2002;3:27&#x2013;34. doi: 10.1016/S1470-2045(01)00619-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(01)00619-2</ArticleId><ArticleId IdType="pubmed">11908507</ArticleId></ArticleIdList></Reference><Reference><Citation>Rickles F.R., Levine M., Edwards R.L. Hemostatic alterations in cancer patients. Cancer Metastasis Rev. 1992;11:237&#x2013;248. doi: 10.1007/BF01307180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01307180</ArticleId><ArticleId IdType="pubmed">1423816</ArticleId></ArticleIdList></Reference><Reference><Citation>Heit J.A., Silverstein M.D., Mohr D.N., Petterson T.M., O&#x2019;Fallon W.M., Melton L.J. Risk Factors for Deep Vein Thrombosis and Pulmonary Embolism. Arch. Intern. Med. 2000;160:809&#x2013;815. doi: 10.1001/archinte.160.6.809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.160.6.809</ArticleId><ArticleId IdType="pubmed">10737280</ArticleId></ArticleIdList></Reference><Reference><Citation>Khorana A.A., Francis C.W., Culakova E., Kuderer N.M., Lyman G.H. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J. Thromb. Haemost. 2007;5:632&#x2013;634. doi: 10.1111/j.1538-7836.2007.02374.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2007.02374.x</ArticleId><ArticleId IdType="pubmed">17319909</ArticleId></ArticleIdList></Reference><Reference><Citation>Wharin C., Tagalakis V. Management of venous thromboembolism in cancer patients and the role of the new oral anticoagulants. Blood Rev. 2014;28:1&#x2013;8. doi: 10.1016/j.blre.2013.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.blre.2013.11.001</ArticleId><ArticleId IdType="pubmed">24360911</ArticleId></ArticleIdList></Reference><Reference><Citation>Santoso J.T., Evans L., Lambrecht L., Wan J. Deep venous thrombosis in gynecological oncology: Incidence and clinical symptoms study. Eur. J. Obstet. Gynecol. Reprod. Biol. 2009;144:173&#x2013;176. doi: 10.1016/j.ejogrb.2009.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejogrb.2009.03.012</ArticleId><ArticleId IdType="pubmed">19394127</ArticleId></ArticleIdList></Reference><Reference><Citation>Khorana A.A., Dalal M., Lin J., Connolly G.C. Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States. Cancer. 2012;119:648&#x2013;655. doi: 10.1002/cncr.27772.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cncr.27772</ArticleId><ArticleId IdType="pubmed">22893596</ArticleId></ArticleIdList></Reference><Reference><Citation>Satoh T., Matsumoto K., Tanaka Y.O., Akiyama A., Nakao S., Sakurai M., Ochi H., Onuki M., Minaguchi T., Sakurai H., et al. Incidence of venous thromboembolism before treatment in cervical cancer and the impact of management on venous thromboembolism after commencement of treatment. Thromb. Res. 2013;131:e127&#x2013;e132. doi: 10.1016/j.thromres.2013.01.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2013.01.027</ArticleId><ArticleId IdType="pubmed">23433998</ArticleId></ArticleIdList></Reference><Reference><Citation>Tasaka N., Minaguchi T., Hosokawa Y., Takao W., Itagaki H., Nishida K., Akiyama A., Shikama A., Ochi H., Satoh T. Prevalence of venous thromboembolism at pretreatment screening and associated risk factors in 2086 patients with gynecological cancer. J. Obstet. Gynaecol. Res. 2020;46:765&#x2013;773. doi: 10.1111/jog.14233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jog.14233</ArticleId><ArticleId IdType="pubmed">32147891</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber E.L., Clarke-Pearson D.L. The limited utility of currently available venous thromboembolism risk assessment tools in gynecological oncology patients. Am. J. Obstet. Gynecol. 2016;215:445.e1&#x2013;445.e9. doi: 10.1016/j.ajog.2016.04.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2016.04.034</ArticleId><ArticleId IdType="pmc">PMC5045759</ArticleId><ArticleId IdType="pubmed">27131583</ArticleId></ArticleIdList></Reference><Reference><Citation>Rauh-Hain J.A., Hariton E., Clemmer J., Clark R.M., Hall T., Boruta D.M., Schorge J.O., del Carmen M.G. Incidence and Effects on Mortality of Venous Thromboembolism in Elderly Women With Endometrial Cancer. Obstet. Gynecol. 2015;125:1362&#x2013;1370. doi: 10.1097/AOG.0000000000000866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AOG.0000000000000866</ArticleId><ArticleId IdType="pubmed">26000507</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunderson C.C., Thomas E.D., Slaughter K.N., Farrell R., Ding K., Farris R.E., Lauer J.K., Perry L.J., McMeekin D.S., Moore K.N. The survival detriment of venous thromboembolism with epithelial ovarian cancer. Gynecol. Oncol. 2014;134:73&#x2013;77. doi: 10.1016/j.ygyno.2014.04.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ygyno.2014.04.046</ArticleId><ArticleId IdType="pubmed">24793732</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavikainen L.I., Guyatt G.H., Lee Y., Couban R.J., Luomaranta A.L., Sallinen V.J., Kalliala I.E.J., Karanicolas P.J., Cartwright R., Aaltonen R.L., et al. Systematic reviews of observational studies of Risk of Thrombosis and Bleeding in General and Gynecologic Surgery (ROTBIGGS): Introduction and methodology. Syst. Rev. 2021;10:1&#x2013;13. doi: 10.1186/s13643-021-01814-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-021-01814-2</ArticleId><ArticleId IdType="pmc">PMC8499502</ArticleId><ArticleId IdType="pubmed">34625092</ArticleId></ArticleIdList></Reference><Reference><Citation>Graul A., Latif N., Zhang X., Dean L.T., Morgan M., Giuntoli R., Burger R., Kim S., Ko E. Incidence of Venous Thromboembolism by Type of Gynecologic Malignancy and Surgical Modality in the National Surgical Quality Improvement Program. Int. J. Gynecol. Cancer. 2017;27:581&#x2013;587. doi: 10.1097/IGC.0000000000000912.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/IGC.0000000000000912</ArticleId><ArticleId IdType="pmc">PMC5539959</ArticleId><ArticleId IdType="pubmed">28187092</ArticleId></ArticleIdList></Reference><Reference><Citation>Shamseer L., Moher D., Clarke M., Ghersi D., Liberati A., Petticrew M., Shekelle P., Stewart L.A., PRISMA-P Group Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: Elaboration and explanation. BMJ. 2015;350:g7647. doi: 10.1136/bmj.g7647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.g7647</ArticleId><ArticleId IdType="pubmed">25555855</ArticleId></ArticleIdList></Reference><Reference><Citation>Brouwers M.C., Kho M.E., Browman G.P., Burgers J.S., Cluzeau F., Feder G., Fervers B., Graham I.D., Grimshaw J., Hanna S.E., et al. AGREE II: Advancing guideline development, reporting and evaluation in health care. Can. Med. Assoc. J. 2010;182:E839&#x2013;E842. doi: 10.1503/cmaj.090449.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.090449</ArticleId><ArticleId IdType="pmc">PMC3001530</ArticleId><ArticleId IdType="pubmed">20603348</ArticleId></ArticleIdList></Reference><Reference><Citation>Siering U., Eikermann M., Hausner E., Hoffmann-E&#xdf;er W., Neugebauer E.A. Appraisal Tools for Clinical Practice Guidelines: A Systematic Review. PLoS ONE. 2013;8:e82915. doi: 10.1371/journal.pone.0082915.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0082915</ArticleId><ArticleId IdType="pmc">PMC3857289</ArticleId><ArticleId IdType="pubmed">24349397</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann-E&#xdf;er W., Siering U., Neugebauer E.A., Lampert U., Eikermann M. Systematic review of current guideline appraisals performed with the Appraisal of Guidelines for Research &amp; Evaluation II instrument&#x2014;a third of AGREE II users apply a cut-off for guideline quality. J. Clin. Epidemiology. 2017;95:120&#x2013;127. doi: 10.1016/j.jclinepi.2017.12.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2017.12.009</ArticleId><ArticleId IdType="pubmed">29288133</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez O., Clerc S., Pinot J., Pastr&#xe9; J., Planquette B. Maladie veineuse thromboembolique. Rev. Des Mal. Respir. Actual. 2020;12:317&#x2013;324. doi: 10.1016/S1877-1203(20)30130-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1877-1203(20)30130-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Key N.S., Khorana A.A., Kuderer N.M., Bohlke K., Lee A.Y., Arcelus J.I., Wong S.L., Balaban E.P., Flowers C.R., Francis C.W., et al. Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update. J. Clin. Oncol. 2020;38:496&#x2013;520. doi: 10.1200/JCO.19.01461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.19.01461</ArticleId><ArticleId IdType="pubmed">31381464</ArticleId></ArticleIdList></Reference><Reference><Citation>Farge D., Frere C., Connors J.M., Ay C., Khorana A.A., Munoz A., Brenner B., Kakkar A., Rafii H., Solymoss S., et al. 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. Lancet Oncol. 2019;20:E566&#x2013;E581. doi: 10.1016/S1470-2045(19)30336-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(19)30336-5</ArticleId><ArticleId IdType="pubmed">31492632</ArticleId></ArticleIdList></Reference><Reference><Citation>Barni S., Petrella M.C., Falanga A., Verso M., Piccioli A., Antonuzzo A., Imberti D., Tarantini L., Labianca R. Linee Guida AIOM Tromboembolismo Venoso Nei Pazienti Con Tumori Solidi. 2019.  [(accessed on 7 July 2021)].  Available online:  https://www.aiom.it/wp-content/uploads/2018/11/2018_LG_AIOM_Tromboembolismo.pdf.</Citation></Reference><Reference><Citation>Mart&#xed;n A.J.M., D&#xed;az E.G., Escobar I.G., Montero R.M., Mart&#xed;nez-Mar&#xed;n V., Olmos V.P., Segura P.P., Verd&#xfa;guez T.Q., Fern&#xe1;ndez M.S. SEOM clinical guideline of venous thromboembolism (VTE) and cancer (2019) Clin. Transl. Oncol. 2020;22:171&#x2013;186. doi: 10.1007/s12094-019-02263-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12094-019-02263-z</ArticleId><ArticleId IdType="pubmed">31981080</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson H.G., Keeling D.M., Laffan M., Tait R.C., Makris M., on behalf of the British Committee for Standards in Haematology Guideline on aspects of cancer-related venous thrombosis. Br. J. Haematol. 2015;170:640&#x2013;648. doi: 10.1111/bjh.13556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.13556</ArticleId><ArticleId IdType="pubmed">26114207</ArticleId></ArticleIdList></Reference><Reference><Citation>Easaw J., Shea&#x2013;Budgell M., Wu C., Czaykowski P., Kassis J., Kuehl B., Lim H., MacNeil M., Martinusen D., McFarlane P., et al. Canadian Consensus Recommendations on the Management of Venous Thromboembolism in Patients with Cancer. Part 1: Prophylaxis. Curr. Oncol. 2015;22:133&#x2013;143. doi: 10.3747/co.22.2586.</Citation><ArticleIdList><ArticleId IdType="doi">10.3747/co.22.2586</ArticleId><ArticleId IdType="pmc">PMC4399610</ArticleId><ArticleId IdType="pubmed">25908912</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyman G.H., Carrier M., Ay C., Di Nisio M., Hicks L.K., Khorana A.A., Leavitt A.D., Lee A.Y.Y., Macbeth F., Morgan R.L., et al. American Society of Hematology 2021 guidelines for management of venous thromboembolism: Prevention and treatment in patients with cancer. Blood Adv. 2021;5:927&#x2013;974. doi: 10.1182/bloodadvances.2020003442. Erratum in Blood Adv. 2021, 5, 1953.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2020003442</ArticleId><ArticleId IdType="pmc">PMC7903232</ArticleId><ArticleId IdType="pubmed">33570602</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal&#xe0; M., Falanga A., Roila F. Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice Guidelines. Ann. Oncol. 2011;22:vi85&#x2013;vi92. doi: 10.1093/annonc/mdr392.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/annonc/mdr392</ArticleId><ArticleId IdType="pubmed">21908511</ArticleId></ArticleIdList></Reference><Reference><Citation>Siragusa S., Armani U., Carpenedo M., Falanga A., Fulfaro F., Imberti D., Laurora R., Molinari A.C., Prisco D., Silingardi M., et al. Prevention of venous thromboembolism in patients with cancer: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET)1. Thromb. Res. 2011;129:e171&#x2013;e176. doi: 10.1016/j.thromres.2011.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2011.09.002</ArticleId><ArticleId IdType="pubmed">21962722</ArticleId></ArticleIdList></Reference><Reference><Citation>Khorana A.A., Kuderer N.M., Culakova E., Lyman G.H., Francis C.W. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood. 2008;111:4902&#x2013;4907. doi: 10.1182/blood-2007-10-116327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2007-10-116327</ArticleId><ArticleId IdType="pmc">PMC2384124</ArticleId><ArticleId IdType="pubmed">18216292</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerotziafas G.T., Taher A., Abdel-Razeq H., AboElnazar E., Spyropoulos A.C., El Shemmari S., Larsen A.K., Elalamy I., on behalf of the COMPASS&#x2013;CAT Working Group A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS&#x2013;Cancer-Associated Thrombosis Study. Oncologist. 2017;22:1222&#x2013;1231. doi: 10.1634/theoncologist.2016-0414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1634/theoncologist.2016-0414</ArticleId><ArticleId IdType="pmc">PMC5634762</ArticleId><ArticleId IdType="pubmed">28550032</ArticleId></ArticleIdList></Reference><Reference><Citation>Cella C.A., Di Minno G., Carlomagno C., Arcopinto M., Cerbone A.M., Matano E., Tufano A., Lordick F., De Simone B., Muehlberg K.S., et al. Preventing Venous Thromboembolism in Ambulatory Cancer Patients: The ONKOTEV Study. Oncol. 2017;22:601&#x2013;608. doi: 10.1634/theoncologist.2016-0246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1634/theoncologist.2016-0246</ArticleId><ArticleId IdType="pmc">PMC5423517</ArticleId><ArticleId IdType="pubmed">28424324</ArticleId></ArticleIdList></Reference><Reference><Citation>Turpie A.G. Thrombosis prophylaxis in the acutely ill medical patient: Insights from the prophylaxis in medical patients with enoxaparin (MEDENOX) trial. Am. J. Cardiol. 2000;86:48&#x2013;52. doi: 10.1016/S0002-9149(00)01481-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9149(00)01481-8</ArticleId><ArticleId IdType="pubmed">11206019</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrier M., Khorana A., Moretto P., Le Gal G., Karp R., Zwicker J.I. Lack of Evidence to Support Thromboprophylaxis in Hospitalized Medical Patients with Cancer. Am. J. Med. 2014;127:82&#x2013;86.e1. doi: 10.1016/j.amjmed.2013.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2013.09.015</ArticleId><ArticleId IdType="pubmed">24384102</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergqvist D., Agnelli G., Cohen A.T., E Nilsson P., Le Moigne-Amrani A., Dietrich-Neto F. The Enoxacan II Investigators Prolonged prophylaxis against venous thromboembolism with enoxaparin in patients undergoing cancer surgery: Long-term survival analysis. Phlebol. J. Venous Dis. 2006;21:195&#x2013;198. doi: 10.1258/026835506779115753.</Citation><ArticleIdList><ArticleId IdType="doi">10.1258/026835506779115753</ArticleId></ArticleIdList></Reference><Reference><Citation>ENOXACAN Study Group Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: A double-blind randomized multicentre trial with venographic assessment. ENOXACAN Study Group. Br. J. Surg. 1997;84:1099&#x2013;1103.</Citation><ArticleIdList><ArticleId IdType="pubmed">9278651</ArticleId></ArticleIdList></Reference><Reference><Citation>Illuminati G., Calio&#x2019; F.G., Pizzardi G., Amatucci C., Masci F., Palumbo P. Fondaparinux for intra and perioperative anticoagulation in patients with heparin-induced thrombocytopenia candidates for peripheral vascular surgery: Report of 4 cases. Int. J. Surg. Case Rep. 2016;28:251&#x2013;254. doi: 10.1016/j.ijscr.2016.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijscr.2016.10.013</ArticleId><ArticleId IdType="pmc">PMC5067092</ArticleId><ArticleId IdType="pubmed">27750177</ArticleId></ArticleIdList></Reference><Reference><Citation>Guntupalli S.R., Brennecke A., Behbakht K., Tayebnejad A., Breed C.A., Babayan L.M., Cheng G., Ramzan A.A., Wheeler L.J., Corr B.R., et al. Safety and Efficacy of Apixaban vs Enoxaparin for Preventing Postoperative Venous Thromboembolism in Women Undergoing Surgery for Gynecologic Malignant Neoplasm: A Randomized Clinical Trial. JAMA Netw. Open. 2020;3:e207410. doi: 10.1001/jamanetworkopen.2020.7410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.7410</ArticleId><ArticleId IdType="pmc">PMC7320298</ArticleId><ArticleId IdType="pubmed">32589230</ArticleId></ArticleIdList></Reference><Reference><Citation>Douros A., Filliter C., Azoulay L., Tagalakis V. Effectiveness and safety of direct oral anticoagulants in patients with cancer associated venous thromboembolism. Thromb. Res. 2021;202:128&#x2013;133. doi: 10.1016/j.thromres.2021.03.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2021.03.026</ArticleId><ArticleId IdType="pubmed">33836492</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng J.-P., Xiong Y.-T., Fan Z.-Q., Yan L.-J., Wang J.-Y., Gu Z.-J. Efficacy of intermittent pneumatic compression for venous thromboembolism prophylaxis in patients undergoing gynecologic surgery: A systematic review and meta-analysis. Oncotarget. 2016;8:20371&#x2013;20379. doi: 10.18632/oncotarget.13620.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.13620</ArticleId><ArticleId IdType="pmc">PMC5386769</ArticleId><ArticleId IdType="pubmed">27901494</ArticleId></ArticleIdList></Reference><Reference><Citation>Togna G.I., Togna A.R., Franconi M., Caprino L. Cisplatin Triggers Platelet Activation. Thromb. Res. 2000;99:503&#x2013;509. doi: 10.1016/S0049-3848(00)00294-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0049-3848(00)00294-2</ArticleId><ArticleId IdType="pubmed">10973681</ArticleId></ArticleIdList></Reference><Reference><Citation>Agnelli G., Gussoni G., Bianchini C., Verso M., Mandal&#xe0; M., Cavanna L., Barni S., Labianca R., Buzzi F., Scambia G., et al. Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: A randomised, placebo-controlled, double-blind study. Lancet Oncol. 2009;10:943&#x2013;949. doi: 10.1016/S1470-2045(09)70232-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(09)70232-3</ArticleId><ArticleId IdType="pubmed">19726226</ArticleId></ArticleIdList></Reference><Reference><Citation>Liakishev A.A. Dabigatran versus warfarin in the treatment of acute venous thromboembolism. Results of the RE-COVER study. Kardiologiia. 2010;50:80&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">20459411</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27485756</PMID><DateCompleted><Year>2017</Year><Month>08</Month><Day>08</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1678-4782</ISSN><JournalIssue CitedMedium="Internet"><Volume>93</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Season>Jan-Feb</Season></PubDate></JournalIssue><Title>Jornal de pediatria</Title><ISOAbbreviation>J Pediatr (Rio J)</ISOAbbreviation></Journal><ArticleTitle>Therapeutic play to prepare children for invasive procedures: a systematic review.</ArticleTitle><Pagination><StartPage>6</StartPage><EndPage>16</EndPage><MedlinePgn>6-16</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jped.2016.06.005</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0021-7557(16)30096-1</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To analyze the available evidence regarding the efficacy of using therapeutic play on behavior and anxiety in children undergoing invasive procedures.</AbstractText><AbstractText Label="DATA SOURCE" NlmCategory="METHODS">The systematic review search was performed in the MEDLINE, LILACS, CENTRAL and CINAHL databases. There was no limitation on the year or language.</AbstractText><AbstractText Label="SYNTHESIS OF DATA" NlmCategory="METHODS">The literature search found 1892 articles and selected 22 for full reading. Eight articles were excluded, as they did not address the objectives assessed in this review. Twelve studies, representing 14 articles, were included. The studies were conducted between 1983 and 2015, five in Brazil, one in the United States, five in China, one in Lebanon, one in Taiwan, and one in Iran. Most studies showed that intervention with therapeutic play promotes reduction in the level of anxiety and promotes collaborative behavior and acceptance of the invasive procedure.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Evidence related to the use of therapeutic play on anxiety and behavior of children undergoing invasive procedures is still questionable. The absence, in most studies, of the creation of a random sequence to assign the subjects to either the control or the experimental group, as well as allocation concealment, are factors that contribute to these questions. Another issue that characterizes an important source of bias is the absence of blinded evaluators. It is necessary to perform further studies that will take into account greater methodological stringency.</AbstractText><CopyrightInformation>Copyright &#xa9; 2016 Sociedade Brasileira de Pediatria. Published by Elsevier Editora Ltda. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Silva</LastName><ForeName>Rosalia Daniela Medeiros da</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Universidade Federal de Pernambuco (UFPE), Programa de P&#xf3;s-gradua&#xe7;&#xe3;o em Sa&#xfa;de da Crian&#xe7;a e do Adolescente, Recife, PE, Brazil. Electronic address: rosaliadaniela@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Austreg&#xe9;silo</LastName><ForeName>Silvia Carr&#xe9;ra</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Universidade Federal de Pernambuco (UFPE), Programa de P&#xf3;s-gradua&#xe7;&#xe3;o em Sa&#xfa;de da Crian&#xe7;a e do Adolescente, Recife, PE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ithamar</LastName><ForeName>Lucas</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Universidade Federal de Pernambuco (UFPE), Programa de P&#xf3;s-gradua&#xe7;&#xe3;o em Sa&#xfa;de da Crian&#xe7;a e do Adolescente, Recife, PE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lima</LastName><ForeName>Luciane Soares de</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>Universidade Federal de Pernambuco (UFPE), Programa de P&#xf3;s-gradua&#xe7;&#xe3;o em Sa&#xfa;de da Crian&#xe7;a e do Adolescente, Recife, PE, Brazil; Universidade Federal de Pernambuco (UFPE), Programa de P&#xf3;s-gradua&#xe7;&#xe3;o em Enfermagem, Recife, PE, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>07</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>J Pediatr (Rio J)</MedlineTA><NlmUniqueID>2985188R</NlmUniqueID><ISSNLinking>0021-7557</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001007" MajorTopicYN="N">Anxiety</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010989" MajorTopicYN="Y">Play Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011300" MajorTopicYN="N">Preoperative Care</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Ansiedade</Keyword><Keyword MajorTopicYN="N">Anxiety</Keyword><Keyword MajorTopicYN="N">Assist&#xea;ncia hospitalar</Keyword><Keyword MajorTopicYN="N">Behavior</Keyword><Keyword MajorTopicYN="N">Children</Keyword><Keyword MajorTopicYN="N">Comportamento</Keyword><Keyword MajorTopicYN="N">Crian&#xe7;a</Keyword><Keyword MajorTopicYN="N">Hospital care</Keyword><Keyword MajorTopicYN="N">Jogos e brinquedos</Keyword><Keyword MajorTopicYN="N">Play and playthings</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>5</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>5</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>8</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>8</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>8</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27485756</ArticleId><ArticleId IdType="doi">10.1016/j.jped.2016.06.005</ArticleId><ArticleId IdType="pii">S0021-7557(16)30096-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32040553</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2473-9537</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Month>Feb</Month><Day>11</Day></PubDate></JournalIssue><Title>Blood advances</Title><ISOAbbreviation>Blood Adv</ISOAbbreviation></Journal><ArticleTitle>Home vs hospital treatment of low-risk venous thromboembolism: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>500</StartPage><EndPage>513</EndPage><MedlinePgn>500-513</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1182/bloodadvances.2019001223</ELocationID><Abstract><AbstractText>Increasing evidence supports the safety and effectiveness of managing low-risk deep vein thrombosis (DVT) or pulmonary embolism (PE) in outpatient settings. We performed a systematic review to assess safety and effectiveness of managing patients with DVT or PE at home compared with the hospital. Medline, Embase, and Cochrane databases were searched up to July 2019 for relevant randomized clinical trials (RCTs), and prospective cohort studies. Two investigators independently screened titles and abstracts of identified citations and extracted data from relevant full-text papers. Risk ratios (RRs) were calculated, and certainty of evidence was assessed using Grading of Recommendations Assessment, Development and Evaluation (GRADE). Seven RCTs (1922 patients) were included in meta-analyses on managing patients with DVT. Pooled estimates indicated decreased risk of PE (RR = 0.64; 95% confidence interval [CI], 0.44-0.93) and recurrent DVT (RR = 0.61; 95% CI, 0.42-0.90) for home management, both with moderate certainty of the evidence. Reductions in mortality and major bleeding were not significant, both with low certainty of the evidence. Two RCTs (445 patients) were included in meta-analyses on home management of low-risk patients with PE. Pooled estimates indicated no significant difference in all-cause mortality, recurrent PE, and major bleeding, all with low certainty of the evidence. Results of pooled estimates from 3 prospective cohort studies (234 patients) on home management of PE showed similar results. Our findings indicate that low-risk DVT patients had similar or lower risk of patient-important outcomes with home treatment compared with hospital treatment. In patients with low-risk PE, there was important uncertainty about a difference between home and hospital treatment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Khatib</LastName><ForeName>Rasha</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Advocate Research Institute, Advocate Health Care, Downers Grove, IL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ross</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kennedy</LastName><ForeName>Sean Alexander</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Florez</LastName><ForeName>Ivan D</ForeName><Initials>ID</Initials><AffiliationInfo><Affiliation>Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, University of Antioquia, Medellin, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ortel</LastName><ForeName>Thomas L</ForeName><Initials>TL</Initials><AffiliationInfo><Affiliation>Division of Hematology, Medicine and Pathology, Duke University Medical Center, Durham, NC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nieuwlaat</LastName><ForeName>Robby</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neumann</LastName><ForeName>Ignacio</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Witt</LastName><ForeName>Daniel M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schulman</LastName><ForeName>Sam</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, The First I. M. Sechenov Moscow State Medical University, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manja</LastName><ForeName>Veena</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of California Davis, Sacramento, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beyth</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine, Department of Medicine, University of Florida, Gainesville, FL.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Malcom Randall Veterans Affairs Medical Center, Gainesville, FL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clark</LastName><ForeName>Nathan P</ForeName><Initials>NP</Initials><AffiliationInfo><Affiliation>Clinical Pharmacy Anticoagulation Service, Kaiser Permanente Colorado, Aurora, CO; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiercioch</LastName><ForeName>Wojtek</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sch&#xfc;nemann</LastName><ForeName>Holger J</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yuqing</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guang' anmen Hospital, China Academy of Chinese Medical Science, Xicheng District, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Blood Adv</MedlineTA><NlmUniqueID>101698425</NlmUniqueID><ISSNLinking>2473-9529</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006761" MajorTopicYN="N">Hospitals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="Y">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="Y">Venous Thrombosis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Conflict-of-interest disclosure: R.K. received research support from Bristol-Myers Squibb and Takeda. D.M.W received research support and consulting fees from Roche Diagnostics. H.J.S. was the principal investigator for the McMaster GRADE Centre and received funding from ASH that supported this systematic review. The remaining authors declare no competing financial interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>11</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>2</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32040553</ArticleId><ArticleId IdType="pmc">PMC7013254</ArticleId><ArticleId IdType="doi">10.1182/bloodadvances.2019001223</ArticleId><ArticleId IdType="pii">S2473-9529(20)31497-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tagalakis V, Patenaude V, Kahn SR, Suissa S. Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE study cohort. Am J Med. 2013;126(9):832.e13-832.e21.</Citation><ArticleIdList><ArticleId IdType="pubmed">23830539</ArticleId></ArticleIdList></Reference><Reference><Citation>Heit JA, Silverstein MD, Mohr DN, Petterson TM, O&#x2019;Fallon WM, Melton LJ III. Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med. 1999;159(5):445-453.</Citation><ArticleIdList><ArticleId IdType="pubmed">10074952</ArticleId></ArticleIdList></Reference><Reference><Citation>McRae SJ, Ginsberg JS. Initial treatment of venous thromboembolism [published corrections appear in Circulation. 2004;110(24 suppl 1):IV33 and Circulation. 2005;111(3):378]. Circulation. 2004;110(9 suppl 1):I3-I9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15339875</ArticleId></ArticleIdList></Reference><Reference><Citation>Koopman MM, Prandoni P, Piovella F, et al. ; The Tasman Study Group . Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. N Engl J Med. 1996;334(11):682-687.</Citation><ArticleIdList><ArticleId IdType="pubmed">8594426</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine M, Gent M, Hirsh J, et al. . A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med. 1996;334(11):677-681.</Citation><ArticleIdList><ArticleId IdType="pubmed">8594425</ArticleId></ArticleIdList></Reference><Reference><Citation>Kearon C, Akl EA, Comerota AJ, et al. . Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines Chest. 2012;141(suppl 2):e419S-e496S.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3278049</ArticleId><ArticleId IdType="pubmed">22315268</ArticleId></ArticleIdList></Reference><Reference><Citation>Kearon C, Akl EA, Ornelas J, et al. . Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report [published correction appears in Chest. 2016;150(4):988]. Chest. 2016;149(2):315-352.</Citation><ArticleIdList><ArticleId IdType="pubmed">26867832</ArticleId></ArticleIdList></Reference><Reference><Citation>Almutairi AR, Zhou L, Gellad WF, et al. . Effectiveness and safety of non-vitamin K antagonist oral anticoagulants for atrial fibrillation and venous thromboembolism: a systematic review and meta-analyses. Clin Ther. 2017;39(7):1456-1478.e36.</Citation><ArticleIdList><ArticleId IdType="pubmed">28668628</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinson DR, Ballard DW, Huang J, et al. ; MAPLE Investigators of the KP CREST Network . Outpatient management of emergency department patients with acute pulmonary embolism: variation, patient characteristics, and outcomes. Ann Emerg Med. 2018;72(1):62-72.e3.</Citation><ArticleIdList><ArticleId IdType="pubmed">29248335</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer AJ, Thode HC Jr., Peacock WF IV. Admission rates for emergency department patients with venous thromboembolism and estimation of the proportion of low risk pulmonary embolism patients: a US perspective. Clin Exp Emerg Med. 2016;3(3):126-131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5065336</ArticleId><ArticleId IdType="pubmed">27752630</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011.  Available at: www.handbook.cochrane.org. Accessed 10 October 2019.</Citation></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, et al. . The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62(10):e1-e34.</Citation><ArticleIdList><ArticleId IdType="pubmed">19631507</ArticleId></ArticleIdList></Reference><Reference><Citation>Othieno R, Okpo E, Forster R. Home versus in-patient treatment for deep vein thrombosis. Cochrane Database Syst Rev. 2018;1:CD003076.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6491318</ArticleId><ArticleId IdType="pubmed">29315455</ArticleId></ArticleIdList></Reference><Reference><Citation>MDCalc. Pulmonary Embolism Severity Index (PESI). Available at: https://www.mdcalc.com/pulmonary-embolism-severity-index-pesi. Accessed 15 November 2019.</Citation></Reference><Reference><Citation>Schulman S, Kearon C; Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis . Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005;3(4):692-694.</Citation><ArticleIdList><ArticleId IdType="pubmed">15842354</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, et al. ; GRADE Working Group . GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924-926.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Boccalon H, Elias A, Chal&#xe9; JJ, Cad&#xe8;ne A, Gabriel S. Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with a low-molecular-weight heparin: the Vascular Midi-Pyrenees study. Arch Intern Med. 2000;160(12):1769-1773.</Citation><ArticleIdList><ArticleId IdType="pubmed">10871969</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramacciotti E, Ara&#xfa;jo GR, Lastoria S, et al. ; CLETRAT Investigators . An open-label, comparative study of the efficacy and safety of once-daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep-vein thrombosis. Thromb Res. 2004;114(3):149-153.</Citation><ArticleIdList><ArticleId IdType="pubmed">15342210</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong BH, Brighton TA, Baker RI, Thurlow P, Lee CH; ASTH DVT Study Group . Once-daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep-vein thrombosis. J Thromb Thrombolysis. 2005;19(3):173-181.</Citation><ArticleIdList><ArticleId IdType="pubmed">16082604</ArticleId></ArticleIdList></Reference><Reference><Citation>Daskalopoulos ME, Daskalopoulou SS, Tzortzis E, et al. . Long-term treatment of deep venous thrombosis with a low molecular weight heparin (tinzaparin): a prospective randomized trial. Eur J Vasc Endovasc Surg. 2005;29(6):638-650.</Citation><ArticleIdList><ArticleId IdType="pubmed">15878544</ArticleId></ArticleIdList></Reference><Reference><Citation>Romera-Villegas A, Cairols-Castellote MA, Vila-Coll R, et al. . Early mobilisation in patients with acute deep vein thrombosis does not increase the risk of a symptomatic pulmonary embolism. Int Angiol. 2008;27(6):494-499.</Citation><ArticleIdList><ArticleId IdType="pubmed">19078912</ArticleId></ArticleIdList></Reference><Reference><Citation>Aujesky D, Roy PM, Verschuren F, et al. . Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial. Lancet. 2011;378(9785):41-48.</Citation><ArticleIdList><ArticleId IdType="pubmed">21703676</ArticleId></ArticleIdList></Reference><Reference><Citation>Frank Peacock W, Coleman CI, Diercks DB, et al. . Emergency department discharge of pulmonary embolus patients. Acad Emerg Med. 2018;25(9):995-1003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6175358</ArticleId><ArticleId IdType="pubmed">29757489</ArticleId></ArticleIdList></Reference><Reference><Citation>Beer JH, Burger M, Gretener S, Bernard-Bagattini S, Bounameaux H. Outpatient treatment of pulmonary embolism is feasible and safe in a substantial proportion of patients. J Thromb Haemost. 2003;1(1):186-187.</Citation><ArticleIdList><ArticleId IdType="pubmed">12871557</ArticleId></ArticleIdList></Reference><Reference><Citation>Siragusa S, Arcara C, Malato A, et al. . Home therapy for deep vein thrombosis and pulmonary embolism in cancer patients. Ann Oncol. 2005;16(suppl 4):iv136-iv139.</Citation><ArticleIdList><ArticleId IdType="pubmed">15923414</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez-Cerrillo M, Alvarez-Arcaya A, Fern&#xe1;ndez-D&#xed;az E, Fern&#xe1;ndez-Cruz A. A prospective study of the management of non-massive pulmonary embolism in the home. Eur J Intern Med. 2009;20(6):598-600.</Citation><ArticleIdList><ArticleId IdType="pubmed">19782920</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovacs MJ, Hawel JD, Rekman JF, Lazo-Langner A. Ambulatory management of pulmonary embolism: a pragmatic evaluation. J Thromb Haemost. 2010;8(11):2406-2411.</Citation><ArticleIdList><ArticleId IdType="pubmed">20626624</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahler ZP, Beam DM, Kline JA. Cost of treating venous thromboembolism with heparin and warfarin versus home treatment with rivaroxaban. Acad Emerg Med. 2015;22(7):796-802.</Citation><ArticleIdList><ArticleId IdType="pubmed">26111453</ArticleId></ArticleIdList></Reference><Reference><Citation>Li A, Garcia DA, Lyman GH, Carrier M. Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): a systematic review and meta-analysis. Thromb Res. 2019;173:158-163.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6119655</ArticleId><ArticleId IdType="pubmed">29506866</ArticleId></ArticleIdList></Reference><Reference><Citation>Barco S, Schmidtmann I, Ageno W, et al. ; HoT-PE Investigators . 
Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial [published online ahead of print 23 May 2019]. Eur Heart J. doi:10.1093/eurheartj/ehz367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehz367</ArticleId><ArticleId IdType="pubmed">31120118</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo HH, Nunes-Nogueira VS, Fortes Villas Boas PJ, Broderick C. Outpatient versus inpatient treatment for acute pulmonary embolism. Cochrane Database Syst Rev. 2019;3:CD010019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6402388</ArticleId><ArticleId IdType="pubmed">30839095</ArticleId></ArticleIdList></Reference><Reference><Citation>Zondag W, Kooiman J, Klok FA, Dekkers OM, Huisman MV. Outpatient versus inpatient treatment in patients with pulmonary embolism: a meta-analysis. Eur Respir J. 2013;42(1):134-144.</Citation><ArticleIdList><ArticleId IdType="pubmed">23100493</ArticleId></ArticleIdList></Reference><Reference><Citation>Lozano F, Trujillo-Santos J, Barron M, et al. . Home versus in-hospital treatment of outpatients with acute deep venous thrombosis of the lower limbs. J Vasc Surg. 2014;59(5):1362-1367.e1.</Citation><ArticleIdList><ArticleId IdType="pubmed">24439322</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29221480</PMID><DateCompleted><Year>2018</Year><Month>07</Month><Day>24</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2466</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>Dec</Month><Day>08</Day></PubDate></JournalIssue><Title>BMC pulmonary medicine</Title><ISOAbbreviation>BMC Pulm Med</ISOAbbreviation></Journal><ArticleTitle>Prevalence and etiologies of pulmonary hypertension in Africa: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>183</StartPage><MedlinePgn>183</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">183</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12890-017-0549-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Despite the recent increasing worldwide attention towards pulmonary hypertension (PH), its epidemiology remains poorly described in Africa. Accordingly, we performed a systematic review and meta-analysis of PH prevalence, incidence and etiologies in Africa.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched PubMed, EMBASE, African Journals Online, and Africa Index Medicus. Published observational studies until September 20, 2017, including adult participants residing in Africa were considered. Two review authors independently selected studies, assessed included studies for methodological quality, and extracted data. A random-effects model was used for meta-analysis. Heterogeneity was evaluated by the &#x3c7; <sup>2</sup> test on Cochrane's Q statistic which is quantified by I<sup>2</sup> values. Using Newcastle-Ottawa Scale, we considered a score of 0-4, 5-7, and 8-10 as indicative of high, moderate, and low risk of bias in included studies, respectively.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 1611 entries, 25 studies were retained. Twelve (48%), seven (28%), and six (24%) papers had respectively a low, moderate and high risk of bias. The prevalence of PH widely varied across different populations: 9.8% (95% confidence interval: 3.2-19.3; I<sup>2</sup>&#x2009;=&#x2009;99.4%; 6 studies) in 11,163 people presenting with cardiac complaints; 10.6% (4.3-19.1; I<sup>2</sup>&#x2009;=&#x2009;90.3%; 4 studies) in 937 HIV-infected people; 32.9% (17.6-50.4; I<sup>2</sup>&#x2009;=&#x2009;97.2%; 3 studies) in 2077 patients with heart failure; 23.2% (15.2-32.2; I<sup>2</sup>&#x2009;=&#x2009;59.4%; 3 studies) in 248 patients on hemodialysis; 12.9% (11.8-14.0; I<sup>2</sup>&#x2009;=&#x2009;79.7%; 2 studies) in 3750 patients with rheumatic heart disease; 36.9% (29.7-44.3; I<sup>2</sup>&#x2009;=&#x2009;79.7; 2 studies) in 79 patients with sickle cell disease; 62.7% (49.0-74.7; 1 study) in 51 patients with chronic obstructive pulmonary disease; 25.4% (16.3-37.3; 1 study) in 63 patients with systemic lupus erythematous; 68.7% (62.8-74.1; 1 study) in 259 patients with cardiac surgery; and 7.4% (4.6-11.9; 1 study) in 202 patients with systemic sclerosis. No study reported PH incidence. From one international study (n&#x2009;=&#x2009;209), PH etiologies were: left heart disease (68.9%), pulmonary arterial hypertension (15.8%), lung disease and/or hypoxia (12.0%), chronic thromboembolic PH (1.9%) and unclear/multifactorial PH (15.8%).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The prevalence of PH is relatively high in some populations in Africa, perhaps mainly driven by left heart diseases, highlighting the need for context-specific interventions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bigna</LastName><ForeName>Jean Joel</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Public Health, Centre Pasteur of Cameroon, Yaound&#xe9;, Cameroon. bignarimjj@yahoo.fr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Paris Sud XI, Le Kremlin Bic&#xea;tre, France. bignarimjj@yahoo.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Noubiap</LastName><ForeName>Jean Jacques</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Medicine, Groote Schuur Hospital and University of Cape Town, Cape Town, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nansseu</LastName><ForeName>Jobert Richie</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Public Health, Faculty of Medicine and Biomedical Sciences, University of Yaound&#xe9; 1, Yaound&#xe9;, Cameroon.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sickle Cell Disease Unit, Mother and Child Centre of the Chantal Biya Foundation, Yaound&#xe9;, Cameroon.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Disease, Epidemics and Pandemics Control, Ministry of Public Health, Yaound&#xe9;, Cameroon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aminde</LastName><ForeName>Leopold Ndemnge</ForeName><Initials>LN</Initials><AffiliationInfo><Affiliation>Clinical Research Education, Networking and Consultancy (CRENC), Douala, Cameroon.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Public Health, Faculty of Medicine &amp; Biomedical Sciences, University of Queensland, Brisbane, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>12</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Pulm Med</MedlineTA><NlmUniqueID>100968563</NlmUniqueID><ISSNLinking>1471-2466</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000349" MajorTopicYN="N">Africa</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000755" MajorTopicYN="N">Anemia, Sickle Cell</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="N">Heart Failure</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006976" MajorTopicYN="N">Hypertension, Pulmonary</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000860" MajorTopicYN="N">Hypoxia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007676" MajorTopicYN="N">Kidney Failure, Chronic</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008171" MajorTopicYN="N">Lung Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029424" MajorTopicYN="N">Pulmonary Disease, Chronic Obstructive</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012214" MajorTopicYN="N">Rheumatic Heart Disease</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012595" MajorTopicYN="N">Scleroderma, Systemic</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Africa</Keyword><Keyword MajorTopicYN="N">Epidemiology</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Pulmonary arterial hypertension</Keyword><Keyword MajorTopicYN="N">Pulmonary hypertension</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword></KeywordList><CoiStatement>ETHICS APPROVAL AND CONSENT TO PARTICIPATE: Not applicable. CONSENT FOR PUBLICATION: Not applicable. COMPETING INTERESTS: The authors declare that they have no competing interests. PUBLISHER&#x2019;S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>12</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>12</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>7</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>12</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29221480</ArticleId><ArticleId IdType="pmc">PMC5723068</ArticleId><ArticleId IdType="doi">10.1186/s12890-017-0549-5</ArticleId><ArticleId IdType="pii">10.1186/s12890-017-0549-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hoeper MM, Bogaard HJ, Condliffe R, Frantz R, Khanna D, Kurzyna M, Langleben D, Manes A, Satoh T, Torres F, et al. Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol. 2013;62(25 Suppl):D42&#x2013;D50. doi: 10.1016/j.jacc.2013.10.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2013.10.032</ArticleId><ArticleId IdType="pubmed">24355641</ArticleId></ArticleIdList></Reference><Reference><Citation>Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT) Eur Respir J. 2015;46(4):903&#x2013;975. doi: 10.1183/13993003.01032-2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01032-2015</ArticleId><ArticleId IdType="pubmed">26318161</ArticleId></ArticleIdList></Reference><Reference><Citation>Tueller C, Stricker H, Soccal P, Tamm M, Aubert JD, Maggiorini M, Zwahlen M, Nicod L. Epidemiology of pulmonary hypertension: new data from the Swiss registry. Swiss Med Wkly. 2008;138(25&#x2013;26):379&#x2013;384.</Citation><ArticleIdList><ArticleId IdType="pubmed">18587690</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown LM, Chen H, Halpern S, Taichman D, McGoon MD, Farber HW, Frost AE, Liou TG, Turner M, Feldkircher K, et al. Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL registry. Chest. 2011;140(1):19&#x2013;26. doi: 10.1378/chest.10-1166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.10-1166</ArticleId><ArticleId IdType="pmc">PMC3198486</ArticleId><ArticleId IdType="pubmed">21393391</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Kernis JT, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med. 1991;115(5):343&#x2013;349. doi: 10.7326/0003-4819-115-5-343.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-115-5-343</ArticleId><ArticleId IdType="pubmed">1863023</ArticleId></ArticleIdList></Reference><Reference><Citation>Benza RL, Miller DP, Barst RJ, Badesch DB, Frost AE, McGoon MD. An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL registry. Chest. 2012;142(2):448&#x2013;456. doi: 10.1378/chest.11-1460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.11-1460</ArticleId><ArticleId IdType="pubmed">22281797</ArticleId></ArticleIdList></Reference><Reference><Citation>Thienemann F, Sliwa K, Rockstroh JK. HIV and the heart: the impact of antiretroviral therapy: a global perspective. Eur Heart J. 2013;34(46):3538&#x2013;3546. doi: 10.1093/eurheartj/eht388.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/eht388</ArticleId><ArticleId IdType="pubmed">24126882</ArticleId></ArticleIdList></Reference><Reference><Citation>Mocumbi AO, Lameira E, Yaksh A, Paul L, Ferreira MB, Sidi D. Challenges on the management of congenital heart disease in developing countries. Int J Cardiol. 2011;148(3):285&#x2013;288. doi: 10.1016/j.ijcard.2009.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2009.11.006</ArticleId><ArticleId IdType="pubmed">19932516</ArticleId></ArticleIdList></Reference><Reference><Citation>Bigna JJ, Nansseu JR, Um LN, Noumegni SR, Sime PS, Aminde LN, Koulla-Shiro S, Noubiap JJ. Prevalence and incidence of pulmonary hypertension among HIV-infected people in Africa: a systematic review and meta-analysis. BMJ Open. 2016;6(8):e011921. doi: 10.1136/bmjopen-2016-011921.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2016-011921</ArticleId><ArticleId IdType="pmc">PMC5013504</ArticleId><ArticleId IdType="pubmed">27554104</ArticleId></ArticleIdList></Reference><Reference><Citation>Bigna JJ, Sime PS, Koulla-Shiro S. HIV related pulmonary arterial hypertension: epidemiology in Africa, physiopathology, and role of antiretroviral treatment. AIDS Res Ther. 2015;12:36. doi: 10.1186/s12981-015-0078-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12981-015-0078-3</ArticleId><ArticleId IdType="pmc">PMC4642627</ArticleId><ArticleId IdType="pubmed">26566389</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization: Shistosomiasis country maps [http://www.who.int/schistosomiasis/epidemiology/global_atlas_maps/en/].</Citation></Reference><Reference><Citation>Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ: Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386(10003):1546-55.</Citation><ArticleIdList><ArticleId IdType="pubmed">26231459</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013;57(4):1333&#x2013;1342. doi: 10.1002/hep.26141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.26141</ArticleId><ArticleId IdType="pubmed">23172780</ArticleId></ArticleIdList></Reference><Reference><Citation>Sliwa K, Wilkinson D, Hansen C, Ntyintyane L, Tibazarwa K, Becker A, Stewart S. Spectrum of heart disease and risk factors in a black urban population in South Africa (the heart of Soweto study): a cohort study. Lancet. 2008;371(9616):915&#x2013;922. doi: 10.1016/S0140-6736(08)60417-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(08)60417-1</ArticleId><ArticleId IdType="pubmed">18342686</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart S, Wilkinson D, Hansen C, Vaghela V, Mvungi R, McMurray J, Sliwa K. Predominance of heart failure in the heart of Soweto study cohort: emerging challenges for urban African communities. Circulation. 2008;118(23):2360&#x2013;2367. doi: 10.1161/CIRCULATIONAHA.108.786244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.108.786244</ArticleId><ArticleId IdType="pubmed">19029467</ArticleId></ArticleIdList></Reference><Reference><Citation>Thienemann F, Dzudie A, Mocumbi AO, Blauwet L, Sani MU, Karaye KM, Ogah OS, Mbanze I, Mbakwem A, Udo P, et al. Rationale and design of the pan African pulmonary hypertension cohort (PAPUCO) study: implementing a contemporary registry on pulmonary hypertension in Africa. BMJ Open. 2014;4(10):e005950. doi: 10.1136/bmjopen-2014-005950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2014-005950</ArticleId><ArticleId IdType="pmc">PMC4202005</ArticleId><ArticleId IdType="pubmed">25763797</ArticleId></ArticleIdList></Reference><Reference><Citation>Thienemann F, Dzudie A, Mocumbi AO, Blauwet L, Sani MU, Karaye KM, Ogah OS, Mbanze I, Mbakwem A, Udo P, et al. The causes, treatment, and outcome of pulmonary hypertension in Africa: insights from the pan African pulmonary hypertension cohort (PAPUCO) registry. Int J Cardiol. 2016;221:205&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">27404676</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000;283(15):2008&#x2013;2012. doi: 10.1001/jama.283.15.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.283.15.2008</ArticleId><ArticleId IdType="pubmed">10789670</ArticleId></ArticleIdList></Reference><Reference><Citation>Bigna JJ, Noubiap JJ, Nansseu JR, Aminde LN. Prevalence, incidence and aetiologies of pulmonary hypertension in Africa: a systematic review and meta-analysis protocol. BMJ Open. 2017;7(6):e014768.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5623436</ArticleId><ArticleId IdType="pubmed">28624758</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.</Citation></Reference><Reference><Citation>Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T. Meta-analysis of prevalence. J Epidemiol Community Health. 2013;67(11):974&#x2013;978. doi: 10.1136/jech-2013-203104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jech-2013-203104</ArticleId><ArticleId IdType="pubmed">23963506</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochran GW. The combination of estimates from different experiments. Biometrics. 1954;10(1):101&#x2013;129. doi: 10.2307/3001666.</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/3001666</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539&#x2013;1558. doi: 10.1002/sim.1186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1186</ArticleId><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med. 2005;37(5):360&#x2013;363.</Citation><ArticleIdList><ArticleId IdType="pubmed">15883903</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629&#x2013;634. doi: 10.1136/bmj.315.7109.629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.315.7109.629</ArticleId><ArticleId IdType="pmc">PMC2127453</ArticleId><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference><Reference><Citation>Adem A, Abebe S, Hailu A, Feleke B, Berhe M, Atsibeha M, Davilla VG. Heart diseases in north ethiopia pattern of echocardiographic abnormalities among adult cardiac patients - an experience from Ayder Hospital of Mekelle University. Ethiop Med J. 2014;52(4):173&#x2013;183.</Citation><ArticleIdList><ArticleId IdType="pubmed">26410990</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin M, Fawzy A, Hamid MA, Elhendy A. Pulmonary hypertension in patients with chronic renal failure: role of parathyroid hormone and pulmonary artery calcifications. Chest. 2003;124(6):2093&#x2013;2097. doi: 10.1378/chest.124.6.2093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.124.6.2093</ArticleId><ArticleId IdType="pubmed">14665485</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakari M, Chillo P, Lwakatare J: Factors associated with, and echocardiographic findings of heart failure among HIV infected patients at a tertiary health care facility in Dar es Salaam, Tanzania. Tanzan J Health Res. 2013;15(2):1-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">26591712</ArticleId></ArticleIdList></Reference><Reference><Citation>Conteh S, Ogola EA, Oyoo GO, Gitura BM, Achieng L. Echocardiographic abnormalities in systemic lupus erythematosus patients at Kenyatta National Hospital. Afr J Rheumatol. 2016;4(1):9-13.</Citation></Reference><Reference><Citation>Ezzahra SF, Meriam A, Rachida H. Value of non-invasive assessment of pulmonary hypertension in heart failure with preserved ejection fraction, and its prognostic importance. Cardiovasc J Afr. 2015;26(5):29&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Ezzahra SF, Meriam A, Rachida H. Prevalence and outcomes of pulmonary hypertension and diastolic dysfunction in a heart failure population. Cardiovasc J Afr. 2015;26(5):30.</Citation></Reference><Reference><Citation>Faqih SA, Noto-Kadou-Kaza B, Abouamrane LM, Mtiou N, El Khayat S, Zamd M, Medkouri G, Benghanem MG, Ramdani B. Pulmonary hypertension: prevalence and risk factors. IJC Heart Vasculature. 2016;11:87&#x2013;89. doi: 10.1016/j.ijcha.2016.05.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcha.2016.05.012</ArticleId><ArticleId IdType="pmc">PMC5462628</ArticleId><ArticleId IdType="pubmed">28616531</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaber K, Elfaitouri O, Hassi S, Embaig O, Najem S: Prevalence of pulmonary hypertension in patients attending echocardiolgy clinic in the eastern part of libya. Chest. 2014;145(3, Supplement):516A.</Citation></Reference><Reference><Citation>Kafata LIO, Ngolet L, Letomo KN, Bakekolo P, Gankama T, Kimbally-Kaky G, Makani J. Echocardiographic aspects of Congolese sickle cell disease heart. Arch Cardiovasc Dis Suppl. 2016;8(1):43.</Citation></Reference><Reference><Citation>Karaye KM, Saidu H, Bala MS, Yahaya IA. Prevalence, clinical characteristics and outcome of pulmonary hypertension among admitted heart failure patients. Ann Afr Med. 2013;12(4):197&#x2013;204. doi: 10.4103/1596-3519.122685.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1596-3519.122685</ArticleId><ArticleId IdType="pubmed">24309407</ArticleId></ArticleIdList></Reference><Reference><Citation>Kingu&#xe9; S, Ba SA, Balde D, Diarra MB, Anzouan-Kacou JB, Anisubia B, Damorou JM, Ndobo P, Menanga A, Kane A, et al. The VALVAFRIC study: a registry of rheumatic heart disease in western and Central Africa. Arch Cardiovasc Dis. 2016;109(5):321&#x2013;329. doi: 10.1016/j.acvd.2015.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.acvd.2015.12.004</ArticleId><ArticleId IdType="pubmed">26988837</ArticleId></ArticleIdList></Reference><Reference><Citation>Mbolla BE, Kouala-Landa C, Mongo-Ngamami SF, Ikama MS, Bassakouahou JM, Bakekolo RP, Gombet TRA, Kimbally-Kaky SG. Clinical and echocardiographic profile of HIV-infected patients in cardiology Department at the University Hospital of Brazzaville (Congo) Arch Cardiovasc Dis Suppl. 2016;8(1):35.</Citation></Reference><Reference><Citation>Menanga AP, Ngomseu CK, Jingi AM, Mfangam BM, Noubiap JJ, Gweth MN, Blackett KN, Kingue S. Patterns of cardiovascular disease in a group of HIV-infected adults in Yaounde, Cameroon. Cardiovasc Diagn Ther. 2015;5(6):420&#x2013;427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4666691</ArticleId><ArticleId IdType="pubmed">26675421</ArticleId></ArticleIdList></Reference><Reference><Citation>Methia N, Latreche S, Benkhedda S. Frequency of PAH in scleroderma Algerian patients. Arch Cardiovasc Dis Suppl. 2016;8(1):62.</Citation></Reference><Reference><Citation>Mocumbi A, Majid N, Manafe N, Carlin A, Zimba I, Schooley R, Benson C. Anemia is a predictor of cardiac abnormalities and systolic function worsening in a African population with access to antiretroviral therapy. Glob Heart. 2016;11(2):e167. doi: 10.1016/j.gheart.2016.03.586.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gheart.2016.03.586</ArticleId></ArticleIdList></Reference><Reference><Citation>Okello E, Wanzhu Z, Musoke C, Twalib A, Kakande B, Lwabi P, Wilson NB, Mondo CK, Odoi-Adome R, Freers J. Cardiovascular complications in newly diagnosed rheumatic heart disease patients at Mulago hospital, Uganda. Cardiovasc J Afr. 2013;24(3):80&#x2013;85. doi: 10.5830/CVJA-2013-004.</Citation><ArticleIdList><ArticleId IdType="doi">10.5830/CVJA-2013-004</ArticleId><ArticleId IdType="pmc">PMC3721959</ArticleId><ArticleId IdType="pubmed">23736132</ArticleId></ArticleIdList></Reference><Reference><Citation>Reuben M. Characteristics and treatment outcomes of patients with and without pulmonary hypertension who underwent cardiac surgery at muhimbili cardiac unit from 2008 to 2012. Cardiovasc J Afr. 2015;26(5):25.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Sliwa K, Carrington MJ, Becker A, Thienemann F, Ntsekhe M, Stewart S. Contribution of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic to de novo presentations of heart disease in the heart of Soweto study cohort. Eur Heart J. 2012;33(7):866&#x2013;874. doi: 10.1093/eurheartj/ehr398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehr398</ArticleId><ArticleId IdType="pmc">PMC3345551</ArticleId><ArticleId IdType="pubmed">22048682</ArticleId></ArticleIdList></Reference><Reference><Citation>Soliman M, Heshmat H, Amen Y, Aboelhassan UE, Mahmod K. Detection of right sided heart changes and pulmonary hypertension in COPD patients. Egypt J Chest Dis Tuberc. 2015;64(2):335&#x2013;341. doi: 10.1016/j.ejcdt.2014.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcdt.2014.12.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart S, Mocumbi AO, Carrington MJ, Pretorius S, Burton R, Sliwa K. A not-so-rare form of heart failure in urban black Africans: pathways to right heart failure in the heart of Soweto study cohort. Eur J Heart Fail. 2011;13(10):1070&#x2013;1077. doi: 10.1093/eurjhf/hfr108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurjhf/hfr108</ArticleId><ArticleId IdType="pubmed">21937709</ArticleId></ArticleIdList></Reference><Reference><Citation>Suiru DB, Anastase D, Cabrai TT, Leopld A, Mocumbi AO, Martin A, Pascal KA, Friedrich T, Karen S. Pulmonary hypertension in a rural area: prevalence, correlates and clinical features from the Shisong cardiac Centre, Cameroon. Cardiovasc J Afr. 2015;26(5):14&#x2013;15.</Citation></Reference><Reference><Citation>Tarrass F, Benjelloun M, Medkouri G, Hachim K, Benghanem MG, Ramdani B. Doppler echocardiograph evaluation of pulmonary hypertension in patients undergoing hemodialysis. Hemodial Int. 2006;10(4):356&#x2013;359. doi: 10.1111/j.1542-4758.2006.00129.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1542-4758.2006.00129.x</ArticleId><ArticleId IdType="pubmed">17014511</ArticleId></ArticleIdList></Reference><Reference><Citation>Amadi VN, Balogun MO, Akinola NO, Adebayo RA, Akintomide AO. Pulmonary hypertension in Nigerian adults with sickle cell anemia. Vasc Health Risk Manag. 2017;13:153&#x2013;160. doi: 10.2147/VHRM.S92799.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/VHRM.S92799</ArticleId><ArticleId IdType="pmc">PMC5428794</ArticleId><ArticleId IdType="pubmed">28507438</ArticleId></ArticleIdList></Reference><Reference><Citation>Aminde LN, Dzudie A, Kengne AP, Ndjebet J, Mapoh S, Kuelang X, Kamdem F, Mbatchou Ngahane BH, Doualla M-S, Ngu KB et al: Gender disparities in pulmonary hypertension at a tertiary centre in Cameroon. S Afr Med J 2017, In press.</Citation><ArticleIdList><ArticleId IdType="pubmed">29022535</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah SJ. Pulmonary hypertension. JAMA. 2012;308(13):1366&#x2013;1374. doi: 10.1001/jama.2012.12347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2012.12347</ArticleId><ArticleId IdType="pubmed">23032553</ArticleId></ArticleIdList></Reference><Reference><Citation>Legendre P, Mouthon L. Pulmonary arterial hypertension associated with connective tissue diseases. Presse Med. 2014;43(9):957&#x2013;969. doi: 10.1016/j.lpm.2014.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lpm.2014.07.009</ArticleId><ArticleId IdType="pubmed">25129118</ArticleId></ArticleIdList></Reference><Reference><Citation>Sitbon O, Lascoux-Combe C, Delfraissy JF, Yeni PG, Raffi F, De Zuttere D, Gressin V, Clerson P, Sereni D, Simonneau G. Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era. Am J Respir Crit Care Med. 2008;177(1):108&#x2013;113. doi: 10.1164/rccm.200704-541OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200704-541OC</ArticleId><ArticleId IdType="pubmed">17932378</ArticleId></ArticleIdList></Reference><Reference><Citation>Quezada M, Martin-Carbonero L, Soriano V, Vispo E, Valencia E, Moreno V, de Isla LP, Lennie V, Almeria C, Zamorano JL. Prevalence and risk factors associated with pulmonary hypertension in HIV-infected patients on regular follow-up. AIDS. 2012;26(11):1387&#x2013;1392. doi: 10.1097/QAD.0b013e328354f5a1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QAD.0b013e328354f5a1</ArticleId><ArticleId IdType="pubmed">22526521</ArticleId></ArticleIdList></Reference><Reference><Citation>Speich R, Jenni R, Opravil M, Pfab M, Russi EW. Primary pulmonary hypertension in HIV infection. Chest. 1991;100(5):1268&#x2013;1271. doi: 10.1378/chest.100.5.1268.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.100.5.1268</ArticleId><ArticleId IdType="pubmed">1935280</ArticleId></ArticleIdList></Reference><Reference><Citation>Bigna JJ, Plottel CS, Koulla-Shiro S. Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count. Infect Dis Poverty. 2016;5:85. doi: 10.1186/s40249-016-0179-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40249-016-0179-9</ArticleId><ArticleId IdType="pmc">PMC5011352</ArticleId><ArticleId IdType="pubmed">27593965</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassaye SG, Katzenstein D. HIV/AIDS care and treatment in sub-Saharan Africa. AIDS Rev. 2003;5(4):195&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pubmed">15011998</ArticleId></ArticleIdList></Reference><Reference><Citation>Giuliano M, Vella S. Inequalities in health: access to treatment for HIV/AIDS. Ann Ist Super Sanita. 2007;43(4):313&#x2013;316.</Citation><ArticleIdList><ArticleId IdType="pubmed">18209264</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleary S. Equity and efficiency in scaling up access to HIV-related interventions in resource-limited settings. Curr Opin HIV AIDS. 2010;5(3):210&#x2013;214. doi: 10.1097/COH.0b013e3283384a6f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/COH.0b013e3283384a6f</ArticleId><ArticleId IdType="pubmed">20539076</ArticleId></ArticleIdList></Reference><Reference><Citation>Dzudie A, Kengne AP, Thienemann F, Sliwa K. Predictors of hospitalisations for heart failure and mortality in patients with pulmonary hypertension associated with left heart disease: a systematic review. BMJ Open. 2014;4(7):e004843. doi: 10.1136/bmjopen-2014-004843.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2014-004843</ArticleId><ArticleId IdType="pmc">PMC4120416</ArticleId><ArticleId IdType="pubmed">25011987</ArticleId></ArticleIdList></Reference><Reference><Citation>Adir Y, Amir O. Pulmonary hypertension associated with left heart disease. Semin Respir Crit Care Med. 2013;34(5):665&#x2013;680. doi: 10.1055/s-0033-1356490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0033-1356490</ArticleId><ArticleId IdType="pubmed">24037633</ArticleId></ArticleIdList></Reference><Reference><Citation>Haddad F, Kudelko K, Mercier O, Vrtovec B, Zamanian RT, de Jesus PV. Pulmonary hypertension associated with left heart disease: characteristics, emerging concepts, and treatment strategies. Prog Cardiovasc Dis. 2011;54(2):154&#x2013;167. doi: 10.1016/j.pcad.2011.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pcad.2011.06.003</ArticleId><ArticleId IdType="pubmed">21875514</ArticleId></ArticleIdList></Reference><Reference><Citation>Thenappan T, Gomberg-Maitland M. Epidemiology of pulmonary hypertension and right ventricular failure in left heart failure. Curr Heart Fail Rep. 2014;11(4):428&#x2013;435. doi: 10.1007/s11897-014-0216-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11897-014-0216-6</ArticleId><ArticleId IdType="pubmed">25135469</ArticleId></ArticleIdList></Reference><Reference><Citation>Privalova EV, Cherepenin LP, Ershov VI, Baloian GM, Buravikhina TA, Ermakov AI, Ivanov AS. Course of pulmonary hypertension in patients operated for rheumatic mitral heart disease. Terapevticheskii arkhiv. 2000;72(4):58&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">10833802</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen KH, Iversen M, Kjaergaard J, Mortensen J, Nielsen-Kudsk JE, Bendstrup E, Videbaek R, Carlsen J. Prevalence, predictors, and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary disease. J Heart Lung Transplant. 2012;31(4):373&#x2013;380. doi: 10.1016/j.healun.2011.11.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.healun.2011.11.020</ArticleId><ArticleId IdType="pubmed">22226804</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolignano D, Rastelli S, Agarwal R, Fliser D, Massy Z, Ortiz A, Wiecek A, Martinez-Castelao A, Covic A, Goldsmith D, et al. Pulmonary hypertension in CKD. Am J Kidney Dis. 2013;61(4):612&#x2013;622. doi: 10.1053/j.ajkd.2012.07.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2012.07.029</ArticleId><ArticleId IdType="pubmed">23164943</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordeuk VR, Castro OL, Machado RF. Pathophysiology and treatment of pulmonary hypertension in sickle cell disease. Blood. 2016;127(7):820&#x2013;828. doi: 10.1182/blood-2015-08-618561.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2015-08-618561</ArticleId><ArticleId IdType="pmc">PMC4760088</ArticleId><ArticleId IdType="pubmed">26758918</ArticleId></ArticleIdList></Reference><Reference><Citation>Ataga KI, Klings ES. Pulmonary hypertension in sickle cell disease: diagnosis and management. Hematology Am Soc Hematol Educ Program. 2014;2014(1):425&#x2013;431.</Citation><ArticleIdList><ArticleId IdType="pubmed">25696889</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenkranz S, Gibbs JS, Wachter R, De Marco T, Vonk-Noordegraaf A, Vachiery JL. Left ventricular heart failure and pulmonary hypertension. Eur Heart J. 2016;37(12):942&#x2013;954. doi: 10.1093/eurheartj/ehv512.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehv512</ArticleId><ArticleId IdType="pmc">PMC4800173</ArticleId><ArticleId IdType="pubmed">26508169</ArticleId></ArticleIdList></Reference><Reference><Citation>Guazzi M. Pulmonary hypertension in heart failure preserved ejection fraction: prevalence, pathophysiology, and clinical perspectives. Circ Heart Fail. 2014;7(2):367&#x2013;377. doi: 10.1161/CIRCHEARTFAILURE.113.000823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCHEARTFAILURE.113.000823</ArticleId><ArticleId IdType="pubmed">24643889</ArticleId></ArticleIdList></Reference><Reference><Citation>Zangiabadi A, De Pasquale CG, Sajkov D. Pulmonary hypertension and right heart dysfunction in chronic lung disease. Biomed Res Int. 2014;2014:739674. doi: 10.1155/2014/739674.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/739674</ArticleId><ArticleId IdType="pmc">PMC4140123</ArticleId><ArticleId IdType="pubmed">25165714</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller AC, Gladwin MT. Pulmonary complications of sickle cell disease. Am J Respir Crit Care Med. 2012;185(11):1154&#x2013;1165. doi: 10.1164/rccm.201111-2082CI.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201111-2082CI</ArticleId><ArticleId IdType="pmc">PMC3373067</ArticleId><ArticleId IdType="pubmed">22447965</ArticleId></ArticleIdList></Reference><Reference><Citation>Badawy MS, El-Senbesy MA, Mahmoud HS. Evaluation of pulmonary hypertension in Bilharzial patients. Egypt J Chest Dis Tuberc. 2013;62(2):305&#x2013;309. doi: 10.1016/j.ejcdt.2013.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcdt.2013.04.009</ArticleId></ArticleIdList></Reference><Reference><Citation>Dosunmu AO, Balogun TM, Adeyeye OO, Daniel FA, Akinola RA, Onakoya JA, Akinbami AA, Sagoe AO, Onadeko BO. Prevalence of pulmonary hypertension in sickle cell anaemia patients of a tertiary hospital in Nigeria. Niger Med J. 2014;55(2):161&#x2013;165. doi: 10.4103/0300-1652.129661.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0300-1652.129661</ArticleId><ArticleId IdType="pmc">PMC4003721</ArticleId><ArticleId IdType="pubmed">24791052</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamel SR, Omar GM, Darwish AF, Asklany HT, Ellabban AS. Asymptomatic pulmonary hypertension in systemic lupus erythematosus. Clin Med Insights Arthritis Musculoskelet Disord. 2011;4:77&#x2013;86. doi: 10.4137/CMAMD.S7667.</Citation><ArticleIdList><ArticleId IdType="doi">10.4137/CMAMD.S7667</ArticleId><ArticleId IdType="pmc">PMC3201107</ArticleId><ArticleId IdType="pubmed">22084605</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller RF, Kaski JP, Hakim J, Matenga J, Nathoo K, Munyati S, Desai SR, Corbett EL, Ferrand RA. Cardiac disease in adolescents with delayed diagnosis of vertically acquired HIV infection. Clin Infect Dis. 2013;56(4):576&#x2013;582. doi: 10.1093/cid/cis911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cis911</ArticleId><ArticleId IdType="pmc">PMC3552526</ArticleId><ArticleId IdType="pubmed">23097588</ArticleId></ArticleIdList></Reference><Reference><Citation>Oguanobi NI, Ejim EC, Anisiuba BC, Onwubere BJ, Ike SO, Ibegbulam OG, Agwu O. Clinical and electrocardiographic evaluation of sickle-cell anaemia patients with pulmonary hypertension. ISRN Hematol. 2012;2012:768718. doi: 10.5402/2012/768718.</Citation><ArticleIdList><ArticleId IdType="doi">10.5402/2012/768718</ArticleId><ArticleId IdType="pmc">PMC3320006</ArticleId><ArticleId IdType="pubmed">22536523</ArticleId></ArticleIdList></Reference><Reference><Citation>Oguanobi NI, Ejim EC, Anisiuba BC, Onwubere BJC, Ike SO, Ibegbulam OG. Echocardiographic assessment of adult Nigerian sickle cell patients with pulmonary hypertension. Eur J Cardiovasc Med. 2015;3(1):430&#x2013;434.</Citation></Reference><Reference><Citation>Orji FT, Adiele DK, Umedum NG, Akpeh JO, Ofoegbu VC, Nwosu JN: The clinical and radiological predictors of pulmonary hypertension in children with adenotonsillar hypertrophy. Eur Arch otorhinolaryngol 2016.</Citation><ArticleIdList><ArticleId IdType="pubmed">27430227</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, Mondo C, Okello E, Musoke C, Kakande B, Nyakoojo W, Kayima J, Freers J. Presenting features of newly diagnosed rheumatic heart disease patients in Mulago hospital: a pilot study. Cardiovasc J Afr. 2013;24(2):28&#x2013;33. doi: 10.5830/CVJA-2012-076.</Citation><ArticleIdList><ArticleId IdType="doi">10.5830/CVJA-2012-076</ArticleId><ArticleId IdType="pmc">PMC3734881</ArticleId><ArticleId IdType="pubmed">23612950</ArticleId></ArticleIdList></Reference><Reference><Citation>Ezzahra SF, Meriam A, Rachida H. Echocardiographic assessment of pulmonary artery systolic pressure and outcomes in ambulatory heart failure patients: a moroccan study. Cardiovasc J Afr. 2015;26(5):29.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrag A, El-Aroussy W, Zaghloul S, El-Guindy M, Yacoub M. Prevalence and severity of pulmonary hypertension in asymptomatic rural residents with schistosomal infection in the Nile Delta. Trop Med Int Health. 2012;17(1):112&#x2013;118. doi: 10.1111/j.1365-3156.2011.02891.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-3156.2011.02891.x</ArticleId><ArticleId IdType="pubmed">21951396</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrag AAM, El Aroussy W, Zaghloul S, El Guindy M, Yacoub M. Assessment of right ventricular function and severity of pulmonary hypertension in subjects previously infected with schistosomaisis in Nile Delta. Eur Heart J. 2011;32:598. doi: 10.1093/eurheartj/ehq452.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehq452</ArticleId><ArticleId IdType="pmc">PMC3257309</ArticleId><ArticleId IdType="pubmed">21156722</ArticleId></ArticleIdList></Reference><Reference><Citation>Rifaie O, El-Damanhory H, Amr M, Nammas W. Prevalence and predictors of pulmonary hypertension in elderly patients with isolated diastolic heart failure. Kardiol Pol. 2010;68(6):655&#x2013;661.</Citation><ArticleIdList><ArticleId IdType="pubmed">20806196</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva PS, Cartacho MP, Castro CC, Salgado Filho MF, Brandao AC. Evaluation of the influence of pulmonary hypertension in ultra-fast-track anesthesia technique in adult patients undergoing cardiac surgery. Rev Bras Cir Cardiovasc. 2015;30(4):449&#x2013;458.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4614928</ArticleId><ArticleId IdType="pubmed">27163419</ArticleId></ArticleIdList></Reference><Reference><Citation>Soliman EZ, Sharma S, Arasteh K, Wohl D, Achhra A, Tambussi G, O'Connor J, Stein JH, Duprez DA, Neaton JD, et al. Baseline cardiovascular risk in the INSIGHT strategic timing of AntiRetroviral treatment (START) trial. HIV Med. 2015;16(Suppl 1):46&#x2013;54. doi: 10.1111/hiv.12233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/hiv.12233</ArticleId><ArticleId IdType="pmc">PMC4341949</ArticleId><ArticleId IdType="pubmed">25711323</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, Gomez Sanchez MA, Krishna Kumar R, Landzberg M, Machado RF, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013;62(25 Suppl):D34&#x2013;D41. doi: 10.1016/j.jacc.2013.10.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2013.10.029</ArticleId><ArticleId IdType="pubmed">24355639</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31039477</PMID><DateCompleted><Year>2020</Year><Month>03</Month><Day>02</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-2472</ISSN><JournalIssue CitedMedium="Internet"><Volume>178</Volume><PubDate><Year>2019</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Thrombosis research</Title><ISOAbbreviation>Thromb Res</ISOAbbreviation></Journal><ArticleTitle>Sex-specific differences in pulmonary embolism.</ArticleTitle><Pagination><StartPage>173</StartPage><EndPage>181</EndPage><MedlinePgn>173-181</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.thromres.2019.04.020</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0049-3848(19)30213-0</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Sex-specific differences regarding risk factors, symptoms and prognosis have been reported for several cardiovascular diseases. For patients with pulmonary embolism (PE), sex-specific data are limited and inconsistent. We aimed to investigate sex-specific differences in PE.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Over a 10-year period (01/2003-09/2013), patients with confirmed PE were enrolled in a prospective single-centre cohort study.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We prospectively examined 569 PE patients (55.9% women). Men more often had cancer (20.7% vs. 13.5%, p&#x202f;=&#x202f;0.024) and unprovoked PE (61.0% vs. 47.5%, p&#x202f;=&#x202f;0.001) while women more frequently presented with risk factors for venous thromboembolism such as older age (median, 71 [IQR, 55-79] vs. 67 [53-75] years, p&#x202f;=&#x202f;0.008), surgery/trauma/immobilisation (38.4% vs. 29.5%, p&#x202f;=&#x202f;0.026) and sex-hormone therapy (14.8% vs. 0.8%, p&#x202f;&lt;&#x202f;0.001). Overall, 84 patients (14.8%) had an adverse 30-day outcome and 43 (7.6%) died within 30&#x202f;days; outcomes did not differ between males and females and were not influenced by the patients' sex. Risk stratification markers and models such as right ventricular dysfunction on TTE/CT, cardiac troponin, sPESI, Bova score and 2014 ESC guidelines algorithm predicted adverse outcome in normotensive female patients only, while tachycardia, hypoxia, NT-proBNP and modified FAST score were able to predict an adverse outcome in both sexes. Using sex-specific biomarker cut-off values, the 2014 ESC guidelines algorithm was able to predict adverse outcome in both sexes.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The 30-day adverse outcomes did not differ between male and female PE patients and were not influenced by the patients' sex despite sex-specific differences in the prognostic performance of risk stratification markers/models.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Keller</LastName><ForeName>Karsten</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Center for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rappold</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Clinic for Internal Medicine, Siloah St. Trudpert Clinic, Pforzheim, Germany; Clinic for Cardiology and Pulmonology, Heart Center, University Medical Center G&#xf6;ttingen, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerhold-Ay</LastName><ForeName>Aslihan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany; Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hobohm</LastName><ForeName>Lukas</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Center for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany; Department of Cardiology, Cardiology I, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hasenfu&#xdf;</LastName><ForeName>Gerd</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Clinic for Cardiology and Pulmonology, Heart Center, University Medical Center G&#xf6;ttingen, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Konstantinides</LastName><ForeName>Stavros V</ForeName><Initials>SV</Initials><AffiliationInfo><Affiliation>Center for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany; Department of Cardiology, Democritus University Thrace, Alexandroupolis, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dellas</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Paediatric Cardiology and Intensive Care, GUCH Center, University Medical Center G&#xf6;ttingen, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lankeit</LastName><ForeName>Mareike</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany; Clinic for Cardiology and Pulmonology, Heart Center, University Medical Center G&#xf6;ttingen, G&#xf6;ttingen, Germany; Department of Internal Medicine and Cardiology, Campus Virchow Klinikum (CVK), Charit&#xe9; - University Medicine Berlin, Berlin, Germany. Electronic address: mareike.lankeit@charite.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>04</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Thromb Res</MedlineTA><NlmUniqueID>0326377</NlmUniqueID><ISSNLinking>0049-3848</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012727" MajorTopicYN="Y">Sex Characteristics</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Gender</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Prognosis</Keyword><Keyword MajorTopicYN="N">Pulmonary embolism</Keyword><Keyword MajorTopicYN="N">Risk stratification</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>1</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>4</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31039477</ArticleId><ArticleId IdType="doi">10.1016/j.thromres.2019.04.020</ArticleId><ArticleId IdType="pii">S0049-3848(19)30213-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">21777063</PMID><DateCompleted><Year>2012</Year><Month>01</Month><Day>25</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-9034</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>8</Issue><PubDate><Year>2011</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of laparoendoscopic &amp; advanced surgical techniques. Part A</Title><ISOAbbreviation>J Laparoendosc Adv Surg Tech A</ISOAbbreviation></Journal><ArticleTitle>Systematic review of 23-hour (outpatient) stay laparoscopic gastric bypass surgery.</ArticleTitle><Pagination><StartPage>677</StartPage><EndPage>681</EndPage><MedlinePgn>677-81</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1089/lap.2011.0042</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The laparoscopic Roux-en-Y gastric bypass (LRYGB) is generally considered the gold-standard bariatric procedure. It has a usual inpatient stay of 3 days. There have been few reports of gastric bypass patients being discharged within 23 hours of surgery, but its safety and feasibility has not been reviewed before. The aim of this study was to review the published literature on 23-hour stay post-LRYGB.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Systematic search was performed in Medline, Embase, and Cochrane library using the medical subject heading terms "ambulatory surgical procedures" and "bariatric surgery" with further free text search and cross references. All articles on 23-hour LRYGB that described patient selection criteria, 23-hour discharge, complications, and readmissions were reviewed. Data were extracted by two independent reviewers.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">There were no randomized controlled trials. Four cohort studies were included in this review. The patients age ranged from 14 to 70 years, mean body mass index ranged from 41.2 to 49.25, and the mean operative time ranged from 112.8 to 169 minutes. 1852/2201(84.14%) patients could be discharged within 23 hours. Forty-eight patients (2.18%) developed complications and 40 patients (1.82%) were readmitted. The commonest 30-day complications were anastomotic strictures (16), gastrointestinal bleeding (9), and internal hernias (9). Five patients developed anastomotic leak and 2 patients developed pulmonary embolism. Two patients died but neither was discharged after their bypass surgery.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">There is a paucity of data regarding 23-hour discharge after LRYGB. The evidence suggests that it is feasible in selected patients. However, further studies are necessary to assess its safety and acceptability.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Harun</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>The Academic Unit of Medical and Surgical Gastroenterology, Homerton University Hospital NHS Trust, Homerton Row, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agrawal</LastName><ForeName>Sanjay</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>07</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Laparoendosc Adv Surg Tech A</MedlineTA><NlmUniqueID>9706293</NlmUniqueID><ISSNLinking>1092-6429</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000556" MajorTopicYN="Y">Ambulatory Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015390" MajorTopicYN="Y">Gastric Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="Y">Laparoscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="Y">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009767" MajorTopicYN="N">Obesity, Morbid</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010359" MajorTopicYN="N">Patient Readmission</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21777063</ArticleId><ArticleId IdType="doi">10.1089/lap.2011.0042</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34318873</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>31</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>31</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1573-4935</ISSN><JournalIssue CitedMedium="Internet"><Volume>41</Volume><Issue>8</Issue><PubDate><Year>2021</Year><Month>Aug</Month><Day>27</Day></PubDate></JournalIssue><Title>Bioscience reports</Title><ISOAbbreviation>Biosci Rep</ISOAbbreviation></Journal><ArticleTitle>MicroRNAs targeting VEGF are related to vascular dysfunction in preeclampsia.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">BSR20210874</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1042/BSR20210874</ELocationID><Abstract><AbstractText>In preeclampsia (PE), pre-existent maternal endothelial dysfunction leads to impaired placentation and vascular maladaptation. The vascular endothelial growth factor (VEGF) pathway is essential in the placentation process and VEGF expression is regulated through post-transcriptional modification by microRNAs (miRNAs). We investigated the expression of VEGF-related circulating miR-16, miR-29b, miR-126, miR-155 and miR-200c in PE vs healthy pregnancies (HPs), and their relation with vascular function, oxidative stress (OS) and systemic inflammation. In this case-control study, 24 women with early PE (&lt;34 weeks) were compared with 30 women with HP. Circulating microRNA levels (RT-qPCR), OS and systemic inflammation were assessed in plasma samples (PE 29.5 vs HP 25.8 weeks) and related to extensive in vivo vascular function (flow-mediated dilatation (FMD), modified FMD (mFMD), carotid-femoral pulse wave velocity (CF-PWV), heart rate corrected augmentation index (AIx75) and reactive hyperemia index (RHI)). FMD, CF-PWV, AIx75 and RHI were all significantly impaired in PE (P&lt;0.05). PE patients had reduced levels of miR-16 (5.53 &#xb1; 0.36 vs 5.84 &#xb1; 0.61) and increased levels of miR-200c (1.34 &#xb1; 0.57 vs 0.97 &#xb1; 0.68) (P&lt;0.05). Independent of age and parity, miR-16 was related to impaired FMD (&#x3b2; 2.771, 95% C.I.: 0.023-5.519, P=0.048) and mFMD (&#x3b2; 3.401, 95% C.I.: 0.201-6.602, P=0.038). Likewise, miR-200c was independently associated with CF-PWV (&#x3b2; 0.513, 95% C.I.: 0.034-0.992, P=0.036). In conclusion, circulating levels of miR-16 were lower in PE, which correlated with impaired endothelial function. Circulating miR-200c was increased in PE and correlated with higher arterial stiffness. These findings suggest a post-transcriptional dysregulation of the VEGF pathway in PE and identify miR-16 and miR-200c as possible diagnostic biomarkers for PE.</AbstractText><CopyrightInformation>&#xa9; 2021 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Witvrouwen</LastName><ForeName>Isabel</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-4444-7192</Identifier><AffiliationInfo><Affiliation>Research Group Cardiovascular Diseases, GENCOR, University of Antwerp, Antwerp, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Antwerp University Hospital, Edegem, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Mannaerts</LastName><ForeName>Dominique</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-4955-1586</Identifier><AffiliationInfo><Affiliation>Research Group ASTARC, Antwerp Surgical Training, Anatomy and Research Centre, University of Antwerp, Antwerp, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, Antwerp University Hospital, Edegem, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ratajczak</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Research Group Cardiovascular Diseases, GENCOR, University of Antwerp, Antwerp, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boeren</LastName><ForeName>Evi</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Research Group Cardiovascular Diseases, GENCOR, University of Antwerp, Antwerp, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faes</LastName><ForeName>Ellen</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Research Group ASTARC, Antwerp Surgical Training, Anatomy and Research Centre, University of Antwerp, Antwerp, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, Antwerp University Hospital, Edegem, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Craenenbroeck</LastName><ForeName>Amaryllis H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Laboratory of Experimental Medicine and Paediatrics, University of Antwerp, Antwerp, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nephrology, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacquemyn</LastName><ForeName>Yves</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Research Group ASTARC, Antwerp Surgical Training, Anatomy and Research Centre, University of Antwerp, Antwerp, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, Antwerp University Hospital, Edegem, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Craenenbroeck</LastName><ForeName>Emeline M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Research Group Cardiovascular Diseases, GENCOR, University of Antwerp, Antwerp, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Antwerp University Hospital, Edegem, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Biosci Rep</MedlineTA><NlmUniqueID>8102797</NlmUniqueID><ISSNLinking>0144-8463</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000074166">Circulating MicroRNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C505362">MIRN16 microRNA, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C533896">MIRN200 microRNA, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C467484">VEGFA protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D042461">Vascular Endothelial Growth Factor A</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000074166" MajorTopicYN="N">Circulating MicroRNA</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="N">Heart Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006940" MajorTopicYN="N">Hyperemia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="N">MicroRNAs</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011225" MajorTopicYN="N">Pre-Eclampsia</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063177" MajorTopicYN="N">Pulse Wave Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042461" MajorTopicYN="N">Vascular Endothelial Growth Factor A</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059289" MajorTopicYN="Y">Vascular Stiffness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014664" MajorTopicYN="Y">Vasodilation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">angiogenesis</Keyword><Keyword MajorTopicYN="N">arterial stiffness</Keyword><Keyword MajorTopicYN="N">endothelial functionlial</Keyword><Keyword MajorTopicYN="N">microRNA</Keyword><Keyword MajorTopicYN="N">oxidative stress</Keyword><Keyword MajorTopicYN="N">preeclampsia</Keyword></KeywordList><CoiStatement>The authors declare that there are no competing interests associated with the manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>28</Day><Hour>8</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>8</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34318873</ArticleId><ArticleId IdType="pmc">PMC8360826</ArticleId><ArticleId IdType="doi">10.1042/BSR20210874</ArticleId><ArticleId IdType="pii">229400</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Friedman R.C., Farh K.K., Burge C.B. and Bartel D.P. (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome. Res. 19, 92&#x2013;105 10.1101/gr.082701.108</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.082701.108</ArticleId><ArticleId IdType="pmc">PMC2612969</ArticleId><ArticleId IdType="pubmed">18955434</ArticleId></ArticleIdList></Reference><Reference><Citation>Sayed D. and Abdellatif M. (2011) MicroRNAs in development and disease. Physiol. Rev. 91, 827&#x2013;887 10.1152/physrev.00006.2010</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00006.2010</ArticleId><ArticleId IdType="pubmed">21742789</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell M.D., Peiris H.N., Kobayashi M., Koh Y.Q., Duncombe G., Illanes S.E.et al. . (2015) Placental exosomes in normal and complicated pregnancy. Am. J. Obstet. Gynecol. 213, S173&#x2013;S181 10.1016/j.ajog.2015.07.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2015.07.001</ArticleId><ArticleId IdType="pubmed">26428497</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayder H., O'Brien J., Nadeem U. and Peng C. (2018) MicroRNAs: crucial regulators of placental development. Reproduction 155, R259&#x2013;R271 10.1530/REP-17-0603</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/REP-17-0603</ArticleId><ArticleId IdType="pubmed">29615475</ArticleId></ArticleIdList></Reference><Reference><Citation>Tranquilli A.L., Dekker G., Magee L., Roberts J., Sibai B.M., Steyn W.et al. . (2014) The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP. Pregnancy Hypertens. 4, 97&#x2013;104 10.1016/j.preghy.2014.02.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.preghy.2014.02.001</ArticleId><ArticleId IdType="pubmed">26104417</ArticleId></ArticleIdList></Reference><Reference><Citation>Mannaerts D., Faes E., Cornette J., Gyselaers W., Spaanderman M., Goovaerts I.et al. . (2019) Low-flow mediated constriction as a marker of endothelial function in healthy pregnancy and preeclampsia: a pilot study. Pregnancy Hypertens. 17, 75&#x2013;81 10.1016/j.preghy.2019.02.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.preghy.2019.02.001</ArticleId><ArticleId IdType="pubmed">31487661</ArticleId></ArticleIdList></Reference><Reference><Citation>Mochan S., Dhingra M.K., Gupta S.K., Saxena S., Arora P., Yadav V.et al. . (2019) Status of VEGF in preeclampsia and its effect on endoplasmic reticulum stress in placental trophoblast cells. Eur. J. Obstet. Gynecol. Reprod. Biol. 4, 100070 10.1016/j.eurox.2019.100070</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eurox.2019.100070</ArticleId><ArticleId IdType="pmc">PMC6728727</ArticleId><ArticleId IdType="pubmed">31517301</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah D.A. and Khalil R.A. (2015) Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia. Biochem. Pharmacol. 95, 211&#x2013;226 10.1016/j.bcp.2015.04.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2015.04.012</ArticleId><ArticleId IdType="pmc">PMC4449835</ArticleId><ArticleId IdType="pubmed">25916268</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y., Lu H., Huo Z., Ma Z., Dang J., Dang W.et al. . (2016) MicroRNA-16 inhibits feto-maternal angiogenesis and causes recurrent spontaneous abortion by targeting vascular endothelial growth factor. Sci. Rep. 6, 35536 10.1038/srep35536</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep35536</ArticleId><ArticleId IdType="pmc">PMC5066269</ArticleId><ArticleId IdType="pubmed">27748453</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeisler H., Llurba E., Chantraine F., Vatish M., Staff A.C., Sennstr&#xf6;m M.et al. . (2016) Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. N. Engl. J. Med. 374, 13&#x2013;22 10.1056/NEJMoa1414838</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1414838</ArticleId><ArticleId IdType="pubmed">26735990</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang V., Bates D.O. and Leach L. (2017) Regulation of human feto-placental endothelial barrier integrity by vascular endothelial growth factors: competitive interplay between VEGF-A165a, VEGF-A165b, PIGF and VE-cadherin. Clin. Sci. (Lond.) 131, 2763&#x2013;2775 10.1042/CS20171252</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20171252</ArticleId><ArticleId IdType="pmc">PMC5869853</ArticleId><ArticleId IdType="pubmed">29054861</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornakova A., Kolkova Z., Holubekova V., Loderer D., Lasabova Z., Biringer K.et al. . (2020) Diagnostic potential of microRNAs as biomarkers in the detection of preeclampsia. Genet. Test Mol. Biomarkers 24, 321&#x2013;327 10.1089/gtmb.2019.0264</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/gtmb.2019.0264</ArticleId><ArticleId IdType="pubmed">32511062</ArticleId></ArticleIdList></Reference><Reference><Citation>Celik H., Avci B. and I&#x15f;ik Y. (2013) Vascular endothelial growth factor and endothelin-1 levels in normal pregnant women and pregnant women with pre-eclampsia. J. Obstet. Gynaecol. 33, 355&#x2013;358 10.3109/01443615.2013.769944</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/01443615.2013.769944</ArticleId><ArticleId IdType="pubmed">23654314</ArticleId></ArticleIdList></Reference><Reference><Citation>Maynard S.E., Min J.Y., Merchan J., Lim K.H., Li J., Mondal S.et al. . (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest. 111, 649&#x2013;658 10.1172/JCI17189</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI17189</ArticleId><ArticleId IdType="pmc">PMC151901</ArticleId><ArticleId IdType="pubmed">12618519</ArticleId></ArticleIdList></Reference><Reference><Citation>Masoura S., Kalogiannidis I., Makedou K., Theodoridis T., Koiou K., Gerou S.et al. . (2014) Biomarkers of endothelial dysfunction in preeclampsia and neonatal morbidity: a case-control study. Eur. J. Obstet. Gynecol. Reprod. Biol. 175, 119&#x2013;123 10.1016/j.ejogrb.2014.01.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejogrb.2014.01.012</ArticleId><ArticleId IdType="pubmed">24485669</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C.Y., Tsai P.Y., Chen T.Y., Tsai H.L., Kuo P.L. and Su M.T. (2019) Elevated miR-200a and miR-141 inhibit endocrine gland-derived vascular endothelial growth factor expression and ciliogenesis in preeclampsia. J. Physiol. 597, 3069&#x2013;3083 10.1113/JP277704</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/JP277704</ArticleId><ArticleId IdType="pubmed">31026335</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y., Li P., Hao S., Liu L., Zhao J. and Hou Y. (2009) Differential expression of microRNAs in the placentae of Chinese patients with severe pre-eclampsia. Clin. Chem. Lab. Med. 47, 923&#x2013;929 10.1515/CCLM.2009.228</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/CCLM.2009.228</ArticleId><ArticleId IdType="pubmed">19642860</ArticleId></ArticleIdList></Reference><Reference><Citation>Mannaerts D., Faes E., Cos P., Bried&#xe9; J.J., Gyselaers W., Cornette J.et al. . (2018) Oxidative stress in healthy pregnancy and preeclampsia is linked to chronic inflammation, iron status and vascular function. PLoS ONE 13, e0202919 10.1371/journal.pone.0202919</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0202919</ArticleId><ArticleId IdType="pmc">PMC6133366</ArticleId><ArticleId IdType="pubmed">30204759</ArticleId></ArticleIdList></Reference><Reference><Citation>Mannaerts D., Faes E., Goovaerts I., Stoop T., Cornette J., Gyselaers W.et al. . (2017) Flow-mediated dilation and peripheral arterial tonometry are disturbed in preeclampsia and reflect different aspects of endothelial function. Am. J. Physiol. Regul. Integr. Comp. Physiol. 313, R518&#x2013;R525 10.1152/ajpregu.00514.2016</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpregu.00514.2016</ArticleId><ArticleId IdType="pubmed">28794106</ArticleId></ArticleIdList></Reference><Reference><Citation>Bates D.O., MacMillan P.P., Manjaly J.G., Qiu Y., Hudson S.J., Bevan H.S.et al. . (2006) The endogenous anti-angiogenic family of splice variants of VEGF, VEGFxxxb, are down-regulated in pre-eclamptic placentae at term. Clin. Sci. (Lond.) 110, 575&#x2013;585 10.1042/CS20050292</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20050292</ArticleId><ArticleId IdType="pubmed">16451124</ArticleId></ArticleIdList></Reference><Reference><Citation>Chamorro-Jorganes A., Araldi E., Penalva L.O., Sandhu D., Fern&#xe1;ndez-Hernando C. and Su&#xe1;rez Y. (2011) MicroRNA-16 and microRNA-424 regulate cell-autonomous angiogenic functions in endothelial cells via targeting vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1. Arterioscler. Thromb. Vasc. Biol. 31, 2595&#x2013;2606 10.1161/ATVBAHA.111.236521</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.111.236521</ArticleId><ArticleId IdType="pmc">PMC3226744</ArticleId><ArticleId IdType="pubmed">21885851</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivas M.A., Venturutti L., Huang Y.W., Schillaci R., Huang T.H. and Elizalde P.V. (2012) Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. Breast Cancer Res. 14, R77 10.1186/bcr3187</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/bcr3187</ArticleId><ArticleId IdType="pmc">PMC3446340</ArticleId><ArticleId IdType="pubmed">22583478</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Fan H., Zhao G., Liu D., Du L., Wang Z.et al. . (2012) miR-16 inhibits the proliferation and angiogenesis-regulating potential of mesenchymal stem cells in severe pre-eclampsia. FEBS J. 279, 4510&#x2013;4524 10.1111/febs.12037</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.12037</ArticleId><ArticleId IdType="pubmed">23083510</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P., Guo W., Du L., Zhao J., Wang Y., Liu L.et al. . (2013) microRNA-29b contributes to pre-eclampsia through its effects on apoptosis, invasion and angiogenesis of trophoblast cells. Clin. Sci. (Lond.) 124, 27&#x2013;40 10.1042/CS20120121</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20120121</ArticleId><ArticleId IdType="pubmed">22716646</ArticleId></ArticleIdList></Reference><Reference><Citation>Frazier S., McBride M.W., Mulvana H. and Graham D. (2020) From animal models to patients: the role of placental microRNAs, miR-210, miR-126, and miR-148a/152 in preeclampsia. Clin. Sci. (Lond.) 134, 1001&#x2013;1025 10.1042/CS20200023</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20200023</ArticleId><ArticleId IdType="pmc">PMC7239341</ArticleId><ArticleId IdType="pubmed">32337535</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Diao Z., Su L., Sun H., Li R., Cui H.et al. . (2010) MicroRNA-155 contributes to preeclampsia by down-regulating CYR61. Am. J. Obstet. Gynecol. 202, 466.e1&#x2013;466.e7 10.1016/j.ajog.2010.01.057</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2010.01.057</ArticleId><ArticleId IdType="pubmed">20452491</ArticleId></ArticleIdList></Reference><Reference><Citation>Magenta A., Sileno S., D'Agostino M., Persiani F., Beji S., Paolini A.et al. . (2018) Atherosclerotic plaque instability in carotid arteries: miR-200c as a promising biomarker. Clin. Sci. (Lond.) 132, 2423&#x2013;2436 10.1042/CS20180684</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20180684</ArticleId><ArticleId IdType="pubmed">30389857</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Ge Y.W., Wang Z.X., Xu Q.L., Guo R. and Xu H.Y. (2019) MiR-200c regulates apoptosis of placental trophoblasts in preeclampsia rats through Wnt/&#x3b2;-catenin signaling pathway. Eur. Rev. Med. Pharmacol. Sci. 23, 7209&#x2013;7216</Citation><ArticleIdList><ArticleId IdType="pubmed">31539107</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu L., Zhou H., Lin H., Qi J., Zhu C., Gao Z.et al. . (2012) Circulating microRNAs are elevated in plasma from severe preeclamptic pregnancies. Reproduction 143, 389&#x2013;397 10.1530/REP-11-0304</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/REP-11-0304</ArticleId><ArticleId IdType="pubmed">22187671</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell G.F., Hwang S.J., Vasan R.S., Larson M.G., Pencina M.J., Hamburg N.M.et al. . (2010) Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation 121, 505&#x2013;511 10.1161/CIRCULATIONAHA.109.886655</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.109.886655</ArticleId><ArticleId IdType="pmc">PMC2836717</ArticleId><ArticleId IdType="pubmed">20083680</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayor-Lynn K., Toloubeydokhti T., Cruz A.C. and Chegini N. (2011) Expression profile of microRNAs and mRNAs in human placentas from pregnancies complicated by preeclampsia and preterm labor. Reprod. Sci. 18, 46&#x2013;56 10.1177/1933719110374115</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1933719110374115</ArticleId><ArticleId IdType="pmc">PMC3343068</ArticleId><ArticleId IdType="pubmed">21079238</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">31984669</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1538-7836</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>5</Issue><PubDate><Year>2020</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of thrombosis and haemostasis : JTH</Title><ISOAbbreviation>J Thromb Haemost</ISOAbbreviation></Journal><ArticleTitle>Epidemiology and outcomes of clinically unsuspected venous thromboembolism in children: A systematic review.</ArticleTitle><Pagination><StartPage>1100</StartPage><EndPage>1112</EndPage><MedlinePgn>1100-1112</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jth.14739</ELocationID><Abstract><AbstractText Label="BACKGROUND">Clinically unsuspected venous thromboembolic events (uVTE) detected during routine imaging pose a management challenge due to limited knowledge about their clinical significance. Unsuspected VTE are often referred as "asymptomatic," "incidental," or "clinically silent/occult" VTE.</AbstractText><AbstractText Label="OBJECTIVE">To understand the epidemiology, management, and outcomes of uVTE in children.</AbstractText><AbstractText Label="METHODS">A systematic review was performed according to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. The search criteria included controlled vocabulary and keywords for VTE, incidental findings, and children (ages&#xa0;&#x2264;&#xa0;21&#xa0;years).</AbstractText><AbstractText Label="RESULTS">Among 10&#xa0;875 articles, 51 studies (8354 children with 758 uVTE) were selected. The studies were heterogeneous, I<sup>2</sup> 96%; P&#xa0;&lt;&#xa0;.0001. Unsuspected VTE were diagnosed in two settings: first, asymptomatic VTE (aVTE) diagnosed through surveillance imaging for VTE (46 studies; n&#xa0;=&#xa0;5894; aVTE: 715, pooled frequency: 19%, 95% confidence interval [CI]: 13%-24%); second, incidental VTE (iVTE) diagnosed during imaging performed for indications without primary suspicion for VTE (6 studies; n&#xa0;=&#xa0;2460; iVTE: 43). The majority (94%) of aVTE were associated with central venous lines (CVL). Non-CVL settings included post-spinal surgery, post-splenectomy, trauma, nephrotic syndrome, and newborns. In general, aVTE were reported to have a benign clinical course, were mostly transient, and resolved without intervention and with few immediate or long-term functional complications. Incidental VTE were primarily detected in children with cancer and ranged from tumor-associated thrombi to pulmonary embolism (PE) with insufficient evidence to draw meaningful conclusions about their management.</AbstractText><AbstractText Label="CONCLUSION">Clinically uVTE were predominantly diagnosed with CVL and their outcomes were generally favorable implying limited benefit of routine surveillance and thromboprophylaxis. Prospective research is needed to clarify the optimal management of iVTE.</AbstractText><CopyrightInformation>&#xa9; 2020 International Society on Thrombosis and Haemostasis.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sharathkumar</LastName><ForeName>Anjali A</ForeName><Initials>AA</Initials><Identifier Source="ORCID">0000-0003-4574-6175</Identifier><AffiliationInfo><Affiliation>Stead Family Department of Pediatrics, University of Iowa Carver School of Medicine, Iowa City, IA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biss</LastName><ForeName>Tina</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Haematology, Royal Victoria Infirmary, Newcastle upon Tyne, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kulkarni</LastName><ForeName>Ketan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Hematology/Oncology, Department of Pediatrics, IWK Health Centre and Dalhousie University, Halifax, NS, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahuja</LastName><ForeName>Sanjay</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Pediatric Hematology/Oncology, UH Cleveland Medical Center, Rainbow Babies &amp; Children's Hospital, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Regan</LastName><ForeName>Matt</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-3339-9073</Identifier><AffiliationInfo><Affiliation>University of Iowa Libraries, Iowa City, IA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Male</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-4989-6421</Identifier><AffiliationInfo><Affiliation>Department of Paediatrics, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Revel-Vilk</LastName><ForeName>Shoshana</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Pediatric Hematology/Oncology Unit, Shaare Zedek Medical Center, Jerusalem, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, Hebrew University, Jerusalem, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>SSC Subcommittee on Pediatrics and Neonatal T&amp;H of the ISTH</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR002537</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Thromb Haemost</MedlineTA><NlmUniqueID>101170508</NlmUniqueID><ISSNLinking>1538-7836</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="Y">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="Y">Venous Thrombosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">asymptomatic venous thromboembolism</Keyword><Keyword MajorTopicYN="N">central venous line</Keyword><Keyword MajorTopicYN="N">incidental venous thromboembolism</Keyword><Keyword MajorTopicYN="N">pediatric</Keyword><Keyword MajorTopicYN="N">unsuspected venous thromboembolism</Keyword><Keyword MajorTopicYN="N">venous thromboembolism</Keyword></KeywordList><CoiStatement>Conflicts of interest. Authors declare report no potential conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>12</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>1</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>5</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31984669</ArticleId><ArticleId IdType="mid">NIHMS1563324</ArticleId><ArticleId IdType="pmc">PMC7192773</ArticleId><ArticleId IdType="doi">10.1111/jth.14739</ArticleId><ArticleId IdType="pii">S1538-7836(22)00304-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Andrew M, Marzinotto V, Pencharz P, Zlotkin S, Burrows P, Ingram J, Adams M, Filler R. A cross-sectional study of catheter-related thrombosis in children receiving total parenteral nutrition at home. The Journal of pediatrics. 1995; 126: 358&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">7869192</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck C, Dubois J, Grignon A, Lacroix J, David M. Incidence and risk factors of catheter-related deep vein thrombosis in a pediatric intensive care unit: a prospective study. The Journal of pediatrics. 1998; 133: 237&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">9709712</ArticleId></ArticleIdList></Reference><Reference><Citation>Faustino EV, Spinella PC, Li S, Pinto MG, Stoltz P, Tala J, Card ME, Northrup V, Baker KE, Goodman TR, Chen L, Silva CT. Incidence and acute complications of asymptomatic central venous catheter-related deep venous thrombosis in critically ill children. The Journal of pediatrics. 2013; 162: 387&#x2013;91. 10.1016/j.jpeds.2012.06.059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2012.06.059</ArticleId><ArticleId IdType="pmc">PMC3575007</ArticleId><ArticleId IdType="pubmed">22883418</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones S, Newall F, Butt W, Monagle P. Asymptomatic thrombosis following the use of central venous lines in children. University of Melbourne Minerva Access. 2017: 26&#x2013;264. 10.1182/blood-2018-05-849737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2018-05-849737</ArticleId></ArticleIdList></Reference><Reference><Citation>Journeycake JM, Quinn CT, Miller KL, Zajac JL, Buchanan GR. Catheter-related deep venous thrombosis in children with hemophilia. Blood. 2001; 98: 1727&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">11535504</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JH, Lee YS, Kim SH, Lee SK, Lim MK, Kim HS. Does umbilical vein catheterization lead to portal venous thrombosis? Prospective US evaluation in 100 neonates. Radiology. 2001; 219: 645&#x2013;50. 10.1148/radiology.219.3.r01jn17645.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiology.219.3.r01jn17645</ArticleId><ArticleId IdType="pubmed">11376248</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee EY, Kritsaneepaiboon S, Arellano CM, Grace RF, Zurakowski D, Boiselle PM. Unsuspected pulmonary emboli in pediatric oncology patients: detection with MDCT. AJR American journal of roentgenology. 2010; 194: 1216&#x2013;22. 10.2214/ajr.09.3463.</Citation><ArticleIdList><ArticleId IdType="doi">10.2214/ajr.09.3463</ArticleId><ArticleId IdType="pubmed">20410406</ArticleId></ArticleIdList></Reference><Reference><Citation>Menendez JJ, Verdu C, Calderon B, Gomez-Zamora A, Schuffelmann C, de la Cruz JJ, de la Oliva P. Incidence and risk factors of superficial and deep vein thrombosis associated with peripherally inserted central catheters in children. Journal of thrombosis and haemostasis : JTH. 2016; 14: 2158&#x2013;68. 10.1111/jth.13478.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.13478</ArticleId><ArticleId IdType="pubmed">27558946</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell LG, Andrew M, Hanna K, Abshire T, Halton J, Anderson R, Cherrick I, Desai S, Mahoney D, McCuster P, Wu J, Dahl G, Chait P, de Veber G, Lee KJ, Mikulis D, Ginsberg J, Way C. A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study. Cancer. 2003; 97: 508&#x2013;16. 10.1002/cncr.11042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cncr.11042</ArticleId><ArticleId IdType="pubmed">12518376</ArticleId></ArticleIdList></Reference><Reference><Citation>Price VE, Carcao M, Connolly B, Chait P, Daneman A, Temple M, Stain AM, Sung L, Al-Tralbosi H, Blanchette VS. A prospective, longitudinal study of central venous catheter-related deep venous thrombosis in boys with hemophilia. Journal of thrombosis and haemostasis : JTH. 2004; 2: 737&#x2013;42. 10.1111/j.1538-7836.2004.00653.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2004.00653.x</ArticleId><ArticleId IdType="pubmed">15099279</ArticleId></ArticleIdList></Reference><Reference><Citation>Radicioni M, Bini V, Chiarini P, Fantauzzi A, Leone F, Scattoni R, Camerini PG. Cerebral Sinovenous Thrombosis in the Asphyxiated Cooled Infants: A Prospective Observational Study. Pediatric neurology. 2017; 66: 63&#x2013;8. 10.1016/j.pediatrneurol.2016.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pediatrneurol.2016.09.006</ArticleId><ArticleId IdType="pubmed">27823842</ArticleId></ArticleIdList></Reference><Reference><Citation>Raets MM, Sol JJ, Govaert P, Lequin MH, Reiss IK, Kroon AA, Appel IM, Dudink J. Serial cranial US for detection of cerebral sinovenous thrombosis in preterm infants. Radiology. 2013; 269: 879&#x2013;86. 10.1148/radiol.13130401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.13130401</ArticleId><ArticleId IdType="pubmed">23985276</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruud E, Holmstrom H, De Lange C, Hogstad EM, Wesenberg F. Low-dose warfarin for the prevention of central line-associated thromboses in children with malignancies--a randomized, controlled study. Acta paediatrica (Oslo, Norway : 1992). 2006; 95: 1053&#x2013;9. 10.1080/08035250600729092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08035250600729092</ArticleId><ArticleId IdType="pubmed">16938749</ArticleId></ArticleIdList></Reference><Reference><Citation>Skarsgard E, Doski J, Jaksic T, Wesson D, Shandling B, Ein S, Babyn P, Heiss K, Hu X. Thrombosis of the portal venous system after splenectomy for pediatric hematologic disease. Journal of pediatric surgery. 1993; 28: 1109&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">8308671</ArticleId></ArticleIdList></Reference><Reference><Citation>Karande GY, Hedgire SS, Sanchez Y, Baliyan V, Mishra V, Ganguli S, Prabhakar AM. Advanced imaging in acute and chronic deep vein thrombosis. Cardiovascular diagnosis and therapy. 2016; 6: 493&#x2013;507. 10.21037/cdt.2016.12.06.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/cdt.2016.12.06</ArticleId><ArticleId IdType="pmc">PMC5220209</ArticleId><ArticleId IdType="pubmed">28123971</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Connell C, Razavi P, Ghalichi M, Boyle S, Vasan S, Mark L, Caton A, Duddalwar V, Boswell W, Grabow K, Liebman HA. Unsuspected pulmonary emboli adversely impact survival in patients with cancer undergoing routine staging multi-row detector computed tomography scanning. Journal of thrombosis and haemostasis : JTH. 2011; 9: 305&#x2013;11. 10.1111/j.1538-7836.2010.04114.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2010.04114.x</ArticleId><ArticleId IdType="pubmed">20955348</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyman GH, Bohlke K, Khorana AA, Kuderer NM, Lee AY, Arcelus JI, Balaban EP, Clarke JM, Flowers CR, Francis CW, Gates LE, Kakkar AK, Key NS, Levine MN, Liebman HA, Tempero MA, Wong SL, Somerfield MR, Falanga A. Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2015; 33: 654&#x2013;6. 10.1200/jco.2014.59.7351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/jco.2014.59.7351</ArticleId><ArticleId IdType="pmc">PMC4881372</ArticleId><ArticleId IdType="pubmed">25605844</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrew M, David M, Adams M, Ali K, Anderson R, Barnard D, Bernstein M, Brisson L, Cairney B, DeSai D, et al. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood. 1994; 83: 1251&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">8118029</ArticleId></ArticleIdList></Reference><Reference><Citation>Raffini L, Huang YS, Witmer C, Feudtner C. Dramatic increase in venous thromboembolism in children&#x2019;s hospitals in the United States from 2001 to 2007. Pediatrics. 2009; 124: 1001&#x2013;8. 10.1542/peds.2009-0768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2009-0768</ArticleId><ArticleId IdType="pubmed">19736261</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annals of internal medicine. 2009; 151: 264&#x2013;9, w64. 10.7326/0003-4819-151-4-200908180-00135.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-151-4-200908180-00135</ArticleId><ArticleId IdType="pubmed">19622511</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook DJ, Mulrow CD, Haynes RB. Systematic reviews: synthesis of best evidence for clinical decisions. Annals of internal medicine. 1997; 126: 376&#x2013;80. 10.7326/0003-4819-126-5-199703010-00006.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-126-5-199703010-00006</ArticleId><ArticleId IdType="pubmed">9054282</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray F F, John W. T. Transformations Related to the Angular and the Square Root. The Annals of Mathematical Statistics. 1950; 21: 607&#x2013;11.</Citation></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ (Clinical research ed). 2003; 327: 557&#x2013;60. 10.1136/bmj.327.7414.557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.327.7414.557</ArticleId><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler-O&#x2019;Hara M, Buzzard CJ, Reubens L, McDermott MP, DiGrazio W, D&#x2019;Angio CT. A randomized trial comparing long-term and short-term use of umbilical venous catheters in premature infants with birth weights of less than 1251 grams. Pediatrics. 2006; 118: e25&#x2013;35. 10.1542/peds.2005-1880.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2005-1880</ArticleId><ArticleId IdType="pubmed">16785289</ArticleId></ArticleIdList></Reference><Reference><Citation>Dursun AC G; Ucan B; Hakan N; Eksioglu S; Dilli D; Okumus N;, Zenciroglu A. UMBILICAL VENOUS CATHETER RELATED PORTAL VENOUS THOROMBOSIS IN NEWBORN BABIES: A PROSPECTIVE STUDY. Pediatric Critical Care Medicine. 2014; 14(4_Suppl): 141: Abstract 624.</Citation></Reference><Reference><Citation>Gharehbaghi MM, Nemati M, Hosseinpour SS, Taei R, Ghargharechi R. Umbilical vascular catheter associated portal vein thrombosis detected by ultrasound. Indian journal of pediatrics. 2011; 78: 161&#x2013;4. 10.1007/s12098-010-0223-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12098-010-0223-x</ArticleId><ArticleId IdType="pubmed">21063811</ArticleId></ArticleIdList></Reference><Reference><Citation>Haddad H, Lee KS, Higgins A, McMillan D, Price V, El-Naggar W. Routine surveillance ultrasound for the management of central venous catheters in neonates. The Journal of pediatrics. 2014; 164: 118&#x2013;22. 10.1016/j.jpeds.2013.08.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2013.08.048</ArticleId><ArticleId IdType="pubmed">24112862</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson SJ, Punzalan RC, Arca MJ, Simpson P, Christensen MA, Hanson SK, Yan K, Braun K, Havens PL. Effectiveness of clinical guidelines for deep vein thrombosis prophylaxis in reducing the incidence of venous thromboembolism in critically ill children after trauma. The journal of trauma and acute care surgery. 2012; 72: 1292&#x2013;7. 10.1097/TA.0b013e31824964d1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e31824964d1</ArticleId><ArticleId IdType="pubmed">22673257</ArticleId></ArticleIdList></Reference><Reference><Citation>Krafte-Jacobs B, Sivit CJ, Mejia R, Pollack MM. Catheter-related thrombosis in critically ill children: comparison of catheters with and without heparin bonding. The Journal of pediatrics. 1995; 126: 50&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">7815223</ArticleId></ArticleIdList></Reference><Reference><Citation>Landisch RM, Hanson SJ, Punzalan RC, Braun K, Cassidy LD, Gourlay DM. Efficacy of surveillance ultrasound for venous thromboembolism diagnosis in critically ill children after trauma. Journal of pediatric surgery. 2018; 53: 2195&#x2013;201. 10.1016/j.jpedsurg.2018.06.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2018.06.013</ArticleId><ArticleId IdType="pubmed">29997028</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroeder AR, Axelrod DM, Silverman NH, Rubesova E, Merkel E, Roth SJ. A continuous heparin infusion does not prevent catheter-related thrombosis in infants after cardiac surgery. Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. 2010; 11: 489&#x2013;95. 10.1097/PCC.0b013e3181ce6e29.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PCC.0b013e3181ce6e29</ArticleId><ArticleId IdType="pubmed">20101197</ArticleId></ArticleIdList></Reference><Reference><Citation>Sol JJ, Knoester H, de Neef M, Smets AM, Betlem A, van Ommen CH. Chronic Complications After Femoral Central Venous Catheter-related Thrombosis in Critically Ill Children. Journal of pediatric hematology/oncology. 2015; 37: 462&#x2013;7. 10.1097/mph.0000000000000370.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/mph.0000000000000370</ArticleId><ArticleId IdType="pubmed">26056799</ArticleId></ArticleIdList></Reference><Reference><Citation>Talbott GA, Winters WD, Bratton SL, O&#x2019;Rourke PP. A prospective study of femoral catheter-related thrombosis in children. Archives of pediatrics &amp; adolescent medicine. 1995; 149: 288&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">7858689</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruud E, Natvig S, Holmstrom H, Wesenberg F. Low prevalence of femoral venous thrombosis after cardiac catheterizations in children: a prospective study. Cardiology in the young. 2002; 12: 513&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">12635998</ArticleId></ArticleIdList></Reference><Reference><Citation>Albisetti M, Kellenberger CJ, Bergstrasser E, Niggli F, Kroiss S, Rizzi M, Schmugge M. Port-a-cath-related thrombosis and postthrombotic syndrome in pediatric oncology patients. The Journal of pediatrics. 2013; 163: 1340&#x2013;6. 10.1016/j.jpeds.2013.06.076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2013.06.076</ArticleId><ArticleId IdType="pubmed">23992671</ArticleId></ArticleIdList></Reference><Reference><Citation>Anton N, Cox PN, Massicotte MP, Chait P, Yasui Y, Dinyari PM, Marzinotto V, Mitchell LG. Heparin-bonded central venous catheters do not reduce thrombosis in infants with congenital heart disease: a blinded randomized, controlled trial. Pediatrics. 2009; 123: e453&#x2013;8. 10.1542/peds.2008-1508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2008-1508</ArticleId><ArticleId IdType="pubmed">19237438</ArticleId></ArticleIdList></Reference><Reference><Citation>Cost CR, Journeycake JM. Deep venous thrombosis screening in patients with inherited bleeding disorders and central venous catheters. Haemophilia : the official journal of the World Federation of Hemophilia. 2011; 17: 890&#x2013;4. 10.1111/j.1365-2516.2011.02515.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2516.2011.02515.x</ArticleId><ArticleId IdType="pmc">PMC4134000</ArticleId><ArticleId IdType="pubmed">21435117</ArticleId></ArticleIdList></Reference><Reference><Citation>Dollery CM, Sullivan ID, Bauraind O, Bull C, Milla PJ. Thrombosis and embolism in long-term central venous access for parenteral nutrition. Lancet (London, England). 1994; 344: 1043&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">7934444</ArticleId></ArticleIdList></Reference><Reference><Citation>Finkelstein Y, Yaniv I, Berant M, Zilber R, Garty BZ, Epstein O, Lahav J, Tamary H. Central venous line thrombosis in children and young adults with thalassemia major. Pediatric hematology and oncology. 2004; 21: 375&#x2013;81. 10.1080/08880010490457042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08880010490457042</ArticleId><ArticleId IdType="pubmed">15205080</ArticleId></ArticleIdList></Reference><Reference><Citation>Glaser DW, Medeiros D, Rollins N, Buchanan GR. Catheter-related thrombosis in children with cancer. The Journal of pediatrics. 2001; 138: 255&#x2013;9. 10.1067/mpd.2001.111272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mpd.2001.111272</ArticleId><ArticleId IdType="pubmed">11174625</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta H, Araki Y, Davidoff AM, Rao BN, Hoffer FA, Billups C, Wu J, Shochat SJ. Evaluation of pediatric oncology patients with previous multiple central catheters for vascular access: is Doppler ultrasound needed? Pediatric blood &amp; cancer. 2007; 48: 527&#x2013;31. 10.1002/pbc.20875.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pbc.20875</ArticleId><ArticleId IdType="pubmed">16642483</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruud E, Holmstrom H, Hopp E, Wesenberg F. Central line-associated venous late effects in children without prior history of thrombosis. Acta paediatrica (Oslo, Norway : 1992). 2006; 95: 1060&#x2013;5. 10.1080/08035250500499457.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08035250500499457</ArticleId><ArticleId IdType="pubmed">16938750</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Hernandez J, Daoud Y, Styers J, Journeycake JM, Channabasappa N, Piper HG. Central venous thrombosis in children with intestinal failure on long-term parenteral nutrition. Journal of pediatric surgery. 2016; 51: 790&#x2013;3. 10.1016/j.jpedsurg.2016.02.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2016.02.024</ArticleId><ArticleId IdType="pubmed">26936289</ArticleId></ArticleIdList></Reference><Reference><Citation>Massicotte P, Adams M, Marzinotto V, Brooker LA, Andrew M. Low-molecular-weight heparin in pediatric patients with thrombotic disease: a dose finding study. The Journal of pediatrics. 1996; 128: 313&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">8774496</ArticleId></ArticleIdList></Reference><Reference><Citation>Massicotte P, Julian JA, Gent M, Shields K, Marzinotto V, Szechtman B, Chan AK, Andrew M. An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial. Thrombosis research. 2003; 109: 101&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">12706638</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoot RA, van de Wetering MD, Stijnen T, Tissing WJ, Michiels E, Abbink FC, Raphael MF, Heij HA, Zwaan M, Lieverst JA, Caron HN, van Ommen H. Prevalence of Symptomatic and Asymptomatic Thrombosis in Pediatric Oncology Patients With Tunneled Central Venous Catheters. Pediatric blood &amp; cancer. 2016; 63: 1438&#x2013;44. 10.1002/pbc.26036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pbc.26036</ArticleId><ArticleId IdType="pubmed">27128820</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanslik A, Thom K, Haumer M, Kitzmuller E, Albinni S, Wolfsberger M, Salzer-Muhar U, Male C. Incidence and diagnosis of thrombosis in children with short-term central venous lines of the upper venous system. Pediatrics. 2008; 122: 1284&#x2013;91. 10.1542/peds.2007-3852.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2007-3852</ArticleId><ArticleId IdType="pubmed">19047247</ArticleId></ArticleIdList></Reference><Reference><Citation>Farinasso L, Bertorello N, Garbarini L, Gajno TM, Barisone E, Artesani L, Valori A, Giacchino M, Pastore G, Saracco P. Risk factors of central venous lines-related thrombosis in children with acute lymphoblastic leukemia during induction therapy: a prospective study. Leukemia. 2007; 21: 552&#x2013;6. 10.1038/sj.leu.2404560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.leu.2404560</ArticleId><ArticleId IdType="pubmed">17268522</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaabachi O, Alkaissi A, Koubaa W, Aloui N, Toumi Nel H. Screening for deep venous thrombosis after idiopathic scoliosis surgery in children: a pilot study. Paediatric anaesthesia. 2010; 20: 144&#x2013;9. 10.1111/j.1460-9592.2009.03237.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9592.2009.03237.x</ArticleId><ArticleId IdType="pubmed">20078811</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruud E, Holmstrom H, Natvig S, Wesenberg F. Prevalence of thrombophilia and central venous catheter-associated neck vein thrombosis in 41 children with cancer--a prospective study. Medical and pediatric oncology. 2002; 38: 405&#x2013;10. 10.1002/mpo.10062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mpo.10062</ArticleId><ArticleId IdType="pubmed">11984801</ArticleId></ArticleIdList></Reference><Reference><Citation>Standridge SM, O&#x2019;Brien SH. Idiopathic intracranial hypertension in a pediatric population: a retrospective analysis of the initial imaging evaluation. Journal of child neurology. 2008; 23: 1308&#x2013;11. 10.1177/0883073808318056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0883073808318056</ArticleId><ArticleId IdType="pubmed">18984841</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore RA, McNicholas KW, Naidech H, Flicker S, Gallagher JD. Clinically silent venous thrombosis following internal and external jugular central venous cannulation in pediatric cardiac patients. Anesthesiology. 1985; 62: 640&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">3994031</ArticleId></ArticleIdList></Reference><Reference><Citation>Journeycake JM, Eshelman D, Buchanan GR. Post-thrombotic syndrome is uncommon in childhood cancer survivors. The Journal of pediatrics. 2006; 148: 275&#x2013;7. 10.1016/j.jpeds.2005.09.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2005.09.033</ArticleId><ArticleId IdType="pubmed">16492443</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranta S, Kalajoki-Helmio T, Pouttu J, Makipernaa A. MRI after removal of central venous access device reveals a high number of asymptomatic thromboses in children with haemophilia. Haemophilia : the official journal of the World Federation of Hemophilia. 2012; 18: 521&#x2013;6. 10.1111/j.1365-2516.2011.02719.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2516.2011.02719.x</ArticleId><ArticleId IdType="pubmed">22176603</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhle S, Spavor M, Massicotte P, Halton J, Cherrick I, Dix D, Mahoney D, Bauman M, Desai S, Mitchell LG. Prevalence of post-thrombotic syndrome following asymptomatic thrombosis in survivors of acute lymphoblastic leukemia. Journal of thrombosis and haemostasis : JTH. 2008; 6: 589&#x2013;94. 10.1111/j.1538-7836.2008.02901.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2008.02901.x</ArticleId><ArticleId IdType="pubmed">18194413</ArticleId></ArticleIdList></Reference><Reference><Citation>Giordano P, Cecinati V, Grassi M, Del Vecchio GC, Dicuonzo F, Palma M, De Mattia D, Santoro N. Magnetic resonance imaging screening of cerebral thromboembolic events in children with acute lymphoblastic leukemia: a pilot study. Neuropediatrics. 2011; 42: 55&#x2013;9. 10.1055/s-0031-1279726.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0031-1279726</ArticleId><ArticleId IdType="pubmed">21611938</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoyer PF, Gonda S, Barthels M, Krohn HP, Brodehl J. Thromboembolic complications in children with nephrotic syndrome. Risk and incidence. Acta paediatrica Scandinavica. 1986; 75: 804&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">2436435</ArticleId></ArticleIdList></Reference><Reference><Citation>Akyuz C, Emir S, Buyukpamukcu N, Atahan L, Caglar M, Kutluk T, Buyukpamukcu M. Cavoatrial tumor extension in children with wilms tumor: a retrospective review of 17 children in a single center. Journal of pediatric hematology/oncology. 2005; 27: 267&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15891562</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollander J, Prabhu S, Haeidary G. Utilization of MRV to evaluate pediatric patients with papilledema. e17 18.</Citation></Reference><Reference><Citation>Petaja J, Lundstrom U, Sairanen H, Marttinen E, Griffin JH. Central venous thrombosis after cardiac operations in children. The Journal of thoracic and cardiovascular surgery. 1996; 112: 883&#x2013;9. 10.1016/s0022-5223(96)70087-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-5223(96)70087-9</ArticleId><ArticleId IdType="pubmed">8873713</ArticleId></ArticleIdList></Reference><Reference><Citation>Journeycake JM, Buchanan GR. Catheter-related deep venous thrombosis and other catheter complications in children with cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006; 24: 4575&#x2013;80. 10.1200/jco.2005.05.5343.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/jco.2005.05.5343</ArticleId><ArticleId IdType="pubmed">17008698</ArticleId></ArticleIdList></Reference><Reference><Citation>Revel-Vilk S, Yacobovich J, Tamary H, Goldstein G, Nemet S, Weintraub M, Paltiel O, Kenet G. Risk factors for central venous catheter thrombotic complications in children and adolescents with cancer. Cancer. 2010; 116: 4197&#x2013;205. 10.1002/cncr.25199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cncr.25199</ArticleId><ArticleId IdType="pubmed">20533566</ArticleId></ArticleIdList></Reference><Reference><Citation>Vidal E, Sharathkumar A, Glover J, Faustino EV. Central venous catheter-related thrombosis and thromboprophylaxis in children: a systematic review and meta-analysis. Journal of thrombosis and haemostasis : JTH. 2014; 12: 1096&#x2013;109. 10.1111/jth.12598.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.12598</ArticleId><ArticleId IdType="pmc">PMC4107177</ArticleId><ArticleId IdType="pubmed">24801495</ArticleId></ArticleIdList></Reference><Reference><Citation>Greiner J, Schrappe M, Claviez A, Zimmermann M, Niemeyer C, Kolb R, Eberl W, Berthold F, Bergstrasser E, Gnekow A, Lassay E, Vorwerk P, Lauten M, Sauerbrey A, Rischewski J, Beilken A, Henze G, Korte W, Moricke A. THROMBOTECT - a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during induction therapy of acute lymphoblastic leukemia in children and adolescents. Haematologica. 2019; 104: 756&#x2013;65. 10.3324/haematol.2018.194175.</Citation><ArticleIdList><ArticleId IdType="doi">10.3324/haematol.2018.194175</ArticleId><ArticleId IdType="pmc">PMC6442986</ArticleId><ArticleId IdType="pubmed">30262570</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao T, Liu H, Han J. Ethanol lock is effective on reducing the incidence of tunneled catheter-related bloodstream infections in hemodialysis patients: a systematic review and meta-analysis. International urology and nephrology. 2018; 50: 1643&#x2013;52. 10.1007/s11255-018-1855-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11255-018-1855-4</ArticleId><ArticleId IdType="pubmed">29667048</ArticleId></ArticleIdList></Reference><Reference><Citation>Avila ML, Amiri N, Stanojevic S, Vu TT, Barron K, Krol P, Yue N, Williams S, Brandao LR. Can thrombophilia predict recurrent catheter-related deep vein thrombosis in children? Blood. 2018; 131: 2712&#x2013;9. 10.1182/blood-2017-10-811216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2017-10-811216</ArticleId><ArticleId IdType="pubmed">29724900</ArticleId></ArticleIdList></Reference><Reference><Citation>Neshat-Vahid S, Pierce R, Hersey D, Raffini LJ, Faustino EV. Association of thrombophilia and catheter-associated thrombosis in children: a systematic review and meta-analysis. Journal of thrombosis and haemostasis : JTH. 2016; 14: 1749&#x2013;58. 10.1111/jth.13388.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.13388</ArticleId><ArticleId IdType="pmc">PMC5035642</ArticleId><ArticleId IdType="pubmed">27306795</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharathkumar AA, Mahajerin A, Heidt L, Doerfer K, Heiny M, Vik T, Fallon R, Rademaker A. Risk-prediction tool for identifying hospitalized children with a predisposition for development of venous thromboembolism: Peds-Clot clinical Decision Rule. Journal of thrombosis and haemostasis : JTH. 2012; 10: 1326&#x2013;34. 10.1111/j.1538-7836.2012.04779.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2012.04779.x</ArticleId><ArticleId IdType="pubmed">22583578</ArticleId></ArticleIdList></Reference><Reference><Citation>Crary SE, Buchanan GR. Vascular complications after splenectomy for hematologic disorders. Blood. 2009; 114: 2861&#x2013;8. 10.1182/blood-2009-04-210112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2009-04-210112</ArticleId><ArticleId IdType="pmc">PMC2756197</ArticleId><ArticleId IdType="pubmed">19636061</ArticleId></ArticleIdList></Reference><Reference><Citation>Athale UH, Chan AK. Thrombosis in children with acute lymphoblastic leukemia: part I. Epidemiology of thrombosis in children with acute lymphoblastic leukemia. Thrombosis research. 2003; 111: 125&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">14678808</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33451609</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>24</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2589-9333</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jan</Month></PubDate></JournalIssue><Title>American journal of obstetrics &amp; gynecology MFM</Title><ISOAbbreviation>Am J Obstet Gynecol MFM</ISOAbbreviation></Journal><ArticleTitle>Management of brain tumors presenting in pregnancy: a case series and systematic review.</ArticleTitle><Pagination><StartPage>100256</StartPage><MedlinePgn>100256</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajogmf.2020.100256</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2589-9333(20)30224-X</ELocationID><Abstract><AbstractText>Patients who present with brain tumors during pregnancy require unique imaging and neurosurgical, obstetrical, and anesthetic considerations. Here, we review the literature and discuss the management of patients who present with brain tumors during pregnancy. Between 2009 and 2019, 9 patients were diagnosed at our institution with brain tumors during pregnancy. Clinical information was extracted from the electronic medical records. The median age at presentation was 29 years (range, 25-38 years). The most common symptoms at presentation included headache (n=5), visual changes (n=4), hemiparesis (n=3), and seizures (n=3). The median gestational age at presentation was 20.5 weeks (range, 11-37 weeks). Of note, 8 patients (89%) delivered healthy newborns, and 1 patient terminated her pregnancy. In addition, 5 patients (56%) required neurosurgical procedures during pregnancy (gestational ages, 14-37 weeks) because of disease progression (n=2) or neurologic instability (n=3). There was 1 episode of postneurosurgery morbidity (pulmonary embolism [PE]) and no surgical maternal mortality. The median length of follow-up was 15 months (range, 6-45 months). In cases demonstrating unstable or progressive neurosurgical status past the point of fetal viability, neurosurgical intervention should be considered. The physiological and pharmacodynamic changes of pregnancy substantially affect anesthetic management. Pregnancy termination should be discussed and offered to the patient when aggressive disease necessitates immediate treatment and the fetal gestational age remains previable, although neurologically stable patients may be able to continue the pregnancy to term. Ultimately, pregnant patients with brain tumors require an individualized approach to their care under the guidance of a multidisciplinary team.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rodrigues</LastName><ForeName>Adrian J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Departments of Neurosurgery, Stanford University School of Medicine, Stanford, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waldrop</LastName><ForeName>Anne R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suharwardy</LastName><ForeName>Sanaa</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Druzin</LastName><ForeName>Maurice L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iv</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Neuroimaging and Neurointervention, Department of Radiology, Stanford University School of Medicine, Stanford, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ansari</LastName><ForeName>Jessica R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stone</LastName><ForeName>Sarah A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jaffe</LastName><ForeName>Richard A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Michael C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Departments of Neurosurgery, Stanford University School of Medicine, Stanford, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Gordon</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Departments of Neurosurgery, Stanford University School of Medicine, Stanford, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hayden-Gephart</LastName><ForeName>Melanie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Departments of Neurosurgery, Stanford University School of Medicine, Stanford, CA. Electronic address: mghayden@stanford.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Obstet Gynecol MFM</MedlineTA><NlmUniqueID>101746609</NlmUniqueID><ISSNLinking>2589-9333</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001932" MajorTopicYN="Y">Brain Neoplasms</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005328" MajorTopicYN="N">Fetal Viability</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005865" MajorTopicYN="N">Gestational Age</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008428" MajorTopicYN="N">Maternal Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019635" MajorTopicYN="N">Neurosurgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">brain tumor</Keyword><Keyword MajorTopicYN="N">patient management</Keyword><Keyword MajorTopicYN="N">pregnancy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>10</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>10</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>16</Day><Hour>5</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33451609</ArticleId><ArticleId IdType="doi">10.1016/j.ajogmf.2020.100256</ArticleId><ArticleId IdType="pii">S2589-9333(20)30224-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25807412</PMID><DateCompleted><Year>2015</Year><Month>06</Month><Day>01</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2163-0763</ISSN><JournalIssue CitedMedium="Internet"><Volume>78</Volume><Issue>4</Issue><PubDate><Year>2015</Year><Month>Apr</Month></PubDate></JournalIssue><Title>The journal of trauma and acute care surgery</Title><ISOAbbreviation>J Trauma Acute Care Surg</ISOAbbreviation></Journal><ArticleTitle>Spinal cord injury without radiologic abnormality in children: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>874</StartPage><EndPage>882</EndPage><MedlinePgn>874-82</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/TA.0000000000000579</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Spinal cord injury in children is associated with severe morbidity and immense socioeconomic burden. In spinal cord injury without radiologic abnormalities (SCIWORA), magnetic resonance imaging (MRI) can detect intramedullary or extramedullary pathologies or show absence of neuroimaging abnormalities. However, the prognostic and therapeutic consequences of specific MRI patterns are unclear. A comprehensive systematic literature search was performed to examine patient characteristics and imaging patterns of pediatric SCIWORA and to evaluate the prognostic value of a MRI-based classification system.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">MEDLINE, Cochrane Central Register of Controlled Trials, and Google Scholar were searched for studies on SCIWORA in children. Inclusion criteria were (1) traumatic spinal cord injury with acute neurologic deficit, (2) absence of fractures and/or dislocations of the spine, and (3) an immature skeleton or age of less than 18 years. MRI patterns and clinical course were correlated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Forty articles reporting 114 patients were identified. At admission, neurologic deficit assessed by the American Spinal Injury Association impairment scale was A in 28%, B in 17%, C in 31%, and D in 25%. At final follow-up, these were 19%, 6%, 10%, and 16%, respectively. In 43%, no MRI abnormalities (Type I) were detected, and 57% exhibited abnormal scan results (Type II): 6% revealed extraneural (Type IIa), 38% intraneural (Type IIb), and 13% combined abnormalities (Type IIc). At admission and follow-up, American Spinal Injury Association impairment scale differed significantly between the imaging types.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This systematic review emphasizes the prognostic value of spinal MRI for children with SCIWORA. It highlights the role of the MRI classification system in improving the comparability and interpretability.</AbstractText><AbstractText Label="LEVEL OF EVIDENCE" NlmCategory="METHODS">Systematic review, level IV.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Boese</LastName><ForeName>Christoph Kolja</ForeName><Initials>CK</Initials><AffiliationInfo><Affiliation>From the Department of Orthopaedic and Trauma Surgery (C.K.B., J.O., J.S., P.E., M.J.S.), University Hospital of Cologne, Cologne; Department of Trauma, Hand and Reconstructive Surgery (P.L.), University of Giessen and Marburg, Giessen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oppermann</LastName><ForeName>Johannes</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Siewe</LastName><ForeName>Jan</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Eysel</LastName><ForeName>Peer</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Scheyerer</LastName><ForeName>Max Joseph</ForeName><Initials>MJ</Initials></Author><Author ValidYN="Y"><LastName>Lechler</LastName><ForeName>Philipp</ForeName><Initials>P</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Trauma Acute Care Surg</MedlineTA><NlmUniqueID>101570622</NlmUniqueID><ISSNLinking>2163-0755</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="Y">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013119" MajorTopicYN="N">Spinal Cord Injuries</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25807412</ArticleId><ArticleId IdType="doi">10.1097/TA.0000000000000579</ArticleId><ArticleId IdType="pii">01586154-201504000-00027</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37053508</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1526-7598</ISSN><JournalIssue CitedMedium="Internet"><Volume>137</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>Complications of Factor V Leiden in Adults Undergoing Noncardiac Surgical Procedures: A Systematic Review.</ArticleTitle><Pagination><StartPage>601</StartPage><EndPage>617</EndPage><MedlinePgn>601-617</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1213/ANE.0000000000006483</ELocationID><Abstract><AbstractText>Factor V Leiden is the commonest hereditary prothrombotic allele, affecting 1% to 5% of the world's population. The objective of this study was to characterize the perioperative and postoperative outcomes of patients with Factor V Leiden compared to patients without a diagnosis of hereditary thrombophilia. This was a focused systematic review of studies including adult (&gt;18 years) patients with Factor V Leiden (heterozygous or homozygous) undergoing noncardiac surgery. Included studies were either randomized controlled trials or observational. The primary clinical outcomes of interest were thromboembolic events occurring from the perioperative period up to 1 year postoperatively, defined as deep venous thrombosis, pulmonary embolism, or other clinically significant thrombosis occurring during or after a surgical procedure. Secondary outcomes included cerebrovascular events, cardiac events, death, transplant-related outcomes, and surgery-specific morbidity. Pediatric and obstetrical patients were excluded, as were case reports and case series. Databases searched included MEDLINE and EMBASE from inception until August 2021. Study bias was assessed through the CLARITY (Collaboration of McMaster University researchers) Risk of Bias tools, and heterogeneity through analysis of study design and end points, as well as the I 2 statistic with its confidence interval and the Q statistic. A total of 5275 potentially relevant studies were identified, with 115 having full text assessed for eligibility and 32 included in the systematic review. On the whole, the literature suggests that patients with Factor V Leiden have an increased risk of perioperative and postoperative thromboembolic events compared to patients without the diagnosis. Increased risk was also seen in relation to surgery-specific morbidity and transplant-related outcomes, particularly arterial thrombotic events. The literature did not support an increased risk for mortality, cerebrovascular, or cardiac complications. Limitations of the data include predisposition toward bias due in many study designs and small sample sizes across the majority of published studies. Variable outcome definitions and durations of patient follow-up across different surgical procedures resulted in high study heterogeneity precluding the effective use of meta-analysis. Factor V Leiden status may confer additional risk for surgery-related adverse outcomes. Large, adequately powered studies are required to accurately estimate the degree of this risk by zygosity.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 International Anesthesia Research Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Au</LastName><ForeName>Emily</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>From the Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shao</LastName><ForeName>Ian</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>From the Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elias</LastName><ForeName>Zeyad</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koivu</LastName><ForeName>Annabel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Edinburgh Medical School, University of Edinburgh, Edinburgh, Scotland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zabida</LastName><ForeName>Amir</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Sinai Health System, Women's College Hospital, University Health Network, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shih</LastName><ForeName>Andrew W</ForeName><Initials>AW</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Blood Research, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cserti-Gazdewich</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Klei</LastName><ForeName>Wilton A</ForeName><Initials>WA</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Sinai Health System, Women's College Hospital, University Health Network, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesiology and Pain Medicine, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bartoszko</LastName><ForeName>Justyna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Sinai Health System, Women's College Hospital, University Health Network, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesiology and Pain Medicine, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C095381">factor V Leiden</NameOfSubstance></Chemical><Chemical><RegistryNumber>9001-24-5</RegistryNumber><NameOfSubstance UI="D005165">Factor V</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C540694">Thrombophilia, hereditary</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005165" MajorTopicYN="N">Factor V</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019851" MajorTopicYN="Y">Thrombophilia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006331" MajorTopicYN="Y">Heart Diseases</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Conflicts of Interest: See Disclosures at the end of the article. Conflicts of Interest: J. Bartoszko supported by a merit award from the Department of Anesthesiology and Pain Medicine, University of Toronto. J. Bartoszko has received honoraria from Octapharma.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>13</Day><Hour>15</Hour><Minute>42</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37053508</ArticleId><ArticleId IdType="doi">10.1213/ANE.0000000000006483</ArticleId><ArticleId IdType="pii">00000539-202309000-00018</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mullen MG, Michaels AD, Mehaffey JH, et al. Risk associated with complications and mortality after urgent surgery vs elective and emergency surgery: implications for defining &#x201c;quality&#x201d; and reporting outcomes for urgent surgery. JAMA Surg. 2017;152:768&#x2013;774.</Citation></Reference><Reference><Citation>Smilowitz NR, Gupta N, Guo Y, et al. Trends in perioperative venous thromboembolism associated with major noncardiac surgery. TH Open. 2017;1:e82&#x2013;e91.</Citation></Reference><Reference><Citation>Smilowitz NR, Gupta N, Guo Y, Beckman JA, Bangalore S, Berger JS. Trends in cardiovascular risk factor and disease prevalence in patients undergoing non-cardiac surgery. Heart. 2018;104:1180&#x2013;1186.</Citation></Reference><Reference><Citation>Wolters U, Wolf T, St&#xfc;tzer H, Schr&#xf6;der T. ASA classification and perioperative variables as predictors of postoperative outcome. Br J Anaesth. 1996;77:217&#x2013;222.</Citation></Reference><Reference><Citation>Partridge JS, Harari D, Dhesi JK. Frailty in the older surgical patient: a review. Age Ageing. 2012;41:142&#x2013;147.</Citation></Reference><Reference><Citation>Kujovich JL. Factor V Leiden thrombophilia. Genet Med. 2011;13:1&#x2013;16.</Citation></Reference><Reference><Citation>De Stefano V, Chiusolo P, Paciaroni K, Leone G. Epidemiology of factor V Leiden: clinical implications. Semin Thromb Hemost. 1998;24:367&#x2013;379.</Citation></Reference><Reference><Citation>Donahue BS. Factor V Leiden and perioperative risk. Anesth Analg. 2004;98:1623&#x2013;1634.</Citation></Reference><Reference><Citation>Cushman M. Epidemiology and risk factors for venous thrombosis. Semin Hematol. 2007;44:62&#x2013;69.</Citation></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.</Citation></Reference><Reference><Citation>Benford D, Halldorsson T, Jeger MJ, et al.; EFSA Scientific Committee. The principles and methods behind EFSA&#x2019;s guidance on uncertainty analysis in scientific assessment. EFSA J. 2018;16:e05122.</Citation></Reference><Reference><Citation>Foley PW, Irvine CD, Standen GR, et al. Activated protein C resistance, factor V Leiden and peripheral vascular disease. Cardiovasc Surg. 1997;5:157&#x2013;160.</Citation></Reference><Reference><Citation>Kreienberg PB, Chang BB, Darling RC III, et al. Long-term results in patients treated with thrombolysis, thoracic inlet decompression, and subclavian vein stenting for Paget-Schroetter syndrome. J Vasc Surg. 2001;33(2 suppl):S100&#x2013;S105.</Citation></Reference><Reference><Citation>Fijnheer R, Paijmans B, Verdonck LF, Nieuwenhuis HK, Roest M, Dekker AW. Factor V Leiden in central venous catheter-associated thrombosis. Br J Haematol. 2002;118:267&#x2013;270.</Citation></Reference><Reference><Citation>van Adrichem RA, Nelissen RG, Schipper IB, Rosendaal FR, Cannegieter SC. Risk of venous thrombosis after arthroscopy of the knee: results from a large population-based case-control study. J Thromb Haemost. 2015;13:1441&#x2013;1448.</Citation></Reference><Reference><Citation>Nemeth B, Lijfering WM, Nelissen R, et al. Risk and risk factors associated with recurrent venous thromboembolism following surgery in patients with history of venous thromboembolism. JAMA Netw Open. 2019;2:e193690.</Citation></Reference><Reference><Citation>Zambelli R, Nemeth B, Touw CE, Rosendaal FR, Rezende SM, Cannegieter SC. High risk of venous thromboembolism after orthopedic surgery in patients with thrombophilia. J Thromb Haemost. 2021;19:444&#x2013;451.</Citation></Reference><Reference><Citation>Ryan DH, Crowther MA, Ginsberg JS, Francis CW. Relation of factor V Leiden genotype to risk for acute deep venous thrombosis after joint replacement surgery. Ann Intern Med. 1998;128:270&#x2013;276.</Citation></Reference><Reference><Citation>Kibbe MR, Hassett AL, McSherry F, et al. Can screening for genetic markers improve peripheral artery bypass patency? J Vasc Surg. 2002;36:1198&#x2013;1206.</Citation></Reference><Reference><Citation>W&#xe5;hlander K, Larson G, Lindahl TL, et al. Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery. Thromb Haemost. 2002;87:580&#x2013;585.</Citation></Reference><Reference><Citation>Douville NJ, Kheterpal S, Engoren M, et al. Genetic mutations associated with susceptibility to perioperative complications in a longitudinal biorepository with integrated genomic and electronic health records. Br J Anaesth. 2020;125:986&#x2013;994.</Citation></Reference><Reference><Citation>Ulrych J, Kvasni&#x10d;ka T, Fr&#xfd;ba V, et al. The impact of hereditary thrombophilia on the incidence of postoperative venous thromboembolism in colorectal cancer patients: a prospective cohort study. Eur Surg. 2018;51:5&#x2013;12.</Citation></Reference><Reference><Citation>Hirshfield G, Collier JD, Brown K, et al. Donor factor V Leiden mutation and vascular thrombosis following liver transplantation. Liver Transpl Surg. 1998;4:58&#x2013;61.</Citation></Reference><Reference><Citation>Ekberg H, Svensson PJ, Simanaitis M, Dahlb&#xe4;ck B. Factor V R506Q mutation (activated protein C resistance) is an additional risk factor for early renal graft loss associated with acute vascular rejection. Transplantation. 2000;69:1577&#x2013;1581.</Citation></Reference><Reference><Citation>Fan J, Nishida S, Selvaggi G, et al. Factor V Leiden mutation is a risk factor for hepatic artery thrombosis in liver transplantation. Transplant Proc. 2013;45:1990&#x2013;1993.</Citation></Reference><Reference><Citation>Loew A, Jacob D, Neuhaus P, Riess H. Resistance to activated protein C caused by factor V Leiden mutation and orthotopic liver transplantation. Transplantation. 2005;79:1422&#x2013;1427.</Citation></Reference><Reference><Citation>Sampram ES, Lindblad B. The impact of factor V mutation on the risk for occlusion in patients undergoing peripheral vascular reconstructions. Eur J Vasc Endovasc Surg. 2001;22:134&#x2013;138.</Citation></Reference><Reference><Citation>Adrogu&#xe9; HE, Matas AJ, McGlennon RC, et al. Do inherited hypercoagulable states play a role in thrombotic events affecting kidney/pancreas transplant recipients? Clin Transplant. 2007;21:32&#x2013;37.</Citation></Reference><Reference><Citation>Heidenreich S, Dercken C, August C, Koch HG, Nowak-G&#xf6;ttl U. High rate of acute rejections in renal allograft recipients with thrombophilic risk factors. J Am Soc Nephrol. 1998;9:1309&#x2013;1313.</Citation></Reference><Reference><Citation>Irish AB, Green FR, Gray DW, Morris PJ. The factor V Leiden (R506Q) mutation and risk of thrombosis in renal transplant recipients. Transplantation. 1997;64:604&#x2013;607.</Citation></Reference><Reference><Citation>Meyer M, Laux G, Scherer S, Tran TH, Opelz G, Mytilineos J. No association of factor V Leiden, prothrombin G20210A, and MTHFR C677T gene polymorphisms with kidney allograft survival: a multicenter study. Transplantation. 2007;83:1055&#x2013;1058.</Citation></Reference><Reference><Citation>Pereboom IT, Adelmeijer J, van der Steege G, van den Berg AP, Lisman T, Porte RJ. Prothrombotic gene polymorphisms: possible contributors to hepatic artery thrombosis after orthotopic liver transplantation. Transplantation. 2011;92:587&#x2013;593.</Citation></Reference><Reference><Citation>Blaszyk H, Bj&#xf6;rnsson J. Factor V Leiden and morbid obesity in fatal postoperative pulmonary embolism. Arch Surg. 2000;135:1410&#x2013;1413.</Citation></Reference><Reference><Citation>Sampram ES, Lindblad B, Dahlb&#xe4;ck B. Activated protein C resistance in patients with peripheral vascular disease. J Vasc Surg. 1998;28:624&#x2013;629.</Citation></Reference><Reference><Citation>W&#xfc;thrich RP, Cicvara-Muzar S, Booy C, Maly FE. Heterozygosity for the factor V Leiden (G1691A) mutation predisposes renal transplant recipients to thrombotic complications and graft loss. Transplantation. 2001;72:549&#x2013;550.</Citation></Reference><Reference><Citation>Baba-Ahmed M, Le Gal G, Couturaud F, Lacut K, Oger E, Leroyer C. High frequency of factor V Leiden in surgical patients with symptomatic venous thromboembolism despite prophylaxis. Thromb Haemost. 2007;97:171&#x2013;175.</Citation></Reference><Reference><Citation>Painter TW, McIlroy D, Myles PS, Leslie K. A survey of anaesthetists&#x2019; use of tranexamic acid in noncardiac surgery. Anaesth Intensive Care. 2019;47:76&#x2013;84.</Citation></Reference><Reference><Citation>Levent A, Kose O, Linke P, Gehrke T, Citak M. Tranexamic acid is safe and effective in patients with heterozygous factor V Leiden mutation during total joint arthroplasty. Arch Orthop Trauma Surg. 2023;143:613&#x2013;620.</Citation></Reference><Reference><Citation>Bowler DJ, Bale E, O'Byrne J. Factor V Leiden: prevalence and thromboembolic complications after total hip replacement in Ireland. Ir J Med Sci. 2007;176(4):273&#x2013;277. doi:10.1007/s11845-007-0095-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11845-007-0095-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Charen DA, Qian ET, Hutzler LH, Bosco JA. Risk factors for postoperative venous thromboembolism in orthopaedic spine surgery, hip arthroplasty, and knee arthroplasty patients. Bull Hosp Jt Dis (2013). 2015;73(3):198&#x2013;203.</Citation></Reference><Reference><Citation>Della Valle CJ, Issack PS, Baitner A, Steiger DJ, Fang C, Di Cesare PE. The relationship of the factor V Leiden mutation or the deletion-deletion polymorphism of the angiotensin converting enzyme to postoperative thromboembolic events following total joint arthroplasty. BMC Musculoskelet Disord. 2001;2:1. doi:10.1186/1471-2474-2-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2474-2-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Donaldson MC, Belkin M, Whittemore AD, Mannick JA, Longtine JA, Dorfman DM. Impact of activated protein C resistance on general vascular surgical patients. J Vasc Surg. 1997;25(6):1054&#x2013;1060. doi:10.1016/s0741-5214(97)70129-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0741-5214(97)70129-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowe GD, Haverkate F, Thompson SG, et al. Prediction of deep vein thrombosis after elective hip replacement surgery by preoperative clinical and haemostatic variables: the ECAT DVT Study. European Concerted Action on Thrombosis. Thromb Haemost. 1999;81(6):879&#x2013;886.</Citation></Reference><Reference><Citation>Joseph JE, Low J, Courtenay B, Neil MJ, McGrath M, Ma D. A single-centre prospective study of clinical and haemostatic risk factors for venous thromboembolism following lower limb arthroplasty. Br J Haematol. 2005;129(1):87&#x2013;92. doi:10.1111/j.1365-2141.2005.05419.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2141.2005.05419.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Ringwald J, Berger A, Adler W, Kraus C, Pitto RP. Genetic polymorphisms in venous thrombosis and pulmonary embolism after total hip arthroplasty: a pilot study. Clin Orthop Relat Res. 2009;467(6):1507&#x2013;1515. doi:10.1007/s11999-008-0498-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11999-008-0498-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Sartori M, Conti E, Favaretto E, Frascaro M, Legnani C, Palareti G. Thrombotic risk factors and cardiovascular events after endovascular intervention for peripheral arterial disease. Eur J Vasc Endovasc Surg. 2011;42(6):817&#x2013;823. doi:10.1016/j.ejvs.2011.08.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejvs.2011.08.016</ArticleId></ArticleIdList></Reference><Reference><Citation>Sz&#xfc;cs G, Ajzner E, Muszbek L, Simon T, Szepesi K, F&#xfc;lesdi B. Assessment of thrombotic risk factors predisposing to thromboembolic complications in prosthetic orthopedic surgery. J Orthop Sci. 2009;14(5):484&#x2013;490. doi:10.1007/s00776-009-1368-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00776-009-1368-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Woolson ST, Zehnder JL, Maloney WJ. Factor V Leiden and the risk of proximal venous thrombosis after total hip arthroplasty. J Arthroplasty. 1998;13(2):207&#x2013;210.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33837274</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>31</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-5640</ISSN><JournalIssue CitedMedium="Internet"><Volume>75</Volume><Issue>12</Issue><PubDate><Year>2021</Year><Month>Dec</Month></PubDate></JournalIssue><Title>European journal of clinical nutrition</Title><ISOAbbreviation>Eur J Clin Nutr</ISOAbbreviation></Journal><ArticleTitle>Preconceptional maternal weight loss and hypertensive disorders in pregnancy: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1684</StartPage><EndPage>1697</EndPage><MedlinePgn>1684-1697</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41430-021-00902-9</ELocationID><Abstract><AbstractText Label="BACKGROUND">Hypertensive disorders of pregnancy (HDP), including pregnancy-induced hypertension (PIH), Preeclampsia (PE), Hemolysis Elevated Liver enzymes and Low Platelets (HELLP) and chronic hypertension, are leading causes of maternal and perinatal morbidity and mortality. Although the pathophysiology of HDP is complex, preconceptional weight reduction in obese women might reduce these complications. We conducted a systematic review and meta-analysis to investigate the effectiveness of preconceptional weight loss by lifestyle intervention or bariatric surgery in overweight and obese women and the reduction of the risk of HDP.</AbstractText><AbstractText Label="METHODS AND RESULTS">Databases are searched until September 2019 resulting in 2547 articles: 110 full-text analysis and 29 detailed analysis. Reduced risks were shown for HDP in seven articles (n&#x2009;=&#x2009;4381) of weight loss after lifestyle intervention or bariatric surgery (OR range 0.10-0.64), for PIH in four articles (n&#x2009;=&#x2009;46,976) (OR range 0.14-0.79), and for PE in seven articles (n&#x2009;=&#x2009;169,734) (OR range 0.14-0.84). The stratified analysis of weight loss after lifestyle intervention and bariatric surgery shows comparable results. The meta-analysis of 20 studies of the effectiveness of lifestyle intervention and bariatric surgery revealed reduced risks of HDP (OR 0.45 (95% CI 0.32-0.63)), PIH (OR 0.61 (95%CI 0.44-0.85)) and PE (OR 0.67 (95%CI 0.51-0.88)).</AbstractText><AbstractText Label="CONCLUSIONS">Preconceptional weight loss after lifestyle intervention or bariatric surgery is effective in reducing risks of HDP, PIH and PE, and emphasizes the need to optimize weight in overweight and obese women with a child wish. More research is recommended to investigate short-term and long-term beneficial and harmful side-effects of these interventions on maternal and offspring health.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s), under exclusive licence to Springer Nature Limited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schenkelaars</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-3498-5579</Identifier><AffiliationInfo><Affiliation>Department Obstetrics and Gynecology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rousian</LastName><ForeName>Melek</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department Obstetrics and Gynecology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoek</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department Obstetrics and Gynecology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schoenmakers</LastName><ForeName>Sam</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department Obstetrics and Gynecology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Willemsen</LastName><ForeName>Sten</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department Biostatistics, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steegers-Theunissen</LastName><ForeName>R&#xe9;gine</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department Obstetrics and Gynecology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands. r.steegers@erasmusmc.nl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Clin Nutr</MedlineTA><NlmUniqueID>8804070</NlmUniqueID><ISSNLinking>0954-3007</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D046110" MajorTopicYN="Y">Hypertension, Pregnancy-Induced</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050177" MajorTopicYN="N">Overweight</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011225" MajorTopicYN="Y">Pre-Eclampsia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015431" MajorTopicYN="N">Weight Loss</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>2</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>10</Day><Hour>5</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33837274</ArticleId><ArticleId IdType="doi">10.1038/s41430-021-00902-9</ArticleId><ArticleId IdType="pii">10.1038/s41430-021-00902-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010;376:631&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">20598363</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(10)60279-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006;367:1066&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">16581405</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(06)68397-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Meikle S, Trumble A. Severe maternal morbidity associated with hypertensive disorders in pregnancy in the United States. Hypertens Pregnancy. 2003;22:203&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">12909005</ArticleId><ArticleId IdType="doi">10.1081/PRG-120021066</ArticleId></ArticleIdList></Reference><Reference><Citation>Baeten JM, Bukusi EA, Lambe M. Pregnancy complications and outcomes among overweight and obese nulliparous women. Am J Public Health. 2001;91:436&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">11236410</ArticleId><ArticleId IdType="pmc">1446581</ArticleId><ArticleId IdType="doi">10.2105/AJPH.91.3.436</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Brien TE, Ray JG, Chan WS. Maternal body mass index and the risk of preeclampsia: a systematic overview. Epidemiology. 2003;14:368&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">12859040</ArticleId><ArticleId IdType="doi">10.1097/01.EDE.0000059921.71494.D1</ArticleId></ArticleIdList></Reference><Reference><Citation>Sebire NJ, Jolly M, Harris JP, Wadsworth J, Joffe M, Beard RW, et al. Maternal obesity and pregnancy outcome: a study of 287,213 pregnancies in London. Int J Obes Relat Metab Disord. 2001;25:1175&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">11477502</ArticleId><ArticleId IdType="doi">10.1038/sj.ijo.0801670</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds RM, Allan KM, Raja EA, Bhattacharya S, McNeill G, Hannaford PC, et al. Maternal obesity during pregnancy and premature mortality from cardiovascular event in adult offspring: follow-up of 1 323 275 person years. BMJ. 2013;347:f4539.</Citation><ArticleIdList><ArticleId IdType="pubmed">23943697</ArticleId><ArticleId IdType="pmc">3805484</ArticleId><ArticleId IdType="doi">10.1136/bmj.f4539</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, et al. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension. 2018;72:24&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">29899139</ArticleId><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.117.10803</ArticleId></ArticleIdList></Reference><Reference><Citation>Apovian CM. Obesity: definition, comorbidities, causes, and burden. Am J Manag Care. 2016;22:s176&#x2013;85. 7 Suppl</Citation><ArticleIdList><ArticleId IdType="pubmed">27356115</ArticleId></ArticleIdList></Reference><Reference><Citation>Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999&#x2013;2008. JAMA. 2010;303:235&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">20071471</ArticleId><ArticleId IdType="doi">10.1001/jama.2009.2014</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma RCW, Schmidt MI, Tam WH, McIntyre HD, Catalano PM. Clinical management of pregnancy in the obese mother: before conception, during pregnancy, and post partum. Lancet Diabetes Endocrinol. 2016;4:1037&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">27743977</ArticleId><ArticleId IdType="pmc">6691730</ArticleId><ArticleId IdType="doi">10.1016/S2213-8587(16)30278-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedergren MI. Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstet Gynecol. 2004;103:219&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">14754687</ArticleId><ArticleId IdType="doi">10.1097/01.AOG.0000107291.46159.00</ArticleId></ArticleIdList></Reference><Reference><Citation>Godfrey KM, Reynolds RM, Prescott SL, Nyirenda M, Jaddoe VW, Eriksson JG, et al. Influence of maternal obesity on the long-term health of offspring. Lancet Diabetes Endocrinol. 2017;5:53&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">27743978</ArticleId><ArticleId IdType="doi">10.1016/S2213-8587(16)30107-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Steegers-Theunissen RPM. Periconception mHealth platform for prevention of placental-related outcomes and non-communicable diseases. Placenta. 2017;60:115&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">28473168</ArticleId><ArticleId IdType="doi">10.1016/j.placenta.2017.04.017</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodd JM, Turnbull D, McPhee AJ, Deussen AR, Grivell RM, Yelland LN, et al. Antenatal lifestyle advice for women who are overweight or obese: LIMIT randomised trial. BMJ. 2014;348:g1285.</Citation><ArticleIdList><ArticleId IdType="pubmed">24513442</ArticleId><ArticleId IdType="pmc">3919179</ArticleId><ArticleId IdType="doi">10.1136/bmj.g1285</ArticleId></ArticleIdList></Reference><Reference><Citation>Muktabhant B, Lawrie TA, Lumbiganon P, Laopaiboon M. Diet or exercise, or both, for preventing excessive weight gain in pregnancy. Cochrane Database Syst Rev. 2015;6:CD007145.</Citation></Reference><Reference><Citation>Poston L, Bell R, Croker H, Flynn AC, Godfrey KM, Goff L, et al. Effect of a behavioural intervention in obese pregnant women (the UPBEAT study): a multicentre, randomised controlled trial. Lancet Diabetes Endocrinol. 2015;3:767&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">26165396</ArticleId><ArticleId IdType="doi">10.1016/S2213-8587(15)00227-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell OM, Graham WJ. Lancet Maternal Survival Series steering g. Strategies for reducing maternal mortality: getting on with what works. Lancet. 2006;368:1284&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">17027735</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(06)69381-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122:248&#x2013;56 e5.</Citation><ArticleIdList><ArticleId IdType="pubmed">19272486</ArticleId><ArticleId IdType="doi">10.1016/j.amjmed.2008.09.041</ArticleId></ArticleIdList></Reference><Reference><Citation>van Oers AM, Mutsaerts MAQ, Burggraaff JM, Kuchenbecker WKH, Perquin DAM, Koks CAM, et al. Association between periconceptional weight loss and maternal and neonatal outcomes in obese infertile women. PLoS One. 2018;13:e0192670.</Citation><ArticleIdList><ArticleId IdType="pubmed">29590118</ArticleId><ArticleId IdType="pmc">5873932</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0192670</ArticleId></ArticleIdList></Reference><Reference><Citation>Villamor E, Cnattingius S. Interpregnancy weight change and risk of adverse pregnancy outcomes: a population-based study. Lancet. 2006;368:1164&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">17011943</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(06)69473-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi XY, Li QF, Zhang J, Wang ZH. A meta-analysis of maternal and fetal outcomes of pregnancy after bariatric surgery. Int J Gynaecol Obstet. 2015;130:3&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">25863541</ArticleId><ArticleId IdType="doi">10.1016/j.ijgo.2015.01.011</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton OMU. Quality assessment tool for quantitative studies. National Collaborating Centre for Methods and Tools. Ontario. 2008.</Citation></Reference><Reference><Citation>Adane AA, Mishra GD, Tooth LR. Adult pre-pregnancy weight change and risk of developing hypertensive disorders in pregnancy. Paediatr Perinat Epidemiol. 2017;31:167&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">28386955</ArticleId><ArticleId IdType="doi">10.1111/ppe.12353</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogaerts A, Van den Bergh BR, Ameye L, Witters I, Martens E, Timmerman D, et al. Interpregnancy weight change and risk for adverse perinatal outcome. Obstet Gynecol. 2013;122:999&#x2013;1009.</Citation><ArticleIdList><ArticleId IdType="pubmed">24104777</ArticleId><ArticleId IdType="doi">10.1097/AOG.0b013e3182a7f63e</ArticleId></ArticleIdList></Reference><Reference><Citation>Diouf I, Charles MA, Thiebaugeorges O, Forhan A, Kaminski M, Heude B, et al. Maternal weight change before pregnancy in relation to birthweight and risks of adverse pregnancy outcomes. Eur J Epidemiol. 2011;26:789&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">21710259</ArticleId><ArticleId IdType="pmc">3925097</ArticleId><ArticleId IdType="doi">10.1007/s10654-011-9599-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Dude AM, Shahawy S, Grobman WA. Delivery-to-delivery weight gain and risk of hypertensive disorders in a subsequent pregnancy. Obstet Gynecol. 2018;132:868&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">30204702</ArticleId><ArticleId IdType="pmc">6153032</ArticleId><ArticleId IdType="doi">10.1097/AOG.0000000000002874</ArticleId></ArticleIdList></Reference><Reference><Citation>Frederick IO, Rudra CB, Miller RS, Foster JC, Williams MA. Adult weight change, weight cycling, and prepregnancy obesity in relation to risk of preeclampsia. Epidemiology. 2006;17:428&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">16755262</ArticleId><ArticleId IdType="doi">10.1097/01.ede.0000221028.33245.0b</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynes C, McLain AC, Yeung EH, Albert P, Liu J, Boghossian NS. Interpregnancy weight change and adverse maternal outcomes: a retrospective cohort study. Ann Epidemiol. 2017;27:632&#x2013;7 e5.</Citation><ArticleIdList><ArticleId IdType="pubmed">29033119</ArticleId><ArticleId IdType="pmc">5751743</ArticleId><ArticleId IdType="doi">10.1016/j.annepidem.2017.09.008</ArticleId></ArticleIdList></Reference><Reference><Citation>McBain RD, Dekker GA, Clifton VL, Mol BW, Grzeskowiak LE. Impact of inter-pregnancy BMI change on perinatal outcomes: a retrospective cohort study. Eur J Obstet Gynecol Reprod Biol. 2016;205:98&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pubmed">27567535</ArticleId><ArticleId IdType="doi">10.1016/j.ejogrb.2016.07.487</ArticleId></ArticleIdList></Reference><Reference><Citation>Mostello D, Jen Chang J, Allen J, Luehr L, Shyken J, Leet T. Recurrent preeclampsia: the effect of weight change between pregnancies. Obstet Gynecol. 2010;116:667&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">20733450</ArticleId><ArticleId IdType="doi">10.1097/AOG.0b013e3181ed74ea</ArticleId></ArticleIdList></Reference><Reference><Citation>Pole JD, Dodds LA. Maternal outcomes associated with weight change between pregnancies. Can J Public Health. 1999;90:233&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">10489718</ArticleId><ArticleId IdType="pmc">6979634</ArticleId><ArticleId IdType="doi">10.1007/BF03404122</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallace JM, Bhattacharya S, Campbell DM, Horgan GW. Inter-pregnancy weight change impacts placental weight and is associated with the risk of adverse pregnancy outcomes in the second pregnancy. BMC Pregnancy Childbirth. 2014;14:40.</Citation><ArticleIdList><ArticleId IdType="pubmed">24450357</ArticleId><ArticleId IdType="pmc">3900734</ArticleId><ArticleId IdType="doi">10.1186/1471-2393-14-40</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallace JM, Bhattacharya S, Campbell DM, Horgan GW. Inter-pregnancy weight change and the risk of recurrent pregnancy complications. PLoS One. 2016;11:e0154812.</Citation><ArticleIdList><ArticleId IdType="pubmed">27145132</ArticleId><ArticleId IdType="pmc">4856284</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0154812</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams TD, Hammoud AO, Davidson LE, Laferrere B, Fraser A, Stanford JB, et al. Maternal and neonatal outcomes for pregnancies before and after gastric bypass surgery. Int J Obes. 2015;39:686&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ijo.2015.9</ArticleId></ArticleIdList></Reference><Reference><Citation>Amsalem D, Aricha-Tamir B, Levi I, Shai D, Sheiner E. Obstetric outcomes after restrictive bariatric surgery: what happens after 2 consecutive pregnancies? Surg Obes Relat Dis. 2014;10:445&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">24342035</ArticleId><ArticleId IdType="doi">10.1016/j.soard.2013.08.016</ArticleId></ArticleIdList></Reference><Reference><Citation>Aricha-Tamir B, Weintraub AY, Levi I, Sheiner E. Downsizing pregnancy complications: a study of paired pregnancy outcomes before and after bariatric surgery. Surg Obes Relat Dis. 2012;8:434&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">22301092</ArticleId><ArticleId IdType="doi">10.1016/j.soard.2011.12.009</ArticleId></ArticleIdList></Reference><Reference><Citation>Balestrin B, Urbanetz AA, Barbieri MM, Paes A, Fujie J. Pregnancy after bariatric surgery: a comparative study of post-bariatric pregnant women versus non-bariatric obese pregnant women. Obes Surg. 2019;29:3142&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">31129885</ArticleId><ArticleId IdType="doi">10.1007/s11695-019-03961-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Basbug A, Ellibes Kaya A, Dogan S, Pehlivan M, Goynumer G. Does pregnancy interval after laparoscopic sleeve gastrectomy affect maternal and perinatal outcomes? J Matern Fetal Neonatal Med. 2019;32:3764&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">29712482</ArticleId><ArticleId IdType="doi">10.1080/14767058.2018.1471678</ArticleId></ArticleIdList></Reference><Reference><Citation>Blume CA, Machado BM, da Rosa RR, Rigoni MDS, Casagrande DS, Mottin CC, et al. Association of maternal roux-en-Y gastric bypass with obstetric outcomes and fluid intelligence in offspring. Obes Surg. 2018;28:3611&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">30030729</ArticleId><ArticleId IdType="doi">10.1007/s11695-018-3407-5</ArticleId></ArticleIdList></Reference><Reference><Citation>de Alencar Costa LA, Araujo Junior E, de Lucena Feitosa FE, Dos Santos AC, Moura Junior LG, Costa Carvalho FH. Maternal and perinatal outcomes after bariatric surgery: a case control study. J Perinat Med 2016;44:383&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">26352065</ArticleId><ArticleId IdType="doi">10.1515/jpm-2015-0092</ArticleId></ArticleIdList></Reference><Reference><Citation>De Carolis S, Botta A, Del Sordo G, Guerrisi R, Salvi S, De Carolis MP, et al. Influence of biliopancreatic diversion on pregnancy outcomes in comparison to other bariatric surgery procedures. Obes Surg. 2018;28:3284&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">29909515</ArticleId><ArticleId IdType="doi">10.1007/s11695-018-3350-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Deitel M, Stone E, Kassam HA, Wilk EJ, Sutherland DJ. Gynecologic-obstetric changes after loss of massive excess weight following bariatric surgery. J Am Coll Nutr. 1988;7:147&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">3361039</ArticleId><ArticleId IdType="doi">10.1080/07315724.1988.10720232</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixon JB, Dixon ME, O&#x2019;Brien PE. Birth outcomes in obese women after laparoscopic adjustable gastric banding. Obstet Gynecol.2005;106:965&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">16260513</ArticleId><ArticleId IdType="doi">10.1097/01.AOG.0000181821.82022.82</ArticleId></ArticleIdList></Reference><Reference><Citation>Ducarme G, Revaux A, Rodrigues A, Aissaoui F, Pharisien I, Uzan M. Obstetric outcome following laparoscopic adjustable gastric banding. Int J Gynaecol Obstet. 2007;98:244&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">17433814</ArticleId><ArticleId IdType="doi">10.1016/j.ijgo.2007.02.020</ArticleId></ArticleIdList></Reference><Reference><Citation>Lapolla A, Marangon M, Dalfra MG, Segato G, De Luca M, Fedele D, et al. Pregnancy outcome in morbidly obese women before and after laparoscopic gastric banding. Obes Surg. 2010;20:1251&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">20524157</ArticleId><ArticleId IdType="doi">10.1007/s11695-010-0199-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Lesko J, Peaceman A. Pregnancy outcomes in women after bariatric surgery compared with obese and morbidly obese controls. Obstet Gynecol. 2012;119:547&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">22353952</ArticleId><ArticleId IdType="doi">10.1097/AOG.0b013e318239060e</ArticleId></ArticleIdList></Reference><Reference><Citation>Rottenstreich A, Elchalal U, Kleinstern G, Beglaibter N, Khalaileh A, Elazary R. Maternal and perinatal outcomes after laparoscopic sleeve gastrectomy. Obstet Gynecol. 2018;131:451&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">29420411</ArticleId><ArticleId IdType="doi">10.1097/AOG.0000000000002481</ArticleId></ArticleIdList></Reference><Reference><Citation>Santulli P, Mandelbrot L, Facchiano E, Dussaux C, Ceccaldi PF, Ledoux S, et al. Obstetrical and neonatal outcomes of pregnancies following gastric bypass surgery: a retrospective cohort study in a French referral centre. Obes Surg. 2010;20:1501&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">20803358</ArticleId><ArticleId IdType="doi">10.1007/s11695-010-0260-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Skull AJ, Slater GH, Duncombe JE, Fielding GA. Laparoscopic adjustable banding in pregnancy: safety, patient tolerance and effect on obesity-related pregnancy outcomes. Obes Surg. 2004;14:230&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">15018752</ArticleId><ArticleId IdType="doi">10.1381/096089204322857618</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson K, Cnattingius S, Naslund I, Roos N, Trolle Lagerros Y, Granath F, et al. Outcomes of pregnancy after bariatric surgery. N. Engl J Med. 2015;372:814&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">25714159</ArticleId><ArticleId IdType="doi">10.1056/NEJMoa1405789</ArticleId></ArticleIdList></Reference><Reference><Citation>Roos N, Neovius M, Cnattingius S, Trolle Lagerros Y, Saaf M, Granath F, et al. Perinatal outcomes after bariatric surgery: nationwide population based matched cohort study. BMJ. 2013;347:f6460.</Citation><ArticleIdList><ArticleId IdType="pubmed">24222480</ArticleId><ArticleId IdType="pmc">3898199</ArticleId><ArticleId IdType="doi">10.1136/bmj.f6460</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Gorman N, Wright D, Syngelaki A, Akolekar R, Wright A, Poon LC, et al. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation. Am J Obstet Gynecol. 2016;214:103.e1&#x2013;e12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2015.08.034</ArticleId></ArticleIdList></Reference><Reference><Citation>Spradley FT, Palei AC, Granger JP. Increased risk for the development of preeclampsia in obese pregnancies: weighing in on the mechanisms. Am J Physiol Regul Integr Comp Physiol. 2015;309:R1326&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">26447211</ArticleId><ArticleId IdType="pmc">4698403</ArticleId><ArticleId IdType="doi">10.1152/ajpregu.00178.2015</ArticleId></ArticleIdList></Reference><Reference><Citation>Engin AB. What is lipotoxicity? Adv Exp Med Biol. 2017;960:197&#x2013;220.</Citation><ArticleIdList><ArticleId IdType="pubmed">28585200</ArticleId><ArticleId IdType="doi">10.1007/978-3-319-48382-5_8</ArticleId></ArticleIdList></Reference><Reference><Citation>Howell KR, Powell TL. Effects of maternal obesity on placental function and fetal development. Reproduction. 2017;153:R97&#x2013;R108.</Citation><ArticleIdList><ArticleId IdType="pubmed">27864335</ArticleId><ArticleId IdType="doi">10.1530/REP-16-0495</ArticleId></ArticleIdList></Reference><Reference><Citation>Heymsfield SB, Wadden TA. Mechanisms, pathophysiology, and management of obesity. N Engl J Med. 2017;376:254&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">28099824</ArticleId><ArticleId IdType="doi">10.1056/NEJMra1514009</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444:840&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">17167471</ArticleId><ArticleId IdType="doi">10.1038/nature05482</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Jaramillo P, Barajas J, Rueda-Quijano SM, Lopez-Lopez C, Felix C. Obesity and preeclampsia: common pathophysiological mechanisms. Front Physiol. 2018;9:1838.</Citation><ArticleIdList><ArticleId IdType="pubmed">30618843</ArticleId><ArticleId IdType="pmc">6305943</ArticleId><ArticleId IdType="doi">10.3389/fphys.2018.01838</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf M, Kettyle E, Sandler L, Ecker JL, Roberts J, Thadhani R. Obesity and preeclampsia: the potential role of inflammation. Obstet Gynecol.2001;98:757&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">11704165</ArticleId></ArticleIdList></Reference><Reference><Citation>Yogev Y, Catalano PM. Pregnancy and obesity. Obstet Gynecol Clin North Am.2009;36:285&#x2013;300.viii.</Citation><ArticleIdList><ArticleId IdType="pubmed">19501314</ArticleId><ArticleId IdType="doi">10.1016/j.ogc.2009.03.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsythe LK, Wallace JM, Livingstone MB. Obesity and inflammation: the effects of weight loss. Nutr Res Rev. 2008;21:117&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">19087366</ArticleId><ArticleId IdType="doi">10.1017/S0954422408138732</ArticleId></ArticleIdList></Reference><Reference><Citation>Magkos F, Fraterrigo G, Yoshino J, Luecking C, Kirbach K, Kelly SC, et al. Effects of moderate and subsequent progressive weight loss on metabolic function and adipose tissue biology in humans with obesity. Cell Metab. 2016;23:591&#x2013;601.</Citation><ArticleIdList><ArticleId IdType="pubmed">26916363</ArticleId><ArticleId IdType="pmc">4833627</ArticleId><ArticleId IdType="doi">10.1016/j.cmet.2016.02.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Schummers L, Hutcheon JA, Bodnar LM, Lieberman E, Himes KP. Risk of adverse pregnancy outcomes by prepregnancy body mass index: a population-based study to inform prepregnancy weight loss counseling. Obstet Gynecol. 2015;125:133&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">25560115</ArticleId><ArticleId IdType="pmc">4285688</ArticleId><ArticleId IdType="doi">10.1097/AOG.0000000000000591</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodnar LM, Catov JM, Klebanoff MA, Ness RB, Roberts JM. Prepregnancy body mass index and the occurrence of severe hypertensive disorders of pregnancy. Epidemiology. 2007;18:234&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">17237733</ArticleId><ArticleId IdType="doi">10.1097/01.ede.0000254119.99660.e7</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dijk MR, Koster MPH, Oostingh EC, Willemsen SP, Steegers EAP, Steegers-Theunissen RPM. A mobile app lifestyle intervention to improve healthy nutrition in women before and during early pregnancy: single-center randomized controlled trial. J Med Internet Res. 2020;22:e15773.</Citation><ArticleIdList><ArticleId IdType="pubmed">32412417</ArticleId><ArticleId IdType="pmc">7260659</ArticleId><ArticleId IdType="doi">10.2196/15773</ArticleId></ArticleIdList></Reference><Reference><Citation>Parrott J, Frank L, Rabena R, Craggs-Dino L, Isom KA, Greiman L. American society for metabolic and bariatric surgery integrated health nutritional guidelines for the surgical weight loss patient 2016 update: micronutrients. Surg Obes Relat Dis. 2017;13:727&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">28392254</ArticleId><ArticleId IdType="doi">10.1016/j.soard.2016.12.018</ArticleId></ArticleIdList></Reference><Reference><Citation>Xanthakos SA. Nutritional deficiencies in obesity and after bariatric surgery. Pediatr Clin North Am. 2009;56:1105&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">19931066</ArticleId><ArticleId IdType="pmc">2784422</ArticleId><ArticleId IdType="doi">10.1016/j.pcl.2009.07.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolin CD, Chervenak J, Pivo S, Ude Welcome A, Kominiarek MA. Association between time interval from bariatric surgery to pregnancy and maternal weight outcomes. J Matern Fetal Neonatal Med. 2019, 1&#x2013;7, (ahead-of-print).</Citation></Reference><Reference><Citation>Parent B, Martopullo I, Weiss NS, Khandelwal S, Fay EE, Rowhani-Rahbar A. Bariatric surgery in women of childbearing age, timing between an operation and birth, and associated perinatal complications. JAMA Surg. 2017;152:128&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">27760265</ArticleId><ArticleId IdType="doi">10.1001/jamasurg.2016.3621</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34252454</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>10</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2352-2291</ISSN><JournalIssue CitedMedium="Internet"><Volume>73</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Season>Jul-Aug</Season></PubDate></JournalIssue><Title>Brazilian journal of anesthesiology (Elsevier)</Title><ISOAbbreviation>Braz J Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>Predictive performance of thyromental height for difficult laryngoscopies in adults: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>491</StartPage><EndPage>499</EndPage><MedlinePgn>491-499</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bjane.2021.06.015</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0104-0014(21)00271-2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Thyromental height (TMH) was first reported as a great single test for prediction of difficult laryngoscopies, although further studies have shown variable estimates of its accuracy. We thus performed this meta-analysis to summarize the predictive values of TMH mainly for prediction of difficult laryngoscopies.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A search in PubMed, EMBASE, LILACS, and Scielo was conducted in June 2020. We included prospective cohorts fully reported with patients ... 16 years old, providing data on predictive values of TMH for prediction of either difficult laryngoscopies or difficult intubations. Diagnostic properties and association between TMH and Cormack and Lehanes...s classification by direct laryngoscopy were evaluated. A random-effects meta-analysis using hierarchical models was performed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Eight studies evaluating 2844 patients were included. All included studies had high risk of bias and low concern regarding applicability. There was significant heterogeneity among the studies. The pooled diagnostic odds ratio (DOR) and positive (LR+) and negative (LR-) likelihood ratios were as follows: DOR, 57.94 (95% CI: 18.19...184.55); LR+, 11.32 (95% CI: 4.28...29.92); and LR-, 0.23 (95% CI: 0.15...0.35). Summary sensitivity and specificity for studies with common threshold were 82.6 (95% CI: 74...88.8%) and 93.5 (95% CI: 79...98.2%), respectively. The estimated AUC was 81.1%.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">TMH arises as a good predictor of difficult laryngoscopies in adult patients from diverse populations presenting better predictive values than most previously reported bedside tests. However, the high risk of bias throughout the studies may have skewed the results of the individual research as well as the summary points of the present meta-analysis.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Sociedade Brasileira de Anestesiologia. Published by Elsevier Espa&#xf1;a, S.L.U. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Carvalho</LastName><ForeName>Cl &#xcd;stenes Cr &#xcd;stian de</ForeName><Initials>C&#xcd;C&#xcd;</Initials><AffiliationInfo><Affiliation>Instituto de Medicina Integral Prof. Fernando Figueira (IMIP), Department of Post-graduation, Recife, PE, Brazil. Electronic address: clistenescristian@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos Neto</LastName><ForeName>Jayme Marques</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Universidade Federal de Pernambuco (UFPE), Hospital das Cl.&#xed;nicas, Department of Anesthesia, Recife, PE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orange</LastName><ForeName>Fl Via Augusta de</ForeName><Initials>FVA</Initials><AffiliationInfo><Affiliation>Instituto de Medicina Integral Prof. Fernando Figueira (IMIP), Department of Post-graduation, Recife, PE, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Braz J Anesthesiol</MedlineTA><NlmUniqueID>101624623</NlmUniqueID><ISSNLinking>0104-0014</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007828" MajorTopicYN="Y">Laryngoscopy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007442" MajorTopicYN="Y">Intubation, Intratracheal</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Airway management</Keyword><Keyword MajorTopicYN="N">Intubation, intratracheal</Keyword><Keyword MajorTopicYN="N">Laryngoscopy</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Sensitivity and specificity</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>2</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>12</Day><Hour>20</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>7</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34252454</ArticleId><ArticleId IdType="pmc">PMC10362459</ArticleId><ArticleId IdType="doi">10.1016/j.bjane.2021.06.015</ArticleId><ArticleId IdType="pii">S0104-0014(21)00271-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cook T.M., Woodall N., Frerk C. Major complications of airway management in the UK: Results of the Fourth National Audit Project of the Royal College of Anaesthetists and the Difficult Airway Society. Part 1: Anaesthesia. Br J Anaesth. 2011;106:617&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pubmed">21447488</ArticleId></ArticleIdList></Reference><Reference><Citation>Frerk C., Mitchell V.S., McNarry A.F., et al. Difficult Airway Society 2015 guidelines for management of unanticipated difficult intubation in adults. Br J Anaesth. 2015;115:827&#x2013;848.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4650961</ArticleId><ArticleId IdType="pubmed">26556848</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgs A., McGrath B.A., Goddard C., et al. Guidelines for the management of tracheal intubation in critically ill adults. Br J Anaesth. 2018;120:323&#x2013;352.</Citation><ArticleIdList><ArticleId IdType="pubmed">29406182</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth D., Pace N.L., Lee A., et al. Bedside tests for predicting difficult airways: an abridged Cochrane diagnostic test accuracy systematic review. Anaesthesia. 2019;74:915&#x2013;928.</Citation><ArticleIdList><ArticleId IdType="pubmed">30843190</ArticleId></ArticleIdList></Reference><Reference><Citation>Detsky M.E., Jivraj N., Adhikari N.K., et al. Will this patient be difficult to intubate? the rational clinical examination systematic review. JAMA. 2019;321:493&#x2013;503.</Citation><ArticleIdList><ArticleId IdType="pubmed">30721300</ArticleId></ArticleIdList></Reference><Reference><Citation>N..rskov A.K., Rosenstock C.V., Wetterslev J., et al. Diagnostic accuracy of anaesthesiologists... prediction of difficult airway management in daily clinical practice: a cohort study of 188 064 patients registered in the Danish Anaesthesia Database. Anaesthesia. 2015;70:272&#x2013;281.</Citation><ArticleIdList><ArticleId IdType="pubmed">25511370</ArticleId></ArticleIdList></Reference><Reference><Citation>Apfelbaum J.L., Hagberg C.A., Caplan R.A., et al. Practice Guidelines for Management of the Difficult Airway: An Updated Report by the American Society of Anesthesiologists Task Force on Management of the Difficult Airway. Anesthesiology. 2013;118:251&#x2013;270.</Citation><ArticleIdList><ArticleId IdType="pubmed">23364566</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook T.M., Woodall N., Harper J., et al. Major complications of airway management in the UK: results of the Fourth National Audit Project of the Royal College of Anaesthetists and the Difficult Airway Society. Part 2: intensive care and emergency departments. Br J Anaesth. 2011;106:632&#x2013;642.</Citation><ArticleIdList><ArticleId IdType="pubmed">21447489</ArticleId></ArticleIdList></Reference><Reference><Citation>Law J.A., Broemling N., Cooper R.M., et al. The difficult airway with recommendations for management - Part 2 - Difficult airway. Can J Anesth. 2013;60:1119&#x2013;1138.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3825645</ArticleId><ArticleId IdType="pubmed">24132408</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandit J.J., Heidegger T. Putting the ..&#xfa;point..&#xd1; back into the ritual: a binary approach to difficult airway prediction. Anaesthesia. 2017;72:283&#x2013;288.</Citation><ArticleIdList><ArticleId IdType="pubmed">27891606</ArticleId></ArticleIdList></Reference><Reference><Citation>Vannucci A., Cavallone L.F. Bedside predictors of difficult intubation...: a systematic review. Minerva Anestesiol. 2016;82:69&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">25990431</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung O., Law J.A., Morris I., et al. Airway assessment before intervention: What we know and what we do. Anesth Analg. 2016;122:1752&#x2013;1754.</Citation><ArticleIdList><ArticleId IdType="pubmed">27195622</ArticleId></ArticleIdList></Reference><Reference><Citation>Etezadi F., Ahangari A., Shokri H., et al. Thyromental height: A new clinical test for prediction of difficult laryngoscopy. Anesth Analg. 2013;117:1347&#x2013;1351.</Citation><ArticleIdList><ArticleId IdType="pubmed">24257384</ArticleId></ArticleIdList></Reference><Reference><Citation>Selvi O., Kahraman T., Senturk O., et al. Evaluation of the reliability of preoperative descriptive airway assessment tests in prediction of the Cormack-Lehane score: A prospective randomized clinical study. J Clin Anesth. 2017;36:21&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">28183567</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain N., Das S., Kanchi M. Thyromental height test for prediction of difficult laryngoscopy in patients undergoing coronary artery bypass graft surgical procedure. Ann Card Anaesth. 2017;20:207&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5408527</ArticleId><ArticleId IdType="pubmed">28393782</ArticleId></ArticleIdList></Reference><Reference><Citation>Nurullah M., Alam M.S., Hossen M., et al. Prediction of difficult airway by thyromental height test-a comparison with modified mallampati test. Bangladesh J Med Sci. 2018;17:455&#x2013;461.</Citation></Reference><Reference><Citation>Rao K.V.N., Dhatchinamoorthi D., Nandhakumar A., et al. Validity of thyromental height test as a predictor of difficult laryngoscopy: A prospective evaluation comparing modified Mallampati score, interincisor gap, thyromental distance, neck circumference, and neck extension. Indian J Anaesth. 2018;62:603&#x2013;608.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6100275</ArticleId><ArticleId IdType="pubmed">30166655</ArticleId></ArticleIdList></Reference><Reference><Citation>Yabuki S., Iwaoka S., Murakami M., et al. Reliability of the thyromental height test for prediction of difficult visualisation of the larynx: A prospective external validation. Indian J Anaesth. 2019;63:270&#x2013;276.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6460976</ArticleId><ArticleId IdType="pubmed">31000890</ArticleId></ArticleIdList></Reference><Reference><Citation>Panjiar P., Kochhar A., Bhat K., et al. Comparison of thyromental height test with ratio of height to thyromental distance, thyromental distance, and modified Mallampati test in predicting difficult laryngoscopy: A prospective study. J Anaesthesiol Clin Pharmacol. 2019;35:390&#x2013;395.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6748003</ArticleId><ArticleId IdType="pubmed">31543591</ArticleId></ArticleIdList></Reference><Reference><Citation>Mostafa M., Saeed M., Hasanin A., et al. Accuracy of thyromental height test for predicting difficult intubation in elderly. J Anesth. 2020;34:217&#x2013;223.</Citation><ArticleIdList><ArticleId IdType="pubmed">31858239</ArticleId></ArticleIdList></Reference><Reference><Citation>Macaskill P., Gatsonis C., Deeks J.J., et al.   In: Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 1.0. Deeks J.J., Bossuyt P.M., Gatsonis C., editors. The Cochrane Collaboration; 2010. Analysing and presenting results. Available at:  http://srdta.cochrane.org/. (Accessed April 1, 2020)</Citation></Reference><Reference><Citation>Kim K.W., Lee J., Choi S.H., et al. Systematic review and meta-analysis of studies evaluating diagnostic test accuracy: A practical review for clinical researchers...part I. General guidance and tips. Korean J Radiol. 2015;16:1175&#x2013;1187.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4644738</ArticleId><ArticleId IdType="pubmed">26576106</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J., Kim K.W., Choi S.H., et al. Systematic review and meta-analysis of studies evaluating diagnostic test accuracy: A practical review for clinical researchers...part II. Statistical methods of meta-analysis. Korean J Radiol. 2015;16:1188&#x2013;1196.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4644739</ArticleId><ArticleId IdType="pubmed">26576107</ArticleId></ArticleIdList></Reference><Reference><Citation>Bramer W.M., de Jonge G.B., Rethlefsen M.L., et al. A systematic approach to searching: An efficient and complete method to develop literature searches. J Med Libr Assoc. 2018;106:531&#x2013;541.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6148622</ArticleId><ArticleId IdType="pubmed">30271302</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D., Shamseer L., Clarke M., et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4320440</ArticleId><ArticleId IdType="pubmed">25554246</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D., Liberati A., Tetzlaff J., et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 2009;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2707599</ArticleId><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference><Reference><Citation>McGrath T.A., Alabousi M., Skidmore B., et al. Recommendations for reporting of systematic reviews and meta-analyses of diagnostic test accuracy: A systematic review. Syst Rev. 2017;6:194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5633882</ArticleId><ArticleId IdType="pubmed">29017574</ArticleId></ArticleIdList></Reference><Reference><Citation>Mclnnes M.D.F., Moher D., Thombs B.D., et al. Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement. JAMA. 2018;319:388&#x2013;396.</Citation><ArticleIdList><ArticleId IdType="pubmed">29362800</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiting P.F., Rutjes A.W.S., Westwood M.E., et al. Quadas-2: A revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529&#x2013;536.</Citation><ArticleIdList><ArticleId IdType="pubmed">22007046</ArticleId></ArticleIdList></Reference><Reference><Citation>Review Manager (RevMan) [Computer program] The Cochrane Collaboration; 2014. Version 5.3. Copenhagen, Denmark: The Nordic Cochrane Centre,</Citation></Reference><Reference><Citation>R CoreTeam . R Foundation for Statistical Computing; Vienna, Austria: 2013. R: A Language and Environment for Statistical Computing.</Citation></Reference><Reference><Citation>Shim S.R., Kim S.-J., Lee J. Diagnostic test accuracy: application and practice using R software. Epidemiol Health. 2019;41</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6545496</ArticleId><ArticleId IdType="pubmed">30999739</ArticleId></ArticleIdList></Reference><Reference><Citation>Palczynski P., Bialka S., Misiolek H., et al. Thyromental height test as a new method for prediction of difficult intubation with double lumen tube. PLoS One. 2018;13:1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6136707</ArticleId><ArticleId IdType="pubmed">30212462</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiga T., Wajima Z., Inoue T., et al. Predicting difficult intubation in apparently normal patients: a meta-analysis of bedside screening test performance. Anesthesiology. 2005;103:429&#x2013;437.</Citation><ArticleIdList><ArticleId IdType="pubmed">16052126</ArticleId></ArticleIdList></Reference><Reference><Citation>N..rskov A.K. University of Copenhagen; Copenhagen, Denmark: 2015. Pre-operative Airway Assessment ... Experience Gained from a Multicentre Cluster Randomised Trial and the Danish Anaesthesia Database. [PhD thesis]</Citation></Reference><Reference><Citation>Fischer J.E., Bachmann L.M., Jaeschke R. A reader...s guide to the interpretation of diagnostic test properties: clinical examples of sepsis. Intensive Care Med. 2003;29:1043&#x2013;1051.</Citation><ArticleIdList><ArticleId IdType="pubmed">12734652</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40011375</PMID><DateCompleted><Year>2025</Year><Month>04</Month><Day>01</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1496-8975</ISSN><JournalIssue CitedMedium="Internet"><Volume>72</Volume><Issue>3</Issue><PubDate><Year>2025</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Canadian journal of anaesthesia = Journal canadien d'anesthesie</Title><ISOAbbreviation>Can J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Risk factors for pediatric emergence delirium: a systematic review.</ArticleTitle><Pagination><StartPage>384</StartPage><EndPage>396</EndPage><MedlinePgn>384-396</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12630-024-02889-w</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Emergence delirium (ED) impacts approximately 25% of pediatric patients undergoing general anesthesia and is associated with with concerning consequences, including injury to patients and health care personnel. Risk prediction models with good usability for pediatric ED are lacking. We aimed to identify published risk factors in this systematic review.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a systematic literature search of prospective observational studies and clinical trials through eight major databases from inception to 11 January 2023. We included prospective studies published in English that examined the pediatric population (&lt; 18&#xa0;yr old) undergoing general anesthesia for any surgical or imaging procedure, that measured the risk factor(s) for ED preoperatively/intraoperatively, and that reported the incidence of ED. We excluded studies investigating therapeutic or prophylactic interventions of ED. We assessed the quality of eligible articles according to a modified version of the Scottish Intercollegiate Guidelines Network quality checklists and rated them as high, acceptable, or low quality. Risk factors discovered were qualitatively evaluated and synthesized with the following levels of evidence: strong evidence, moderate evidence, inconclusive evidence, or lack of evidence.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Thirty-one studies, comprising a total of 6,068 patients, met the inclusion criteria. The median incidence of ED was 32%. Twelve studies were rated as high quality, 15 as acceptable quality, and the remaining four as low quality. Younger age and agitated/excited induction behaviour with strong evidence, followed by sevoflurane with moderate evidence, were identified as risk factors for pediatric ED. Quantitative synthesis was not feasible as there were no more than two studies that explored the same risk factor with the same cut-off.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Although quantitative analyses were not feasible, the current systematic review qualitatively identified three risk factors for pediatric ED with robust evidence.</AbstractText><AbstractText Label="STUDY REGISTRATION" NlmCategory="BACKGROUND">PROSPERO ( CRD42020192221 ); first submitted 18 June 2020.</AbstractText><CopyrightInformation>&#xa9; 2025. Canadian Anesthesiologists' Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aoyama</LastName><ForeName>Kazuyoshi</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-7502-0896</Identifier><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Medicine, The Hospital for Sick Children (SickKids), Toronto, ON, Canada. kazu.aoyama@utoronto.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Program in Child Health Evaluative Sciences, SickKids Research Institute, Toronto, ON, Canada. kazu.aoyama@utoronto.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology &amp; Pain Medicine, University of Toronto, Toronto, ON, Canada. kazu.aoyama@utoronto.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Medicine, The Hospital for Sick Children, 555 University Ave, Toronto, ON, M5G 1X8, Canada. kazu.aoyama@utoronto.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Furuta</LastName><ForeName>Machiko</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Critical Care Medicine, National Center for Child Health and Development, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ameye</LastName><ForeName>Lieven</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Medicine, The Hospital for Sick Children (SickKids), Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petre</LastName><ForeName>Maria-Alexandra</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Montreal Children's Hospital, Montreal, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia, McGill University, Montreal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Englesakis</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Library and Information Services, University Health Network, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rana</LastName><ForeName>Mehwish</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gai</LastName><ForeName>Nan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Medicine, The Hospital for Sick Children (SickKids), Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology &amp; Pain Medicine, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peliowski</LastName><ForeName>Arie</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Medicine, The Hospital for Sick Children (SickKids), Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology &amp; Pain Medicine, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saha</LastName><ForeName>Bibek</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Perioperative Services Summer Studentship Program 2019</GrantID><Agency>Hospital for Sick Children</Agency><Country/></Grant><Grant><GrantID>Outcomes Research Award 2020-2021, Department of Anesthesia and Pain Medicine</GrantID><Agency>Hospital for Sick Children</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><VernacularTitle>Facteurs de risque du d&#xe9;lire d&#x2019;&#xe9;mergence en p&#xe9;diatrie : une revue syst&#xe9;matique.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2025</Year><Month>02</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Can J Anaesth</MedlineTA><NlmUniqueID>8701709</NlmUniqueID><ISSNLinking>0832-610X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071257" MajorTopicYN="Y">Emergence Delirium</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="fre"><AbstractText>R&#xe9;SUM&#xe9;: OBJECTIF: Le d&#xe9;lire d&#x2019;&#xe9;mergence touche environ 25&#xa0;% de la patient&#xe8;le p&#xe9;diatrique b&#xe9;n&#xe9;ficiant d&#x2019;une anesth&#xe9;sie g&#xe9;n&#xe9;rale et est associ&#xe9; &#xe0; des cons&#xe9;quences inqui&#xe9;tantes, notamment &#xe0; des blessures aux patient&#xb7;es et au personnel de sant&#xe9;. Il n&#x2019;existe pas de mod&#xe8;les de pr&#xe9;diction du risque dont l&#x2019;utilisabilit&#xe9; est bonne pour les services d&#x2019;urgence p&#xe9;diatriques. Cette revue syst&#xe9;matique avait pour objectif d&#x2019;identifier les facteurs de risque publi&#xe9;s. M&#xe9;THODE: Nous avons r&#xe9;alis&#xe9; une recherche syst&#xe9;matique dans la litt&#xe9;rature des &#xe9;tudes observationnelles prospectives et des &#xe9;tudes cliniques &#xe0; travers huit bases de donn&#xe9;es majeures de leur cr&#xe9;ation jusqu&#x2019;au 11 janvier 2023. Nous avons inclus des &#xe9;tudes prospectives publi&#xe9;es en anglais qui examinaient la population p&#xe9;diatrique (&lt; 18 ans) b&#xe9;n&#xe9;ficiant d&#x2019;une anesth&#xe9;sie g&#xe9;n&#xe9;rale pour toute intervention chirurgicale ou d&#x2019;imagerie, qui mesuraient le(s) facteur(s) de risque pr&#xe9;- ou perop&#xe9;ratoire(s) de d&#xe9;lire d&#x2019;&#xe9;mergence et qui rapportaient l&#x2019;incidence de d&#xe9;lire d&#x2019;&#xe9;mergence. Nous avons exclu les &#xe9;tudes portant sur des interventions th&#xe9;rapeutiques ou prophylactiques pour traiter le d&#xe9;lire d&#x2019;&#xe9;mergence. Nous avons &#xe9;valu&#xe9; la qualit&#xe9; des articles &#xe9;ligibles selon une version modifi&#xe9;e des listes de contr&#xf4;le de qualit&#xe9; du Scottish Intercollegiate Guidelines Network et les avons jug&#xe9;s de qualit&#xe9; &#xe9;lev&#xe9;e, acceptable ou faible. Les facteurs de risque d&#xe9;couverts ont &#xe9;t&#xe9; &#xe9;valu&#xe9;s qualitativement et synth&#xe9;tis&#xe9;s &#xe0; l&#x2019;aide des niveaux de donn&#xe9;es probantes suivants : donn&#xe9;es probantes solides, mod&#xe9;r&#xe9;es, non concluantes ou manque de donn&#xe9;es probantes. R&#xe9;SULTATS: Trente et une &#xe9;tudes, portant sur un total de 6068 enfants, r&#xe9;pondaient &#xe0; nos crit&#xe8;res d&#x2019;inclusion. L&#x2019;incidence m&#xe9;diane de d&#xe9;lire d&#x2019;&#xe9;mergence &#xe9;tait de 32&#xa0;%. Douze &#xe9;tudes ont &#xe9;t&#xe9; jug&#xe9;es de haute qualit&#xe9;, 15 de qualit&#xe9; acceptable et quatre de faible qualit&#xe9;. Le jeune &#xe2;ge et un comportement agit&#xe9;/excit&#xe9; &#xe0; l&#x2019;induction pr&#xe9;sent&#xe9; avec des donn&#xe9;es probantes solides, suivis du s&#xe9;voflurane avec des donn&#xe9;es probantes mod&#xe9;r&#xe9;es, ont &#xe9;t&#xe9; identifi&#xe9;s comme facteurs de risque de d&#xe9;lire d&#x2019;&#xe9;mergence p&#xe9;diatrique. Nous n&#x2019;avons pas pu r&#xe9;aliser de synth&#xe8;se quantitative car il n&#x2019;y avait pas plus de deux &#xe9;tudes qui ont explor&#xe9; le m&#xea;me facteur de risque avec le m&#xea;me seuil. CONCLUSION: Bien que les analyses quantitatives n&#x2019;aient pas &#xe9;t&#xe9; r&#xe9;alisables, la pr&#xe9;sente revue syst&#xe9;matique a permis d&#x2019;identifier qualitativement trois facteurs de risque du d&#xe9;lire d&#x2019;&#xe9;mergence p&#xe9;diatrique avec des donn&#xe9;es probantes solides. Enregistrement de l&#x2019;&#xe9;tude : PROSPERO ( CRD42020192221 ); premi&#xe8;re soumission le 18 juin 2020.</AbstractText><CopyrightInformation>&#xa9; 2025. Canadian Anesthesiologists' Society.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">emergence delirium</Keyword><Keyword MajorTopicYN="N">general anesthesia</Keyword><Keyword MajorTopicYN="N">pediatric anesthesia</Keyword><Keyword MajorTopicYN="N">risk factors</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>6</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>4</Month><Day>2</Day><Hour>0</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>2</Month><Day>27</Day><Hour>5</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>2</Month><Day>26</Day><Hour>23</Hour><Minute>18</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40011375</ArticleId><ArticleId IdType="doi">10.1007/s12630-024-02889-w</ArticleId><ArticleId IdType="pii">10.1007/s12630-024-02889-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mason KP. Paediatric emergence delirium: a comprehensive review and interpretation of the literature. Br J Anaesth 2017; 118: 335&#x2013;43. https://doi.org/10.1093/bja/aew477</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aew477</ArticleId><ArticleId IdType="pubmed">28203739</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortiz AC, Atallah AN, Matos D, da Silva EM. Intravenous versus inhalational anaesthesia for paediatric outpatient surgery. Cochrane Database Syst Rev 2014; CD009015. https://doi.org/10.1002/14651858.CD009015.pub2</Citation></Reference><Reference><Citation>Voepel-Lewis T, Malviya S, Tait AR. A prospective cohort study of emergence agitation in the pediatric postanesthesia care unit. Anesth Analg 2003; 96: 1625&#x2013;30. https://doi.org/10.1213/01.ane.0000062522.21048.61</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ane.0000062522.21048.61</ArticleId><ArticleId IdType="pubmed">12760985</ArticleId></ArticleIdList></Reference><Reference><Citation>Petre MA, Saha B, Kasuya S, et al. Risk prediction models for emergence delirium in paediatric general anaesthesia: a systematic review. BMJ Open 2021; 11: e043968. https://doi.org/10.1136/bmjopen-2020-043968</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-043968</ArticleId><ArticleId IdType="pubmed">33408214</ArticleId><ArticleId IdType="pmc">7789445</ArticleId></ArticleIdList></Reference><Reference><Citation>Kain ZN, Caldwell-Andrews AA, Maranets I, et al. Preoperative anxiety and emergence delirium and postoperative maladaptive behaviors. Anesth Analg 2004; 99: 1648&#x2013;54. https://doi.org/10.1213/01.ane.0000136471.36680.97</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ane.0000136471.36680.97</ArticleId><ArticleId IdType="pubmed">15562048</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 2015; 4: 1. https://doi.org/10.1186/2046-4053-4-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2046-4053-4-1</ArticleId><ArticleId IdType="pubmed">25554246</ArticleId><ArticleId IdType="pmc">4320440</ArticleId></ArticleIdList></Reference><Reference><Citation>Sikich N, Lerman J. Development and psychometric evaluation of the pediatric anesthesia emergence delirium scale. Anesthesiology 2004; 100: 1138&#x2013;45. https://doi.org/10.1097/00000542-200405000-00015</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200405000-00015</ArticleId><ArticleId IdType="pubmed">15114210</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen IT, Finkel JC, Hannallah RS, Hummer KA, Patel KM. Rapid emergence does not explain agitation following sevoflurane anaesthesia in infants and children: a comparison with propofol. Pediatr Anesth 2003; 13: 63&#x2013;7. https://doi.org/10.1046/j.1460-9592.2003.00948.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1460-9592.2003.00948.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Aono J, Ueda W, Mamiya K, Takimoto E, Manabe M. Greater incidence of delirium during recovery from sevoflurane anesthesia in preschool boys. Anesthesiology 1997; 87: 1298&#x2013;300. https://doi.org/10.1097/00000542-199712000-00006</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-199712000-00006</ArticleId><ArticleId IdType="pubmed">9416712</ArticleId></ArticleIdList></Reference><Reference><Citation>Watcha MF, Ramirez-Ruiz M, White PF, Jones MB, Lagueruela RG, Terkonda RP. Perioperative effects of oral ketorolac and acetaminophen in children undergoing bilateral myringotomy. Can J Anesth 1992; 39: 649&#x2013;54. https://doi.org/10.1007/bf03008224</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/bf03008224</ArticleId><ArticleId IdType="pubmed">1394752</ArticleId></ArticleIdList></Reference><Reference><Citation>Cole JW, Murray DJ, McAllister JD, Hirshberg GE. Emergence behaviour in children: defining the incidence of excitement and agitation following anaesthesia. Pediatr Anesth 2002; 12: 442&#x2013;7. https://doi.org/10.1046/j.1460-9592.2002.00868.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1460-9592.2002.00868.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen J. Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull 1968; 70: 213&#x2013;20. https://doi.org/10.1037/h0026256</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/h0026256</ArticleId><ArticleId IdType="pubmed">19673146</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaal IJ, Devlin JW, Peelen LM, Slooter AJ. A systematic review of risk factors for delirium in the ICU. Crit Care Med 2015; 43: 40&#x2013;7. https://doi.org/10.1097/ccm.0000000000000625</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ccm.0000000000000625</ArticleId><ArticleId IdType="pubmed">25251759</ArticleId></ArticleIdList></Reference><Reference><Citation>Aono J, Mamiya K, Manabe M. Preoperative anxiety is associated with a high incidence of problematic behavior on emergence after halothane anesthesia in boys. Acta Anaesthesiol Scand 1999; 43: 542&#x2013;4. https://doi.org/10.1034/j.1399-6576.1999.430509.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1399-6576.1999.430509.x</ArticleId><ArticleId IdType="pubmed">10342002</ArticleId></ArticleIdList></Reference><Reference><Citation>Bong CL, Ng AS. Evaluation of emergence delirium in Asian children using the Pediatric Anesthesia Emergence Delirium Scale. Pediatr Anesth 2009; 19: 593&#x2013;600. https://doi.org/10.1111/j.1460-9592.2009.03024.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9592.2009.03024.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Doerrfuss JI, Kramer S, Tafelski S, Spies CD, Wernecke KD, Nachtigall I. Frequency, predictive factors and therapy of emergence delirium: data from a large observational clinical trial in a broad spectrum of postoperative pediatric patients. Minerva Anestesiol 2019; 85: 617&#x2013;24. https://doi.org/10.23736/s0375-9393.19.13038-6</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/s0375-9393.19.13038-6</ArticleId><ArticleId IdType="pubmed">30665281</ArticleId></ArticleIdList></Reference><Reference><Citation>Faulk DJ, Twite MD, Zuk J, Pan Z, Wallen B, Friesen RH. Hypnotic depth and the incidence of emergence agitation and negative postoperative behavioral changes. Pediatr Anesth 2010; 20: 72&#x2013;81. https://doi.org/10.1111/j.1460-9592.2009.03191.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9592.2009.03191.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayhoe S, Pallett S, Zani J, Trott J. Reduction of postanesthetic pediatric distress: a coordinated approach. J Perianesth Nurs 2018; 33: 312&#x2013;8. https://doi.org/10.1016/j.jopan.2016.11.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jopan.2016.11.005</ArticleId><ArticleId IdType="pubmed">29784261</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob Z, Li H, Makaryus R, et al. Metabolomic profiling of children&#x2019;s brains undergoing general anesthesia with sevoflurane and propofol. Anesthesiology 2012; 117: 1062&#x2013;71. https://doi.org/10.1097/aln.0b013e31826be417</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/aln.0b013e31826be417</ArticleId><ArticleId IdType="pubmed">22929729</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang YE, Jeong SA, Kim SY, et al. The efficacy of intraoperative EEG to predict the occurrence of emergence agitation in the postanesthetic room after sevoflurane anesthesia in children. J Perianesth Nurs 2018; 33: 45&#x2013;52. https://doi.org/10.1016/j.jopan.2015.10.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jopan.2015.10.001</ArticleId><ArticleId IdType="pubmed">29362046</ArticleId></ArticleIdList></Reference><Reference><Citation>Joo J, Lee S, Lee Y. Emergence delirium is related to the invasiveness of strabismus surgery in preschool-age children. J Int Med Res 2014; 42: 1311&#x2013;22. https://doi.org/10.1177/0300060514549783</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0300060514549783</ArticleId><ArticleId IdType="pubmed">25298011</ArticleId></ArticleIdList></Reference><Reference><Citation>Khanna P, Saini K, Sinha R, Nisa N, Kumar S, Maitra S. Correlation between duration of preoperative fasting and emergence delirium in pediatric patients undergoing ophthalmic examination under anesthesia: a prospective observational study. Pediatr Anesth 2018; 28: 547&#x2013;51. https://doi.org/10.1111/pan.13381</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pan.13381</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch S, Rupp L, Prager C, et al. Emergence delirium in children is related to epileptiform discharges during anaesthesia induction: an observational study. Eur J Anaesthesiol 2018; 35: 929&#x2013;36. https://doi.org/10.1097/eja.0000000000000867</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/eja.0000000000000867</ArticleId><ArticleId IdType="pubmed">30113351</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohkamkar M, Farhoudi F, Alam-Sahebpour A, Mousavi SA, Khani S, Shahmohammadi S. Postanesthetic emergence agitation in pediatric patients under general anesthesia. Iran J Pediatr 2014; 24: 184&#x2013;90. Available from URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268839/pdf/IJPD-24-184.pdf (accessed July 2024).</Citation></Reference><Reference><Citation>Saringcarinkul A, Manchupong S, Punjasawadwong Y. Incidence and risk factors of emergence agitation in pediatric patients after general anesthesia. J Med Assoc Thai 2008; 91: 1226&#x2013;31. Available from URL: https://www.thaiscience.info/Journals/Article/JMAT/10402611.pdf?utm_medium=email&amp;utm_source=transaction (accessed July 2024).</Citation></Reference><Reference><Citation>Gonz&#xe1;lez-Cardenas VH, Munar-Gonz&#xe1;lez FD, Pinz&#xf3;n-Villazon IL, et al. Study of paediatric postoperative delirium and acute pain in low surgical risk procedures. Colomb J Anesthesiol 2018; 46: 126&#x2013;33. https://doi.org/10.1097/CJ9.0000000000000024</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CJ9.0000000000000024</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, Zhang X, Sun Y, Mei E, Wan X, Tian L. Emergence agitation after the cleft lip or palate surgery in pediatric patients: a prospective study. J Stomatol Oral Maxillofac Surg 2021; 122: 539&#x2013;43. https://doi.org/10.1016/j.jormas.2020.11.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jormas.2020.11.006</ArticleId><ArticleId IdType="pubmed">33301949</ArticleId></ArticleIdList></Reference><Reference><Citation>Do W, Kim H-S, Kim SH, et al. Sleep quality and emergence delirium in children undergoing strabismus surgery: a comparison between preschool- and school-age patients. BMC Anesthesiol 2021; 21: 290. https://doi.org/10.1186/s12871-021-01507-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-021-01507-2</ArticleId><ArticleId IdType="pubmed">34809579</ArticleId><ArticleId IdType="pmc">8607612</ArticleId></ArticleIdList></Reference><Reference><Citation>Jooma Z, Perrie H, Scribante J, Kleyenstuber T. Emergence delirium in children undergoing dental surgery under general anesthesia. Pediatr Anesth 2020; 30: 1020&#x2013;6. https://doi.org/10.1111/pan.13937</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pan.13937</ArticleId></ArticleIdList></Reference><Reference><Citation>Bong CL, Lim E, Allen JC, et al. A comparison of single-dose dexmedetomidine or propofol on the incidence of emergence delirium in children undergoing general anaesthesia for magnetic resonance imaging. Anaesthesia 2015; 70: 393&#x2013;9. https://doi.org/10.1111/anae.12867</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.12867</ArticleId><ArticleId IdType="pubmed">25311146</ArticleId></ArticleIdList></Reference><Reference><Citation>Breschan C, Platzer M, Jost R, Stettner H, Likar R. Midazolam does not reduce emergence delirium after sevoflurane anesthesia in children. Pediatr Anesth 2007; 17: 347&#x2013;52 . https://doi.org/10.1111/j.1460-9592.2006.02101.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9592.2006.02101.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh AY, Seo KS, Kim SD, Kim CS, Kim HS. Delayed emergence process does not result in a lower incidence of emergence agitation after sevoflurane anesthesia in children. Acta Anaesthesiol Scand 2005; 49: 297&#x2013;9. d https://doi.org/10.1111/j.1399-6576.2005.00687.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-6576.2005.00687.x</ArticleId><ArticleId IdType="pubmed">15752391</ArticleId></ArticleIdList></Reference><Reference><Citation>Weldon BC, Bell M, Craddock T. The effect of caudal analgesia on emergence agitation in children after sevoflurane versus halothane anesthesia. Anesth Analg 2004; 98: 321&#x2013;6. https://doi.org/10.1213/01.ane.0000096004.96603.08</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ane.0000096004.96603.08</ArticleId><ArticleId IdType="pubmed">14742362</ArticleId></ArticleIdList></Reference><Reference><Citation>Keles S, Kocaturk O. Postoperative discomfort and emergence delirium in children undergoing dental rehabilitation under general anesthesia: comparison of nasal tracheal intubation and laryngeal mask airway. J Pain Res 2018; 11: 103&#x2013;10. https://doi.org/10.2147/jpr.s153637</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/jpr.s153637</ArticleId><ArticleId IdType="pubmed">29379311</ArticleId><ArticleId IdType="pmc">5757964</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Song T, Wang H, et al. Comparison of two different sevoflurane expelling methods on emergence agitation in infants following sevoflurane anesthesia. Int J Clin Exp Med 2015; 8: 6200&#x2013;5. Available from URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4483804/pdf/ijcem0008-6200.pdf (accessed July 2024).</Citation></Reference><Reference><Citation>Singh R, Kharbanda M, Sood N, Mahajan V, Chatterji C. Comparative evaluation of incidence of emergence agitation and post-operative recovery profile in paediatric patients after isoflurane, sevoflurane and desflurane anaesthesia. Indian J Anaesth 2012; 56: 156&#x2013;61. https://doi.org/10.4103/0019-5049.96325</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0019-5049.96325</ArticleId><ArticleId IdType="pubmed">22701207</ArticleId><ArticleId IdType="pmc">3371491</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi HR, Cho JK, Lee S, Yoo BH, Yon JH, Kim KM. The effect of remifentanil versus N(2)O on postoperative pain and emergence agitation after pediatric tonsillectomy/adenoidectomy. Korean J Anesthesiol 2011; 61: 148&#x2013;53. https://doi.org/10.4097/kjae.2011.61.2.148</Citation><ArticleIdList><ArticleId IdType="doi">10.4097/kjae.2011.61.2.148</ArticleId><ArticleId IdType="pubmed">21927686</ArticleId><ArticleId IdType="pmc">3167135</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung HJ, Kim JB, Im KS, Oh SH, Lee JM. Effect of ketamine versus thiopental sodium anesthetic induction and a small dose of fentanyl on emergence agitation after sevoflurane anesthesia in children undergoing brief ophthalmic surgery. Korean J Anesthesiol 2010; 58: 148&#x2013;52. https://doi.org/10.4097/kjae.2010.58.2.148</Citation><ArticleIdList><ArticleId IdType="doi">10.4097/kjae.2010.58.2.148</ArticleId><ArticleId IdType="pubmed">20498793</ArticleId><ArticleId IdType="pmc">2872852</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradeep T, Manissery JJ, Upadya M. Emergence agitation in paediatric patients using sevoflurane and isoflurane anaesthesia: a randomised controlled study. South African J Anaesth Analg 2017; 23: 32&#x2013;5. https://doi.org/10.1080/22201181.2017.1307568</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22201181.2017.1307568</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas D, Lagoo J, Kilpadi K. Emergence agitation in children after sevoflurane anaesthesia: a comparative evaluation of ketamine and varying doses of fentanyl. Sri Lankan J Anaesthesiol 2015; 23: 10&#x2013;6. https://doi.org/10.4038/slja.v23i1.7514</Citation><ArticleIdList><ArticleId IdType="doi">10.4038/slja.v23i1.7514</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali AB, Khan F. Emergence delirium and its association with preoperative anxiety in paediatric patients undergoing infra umbilical surgery under combined general and caudal anaesthesia: an observational study from a tertiary care centre in a South Asian country. Turkish J Anaesthesiol Reanim 2022; 50: 129&#x2013;34. https://doi.org/10.5152/tjar.2021.1104</Citation><ArticleIdList><ArticleId IdType="doi">10.5152/tjar.2021.1104</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Li J, Shi Y, et al. Urinary aromatic amino acid metabolites associated with postoperative emergence agitation in paediatric patients after general anaesthesia: urine metabolomics study. Front Pharmacol 2022; 13: 932776 . https://doi.org/10.3389/fphar.2022.932776</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.932776</ArticleId><ArticleId IdType="pubmed">35928271</ArticleId><ArticleId IdType="pmc">9343964</ArticleId></ArticleIdList></Reference><Reference><Citation>Reid C, Butorac M, Baitch L. Emergence delirium and caregiver anxiety: a non-existent link? Trends Anaesth Crit Care 2022; 45: 28&#x2013;31. https://doi.org/10.1016/j.tacc.2022.06.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tacc.2022.06.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Petre MA, Levin DN, Englesakis M, Maynes JT, Pechlivanoglou P, Aoyama K. Dexmedetomidine vs. total intravenous anaesthesia in paediatric emergence delirium: a network meta-analysis. Eur J Anaesthesiol 2021; 38: 1111&#x2013;23. https://doi.org/10.1097/eja.0000000000001490</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/eja.0000000000001490</ArticleId><ArticleId IdType="pubmed">33720063</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyake T, Miyamoto Y, Nakamura N. Subanesthetic-dose propofol infusion for preventing emergence agitation in children: a retrospective observational study. J Anesth 2023; 37: 546&#x2013;54. https://doi.org/10.1007/s00540-023-03201-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-023-03201-8</ArticleId><ArticleId IdType="pubmed">37188963</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumie M, Yang A, Hayes J, Yamaura K, Aoyama K. How to mitigate confounding factors in observational studies. J Anesth 2023; 37: 663&#x2013;5. https://doi.org/10.1007/s00540-023-03236-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-023-03236-x</ArticleId><ArticleId IdType="pubmed">37530815</ArticleId></ArticleIdList></Reference><Reference><Citation>Hino M, Mihara T, Miyazaki S, et al. Development and validation of a risk scale for emergence agitation after general anesthesia in children: a prospective observational study. Anesth Analg 2017; 125: 550&#x2013;5. https://doi.org/10.1213/ane.0000000000002126</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0000000000002126</ArticleId><ArticleId IdType="pubmed">28614125</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehrotra S. Postoperative anaesthetic concerns in children: postoperative pain, emergence delirium and postoperative nausea and vomiting. Indian J Anaesth 2019; 63: 763&#x2013;70. https://doi.org/10.4103/ija.ija_391_19</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ija.ija_391_19</ArticleId><ArticleId IdType="pubmed">31571690</ArticleId><ArticleId IdType="pmc">6761783</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes J, Zuercher M, Gai N, Chowdhury AR, Aoyama K. The Fragility Index of randomized controlled trials in pediatric anesthesiology. Can J Anesth 2023; 70: 1449&#x2013;60. https://doi.org/10.1007/s12630-023-02513-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12630-023-02513-3</ArticleId><ArticleId IdType="pubmed">37286747</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho AM, Sehgal A, Leitch J, Saha T, Mizubuti GB. Comment on: The fragility index of randomized controlled trials in pediatric anesthesiology. Can J Anesth 2024; 71: 163&#x2013;4. https://doi.org/10.1007/s12630-023-02658-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12630-023-02658-1</ArticleId><ArticleId IdType="pubmed">37989936</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes J, Aoyama K. In reply: Comment on: The fragility index of randomized controlled trials in pediatric anesthesiology. Can J Anesth 2024; 71: 165&#x2013;6. https://doi.org/10.1007/s12630-023-02659-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12630-023-02659-0</ArticleId><ArticleId IdType="pubmed">37989935</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37169362</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>08</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2005-7563</ISSN><JournalIssue CitedMedium="Internet"><Volume>77</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Korean journal of anesthesiology</Title><ISOAbbreviation>Korean J Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>Perioperative adverse cardiac events and mortality after non-cardiac surgery: a multicenter study.</ArticleTitle><Pagination><StartPage>66</StartPage><EndPage>76</EndPage><MedlinePgn>66-76</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4097/kja.23043</ELocationID><Abstract><AbstractText Label="BACKGROUND">Perioperative adverse cardiac events (PACE), a composite of myocardial infarction, coronary revascularization, congestive heart failure, arrhythmic attack, acute pulmonary embolism, cardiac arrest, and stroke during 30-day postoperative period, is associated with long-term mortality, but with limited clinical evidence. We compared long-term mortality with PACE using data from nationwide multicenter electronic health records.</AbstractText><AbstractText Label="METHODS">Data from 7 hospitals, converted to Observational Medical Outcomes Partnership Common Data Model, were used. We extracted records of 277,787 adult patients over 18 years old undergoing non-cardiac surgery for the first time at the hospital and had medical records for more than 180 days before surgery. We performed propensity score matching and then an aggregated meta&#x2011;analysis.</AbstractText><AbstractText Label="RESULTS">After 1:4 propensity score matching, 7,970 patients with PACE and 28,807 patients without PACE were matched. The meta&#x2011;analysis showed that PACE was associated with higher one-year mortality risk (hazard ratio [HR]: 1.33, 95% CI [1.10, 1.60], P = 0.005) and higher three-year mortality (HR: 1.18, 95% CI [1.01, 1.38], P = 0.038). In subgroup analysis, the risk of one-year mortality by PACE became greater with higher-risk surgical procedures (HR: 1.20, 95% CI [1.04, 1.39], P = 0.020 for low-risk surgery; HR: 1.69, 95% CI [1.45, 1.96], P &lt; 0.001 for intermediate-risk; and HR: 2.38, 95% CI [1.47, 3.86], P = 0.034 for high-risk).</AbstractText><AbstractText Label="CONCLUSIONS">A nationwide multicenter study showed that PACE was significantly associated with increased one-year mortality. This association was stronger in high-risk surgery, older, male, and chronic kidney disease subgroups. Further studies to improve mortality associated with PACE are needed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Byungjin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oh</LastName><ForeName>Ah Ran</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Kangwon National University Hospital, Chuncheon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Jungchan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jong-Hwan</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Kwangmo</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Health Promotion, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Dong Yun</ForeName><Initials>DY</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rhee</LastName><ForeName>Sang Youl</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Endocrinology and Metabolism, Kyung Hee University School of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Sang-Soo</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Kangdong Sacred Heart Hospital, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Seung Do</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Internal Medicine, Gyeongsang National University Hospital, Jinju, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Sun Hack</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Internal Medicine, Pusan National University Hospital, Busan, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeong</LastName><ForeName>Chang Won</ForeName><Initials>CW</Initials><AffiliationInfo><Affiliation>Central Research Center of Biomedical Research Institute, Wonkwang University Hospital, Iksan, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Bumhee</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Office of Biostatistics, Medical Research Collaborating Center, Ajou Research Institute for Innovative Medicine, Ajou University Medical Center, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seol</LastName><ForeName>Soobeen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Rae Woong</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Seunghwa</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Wiltse Memorial Hospital, Suwon, Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>20003883</GrantID><Agency>Ministry of Trade, Industry and Energy</Agency><Country/></Grant><Grant><GrantID>20005021</GrantID><Agency>Ministry of Trade, Industry and Energy</Agency><Country/></Grant><Grant><GrantID>HR16C0001</GrantID><Agency>Ministry of Health and Welfare</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Korea (South)</Country><MedlineTA>Korean J Anesthesiol</MedlineTA><NlmUniqueID>101502451</NlmUniqueID><ISSNLinking>2005-6419</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Korean J Anesthesiol. 2024 Feb;77(1):3-4. doi: 10.4097/kja.24038.</RefSource><PMID Version="1">38267834</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006323" MajorTopicYN="Y">Heart Arrest</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="Y">Myocardial Infarction</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiac arrhythmias</Keyword><Keyword MajorTopicYN="N">Cardiovascular diseases</Keyword><Keyword MajorTopicYN="N">Embolism</Keyword><Keyword MajorTopicYN="N">General surgery</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Myocardial infarction.</Keyword></KeywordList><CoiStatement>
<b>Conflicts of Interest</b>
. No potential conflict of interest relevant to this article was reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>5</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>12</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>11</Day><Hour>20</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37169362</ArticleId><ArticleId IdType="pmc">PMC10834726</ArticleId><ArticleId IdType="doi">10.4097/kja.23043</ArticleId><ArticleId IdType="pii">kja.23043</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Devereaux PJ, Sessler DI. Cardiac complications in patients undergoing major noncardiac surgery. N Engl J Med. 2015;373:2258&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pubmed">26630144</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearse RM, Moreno RP, Bauer P, Pelosi P, Metnitz P, Spies C, et al. Mortality after surgery in Europe: a 7 day cohort study. Lancet. 2012;380:1059&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3493988</ArticleId><ArticleId IdType="pubmed">22998715</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh SR, Tang T, Wijewardena C, Yarham SI, Boyle JR, Gaunt ME. Postoperative arrhythmias in general surgical patients. Ann R Coll Surg Engl. 2007;89:91&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1964549</ArticleId><ArticleId IdType="pubmed">17346395</ArticleId></ArticleIdList></Reference><Reference><Citation>Poise Study Group. Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008;371:1839&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">18479744</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh AR, Park J, Lee JH, Kim H, Yang K, Choi JH, et al. Association between perioperative adverse cardiac events and mortality during one-year follow-up after noncardiac surgery. J Am Heart Assoc. 2022;11:e024325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9238468</ArticleId><ArticleId IdType="pubmed">35411778</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, Schuemie MJ, Krumholz HM, You SC, Chen R, Pratt N, et al. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis. Lancet. 2019;394:1816&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6924620</ArticleId><ArticleId IdType="pubmed">31668726</ArticleId></ArticleIdList></Reference><Reference><Citation>Seo WW, Seo SI, Kim Y, Yoo JJ, Shin WG, Kim J, et al. Impact of pitavastatin on new-onset diabetes mellitus compared to atorvastatin and rosuvastatin: a distributed network analysis of 10 real-world databases. Cardiovasc Diabetol. 2022;21:82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9128291</ArticleId><ArticleId IdType="pubmed">35606846</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, et al. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan CJ. Reducing bias using propensity score matching. J Nucl Cardiol. 2018;25:404&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">28776312</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, Ghali WA. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol. 2004;57:1288&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">15617955</ArticleId></ArticleIdList></Reference><Reference><Citation>Kristensen SD, Knuuti J, Saraste A, Anker S, B&#xf8;tker HE, Hert SD, et al. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA) Eur Heart J. 2014;35:2383&#x2013;431.</Citation><ArticleIdList><ArticleId IdType="pubmed">25086026</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong PW, Westerhout CM. Composite end points in clinical research: a time for reappraisal. Circulation. 2017;135:2299&#x2013;307.</Citation><ArticleIdList><ArticleId IdType="pubmed">28584030</ArticleId></ArticleIdList></Reference><Reference><Citation>Sankoh AJ, Li H, D&#x2019;Agostino RB Sr. Use of composite endpoints in clinical trials. Stat Med. 2014;33:4709&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">24833282</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta NN, Yu Y, Pinnelas R, Krishnamoorthy P, Shin DB, Troxel AB, et al. Attributable risk estimate of severe psoriasis on major cardiovascular events. Am J Med. 2011;124:775.e1-6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3146037</ArticleId><ArticleId IdType="pubmed">21787906</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhave PD, Goldman LE, Vittinghoff E, Maselli J, Auerbach A. Incidence, predictors, and outcomes associated with postoperative atrial fibrillation after major noncardiac surgery. Am Heart J. 2012;164:918&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4096141</ArticleId><ArticleId IdType="pubmed">23194493</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh SR, Tang T, Gaunt ME, Schneider HJ. New arrhythmias after non-cardiothoracic surgery. BMJ. 2006;333:715.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1592375</ArticleId><ArticleId IdType="pubmed">17023439</ArticleId></ArticleIdList></Reference><Reference><Citation>Albini A, Malavasi VL, Vitolo M, Imberti JF, Marietta M, Lip GY, et al. Long-term outcomes of postoperative atrial fibrillation following non cardiac surgery: a systematic review and metanalysis. Eur J Intern Med. 2021;85:27&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">33402281</ArticleId></ArticleIdList></Reference><Reference><Citation>Afzal S, Arshad A. Ethical issues among healthcare workers using electronic medical records: a systematic review. Comput Methods Programs Biomed Update. 2021;1:100030.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36074378</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1678-4170</ISSN><JournalIssue CitedMedium="Internet"><Volume>119</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Arquivos brasileiros de cardiologia</Title><ISOAbbreviation>Arq Bras Cardiol</ISOAbbreviation></Journal><ArticleTitle>Percutaneous Closure of Ductus Arteriosus in Preterm Babies: The Initial Brazilian Experience.</ArticleTitle><Pagination><StartPage>460</StartPage><EndPage>467</EndPage><MedlinePgn>460-467</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.36660/abc.20210818</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0066-782X2022000900460</ELocationID><Abstract><AbstractText Label="BACKGROUND">The presence of patent ductus arteriosus can be as high as 50% in preterm babies. Hemodynamically significant patent ductus arteriosus is a common cause of delayed weaning of respiratory support and an important risk factor of necrotizing enterocolitis, intraventricular hemorrhage, and bronchopulmonary dysplasia in this population.</AbstractText><AbstractText Label="OBJECTIVE">The aim of this study is to describe an initial experience of percutaneous closure of the ductus arteriosus in preterm infants weighing less than 2 kg.</AbstractText><AbstractText Label="METHODS">This was a prospective study, comprised of 14 consecutive patients submitted to percutaneous closure of ductus arteriosus between March 2020 and February 2021 in 6 institutions in Brazil.</AbstractText><AbstractText Label="RESULTS">Mean gestational age was 28.45&#xb1;3.14 weeks, mean age at the procedure was 38.85&#xb1;17.35 days and mean weight was 1.41 &#xb1;0.41 kg; 79% of the patients were under mechanical ventilation, and 79% had been submitted, on average, to a 1.5 cycle of non-steroidal anti-inflammatory drugs. Most patients were weaned off of mechanical ventilation in a mean of 12.6 &#xb1;7.24 days after the procedure. Success rate was 100%. No procedure-related mortality was observed.</AbstractText><AbstractText Label="CONCLUSION">This study concluded that percutaneous closure of ductus arteriosus in premature babies below 2 kg has satisfactory results and a low complication rate in this study sample.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Manica</LastName><ForeName>Jo&#xe3;o Luiz Langer</ForeName><Initials>JLL</Initials><Identifier Source="ORCID">0000-0002-5714-9880</Identifier><AffiliationInfo><Affiliation>Instituto de Cardiologia/Funda&#xe7;&#xe3;o Universit&#xe1;ria de Cardiologia (IC/FUC), Porto Alegre, RS - Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neves</LastName><ForeName>Juliana Rodrigues</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Real Hospital Portugu&#xea;s de Benefic&#xea;ncia em Pernambuco, Recife, PE - Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arrieta</LastName><ForeName>Raul</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Hospital Sepaco, S&#xe3;o Paulo, SP - Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abujamra</LastName><ForeName>Pedro</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-3055-0903</Identifier><AffiliationInfo><Affiliation>Santa Casa de S&#xe3;o Jos&#xe9; dos Campos, S&#xe3;o Jos&#xe9; dos Campos, SP - Brasil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital de Cl&#xed;nicas da UNICAMP, Campinas, SP - Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rossi Filho</LastName><ForeName>Raul Ivo</ForeName><Initials>RI</Initials><AffiliationInfo><Affiliation>Instituto de Cardiologia/Funda&#xe7;&#xe3;o Universit&#xe1;ria de Cardiologia (IC/FUC), Porto Alegre, RS - Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giuliano</LastName><ForeName>Luiz Carlos</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Universidade Federal de Santa Catarina, Florian&#xf3;polis, SC - Brasil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital SOS C&#xe1;rdio, Florian&#xf3;polis, SC - Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coimbra</LastName><ForeName>Germana</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Hospital Sepaco, S&#xe3;o Paulo, SP - Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teixeirense</LastName><ForeName>Pablo Tom&#xe9;</ForeName><Initials>PT</Initials><AffiliationInfo><Affiliation>Hospital Unimed de Piracicaba, Piracicaba, SP - Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rossi</LastName><ForeName>Jo&#xe3;o Henrique Aramayo</ForeName><Initials>JHA</Initials><Identifier Source="ORCID">0000-0003-2894-6626</Identifier><AffiliationInfo><Affiliation>Instituto de Cardiologia/Funda&#xe7;&#xe3;o Universit&#xe1;ria de Cardiologia (IC/FUC), Porto Alegre, RS - Brasil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pontif&#xed;cia Universidade Cat&#xf3;lica do Rio Grande do Sul, Porto Alegre, RS - Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costa</LastName><ForeName>Rodrigo Nieckel da</ForeName><Initials>RND</Initials><AffiliationInfo><Affiliation>Instituto Dante Pazzanese de Cardiologia, S&#xe3;o Paulo, SP - Brasil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital e Maternidade Santa Joana, S&#xe3;o Paulo, SP - Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crist&#xf3;v&#xe3;o</LastName><ForeName>Salvador Andr&#xe9; Bavaresco</ForeName><Initials>SAB</Initials><AffiliationInfo><Affiliation>Hospital e Maternidade Santa Joana, S&#xe3;o Paulo, SP - Brasil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Benefic&#xea;ncia Portuguesa de S&#xe3;o Paulo, S&#xe3;o Paulo, SP - Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pedra</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Instituto Dante Pazzanese de Cardiologia, S&#xe3;o Paulo, SP - Brasil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital do Cora&#xe7;&#xe3;o, S&#xe3;o Paulo, SP - Brasil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>por</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Fechamento Percut&#xe2;neo do Canal Arterial em Pacientes Prematuros Abaixo de 2 Kg: Experi&#xea;ncia Inicial Brasileira.</VernacularTitle></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Arq Bras Cardiol</MedlineTA><NlmUniqueID>0421031</NlmUniqueID><ISSNLinking>0066-782X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>WK2XYI10QM</RegistryNumber><NameOfSubstance UI="D007052">Ibuprofen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001938" MajorTopicYN="N" Type="Geographic">Brazil</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004373" MajorTopicYN="Y">Ductus Arteriosus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004374" MajorTopicYN="Y">Ductus Arteriosus, Patent</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007052" MajorTopicYN="N">Ibuprofen</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007234" MajorTopicYN="N">Infant, Premature</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="por"><AbstractText Label="FUNDAMENTO">A incid&#xea;ncia de ductus arteriosus patente (PCA) pode chegar a 50% em pacientes prematuros. Quando hemodinamicamente significativo, pode ser respons&#xe1;vel por tempo de ventila&#xe7;&#xe3;o mec&#xe2;nica prolongado, al&#xe9;m de importante fator de risco para o aparecimento de enterocolite necrotizante, hemorragia intraventricular e displasia broncopulmonar nessa popula&#xe7;&#xe3;o.</AbstractText><AbstractText Label="OBJETIVO">O objetivo deste estudo &#xe9; descrever a experi&#xea;ncia inicial do fechamento percut&#xe2;neo de canal arterial em prematuros pesando menos de 2 kg.</AbstractText><AbstractText Label="M&#xc9;TODOS">Trata-se de estudo prospectivo que compreendeu 14 pacientes consecutivos submetidos a fechamento percut&#xe2;neo de canal arterial de mar&#xe7;o de 2020 a fevereiro de 2021 em 6 institui&#xe7;&#xf5;es no Brasil.</AbstractText><AbstractText Label="RESULTADOS">A idade gestacional m&#xe9;dia ao nascimento foi de 28,45 &#xb1;3,14 semanas, a idade m&#xe9;dia no momento do procedimento foi de 38,85 &#xb1;17,35 dias e o peso m&#xe9;dio de 1,41&#xb1;0,41 kg. Dentre os prematuros, 79% necessitavam de ventila&#xe7;&#xe3;o mec&#xe2;nica e 79% tinham feito uso de, em m&#xe9;dia, 1,5 ciclos de anti-inflamat&#xf3;rios n&#xe3;o esteroides. A maioria dos pacientes teve melhora dos par&#xe2;metros ventilat&#xf3;rios e o tempo m&#xe9;dio de extuba&#xe7;&#xe3;o foi de 12,6 &#xb1;7,24 dias. A taxa de sucesso foi de 100%. N&#xe3;o houve mortalidade relacionada ao procedimento.</AbstractText><AbstractText Label="CONCLUS&#xc3;O">Este estudo concluiu que o fechamento percut&#xe2;neo do canal arterial em prematuros &#xe9; uma realidade no Brasil, com resultados satisfat&#xf3;rios e baixa taxa de complica&#xe7;&#xf5;es.</AbstractText></OtherAbstract><OtherAbstract Type="Publisher" Language="eng"><AbstractText Label="BACKGROUND">The presence of patent ductus arteriosus can be as high as 50% in preterm babies. Hemodynamically significant patent ductus arteriosus is a common cause of delayed weaning of respiratory support and an important risk factor of necrotizing enterocolitis, intraventricular hemorrhage, and bronchopulmonary dysplasia in this population.</AbstractText><AbstractText Label="OBJECTIVE">The aim of this study is to describe an initial experience of percutaneous closure of the ductus arteriosus in preterm infants weighing less than 2 kg.</AbstractText><AbstractText Label="METHODS">This was a prospective study, comprised of 14 consecutive patients submitted to percutaneous closure of ductus arteriosus between March 2020 and February 2021 in 6 institutions in Brazil.</AbstractText><AbstractText Label="RESULTS">Mean gestational age was 28.45&#xb1;3.14 weeks, mean age at the procedure was 38.85&#xb1;17.35 days and mean weight was 1.41 &#xb1;0.41 kg; 79% of the patients were under mechanical ventilation, and 79% had been submitted, on average, to a 1.5 cycle of non-steroidal anti-inflammatory drugs. Most patients were weaned off of mechanical ventilation in a mean of 12.6 &#xb1;7.24 days after the procedure. Success rate was 100%. No procedure-related mortality was observed.</AbstractText><AbstractText Label="CONCLUSION">This study concluded that percutaneous closure of ductus arteriosus in premature babies below 2 kg has satisfactory results and a low complication rate in this study sample.</AbstractText></OtherAbstract><CoiStatement>Potencial conflito de interesse. N&#xe3;o h&#xe1; conflito com o presente artigo</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>8</Day><Hour>11</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36074378</ArticleId><ArticleId IdType="pmc">PMC9438535</ArticleId><ArticleId IdType="doi">10.36660/abc.20210818</ArticleId><ArticleId IdType="pii">S0066-782X2022000900460</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chiruvolu A, Punjwani P, Ramaciotti C. Clinical and echo- cardiographic diagnosis of patent ductus arteriosus in premature neonates. 10.1016/j.earlhumdev.2008.12.008Early Hum Dev. 2009;85(3):147&#x2013;149.</Citation><ArticleIdList><ArticleId IdType="pubmed">19217224</ArticleId></ArticleIdList></Reference><Reference><Citation>Dollberg S, Lusky A, Reichman B. Patent ductus arteriosus, indomethacin and necrotizing enterocolitis in very low birth weight infants: a population-based study. 10.1097/00005176-200502000-00019J Pediatr Gastroenterol Nutr. 2005;40(2):184&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pubmed">15699694</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans N, Kluckow M. Early ductal shunting and intraventricular haemorrhage in ventilated preterm infants. 10.1136/fn.75.3.f183Arch Dis Child Fetal Neonatal Ed. 1996;75(3):F183&#x2013;F186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1061197</ArticleId><ArticleId IdType="pubmed">8976684</ArticleId></ArticleIdList></Reference><Reference><Citation>Garland J, Buck R, Weinberg M. Pulmonary hemorrhage risk in infants with a clinically diagnosed patent ductus arteriosus: a retrospective cohort study. Pediatrics. 1994;94(5):719&#x2013;723. PMID: 7936902.</Citation><ArticleIdList><ArticleId IdType="pubmed">7936902</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunha GS, Mezzacappa-Filho F, Ribeiro JD. Risk factors for bronchopulmonary dysplasia in very low birth weight newborns treated with mechanical ventilation in the first week of life. J Trop Pediatr. 2005;51(6):334&#x2013;340. doi: 10.1093/ropej/fmi051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ropej/fmi051</ArticleId><ArticleId IdType="pubmed">15927945</ArticleId></ArticleIdList></Reference><Reference><Citation>Koehne PS, Bein G, Alexi-Meskhishvili V, Weng Y, B&#xfc;hrer C, Obladen M. Patent ductus arteriosus in very low birthweight infants: complications of pharmacological and surgical treatment. J Perinat Med. 2001;29(4):327&#x2013;334. doi: 10.1093/tropej/fmi051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/tropej/fmi051</ArticleId><ArticleId IdType="pubmed">11565202</ArticleId></ArticleIdList></Reference><Reference><Citation>Noori S, Friedlich P, Seri I, Wong P. Changes in myocardial function and hemodynamics after ligation of the ductus arteriosus in preterm infants. 10.1016/j.jpeds.2007.01.035J Pediatr. 2007;150(6):597&#x2013;602.</Citation><ArticleIdList><ArticleId IdType="pubmed">17517241</ArticleId></ArticleIdList></Reference><Reference><Citation>McNamara PJ, Stewart L, Shivananda SP, Stephens D, Sehgal A. Patent ductus arteriosus ligation is associated with impaired left ventricular systolic performance in premature infants weighing less than 1000g. J Thorac Cardiovasc Surg. 2010;140(1):150&#x2013;157. doi: 10.1016/j.jtcvs.2010.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2010.01.011</ArticleId><ArticleId IdType="pubmed">20363478</ArticleId></ArticleIdList></Reference><Reference><Citation>Noori S, McNamara P, Jain A, Lavoie PM, Wickremasinghe A, Merritt TA, PDA Ligation/Hypotension Trial Investigators. et al. Catecholamine-resistant hypotension and myocardial performance following patent ductus arteriosus ligation. 10.1038/jp.2014.151J Perinatol. 2015;35(2):123&#x2013;127.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4310792</ArticleId><ArticleId IdType="pubmed">25118721</ArticleId></ArticleIdList></Reference><Reference><Citation>1Noori S. Patent ductus arteriosus in the preterm infant: to treat or not to treat? 10.1038/jp.2010.97J Perinatol. 2010;30(Suppl):S31&#x2013;S37.</Citation><ArticleIdList><ArticleId IdType="pubmed">20877405</ArticleId></ArticleIdList></Reference><Reference><Citation>Thukaram R, Suarez WA, Sundaraghavan S. Transcatheter closure of the patent arterial duct using the Flipper coil in a premature infant weighing 1,400 g: a case report. 10.1002/ccd.20402Catheter Cardiovasc Interv. 2005;66(1):18&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">16082683</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts P, Adwani S, Archer N, Wilson N. Catheter closure of the arterial duct in preterm infants. 10.1136/adc.2005.078600Arch Dis Child Fetal Neonatal Ed. 2007;92(4):F248&#x2013;F250.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2675419</ArticleId><ArticleId IdType="pubmed">16920755</ArticleId></ArticleIdList></Reference><Reference><Citation>Francis E, Singhi AK, Lakshmivenkateshaiah S, Kumar RK. Transcatheter occlusion of patent ductus arteriosus in pre-term infants. 10.1016/j.jcin.2010.01.016JACC Cardiovasc Interv. 2010;3(5):550&#x2013;555.</Citation><ArticleIdList><ArticleId IdType="pubmed">20488412</ArticleId></ArticleIdList></Reference><Reference><Citation>Trefz M, Wilson N, Acton R, Hess D, Bass T. 16 Echocardiographic assess- ment of ductal anatomy in premature infants-lessons for device design. 10.1111/j.1540-8175.2009.01048.xEchocardiography. 2010;27:575&#x2013;579.</Citation><ArticleIdList><ArticleId IdType="pubmed">20374268</ArticleId></ArticleIdList></Reference><Reference><Citation>Bentham J, Meur S, Hudsmith L, Archer N, Echoc Wilson N. ar- cardiographically guided catheter closure of arterial ducts in small preterm infants on the neonatal intensive care unit. 10.1002/ccd.22637Catheter Cardiovasc Interv. 2011;77(3):409&#x2013;415.</Citation><ArticleIdList><ArticleId IdType="pubmed">20928843</ArticleId></ArticleIdList></Reference><Reference><Citation>Philip R, Rush Waller B, Agrawal V, Wright D, Arevalo A, Zurakowski D, et al. Morphologic characteriza- tion of the patent ductus arteriosus in the premature infant and the choice of transcatheter occlusion device. 10.1002/ccd.26287Catheter Cardiovasc Interv. 2016;87(2):310&#x2013;317.</Citation><ArticleIdList><ArticleId IdType="pubmed">26525611</ArticleId></ArticleIdList></Reference><Reference><Citation>Sungur M, Karakurt C, Ozbarlas N, Baspinar O. Closure of patent ductus arteriosus in children, small infants, and premature babies with Amplatzer duct occluder II additional sizes: multicenter study. 10.1002/ccd.24905Catheter Cardiovasc Interv. 2013;82(2):245&#x2013;252.</Citation><ArticleIdList><ArticleId IdType="pubmed">23460349</ArticleId></ArticleIdList></Reference><Reference><Citation>Narin N, Pamukcu O, Baykan A, Sunkak S, Tasci O, Uzum K, et al. Percutaneous PDA closure in extremely low birth weight babies. 10.1111/joic.12352J Interv Cardiol. 2016;29(6):654&#x2013;660.</Citation><ArticleIdList><ArticleId IdType="pubmed">27813244</ArticleId></ArticleIdList></Reference><Reference><Citation>Malekzadeh-Milani S, Akhavi A, Douchin S, Dauphin C, Chalard A, Mauran P, et al. Percutaneous closure of patent ductus arteriosus in premature infants: a French national survey. 10.1002/ccd.28502Catheter Cardiovasc Interv. 2020;95(1):71&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">31609068</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathanandam SK, Gutfinger D, O`Brien L, et al. Amplatzer Piccolo Occluder clinical trial for percutaneous closure of the patent ductus arteriosus in patients &#x2265; 700 grams. 10.1002/ccd.28973Catheter Cardiovasc Interv. 2020;96(6):1266&#x2013;1276.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7754477</ArticleId><ArticleId IdType="pubmed">32433821</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Khuffash AF, Jain A, McNamara PJ. Ligation of the patent ductus arteriosus in preterms infants: Understanding the physiology. J Pediatr. 2013;162(5):1100&#x2013;1106. doi: 10.1016/j.jpeds.2012.11.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2012.11.021</ArticleId><ArticleId IdType="pubmed">23410600</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY, McCurnin D, Yoder B, Shaul NW, Clyman R. Ductus arteriosus ligation and alveolar growth in preterm baboons with a patent ductus arteriosus. Pediatr Res. 2008;63(3):299&#x2013;302. doi: 10.1203/PDR.0b013e318163a8e4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1203/PDR.0b013e318163a8e4</ArticleId><ArticleId IdType="pubmed">18287969</ArticleId></ArticleIdList></Reference><Reference><Citation>Madan JC, Kendrick D, Hagadorn JI, Franz ID. Patent ductus arteriosus therapy: Impact on neonatal and 18-month outcome. 10.1542/peds.2007-2781Pediatrics. 2009;123(2):674&#x2013;681.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2752886</ArticleId><ArticleId IdType="pubmed">19171637</ArticleId></ArticleIdList></Reference><Reference><Citation>Bixler GM, Powers GC, Clark RH, Walker MW, Tolia VN. Changes in the Diagnosis and Management of Patent Ductus Arteriosus from 2006 to 2015 in United States Neonatal Intensive Care Units. 10.1016/j.jpeds.2017.05.024J Pediatr. 2017;189:105&#x2013;112.</Citation><ArticleIdList><ArticleId IdType="pubmed">28600155</ArticleId></ArticleIdList></Reference><Reference><Citation>Relangi D, Somashekar S, Jain D, Vanbuskirk S, Bancalari E, Sosenko I, Claure N. Changes in Patent Ductus Arteriosus Treatment Strategy and Respiratory Outcomes in Premature Infants. 10.1016/j.jpeds.2021.04.030J Pediatr. 2021;235:58&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">33894266</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogango AR, Asensio IP, de la Blanca AR, Tegerizo FB, Sanchez-Luna M, Jaurena JMG, et al. Surgical Ligation Versus Percutaneous Closure of Patent Ductus Arteriosus in Very Low-Weight Preterm Infants: Which are Real Benefits of the Percutaneous Approach? 10.1007/s00246-017-1768-5Pediatr Cardiol. 2018;39(2):398&#x2013;410.</Citation><ArticleIdList><ArticleId IdType="pubmed">29119215</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32481281</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>19</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>99</Volume><Issue>21</Issue><PubDate><Year>2020</Year><Month>May</Month><Day>22</Day></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Thromboprophylaxis in elective spinal surgery: A protocol for systematic review.</ArticleTitle><Pagination><StartPage>e20127</StartPage><MedlinePgn>e20127</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e20127</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000020127</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Venous thromboembolism (VTE) is a serious, sometimes life-threatening complication that can occur following spine surgery. The incidence of VTE, and the optimal type and timing of thromboprophylaxis for this complication in elective spine surgery is a matter of debate.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To perform a systematic review with the aim of clarifying the efficacy and adverse effects of mechanical and chemical prophylaxis for preventing thromboembolic complications in elective spine surgery for conditions other than trauma and malignant disease.</AbstractText><AbstractText Label="METHODS/DESIGN" NlmCategory="METHODS">A search strategy of related articles up to March 2018 was designed and executed in Medline and Embase.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">adolescents (&gt;10 years) and adults undergoing elective surgery for spinal deformity or degenerative disease (from C1 to S1).</AbstractText><AbstractText Label="INTERVENTION" NlmCategory="METHODS">Perioperative mechanical and chemical thromboprophylaxis. Studies could be randomized controlled trials or observational studies that reported data on any relevant clinical outcomes.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, 2451 uniquecitations were identified and 35 studies were ultimately included in the systematic review. The overall mean incidence of complications was 3.7% for deep venous thrombosis, 0.0% for pulmonary embolism, and 3.7% for bleeding in chemoprophylaxis group; 2.9% for deep venous thrombosis, 0.4% for pulmonary embolism and 0.0% for bleeding in mechanoprophylaxis; and 0.7% for deep venous thrombosis, 0.1% for pulmonary embolism and 0.2% for bleeding in mixed prophylaxis group with no specific data on these rates for the type of patient and type and location of surgery. None of the articles retrieved provided information on the adolescent population.</AbstractText><AbstractText Label="DISCUSSION AND CONCLUSIONS" NlmCategory="CONCLUSIONS">The poor design and high variability among the studies regarding characteristics of study population, details of interventions, and definitions of outcomes, determines a low quality of the available evidence and limits the interpretation of the results. We were unable to identify a clear advantage of one type of thromboprophylaxis over the other, although there was an increased risk of bleeding with chemoprophylaxis, which could favor the use of mechanoprophylaxis in this scenario.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Colomina</LastName><ForeName>Mar&#xed;a J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">00000003-0106-0956</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care, Hospital Universitari Bellvitge, L'Hospitalet de LLobregat, Barcelona, Universitat de Barcelona.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bag&#xf3;</LastName><ForeName>Joan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Spine Surgery Unit, Department of Orthopedic and Trauma Surgery, Hospital Universitari Vall d'Hebron, Barcelona, Universitat Aut&#xf2;noma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#xe9;rez-Bracchiglione</LastName><ForeName>Javier</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Interdisciplinary Centre for Health Studies (CIESAL), Universidad de Valpara&#xed;so, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nishishinya Aquino</LastName><ForeName>Maria Betina</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Iberoamerican Cochrane Centre, Sant Pau Biomedical Research Institute (IIB Sant Pau).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salas</LastName><ForeName>Karla R</ForeName><Initials>KR</Initials><AffiliationInfo><Affiliation>Iberoamerican Cochrane Centre, Sant Pau Biomedical Research Institute (IIB Sant Pau).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Requeijo</LastName><ForeName>Carolina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Iberoamerican Cochrane Centre, Sant Pau Biomedical Research Institute (IIB Sant Pau).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Urr&#xfa;tia</LastName><ForeName>Gerard</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Iberoamerican Cochrane Centre, Sant Pau Biomedical Research Institute (IIB Sant Pau), CIBERESP, Barcelona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015201" MajorTopicYN="N">Meta-Analysis as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019635" MajorTopicYN="N">Neurosurgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013131" MajorTopicYN="N">Spine</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000078202" MajorTopicYN="N">Systematic Reviews as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="N">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>5</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32481281</ArticleId><ArticleId IdType="pmc">PMC7249943</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000020127</ArticleId><ArticleId IdType="pii">00005792-202005220-00036</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Eskildsen SM, Moll S, Lim MR. An algorithmic approach to venous thromboembolism prophylaxis in Spine Surgery. J Spinal Disord Tech 2015;28:275&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">26327600</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryson DJ, Uzoigwe CE, Braybrooke J. Thromboprophylaxis in spinal surgery: a survey. J Orthop Surg Res 2012;7:14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3349591</ArticleId><ArticleId IdType="pubmed">22458927</ArticleId></ArticleIdList></Reference><Reference><Citation>Moayer A, Mohebali N, Razmkon A. Incidence of deep vein thrombosis in patients undergoing degenerative spine surgery on prophylactic dalteparin; a single center report. Bull Emerg Trauma 2016;4:38&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4779468</ArticleId><ArticleId IdType="pubmed">27162925</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei J, Li W, Pei Y, et al. Clinical analysis of preoperative risk factors for the incidence of deep venous thromboembolism in patients undergoing posterior lumbar interbody fusion. J Orthop Surg Res 2016;11:68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4907081</ArticleId><ArticleId IdType="pubmed">27297081</ArticleId></ArticleIdList></Reference><Reference><Citation>Glotzbecker MP, Bono CM, Wood KB, et al. Thromboembolic disease in spinal surgery. Spine 2009;34:291&#x2013;303.</Citation><ArticleIdList><ArticleId IdType="pubmed">19179925</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferree BA. Deep venous thrombosis following lumbar laminotomy and laminectomy. Orthopedics 1994;17:35&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">8121832</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferree BA, Stern PJ, Jolson RS, et al. Deep venous thrombosis after spinal surgery. Spine 1993;18:315&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">8475429</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferree BA, Wright AM. Deep venous thrombosis following posterior lumbar spinal surgery. Spine 1993;18:1079&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">8367776</ArticleId></ArticleIdList></Reference><Reference><Citation>Oda T, Fuji T, Kato Y, et al. Deep venous thrombosis after posterior spinal surgery. Spine 2000;25:2962&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">11074685</ArticleId></ArticleIdList></Reference><Reference><Citation>Leon L, Rodriguez H, Tawk RG, et al. The prophylactic use of inferior vena cava filters in patients undergoing high-risk spinal surgery. Ann Vasc Surg 2005;19:442&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">15864473</ArticleId></ArticleIdList></Reference><Reference><Citation>Rokito SE, Schwartz MC, Neuwirth MG. Deep vein thrombosis after major reconstructive spinal surgery. Spine 1996;21:853&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">8779018</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng JS, Arnold PM, Anderson PA, et al. Anticoagulation risk in spine surgery. Spine 2010;35:S117&#x2013;124.</Citation><ArticleIdList><ArticleId IdType="pubmed">20407343</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira L, Marchi L, Pimenta L. Up-to-date thromboprophylaxis in elective spinal surgery. A systematic review. Coluna/Columna 2014;13:143&#x2013;6.</Citation></Reference><Reference><Citation>Mosenthal WP, Landy DC, Boyajian HH, et al. Thromboprophylaxis in spinal surgery. Spine 2018;43:E474&#x2013;481.</Citation><ArticleIdList><ArticleId IdType="pubmed">28820759</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi S, Yoon DH, Kim KN, et al. Postoperative spinal epidural hematoma: risk factor and clinical outcome. Yonsei Med J 2006;47:326&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2688151</ArticleId><ArticleId IdType="pubmed">16807981</ArticleId></ArticleIdList></Reference><Reference><Citation>Kou J, Fischgrund J, Biddinger A, et al. Risk factors for spinal epidural hematoma after spinal surgery. Spine 2002;27:1670&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">12163731</ArticleId></ArticleIdList></Reference><Reference><Citation>Bono CM, Watters WC, 3rd, Heggeness MH, et al. An evidence-based clinical guideline for the use of antithrombotic therapies in spine surgery. Spine J 2009;9:1046&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">19931184</ArticleId></ArticleIdList></Reference><Reference><Citation>Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141:e419S&#x2013;96S.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3278049</ArticleId><ArticleId IdType="pubmed">22315268</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Hoboken, NJ: John Wiley &amp; Sons; 2011.</Citation></Reference><Reference><Citation>Du W, Zhao C, Wang J, et al. Comparison of rivaroxaban and parnaparin for preventing venous thromboembolism after lumbar spine surgery. J Orthop Surg Res 2015;10:78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4455337</ArticleId><ArticleId IdType="pubmed">25998624</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamidi S, Riazi M. Incidence of venous thromboembolic complications in instrumental spinal surgeries with preoperative chemoprophylaxis. J Korean Neurosurg Soc 2015;57:114&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4345188</ArticleId><ArticleId IdType="pubmed">25733992</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson LD, Jr, Montgomery SP, Dameron TB, Jr, et al. Deep vein thrombosis in lumbar spinal fusion: a prospective study of antiembolic and pneumatic compression stockings. J South Orthop Assoc 1996;5:181&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">8884705</ArticleId></ArticleIdList></Reference><Reference><Citation>Voth D, Schwarz M, Hahn K, et al. Prevention of deep vein thrombosis in neurosurgical patients: a prospective double-blind comparison of two prophylactic regimen. Neurosurg Rev 1992;15:289&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">1336131</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood KB, Kos PB, Abnet JK, et al. Prevention of deep-vein thrombosis after major spinal surgery: a comparison study of external devices. J Spinal Disord 1997;10:209&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">9213276</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruber UF, Rem J, Meisner C, et al. Prevention of thromboembolic complications with miniheparin-dihydroergotamine in patients undergoing lumbar disc operations. Eur Arch Psychiatry Neurol Sci 1984;234:157&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">6386481</ArticleId></ArticleIdList></Reference><Reference><Citation>Akeda K, Matsunaga H, Imanishi T, et al. Prevalence and countermeasures for venous thromboembolic diseases associated with spinal surgery: a follow-up study of an institutional protocol in 209 patients. Spine 2014;39:791&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">24583727</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Dujaili TM, Majer CN, Madhoun TE, et al. Deep venous thrombosis in spine surgery patients: incidence and hematoma formation. Int Surg 2012;97:150&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3723201</ArticleId><ArticleId IdType="pubmed">23102081</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox JB, Bridger Cox J, Weaver KJ, et al. Decreased incidence of venous thromboembolism after spine surgery with early multimodal prophylaxis. J Neurosurg Spine 2014;4:677&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">25105337</ArticleId></ArticleIdList></Reference><Reference><Citation>Dearborn JT, Hu SS, Tribus CB, et al. Thromboembolic complications after major thoracolumbar spine surgery. Spine 1999;24:1471&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">10423793</ArticleId></ArticleIdList></Reference><Reference><Citation>Epstein NE. A review of the risks and benefits of differing prophylaxis regimens for the treatment of deep venous thrombosis and pulmonary embolism in neurosurgery. Surg Neurol 2005;64:295&#x2013;301.</Citation><ArticleIdList><ArticleId IdType="pubmed">16181995</ArticleId></ArticleIdList></Reference><Reference><Citation>Epstein NE. Efficacy of pneumatic compression stocking prophylaxis in the prevention of deep venous thrombosis and pulmonary embolism following 139 lumbar laminectomies with instrumented fusions. J Spinal Disord Tech 2006;19:28&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">16462215</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohl JB, Lee JY, Rayappa SP, et al. Prevalence of venous thromboembolic events after elective major thoracolumbar degenerative spine surgery. J Spinal Disord Tech 2015;28:E310&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">23511649</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicol M, Sun Y, Craig N, et al. Incidence of thromboembolic complications in lumbar spinal surgery in 1,111 patients. Eur Spine J 2009;18:1548&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2899370</ArticleId><ArticleId IdType="pubmed">19484271</ArticleId></ArticleIdList></Reference><Reference><Citation>Pateder DB, Gonzales RA, Kebaish KM, et al. Pulmonary embolism after adult spinal deformity surgery. Spine 2008;33:301&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">18303463</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizas C, Neumayer F, Kosmopoulos V. Incidence and management of pulmonary embolism following spinal surgery occurring while under chemical thromboprophylaxis. Eur Spine J 2008;17:970&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2443263</ArticleId><ArticleId IdType="pubmed">18421483</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith MD, Bressler EL, Lonstein JE, et al. Deep venous thrombosis and pulmonary embolism after major reconstructive operations on the spine. A prospective analysis of three hundred and seventeen patients. J Bone Joint Surg Am 1994;76:980&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">8027126</ArticleId></ArticleIdList></Reference><Reference><Citation>Strom RG, Frempong-Boadu AK. Low-molecular-weight heparin prophylaxis 24 to 36&#x200a;hours after degenerative spine surgery: risk of hemorrhage and venous thromboembolism. Spine 2013;38:E1498&#x2013;502.</Citation><ArticleIdList><ArticleId IdType="pubmed">23873245</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi H, Yokoyama Y, Iida Y, et al. Incidence of venous thromboembolism after spine surgery. J Orthop Sci 2012;17:114&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">22222443</ArticleId></ArticleIdList></Reference><Reference><Citation>Tominaga H, Setoguchi T, Tanabe F, et al. Risk factors for venous thromboembolism after spine surgery. Medicine 2015;94:e466.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4602703</ArticleId><ArticleId IdType="pubmed">25654385</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshioka K, Murakami H, Demura S, et al. Prevalence and risk factors for development of venous thromboembolism after degenerative spinal surgery. Spine 2015;40:E301&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">25494320</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhi-jian S, Yu Z, Giu-xing Q, et al. Efficacy and safety of low molecular weight heparin prophylaxis for venous thromboembolism following lumbar decompression surgery. Chin Med Sci J 2011;26:221&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">22218049</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerlach R, Raabe A, Beck J, et al. Postoperative nadroparin administration for prophylaxis of thromboembolic events is not associated with an increased risk of hemorrhage after spinal surgery. Eur Spine J 2004;13:9&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3468029</ArticleId><ArticleId IdType="pubmed">14615928</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S-D, Liu H, Sun Y-P, et al. Prevalence and risk factors of deep vein thrombosis in patients after spine surgery: a retrospective case-cohort study. Sci Rep 2015. 5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4488742</ArticleId><ArticleId IdType="pubmed">26135271</ArticleId></ArticleIdList></Reference><Reference><Citation>Piasecki DP, Poynton AR, Mintz DN, et al. Thromboembolic disease after combined anterior/posterior reconstruction for adult spinal deformity: a prospective cohort study using magnetic resonance venography. Spine 2008;33:668&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">18344861</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamasaki K, Hoshino M, Omori K, et al. Prevalence and risk factors of deep vein thrombosis in patients undergoing lumbar spine surgery. J Orthop Sci 2017;22:1021&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">28818570</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber B, Seal A, McGirr J, et al. Case series of elective instrumented posterior lumbar spinal fusions demonstrating a low incidence of venous thromboembolism. ANZ J Surg 2016;86:796&#x2013;800.</Citation><ArticleIdList><ArticleId IdType="pubmed">24897952</ArticleId></ArticleIdList></Reference><Reference><Citation>McLynn RP, Diaz-Collado PJ, Ottesen TD, et al. Risk factors and pharmacologic prophylaxis for venous thromboembolism in elective spine surgery. Spine J 2018;8:970&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">29056565</ArticleId></ArticleIdList></Reference><Reference><Citation>Fawi HMT, Saba K, Cunningham A, et al. Venous thromboembolism in adult elective spinal surgery: a tertiary centre review of 2181 patients. Bone Joint J 2017;99-B:1204&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">28860401</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S-D, Ding W-Y, Yang D-L, et al. Prevalence and risk factors of deep vein thrombosis in patients undergoing lumbar interbody fusion surgery: a single-center cross-sectional study. Medicine 2015;94:e2205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4674212</ArticleId><ArticleId IdType="pubmed">26632909</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y, Zou Z, Jia L, et al. Safety and effectiveness of argatroban versus heparin for preventing venous thromboembolism after lumbar decompressive surgery. Int J Surg 2017;44:324&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">28694001</ArticleId></ArticleIdList></Reference><Reference><Citation>Catre MG. Anticoagulation in spinal surgery. A critical review of the literature. Can J Surg 1997;40:413&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3950029</ArticleId><ArticleId IdType="pubmed">9416250</ArticleId></ArticleIdList></Reference><Reference><Citation>Glotzbecker MP, Bono CM, Wood KB, et al. Postoperative spinal epidural hematoma: a systematic review. Spine 2010;35:E413&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">20431474</ArticleId></ArticleIdList></Reference><Reference><Citation>Sansone JM, del Rio AM, Anderson PA. The prevalence of and specific risk factors for venous thromboembolic disease following elective spine surgery. J Bone Joint Surg Am 2010;92:304&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">20124056</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster JM, Fischer D, Dettori JR. Is chemical antithrombotic prophylaxis effective in elective thoracolumbar spine surgery? Results of a systematic review. Evid Based Spine Care J 2010;1:40&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3623098</ArticleId><ArticleId IdType="pubmed">23637666</ArticleId></ArticleIdList></Reference><Reference><Citation>Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:381S&#x2013;453S.</Citation><ArticleIdList><ArticleId IdType="pubmed">18574271</ArticleId></ArticleIdList></Reference><Reference><Citation>Venous thromboembolism: reducing the risk: reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital [CG92]. NICE; n.d. https://www.nice.org.uk/guidance/CG92/uptake [access December 31, 2018].</Citation><ArticleIdList><ArticleId IdType="pubmed">23346611</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38580159</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>20</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-6809</ISSN><JournalIssue CitedMedium="Internet"><Volume>80</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of vascular surgery</Title><ISOAbbreviation>J Vasc Surg</ISOAbbreviation></Journal><ArticleTitle>Prevalence, characteristics, evaluation, and management of carotid body tumors: Systematic analysis based on available evidence.</ArticleTitle><Pagination><StartPage>574</StartPage><EndPage>585.e4</EndPage><MedlinePgn>574-585.e4</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jvs.2024.03.443</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0741-5214(24)00930-3</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Although carotid body tumors (CBTs) are rare, they attract particular attention because of their propensity for malignant transformation and the high surgical risk. Because data are scarce and as it is difficult to achieve a large sample size, no study has yet comprehensively analyzed the characteristics, management, or operative complications of CBTs. Therefore, we collected and analyzed all currently available information on CBTs and used the pooled data to derive quantitative information on disease characteristics and management.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We systematically searched PubMed, Embase, the Cochrane Library, and the Web of Science up to December 1, 2022, for studies that investigated the characteristics and management of CBTs. The primary objective was to identify the prevalence of the various characteristics and the incidence of complications. The secondary objective was to compare patients who underwent preoperative embolization (PE) and those who did not (non-PE), as well as to compare patients with different Shamblin grades and those with and without succinate dehydrogenase (SDH) mutations in terms of CBT characteristics and complications. Two reviewers selected studies for inclusion and independently extracted data. All statistical analyses were performed using the standard statistical procedures of Review Manager 5.2 and Stata 12.0.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 155 studies with 9291 patients and 9862 tumors were identified. The pooled results indicated that the median age of patients with CBT was 45.72&#xa0;years, and 65% were female. The proportion of patients with bilateral lesions was 13%. In addition, 16% of patients had relevant family histories, and the proportion of those with SDH gene mutations was 36%. Sixteen percent of patients experienced multiple paragangliomas, and 12% of CBTs had catecholamine function. The incidence of cranial nerve injury (CNI) was 27%, and 14% of patients suffered from permanent CNI. The incidence rates of operative mortality and stroke were both 1%, and 4% of patients developed transient ischemic attacks. Of all CBTs, 6% were malignant or associated with metastases or recurrences. The most common metastatic locations were the lymph nodes (3%) and bone (3%), followed by the lungs (2%). Compared with non-PE, PE reduced the estimated blood loss (standardized mean difference,&#xa0;-0.95; 95% confidence interval [CI],&#xa0;-1.70 to&#xa0;-0.20) and the operation time (standardized mean difference,&#xa0;-0.56; 95% CI,&#xa0;-1.03 to&#xa0;-0.09), but it increased the incidence of stroke (odds ratio, 2.44; 95% CI, 1.04-5.73). Higher Shamblin grade tumors were associated with more operative complications. Patients who were SDH gene mutation-positive were more likely to have a relevant family history and had more symptoms.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">CBT was most common in middle-aged females, and early surgical resection was feasible; there was a low incidence of serious operative complications. Routine PE is not recommended because this may increase the incidence of stroke, although PE somewhat reduced the estimated blood loss and operation time. Higher Shamblin grade tumors increased the incidence of operative complications. Patients who were SDH gene mutation-positive had the most relevant family histories and symptoms.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yong-Hong</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Qinghai University Affiliated Hospital, Xi'ning, China; Medical College of Qinghai University, Qinghai University, Xi'ning, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Jia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Qinghai University Affiliated Hospital, Xi'ning, China; Medical College of Qinghai University, Qinghai University, Xi'ning, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Qinghai University Affiliated Hospital, Xi'ning, China; Medical College of Qinghai University, Qinghai University, Xi'ning, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Jun-Jie</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Qinghai University Affiliated Hospital, Xi'ning, China; Medical College of Qinghai University, Qinghai University, Xi'ning, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Kai</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Qinghai University Affiliated Hospital, Xi'ning, China; Medical College of Qinghai University, Qinghai University, Xi'ning, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Anguo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Qinghai University Affiliated Hospital, Xi'ning, China; Medical College of Qinghai University, Qinghai University, Xi'ning, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Jian-Ying</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Qinghai University Affiliated Hospital, Xi'ning, China; Medical College of Qinghai University, Qinghai University, Xi'ning, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Ji-Hai</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Qinghai University Affiliated Hospital, Xi'ning, China; Medical College of Qinghai University, Qinghai University, Xi'ning, China. Electronic address: quah_cvs2019@yeah.net.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Vasc Surg</MedlineTA><NlmUniqueID>8407742</NlmUniqueID><ISSNLinking>0741-5214</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002345" MajorTopicYN="Y">Carotid Body Tumor</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004621" MajorTopicYN="Y">Embolization, Therapeutic</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Carotid body tumor</Keyword><Keyword MajorTopicYN="N">Characteristics</Keyword><Keyword MajorTopicYN="N">Evaluation</Keyword><Keyword MajorTopicYN="N">Management</Keyword><Keyword MajorTopicYN="N">Prevalence</Keyword></KeywordList><CoiStatement>Disclosures None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>21</Day><Hour>15</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>6</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>5</Day><Hour>19</Hour><Minute>24</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38580159</ArticleId><ArticleId IdType="doi">10.1016/j.jvs.2024.03.443</ArticleId><ArticleId IdType="pii">S0741-5214(24)00930-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36960630</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>01</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1305-3612</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>31</Day></PubDate></JournalIssue><Title>Diagnostic and interventional radiology (Ankara, Turkey)</Title><ISOAbbreviation>Diagn Interv Radiol</ISOAbbreviation></Journal><ArticleTitle>Inferior vena cava filter retrievals using advanced techniques: a systematic review.</ArticleTitle><Pagination><StartPage>500</StartPage><EndPage>508</EndPage><MedlinePgn>500-508</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4274/dir.2022.22908</ELocationID><Abstract><AbstractText>This study aimed to assess the safety of complex inferior vena cava (IVC) filter retrieval techniques through a systematic review of published literature. Using PubMed, a systematic review was conducted in line with the 2020 Preferred Reporting Items for Systematic Review and Meta-Analysis guidelines to identify articles published through April 2020 that reported on complex IVC filter retrieval techniques in &gt;5 patients. Case reports, review papers, and studies that did not report on primary outcomes or variables of interest were excluded. Risk of bias was assessed using a modified Newcastle-Ottawa Quality Assessment scale. Pooled success and complication rates were calculated for the overall number of complex retrieval attempts as well as for each filter type and each complex retrieval method. Sixteen fair-quality and three good-quality studies met the inclusion criteria, with 758 patients (428 female) who had undergone 770 advanced retrieval attempts. The mean age of the patients was 46.5 &#xb1; 7.1 years (range: 14.1-90), and the mean dwell time was 602.5 &#xb1; 388.6 days (range: 5-7336). Regarding filters, 92.6% (702/758) were retrievable and 7.4% (56/758) were permanent. Indications for complex retrieval included the failure of standard retrieval (89.2%; 676/758) and tilting or embedding in the caval wall (53.8%; 408/758); 92.6% (713/770) of the advanced retrieval attempts were successful. The pooled success rate was 92.0% (602/654) for retrievable filters and 96.4% (53/55) for permanent filters (<i>P</i> = 0.422). Only 2.8% (21/758) of patients experienced major complications, and the major complication rate was not significantly associated with filter type (<i>P</i> = 0.183). Advanced techniques for IVC filter retrieval appear safe for the retrieval of retrievable filters and certain permanent filters, with a low short-term major complication rate. Further studies on complex retrieval techniques used to remove permanent filters should be conducted to clarify their safety with respect to filter type.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kethidi</LastName><ForeName>Nikhit</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-1417-201X</Identifier><AffiliationInfo><Affiliation>Department of Radiology, Division of Vascular and Interventional Radiology, Rutgers New Jersey Medical School, Newark, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barsoum</LastName><ForeName>Kyrollos</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-0338-1307</Identifier><AffiliationInfo><Affiliation>Department of Radiology, Division of Vascular and Interventional Radiology, Rutgers New Jersey Medical School, Newark, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shukla</LastName><ForeName>Pratik A</ForeName><Initials>PA</Initials><Identifier Source="ORCID">0000-0003-3926-1868</Identifier><AffiliationInfo><Affiliation>Department of Radiology, Division of Vascular and Interventional Radiology, Rutgers New Jersey Medical School, Newark, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Abhishek</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-0134-2857</Identifier><AffiliationInfo><Affiliation>Department of Radiology, Division of Vascular and Interventional Radiology, Rutgers New Jersey Medical School, Newark, NJ, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Turkey</Country><MedlineTA>Diagn Interv Radiol</MedlineTA><NlmUniqueID>101241152</NlmUniqueID><ISSNLinking>1305-3825</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016306" MajorTopicYN="Y">Vena Cava Filters</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020878" MajorTopicYN="N">Device Removal</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014682" MajorTopicYN="N">Vena Cava, Inferior</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Advanced filter retrieval</Keyword><Keyword MajorTopicYN="N">complex filter retrieval</Keyword><Keyword MajorTopicYN="N">pulmonary embolism</Keyword><Keyword MajorTopicYN="N">thromboembolism</Keyword><Keyword MajorTopicYN="N">venous thromboembolism</Keyword></KeywordList><CoiStatement>
<b>Conflict of interest disclosure</b>
. The authors declared no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>24</Day><Hour>3</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36960630</ArticleId><ArticleId IdType="pmc">PMC10679615</ArticleId><ArticleId IdType="doi">10.4274/dir.2022.22908</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Decousus H, Leizorovicz A, Parent F, et al Pr&#xe9;vention du Risque d&#x2019;Embolie Pulmonaire par Interruption Cave Study Group. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N Engl J Med. 1998;338(7):409&#x2013;416.</Citation><ArticleIdList><ArticleId IdType="pubmed">9459643</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy S, Lakhter V, Zack CJ, Zhao H, Chatterjee S, Bashir R. Association between contemporary trends in inferior vena cava filter placement and the 2010 US Food and Drug Administration Advisory. JAMA Int Med. 2017;177(9):1373&#x2013;1374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5818830</ArticleId><ArticleId IdType="pubmed">28692712</ArticleId></ArticleIdList></Reference><Reference><Citation>Endovascular Today. (2014, May 7). FDA Updates Safety Communication on IVC Filter Retrieval. [Internet]</Citation></Reference><Reference><Citation>Brown JD, Raissi D, Han Q, Adams VR, Talbert JC. Vena cava filter retrieval rates and factors associated with retrieval in a large US cohort. J Am Heart Assoc. 2017;6(9):e006708.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5634307</ArticleId><ArticleId IdType="pubmed">28871041</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed O, Wadhwa V, Patel K, Patel MV, Turba UC, Arslan B. Rising retrieval rates of inferior vena cava filters in the United States: insights from the 2012 to 2016 Summary Medicare Claims Data. J Am Coll Rad. 2018;15(11):1553&#x2013;1557.</Citation><ArticleIdList><ArticleId IdType="pubmed">29606636</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray CE Jr, Mitchell E, Zipser S, Kao EY, Brown CF, Moneta GL. Outcomes with retrievable inferior vena cava filters: a multicenter study. J Vasc Interv Radiol. 2006;17(10):1595&#x2013;1604.</Citation><ArticleIdList><ArticleId IdType="pubmed">17057000</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenthal D, Wellons ED, Levitt AB, Shuler FW, O&#x2019;Conner RE, Henderson VJ. Role of Prophylactic Temporary Inferior Vena Cava Filters Placed at the ICU bedside under intravascular ultrasound guidance in patients with multiple trauma. J Vasc Surg. 2004;40(5):958&#x2013;964.</Citation><ArticleIdList><ArticleId IdType="pubmed">15557911</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo WT, Cupp JS, Louie JD, et al. Complex Retrieval of Embedded IVC filters: alternative techniques and histologic tissue analysis. Cardiovasc Interv Radiol. 2012;35(3):588&#x2013;597.</Citation><ArticleIdList><ArticleId IdType="pubmed">21562933</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan - a Web and Mobile app for systematic reviews. Syst Rev. 2016;5(1):210.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5139140</ArticleId><ArticleId IdType="pubmed">27919275</ArticleId></ArticleIdList></Reference><Reference><Citation>Dowell JD, Wagner D, Elliott E, Yildiz VO, Pan X. Factors associated with advanced inferior vena cava filter removals: a single-center retrospective study of 203 patients over 7 years. Cardiovasc Intervent Radiol. 2016;39(2):218&#x2013;226.</Citation><ArticleIdList><ArticleId IdType="pubmed">26662292</ArticleId></ArticleIdList></Reference><Reference><Citation>Posham R, Fischman AM, Nowakowski FS, et al. Transfemoral filter eversion technique following unsuccessful retrieval of option inferior vena cava filters: a single center experience. J Vasc Interv Radiol. 2017;28(6):889&#x2013;894.</Citation><ArticleIdList><ArticleId IdType="pubmed">28532748</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavropoulos SW, Ge BH, Mondschein JI, et al. Retrieval of tip-embedded inferior vena cava filters by using the endobronchial forceps technique: experience at a single institution. Radiology. 2015;275(3):900&#x2013;907.</Citation><ArticleIdList><ArticleId IdType="pubmed">25581368</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacks D, McClenny TE, Cardella JF, Lewis CA. Society of Interventional Radiology Clinical Practice guidelines. J Vasc Interv Radiol. 2003;14(9 Pt 2):199&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pubmed">14514818</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam MD, Spain J, Lieber M, Geisinger M, Sands MJ, Wang W. Fracture and distant migration of the bard recovery filter: a retrospective review of 363 implantations for potentially life-threatening complications. J Vasc Interv Radiol. 2012;23(2):199&#x2013;205.</Citation><ArticleIdList><ArticleId IdType="pubmed">22188776</ArticleId></ArticleIdList></Reference><Reference><Citation>Trerotola SO, Stavropoulos SW. Management of fractured inferior vena cava filters: outcomes by fragment location. Radiology. 2017;284(3):887&#x2013;896.</Citation><ArticleIdList><ArticleId IdType="pubmed">28421970</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavri S, Patel IJ, Kavali P, Irani Z, Ganguli S, Walker TG. Endobronchial forceps-assisted complex retrieval of inferior vena cava filters. J Vasc Surg Venous Lymphat Disord. 2019;7(3):413&#x2013;419.</Citation><ArticleIdList><ArticleId IdType="pubmed">30477980</ArticleId></ArticleIdList></Reference><Reference><Citation>Brahmandam A, Skrip L, Mojibian H, et al. Costs and complications of endovascular inferior vena cava filter retrieval. J Vasc Surg Venous Lymphat Disord. 2019;7(5):653&#x2013;659.</Citation><ArticleIdList><ArticleId IdType="pubmed">31307952</ArticleId></ArticleIdList></Reference><Reference><Citation>Chick JF, Stavropoulos SW, Shin BJ, et al. A 16-F sheath with endobronchial forceps improves reported retrieval success of long-dwelling &#x201c;closed cell&#x201d; inferior vena cava filter designs. J Vasc Interv Radiol. 2016;27(7):1027&#x2013;1033.</Citation><ArticleIdList><ArticleId IdType="pubmed">27241396</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo WT, Odegaard JI, Louie JD, et al. Photothermal ablation with the excimer laser sheath technique for embedded inferior vena cava filter removal: initial results from a prospective study. J Vasc Interv Radiol. 2011;22(6):813&#x2013;823.</Citation><ArticleIdList><ArticleId IdType="pubmed">21530309</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo WT, Odegaard JI, Rosenberg JK, Hofmann LV. Excimer laser-assisted removal of embedded inferior vena cava filters: a single-center prospective study. Circ Cardiovasc Interv. 2013;6(5):560&#x2013;566.</Citation><ArticleIdList><ArticleId IdType="pubmed">24065445</ArticleId></ArticleIdList></Reference><Reference><Citation>Mintz JD, Stavropoulos SW, Trerotola SO. Is a venacavogram necessary after inferior vena cava filter retrieval? J Vasc Interv Radiol. 2016;27(12):1857&#x2013;1864.</Citation><ArticleIdList><ArticleId IdType="pubmed">26460235</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavropoulos SW, Dixon RG, Burke CT, et al. Embedded inferior vena cava filter removal: use of endobronchial forceps. J Vasc Interv Radiol. 2008;19(9):1297&#x2013;1301.</Citation><ArticleIdList><ArticleId IdType="pubmed">18725092</ArticleId></ArticleIdList></Reference><Reference><Citation>Moriarty HK, Marshall E, Clements W. A 7-year retrospective review of the technical success of the &#x201c;low-profile&#x201d; hangman technique for complicated inferior vena cava (IVC) filter retrievals. Diagn Interv Radiol. 2020;26(2):118&#x2013;123.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7051261</ArticleId><ArticleId IdType="pubmed">32071027</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hakim R, McWilliams JP, Derry W, Kee ST. The hangman technique: a modified loop snare technique for the retrieval of inferior vena cava filters with embedded hooks. J Vasc Interv Radiol. 2015;26(1):107&#x2013;110.</Citation><ArticleIdList><ArticleId IdType="pubmed">25541448</ArticleId></ArticleIdList></Reference><Reference><Citation>Avery A, Stephens M, Redmond K, Harper J. Initial experience using the rigid forceps technique to remove wall-embedded IVC filters. J Med Imaging Radiat Oncol. 2015;59(3):306&#x2013;311.</Citation><ArticleIdList><ArticleId IdType="pubmed">25754369</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo WT, Tong RT, Hwang GL, et al. High-risk retrieval of adherent and chronically implanted IVC filters: techniques for removal and management of thrombotic complications. J Vasc Interv Radiol. 2009;20(12):1548&#x2013;1556.</Citation><ArticleIdList><ArticleId IdType="pubmed">19864160</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynch FC. Balloon-assisted removal of tilted inferior vena cava filters with embedded Tips. J Vasc Interv Radiol. 2009;20(9):1210&#x2013;1214.</Citation><ArticleIdList><ArticleId IdType="pubmed">19729132</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo WT, Odegaard JI, Rosenberg JK, Hofmann LV. Laser-assisted removal of embedded vena cava filters: a 5-year first-in-human study. Chest. 2017;151(2):417&#x2013;424.</Citation><ArticleIdList><ArticleId IdType="pubmed">27729265</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamrazi A, Wadhwa V, Holly B, et al. Percutaneous retrieval of permanent inferior vena cava filters. Cardiovasc Intervent Radiol. 2016;39(4):538&#x2013;546.</Citation><ArticleIdList><ArticleId IdType="pubmed">26486152</ArticleId></ArticleIdList></Reference><Reference><Citation>Doody O, No&#xeb; G, Given MF, Foley PT, Lyon SM. Assessment of snared-loop technique when standard retrieval of inferior vena cava filters fails. Cardiovasc Intervent Radiol. 2009;32(1):145&#x2013;149.</Citation><ArticleIdList><ArticleId IdType="pubmed">18839244</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed O, Kim YJ, Patel MV, et al. A Single-institutional comparative analysis of advanced versus standard snare removal of inferior vena cava filters. J Vasc Interv Radiol. 2020;31(1):53&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">31734075</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Q, Ding X, Dong Z, Liu Y, Li G, Jiang J. A modified loop snare technique for difficult retrievals of inferior vena cava filter and migrated coil. Int Heart J. 2019;60(1):93&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">30518716</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo WT, Bostaph AS, Loh CT, Frisoli JK, Kee ST. Retrieval of trapped G&#xfc;nther Tulip inferior vena cava filters: snare-over-guide wire loop technique. J Vasc Interv Radiol. 2006;17(11 Pt 1):1845&#x2013;1849.</Citation><ArticleIdList><ArticleId IdType="pubmed">17142717</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho E, Lim KJ, Jo JH, Jung GS, Park BH. Failed inferior vena cava filter retrieval by conventional method: analysis of its causes and retrieval of it by modified double-loop technique. Phlebology. 2015;30(8):549&#x2013;556.</Citation><ArticleIdList><ArticleId IdType="pubmed">25096757</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo WT, Cupp JS. The excimer laser sheath technique for embedded inferior vena cava filter removal. J Vasc Interv Radiol. 2010;21(12):1896&#x2013;1899.</Citation><ArticleIdList><ArticleId IdType="pubmed">21050774</ArticleId></ArticleIdList></Reference><Reference><Citation>Du X, Li C, Qian A, et al. Bidirectional pull-back technique for retrieval of strut-embedded cylinder-shaped filters in inferior vena cava. Med Sci Monit. 2017;23:2796&#x2013;2804.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5473375</ArticleId><ArticleId IdType="pubmed">28596513</ArticleId></ArticleIdList></Reference><Reference><Citation>Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in metaanalyses. Eur J Epidemiol. 2010;25(9):603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pubmed">20652370</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartling L, Milne A, Hamm MP, et al. Testing the Newcastle Ottawa scale showed low reliability between individual reviewers. J Clin Epidemiol. 2013;66(9):982&#x2013;993.</Citation><ArticleIdList><ArticleId IdType="pubmed">23683848</ArticleId></ArticleIdList></Reference><Reference><Citation>Brahmandam A, Skrip L, Sumpio B, et al. A survey of vascular specialists&#x2019; practice patterns of inferior vena cava filter placement and retrieval. Vascular. 2019;27(3):291&#x2013;298.</Citation><ArticleIdList><ArticleId IdType="pubmed">30501583</ArticleId></ArticleIdList></Reference><Reference><Citation>Minocha J, Idakoji I, Riaz A, et al. Improving inferior vena cava filter retrieval rates: impact of a dedicated inferior vena cava filter clinic. J Vasc Interv Radiol. 2010;21(12):1847&#x2013;1851.</Citation><ArticleIdList><ArticleId IdType="pubmed">21035356</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo WT, Robertson SW, Odegaard JI, Hofmann LV. Complex retrieval of fractured, embedded, and penetrating inferior vena cava filters: a prospective study with histologic and electron microscopic analysis. J Vasc Interv Radiol. 2013;24(5):622&#x2013;630.</Citation><ArticleIdList><ArticleId IdType="pubmed">23523157</ArticleId></ArticleIdList></Reference><Reference><Citation>Lian W, Tian F, Li S, Gu X, Jia Z. Forceps-assisted removal of difficult-to-retrieve filters: preliminary results. Ann Vasc Surg. 2019;61:371&#x2013;376.</Citation><ArticleIdList><ArticleId IdType="pubmed">31394218</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27975103</PMID><DateCompleted><Year>2018</Year><Month>02</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2567-689X</ISSN><JournalIssue CitedMedium="Internet"><Volume>117</Volume><Issue>2</Issue><PubDate><Year>2017</Year><Month>Jan</Month><Day>26</Day></PubDate></JournalIssue><Title>Thrombosis and haemostasis</Title><ISOAbbreviation>Thromb Haemost</ISOAbbreviation></Journal><ArticleTitle>Reasons for the persistent incidence of venous thromboembolism.</ArticleTitle><Pagination><StartPage>390</StartPage><EndPage>400</EndPage><MedlinePgn>390-400</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1160/TH16-07-0509</ELocationID><Abstract><AbstractText>Reasons for trends in venous thromboembolism (VTE) incidence are uncertain. It was our objective to determine VTE incidence trends and risk factor prevalence, and estimate population-attributable risk (PAR) trends for each risk factor. In a population-based cohort study of all residents of Olmsted County, Minnesota from 1981-2010, annual incidence rates were calculated using incident VTE cases as the numerator and age- and sex-specific Olmsted County population estimates as the denominator. Poisson regression models were used to assess the relationship of crude incidence rates to year of diagnosis, age at diagnosis, and sex. Trends in annual prevalence of major VTE risk factors were estimated using linear regression. Poisson regression with time-dependent risk factors (person-years approach) was used to model the entire population of Olmsted County and derive the PAR. The age- and sex-adjusted annual VTE incidence, 1981-2010, did not change significantly. Over the time period, 1988-2010, the prevalence of obesity, surgery, active cancer and leg paresis increased. Patient age, hospitalisation, surgery, cancer, trauma, leg paresis and nursing home confinement jointly accounted for 79&#x2009;% of incident VTE; obesity accounted for 33&#x2009;% of incident idiopathic VTE. The increasing prevalence of obesity, cancer and surgery accounted in part for the persistent VTE incidence. The PAR of active cancer and surgery, 1981-2010, significantly increased. In conclusion, almost 80&#x2009;% of incident VTE events are attributable to known major VTE risk factors and one-third of incident idiopathic VTE events are attributable to obesity. Increasing surgery PAR suggests that concurrent efforts to prevent VTE may have been insufficient.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Heit</LastName><ForeName>John A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>John A. Heit, MD, Stabile 6-Hematology Research, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA, Tel.: +1 507 284 4634, Fax: +1 507 266 9302, E-mail: heit.john@mayo.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ashrani</LastName><ForeName>Aneel</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Crusan</LastName><ForeName>Daniel J</ForeName><Initials>DJ</Initials></Author><Author ValidYN="Y"><LastName>McBane</LastName><ForeName>Robert D</ForeName><Initials>RD</Initials></Author><Author ValidYN="Y"><LastName>Petterson</LastName><ForeName>Tanya M</ForeName><Initials>TM</Initials></Author><Author ValidYN="Y"><LastName>Bailey</LastName><ForeName>Kent R</ForeName><Initials>KR</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG034676</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL066216</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>12</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Thromb Haemost</MedlineTA><NlmUniqueID>7608063</NlmUniqueID><ISSNLinking>0340-6245</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Thromb Haemost. 2017 Feb 28;117(3):643. doi: 10.1160/TH1703002.</RefSource><PMID Version="1">28245032</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017677" MajorTopicYN="N">Age Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016014" MajorTopicYN="N">Linear Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008910" MajorTopicYN="N">Minnesota</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017678" MajorTopicYN="N">Sex Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="N">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Venous thrombosis</Keyword><Keyword MajorTopicYN="N">epidemiology</Keyword><Keyword MajorTopicYN="N">phlebitis</Keyword><Keyword MajorTopicYN="N">pulmonary embolism</Keyword><Keyword MajorTopicYN="N">thrombophlebitis</Keyword></KeywordList><CoiStatement><b>Disclosures</b>. Dr. Heit declares no conflict of interest. Dr. Ashrani declares no conflict of interest. Mr. Crusan declares no conflict of interest. Ms. Petterson declares no conflict of interest. Dr. Bailey declares no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>7</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>10</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>12</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>12</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>1</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27975103</ArticleId><ArticleId IdType="mid">NIHMS903702</ArticleId><ArticleId IdType="pmc">PMC5597250</ArticleId><ArticleId IdType="doi">10.1160/TH16-07-0509</ArticleId><ArticleId IdType="pii">16-07-0509</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>The Surgeon General&#x2019;s Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism. U.S. Public Health Service 2008. U.S. Department of Health and Human Services. 2008</Citation></Reference><Reference><Citation>Shojania K, Duncan B, McDonald K-SU, Wachter R. Making Health Care Safer: A Critical Analysis of Patient Safety
Practices: UCSF-Stanford Evidence-Based Practice Center. Agency for Healthcare Research and Quality. 2001 Jul 20; Publication no. 01-E058, Evidence report no. 43.  www.ahrq.gov/clinic/ptsafety/summary/htm; 2001.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4781305</ArticleId><ArticleId IdType="pubmed">11510252</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn SR, Lim W, Dunn AS, Cushman M, Dentali F, Akl EA, Cook DJ, Balekian AA, Klein RC, Le H, Schulman S, Murad MH. Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e195S&#x2013;226S.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3278052</ArticleId><ArticleId IdType="pubmed">22315261</ArticleId></ArticleIdList></Reference><Reference><Citation>Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA, Samama CM. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e227S&#x2013;277S.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3278061</ArticleId><ArticleId IdType="pubmed">22315263</ArticleId></ArticleIdList></Reference><Reference><Citation>Falck-Ytter Y, Francis CW, Johanson NA, Curley C, Dahl OE, Schulman S, Ortel TL, Pauker SG, Colwell CW., Jr Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e278S&#x2013;325S.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3278063</ArticleId><ArticleId IdType="pubmed">22315265</ArticleId></ArticleIdList></Reference><Reference><Citation>Naess IA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR, Hammerstrom J. Incidence and mortality of venous thrombosis: A population-based study. J Thromb Haemost. 2007;5:692&#x2013;699.</Citation><ArticleIdList><ArticleId IdType="pubmed">17367492</ArticleId></ArticleIdList></Reference><Reference><Citation>DeMonaco NA, Dang Q, Kapoor WN, Ragni MV. Pulmonary embolism incidence is increasing with use of spiral computed tomography. Am J Med. 2008;121:611&#x2013;617.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2711635</ArticleId><ArticleId IdType="pubmed">18589057</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiener RS, Schwartz LM, Woloshin S. Time trends in pulmonary embolism in the United States: Evidence of overdiagnosis. Archives of Internal Medicine. 2011;171:831&#x2013;837.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3140219</ArticleId><ArticleId IdType="pubmed">21555660</ArticleId></ArticleIdList></Reference><Reference><Citation>Tagalakis V, Wharin C, Kahn SR. Comprehensive update on the prevention and treatment of venous thromboembolism in cancer patients. Seminars in Thrombosis and Hemostasis. 2013;39:127&#x2013;140.</Citation><ArticleIdList><ArticleId IdType="pubmed">23386467</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang W, Goldberg RJ, Anderson FA, Kiefe CI, Spencer FA. Secular trends in occurrence of acute venous thromboembolism: The Worcester VTE Study (1985&#x2013;2009) Am J Med. 2014;127:829&#x2013;839. e825.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4161646</ArticleId><ArticleId IdType="pubmed">24813864</ArticleId></ArticleIdList></Reference><Reference><Citation>Melton L. History of the Rochester Epidemiology Project. Mayo Clinic Proceedings. 1996;71:266&#x2013;274.</Citation><ArticleIdList><ArticleId IdType="pubmed">8594285</ArticleId></ArticleIdList></Reference><Reference><Citation>St Sauver JL, Grossardt BR, Yawn BP, Melton LJ, 3rd, Rocca WA. Use of a medical records linkage system to enumerate a dynamic population over time: The Rochester Epidemiology Project. American Journal of Epidemiology. 2011;173:1059&#x2013;1068.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3105274</ArticleId><ArticleId IdType="pubmed">21430193</ArticleId></ArticleIdList></Reference><Reference><Citation>St Sauver JL, Grossardt BR, Leibson CL, Yawn BP, Melton LJ, 3rd, Rocca WA. Generalizability of epidemiological findings and public health decisions: An illustration from the Rochester Epidemiology Project. Mayo Clinic Proceedings. 2012;87:151&#x2013;160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3538404</ArticleId><ArticleId IdType="pubmed">22305027</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ., 3rd Trends in the incidence of deep vein thrombosis and pulmonary embolism: A 25-year population-based study. Archives of Internal Medicine. 1998;158:585&#x2013;593.</Citation><ArticleIdList><ArticleId IdType="pubmed">9521222</ArticleId></ArticleIdList></Reference><Reference><Citation>Heit JA, Melton LJ, 3rd, Lohse CM, Petterson TM, Silverstein MD, Mohr DN, O'Fallon WM. Incidence of venous thromboembolism in hospitalized patients vs community residents. Mayo Clinic Proceedings. 2001;76:1102&#x2013;1110.</Citation><ArticleIdList><ArticleId IdType="pubmed">11702898</ArticleId></ArticleIdList></Reference><Reference><Citation>Heit JA. Venous thromboembolism: Disease burden, outcomes and risk factors. J Thromb Haemost. 2005;3:1611&#x2013;1617.</Citation><ArticleIdList><ArticleId IdType="pubmed">16102026</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurland LT, Molgaard CA. The patient record in epidemiology. Scientific American. 1981;245:54&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">7027437</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashrani AA, Gullerud RE, Petterson TM, Marks RS, Bailey KR, Heit JA. Risk factors for venous thromboembolism among active cancer patients: a population-based case-control study. Thromb Res. 2016;139:29&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4769375</ArticleId><ArticleId IdType="pubmed">26916293</ArticleId></ArticleIdList></Reference><Reference><Citation>Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ., 3rd Risk factors for deep vein thrombosis and pulmonary embolism: A population-based case-control study. Archives of Internal Medicine. 2000;160:809&#x2013;815.</Citation><ArticleIdList><ArticleId IdType="pubmed">10737280</ArticleId></ArticleIdList></Reference><Reference><Citation>Cram&#xe9;r H. Mathematical methods of statistics. Princeton, NJ: Princeton University Press; 1946. p. 353.</Citation></Reference><Reference><Citation>Heit JA, Leibson CL, Ashrani AA, Petterson TM, Bailey KR, Melton LJ., 3rd Is diabetes mellitus an independent risk factor for venous thromboembolism?: A population-based case-control study. Arteriosclerosis, Thrombosis, and Vascular Biology. 2009;29:1399&#x2013;1405.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2735343</ArticleId><ArticleId IdType="pubmed">19542020</ArticleId></ArticleIdList></Reference><Reference><Citation>Spencer FA, Gore JM, Reed G, Lessard D, Pacifico L, Emery C, Crowther MA, Goldberg RJ. Venous thromboembolism and bleeding in a community setting. The Worcester Venous Thromboembolism Study. Thrombosis and Haemostasis. 2009;101:878&#x2013;885.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2827872</ArticleId><ArticleId IdType="pubmed">19404541</ArticleId></ArticleIdList></Reference><Reference><Citation>Cushman M, Tsai AW, White RH, Heckbert SR, Rosamond WD, Enright P, Folsom AR. Deep vein thrombosis and pulmonary embolism in two cohorts: The Longitudinal Investigation of Thromboembolism Etiology. Am J Med. 2004;117:19&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">15210384</ArticleId></ArticleIdList></Reference><Reference><Citation>Palareti G. How I treat isolated distal deep vein thrombosis (IDDVT) Blood. 2014;123(12):1802&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">24472834</ArticleId></ArticleIdList></Reference><Reference><Citation>Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ., 3rd Predictors of survival after deep vein thrombosis and pulmonary embolism: A population-based, cohort study. Archives of Internal Medicine. 1999;159:445&#x2013;453.</Citation><ArticleIdList><ArticleId IdType="pubmed">10074952</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahronheim JC, Bernholc AS, Clark WD. Age trends in autopsy rates. Striking decline in late life. JAMA. 1983;250:1182&#x2013;1186.</Citation><ArticleIdList><ArticleId IdType="pubmed">6876357</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoyert DL. The changing profile of autopsied deaths in the United States, 1972&#x2013;2007. NCHS Data Brief. 2011:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">22142988</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein PD, Matta F, Dalen JE. Is the campaign to prevent VTE in hospitalized patients working? Chest. 2011;139:1317&#x2013;1321.</Citation><ArticleIdList><ArticleId IdType="pubmed">20884726</ArticleId></ArticleIdList></Reference><Reference><Citation>Burge AJ, Freeman KD, Klapper PJ, Haramati LB. Increased diagnosis of pulmonary embolism without a corresponding decline in mortality during the CT era. Clin Radiol. 2008;63:381&#x2013;386.</Citation><ArticleIdList><ArticleId IdType="pubmed">18325357</ArticleId></ArticleIdList></Reference><Reference><Citation>Leibson CL, Needleman J, Buerhaus P, Heit JA, Melton LJ, 3rd, Naessens JM, Bailey KR, Petterson TM, Ransom JE, Harris MR. Identifying in-hospital venous thromboembolism (VTE): A comparison of claims-based approaches with the Rochester Epidemiology Project VTE cohort. Medical Care. 2008;46:127&#x2013;132.</Citation><ArticleIdList><ArticleId IdType="pubmed">18219240</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarrazin MS, Rosenthal GE. Finding pure and simple truths with administrative data. JAMA. 2012;307:1433&#x2013;1435.</Citation><ArticleIdList><ArticleId IdType="pubmed">22474208</ArticleId></ArticleIdList></Reference><Reference><Citation>Haut ER, Pronovost PJ, Schneider EB. Limitations of administrative databases. JAMA. 2012;307:2589. author reply 2589&#x2013;2590.</Citation><ArticleIdList><ArticleId IdType="pubmed">22735421</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashrani AA, Heit JA. Caution on interpreting the time trends in pulmonary embolism as "overdiagnosis". Archives of Internal Medicine. 2011;171:1962. author reply 1962&#x2013;1963.</Citation><ArticleIdList><ArticleId IdType="pubmed">22123814</ArticleId></ArticleIdList></Reference><Reference><Citation>Delluc A, Mottier D, Le Gal G, Oger E, Lacut K. Underweight is associated with a reduced risk of venous thromboembolism. Results from the EDITH case-control study. J Thromb Haemost. 2009;7:728&#x2013;729.</Citation><ArticleIdList><ArticleId IdType="pubmed">19192117</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn SR, Lim W, Dunn AS, Cushman M, Dentali F, Akl EA, Cook DJ, Balekian AA, Klein RC, Le H, Schulman S, Hassan Murad M. Prevention of VTE in nonsurgical patients. Chest. 2012;141(2 suppl):e195S&#x2013;e226S.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3278052</ArticleId><ArticleId IdType="pubmed">22315261</ArticleId></ArticleIdList></Reference><Reference><Citation>Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA, Samama CM. Prevention of VTE in nonorthopedic surgical patients. Chest. 2012;141(2 suppl):e227S&#x2013;e277S.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3278061</ArticleId><ArticleId IdType="pubmed">22315263</ArticleId></ArticleIdList></Reference><Reference><Citation>Falck-Ytter Y, Francis CW, Johanson NA, Curley C, Dahl OE, Schulman S, Ortel TL, Pauker SG, Colwell CW., Jr Prevention of VTE in orthopedic surgery patients. Chest. 2012;141(2 suppl):e278S&#x2013;e325S.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3278063</ArticleId><ArticleId IdType="pubmed">22315265</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39498835</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>05</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1469-493X</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>11</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>05</Day></PubDate></JournalIssue><Title>The Cochrane database of systematic reviews</Title><ISOAbbreviation>Cochrane Database Syst Rev</ISOAbbreviation></Journal><ArticleTitle>Statins for the primary prevention of venous thromboembolism.</ArticleTitle><Pagination><StartPage>CD014769</StartPage><MedlinePgn>CD014769</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">CD014769</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/14651858.CD014769.pub2</ELocationID><Abstract><AbstractText Label="BACKGROUND">Venous thromboembolism (VTE) involves the formation of a blood clot in a vein, and includes deep venous thrombosis (DVT) or pulmonary embolism (PE). The annual incidence for VTE varies from 0.75 to 2.69 per 1000 individuals, with about 40 million people worldwide impacted by VTE. Statins, 3-hydroxy-3-methylglutaryl (HMG)-coenzyme A (CoA) reductase inhibitors, inhibit cholesterol biosynthesis and display several vascular-protective effects, including antithrombotic properties. However, the potential role of statins in the primary prevention of VTE is still not clear.</AbstractText><AbstractText Label="OBJECTIVES">To evaluate the benefits and risks of statins in preventing venous thromboembolism (VTE) in individuals with no prior history of VTE.</AbstractText><AbstractText Label="SEARCH METHODS">We used standard Cochrane search methods. The search was last updated on 13 March 2023.</AbstractText><AbstractText Label="SELECTION CRITERIA">We included randomized controlled trials (RCTs) comparing statins with any control intervention (including placebo and usual care) in healthy individuals or participants with conditions other than VTE. There were no restrictions on the dose, duration, route, or timing of statins.</AbstractText><AbstractText Label="DATA COLLECTION AND ANALYSIS">We used standard Cochrane methods. Our primary outcomes were VTE, DVT, and PE. Our secondary outcomes were serious adverse events, adverse events, and mortality. We used the trial sequential analysis (TSA) method to judge whether the evidence was sufficient, and we used the GRADE approach to assess the certainty of the evidence for each outcome.</AbstractText><AbstractText Label="MAIN RESULTS">We included 27 RCTs involving 122,601 adults (aged 18 years and above) who were healthy, had various medical conditions (e.g. hypercholesterolemia), or were at risk for cardiovascular disease. Both males and females were included in all studies. Two studies focused solely on participants over 60 years of age. We deemed four studies to have a low risk of bias overall, while 19 were at high risk of bias, and four were unclear. The 27 studies compared use of statins versus placebo or usual care in individuals who had never experienced VTE. The statins used in the studies were atorvastatin, rosuvastatin, pravastatin, lovastatin, fluvastatin, and simvastatin. Twenty-three studies followed up participants for over a year, with six of those extending follow-ups for over five years. Twenty-five studies were based in hospitals, and 24 studies were funded by industry. Only one study used VTE as a primary endpoint. The median incidence of VTE in the statins group was 0.72% (ranging from 0% to 10.53%), and in the control group it was 0.89% (ranging from 0% to 6.83%). Our pooled analysis of the 27 studies showed that, relative to control groups, statins may slightly reduce the overall incidence of VTE (odds ratio (OR) 0.86, 95% confidence intervals (CI) 0.76 to 0.98; 27 studies, 122,601 participants; low-certainty evidence). Of the statins we evaluated, only rosuvastatin seemed to be associated with a reduced incidence of VTE, albeit the reduction in incidence was very small. The evidence did not clearly indicate a difference between groups in the incidence of DVT (OR 0.70, 95% CI 0.41 to 1.18; six studies, 40,305 participants; low-certainty evidence), PE (OR 0.83, 95% CI 0.46 to 1.52; five studies, 28,427 participants; low-certainty evidence), or myopathy (OR 1.10, 95% CI 0.83 to 1.45; 10 studies, 75,551 participants; low-certainty evidence). Nonetheless, statin use might slightly decrease the incidence of any serious adverse event (OR 0.95, 95% CI 0.91 to 0.99; 13 studies, 67,020 participants; low-certainty evidence) and any death (OR 0.90, 95% CI 0.86 to 0.95; 24 studies, 116,761 participants; low-certainty evidence), compared to control.</AbstractText><AbstractText Label="AUTHORS' CONCLUSIONS">Using statins for the primary prevention of VTE may slightly reduce the incidence of VTE and all-cause mortality. However, this effect is likely too weak to be considered significant. Statin use may not decrease the occurrence of DVT and PE. The current evidence is insufficient to draw strong conclusions because of the risk of bias in the studies, imprecision in the effect estimates, and potential publication bias. More evidence from well conducted and fully reported RCTs is needed to assess the preventive effects of different types of statins, as well as the effects of different dosages and treatment durations in various populations.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zixin</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Breast Surgery, The Second Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Research Center for Breast Disease, Hunan Province, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Peng</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Pediatric Surgery, The Second Hospital of Nanyang City, Nanyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Jinhui</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou City, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Peizhen</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Maternity and Child-care, Hospital of Lanzhou City, Lanzhou City, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Kehu</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Key Laboratory of Evidence Based Medicine and Knowledge Translation of Gansu Province, Lanzhou University, Lanzhou City, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Lun</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Breast Surgery, The Second Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Research Center for Breast Disease, Hunan Province, Changsha, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cochrane Database Syst Rev</MedlineTA><NlmUniqueID>100909747</NlmUniqueID><ISSNLinking>1361-6137</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019161">Hydroxymethylglutaryl-CoA Reductase Inhibitors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>doi: 10.1002/14651858.CD014769</RefSource></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015982" MajorTopicYN="N">Bias</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019161" MajorTopicYN="Y">Hydroxymethylglutaryl-CoA Reductase Inhibitors</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011322" MajorTopicYN="Y">Primary Prevention</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="Y">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="Y">Venous Thrombosis</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>LL is a surgeon in breast cancer at the Second Xiangya Hospital, Central South University. He received funding from the Changsha Natural Science Foundation (kq2208336), the Hunan Provincial Natural Science Foundation (2023JJ40831; 2023JJ60441), and Scientific Research Launch Project for new employees of the Second Xiangya Hospital of Central South University (2022&#x2010;086). These funds supported this review, but the funders had no role in the design, conduct, or publication of the review update.&#x2028;ZxW: none known&#x2028;PZ is a surgeon at the Second Hospital of Nanyang City. &#x2028;JHT: none known&#x2028;Pz&#x2010;Z: none known&#x2028;KY: none known</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>11</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>5</Day><Hour>19</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>5</Day><Hour>17</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>5</Day><Hour>7</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39498835</ArticleId><ArticleId IdType="pmc">PMC11536507</ArticleId><ArticleId IdType="doi">10.1002/14651858.CD014769.pub2</ArticleId></ArticleIdList><ReferenceList><Title>References to studies included in this review</Title><ReferenceList><Title>Ades 2018 {published data only}</Title><Reference><Citation>Ades S, Douce D, Holmes CE, Cory S, Prior S, Butenas S, et al. Effect of rosuvastatin on risk markers for venous thromboembolism in cancer. Journal of Thrombosis and Haemostasis 2018;16(6):1099-106. [DOI: 10.1111/jth.14004] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14004</ArticleId><ArticleId IdType="pubmed">29575637</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Amarenco 2006 {published data only}</Title><Reference><Citation>Amarenco P, Bogousslavsky J, Callahan A 3rd, Goldstein LB, Hennerici M, Rudolph AE, et al. High-dose atorvastatin after stroke or transient ischemic attack. New England Journal of Medicine 2006;355(6):549-59. [DOI: 10.1056/NEJMoa061894] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa061894</ArticleId><ArticleId IdType="pubmed">16899775</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Asselbergs 2004 {published data only}</Title><Reference><Citation>Asselbergs FW, Diercks GF, Hillege HL, Van Boven AJ, Janssen WM, Voors AA, et al. Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria. Circulation 2004;110(18):2809-16. [DOI: 10.1161/01.CIR.0000146378.65439.7A] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000146378.65439.7A</ArticleId><ArticleId IdType="pubmed">15492322</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Chan 2010 {published data only}</Title><Reference><Citation>Chan KL, Teo K, Dumesnil JG, Ni A, Tam J, ASTRONOMER Investigators. Effect of lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial. Circulation 2010;121(2):306-14. [DOI: 10.1161/CIRCULATIONAHA.109.900027] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.109.900027</ArticleId><ArticleId IdType="pubmed">20048204</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan KL, Teo K, Tam J, Dumesnil JG, Astronomer Investigators. Rationale, design, and baseline characteristics of a randomized trial to assess the effect of cholesterol lowering on the progression of aortic stenosis: the Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin (ASTRONOMER) trial. American Heart Journal 2007;153(6):925-31. [DOI: 10.1016/j.ahj.2007.03.011] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2007.03.011</ArticleId><ArticleId IdType="pubmed">17540192</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Colhoun 2004 {published data only}</Title><Reference><Citation>Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 2004;364(9435):685-96. [DOI: 10.1016/S0140-6736(04)16895-5] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(04)16895-5</ArticleId><ArticleId IdType="pubmed">15325833</ArticleId></ArticleIdList></Reference><Reference><Citation>Colhoun HM, Thomason MJ, Mackness MI, Maton SM, Betteridge DJ, Durrington PN, et al. Design of the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with type 2 diabetes. Diabetic Medicine 2002;19(3):201-11. [DOI: 10.1046/j.1464-5491.2002.00643.x] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1464-5491.2002.00643.x</ArticleId><ArticleId IdType="pubmed">11918622</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Cowell 2005 {published data only}</Title><Reference><Citation>Cowell SJ, Newby DE, Prescott RJ, Bloomfield P, Reid J, Northridge DB, et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. New England Journal of Medicine 2005;352(23):2389-97. [DOI: 10.1056/NEJMoa043876] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa043876</ArticleId><ArticleId IdType="pubmed">15944423</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Crouse 2007 {published data only}</Title><Reference><Citation>Crouse JR 3rd, Grobbee DE, O'Leary DH, Bots ML, Evans GW, Palmer MK, et al. Measuring effects on intima media thickness: an evaluation of rosuvastatin in subclinical atherosclerosis - the rationale and methodology of the METEOR study. Cardiovascular Drugs and Therapy 2004;18(3):231-8. [DOI: 10.1023/B:CARD.0000033645.55138.3d] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/B:CARD.0000033645.55138.3d</ArticleId><ArticleId IdType="pubmed">15229392</ArticleId></ArticleIdList></Reference><Reference><Citation>Crouse JR 3rd, Raichlen JS, Riley WA, Evans GW, Palmer MK, O'Leary DH, et al. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial. Journal of the American Medical Association 2007;297(12):1344-53. [DOI: 10.1001/jama.297.12.1344] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.297.12.1344</ArticleId><ArticleId IdType="pubmed">17384434</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Dinglas 2016 {published data only}</Title><Reference><Citation>Dinglas VD, Hopkins RO, Wozniak AW, et al. One-year outcomes of rosuvastatin versus placebo in sepsis-associated acute respiratory distress syndrome: prospective follow-up of SAILS randomised trial. Thorax 2016;71(5):401-10. [DOI: 10.1136/thoraxjnl-2015-208017] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2015-208017</ArticleId><ArticleId IdType="pmc">PMC6998199</ArticleId><ArticleId IdType="pubmed">26936876</ArticleId></ArticleIdList></Reference><Reference><Citation>Truwit JD, Bernard GR, Steingrub J, Matthay MA, Liu KD, Albertson TE, et al. Rosuvastatin for sepsis-associated acute respiratory distress syndrome. New England Journal of Medicine 2014;370(23):2191-200. [DOI: 10.1056/NEJMoa1401520] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1401520</ArticleId><ArticleId IdType="pmc">PMC4241052</ArticleId><ArticleId IdType="pubmed">24835849</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Downs 1998 {published data only}</Title><Reference><Citation>Downs JR, Beere PA, Whitney E, Clearfield M, Weis S, Rochen J, et al. Design and rationale of the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). American Journal of Cardiology 1997;80(3):287-93. [DOI: 10.1016/s0002-9149(97)00347-0] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0002-9149(97)00347-0</ArticleId><ArticleId IdType="pubmed">9264420</ArticleId></ArticleIdList></Reference><Reference><Citation>Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS (Air Force/Texas Coronary Atherosclerosis Prevention Study). Journal of the American Medical Association 1998;279(20):1615-22. [DOI: 10.1001/jama.279.20.1615] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.279.20.1615</ArticleId><ArticleId IdType="pubmed">9613910</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Fassett 2010 {published data only}</Title><Reference><Citation>Fassett RG, Robertson IK, Ball MJ, Geraghty DP, Coombes JS. Effect of atorvastatin on kidney function in chronic kidney disease: a randomised double-blind placebo-controlled trial. Atherosclerosis 2010;213(1):218-24. [DOI: 10.1016/j.atherosclerosis.2010.07.053] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.atherosclerosis.2010.07.053</ArticleId><ArticleId IdType="pubmed">20810109</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Feldman 2010 {published data only}</Title><Reference><Citation>Feldman HH, Doody RS, Kivipelto M, Sparks DL, Waters DD, Jones RW, et al. Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe. Neurology 2010;74(12):956-64. [DOI: 10.1212/WNL.0b013e3181d6476a] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181d6476a</ArticleId><ArticleId IdType="pubmed">20200346</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones RW, Kivipelto M, Feldman H, Sparks L, Doody R, Waters DD, et al. The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristics. Alzheimer's &amp; Dementia 2008;4(2):145-53. [DOI: 10.1016/j.jalz.2008.02.001] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2008.02.001</ArticleId><ArticleId IdType="pubmed">18631958</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Fellstr&#xf6;m 2004 {published data only}</Title><Reference><Citation>Fellstr&#xf6;m B, Holdaas H, Jardine AG, Holme I, Nyberg G, Fauchald P, et al. Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trial. Kidney International 2004;66(4):1549-55. [DOI: 10.1111/j.1523-1755.2004.00919.x] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1523-1755.2004.00919.x</ArticleId><ArticleId IdType="pubmed">15458450</ArticleId></ArticleIdList></Reference><Reference><Citation>Holdaas H, Fellstr&#xf6;m B, Jardine AG, Holme I, Nyberg G, Fauchald P, et al. Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial. Lancet 2003;361(9374):2024-31. [DOI: 10.1016/S0140-6736(03)13638-0] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(03)13638-0</ArticleId><ArticleId IdType="pubmed">12814712</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Fellstr&#xf6;m 2009 {published data only}</Title><Reference><Citation>Fellstr&#xf6;m BC, Jardine AG, Schmieder RE, et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. New England Journal of Medicine 2009;360(14):1395-407. [DOI: 10.1056/NEJMoa0810177] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0810177</ArticleId><ArticleId IdType="pubmed">19332456</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Freeman 2011 {published data only}</Title><Reference><Citation>Freeman DJ, Robertson M, Brown EA, Rumley A, Tobias ES, Fr&#xf6;lich M, et al. Incident venous thromboembolic events in the prospective study of pravastatin in the elderly at risk (PROSPER). BMC Geriatrics 2011;11:8. [DOI: 10.1186/1471-2318-11-8] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2318-11-8</ArticleId><ArticleId IdType="pmc">PMC3053238</ArticleId><ArticleId IdType="pubmed">21342490</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Glynn 2009 {published data only}</Title><Reference><Citation>Everett BM, Glynn RJ, MacFadyen JG, Ridker PM. Rosuvastatin in the prevention of stroke among men and women with elevated levels of C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER). Circulation 2010;121(1):143-50. [DOI: 10.1161/CIRCULATIONAHA.109.874834] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.109.874834</ArticleId><ArticleId IdType="pubmed">20026779</ArticleId></ArticleIdList></Reference><Reference><Citation>Fonseca FA, Izar MC. Primary prevention of vascular events in patients with high levels of C-reactive protein: the JUPITER study. Expert Review of Cardiovascular Therapy 2009;7(9):1041-56. [DOI: 10.1586/erc.09.93] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/erc.09.93</ArticleId><ArticleId IdType="pubmed">19764857</ArticleId></ArticleIdList></Reference><Reference><Citation>Glynn RJ, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, et al. A randomized trial of rosuvastatin in the prevention of venous thromboembolism. New England Journal of Medicine 2009;360(18):1851-61. [DOI: 10.1056/NEJMoa0900241] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0900241</ArticleId><ArticleId IdType="pmc">PMC2710995</ArticleId><ArticleId IdType="pubmed">19329822</ArticleId></ArticleIdList></Reference><Reference><Citation>Glynn RJ, Koenig W, Nordestgaard BG, Shepherd J, Ridker PM. Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial. Annals of Internal Medicine 2010;152(8):488-96, W174. [DOI: 10.7326/0003-4819-152-8-201004200-00005] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-152-8-201004200-00005</ArticleId><ArticleId IdType="pmc">PMC2946369</ArticleId><ArticleId IdType="pubmed">20404379</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsia J, MacFadyen JG, Monyak J, Ridker PM. Cardiovascular event reduction and adverse events among subjects attaining low-density lipoprotein cholesterol &lt;50 mg/dl with rosuvastatin. The JUPITER trial (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin). Journal of the American College of Cardiology 2011;57(16):1666-75. [DOI: 10.1016/j.jacc.2010.09.082] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2010.09.082</ArticleId><ArticleId IdType="pubmed">21492764</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerst AJ. A randomised study of efficacy of statins in the prevention of venous thromboembolism. Geneesmiddelenbulletin 2009;43:104-5.</Citation></Reference><Reference><Citation>Koenig W, Ridker PM. Rosuvastatin for primary prevention in patients with European systematic coronary risk evaluation risk &gt;/= 5% or Framingham risk &gt;20%: post hoc analyses of the JUPITER trial requested by European health authorities. European Heart Journal 2011;32(1):75-83. [DOI: 10.1093/eurheartj/ehq370] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehq370</ArticleId><ArticleId IdType="pmc">PMC3013199</ArticleId><ArticleId IdType="pubmed">20971747</ArticleId></ArticleIdList></Reference><Reference><Citation>Mora S, Glynn RJ, Hsia J, MacFadyen JG, Genest J, Ridker PM. Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials. Circulation 2010;121(9):1069-77. [DOI: 10.1161/CIRCULATIONAHA.109.906479] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.109.906479</ArticleId><ArticleId IdType="pmc">PMC4439924</ArticleId><ArticleId IdType="pubmed">20176986</ArticleId></ArticleIdList></Reference><Reference><Citation>NCT00239681. A randomized, double-blind, placebo controlled, multicenter, phase 3 study of rosuvastatin (CRESTOR&#xae;) 20 mg in the prevention of cardiovascular events among subjects with low levels of LDL cholesterol and elevated levels of C-reactive protein. clinicaltrials.gov/ct2/show/NCT00239681 (first received 24 March 2014). [CLINICALTRIALS.GOV IDENTIFIER: NCT00239681]</Citation></Reference><Reference><Citation>Ridker PM, Danielson E, Fonseca F, Genest J, Gotto AM, Kastelein JJ, et al. Rosuvastatin in the prevention of cardiovascular events among 17,802 men and women with elevated levels of C-reactive protein: the JUPITER trial. In: Circulation. Vol. 118. 2008:2310. [DOI: 10.1161/CIRCULATIONAHA.108.191458]</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.108.191458</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, et al. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet 2009;373(9670):1175-82. [DOI: 10.1016/S0140-6736(09)60447-5] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(09)60447-5</ArticleId><ArticleId IdType="pubmed">19329177</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. New England Journal of Medicine 2008;359(21):2195-207. [DOI: 10.1056/NEJMoa0807646] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0807646</ArticleId><ArticleId IdType="pubmed">18997196</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridker PM, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, Khurmi NS, et al. Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein. American Journal of Cardiology 2007;100(11):1659-64. [DOI: 10.1016/j.amjcard.2007.09.072] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2007.09.072</ArticleId><ArticleId IdType="pubmed">18036365</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridker PM, Genest J, Boekholdt SM, Libby P, Gotto AM, Nordestgaard BG, et al. HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial. Lancet 2010;376(9738):333-9. [DOI: 10.1016/S0140-6736(10)60713-1] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)60713-1</ArticleId><ArticleId IdType="pubmed">20655105</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridker PM, MacFadyen JG, Cressman M, Glynn RJ. Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: a secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention-an Intervention Trial Evaluating Rosuvastatin) trial. American Journal of Cardiology 2010;55(12):1266-73. [DOI: 10.1016/j.jacc.2010.01.020] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2010.01.020</ArticleId><ArticleId IdType="pubmed">20206456</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridker PM, MacFadyen JG, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, et al. Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER). Circulation: Cardiovascular Quality and Outcomes 2009;2(6):616-23. [DOI: 10.1161/CIRCOUTCOMES.109.848473] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCOUTCOMES.109.848473</ArticleId><ArticleId IdType="pubmed">20031900</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridker PM, MacFadyen JG, Nordestgaard BG, Koenig W, Kastelein JJ, Genest J, et al. Rosuvastatin for primary prevention among individuals with elevated high-sensitivity C-reactive protein and 5% to 10% and 10% to 20% 10-year risk. Implications of the Justification for Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial for 'intermediate risk'. Circulation: Cardiovascular Quality and Outcomes 2010;3(5):447-52. [DOI: 10.1161/CIRCOUTCOMES.110.938118] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCOUTCOMES.110.938118</ArticleId><ArticleId IdType="pubmed">20736443</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridker PM, Pradhan A, MacFadyen JG, Libby P, Glynn RJ. Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial. Lancet 2012;380(9841):565-71. [DOI: 10.1016/S0140-6736(12)61190-8] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(12)61190-8</ArticleId><ArticleId IdType="pmc">PMC3774022</ArticleId><ArticleId IdType="pubmed">22883507</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridker PM, JUPITER Study Group. Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial. Circulation 2003;108(19):2292-7. [DOI: 10.1161/01.CIR.0000100688.17280.E6] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000100688.17280.E6</ArticleId><ArticleId IdType="pubmed">14609996</ArticleId></ArticleIdList></Reference><Reference><Citation>Slejko JF, Page RL 2nd, Sullivan PW. Cost-effectiveness of statin therapy for vascular event prevention in adults with elevated C-reactive protein: implications of JUPITER. Current Medical Research and Opinion 2010;26(10):2485-97. [DOI: 10.1185/03007995.2010.516994] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1185/03007995.2010.516994</ArticleId><ArticleId IdType="pubmed">20828360</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>HPS study 2002 {published data only}</Title><Reference><Citation>Heart Protection Study Collaborative Group. MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360(9326):7-22. [DOI: 10.1016/S0140-6736(02)09327-3] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(02)09327-3</ArticleId><ArticleId IdType="pubmed">12114036</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kjekshus 2007 {published data only}</Title><Reference><Citation>Kjekshus J, Apetrei E, Barrios V, B&#xf6;hm M, Cleland JG, Cornel JH, et al. Rosuvastatin in older patients with systolic heart failure. New England Journal of Medicine 2007;357(22):2248-61. [DOI: 10.1056/NEJMoa0706201] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0706201</ArticleId><ArticleId IdType="pubmed">17984166</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Knopp 2006 {published data only}</Title><Reference><Citation>Knopp RH, d'Emden M, Smilde JG, Pocock SJ. Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN). Diabetes Care 2006;29(7):1478-85. [DOI: 10.2337/dc05-2415] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc05-2415</ArticleId><ArticleId IdType="pubmed">16801565</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Koren 2004 {published data only}</Title><Reference><Citation>Koren MJ, Hunninghake DB, ALLIANCE Investigators. Clinical outcomes in managed-care patients with coronary heart disease treated aggressively in lipid-lowering disease management clinics: the alliance study. Journal of the American College of Cardiology 2004;44(9):1772-9. [DOI: 10.1016/j.jacc.2004.07.053] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2004.07.053</ArticleId><ArticleId IdType="pubmed">15519006</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>LIPID Study 1998 {published data only}</Title><Reference><Citation>Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) study group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. New England Journal of Medicine 1998;339(19):1349-57. [DOI: 10.1056/NEJM199811053391902] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199811053391902</ArticleId><ArticleId IdType="pubmed">9841303</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Nakamura 2006 {published data only}</Title><Reference><Citation>Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) study group. Design and baseline characteristics of a study of primary prevention of coronary events with pravastatin among Japanese with mildly elevated cholesterol levels. Circulation Journal 2004;68(9):860-7. [DOI: 10.1253/circj.68.860] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.68.860</ArticleId><ArticleId IdType="pubmed">15329509</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura H, Arakawa K, Itakura H, Kitabatake A, Goto Y, Toyota T, et al. Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial. Lancet 2006;368(9542):1155-63. [DOI: 10.1016/S0140-6736(06)69472-5] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(06)69472-5</ArticleId><ArticleId IdType="pubmed">17011942</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Sever 2003 {published data only}</Title><Reference><Citation>Gupta A, Thompson D, Whitehouse A, Collier T, Dahlof B, Poulter N, et al. Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase. Lancet 2017;389(10088):2473-81. [DOI: 10.1016/S0140-6736(17)31075-9] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31075-9</ArticleId><ArticleId IdType="pubmed">28476288</ArticleId></ArticleIdList></Reference><Reference><Citation>Sever PS, Dahl&#xf6;f B, Poulter NR, Wedel H, Beevers G, Caulfield M, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 2003;361(9364):1149-58. [DOI: 10.1016/S0140-6736(03)12948-0] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(03)12948-0</ArticleId><ArticleId IdType="pubmed">12686036</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Sola 2006 {published data only}</Title><Reference><Citation>Sola S, Mir MQ, Lerakis S, Tandon N, Khan BV. Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure. Journal of the American College of Cardiology 2006;47(2):332-7. [DOI: 10.1016/j.jacc.2005.06.088] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2005.06.088</ArticleId><ArticleId IdType="pubmed">16412856</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Talasaz 2023 {published data only}</Title><Reference><Citation>INSPIRATION-S Investigators. Atorvastatin versus placebo in patients with covid-19 in intensive care: randomized controlled trial. BMJ 2022;376:e068407. [DOI: 10.1136/bmj-2021-068407] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-068407</ArticleId><ArticleId IdType="pmc">PMC11785411</ArticleId><ArticleId IdType="pubmed">34996756</ArticleId></ArticleIdList></Reference><Reference><Citation>Talasaz AH, Sadeghipour P, Bakhshandeh H, Sharif-Kashani B, Rashidi F, Beigmohammadi MT, et al. Atorvastatin versus placebo in ICU patients with COVID-19: ninety-day results of the INSPIRATION-S trial. Thrombosis and Haemostasis 2023;123(7):723-33. [DOI: 10.1055/a-2059-4844] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-2059-4844</ArticleId><ArticleId IdType="pubmed">36944357</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Tavazzi 2008 {published data only}</Title><Reference><Citation>Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG, Latini R, et al. Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 2008;372(9645):1231-9. [DOI: 10.1016/S0140-6736(08)61240-4] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(08)61240-4</ArticleId><ArticleId IdType="pubmed">18757089</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Wanner 2005 {published data only}</Title><Reference><Citation>Wanner C, Krane V, M&#xe4;rz W, Olschewski M, Mann JF, Ruf G, et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. New England Journal of Medicine 2005;353(3):238-48. [DOI: 10.1056/NEJMoa043545] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa043545</ArticleId><ArticleId IdType="pubmed">16034009</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Yusuf 2016 {published data only}</Title><Reference><Citation>Yusuf S, Bosch J, Dagenais G, Zhu J, Xavier D, Liu L, et al. Cholesterol lowering in intermediate-risk persons without cardiovascular disease. New England Journal of Medicine 2016;374(21):2021-31. [DOI: 10.1056/NEJMoa1600176] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1600176</ArticleId><ArticleId IdType="pubmed">27040132</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to studies excluded from this review</Title><ReferenceList><Title>Barrett 2023 {published data only}</Title><Reference><Citation>Barrett CD, Moore HB, Moore EE, Chandler J, Sauaia A. Combination of aspirin and rosuvastatin for reduction of venous thromboembolism in severely injured patients: a double-blind, placebo-controlled, pragmatic randomized phase II clinical trial (The STAT Trial). Blood Coagulation &amp; Fibrinolysis 2023;34(8):499-507. [DOI: 10.1097/MBC.0000000000001258] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MBC.0000000000001258</ArticleId><ArticleId IdType="pmc">PMC10655842</ArticleId><ArticleId IdType="pubmed">37942744</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Delluc 2022 {published data only}</Title><Reference><Citation>Delluc A, Ghanima W, Kovacs MJ, Shivakumar S, Kahn SR, Sandset PM, et al. Statins for venous event reduction in patients with venous thromboembolism: a multicenter randomized controlled pilot trial assessing feasibility. Journal of Thrombosis and Haemostasis 2022;20(1):126-32. [DOI: 10.1111/jth.15537] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15537</ArticleId><ArticleId IdType="pubmed">34564938</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Orsi 2019 {published data only}</Title><Reference><Citation>Orsi FA, Biedermann JS, Kruip MJHA, Van der Meer FJ, Rosendaal FR, Van Hylckama Vlieg A, et al. Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial. Journal of Thrombosis &amp; Haemostatis 2019;17(2):319-28. [DOI: 10.1111/jth.14364] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14364</ArticleId><ArticleId IdType="pmc">PMC6850636</ArticleId><ArticleId IdType="pubmed">30565854</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to ongoing studies</Title><ReferenceList><Title>ChiCTR2100048407 {unpublished data only}</Title><Reference><Citation>ChiCTR2100048407. A randomized controlled trial of rosuvastatin in the prevention of deep vein thrombosis in total knee arthroplasty. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR2100048407 (first received 6 July 2021).</Citation></Reference></ReferenceList><ReferenceList><Title>NCT00259662 {published data only}</Title><Reference><Citation>NCT00259662. High-dose periop statins for prevention of DVT. clinicaltrials.gov/show/NCT00259662 (first received 29 November 2005).</Citation></Reference></ReferenceList><ReferenceList><Title>NCT01021488 {published data only}</Title><Reference><Citation>NCT01021488. Rosuvastatin for preventing deep vein thrombosis (STOP-DVT). clinicaltrials.gov/ct2/show/results/NCT01021488 (first received 30 November 2009).</Citation></Reference><Reference><Citation>Park WJ, Jo SH, Kim SA, Kim HS, Han SJ, Choi YJ, et al. Rationale and design of STOP DVT study: rosuvastatin for the prevention of deep vein thrombosis in patients undergoing total knee replacement arthroplasty - a prospective randomized open-label controlled trial. Contemporary Clinical Trials 2011;32(5):779-82. [DOI: 10.1016/j.cct.2011.06.001] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cct.2011.06.001</ArticleId><ArticleId IdType="pubmed">21684353</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>NCT01063426 {published data only}</Title><Reference><Citation>NCT01063426. Re-STOP DVT: reload of high dose atorvastatin for preventing deep vein thrombosis in statin users. clinicaltrials.gov/ct2/show/NCT01063426 (first received 5 February 2010).</Citation></Reference></ReferenceList><ReferenceList><Title>NCT01524653 {published data only}</Title><Reference><Citation>NCT01524653. Detecting the impact of statin therapy on lowering risk of venous thrombo-embolic events (DISOLVE). clinicaltrials.gov/ct2/show/NCT01524653 (first received 2 February 2012).</Citation></Reference></ReferenceList><ReferenceList><Title>NCT02285738 {published data only}</Title><Reference><Citation>NCT02285738. Anti-platelet and statin therapy to prevent cancer-associated thrombosis. clinicaltrials.gov/show/NCT02285738 (first received 7 November 2014).</Citation></Reference></ReferenceList><ReferenceList><Title>NCT03532139 {published data only}</Title><Reference><Citation>NCT03532139. Pilot study of rosuvastatin and enoxaparin thromboprophylaxis following ovarian cancer surgery (O-STAT Study). clinicaltrials.gov/show/NCT03532139 (first received 22 May 2018).</Citation></Reference></ReferenceList></ReferenceList><ReferenceList><Title>Additional references</Title><ReferenceList><Title>Adams 2013</Title><Reference><Citation>Adams NB, Lutsey PL, Folsom AR, Herrington DH, Sibley CT, Zakai NA, et al. Statin therapy and levels of hemostatic factors in a healthy population: the multi-ethnic study of atherosclerosis. Journal of Thrombosis and Haemostasis 2013;11(6):1078-84. [DOI: 10.1111/jth.12223] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.12223</ArticleId><ArticleId IdType="pmc">PMC3702638</ArticleId><ArticleId IdType="pubmed">23565981</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Agarwal 2010</Title><Reference><Citation>Agarwal V, Phung OJ, Tongbram V, Bhardwaj A, Coleman CI. Statin use and the prevention of venous thromboembolism: a meta-analysis. International Journal of Clinical Practice 2010;64(10):1375-83. [DOI: 10.1111/j.1742-1241.2010.02439.x] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-1241.2010.02439.x</ArticleId><ArticleId IdType="pubmed">20716146</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Al Harbi 2013</Title><Reference><Citation>Al Harbi SA, Khedr M, Al-Dorzi HM, Tlayjeh HM, Rishu AH, Arabi YM. The association between statin therapy during intensive care unit stay and the incidence of venous thromboembolism: a propensity score-adjusted analysis. BMC pharmacology &amp; toxicology 2013;14:57. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3829807</ArticleId><ArticleId IdType="pubmed">24206781</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Albert 2001</Title><Reference><Citation>Albert MA, Danielson E, Rifai N, Ridker PM. Effect of statin therapy on C-reactive protein levels: the pravastatin Inflammation/CRP Evaluation (PRINCE): a randomized trial and cohort study. Journal of the American Medical Association 2001;286(1):64-70. [DOI: 10.1001/jama.286.1.64] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.286.1.64</ArticleId><ArticleId IdType="pubmed">11434828</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Alotaibi 2016</Title><Reference><Citation>Alotaibi GS, Wu C, Senthilselvan A, McMurtry MS. Secular trends in incidence and mortality of acute venous thromboembolism: the AB-VTE population-based study. American Journal of Medicine 2016;129(8):879.e19-25. [DOI: 10.1016/j.amjmed.2016.01.041] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2016.01.041</ArticleId><ArticleId IdType="pubmed">26925811</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Alpert 2001</Title><Reference><Citation>Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Journal of the American College of Cardiology 2000;36(3):959-69. [DOI: 10.1016/s0735-1097(00)00804-4] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0735-1097(00)00804-4</ArticleId><ArticleId IdType="pubmed">10987628</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Arshad&#xa0;2017</Title><Reference><Citation>Arshad N, Isaksen T, Hansen JB, Br&#xe6;kkan SK. Time trends in incidence rates of venous thromboembolism in a large cohort recruited from the general population. European Journal of Epidemiology 2017;32(4):299-305. [DOI: 10.1007/s10654-017-0238-y] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-017-0238-y</ArticleId><ArticleId IdType="pubmed">28314981</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Atkins 2004</Title><Reference><Citation>Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al. Grading quality of evidence and strength of recommendations. BMJ 2004;328(7454):1490. [DOI: 10.1136/bmj.328.7454.1490] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.328.7454.1490</ArticleId><ArticleId IdType="pmc">PMC428525</ArticleId><ArticleId IdType="pubmed">15205295</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Biedermann 2016</Title><Reference><Citation>Biedermann JS, Cannegieter SC, Roest M, Meer FJ, Reitsma PH, Kruip MJ, et al. Platelet reactivity in patients with venous thrombosis who use rosuvastatin: a randomized controlled clinical trial. Journal of Thrombosis and Haemostasis 2016;14(7):1404-9. [DOI: 10.1111/jth.13343] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.13343</ArticleId><ArticleId IdType="pubmed">27094802</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Billings 2011</Title><Reference><Citation>Billings FT, Riedel B. Statins. In: Essence of Anesthesia Practice . 3rd edition. Philadelphia (PA): Elsevier, 2011:643.</Citation></Reference></ReferenceList><ReferenceList><Title>Bjelakovic 2014</Title><Reference><Citation>Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Krstic G, Wetterslev J, et al. Vitamin D supplementation for prevention of cancer in adults. Cochrane Database of Systematic Reviews 2014, Issue 6. Art. No: CD007469. [DOI: 10.1002/14651858.CD007469.pub2] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD007469.pub2</ArticleId><ArticleId IdType="pmc">PMC11285304</ArticleId><ArticleId IdType="pubmed">24953955</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Brok 2008</Title><Reference><Citation>Brok J, Thorlund K, Gluud C, Wetterslev J. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. Journal of Clinical Epidemiology 2008;61(8):763-9. [PMID: 10.1016/j.jclinepi.2007.10.007] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2007.10.007</ArticleId><ArticleId IdType="pubmed">18411040</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Chapman 2009</Title><Reference><Citation>Chapman NH, Brighton T, Harris MF, Caplan GA, Braithwaite J, Chong BH. Venous thromboembolism - management in general practice. Australian Family Physician 2009;38(1-2):36-40. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">19283234</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Cohen 2021</Title><Reference><Citation>Cohen D. Current issues in venous thromboembolism. Postgraduate Medicine 2021;133(Supp1):1-2. [DOI: 10.1080/00325481.2021.1955541] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00325481.2021.1955541</ArticleId><ArticleId IdType="pubmed">34266357</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>De Moreuil 2017</Title><Reference><Citation>De Moreuil C, Le Mao R, Tromeur C, Couturaud F, Lacut K, Delluc A. Association between statin exposure and venous thromboembolism risk in cancer patients. Data from the EDITH case-control study. European journal of internal medicine 2017;46:e42-e44. [DOI: 10.1016/j.ejim.2017.10.008] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2017.10.008</ArticleId><ArticleId IdType="pubmed">29046258</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Deeks 2022</Title><Reference><Citation>Deeks JJ, Higgins JP, Altman DG, editor(s). Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022. Available from www.training.cochrane.org/handbook.</Citation></Reference></ReferenceList><ReferenceList><Title>Diuguid 2001</Title><Reference><Citation>Diuguid DL. Choosing a parenteral anticoagulant agent. New England Journal of Medicine 2001;345(18):1340-2. [PMID: 10.1056/NEJM200111013451811] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200111013451811</ArticleId><ArticleId IdType="pubmed">11794155</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Doggen 2004</Title><Reference><Citation>Doggen CJ, Lemaitre RN, Smith NL, Heckbert SR, Psaty BM. HMG CoA reductase inhibitors and the risk of venous thrombosis among postmenopausal women. Journal of Thrombosis and Haemostasis 2004;2(5):700-1. [DOI: 10.1111/j.1538-7836.2004.00696.x] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2004.00696.x</ArticleId><ArticleId IdType="pubmed">15099273</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>El&#x2010;Refai &#xa0;2017</Title><Reference><Citation>El-Refai SM, Black EP, Adams VR, Talbert JC, Brown JD. Statin use and venous thromboembolism in cancer: a large, active comparator, propensity score matched cohort study. Thrombosis Research 2017;158:49-58. [PMID: 10.1016/j.thromres.2017.08.001] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2017.08.001</ArticleId><ArticleId IdType="pmc">PMC5755594</ArticleId><ArticleId IdType="pubmed">28822240</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Frasco 2022</Title><Reference><Citation>Frasco PE, Rosenfeld DM, Jadlowiec CC, Zhang N, Heilman RL, Bauer IL, et al. Postoperative statin therapy is not associated with reduced incidence of venous thromboembolic events following kidney transplantation. Clinical transplantation 2022;36(12):e14805. [DOI: 10.1111/ctr.14805] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ctr.14805</ArticleId><ArticleId IdType="pubmed">36065684</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Gaertner 2016</Title><Reference><Citation>Gaertner S, Cordeanu EM, Nouri S, Mirea C, Stephan D. Statins and prevention of venous thromboembolism: myth or reality? Archives of Cardiovascular Diseases 2016;109(3):216-22. [DOI: 10.1016/j.acvd.2015.11.007] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.acvd.2015.11.007</ArticleId><ArticleId IdType="pubmed">26778087</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ginter 2009</Title><Reference><Citation>Ginter E, Simko V. Statins: the drugs for the 21st century? Bratislavske Lekarske Listy 2009;110(10):664-8. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">20017462</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>GRADEpro GDT [Computer program]</Title><Reference><Citation>GRADEpro GDT. Version accessed 17 July 2020. Hamilton (ON): McMaster University (developed by Evidence Prime), 2020. Available at gradepro.org.</Citation></Reference></ReferenceList><ReferenceList><Title>Grady 2000</Title><Reference><Citation>Grady D, Wenger NK, Herrington D, Khan S, Furberg C, Hunninghake D, et al. Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study. Annals of Internal Medicine 2000;132(9):689-96. [DOI: 10.7326/0003-4819-132-9-200005020-00002] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-132-9-200005020-00002</ArticleId><ArticleId IdType="pubmed">10787361</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Guntupalli 2023</Title><Reference><Citation>Guntupalli SR, Spinosa D, Wethington S, Eskander R, Khorana AA. Prevention of venous thromboembolism in patients with cancer. British Medical Association 2023;381:e072715. [DOI: 10.1136/bmj-2022-072715] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-072715</ArticleId><ArticleId IdType="pubmed">37263632</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Guyatt 2008</Title><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336(7650):924-6. [DOI: 10.1136/bmj.39489.470347.AD] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39489.470347.AD</ArticleId><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Guyatt 2011</Title><Reference><Citation>Guyatt GH, Oxman AD, Kunz R, Brozek J, Alonso-Coello P, Rind D, et al. GRADE guidelines 6. Rating the quality of evidence - imprecision. Journal of Clinical Epidemiology 2011;64(12):1283-93. [DOI: 10.1016/j.jclinepi.2011.01.012] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2011.01.012</ArticleId><ArticleId IdType="pubmed">21839614</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Heit 2015</Title><Reference><Citation>Heit JA. Epidemiology of venous thromboembolism. Nature Reviews Cardiology 2015;12(8):464-74. [DOI: 10.1038/nrcardio.2015.83] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrcardio.2015.83</ArticleId><ArticleId IdType="pmc">PMC4624298</ArticleId><ArticleId IdType="pubmed">26076949</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Heit&#xa0;2016</Title><Reference><Citation>Heit JA, Spencer FA, White RH. The epidemiology of venous thromboembolism. Journal of Thrombosis and Thrombolysis 2016;41(1):3-14. [PMID: 10.1007/s11239-015-1311-6] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-015-1311-6</ArticleId><ArticleId IdType="pmc">PMC4715842</ArticleId><ArticleId IdType="pubmed">26780736</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Herrington 2002</Title><Reference><Citation>Herrington DM, Vittinghoff E, Lin F, Fong J, Harris F, Hunninghake D, et al. Statin therapy, cardiovascular events, and total mortality in the heart and estrogen/progestin replacement study (HERS). Circulation 2002;105(25):2962-7. [DOI: 10.1161/01.cir.0000019406.74017.b2] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.cir.0000019406.74017.b2</ArticleId><ArticleId IdType="pubmed">12081988</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Higgins 2017</Title><Reference><Citation>Higgins JP, Altman DG, Sterne JA, editor(s). Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017), Cochrane, 2017. Available from www.training.cochrane.org/handbook.</Citation></Reference></ReferenceList><ReferenceList><Title>Higgins 2022</Title><Reference><Citation>Higgins JP, Li T, Deeks JJ, editor(s). Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022. Available from www.training.cochrane.org/handbook.</Citation></Reference></ReferenceList><ReferenceList><Title>Ho 2008</Title><Reference><Citation>Ho WK, Hankey GJ, Eikelboom JW. The incidence of venous thromboembolism: a prospective, community-based study in Perth, Western Australia. Medical Journal of Australia 2008;189(3):144-7. [DOI: 10.5694/j.1326-5377.2008.tb01947.x] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.5694/j.1326-5377.2008.tb01947.x</ArticleId><ArticleId IdType="pubmed">18673100</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Huerta 2007</Title><Reference><Citation>Huerta C, Johansson S, Wallander MA, Garcia Rodriguez LA. Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom. Archives of Internal Medicine 2007;167(9):935-43. [DOI: 10.1001/archinte.167.9.935] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.167.9.935</ArticleId><ArticleId IdType="pubmed">17502535</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Hwang 2022</Title><Reference><Citation>Hwang HG, Lee JH, Kim SA, Kim YK, Yhim HY, Hong J, et al. Incidence of venous thromboembolism: the 3rd Korean nationwide study. Journal of Korean Medical Science 2022;37(17):e130. [DOI: 10.3346/jkms.2022.37.e130] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2022.37.e130</ArticleId><ArticleId IdType="pmc">PMC9062279</ArticleId><ArticleId IdType="pubmed">35502501</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>ISTH 2014</Title><Reference><Citation>ISTH Steering Committee for World Thrombosis Day. Thrombosis: a major contributor to the global disease burden. Journal of Thrombis and Haemostasis 2014;12(10):1580-90. [DOI: 10.1111/jth.12698] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.12698</ArticleId><ArticleId IdType="pubmed">25302663</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Istvan 2002</Title><Reference><Citation>Istvan ES. Structural mechanism for statin inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase. American Heart Journal 2002;144(Suppl 6):S27-32. [PMID: 10.1067/mhj.2002.130300] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mhj.2002.130300</ArticleId><ArticleId IdType="pubmed">12486413</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Joseph 2022</Title><Reference><Citation>Joseph P, Glynn R, Lonn E, Ramasundarahettige C, Eikelboom J, MacFadyen J, et al. Rosuvastatin for the prevention of venous thromboembolism: a pooled analysis of the HOPE-3 and JUPITER randomized controlled trials. Cardiovascular Research 2022;118(3):897-903. [DOI: 10.1093/cvr/cvab078] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvab078</ArticleId><ArticleId IdType="pmc">PMC8859624</ArticleId><ArticleId IdType="pubmed">33705531</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kaba 2004</Title><Reference><Citation>Kaba NK, Francis CW, Moss AJ, Zareba W, Oakes D, Knox KL, et al. Effects of lipids and lipid-lowering therapy on hemostatic factors in patients with myocardial infarction. Journal of Thrombosis and Haemostasis 2004;2(5):718-25. [DOI: 10.1111/j.1538-7836.2004.00658.x] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2004.00658.x</ArticleId><ArticleId IdType="pubmed">15099276</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kacimi 2022</Title><Reference><Citation>Kacimi SE, Moeinafshar A, Haghighi SS, Saghazadeh A, Rezaei N. Venous thromboembolism in cancer and cancer immunotherapy. Critical Reviews in Oncology/Hematology 2022;178:103782. [DOI: 10.1016/j.critrevonc.2022.103782] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.critrevonc.2022.103782</ArticleId><ArticleId IdType="pubmed">35961476</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kunutsor 2017</Title><Reference><Citation>Kunutsor SK, Seidu S, Khunti K. Statins and primary prevention of venous thromboembolism: a systematic review and meta-analysis. Lancet Haematology 2017;4(2):e83-93. [DOI: 10.1016/S2352-3026(16)30184-3] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(16)30184-3</ArticleId><ArticleId IdType="pubmed">28089655</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lacut 2004</Title><Reference><Citation>Lacut K, Oger E, Le Gal G, Couturaud F, Louis S, Leroyer C, et al. Statins but not fibrates are associated with a reduced risk of venous thromboembolism: a hospital-based case-control study. Fundamental and Clinical Pharmacology 2004;18(4):477-82. [DOI: 10.1111/j.1472-8206.2004.00252.x] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1472-8206.2004.00252.x</ArticleId><ArticleId IdType="pubmed">15312155</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lacut 2008</Title><Reference><Citation>Lacut K, Le Gal G, Abalain JH, Mottier D, Oger E. Differential associations between lipid-lowering drugs, statins and fibrates, and venous thromboembolism: role of drug induced homocysteinemia? Thrombosis Research 2008;122(3):314-9. [PMID: 10.1016/j.thromres.2007.10.014] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2007.10.014</ArticleId><ArticleId IdType="pubmed">18048086</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lassila 2014</Title><Reference><Citation>Lassila R, Jula A, Pitk&#xe4;niemi J, Haukka J. The association of statin use with reduced incidence of venous thromboembolism: a population-based cohort study. BMJ Open 2014;4(11):e005862. [DOI: 10.1136/bmjopen-2014-005862] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2014-005862</ArticleId><ArticleId IdType="pmc">PMC4225235</ArticleId><ArticleId IdType="pubmed">25377011</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lee 2017</Title><Reference><Citation>Lee LH, Gallus A, Jindal R, Wang C, Wu CC. Incidence of venous thromboembolism in Asian populations: a systematic review. Thrombosis and Haemostasis 2017;117(12):2243-60. [DOI: 10.1160/TH17-02-0134] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH17-02-0134</ArticleId><ArticleId IdType="pubmed">29212112</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lefebvre 2022</Title><Reference><Citation>Lefebvre C, Glanville J, Briscoe S, Featherstone R, Littlewood A, Marshall C, et al. Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022. Available from training.cochrane.org/handbook.</Citation></Reference></ReferenceList><ReferenceList><Title>Li 2014</Title><Reference><Citation>Li L, Zhang P, Tian JH, Yang K. Statins for primary prevention of venous thromboembolism. Cochrane Database of Systematic Reviews 2014, Issue 12. Art. No: CD008203. [DOI: 10.1002/14651858.CD008203.pub3] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD008203.pub3</ArticleId><ArticleId IdType="pmc">PMC11127252</ArticleId><ArticleId IdType="pubmed">25518837</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Li 2023</Title><Reference><Citation>Li M, Li J, Wang X, Hui X, Wang Q, Xie S, et al. Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism. Cochrane Database of Systematic Reviews 2023, Issue 4. Art. No: CD010957. [DOI: 10.1002/14651858.CD010957.pub3] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD010957.pub3</ArticleId><ArticleId IdType="pmc">PMC10103165</ArticleId><ArticleId IdType="pubmed">37057837</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lippi 2013</Title><Reference><Citation>Lippi G, Favaloro EJ, Sanchis-Gomar F. Venous thrombosis associated with HMG-CoA reductase inhibitors. Seminars in Thrombosis and Hemostasis 2013;39(5):515-32. [DOI: 10.1055/s-0033-1343892] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0033-1343892</ArticleId><ArticleId IdType="pubmed">23629822</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Liu 2013</Title><Reference><Citation>Liu X, Phatak H, Dillon R, Mitchell SA. Epidemiology and mortality of venous thromboembolism across patient populations: a systematic literature review. Value in Health 2013;16(3):A272. [DOI: 10.1016/j.jval.2013.03.1407]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2013.03.1407</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Liu 2022</Title><Reference><Citation>Liu C, Yan W, Shi J, Wang S, Peng A, Chen Y, et al. Biological actions, implications and cautions of statins therapy in COVID-19. Frontiers in Nutrition 2022;9:927092. [DOI: 10.3389/fnut.2022.927092] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2022.927092</ArticleId><ArticleId IdType="pmc">PMC9257176</ArticleId><ArticleId IdType="pubmed">35811982</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>L&#xf6;tsch 2014</Title><Reference><Citation>L&#xf6;tsch F, K&#xf6;nigsbr&#xfc;gge O, Posch F, Zielinski C, Pabinger I, Ay C. Statins are associated with low risk of venous thromboembolism in patients with cancer: a prospective and observational cohort study. Thrombosis research 2014;134(5):1008-13. [DOI: 10.1016/j.thromres.2014.09.001] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2014.09.001</ArticleId><ArticleId IdType="pubmed">25234407</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mihaylova 2012</Title><Reference><Citation>Mihaylova B, Emberson J, Blackwell L, Keech A, Simes J, Barnes EH, Voysey M, et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet 2012;380(9841):581-90. [DOI: 10.1016/S0140-6736(12)60367-5] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(12)60367-5</ArticleId><ArticleId IdType="pmc">PMC3437972</ArticleId><ArticleId IdType="pubmed">22607822</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Miksza 2019</Title><Reference><Citation>Miksza JK, Zaccardi F, Kunutsor SK, Seidu S, Davies MJ, Khunti K. Statins and risk of thromboembolism: a meta-regression to disentangle the efficacy-to-effectiveness gap using observational and trial evidence. Nutrition, Metabolism, and Cardiovascular Diseases 2019;29(10):1023-9. [DOI: 10.1016/j.numecd.2019.06.022] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.numecd.2019.06.022</ArticleId><ArticleId IdType="pubmed">31383500</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Moheimani 2011</Title><Reference><Citation>Moheimani F, Jackson DE. Venous thromboembolism: classification, risk factors, diagnosis, and management. ISRN Hematology 2011;2011:124610. [DOI: 10.5402/2011/124610] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.5402/2011/124610</ArticleId><ArticleId IdType="pmc">PMC3196154</ArticleId><ArticleId IdType="pubmed">22084692</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Moraes 2013</Title><Reference><Citation>Moraes LA, Vaiyapuri S, Sasikumar P, Ali MS, Kriek N, Sage T, et al. Antithrombotic actions of statins involve PECAM-1 signaling. Blood 2013;122(18):3188-96. [DOI: 10.1182/blood-2013-04-491845] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2013-04-491845</ArticleId><ArticleId IdType="pmc">PMC3814735</ArticleId><ArticleId IdType="pubmed">24030383</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Oleksiuk&#x2010;B&#xf3;jk 2023</Title><Reference><Citation>Oleksiuk-B&#xf3;jko M, Lisowska A. Venous thromboembolism: Why is it still a significant health problem? Adv Med Sci 2023;68(1):10-20. [DOI: 10.1016/j.advms.2022.10.002] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.advms.2022.10.002</ArticleId><ArticleId IdType="pubmed">36368288</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Orsi 2019</Title><Reference><Citation>Orsi FA, Cannegieter SC, Lijfering WM. Statin therapy to revert hypercoagulability and prevent venous thromboembolism: a narrative review. Seminars in Thrombosis and Hemostosis 2019;45(8):825-33. [DOI: 10.1055/s-0039-1687911] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0039-1687911</ArticleId><ArticleId IdType="pubmed">31096309</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Page 2021</Title><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71. [DOI: 10.1136/bmj.n71] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Page 2022</Title><Reference><Citation>Page M J, Higgins J P T, Sterne J A C. Chapter 13: Assessing risk of bias due to missing results in a synthesis. In: Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Available from training.cochrane.org/handbook. Cochrane, 2022.</Citation></Reference></ReferenceList><ReferenceList><Title>Pai 2011</Title><Reference><Citation>Pai M, Evans NS, Shah SJ, Green D, Cook D, Crowther MA. Statins in the prevention of venous thromboembolism: a meta-analysis of observational studies. Thrombosis Research 2011;128(5):422-30. [DOI: 10.1016/j.thromres.2011.05.012] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2011.05.012</ArticleId><ArticleId IdType="pubmed">21641019</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Pawelczyk 2015</Title><Reference><Citation>Pawelczyk M, Chmielewski H, Kaczorowska B, Przyby&#x142;a M, Baj Z. The influence of statin therapy on platelet activity markers in hyperlipidemic patients after ischemic stroke. Archives of Medical Science 2015;11(1):115-21. [DOI: 10.5114/aoms.2015.49216] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/aoms.2015.49216</ArticleId><ArticleId IdType="pmc">PMC4379378</ArticleId><ArticleId IdType="pubmed">25861297</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Pinal&#x2010;Fernandez 2018</Title><Reference><Citation>Pinal-Fernandez I, Casal-Dominguez M, Mammen AL. Statins: pros and cons. Medicina cl&#xed;nica 2018;150(10):398-402. [DOI: 10.1016/j.medcli.2017.11.030] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medcli.2017.11.030</ArticleId><ArticleId IdType="pmc">PMC6019636</ArticleId><ArticleId IdType="pubmed">29292104</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Rahimi 2012</Title><Reference><Citation>Rahimi K, Bhala N, Kamphuisen P, Emberson J, Biere-Rafi S, Krane V, et al. Effect of statins on venous thromboembolic events: a meta-analysis of published and unpublished evidence from randomised controlled trials. PLOS Medicine 2012;9(9):e1001310. [PMID: 10.1371/journal.pmed.1001310] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1001310</ArticleId><ArticleId IdType="pmc">PMC3445446</ArticleId><ArticleId IdType="pubmed">23028261</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Raju 2009</Title><Reference><Citation>Raju NC, Hirsh J, Eikelboom JW. Duration of anticoagulant therapy for venous thromboembolism. Medical Journal of Australia 2009;190(12):659-60. [DOI: 10.5694/j.1326-5377.2009.tb02629.x] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.5694/j.1326-5377.2009.tb02629.x</ArticleId><ArticleId IdType="pubmed">19527196</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ramcharan 2009</Title><Reference><Citation>Ramcharan AS, Stralen KJ, Snoep JD, Mantel-Teeuwisse AK, Rosendaal FR, Doggen CJ. HMG-CoA-reductase inhibitors, other lipid-lowering medication, antiplatelet therapy, and the risk of venous thrombosis. Journal of Thrombosis and Haemostasis 2009;7(4):514-20. [DOI: 10.1111/j.1538-7836.2008.03235.x] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2008.03235.x</ArticleId><ArticleId IdType="pubmed">19036068</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ray 2001a</Title><Reference><Citation>Ray JG, Rosendaal FR. The role of dyslipidemia and statins in venous thromboembolism. Current Controlled Trials in Cardiovascular Medicine 2001;2(4):165-70. [DOI: 10.1186/cvm-2-4-165] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cvm-2-4-165</ArticleId><ArticleId IdType="pmc">PMC59643</ArticleId><ArticleId IdType="pubmed">11806791</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ray 2001b</Title><Reference><Citation>Ray JG, Mamdani M, Tsuyuki RT, Anderson DR, Yeo EL, Laupacis A. Use of statins and the subsequent development of deep vein thrombosis. Archives of Internal Medicine 2001;161(11):1405-10. [DOI: 10.1001/archinte.161.11.1405] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.161.11.1405</ArticleId><ArticleId IdType="pubmed">11386889</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ray 2003</Title><Reference><Citation>Ray JG. Dyslipidemia, statins, and venous thromboembolism: a potential risk factor and a potential treatment. Current Opinion in Pulmonary Medicine 2003;9(5):378-84. [DOI: 10.1097/00063198-200309000-00007] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00063198-200309000-00007</ArticleId><ArticleId IdType="pubmed">12904707</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Review Manager 2020 [Computer program]</Title><Reference><Citation>Review Manager 5 (RevMan 5). Version 5.4. Copenhagen: The Cochrane Collaboration, 2020.</Citation></Reference></ReferenceList><ReferenceList><Title>RevMan 2019 [Computer program]</Title><Reference><Citation>Review Manager (RevMan). Version 5.8.0. Copenhagen: The Cochrane Collaboration, 2019. Available at revman.cochrane.org.</Citation></Reference></ReferenceList><ReferenceList><Title>Ridker 2012</Title><Reference><Citation>Ridker PM, Pradhan A, MacFadyen JG, Libby P, Glynn RJ. Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial. Lancet 2012;380(9841):565-71. [DOI: 10.1016/S0140-6736(12)61190-8] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(12)61190-8</ArticleId><ArticleId IdType="pmc">PMC3774022</ArticleId><ArticleId IdType="pubmed">22883507</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Riva 2015</Title><Reference><Citation>Riva N, Di Minno MN, Mumoli N, Pomero F, Franchini M, Bellesini M, et al. Statin use and bleeding risk during vitamin K antagonist treatment for venous thromboembolism: a multicenter retrospective cohort study. Haematologica 2015;100(8):e295-8. [PMID: 10.3324/haematol.2015.127183] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.3324/haematol.2015.127183</ArticleId><ArticleId IdType="pmc">PMC5004428</ArticleId><ArticleId IdType="pubmed">25887499</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Rodriguez 2012</Title><Reference><Citation>Rodriguez AL, Wojcik BM, Wrobleski SK, Myers DD, Wakefield TW, Diaz JA. Statins, inflammation and deep vein thrombosis: a systematic review. Journal of Thrombosis and Thrombolysis 2012;33(4):371-82. [DOI: 10.1007/s11239-012-0687-9] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-012-0687-9</ArticleId><ArticleId IdType="pmc">PMC3338886</ArticleId><ArticleId IdType="pubmed">22278047</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Sch&#xfc;nemann 2022</Title><Reference><Citation>Sch&#xfc;nemann HJ, Higgins JP, Vist GE, Glasziou P, Akl EA, Skoetz N, et al. Chapter 14: Completing &#x2018;Summary of findings&#x2019; tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022. Available from www.training.cochrane.org/handbook.</Citation></Reference></ReferenceList><ReferenceList><Title>Shai 2014</Title><Reference><Citation>Shai A, Rennert HS, Lavie O, Ballan-Haj M, Bitterman A, Steiner M, et al. Statins, aspirin and risk of venous thromboembolic events in breast cancer patients. Journal of thrombosis and thrombolysis 2014;38(1):32-8. [DOI: 10.1007/s11239-013-1015-8] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-013-1015-8</ArticleId><ArticleId IdType="pubmed">24154915</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Skajaa&#xa0;2019</Title><Reference><Citation>Skajaa N, Sz&#xe9;pligeti SK, Horv&#xe1;th-Puh&#xf3; E, Ghanima W, Hansen JB, S&#xf8;rensen HT. Initiation of statins and risk of venous thromboembolism: population-based matched cohort study. Thrombosis Research 2019;184:99-104. [DOI: 10.1016/j.thromres.2019.11.003] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2019.11.003</ArticleId><ArticleId IdType="pubmed">31715545</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Smeeth 2009</Title><Reference><Citation>Smeeth L, Douglas I, Hall AJ, Hubbard R, Evans S. Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials. British Journal of Clinical Pharmacology 2009;67(1):99-109. [DOI: 10.1111/j.1365-2125.2008.03308.x] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2125.2008.03308.x</ArticleId><ArticleId IdType="pmc">PMC2668090</ArticleId><ArticleId IdType="pubmed">19006546</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Soares 2002</Title><Reference><Citation>Soares I, Carneiro AV. Drug class effects: definitions and practical applications. Revista Portuguesa de Cardiologia 2002;21(9):1031-42. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">12416274</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Song 2019</Title><Reference><Citation>Song AB, Rosovsky RP, Connors JM, Al-Samkari H. Direct oral anticoagulants for treatment and prevention of venous thromboembolism in cancer patients. Vascular Health and Risk Management 2019;15:175-86. [DOI: 10.2147/VHRM.S132556] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/VHRM.S132556</ArticleId><ArticleId IdType="pmc">PMC6593743</ArticleId><ArticleId IdType="pubmed">31417269</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Squizzato 2010</Title><Reference><Citation>Squizzato A, Galli M, Romualdi E, Dentali F, Kamphuisen PW, Guasti L, et al. Statins, fibrates, and venous thromboembolism: a meta-analysis. European Heart Journal 2010;31(10):1248-56. [DOI: 10.1093/eurheartj/ehp556] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehp556</ArticleId><ArticleId IdType="pubmed">20031958</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Stuijver 2015</Title><Reference><Citation>Stuijver DJ, Romualdi E, Zaane B, Bax L, B&#xfc;ller HR, Gerdes VE, et al. Under-reporting of venous and arterial thrombotic events in randomized clinical trials: a meta-analysis. Internal and Emergency Medicine 2015;10(2):219-46. [DOI: 10.1007/s11739-014-1168-2] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-014-1168-2</ArticleId><ArticleId IdType="pubmed">25502591</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>S&#xf8;rensen 2009</Title><Reference><Citation>S&#xf8;rensen HT, Horvath-Puho E, S&#xf8;gaard KK, Christensen S, Johnsen SP, Thomsen RW, et al. Arterial cardiovascular events, statins, low-dose aspirin and subsequent risk of venous thromboembolism: a population-based case-control study. Journal of Thrombosis and Haemostasis 2009;7(4):521-8. [DOI: 10.1111/j.1538-7836.2009.03279.x] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2009.03279.x</ArticleId><ArticleId IdType="pubmed">19192118</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Tagalakis&#xa0;2013</Title><Reference><Citation>Tagalakis V, Patenaude V, Kahn SR, Suissa S. Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE study cohort. American Journal of Medicine 2013;126(9):832.e13-21. [DOI: 10.1016/j.amjmed.2013.02.024] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2013.02.024</ArticleId><ArticleId IdType="pubmed">23830539</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Taylor 2013</Title><Reference><Citation>Taylor F, Huffman MD, Macedo AF, Moore TH, Burke M, Davey Smith G, et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews 2013, Issue 1. Art. No: CD004816. [DOI: 10.1002/14651858.CD004816.pub5] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD004816.pub5</ArticleId><ArticleId IdType="pmc">PMC6481400</ArticleId><ArticleId IdType="pubmed">23440795</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Thakker 2016</Title><Reference><Citation>Thakker D, Nair S, Pagada A, Jamdade V, Malik A. Statin use and the risk of developing diabetes: a network meta-analysis. Pharmacoepidemiology and Drug Safety 2016;25(10):1131-49. [DOI: 10.1002/pds.4020] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.4020</ArticleId><ArticleId IdType="pubmed">27277934</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Thorlund 2011</Title><Reference><Citation>Thorlund K, Engstr&#xf8;m J, Wetterslev J, Brok J, Imberger G, Gluud C. User Manual for Trial Sequential Analysis (TSA). Copenhagen, Denmark: Copenhagen Trial Unit, Centre for Clinical Intervention Research, 2011. [URL: www.ctu.dk/tsa]</Citation></Reference></ReferenceList><ReferenceList><Title>Undas 2005</Title><Reference><Citation>Undas A, Brummel-Ziedins KE, Mann KG. Statins and blood coagulation. Arteriosclerosis, Thrombosis, and Vascular Biology 2005;25(2):287-94. [DOI: 10.1161/01.ATV.0000151647.14923.ec] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.ATV.0000151647.14923.ec</ArticleId><ArticleId IdType="pubmed">15569822</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Undas 2022</Title><Reference><Citation>Undas A. Statins in prevention of thromboembolic events: from seminal studies to recent advances. Polish Archives of Internal Medicine 2022;132(2):16208. [DOI: 10.20452/pamw.16208] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.20452/pamw.16208</ArticleId><ArticleId IdType="pubmed">35226441</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Wallace 2017</Title><Reference><Citation>Wallace A, Albadawi H, Hoang P, Fleck A, Naidu S, Knuttinen G, et al. Statins as a preventative therapy for venous thromboembolism. Cardiovascular Diagnosis and Therapy 2017;7(Suppl 3):S207-18. [DOI: 10.21037/cdt.2017.09.12] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/cdt.2017.09.12</ArticleId><ArticleId IdType="pmc">PMC5778529</ArticleId><ArticleId IdType="pubmed">29399524</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Wetterslev 2009</Title><Reference><Citation>Wetterslev J, Thorlund K, Brok J, Gluud C. Estimating required information size by quantifying diversity in random-effects model meta-analyses. BMC Medical Research Methodology 2009;9:86. [PMID: 10.1186/1471-2288-9-86] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-9-86</ArticleId><ArticleId IdType="pmc">PMC2809074</ArticleId><ArticleId IdType="pubmed">20042080</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Yang 2002</Title><Reference><Citation>Yang CC, Jick SS, Jick H. Statins and the risk of idiopathic venous thromboembolism. British Journal of Clinical Pharmacology 2002;53(1):101-5. [DOI: 10.1046/j.0306-5251.2001.01523.x] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.0306-5251.2001.01523.x</ArticleId><ArticleId IdType="pmc">PMC1874555</ArticleId><ArticleId IdType="pubmed">11849201</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Zaccardi 2018</Title><Reference><Citation>Zaccardi F, Kunutsor SK, Seidu S, Davies MJ, Khunti K. Is the lower risk of venous thromboembolism with statins related to low-density-lipoprotein reduction? A network meta-analysis and meta-regression of randomised controlled trials. Atherosclerosis 2018;271:223-31. [DOI: 10.1016/j.atherosclerosis.2018.02.035] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.atherosclerosis.2018.02.035</ArticleId><ArticleId IdType="pubmed">29524865</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to other published versions of this review</Title><ReferenceList><Title>Zhang 2021</Title><Reference><Citation>Zhang P, Li L, Tian J, Zhang P, Yang K. Statins for the prevention of primary venous thromboembolism. Cochrane Database of Systematic Reviews 2021, Issue 6. Art. No: CD014769. [DOI: 10.1002/14651858.CD014769]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD014769</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">37526740</PMID><DateRevised><Year>2023</Year><Month>10</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1436-3771</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Clinical oral investigations</Title><ISOAbbreviation>Clin Oral Investig</ISOAbbreviation></Journal><ArticleTitle>The influence of anxiety on pain perception and its repercussion on endodontic treatment: a systematic review.</ArticleTitle><Pagination><StartPage>5709</StartPage><EndPage>5718</EndPage><MedlinePgn>5709-5718</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00784-023-05181-1</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To evaluate the influence of dental anxiety on the perception of pain before and during endodontic treatments.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">The PRISMA checklist was followed. A search was conducted in Scopus, Medline/PubMed, The Cochrane Library, and Web of Science databases. Based on PECOS criteria, the first outcome was a possible association between pre-operative pain and anxiety. The second outcome was a possible association between intraoperative pain and anxiety. The type of studies was observational. The JBI Critical Appraisal Checklist was used to evaluate the methodological quality of articles. The certainty of the evidence was analyzed using the GRADE approach.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Four articles were included with a total of 471 patients. Two studies found a positive association between pain and pre-endodontic treatment anxiety. Three studies investigated the relationship between anxiety and intraoperative pain; two identified an extremely significant positive association. One article noted that anxiety influences pain expectancy. The studies were of good quality as assessed by the JBI Critical Appraisal Checklist for cross-sectional studies. However, the certainty of the evidence was considered low and very low.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Dental anxiety can be directly associated with pre- and intraoperative pain during endodontic procedures.</AbstractText><AbstractText Label="CLINICAL RELEVANCE" NlmCategory="CONCLUSIONS">It is necessary to identify patients with dental anxiety to employ therapies to bring their anxiety under control, avoiding the increase of endodontic infections, and the postponement and evasion of endodontic treatments.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Farias</LastName><ForeName>Zilda Bet&#xe2;nia Barbosa Medeiros de</ForeName><Initials>ZBBM</Initials><Identifier Source="ORCID">0000-0001-9549-2260</Identifier><AffiliationInfo><Affiliation>Department of Oral and Maxillofacial Pathology, School of Dentistry, University of Pernambuco (UPE), Rua Arn&#xf3;bio Marqu&#xea;s, 310 - Santo Amaro, Recife, PE, 50100-130, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campello</LastName><ForeName>Camilla Porto</ForeName><Initials>CP</Initials><Identifier Source="ORCID">0000-0001-6689-5466</Identifier><AffiliationInfo><Affiliation>Department of Hebiatrics, Determinants of Health in Adolescence, School of Dentistry, University of Pernambuco (UPE), Recife, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Silveira</LastName><ForeName>M&#xe1;rcia Maria Fonseca</ForeName><Initials>MMF</Initials><Identifier Source="ORCID">0000-0002-2611-5661</Identifier><AffiliationInfo><Affiliation>Department of Oral and Maxillofacial Pathology, School of Dentistry, University of Pernambuco (UPE), Rua Arn&#xf3;bio Marqu&#xea;s, 310 - Santo Amaro, Recife, PE, 50100-130, Brazil. marcia.silveira@upe.br.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moraes</LastName><ForeName>Sandra L&#xfa;cia Dantas</ForeName><Initials>SLD</Initials><Identifier Source="ORCID">0000-0002-3154-5092</Identifier><AffiliationInfo><Affiliation>Department of Prosthodontics, School of Dentistry, University of Pernambuco (UPE), Recife, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>do Egito Vasconcelos</LastName><ForeName>Belmiro Cavalcanti</ForeName><Initials>BC</Initials><Identifier Source="ORCID">0000-0002-6515-1489</Identifier><AffiliationInfo><Affiliation>Department of Oral and Maxillofacial Surgery, School of Dentistry, University of Pernambuco (UPE), Recife, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pellizzer</LastName><ForeName>Eduardo Piza</ForeName><Initials>EP</Initials><Identifier Source="ORCID">0000-0003-0670-5004</Identifier><AffiliationInfo><Affiliation>Department of Dental Materials and Prosthodontics, Dental School of Ara&#xe7;atuba, S&#xe3;o Paulo State University (UNESP), Jos&#xe9; Bonifacio street 1193, Ara&#xe7;atuba, S&#xe3;o Paulo, 1605000, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Clin Oral Investig</MedlineTA><NlmUniqueID>9707115</NlmUniqueID><ISSNLinking>1432-6981</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Dental anxiety</Keyword><Keyword MajorTopicYN="N">Endodontics</Keyword><Keyword MajorTopicYN="N">Pain</Keyword><Keyword MajorTopicYN="N">Root canal therapy</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>1</Day><Hour>13</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>1</Day><Hour>13</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>1</Day><Hour>11</Hour><Minute>6</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37526740</ArticleId><ArticleId IdType="doi">10.1007/s00784-023-05181-1</ArticleId><ArticleId IdType="pii">10.1007/s00784-023-05181-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>American Psychiatric Association (2013) Glossary of technical terms: diagnostic and statistical manual of mental disorders. American Psychiatric Association Publishing, Arlington</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.books.9780890425596</ArticleId></ArticleIdList></Reference><Reference><Citation>Tellez M, Kinner DG, Heimberg RG, Lim S, Ismail AI (2015) Prevalence and correlates of dental anxiety in patients seeking dental care. Community Dent Oral Epidemiol 43:135&#x2013;142. https://doi.org/10.1111/cdoe.12132</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cdoe.12132</ArticleId><ArticleId IdType="pubmed">25346261</ArticleId></ArticleIdList></Reference><Reference><Citation>Goettems ML, Schuch HS, Demarco FF, Ardenghi TM, Torriani DD (2014) Impact of dental anxiety and fear on dental care use in Brazilian women. J Public Health Dent 74:310&#x2013;316. https://doi.org/10.1111/jphd.12060</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jphd.12060</ArticleId><ArticleId IdType="pubmed">24946683</ArticleId></ArticleIdList></Reference><Reference><Citation>Halonen H, Nissinen J, Lehtiniemi H, Salo T, Riipinen P, Miettunen J (2018) The association between dental anxiety and psychiatric disorders and symptoms: a systematic review. Clin Pract Epidemiol Ment Health 14:207&#x2013;222. https://doi.org/10.2174/1745017901814010207</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1745017901814010207</ArticleId><ArticleId IdType="pubmed">30288171</ArticleId><ArticleId IdType="pmc">6142663</ArticleId></ArticleIdList></Reference><Reference><Citation>Prathima V, Anjum MS, Reddy PP, Jayakumar A, Mounica M (2014) Assessment of anxiety related to dental treatments among patients attending dental clinics and hospitals in Ranga Reddy District, Andhra Pradesh, India. Oral Health Prev Dent 12:357&#x2013;364. https://doi.org/10.3290/j.ohpd.a31660</Citation><ArticleIdList><ArticleId IdType="doi">10.3290/j.ohpd.a31660</ArticleId><ArticleId IdType="pubmed">24624386</ArticleId></ArticleIdList></Reference><Reference><Citation>Rayman S, Dincer E, Almas K (2013) Managing dental fear and anxiety. N Y State Dent J 79:25&#x2013;29</Citation><ArticleIdList><ArticleId IdType="pubmed">24600761</ArticleId></ArticleIdList></Reference><Reference><Citation>Carter AE, Carter G, George R (2015) Pathways of fear and anxiety in endodontic patients. Int Endod J 48:528&#x2013;532. https://doi.org/10.1111/iej.12343</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/iej.12343</ArticleId><ArticleId IdType="pubmed">25066388</ArticleId></ArticleIdList></Reference><Reference><Citation>Alroomy R, Kim D, Hochberg R, Chubak J, Rosenberg P, Malek M (2020) Factors influencing pain and anxiety before endodontic treatment: a cross-sectional study amongst American individuals. Eur Endod J 5:199&#x2013;204. https://doi.org/10.14744/eej.2020.17363</Citation><ArticleIdList><ArticleId IdType="doi">10.14744/eej.2020.17363</ArticleId><ArticleId IdType="pubmed">33353908</ArticleId><ArticleId IdType="pmc">7881385</ArticleId></ArticleIdList></Reference><Reference><Citation>Dou L, Vanschaayk MM, Zhang Y, Fu X, Ji P, Yang D (2018) The prevalence of dental anxiety and its association with pain and other variables among adult patients with irreversible pulpitis. BMC Oral Health 18:101. https://doi.org/10.1186/s12903-018-0563-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12903-018-0563-x</ArticleId><ArticleId IdType="pubmed">29879974</ArticleId><ArticleId IdType="pmc">5992818</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunningham CJ, Mullaney TP (1992) Pain control in endodontics. Dent Clin North Am 36:393&#x2013;408</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0011-8532(22)02503-4</ArticleId><ArticleId IdType="pubmed">1572506</ArticleId></ArticleIdList></Reference><Reference><Citation>Craveiro MA, Caldeira CL (2020) Influence of an audiovisual resource on the preoperative anxiety of adult endodontic patients: a randomized controlled clinical trial. J Endod 46:909&#x2013;914. https://doi.org/10.1016/j.joen.2020.03.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joen.2020.03.024</ArticleId><ArticleId IdType="pubmed">32389383</ArticleId></ArticleIdList></Reference><Reference><Citation>Maggirias J, Locker D (2002) Psychological factors and perceptions of pain associated with dental treatment. Community Dent Oral Epidemiol 30:151&#x2013;159. https://doi.org/10.1034/j.1600-0528.2002.300209.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1600-0528.2002.300209.x</ArticleId><ArticleId IdType="pubmed">12000356</ArticleId></ArticleIdList></Reference><Reference><Citation>Law AS, Nixdorf DR, Aguirre AM, Reams GJ, Tortomasi AJ, Manne BD, Harris DR, National Dental PBRN Collaborative Group (2015) Predicting severe pain after root canal therapy in the National Dental PBRN. J Dent Res 94:37S&#x2013;43S. https://doi.org/10.1177/0022034514555144</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0022034514555144</ArticleId><ArticleId IdType="pubmed">25355775</ArticleId><ArticleId IdType="pmc">4336154</ArticleId></ArticleIdList></Reference><Reference><Citation>Watkins CA, Logan HL, Kirchner HL (2002) Anticipated and experienced pain associated with endodontic therapy. J Am Dent Assoc 133:45&#x2013;54. https://doi.org/10.14219/jada.archive.2002.0020</Citation><ArticleIdList><ArticleId IdType="doi">10.14219/jada.archive.2002.0020</ArticleId><ArticleId IdType="pubmed">11811742</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;n-Gonz&#xe1;lez J, Echevarr&#xed;a-P&#xe9;rez M, S&#xe1;nchez-Dom&#xed;nguez B, Tarilonte-Delgado ML, Castellanos-Cosano L, L&#xf3;pez-Fr&#xed;as FJ, Segura-Egea JJ (2012) Influence of root canal instrumentation and obturation techniques on intra-operative pain during endodontic therapy. Med Oral Patol Oral Cir Bucal 17:e912&#x2013;e918. https://doi.org/10.4317/medoral.18234</Citation><ArticleIdList><ArticleId IdType="doi">10.4317/medoral.18234</ArticleId><ArticleId IdType="pubmed">22549694</ArticleId><ArticleId IdType="pmc">3482542</ArticleId></ArticleIdList></Reference><Reference><Citation>Eitner S, Wichmann M, Paulsen A, Holst S (2006) Dental anxiety--an epidemiological study on its clinical correlation and effects on oral health. J Oral Rehabil 33:588&#x2013;593. https://doi.org/10.1111/j.1365-2842.2005.01589.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2842.2005.01589.x</ArticleId><ArticleId IdType="pubmed">16856956</ArticleId></ArticleIdList></Reference><Reference><Citation>Perkovi&#x107; I, Romi&#x107; MK, Peri&#x107; M, Krmek SJ (2014) The level of anxiety and pain perception of endodontic patients. Acta Stomatol Croat 48:258&#x2013;267. https://doi.org/10.15644/asc47/4/3</Citation><ArticleIdList><ArticleId IdType="doi">10.15644/asc47/4/3</ArticleId><ArticleId IdType="pubmed">27688374</ArticleId><ArticleId IdType="pmc">4872819</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu LT, Lin CS, Yang SF (2022) Association between pain, anxiety, and pain relief in patients receiving emergent endodontic treatment. Clin Oral Investig 26:275&#x2013;285. https://doi.org/10.1007/s00784-021-03997-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00784-021-03997-3</ArticleId><ArticleId IdType="pubmed">34080062</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr&#xf3;bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 29:372. https://doi.org/10.1136/bmj.n71</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId></ArticleIdList></Reference><Reference><Citation>Aromataris E, Munn Z (eds) (2020) JBI Manual for evidence synthesis. Available from https://synthesismanual.jbi.global . Accessed 2 June 2022</Citation></Reference><Reference><Citation>Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, Norris S, Falck-Ytter Y, Glasziou P, DeBeer H, Jaeschke R, Rind D, Meerpohl J, Dahm P, Sch&#xfc;nemann HJ (2011) GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 64:383&#x2013;394. https://doi.org/10.1016/j.jclinepi.2010.04.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2010.04.026</ArticleId><ArticleId IdType="pubmed">21195583</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandraweera L, Goh K, Lai-Tong J, Newby J, Abbott P (2019) A survey of patients&#x2019; perceptions about, and their experiences of, root canal treatment. Aust Endod J 45:225&#x2013;232. https://doi.org/10.1111/aej.12312</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aej.12312</ArticleId><ArticleId IdType="pubmed">30341798</ArticleId></ArticleIdList></Reference><Reference><Citation>Murillo-Ben&#xed;tez M, Mart&#xed;n-Gonz&#xe1;lez J, Jim&#xe9;nez-S&#xe1;nchez MC, Cabanillas-Balsera D, Velasco-Ortega E, Segura-Egea JJ (2020) Association between dental anxiety and intraoperative pain during root canal treatment: a cross-sectional study. Int Endod J 53:447&#x2013;454. https://doi.org/10.1111/iej.13245</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/iej.13245</ArticleId><ArticleId IdType="pubmed">31691312</ArticleId></ArticleIdList></Reference><Reference><Citation>Segura-Egea JJ, Cisneros-Cabello R, Llamas-Carreras JM, Velasco-Ortega E (2009) Pain associated with root canal treatment. Int Endod J 42:614&#x2013;620. https://doi.org/10.1111/j.1365-2591.2009.01562.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2591.2009.01562.x</ArticleId><ArticleId IdType="pubmed">19467050</ArticleId></ArticleIdList></Reference><Reference><Citation>Montero J, Lorenzo B, Barrios R, Albaladejo A, Mir&#xf3;n Canelo JA, L&#xf3;pez-Valverde A (2015) Patient-centered outcomes of root canal treatment: a cohort follow-up study. J Endod 41:1456&#x2013;1461. https://doi.org/10.1016/j.joen.2015.06.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joen.2015.06.003</ArticleId><ArticleId IdType="pubmed">26211565</ArticleId></ArticleIdList></Reference><Reference><Citation>AlRahabi MK (2017) Predictors, prevention, and management of postoperative pain associated with nonsurgical root canal treatment: a systematic review. J Taibah Univ Med Sci 12:376&#x2013;384. https://doi.org/10.1016/j.jtumed.2017.03.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtumed.2017.03.004</ArticleId><ArticleId IdType="pubmed">31435267</ArticleId><ArticleId IdType="pmc">6695063</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes-Gilabert E, Luque-Romero LG, Bejarano-Avila G, Garcia-Palma A, Rollon-Mayordomo A, Infante-Cossio P (2017) Assessment of pre and postoperative anxiety in patients undergoing ambulatory oral surgery in primary care. Med Oral Patol Oral Cir Bucal 22:e716&#x2013;e722. https://doi.org/10.4317/medoral.21929</Citation><ArticleIdList><ArticleId IdType="doi">10.4317/medoral.21929</ArticleId><ArticleId IdType="pubmed">29053655</ArticleId><ArticleId IdType="pmc">5813990</ArticleId></ArticleIdList></Reference><Reference><Citation>Tickle M, Milsom K, Crawford FI, Aggarwal VR (2012) Predictors of pain associated with routine procedures performed in general dental practice. Community Dent Oral Epidemiol 40:343&#x2013;350. https://doi.org/10.1111/j.1600-0528.2012.00673.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0528.2012.00673.x</ArticleId><ArticleId IdType="pubmed">22316006</ArticleId></ArticleIdList></Reference><Reference><Citation>Fillingim RB (2017) Individual differences in pain: understanding the mosaic that makes pain personal. Pain 158:S11&#x2013;S18. https://doi.org/10.1097/j.pain.0000000000000775</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000000775</ArticleId><ArticleId IdType="pubmed">27902569</ArticleId><ArticleId IdType="pmc">5350021</ArticleId></ArticleIdList></Reference><Reference><Citation>Shankland WE 2nd. (2011) Factors that affect pain behavior. Cranio 29:144&#x2013;154. https://doi.org/10.1179/crn.2011.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/crn.2011.023</ArticleId><ArticleId IdType="pubmed">21661589</ArticleId></ArticleIdList></Reference><Reference><Citation>Richert R, Ducret M, Alliot-Licht B, Bekhouche M, Gobert S, Farges JC (2022) A critical analysis of research methods and experimental models to study pulpitis. Int Endod J 55:14&#x2013;36. https://doi.org/10.1111/iej.13683</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/iej.13683</ArticleId><ArticleId IdType="pubmed">35034368</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamedy R, Shakiba B, Fayazi S, Pak JG, White SN (2013) Patient-centered endodontic outcomes: a narrative review. Iran Endod J 8:197&#x2013;204</Citation><ArticleIdList><ArticleId IdType="pubmed">24171029</ArticleId><ArticleId IdType="pmc">3808681</ArticleId></ArticleIdList></Reference><Reference><Citation>Grupe DW, Nitschke JB (2013) Uncertainty and anticipation in anxiety: an integrated neurobiological and psychological perspective. Nat Rev Neurosci 14:488&#x2013;501. https://doi.org/10.1038/nrn3524</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3524</ArticleId><ArticleId IdType="pubmed">23783199</ArticleId><ArticleId IdType="pmc">4276319</ArticleId></ArticleIdList></Reference><Reference><Citation>Appukuttan D, Subramanian S, Tadepalli A, Damodaran LK (2015) Dental anxiety among adults: an epidemiological study in South India. N Am J Med Sci 7:13&#x2013;18. https://doi.org/10.4103/1947-2714.150082</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1947-2714.150082</ArticleId><ArticleId IdType="pubmed">25709973</ArticleId><ArticleId IdType="pmc">4325391</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller M, Schorle S, Vach K, Hartmann A, Zeeck A, Schlueter N (2022) Relationship between dental experiences, oral hygiene education and self-reported oral hygiene behaviour. PLoS One 17:e0264306. https://doi.org/10.1371/journal.pone.0264306</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0264306</ArticleId><ArticleId IdType="pubmed">35202439</ArticleId><ArticleId IdType="pmc">8870456</ArticleId></ArticleIdList></Reference><Reference><Citation>van Wijk AJ, Hoogstraten J (2006) Reducing fear of pain associated with endodontic therapy. Int Endod J 39:384&#x2013;388. https://doi.org/10.1111/j.1365-2591.2006.01090.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2591.2006.01090.x</ArticleId><ArticleId IdType="pubmed">16640637</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos-Puerta N, Pe&#xf1;acoba-Puente C (2022) Pain and avoidance during and after endodontic therapy: the role of pain anticipation and self-efficacy. Int J Environ Res Public Health 19:1399. https://doi.org/10.3390/ijerph19031399</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19031399</ArticleId><ArticleId IdType="pubmed">35162422</ArticleId><ArticleId IdType="pmc">8834740</ArticleId></ArticleIdList></Reference><Reference><Citation>Pak JG, White SN (2011) Pain prevalence and severity before, during, and after root canal treatment: a systematic review. J Endod 37:429&#x2013;438. https://doi.org/10.1016/j.joen.2010.12.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joen.2010.12.016</ArticleId><ArticleId IdType="pubmed">21419285</ArticleId></ArticleIdList></Reference><Reference><Citation>Armfield JM, Heaton LJ (2013) Management of fear and anxiety in the dental clinic: a review. Aust Dent J 58:390&#x2013;407. https://doi.org/10.1111/adj.12118</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/adj.12118</ArticleId><ArticleId IdType="pubmed">24320894</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradt J, Teague A (2018) Music interventions for dental anxiety. Oral Dis 24:300&#x2013;306. https://doi.org/10.1111/odi.12615</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/odi.12615</ArticleId><ArticleId IdType="pubmed">27886431</ArticleId></ArticleIdList></Reference><Reference><Citation>Sud S, Sud N (2012) Dental anxiety and oral health care in India the role of self-efficacy. J Psychosoc Res 7:1&#x2013;9</Citation></Reference><Reference><Citation>Di Nasso L, Nizzardo A, Pace R, Pierleoni F, Pagavino G, Giuliani V (2016) Influences of 432 Hz music on the perception of anxiety during endodontic treatment: a randomized controlled clinical trial. J Endod 42:1338&#x2013;1343. https://doi.org/10.1016/j.joen.2016.05.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joen.2016.05.015</ArticleId><ArticleId IdType="pubmed">27430941</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma MR, Rao RD, Langade D, Jain AK, Guha A, Mohan M (2021) Assessment of yogic relaxation techniques for its anxiolytic effects in patients requiring endodontic treatment: a prospective, randomized controlled study. J Conserv Dent 24(2):209&#x2013;213. https://doi.org/10.4103/jcd.jcd_97_21</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jcd.jcd_97_21</ArticleId><ArticleId IdType="pubmed">34759592</ArticleId><ArticleId IdType="pmc">8562829</ArticleId></ArticleIdList></Reference><Reference><Citation>Berggren U, Hakeberg M, Carlsson SG (2000) Relaxation vs. cognitively oriented therapies for dental fear. J Dent Res 79:1645&#x2013;1651. https://doi.org/10.1177/00220345000790090201</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00220345000790090201</ArticleId><ArticleId IdType="pubmed">11023258</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundgren J, Carlsson SG, Berggren U (2006) Relaxation versus cognitive therapies for dental fear--a psychophysiological approach. Health Psychol 25:267&#x2013;273. https://doi.org/10.1037/0278-6133.25.3.267</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/0278-6133.25.3.267</ArticleId><ArticleId IdType="pubmed">16719597</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies JG, Wilson KI, Clements AL (2011) A joint approach to treating dental phobia: a re-evaluation of a collaboration between community dental services and specialist psychotherapy services ten years on. Br Dent J 211:159&#x2013;162. https://doi.org/10.1038/sj.bdj.2011.674</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.bdj.2011.674</ArticleId><ArticleId IdType="pubmed">21869789</ArticleId></ArticleIdList></Reference><Reference><Citation>Choy Y, Fyer AJ, Lipsitz JD (2007) Treatment of specific phobia in adults. Clin Psychol Ver 27:266&#x2013;286. https://doi.org/10.1016/j.cpr.2006.10.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cpr.2006.10.002</ArticleId></ArticleIdList></Reference><Reference><Citation>GBD (2019) Mental Disorders Collaborators (2022) Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiat 9:137&#x2013;150. https://doi.org/10.1016/S2215-0366(21)00395-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00395-3</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40683912</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>19</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jul</Month><Day>19</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Cardiorespiratory fitness after correction of pectus excavatum: a systematic review with meta-analysis.</ArticleTitle><Pagination><StartPage>26282</StartPage><MedlinePgn>26282</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">26282</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-025-08038-7</ELocationID><Abstract><AbstractText>Pectus excavatum or funnel chest is the most prevalent chest wall deformity. Surgical correction is the treatment of choice which is predominantly performed on children and adolescents, often with significant surgical complication rates. While correction is primarily pursued for aesthetic reasons, proponents argue that correction of the inward deformity alleviates compression of the heart, consequently enhancing cardiorespiratory fitness. This systematic review and meta-analysis aims to assess whether surgical correction of pectus excavatum yields improvements in cardiorespiratory fitness, quantified as maximal oxygen uptake ([Formula: see text]O<sub>2</sub>max). A search of PubMed, Scopus, and Embase was conducted for studies evaluating the changes in [Formula: see text]O<sub>2</sub>max/[Formula: see text]O<sub>2</sub>peak following surgical correction of pectus excavatum. Systematic qualitative evaluation of the included studies utilized the Risk of Bias in Non-randomized Studies of Interventions tool. Quantitative assessment of intervention effect sizes was executed using a random-effects model, supplemented by meta-regression. Among the 1,598 screened studies, 15 non-randomized studies were included. Systematic qualitative assessment revealed serious or critical risk of bias in all included studies. Quantitative assessment identified systematic errors in outcome measurements in several studies. Following surgical correction, we found no statistically or clinically significant improvement in [Formula: see text]O<sub>2</sub>max/[Formula: see text]O<sub>2</sub>peak. Our findings highlight a lack of high-quality studies in this field of research. Our analysis could not demonstrate any significant physiological impacts resulting from PE correction. Future studies should adopt randomized controlled trial designs and implement rigorous testing protocols for [Formula: see text]O<sub>2</sub>max/[Formula: see text]O<sub>2</sub>peak. The outcome of this study should prompt a restrained and cautious approach in communicating enhancement of physiological effects arising from surgical correction of pectus excavatum.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Media</LastName><ForeName>Ara S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic and Vascular Surgery, Aarhus University Hospital, 8200, Aarhus N, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Juhl-Olesen</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic and Vascular Surgery, Aarhus University Hospital, 8200, Aarhus N, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, Aarhus University, 8200, Aarhus N, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Christensen</LastName><ForeName>Thomas Decker</ForeName><Initials>TD</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic and Vascular Surgery, Aarhus University Hospital, 8200, Aarhus N, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, Aarhus University, 8200, Aarhus N, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katballe</LastName><ForeName>Niels</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic and Vascular Surgery, Aarhus University Hospital, 8200, Aarhus N, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, Aarhus University, 8200, Aarhus N, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vad</LastName><ForeName>Henrik</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Rigshospitalet, 2100, Copenhagen &#xd8;, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petersen</LastName><ForeName>Ren&#xe9; Horsleben</ForeName><Initials>RH</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Rigshospitalet, 2100, Copenhagen &#xd8;, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiggers</LastName><ForeName>Henrik</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine, Aarhus University, 8200, Aarhus N, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Aarhus University Hospital, 8200, Aarhus N, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hansen</LastName><ForeName>Stefan Nygaard</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Department of Public Health, Department of Biostatistics, Aarhus University, 8000, Aarhus C, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farup</LastName><ForeName>Jean</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biomedicine, Aarhus University, Ole Worms All&#xe9;, 8000, Aarhus C, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Steno Diabetes Center Aarhus, 8200, Aarhus N, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Overgaard</LastName><ForeName>Kristian</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Public Health - Sport Science, Aarhus University, 8000, Aarhus C, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Paoli</LastName><ForeName>Frank Vincenzo</ForeName><Initials>FV</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic and Vascular Surgery, Aarhus University Hospital, 8200, Aarhus N, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedicine, Aarhus University, Ole Worms All&#xe9;, 8000, Aarhus C, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005660" MajorTopicYN="Y">Funnel Chest</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072599" MajorTopicYN="Y">Cardiorespiratory Fitness</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010101" MajorTopicYN="N">Oxygen Consumption</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CPET</Keyword><Keyword MajorTopicYN="N">Cardiopulmonary fitness</Keyword><Keyword MajorTopicYN="N">Exercise tolerance</Keyword><Keyword MajorTopicYN="N">O2max</Keyword><Keyword MajorTopicYN="N">Pectus excavatum</Keyword><Keyword MajorTopicYN="N">Physical capacity</Keyword></KeywordList><CoiStatement>Declarations. Competing interests: The authors declare no competing interests. Institutional Review Board (IRB) approval: Institutional Review Board (IRB) approval was not required since data is extracted from already published papers (Systematic Review and Meta-analysis). Disclosures: TDC: Speaker bureaus for Novartis, AstraZeneca, Bristol-Myers Squibb, Chiesi Pharma AB and GSK (GlaxoSmithKline) and has been in an Advisory Board for Merck Sharp &amp; Dohme (MSD), Sanofi and AstraZeneca. RHP: Speaker fee Medtronic, AMBU, Medela, AstraZeneca. Adv. Board: AstraZeneca, BMS, MSD and Roche. All other authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>20</Day><Hour>4</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>20</Day><Hour>4</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>19</Day><Hour>23</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40683912</ArticleId><ArticleId IdType="pmc">PMC12276308</ArticleId><ArticleId IdType="doi">10.1038/s41598-025-08038-7</ArticleId><ArticleId IdType="pii">10.1038/s41598-025-08038-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Krasopoulos, G., Dusmet, M., Ladas, G. &amp; Goldstraw, P. Nuss procedure improves the quality of life in young male adults with pectus excavatum deformity. <i>Eur. J. Cardiothorac. Surg.</i><b>29</b> (1), 1&#x2013;5 (2006).
</Citation><ArticleIdList><ArticleId IdType="pubmed">16337131</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawson, M. L. et al. A pilot study of the impact of surgical repair on disease-specific quality of life among patients with pectus excavatum. <i>J. Pediatr. Surg.</i><b>38</b> (6), 916&#x2013;918 (2003).
</Citation><ArticleIdList><ArticleId IdType="pubmed">12778393</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts, J., Hayashi, A., Anderson, J. O., Martin, J. M. &amp; Maxwell, L. L. Quality of life of patients who have undergone the Nuss procedure for pectus excavatum: preliminary findings. <i>J. Pediatr. Surg.</i><b>38</b> (5), 779&#x2013;783 (2003).
</Citation><ArticleIdList><ArticleId IdType="pubmed">12720193</ArticleId></ArticleIdList></Reference><Reference><Citation>Tardy, M. M. et al. Exercise cardiac output limitation in pectus excavatum. <i>J. Am. Coll. Cardiol.</i><b>66</b> (8), 976&#x2013;977 (2015).
</Citation><ArticleIdList><ArticleId IdType="pubmed">26293769</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Granillo, G. A. et al. Impact of pectus excavatum on cardiac morphology and function according to the site of maximum compression: Effect of physical exertion and respiratory cycle. <i>Eur. Heart J. Cardiovasc. Imaging</i>. <b>21</b> (1), 77&#x2013;84 (2020).
</Citation><ArticleIdList><ArticleId IdType="pubmed">30938414</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu-Tair, T. et al. Impact of pectus excavatum on cardiopulmonary function. <i>Ann. Thorac. Surg.</i><b>105</b> (2), 455&#x2013;460 (2018).
</Citation><ArticleIdList><ArticleId IdType="pubmed">29248153</ArticleId></ArticleIdList></Reference><Reference><Citation>Obermeyer, R. J., Cohen, N. S. &amp; Jaroszewski, D. E. The physiologic impact of pectus excavatum repair. <i>Semin Pediatr. Surg.</i><b>27</b> (3), 127&#x2013;132 (2018).
</Citation><ArticleIdList><ArticleId IdType="pubmed">30078483</ArticleId></ArticleIdList></Reference><Reference><Citation>Swanson, J. W. et al. Correlating Haller index and cardiopulmonary disease in pectus excavatum. <i>Am. J. Surg.</i><b>203</b> (5), 660&#x2013;664 (2012).
</Citation><ArticleIdList><ArticleId IdType="pubmed">22417849</ArticleId></ArticleIdList></Reference><Reference><Citation>Maagaard, M. &amp; Heiberg, J. Improved cardiac function and exercise capacity following correction of pectus excavatum: A review of current literature. <i>Ann. Cardiothorac. Surg.</i><b>5</b> (5), 485&#x2013;492 (2016).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5056930</ArticleId><ArticleId IdType="pubmed">27747182</ArticleId></ArticleIdList></Reference><Reference><Citation>Coln, E., Carrasco, J. &amp; Coln, D. Demonstrating relief of cardiac compression with the Nuss minimally invasive repair for pectus excavatum. <i>J. Pediatr. Surg.</i><b>41</b> (4), 683&#x2013;686 (2006). discussion &#x2013;&#x2009;6.
</Citation><ArticleIdList><ArticleId IdType="pubmed">16567176</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly, R. E. Jr. et al. Surgical repair of pectus excavatum markedly improves body image and perceived ability for physical activity: multicenter study. <i>Pediatrics</i><b>122</b> (6), 1218&#x2013;1222 (2008).
</Citation><ArticleIdList><ArticleId IdType="pubmed">19047237</ArticleId></ArticleIdList></Reference><Reference><Citation>Lomholt, J. J., Jacobsen, E. B., Thastum, M. &amp; Pilegaard, H. A prospective study on quality of life in youths after pectus excavatum correction. <i>Ann. Cardiothorac. Surg.</i><b>5</b> (5), 456&#x2013;465 (2016).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5056941</ArticleId><ArticleId IdType="pubmed">27747179</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong, J. Y., Park, H. J., Lee, J., Park, J. K. &amp; Jo, K. H. Cardiac morphologic changes after the Nuss operation for correction of pectus excavatum. <i>Ann. Thorac. Surg.</i><b>97</b> (2), 474&#x2013;478 (2014).
</Citation><ArticleIdList><ArticleId IdType="pubmed">24268435</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawson, M. L. et al. Impact of pectus excavatum on pulmonary function before and after repair with the Nuss procedure. <i>J. Pediatr. Surg.</i><b>40</b> (1), 174&#x2013;180 (2005).
</Citation><ArticleIdList><ArticleId IdType="pubmed">15868581</ArticleId></ArticleIdList></Reference><Reference><Citation>Maagaard, M. et al. Normalized cardiopulmonary exercise function in patients with pectus excavatum three years after operation. <i>Ann. Thorac. Surg.</i><b>96</b> (1), 272&#x2013;278 (2013).
</Citation><ArticleIdList><ArticleId IdType="pubmed">23684487</ArticleId></ArticleIdList></Reference><Reference><Citation>Malek, M. H. et al. Cardiovascular function following surgical repair of pectus excavatum: A metaanalysis. <i>Chest</i><b>130</b> (2), 506&#x2013;516 (2006).
</Citation><ArticleIdList><ArticleId IdType="pubmed">16899852</ArticleId></ArticleIdList></Reference><Reference><Citation>Redlinger, R. E. Jr. et al. Regional chest wall motion dysfunction in patients with pectus excavatum demonstrated via optoelectronic plethysmography. <i>J. Pediatr. Surg.</i><b>46</b> (6), 1172&#x2013;1176 (2011).
</Citation><ArticleIdList><ArticleId IdType="pubmed">21683217</ArticleId></ArticleIdList></Reference><Reference><Citation>Caspersen, C. J., Powell, K. E. &amp; Christenson, G. M. Physical activity, exercise, and physical fitness: Definitions and distinctions for health-related research. <i>Public. Health Rep.</i><b>100</b> (2), 126&#x2013;131 (1985).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1424733</ArticleId><ArticleId IdType="pubmed">3920711</ArticleId></ArticleIdList></Reference><Reference><Citation>Das, B. B., Recto, M. R. &amp; Yeh, T. Improvement of cardiopulmonary function after minimally invasive surgical repair of pectus excavatum (Nuss procedure) in children. <i>Ann. Pediatr. Cardiol.</i><b>12</b> (2), 77&#x2013;82 (2019).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6521667</ArticleId><ArticleId IdType="pubmed">31143030</ArticleId></ArticleIdList></Reference><Reference><Citation>Borowitz, D. et al. Pulmonary function and exercise response in patients with pectus excavatum after Nuss repair. <i>J. Pediatr. Surg.</i><b>38</b> (4), 544&#x2013;547 (2003).
</Citation><ArticleIdList><ArticleId IdType="pubmed">12677562</ArticleId></ArticleIdList></Reference><Reference><Citation>Cebeci, H. et al. The effect of pectus excavatum deformity on lung volume: Fact or myth? <i>Surg. Radiol. Anat.</i><b>42</b> (11), 1287&#x2013;1292 (2020).
</Citation><ArticleIdList><ArticleId IdType="pubmed">32495037</ArticleId></ArticleIdList></Reference><Reference><Citation>Raghuveer, G. et al. Cardiorespiratory fitness in youth: an important marker of health: A scientific statement from the American heart association. <i>Circulation</i><b>142</b> (7), e101&#x2013;e18 (2020).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7524041</ArticleId><ArticleId IdType="pubmed">32686505</ArticleId></ArticleIdList></Reference><Reference><Citation>Shephard, R. J. et al. The maximum oxygen intake. An international reference standard of cardiorespiratory fitness. <i>Bull. World Health Organ.</i><b>38</b> (5), 757&#x2013;764 (1968).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2554684</ArticleId><ArticleId IdType="pubmed">5303329</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross, R. et al. Importance of assessing cardiorespiratory fitness in clinical practice: A case for fitness as a clinical vital sign: A scientific statement from the American heart association. <i>Circulation</i><b>134</b> (24), e653&#x2013;e99 (2016).
</Citation><ArticleIdList><ArticleId IdType="pubmed">27881567</ArticleId></ArticleIdList></Reference><Reference><Citation>Coughlin, A. C. et al. When to nuss?? Patient age as a risk factor for complications of minimally invasive repair of pectus excavatum: A systematic review and meta-analysis. <i>Pediatr. Surg. Int.</i><b>38</b> (3), 365&#x2013;375 (2022).
</Citation><ArticleIdList><ArticleId IdType="pubmed">35006367</ArticleId></ArticleIdList></Reference><Reference><Citation>Media, A. S. et al. Complication rates rise with age and Haller index in minimally invasive correction of pectus excavatum: A high-volume, single-center retrospective cohort study. <i>J. Thorac. Cardiovasc. Surg.</i> (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38340954</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher, D. et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. <i>Syst. Rev.</i><b>4</b> (1), 1 (2015).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4320440</ArticleId><ArticleId IdType="pubmed">25554246</ArticleId></ArticleIdList></Reference><Reference><Citation>Page, M. J. et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. <i>Bmj</i><b>372</b>, n71 (2021).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Christopher, B., Cooper, M. A., Saleh, R., Elashoff, R. &amp; Finn, J. P. Eric W. Fronkalsrud. Anatomical and physiological improvements following surgical correction of pectus excavatum: A prospective study. D42 Interventional Pulmonology and Thoracic Surgery 2010. p. A5841&#x2013;A .</Citation></Reference><Reference><Citation>Poole, D. C. &amp; Jones, A. M. Measurement of the maximum oxygen uptake V&#x307;o(2max): V&#x307;o(2peak) is no longer acceptable. <i>J. Appl. Physiol. (1985)</i>. <b>122</b> (4), 997&#x2013;1002 (2017).
</Citation><ArticleIdList><ArticleId IdType="pubmed">28153947</ArticleId></ArticleIdList></Reference><Reference><Citation>Thornton, A. &amp; Lee, P. Publication bias in meta-analysis: Its causes and consequences. <i>J. Clin. Epidemiol.</i><b>53</b> (2), 207&#x2013;216 (2000).
</Citation><ArticleIdList><ArticleId IdType="pubmed">10729693</ArticleId></ArticleIdList></Reference><Reference><Citation>Haller, J. A. Jr. &amp; Loughlin, G. M. Cardiorespiratory function is significantly improved following corrective surgery for severe pectus excavatum. Proposed treatment guidelines. <i>J. Cardiovasc. Surg. (Torino)</i>. <b>41</b> (1), 125&#x2013;130 (2000).
</Citation><ArticleIdList><ArticleId IdType="pubmed">10836238</ArticleId></ArticleIdList></Reference><Reference><Citation>Wurtz, A. et al. Simplified open repair for anterior chest wall deformities. Analysis of results in 205 patients. <i>Orthop. Traumatol. Surg. Res.</i><b>98</b> (3), 319&#x2013;326 (2012).
</Citation><ArticleIdList><ArticleId IdType="pubmed">22483862</ArticleId></ArticleIdList></Reference><Reference><Citation>Bawazir, O. A., Montgomery, M., Harder, J. &amp; Sigalet, D. L. Midterm evaluation of cardiopulmonary effects of closed repair for pectus excavatum. <i>J. Pediatr. Surg.</i><b>40</b> (5), 863&#x2013;867 (2005).
</Citation><ArticleIdList><ArticleId IdType="pubmed">15937832</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigalet, D. L., Montgomery, M. &amp; Harder, J. Cardiopulmonary effects of closed repair of pectus excavatum. <i>J. Pediatr. Surg.</i><b>38</b> (3), 380&#x2013;385 (2003). discussion &#x2013;&#x2009;5.
</Citation><ArticleIdList><ArticleId IdType="pubmed">12632353</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigalet, D. L. et al. Long term cardiopulmonary effects of closed repair of pectus excavatum. <i>Pediatr. Surg. Int.</i><b>23</b> (5), 493&#x2013;497 (2007).
</Citation><ArticleIdList><ArticleId IdType="pubmed">17252283</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Assiri, A. et al. Operative innovation to the Nuss procedure for pectus excavatum: Operative and functional effects. <i>J. Pediatr. Surg.</i><b>44</b> (5), 888&#x2013;892 (2009).
</Citation><ArticleIdList><ArticleId IdType="pubmed">19433163</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang, M. et al. Improved cardiopulmonary exercise function after modified Nuss operation for pectus excavatum. <i>Eur. J. Cardiothorac. Surg.</i><b>41</b> (5), 1063&#x2013;1067 (2012).
</Citation><ArticleIdList><ArticleId IdType="pubmed">22219453</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravanbakhsh, S. et al. Sex differences in objective measures of adult patients presenting for pectus excavatum repair. <i>Ann. Thorac. Surg.</i><b>114</b> (4), 1159&#x2013;1167 (2022).
</Citation><ArticleIdList><ArticleId IdType="pubmed">34600903</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynn, S. R. et al. Exercise cardiorespiratory function in adolescents with pectus excavatum. Observations before and after operation. <i>J. Thorac. Cardiovasc. Surg.</i><b>99</b> (1), 41&#x2013;47 (1990).
</Citation><ArticleIdList><ArticleId IdType="pubmed">2294364</ArticleId></ArticleIdList></Reference><Reference><Citation>Quigley, P. M., Haller, J. A. Jr., Jelus, K. L., Loughlin, G. M. &amp; Marcus, C. L. Cardiorespiratory function before and after corrective surgery in pectus excavatum. <i>J. Pediatr.</i><b>128</b> (5 Pt 1), 638&#x2013;643 (1996).
</Citation><ArticleIdList><ArticleId IdType="pubmed">8627435</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaroszewski, D. E. et al. Cardiopulmonary outcomes after the Nuss procedure in pectus excavatum. <i>J. Am. Heart Assoc.</i><b>11</b> (7), e022149 (2022).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9075480</ArticleId><ArticleId IdType="pubmed">35377159</ArticleId></ArticleIdList></Reference><Reference><Citation>Neviere, R., Benhamed, L., Duva Pentiah, A. &amp; Wurtz, A. Pectus excavatum repair improves respiratory pump efficacy and cardiovascular function at exercise. <i>J. Thorac. Cardiovasc. Surg.</i><b>145</b> (2), 605&#x2013;606 (2013).
</Citation><ArticleIdList><ArticleId IdType="pubmed">22929222</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Keefe, J. et al. Longer term effects of closed repair of pectus excavatum on cardiopulmonary status. <i>J. Pediatr. Surg.</i><b>48</b> (5), 1049&#x2013;1054 (2013).
</Citation><ArticleIdList><ArticleId IdType="pubmed">23701781</ArticleId></ArticleIdList></Reference><Reference><Citation>Morshuis, W. J. et al. Exercise cardiorespiratory function before and one year after operation for pectus excavatum. <i>J. Thorac. Cardiovasc. Surg.</i><b>107</b> (6), 1403&#x2013;1409 (1994).
</Citation><ArticleIdList><ArticleId IdType="pubmed">8196380</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Frari, B. et al. The questionable benefit of pectus excavatum repair on cardiopulmonary function: a prospective study. <i>Eur. J. Cardiothorac. Surg.</i><b>61</b> (1), 75&#x2013;82 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8715845</ArticleId><ArticleId IdType="pubmed">34263302</ArticleId></ArticleIdList></Reference><Reference><Citation>Cahill, J. L., Lees, G. M. &amp; Robertson, H. T. A summary of preoperative and postoperative cardiorespiratory performance in patients undergoing pectus excavatum and carinatum repair. <i>J. Pediatr. Surg.</i><b>19</b> (4), 430&#x2013;433 (1984).
</Citation><ArticleIdList><ArticleId IdType="pubmed">6481587</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly, R. E. Jr. et al. Multicenter study of pectus excavatum, final report: Complications, static/exercise pulmonary function, and anatomic outcomes. <i>J. Am. Coll. Surg.</i><b>217</b> (6), 1080&#x2013;1089 (2013).
</Citation><ArticleIdList><ArticleId IdType="pubmed">24246622</ArticleId></ArticleIdList></Reference><Reference><Citation>Udholm, S., Maagaard, M., Pilegaard, H. &amp; Hjortdal, V. Cardiac function in adults following minimally invasive repair of pectus excavatum. <i>Interact. Cardiovasc. Thorac. Surg.</i><b>22</b> (5), 525&#x2013;529 (2016).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4892151</ArticleId><ArticleId IdType="pubmed">26860899</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka, H., Monahan, K. D. &amp; Seals, D. R. Age-predicted maximal heart rate revisited. <i>J. Am. Coll. Cardiol.</i><b>37</b> (1), 153&#x2013;156 (2001).
</Citation><ArticleIdList><ArticleId IdType="pubmed">11153730</ArticleId></ArticleIdList></Reference><Reference><Citation>Cicone, Z. S., Holmes, C. J., Fedewa, M. V., MacDonald, H. V. &amp; Esco, M. R. Age-Based prediction of maximal heart rate in children and adolescents: A systematic review and Meta-Analysis. <i>Res. Q. Exerc. Sport</i>. <b>90</b> (3), 417&#x2013;428 (2019).
</Citation><ArticleIdList><ArticleId IdType="pubmed">31157608</ArticleId></ArticleIdList></Reference><Reference><Citation>Neviere, R. et al. Cardiopulmonary response following surgical repair of pectus excavatum in adult patients. <i>Eur. J. Cardiothorac. Surg.</i><b>40</b> (2), e77&#x2013;82 (2011).
</Citation><ArticleIdList><ArticleId IdType="pubmed">21570313</ArticleId></ArticleIdList></Reference><Reference><Citation>Poston, P. M. et al. The correction index: setting the standard for recommending operative repair of pectus excavatum. <i>Ann. Thorac. Surg.</i><b>97</b> (4), 1176&#x2013;1179 (2014). discussion 9&#x2013;80.
</Citation><ArticleIdList><ArticleId IdType="pubmed">24582050</ArticleId></ArticleIdList></Reference><Reference><Citation>Castellani, C., Windhaber, J., Schober, P. H. &amp; Hoellwarth, M. E. Exercise performance testing in patients with pectus excavatum before and after Nuss procedure. <i>Pediatr. Surg. Int.</i><b>26</b> (7), 659&#x2013;663 (2010).
</Citation><ArticleIdList><ArticleId IdType="pubmed">20532529</ArticleId></ArticleIdList></Reference><Reference><Citation>Julious, S. A. Sample sizes for clinical trials with normal data. <i>Stat. Med.</i><b>23</b> (12), 1921&#x2013;1986 (2004).
</Citation><ArticleIdList><ArticleId IdType="pubmed">15195324</ArticleId></ArticleIdList></Reference><Reference><Citation>Arena, R., Myers, J. &amp; Kaminsky, L. A. Revisiting age-predicted maximal heart rate: Can it be used as a valid measure of effort? <i>Am. Heart J.</i><b>173</b>, 49&#x2013;56 (2016).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4919019</ArticleId><ArticleId IdType="pubmed">26920596</ArticleId></ArticleIdList></Reference><Reference><Citation>Neviere, R. &amp; Wurtz, A. Longer term effects of closed repair of pectus excavatum on cardiopulmonary status. <i>J. Pediatr. Surg.</i><b>48</b> (9), 1988&#x2013;1989 (2013).
</Citation><ArticleIdList><ArticleId IdType="pubmed">24074683</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;rkan, U. et al. Echocardiographic assessment of right ventricular function before and after surgery in patients with pectus excavatum and right ventricular compression. <i>Thorac. Cardiovasc. Surg.</i><b>62</b> (3), 231&#x2013;235 (2014).
</Citation><ArticleIdList><ArticleId IdType="pubmed">23619591</ArticleId></ArticleIdList></Reference><Reference><Citation>Krueger, T. et al. Cardiac function assessed by transesophageal echocardiography during pectus excavatum repair. <i>Ann. Thorac. Surg.</i><b>89</b> (1), 240&#x2013;243 (2010).
</Citation><ArticleIdList><ArticleId IdType="pubmed">20103244</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunning, J. et al. The pectus care guidelines: Best practice consensus guidelines from the joint specialist societies SCTS/MF/CWIG/BOA/BAPS for the treatment of patients with pectus abnormalities. <i>Eur. J. Cardiothorac. Surg.</i> ;<b>66</b>(1). (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38964837</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundby, C., Montero, D. &amp; Joyner, M. Biology of VO(2) max: Looking under the physiology lamp. <i>Acta Physiol. (Oxf)</i>. <b>220</b> (2), 218&#x2013;228 (2017).
</Citation><ArticleIdList><ArticleId IdType="pubmed">27888580</ArticleId></ArticleIdList></Reference><Reference><Citation>Montero, D., Diaz-Ca&#xf1;estro, C. &amp; Lundby, C. Endurance training and V&#x2d9;O2max: Role of maximal cardiac output and oxygen extraction. <i>Med. Sci. Sports Exerc.</i><b>47</b> (10), 2024&#x2013;2033 (2015).
</Citation><ArticleIdList><ArticleId IdType="pubmed">25680086</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundby, C. &amp; Robach, P. Performance enhancement: What are the physiological limits? <i>Physiol. (Bethesda)</i>. <b>30</b> (4), 282&#x2013;292 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26136542</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassett, D. R. Jr. &amp; Howley, E. T. Limiting factors for maximum oxygen uptake and determinants of endurance performance. <i>Med. Sci. Sports Exerc.</i><b>32</b> (1), 70&#x2013;84 (2000).
</Citation><ArticleIdList><ArticleId IdType="pubmed">10647532</ArticleId></ArticleIdList></Reference><Reference><Citation>Niemeyer, M., Knaier, R. &amp; Beneke, R. The oxygen uptake Plateau-A critical review of the frequently misunderstood phenomenon. <i>Sports Med.</i><b>51</b> (9), 1815&#x2013;1834 (2021).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8363556</ArticleId><ArticleId IdType="pubmed">33914281</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor, H. L., Buskirk, E. &amp; Henschel, A. Maximal oxygen intake as an objective measure of cardio-respiratory performance. <i>J. Appl. Physiol.</i><b>8</b> (1), 73&#x2013;80 (1955).
</Citation><ArticleIdList><ArticleId IdType="pubmed">13242493</ArticleId></ArticleIdList></Reference><Reference><Citation>Midgley, A. W., McNaughton, L. R., Polman, R. &amp; Marchant, D. Criteria for determination of maximal oxygen uptake: A brief critique and recommendations for future research. <i>Sports Med.</i><b>37</b> (12), 1019&#x2013;1028 (2007).
</Citation><ArticleIdList><ArticleId IdType="pubmed">18027991</ArticleId></ArticleIdList></Reference><Reference><Citation>Glassford, R. G., Baycroft, G. H., Sedgwick, A. W. &amp; Macnab, R. B. Comparison of maximal oxygen uptake values determined by predicted and actual methods. <i>J. Appl. Physiol.</i><b>20</b> (3), 509&#x2013;513 (1965).
</Citation><ArticleIdList><ArticleId IdType="pubmed">5319996</ArticleId></ArticleIdList></Reference><Reference><Citation>Astrand, P. O. &amp; Saltin, B. Maximal oxygen uptake and heart rate in various types of muscular activity. <i>J. Appl. Physiol.</i><b>16</b>, 977&#x2013;981 (1961).
</Citation><ArticleIdList><ArticleId IdType="pubmed">13863012</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyndham, C. H., Strydom, N. B., Leary, W. P. &amp; Williams, C. G. Studies of the maximum capacity of men for physical effort. I. A comparison of methods of assessing the maximum oxygen intake. <i>Int. Z. Angew Physiol.</i><b>22</b> (4), 285&#x2013;295 (1966).
</Citation><ArticleIdList><ArticleId IdType="pubmed">5989958</ArticleId></ArticleIdList></Reference><Reference><Citation>Millet, G. P., Vleck, V. E. &amp; Bentley, D. J. Physiological differences between cycling and running: Lessons from triathletes. <i>Sports Med.</i><b>39</b> (3), 179&#x2013;206 (2009).
</Citation><ArticleIdList><ArticleId IdType="pubmed">19290675</ArticleId></ArticleIdList></Reference><Reference><Citation>Stromme, S. B., Ingjer, F. &amp; Meen, H. D. Assessment of maximal aerobic power in specifically trained athletes. <i>J. Appl. Physiol. Respir Environ. Exerc. Physiol.</i><b>42</b> (6), 833&#x2013;837 (1977).
</Citation><ArticleIdList><ArticleId IdType="pubmed">881383</ArticleId></ArticleIdList></Reference><Reference><Citation>Hermansen, L., Ekblom, B. &amp; Saltin, B. Cardiac output during submaximal and maximal treadmill and bicycle exercise. <i>J. Appl. Physiol.</i><b>29</b> (1), 82&#x2013;86 (1970).
</Citation><ArticleIdList><ArticleId IdType="pubmed">4912876</ArticleId></ArticleIdList></Reference><Reference><Citation>Hermansen, L. &amp; Saltin, B. Oxygen uptake during maximal treadmill and bicycle exercise. <i>J. Appl. Physiol.</i><b>26</b> (1), 31&#x2013;37 (1969).
</Citation><ArticleIdList><ArticleId IdType="pubmed">5762873</ArticleId></ArticleIdList></Reference><Reference><Citation>Brink-Elfegoun, T., Holmberg, H. C., Ekblom, M. N. &amp; Ekblom, B. Neuromuscular and circulatory adaptation during combined arm and leg exercise with different maximal work loads. <i>Eur. J. Appl. Physiol.</i><b>101</b> (5), 603&#x2013;611 (2007).
</Citation><ArticleIdList><ArticleId IdType="pubmed">17690901</ArticleId></ArticleIdList></Reference><Reference><Citation>Langeskov-Christensen, M., Langeskov-Christensen, D., Overgaard, K., M&#xf8;ller, A. B. &amp; Dalgas, U. Validity and reliability of VO<sub>2</sub>-max measurements in persons with multiple sclerosis. <i>J. Neurol. Sci.</i><b>342</b> (1&#x2013;2), 79&#x2013;87 (2014).
</Citation><ArticleIdList><ArticleId IdType="pubmed">24825731</ArticleId></ArticleIdList></Reference><Reference><Citation>Pivarnik, J. M., Dwyer, M. C. &amp; Lauderdale, M. A. The reliability of aerobic capacity (VO2max) testing in adolescent girls. <i>Res. Q. Exerc. Sport</i>. <b>67</b> (3), 345&#x2013;348 (1996).
</Citation><ArticleIdList><ArticleId IdType="pubmed">8888423</ArticleId></ArticleIdList></Reference><Reference><Citation>Day, J. R., Rossiter, H. B., Coats, E. M., Skasick, A. &amp; Whipp, B. J. The maximally attainable VO2 during exercise in humans: The peak vs. maximum issue. <i>J. Appl. Physiol. (1985)</i>. <b>95</b> (5), 1901&#x2013;1907 (2003).
</Citation><ArticleIdList><ArticleId IdType="pubmed">12857763</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen, L. B. A maximal cycle exercise protocol to predict maximal oxygen uptake. <i>Scand. J. Med. Sci. Sports</i>. <b>5</b> (3), 143&#x2013;146 (1995).
</Citation><ArticleIdList><ArticleId IdType="pubmed">7552756</ArticleId></ArticleIdList></Reference><Reference><Citation>Katch, V. L., Sady, S. S. &amp; Freedson, P. Biological variability in maximum aerobic power. <i>Med. Sci. Sports Exerc.</i><b>14</b> (1), 21&#x2013;25 (1982).
</Citation><ArticleIdList><ArticleId IdType="pubmed">7070252</ArticleId></ArticleIdList></Reference><Reference><Citation>Beltz, N. M. et al. Graded exercise testing protocols for the determination of VO(2)max: Historical perspectives, progress, and future considerations. <i>J. Sports Med. (Hindawi Publ Corp)</i>. <b>2016</b>, 3968393 (2016).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5221270</ArticleId><ArticleId IdType="pubmed">28116349</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Hooren, B., Souren, T. &amp; Bongers, B. C. Accuracy of respiratory gas variables, substrate, and energy use from 15 CPET systems during simulated and human exercise. <i>Scand. J. Med. Sci. Sports</i>. <b>34</b> (1), e14490 (2024).
</Citation><ArticleIdList><ArticleId IdType="pubmed">37697640</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccaro, P. &amp; Mahon, A. Cardiorespiratory responses to endurance training in children. <i>Sports Med.</i><b>4</b> (5), 352&#x2013;363 (1987).
</Citation><ArticleIdList><ArticleId IdType="pubmed">3313618</ArticleId></ArticleIdList></Reference><Reference><Citation>Astrand, I., Astrand, P. O., Hallb&#xe4;ck, I. &amp; Kilbom, A. Reduction in maximal oxygen uptake with age. <i>J. Appl. Physiol.</i><b>35</b> (5), 649&#x2013;654 (1973).
</Citation><ArticleIdList><ArticleId IdType="pubmed">4770349</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh, J., Walsh, R. &amp; Redmond, K. Systematic review of physiological and psychological outcomes of surgery for pectus excavatum supporting commissioning of service in the UK. <i>BMJ Open. Respir Res.</i> ;<b>10</b>(1). (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10582895</ArticleId><ArticleId IdType="pubmed">37827806</ArticleId></ArticleIdList></Reference><Reference><Citation>Casar Berazaluce, A. M. et al. The chest wall gender divide: Females have better cardiopulmonary function and exercise tolerance despite worse deformity in pectus excavatum. <i>Pediatr. Surg. Int.</i><b>36</b> (11), 1281&#x2013;1286 (2020).
</Citation><ArticleIdList><ArticleId IdType="pubmed">32940825</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis, M. et al. Impact of pectus excavatum on pulmonary function and exercise capacity in patients treated with 3D custom-made silicone implants. <i>Ann. Chir. Plast. Esthet</i>. <b>69</b> (1), 53&#x2013;58 (2024).
</Citation><ArticleIdList><ArticleId IdType="pubmed">36737354</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen, K., Johansen, L. &amp; Secher, N. H. Influence of body mass on maximal oxygen uptake: Effect of sample size. <i>Eur. J. Appl. Physiol.</i><b>84</b> (3), 201&#x2013;205 (2001).
</Citation><ArticleIdList><ArticleId IdType="pubmed">11320636</ArticleId></ArticleIdList></Reference><Reference><Citation>Haecker, F. M. &amp; Sesia, S. B. Intraoperative use of the vacuum bell for elevating the sternum during the Nuss procedure. <i>J. Laparoendosc. Adv. Surg. Tech. A</i>. <b>22</b> (9), 934&#x2013;936 (2012).
</Citation><ArticleIdList><ArticleId IdType="pubmed">23137116</ArticleId></ArticleIdList></Reference><Reference><Citation>Kar, A., Baghai, M. &amp; Hunt, I. Reshaping the evidence for surgical correction of pectus excavatum using cardiopulmonary exercise testing. <i>J. Am. Heart Assoc.</i><b>11</b> (7), e025273 (2022).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9075475</ArticleId><ArticleId IdType="pubmed">35377161</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32439296</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>25</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-3374</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><PubDate><Year>2020</Year><Month>Aug</Month></PubDate></JournalIssue><Title>International journal of obstetric anesthesia</Title><ISOAbbreviation>Int J Obstet Anesth</ISOAbbreviation></Journal><ArticleTitle>Extracorporeal membrane oxygenation in pregnancy and the postpartum period: a systematic review of case reports.</ArticleTitle><Pagination><StartPage>106</StartPage><EndPage>113</EndPage><MedlinePgn>106-113</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijoa.2020.04.004</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0959-289X(20)30053-4</ELocationID><Abstract><AbstractText>The use of extracorporeal membrane oxygenation (ECMO) as salvage therapy for patients with severe cardiopulmonary failure has increased significantly in the past decade. However, the use of ECMO in pregnant and peripartum patients has received scant attention. We performed a systematic review of case reports in the literature, documenting indications and outcomes of ECMO in pregnancy and postpartum patients. Case reports on ECMO use in pregnant and postpartum patients were retrieved from MEDLINE, EMBASE and SCOPUS databases up to December 2018. Ninety publications reporting on 97 patients met our inclusion criteria. The majority of publications reported peripartum or postpartum ECMO use for cardiovascular failure (60.8%), while the remainder had respiratory failure. Adult Respiratory Distress Syndrome (91.9%) was the most common respiratory indication while pulmonary embolism (23.7%) and peripartum cardiomyopathy (16.9%) accounted for the two most common cardiovascular indications. Hemorrhage was the most common complication of ECMO reported (31.9%). Of 96 documented neonatal outcomes, 80 neonates (83.3%) survived while 88 of 97 (90.7%) mothers survived. Extracorporeal membrane oxygenation appears to be a viable life support modality in pregnant and postpartum women with severe cardiopulmonary failure, but publication bias in our study cohort should be considered.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ong</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Yong Loo Lin School of Medicine, National University of Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>J J Y</ForeName><Initials>JJY</Initials><AffiliationInfo><Affiliation>Yong Loo Lin School of Medicine, National University of Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lorusso</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardio-Thoracic Surgery, Heart and Vascular Centre, Maastricht University Medical Centre (MUMC), Cardiovascular Research Institute Maastricht (CARIM), Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>MacLaren</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Cardiothoracic ICU, Department of Cardiac Thoracic and Vascular Surgery, National University Heart Centre, National University Hospital, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramanathan</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Cardiothoracic ICU, Department of Cardiac Thoracic and Vascular Surgery, National University Heart Centre, National University Hospital, Singapore. Electronic address: ram_ramanathan@nuhs.edu.sg.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Int J Obstet Anesth</MedlineTA><NlmUniqueID>9200430</NlmUniqueID><ISSNLinking>0959-289X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015199" MajorTopicYN="N">Extracorporeal Membrane Oxygenation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006323" MajorTopicYN="N">Heart Arrest</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049590" MajorTopicYN="N">Postpartum Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011249" MajorTopicYN="N">Pregnancy Complications, Cardiovascular</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011644" MajorTopicYN="N">Puerperal Disorders</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Complications</Keyword><Keyword MajorTopicYN="N">Extracorporeal</Keyword><Keyword MajorTopicYN="N">Pregnancy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>5</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>3</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32439296</ArticleId><ArticleId IdType="doi">10.1016/j.ijoa.2020.04.004</ArticleId><ArticleId IdType="pii">S0959-289X(20)30053-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38306100</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>05</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2574-3805</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>05</Day></PubDate></JournalIssue><Title>JAMA network open</Title><ISOAbbreviation>JAMA Netw Open</ISOAbbreviation></Journal><ArticleTitle>Risk of Venous Thromboembolic Events After Surgery for Cancer.</ArticleTitle><Pagination><StartPage>e2354352</StartPage><MedlinePgn>e2354352</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e2354352</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2023.54352</ELocationID><Abstract><AbstractText Label="IMPORTANCE">The risks and benefits of thromboprophylaxis therapy after cancer surgery are debated. Studies that determine thrombosis risk after cancer surgery with high accuracy are needed.</AbstractText><AbstractText Label="OBJECTIVES">To evaluate 1-year risk of venous thromboembolic events after major cancer surgery and how these events vary over time.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">This register-based retrospective observational matched cohort study included data on the full population of Sweden between 1998 and 2016. All patients who underwent major surgery for cancer of the bladder, breast, colon or rectum, gynecologic organs, kidney and upper urothelial tract, lung, prostate, or gastroesophageal tract were matched in a 1:10 ratio with cancer-free members of the general population on year of birth, sex, and county of residence. Data were analyzed from February 13 to December 5, 2023.</AbstractText><AbstractText Label="EXPOSURE">Major surgery for cancer.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">The main outcome was incidence of venous thromboembolic events within 1 year after the surgery. Crude absolute risks and risk differences of events within 1 year and adjusted time-dependent cause-specific hazard ratios (HRs) of postdischarge events were calculated.</AbstractText><AbstractText Label="RESULTS">A total of 432&#x202f;218 patients with cancer (median age, 67 years [IQR, 58-75 years]; 68.7% women) and 4&#x202f;009&#x202f;343 cancer-free comparators (median age, 66 years [IQR, 57-74 years]; 69.3% women) were included in the study. The crude 1-year cumulative risk of pulmonary embolism was higher among the cancer surgery population for all cancers, with the following absolute risk differences: for bladder cancer, 2.69 percentage points (95% CI, 2.33-3.05 percentage points); for breast cancer, 0.59 percentage points (95% CI 0.55-0.63 percentage points); for colorectal cancer, 1.57 percentage points (95% CI, 1.50-1.65 percentage points); for gynecologic organ cancer, 1.32 percentage points (95% CI, 1.22-1.41 percentage points); for kidney and upper urinary tract cancer, 1.38 percentage points (95% CI, 1.21-1.55 percentage points); for lung cancer, 2.61 percentage points (95% CI, 2.34-2.89 percentage points); for gastroesophageal cancer, 2.13 percentage points (95% CI, 1.89-2.38 percentage points); and for prostate cancer, 0.57 percentage points (95% CI, 0.49-0.66 percentage points). The cause-specific HR of pulmonary embolism comparing patients who underwent cancer surgery with matched comparators peaked just after discharge and generally plateaued 60 to 90 days later. At 30 days after surgery, the HR was 10 to 30 times higher than in the comparison cohort for all cancers except breast cancer (colorectal cancer: HR, 9.18 [95% CI, 8.03-10.50]; lung cancer: HR, 25.66 [95% CI, 17.41-37.84]; breast cancer: HR, 5.18 [95% CI, 4.45-6.05]). The hazards subsided but never reached the level of the comparison cohort except for prostate cancer. Similar results were observed for deep vein thrombosis.</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">This cohort study found an increased rate of venous thromboembolism associated with cancer surgery. The risk persisted for about 2 to 4 months postoperatively but varied between cancer types. The increased rate is likely explained by the underlying cancer disease and adjuvant treatments. The results highlight the need for individualized venous thromboembolism risk evaluation and prophylaxis regimens for patients undergoing different surgery for different cancers.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bj&#xf6;rklund</LastName><ForeName>Johan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rautiola</LastName><ForeName>Juhana</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zelic</LastName><ForeName>Renata</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Edgren</LastName><ForeName>Gustaf</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Clinical Epidemiology Division, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, S&#xf6;dersjukhuset, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bottai</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nilsson</LastName><ForeName>Magnus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Surgery and Oncology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vincent</LastName><ForeName>Per Henrik</ForeName><Initials>PH</Initials><AffiliationInfo><Affiliation>Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fredholm</LastName><ForeName>Hanna</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falconer</LastName><ForeName>Henrik</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sj&#xf6;vall</LastName><ForeName>Annika</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nilsson</LastName><ForeName>Per J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiklund</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aly</LastName><ForeName>Markus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akre</LastName><ForeName>Olof</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Netw Open</MedlineTA><NlmUniqueID>101729235</NlmUniqueID><ISSNLinking>2574-3805</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000359" MajorTopicYN="N">Aftercare</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="Y">Breast Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015179" MajorTopicYN="Y">Colorectal Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005833" MajorTopicYN="Y">Genital Neoplasms, Female</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008175" MajorTopicYN="Y">Lung Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010351" MajorTopicYN="N">Patient Discharge</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011471" MajorTopicYN="Y">Prostatic Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="Y">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="Y">Venous Thrombosis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr Edgren reported receiving consulting fees from Vifor Pharma Sweden AB for work outside the submitted work. Dr Falconer reported receiving personal fees from Surgical Science outside the submitted work. No other disclosures were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>5</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>2</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>2</Day><Hour>11</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38306100</ArticleId><ArticleId IdType="pmc">PMC10837742</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.54352</ArticleId><ArticleId IdType="pii">2814634</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kakkar VV, Howe CT, Nicolaides AN, Renney JT, Clarke MB. Deep vein thrombosis of the leg: is there a &#x201c;high risk&#x201d; group? Am J Surg. 1970;120(4):527-530. doi:10.1016/S0002-9610(70)80023-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9610(70)80023-X</ArticleId><ArticleId IdType="pubmed">4097038</ArticleId></ArticleIdList></Reference><Reference><Citation>White RH, Zhou H, Romano PS. Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures. Thromb Haemost. 2003;90(3):446-455.</Citation><ArticleIdList><ArticleId IdType="pubmed">12958614</ArticleId></ArticleIdList></Reference><Reference><Citation>Kakkar AK, Haas S, Wolf H, Encke A. Evaluation of perioperative fatal pulmonary embolism and death in cancer surgical patients: the MC-4 cancer substudy. Thromb Haemost. 2005;94(4):867-871.</Citation><ArticleIdList><ArticleId IdType="pubmed">16270644</ArticleId></ArticleIdList></Reference><Reference><Citation>Agnelli G, Bolis G, Capussotti L, et al. . A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project. Ann Surg. 2006;243(1):89-95. doi:10.1097/01.sla.0000193959.44677.48</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.sla.0000193959.44677.48</ArticleId><ArticleId IdType="pmc">PMC1449979</ArticleId><ArticleId IdType="pubmed">16371741</ArticleId></ArticleIdList></Reference><Reference><Citation>Key NS, Khorana AA, Kuderer NM, et al. . Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol. 2020;38(5):496-520. doi:10.1200/JCO.19.01461</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.19.01461</ArticleId><ArticleId IdType="pubmed">31381464</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergqvist D, Agnelli G, Cohen AT, et al. ; ENOXACAN II Investigators . Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med. 2002;346(13):975-980. doi:10.1056/NEJMoa012385</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa012385</ArticleId><ArticleId IdType="pubmed">11919306</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagarasanu A, Alotaibi GS, Hrimiuc R, Lee AY, Wu C. Role of extended thromboprophylaxis after abdominal and pelvic surgery in cancer patients: a systematic review and meta-analysis. Ann Surg Oncol. 2016;23(5):1422-1430. doi:10.1245/s10434-016-5127-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1245/s10434-016-5127-1</ArticleId><ArticleId IdType="pubmed">26887853</ArticleId></ArticleIdList></Reference><Reference><Citation>Tikkinen KA, Agarwal A, Craigie S, et al. . Systematic reviews of observational studies of risk of thrombosis and bleeding in urological surgery (ROTBUS): introduction and methodology. Syst Rev. 2014;3:150. doi:10.1186/2046-4053-3-150</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2046-4053-3-150</ArticleId><ArticleId IdType="pmc">PMC4307154</ArticleId><ArticleId IdType="pubmed">25540016</ArticleId></ArticleIdList></Reference><Reference><Citation>European Association of Urology . Guidelines. Accessed October 3, 2022. https://uroweb.org/guidelines</Citation></Reference><Reference><Citation>Rasmussen MS. Preventing thromboembolic complications in cancer patients after surgery: a role for prolonged thromboprophylaxis. Cancer Treat Rev. 2002;28(3):141-144. doi:10.1016/S0305-7372(02)00043-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0305-7372(02)00043-9</ArticleId><ArticleId IdType="pubmed">12234565</ArticleId></ArticleIdList></Reference><Reference><Citation>McAlpine K, Breau RH, Mallick R, et al. . Current guidelines do not sufficiently discriminate venous thromboembolism risk in urology. Urol Oncol. 2017;35(7):457.e1-457.e8. doi:10.1016/j.urolonc.2017.01.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.urolonc.2017.01.015</ArticleId><ArticleId IdType="pubmed">28214280</ArticleId></ArticleIdList></Reference><Reference><Citation>Naik R, Mandal I, Hampson A, et al. . The role of extended venous thromboembolism prophylaxis for major urological cancer operations. BJU Int. 2019;124(6):935-944. doi:10.1111/bju.14906</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bju.14906</ArticleId><ArticleId IdType="pubmed">31468645</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludvigsson JF, Andersson E, Ekbom A, et al. . External review and validation of the Swedish National Inpatient Register. BMC Public Health. 2011;11:450. doi:10.1186/1471-2458-11-450</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2458-11-450</ArticleId><ArticleId IdType="pmc">PMC3142234</ArticleId><ArticleId IdType="pubmed">21658213</ArticleId></ArticleIdList></Reference><Reference><Citation>Socialstyrelsen . National Patient Register. Updated January 14, 2022. Accessed December 20, 2022. https://www.socialstyrelsen.se/en/statistics-and-data/registers/national-patient-register/</Citation></Reference><Reference><Citation>Socialstyrelsen . Klassifikation av operationer: sj&#xe4;tte upplagan. 1988. Accessed December 20, 2022. https://www.socialstyrelsen.se/globalassets/sharepoint-dokument/dokument-webb/klassifikationer-och-koder/klassifikation-av-operationer-sjatte-upplagan.pdf</Citation></Reference><Reference><Citation>Smedby B, Schi&#xf6;ler G. Health Classifications in the Nordic Countries: Historic Development in a National and International Perspective. Nordisk Medicinalstatistisk Copenhagen; 2006.</Citation></Reference><Reference><Citation>Socialstyrelsen . The Swedish Cause of Death Register. Updated October 18, 2019. Accessed December 2, 2022. https://www.socialstyrelsen.se/statistik-och-data/register/dodsorsaksregistret/</Citation></Reference><Reference><Citation>StatisticsSweden . Description of the register: Total Population Register. Updated June 19, 2017. Accessed December 2, 2022. https://www.scb.se/contentassets/8f66bcf5abc34d0b98afa4fcbfc0e060/rtb-bar-2016-eng.pdf</Citation></Reference><Reference><Citation>Socialstyrelsen . National Cancer Register. Updated January 14, 2022. Accessed December 20, 2022. https://www.socialstyrelsen.se/en/statistics-and-data/registers/national-cancer-register/</Citation></Reference><Reference><Citation>Geskus RB. Data Analysis With Competing Risks and Intermediate States. CRC Press; 2016.</Citation></Reference><Reference><Citation>Royston P, Parmar MK. Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. Stat Med. 2002;21(15):2175-2197. doi:10.1002/sim.1203</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1203</ArticleId><ArticleId IdType="pubmed">12210632</ArticleId></ArticleIdList></Reference><Reference><Citation>Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81(3):515-526. doi:10.1093/biomet/81.3.515</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/biomet/81.3.515</ArticleId></ArticleIdList></Reference><Reference><Citation>Sj&#xf6;lander A, Greenland S. Ignoring the matching variables in cohort studies&#x2014;when is it valid and why? Stat Med. 2013;32(27):4696-4708. doi:10.1002/sim.5879</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.5879</ArticleId><ArticleId IdType="pubmed">23761197</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallick S, Aiken T, Varley P, et al. . Readmissions from venous thromboembolism after complex cancer surgery. JAMA Surg. 2022;157(4):312-320. doi:10.1001/jamasurg.2021.7126</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2021.7126</ArticleId><ArticleId IdType="pmc">PMC8792793</ArticleId><ArticleId IdType="pubmed">35080619</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarvis CA, Bonney PA, Ding L, et al. . Readmission with venous thromboembolism after surgical treatment by primary cancer site. Surg Oncol. 2020;35:268-275. doi:10.1016/j.suronc.2020.09.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.suronc.2020.09.013</ArticleId><ArticleId IdType="pubmed">32942082</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh T, Lavikainen LI, Halme ALE, et al. . Timing of symptomatic venous thromboembolism after surgery: meta-analysis. Br J Surg. 2023;110(5):553-561. doi:10.1093/bjs/znad035</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bjs/znad035</ArticleId><ArticleId IdType="pmc">PMC10364527</ArticleId><ArticleId IdType="pubmed">36912116</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Hemelrijck M, Garmo H, Holmberg L, et al. . Thromboembolic events following surgery for prostate cancer. Eur Urol. 2013;63(2):354-363. doi:10.1016/j.eururo.2012.09.041</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eururo.2012.09.041</ArticleId><ArticleId IdType="pubmed">23021972</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyritzis SI, Wallerstedt A, Steineck G, et al. ; LAPPRO Steering Committee . Thromboembolic complications in 3,544 patients undergoing radical prostatectomy with or without lymph node dissection. J Urol. 2015;193(1):117-125. doi:10.1016/j.juro.2014.08.091</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.juro.2014.08.091</ArticleId><ArticleId IdType="pubmed">25158271</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyman GH, Eckert L, Wang Y, Wang H, Cohen A. Venous thromboembolism risk in patients with cancer receiving chemotherapy: a real-world analysis. Oncologist. 2013;18(12):1321-1329. doi:10.1634/theoncologist.2013-0226</Citation><ArticleIdList><ArticleId IdType="doi">10.1634/theoncologist.2013-0226</ArticleId><ArticleId IdType="pmc">PMC3868427</ArticleId><ArticleId IdType="pubmed">24212499</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulder FI, Horv&#xe1;th-Puh&#xf3; E, van Es N, et al. . Venous thromboembolism in cancer patients: a population-based cohort study. Blood. 2021;137(14):1959-1969. doi:10.1182/blood.2020007338</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020007338</ArticleId><ArticleId IdType="pubmed">33171494</ArticleId></ArticleIdList></Reference><Reference><Citation>Temraz S, Moukalled N, Gerotziafas GT, et al. . Association between radiotherapy and risk of cancer associated venous thromboembolism: a sub-analysis of the COMPASS-CAT Study. Cancers (Basel). 2021;13(5):1033. doi:10.3390/cancers13051033</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers13051033</ArticleId><ArticleId IdType="pmc">PMC7957620</ArticleId><ArticleId IdType="pubmed">33801174</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39224961</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>03</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1742-481X</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>International wound journal</Title><ISOAbbreviation>Int Wound J</ISOAbbreviation></Journal><ArticleTitle>Incisional negative pressure wound therapy for the prevention of surgical site complications in Paediatric patients with non-idiopathic scoliosis: A randomized clinical trial.</ArticleTitle><Pagination><StartPage>e70034</StartPage><MedlinePgn>e70034</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e70034</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1111/iwj.70034</ELocationID><Abstract><AbstractText>Surgical wound complications are adverse events with important repercussions for the health of patients and health system. Surgical site infections and wound dehiscences are among the most important surgical wound complications, with a high incidence in paediatric patients undergoing surgery for non-idiopathic scoliosis. Incisional negative pressure wound therapy for surgical incisions is used as a preventive measure against surgical wound complications in adults; however, there has been scant evidence for using it in children. The purpose of this study is to evaluate the cost-effectiveness of incisional negative pressure wound therapy in preventing surgical wound complications in paediatric patients undergoing surgery to treat non-idiopathic scoliosis. Randomized clinical trial. Children younger than 18&#x2009;years of age undergoing surgery for non-idiopathic scoliosis were randomly assigned into two groups to receive one of two different types of dressings for the first 7&#x2009;days after surgery. One group were treated with a postoperative hydrofibre and hydrocolloid dressing with silver for wounds (control group), and the other group received a single-use incisional negative pressure wound therapy system (intervention group). The wounds were assessed after removal of the dressings at 7&#x2009;days after surgery and again at 30, 90, and 180&#x2009;days after surgery. Surgical wound complications, sociodemographic variables, variables related to the procedure and postoperative period, economic costs of treatment of surgical wound complications, and time to healing of the surgical wound were recorded. Per protocol and per intention to treat analysis was made. The per protocol incidence of surgical wound complications was 7.7% in the intervention group versus 38.5% in the control group (p&#x2009;=&#x2009;0.009; Fisher exact test. RR&#x2009;=&#x2009;0.20 IC95%: 0.05-0.83). Surgical wound dehiscence, surgical site infections, seroma, and fibrin were the most common surgical wound complications. The type of surgery, duration of surgery, and patients' age were associated with a higher risk for surgical wound complications. Postoperative hydrofibre and hydrocolloid dressing with silver for wounds were found to be associated with a longer time to healing. Initial costs for dressings in the group receiving incisional negative pressure wound therapy were higher, but the total postoperative costs were higher for those receiving postoperative hydrofibre and hydrocolloid dressing with silver for wounds. It was found that for each US$1.00 of extra costs for using incisional negative pressure wound therapy, there was a benefit of US$12.93 in relation to the cost of complications prevented. Incisional negative pressure wound therapy is cost-effective in the prevention of surgical wound complications in children undergoing surgery for non-idiopathic scoliosis.</AbstractText><CopyrightInformation>&#xa9; 2024 The Author(s). International Wound Journal published by Medicalhelplines.com Inc and John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>P&#xe9;rez-Acevedo</LastName><ForeName>Gemma</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Doctoral candidate in health and advance practice nurse in pediatric complex wounds, Sant Joan de D&#xe9;u Hospital, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torra-Bou</LastName><ForeName>Joan Enric</ForeName><Initials>JE</Initials><Identifier Source="ORCID">0000-0001-9410-4668</Identifier><AffiliationInfo><Affiliation>Doctoral Program, Faculty of Nursing and Physiotherapy-GESEC, University of Lleida, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Researcher and GRECS-IRBLleida, Tr2Lab (Tissue Repair and Regeneration Laboratory) Research Group, Institute for Research and Innovation in Life and Health Sciences in Central Catalonia (IRIS-CC), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peir&#xf3;-Garc&#xed;a</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Unidad de Columna, Hospital Sant Joan de D&#xe9;u, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vilalta-Vidal</LastName><ForeName>Inmaculada</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Unidad de Columna, Hospital Sant Joan de D&#xe9;u, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Urrea-Ayala</LastName><ForeName>Mireia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Head, Clinical Safety Program, Sant Joan de D&#xe9;u Hospital, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bosch-Alcaraz</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-6369-9697</Identifier><AffiliationInfo><Affiliation>Department of Public Health, Mental Health and Maternal and Child Health Nursing, Faculty of Nursing, University of Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blanco-Blanco</LastName><ForeName>Joan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Faculty of Nursing and Physiotherapy-GESEC, University of Lleida, Lleida, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>GRECS-IRBLleida Research Group, University of Lleida, Lleida, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBERFES Biomedical Research Center en Red, Institute for Research and Innovation, Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>PERIS 2017-2021- SLT017/20/000194</GrantID><Agency>Support was provided by a Catalonian Health Department research grant</Agency><Country/></Grant><Grant><GrantID>CCG00159</GrantID><Agency>unrestricted Smith &amp; Nephew grant</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int Wound J</MedlineTA><NlmUniqueID>101230907</NlmUniqueID><ISSNLinking>1742-4801</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Int Wound J. 2024 Oct;21(10):e70067. doi: 10.1111/iwj.70067.</RefSource><PMID Version="1">39353601</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054843" MajorTopicYN="Y">Negative-Pressure Wound Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013530" MajorTopicYN="Y">Surgical Wound Infection</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012600" MajorTopicYN="Y">Scoliosis</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014945" MajorTopicYN="N">Wound Healing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001458" MajorTopicYN="N">Bandages</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013529" MajorTopicYN="N">Surgical Wound Dehiscence</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003362" MajorTopicYN="N">Cost-Benefit Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">negative pressure wound therapy</Keyword><Keyword MajorTopicYN="N">paediatrics</Keyword><Keyword MajorTopicYN="N">prevention</Keyword><Keyword MajorTopicYN="N">spine surgery</Keyword><Keyword MajorTopicYN="N">surgical wound complications</Keyword></KeywordList><CoiStatement>All authors declare that they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>3</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>3</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>3</Day><Hour>4</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39224961</ArticleId><ArticleId IdType="pmc">PMC11369491</ArticleId><ArticleId IdType="doi">10.1111/iwj.70034</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Xiaojie W, Banda J, Qi H, et al. Scarless wound healing: current insights from the perspectives of TGF&#x2010;&#x3b2;, KGF&#x2010;1, and KGF&#x2010;2. Cytokine Growth Factor Rev. 2022;66:26&#x2010;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">35690568</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochetti G, Abraha I, Randolph J, et al. Surgical wound closure by staples or sutures? Systematic review. Medicine (Baltimore). 2020;99(25):e20573.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7310845</ArticleId><ArticleId IdType="pubmed">32569183</ArticleId></ArticleIdList></Reference><Reference><Citation>Fry DE. The economic costs of surgical site infection. Surg Infect. 2002;3(1):S37&#x2010;S43.</Citation><ArticleIdList><ArticleId IdType="pubmed">12573038</ArticleId></ArticleIdList></Reference><Reference><Citation>de Lissovoy G, Fraeman K, Hutchins V, Murphy D, Song D, Vaughn BB. Surgical site infection: incidence and impact on hospital utilization and treatment costs. Am J Infect Control. 2009;37(5):387&#x2010;397.</Citation><ArticleIdList><ArticleId IdType="pubmed">19398246</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridderstolpe L, Gill H, Granfeldt H, Ahlfeldt H, Rutberg H. Superficial and deep sternal wound complications: incidence, risk factors and mortality. Eur J Cardiothorac Surg. 2001;20(6):1168&#x2010;1175.</Citation><ArticleIdList><ArticleId IdType="pubmed">11717023</ArticleId></ArticleIdList></Reference><Reference><Citation>
Centers for Disease Control and Prevention
. Surgical site infection event (SSI). National Healthcare Safety. Network. 2022. Accessed January 7, 2023. https://www.cdc.gov/nhsn/pdfs/pscmanual/9pscssicurrent.pdf
</Citation></Reference><Reference><Citation>Tipper GA, Chiwera L, Lucas J. Reducing surgical site infection in pediatric scoliosis surgery: a multidisciplinary improvement program and prospective 4&#x2010;year audit. Global Spine J. 2020;10(5):633&#x2010;639.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7359689</ArticleId><ArticleId IdType="pubmed">32677570</ArticleId></ArticleIdList></Reference><Reference><Citation>Berr&#xed;os&#x2010;Torres SI, Umscheid CA, Bratzler DW, et al. Healthcare infection control practices advisory committee. Centers for Disease Control and Prevention guideline for the prevention of surgical site infection, 2017. JAMA Surg. 2017;152(8):784&#x2010;791.</Citation><ArticleIdList><ArticleId IdType="pubmed">28467526</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart DB. Commentary: negative pressure wound therapy for closed incisions&#x2014;the new standard wound care? Surgery. 2020;167(6):1010&#x2010;1011.</Citation><ArticleIdList><ArticleId IdType="pubmed">32067783</ArticleId></ArticleIdList></Reference><Reference><Citation>Maehara Y, Shirabe K, Kohnoe S, et al. Impact of intra abdominal absorbable sutures on surgical site infection in gastrointestinal and hepato&#x2010;biliary&#x2010;pancreatic surgery: results of a multicenter, randomized, prospective, phase II clinical trial. Surg Today. 2017;47(9):1060&#x2010;1071.</Citation><ArticleIdList><ArticleId IdType="pubmed">28233105</ArticleId></ArticleIdList></Reference><Reference><Citation>Deveza LR, Chhabra BN, Heydemann J, et al. Comparison of baseline characteristics and postoperative complications in neuromuscular, syndromic and congenital scoliosis. J Pediatr Orthop B. 2023;32(4):350&#x2010;356.</Citation><ArticleIdList><ArticleId IdType="pubmed">35762668</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, Wang R, Huo X, Xiong W, Kang L, Xue Y. Incidence of surgical site infection after spine surgery: a systematic review and meta&#x2010;analysis. Spine (Phila Pa 1976). 2020;45(3):208&#x2010;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">31464972</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanyam R, Schaffzin J, Cudilo EM, Rao MB, Varughese AM, Varughese AM. Systematic review of risk factors for surgical site infection in pediatric scoliosis surgery. Spine J. 2015;15(6):1422&#x2010;1431.</Citation><ArticleIdList><ArticleId IdType="pubmed">25796355</ArticleId></ArticleIdList></Reference><Reference><Citation>Minkara AA, Matsumoto H, Glotzbecker M, et al. Children's spine study group. A multicenter study of the epidemiology of deep surgical site infections in children with nonidiopathic early&#x2010;onset scoliosis including associated pathogens. Spine Deform. 2019;7(4):647&#x2010;651.</Citation><ArticleIdList><ArticleId IdType="pubmed">31202384</ArticleId></ArticleIdList></Reference><Reference><Citation>Canavese F, Marengo L, Corradin M, et al. Deep postoperative spine infection treated by negative pressure therapy in patients with progressive spinal deformities. Arch Orthop Trauma Surg. 2018;138(4):463&#x2010;469.</Citation><ArticleIdList><ArticleId IdType="pubmed">29270822</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleischmann W, Lang E, Russ M. Treatment of infection by vacuum sealing. Unfallchirurg. 1997;100(4):301&#x2010;304.</Citation><ArticleIdList><ArticleId IdType="pubmed">9229781</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomoll AH, Lin A, Harris MB. Incisional vacuum&#x2010;assisted closure therapy. J Orthop Trauma. 2006;20(10):705&#x2010;709.</Citation><ArticleIdList><ArticleId IdType="pubmed">17106382</ArticleId></ArticleIdList></Reference><Reference><Citation>Logan J, Scott G, Peake C, Watson JJ, Jose R. Topical negative pressure wound dressing and its applications in the hand&#x2014;a review of the literature. J Hand Microsurg. 2021;14(4):276&#x2010;283.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9666070</ArticleId><ArticleId IdType="pubmed">36398157</ArticleId></ArticleIdList></Reference><Reference><Citation>Santosa KB, Keane AM, Keller M, Olsen MA, Sears E, Snyder&#x2010;Warwick AK. Inpatient versus outpatient management of negative pressure wound therapy in pediatric patients. J Surg Res. 2020;254:197&#x2010;205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7484025</ArticleId><ArticleId IdType="pubmed">32450421</ArticleId></ArticleIdList></Reference><Reference><Citation>Apelqvist J, Fagerdahl A, Te&#xf3;t L. Willy C Terapia de heridas con presi&#xf3;n negativa: una actualizaci&#xf3;n para m&#xe9;dicos y cuidadores ambulatorios. J Wound Manag. 2024;25(2Sup1):S1&#x2010;S56.</Citation></Reference><Reference><Citation>De Vries FEE, Wallert ED, Solomkin JS, et al. A systematic review and meta&#x2010;analysis including GRADE qualification of the risk of surgical site infections after prophylactic negative pressure wound therapy compared with conventional dressings in clean and contaminated surgery. Medicine (Baltimore). 2016;95(36):e4673.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5023882</ArticleId><ArticleId IdType="pubmed">27603360</ArticleId></ArticleIdList></Reference><Reference><Citation>Norman G, Shi C, Goh EL, et al. Negative pressure wound therapy for surgical wounds healing by primary closure. Cochrane Database Syst Rev. 2022;4(4):1&#x2013;274.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9040710</ArticleId><ArticleId IdType="pubmed">35471497</ArticleId></ArticleIdList></Reference><Reference><Citation>Zwanenburg PR, Tol BT, Obdeijn MC, Lapid O, Gans SL, Boermeester MA. Meta&#x2010;analysis, meta&#x2010;regression, and GRADE assessment of randomized and nonrandomized studies of incisional negative pressure wound therapy versus control dressings for the prevention of postoperative wound complications. Ann Surg. 2020;272(1):81&#x2010;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">31592899</ArticleId></ArticleIdList></Reference><Reference><Citation>Adogwa O, Fatemi P, Perez E, et al. Negative pressure wound therapy reduces incidence of postoperative wound infection and dehiscence after long&#x2010;segment thoracolumbar spinal fusion: a single institutional experience. Spine J. 2014;14(12):2911&#x2010;2917.</Citation><ArticleIdList><ArticleId IdType="pubmed">24769401</ArticleId></ArticleIdList></Reference><Reference><Citation>Visser R, Milbrandt K, Lum Min S, et al. Applying vacuum to accomplish reduced wound infections in laparoscopic pediatric surgery. J Pediatr Surg. 2017;52(5):849&#x2010;852.</Citation><ArticleIdList><ArticleId IdType="pubmed">28245914</ArticleId></ArticleIdList></Reference><Reference><Citation>White AJ, Gilad R, Motivala S, Fiani B, Rasouli J. Negative pressure wound therapy in spinal surgery. Bioengineering (Basel). 2022;9(11):614.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9687616</ArticleId><ArticleId IdType="pubmed">36354525</ArticleId></ArticleIdList></Reference><Reference><Citation>Willy C, Agarwal A, Andersen CA, et al. Closed incision negative pressure therapy: international multidisciplinary consensus recommendations. Int Wound J. 2017;14(2):385&#x2010;398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7949983</ArticleId><ArticleId IdType="pubmed">27170231</ArticleId></ArticleIdList></Reference><Reference><Citation>Nam D, Sershon RA, Levine BR, Della Valle CJ. The use of closed incision negative&#x2010;pressure wound therapy in orthopaedic surgery. J Am Acad Orthop Surg. 2018;26(9):295&#x2010;302.</Citation><ArticleIdList><ArticleId IdType="pubmed">29620609</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie W, Dai L, Qi Y, Jiang X. Negative pressure wound therapy compared with conventional wound dressing for closed incisions in orthopaedic trauma surgery: a meta&#x2010;analysis. Int Wound J. 2022;19(6):1319&#x2010;1328.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9493229</ArticleId><ArticleId IdType="pubmed">34854236</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z, Sun J, Yao Z, Song C, Liu W. Can prophylactic negative pressure wound therapy improve clinical outcomes in spinal fusion surgery? A meta&#x2010;analysis. Eur Spine J. 2022;31(6):1546&#x2010;1552.</Citation><ArticleIdList><ArticleId IdType="pubmed">35306599</ArticleId></ArticleIdList></Reference><Reference><Citation>Dragu A, Schn&#xfc;rer S, Unglaub F, et al. Wide topical negative pressure wound dressing treatment for patients undergoing abdominal dermolipectomy following massive weight loss. Obes Surg. 2011;21(11):1781&#x2010;1786.</Citation><ArticleIdList><ArticleId IdType="pubmed">21110232</ArticleId></ArticleIdList></Reference><Reference><Citation>de Jesus LE, Martins AB, Oliveira PB, Gomes F, Leve T, Dekermacher S. Negative pressure wound therapy in pediatric surgery: how and when to use. J Pediatr Surg. 2018;53(4):585&#x2010;591.</Citation><ArticleIdList><ArticleId IdType="pubmed">29241963</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rhee MA, de Klerk LWL, Verhaar JAN. Vacuum&#x2010;assisted wound closure of deep infections after instrumented spinal fusion in six children with neuromuscular scoliosis. Spine J. 2007;7(5):596&#x2010;600.</Citation><ArticleIdList><ArticleId IdType="pubmed">17905322</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A, Badin D, Leland CR, Vitale MG, Sponseller PD. Updating the evidence: systematic literature review of risk factors and strategies for prevention, diagnosis, and treatment of surgical site infection after pediatric scoliosis surgery. J Pediatr Orthop. 2023;43(8):e657&#x2010;e668.</Citation><ArticleIdList><ArticleId IdType="pubmed">37442780</ArticleId></ArticleIdList></Reference><Reference><Citation>Badin D, Leland CR, Matsumoto H, et al. Best practice guidelines for surgical site infection in high&#x2010;risk pediatric spine surgery: definition, prevention, diagnosis, and treatment. J Pediatr Orthop. 2022;42(10):e1008&#x2010;e1017.</Citation><ArticleIdList><ArticleId IdType="pubmed">36037438</ArticleId></ArticleIdList></Reference><Reference><Citation>Groenen H, Jalalzadeh H, Buis DR, et al. Incisional negative pressure wound therapy for the prevention of surgical site infection: an up&#x2010;to&#x2010;date meta&#x2010;analysis and trial sequential analysis. EClinicalMedicine. 2023;62:102105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10393772</ArticleId><ArticleId IdType="pubmed">37538540</ArticleId></ArticleIdList></Reference><Reference><Citation>Peart J. A tool to assess the risk of surgical site infections and the suitability of negative pressure wound therapy. Wounds UK. 2019;15(1):20&#x2010;26.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27378573</PMID><DateCompleted><Year>2017</Year><Month>09</Month><Day>12</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1970-9366</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>6</Issue><PubDate><Year>2016</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Internal and emergency medicine</Title><ISOAbbreviation>Intern Emerg Med</ISOAbbreviation></Journal><ArticleTitle>Effect of colchicine in prevention of pericardial effusion and atrial fibrillation: a meta-analysis.</ArticleTitle><Pagination><StartPage>867</StartPage><EndPage>876</EndPage><MedlinePgn>867-76</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11739-016-1496-5</ELocationID><Abstract><AbstractText>Randomized, controlled trials (RCTs) have assessed the effect of colchicine therapy in prevention of pericardial effusion (PE) and atrial fibrillation (AF). However, the effects are still inconclusive. PubMed, Cochrane Library, Google Scholar, and EMBASE database were searched. Primary outcome was the risk of PE and AF. Ten RCTs with 1981 patients and a mean follow-up of 12.6&#xa0;months were included. Colchicine therapy was not associated with a significantly lower risk of post-operative PE (RR, 0.89; 95&#xa0;% CI 0.70-1.13; p&#xa0;=&#xa0;0.33, I (2)&#xa0;=&#xa0;72.8&#xa0;%) and AF (RR, 0.77; 95&#xa0;% CI 0.52-1.13; p&#xa0;=&#xa0;0.18, I (2)&#xa0;=&#xa0;47.3&#xa0;%). However, rates of pericarditis recurrence, symptoms persistence, and pericarditis-related hospitalization were significantly decreased with colchicine treatment. In addition, cardiac tamponade occurrence was similar between groups, and adverse events were significantly higher in the colchicine group. Colchicine may not significantly decrease the post-operative risk of PE and AF. However, only limited studies about patients undergoing cardiac surgery provide data about PE and AF.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ming-Xuan</ForeName><Initials>MX</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Xiao-Long</ForeName><Initials>XL</Initials><AffiliationInfo><Affiliation>Department of Neurology, Wuhan Medical &amp; Healthcare Center for Women and Children, Wuhan Children's Hospital, Wuhan, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mu</LastName><ForeName>Bing-Yao</ForeName><Initials>BY</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Beijing Hospital, No. 1, Dahua Road, East District, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Yong-Jing</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Beijing Hospital, No. 1, Dahua Road, East District, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Ying-Juan</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Beijing Hospital, No. 1, Dahua Road, East District, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Qian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Beijing Hospital, No. 1, Dahua Road, East District, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Jia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Beijing Hospital, No. 1, Dahua Road, East District, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Rong-Wei</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Beijing Hospital, No. 1, Dahua Road, East District, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Ci-Bo</ForeName><Initials>CB</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Beijing Hospital, No. 1, Dahua Road, East District, Beijing, China. huangcb1208@sina.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>07</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Intern Emerg Med</MedlineTA><NlmUniqueID>101263418</NlmUniqueID><ISSNLinking>1828-0447</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>SML2Y3J35T</RegistryNumber><NameOfSubstance UI="D003078">Colchicine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="N">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016009" MajorTopicYN="N">Chi-Square Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003078" MajorTopicYN="N">Colchicine</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010490" MajorTopicYN="N">Pericardial Effusion</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010493" MajorTopicYN="N">Pericarditis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Atrial fibrillation</Keyword><Keyword MajorTopicYN="N">Cardiac tamponade</Keyword><Keyword MajorTopicYN="N">Colchicine</Keyword><Keyword MajorTopicYN="N">Pericardial effusion</Keyword><Keyword MajorTopicYN="N">Pericarditis recurrence</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>3</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>6</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27378573</ArticleId><ArticleId IdType="doi">10.1007/s11739-016-1496-5</ArticleId><ArticleId IdType="pii">10.1007/s11739-016-1496-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Indian J Pharmacol. 2014 Nov-Dec;46(6):590-5</Citation><ArticleIdList><ArticleId IdType="pubmed">25538328</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart. 2015 Nov;101(21):1711-6</Citation><ArticleIdList><ArticleId IdType="pubmed">26076938</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2015 Oct 13;314(14):1498-506</Citation><ArticleIdList><ArticleId IdType="pubmed">26461998</ArticleId></ArticleIdList></Reference><Reference><Citation>JACC Heart Fail. 2014 Apr;2(2):131-7</Citation><ArticleIdList><ArticleId IdType="pubmed">24720919</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2013 Oct 17;369(16):1522-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23992557</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2014 Sep 10;312(10):1016-23</Citation><ArticleIdList><ArticleId IdType="pubmed">25172965</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Epidemiol. 2009 Oct;62(10):1006-12</Citation><ArticleIdList><ArticleId IdType="pubmed">19631508</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood. 2010 Oct 28;116(17):3140-6</Citation><ArticleIdList><ArticleId IdType="pubmed">20656933</ArticleId></ArticleIdList></Reference><Reference><Citation>Control Clin Trials. 1986 Sep;7(3):177-88</Citation><ArticleIdList><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2005 Sep 27;112(13):2012-6</Citation><ArticleIdList><ArticleId IdType="pubmed">16186437</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cardiovasc Med (Hagerstown). 2014 Dec;15(12):840-6</Citation><ArticleIdList><ArticleId IdType="pubmed">25000255</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2011 Nov 22;124(21):2290-5</Citation><ArticleIdList><ArticleId IdType="pubmed">22090167</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorac Surg Clin. 2015 Nov;25(4):371-92</Citation><ArticleIdList><ArticleId IdType="pubmed">26515939</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart. 2015 Sep;101(18):1463-7</Citation><ArticleIdList><ArticleId IdType="pubmed">25926597</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Intern Med. 2005 Sep 26;165(17):1987-91</Citation><ArticleIdList><ArticleId IdType="pubmed">16186468</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Heart J. 2010 Nov;31(22):2749-54</Citation><ArticleIdList><ArticleId IdType="pubmed">20805112</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2014 Aug 28;(8):CD010652</Citation><ArticleIdList><ArticleId IdType="pubmed">25164988</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Cardiol. 2016 Feb;13(2):99-105</Citation><ArticleIdList><ArticleId IdType="pubmed">26259934</ArticleId></ArticleIdList></Reference><Reference><Citation>Am Heart J. 2015 Dec;170(6):1195-201</Citation><ArticleIdList><ArticleId IdType="pubmed">26678641</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2012 Oct 30;60(18):1790-6</Citation><ArticleIdList><ArticleId IdType="pubmed">23040570</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2011 Oct 4;155(7):409-14</Citation><ArticleIdList><ArticleId IdType="pubmed">21873705</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Lung Circ. 2015 Jul;24(7):660-6</Citation><ArticleIdList><ArticleId IdType="pubmed">25766664</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacol Ther. 2015 Oct;154:13-20</Citation><ArticleIdList><ArticleId IdType="pubmed">26116810</ArticleId></ArticleIdList></Reference><Reference><Citation>Herz. 2002 Dec;27(8):791-4</Citation><ArticleIdList><ArticleId IdType="pubmed">12574898</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2014 Jun 28;383(9936):2232-7</Citation><ArticleIdList><ArticleId IdType="pubmed">24694983</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35268332</PMID><DateRevised><Year>2022</Year><Month>03</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>Feb</Month><Day>24</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Current Concepts in the Etiology and Pathogenesis of Pectus Excavatum in Humans-A Systematic Review.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1241</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm11051241</ELocationID><Abstract><AbstractText>Pectus excavatum (PE) is the most common deformity of the chest wall and is characterized by the posterior depression of the sternum and the lower costal cartilages. To date, the etiology of PE in humans remains enigmatic. Several etiologic hypotheses have been proposed over the past two centuries. However, most of them have been scientifically dismissed and now have only historic value. In this systematic review, we assess scientific publications of the past two centuries addressing the issue of the origin of PE in humans. We present and discuss the histologic, genetic, biomechanical, and experimental scientific achievements that contributed to the clarification of its etiology and pathogenesis. With no clear consensus over the exact mechanism, most recent studies agree that the primordial defect leading the deformation of the anterior chest wall in PE is related to the costal hyaline cartilage structure and function. Further studies on this subject must be carried out. Genetic studies seem to be the most promising way to understand the exact mechanism of PE's origin and pathogenesis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>David</LastName><ForeName>Vlad Laurentiu</ForeName><Initials>VL</Initials><Identifier Source="ORCID">0000-0003-4295-7487</Identifier><AffiliationInfo><Affiliation>Department of Pediatric Surgery and Orthopedics, "Victor Babes" University of Medicine and Pharmacy, 2 Eftimie Murgu, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">chest wall malformations</Keyword><Keyword MajorTopicYN="N">etiology</Keyword><Keyword MajorTopicYN="N">pathogenesis</Keyword><Keyword MajorTopicYN="N">pectus excavatum</Keyword></KeywordList><CoiStatement>The author declares no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>2</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>10</Day><Hour>15</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>2</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35268332</ArticleId><ArticleId IdType="pmc">PMC8911421</ArticleId><ArticleId IdType="doi">10.3390/jcm11051241</ArticleId><ArticleId IdType="pii">jcm11051241</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kelly R.E., Jr. Pectus excavatum: Historical background, clinical picture, preoperative evaluation and criteria for operation. Semin. Pediatr. Surg. 2008;17:181&#x2013;193. doi: 10.1053/j.sempedsurg.2008.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.sempedsurg.2008.03.002</ArticleId><ArticleId IdType="pubmed">18582824</ArticleId></ArticleIdList></Reference><Reference><Citation>Brochhausen C., Turial S., M&#xfc;ller F.K.P., Schmitt V.H., Coerdt W., Wihlm J.M., Schier F., Kirkpatrick C.J. Pectus excavatum: History, hypotheses and treatment options. Interact. Cardiovasc. Thorac. Surg. 2012;14:801&#x2013;806. doi: 10.1093/icvts/ivs045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivs045</ArticleId><ArticleId IdType="pmc">PMC3352718</ArticleId><ArticleId IdType="pubmed">22394989</ArticleId></ArticleIdList></Reference><Reference><Citation>Shamberger R.C., Welch K.J. Surgical repair of pectus excavatum. J. Pediatr. Surg. 1988;23:615&#x2013;622. doi: 10.1016/S0022-3468(88)80629-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3468(88)80629-8</ArticleId><ArticleId IdType="pubmed">3204460</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuss D., Obermeyer R.J., Kelly R.E., Jr. Pectus excavatum from a pediatric surgeon&#x2019;s perspective. Ann. Cardiothorac. Surg. 2016;5:493&#x2013;500. doi: 10.21037/acs.2016.06.04.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/acs.2016.06.04</ArticleId><ArticleId IdType="pmc">PMC5056929</ArticleId><ArticleId IdType="pubmed">27747183</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicodin A., Boi A.E.S., Popoiu M.C., Cozma G., Nicodin G., Badeti R., Trailescu M., Adam O., David V.L. Preliminary results after Nuss procedure. Chirurgia. 2010;105:203&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pubmed">20540233</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulik I.O., Plyakin V.A., Sarukhanyan O.O., Ignat&#x2019;Eva N.Y., Poludov S.A. Etiology and pathogenesis of pectus excavatum in children. Traumatol. Orthop. Russ. 2013;19:136&#x2013;141. doi: 10.21823/2311-2905-2013--2-136-141.</Citation><ArticleIdList><ArticleId IdType="doi">10.21823/2311-2905-2013--2-136-141</ArticleId></ArticleIdList></Reference><Reference><Citation>Toth G.A., Bud A.B.L. Funnel chest (pectus excavatum) in 10&#x2013;16th century fossil material. J. Paleontol. 2001;13:63&#x2013;66.</Citation></Reference><Reference><Citation>Bauhinus J. Ioannis Schenckii a Grafenberg. De partibus Vitalibus, Thorace Contentis; Frankfurt, Germany: 1609. Observatio; p. 322. Johannes Observatorium Medicarum, Rararum, Novar-um, Admirabilium, et Montrosarum, Liber Secundus.</Citation></Reference><Reference><Citation>Eggel C. Eine seltene Mi&#xdf;bildung des Thorax. Virchows. Arch. Path Anat. 1870;49:230. doi: 10.1007/BF02230501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02230501</ArticleId></ArticleIdList></Reference><Reference><Citation>Langer H., Zuckerkandel E. Untersuchungen &#xfc;ber den mi&#xdf;bildeten Brustkorb des. Herrn. JW Wien. Med. Zeit. 1880;49:515.</Citation></Reference><Reference><Citation>Flesch M. Ueber eine seltene Missbildung des Thorax. Virchow. Arch. Path Anat. 1873;57:289&#x2013;294. doi: 10.1007/BF01926731.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01926731</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagmann Selten vorkommende Abnormit&#xe4;t des Brustkastens. J. B Kinderheilkd. 1888;15:455.</Citation></Reference><Reference><Citation>Meyer L. Zur chirurgischen Behandlung der angeborenen Trichterbrust. Berl. Klin. Wschr. 1911;48:1563&#x2013;1566.</Citation></Reference><Reference><Citation>Muller C. Zur Entwicklung des Menschlichen Brustkorbs, Morphol Jahrb. Volume 35. W Engelman; Leipzig, Germany: 1906. pp. 591&#x2013;596.</Citation></Reference><Reference><Citation>Ochsner A., Debakey M.E. Chonechondrosternon: Report of a case and review of the Iiterature. J. Tboracic. Surg. 1938;8:469&#x2013;511. doi: 10.1016/S0096-5588(20)32070-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0096-5588(20)32070-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelley S.W. Surgical Diseases of Children: A Modern Treatise on Pediatric Surgery. Ann. Surg. 1910;51:438.</Citation></Reference><Reference><Citation>Brown A.L., Cook O. Funnel chest (pectus excavatum) in infancy and adult life. Calif. Med. 1951;74:174&#x2013;178.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1520853</ArticleId><ArticleId IdType="pubmed">14812351</ArticleId></ArticleIdList></Reference><Reference><Citation>Maneke M. Untersuchungen zur Pathogenese der Brustkorbverformungen1. DMW Dtsch. Med. Wochenschr. 1959;84:504&#x2013;509. doi: 10.1055/s-0028-1113633.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0028-1113633</ArticleId><ArticleId IdType="pubmed">13639685</ArticleId></ArticleIdList></Reference><Reference><Citation>Curschmann H. &#xdc;ber erbliche Arachnodaktylie. Nervenarzt. 1936;9:624.</Citation></Reference><Reference><Citation>Saxena A.K. Chest Wall Deformities. Springer; Berlin/Heidelberg, Germany: 2017. History of Surgical Repairs of Chest Wall Deformities in Saxena AK editor; pp. 3&#x2013;18.</Citation></Reference><Reference><Citation>Brown A.L. Pectus Excavatum. J. Thorac. Surg. 1939;9:164. doi: 10.1016/S0096-5588(20)32033-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0096-5588(20)32033-X</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown A. Lincoln: Pectus Excavatum (Funnel Chest). Anatomic Basis: Surgical Treatment of the Incipient Stage in In-fancy; and Correction of the Deformity in the Fully Developed Stage. J. Thorac. Surg. 1940;9:164&#x2013;184. doi: 10.1016/S0096-5588(20)32033-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0096-5588(20)32033-X</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodkin H.A. Congenital chondrosternal depression (funnel chest) Its treatment by phrenosternolysis and chondroster-noplasty. Dis. Chest. 1951;19:288&#x2013;306. doi: 10.1378/chest.19.3.288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.19.3.288</ArticleId><ArticleId IdType="pubmed">14813131</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodkin H.A. Congenital Anterior Chest Wall Deformities of Diaphragmatic Origin. Dis. Chest. 1953;24:259&#x2013;277. doi: 10.1378/chest.24.3.259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.24.3.259</ArticleId><ArticleId IdType="pubmed">13095240</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson J.L., George R.E., Hewlett T.H., Bowers W.F. Pectus excavatum: Surgical experiences in thirty-four cases. Am. J. Surg. 1959;98:664&#x2013;676. doi: 10.1016/0002-9610(59)90488-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9610(59)90488-X</ArticleId><ArticleId IdType="pubmed">14406302</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravitch M.M. The Operative Treatment of Pectus Excavatum. Ann. Surg. 1949;129:429&#x2013;444. doi: 10.1097/00000658-194904000-00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000658-194904000-00002</ArticleId><ArticleId IdType="pmc">PMC1514034</ArticleId><ArticleId IdType="pubmed">17859324</ArticleId></ArticleIdList></Reference><Reference><Citation>Lester C.W. Funnel chest: Its cause, effects, and treatment. J. Pediatr. 1950;37:224&#x2013;230. doi: 10.1016/S0022-3476(50)80026-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3476(50)80026-4</ArticleId><ArticleId IdType="pubmed">15437262</ArticleId></ArticleIdList></Reference><Reference><Citation>Koop C.E. The Management of Pectus Excavatum. Surg. Clin. N. Am. 1956;36:1627&#x2013;1637. doi: 10.1016/S0039-6109(16)35047-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0039-6109(16)35047-2</ArticleId><ArticleId IdType="pubmed">13380722</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweet R.H. Pectus Excavatum: Report of Two Cases Successfully Operated Upon. Ann. Surg. 1944;119:922&#x2013;934.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1617978</ArticleId><ArticleId IdType="pubmed">17858419</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindskog G.E., Felton W.L. Considerations in the Surgical Treatment of Pectus Excavatum. Ann. Surg. 1955;142:654&#x2013;661. doi: 10.1097/00000658-195510000-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000658-195510000-00009</ArticleId><ArticleId IdType="pmc">PMC1465194</ArticleId><ArticleId IdType="pubmed">13259426</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahoney E.B., Emerson G.L. Surgical treatment of the congenital funnel-chest deformity. AMA Arch. Surg. 1953;67:317&#x2013;329. doi: 10.1001/archsurg.1953.01260040324003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archsurg.1953.01260040324003</ArticleId><ArticleId IdType="pubmed">13079398</ArticleId></ArticleIdList></Reference><Reference><Citation>Mullard K. Observations on the aetiology of pectus excavatum and other chest deformities, and a method of recording them. Br. J. Surg. 1967;54:115&#x2013;120. doi: 10.1002/bjs.1800540209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.1800540209</ArticleId><ArticleId IdType="pubmed">6016763</ArticleId></ArticleIdList></Reference><Reference><Citation>Sauerbruch F. Die Chirurgie Der Brustorgane. Volume 1. Julius Springer; Berlin, Germany: 1920. p. 437.</Citation></Reference><Reference><Citation>Nuss D., Kelly R.E., Jr., Croitoru D.P., Katz M.E. A 10-year review of a minimally invasive technique for the correction of pectus excavatum. J. Pediatr. Surg. 1998;33:545&#x2013;552. doi: 10.1016/S0022-3468(98)90314-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3468(98)90314-1</ArticleId><ArticleId IdType="pubmed">9574749</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen R.G., Douglas M. Cosmetic improvement of thoracic wall defects using a rapid setting silastic mold: A special technique. J. Pediatr. Surg. 1979;14:745&#x2013;749. doi: 10.1016/S0022-3468(79)80258-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3468(79)80258-4</ArticleId><ArticleId IdType="pubmed">551154</ArticleId></ArticleIdList></Reference><Reference><Citation>Rehbein F., Wernicke H.H. The operative treatment of the funnel chest. Arch. Dis. Child. 1957;32:5&#x2013;8. doi: 10.1136/adc.32.161.5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/adc.32.161.5</ArticleId><ArticleId IdType="pmc">PMC2012038</ArticleId><ArticleId IdType="pubmed">13403703</ArticleId></ArticleIdList></Reference><Reference><Citation>Welch K.J. Satisfactory surgical correction of pectus excavatum deformity in childhood; a limited opportunity. J. Thorac. Surg. 1958;36:697&#x2013;713. doi: 10.1016/S0096-5588(20)30116-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0096-5588(20)30116-1</ArticleId><ArticleId IdType="pubmed">13588724</ArticleId></ArticleIdList></Reference><Reference><Citation>Haller J.A., Jr., Kramer S.S., Lietman S.A. Use of CT scans in selection of patients for pectus excavatum surgery: A preliminary report. J. Pediatr Surg. 1987;22:904&#x2013;906. doi: 10.1016/S0022-3468(87)80585-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3468(87)80585-7</ArticleId><ArticleId IdType="pubmed">3681619</ArticleId></ArticleIdList></Reference><Reference><Citation>Fonkalsrud E.W. 912 Open Pectus Excavatum Repairs: Changing Trends, Lessons Learned: One Surgeon&#x2019;s Experience. World J. Surg. 2008;33:180&#x2013;190. doi: 10.1007/s00268-008-9793-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-008-9793-4</ArticleId><ArticleId IdType="pubmed">19002739</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena A.K., Willital G.H. Valuable lessons from two decades of pectus repair with the Willital-Hegemann procedure. J. Thorac. Cardiovasc. Surg. 2007;134:871&#x2013;876. doi: 10.1016/j.jtcvs.2007.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2007.06.008</ArticleId><ArticleId IdType="pubmed">17903499</ArticleId></ArticleIdList></Reference><Reference><Citation>Wada J. Surgical correction of the funnel chest &#x201c;sternoturnover&#x201d;. West. J. Surg. Obstet. Gynecol. 1961;69:358&#x2013;361.</Citation><ArticleIdList><ArticleId IdType="pubmed">14004233</ArticleId></ArticleIdList></Reference><Reference><Citation>Isakov J.F., Geraskin V.I., Rudakov S.S., Vasiljev G.S., Gerberg A.N., Burinov G.M., Muho S.B., Kondrashin N.I., Besjadovskaja G.L. A new method of surgical treatment of funnel chest with help of permanent magnets. Chir. Pediatr. 1980;21:361&#x2013;362.</Citation><ArticleIdList><ArticleId IdType="pubmed">7460117</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison M.R., Estefan-Ventura D., Fechter R., Moran A.M., Jr., Christensen D. Magnetic mini-mover procedure for pectus excavatum: I. Development, design, and simulations for feasibility and safety. J. Pediatr. Surg. 2007;42:81&#x2013;85, discussion 85&#x2013;86. doi: 10.1016/j.jpedsurg.2006.09.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2006.09.042</ArticleId><ArticleId IdType="pubmed">17208545</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamshidi R., Harrison M. Magnet-mediated thoracic remodeling: A new approach to the sunken chest. Expert Rev. Med. Devices. 2007;4:283&#x2013;286. doi: 10.1586/17434440.4.3.283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/17434440.4.3.283</ArticleId><ArticleId IdType="pubmed">17488221</ArticleId></ArticleIdList></Reference><Reference><Citation>Graves C.E., Hirose S., Raff G.W., Iqbal C.W., Imamura-Ching J., Christensen D., Fechter R., Kwiat D., Harrison M.R. Magnetic Mini-Mover Procedure for pectus excavatum IV: FDA sponsored multicenter trial. J. Pediatr. Surg. 2017;52:913&#x2013;919. doi: 10.1016/j.jpedsurg.2017.03.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2017.03.009</ArticleId><ArticleId IdType="pubmed">28342579</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber P.G., H&#xfc;mmer H.P. Die &#x201c;neue&#x201d; Erlanger Trichterbrustkorrektur&#x2014;Minimalisierung eines bew&#xe4;hrten Verfahrens [The &#x201c;new&#x201d; Erlangen technique of funnel chest correction&#x2014;minimalization of a well working procedure] Zentralbl. Chir. 2006;131:493&#x2013;498. doi: 10.1055/s-2006-956178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2006-956178</ArticleId><ArticleId IdType="pubmed">17206569</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz-Drost S., Luber A.M., Simon K., Schulz-Drost M., Syed J., Carbon R.T., Besend&#xf6;rfer M. Elastic stable chest repair and its hybrid variants in 86 patients with pectus excavatum. J. Thorac. Dis. 2018;10:5736&#x2013;5746. doi: 10.21037/jtd.2018.09.148.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd.2018.09.148</ArticleId><ArticleId IdType="pmc">PMC6236149</ArticleId><ArticleId IdType="pubmed">30505481</ArticleId></ArticleIdList></Reference><Reference><Citation>Giem R.N., Paulsen G.A., Dykes J. Pectus deformities. Calif. Med. 1961;94:306&#x2013;309.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1575897</ArticleId><ArticleId IdType="pubmed">13705160</ArticleId></ArticleIdList></Reference><Reference><Citation>Lester C.W. The etiology and pathogenesis of funnel chest, pigeon breast, and related deformities of the anterior chest wall. J. Thorac. Surg. 1957;34:1&#x2013;10. doi: 10.1016/S0096-5588(20)30366-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0096-5588(20)30366-4</ArticleId><ArticleId IdType="pubmed">13439662</ArticleId></ArticleIdList></Reference><Reference><Citation>Cormack D.H. Essential Histology. 2nd ed. Lippincott Williams &amp;Wilkins; Philadelphia, PA, USA: 2001.</Citation></Reference><Reference><Citation>Geisbe H., Buddecke E., Flach A., M&#xfc;ller G., Stein U. Biochemical, morphological and physical as well as animal ex-perimental studies on the pathogenesis of funnel chest. Langenbecks Arch. Chir. 1967;319:536&#x2013;541. doi: 10.1007/BF02659333.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02659333</ArticleId><ArticleId IdType="pubmed">5587334</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller G., Flach A., Geisbe H. Morphological studies on resected rib cartilage in funnel chest. Frankf. Z. Fur Pathol. 1967;76:164&#x2013;178.</Citation><ArticleIdList><ArticleId IdType="pubmed">6032131</ArticleId></ArticleIdList></Reference><Reference><Citation>Geisbe H., Mildenberger H., Flach A., Fendel H. The aetiology and pathogenesis of funnel chest. Prog. Pediatr. Surg. 1971;3:13&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">5150677</ArticleId></ArticleIdList></Reference><Reference><Citation>Tischer W., Leutert G. Morphologische Ver&#xe4;nderungen der Rippenknorpel bei Trichterbrust (Morphologic changes of rib cartilages in funnel chest) Beitr. Orthop. Traumatol. 1968;15:65&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">5716240</ArticleId></ArticleIdList></Reference><Reference><Citation>Rupprecht H., H&#xfc;mmer H.P., St&#xf6;ss H., Waldherr T. Pathogenesis of chest wall abnormalities&#x2014;electron microscopy studies and trace element analysis of rib cartilage. Zeitschrift Kinderchirurgie. 1987;42:228&#x2013;229.</Citation><ArticleIdList><ArticleId IdType="pubmed">3673280</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuritsyn V.M., Shabanov A.M., Shekhonin B.V., Rukosuev V.S., Rudakov S.S. Pathohistology of costal cartilage and immunomorphologic characteristics of collagen in funnel chest. Arkhiv. Patol. 1987;49:20&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">3827628</ArticleId></ArticleIdList></Reference><Reference><Citation>Rupprecht H., Freiberger N. Light microscopic studies of the cartilage in funnel chest. A new view of the pathogenesis. Z. Exp. Chir. Transpl. Kunstl. Organe. 1989;22:314&#x2013;318.</Citation><ArticleIdList><ArticleId IdType="pubmed">2588750</ArticleId></ArticleIdList></Reference><Reference><Citation>Sokolov B.P., Sher B.M., Kozlov E.A., Tsvetkova T.A., Rudakov S.S., Del&#x2019;vig A.A., Kalinin V.N. Changes in the structure of type I collagen and cross-links between type I and type III collagen chains in a patient with funnel chest. Vopr. Med. Khim. 1989;35:91&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pubmed">2629245</ArticleId></ArticleIdList></Reference><Reference><Citation>Sokolov B.P., She R.B.M., Kozlov E.A., Tsvetkova T.A., Rudakov S.S., Del&#x2019;vig A.A., Kalinin V.N. Structural charac-teristics of collagens from the skin and rib cartilage of patients with Ehlers-Danlos syndrome type II. Vopr. Med. Khim. 1990;36:90&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">2343586</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsvetkova T.A., Kozlov E.A., Rudakov S.S., Del&#x2019;vig A.A. Extractability of collagen from the rib cartilage and skin in funnel chest in children. Vopr. Med. Khim. 1988;34:71&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">3369129</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsvetkova T.A., Gorokhova T.A., Del&#x2019;vig A.A. The effect of ascorbic acid on the collagen synthesis in skin fibroblasts of children with funnel chest. Vopr. Med. Khim. 1990;36:53&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">2238533</ArticleId></ArticleIdList></Reference><Reference><Citation>Prozorovskaya N.N., Kozlov E.A., Voronov A.V., Verovskii V.A., Delvig A.A. Characterization of Costal Cartilage Collagen in Funnel Chest. Biomed. Sci. 1991;2:576&#x2013;580.</Citation><ArticleIdList><ArticleId IdType="pubmed">1841625</ArticleId></ArticleIdList></Reference><Reference><Citation>Borisova N.V., Pokrovskaya A.Y., Zakharova E.Y., Krasnopol&#x2019;skaya K.D. Analysis of collagen hydroxypyridinium crosslinks in samples of tissues and urine of patients with inherited connective tissue disorders. Connect. Tissue Res. 1994;30:177&#x2013;190. doi: 10.3109/03008209409061970.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/03008209409061970</ArticleId><ArticleId IdType="pubmed">8039385</ArticleId></ArticleIdList></Reference><Reference><Citation>Borisova N.V., Pokrovskaya A.Y., Zakharova E.Y., Krasnopol&#x2019;skaya K.D., Poliudov S.A. Analysis of hydroxypyri-dine cross-links of collagen from human rib cartilage. Biull. Eksp. Biol. Med. 1993;115:516&#x2013;518. doi: 10.1007/BF00784192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00784192</ArticleId><ArticleId IdType="pubmed">8043840</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng J., Hu T., Liu W., Zhang S., Tang Y., Chen R., Jiang X., Wei F. The biomechanical, morphologic, and histochem-ical properties of the costal cartilages in children with pectus excavatum. J. Pediatr. Surg. 2001;36:1770&#x2013;1776. doi: 10.1053/jpsu.2001.28820.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/jpsu.2001.28820</ArticleId><ArticleId IdType="pubmed">11733904</ArticleId></ArticleIdList></Reference><Reference><Citation>Serafin J., Swiatkowski J., Majkusiak R., Nowakowski P. 40-year experience in surgical treatment of congenital chest deformationsethio&#x2013;pathogenesis, operative techniques and clinical results. Acta Chir. Orthop. Traumatol. Cech. 2003;70:207&#x2013;213.</Citation><ArticleIdList><ArticleId IdType="pubmed">14569856</ArticleId></ArticleIdList></Reference><Reference><Citation>Fokin A.A., Steuerwald N.M., Ahrens W.A., Allen K.E. Anatomical, histologic, and genetic characteristics of congeni-tal chest wall deformities. Semin. Thorac. Cardiovasc. Surg. 2009;21:44&#x2013;57. doi: 10.1053/j.semtcvs.2009.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.semtcvs.2009.03.001</ArticleId><ArticleId IdType="pubmed">19632563</ArticleId></ArticleIdList></Reference><Reference><Citation>David V.L., Izvernariu D.A., Popoiu C.M., Puiu M., Boia E.S. Morphologic, morphometrical and histochemical pro-prieties of the costal cartilage in children with pectus excavatum. Rom. J. Morphol. Embryol. 2011;52:625&#x2013;629.</Citation><ArticleIdList><ArticleId IdType="pubmed">21655653</ArticleId></ArticleIdList></Reference><Reference><Citation>Tocchioni F., Ghionzoli M., Calosi L., Guasti D., Romagnoli P., Messineo A. Rib Cartilage Characterization in Patients Affected by Pectus Excavatum. Anat. Rec. Adv. Integr. Anat. Evol. Biol. 2013;296:1813&#x2013;1820. doi: 10.1002/ar.22824.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ar.22824</ArticleId><ArticleId IdType="pubmed">24170345</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurkov A.V., Paukov V., Fayzullin A.L., Shekhter A.B. Costal cartilage changes in children with pectus excavatum and pectus carinatum. Arkhiv. Patol. 2018;80:8&#x2013;15. doi: 10.17116/patol2018800518.</Citation><ArticleIdList><ArticleId IdType="doi">10.17116/patol2018800518</ArticleId><ArticleId IdType="pubmed">30335055</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurkov A., Guller A., Fayzullin A., Fayzullina N., Plyakin V., Kotova S., Timashev P., Frolova A., Kurtak N., Pau-kov V., et al. Amianthoid transformation of costal cartilage matrix in children with pectus excavatum and pec-tus carinatum. PLoS ONE. 2021;16:e0245159. doi: 10.1371/journal.pone.0245159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0245159</ArticleId><ArticleId IdType="pmc">PMC7833175</ArticleId><ArticleId IdType="pubmed">33493174</ArticleId></ArticleIdList></Reference><Reference><Citation>Bardakhch&#x2019;ian E., Chepurno&#x12d; G., Shamik V. Ultrastructural changes of child rib cartilage in different deformations of chest cells. Arkhiv. Patologii. 2001;64:40&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">12575541</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall A.C., Horwitz E.R., Wilkins R.J. The cellular physiology of articular cartilage. Exp. Physiol. 1996;81:535&#x2013;545. doi: 10.1113/expphysiol.1996.sp003956.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/expphysiol.1996.sp003956</ArticleId><ArticleId IdType="pubmed">8737086</ArticleId></ArticleIdList></Reference><Reference><Citation>Coulson W. Deformities of the chest. Lond. Med. Gaz. 1820;4:69&#x2013;73.</Citation></Reference><Reference><Citation>Sainsbury H. Congenital Funnel Chest. Lancet. 1947;250:615. doi: 10.1016/S0140-6736(47)90629-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(47)90629-6</ArticleId><ArticleId IdType="pubmed">20268692</ArticleId></ArticleIdList></Reference><Reference><Citation>Eggel W. Eine seltene Missbildung des Thorax. Virchow&#x2019;s Archiv. 1870;49:230&#x2013;236. doi: 10.1007/BF02230501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02230501</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams C.T. Congenital malformation of the thorax: Great depression of the sternum. Trans. Path Soc. 1872;24:50.</Citation></Reference><Reference><Citation>Grunenthal A. Ueber Trichterbrust. Inaug. Diss.; Berlin, Germany: 1888.</Citation></Reference><Reference><Citation>Herbst E. Zur Kasuistik der Trichterbrust. Deutsch. Arch. Klin. Med. 1887;41:308.</Citation></Reference><Reference><Citation>Creswick H.A., Stacey M.W., Kelly R.E., Jr., Gustin T., Nuss D., Harvey H., Goretsky M.J., Vasser E., Welch J.C., Mitchell K., et al. Family study of the inheritance of pectus excavatum. J. Pediatr. Surg. 2006;41:1699&#x2013;1703. doi: 10.1016/j.jpedsurg.2006.05.071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2006.05.071</ArticleId><ArticleId IdType="pubmed">17011272</ArticleId></ArticleIdList></Reference><Reference><Citation>Goretsky M.J., Kelly R.E., Jr., Croitoru D., Nuss D. Chest wall anomalies: Pectus excavatum and pectus carinatum. Adolesc. Med. Clin. 2004;15:455&#x2013;471. doi: 10.1016/j.admecli.2004.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.admecli.2004.06.002</ArticleId><ArticleId IdType="pubmed">15625987</ArticleId></ArticleIdList></Reference><Reference><Citation>Horth L., Stacey M.W., Proud V.K., Segna K., Rutherford C., Nuss D., Kelly R.E. Advancing our understanding of the inheritance and transmission of pectus excavatum. J. Pediatr. Genet. 2012;1:161&#x2013;173.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5020937</ArticleId><ArticleId IdType="pubmed">27625818</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotzot D., Schwabegger A.H. Etiology of chest wall deformities&#x2014;A genetic review for the treating physician. J. Pediatr. Surg. 2009;44:2004&#x2013;2011. doi: 10.1016/j.jpedsurg.2009.07.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2009.07.029</ArticleId><ArticleId IdType="pubmed">19853763</ArticleId></ArticleIdList></Reference><Reference><Citation>Dietz H. In: Marfan Syndrome. Adam M.P., Ardinger H.H., Pagon R.A., editors. University of Washington; Seattle, WA, USA: 1993&#x2013;2022. GeneReviews&#xae; [Internet]</Citation><ArticleIdList><ArticleId IdType="pubmed">20301510</ArticleId></ArticleIdList></Reference><Reference><Citation>Loeys B.L., Dietz H.C., Braverman A.C., Callewaert B.L., de Backer J., Devereux R.B., Hilhorst-Hofstee Y., Jondeau G., Faivre L., Milewicz D.M., et al. The revised Ghent nosology for the Marfan syndrome. J. Med. Genet. 2010;47:476&#x2013;485. doi: 10.1136/jmg.2009.072785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmg.2009.072785</ArticleId><ArticleId IdType="pubmed">20591885</ArticleId></ArticleIdList></Reference><Reference><Citation>Antia A.U. Familial skeletal cardiovascular syndrome (Holt-Oram) in a polygamous African family. Heart. 1970;32:241&#x2013;244. doi: 10.1136/hrt.32.2.241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/hrt.32.2.241</ArticleId><ArticleId IdType="pmc">PMC487310</ArticleId><ArticleId IdType="pubmed">5440519</ArticleId></ArticleIdList></Reference><Reference><Citation>Allanson J.E., Roberts A.E. In: Noonan Syndrome. Adam M.P., Ardinger H.H., Pagon R.A., editors. University of Washington; Washington, DC, USA: 1993&#x2013;2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">20301303</ArticleId></ArticleIdList></Reference><Reference><Citation>Miklovic T., Sieg V.C. Ehlers Danlos Syndrome. StatPearls Publishing; Treasure Island, FL, USA: 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">31747221</ArticleId></ArticleIdList></Reference><Reference><Citation>Romanini M.V., Calevo M.G., Puliti A., Vaccari C., Valle M., Senes F., Torre M. Poland syndrome: A proposed classification system and perspectives on diagnosis and treatment. Semin. Pediatr. Surg. 2018;27:189&#x2013;199. doi: 10.1053/j.sempedsurg.2018.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.sempedsurg.2018.05.007</ArticleId><ArticleId IdType="pubmed">30078491</ArticleId></ArticleIdList></Reference><Reference><Citation>Bavinck J.N., Weaver D.D. Subclavian artery supply disruption sequence: Hypothesis of a vascular etiology for Poland, Klippel-Feil, and M&#xf6;bius anomalies. Am. J. Med. Genet. 1986;23:903&#x2013;918. doi: 10.1002/ajmg.1320230405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajmg.1320230405</ArticleId><ArticleId IdType="pubmed">3008556</ArticleId></ArticleIdList></Reference><Reference><Citation>Armon K., Bale P. Identifying heritable connective tissue disorders in childhood. Practitioner. 2012;256:19&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">22916581</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurnett C.A., Alaee F., Bowcock A., Kruse L., Lenke L.G., Bridwell K.H., Kuklo T., Luhmann S.J., Dobbs M.B. Genetic linkage localizes an adolescent idiopathic scoliosis and pectus excavatum gene to chromosome 18 q. Spine. 2009;34:E94&#x2013;E100. doi: 10.1097/BRS.0b013e31818b88a5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BRS.0b013e31818b88a5</ArticleId><ArticleId IdType="pmc">PMC2638207</ArticleId><ArticleId IdType="pubmed">19139660</ArticleId></ArticleIdList></Reference><Reference><Citation>Karner C.M., Long F., Solnica-Krezel L., Monk K.R., Gray R.S. Gpr126/Adgrg6 deletion in cartilage models idiopathic scoliosis and pectus excavatum in mice. Hum. Mol. Genet. 2015;24:4365&#x2013;4373. doi: 10.1093/hmg/ddv170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddv170</ArticleId><ArticleId IdType="pmc">PMC4492399</ArticleId><ArticleId IdType="pubmed">25954032</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamann J., Aust G., Ara&#xe7; D., Engel F., Formstone C., Fredriksson R., Hall R., Harty B.L., Kirchhoff C., Knapp B., et al. International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G Protein&#x2013;Coupled Receptors. Pharmacol. Rev. 2015;67:338&#x2013;367. doi: 10.1124/pr.114.009647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/pr.114.009647</ArticleId><ArticleId IdType="pmc">PMC4394687</ArticleId><ArticleId IdType="pubmed">25713288</ArticleId></ArticleIdList></Reference><Reference><Citation>Paavola K.J., Sidik H., Zuchero J.B., Eckart M., Talbot W.S. Type IV collagen is an activating ligand for the adhesion G protein&#x2013;coupled receptor GPR126. Sci. Signal. 2014;7:ra76. doi: 10.1126/scisignal.2005347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.2005347</ArticleId><ArticleId IdType="pmc">PMC4159047</ArticleId><ArticleId IdType="pubmed">25118328</ArticleId></ArticleIdList></Reference><Reference><Citation>Gudbjartsson D.F., Walters G.B., Thorleifsson G., Stefansson H., Halldorsson B.V., Zusmanovich P., Sulem P., Thorlacius S., Gylfason A., Steinberg S., et al. Many sequence variants affecting diversity of adult human height. Nat. Genet. 2008;40:609&#x2013;615. doi: 10.1038/ng.122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.122</ArticleId><ArticleId IdType="pubmed">18391951</ArticleId></ArticleIdList></Reference><Reference><Citation>Seko A., Hara-Kuge S., Yamashita K. Molecular cloning and characterization of a novel human galactose 3-O-sulfotransferase that transfers sulfate to gal beta 1&#x2014;&gt;3galNAc residue in O-glycans. J. Biol. Chem. 2001;276:25697&#x2013;25704. doi: 10.1074/jbc.M101558200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M101558200</ArticleId><ArticleId IdType="pubmed">11333265</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S., Sun X., Zhu W., Huang Y., Mou L., Liu M., Li X., Li F., Li X., Zhang Y., et al. Evidence for GAL3ST4 mutation as the potential cause of pectus excavatum. Cell Res. 2012;22:1712&#x2013;1715. doi: 10.1038/cr.2012.149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2012.149</ArticleId><ArticleId IdType="pmc">PMC3515755</ArticleId><ArticleId IdType="pubmed">23147795</ArticleId></ArticleIdList></Reference><Reference><Citation>Heineg&#xe5;rd D., Oldberg &#xc5;. Structure and biology of cartilage and bone matrix noncollagenous macromolecules. FASEB J. 1989;3:2042&#x2013;2051. doi: 10.1096/fasebj.3.9.2663581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fasebj.3.9.2663581</ArticleId><ArticleId IdType="pubmed">2663581</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong X., Li G., Feng Y. TINAG mutation as a genetic cause of pectus excavatum. Med. Hypotheses. 2020;137:109557. doi: 10.1016/j.mehy.2020.109557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.109557</ArticleId><ArticleId IdType="pubmed">31981812</ArticleId></ArticleIdList></Reference><Reference><Citation>TINAG  Tubulointerstitial Nephritis Antigen.  [(accessed on 12 December 2021)]; Available online:  https://www.ncbi.nlm.nih.gov/gene?Db=gene&amp;Cmd=ShowDetailView&amp;TermToSearch=27283.</Citation></Reference><Reference><Citation>Jakowlev K., Livshits G., Kalichman L., Ben-Asher E., Malkin I., Lancet D., Kobyliansky E. Search for hand osteoar-thritis susceptibility locus on chromosome 6p12.3-p12.1. Hum. Biol. 2007;79:1&#x2013;14. doi: 10.1353/hub.2007.0026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1353/hub.2007.0026</ArticleId><ArticleId IdType="pubmed">17985653</ArticleId></ArticleIdList></Reference><Reference><Citation>Shamberger R.C. Congenital chest wall deformities. Curr. Probl. Surg. 1996;33:469&#x2013;542. doi: 10.1016/S0011-3840(96)80005-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0011-3840(96)80005-0</ArticleId><ArticleId IdType="pubmed">8641129</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilegaard H.K. Growth and pectus excavatum: Is there a relation? Eur. J. Cardiothorac. Surg. 2016;50:1110. doi: 10.1093/ejcts/ezw195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezw195</ArticleId><ArticleId IdType="pubmed">27261075</ArticleId></ArticleIdList></Reference><Reference><Citation>Schamberger R.C., Welch K.J. In: Chest Wall Deformities in Ashcraft KW. 2nd ed. Holder T.M., editor. Saunders Compmany; Philadelphia, PA, USA: 1986. pp. 146&#x2013;150.</Citation></Reference><Reference><Citation>Schamberger R.C. In: Congenital Chest Wall Deformities. 6th ed. Grosfeld J.L., O&#x2019;Neil J.A. Jr., Fonkalsrud E.W., Corab A.G., editors. Mosby; Philadelphia, PA, USA: 2006. pp. 894&#x2013;930.</Citation></Reference><Reference><Citation>Peltom&#xe4;ki T., H&#xe4;kkinen L. Growth of the ribs at the costochondral junction in the rat. J. Anat. 1992;181:259&#x2013;264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1259721</ArticleId><ArticleId IdType="pubmed">1295864</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakaoka T., Uemura S., Yano T., Nakagawa Y., Tanimoto T., Suehiro S. Does overgrowth of costal cartilage cause pectus excavatum? A study on the lengths of ribs and costal cartilages in asymmetric patients. J. Pediatr. Surg. 2009;44:1333&#x2013;1336. doi: 10.1016/j.jpedsurg.2008.09.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2008.09.023</ArticleId><ArticleId IdType="pubmed">19573657</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakaoka T., Uemura S., Yoshida T., Tanimoto T., Miyake H. Overgrowth of costal cartilage is not the etiology of pec-tus excavatum. J. Pediatr. Surg. 2010;45:2015&#x2013;2018. doi: 10.1016/j.jpedsurg.2010.04.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2010.04.018</ArticleId><ArticleId IdType="pubmed">20920721</ArticleId></ArticleIdList></Reference><Reference><Citation>David V.L., Cerbu S., Haragus H., Popoiu M.C., Stanciulescu C.M., Cozma G., Burlac O., Boia E.S. Costal Cartilages Do Not Overgrow in Patients with Pectus Excavatum. Med. Princ. Pract. 2016;25:533&#x2013;538. doi: 10.1159/000449133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000449133</ArticleId><ArticleId IdType="pmc">PMC5588508</ArticleId><ArticleId IdType="pubmed">27529702</ArticleId></ArticleIdList></Reference><Reference><Citation>Karak&#x131;l&#x131;&#xe7; A., Kara&#xe7;am V., Ers&#xf6;z H., A&#x11f;ababao&#x11f;lu I., Ulug&#xfc;n F.I., &#x15e;anl&#x131; A. Determination of severity of deformity with rib length to costal cartilage length ratio in thorax deformities. Turk. J. Thorac. Cardiovasc. Surg. 2018;26:279&#x2013;285. doi: 10.5606/tgkdc.dergisi.2018.15009.</Citation><ArticleIdList><ArticleId IdType="doi">10.5606/tgkdc.dergisi.2018.15009</ArticleId><ArticleId IdType="pmc">PMC7024116</ArticleId><ArticleId IdType="pubmed">32082746</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisinger R.S., Harris T., Rajderkar D.A., Islam S. Against the Overgrowth Hypothesis: Shorter Costal Cartilage Lengths in Pectus Excavatum. J. Surg. Res. 2019;235:93&#x2013;97. doi: 10.1016/j.jss.2018.09.080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2018.09.080</ArticleId><ArticleId IdType="pubmed">30691856</ArticleId></ArticleIdList></Reference><Reference><Citation>Park C.H., Kim T.H., Haam S., Lee S. Rib overgrowth may be a contributing factor for pectus excavatum: Evaluation of prepubertal patients younger than 10years old. J. Pediatr. Surg. 2015;50:1945&#x2013;1948. doi: 10.1016/j.jpedsurg.2015.07.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2015.07.010</ArticleId><ArticleId IdType="pubmed">26251368</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondo S., Takagi D., Osaga S., Okuda K., Nakanishi R. The costochondral length in patients with pectus excavatum is longer than that of the normal thorax. Pediatr. Surg. Int. 2020;36:305&#x2013;316. doi: 10.1007/s00383-020-04622-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00383-020-04622-2</ArticleId><ArticleId IdType="pubmed">32006092</ArticleId></ArticleIdList></Reference><Reference><Citation>Haje S.A., Harcke H.T., Bowen J.R. Growth disturbance of the sternum and pectus deformities: Imaging studies and clinical correlation. Pediatr Radiol. 1999;29:334&#x2013;341. doi: 10.1007/s002470050602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s002470050602</ArticleId><ArticleId IdType="pubmed">10382210</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee C., Zavala-Garcia A., Teekappanavar N., Lee C., Idowu O., Kim S. Measurement of sternal curvature angle on patients with pectus excavatum. Pediatr Surg Int. 2017;33:65&#x2013;67. doi: 10.1007/s00383-016-3996-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00383-016-3996-9</ArticleId><ArticleId IdType="pubmed">27722896</ArticleId></ArticleIdList></Reference><Reference><Citation>Haje D.P., Teixeira K.O., Silva M., Volpon J.B., Mendlovitz P.S., Dolabela P. Analysis of sternal curvature patterns in patients with pectus and control. Acta Ortop Bras. 2021;29:258&#x2013;262. doi: 10.1590/1413-785220212905243733.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1413-785220212905243733</ArticleId><ArticleId IdType="pmc">PMC8478432</ArticleId><ArticleId IdType="pubmed">34629950</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R., Yang W., Cai L., Yang J., Xiang X., Zhang C., Jiang Q., Yang Y., Chen Z. Establishment of a rabbit model of pectus excavatum. Int. J. Clin. Exp. Med. 2017;10:6429&#x2013;6436.</Citation></Reference><Reference><Citation>David V.-L., Ciornei B., Horhat F.-G., Amaricai E., Horhat I.-D., Hoinoiu T., Boia E.-S. Rat Animal Model of Pectus Excavatum. Life. 2020;10:96. doi: 10.3390/life10060096.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life10060096</ArticleId><ArticleId IdType="pmc">PMC7345094</ArticleId><ArticleId IdType="pubmed">32604800</ArticleId></ArticleIdList></Reference><Reference><Citation>David V.L., Stanciulescu M.C., Horhat F.G., Sharma A., Kundnani N.R., Ciornei B., Stroescu R.F., Popoiu M.C., Boia E. S: Costal cartilage overgrowth does not induce pectus-like deformation in the chest wall of a rat model. Exp. Ther. Med. 2022;23:146. doi: 10.3892/etm.2021.11069.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2021.11069</ArticleId><ArticleId IdType="pmc">PMC8756389</ArticleId><ArticleId IdType="pubmed">35069827</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32728148</PMID><DateCompleted><Year>2020</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jul</Month><Day>29</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Different levels of estradiol are correlated with sexual dysfunction in adult men.</ArticleTitle><Pagination><StartPage>12660</StartPage><MedlinePgn>12660</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">12660</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-020-69712-6</ELocationID><Abstract><AbstractText>Ejaculatory dysfunction, including premature ejaculation (PE) and delayed ejaculation (DE), as well as erectile dysfunction (ED), constitute the majority of male sexual dysfunction. Despite a fair amount of data on the role of hormones and erection and ejaculation, it is inconclusive due to controversy in the current literature. To explore the correlation of male sexual dysfunction with hormonal profile, 1,076 men between the ages of 19-60&#xa0;years (mean: 32.12&#xa0;years) were included in this retrospective case-control study; 507 were categorized as ED, PE and DE groups. Five hundred and sixty-nine men without sexual dysfunction were enrolled in the control group. The background characteristics and clinical features of the four groups were collected and analyzed. The estradiol value was significantly elevated in the ED group than the control group (109.44&#x2009;&#xb1;&#x2009;47.14&#xa0;pmol/L vs. 91.88&#x2009;&#xb1;&#x2009;27.68&#xa0;pmol/L; P&#x2009;&lt;&#x2009;0.001). Conversely, the DE group had significantly lower level of estradiol than control did (70.76&#x2009;&#xb1;&#x2009;27.20&#xa0;pmol/L vs. 91.88&#x2009;&#xb1;&#x2009;27.68&#xa0;pmol/L; P&#x2009;&lt;&#x2009;0.001). The PE group had similar level of estradiol (91.73&#x2009;&#xb1;&#x2009;31.57&#xa0;pmol/L vs. 91.88&#x2009;&#xb1;&#x2009;27.68&#xa0;pmol/L; P&#x2009;=&#x2009;0.960) but significantly higher level of testosterone (17.23&#x2009;&#xb1;&#x2009;5.72&#xa0;nmol/L vs. 15.31&#x2009;&#xb1;&#x2009;4.31&#xa0;nmol/L; P&#x2009;&lt;&#x2009;0.001) compared with the control group. In conclusion, elevated serum testosterone concentration was an independent risk factor for PE. Besides, there was a progressively increasing graded-distribution of estradiol values from DE to PE and ED groups.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Chen</LastName><ForeName>Tong</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Urology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 324 Jingwu Road, Jinan, 250021, Shandong, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Reproductive Medicine, National Research Center for Assisted Reproductive Technology and Reproductive Genetics, The Key Laboratory for Reproductive Endocrinology of Ministry of Education, Shandong University, Jinan, 250021, Shandong, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatric Surgery, Shanghai Children's Hospital, Shanghai Jiao Tong University, Shanghai, 200062, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Wu</LastName><ForeName>Fei</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Urology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 324 Jingwu Road, Jinan, 250021, Shandong, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Urology, Shandong Provincial Qianfoshan Hospital, Jinan, 250002, Shandong, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xianlong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Center for Reproductive Medicine, National Research Center for Assisted Reproductive Technology and Reproductive Genetics, The Key Laboratory for Reproductive Endocrinology of Ministry of Education, Shandong University, Jinan, 250021, Shandong, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Gang</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Center for Reproductive Medicine, National Research Center for Assisted Reproductive Technology and Reproductive Genetics, The Key Laboratory for Reproductive Endocrinology of Ministry of Education, Shandong University, Jinan, 250021, Shandong, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xuan</LastName><ForeName>Xujun</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Center for Reproductive Medicine, National Research Center for Assisted Reproductive Technology and Reproductive Genetics, The Key Laboratory for Reproductive Endocrinology of Ministry of Education, Shandong University, Jinan, 250021, Shandong, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Rong</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Center for Reproductive Medicine, National Research Center for Assisted Reproductive Technology and Reproductive Genetics, The Key Laboratory for Reproductive Endocrinology of Ministry of Education, Shandong University, Jinan, 250021, Shandong, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Sentai</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Urology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 324 Jingwu Road, Jinan, 250021, Shandong, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Jiaju</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Urology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 324 Jingwu Road, Jinan, 250021, Shandong, People's Republic of China. kyoto2310@sina.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Reproductive Medicine, National Research Center for Assisted Reproductive Technology and Reproductive Genetics, The Key Laboratory for Reproductive Endocrinology of Ministry of Education, Shandong University, Jinan, 250021, Shandong, People's Republic of China. kyoto2310@sina.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>3XMK78S47O</RegistryNumber><NameOfSubstance UI="D013739">Testosterone</NameOfSubstance></Chemical><Chemical><RegistryNumber>4TI98Z838E</RegistryNumber><NameOfSubstance UI="D004958">Estradiol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007172" MajorTopicYN="N">Erectile Dysfunction</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004958" MajorTopicYN="N">Estradiol</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013739" MajorTopicYN="N">Testosterone</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="Y">Up-Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>1</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>7</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>7</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32728148</ArticleId><ArticleId IdType="pmc">PMC7391660</ArticleId><ArticleId IdType="doi">10.1038/s41598-020-69712-6</ArticleId><ArticleId IdType="pii">10.1038/s41598-020-69712-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Corona G, Jannini EA, Vignozzi L, Rastrelli G, Maggi M. The hormonal control of ejaculation. Nat. Rev. Urol. 2012;9:508. doi: 10.1038/nrurol.2012.147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrurol.2012.147</ArticleId><ArticleId IdType="pubmed">22869001</ArticleId></ArticleIdList></Reference><Reference><Citation>MD, W. et al. A multinational population survey of intravaginal ejaculation latency time. The journal of sexual medicine2, 492&#x2013;497 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">16422843</ArticleId></ArticleIdList></Reference><Reference><Citation>O'connor, D. B. et al. The relationships between sex hormones and sexual function in middle-aged and older European men. J. Clin. Endocrinol. Metab.96, E1577&#x2013;E1587 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21849522</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulster M, Bernie AM, Ramasamy R. The role of estradiol in male reproductive function. Asian J. Androl. 2016;18:435. doi: 10.4103/1008-682X.173932.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1008-682X.173932</ArticleId><ArticleId IdType="pmc">PMC4854098</ArticleId><ArticleId IdType="pubmed">26908066</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Sakka AI. Impact of the association between elevated oestradiol and low testosterone levels on erectile dysfunction severity. Asian J. Androl. 2013;15:492. doi: 10.1038/aja.2013.20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/aja.2013.20</ArticleId><ArticleId IdType="pmc">PMC3739229</ArticleId><ArticleId IdType="pubmed">23644871</ArticleId></ArticleIdList></Reference><Reference><Citation>Motofei I. The etiology of premature ejaculation starting from a bihormonal model of normal sexual stimulation. Int. J. Impot. Res. 2001;13:49. doi: 10.1038/sj.ijir.3900632.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.ijir.3900632</ArticleId><ArticleId IdType="pubmed">11313842</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou, Q. et al. Localization of androgen and estrogen receptors in adult male mouse reproductive tract. J. Androl.23, 870&#x2013;881 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12399534</ArticleId></ArticleIdList></Reference><Reference><Citation>Vignozzi L, et al. Regulation of epididymal contractility during semen emission, the first part of the ejaculatory process: a role for estrogen (vol 5, pg 2010, 2008) J. Sex. Med. 2008;5:2480&#x2013;2480. doi: 10.1111/j.1743-6109.2008.00914.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1743-6109.2008.00914.x</ArticleId><ArticleId IdType="pubmed">18783525</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogawa S, Lubahn DB, Korach KS, Pfaff DW. Behavioral effects of estrogen receptor gene disruption in male mice. Proc. Natl. Acad. Sci. USA. 1997;94:1476&#x2013;1481. doi: 10.1073/pnas.94.4.1476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.94.4.1476</ArticleId><ArticleId IdType="pmc">PMC19816</ArticleId><ArticleId IdType="pubmed">9037078</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakker J, Honda S, Harada N, Balthazart J. Restoration of male sexual behavior by adult exogenous estrogens in male aromatase knockout mice. Horm. Behav. 2004;46:1&#x2013;10. doi: 10.1016/j.yhbeh.2004.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yhbeh.2004.02.003</ArticleId><ArticleId IdType="pubmed">15215036</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z, et al. Aromatase deficiency in a Chinese adult man caused by novel compound heterozygous CYP19A1 mutations: Effects of estrogen replacement therapy on the bone, lipid, liver and glucose metabolism. Mol. Cell. Endocrinol. 2015;399:32&#x2013;42. doi: 10.1016/j.mce.2014.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mce.2014.09.016</ArticleId><ArticleId IdType="pmc">PMC4457386</ArticleId><ArticleId IdType="pubmed">25301327</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith EP, et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N. Engl. J. Med. 1994;331:1056&#x2013;1061. doi: 10.1056/nejm199410203311604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejm199410203311604</ArticleId><ArticleId IdType="pubmed">8090165</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen RC, et al. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49:822&#x2013;830. doi: 10.1016/S0090-4295(97)00238-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0090-4295(97)00238-0</ArticleId><ArticleId IdType="pubmed">9187685</ArticleId></ArticleIdList></Reference><Reference><Citation>Se, A. et al. An update of the International Society of Sexual Medicine's guidelines for the diagnosis and treatment of premature ejaculation (PE). J. Sex. Med.11, 1392&#x2013;1422 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24848686</ArticleId></ArticleIdList></Reference><Reference><Citation>McMahon CG, Jannini E, Waldinger M, Rowland D. Standard operating procedures in the disorders of orgasm and ejaculation. J. Sex. Med. 2013;10:204&#x2013;229. doi: 10.1111/j.1743-6109.2012.02824.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1743-6109.2012.02824.x</ArticleId><ArticleId IdType="pubmed">22970767</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhoden EL, Teloken C, Sogari PR, Souto CAV. The relationship of serum testosterone to erectile function in normal aging men. J. Urol. 2002;167:1745&#x2013;1748. doi: 10.1016/S0022-5347(05)65191-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-5347(05)65191-9</ArticleId><ArticleId IdType="pubmed">11912401</ArticleId></ArticleIdList></Reference><Reference><Citation>Kupelian V, et al. Is there a relationship between sex hormones and erectile dysfunction? Results from the Massachusetts Male Aging Study. J. Urol. 2006;176:2584&#x2013;2588. doi: 10.1016/j.juro.2006.08.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.juro.2006.08.020</ArticleId><ArticleId IdType="pubmed">17085164</ArticleId></ArticleIdList></Reference><Reference><Citation>Rastrelli G, Corona G, Maggi M. Testosterone and sexual function in men. Maturitas. 2018;112:46&#x2013;52. doi: 10.1016/j.maturitas.2018.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.maturitas.2018.04.004</ArticleId><ArticleId IdType="pubmed">29704917</ArticleId></ArticleIdList></Reference><Reference><Citation>Yafi FA, et al. Erectile dysfunction. Nat. Rev. Dis. Primers. 2016;2:16003. doi: 10.1038/nrdp.2016.3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2016.3</ArticleId><ArticleId IdType="pmc">PMC5027992</ArticleId><ArticleId IdType="pubmed">27188339</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooke PS, Nanjappa MK, Ko C, Prins GS, Hess RA. Estrogens in male physiology. Physiol. Rev. 2017;97:995. doi: 10.1152/physrev.00018.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00018.2016</ArticleId><ArticleId IdType="pmc">PMC6151497</ArticleId><ArticleId IdType="pubmed">28539434</ArticleId></ArticleIdList></Reference><Reference><Citation>Vignozzi L, et al. Estrogen mediates metabolic syndrome-induced erectile dysfunction: a study in the rabbit. J. Sex. Med. 2014;11:2890&#x2013;2902. doi: 10.1111/jsm.12695.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jsm.12695</ArticleId><ArticleId IdType="pubmed">25243860</ArticleId></ArticleIdList></Reference><Reference><Citation>Longcope C, Kato T, Horton R. Conversion of blood androgens to estrogens in normal adult men and women. J. Clin. Invest. 1969;48:2191&#x2013;2201. doi: 10.1172/jci106185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci106185</ArticleId><ArticleId IdType="pmc">PMC297476</ArticleId><ArticleId IdType="pubmed">5355335</ArticleId></ArticleIdList></Reference><Reference><Citation>TS H, et al. Impaired quality of life and sexual function in overweight and obese men: the European Male Ageing Study. Eur. J. Endocrinol. 2011;164:1003&#x2013;1011. doi: 10.1530/eje-10-1129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/eje-10-1129</ArticleId><ArticleId IdType="pubmed">21459980</ArticleId></ArticleIdList></Reference><Reference><Citation>Janiszewski PM, Janssen I, Ross R. Abdominal obesity and physical inactivity are associated with erectile dysfunction independent of body mass index. J. Sex. Med. 2009;6:1990&#x2013;1998. doi: 10.1111/j.1743-6109.2009.01302.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1743-6109.2009.01302.x</ArticleId><ArticleId IdType="pubmed">19453892</ArticleId></ArticleIdList></Reference><Reference><Citation>Sa T, Ac H. Waist circumference predicts increased cardiometabolic risk in normal weight adolescent males. Int. J. Pediatric Obesity. 2011;6:e307&#x2013;311. doi: 10.3109/17477166.2011.575149.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17477166.2011.575149</ArticleId><ArticleId IdType="pubmed">21649469</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuniga KB, Margolin EJ, De Fazio A, Ackerman A, Stahl PJ. The association between elevated serum oestradiol levels and clinically significant erectile dysfunction in men presenting for andrological evaluation. Andrologia. 2019;51:e13345. doi: 10.1111/and.13345.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/and.13345</ArticleId><ArticleId IdType="pmc">PMC6903694</ArticleId><ArticleId IdType="pubmed">31317572</ArticleId></ArticleIdList></Reference><Reference><Citation>Corona G, et al. Premature and delayed ejaculation: two ends of a single continuum influenced by hormonal milieu. Int. J. Androl. 2011;34:41&#x2013;48. doi: 10.1111/j.1365-2605.2010.01059.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2605.2010.01059.x</ArticleId><ArticleId IdType="pubmed">20345874</ArticleId></ArticleIdList></Reference><Reference><Citation>Corona G, et al. Different testosterone levels are associated with ejaculatory dysfunction. J. Sex. Med. 2010;5:1991&#x2013;1998. doi: 10.1111/j.1743-6109.2008.00803.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1743-6109.2008.00803.x</ArticleId><ArticleId IdType="pubmed">18399946</ArticleId></ArticleIdList></Reference><Reference><Citation>Jern P, et al. Associations between salivary testosterone levels, androgen-related genetic polymorphisms, and self-estimated ejaculation latency time. Sex. Med. 2014;2:107&#x2013;114. doi: 10.1002/sm2.34.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sm2.34</ArticleId><ArticleId IdType="pmc">PMC4184490</ArticleId><ArticleId IdType="pubmed">25356307</ArticleId></ArticleIdList></Reference><Reference><Citation>Paduch DA, et al. Clinical and demographic correlates of ejaculatory dysfunctions other than premature ejaculation: a prospective, observational study. J. Sex. Med. 2015;12:2276&#x2013;2286. doi: 10.1111/jsm.13027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jsm.13027</ArticleId><ArticleId IdType="pubmed">26511106</ArticleId></ArticleIdList></Reference><Reference><Citation>Lotti F, et al. Is thyroid hormones evaluation of clinical value in the work-up of males of infertile couples? Hum. Reprod. 2016;31:518&#x2013;529. doi: 10.1093/humrep/dev338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/humrep/dev338</ArticleId><ArticleId IdType="pubmed">26759137</ArticleId></ArticleIdList></Reference><Reference><Citation>Lotti F, et al. Clinical implications of measuring prolactin levels in males of infertile couples. Andrology. 2013;1:764&#x2013;771. doi: 10.1111/j.2047-2927.2013.00114.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.2047-2927.2013.00114.x</ArticleId><ArticleId IdType="pubmed">23970454</ArticleId></ArticleIdList></Reference><Reference><Citation>Finkelstein JS, et al. Gonadal steroids and body composition, strength, and sexual function in men. N. Engl. J. Med. 2013;369:1011&#x2013;1022. doi: 10.1056/NEJMoa1206168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1206168</ArticleId><ArticleId IdType="pmc">PMC4142768</ArticleId><ArticleId IdType="pubmed">24024838</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramasamy, R., Kovac, J. R., Scovell, J. M. &amp; Lipshultz, L. I. Words of wisdom. Re: In older men an optimal plasma testosterone is associated with reduced all-cause mortality and higher dihydrotestosterone with reduced ischemic heart disease mortality, while estradiol levels do not predict mortality. Eur. Urol.65, 844 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24559901</ArticleId></ArticleIdList></Reference><Reference><Citation>Lotti F, Maggi M. Sexual dysfunction and male infertility. Nat. Rev. Urol. 2018;15:287&#x2013;307. doi: 10.1038/nrurol.2018.20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrurol.2018.20</ArticleId><ArticleId IdType="pubmed">29532805</ArticleId></ArticleIdList></Reference><Reference><Citation>Lotti F, et al. Clinical correlates of erectile dysfunction and premature ejaculation in men with couple infertility. J. Sex. Med. 2012;9:2698&#x2013;2707. doi: 10.1111/j.1743-6109.2012.02872.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1743-6109.2012.02872.x</ArticleId><ArticleId IdType="pubmed">22897716</ArticleId></ArticleIdList></Reference><Reference><Citation>Lotti F, et al. Semen quality impairment is associated with sexual dysfunction according to its severity. Hum. Reprod. 2016;31:2668&#x2013;2680. doi: 10.1093/humrep/dew246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/humrep/dew246</ArticleId><ArticleId IdType="pubmed">27733531</ArticleId></ArticleIdList></Reference><Reference><Citation>Lotti F, et al. Seminal, clinical and colour-Doppler ultrasound correlations of prostatitis-like symptoms in males of infertile couples. Andrology. 2014;2:30&#x2013;41. doi: 10.1111/j.2047-2927.2013.00156.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.2047-2927.2013.00156.x</ArticleId><ArticleId IdType="pubmed">24288243</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen RC, et al. Correlates to the clinical diagnosis of premature ejaculation: results from a large observational study of men and their partners. J. Urol. 2007;177:1059&#x2013;1064. doi: 10.1016/j.juro.2006.10.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.juro.2006.10.044</ArticleId><ArticleId IdType="pubmed">17296411</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">28822540</PMID><DateCompleted><Year>2018</Year><Month>08</Month><Day>10</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1531-5037</ISSN><JournalIssue CitedMedium="Internet"><Volume>53</Volume><Issue>4</Issue><PubDate><Year>2018</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of pediatric surgery</Title><ISOAbbreviation>J Pediatr Surg</ISOAbbreviation></Journal><ArticleTitle>Life-threatening complications and mortality of minimally invasive pectus surgery.</ArticleTitle><Pagination><StartPage>728</StartPage><EndPage>732</EndPage><MedlinePgn>728-732</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jpedsurg.2017.07.020</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0022-3468(17)30461-X</ELocationID><Abstract><AbstractText Label="UNLABELLED">The prevalence and type of life-threatening complications related to the minimally invasive repair of pectus excavatum (MIRPE) and bar removal are unknown and underreported. The purpose of this communication is to make surgeons aware of the risk of these life threatening complications as well as the modifications which have been developed to prevent them.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Data related to life-threatening complications of Pectus Excavatum (PE) patients was obtained from four sources: 1. A survey of Chest Wall International Group (CWIG) surgeons who specialize in repairing congenital chest wall malformations, 2. Papers and case reports presented at CWIG meetings, 3. Review of medico-legal cases from the USA and 4. A systematic review of the literature related to major complications post MIRPE.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">From 1998 to 2016, we identified 27 published cases and 32 unreported life-threatening complications including: cardiac perforation, hemothorax, major vessel injury, lung injury, liver injury, gastrointestinal problems, and diaphragm injury. There were seven cases of major complications with bar removal (reported and non-reported) with two lethal outcomes. Mortality data with bar placement surgery: Four published death cases and seven unpublished death cases. The overall incidence of minor &amp; major complications post MIRPE has been reported in the literature to be 2-20%. The true incidence of life-threatening complications and mortality is not known as we do not know the overall number of procedures performed worldwide. However, based on data extrapolated from survey information, the pectus bar manufacturer in the USA, literature reports, and data presented at CWIG meetings as to the number of cases performed we estimated that approximately fifty thousand cases have been performed and that the incidence of life-threatening complications is less than 0.1% with many occurring during the learning curve. Analysis of the cases identified in our survey revealed that previous chest surgery, pectus severity and inexperience were noted to be significant risk factors for mortality.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Published reports support the safety and efficacy of MIRPE; however major adverse outcomes are underreported. Although major complications with MIRPE and pectus bar removal surgery are very rare, awareness of the risk and mortality of life-threatening complications is essential to ensure optimal safety. Factors such as operative technique, patient age, pectus severity and asymmetry, previous chest surgery, and the surgeon's experience play a role in the overall incidence of such events. These preventable events can be avoided with proper training, mentoring, and the use of sternal elevation techniques.</AbstractText><AbstractText Label="TYPE OF STUDY" NlmCategory="METHODS">Treatment Study.</AbstractText><AbstractText Label="LEVEL OF EVIDENCE" NlmCategory="METHODS">Level IV.</AbstractText><CopyrightInformation>Copyright &#xa9; 2017 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hebra</LastName><ForeName>Andr&#xe9;</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Nemours Children's Hospital, Orlando, FL, USA; Children's Hospital of the King's Daughters, Norfolk, VA, USA; Fundaci&#xf3;n Hospitalaria Children's Hospital, Buenos Aires, Argentina; University of Sao Paulo, Sao Paulo, SP, Brazil; Marmara University, Istanbul, Turkey. Electronic address: andre.hebra@nemours.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kelly</LastName><ForeName>Robert E</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>Nemours Children's Hospital, Orlando, FL, USA; Children's Hospital of the King's Daughters, Norfolk, VA, USA; Fundaci&#xf3;n Hospitalaria Children's Hospital, Buenos Aires, Argentina; University of Sao Paulo, Sao Paulo, SP, Brazil; Marmara University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferro</LastName><ForeName>Marcelo M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Nemours Children's Hospital, Orlando, FL, USA; Children's Hospital of the King's Daughters, Norfolk, VA, USA; Fundaci&#xf3;n Hospitalaria Children's Hospital, Buenos Aires, Argentina; University of Sao Paulo, Sao Paulo, SP, Brazil; Marmara University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Y&#xfc;ksel</LastName><ForeName>Mustafa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Nemours Children's Hospital, Orlando, FL, USA; Children's Hospital of the King's Daughters, Norfolk, VA, USA; Fundaci&#xf3;n Hospitalaria Children's Hospital, Buenos Aires, Argentina; University of Sao Paulo, Sao Paulo, SP, Brazil; Marmara University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campos</LastName><ForeName>Jose Ribas M</ForeName><Initials>JRM</Initials><AffiliationInfo><Affiliation>Nemours Children's Hospital, Orlando, FL, USA; Children's Hospital of the King's Daughters, Norfolk, VA, USA; Fundaci&#xf3;n Hospitalaria Children's Hospital, Buenos Aires, Argentina; University of Sao Paulo, Sao Paulo, SP, Brazil; Marmara University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nuss</LastName><ForeName>Donald</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Nemours Children's Hospital, Orlando, FL, USA; Children's Hospital of the King's Daughters, Norfolk, VA, USA; Fundaci&#xf3;n Hospitalaria Children's Hospital, Buenos Aires, Argentina; University of Sao Paulo, Sao Paulo, SP, Brazil; Marmara University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>07</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Pediatr Surg</MedlineTA><NlmUniqueID>0052631</NlmUniqueID><ISSNLinking>0022-3468</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Pediatr Surg. 2018 Apr;53(4):857-858. doi: 10.1016/j.jpedsurg.2017.12.004.</RefSource><PMID Version="1">29366505</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D005660" MajorTopicYN="N">Funnel Chest</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019060" MajorTopicYN="Y">Minimally Invasive Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019637" MajorTopicYN="Y">Orthopedic Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiac injury</Keyword><Keyword MajorTopicYN="N">Chest Wall deformity</Keyword><Keyword MajorTopicYN="N">Life-threatening complications</Keyword><Keyword MajorTopicYN="N">MIRPE</Keyword><Keyword MajorTopicYN="N">Minimally invasive repair</Keyword><Keyword MajorTopicYN="N">Morbidity</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Nuss procedure</Keyword><Keyword MajorTopicYN="N">Pectus bar removal</Keyword><Keyword MajorTopicYN="N">Pectus excavatum</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>6</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>8</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28822540</ArticleId><ArticleId IdType="doi">10.1016/j.jpedsurg.2017.07.020</ArticleId><ArticleId IdType="pii">S0022-3468(17)30461-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33662848</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>06</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-7603</ISSN><JournalIssue CitedMedium="Internet"><Volume>145</Volume><PubDate><Year>2021</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of reproductive immunology</Title><ISOAbbreviation>J Reprod Immunol</ISOAbbreviation></Journal><ArticleTitle>Epigenetic modification via H3K4me3 and H3K9ac in human placenta is reduced in preeclampsia.</ArticleTitle><Pagination><StartPage>103287</StartPage><MedlinePgn>103287</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jri.2021.103287</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0165-0378(21)00017-6</ELocationID><Abstract><AbstractText Label="BACKROUND">Alterations of DNA accessibility and chromatin structure are associated with diseases. We aimed to investigate epigenetic modifications in preeclampsia (PE), a pregnancy-associated hypertonic disease. Specifically, we addressed histone modification proteins H3K9ac (acetylated lysine 9 of the histone H3) and H3K4me3 (trimethylated lysine 4 of the histone H3) in PE.</AbstractText><AbstractText Label="METHODS">We analyzed expression of histone proteins H3K4me3 and H3K9ac in 32 PE and 32 control placentas by immunohistochemistry. Further, we carried out confirmatory western blot analysis of respective proteins in 6 representative placentas. We then applied regression models with additional adjustment for potential confounders.</AbstractText><AbstractText Label="RESULTS">Expression of H3K4me3 and H3K9ac is reduced in PE placentas as demonstrated by immunohistochemical stainings and western blot. There are no differences between female and male fetuses in the presence of these histone modifications. H3K4me3 positively correlated with maternal age (r&#x202f;=&#x202f;0.444, p&#x202f;=&#x202f;0.034).</AbstractText><AbstractText Label="CONCLUSION">Expression of the placental histone proteins H3K4me3 and H3K9ac is reduced in PE, and independent of fetal gender. Our study underlines the involvement of epigenetic changes in the placenta of women suffering from PE.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Meister</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. Electronic address: sarah.meister@med.uni-muenchen.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hahn</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. Electronic address: laura.hahn97@t-online.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beyer</LastName><ForeName>Susanne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. Electronic address: susanne.beyer@med.uni-muenchen.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuhn</LastName><ForeName>Christina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. Electronic address: christina.kuhn@med.uni-muenchen.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jegen</LastName><ForeName>Magdalena</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. Electronic address: magdalena.jegen@med.uni-muenchen.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>von Sch&#xf6;nfeldt</LastName><ForeName>Viktoria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. Electronic address: viktoria.schoenfeldt@med.uni-muenchen.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corradini</LastName><ForeName>Stefanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, University Hospital, LMU, Munich, Marchioninistr. 15, 81377, Germany. Electronic address: stefanie.corradini@med.uni-muenchen.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schulz</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Medizinische Klinik und Poliklinik I, Klinikum der Universit&#xe4;t, Ludwig-Maximilians-Universit&#xe4;t, Marchioninistrasse 15, 81377, Munich, Germany. Electronic address: Christian.schulz@med.uni-muenchen.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kolben</LastName><ForeName>Theresa Maria</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. Electronic address: theresa.kolben@med.uni-muenchen.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hester</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. Electronic address: anna.hester@med.uni-muenchen.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Appelt</LastName><ForeName>Tamara</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of General and Visceral Surgery, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Strasse 22, 81675, Munich, Germany. Electronic address: Tamara.appelt@web.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahner</LastName><ForeName>Sven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. Electronic address: sven.mahner@med.uni-muenchen.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeschke</LastName><ForeName>Udo</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany; Department of Gynecology and Obstetrics, University Hospital Augsburg, 86156, Augsburg, Germany. Electronic address: udo.jeschke@med.uni-muenchen.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kolben</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. Electronic address: thomas.kolben@med.uni-muenchen.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>J Reprod Immunol</MedlineTA><NlmUniqueID>8001906</NlmUniqueID><ISSNLinking>0165-0378</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006657">Histones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000626468">histone H3 trimethyl Lys4</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044127" MajorTopicYN="N">Epigenesis, Genetic</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005333" MajorTopicYN="N">Fetus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042421" MajorTopicYN="N">Histone Code</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006657" MajorTopicYN="N">Histones</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008423" MajorTopicYN="N">Maternal Age</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010920" MajorTopicYN="N">Placenta</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011225" MajorTopicYN="N">Pre-Eclampsia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">H3K4me3</Keyword><Keyword MajorTopicYN="N">H3K9ac</Keyword><Keyword MajorTopicYN="N">Histone modification</Keyword><Keyword MajorTopicYN="N">Placenta</Keyword><Keyword MajorTopicYN="N">Preeclampsia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>1</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>4</Day><Hour>20</Hour><Minute>19</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33662848</ArticleId><ArticleId IdType="doi">10.1016/j.jri.2021.103287</ArticleId><ArticleId IdType="pii">S0165-0378(21)00017-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33295500</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>18</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1678-4561</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>12</Issue><PubDate><Year>2020</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Ciencia &amp; saude coletiva</Title><ISOAbbreviation>Cien Saude Colet</ISOAbbreviation></Journal><ArticleTitle>Mental Health Studies published in the last 25 years in the Journal Ci&#xea;ncia &amp; Sa&#xfa;de Coletiva.</ArticleTitle><Pagination><StartPage>4771</StartPage><EndPage>4790</EndPage><MedlinePgn>4771-4790</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1590/1413-812320202512.27932020</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1413-81232020001204771</ELocationID><Abstract><AbstractText>A systematic review of the 25-year Mental Health production of Journal Ci&#xea;ncia &amp; Sa&#xfa;de Coletiva was performed to identify whether this production had changed over time. We investigated whether these changes would have any relationship with the implementation of a new regulatory and legal framework for this field and the expansion of public services and the promotion of public funding agencies' investigation on the subject. A total of 278 original papers were analyzed from the following categories: sociocultural transformations related to madness and its approach; legislative changes; implantation, coverage range and operation of the network of substitute services; clinic/care developed in substitute services; the role and possibilities of primary care; drug use-related problems; mental health of children and adolescents; epidemiological studies/psychiatric categories; and others - which included ethnic-racial issues, violence, about the elderly population, suicide, bullying, and migration. A chronological relationship can be observed between the increase in publications and research notices and the expansion of services, not seemingly in the same way concerning care for people with alcohol and other drug problems.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Campos</LastName><ForeName>Rosana Onocko</ForeName><Initials>RO</Initials><Identifier Source="ORCID">0000-0003-0469-5447</Identifier><AffiliationInfo><Affiliation>Faculdade de Ci&#xea;ncias M&#xe9;dicas, Universidade Estadual de Campinas (Unicamp). R. Tess&#xe1;lia Vieira de Camargo 126, Bar&#xe3;o Geraldo. 13084-971 Campinas SP Brasil. rosanaoc@unicamp.br.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos</LastName><ForeName>Deivisson Vianna Dantas Dos</ForeName><Initials>DVDD</Initials><Identifier Source="ORCID">0000-0002-1198-1890</Identifier><AffiliationInfo><Affiliation>Departamento de Sa&#xfa;de Coletiva, Universidade Federal do Paran&#xe1;. Curitiba PR Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diaz</LastName><ForeName>Alberto Velzi</ForeName><Initials>AV</Initials><Identifier Source="ORCID">0000-0001-6304-2150</Identifier><AffiliationInfo><Affiliation>Consejo de Investigadores, Universidad Nacional de Rosario. Rosario Santa F&#xe9; Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Emerich</LastName><ForeName>Bruno</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-7246-5809</Identifier><AffiliationInfo><Affiliation>Faculdade de Ci&#xea;ncias M&#xe9;dicas, Universidade Estadual de Campinas (Unicamp). R. Tess&#xe1;lia Vieira de Camargo 126, Bar&#xe3;o Geraldo. 13084-971 Campinas SP Brasil. rosanaoc@unicamp.br.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trape</LastName><ForeName>Thiago</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-5288-4966</Identifier><AffiliationInfo><Affiliation>Faculdade S&#xe3;o Leopoldo Mandic. Rio de Janeiro RJ Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gama</LastName><ForeName>Carlos Alberto Pegolo da</ForeName><Initials>CAPD</Initials><Identifier Source="ORCID">0000-0002-6345-7476</Identifier><AffiliationInfo><Affiliation>Universidade Federal de S&#xe3;o Jo&#xe3;o Del Rei. S&#xe3;o Jo&#xe3;o Del Rei MG Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amaral</LastName><ForeName>Carlos Eduardo Menezes</ForeName><Initials>CEM</Initials><Identifier Source="ORCID">0000-0002-1719-1080</Identifier><AffiliationInfo><Affiliation>Universidade Federal do Vale do S&#xe3;o Francisco. Petrolina PE Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poderoso</LastName><ForeName>Rosana Evangelista</ForeName><Initials>RE</Initials><Identifier Source="ORCID">0000-0001-8661-1168</Identifier><AffiliationInfo><Affiliation>Faculdade de Ci&#xea;ncias M&#xe9;dicas, Universidade Estadual de Campinas (Unicamp). R. Tess&#xe1;lia Vieira de Camargo 126, Bar&#xe3;o Geraldo. 13084-971 Campinas SP Brasil. rosanaoc@unicamp.br.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrer</LastName><ForeName>Ana Luiza</ForeName><Initials>AL</Initials><Identifier Source="ORCID">0000-0003-0862-1015</Identifier><AffiliationInfo><Affiliation>Universidade Federal de Santa Maria. Santa Maria RS Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miranda</LastName><ForeName>Lilian</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-8238-8111</Identifier><AffiliationInfo><Affiliation>Universidade Federal Rural do Rio de Janeiro. Rio de Janeiro RJ Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pereira</LastName><ForeName>Mariana Barbosa</ForeName><Initials>MB</Initials><Identifier Source="ORCID">0000-0003-3276-9407</Identifier><AffiliationInfo><Affiliation>Faculdade de Ci&#xea;ncias M&#xe9;dicas, Universidade Estadual de Campinas (Unicamp). R. Tess&#xe1;lia Vieira de Camargo 126, Bar&#xe3;o Geraldo. 13084-971 Campinas SP Brasil. rosanaoc@unicamp.br.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Surjus</LastName><ForeName>Luciana Togni</ForeName><Initials>LT</Initials><Identifier Source="ORCID">0000-0002-3419-9797</Identifier><AffiliationInfo><Affiliation>Faculdade de Ci&#xea;ncias M&#xe9;dicas, Universidade Estadual de Campinas (Unicamp). R. Tess&#xe1;lia Vieira de Camargo 126, Bar&#xe3;o Geraldo. 13084-971 Campinas SP Brasil. rosanaoc@unicamp.br.</Affiliation></AffiliationInfo></Author></AuthorList><Language>por</Language><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><VernacularTitle>Estudos de Sa&#xfa;de Mental publicados nos &#xfa;ltimos 25 anos na Revista Ci&#xea;ncia &amp; Sa&#xfa;de Coletiva.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Cien Saude Colet</MedlineTA><NlmUniqueID>9713483</NlmUniqueID><ISSNLinking>1413-8123</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058445" MajorTopicYN="Y">Bullying</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008603" MajorTopicYN="N">Mental Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011634" MajorTopicYN="N">Public Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013405" MajorTopicYN="Y">Suicide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014754" MajorTopicYN="N">Violence</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="por"><AbstractText>Realizou-se revis&#xe3;o sistem&#xe1;tica de 25 anos de produ&#xe7;&#xe3;o da Revista Ci&#xea;ncia &amp; Sa&#xfa;de Coletiva sobre a tem&#xe1;tica de Sa&#xfa;de Mental buscando responder se essa produ&#xe7;&#xe3;o tinha se modificado ao longo do tempo. Perguntou-se se essas mudan&#xe7;as guardariam alguma rela&#xe7;&#xe3;o com a implementa&#xe7;&#xe3;o de um novo marco regulat&#xf3;rio e legal para essa &#xe1;rea assim como com a expans&#xe3;o de servi&#xe7;os p&#xfa;blicos e com os est&#xed;mulos &#xe0; investiga&#xe7;&#xe3;o do tema por Agencias P&#xfa;blicas de financiamento. Analisaram-se 278 artigos originais, apresentados a partir das categorias: transforma&#xe7;&#xf5;es socioculturais relacionadas &#xe0; loucura e sua abordagem; mudan&#xe7;as legislativas; implanta&#xe7;&#xe3;o, capilaridade e funcionamento da rede de servi&#xe7;os substitutivos; cl&#xed;nica/cuidado desenvolvido nos servi&#xe7;os substitutivos; o papel e as possibilidades da aten&#xe7;&#xe3;o b&#xe1;sica; problemas relacionados ao uso de drogas; sa&#xfa;de mental de crian&#xe7;as e adolescentes; estudos epidemiol&#xf3;gicos/categorias psiqui&#xe1;tricas; e outros - nas quais foram inclu&#xed;das as quest&#xf5;es &#xe9;tnico-raciais, de viol&#xea;ncia, acerca da popula&#xe7;&#xe3;o idosa, suic&#xed;dio, bullying e migra&#xe7;&#xe3;o. Pode ser observada rela&#xe7;&#xe3;o cronol&#xf3;gica entre o aumento de publica&#xe7;&#xf5;es e os editais de pesquisa e a expans&#xe3;o de servi&#xe7;os, n&#xe3;o parecendo ser da mesma forma em rela&#xe7;&#xe3;o ao tema dos cuidados a pessoas com problemas com &#xe1;lcool e outras drogas.</AbstractText></OtherAbstract></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>9</Day><Hour>8</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33295500</ArticleId><ArticleId IdType="doi">10.1590/1413-812320202512.27932020</ArticleId><ArticleId IdType="pii">S1413-81232020001204771</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32203174</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>31</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-5543</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>5</Issue><PubDate><Year>2020</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of perinatology : official journal of the California Perinatal Association</Title><ISOAbbreviation>J Perinatol</ISOAbbreviation></Journal><ArticleTitle>Comparing mortality risk models in VLBW and preterm infants: systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>695</StartPage><EndPage>703</EndPage><MedlinePgn>695-703</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41372-020-0650-0</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To compare the prognostic accuracy of six neonatal illness severity scores (CRIB, CRIB II, SNAP, SNAP II, SNAP-PE, and SNAP-PE II), birthweight (BW), and gestational age (GA) for predicting pre-discharge mortality among very low birth weight (VLBW) infants (&lt;1500&#x2009;g) and very preterm infants (&lt;32 weeks' gestational age).</AbstractText><AbstractText Label="STUDY DESIGN">PubMed, EMBASE, and Scopus were the data sources searched for studies published before January 2019. Data were extracted, pooled, and analyzed using random-effects models and reported as AUC with 95% confidence intervals (CI).</AbstractText><AbstractText Label="RESULTS">Of 1659 screened studies, 24 met inclusion criteria. CRIB was the most discriminate for predicting pre-discharge mortality [AUC 0.88 (0.86-0.90)]. GA was the least discriminate [AUC 0.76 (0.72-0.80)].</AbstractText><AbstractText Label="CONCLUSIONS">Although the original CRIB score was the most accurate predictor of pre-discharge mortality, significant heterogeneity between studies lowers confidence in this pooled estimate. A more precise illness severity score to predict pre-discharge mortality is still needed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>McLeod</LastName><ForeName>Jennifer S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Surgery, Section of Pediatric Surgery, University of Michigan, Michigan Medicine, Ann Arbor, MI, 48109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Menon</LastName><ForeName>Anitha</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Michigan Medical School, Ann Arbor, MI, 48109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matusko</LastName><ForeName>Niki</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Surgery Statistics, University of Michigan, Michigan Medicine, Ann Arbor, MI, 48109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weiner</LastName><ForeName>Gary M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>University of Michigan, Michigan Medicine, Fetal Diagnosis and Treatment Center, Ann Arbor, MI, 48109, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Neonatal-Perinatal Medicine Division, University of Michigan, Michigan Medicine, Ann Arbor, MI, 48109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gadepalli</LastName><ForeName>Samir K</ForeName><Initials>SK</Initials><Identifier Source="ORCID">0000-0001-8268-8723</Identifier><AffiliationInfo><Affiliation>Department of Surgery, Section of Pediatric Surgery, University of Michigan, Michigan Medicine, Ann Arbor, MI, 48109, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Michigan, Michigan Medicine, Fetal Diagnosis and Treatment Center, Ann Arbor, MI, 48109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barks</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of Michigan, Michigan Medicine, Fetal Diagnosis and Treatment Center, Ann Arbor, MI, 48109, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Neonatal-Perinatal Medicine Division, University of Michigan, Michigan Medicine, Ann Arbor, MI, 48109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mychaliska</LastName><ForeName>George B</ForeName><Initials>GB</Initials><AffiliationInfo><Affiliation>Department of Surgery, Section of Pediatric Surgery, University of Michigan, Michigan Medicine, Ann Arbor, MI, 48109, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Michigan, Michigan Medicine, Fetal Diagnosis and Treatment Center, Ann Arbor, MI, 48109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perrone</LastName><ForeName>Erin E</ForeName><Initials>EE</Initials><AffiliationInfo><Affiliation>Department of Surgery, Section of Pediatric Surgery, University of Michigan, Michigan Medicine, Ann Arbor, MI, 48109, USA. eperrone@med.umich.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Michigan, Michigan Medicine, Fetal Diagnosis and Treatment Center, Ann Arbor, MI, 48109, USA. eperrone@med.umich.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Perinatol</MedlineTA><NlmUniqueID>8501884</NlmUniqueID><ISSNLinking>0743-8346</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001724" MajorTopicYN="N">Birth Weight</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005865" MajorTopicYN="N">Gestational Age</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007226" MajorTopicYN="N">Infant Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007234" MajorTopicYN="Y">Infant, Premature</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019102" MajorTopicYN="Y">Infant, Very Low Birth Weight</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>11</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>3</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>2</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32203174</ArticleId><ArticleId IdType="doi">10.1038/s41372-020-0650-0</ArticleId><ArticleId IdType="pii">10.1038/s41372-020-0650-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Althabe F, Bhutta Z, Blencowe H, Chandra-Mouli V, Chou D, Costello A, et al. Born Too Soon: The Global Action Report on Preterm Birth. World Health Organization, 2012. p. 1-112.</Citation></Reference><Reference><Citation>Beck S, Wojdyla D, Say L, Beltran AP, Merialdi M, Requejo JH, et al. The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Organ. 2010;88:31&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">20428351</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel RM, Rysavy MA, Bell EF, Tyson JE. Survival of infants born at periviable gestational ages. Clin Perinatol. 2017;44:287&#x2013;303.</Citation><ArticleIdList><ArticleId IdType="pubmed">28477661</ArticleId><ArticleId IdType="pmc">5424630</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilbert WM. The cost of preterm birth: the low cost versus high value of tocolysis. BJOG 2006;113(Suppl 3):4&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">17206959</ArticleId></ArticleIdList></Reference><Reference><Citation>MacDorman MF, Mathews TJ. The challenge of infant mortality: have we reached a plateau? Public health Rep. (Wash, DC: 1974). 2009;124:670&#x2013;81.</Citation></Reference><Reference><Citation>Patrick SW, Schumacher RE, Davis MM. Methods of mortality risk adjustment in the NICU: A 20-year review. Pediatrics. 2013;131((SUPPL.1):S68&#x2013;S74.</Citation></Reference><Reference><Citation>Dorling JS, Field DJ, Manktelow B. Neonatal disease severity scoring systems. Arch Dis Child Fetal Neonatal Ed. 2005;90:F11&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">15613564</ArticleId><ArticleId IdType="pmc">1721834</ArticleId></ArticleIdList></Reference><Reference><Citation>Buhrer C, Grimmer I, Metze B, Obladen M. The CRIB (Clinial Risk Index for Babies) score and neurodevelopmental impairment at one year corrected age in very low birth weight infants. Intensive Care Med. 2000;26:325&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">10823390</ArticleId></ArticleIdList></Reference><Reference><Citation>The CRIB (clinical risk index for babies) score: a tool for assessing initial neonatal risk and comparing performance of neonatal intensive care units. The International Neonatal Network. Lancet 1993;342:193&#x2013;8.</Citation></Reference><Reference><Citation>De Felice C, Del Vecchio A, Latini G. Evaluating illness severity for very low birth weight infants: CRIB or CRIB-II? J Matern Fetal Neonatal Med. 2005;17:257&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">16147834</ArticleId></ArticleIdList></Reference><Reference><Citation>De Brito ASJ, Matsuo T, Gonzalez MRC, De Carvalho ABR, Ferrari LSLCRIBScore. Birth weight, and gestational age in neonatal mortality risk evaluation. Rev Saude Publica. 2003;37:1&#x2013;10.</Citation></Reference><Reference><Citation>Lago P, F. F, Bettiol T, Chiadetti L, Vianello A. Is the CRIB score (Clinical Risk Index for Babies) a valid tool in predicting neurodevelopmental outcome in extremely low birth weight infants? Biol Neonate 1999;76:220&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">10473896</ArticleId></ArticleIdList></Reference><Reference><Citation>Rautonen J, Makela A, Boyd H, Apajasalo M, Pohjavouri M. CRIB and SNAP: assessing the risk of death for preterm neonates. Lancet 1994;343:1272&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">7910282</ArticleId></ArticleIdList></Reference><Reference><Citation>Eriksson M, Bodin L, Finnstrom O, Schollin J. Can severity-of-illness indices for neonatal intensive care predict outcome at 4 years of age? Acta Paediatr. 2002;91:1093&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pubmed">12434896</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips LA, Dewhurst CJ, Yoxall CW. The prognostic value of initial blood lactate concentration measurements in very low birthweight infants and their use in development of a new disease severity scoring system. Arch Dis Child Fetal Neonatal Ed. 2011;96:F275&#x2013;80.</Citation></Reference><Reference><Citation>Kaaresen PI, Dohlen G, Fundingsrud HP, Dahl LB. The use of CRIB (Clinical Risk Index for Babies) score in auditing the performance of one neonatal intensive care unit. Acta Paediatr. 1998;87:195&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pubmed">9512208</ArticleId></ArticleIdList></Reference><Reference><Citation>Buhrer C, Metze B, Obladen M. CRIB, CRIB-II, birth weight or gestational age to assess mortality risk in very low birth weight infants? Acta Paediatr 2008;97:899&#x2013;903.</Citation><ArticleIdList><ArticleId IdType="pubmed">18435815</ArticleId></ArticleIdList></Reference><Reference><Citation>Ezz-Eldin ZM, Hamid TA, Youssef MR, Nabil Hel D. Clinical risk index for babies (CRIB II) scoring system in prediction of mortality in premature babies. J Clin Diagn Res. 2015;9:SC08&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">26266178</ArticleId><ArticleId IdType="pmc">4525567</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagliardi L, Cavazza A, Brunelli A, Battaglioli M, Merazzi D, Tandoi F, et al. Assessing mortality risk in very low birthweight infants: a comparison of CRIB, CRIB-II, and SNAPPE-II. Arch Dis Child Fetal Neonatal Ed. 2004;89:F419&#x2013;22.</Citation></Reference><Reference><Citation>Rastogi PK, Sreenivas V, Kumar N. Validation of CRIB II for prediction of moratality in premature babies. Indian Pediatrics 2009;47:145&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">19578231</ArticleId></ArticleIdList></Reference><Reference><Citation>Reid S, Bajuk B, Lui K, Sullivan EA, NSW, ACT Neonatal Intensive Care Units Audit Group PSN. Comparing CRIB-II and SNAPPE-II as mortality predictors for very preterm infants. J Paediatr Child Health. 2014;51:524&#x2013;28.</Citation></Reference><Reference><Citation>Gooden M, Younger N, Trotman H. What is the best predictor of mortality in a very low birth weight infant population with a high mortality rate in a medical setting with limited resources? Am J Perinatol. 2014;31:441&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">23945903</ArticleId></ArticleIdList></Reference><Reference><Citation>Zupancic JA, Richardson DK, Horbar JD, Carpenter JH, Lee SK, Escobar GJ, et al. Revalidation of the score for neonatal acute physiology in the Vermont Oxford Network. Pediatrics 2007;119:e156&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">17158947</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson DK, Corcoran JD, Escobar GJ, Lee SK. SNAP-II and SNAPPE-II simplified newborn illness severity and mortality risk scores. J Pediatr 2001;138:92&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pubmed">11148519</ArticleId></ArticleIdList></Reference><Reference><Citation>Parry G, Tucker J, Tarnow-Mordi W. CRIB II: an update of the clinical risk index for babies score. Lancet (Lond, Engl). 2003;361:1789&#x2013;91.</Citation></Reference><Reference><Citation>Richardson DK, Gray JE, McCormick MC, Workman K, Goldmann DA. Score for neonatal acute physiology: a physiologic severity index for neonatal intensive care. Pediatrics 1993;91:617&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">8441569</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson DK, Phibbs CS, Gray JE, McCormick MC, Workman-Daniels K, Goldmann DA. Birth weight and illness severity: independent predictors of neonatal mortality. Pediatrics 1993;91:969&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">8474818</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg B, Sharma D, Farahbakhsh N. Assessment of sickness severity of illness in neonates: review of various neonatal illness scoring systems. J Matern Fetal Neonatal Med. 2018;31:1373&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">28372507</ArticleId></ArticleIdList></Reference><Reference><Citation>Manktelow BN, Draper ES, Field DJ. Predicting neonatal mortality among very preterm infants: a comparison of three versions of the CRIB score. Arch Dis Child Fetal Neonatal Ed. 2010;95:F9&#x2013;F13.</Citation><ArticleIdList><ArticleId IdType="pubmed">19608556</ArticleId></ArticleIdList></Reference><Reference><Citation>McHugh ML. Interrater Reliability: The Kappa Statistic. Biochem Med (Zagreb). 2012;22:276&#x2013;82.</Citation></Reference><Reference><Citation>Zeng X, Zhang Y, Kwong Joey SW, Zhang C, Li S, Sun F, et al. The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review. J Evid-Based Med. 2015;8:2&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">25594108</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">22007046</ArticleId></ArticleIdList></Reference><Reference><Citation>Boussuyt P, Davenport C, Deeks J, Hyde C, Leeflang MM, Scholten R, The Cochrane Collaboration. Chapter 11 Interpreting Results and Drawing Conclusions. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy. Version. 2013;0:9.</Citation></Reference><Reference><Citation>Leeflang MM, Deeks JJ, Gatsonis C, Bossuyt PM. Systematic reviews of diagnostic test accuracy. Ann Intern Med. 2008;149:889&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">19075208</ArticleId><ArticleId IdType="pmc">2956514</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557&#x2013;60.</Citation></Reference><Reference><Citation>Fantom N, Serajuddin U The World Bank&#x2019;s classification of countries by income: The World Bank; 2016.</Citation></Reference><Reference><Citation>Maier RF, Caspar-Karweck UE, Grauel EL, Bassir C, Metze BC, Obladen M. A comparison of two mortality risk scores for very low birthweight infants: clinical risk index for babies and Berlin score. Intensive Care Med. 2002;28:1332&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">12209285</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan BA, McClure C, Hicks J, Lake DE, Moorman JR, Fairchild KD. Early heart rate characteristics predict death and morbidities in preterm infants. J Pediatr 2016;174:57&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">27113378</ArticleId><ArticleId IdType="pmc">5672906</ArticleId></ArticleIdList></Reference><Reference><Citation>Asker HS, Satar M, Yildizdas HY, Mutlu B, Ozyurt BM, Ipek MS, et al. Evaluation of score for neonatal acute physiology and perinatal extension II and Clinical risk index for babies with additional parameters. Pediatrics Int 2016;58:984&#x2013;7.</Citation></Reference><Reference><Citation>Courcy-Wheeler RHB, Wolfe CDA, Fitzgerald A, Spencer M, Goodman JDS, Gamsu HR. Use of the CRIB (Clinial Risk Index for Babies) score in prediction of neonatal mortality and morbidity. Arch Dis Child. 1995;73:F32&#x2013;F6.</Citation></Reference><Reference><Citation>Hussain F, Gilshenan K, Gray PH. Does lactate level in the first 12&#x2009;h of life predict mortality in extremely premature infants? J Paediatr Child Health. 2009;45:263&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">19493117</ArticleId></ArticleIdList></Reference><Reference><Citation>Khanna R, Taneja V, Singh SK, Kumar N, Sreenivas V, Puliyel J. The clinical risk index of babies (CRIB) score in India. Indian J Pediatr. 2002;69:957&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">12503659</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall G, Tapia JL, D&#x2019;Apremont I, Grandi C, Barros C, Alegria A, et al. A new score for predicting neonatal very low birth weight mortality risk in the NEOCOSUR South American Network. J Perinatol 2005;25:577&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">16049510</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollack MM, Koch MA, Bartel DA, Rapoport I, Dhanireddy R, El-Mohandes AAE, et al. A comparison of neonatal mortality risk prediction models in very low birth weight infants. Pediatrics 2000;105:1051&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">10790462</ArticleId></ArticleIdList></Reference><Reference><Citation>Zardo MS, Procianoy RS. Comparison between different mortality risk score in a neonatal intensive care unit. Rev Saude Publica. 2003;37:1&#x2013;9.</Citation></Reference><Reference><Citation>Hosmer Jr DW, Lemeshow S, Sturdivant RX. Applied logistic regression: John Wiley &amp; Sons; 2013.</Citation></Reference><Reference><Citation>Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. GRADE guidelines: 7. Rating the quality of evidence-inconsistency. J Clin Epidemiol. 2011;64:1294&#x2013;302.</Citation><ArticleIdList><ArticleId IdType="pubmed">21803546</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557&#x2013;60.</Citation></Reference><Reference><Citation>Tyson JE, Parikh NA, Langer J, Green C, Higgins RD. Intensive care for extreme prematurity-moving beyond gestational age. N. Engl J Med. 2008;358:1672&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">18420500</ArticleId><ArticleId IdType="pmc">2597069</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews B, Myers P, Lagatta J, Meadow W. A comparison of prenatal and postnatal models to predict outcomes at the border of viability. J Pediatr 2016;173:96&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pubmed">26995702</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JH, Chang YS, Ahn SY, Sung SI, Park WS. Predicting mortality in extremely low birth weight infants: Comparison between gestational age, birth weight, Apgar score, CRIB II score, initial and lowest serum albumin levels. PLoS ONE. 2018;13:e0192232.</Citation></Reference><Reference><Citation>Halligan S, Altman DG, Mallett S. Disadvantages of using the area under the receiver operating characteristic curve to assess imaging tests: a discussion and proposal for an alternative approach. Eur Radiol 2015;25:932&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">25599932</ArticleId><ArticleId IdType="pmc">4356897</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallett S, Halligan S, Thompson M, Collins GS, Altman DG. Interpreting diagnostic accuracy studies for patient care. BMJ. 2012;345:e3999.</Citation></Reference><Reference><Citation>Greenwood S, Abdel-Latif ME, Bajuk B, Lui K, Nsw, Group ACTNICUA. Can the early condition at admission of a high-risk infant aid in the prediction of mortality and poor neurodevelopmental outcome? A population study in Australia. J Paediatr Child Health. 2012;48:588&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">22452621</ArticleId></ArticleIdList></Reference><Reference><Citation>Guenther K, Vach W, Kachel W, Bruder I, Hentschel R. Auditing neonatal intensive care: is PREM a good alternative to CRIB for mortality risk adjustment in premature infants? Neonatology 2015;108:172&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">26278218</ArticleId></ArticleIdList></Reference><Reference><Citation>Heidarzadeh M, Ghorbani F, Dastgiri S. Prediction value of CRIB-II in outcome of preterm and low birth weight infants: a prospective cohort study. International. J Pediatrics. 2016;4:1583&#x2013;9.</Citation></Reference><Reference><Citation>Ja&#x161;i&#x107; M, Dessardo NS, Dessardo S, Rukavina KM. CRIB II score versus gestational age and birth weight in preterm infant mortality prediction: Who will win the bet? Signa Vitae. 2016;11:172&#x2013;81.</Citation></Reference><Reference><Citation>Rinta-Koski OP, S&#xe4;rkk&#xe4; S, Hollm&#xe9;n J, Leskinen M, Andersson S. Gaussian process classification for prediction of in-hospital mortality among preterm infants. Neurocomputing 2018;298:134&#x2013;41.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35339716</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>17</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-3511</ISSN><JournalIssue CitedMedium="Internet"><Volume>119</Volume><PubDate><Year>2022</Year><Month>Jun</Month></PubDate></JournalIssue><Title>International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases</Title><ISOAbbreviation>Int J Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>130</StartPage><EndPage>139</EndPage><MedlinePgn>130-139</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijid.2022.03.034</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1201-9712(22)00171-0</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To meta-analyse the clinical manifestations, diagnosis, treatment, and mortality of vaccine-induced immune thrombotic thrombocytopenia (VITT) after adenoviral vector vaccination.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Eighteen studies of VITT after ChAdOx1 nCoV-19 or Ad26.COV2.S vaccine administration were reviewed from PubMed, Scopus, Embase, and Web of Science. The meta-analysis estimated the summary effects and between-study heterogeneity regarding the incidence, manifestations, sites of thrombosis, diagnostic findings, and clinical outcomes.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The incidence of total venous thrombosis after ChAdOx1 nCoV-19 vaccination was 28 (95% CI 12-52, I<sup>2</sup>=100%) per 100,000 doses administered. Of 664 patients included in the quantitative analysis (10 studies), the mean age of patients with VITT was 45.6 years (95% CI 43.8-47.4, I<sup>2</sup>=57%), with a female predominance (70%). Cerebral venous thrombosis (CVT), deep vein thrombosis (DVT)/pulmonary thromboembolism (PE), and splanchnic vein thrombosis occurred in 54%, 36%, and 19% of patients with VITT, respectively. The pooled incidence rate of CVT after ChAdOx1 nCoV-19 vaccination (23 per 100,000 person-years) was higher than that reported in the pre-pandemic general population (0.9 per 100,000 person-years). Intracranial haemorrhage and extracranial thrombosis accompanied 47% and 33% of all patients with CVT, respectively. The antiplatelet factor 4 antibody positivity rate was 91% (95% CI 88-94, I<sup>2</sup>=0%) and the overall mortality was 32% (95% CI 24-41, I<sup>2</sup>=69%), and no significant difference was observed between heparin- and non-heparin-based anticoagulation treatments (risk ratio 0.84, 95% CI 0.47-1.50, I<sup>2</sup>=0%).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Patients with VITT after SARS-CoV-2 vaccination most frequently presented with CVT following DVT/PE and splanchnic vein thrombosis, and about one-third of patients had a fatal outcome. This meta-analysis should provide a better understanding of VITT and assist clinicians in identifying VITT early to improve outcomes and optimise management.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Ah Young</ForeName><Initials>AY</Initials><AffiliationInfo><Affiliation>Division of Pediatric Cardiology, Department of Pediatrics, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea; Department of Nephrology, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Woo</LastName><ForeName>Wongi</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Thoracic and Cardiovascular Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yon</LastName><ForeName>Dong Keon</ForeName><Initials>DK</Initials><AffiliationInfo><Affiliation>Center for Digital Health, Medical Science Research Institute, Kyung Hee University College of Medicine, Seoul, South Korea; Department of Data Science, Sejong University College of Software Convergence, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Seung Won</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>Department of Data Science, Sejong University College of Software Convergence, Seoul, South Korea; Department of Precision Medicine, Sungkyunkwan University School of Medicine, Suwon, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Jae Won</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Ji Hong</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Yonsei University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Seoyeon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Yonsei University College of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koyanagi</LastName><ForeName>Ai</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Parc Sanitari Sant Joan de Deu/CIBERSAM, Universitat de Barcelona, Fundacio Sant Joan de Deu, Sant Boi de Llobregat, Barcelona, Spain; ICREA, Pg. Lluis Companys 23, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Min Seo</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Samsung Advanced Institute for Health Sciences &amp; Technology (SAIHST), Sungkyunkwan University, Samsung Medical Center, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Sungsoo</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Thoracic and Cardiovascular Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Jae Il</ForeName><Initials>JI</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Yonsei University College of Medicine, Seoul, Korea. Electronic address: shinji@yuhs.ac.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Lee</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Cambridge Centre for Health, Performance, and Wellbeing, Anglia Ruskin University, Cambridge, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>Int J Infect Dis</MedlineTA><NlmUniqueID>9610933</NlmUniqueID><ISSNLinking>1201-9712</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>JT2NS6183B</RegistryNumber><NameOfSubstance UI="D000090984">Ad26COVS1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014612">Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>B5S3K2V0G8</RegistryNumber><NameOfSubstance UI="D000090985">ChAdOx1 nCoV-19</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Int J Infect Dis. 2022 Oct;123:166. doi: 10.1016/j.ijid.2022.08.025.</RefSource><PMID Version="1">36116211</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000090984" MajorTopicYN="N">Ad26COVS1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000090985" MajorTopicYN="N">ChAdOx1 nCoV-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016553" MajorTopicYN="Y">Purpura, Thrombocytopenic, Idiopathic</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013921" MajorTopicYN="Y">Thrombocytopenia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013927" MajorTopicYN="Y">Thrombosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014612" MajorTopicYN="Y">Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="Y">Venous Thrombosis</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 vaccine</Keyword><Keyword MajorTopicYN="N">adverse event</Keyword><Keyword MajorTopicYN="N">cerebral venous thrombosis</Keyword><Keyword MajorTopicYN="N">splanchnic vein thrombosis</Keyword><Keyword MajorTopicYN="N">vaccine thrombosis</Keyword><Keyword MajorTopicYN="N">vaccine-induced immune thrombotic thrombocytopenia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>27</Day><Hour>20</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>3</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35339716</ArticleId><ArticleId IdType="pmc">PMC8942584</ArticleId><ArticleId IdType="doi">10.1016/j.ijid.2022.03.034</ArticleId><ArticleId IdType="pii">S1201-9712(22)00171-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abbattista M, Martinelli I, Peyvandi F. Comparison of adverse drug reactions among four COVID-19 vaccines in Europe using the EudraVigilance database: Thrombosis at unusual sites. J Thromb Haemost. 2021 doi: 10.1111/jth.15493. ss.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15493</ArticleId><ArticleId IdType="pmc">PMC8420446</ArticleId><ArticleId IdType="pubmed">34375510</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciccone A. SARS-CoV-2 vaccine-induced cerebral venous thrombosis. Eur J Intern Med. 2021;89:19&#x2013;21. doi: 10.1016/j.ejim.2021.05.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.05.026</ArticleId><ArticleId IdType="pmc">PMC8148433</ArticleId><ArticleId IdType="pubmed">34090750</ArticleId></ArticleIdList></Reference><Reference><Citation>Cines DB, Bussel JB. SARS-CoV-2 Vaccine&#x2013;Induced Immune Thrombotic Thrombocytopenia. New England Journal of Medicine. 2021;384:2254&#x2013;2256. doi: 10.1056/NEJMe2106315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMe2106315</ArticleId><ArticleId IdType="pmc">PMC8063912</ArticleId><ArticleId IdType="pubmed">33861524</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Map. Johns Hopkins Coronavirus Resource Center 2021. https://coronavirus.jhu.edu/map.html (accessed October 1, 2021).</Citation></Reference><Reference><Citation>DerSimonian R, Laird N. Meta-Analysis in Clinical Trials Revisited. Contemp Clin Trials. 2015;45:139&#x2013;145. doi: 10.1016/j.cct.2015.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cct.2015.09.002</ArticleId><ArticleId IdType="pmc">PMC4639420</ArticleId><ArticleId IdType="pubmed">26343745</ArticleId></ArticleIdList></Reference><Reference><Citation>Dotan A, Shoenfeld Y. Perspectives on vaccine induced thrombotic thrombocytopenia. J Autoimmun. 2021;121 doi: 10.1016/j.jaut.2021.102663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2021.102663</ArticleId><ArticleId IdType="pmc">PMC8129886</ArticleId><ArticleId IdType="pubmed">34020254</ArticleId></ArticleIdList></Reference><Reference><Citation>Gras-Champel V, Liabeuf S, Baud M, Albucher J-F, Benkebil M, Boulay C, et al. Atypical thrombosis associated with VaxZevria&#xae; (AstraZeneca) vaccine: Data from the French Network of Regional Pharmacovigilance Centres. Therapie. 2021;76:369&#x2013;373. doi: 10.1016/j.therap.2021.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.therap.2021.05.007</ArticleId><ArticleId IdType="pmc">PMC8165560</ArticleId><ArticleId IdType="pubmed">34083026</ArticleId></ArticleIdList></Reference><Reference><Citation>Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination. N Engl J Med. 2021;384:2092&#x2013;2101. doi: 10.1056/NEJMoa2104840.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2104840</ArticleId><ArticleId IdType="pmc">PMC8095372</ArticleId><ArticleId IdType="pubmed">33835769</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557&#x2013;560. doi: 10.1136/bmj.327.7414.557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.327.7414.557</ArticleId><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Hippisley-Cox J, Patone M, Mei XW, Saatci D, Dixon S, Khunti K, et al. Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study. BMJ. 2021:n1931. doi: 10.1136/bmj.n1931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1931</ArticleId><ArticleId IdType="pmc">PMC8388189</ArticleId><ArticleId IdType="pubmed">34446426</ArticleId></ArticleIdList></Reference><Reference><Citation>Huh K, Na Y, Kim Y-E, Radnaabaatar M, Peck KR, Jung J. Predicted and Observed Incidence of Thromboembolic Events among Koreans Vaccinated with ChAdOx1 nCoV-19 Vaccine. Journal of Korean Medical Science. 2021;36 doi: 10.3346/jkms.2021.36.e197.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2021.36.e197</ArticleId><ArticleId IdType="pmc">PMC8275463</ArticleId><ArticleId IdType="pubmed">34254476</ArticleId></ArticleIdList></Reference><Reference><Citation>Hursting MJ, Pai PJ, McCracken JE, Hwang F, Suvarna S, Lokhnygina Y, et al. Platelet factor 4/heparin antibodies in blood bank donors. Am J Clin Pathol. 2010;134:774&#x2013;780. doi: 10.1309/AJCPG0MNR5NGKNFX.</Citation><ArticleIdList><ArticleId IdType="doi">10.1309/AJCPG0MNR5NGKNFX</ArticleId><ArticleId IdType="pmc">PMC3766530</ArticleId><ArticleId IdType="pubmed">20959660</ArticleId></ArticleIdList></Reference><Reference><Citation>Huynh A, Kelton JG, Arnold DM, Daka M, Nazy I. Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia. Nature. 2021;596:565&#x2013;569. doi: 10.1038/s41586-021-03744-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03744-4</ArticleId><ArticleId IdType="pubmed">34233346</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang J, Park SH, Lee SW, Lee SB, Lee MH, Jeong GH, et al. Predictors of mortality in thrombotic thrombocytopenia after adenoviral COVID-19 vaccination: the FAPIC score. European Heart Journal. 2021 doi: 10.1093/eurheartj/ehab592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab592</ArticleId><ArticleId IdType="pmc">PMC8500026</ArticleId><ArticleId IdType="pubmed">34545400</ArticleId></ArticleIdList></Reference><Reference><Citation>Idiculla PS, Gurala D, Palanisamy M, Vijayakumar R, Dhandapani S, Nagarajan E. Cerebral Venous Thrombosis: A Comprehensive Review. Eur Neurol. 2020;83:369&#x2013;379. doi: 10.1159/000509802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000509802</ArticleId><ArticleId IdType="pubmed">32877892</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannidis JPA, Tarone R, McLaughlin JK. The false-positive to false-negative ratio in epidemiologic studies. Epidemiology. 2011;22:450&#x2013;456. doi: 10.1097/EDE.0b013e31821b506e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0b013e31821b506e</ArticleId><ArticleId IdType="pubmed">21490505</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaax ME, Krauel K, Marschall T, Brandt S, Gansler J, F&#xfc;rll B, et al. Complex formation with nucleic acids and aptamers alters the antigenic properties of platelet factor 4. Blood. 2013;122:272&#x2013;281. doi: 10.1182/blood-2013-01-478966.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2013-01-478966</ArticleId><ArticleId IdType="pmc">PMC3709655</ArticleId><ArticleId IdType="pubmed">23673861</ArticleId></ArticleIdList></Reference><Reference><Citation>Klatsky AL, Armstrong MA, Poggi J. Risk of pulmonary embolism and/or deep venous thrombosis in Asian-Americans. Am J Cardiol. 2000;85:1334&#x2013;1337. doi: 10.1016/s0002-9149(00)00766-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0002-9149(00)00766-9</ArticleId><ArticleId IdType="pubmed">10831950</ArticleId></ArticleIdList></Reference><Reference><Citation>Krzywicka K, Heldner MR, S&#xe1;nchez van Kammen M, van Haaps T, Hiltunen S, Silvis SM, et al. Post-SARS-CoV-2-vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines Agency. Eur J Neurol. 2021;28:3656&#x2013;3662. doi: 10.1111/ene.15029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15029</ArticleId><ArticleId IdType="pmc">PMC8444640</ArticleId><ArticleId IdType="pubmed">34293217</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med. 1997;127:820&#x2013;826. doi: 10.7326/0003-4819-127-9-199711010-00008.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-127-9-199711010-00008</ArticleId><ArticleId IdType="pubmed">9382404</ArticleId></ArticleIdList></Reference><Reference><Citation>Makris M, Pavord S, Lester W, Scully M, Hunt B. Vaccine-induced Immune Thrombocytopenia and Thrombosis (VITT) Research and Practice in Thrombosis and Haemostasis. 2021;5:e12529. doi: 10.1002/rth2.12529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rth2.12529</ArticleId><ArticleId IdType="pmc">PMC8178610</ArticleId><ArticleId IdType="pubmed">34136745</ArticleId></ArticleIdList></Reference><Reference><Citation>Marjot T, Yadav S, Hasan N, Bentley P, Sharma P. Genes associated with adult cerebral venous thrombosis. Stroke. 2011;42:913&#x2013;918. doi: 10.1161/STROKEAHA.110.602672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.110.602672</ArticleId><ArticleId IdType="pubmed">21350198</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavord S, Scully M, Hunt BJ, Lester W, Bagot C, Craven B, et al. Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis. New England Journal of Medicine. 2021;385:1680&#x2013;1689. doi: 10.1056/NEJMoa2109908.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2109908</ArticleId><ArticleId IdType="pmc">PMC10662971</ArticleId><ArticleId IdType="pubmed">34379914</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry RJ, Tamborska A, Singh B, Craven B, Marigold R, Arthur-Farraj P, et al. Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study. The Lancet. 2021 doi: 10.1016/S0140-6736(21)01608-1. S0140673621016081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01608-1</ArticleId><ArticleId IdType="pmc">PMC8346241</ArticleId><ArticleId IdType="pubmed">34370972</ArticleId></ArticleIdList></Reference><Reference><Citation>Potteg&#xe5;rd A, Lund LC, Karlstad &#xd8;, Dahl J, Andersen M, Hallas J, et al. Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study. BMJ. 2021;373:n1114. doi: 10.1136/bmj.n1114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1114</ArticleId><ArticleId IdType="pmc">PMC8097496</ArticleId><ArticleId IdType="pubmed">33952445</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenblum HG, Hadler SC, Moulia D, Shimabukuro TT, Su JR, Tepper NK, et al. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson &amp; Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices &#x2014; United States, July 2021. MMWR Morb Mortal Wkly Rep. 2021;70:1094&#x2013;1099. doi: 10.15585/mmwr.mm7032e4.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7032e4</ArticleId><ArticleId IdType="pmc">PMC8360272</ArticleId><ArticleId IdType="pubmed">34383735</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1;nchez van Kammen M, Aguiar de Sousa D, Poli S, Cordonnier C, Heldner MR, van de Munckhof A, et al. Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia. JAMA Neurol. 2021;78:1314&#x2013;1323. doi: 10.1001/jamaneurol.2021.3619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2021.3619</ArticleId><ArticleId IdType="pmc">PMC8479648</ArticleId><ArticleId IdType="pubmed">34581763</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1;nchez van Kammen M, Heldner MR, Brodard J, Scutelnic A, Silvis S, Schroeder V, et al. Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic. JAMA. 2021;326:332&#x2013;338. doi: 10.1001/jama.2021.9889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.9889</ArticleId><ArticleId IdType="pmc">PMC8317004</ArticleId><ArticleId IdType="pubmed">34213527</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultz NH, S&#xf8;rvoll IH, Michelsen AE, Munthe LA, Lund-Johansen F, Ahlen MT, et&#xa0;al. Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. N Engl J Med 2021;384:2124&#x2013;30. doi:10.1056/NEJMoa2104882.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2104882</ArticleId><ArticleId IdType="pmc">PMC8112568</ArticleId><ArticleId IdType="pubmed">33835768</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz JB, Berlit P, Diener H, Gerloff C, Greinacher A, Klein C, et al. COVID-19 Vaccine-Associated Cerebral Venous Thrombosis in Germany. Ann Neurol. 2021 doi: 10.1002/ana.26172. 10.1002/ana.26172.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26172</ArticleId><ArticleId IdType="pmc">PMC8427115</ArticleId><ArticleId IdType="pubmed">34288044</ArticleId></ArticleIdList></Reference><Reference><Citation>Scully M, Singh D, Lown R, Poles A, Solomon T, Levi M, et al. Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination. N Engl J Med. 2021;384:2202&#x2013;2211. doi: 10.1056/NEJMoa2105385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2105385</ArticleId><ArticleId IdType="pmc">PMC8112532</ArticleId><ArticleId IdType="pubmed">33861525</ArticleId></ArticleIdList></Reference><Reference><Citation>See I, Su JR, Lale A, Woo EJ, Guh AY, Shimabukuro TT, et al. US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021. JAMA. 2021;325:2448&#x2013;2456. doi: 10.1001/jama.2021.7517.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.7517</ArticleId><ArticleId IdType="pmc">PMC8087975</ArticleId><ArticleId IdType="pubmed">33929487</ArticleId></ArticleIdList></Reference><Reference><Citation>Segal Y, Shoenfeld Y. Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction. Cell Mol Immunol. 2018;15:586&#x2013;594. doi: 10.1038/cmi.2017.151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cmi.2017.151</ArticleId><ArticleId IdType="pmc">PMC6078966</ArticleId><ArticleId IdType="pubmed">29503439</ArticleId></ArticleIdList></Reference><Reference><Citation>de Simone G, Stranges S, Gentile I. Incidence of cerebral venous thrombosis and COVID-19 vaccination: possible causal effect or just chance? Eur Heart J Cardiovasc Pharmacother. 2021;7:e77&#x2013;e78. doi: 10.1093/ehjcvp/pvab036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjcvp/pvab036</ArticleId><ArticleId IdType="pmc">PMC8135678</ArticleId><ArticleId IdType="pubmed">33930114</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson CR, Shi T, Vasileiou E, Katikireddi SV, Kerr S, Moore E, et al. First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland. Nat Med. 2021;27:1290&#x2013;1297. doi: 10.1038/s41591-021-01408-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01408-4</ArticleId><ArticleId IdType="pmc">PMC8282499</ArticleId><ArticleId IdType="pubmed">34108714</ArticleId></ArticleIdList></Reference><Reference><Citation>Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, et al. Hematological findings and complications of COVID-19. Am J Hematol. 2020 doi: 10.1002/ajh.25829. 10.1002/ajh.25829.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.25829</ArticleId><ArticleId IdType="pmc">PMC7262337</ArticleId><ArticleId IdType="pubmed">32282949</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiede A, Sachs UJ, Czwalinna A, Werwitzke S, Bikker R, Krauss JK, et al. Prothrombotic immune thrombocytopenia after COVID-19 vaccination. Blood. 2021;138:350&#x2013;353. doi: 10.1182/blood.2021011958.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2021011958</ArticleId><ArticleId IdType="pmc">PMC8084604</ArticleId><ArticleId IdType="pubmed">34323939</ArticleId></ArticleIdList></Reference><Reference><Citation>Vayne C, Nguyen T-H, Rollin J, Charuel N, Poupon A, Pouplard C, et al. Characterization of New Monoclonal PF4-Specific Antibodies as Useful Tools for Studies on Typical and Autoimmune Heparin-Induced Thrombocytopenia. Thromb Haemost. 2021;121:322&#x2013;331. doi: 10.1055/s-0040-1717078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1717078</ArticleId><ArticleId IdType="pubmed">33086397</ArticleId></ArticleIdList></Reference><Reference><Citation>Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomized controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;397:99&#x2013;111. doi: 10.1016/S0140-6736(20)32661-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32661-1</ArticleId><ArticleId IdType="pmc">PMC7723445</ArticleId><ArticleId IdType="pubmed">33306989</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32726711</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>19</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-1810</ISSN><JournalIssue CitedMedium="Internet"><Volume>228</Volume><PubDate><Year>2021</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Translational research : the journal of laboratory and clinical medicine</Title><ISOAbbreviation>Transl Res</ISOAbbreviation></Journal><ArticleTitle>Pre-eclampsia predictive ability of maternal miR-125b: a clinical and experimental study.</ArticleTitle><Pagination><StartPage>13</StartPage><EndPage>27</EndPage><MedlinePgn>13-27</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.trsl.2020.07.011</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1931-5244(20)30179-1</ELocationID><Abstract><AbstractText>Pre-eclampsia (PE) is a systemic maternal syndrome affecting 2-8% of pregnancies worldwide and involving poor placental perfusion and impaired blood supply to the foetus. It manifests after the 20<sup>th</sup> week of pregnancy as new-onset hypertension and substantial proteinuria and is responsible for severe maternal and newborn morbidity and mortality. Identifying biomarkers that predict PE onset prior to its establishment would critically help treatment and attenuate outcome severity. MicroRNAs are ubiquitous gene expression modulators found in blood and tissues. Trophoblast cell surface antigen (Trop)-2 promotes cell growth and is involved in several cancers. We assessed the PE predictive ability of maternal miR-125b in the first trimester of pregnancy by measuring its plasma levels in women with normal pregnancies and with pregnancies complicated by PE on the 12<sup>th</sup> week of gestation. To gain insight into PE pathogenesis we investigated whether Trop-2 is targeted by miR-125b in placental tissue. Data analysis demonstrated a significant association between plasma miR-125b levels and PE, which together with maternal body mass index before pregnancy provided a predictive model with an area under the curve of 0.85 (95% confidence interval, 0.70-1.00). We also found that Trop-2 is a target of miR-125b in placental cells; its localization in the basal part of the syncytiotrophoblast plasma membrane suggests a role for it in the early onset of PE. Altogether, maternal miR-125b proved a promising early biomarker of PE, suggesting that it may be involved in placental development through its action on Trop-2 well before the clinical manifestations of PE.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Licini</LastName><ForeName>Caterina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Experimental and Clinical Medicine, Universit&#xe0; Politecnica delle Marche, 60126 Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Avellini</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Experimental and Clinical Medicine, Universit&#xe0; Politecnica delle Marche, 60126 Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Picchiassi</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Surgical Science, Clinic of Obstetrics and Gynaecology, University of Perugia, 06132 Perugia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mens&#xe0;</LastName><ForeName>Emanuela</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Clinical and Molecular Sciences, Universit&#xe0; Politecnica delle Marche, 60126 Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fantone</LastName><ForeName>Sonia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Experimental and Clinical Medicine, Universit&#xe0; Politecnica delle Marche, 60126 Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramini</LastName><ForeName>Deborah</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Clinical and Molecular Sciences, Universit&#xe0; Politecnica delle Marche, 60126 Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tersigni</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario A. Gemelli IRCCS, U.O.C. di Ostetricia e Patologia Ostetrica, Dipartimento di Scienze della Salute della Donna, del Bambino e di Sanit&#xe0; Pubblica, 00168 Roma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tossetta</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Experimental and Clinical Medicine, Universit&#xe0; Politecnica delle Marche, 60126 Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castellucci</LastName><ForeName>Clara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Clinical and Molecular Sciences, Universit&#xe0; Politecnica delle Marche, 60126 Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tarquini</LastName><ForeName>Federica</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Surgical Science, Clinic of Obstetrics and Gynaecology, University of Perugia, 06132 Perugia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coata</LastName><ForeName>Giuliana</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Surgical Science, Clinic of Obstetrics and Gynaecology, University of Perugia, 06132 Perugia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giardina</LastName><ForeName>Irene</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Centre of Perinatal and Reproductive Medicine, University of Perugia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciavattini</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Clinical Sciences, Universit&#xe0; Politecnica delle Marche, Salesi Hospital, 60123 Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scambia</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario A. Gemelli IRCCS, U.O.C. di Ostetricia e Patologia Ostetrica, Dipartimento di Scienze della Salute della Donna, del Bambino e di Sanit&#xe0; Pubblica, 00168 Roma, Italy; Universit&#xe0; Cattolica del Sacro Cuore, Istituto di Clinica Ostetrica e Ginecologica, 00168 Roma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Renzo</LastName><ForeName>Gian Carlo</ForeName><Initials>GC</Initials><AffiliationInfo><Affiliation>Centre of Perinatal and Reproductive Medicine, University of Perugia, Italy; Department of Obstetrics and Gynaecology I.M. Sechenov First State University, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Simone</LastName><ForeName>Nicoletta</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario A. Gemelli IRCCS, U.O.C. di Ostetricia e Patologia Ostetrica, Dipartimento di Scienze della Salute della Donna, del Bambino e di Sanit&#xe0; Pubblica, 00168 Roma, Italy; Universit&#xe0; Cattolica del Sacro Cuore, Istituto di Clinica Ostetrica e Ginecologica, 00168 Roma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gesuita</LastName><ForeName>Rosaria</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Centre of Epidemiology and Biostatistics, Universit&#xe0; Politecnica delle Marche, 60126 Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giannubilo</LastName><ForeName>Stefano R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Department of Clinical Sciences, Universit&#xe0; Politecnica delle Marche, Salesi Hospital, 60123 Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olivieri</LastName><ForeName>Fabiola</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Clinical and Molecular Sciences, Universit&#xe0; Politecnica delle Marche, 60126 Ancona, Italy; Center of Clinical Pathology and Innovative Therapy, IRCCS INRCA National Institute, 60100 Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marzioni</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Experimental and Clinical Medicine, Universit&#xe0; Politecnica delle Marche, 60126 Ancona, Italy. Electronic address: d.marzioni@staff.univpm.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Transl Res</MedlineTA><NlmUniqueID>101280339</NlmUniqueID><ISSNLinking>1878-1810</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C531888">MIRN125 microRNA, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Front Endocrinol (Lausanne). 2024 Jan 08;14:1297731. doi: 10.3389/fendo.2023.1297731.</RefSource><PMID Version="1">38260145</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="N">MicroRNAs</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011225" MajorTopicYN="N">Pre-Eclampsia</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011256" MajorTopicYN="N">Pregnancy Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014327" MajorTopicYN="N">Trophoblasts</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>2</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32726711</ArticleId><ArticleId IdType="doi">10.1016/j.trsl.2020.07.011</ArticleId><ArticleId IdType="pii">S1931-5244(20)30179-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36003447</PMID><DateRevised><Year>2022</Year><Month>08</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2666-2736</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><PubDate><Year>2022</Year><Month>Mar</Month></PubDate></JournalIssue><Title>JTCVS open</Title><ISOAbbreviation>JTCVS Open</ISOAbbreviation></Journal><ArticleTitle>Pericardial effusion after congenital heart surgery.</ArticleTitle><Pagination><StartPage>237</StartPage><EndPage>243</EndPage><MedlinePgn>237-243</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.xjon.2022.01.001</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">Pericardial effusion after cardiac surgery remains an important cause of morbidity and mortality. We describe the risk factors of pericardial effusion after congenital heart surgery through analyzing data from a nationwide, multi-institutional registry.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">The Japan Congenital Cardiovascular Surgery Database, which reflects routine clinical care in Japan, was used for this retrospective cohort study. Multivariable regression analysis was done after univariable comparison of patients with pericardial effusion and no pericardial effusion.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The study enrolled 64,777 patients registered with the Japan Congenital Cardiovascular Surgery Database between 2008 and 2016; 909 of these had postoperative pericardial effusion (1.4%) and were analyzed along with 63,868 patients without pericardial effusion. Univariable analysis found no difference between the groups in terms of gender, early delivery, or preoperative mechanical ventilatory support. In the pericardial effusion group, cardiopulmonary bypass use was lower (58.4% vs 62.1%), whereas the cardiopulmonary bypass time (176.9 vs 139.9&#xa0;minutes) and aortic crossclamp time (75.1 vs 62.2&#xa0;minutes) were longer, and 30-day mortality was higher (4.1% vs 2.2%). Multivariable analysis identified trisomy 21 (odds ratio, 1.54), 22q.11 deletion (odds ratio, 2.17), first-time cardiac surgery (odds ratio, 2.01), and blood transfusion (odds ratio, 1.43) as independent risk factors of postoperative pericardial effusion. In contrast, neonates, infants, ventricular septal defect, atrial septal defect, tetralogy of Fallot repair, and arterial switch operation were correlated with a low risk of pericardial effusion development.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">The incidence of postoperative pericardial effusion in congenital cardiac surgery was 1.4%. Trisomy 21, 22q.11 deletion, first-time cardiac surgery, and blood transfusion were identified as the principal factors predicting the need for pericardial effusion drainage.</AbstractText><CopyrightInformation>&#xa9; 2022 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Noma</LastName><ForeName>Mio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hirata</LastName><ForeName>Yasutaka</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, The University of Tokyo School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Japan Congenital Cardiovascular Surgery Database Organization, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hirahara</LastName><ForeName>Norimichi</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Health Policy and Management, Keio University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suzuki</LastName><ForeName>Takaaki</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Japan Congenital Cardiovascular Surgery Database Organization, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miyata</LastName><ForeName>Hiroaki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Health Policy and Management, Keio University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hiramatsu</LastName><ForeName>Yuji</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, School of Medicine, The University of Tsukuba, Tsukuba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoshimura</LastName><ForeName>Yukihiro</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takamoto</LastName><ForeName>Shinichi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Japan Congenital Cardiovascular Surgery Database Organization, Tokyo, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>JTCVS Open</MedlineTA><NlmUniqueID>101768541</NlmUniqueID><ISSNLinking>2666-2736</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">22q.11 deletion</Keyword><Keyword MajorTopicYN="N">ASD, atrial septal defect</Keyword><Keyword MajorTopicYN="N">CPB, cardiopulmonary bypass</Keyword><Keyword MajorTopicYN="N">JCCVSD, Japan Congenital Cardiovascular Surgery Database</Keyword><Keyword MajorTopicYN="N">OR, odds ratio</Keyword><Keyword MajorTopicYN="N">PA, pulmonary artery</Keyword><Keyword MajorTopicYN="N">PE, pericardial effusion</Keyword><Keyword MajorTopicYN="N">PPS, postpericardiotomy syndrome</Keyword><Keyword MajorTopicYN="N">TOF, tetralogy of Fallot</Keyword><Keyword MajorTopicYN="N">VSD, ventricular septal defect</Keyword><Keyword MajorTopicYN="N">blood transfusion</Keyword><Keyword MajorTopicYN="N">congenital heart surgery</Keyword><Keyword MajorTopicYN="N">first-time surgery</Keyword><Keyword MajorTopicYN="N">postoperative pericardial effusion</Keyword><Keyword MajorTopicYN="N">postpericardiotomy syndrome</Keyword><Keyword MajorTopicYN="N">trisomy 21</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>5</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>25</Day><Hour>2</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>26</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36003447</ArticleId><ArticleId IdType="pmc">PMC9390554</ArticleId><ArticleId IdType="doi">10.1016/j.xjon.2022.01.001</ArticleId><ArticleId IdType="pii">S2666-2736(22)00006-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Adrichem R., Cessie S.L., Hazekamp M.G., Van Dam N.A.M., Blom N.A., Rammeloo L.A.J., et al. Risk of clinically relevant pericardial effusion after pediatric cardiac surgery. Pediatr Cardiol. 2019;40:585&#x2013;594.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6420454</ArticleId><ArticleId IdType="pubmed">30539239</ArticleId></ArticleIdList></Reference><Reference><Citation>Elias M.D., Glatz A.C., O'Connor M.J., Schachtner S., Ravishankar C., Mascio C.E., et al. Prevalence and risk factors for pericardial effusions requiring readmission after pediatric cardiac surgery. Pediatr Cardiol. 2017;38:484&#x2013;494.</Citation><ArticleIdList><ArticleId IdType="pubmed">27900408</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalili M., Zamani H., Aarabi-Moghaddam M. Pericardial effusion after pediatric cardiac surgeries: a single center observation. Res Cardiovasc Med. 2012;1:28&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4253886</ArticleId><ArticleId IdType="pubmed">25478485</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung E.W.Y., Ho S.A., Tang K.K.Y., Chau A.K.T., Chiu C.S.W., Cheung Y.F. Pericardial effusion after open heart surgery for congenital heart disease. Heart. 2003;89:780&#x2013;783.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1767733</ArticleId><ArticleId IdType="pubmed">12807856</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyata M., Murakami A., Tomotaki A., Takaoka T., Konuma T., Matsumura G., et al. Predictors of 90-day mortality after congenital heart surgery: the first report of risk models from a Japanese database. J Thorac Cardiovasc Surg. 2014;148:2201&#x2013;2206.</Citation><ArticleIdList><ArticleId IdType="pubmed">25444193</ArticleId></ArticleIdList></Reference><Reference><Citation>Erlich J.F., Paz Z. Postpericardial injury syndrome: an autoimmune phenomenon. Clin Rev Allergy Immunol. 2010;38:156&#x2013;158.</Citation><ArticleIdList><ArticleId IdType="pubmed">19582596</ArticleId></ArticleIdList></Reference><Reference><Citation>Sevuk U., Bilgic A., Altindag R., Baysal E., Yaylak B., Adiyaman M.S., et al. Value of the neutrophil-to-lymphocyte ratio in predicting post-pericardiotomy syndrome after cardiac surgery. Eur Rev Med Pharmacol Sci. 2016;20:906&#x2013;911.</Citation><ArticleIdList><ArticleId IdType="pubmed">27010149</ArticleId></ArticleIdList></Reference><Reference><Citation>Imazio M., Brucato A., Adler Y. Is possible to prevent the post-pericardiotomy syndrome? Int J Cardiol. 2012;159:1&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">22360943</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan N.K., J&#xe4;rvel&#xe4; K.M., Loisa E.L., Sutinen J.A., Laurikka J.O., Khan J.A. Incidence, presentation and risk factors of late postoperative pericardial effusions requiring invasive treatment after cardiac surgery. Interact Cardiovasc Thorac Surg. 2017;24:835&#x2013;840.</Citation><ArticleIdList><ArticleId IdType="pubmed">28329077</ArticleId></ArticleIdList></Reference><Reference><Citation>Alraies M.C., Jaroudi W.A., Shabrang C., Yarmohammadi H., Klein A.L., Tamarappoo B.K. Clinical features associated with adverse events in patients with post-pericardiotomy syndrome following cardiac surgery. Am J Cardiol. 2014;114:1426&#x2013;1430.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4316687</ArticleId><ArticleId IdType="pubmed">25306427</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashikhmina E.A., Schaff H.V., Sinak L.J., Li Z., Dearani J.A., Suri R.M., et al. Pericardial effusion after cardiac surgery: risk factors, patient profiles, and contemporary management. Ann Thorac Surg. 2010;89:112&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pubmed">20103217</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehto J., Kiviniemi T., Gunn J., Airaksinen J., Rautava P., Kyt&#xf6; V. Occurrence of postpericardiotomy syndrome: association with operation type and postoperative mortality after open-heart operations. J Am Heart Assoc. 2018;7:e010269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6404434</ArticleId><ArticleId IdType="pubmed">30571490</ArticleId></ArticleIdList></Reference><Reference><Citation>Engle M.A., McCabe J.C., Ebert P.A., Zabriskie J. The Postpericardiotomy syndrome and antiheart antibodies. Circulation. 1974;49:401&#x2013;406.</Citation><ArticleIdList><ArticleId IdType="pubmed">4591546</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuvin J.T., Harati N.A., Pandian N.G., Bojar R.M., Khabbaz K.R. Postoperative cardiac tamponade in the modern surgical era. Ann Thorac Surg. 2002;74:1148&#x2013;1153.</Citation><ArticleIdList><ArticleId IdType="pubmed">12400760</ArticleId></ArticleIdList></Reference><Reference><Citation>Imazio M., Brucato A., Rovere M.E., Gandino A., Cemin R., Ferrua S., et al. Contemporary features, risk factors, and prognosis of the post-pericardiotomy syndrome. Am J Cardiol. 2011;108:1183&#x2013;1187.</Citation><ArticleIdList><ArticleId IdType="pubmed">21798503</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson J.K., Kochilas L.K., Catton K.G., Moller J.H., Setty S.P. Long-term outcomes of children with Trisomy 13 and 18 after congenital heart disease interventions. Ann Thorac Surg. 2017;103:1941&#x2013;1949.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5526352</ArticleId><ArticleId IdType="pubmed">28456396</ArticleId></ArticleIdList></Reference><Reference><Citation>Michielon G., Marino B., Oricchio G., Digilio M.C., Iorio F., Filippelli S., et al. Impact of DEL22q11, trisomy 21, and other genetic syndromes on surgical outcome of conotruncal heart defects. J Thorac Cardiovasc Surg. 2009;138:565&#x2013;570.e2.</Citation><ArticleIdList><ArticleId IdType="pubmed">19698836</ArticleId></ArticleIdList></Reference><Reference><Citation>Fudge J.C., Jr., Li S., Jaggers J., O'Brien S.M., Peterson E.D., Jacobs J.P., et al. Congenital heart surgery outcomes in Down syndrome: analysis of a national clinical database. Pediatrics. 2010;126:315&#x2013;322.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4006076</ArticleId><ArticleId IdType="pubmed">20624800</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharande P., Virupakshappa K.K.B., Mehta B., Badawi N. Fetal/neonatal pericardial effusion in Down's syndrome: case report and review of literature. AJP Rep. 2018;8:e301&#x2013;e306.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6205858</ArticleId><ArticleId IdType="pubmed">30377554</ArticleId></ArticleIdList></Reference><Reference><Citation>Concolino D., Pascuzzi A., Pietragalla E., Lia R., Canepa S., Strisciuglio P. High prevalence of isolated pericardial effusion in Down syndrome. Am J Med Genet A. 2005;132A:331&#x2013;332.</Citation><ArticleIdList><ArticleId IdType="pubmed">15523613</ArticleId></ArticleIdList></Reference><Reference><Citation>Beco G., Mambour N., V&#xf4; C., Vanhoutte L., Moniotte S., Poncelet A., et al. Recent experience and follow-up after surgical closure of secundum atrial septal defect in 120 children. Pediatr Cardiol. 2018;39:1440&#x2013;1444.</Citation><ArticleIdList><ArticleId IdType="pubmed">29789918</ArticleId></ArticleIdList></Reference><Reference><Citation>Heching H.J., Bacha E.A., Liberman L. Post-pericardiotomy syndrome in pediatric patients following surgical closure of secundum atrial septal defects: incidence and risk factors. Pediatr Cardiol. 2015;36:498&#x2013;502.</Citation><ArticleIdList><ArticleId IdType="pubmed">25293428</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones D.A., Radford D.J., Pohlner P.G. Outcome following surgical closure of secundum atrial septal defect. J Paediatr Child Health. 2001;37:274&#x2013;277.</Citation><ArticleIdList><ArticleId IdType="pubmed">11468044</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Z.D., Hijazi Z.M., Kleinman C.S., Silverman N.H., Larntz K., Amplatzer Investigators Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. J Am Coll Cardiol. 2002;39:1836&#x2013;1844.</Citation><ArticleIdList><ArticleId IdType="pubmed">12039500</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewachter C., Belhaj A., Rondelet B., Vercruyssen M., Schraufnagel D.P., Remmelink M., et al. Myocardial inflammation in experimental acute right ventricular failure: effects of prostacyclin therapy. J Heart Lung Transplant. 2015;34:1334&#x2013;1345.</Citation><ArticleIdList><ArticleId IdType="pubmed">26087665</ArticleId></ArticleIdList></Reference><Reference><Citation>Noma M., Matsubara M., Tokunaga C., Nakajima T., Mathis B.J., Sakamoto H., et al. Predictors of pericardial effusion in patients undergoing pulmonary artery banding. World J Pediatr Congenit Heart Surg. 2018;9:201&#x2013;205.</Citation><ArticleIdList><ArticleId IdType="pubmed">29544417</ArticleId></ArticleIdList></Reference><Reference><Citation>Paparella D., Yau T.M., Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg. 2002;21:232&#x2013;244.</Citation><ArticleIdList><ArticleId IdType="pubmed">11825729</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehto J., Gunn J., Karjalainen P., Airaksinen J., Kiviniemi T. Incidence and risk factors of postpericardiotomy syndrome requiring medical attention: the Finland postpericardiotomy syndrome study. J Thorac Cardiovasc Surg. 2015;149:1324&#x2013;1329.</Citation><ArticleIdList><ArticleId IdType="pubmed">25702324</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30383109</PMID><DateCompleted><Year>2019</Year><Month>08</Month><Day>27</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1539-3704</ISSN><JournalIssue CitedMedium="Internet"><Volume>169</Volume><Issue>9</Issue><PubDate><Year>2018</Year><Month>Nov</Month><Day>06</Day></PubDate></JournalIssue><Title>Annals of internal medicine</Title><ISOAbbreviation>Ann Intern Med</ISOAbbreviation></Journal><ArticleTitle>Clinical Outcomes Associated With Sickle Cell Trait: A Systematic Review.</ArticleTitle><Pagination><StartPage>619</StartPage><EndPage>627</EndPage><MedlinePgn>619-627</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.7326/M18-1161</ELocationID><Abstract><AbstractText Label="BACKGROUND">Although sickle cell trait (SCT) is largely a benign carrier state, it may increase risk for certain clinical outcomes.</AbstractText><AbstractText Label="PURPOSE">To evaluate associations between SCT and clinical outcomes in children and adults.</AbstractText><AbstractText Label="DATA SOURCES">English-language searches of PubMed, CINAHL, the Cochrane Library, Current Contents Connect, Scopus, and Embase (1 January 1970 to 30 June 2018) and bibliographies of review articles.</AbstractText><AbstractText Label="STUDY SELECTION">Observational controlled studies (published in English) in children or adults that examined an association between SCT and any of 24 clinical outcomes specified a priori in the following 6 categories: exertion-related injury; renal, vascular, pediatric, and surgery- or trauma-related outcomes; and overall mortality.</AbstractText><AbstractText Label="DATA EXTRACTION">A single reviewer extracted study data, which was checked by another; 2 reviewers independently assessed study quality; and strength of evidence was assessed by consensus.</AbstractText><AbstractText Label="DATA SYNTHESIS">Of 7083 screened studies, 41 met inclusion criteria. High-strength evidence supported a positive association between SCT and risk for pulmonary embolism, proteinuria, and chronic kidney disease. Moderate-strength evidence supported a positive association between SCT and exertional rhabdomyolysis and a null association between SCT and deep venous thrombosis, heart failure or cardiomyopathy, stroke, and pediatric height or weight. Absolute risks for thromboembolism and rhabdomyolysis were small. For the remaining 15 clinical outcomes, data were insufficient or strength of evidence was low.</AbstractText><AbstractText Label="LIMITATION">Publication bias was possible, and high-quality evidence was scant.</AbstractText><AbstractText Label="CONCLUSION">Sickle cell trait is a risk factor for a few adverse health outcomes, such as pulmonary embolism, kidney disease, and exertional rhabdomyolysis, but does not seem to be associated with such complications as heart failure and stroke. Insufficient data or low-strength evidence exists for most speculated complications of SCT.</AbstractText><AbstractText Label="PRIMARY FUNDING SOURCE">National Human Genome Research Institute.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Naik</LastName><ForeName>Rakhi P</ForeName><Initials>RP</Initials><AffiliationInfo><Affiliation>Johns Hopkins University, Baltimore, Maryland (R.P.N.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith-Whitley</LastName><ForeName>Kim</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia, Pennsylvania (K.S., P.S.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hassell</LastName><ForeName>Kathryn L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>University of Colorado Denver School of Medicine, Denver, Colorado (K.L.H.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Umeh</LastName><ForeName>Nkeiruka I</ForeName><Initials>NI</Initials><AffiliationInfo><Affiliation>National Human Genome Research Institute of the National Institutes of Health, Bethesda, Maryland (N.I.U., J.J., V.L.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Montalembert</LastName><ForeName>Mariane</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>H&#xf4;pital Universitaire Necker-Enfants Malades, Paris, France (M.D.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sahota</LastName><ForeName>Puneet</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia, Pennsylvania (K.S., P.S.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haywood</LastName><ForeName>Carlton</ForeName><Initials>C</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Johns Hopkins Berman Institute of Bioethics, Baltimore, Maryland (C.H.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jenkins</LastName><ForeName>Jean</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>National Human Genome Research Institute of the National Institutes of Health, Bethesda, Maryland (N.I.U., J.J., V.L.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lloyd-Puryear</LastName><ForeName>Michele A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>American College of Medical Genetics and Genomics, Bethesda, Maryland (M.A.L.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joiner</LastName><ForeName>Clinton H</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>University of Pennsylvania, Philadelphia, Pennsylvania; Johns Hopkins Berman Institute of Bioethics, Baltimore, Maryland; Emory University School of Medicine, Atlanta, Georgia (C.H.J.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonham</LastName><ForeName>Vence L</ForeName><Initials>VL</Initials><AffiliationInfo><Affiliation>National Human Genome Research Institute of the National Institutes of Health, Bethesda, Maryland (N.I.U., J.J., V.L.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kato</LastName><ForeName>Gregory J</ForeName><Initials>GJ</Initials><AffiliationInfo><Affiliation>Vascular Medicine Institute at the University of Pittsburgh, Pittsburgh, Pennsylvania (G.J.K.).</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K08 HL125100</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>ZIA HG200394</GrantID><Acronym>ImNIH</Acronym><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>10</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Intern Med</MedlineTA><NlmUniqueID>0372351</NlmUniqueID><ISSNLinking>0003-4819</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001827" MajorTopicYN="N">Body Height</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="N">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011507" MajorTopicYN="N">Proteinuria</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051436" MajorTopicYN="N">Renal Insufficiency, Chronic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012206" MajorTopicYN="N">Rhabdomyolysis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012805" MajorTopicYN="N">Sickle Cell Trait</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014947" MajorTopicYN="N">Wounds and Injuries</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>5</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30383109</ArticleId><ArticleId IdType="mid">NIHMS1005388</ArticleId><ArticleId IdType="pmc">PMC6487193</ArticleId><ArticleId IdType="doi">10.7326/M18-1161</ArticleId><ArticleId IdType="pii">2709819</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Taylor SM, Parobek CM, Fairhurst RM. Haemoglobinopathies and the clinical epidemiology of malaria: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12:457&#x2013;68. [PMID: ] doi:10.1016/S1473-3099(12)70055-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(12)70055-5</ArticleId><ArticleId IdType="pmc">PMC3404513</ArticleId><ArticleId IdType="pubmed">22445352</ArticleId></ArticleIdList></Reference><Reference><Citation>Ojodu J, Hulihan MM, Pope SN, Grant AM; Centers for Disease Control and Prevention (CDC). Incidence of sickle cell trait&#x2014;United States, 2010. MMWR Morb Mortal Wkly Rep. 2014;63:1155&#x2013;8. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4584538</ArticleId><ArticleId IdType="pubmed">25503918</ArticleId></ArticleIdList></Reference><Reference><Citation>Naik RP, Haywood C Jr. Sickle cell trait diagnosis: clinical and social implications. Hematology Am Soc Hematol Educ Program. 2015;2015:160&#x2013;7. [PMID: ] doi:10.1182/asheducation-2015.1.160</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/asheducation-2015.1.160</ArticleId><ArticleId IdType="pmc">PMC4697437</ArticleId><ArticleId IdType="pubmed">26637716</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant AM, Parker CS, Jordan LB, Hulihan MM, Creary MS, Lloyd-Puryear MA, et al. Public health implications of sickle cell trait: a report of the CDC meeting. Am J Prev Med. 2011;41:S435&#x2013;9. [PMID: ] doi:10.1016/j.amepre.2011.09.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amepre.2011.09.012</ArticleId><ArticleId IdType="pubmed">22099370</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization Regional
Committee for Africa. Sickle-cell disease: a strategy for
the WHO African region. 22 June
2010. 
Accessed at http://apps.who.int/iris/bitstream/10665/1682/1/AFR-RC60-8.pdf
on 1 February 2018.</Citation></Reference><Reference><Citation>Tsaras G, Owusu-Ansah A, Boateng FO, Amoateng-Adjepong Y. Complications associated with sickle cell trait: a brief narrative review. Am J Med. 2009;122:507&#x2013;12. [PMID: ] doi:10.1016/j.amjmed.2008.12.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2008.12.020</ArticleId><ArticleId IdType="pubmed">19393983</ArticleId></ArticleIdList></Reference><Reference><Citation>Jordan LB, Smith-Whitley K, Treadwell MJ, Telfair J, Grant AM, Ohene-Frempong K. Screening U.S. college athletes for their sickle cell disease carrier status. Am J Prev Med. 2011;41:S406&#x2013;12. [PMID: ] doi:10.1016/j.amepre.2011.09.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amepre.2011.09.014</ArticleId><ArticleId IdType="pubmed">22099365</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldsmith JC, Bonham VL, Joiner CH, Kato GJ, Noonan AS, Steinberg MH. Framing the research agenda for sickle cell trait: building on the current understanding of clinical events and their potential implications. Am J Hematol. 2012;87:340&#x2013;6. [PMID: ] doi:10.1002/ajh.22271</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.22271</ArticleId><ArticleId IdType="pmc">PMC3513289</ArticleId><ArticleId IdType="pubmed">22307997</ArticleId></ArticleIdList></Reference><Reference><Citation>American Society of
Hematology. Statement on screening for sickle cell trait
and athletic participation. 26 January
2012. 
Accessed at www.hematology.org/Advocacy/Statements/2650.aspx
on 1 February 2018.</Citation></Reference><Reference><Citation>Benson JM, Therrell BL Jr. History and current status of newborn screening for hemoglobinopathies. Semin Perinatol. 2010;34:134&#x2013;44. [PMID: ] doi:10.1053/j.semperi.2009.12.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.semperi.2009.12.006</ArticleId><ArticleId IdType="pubmed">20207263</ArticleId></ArticleIdList></Reference><Reference><Citation>Viswanathan M, Berkman ND. Development of the RTI item bank on risk of bias and precision of observational studies. J Clin Epidemiol. 2012;65:163&#x2013;78. [PMID: ] doi:10.1016/j.jclinepi.2011.05.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2011.05.008</ArticleId><ArticleId IdType="pubmed">21959223</ArticleId></ArticleIdList></Reference><Reference><Citation>Owens DK, Lohr KN, Atkins D, Treadwell JR, Reston JT, Bass EB, et al. AHRQ series paper 5: grading the strength of a body of evidence when comparing medical interventions&#x2014;Agency for Healthcare Research and Quality and the Effective Health-Care Program. J Clin Epidemiol. 2010;63:513&#x2013;23. [PMID: ] doi:10.1016/j.jclinepi.2009.03.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2009.03.009</ArticleId><ArticleId IdType="pubmed">19595577</ArticleId></ArticleIdList></Reference><Reference><Citation>Kark JA, Posey DM, Schumacher HR, Ruehle CJ. Sickle-cell trait as a risk factor for sudden death in physical training. N Engl J Med. 1987;317:781&#x2013;7. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">3627196</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson DA, Deuster PA, Carter R 3rd, Hill OT, Wolcott VL, Kurina LM. Sickle cell trait, rhabdomyolysis, and mortality among U.S. Army soldiers. N Engl J Med. 2016;375:435&#x2013;42. [PMID: ] doi:10.1056/NEJMoa1516257</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1516257</ArticleId><ArticleId IdType="pmc">PMC5026312</ArticleId><ArticleId IdType="pubmed">27518662</ArticleId></ArticleIdList></Reference><Reference><Citation>Deuster PA, Contreras-Sesvold CL, O&#x2019;Connor FG, Campbell WW, Kenney K, Capacchione JF, et al. Genetic polymorphisms associated with exertional rhabdomyolysis. Eur J Appl Physiol. 2013;113:1997&#x2013;2004. [PMID: ] doi:10.1007/s00421-013-2622-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00421-013-2622-y</ArticleId><ArticleId IdType="pubmed">23543093</ArticleId></ArticleIdList></Reference><Reference><Citation>Heller P, Best WR, Nelson RB, Becktel J. Clinical implications of sickle-cell trait and glucose-6-phosphate dehydrogenase deficiency in hospitalized black male patients. N Engl J Med. 1979;300:1001&#x2013;5. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">431593</ArticleId></ArticleIdList></Reference><Reference><Citation>Naik RP, Derebail VK, Grams ME, Franceschini N, Auer PL, Peloso GM, et al. Association of sickle cell trait with chronic kidney disease and albuminuria in African Americans. JAMA. 2014;312:2115&#x2013;25. [PMID: ] doi:10.1001/jama.2014.15063</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2014.15063</ArticleId><ArticleId IdType="pmc">PMC4356116</ArticleId><ArticleId IdType="pubmed">25393378</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajayi AA, Kolawole BA. Sickle cell trait and gender influence type 2 diabetic complications in African patients. Eur J Intern Med. 2004;15:312&#x2013;5. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">15450989</ArticleId></ArticleIdList></Reference><Reference><Citation>Lonsdorfer A, Comoe L, Yapo AE, Lonsdorfer J. Proteinuria in sickle cell trait and disease: an electrophoretic analysis. Clin Chim Acta. 1989;181:239&#x2013;47. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">2758678</ArticleId></ArticleIdList></Reference><Reference><Citation>Oli JM, Reid HL. Do Nigerian diabetics with haemoglobin genotype Hb AS have greater risks of developing renal complications and hypertension? A preliminary report. Trop Geogr Med. 1985;37:309&#x2013;13. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">4095768</ArticleId></ArticleIdList></Reference><Reference><Citation>Oli JM, Watkins PJ, Wild B, Adegoke OJ. Albuminuria in Afro-Caribbeans with type 2 diabetes mellitus: is the sickle cell trait a risk factor? Diabet Med. 2004;21:483&#x2013;6. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">15089795</ArticleId></ArticleIdList></Reference><Reference><Citation>Aloni MN, Ngiyulu RM, Nsibu CN, Ekulu PM, Makulo JR, Gini-Ehungu JL, et al. Congolese children with sickle cell trait may exhibit glomerular hyperfiltration: a case control study. J Clin Lab Anal. 2017;31 [PMID: ] doi:10.1002/jcla.22143</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcla.22143</ArticleId><ArticleId IdType="pmc">PMC6817090</ArticleId><ArticleId IdType="pubmed">28102613</ArticleId></ArticleIdList></Reference><Reference><Citation>Naik RP, Irvin MR, Judd S, Guti&#xe9;rrez OM, Zakai NA, Derebail VK, et al. Sickle cell trait and the risk of ESRD in blacks. J Am Soc Nephrol. 2017;28:2180&#x2013;7. [PMID: ] doi:10.1681/ASN.2016101086</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2016101086</ArticleId><ArticleId IdType="pmc">PMC5491293</ArticleId><ArticleId IdType="pubmed">28280138</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukendi K, Lepira FB, Makulo JR, Sumaili KE, Kayembe PK, Nseka MN. Sickle cell trait is not associated with chronic kidney disease in adult Congolese patients: a clinic-based, cross-sectional study. Cardiovasc J Afr. 2015;26:125&#x2013;9. [PMID: ] doi:10.5830/CVJA-2014-076</Citation><ArticleIdList><ArticleId IdType="doi">10.5830/CVJA-2014-076</ArticleId><ArticleId IdType="pmc">PMC4538907</ArticleId><ArticleId IdType="pubmed">26592908</ArticleId></ArticleIdList></Reference><Reference><Citation>Dueker ND, Della-Morte D, Rundek T, Sacco RL, Blanton SH. Sickle cell trait and renal function in Hispanics in the United States: the Northern Manhattan study. Ethn Dis. 2017;27:11&#x2013;4. [PMID: ] doi:10.18865/ed.27.1.11</Citation><ArticleIdList><ArticleId IdType="doi">10.18865/ed.27.1.11</ArticleId><ArticleId IdType="pmc">PMC5245602</ArticleId><ArticleId IdType="pubmed">28115816</ArticleId></ArticleIdList></Reference><Reference><Citation>Hicks PJ, Langefeld CD, Lu L, Bleyer AJ, Divers J, Nachman PH, et al. Sickle cell trait is not independently associated with susceptibility to end-stage renal disease in African Americans. Kidney Int. 2011;80:1339&#x2013;43. [PMID: ] doi:10.1038/ki.2011.286</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2011.286</ArticleId><ArticleId IdType="pmc">PMC3280424</ArticleId><ArticleId IdType="pubmed">21849968</ArticleId></ArticleIdList></Reference><Reference><Citation>Derebail VK, Nachman PH, Key NS, Ansede H, Falk RJ, Kshirsagar AV. High prevalence of sickle cell trait in African Americans with ESRD. J Am Soc Nephrol. 2010;21:413&#x2013;7. [PMID: ] doi:10.1681/ASN.2009070705</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2009070705</ArticleId><ArticleId IdType="pmc">PMC2831865</ArticleId><ArticleId IdType="pubmed">20056747</ArticleId></ArticleIdList></Reference><Reference><Citation>Derebail VK, Lacson EK Jr, Kshirsagar AV, Key NS, Hogan SL, Hakim RM, et al. Sickle trait in African-American hemodialysis patients and higher erythropoiesis-stimulating agent dose. J Am Soc Nephrol. 2014;25:819&#x2013;26. [PMID: ] doi:10.1681/ASN.2013060575</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2013060575</ArticleId><ArticleId IdType="pmc">PMC3968502</ArticleId><ArticleId IdType="pubmed">24459231</ArticleId></ArticleIdList></Reference><Reference><Citation>Folsom AR, Tang W, Roetker NS, Kshirsagar AV, Derebail VK, Lutsey PL, et al. Prospective study of sickle cell trait and venous thromboembolism incidence. J Thromb Haemost. 2015;13:2&#x2013;9. [PMID: ] doi:10.1111/jth.12787</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.12787</ArticleId><ArticleId IdType="pmc">PMC4294976</ArticleId><ArticleId IdType="pubmed">25393788</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin H, Key NS, Benson JM, Lally C, Dowling NF, Whitsett C, et al. Sickle cell trait and the risk of venous thromboembolism among blacks. Blood. 2007;110:908&#x2013;12. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">17409269</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed SG, Kagu MB, Ibrahim UA, Bukar AA. Impact of sickle cell trait on the thrombotic risk associated with non-O blood groups in northern Nigeria. Blood Transfus. 2015;13:639&#x2013;43. [PMID: ] doi:10.2450/2015.0335-14</Citation><ArticleIdList><ArticleId IdType="doi">10.2450/2015.0335-14</ArticleId><ArticleId IdType="pmc">PMC4624541</ArticleId><ArticleId IdType="pubmed">26057489</ArticleId></ArticleIdList></Reference><Reference><Citation>Liem RI, Chan C, Vu TT, Fornage M, Thompson AA, Liu K, et al. Association among sickle cell trait, fitness, and cardiovascular risk factors in CARDIA. Blood. 2017;129:723&#x2013;8. [PMID: ] doi:10.1182/blood-2016-07-727719</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2016-07-727719</ArticleId><ArticleId IdType="pmc">PMC5301825</ArticleId><ArticleId IdType="pubmed">27856464</ArticleId></ArticleIdList></Reference><Reference><Citation>Etyang AO, Wandabwa CK, Kapesa S, Muthumbi E, Odipo E, Wamukoya M, et al. Blood Pressure and Arterial Stiffness in Kenyan Adolescents With the Sickle Cell Trait. Am J Epidemiol. 2018; 187 199&#x2013;205. [PMID: ] doi:10.1093/aje/kwx232</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwx232</ArticleId><ArticleId IdType="pmc">PMC5860135</ArticleId><ArticleId IdType="pubmed">28992220</ArticleId></ArticleIdList></Reference><Reference><Citation>Bello NA, Hyacinth HI, Roetker NS, Seals SR, Naik RP, Derebail VK, et al. Sickle cell trait is not associated with an increased risk of heart failure or abnormalities of cardiac structure and function [Letter]. Blood. 2017;129:799&#x2013;801. [PMID: ] doi:10.1182/blood-2016-08-705541</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2016-08-705541</ArticleId><ArticleId IdType="pmc">PMC5301821</ArticleId><ArticleId IdType="pubmed">27932373</ArticleId></ArticleIdList></Reference><Reference><Citation>Caughey MC, Loehr LR, Key NS, Derebail VK, Gottesman RF, Kshirsagar AV, et al. Sickle cell trait and incident ischemic stroke in the Atherosclerosis Risk in Communities study. Stroke. 2014;45:2863&#x2013;7. [PMID: ] doi:10.1161/STROKEAHA.114.006110</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.114.006110</ArticleId><ArticleId IdType="pmc">PMC4174726</ArticleId><ArticleId IdType="pubmed">25139879</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyacinth HI, Carty CL, Seals SR, Irvin MR, Naik RP, Burke GL, et al. Association of sickle cell trait with ischemic stroke among African Americans: a meta-analysis. JAMA Neurol. 2018;75:802&#x2013;7. [PMID: ] doi:10.1001/jamaneurol.2018.0571</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2018.0571</ArticleId><ArticleId IdType="pmc">PMC6145767</ArticleId><ArticleId IdType="pubmed">29710269</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Harbi M, Khandekar R, Kozak I, Schatz P. Association between sickle cell trait and the prevalence and severity of diabetic retinopathy. PLoS One. 2016;11:e0159215 [PMID: ] doi:10.1371/journal.pone.0159215</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0159215</ArticleId><ArticleId IdType="pmc">PMC4944991</ArticleId><ArticleId IdType="pubmed">27414024</ArticleId></ArticleIdList></Reference><Reference><Citation>Qamra S, Roy J, Srivastava P. Impact of sickle cell trait on physical growth in tribal children of Mandla district in Madhya Pradesh, India. Ann Hum Biol. 2011;38:685&#x2013;90. [PMID: ] doi:10.3109/03014460.2011.608378</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/03014460.2011.608378</ArticleId><ArticleId IdType="pubmed">21864082</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashcroft MT, Desai P, Richardson SA, Serjeant. Growth, behaviour, and educational achievement of Jamaican children with sickle-cell trait. Br Med J. 1976;1:1371&#x2013;3. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1640080</ArticleId><ArticleId IdType="pubmed">1276695</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashcroft MT, Desai P, Grell GA, Serjeant BE, Serjeant GR. Heights and weights of West Indian children with the sickle cell trait. Arch Dis Child. 1978;53:596&#x2013;8. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1545004</ArticleId><ArticleId IdType="pubmed">686800</ArticleId></ArticleIdList></Reference><Reference><Citation>Barmate N, Wakode S, Fulpatil M. Influence of sickle hemoglobinopathies on growth &amp; development. Medico-Legal Update. 2010;10:82&#x2013;5.</Citation></Reference><Reference><Citation>Freire-Maia N, Paes Alves AF, Oliveira MP, Olympio da Silva MC, Lima Machado MA, Azev&#xea;do ES. Anthropometric data of children heterozygous for abnormal hemoglobins (Hb AS, Hb AC) and paired controls Hb AA. Hum Hered. 1981;31:70&#x2013;3. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">7228060</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer MS, Rooks Y, Pearson HA. Growth and development in children with sickle-cell trait. A prospective study of matched pairs. N Engl J Med. 1978;299:686&#x2013;9. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">683252</ArticleId></ArticleIdList></Reference><Reference><Citation>Rehan N Growth status of children with and without sickle cell trait. Clin Pediatr (Phila). 1981;20:705&#x2013;9. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">7297011</ArticleId></ArticleIdList></Reference><Reference><Citation>McCormack MK, Scarr-Salapatek S, Polesky H, Thompson W, Katz SH, Barker WB. A comparison of the physical and intellectual development of black children with and without sickle-cell trait. Pediatrics. 1975;56:1021&#x2013;5. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">172854</ArticleId></ArticleIdList></Reference><Reference><Citation>Gozal D, Lorey FW, Chandler D, Derry MK, Lisbin A, Keens TG, et al. Incidence of sudden infant death syndrome in infants with sickle cell trait. J Pediatr. 1994;124:211&#x2013;4. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">8301424</ArticleId></ArticleIdList></Reference><Reference><Citation>Atlas SA. The sickle cell trait and surgical complications. A matched-pair patient analysis. JAMA. 1974;229:1078&#x2013;80. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">4407956</ArticleId></ArticleIdList></Reference><Reference><Citation>Djaiani GN, Cheng DC, Carroll JA, Yudin M, Karski JM. Fast-track cardiac anesthesia in patients with sickle cell abnormalities. Anesth Analg. 1999;89:598&#x2013;603. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">10475287</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasrullah A, Kerr NC. Sickle cell trait as a risk factor for secondary hemorrhage in children with traumatic hyphema. Am J Ophthalmol. 1997;123:783&#x2013;90. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">9535622</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashcroft MT, Desai P. Mortality and morbidity in Jamaican adults with sickle-cell trait and with normal haemoglobin followed up for twelve years. Lancet. 1976;2:784&#x2013;6. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">61453</ArticleId></ArticleIdList></Reference><Reference><Citation>Stark AD, Janerich DT, Jereb SK. The incidence and causes of death in a follow-up study of individuals with haemoglobin AS and AA. Int J Epidemiol. 1980;9:325&#x2013;8. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">7203774</ArticleId></ArticleIdList></Reference><Reference><Citation>Balgir R Epidemiologic-study of sickle-cell disease in Western Orissa. Man India. 1993;73:363&#x2013;70.</Citation></Reference><Reference><Citation>Castro O, Rana SR, Bang KM, Scott RB. Age and prevalence of sickle-cell trait in a large ambulatory population. Genet Epidemiol. 1987;4:307&#x2013;11. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">3666437</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonham VL, Dover GJ, Brody LC. Screening student athletes for sickle cell trait&#x2014;a social and clinical experiment. N Engl J Med. 2010;363:997&#x2013;9. [PMID: ] doi:10.1056/NEJMp1007639</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp1007639</ArticleId><ArticleId IdType="pubmed">20825310</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowman JE. Genetic screening programs and public policy. Phylon. 1977;38:117&#x2013;42. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">11663029</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowman JE. Mass screening programs for sickle hemoglobin: a sickle cell crisis. JAMA. 1972;222:1650 [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">4678369</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein R
Sickle cell testing of athletes stirs discrimination fears. The
Washington Post. 20 September
2010. 
Accessed at www.washingtonpost.com/wp-dyn/content/article/2010/09/19/AR2010091904417.html
on 1 February 2018.</Citation></Reference><Reference><Citation>Beachum L
Sickle cell trait may not increase the risk of death. The Washington
Post. 3 August
2016. 
Accessed at www.washingtonpost.com/news/to-your-health/wp/2016/08/03/sickle-cell-trait-may-not-increase-the-risk-of-death
on 1 February 2018.</Citation></Reference><Reference><Citation>Naik RP, Wilson JG, Ekunwe L, Mwasongwe S, Duan Q, Li Y, et al. Elevated D-dimer levels in African Americans with sickle cell trait [Letter]. Blood. 2016;127:2261&#x2013;3. [PMID: ] doi:10.1182/blood-2016-01-694422</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2016-01-694422</ArticleId><ArticleId IdType="pmc">PMC4859200</ArticleId><ArticleId IdType="pubmed">26968536</ArticleId></ArticleIdList></Reference><Reference><Citation>Folsom AR, Alonso A, George KM, Roetker NS, Tang W, Cushman M. Prospective study of plasma D-dimer and incident venous thromboembolism: the Atherosclerosis Risk in Communities (ARIC) study. Thromb Res. 2015;136:781&#x2013;5. [PMID: ] doi:10.1016/j.thromres.2015.08.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2015.08.013</ArticleId><ArticleId IdType="pmc">PMC4577468</ArticleId><ArticleId IdType="pubmed">26337932</ArticleId></ArticleIdList></Reference><Reference><Citation>Westerman MP, Green D, Gilman-Sachs A, Beaman K, Freels S, Boggio L, et al. Coagulation changes in individuals with sickle cell trait. Am J Hematol. 2002;69:89&#x2013;94. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">11835343</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin C, Adam S, Mooberry MJ, Kutlar A, Kutlar F, Esserman D, et al. Coagulation activation in sickle cell trait: an exploratory study. Br J Haematol. 2015;171:638&#x2013;46. [PMID: ] doi:10.1111/bjh.13641</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.13641</ArticleId><ArticleId IdType="pmc">PMC4782194</ArticleId><ArticleId IdType="pubmed">26511074</ArticleId></ArticleIdList></Reference><Reference><Citation>Statius van Eps LW, Pinedo-Veels C, de Vries GH, de Koning J. Nature of concentrating defect in sickle-cell nephropathy. Microradioangiographic studies. Lancet. 1970;1:450&#x2013;2. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">4189754</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39735018</PMID><DateRevised><Year>2025</Year><Month>01</Month><Day>04</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>11</Issue><PubDate><Year>2024</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Risk Factors and Outcomes of Acute Pulmonary Embolism in African Patients: A Systematic Review.</ArticleTitle><Pagination><StartPage>e74673</StartPage><MedlinePgn>e74673</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e74673</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.74673</ELocationID><Abstract><AbstractText>Pulmonary embolism is a common cause of morbidity and mortality. Numerous risk factors have been identified that predispose patients to this disease. This study aims to identify these risk factors and the possible outcomes (recovery or mortality) after receiving treatment from any hospital. Healthcare is expensive in Africa, hence hindering its easy accessibility.&#xa0; PubMed, Scopus, and African Journals Online were searched from the database inception to October 2024 to identify relevant studies. A total of 719 articles were identified, for which 172 duplicate articles were removed. After screening 592 articles by title and abstract, 508 were excluded. Eighty-four articles were screened by full text to determine their eligibility. Finally, 13 articles were used in the final qualitative analysis. We included original research published in English in peer-reviewed journals from January 2000 to September 2024 that reported the risk factors and outcomes of pulmonary embolism, and studies that used computed tomography pulmonary angiography as a diagnosis of acute pulmonary embolism in patients more than 18 years old, irrespective of gender and medical or surgical condition, managed in any African hospital, were included. In total, 7650 patients were included in 13 articles, from 10 countries (Nigeria, Togo, Angola, Kenya, Cameroon, South Africa, Sierra Leone, Egypt, DR Congo, and Ethiopia), and 861 patients had pulmonary embolism. The mean age of the reported patients ranged from 40.8 to 64.4 years across the studies. There were 309 male and 552 female patients diagnosed with pulmonary embolism. The study types included in this review are retrospective studies,&#xa0;cross-sectional studies, and case-control studies. Deep vein thrombosis (DVT), heart disease, immobilization, obesity, smoking, recent surgery, and malignancy were the most commonly identified risk factors across the included articles. Pulmonary embolism contributes significantly to morbidity and mortality among African patients, with key risk factors including DVT, immobilization, heart disease, obesity, smoking, recent surgery, malignancy, pregnancy, and contraceptive use. Limited diagnostic resources in low-resource settings pose a major challenge, but adopting affordable diagnostic alternatives and clinical algorithms could improve outcomes by enabling earlier diagnosis and timely treatment. The availability and implementation of a standardized PE treatment protocol will ensure quality care, decrease mortality, and increase recovery rates.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024, Okeke et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Okeke</LastName><ForeName>Collins C</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Port Harcourt Teaching Hospital, Port Harcourt, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amadi</LastName><ForeName>Emmanuel S</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Hallel Hospital and Maternity, Port Harcourt, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ebiliekwe</LastName><ForeName>Onyinye E</ForeName><Initials>OE</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Nnamdi Azikiwe University Teaching Hospital, Nnewi, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ekeocha</LastName><ForeName>Ifunanya R</ForeName><Initials>IR</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Nnamdi Azikiwe University Teaching Hospital, Nnewi, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nnanna Okoro</LastName><ForeName>Emeka</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Imo State University College of Medicine, Owerri, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nduji</LastName><ForeName>Oluchi J</ForeName><Initials>OJ</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, Abia State University, Uturu, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Undie</LastName><ForeName>Malipeh-Unim</ForeName><Initials>MU</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Surgery Interest Group of Africa, Lagos, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ngige</LastName><ForeName>Onyinye</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Nnamdi Azikiwe University Teaching Hospital, Nnewi, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eze-Odurukwe</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgery, Salford Royal NHS Foundation Trust, Manchester, GBR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ezema</LastName><ForeName>Chinecherem</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Nnamdi Azikiwe University Teaching Hospital, Nnewi, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Onyeogulu</LastName><ForeName>Afamefuna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Nnamdi Azikiwe University Teaching Hospital, Nnewi, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ojo</LastName><ForeName>Angela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Afe Babalola University, Ado Ekiti, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Obuseh</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Delta State University Teaching Hospital, Oghara, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okonta</LastName><ForeName>Kelechi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Cardiothoracic Surgery Unit, Department of Surgery, University of Port Harcourt Teaching Hospital, Port Harcourt, NGA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">deep vein thrombosis</Keyword><Keyword MajorTopicYN="N">outcome</Keyword><Keyword MajorTopicYN="N">pulmonary embolism</Keyword><Keyword MajorTopicYN="N">risk factors</Keyword><Keyword MajorTopicYN="N">venous thromboembolism</Keyword></KeywordList><CoiStatement>Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>12</Month><Day>30</Day><Hour>6</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>12</Month><Day>30</Day><Hour>6</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>12</Month><Day>30</Day><Hour>5</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39735018</ArticleId><ArticleId IdType="pmc">PMC11681974</ArticleId><ArticleId IdType="doi">10.7759/cureus.74673</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pulmonary embolism. Tarbox AK, Swaroop M. Int J Crit Illn Inj Sci. 2013;3:69&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3665123</ArticleId><ArticleId IdType="pubmed">23724389</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemiology, pathophysiology, and natural history of pulmonary embolism. Turetz M, Sideris AT, Friedman OA, Triphathi N, Horowitz JM. Semin Intervent Radiol. 2018;35:92&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5986574</ArticleId><ArticleId IdType="pubmed">29872243</ArticleId></ArticleIdList></Reference><Reference><Citation>Global incidence and case fatality rate of pulmonary embolism following major surgery: a protocol for a systematic review and meta-analysis of cohort studies. Temgoua MN, Tochie JN, Noubiap JJ, Agbor VN, Danwang C, Endomba FT, Nkemngu NJ. Syst Rev. 2017;6:240.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5716368</ArticleId><ArticleId IdType="pubmed">29202836</ArticleId></ArticleIdList></Reference><Reference><Citation>Global reporting of pulmonary embolism-related deaths in the World Health Organization mortality database: vital registration data from 123&#xa0;countries. Barco S, Valerio L, Gallo A, et al. Res Pract Thromb Haemost. 2021;5:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8268665</ArticleId><ArticleId IdType="pubmed">34263098</ArticleId></ArticleIdList></Reference><Reference><Citation>Association AL. Pulmonary embolism symptoms and diagnosis.  [
Oct;
2024 
]. 2024. https://www.lung.org/lung-health-diseases/lung-disease-lookup/pulmonary-embolism/symptoms-diagnosis https://www.lung.org/lung-health-diseases/lung-disease-lookup/pulmonary-embolism/symptoms-diagnosis</Citation></Reference><Reference><Citation>Pulmonary embolism. Essien EO, Rali P, Mathai SC. Med Clin North Am. 2019;103:549&#x2013;564.</Citation><ArticleIdList><ArticleId IdType="pubmed">30955521</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulmonary embolism (PE) clinical presentation. 2024. https://emedicine.medscape.com/article/300901-clinical https://emedicine.medscape.com/article/300901-clinical</Citation></Reference><Reference><Citation>The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Page MJ, McKenzie JE, Bossuyt PM, et al. BMJ. 2021;372:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8008539</ArticleId><ArticleId IdType="pubmed">33781348</ArticleId></ArticleIdList></Reference><Reference><Citation>Critical appraisal tools.  [
Oct;
2024 
]. 2024. https://jbi.global/critical-appraisal-tools https://jbi.global/critical-appraisal-tools</Citation></Reference><Reference><Citation>Acute pulmonary thromboembolism: a retrospective study in a Nigerian private tertiary hospital. Ogunkoya J, Oluwole A, Adefuye B, Adebola-Yusuf AO, Ehioghae O. https://www.ajol.info/index.php/ahr/article/view/226821 Ann Health Res. 2021;7:107&#x2013;117.</Citation></Reference><Reference><Citation>Pulmonary embolism at the University Hospital Campus of Lome (Togo): a retrospective study about 51 cases [Article in French] Pessinaba S, Atti YD, Baragou S, et al. Pan Afr Med J. 2017;27:129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5567959</ArticleId><ArticleId IdType="pubmed">28904659</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical profile, management and outcomes of patients with pulmonary embolism: a retrospective tertiary centre study in Angola. Manuel A, Aufico A, Africano R, et al.  https://pubmed.ncbi.nlm.nih.gov/28556850/ Cardiovasc J Afr. 2017;28:356&#x2013;361.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5885046</ArticleId><ArticleId IdType="pubmed">28556850</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulmonary thromboembolism in an East African tertiary referral hospital. Ogeng'o JA, Obimbo MM, Olabu BO, Gatonga PM, Ong'era D. J Thromb Thrombolysis. 2011;32:386&#x2013;391.</Citation><ArticleIdList><ArticleId IdType="pubmed">21674133</ArticleId></ArticleIdList></Reference><Reference><Citation>Acute pulmonary embolism in the era of multi-detector CT: a reality in sub-Saharan Africa. Tambe J, Moifo B, Fongang E, Guegang E, Juimo AG. BMC Med Imaging. 2012;12:31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3485620</ArticleId><ArticleId IdType="pubmed">23072500</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical presentation and diagnostic work up of suspected pulmonary embolism in a district hospital emergency centre serving a high HIV/TB burden population. Bulajic B, Welzel T, Vallabh K. Afr J Emerg Med. 2019;9:134&#x2013;139.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6742596</ArticleId><ArticleId IdType="pubmed">31528531</ArticleId></ArticleIdList></Reference><Reference><Citation>The clinical features and management of pulmonary embolism at Chris Hani Baragwanath Academic Hospital. Meel S, Peter A, Menezes C. https://pmc.ncbi.nlm.nih.gov/articles/PMC8424778/ Afr J Thorac Crit Care Med. 2018;24</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8424778</ArticleId><ArticleId IdType="pubmed">34541509</ArticleId></ArticleIdList></Reference><Reference><Citation>Acute pulmonary embolism in an intensive care unit setting in Sierra Leone. Russell JB, Baio S, Koroma TR, et al.  https://pubmed.ncbi.nlm.nih.gov/36260002/ West Afr J Med. 2022;39:997&#x2013;1006.</Citation><ArticleIdList><ArticleId IdType="pubmed">36260002</ArticleId></ArticleIdList></Reference><Reference><Citation>Patient characteristics and predictors of pulmonary embolism in patients infected with COVID - 19 in Upper Egypt. Hussein A, Khalaf AM, Alsharawy LA, Abdelrazek G, Shafiq Awad M. Vasc Health Risk Manag. 2023;19:201&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10084826</ArticleId><ArticleId IdType="pubmed">37050930</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulmonary embolism: epidemiological data and diagnosis in Kinshasa hospitals. Bakebe A, Kashongwe I, Mulenga C, et al. Int J Tuberc Lung Dis. 2017;21:875&#x2013;879.</Citation><ArticleIdList><ArticleId IdType="pubmed">28786795</ArticleId></ArticleIdList></Reference><Reference><Citation>The value of electrocardiography in predicting inpatient mortality in patients with acute pulmonary embolism: a cross sectional analysis. Raghubeer N, Lahri S, Hendrikse C. Afr J Emerg Med. 2024;14:65&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10899042</ArticleId><ArticleId IdType="pubmed">38425642</ArticleId></ArticleIdList></Reference><Reference><Citation>Hospital survival of patients with pulmonary embolism in a country with limited resources case of the city of Kinshasa. Marc TB, Michel TP, Florence M, et al. BMC Cardiovasc Disord. 2023;23:439.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10476371</ArticleId><ArticleId IdType="pubmed">37667172</ArticleId></ArticleIdList></Reference><Reference><Citation>Incidence and factors associated with pulmonary embolism among RT-PCR confirmed Covid-19 patients with upfront CT pulmonary angiography in Ethiopia: a nested casecontrol study. Belayneh EK, Leulseged TW, Tarekegn TK, et al.  https://www.ajol.info/index.php/emj/article/view/249901 Ethiop Med J. 2023;61:1.</Citation></Reference><Reference><Citation>Prevalence and risk factors of pulmonary embolism in COPD patients complicated with secondary polycythemia. Li J, Xiong Y, Li S, et al. Int J Chron Obstruct Pulmon Dis. 2024;19:2371&#x2013;2385.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11542496</ArticleId><ArticleId IdType="pubmed">39512997</ArticleId></ArticleIdList></Reference><Reference><Citation>Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ 3rd. Arch Intern Med. 2000;160:809&#x2013;815.</Citation><ArticleIdList><ArticleId IdType="pubmed">10737280</ArticleId></ArticleIdList></Reference><Reference><Citation>A prospective study of risk factors for pulmonary embolism in women. Goldhaber SZ, Grodstein F, Stampfer MJ, et al.  https://pubmed.ncbi.nlm.nih.gov/9039882/ JAMA. 1997;277:642&#x2013;645.</Citation><ArticleIdList><ArticleId IdType="pubmed">9039882</ArticleId></ArticleIdList></Reference><Reference><Citation>Incidence and risk factors for pulmonary embolism in the postpartum period. Morris JM, Algert CS, Roberts CL. J Thromb Haemost. 2010;8:998&#x2013;1003.</Citation><ArticleIdList><ArticleId IdType="pubmed">20128859</ArticleId></ArticleIdList></Reference><Reference><Citation>Antenatal pulmonary embolism: risk factors, management and outcomes. Knight M. BJOG. 2008;115:453&#x2013;461.</Citation><ArticleIdList><ArticleId IdType="pubmed">18201281</ArticleId></ArticleIdList></Reference><Reference><Citation>Risk factors for pulmonary embolism. The Framingham study. Goldhaber SZ, Savage DD, Garrison RJ, et al. Am J Med. 1983;74:1023&#x2013;1028.</Citation><ArticleIdList><ArticleId IdType="pubmed">6859053</ArticleId></ArticleIdList></Reference><Reference><Citation>Risk factor and mortality in patients with pulmonary embolism combined with infectious disease. Lee GD, Ju S, Kim JY, et al. Tuberc Respir Dis (Seoul) 2020;83:157&#x2013;166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7105430</ArticleId><ArticleId IdType="pubmed">32185917</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical characteristics, risk factors, and outcomes of acute pulmonary embolism in Asian population. Bumroongkit C, Deesomchok A, Liwsrisakun C, et al. J Clin Med. 2022;11:6954.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9741370</ArticleId><ArticleId IdType="pubmed">36498530</ArticleId></ArticleIdList></Reference><Reference><Citation>Outpatient treatment of pulmonary embolism with dalteparin. Kovacs MJ, Anderson D, Morrow B, Gray L, Touchie D, Wells PS. https://pubmed.ncbi.nlm.nih.gov/10739374/ Thromb Haemost. 2000;83:209&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pubmed">10739374</ArticleId></ArticleIdList></Reference><Reference><Citation>Catheter-directed thrombolysis compared with systemic thrombolysis and anticoagulation in patients with intermediate- or high-risk pulmonary embolism: systematic review and network meta-analysis. Planer D, Yanko S, Matok I, et al. CMAJ. 2023;195:0&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10281204</ArticleId><ArticleId IdType="pubmed">37336568</ArticleId></ArticleIdList></Reference><Reference><Citation>Comparison of interventions for intermediate to high-risk pulmonary embolism: a network meta-analysis. Ishisaka Y, Watanabe A, Fujisaki T, et al. Catheter Cardiovasc Interv. 2023;102:249&#x2013;265.</Citation><ArticleIdList><ArticleId IdType="pubmed">37269229</ArticleId></ArticleIdList></Reference><Reference><Citation>Efficacy and safety of anticoagulation,&#xa0;catheter-directed thrombolysis, or systemic thrombolysis in acute&#xa0;pulmonary embolism. Zhang RS, Maqsood MH, Sharp AS, et al. JACC Cardiovasc Interv. 2023;16:2644&#x2013;2651.</Citation><ArticleIdList><ArticleId IdType="pubmed">37855802</ArticleId></ArticleIdList></Reference><Reference><Citation>Long-term mortality in patients with pulmonary embolism: results in a single-center registry. Eckelt J, Hobohm L, Merten MC, et al. Res Pract Thromb Haemost. 2023;7:100280.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10439384</ArticleId><ArticleId IdType="pubmed">37601025</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuberculosis and venous thromboembolism: a case series. Goncalves IM, Alves DC, Carvalho A, do Ceu Brito M, Calvario F, Duarte R. Cases J. 2009;2:9333.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2804722</ArticleId><ArticleId IdType="pubmed">20066058</ArticleId></ArticleIdList></Reference><Reference><Citation>Incidence of venous thromboembolism in tuberculosis patients. Ambrosetti M, Ferrarese M, Codecasa LR, Besozzi G, Sarassi A, Viggiani P, Migliori GB. Respiration. 2006;73:396.</Citation><ArticleIdList><ArticleId IdType="pubmed">16439829</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuberculose (TB)  [
Nov;
2024 
]. 2024. https://www.afro.who.int/health-topics/tuberculosis-tb https://www.afro.who.int/health-topics/tuberculosis-tb</Citation></Reference><Reference><Citation>HIV/AIDS.  [
Nov;
2024 
]. 2024. https://www.afro.who.int/health-topics/hivaids https://www.afro.who.int/health-topics/hivaids</Citation></Reference><Reference><Citation>Acute pulmonary embolism in patients with HIV disease. Howling SJ, Shaw PJ, Miller RF. Sex Transm Infect. 1999;75:25&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1758180</ArticleId><ArticleId IdType="pubmed">10448338</ArticleId></ArticleIdList></Reference><Reference><Citation>Venous thromboembolic disease in the HIV-infected patient. Malek J, Rogers R, Kufera J, Hirshon JM. Am J Emerg Med. 2011;29:278&#x2013;282.</Citation><ArticleIdList><ArticleId IdType="pubmed">20825798</ArticleId></ArticleIdList></Reference><Reference><Citation>AIDS and thrombosis: retrospective study of 131 HIV-infected patients. Saif MW, Bona R, Greenberg B. AIDS Patient Care STDS. 2001;15:311&#x2013;320.</Citation><ArticleIdList><ArticleId IdType="pubmed">11445013</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38613027</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2072-6643</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>7</Issue><PubDate><Year>2024</Year><Month>Mar</Month><Day>28</Day></PubDate></JournalIssue><Title>Nutrients</Title><ISOAbbreviation>Nutrients</ISOAbbreviation></Journal><ArticleTitle>Exploring Gene-Diet Interactions for Mother-Child Health: A Systematic Review of Epidemiological Studies.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">994</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/nu16070994</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Maternal-child health suggests the critical impact of maternal nutrition during the pre-conception and gestational periods, with some genetic variants also playing a significant role. Our systematic review provides an overview of epidemiological studies exploring the interactions between genetic variants, maternal dietary habits, and neonatal and/or maternal pregnancy outcomes.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">From its inception until June 2023, we conducted a comprehensive literature search on PubMed, Embase, and Web of Science databases.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">On a total of 29 epidemiological studies, 11 studies were conducted to explore the interplay between genetic variants and dietary factors, focusing on the risks associated with gestational diabetes mellitus, hypertensive disorders of pregnancy, recurrent spontaneous abortion, recurrent pregnancy loss, iron deficiency anemia, and gestational weight gain. Concerning neonatal outcomes, six studies investigated the interplay between genetic variants, dietary factors, and anthropometric measures, while eight studies delved into abnormal embryonic development, two studies focused on preterm birth, and two studies explored other neonatal outcomes.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Deeply understanding gene-diet interactions could be useful in developing highly personalized approaches to maternal and child nutrition, as well as in exploring the potential implications in disease prevention and the promotion of the long-term well-being of both mothers and their offspring.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Favara</LastName><ForeName>Giuliana</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences and Advanced Technologies "GF Ingrassia", University of Catania, 95123 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maugeri</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-2655-8574</Identifier><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences and Advanced Technologies "GF Ingrassia", University of Catania, 95123 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magnano San Lio</LastName><ForeName>Roberta</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-2023-2135</Identifier><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences and Advanced Technologies "GF Ingrassia", University of Catania, 95123 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barchitta</LastName><ForeName>Martina</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0905-5003</Identifier><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences and Advanced Technologies "GF Ingrassia", University of Catania, 95123 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agodi</LastName><ForeName>Antonella</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4405-8162</Identifier><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences and Advanced Technologies "GF Ingrassia", University of Catania, 95123 Catania, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MUR-PNRR project HEAL ITALIA (MUR code: PE_00000019).</GrantID><Agency>European Union (NextGeneration EU)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Nutrients</MedlineTA><NlmUniqueID>101521595</NlmUniqueID><ISSNLinking>2072-6643</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D039382" MajorTopicYN="Y">Maternal Nutritional Physiological Phenomena</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004032" MajorTopicYN="Y">Diet</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011256" MajorTopicYN="N">Pregnancy Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016021" MajorTopicYN="N">Epidemiologic Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000068097" MajorTopicYN="N">Maternal Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011248" MajorTopicYN="N">Pregnancy Complications</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005247" MajorTopicYN="N">Feeding Behavior</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014644" MajorTopicYN="N">Genetic Variation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000067576" MajorTopicYN="N">Child Health</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">diet</Keyword><Keyword MajorTopicYN="N">genetic variants</Keyword><Keyword MajorTopicYN="N">interaction</Keyword><Keyword MajorTopicYN="N">mother&#x2013;child health</Keyword><Keyword MajorTopicYN="N">nutrition</Keyword><Keyword MajorTopicYN="N">pregnancy</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>13</Day><Hour>10</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>13</Day><Hour>1</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38613027</ArticleId><ArticleId IdType="pmc">PMC11013682</ArticleId><ArticleId IdType="doi">10.3390/nu16070994</ArticleId><ArticleId IdType="pii">nu16070994</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Barchitta M., Magnano San Lio R., La Rosa M.C., La Mastra C., Favara G., Ferrante G., Galvani F., Pappalardo E., Ettore C., Ettore G., et al. The Effect of Maternal Dietary Patterns on Birth Weight for Gestational Age: Findings from the MAMI-MED Cohort. Nutrients. 2023;15:1922. doi: 10.3390/nu15081922.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu15081922</ArticleId><ArticleId IdType="pmc">PMC10147093</ArticleId><ArticleId IdType="pubmed">37111140</ArticleId></ArticleIdList></Reference><Reference><Citation>Montagnoli C., Santoro C.B., Buzzi T., Bortolus R. Maternal periconceptional nutrition matters. A scoping review of the current literature. J. Matern. Fetal Neonatal Med. 2022;35:8123&#x2013;8140. doi: 10.1080/14767058.2021.1962843.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14767058.2021.1962843</ArticleId><ArticleId IdType="pubmed">34392783</ArticleId></ArticleIdList></Reference><Reference><Citation>Paknahad Z., Fallah A., Moravejolahkami A.R. Maternal Dietary Patterns and Their Association with Pregnancy Outcomes. Clin. Nutr. Res. 2019;8:64&#x2013;73. doi: 10.7762/cnr.2019.8.1.64.</Citation><ArticleIdList><ArticleId IdType="doi">10.7762/cnr.2019.8.1.64</ArticleId><ArticleId IdType="pmc">PMC6355947</ArticleId><ArticleId IdType="pubmed">30746349</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramakrishnan U., Grant F., Goldenberg T., Zongrone A., Martorell R. Effect of women&#x2019;s nutrition before and during early pregnancy on maternal and infant outcomes: A systematic review. Paediatr. Perinat. Epidemiol. 2012;26((Suppl. S1)):285&#x2013;301. doi: 10.1111/j.1365-3016.2012.01281.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-3016.2012.01281.x</ArticleId><ArticleId IdType="pubmed">22742616</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall N.E., Abrams B., Barbour L.A., Catalano P., Christian P., Friedman J.E., Hay W.W., Hernandez T.L., Krebs N.F., Oken E., et al. The importance of nutrition in pregnancy and lactation: Lifelong consequences. Am. J. Obstet. Gynecol. 2022;226:607&#x2013;632. doi: 10.1016/j.ajog.2021.12.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2021.12.035</ArticleId><ArticleId IdType="pmc">PMC9182711</ArticleId><ArticleId IdType="pubmed">34968458</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizuno S., Nagaie S., Tamiya G., Kuriyama S., Obara T., Ishikuro M., Tanaka H., Kinoshita K., Sugawara J., Yamamoto M., et al. Establishment of the early prediction models of low-birth-weight reveals influential genetic and environmental factors: A prospective cohort study. BMC Pregnancy Childbirth. 2023;23:628. doi: 10.1186/s12884-023-05919-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12884-023-05919-5</ArticleId><ArticleId IdType="pmc">PMC10472725</ArticleId><ArticleId IdType="pubmed">37653383</ArticleId></ArticleIdList></Reference><Reference><Citation>Grieger J.A., Grzeskowiak L.E., Clifton V.L. Preconception dietary patterns in human pregnancies are associated with preterm delivery. J. Nutr. 2014;144:1075&#x2013;1080. doi: 10.3945/jn.114.190686.</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/jn.114.190686</ArticleId><ArticleId IdType="pubmed">24790026</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowensohn R.I., Stadler D.D., Naze C. Current Concepts of Maternal Nutrition. Obstet. Gynecol. Surv. 2016;71:413&#x2013;426. doi: 10.1097/OGX.0000000000000329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/OGX.0000000000000329</ArticleId><ArticleId IdType="pmc">PMC4949006</ArticleId><ArticleId IdType="pubmed">27436176</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji J.L., Muyayalo K.P., Zhang Y.H., Hu X.H., Liao A.H. Immunological function of vitamin D during human pregnancy. Am. J. Reprod. Immunol. 2017;78:e12716. doi: 10.1111/aji.12716.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aji.12716</ArticleId><ArticleId IdType="pubmed">28585734</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiely M., Hemmingway A., O&#x2019;Callaghan K.M. Vitamin D in pregnancy: Current perspectives and future directions. Ther. Adv. Musculoskelet. Dis. 2017;9:145&#x2013;154. doi: 10.1177/1759720X17706453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1759720X17706453</ArticleId><ArticleId IdType="pmc">PMC5466149</ArticleId><ArticleId IdType="pubmed">28620423</ArticleId></ArticleIdList></Reference><Reference><Citation>Talaulikar V.S., Arulkumaran S. Folic acid in obstetric practice: A review. Obstet. Gynecol. Surv. 2011;66:240&#x2013;247. doi: 10.1097/OGX.0b013e318223614c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/OGX.0b013e318223614c</ArticleId><ArticleId IdType="pubmed">21756406</ArticleId></ArticleIdList></Reference><Reference><Citation>Lassi Z.S., Salam R.A., Haider B.A., Bhutta Z.A. Folic acid supplementation during pregnancy for maternal health and pregnancy outcomes. Cochrane Database Syst. Rev. 2013;2013:CD006896. doi: 10.1002/14651858.CD006896.pub2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD006896.pub2</ArticleId><ArticleId IdType="pmc">PMC10069458</ArticleId><ArticleId IdType="pubmed">23543547</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi S., Sata F., Kishi R. Gene-environment interactions related to maternal exposure to environmental and lifestyle-related chemicals during pregnancy and the resulting adverse fetal growth: A review. Environ. Health Prev. Med. 2022;27:24. doi: 10.1265/ehpm.21-00033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1265/ehpm.21-00033</ArticleId><ArticleId IdType="pmc">PMC9251623</ArticleId><ArticleId IdType="pubmed">35675978</ArticleId></ArticleIdList></Reference><Reference><Citation>Englund-&#xd6;gge L., Brants&#xe6;ter A.L., Juodakis J., Haugen M., Meltzer H.M., Jacobsson B., Sengpiel V. Associations between maternal dietary patterns and infant birth weight, small and large for gestational age in the Norwegian Mother and Child Cohort Study. Eur. J. Clin. Nutr. 2019;73:1270&#x2013;1282. doi: 10.1038/s41430-018-0356-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41430-018-0356-y</ArticleId><ArticleId IdType="pmc">PMC6760641</ArticleId><ArticleId IdType="pubmed">30459338</ArticleId></ArticleIdList></Reference><Reference><Citation>Zinck J.W., de Groh M., MacFarlane A.J. Genetic modifiers of folate, vitamin B-12, and homocysteine status in a cross-sectional study of the Canadian population. Am. J. Clin. Nutr. 2015;101:1295&#x2013;1304. doi: 10.3945/ajcn.115.107219.</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/ajcn.115.107219</ArticleId><ArticleId IdType="pubmed">25948668</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobbs C.A., Cleves M.A., Karim M.A., Zhao W., MacLeod S.L. Maternal folate-related gene environment interactions and congenital heart defects. Obstet. Gynecol. 2010;116:316&#x2013;322. doi: 10.1097/AOG.0b013e3181e80979.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AOG.0b013e3181e80979</ArticleId><ArticleId IdType="pmc">PMC3027124</ArticleId><ArticleId IdType="pubmed">20664391</ArticleId></ArticleIdList></Reference><Reference><Citation>Panigrahi D.D., Patel S., Rajbhar S., Padhi P., Shah S., Nanda R., Mohapatra E. Association of Methylenetetrahydrofolate Reductase Gene Polymorphism in Mothers With Adverse Clinical Outcomes in Neonates. Cureus. 2023;15:e38001. doi: 10.7759/cureus.38001.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.38001</ArticleId><ArticleId IdType="pmc">PMC10203823</ArticleId><ArticleId IdType="pubmed">37223177</ArticleId></ArticleIdList></Reference><Reference><Citation>Javorski N., Lima C.A.D., Silva L.V.C., Crovella S., de Az&#xea;vedo Silva J. Vitamin D receptor (VDR) polymorphisms are associated to spontaneous preterm birth and maternal aspects. Gene. 2018;642:58&#x2013;63. doi: 10.1016/j.gene.2017.10.087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2017.10.087</ArticleId><ArticleId IdType="pubmed">29128634</ArticleId></ArticleIdList></Reference><Reference><Citation>Workalemahu T., Badon S.E., Dishi-Galitzky M., Qiu C., Williams M.A., Sorensen T., Enquobahrie D.A. Placental genetic variations in vitamin D metabolism and birthweight. Placenta. 2017;50:78&#x2013;83. doi: 10.1016/j.placenta.2016.12.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.placenta.2016.12.028</ArticleId><ArticleId IdType="pmc">PMC5319727</ArticleId><ArticleId IdType="pubmed">28161065</ArticleId></ArticleIdList></Reference><Reference><Citation>Arshad R., Sameen A., Murtaza M.A., Sharif H.R., Iahtisham-Ul-Haq, Dawood S., Ahmed Z., Nemat A., Manzoor M.F. Impact of vitamin D on maternal and fetal health: A review. Food Sci. Nutr. 2022;10:3230&#x2013;3240. doi: 10.1002/fsn3.2948.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/fsn3.2948</ArticleId><ArticleId IdType="pmc">PMC9548347</ArticleId><ArticleId IdType="pubmed">36249984</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulloch R.E., Wall C.R., McCowan L.M.E., Taylor R.S., Roberts C.T., Thompson J.M.D. The Effect of Interactions between Folic Acid Supplementation and One Carbon Metabolism Gene Variants on Small-for-Gestational-Age Births in the Screening for Pregnancy Endpoints (SCOPE) Cohort Study. Nutrients. 2020;12:1677. doi: 10.3390/nu12061677.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12061677</ArticleId><ArticleId IdType="pmc">PMC7352423</ArticleId><ArticleId IdType="pubmed">32512764</ArticleId></ArticleIdList></Reference><Reference><Citation>Engel S.M., Olshan A.F., Siega-Riz A.M., Savitz D.A., Chanock S.J. Polymorphisms in folate metabolizing genes and risk for spontaneous preterm and small-for-gestational age birth. Am. J. Obstet. Gynecol. 2006;195:1231.e1&#x2013;1231.e11. doi: 10.1016/j.ajog.2006.07.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2006.07.024</ArticleId><ArticleId IdType="pubmed">17074544</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., Duan Y., Jiang S., Bi Y., Pang X., Liu C., Yang Z., Lai J. Relationships between Maternal Gene Polymorphisms in One Carbon Metabolism and Adverse Pregnancy Outcomes: A Prospective Mother and Child Cohort Study in China. Nutrients. 2022;14:2108. doi: 10.3390/nu14102108.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14102108</ArticleId><ArticleId IdType="pmc">PMC9146434</ArticleId><ArticleId IdType="pubmed">35631247</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D., Shamseer L., Clarke M., Ghersi D., Liberati A., Petticrew M., Shekelle P., Stewart L.A., Group P.-P. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst. Rev. 2015;4:1. doi: 10.1186/2046-4053-4-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2046-4053-4-1</ArticleId><ArticleId IdType="pmc">PMC4320440</ArticleId><ArticleId IdType="pubmed">25554246</ArticleId></ArticleIdList></Reference><Reference><Citation>Popova P.V., Klyushina A.A., Vasilyeva L.B., Tkachuk A.S., Bolotko Y.A., Gerasimov A.S., Pustozerov E.A., Kravchuk E.N., Predeus A., Kostareva A.A., et al. Effect of gene-lifestyle interaction on gestational diabetes risk. Oncotarget. 2017;8:112024&#x2013;112035. doi: 10.18632/oncotarget.22999.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.22999</ArticleId><ArticleId IdType="pmc">PMC5762376</ArticleId><ArticleId IdType="pubmed">29340108</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Li J., Liu J., Leng J., Li W., Yu Z., Tam C.H.T., Hu G., Ma R.C.W., Fang Z., et al. Interactions of CDKAL1 rs7747752 polymorphism and serum levels of L-carnitine and choline are related to increased risk of gestational diabetes mellitus. Genes Nutr. 2022;17:14. doi: 10.1186/s12263-022-00716-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12263-022-00716-9</ArticleId><ArticleId IdType="pmc">PMC9526259</ArticleId><ArticleId IdType="pubmed">36183068</ArticleId></ArticleIdList></Reference><Reference><Citation>Ao D., Zhao Q., Song J.Y., Liu Z., Wang Y., Wang H.J., Yang H.X. The association of the glucokinase rs4607517 polymorphism with gestational diabetes mellitus and its interaction with sweets consumption in Chinese women. Public Health Nutr. 2021;24:2563&#x2013;2569. doi: 10.1017/S1368980020000609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1368980020000609</ArticleId><ArticleId IdType="pmc">PMC10195427</ArticleId><ArticleId IdType="pubmed">32482198</ArticleId></ArticleIdList></Reference><Reference><Citation>Barabash A., Valerio J.D., Garcia de la Torre N., Jimenez I., Del Valle L., Melero V., Assaf-Balut C., Fuentes M., Bordiu E., Dur&#xe1;n A., et al. TCF7L2 rs7903146 polymorphism modulates the association between adherence to a Mediterranean diet and the risk of gestational diabetes mellitus. Metab. Open. 2020;8:100069. doi: 10.1016/j.metop.2020.100069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metop.2020.100069</ArticleId><ArticleId IdType="pmc">PMC7718167</ArticleId><ArticleId IdType="pubmed">33305252</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo M., Shao B., Xin X., Luo W., Si S., Jiang W., Wang S., Shen Y., Wu J., Yu Y. The Association of Gene Variants in the Vitamin D Metabolic Pathway and Its Interaction with Vitamin D on Gestational Diabetes Mellitus: A Prospective Cohort Study. Nutrients. 2021;13:4220. doi: 10.3390/nu13124220.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13124220</ArticleId><ArticleId IdType="pmc">PMC8706628</ArticleId><ArticleId IdType="pubmed">34959770</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu B., Huang K., Yan S., Hao J., Zhu P., Chen Y., Ye A., Tao F. VDR Variants rather than Early Pregnancy Vitamin D Concentrations Are Associated with the Risk of Gestational Diabetes: The Ma&#x2019;anshan Birth Cohort (MABC) Study. J. Diabetes Res. 2019;2019:8313901. doi: 10.1155/2019/8313901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/8313901</ArticleId><ArticleId IdType="pmc">PMC6613005</ArticleId><ArticleId IdType="pubmed">31341914</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu T.Y., Mayasari N.R., Cheng T.M., Bai C.H., Chao J.C., Huang Y.L., Wang F.F., Skalny A.V., Tinkov A.A., Chang J.S. Polymorphisms of haptoglobin modify the relationship between dietary iron and the risk of gestational iron-deficiency anemia. Eur. J. Nutr. 2023;62:299&#x2013;309. doi: 10.1007/s00394-022-02987-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00394-022-02987-9</ArticleId><ArticleId IdType="pubmed">35974112</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng Y., Groth S.W., Li D. The Association between Obesity-Risk Genes and Gestational Weight Gain Is Modified by Dietary Intake in African American Women. J. Nutr. Metab. 2018;2018:5080492. doi: 10.1155/2018/5080492.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/5080492</ArticleId><ArticleId IdType="pmc">PMC5852892</ArticleId><ArticleId IdType="pubmed">29686896</ArticleId></ArticleIdList></Reference><Reference><Citation>Si S., Mo M., Cheng H., Peng Z., Alifu X., Zhou H., Chi P., Zhuang Y., Yu Y. The Association of Vitamin D and Its Pathway Genes&#x2019; Polymorphisms with Hypertensive Disorders of Pregnancy: A Prospective Cohort Study. Nutrients. 2022;14:2355. doi: 10.3390/nu14112355.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14112355</ArticleId><ArticleId IdType="pmc">PMC9183033</ArticleId><ArticleId IdType="pubmed">35684156</ArticleId></ArticleIdList></Reference><Reference><Citation>Ota K., Takahashi T., Han A., Damvaeba S., Mizunuma H., Kwak-Kim J. Effects of MTHFR C677T polymorphism on vitamin D, homocysteine and natural killer cell cytotoxicity in women with recurrent pregnancy losses. Hum. Reprod. 2020;35:1276&#x2013;1287. doi: 10.1093/humrep/deaa095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/humrep/deaa095</ArticleId><ArticleId IdType="pubmed">32478379</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G., Sun J. Interactive Effects of Snps Located within CD28/B7Pathway and Environment on Susceptibility to Recurrent Spontaneous Abortion. Cell. Physiol. Biochem. 2017;43:2185&#x2013;2199. doi: 10.1159/000484297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000484297</ArticleId><ArticleId IdType="pubmed">29069644</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S.S., Ling K.H., Tusimin M., Subramaniam R., Rahim K.F., Loh S.P. Interplay between Maternal and Neonatal Vitamin D Deficiency and Vitamin-D-Related Gene Polymorphism with Neonatal Birth Anthropometry. Nutrients. 2022;14:564. doi: 10.3390/nu14030564.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14030564</ArticleId><ArticleId IdType="pmc">PMC8839863</ArticleId><ArticleId IdType="pubmed">35276923</ArticleId></ArticleIdList></Reference><Reference><Citation>Chun S.K., Shin S., Kim M.Y., Joung H., Chung J. Effects of maternal genetic polymorphisms in vitamin D-binding protein and serum 25-hydroxyvitamin D concentration on infant birth weight. Nutrition. 2017;35:36&#x2013;42. doi: 10.1016/j.nut.2016.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2016.10.006</ArticleId><ArticleId IdType="pubmed">28241988</ArticleId></ArticleIdList></Reference><Reference><Citation>Aji A.S., Lipoeto N.I., Yusrawati Y., Malik S.G., Kusmayanti N.A., Susanto I., Nurunniyah S., Alfiana R.D., Wahyuningsih W., Majidah N.M., et al. Impact of maternal dietary carbohydrate intake and vitamin D-related genetic risk score on birth length: The Vitamin D Pregnant Mother (VDPM) cohort study. BMC Pregnancy Childbirth. 2022;22:690. doi: 10.1186/s12884-022-05020-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12884-022-05020-3</ArticleId><ArticleId IdType="pmc">PMC9450237</ArticleId><ArticleId IdType="pubmed">36071390</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres-S&#xe1;nchez L., L&#xf3;pez-Carrillo L., Blanco-Mu&#xf1;oz J., Chen J. Maternal dietary intake of folate, vitamin B12 and MTHFR 677C&gt;T genotype: Their impact on newborn&#x2019;s anthropometric parameters. Genes Nutr. 2014;9:429. doi: 10.1007/s12263-014-0429-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12263-014-0429-z</ArticleId><ArticleId IdType="pmc">PMC4172646</ArticleId><ArticleId IdType="pubmed">25173112</ArticleId></ArticleIdList></Reference><Reference><Citation>Aji A.S., Erwinda E., Rasyid R., Yusrawati Y., Malik S.G., Alathari B., Lovegrove J.A., Lipoeto N.I., Vimaleswaran K.S. A genetic approach to study the relationship between maternal Vitamin D status and newborn anthropometry measurements: The Vitamin D pregnant mother (VDPM) cohort study. J. Diabetes Metab. Disord. 2020;19:91&#x2013;103. doi: 10.1007/s40200-019-00480-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40200-019-00480-5</ArticleId><ArticleId IdType="pmc">PMC7270445</ArticleId><ArticleId IdType="pubmed">32548071</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., Xin X., Luo W., Mo M., Si S., Shao B., Shen Y., Cheng H., Yu Y. Association of vitamin D and gene variants in the vitamin D metabolic pathway with preterm birth. Nutrition. 2021;89:111349. doi: 10.1016/j.nut.2021.111349.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2021.111349</ArticleId><ArticleId IdType="pubmed">34217944</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao Y., Yan L., Pang Y., Yan H., Zhang L., Liu J., Li N., Wang B., Zhang Y., Li Z., et al. Maternal serum level of manganese, single nucleotide polymorphisms, and risk of spontaneous preterm birth: A nested case-control study in China. Environ. Pollut. 2020;262:114187. doi: 10.1016/j.envpol.2020.114187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envpol.2020.114187</ArticleId><ArticleId IdType="pubmed">32443183</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu W.C., Lin H.C., Liao W.L., Tsai Y.Y., Chen A.C., Chen H.C., Lin H.Y., Liao L.N., Chao P.M. FADS Genetic Variants in Taiwanese Modify Association of DHA Intake and Its Proportions in Human Milk. Nutrients. 2020;12:543. doi: 10.3390/nu12020543.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12020543</ArticleId><ArticleId IdType="pmc">PMC7071481</ArticleId><ArticleId IdType="pubmed">32093185</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Z., Huang C., Ding K., Lin J., Gong B. Transforming growth factor beta-3 and environmental factors and cleft lip with/without cleft palate. DNA Cell Biol. 2010;29:375&#x2013;380. doi: 10.1089/dna.2009.1009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/dna.2009.1009</ArticleId><ArticleId IdType="pubmed">20408761</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Diao J., Li J., Luo L., Zhao L., Zhang S., Wang T., Chen L., Yang T., Zhu P., et al. Association of maternal dietary intakes and CBS gene polymorphisms with congenital heart disease in offspring. Int. J. Cardiol. 2021;322:121&#x2013;128. doi: 10.1016/j.ijcard.2020.08.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2020.08.018</ArticleId><ArticleId IdType="pubmed">32800907</ArticleId></ArticleIdList></Reference><Reference><Citation>van Beynum I.M., Kouwenberg M., Kapusta L., den Heijer M., van der Linden I.J., Daniels O., Blom H.J. MTRR 66A&gt;G polymorphism in relation to congenital heart defects. Clin. Chem. Lab. Med. 2006;44:1317&#x2013;1323. doi: 10.1515/CCLM.2006.254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/CCLM.2006.254</ArticleId><ArticleId IdType="pubmed">17087642</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw G.M., Rozen R., Finnell R.H., Wasserman C.R., Lammer E.J. Maternal vitamin use, genetic variation of infant methylenetetrahydrofolate reductase, and risk for spina bifida. Am. J. Epidemiol. 1998;148:30&#x2013;37. doi: 10.1093/oxfordjournals.aje.a009555.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a009555</ArticleId><ArticleId IdType="pubmed">9663401</ArticleId></ArticleIdList></Reference><Reference><Citation>Miettinen M.E., Smart M.C., Kinnunen L., Harjutsalo V., Reinert-Hartwall L., Ylivinkka I., Surcel H.M., Lamberg-Allardt C., Hitman G.A., Tuomilehto J. Genetic determinants of serum 25-hydroxyvitamin D concentration during pregnancy and type 1 diabetes in the child. PLoS ONE. 2017;12:e0184942. doi: 10.1371/journal.pone.0184942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0184942</ArticleId><ArticleId IdType="pmc">PMC5627909</ArticleId><ArticleId IdType="pubmed">28976992</ArticleId></ArticleIdList></Reference><Reference><Citation>Song X., Liu Y., Wang T., Zhang S., Sun M., Shu J., Wei J., Diao J., Li J., Li Y., et al. Association of Maternal Dietary Habits and. Front. Pediatr. 2021;9:785440. doi: 10.3389/fped.2021.785440.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2021.785440</ArticleId><ArticleId IdType="pmc">PMC8847777</ArticleId><ArticleId IdType="pubmed">35186819</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo M., Wang T., Huang P., Zhang S., Song X., Sun M., Liu Y., Wei J., Shu J., Zhong T., et al. Association and Interaction Effect of. Nutrients. 2022;14:3094. doi: 10.3390/nu14153094.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14153094</ArticleId><ArticleId IdType="pmc">PMC9370527</ArticleId><ArticleId IdType="pubmed">35956270</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazul A.L., Siega-Riz A.M., Weinberg C.R., Engel S.M., Zou F., Carrier K.S., Basta P.V., Vaksman Z., Maris J.M., Diskin S.J., et al. A family-based study of gene variants and maternal folate and choline in neuroblastoma: A report from the Children&#x2019;s Oncology Group. Cancer Causes Control. 2016;27:1209&#x2013;1218. doi: 10.1007/s10552-016-0799-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10552-016-0799-1</ArticleId><ArticleId IdType="pmc">PMC5025391</ArticleId><ArticleId IdType="pubmed">27541142</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong S.A., Lee E., Kwon S.O., Kim K.W., Shin Y.H., Ahn K.M., Kim E.J., Lee J.G., Oh S.Y., Hong S.J. Effect of prenatal antioxidant intake on infants&#x2019; respiratory infection is modified by a CD14 polymorphism. World J. Pediatr. 2017;13:173&#x2013;182. doi: 10.1007/s12519-016-0054-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-016-0054-6</ArticleId><ArticleId IdType="pubmed">27830580</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryson C.L., Ioannou G.N., Rulyak S.J., Critchlow C. Association between gestational diabetes and pregnancy-induced hypertension. Am. J. Epidemiol. 2003;158:1148&#x2013;1153. doi: 10.1093/aje/kwg273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwg273</ArticleId><ArticleId IdType="pubmed">14652299</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedderson M.M., Ferrara A., Sacks D.A. Gestational diabetes mellitus and lesser degrees of pregnancy hyperglycemia: Association with increased risk of spontaneous preterm birth. Obstet. Gynecol. 2003;102:850&#x2013;856. doi: 10.1097/00006250-200310000-00030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00006250-200310000-00030</ArticleId><ArticleId IdType="pubmed">14551018</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y., Arah O.A., Liew Z., Cnattingius S., Olsen J., S&#xf8;rensen H.T., Qin G., Li J. Maternal diabetes during pregnancy and early onset of cardiovascular disease in offspring: Population based cohort study with 40 years of follow-up. BMJ. 2019;367:l6398. doi: 10.1136/bmj.l6398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l6398</ArticleId><ArticleId IdType="pmc">PMC6891797</ArticleId><ArticleId IdType="pubmed">31801789</ArticleId></ArticleIdList></Reference><Reference><Citation>Casagrande S.S., Linder B., Cowie C.C. Prevalence of gestational diabetes and subsequent Type 2 diabetes among U.S. women. Diabetes Res. Clin. Pract. 2018;141:200&#x2013;208. doi: 10.1016/j.diabres.2018.05.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2018.05.010</ArticleId><ArticleId IdType="pubmed">29772286</ArticleId></ArticleIdList></Reference><Reference><Citation>Baptiste-Roberts K., Barone B.B., Gary T.L., Golden S.H., Wilson L.M., Bass E.B., Nicholson W.K. Risk factors for type 2 diabetes among women with gestational diabetes: A systematic review. Am. J. Med. 2009;122:207&#x2013;214.e204. doi: 10.1016/j.amjmed.2008.09.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2008.09.034</ArticleId><ArticleId IdType="pmc">PMC6393925</ArticleId><ArticleId IdType="pubmed">19272478</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo F., Long W., Zhou W., Zhang B., Liu J., Yu B. FTO, GCKR, CDKAL1 and CDKN2A/B gene polymorphisms and the risk of gestational diabetes mellitus: A meta-analysis. Arch. Gynecol. Obstet. 2018;298:705&#x2013;715. doi: 10.1007/s00404-018-4857-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00404-018-4857-7</ArticleId><ArticleId IdType="pubmed">30074065</ArticleId></ArticleIdList></Reference><Reference><Citation>Say L., Chou D., Gemmill A., Tun&#xe7;alp &#xd6;., Moller A.B., Daniels J., G&#xfc;lmezoglu A.M., Temmerman M., Alkema L. Global causes of maternal death: A WHO systematic analysis. Lancet Glob. Health. 2014;2:e323&#x2013;e333. doi: 10.1016/S2214-109X(14)70227-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(14)70227-X</ArticleId><ArticleId IdType="pubmed">25103301</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan K.S., Wojdyla D., Say L., G&#xfc;lmezoglu A.M., Van Look P.F. WHO analysis of causes of maternal death: A systematic review. Lancet. 2006;367:1066&#x2013;1074. doi: 10.1016/S0140-6736(06)68397-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(06)68397-9</ArticleId><ArticleId IdType="pubmed">16581405</ArticleId></ArticleIdList></Reference><Reference><Citation>Theilen L.H., Meeks H., Fraser A., Esplin M.S., Smith K.R., Varner M.W. Long-term mortality risk and life expectancy following recurrent hypertensive disease of pregnancy. Am. J. Obstet. Gynecol. 2018;219:107.e101&#x2013;107.e106. doi: 10.1016/j.ajog.2018.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2018.04.002</ArticleId><ArticleId IdType="pmc">PMC6019643</ArticleId><ArticleId IdType="pubmed">29630888</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y. Micronutrients in Maternal and Infant Health: Where We Are and Where We Should Go. Nutrients. 2023;15:2192. doi: 10.3390/nu15092192.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu15092192</ArticleId><ArticleId IdType="pmc">PMC10180937</ArticleId><ArticleId IdType="pubmed">37432328</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y., Zhang Y., Tang X., Liu X., Xu H. Association between. PeerJ. 2023;11:e15181. doi: 10.7717/peerj.15181.</Citation><ArticleIdList><ArticleId IdType="doi">10.7717/peerj.15181</ArticleId><ArticleId IdType="pmc">PMC10143592</ArticleId><ArticleId IdType="pubmed">37123013</ArticleId></ArticleIdList></Reference><Reference><Citation>Shankarkumar U., Pradhan V.D., Patwardhan M.M., Shankarkumar A., Ghosh K. Autoantibody profile and other immunological parameters in recurrent spontaneous abortion patients. Niger. Med. J. 2011;52:163&#x2013;166. doi: 10.4103/0300-1652.86126.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0300-1652.86126</ArticleId><ArticleId IdType="pmc">PMC3213746</ArticleId><ArticleId IdType="pubmed">22082909</ArticleId></ArticleIdList></Reference><Reference><Citation>Teichman J., Nisenbaum R., Lausman A., Sholzberg M. Suboptimal iron deficiency screening in pregnancy and the impact of socioeconomic status in a high-resource setting. Blood Adv. 2021;5:4666&#x2013;4673. doi: 10.1182/bloodadvances.2021004352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2021004352</ArticleId><ArticleId IdType="pmc">PMC8759118</ArticleId><ArticleId IdType="pubmed">34459878</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang K.Y., Huang S.Y., Cheng T.M., Bai C.H., Chang J.S. Haptoglobin phenotype influences the effectiveness of diet-induced weight loss in middle-age abdominally obese women with metabolic abnormalities. Clin. Nutr. 2020;39:225&#x2013;233. doi: 10.1016/j.clnu.2019.01.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2019.01.019</ArticleId><ArticleId IdType="pubmed">30737047</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen C.B.F., St&#xf8;dkilde K., S&#xe6;derup K.L., Kuhlee A., Raunser S., Graversen J.H., Moestrup S.K. Haptoglobin. Antioxid. Redox Signal. 2017;26:814&#x2013;831. doi: 10.1089/ars.2016.6793.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2016.6793</ArticleId><ArticleId IdType="pubmed">27650279</ArticleId></ArticleIdList></Reference><Reference><Citation>Martins M.C., Trujillo J., Farias D.R., Struchiner C.J., Kac G. Association of the FTO (rs9939609) and MC4R (rs17782313) gene polymorphisms with maternal body weight during pregnancy. Nutrition. 2016;32:1223&#x2013;1230. doi: 10.1016/j.nut.2016.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2016.04.009</ArticleId><ArticleId IdType="pubmed">27377581</ArticleId></ArticleIdList></Reference><Reference><Citation>Finken M.J.J., van der Steen M., Smeets C.C.J., Walenkamp M.J.E., de Bruin C., Hokken-Koelega A.C.S., Wit J.M. Children Born Small for Gestational Age: Differential Diagnosis, Molecular Genetic Evaluation, and Implications. Endocr. Rev. 2018;39:851&#x2013;894. doi: 10.1210/er.2018-00083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/er.2018-00083</ArticleId><ArticleId IdType="pubmed">29982551</ArticleId></ArticleIdList></Reference><Reference><Citation>McCowan L.M., Thompson J.M., Taylor R.S., Baker P.N., North R.A., Poston L., Roberts C.T., Simpson N.A., Walker J.J., Myers J., et al. Prediction of Small for Gestational Age Infants in Healthy Nulliparous Women Using Clinical and Ultrasound Risk Factors Combined with Early Pregnancy Biomarkers. PLoS ONE. 2017;12:e0169311. doi: 10.1371/journal.pone.0169311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0169311</ArticleId><ArticleId IdType="pmc">PMC5221822</ArticleId><ArticleId IdType="pubmed">28068394</ArticleId></ArticleIdList></Reference><Reference><Citation>Lage K., Greenway S.C., Rosenfeld J.A., Wakimoto H., Gorham J.M., Segr&#xe8; A.V., Roberts A.E., Smoot L.B., Pu W.T., Pereira A.C., et al. Genetic and environmental risk factors in congenital heart disease functionally converge in protein networks driving heart development. Proc. Natl. Acad. Sci. USA. 2012;109:14035&#x2013;14040. doi: 10.1073/pnas.1210730109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1210730109</ArticleId><ArticleId IdType="pmc">PMC3435181</ArticleId><ArticleId IdType="pubmed">22904188</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalisch-Smith J.I., Ved N., Sparrow D.B. Environmental Risk Factors for Congenital Heart Disease. Cold Spring Harb. Perspect. Biol. 2020;12:a037234. doi: 10.1101/cshperspect.a037234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a037234</ArticleId><ArticleId IdType="pmc">PMC7050589</ArticleId><ArticleId IdType="pubmed">31548181</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Li N., Chivese T., Werfalli M., Sun H., Yuen L., Hoegfeldt C.A., Elise Powe C., Immanuel J., Karuranga S., et al. IDF Diabetes Atlas: Estimation of Global and Regional Gestational Diabetes Mellitus Prevalence for 2021 by International Association of Diabetes in Pregnancy Study Group&#x2019;s Criteria. Diabetes Res. Clin. Pract. 2022;183:109050. doi: 10.1016/j.diabres.2021.109050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2021.109050</ArticleId><ArticleId IdType="pubmed">34883186</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Zhu J., DeLuca H.F. Where is the vitamin D receptor? Arch. Biochem. Biophys. 2012;523:123&#x2013;133. doi: 10.1016/j.abb.2012.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.abb.2012.04.001</ArticleId><ArticleId IdType="pubmed">22503810</ArticleId></ArticleIdList></Reference><Reference><Citation>Voltan G., Cannito M., Ferrarese M., Ceccato F., Camozzi V. Vitamin D: An Overview of Gene Regulation, Ranging from Metabolism to Genomic Effects. Genes. 2023;14:1691. doi: 10.3390/genes14091691.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes14091691</ArticleId><ArticleId IdType="pmc">PMC10531002</ArticleId><ArticleId IdType="pubmed">37761831</ArticleId></ArticleIdList></Reference><Reference><Citation>Finnell R.H., Shaw G.M., Lammer E.J., Rosenquist T.H. Gene-nutrient interactions: Importance of folic acid and vitamin B12 during early embryogenesis. Food Nutr. Bull. 2008;29:S86&#x2013;S98; discussion S99&#x2013;S100. doi: 10.1177/15648265080292S112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/15648265080292S112</ArticleId><ArticleId IdType="pubmed">18709884</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiraoka M., Kagawa Y. Genetic polymorphisms and folate status. Congenit. Anom. 2017;57:142&#x2013;149. doi: 10.1111/cga.12232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cga.12232</ArticleId><ArticleId IdType="pmc">PMC5601299</ArticleId><ArticleId IdType="pubmed">28598562</ArticleId></ArticleIdList></Reference><Reference><Citation>Amigou A., Rudant J., Orsi L., Goujon-Bellec S., Leverger G., Baruchel A., Bertrand Y., Nelken B., Plat G., Michel G., et al. Folic acid supplementation, MTHFR and MTRR polymorphisms, and the risk of childhood leukemia: The ESCALE study (SFCE) Cancer Causes Control. 2012;23:1265&#x2013;1277. doi: 10.1007/s10552-012-0004-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10552-012-0004-0</ArticleId><ArticleId IdType="pubmed">22706675</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbosa P.R., Stabler S.P., Machado A.L., Braga R.C., Hirata R.D., Hirata M.H., Sampaio-Neto L.F., Allen R.H., Guerra-Shinohara E.M. Association between decreased vitamin levels and MTHFR, MTR and MTRR gene polymorphisms as determinants for elevated total homocysteine concentrations in pregnant women. Eur. J. Clin. Nutr. 2008;62:1010&#x2013;1021. doi: 10.1038/sj.ejcn.1602810.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.ejcn.1602810</ArticleId><ArticleId IdType="pubmed">17522601</ArticleId></ArticleIdList></Reference><Reference><Citation>Nazki F.H., Sameer A.S., Ganaie B.A. Folate: Metabolism, genes, polymorphisms and the associated diseases. Gene. 2014;533:11&#x2013;20. doi: 10.1016/j.gene.2013.09.063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2013.09.063</ArticleId><ArticleId IdType="pubmed">24091066</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodgetts V.A., Morris R.K., Francis A., Gardosi J., Ismail K.M. Effectiveness of folic acid supplementation in pregnancy on reducing the risk of small-for-gestational age neonates: A population study, systematic review and meta-analysis. Int. J. Obstet. Gynaecol. 2015;122:478&#x2013;490. doi: 10.1111/1471-0528.13202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1471-0528.13202</ArticleId><ArticleId IdType="pubmed">25424556</ArticleId></ArticleIdList></Reference><Reference><Citation>Klai S., Fekih-Mrissa N., El Housaini S., Kaabechi N., Nsiri B., Rachdi R., Gritli N. Association of MTHFR A1298C polymorphism (but not of MTHFR C677T) with elevated homocysteine levels and placental vasculopathies. Blood Coagul. Fibrinolysis. 2011;22:374&#x2013;378. doi: 10.1097/MBC.0b013e328344f80f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MBC.0b013e328344f80f</ArticleId><ArticleId IdType="pubmed">21577095</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogeveen M., Blom H.J., den Heijer M. Maternal homocysteine and small-for-gestational-age offspring: Systematic review and meta-analysis. Am. J. Clin. Nutr. 2012;95:130&#x2013;136. doi: 10.3945/ajcn.111.016212.</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/ajcn.111.016212</ArticleId><ArticleId IdType="pubmed">22170376</ArticleId></ArticleIdList></Reference><Reference><Citation>Nobles C.J., Markenson G., Chasan-Taber L. Early pregnancy vitamin D status and risk for adverse maternal and infant outcomes in a bi-ethnic cohort: The Behaviors Affecting Baby and You (B.A.B.Y.) Study. Br. J. Nutr. 2015;114:2116&#x2013;2128. doi: 10.1017/S0007114515003980.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0007114515003980</ArticleId><ArticleId IdType="pmc">PMC5653966</ArticleId><ArticleId IdType="pubmed">26507186</ArticleId></ArticleIdList></Reference><Reference><Citation>Leffelaar E.R., Vrijkotte T.G., van Eijsden M. Maternal early pregnancy vitamin D status in relation to fetal and neonatal growth: Results of the multi-ethnic Amsterdam Born Children and their Development cohort. Br. J. Nutr. 2010;104:108&#x2013;117. doi: 10.1017/S000711451000022X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S000711451000022X</ArticleId><ArticleId IdType="pubmed">20193097</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y.H., Fu L., Hao J.H., Yu Z., Zhu P., Wang H., Xu Y.Y., Zhang C., Tao F.B., Xu D.X. Maternal vitamin D deficiency during pregnancy elevates the risks of small for gestational age and low birth weight infants in Chinese population. J. Clin. Endocrinol. Metab. 2015;100:1912&#x2013;1919. doi: 10.1210/jc.2014-4407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2014-4407</ArticleId><ArticleId IdType="pubmed">25774884</ArticleId></ArticleIdList></Reference><Reference><Citation>Malecki E.A. Manganese toxicity is associated with mitochondrial dysfunction and DNA fragmentation in rat primary striatal neurons. Brain Res. Bull. 2001;55:225&#x2013;228. doi: 10.1016/S0361-9230(01)00456-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0361-9230(01)00456-7</ArticleId><ArticleId IdType="pubmed">11470319</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L., Yang X. The Essential Element Manganese, Oxidative Stress, and Metabolic Diseases: Links and Interactions. Oxidative Med. Cell Longev. 2018;2018:7580707. doi: 10.1155/2018/7580707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/7580707</ArticleId><ArticleId IdType="pmc">PMC5907490</ArticleId><ArticleId IdType="pubmed">29849912</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Finley E.J., Gavin C.E., Aschner M., Gunter T.E. Manganese neurotoxicity and the role of reactive oxygen species. Free Radic. Biol. Med. 2013;62:65&#x2013;75. doi: 10.1016/j.freeradbiomed.2013.01.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2013.01.032</ArticleId><ArticleId IdType="pmc">PMC3713115</ArticleId><ArticleId IdType="pubmed">23395780</ArticleId></ArticleIdList></Reference><Reference><Citation>Zadrozna M., Gawlik M., Nowak B., Marcinek A., Mrowiec H., Walas S., Wietecha-Pos&#x142;uszny R., Zagrodzki P. Antioxidants activities and concentration of selenium, zinc and copper in preterm and IUGR human placentas. J. Trace Elem. Med. Biol. 2009;23:144&#x2013;148. doi: 10.1016/j.jtemb.2009.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtemb.2009.02.005</ArticleId><ArticleId IdType="pubmed">19398063</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis J.M., Auten R.L. Maturation of the antioxidant system and the effects on preterm birth. Semin. Fetal Neonatal Med. 2010;15:191&#x2013;195. doi: 10.1016/j.siny.2010.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.siny.2010.04.001</ArticleId><ArticleId IdType="pubmed">20452845</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong J., Zhou Q., Wang J., Lu Y., Li J., Wang L., Meng P., Li F., Zhou H., Liu C., et al. Association between variants in vitamin D-binding protein gene and vitamin D deficiency among pregnant women in china. J. Clin. Lab. Anal. 2020;34:e23376. doi: 10.1002/jcla.23376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcla.23376</ArticleId><ArticleId IdType="pmc">PMC7521226</ArticleId><ArticleId IdType="pubmed">32537819</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">27747179</PMID><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2225-319X</ISSN><JournalIssue CitedMedium="Print"><Volume>5</Volume><Issue>5</Issue><PubDate><Year>2016</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Annals of cardiothoracic surgery</Title><ISOAbbreviation>Ann Cardiothorac Surg</ISOAbbreviation></Journal><ArticleTitle>A prospective study on quality of life in youths after pectus excavatum correction.</ArticleTitle><Pagination><StartPage>456</StartPage><EndPage>465</EndPage><MedlinePgn>456-465</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The impact of correction of pectus excavatum (PE) on adolescents' health-related quality of life (HRQL) has only been investigated in prospective designs using disease-specific measures and without controls. The aim of this prospective study was to evaluate the HRQL before and after surgical correction of PE using a generic HRQL measure, and to compare the reported level of HRQL before surgery with an age-comparable control group.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Patients (n=107) and one of their parents (n=106) completed the generic HRQL measure: the Child Health Questionnaire before, 3 months, and 6 months after correction for PE. A control group (n=183) consisting of school children comparable in age completed the same measure on one occasion.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The patients' level of HRQL before surgery was comparable to the level of the controls except for physical functioning; here boys reported impaired function compared to controls (P&lt;0.0001, d=0.72). Both patients and parents reported improved emotional wellbeing and self-esteem, as well as an increase in physical and social activities from pre- to post-surgery. These improvements were statistically significant (P&#x2264;0.001-0.03) and yielded moderate to high effect sizes (&#x19e;<sup>2</sup>=0.04-0.22).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The improvement of physical and psychosocial HRQL reported by both patients and their parents as proxy indicates the psychological implications of the deformity. Patients reported impaired physical function compared to controls. Further, pre-surgery differences in HRQL between the patients and the controls were lacking. However, the improvement in the patients' HRQL following surgery may justify the correction of pectus excavatum. The effect of the deformity on patients wellbeing compared with controls' needs to be addressed in further studies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lomholt</LastName><ForeName>Johanne Jeppesen</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Psychology and Behavioural Sciences, Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacobsen</LastName><ForeName>Elisabeth Brammer</ForeName><Initials>EB</Initials><AffiliationInfo><Affiliation>Diploma in Health Science Program and Bachelor of Science in Nursing Program, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thastum</LastName><ForeName>Mikael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychology and Behavioural Sciences, Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pilegaard</LastName><ForeName>Hans</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic and Vascular Surgery, Aarhus University Hospital, Aarhus, Denmark;; Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Ann Cardiothorac Surg</MedlineTA><NlmUniqueID>101605877</NlmUniqueID><ISSNLinking>2225-319X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Nuss procedure</Keyword><Keyword MajorTopicYN="N">Pectus excavatum</Keyword><Keyword MajorTopicYN="N">health-related quality of life</Keyword><Keyword MajorTopicYN="N">prospective design</Keyword><Keyword MajorTopicYN="N">youths</Keyword></KeywordList><CoiStatement>HP is a consultant at Biomet. The other authors have no conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27747179</ArticleId><ArticleId IdType="pmc">PMC5056941</ArticleId><ArticleId IdType="doi">10.21037/acs.2016.08.02</ArticleId><ArticleId IdType="pii">acs-05-05-456</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fokin AA, Steuerwald NM, Ahrens WA, et al. Anatomical, histologic, and genetic characteristics of congenital chest wall deformities. Semin Thorac Cardiovasc Surg 2009;21:44-57. 10.1053/j.semtcvs.2009.03.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.semtcvs.2009.03.001</ArticleId><ArticleId IdType="pubmed">19632563</ArticleId></ArticleIdList></Reference><Reference><Citation>Goretsky MJ, Kelly RE, Jr, Croitoru D, et al. Chest wall anomalies: pectus excavatum and pectus carinatum. Adolesc Med Clin 2004;15:455-71. 10.1016/j.admecli.2004.06.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.admecli.2004.06.002</ArticleId><ArticleId IdType="pubmed">15625987</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowland T, Moriarty K, Banever G. Effect of pectus excavatum deformity on cardiorespiratory fitness in adolescent boys. Arch Pediatr Adolesc Med 2005;159:1069-73. 10.1001/archpedi.159.11.1069</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archpedi.159.11.1069</ArticleId><ArticleId IdType="pubmed">16275799</ArticleId></ArticleIdList></Reference><Reference><Citation>Lesbo M, Tang M, Nielsen HH, et al. Compromised cardiac function in exercising teenagers with pectus excavatum. Interact Cardiovasc Thorac Surg 2011;13:377-80. 10.1510/icvts.2011.267054</Citation><ArticleIdList><ArticleId IdType="doi">10.1510/icvts.2011.267054</ArticleId><ArticleId IdType="pubmed">21788301</ArticleId></ArticleIdList></Reference><Reference><Citation>Redlinger RE, Jr, Kelly RE, Nuss D, et al. Regional chest wall motion dysfunction in patients with pectus excavatum demonstrated via optoelectronic plethysmography. J Pediatr Surg 2011;46:1172-6. 10.1016/j.jpedsurg.2011.03.047</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2011.03.047</ArticleId><ArticleId IdType="pubmed">21683217</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaroszewski D, Notrica D, McMahon L, et al. Current management of pectus excavatum: a review and update of therapy and treatment recommendations. J Am Board Fam Med 2010;23:230-9. 10.3122/jabfm.2010.02.090234</Citation><ArticleIdList><ArticleId IdType="doi">10.3122/jabfm.2010.02.090234</ArticleId><ArticleId IdType="pubmed">20207934</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinmann C, Krille S, Mueller A, et al. Pectus excavatum and pectus carinatum patients suffer from lower quality of life and impaired body image: a control group comparison of psychological characteristics prior to surgical correction. Eur J Cardiothorac Surg 2011;40:1138-45.</Citation><ArticleIdList><ArticleId IdType="pubmed">21440452</ArticleId></ArticleIdList></Reference><Reference><Citation>Neviere R, Montaigne D, Benhamed L, et al. Cardiopulmonary response following surgical repair of pectus excavatum in adult patients. Eur J Cardiothorac Surg 2011;40:e77-82.</Citation><ArticleIdList><ArticleId IdType="pubmed">21570313</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang M, Nielsen HH, Lesbo M, et al. Improved cardiopulmonary exercise function after modified Nuss operation for pectus excavatum. Eur J Cardiothorac Surg 2012;41:1063-7. 10.1093/ejcts/ezr170</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezr170</ArticleId><ArticleId IdType="pubmed">22219453</ArticleId></ArticleIdList></Reference><Reference><Citation>Maagaard M, Tang M, Ringgaard S, et al. Normalized cardiopulmonary exercise function in patients with pectus excavatum three years after operation. Ann Thorac Surg 2013;96:272-8. 10.1016/j.athoracsur.2013.03.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2013.03.034</ArticleId><ArticleId IdType="pubmed">23684487</ArticleId></ArticleIdList></Reference><Reference><Citation>Redlinger RE, Jr, Wootton A, Kelly RE, et al. Optoelectronic plethysmography demonstrates abrogation of regional chest wall motion dysfunction in patients with pectus excavatum after Nuss repair. J Pediatr Surg 2012;47:160-4. 10.1016/j.jpedsurg.2011.10.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2011.10.038</ArticleId><ArticleId IdType="pubmed">22244410</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly RE, Jr, Mellins RB, Shamberger RC, et al. Multicenter study of pectus excavatum, final report: complications, static/exercise pulmonary function, and anatomic outcomes. J Am Coll Surg 2013;217:1080-9. 10.1016/j.jamcollsurg.2013.06.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2013.06.019</ArticleId><ArticleId IdType="pubmed">24246622</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasopoulos G, Goldstraw P. Minimally invasive repair of pectus excavatum deformity. Eur J Cardiothorac Surg 2011;39:149-58. 10.1016/j.ejcts.2010.07.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcts.2010.07.019</ArticleId><ArticleId IdType="pubmed">20739187</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts J, Hayashi A, Anderson JO, et al. Quality of life of patients who have undergone the Nuss procedure for pectus excavatum: Preliminary findings. J Pediatr Surg 2003;38:779-83. 10.1016/jpsu.2003.50166</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/jpsu.2003.50166</ArticleId><ArticleId IdType="pubmed">12720193</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawson ML, Cash TF, Akers R, et al. A pilot study of the impact of surgical repair on disease-specific quality of life among patients with pectus excavatum. J Pediatr Surg 2003;38:916-8. 10.1016/S0022-3468(03)00123-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3468(03)00123-4</ArticleId><ArticleId IdType="pubmed">12778393</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasopoulos G, Dusmet M, Ladas G, et al. Nuss procedure improves the quality of life in young male adults with pectus excavatum deformity. Eur J Cardiothorac Surg 2006;29:1-5. 10.1016/j.ejcts.2005.09.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcts.2005.09.018</ArticleId><ArticleId IdType="pubmed">16337131</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobsen EB, Thastum M, Jeppesen JH, et al. Health-related quality of life in children and adolescents undergoing surgery for pectus excavatum. Eur J Pediatr Surg 2010;20:85-91. 10.1055/s-0029-1243621</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0029-1243621</ArticleId><ArticleId IdType="pubmed">20112187</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly RE, Jr, Cash TF, Shamberger RC, et al. Surgical repair of pectus excavatum markedly improves body image and perceived ability for physical activity: multicenter study. Pediatrics 2008;122:1218-22. 10.1542/peds.2007-2723</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2007-2723</ArticleId><ArticleId IdType="pubmed">19047237</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HK, Shim JH, Choi KS, et al. The quality of life after bar removal in patients after the nuss procedure for pectus excavatum. World J Surg 2011;35:1656-61. 10.1007/s00268-011-1111-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-011-1111-x</ArticleId><ArticleId IdType="pubmed">21560000</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadolt B, Wallisch A, Egger JW, et al. Body-image, self-concept and mental exposure in patients with pectus excavatum. Pediatr Surg Int 2011;27:665-70. 10.1007/s00383-011-2854-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00383-011-2854-z</ArticleId><ArticleId IdType="pubmed">21290134</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuru P, Bostanci K, Ermerak NO, et al. Quality of life improves after minimally invasive repair of pectus excavatum. Asian Cardiovasc Thorac Ann 2015;23:302-7. 10.1177/0218492314553442</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0218492314553442</ArticleId><ArticleId IdType="pubmed">25293414</ArticleId></ArticleIdList></Reference><Reference><Citation>Solans M, Pane S, Estrada MD, et al. Health-related quality of life measurement in children and adolescents: a systematic review of generic and disease-specific instruments. Value Health 2008;11:742-64. 10.1111/j.1524-4733.2007.00293.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1524-4733.2007.00293.x</ArticleId><ArticleId IdType="pubmed">18179668</ArticleId></ArticleIdList></Reference><Reference><Citation>Raat H, Mohangoo AD, Grootenhuis MA. Pediatric health-related quality of life questionnaires in clinical trials. Curr Opin Allergy Clin Immunol 2006;6:180-5. 10.1097/01.all.0000225157.67897.c2</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.all.0000225157.67897.c2</ArticleId><ArticleId IdType="pubmed">16670511</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam MW, Klassen AF, Montgomery CJ, et al. Quality-of-life outcomes after surgical correction of pectus excavatum: a comparison of the Ravitch and Nuss procedures. J Pediatr Surg 2008;43:819-25. 10.1016/j.jpedsurg.2007.12.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2007.12.020</ArticleId><ArticleId IdType="pubmed">18485946</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuss D, Kelly RE, Jr, Croitoru DP, et al. A 10-year review of a minimally invasive technique for the correction of pectus excavatum. J Pediatr Surg 1998;33:545-52. 10.1016/S0022-3468(98)90314-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3468(98)90314-1</ArticleId><ArticleId IdType="pubmed">9574749</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuss D, Kelly RE, Jr. Indications and technique of Nuss procedure for pectus excavatum. Thorac Surg Clin 2010;20:583-97. 10.1016/j.thorsurg.2010.07.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thorsurg.2010.07.002</ArticleId><ArticleId IdType="pubmed">20974443</ArticleId></ArticleIdList></Reference><Reference><Citation>Landgraf JM, Ware JE. Child Health Questionnaire (CHQ): A User's Manual. Boston: The Health Institute, New England Medical Center; 1996. Available online: https://www.healthactchq.com/survey/chq</Citation></Reference><Reference><Citation>Raat H, Landgraf JM, Bonsel GJ, et al. Reliability and validity of the child health questionnaire-child form (CHQ-CF87) in a Dutch adolescent population. Qual Life Res 2002;11:575-81. 10.1023/A:1016393311799</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1016393311799</ArticleId><ArticleId IdType="pubmed">12206578</ArticleId></ArticleIdList></Reference><Reference><Citation>Waters E, Salmon L, Wake M. The parent-form Child Health Questionnaire in Australia: comparison of reliability, validity, structure, and norms. J Pediatr Psychol 2000;25:381-91. 10.1093/jpepsy/25.6.381</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jpepsy/25.6.381</ArticleId><ArticleId IdType="pubmed">10980043</ArticleId></ArticleIdList></Reference><Reference><Citation>Waters EB, Salmon LA, Wake M, et al. The health and well-being of adolescents: a school-based population study of the self-report Child Health Questionnaire. J Adolesc Health 2001;29:140-9. 10.1016/S1054-139X(01)00211-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1054-139X(01)00211-7</ArticleId><ArticleId IdType="pubmed">11472873</ArticleId></ArticleIdList></Reference><Reference><Citation>Drotar D, Schwartz L, Palermo TM, et al. Factor structure of the child health questionnaire-parent form in pediatric populations. J Pediatr Psychol 2006;31:127-38. 10.1093/jpepsy/jsi078</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jpepsy/jsi078</ArticleId><ArticleId IdType="pubmed">16467313</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen S, Ruperto N, Herlin T, et al. The Danish version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp Rheumatol 2001;19:S50-4.</Citation><ArticleIdList><ArticleId IdType="pubmed">11510331</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen J. Statistical Power Analysis for the Behavioral Sciences (2nd Edition). Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.</Citation></Reference><Reference><Citation>IASP Task Force on Taxonomy. Classification of Chronic Pain. 2nd (revised) ed. Seattle: IASP Press; 2011.</Citation></Reference><Reference><Citation>McGrath PJ, Walco GA, Turk DC, et al. Core outcome domains and measures for pediatric acute and chronic/recurrent pain clinical trials: PedIMMPACT recommendations. J Pain 2008;9:771-83. 10.1016/j.jpain.2008.04.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpain.2008.04.007</ArticleId><ArticleId IdType="pubmed">18562251</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Keefe J, Byrne R, Montgomery M, et al. Longer term effects of closed repair of pectus excavatum on cardiopulmonary status. J Pediatr Surg 2013;48:1049-54. 10.1016/j.jpedsurg.2013.02.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2013.02.024</ArticleId><ArticleId IdType="pubmed">23701781</ArticleId></ArticleIdList></Reference><Reference><Citation>Asmussen L, Olson LM, Grant EN, et al. Use of the child health questionnaire in a sample of moderate and low-income inner-city children with asthma. Am J Respir Crit Care Med 2000;162:1215-21. 10.1164/ajrccm.162.4.2001067</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.162.4.2001067</ArticleId><ArticleId IdType="pubmed">11029320</ArticleId></ArticleIdList></Reference><Reference><Citation>Raat H, Bonsel GJ, Essink-Bot ML, et al. Reliability and validity of comprehensive health status measures in children: The Child Health Questionnaire in relation to the Health Utilities Index. J Clin Epidemiol 2002;55:67-76. 10.1016/S0895-4356(01)00411-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0895-4356(01)00411-5</ArticleId><ArticleId IdType="pubmed">11781124</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35814492</PMID><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2666-5484</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><PubDate><Year>2022</Year><Month>Sep</Month></PubDate></JournalIssue><Title>North American Spine Society journal</Title><ISOAbbreviation>N Am Spine Soc J</ISOAbbreviation></Journal><ArticleTitle>Clinical significance of concomitant pectus deformity and adolescent idiopathic scoliosis: systematic review with best evidence synthesis.</ArticleTitle><Pagination><StartPage>100140</StartPage><MedlinePgn>100140</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100140</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.xnsj.2022.100140</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">A misbalance in forces is proposed for causing adolescent idiopathic scoliosis (AIS). AIS is therefore correlated to adjacent musculoskeletal pathologies. Its concomitance with idiopathic pectus deformities (PD) is underexposed. This systematic review analyzes the clinical significance and predictive factors of PD-associated AIS.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A search was performed in PubMed, UpToDate, Embase, and Cochrane. A study was included if it: assessed the association between PD and scoliosis (category I), reported a prevalence of scoliosis in PD patients (category II), or addressed other topics about PD-associated AIS (category III). Studies in category I discussing predictive factors were appraised using the Quality in Prognosis Studies tool. Because of heterogeneity among the studies, predictive factors were analyzed according to a best evidence synthesis. A mean prevalence of scoliosis in PD patients was calculated using category I and II. Category III was narratively reviewed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Forty-eight studies were included (I:19, II:21, III:8). Category I comprised 512 patients with PD-concomitant scoliosis. Thirteen studies reported predictive factors, of which 15 concerned the prevalence of scoliosis in PD patients and 12 Cobb Angle (CA) change after PD correction. Compared with AIS, PD seems to develop earlier in adolescence, and PD with concomitant AIS was more frequently reported in older patients. Evidence remained conflicting regarding the association between the severity of PD and that of scoliosis. As opposed to at a younger age, late PD correction is not associated with a postoperative increase of CA. Limited evidence showed that patients with a high CA undergoing PD correction do not experience an increase in CA, though, strong evidence indicated that it would not lead to a decrease in CA. The mean probable prevalence of AIS in PD patients was 13.1%.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Current literature confirms the association between PD and AIS in patients with an indication for PD correction.<b>Level of evidence:</b> III.</AbstractText><CopyrightInformation>&#xa9; 2022 The Author(s). Published by Elsevier Ltd on behalf of North American Spine Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>van Es</LastName><ForeName>Laurian J M</ForeName><Initials>LJM</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Noordwest Ziekenhuis, Wilhelminalaan 12 1815 JD Alkmaar, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Royen</LastName><ForeName>Barend J</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Amsterdam UMC, University of Amsterdam and Vrije Universiteit, Amsterdam Movement Sciences, Meibergdreef 9, 1105 AZ, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oomen</LastName><ForeName>Matthijs W N</ForeName><Initials>MWN</Initials><AffiliationInfo><Affiliation>Department of Pediatric surgery, Amsterdam UMC, University of Amsterdam, Amsterdam Movement Sciences, Meibergdreef 9, 1105 AZ, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>N Am Spine Soc J</MedlineTA><NlmUniqueID>9918335076906676</NlmUniqueID><ISSNLinking>2666-5484</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AIS, Adolescent Idiopathic Scoliosis</Keyword><Keyword MajorTopicYN="N">Adolescent idiopathic scoliosis (AIS)</Keyword><Keyword MajorTopicYN="N">BES, Best Evidence Synthesis</Keyword><Keyword MajorTopicYN="N">BMI, Body Mass Index</Keyword><Keyword MajorTopicYN="N">CA, Cobb Angle</Keyword><Keyword MajorTopicYN="N">CT, Computed Tomography</Keyword><Keyword MajorTopicYN="N">Chest wall deformities</Keyword><Keyword MajorTopicYN="N">Funnel chest</Keyword><Keyword MajorTopicYN="N">HI, Haller Index</Keyword><Keyword MajorTopicYN="N">PC, Pectus Carinatum</Keyword><Keyword MajorTopicYN="N">PD, Pectus Deformity</Keyword><Keyword MajorTopicYN="N">PE, Pectus Excavatum</Keyword><Keyword MajorTopicYN="N">Pectus carinatum</Keyword><Keyword MajorTopicYN="N">Pectus excavatum</Keyword><Keyword MajorTopicYN="N">Pigeon breast</Keyword><Keyword MajorTopicYN="N">STA, Sternal Tilt Angle</Keyword><Keyword MajorTopicYN="N">Scoliosis</Keyword></KeywordList><CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>6</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>11</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>12</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>6</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35814492</ArticleId><ArticleId IdType="pmc">PMC9256832</ArticleId><ArticleId IdType="doi">10.1016/j.xnsj.2022.100140</ArticleId><ArticleId IdType="pii">S2666-5484(22)00043-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Shakil H., Iqbal Z.A., Al-Ghadir A.H. Scoliosis: review of types of curves, etiological theories and conservative treatment. J Back Musculoskelet Rehabil. 2014;27(2):111&#x2013;115.</Citation><ArticleIdList><ArticleId IdType="pubmed">24284269</ArticleId></ArticleIdList></Reference><Reference><Citation>Smit T.H. Adolescent idiopathic scoliosis: The mechanobiology of differential growth. JOR Spine. 2020;3(4):e1115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7770204</ArticleId><ArticleId IdType="pubmed">33392452</ArticleId></ArticleIdList></Reference><Reference><Citation>U&#xe7;ar &#x130;., et al. Is scoliosis related to mastication muscle asymmetry and temporomandibular disorders? A cross-sectional study. Musculoskelet Sci Pract. 2022;58:1025&#x2013;1033.</Citation><ArticleIdList><ArticleId IdType="pubmed">35217300</ArticleId></ArticleIdList></Reference><Reference><Citation>Bortz C., et al. The Prevalence of Hip Pathologies in Adolescent Idiopathic Scoliosis. J Orthop. 2022;31:29&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8961074</ArticleId><ArticleId IdType="pubmed">35360471</ArticleId></ArticleIdList></Reference><Reference><Citation>Waters P., et al. Scoliosis in children with pectus excavatum and pectus carinatum. J Pediatr Orthop. 1989;9(5):551&#x2013;556.</Citation><ArticleIdList><ArticleId IdType="pubmed">2794028</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Qadi M.O. Disorders of the Chest Wall: Clinical Manifestations. Clin Chest Med. 2018;39(2):361&#x2013;375.</Citation><ArticleIdList><ArticleId IdType="pubmed">29779595</ArticleId></ArticleIdList></Reference><Reference><Citation>Haller J.A., Jr., Kramer S.S., Lietman S.A. Use of CT scans in selection of patients for pectus excavatum surgery: a preliminary report. J Pediatr Surg. 1987;22(10):904&#x2013;906.</Citation><ArticleIdList><ArticleId IdType="pubmed">3681619</ArticleId></ArticleIdList></Reference><Reference><Citation>Swoveland B., et al. The Nuss procedure for pectus excavatum correction. Aorn j. 2001;74(6):828&#x2013;841. quiz 842-5, 848-50.</Citation><ArticleIdList><ArticleId IdType="pubmed">11795057</ArticleId></ArticleIdList></Reference><Reference><Citation>Niedbala A., et al. Acquired thoracic scoliosis following minimally invasive repair of pectus excavatum. Am Surg. 2003;69(6):530&#x2013;533.</Citation><ArticleIdList><ArticleId IdType="pubmed">12852514</ArticleId></ArticleIdList></Reference><Reference><Citation>Beltsios E.T., Mitsos S.L., Panagiotopoulos N.T. Pectus excavatum and scoliosis: a review about the patient's surgical management. Gen Thorac Cardiovasc Surg. 2020;68(11):1225&#x2013;1233.</Citation><ArticleIdList><ArticleId IdType="pubmed">32990868</ArticleId></ArticleIdList></Reference><Reference><Citation>Page M.J., et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. International Journal of Surgery. 2021;88</Citation><ArticleIdList><ArticleId IdType="pubmed">33789826</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayden J.A., et al. Assessing bias in studies of prognostic factors. Ann Intern Med. 2013;158(4):280&#x2013;286.</Citation><ArticleIdList><ArticleId IdType="pubmed">23420236</ArticleId></ArticleIdList></Reference><Reference><Citation>Faraj S.S., et al. De novo degenerative lumbar scoliosis: a systematic review of prognostic factors for curve progression. Eur Spine J. 2016;25(8):2347&#x2013;2358.</Citation><ArticleIdList><ArticleId IdType="pubmed">27220970</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Bogaart M., et al. Predictive factors for brace treatment outcome in adolescent idiopathic scoliosis: a best-evidence synthesis. Eur Spine J. 2019;28(3):511&#x2013;525.</Citation><ArticleIdList><ArticleId IdType="pubmed">30607519</ArticleId></ArticleIdList></Reference><Reference><Citation>Slavin R.E. Best evidence synthesis: an intelligent alternative to meta-analysis. J Clin Epidemiol. 1995;48(1):9&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">7853053</ArticleId></ArticleIdList></Reference><Reference><Citation>Alaca N., Y&#xfc;ksel M. Comparison of physical functions and psychosocial conditions between adolescents with pectus excavatum, pectus carinatum and healthy controls. Pediatr Surg Int. 2021;37(6):765&#x2013;775.</Citation><ArticleIdList><ArticleId IdType="pubmed">33454849</ArticleId></ArticleIdList></Reference><Reference><Citation>Berdan E., et al. Double Crush to the Thorax: Pectus Excavatum and Kyphoscoliosis. Journal of Pediatric Surgery Case Reports. 2013;2</Citation></Reference><Reference><Citation>Choi J.H., et al. Classification of Pectus Excavatum According to Objective Parameters From Chest Computed Tomography. Ann Thorac Surg. 2016;102(6):1886&#x2013;1891.</Citation><ArticleIdList><ArticleId IdType="pubmed">27526652</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung J.H., Park H.J., Kim K.T. Scoliosis after pectus excavatum correction: does it improve or worsen? Eur J Cardiothorac Surg. 2017;52(1):76&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">28329150</ArticleId></ArticleIdList></Reference><Reference><Citation>Floccari L.V., Sucato D.J., Ramo B.A. Scoliosis Progression After the Nuss Procedure for Pectus Excavatum: A Case Report. Spine Deform. 2019;7(6):1003&#x2013;1009.</Citation><ArticleIdList><ArticleId IdType="pubmed">31731992</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghionzoli M., et al. Scoliosis and Pectus Excavatum in Adolescents: Does the Nuss Procedure Affect the Scoliotic Curvature? J Laparoendosc Adv Surg Tech A. 2016;26(9):734&#x2013;739.</Citation><ArticleIdList><ArticleId IdType="pubmed">27529379</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong J.Y., et al. Correlations of adolescent idiopathic scoliosis and pectus excavatum. J Pediatr Orthop. 2011;31(8):870&#x2013;874.</Citation><ArticleIdList><ArticleId IdType="pubmed">22101666</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x130;&#x15f;can M., et al. The effect of minimally invasive pectus excavatum repair on thoracic scoliosis. Eur J Cardiothorac Surg. 2020</Citation><ArticleIdList><ArticleId IdType="pubmed">33123728</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng Y., et al. Acquired scoliosis following Nuss procedure for pectus excavatum: A case report. Medicine (Baltimore) 2019;98(1):e13855.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6344195</ArticleId><ArticleId IdType="pubmed">30608404</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagasao T., et al. Dynamic effects of the Nuss procedure on the spine in asymmetric pectus excavatum. J Thorac Cardiovasc Surg. 2010;140(6) p. 1294-9 e1.</Citation><ArticleIdList><ArticleId IdType="pubmed">20650473</ArticleId></ArticleIdList></Reference><Reference><Citation>Park H.J., et al. Effects of Nuss procedure on thoracic scoliosis in patients with pectus excavatum. J Thorac Dis. 2017;9(10):3810&#x2013;3816.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5723842</ArticleId><ArticleId IdType="pubmed">29268389</ArticleId></ArticleIdList></Reference><Reference><Citation>Shu Q., et al. Experience in minimally invasive Nuss operation for 406 children with pectus excavatum. World J Pediatr. 2011;7(3):257&#x2013;261.</Citation><ArticleIdList><ArticleId IdType="pubmed">21822992</ArticleId></ArticleIdList></Reference><Reference><Citation>Tauchi R., et al. Evaluation of thoracic factors after scoliosis surgery in patients with both scoliosis and pectus excavatum. Eur Spine J. 2018;27(2):381&#x2013;387.</Citation><ArticleIdList><ArticleId IdType="pubmed">27568387</ArticleId></ArticleIdList></Reference><Reference><Citation>Tauchi R., et al. Clinical Characteristics and Thoracic factors in patients with Idiopathic and Syndromic Scoliosis Associated with Pectus Excavatum. Spine Surg Relat Res. 2018;2(1):37&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6698549</ArticleId><ArticleId IdType="pubmed">31440644</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomaszewski R., Wiktor L., Machala L. Evaluation of thoracic vertebrae rotation in patients with pectus excavatum. Acta Orthop Traumatol Turc. 2017;51(4):284&#x2013;289.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6197356</ArticleId><ArticleId IdType="pubmed">28624480</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., et al. Mechanical factors play an important role in pectus excavatum with thoracic scoliosis. J Cardiothorac Surg. 2012;7:118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3514121</ArticleId><ArticleId IdType="pubmed">23140473</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong W., et al. Effects of Pectus Excavatum on the Spine of Pectus Excavatum Patients with Scoliosis. J Healthc Eng. 2017;2017</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5512045</ArticleId><ArticleId IdType="pubmed">29065615</ArticleId></ArticleIdList></Reference><Reference><Citation>Akcali Y., Ceyran H., Hasdiraz L. Chest wall deformities. Acta Chir Hung. 1999;38(1):1&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">10439083</ArticleId></ArticleIdList></Reference><Reference><Citation>Coln D., et al. Early experience with the Nuss minimally invasive correction of pectus excavatum in adults. World J Surg. 2002;26(10):1217&#x2013;1221.</Citation><ArticleIdList><ArticleId IdType="pubmed">12209230</ArticleId></ArticleIdList></Reference><Reference><Citation>Fonkalsrud E.W. Surgical correction of pectus carinatum: lessons learned from 260 patients. J Pediatr Surg. 2008;43(7):1235&#x2013;1243.</Citation><ArticleIdList><ArticleId IdType="pubmed">18639675</ArticleId></ArticleIdList></Reference><Reference><Citation>Fonkalsrud E.W. 912 open pectus excavatum repairs: changing trends, lessons learned: one surgeon's experience. World J Surg. 2009;33(2):180&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pubmed">19002739</ArticleId></ArticleIdList></Reference><Reference><Citation>Haje S.A., de Podesta Haje D. Orthopedic Approach to Pectus Deformities: 32 Years of Studies. Rev Bras Ortop. 2009;44(3):191&#x2013;198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4783668</ArticleId><ArticleId IdType="pubmed">27004171</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly R.E., et al. Twenty-one years of experience with minimally invasive repair of pectus excavatum by the Nuss procedure in 1215 patients. Ann Surg. 2010;252(6):1072&#x2013;1081.</Citation><ArticleIdList><ArticleId IdType="pubmed">21107118</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly R.E., Jr., et al. Recent Modifications of the Nuss Procedure: The Pursuit of Safety During the Minimally Invasive Repair of Pectus Excavatum. Ann Surg. 2020</Citation><ArticleIdList><ArticleId IdType="pubmed">32224740</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly R.E., Jr., et al. Prospective multicenter study of surgical correction of pectus excavatum: design, perioperative complications, pain, and baseline pulmonary function facilitated by internet-based data collection. J Am Coll Surg. 2007;205(2):205&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">17660066</ArticleId></ArticleIdList></Reference><Reference><Citation>Koumbourlis A.C., Stolar C.J. Lung growth and function in children and adolescents with idiopathic pectus excavatum. Pediatr Pulmonol. 2004;38(4):339&#x2013;343.</Citation><ArticleIdList><ArticleId IdType="pubmed">15334513</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuru P., et al. Quality of life improves after minimally invasive repair of pectus excavatum. Asian Cardiovasc Thorac Ann. 2015;23(3):302&#x2013;307.</Citation><ArticleIdList><ArticleId IdType="pubmed">25293414</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuru P., et al. Pectus Excavatum and Pectus Carinatum: Associated Conditions, Family History, and Postoperative Patient Satisfaction. Korean J Thorac Cardiovasc Surg. 2016;49(1):29&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4757394</ArticleId><ArticleId IdType="pubmed">26889443</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez M., et al. Preliminary study of efficacy of dynamic compression system in the correction of typical pectus carinatum. Eur J Cardiothorac Surg. 2013;44(5):e316&#x2013;e319.</Citation><ArticleIdList><ArticleId IdType="pubmed">24014551</ArticleId></ArticleIdList></Reference><Reference><Citation>Luu T.D., et al. Surgery for recurrent pectus deformities. Ann Thorac Surg. 2009;88(5):1627&#x2013;1631.</Citation><ArticleIdList><ArticleId IdType="pubmed">19853122</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandhan P., et al. Pectus Deformities in Children: A nine-year experience from CMH, USA. Asian J Surg. 1999;22:301&#x2013;307.</Citation></Reference><Reference><Citation>McHugh M.A., et al. Assessment of potential confounders when imaging pectus excavatum with chest radiography alone. J Pediatr Surg. 2016;51(9):1485&#x2013;1489.</Citation><ArticleIdList><ArticleId IdType="pubmed">27577182</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy B.L., et al. Minimal cosmetic revision required after minimally invasive pectus repair. Pediatr Surg Int. 2018;34(7):775&#x2013;780.</Citation><ArticleIdList><ArticleId IdType="pubmed">29744653</ArticleId></ArticleIdList></Reference><Reference><Citation>Okuyama H., et al. Thoracoscopic Costal Cartilage Excision Combined with the Nuss Procedure for Patients with Asymmetrical Pectus Excavatum. J Laparoendosc Adv Surg Tech A. 2021;31(1):95&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">33227219</ArticleId></ArticleIdList></Reference><Reference><Citation>Prats M.R., et al. Correcci&#xf3;n m&#xed;nimamente invasiva (Operaci&#xf3;n de Nuss) del pectus excavatum en pacientes adultos. Revista m&#xe9;dica de Chile. 2009;137:1583&#x2013;1590.</Citation><ArticleIdList><ArticleId IdType="pubmed">20361134</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramadan S., et al. Cardiopulmonary function in adolescent patients with pectus excavatum or carinatum. BMJ Open Respir Res. 2021;8(1)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8323368</ArticleId><ArticleId IdType="pubmed">34326157</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoenmakers M.A., et al. Physiotherapy as an adjuvant to the surgical treatment of anterior chest wall deformities: a necessity? A prospective descriptive study in 21 patients. J Pediatr Surg. 2000;35(10):1440&#x2013;1443.</Citation><ArticleIdList><ArticleId IdType="pubmed">11051146</ArticleId></ArticleIdList></Reference><Reference><Citation>Westphal F.L., et al. Prevalence of pectus carinatum and pectus excavatum in students in the city of Manaus, Brazil. J Bras Pneumol. 2009;35(3):221&#x2013;226.</Citation><ArticleIdList><ArticleId IdType="pubmed">19390719</ArticleId></ArticleIdList></Reference><Reference><Citation>Creswick H.A., et al. Family study of the inheritance of pectus excavatum. J Pediatr Surg. 2006;41(10):1699&#x2013;1703.</Citation><ArticleIdList><ArticleId IdType="pubmed">17011272</ArticleId></ArticleIdList></Reference><Reference><Citation>de Beer S.A., et al. The Dynamic Compression Brace for Pectus Carinatum: Intermediate Results in 286 Patients. Ann Thorac Surg. 2017;103(6):1742&#x2013;1749.</Citation><ArticleIdList><ArticleId IdType="pubmed">28274516</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurnett C.A., et al. Genetic linkage localizes an adolescent idiopathic scoliosis and pectus excavatum gene to chromosome 18 q. Spine (Phila Pa 1976) 2009;34(2):E94&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2638207</ArticleId><ArticleId IdType="pubmed">19139660</ArticleId></ArticleIdList></Reference><Reference><Citation>Karner C.M., et al. Gpr126/Adgrg6 deletion in cartilage models idiopathic scoliosis and pectus excavatum in mice. Hum Mol Genet. 2015;24(15):4365&#x2013;4373.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4492399</ArticleId><ArticleId IdType="pubmed">25954032</ArticleId></ArticleIdList></Reference><Reference><Citation>Neves S.C., et al. Finite element analysis of pectus carinatum surgical correction via a minimally invasive approach. Computer Methods in Biomechanics and Biomedical Engineering. 2015;18(7):711&#x2013;720.</Citation><ArticleIdList><ArticleId IdType="pubmed">24428546</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye J.D., H Y.-W., Zhong W-H, Liu J-F, Zhang C-Q. Investigation on the electrometric measurement experiment of the artificial thoracic model of pectus excavatum with scoliosis. Biomedical Research. 2017;28(9):3845&#x2013;3850.</Citation></Reference><Reference><Citation>Ye J.D., et al. Effect on Chest Deformation of Simultaneous Correction of Pectus Excavatum with Scoliosis. J Healthc Eng. 2017;2017</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5613367</ArticleId><ArticleId IdType="pubmed">29138688</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye J.-D., et al. The analysis of the effect of intervertebral disc on the lateral bending of the spine in deformed thorax model. Biomedical Research (India) 2017;28(7):3271&#x2013;3275.</Citation></Reference><Reference><Citation>Ye, J.-D., et&#xa0;al., Investigation on the electrometric measurement experiment of the artificial thoracic model of pectus excavatum with scoliosis. 2017.</Citation></Reference><Reference><Citation>Sanders J.O., et al. Maturity assessment and curve progression in girls with idiopathic scoliosis. J Bone Joint Surg Am. 2007;89(1):64&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">17200312</ArticleId></ArticleIdList></Reference><Reference><Citation>Konieczny M.R., Senyurt H., Krauspe R. Epidemiology of adolescent idiopathic scoliosis. J Child Orthop. 2013;7(1):3&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3566258</ArticleId><ArticleId IdType="pubmed">24432052</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexianu D., et al. Severe hypotension in the prone position in a child with neurofibromatosis, scoliosis and pectus excavatum presenting for posterior spinal fusion. Anesth Analg. 2004;98(2):334&#x2013;335.</Citation><ArticleIdList><ArticleId IdType="pubmed">14742365</ArticleId></ArticleIdList></Reference><Reference><Citation>Bafus B.T., et al. Severe hypotension associated with the prone position in a child with scoliosis and pectus excavatum undergoing posterior spinal fusion. J Spinal Disord Tech. 2008;21(6):451&#x2013;454.</Citation><ArticleIdList><ArticleId IdType="pubmed">18679103</ArticleId></ArticleIdList></Reference><Reference><Citation>Galas J.M., et al. Echocardiographic diagnosis of right ventricular inflow compression associated with pectus excavatum during spinal fusion in prone position. Congenit Heart Dis. 2009;4(3):193&#x2013;195.</Citation><ArticleIdList><ArticleId IdType="pubmed">19489950</ArticleId></ArticleIdList></Reference><Reference><Citation>Akka&#x15f; Y., et al. The prevalence of chest wall deformity in Turkish children. Turk J Med Sci. 2018;48(6):1200&#x2013;1206.</Citation><ArticleIdList><ArticleId IdType="pubmed">30541247</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27480208</PMID><DateCompleted><Year>2017</Year><Month>01</Month><Day>30</Day></DateCompleted><DateRevised><Year>2017</Year><Month>01</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-4954</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>13</Issue><PubDate><Year>2016</Year></PubDate></JournalIssue><Title>The journal of maternal-fetal &amp; neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians</Title><ISOAbbreviation>J Matern Fetal Neonatal Med</ISOAbbreviation></Journal><ArticleTitle>Maternal pre-eclampsia as a risk factor for necrotizing enterocolitis.</ArticleTitle><Pagination><StartPage>2098</StartPage><EndPage>2103</EndPage><MedlinePgn>2098-103</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3109/14767058.2015.1076386</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Similar pro-inflammatory responses are present in pre-eclampsia (PE) and necrotizing enterocolitis (NEC). We hypothesized that maternal PE is an independent risk factor for the development of NEC.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A retrospective database of all live births (2008-2011) at a tertiary center was constructed. Infant and maternal characteristics were gathered. Babies born to mothers with or without PE were compared. Data were analyzed using Mann-Whitney U, Pearson's &#x3c7;(2), binary logistic regression and relative risks.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Incidence of NEC was 1.5% in non-PE and 4.6% in the PE group (p&#x2009;&lt;&#x2009;0.001), but once controlled for gestational age and birth weight, the difference lost statistical significance. PE babies were more frequently preterm (41.4% versus 14.5%, p&#x2009;&lt;&#x2009;0.001) and had intrauterine growth restriction (IUGR) (10.2% versus 6.3%, p&#x2009;&lt;&#x2009;0.001). Within preterm babies, 9.0% of non-PE and 10.8% of PE babies developed NEC (p&#x2009;=&#x2009;0.25). Effect of PE was significant in sub-group of IUGR babies, with NEC in 1.5% of non-PE and 13.6% in PE babies (p&#x2009;&lt;&#x2009;0.001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Maternal PE is an independent risk factor for the development of NEC in some sub-groups of babies, most notably with IUGR. Fetal hypoxia caused by abnormal placentation in PE leads to restricted growth, and may be the underlying mechanism that predisposes the newborn to NEC.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Perger</LastName><ForeName>Lena</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>a Texas A&amp;M College of Medicine , Temple , TX , USA .</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>b Department of Pediatric Surgery and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>c Department of Pediatrics , McLane Children's Hospital at Scott &amp; White , Temple , TX , USA .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mukhopadhyay</LastName><ForeName>Dhriti</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>a Texas A&amp;M College of Medicine , Temple , TX , USA .</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>d Department of Surgery , Scott &amp; White Hospital , Temple , TX , USA .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Komidar</LastName><ForeName>Luka</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>e Faculty of Arts , University of Ljubljana , Ljubljana , Slovenia , and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiggins-Dohlvik</LastName><ForeName>Katie</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>a Texas A&amp;M College of Medicine , Temple , TX , USA .</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>d Department of Surgery , Scott &amp; White Hospital , Temple , TX , USA .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uddin</LastName><ForeName>Mohammad N</ForeName><Initials>MN</Initials><AffiliationInfo><Affiliation>a Texas A&amp;M College of Medicine , Temple , TX , USA .</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>f Department of Gynecology and Obstetrics , Scott &amp; White Hospital , Temple , TX , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beeram</LastName><ForeName>Madhava</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>a Texas A&amp;M College of Medicine , Temple , TX , USA .</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>c Department of Pediatrics , McLane Children's Hospital at Scott &amp; White , Temple , TX , USA .</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>08</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Matern Fetal Neonatal Med</MedlineTA><NlmUniqueID>101136916</NlmUniqueID><ISSNLinking>1476-4954</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Matern Fetal Neonatal Med. 2019 Feb;32(4):702. doi: 10.1080/14767058.2017.1376642.</RefSource><PMID Version="1">28911253</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020345" MajorTopicYN="N">Enterocolitis, Necrotizing</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011225" MajorTopicYN="N">Pre-Eclampsia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Necrotizing enterocolitis</Keyword><Keyword MajorTopicYN="N">newborn</Keyword><Keyword MajorTopicYN="N">pre-eclampsia</Keyword><Keyword MajorTopicYN="N">small for gestational age</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>8</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>8</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27480208</ArticleId><ArticleId IdType="doi">10.3109/14767058.2015.1076386</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40557054</PMID><DateCompleted><Year>2025</Year><Month>06</Month><Day>25</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1177-8881</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><PubDate><Year>2025</Year></PubDate></JournalIssue><Title>Drug design, development and therapy</Title><ISOAbbreviation>Drug Des Devel Ther</ISOAbbreviation></Journal><ArticleTitle>Effects of Prophylactic Infusion of Equivalent Doses of Norepinephrine and Phenylephrine in Preventing Spinal Anesthesia-Induced Hypotension During Cesarean Delivery on Fetal and Maternal Outcomes: A Dual-Center, Non-Inferiority Controlled Trial.</ArticleTitle><Pagination><StartPage>5143</StartPage><EndPage>5152</EndPage><MedlinePgn>5143-5152</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2147/DDDT.S514091</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Numerous studies have compared the effects of norepinephrine and phenylephrine on maternal and neonatal outcomes during cesarean delivery. However, the infusion rates are often based on clinical experience, resulting in non-equivalent doses. We aimed to compare the effects of norepinephrine and phenylephrine at equivalent doses on fetal and maternal outcomes, and assess their efficacy at the 90% effective dose (ED<sub>90</sub>).</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A total of 100 parturients scheduled for cesarean delivery were randomly allocated to receive either 0.10&#xa0;&#x3bc;g/kg/min norepinephrine (Group NE) or 0.60&#xa0;&#x3bc;g/kg/min phenylephrine (Group PE) to prevent spinal anesthesia-induced hypotension. The primary endpoint was neonatal umbilical arterial (UA) pH and the incidence of maternal hypotension, while secondary endpoints included hemodynamic changes within the first 15&#xa0;minutes, maternal adverse events, and additional neonatal measures.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Of the 95 subjects who completed the study, the UA pH in Group NE (7.296 &#xb1; 0.041) was found to be non-inferior to Group PE (7.292 &#xb1; 0.040), with a mean difference of 0.003 [95% confidence interval (CI): -0.016 to 0.022; P = 0.009]. The incidences of hypotension (NE: 8.3% vs PE: 10.6%, P = 0.701), hypertension, nausea, and vomiting were comparable between groups. However, bradycardia incidence was significantly reduced in Group NE compared to Group PE (2.1% vs 12.8%, P = 0.046). The two groups showed no significant difference in systolic blood pressure (SBP) at most time points within the first 15&#xa0;minutes, except at 7&#xa0;minutes. Group NE also had a higher heart rate (HR) than Group PE in most measurements. Both groups showed similar neonatal outcomes.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Prophylactic infusion of 0.10&#xa0;&#x3bc;g/kg/min norepinephrine was non-inferior to 0.60&#xa0;&#x3bc;g/kg/min phenylephrine in terms of neonatal UA pH. These findings further support the safety of norepinephrine in obstetric anesthesia, although additional research is warranted to assess its long-term maternal and neonatal outcomes.</AbstractText><CopyrightInformation>&#xa9; 2025 Mao et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Mao</LastName><ForeName>Junqin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Wenling Maternity and Child Health Care Hospital, Taizhou, Zhejiang, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Lin</LastName><ForeName>Kang</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Wenling First People's Hospital (The Affiliated Wenling Hospital of Wenzhou Medical University), Taizhou, Zhejiang, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xiang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Wenling Maternity and Child Health Care Hospital, Taizhou, Zhejiang, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Wenling Maternity and Child Health Care Hospital, Taizhou, Zhejiang, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Gang</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Wenling Maternity and Child Health Care Hospital, Taizhou, Zhejiang, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheng</LastName><ForeName>Zhimin</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0003-3806-9620</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Wenling Maternity and Child Health Care Hospital, Taizhou, Zhejiang, People's Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016441">Retracted Publication</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Drug Des Devel Ther</MedlineTA><NlmUniqueID>101475745</NlmUniqueID><ISSNLinking>1177-8881</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>X4W3ENH1CV</RegistryNumber><NameOfSubstance UI="D009638">Norepinephrine</NameOfSubstance></Chemical><Chemical><RegistryNumber>1WS297W6MV</RegistryNumber><NameOfSubstance UI="D010656">Phenylephrine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="RetractionIn"><RefSource>Drug Des Devel Ther. 2025 Sep 10;19:8049-8050. doi: 10.2147/DDDT.S563756.</RefSource><PMID Version="1">40955308</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000775" MajorTopicYN="Y">Anesthesia, Spinal</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002585" MajorTopicYN="Y">Cesarean Section</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="Y">Hypotension</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007262" MajorTopicYN="N">Infusions, Intravenous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009638" MajorTopicYN="Y">Norepinephrine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010656" MajorTopicYN="Y">Phenylephrine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cesarean delivery</Keyword><Keyword MajorTopicYN="N">hypotension</Keyword><Keyword MajorTopicYN="N">non-inferiority</Keyword><Keyword MajorTopicYN="N">norepinephrine</Keyword><Keyword MajorTopicYN="N">phenylephrine</Keyword><Keyword MajorTopicYN="N">umbilical arterial pH</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>12</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>25</Day><Hour>4</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>6</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40557054</ArticleId><ArticleId IdType="pmc">PMC12186749</ArticleId><ArticleId IdType="doi">10.2147/DDDT.S514091</ArticleId><ArticleId IdType="pii">514091</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lee A, Ngan Kee W. Effects of vasoactive medications and maternal positioning during cesarean delivery on maternal hemodynamics and neonatal acid-base status. <i>Clin Perinatol</i>. 2019;46(4):765&#x2013;783. doi: 10.1016/j.clp.2019.08.009
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clp.2019.08.009</ArticleId><ArticleId IdType="pubmed">31653307</ArticleId></ArticleIdList></Reference><Reference><Citation>Consensus Statement Collaborators; Kinsella SM, Carvalho B, Dyer RA, et al. International consensus statement on the management of hypotension with vasopressors during caesarean section under spinal anaesthesia. <i>Anaesthesia</i>. 2018;73(1):71&#x2013;92. doi: 10.1111/anae.14080
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.14080</ArticleId><ArticleId IdType="pubmed">29090733</ArticleId></ArticleIdList></Reference><Reference><Citation>Sklebar I, Bujas T, Habek D. Spinal anaesthesia-induced hypotension in obstetrics: prevention and therapy. <i>Acta Clin Croat</i>. 2019;58(1):90&#x2013;95. doi: 10.20471/acc.2019.58.s1.13
</Citation><ArticleIdList><ArticleId IdType="doi">10.20471/acc.2019.58.s1.13</ArticleId><ArticleId IdType="pmc">PMC6813480</ArticleId><ArticleId IdType="pubmed">31741565</ArticleId></ArticleIdList></Reference><Reference><Citation>Lirk P, Haller I, Wong C. Management of spinal anaesthesia-induced hypotension for caesarean delivery: a European survey. <i>Eur J Anaesthesiol</i>. 2012;29(9):452&#x2013;453. doi: 10.1097/EJA.0b013e328352ab10
</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0b013e328352ab10</ArticleId><ArticleId IdType="pubmed">22472628</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Shen X, Liu S, Yang J, Xu S. The efficacy and safety of norepinephrine and its feasibility as a replacement for phenylephrine to manage maternal hypotension during elective cesarean delivery under spinal anesthesia. <i>Biomed Res Int</i>. 2018;2018:1869189. doi: 10.1155/2018/1869189
</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/1869189</ArticleId><ArticleId IdType="pmc">PMC6330831</ArticleId><ArticleId IdType="pubmed">30687737</ArticleId></ArticleIdList></Reference><Reference><Citation>Heesen M, K&#xf6;lhr S, Rossaint R, Straube S. Prophylactic phenylephrine for caesarean section under spinal anaesthesia: systematic review and meta-analysis. <i>Anaesthesia</i>. 2014;69(2):143&#x2013;165. doi: 10.1111/anae.12445
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.12445</ArticleId><ArticleId IdType="pubmed">24588024</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngan Kee WD, Lee SWY, Ng FF, et al. Randomized double-blinded comparison of norepinephrine and phenylephrine for maintenance of blood pressure during spinal anesthesia for cesarean delivery. <i>Anesthesiology</i>. 2015;122(4):736&#x2013;745. doi: 10.1097/ALN.0000000000000601
</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000601</ArticleId><ArticleId IdType="pubmed">25635593</ArticleId></ArticleIdList></Reference><Reference><Citation>Mon W, Stewart A, Fernando R, et al. Cardiac output changes with phenylephrine and ephedrine infusions during spinal anesthesia for cesarean section: a randomized, double-blind trial. <i>J Clin Anesth</i>. 2017;37:43&#x2013;48. doi: 10.1016/j.jclinane.2016.11.001
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2016.11.001</ArticleId><ArticleId IdType="pubmed">28235526</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Zou L, Li Z, et al. Prophylactic norepinephrine infusion for postspinal anaesthesia hypotension in patients undergoing caesarean section: a randomized, controlled, dose-finding trial. <i>Pharmacotherapy</i>. 2021;41(4):370&#x2013;378. doi: 10.1002/phar.2514
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/phar.2514</ArticleId><ArticleId IdType="pubmed">33583066</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasanin A, Amin S, Refaat S, et al. Norepinephrine versus phenylephrine infusion for prophylaxis against post-spinal anaesthesia hypotension during elective caesarean delivery: a randomised controlled trial. <i>Anaesth Crit Care Pain Med</i>. 2019;38(6):601&#x2013;607. doi: 10.1016/j.accpm.2019.03.005
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.accpm.2019.03.005</ArticleId><ArticleId IdType="pubmed">30935897</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondo Y, Hirose N, Maeda T, et al. Relationship between changes in regional cerebral blood volume and oxygenation and changes in cardiac output and systemic vascular resistance during spinal anesthesia in women undergoing cesarean section. <i>J Anesth</i>. 2019;33(5):579&#x2013;586. doi: 10.1007/s00540-019-02670-0
</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-019-02670-0</ArticleId><ArticleId IdType="pubmed">31392418</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngan Kee WD, Lee SWY, Ng FF, Lee A. Norepinephrine or phenylephrine during spinal anaesthesia for Caesarean delivery: a randomised double-blind pragmatic non-inferiority study of neonatal outcome. <i>Br J Anaesth</i>. 2020;125(4):588&#x2013;595. doi: 10.1016/j.bja.2020.05.057
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2020.05.057</ArticleId><ArticleId IdType="pubmed">32682556</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L, Tang Y, Guo F, et al. Norepinephrine or phenylephrine for the prevention of post-spinal hypotension after caesarean section: a double-blinded, randomized, controlled study of fetal heart rate and fetal cardiac output. <i>J Clin Anesth</i>. 2024;97:111533. doi: 10.1016/j.jclinane.2024.111533
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2024.111533</ArticleId><ArticleId IdType="pubmed">38880002</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T, Cheng Z, Zou S, et al. Effect of weight-adjusted phenylephrine, norepinephrine, and metaraminol for elective cesarean delivery on neonatal acid-base status: a randomized controlled trial. <i>Drug Des Devel Ther</i>. 2022;16:3215&#x2013;3223. doi: 10.2147/DDDT.S381048</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DDDT.S381048</ArticleId><ArticleId IdType="pmc">PMC9511707</ArticleId><ArticleId IdType="pubmed">36172051</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasanin AM, Amin SM, Agiza NA, et al. Norepinephrine infusion for preventing postspinal anesthesia hypotension during cesarean delivery: a randomized dose-finding trial. <i>Anesthesiology</i>. 2019;130(1):55&#x2013;62. doi: 10.1097/ALN.0000000000002483
</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000002483</ArticleId><ArticleId IdType="pubmed">30335625</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh PM, Singh NP, Reschke M, et al. Vasopressor drugs for the prevention and treatment of hypotension during neuraxial anaesthesia for caesarean delivery: a Bayesian network meta-analysis of fetal and maternal outcomes. <i>Br J Anaesth</i>. 2020;124(1):95&#x2013;107. doi: 10.1016/j.bja.2019.09.045</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2019.09.045</ArticleId><ArticleId IdType="pubmed">31810562</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin WD, Mao JQ, Liu J, et al. Comparative dose-response study on the infusion of norepinephrine combined with crystalloid coload versus colloid coload for preventing hypotension during spinal anesthesia for cesarean delivery. <i>Drug Des Devel Ther</i>. 2022;16:2617&#x2013;2626. doi: 10.2147/DDDT.S378453</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DDDT.S378453</ArticleId><ArticleId IdType="pmc">PMC9365323</ArticleId><ArticleId IdType="pubmed">35965962</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao F, Shen B, Xu WP, et al. Dose-response study of 4 weight-based phenylephrine infusion regimens for preventing hypotension during cesarean delivery under combined spinal-epidural anesthesia. <i>Anesth Analg</i>. 2020;130(1):187&#x2013;193. doi: 10.1213/ANE.0000000000004092
</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000004092</ArticleId><ArticleId IdType="pubmed">30829668</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian J, Zhao YP, Deng JL, et al. Determination of the relative potency of norepinephrine and phenylephrine given as infusions for preventing hypotension during combined spinal-epidural anesthesia for cesarean delivery: a randomized up-and-down sequential allocation study. <i>Front Pharmacol</i>. 2022;13:942005. doi: 10.3389/fphar.2022.942005
</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.942005</ArticleId><ArticleId IdType="pmc">PMC9330490</ArticleId><ArticleId IdType="pubmed">35910385</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H, Huang Y, Diao M, et al. Determination of the 90% effective dose (ED90) of phenylephrine for hypotension during elective cesarean delivery using a continual reassessment method. <i>Eur J Obstet Gynecol Reprod Biol</i>. 2015;194:136&#x2013;140. doi: 10.1016/j.ejogrb.2015.07.001
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejogrb.2015.07.001</ArticleId><ArticleId IdType="pubmed">26372882</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharkey AM, Siddiqui N, Downey K, et al. Comparison of intermittent intravenous boluses of phenylephrine and norepinephrine to prevent and treat spinal-induced hypotension in cesarean deliveries: randomized controlled trial. <i>Anesth Analg</i>. 2019;129(5):1312&#x2013;1318. doi: 10.1213/ANE.0000000000003704
</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000003704</ArticleId><ArticleId IdType="pubmed">30113395</ArticleId></ArticleIdList></Reference><Reference><Citation>Theodoraki K, Hadzilia S, Valsamidis D, Stamatakis E. Prevention of hypotension during elective cesarean section with a fixed-rate norepinephrine infusion versus a fixed-rate phenylephrine infusion. &#x391; double-blinded randomized controlled trial. <i>Int J Surg</i>. 2020;84:41&#x2013;49. doi: 10.1016/j.ijsu.2020.10.006
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2020.10.006</ArticleId><ArticleId IdType="pubmed">33080415</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh P, Emary K, Impey L. The relationship between umbilical cord arterial pH and serious adverse neonatal outcome: analysis of 51,519 consecutive validated samples. <i>BJOG</i>. 2012;119(7):824&#x2013;831. doi: 10.1111/j.1471-0528.2012.03335.x
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-0528.2012.03335.x</ArticleId><ArticleId IdType="pubmed">22571747</ArticleId></ArticleIdList></Reference><Reference><Citation>Knutzen L, Svirko E, Impey L. The significance of base deficit in acidemic term neonates. <i>Am J Obstet Gynecol</i>. 2015;213(3):373.e1&#x2013;373.e7. doi: 10.1016/j.ajog.2015.03.051</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2015.03.051</ArticleId><ArticleId IdType="pubmed">25827502</ArticleId></ArticleIdList></Reference><Reference><Citation>Theodoraki K, Hadzilia S, Valsamidis D, et al. Colloid preload versus crystalloid co-load in the setting of norepinephrine infusion during cesarean section: time and type of administered fluids do not matter. <i>J Clin Med</i>. 2023;12(4):1333. doi: 10.3390/jcm12041333
</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12041333</ArticleId><ArticleId IdType="pmc">PMC9964611</ArticleId><ArticleId IdType="pubmed">36835869</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W, Drzymalski DM, Ai L, et al. The ED50 and ED95 of prophylactic norepinephrine for preventing post-spinal hypotension during cesarean delivery under combined spinal-epidural anesthesia: a prospective dose-finding study. <i>Front Pharmacol</i>. 2021;12:691809. doi: 10.3389/fphar.2021.691809
</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.691809</ArticleId><ArticleId IdType="pmc">PMC8312548</ArticleId><ArticleId IdType="pubmed">34322021</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu F, Xiao F, Chen W, et al. A randomised double-blind dose-response study of weight-adjusted infusions of norepinephrine for preventing hypotension during combined spinal-epidural anaesthesia for Caesarean delivery. <i>Br J Anaesth</i>. 2020;124(3):e108&#x2013;e114. doi: 10.1016/j.bja.2019.12.019
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2019.12.019</ArticleId><ArticleId IdType="pubmed">31959386</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngan Kee WD, Lee A. Multivariate analysis of factors associated with umbilical arterial pH and standard base excess after Caesarean section under spinal anaesthesia. <i>Anaesthesia</i>. 2003;58(2):125&#x2013;130. doi: 10.1046/j.1365-2044.2003.02888.x
</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2044.2003.02888.x</ArticleId><ArticleId IdType="pubmed">12562407</ArticleId></ArticleIdList></Reference><Reference><Citation>Murlewska J, Sylwestrzak O, Poszwa P, et al. The effect of nuchal umbilical cord on fetal cardiac and cerebral circulation: cross-sectional study. <i>J Perinat Med</i>. 2021;49(5):590&#x2013;595. doi: 10.1515/jpm-2020-0316
</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/jpm-2020-0316</ArticleId><ArticleId IdType="pubmed">33567478</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28796427</PMID><DateCompleted><Year>2018</Year><Month>07</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1538-7836</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>9</Issue><PubDate><Year>2017</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of thrombosis and haemostasis : JTH</Title><ISOAbbreviation>J Thromb Haemost</ISOAbbreviation></Journal><ArticleTitle>Epidemiology of venous thromboembolism in Africa: a systematic review.</ArticleTitle><Pagination><StartPage>1770</StartPage><EndPage>1781</EndPage><MedlinePgn>1770-1781</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jth.13769</ELocationID><Abstract><AbstractText Label="UNLABELLED">Essentials Venous thromboembolism (VTE) is among the three main causes of cardiovascular disease worldwide. This review is the first to summarize the epidemiology of VTE in African populations. The prevalence of VTE in Africa is high following surgery, in pregnancy and post-partum. At least one quarter of patients at risk of VTE in Africa are not receiving prophylaxis.</AbstractText><AbstractText Label="SUMMARY">Background Venous thromboembolism (VTE) is among the three leading causes of cardiovascular disease worldwide. Despite its high burden, there has been no previous study summarizing the epidemiology of VTE in African populations. Hence, we conducted this systematic review to determine the prevalence, incidence and mortality associated with VTE, and to evaluate the use of VTE prophylaxis in Africa. Methods We searched PubMed, Scopus and African Journals Online to identify articles published on VTE in Africa from inception to November 19, 2016, without language restriction. The reference list of eligible articles were further scrutinized to identify potential additional studies. Results Overall, we included 21 studies. The great majority of the studies yielded a moderate risk of bias. The prevalence of deep vein thrombosis (DVT) varied between 2.4% and 9.6% in postoperative patients, and between 380 and 448 per 100 000 births per year in pregnant and postpartum women. The prevalence of pulmonary embolism (PE) in medical patients varied between 0.14% and 61.5%, with a mortality rate of PE between 40% and 69.5%. The case-fatality rate after surgery was 60%. Overall, 31.7-75% of the patients were at risk of VTE, and between 34.2% and 96.5% of these received VTE prophylaxis. Conclusion The prevalence of VTE and associated mortality are high following surgery, and in pregnant and postpartum women in Africa. At least one-quarter of patients who are at risk for VTE in Africa are not receiving prophylaxis. These results are generated from studies with small sample size, highlighting an urgent need for well-designed studies with larger sample size to evaluate the true burden of VTE in Africa.</AbstractText><CopyrightInformation>&#xa9; 2017 International Society on Thrombosis and Haemostasis.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Danwang</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Surgery and Specialties, Faculty of Medicine and Biomedical Sciences, University of Yaound&#xe9; I, Yaound&#xe9;, Cameroon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Temgoua</LastName><ForeName>M N</ForeName><Initials>MN</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Specialties, Faculty of Medicine and Biomedical Sciences, University of Yaound&#xe9; I, Yaound&#xe9;, Cameroon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agbor</LastName><ForeName>V N</ForeName><Initials>VN</Initials><AffiliationInfo><Affiliation>Ibal Sub-divisional Hospital, Oku, North-west Region, Cameroon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tankeu</LastName><ForeName>A T</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Specialties, Faculty of Medicine and Biomedical Sciences, University of Yaound&#xe9; I, Yaound&#xe9;, Cameroon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Noubiap</LastName><ForeName>J J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Medicine, Groote Schuur Hospital and University of Cape Town, Cape Town, South Africa.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>08</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Thromb Haemost</MedlineTA><NlmUniqueID>101170508</NlmUniqueID><ISSNLinking>1538-7836</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005343">Fibrinolytic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000349" MajorTopicYN="N">Africa</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002423" MajorTopicYN="N">Cause of Death</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005343" MajorTopicYN="N">Fibrinolytic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008428" MajorTopicYN="N">Maternal Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011249" MajorTopicYN="N">Pregnancy Complications, Cardiovascular</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="N">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Africa</Keyword><Keyword MajorTopicYN="N">deep vein thrombosis</Keyword><Keyword MajorTopicYN="N">pulmonary embolism</Keyword><Keyword MajorTopicYN="N">venous thrombosis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>5</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>7</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28796427</ArticleId><ArticleId IdType="doi">10.1111/jth.13769</ArticleId><ArticleId IdType="pii">S1538-7836(22)00861-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29229621</PMID><DateCompleted><Year>2017</Year><Month>12</Month><Day>26</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1524-4539</ISSN><JournalIssue CitedMedium="Internet"><Volume>136</Volume><Issue>24</Issue><PubDate><Year>2017</Year><Month>Dec</Month><Day>12</Day></PubDate></JournalIssue><Title>Circulation</Title><ISOAbbreviation>Circulation</ISOAbbreviation></Journal><ArticleTitle>Stem Cell Therapy for Congenital Heart Disease: A Systematic Review.</ArticleTitle><Pagination><StartPage>2373</StartPage><EndPage>2385</EndPage><MedlinePgn>2373-2385</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1161/CIRCULATIONAHA.117.029607</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Congenital heart disease (CHD) constitutes the most prevalent and heterogeneous group of congenital anomalies. Although surgery remains the gold standard treatment modality, stem cell therapy has been gaining ground as a complimentary or alternative treatment option in certain types of CHD. The aim of this study was to present the existing published evidence and ongoing research efforts on the implementation of stem cell-based therapeutic strategies in CHD.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic review was conducted by searching Medline, ClinicalTrials.gov, and the Cochrane library, along with reference lists of the included studies through April 23, 2017.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Nineteen studies were included in this review (8 preclinical, 6 clinical, and 5 ongoing trials). Various routes of cardiac stem cell delivery have been reported, including intracoronary, intramyocardial, intravenous, and epicardial. Depending on their origin and level of differentiation at which they are harvested, stem cells may exhibit different properties. Preclinical studies have mostly focused on modeling right ventricle dysfunction or failure and pulmonary artery hypertension by using pressure or volume overload in vitro or in vivo. Only a limited number of clinical trials on patients with CHD exist, and these primarily focus on hypoplastic left heart syndrome. Cell-based tissue engineering has recently been introduced, and research currently is focusing on developing cell-seeded grafts and patches that could potentially grow in parallel with whole body growth once implanted in the heart.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">It seems that stem cell delivery to the diseased heart as an adjunct to surgical palliation may provide some benefits over surgery alone in terms of cardiac function, somatic growth, and quality of life. Despite encouraging preliminary results, stem cell therapies for patients with CHD should only be considered in the setting of well-designed clinical trials. More wet laboratory research experience is needed, and translation of promising findings to large clinical studies is warranted to clearly define the efficacy and safety profile of this alternative and potentially groundbreaking therapeutic approach.</AbstractText><CopyrightInformation>&#xa9; 2017 American Heart Association, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tsilimigras</LastName><ForeName>Diamantis I</ForeName><Initials>DI</Initials><AffiliationInfo><Affiliation>School of Medicine (D.I.T.).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National and Kapodistrian University of Athens, Greece. Surgery Working Group (D.I.T., D.M., D.S., K.P.E).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oikonomou</LastName><ForeName>Evangelos K</ForeName><Initials>EK</Initials><AffiliationInfo><Affiliation>Cardiology Working Group (E.K.O.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moris</LastName><ForeName>Demetrios</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>National and Kapodistrian University of Athens, Greece. Surgery Working Group (D.I.T., D.M., D.S., K.P.E).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Society of Junior Doctors, Athens, Greece. Department of Surgery, The Ohio State Comprehensive Cancer Center, The Ohio State University, Columbus (D.M.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schizas</LastName><ForeName>Dimitrios</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>First Department of Surgery, Laiko General Hospital (D.S.).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National and Kapodistrian University of Athens, Greece. Surgery Working Group (D.I.T., D.M., D.S., K.P.E).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Economopoulos</LastName><ForeName>Konstantinos P</ForeName><Initials>KP</Initials><AffiliationInfo><Affiliation>National and Kapodistrian University of Athens, Greece. Surgery Working Group (D.I.T., D.M., D.S., K.P.E) economopoulos@sni.gr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Organ Engineering and Regeneration Laboratory (K.P.E.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mylonas</LastName><ForeName>Konstantinos S</ForeName><Initials>KS</Initials><AffiliationInfo><Affiliation>Pediatrics Working Group (K.S.M.).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatric Surgery (K.S.M.), Massachusetts General Hospital, Harvard Medical School, Boston.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Circulation</MedlineTA><NlmUniqueID>0147763</NlmUniqueID><ISSNLinking>0009-7322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D048091" MajorTopicYN="N">Guided Tissue Regeneration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006330" MajorTopicYN="N">Heart Defects, Congenital</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018636" MajorTopicYN="N">Hypoplastic Left Heart Syndrome</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D033581" MajorTopicYN="Y">Stem Cell Transplantation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D023822" MajorTopicYN="N">Tissue Engineering</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">congenital cardiac defects</Keyword><Keyword MajorTopicYN="N">congenital heart disease</Keyword><Keyword MajorTopicYN="N">stem cells</Keyword><Keyword MajorTopicYN="N">tissue engineering</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>5</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>10</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>12</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>12</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>12</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29229621</ArticleId><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.117.029607</ArticleId><ArticleId IdType="pii">CIRCULATIONAHA.117.029607</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37487402</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>12</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1808-8686</ISSN><JournalIssue CitedMedium="Internet"><Volume>89</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Season>Sep-Oct</Season></PubDate></JournalIssue><Title>Brazilian journal of otorhinolaryngology</Title><ISOAbbreviation>Braz J Otorhinolaryngol</ISOAbbreviation></Journal><ArticleTitle>Sialendoscopy for treatment of major salivary glands diseases: a comprehensive analysis of published systematic reviews and meta-analyses.</ArticleTitle><Pagination><StartPage>101293</StartPage><MedlinePgn>101293</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">101293</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bjorl.2023.101293</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1808-8694(23)00061-7</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Sialendoscopy is a minimally invasive procedure used to diagnose and treat obstructive salivary gland diseases. Previous studies in the topic have shown mixed results. The present study aimed to evaluate the efficacy and safety of sialendoscopy through previous systematic reviews for different outcomes of several diseases. We also aimed to assess studies' methodological quality and heterogeneity.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a comprehensive systematic literature search of Pubmed, Embase, Lilacs and Cochrane Library. We included systematic reviews and meta-analyses that used sialendoscopy to treat both lithiasic and alithiasic salivary glands diseases. Data extraction included studies' characteristics and results. We assessed studies' methodological quality using the AMSTAR-2 (A MeaSurement Tool to Assess systematic Reviews 2) tool.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">13 studies were included in the review, being 9 in adult populations and 4 in pediatric populations. Sialendoscopy proved to be effective at the treatment of different lithiasic and other obstructive diseases, but with important heterogeneity. The technique was also considered highly safe in most studies. However, studies had a critically low quality of evidence.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Most studies demonstrated high efficacy and safety of sialendoscopy, but with critically low quality of evidence. We still lack randomized studies in this field, and future systematic reviews on the topic should follow current guidelines to improve conduction and reporting.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Associa&#xe7;&#xe3;o Brasileira de Otorrinolaringologia e Cirurgia C&#xe9;rvico-Facial. Published by Elsevier Espa&#xf1;a S.L.U. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kallas-Silva</LastName><ForeName>Lucas</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Faculdade Israelita de Ci&#xea;ncias da Sa&#xfa;de Albert Einstein, Servi&#xe7;o de Cirurgia de Cabe&#xe7;a e Pesco&#xe7;o, S&#xe3;o Paulo, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Azevedo</LastName><ForeName>Maria Fernanda Dias</ForeName><Initials>MFD</Initials><AffiliationInfo><Affiliation>Faculdade Israelita de Ci&#xea;ncias da Sa&#xfa;de Albert Einstein, Servi&#xe7;o de Cirurgia de Cabe&#xe7;a e Pesco&#xe7;o, S&#xe3;o Paulo, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Matos</LastName><ForeName>F&#xe1;tima Cristina Mendes</ForeName><Initials>FCM</Initials><AffiliationInfo><Affiliation>Universidade de Pernambuco (UPE), Pernambuco, PE, Brazil; Vice-presidente da Sociedade Brasileira de Cirurgia de Cabe&#xe7;a e Pesco&#xe7;o, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petrarrolha</LastName><ForeName>Silvia Picado</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>Hospital das Cl&#xed;nicas da Faculdade de Medicina da Universidade de S&#xe3;o Paulo (HCFMUSP), Departamento de Cirurgia (Cirurgia de Cabe&#xe7;a e Pesco&#xe7;o), S&#xe3;o Paulo, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dedivitis</LastName><ForeName>Rog&#xe9;rio Aparecido</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Hospital das Cl&#xed;nicas da Faculdade de Medicina da Universidade de S&#xe3;o Paulo (HCFMUSP), Departamento de Cirurgia (Cirurgia de Cabe&#xe7;a e Pesco&#xe7;o), S&#xe3;o Paulo, SP, Brazil; Ex-presidente da Sociedade Brasileira de Cirurgia de Cabe&#xe7;a e Pesco&#xe7;o, Brazil. Electronic address: dedivitis.hns@uol.com.br.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kulcsar</LastName><ForeName>Marco Aur&#xe9;lio Vamondes</ForeName><Initials>MAV</Initials><AffiliationInfo><Affiliation>Hospital das Cl&#xed;nicas da Faculdade de Medicina da Universidade de S&#xe3;o Paulo (HCFMUSP), Instituto do C&#xe2;ncer do Estado de S&#xe3;o Paulo (Icesp), Cirurgia de Cabe&#xe7;a e Pesco&#xe7;o, S&#xe3;o Paulo, SP, Brazil; Presidente da Sociedade Brasileira de Cirurgia de Cabe&#xe7;a e Pesco&#xe7;o, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matos</LastName><ForeName>Leandro Luongo</ForeName><Initials>LL</Initials><AffiliationInfo><Affiliation>Hospital das Cl&#xed;nicas da Faculdade de Medicina da Universidade de S&#xe3;o Paulo (HCFMUSP), Instituto do C&#xe2;ncer do Estado de S&#xe3;o Paulo (Icesp), Cirurgia de Cabe&#xe7;a e Pesco&#xe7;o, S&#xe3;o Paulo, SP, Brazil; Faculdade Israelita de Ci&#xea;ncias da Sa&#xfa;de Albert Einstein, Cl&#xed;nica Cir&#xfa;rgica, S&#xe3;o Paulo, SP, Brazil; Diretor Cient&#xed;fico da Sociedade Brasileira de Cirurgia de Cabe&#xe7;a e Pesco&#xe7;o, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Braz J Otorhinolaryngol</MedlineTA><NlmUniqueID>101207337</NlmUniqueID><ISSNLinking>1808-8686</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004724" MajorTopicYN="Y">Endoscopy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012466" MajorTopicYN="Y">Salivary Gland Diseases</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012469" MajorTopicYN="N">Salivary Glands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000078202" MajorTopicYN="N">Systematic Reviews as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015201" MajorTopicYN="N">Meta-Analysis as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Evidence-based practice</Keyword><Keyword MajorTopicYN="N">Salivary gland</Keyword><Keyword MajorTopicYN="N">Salivary gland calculi</Keyword><Keyword MajorTopicYN="N">Sialadenitis</Keyword><Keyword MajorTopicYN="N">Sialendoscopy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>25</Day><Hour>1</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>25</Day><Hour>1</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>24</Day><Hour>18</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37487402</ArticleId><ArticleId IdType="pmc">PMC10382863</ArticleId><ArticleId IdType="doi">10.1016/j.bjorl.2023.101293</ArticleId><ArticleId IdType="pii">S1808-8694(23)00061-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Richardson W.S., Wilson M.C., Nishikawa J., Hayward R.S. The well-built clinical question: a key to evidence-based decisions. ACP J Club. 1995;12:A12&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">7582737</ArticleId></ArticleIdList></Reference><Reference><Citation>Page M.J., McKenzie J.E., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D., et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Shea B.J., Reeves B.C., Wells G., Thuku M., Hamel C., Moran J., et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5833365</ArticleId><ArticleId IdType="pubmed">28935701</ArticleId></ArticleIdList></Reference><Reference><Citation>Strychowsky J.E., Sommer D.D., Gupta M.K., Cohen N., Nahlieli O. Sialendoscopy for the management of obstructive salivary gland disease a systematic review and meta-analysis. Arch Otolaryngol Head Neck Surg. 2012;138:541&#x2013;547.</Citation><ArticleIdList><ArticleId IdType="pubmed">22710505</ArticleId></ArticleIdList></Reference><Reference><Citation>Jadu F.M., Jan A.M. A meta-analysis of the efficacy and safety of managing parotid and submandibular sialoliths using sialendoscopy assisted surgery. Saudi Med J. 2014;35:1188&#x2013;1194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4362127</ArticleId><ArticleId IdType="pubmed">25316462</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramakrishna J., Strychowsky J., Gupta M., Sommer D.D. Sialendoscopy for the management of juvenile recurrent parotitis: a systematic review and meta-analysis. Laryngoscope. 2015;125:1472&#x2013;1479.</Citation><ArticleIdList><ArticleId IdType="pubmed">25393103</ArticleId></ArticleIdList></Reference><Reference><Citation>Atienza G., L&#xf3;pez-Cedr&#xfa;n J.L. Management of obstructive salivary disorders by sialendoscopy: a systematic review. Br J Oral and Maxillofac Surg. 2015;53:507&#x2013;519.</Citation><ArticleIdList><ArticleId IdType="pubmed">25823614</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva L., Babicsak G., Dolci R.L. Salivary gland endoscopy in children: a systematic review. Rev Assoc Med Bras (1992) 2016;62:795&#x2013;799.</Citation><ArticleIdList><ArticleId IdType="pubmed">27992022</ArticleId></ArticleIdList></Reference><Reference><Citation>Cung T.D., Lai W., Svider P.F., Hanba C., Samantray J., Folbe A.J., et al. Sialendoscopy in the management of radioiodine induced sialadenitis: a systematic review. Ann Otol Rhinol Laryngol. 2017;126:768&#x2013;773.</Citation><ArticleIdList><ArticleId IdType="pubmed">28949251</ArticleId></ArticleIdList></Reference><Reference><Citation>Roland L.T., Skillington S.A., Ogden M.A. Sialendoscopy-assisted transfacial removal of parotid sialoliths: a systematic review and meta-analysis. Laryngoscope. 2017;127:2510&#x2013;2516.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5654665</ArticleId><ArticleId IdType="pubmed">28480577</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarz Y., Bezdjian A., Daniel S.J. Sialendoscopy in treating pediatric salivary gland disorders: a systematic review. Eur Arch Otorhinolaryngol. 2018;275:347&#x2013;356.</Citation><ArticleIdList><ArticleId IdType="pubmed">29204918</ArticleId></ArticleIdList></Reference><Reference><Citation>Garavello W., Redaelli M., Galluzzi F., Pignataro L. Juvenile recurrent parotitis: a systematic review of treatment studies. Int J Pediatr Otorhinolaryngol. 2018;112:151&#x2013;157.</Citation><ArticleIdList><ArticleId IdType="pubmed">30055724</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiesa-Estomba C.M., Saga-Gutierrez C., Calvo-Henriquez C., et al. Laser-assisted lithotripsy with sialendoscopy: systematic review of yo-ifos head and neck study group. Ear Nose Throat J. 2021;100(1_suppl):42S&#x2013;50S.</Citation><ArticleIdList><ArticleId IdType="pubmed">32442031</ArticleId></ArticleIdList></Reference><Reference><Citation>Coca K.K., Gillespie M.B., Beckmann N.A., Zhu R., Nelson T.M., Witt R.L. Sialendoscopy and Sjogren&#x2019;s disease: a systematic review. Laryngoscope. 2021;131:1474&#x2013;1481.</Citation><ArticleIdList><ArticleId IdType="pubmed">33141438</ArticleId></ArticleIdList></Reference><Reference><Citation>Galdermans M., Gemels B. Success rate and complications of sialendoscopy and sialolithotripsy in patients with parotid sialolithiasis: a systematic review. Oral Maxillofac Surg. 2020;24:145&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pubmed">32162129</ArticleId></ArticleIdList></Reference><Reference><Citation>Donaldson G., de Paiva Leite S., Hardcastle T., Ahmad Z., Morton R.P. The need for studies on oral corticosteroids after sialendoscopy for obstructive salivary gland disease: systematic review. Ann Otol Rhinol Laryngol. 2022;131:805&#x2013;811.</Citation><ArticleIdList><ArticleId IdType="pubmed">34493105</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanabria A., Kowalski L.P., Nixon I., Angelos P., Shaha A., Owen R.P., et al. Methodological quality of systematic reviews of intraoperative neuromonitoring in thyroidectomy: a systematic review. JAMA Otolaryngol Head Neck Surg. 2019;145:563&#x2013;573.</Citation><ArticleIdList><ArticleId IdType="pubmed">30973598</ArticleId></ArticleIdList></Reference><Reference><Citation>Henry B.M., Graves M.J., Vikse J., Sanna B., P&#x119;kala P.A., Walocha J.A., et al. The current state of intermittent intraoperative neural monitoring for prevention of recurrent laryngeal nerve injury during thyroidectomy: a PRISMA-compliant systematic review of overlapping meta-analyses. Langenbecks Arch Surg. 2017;402:663&#x2013;673.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5437188</ArticleId><ArticleId IdType="pubmed">28378238</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25635593</PMID><DateCompleted><Year>2015</Year><Month>06</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>29</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1528-1175</ISSN><JournalIssue CitedMedium="Internet"><Volume>122</Volume><Issue>4</Issue><PubDate><Year>2015</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Anesthesiology</Title><ISOAbbreviation>Anesthesiology</ISOAbbreviation></Journal><ArticleTitle>Randomized double-blinded comparison of norepinephrine and phenylephrine for maintenance of blood pressure during spinal anesthesia for cesarean delivery.</ArticleTitle><Pagination><StartPage>736</StartPage><EndPage>745</EndPage><MedlinePgn>736-45</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/ALN.0000000000000601</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">During spinal anesthesia for cesarean delivery, phenylephrine can cause reflexive decreases in maternal heart rate and cardiac output. Norepinephrine has weak &#x3b2;-adrenergic receptor agonist activity in addition to potent &#x3b1;-adrenergic receptor activity and therefore may be suitable for maintaining blood pressure with less negative effects on heart rate and cardiac output compared with phenylephrine.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In a randomized, double-blinded study, 104 healthy patients having cesarean delivery under spinal anesthesia were randomized to have systolic blood pressure maintained with a computer-controlled infusion of norepinephrine 5 &#x3bc;g/ml or phenylephrine 100 &#x3bc;g/ml. The primary outcome compared was cardiac output. Blood pressure heart rate and neonatal outcome were also compared.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Normalized cardiac output 5 min after induction was greater in the norepinephrine group versus the phenylephrine group (median 102.7% [interquartile range, 94.3 to 116.7%] versus 93.8% [85.0 to 103.1%], P = 0.004, median difference 9.8%, 95% CI of difference between medians 2.8 to 16.1%). From induction until uterine incision, for norepinephrine versus phenylephrine, systolic blood pressure and stroke volume were similar, heart rate and cardiac output were greater, systemic vascular resistance was lower, and the incidence of bradycardia was smaller. Neonatal outcome was similar between groups.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">When given by computer-controlled infusion during spinal anesthesia for cesarean delivery, norepinephrine was effective for maintaining blood pressure and was associated with greater heart rate and cardiac output compared with phenylephrine. Further work would be of interest to confirm the safety and efficacy of norepinephrine as a vasopressor in obstetric patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ngan Kee</LastName><ForeName>Warwick D</ForeName><Initials>WD</Initials><AffiliationInfo><Affiliation>From the Department of Anaesthesia and Intensive Care, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong, China (W.D.N.K., F.F.N., P.E.T., K.S.K.); and Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Kowloon, Hong Kong, China (S.W.Y.L.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Shara W Y</ForeName><Initials>SW</Initials></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Floria F</ForeName><Initials>FF</Initials></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Perpetua E</ForeName><Initials>PE</Initials></Author><Author ValidYN="Y"><LastName>Khaw</LastName><ForeName>Kim S</ForeName><Initials>KS</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesthesiology</MedlineTA><NlmUniqueID>1300217</NlmUniqueID><ISSNLinking>0003-3022</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>1WS297W6MV</RegistryNumber><NameOfSubstance UI="D010656">Phenylephrine</NameOfSubstance></Chemical><Chemical><RegistryNumber>X4W3ENH1CV</RegistryNumber><NameOfSubstance UI="D009638">Norepinephrine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Anesthesiology. 2015 Apr;122(4):728-30. doi: 10.1097/ALN.0000000000000602.</RefSource><PMID Version="1">25654435</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000775" MajorTopicYN="Y">Anesthesia, Spinal</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001794" MajorTopicYN="N">Blood Pressure</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001795" MajorTopicYN="N">Blood Pressure Determination</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002585" MajorTopicYN="Y">Cesarean Section</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016343" MajorTopicYN="N">Monitoring, Intraoperative</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009638" MajorTopicYN="N">Norepinephrine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010656" MajorTopicYN="N">Phenylephrine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25635593</ArticleId><ArticleId IdType="doi">10.1097/ALN.0000000000000601</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37364610</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>05</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1439-359X</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Aug</Month></PubDate></JournalIssue><Title>European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie</Title><ISOAbbreviation>Eur J Pediatr Surg</ISOAbbreviation></Journal><ArticleTitle>A Randomized Controlled Trial of Cryoanalgesia for Pain Management following Pectus Excavatum Repair: A Single-Center, Single-Blind, Parallel Design Study.</ArticleTitle><Pagination><StartPage>338</StartPage><EndPage>345</EndPage><MedlinePgn>338-345</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1055/a-2117-4628</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">&#x2003;Conventional postoperative pain management, with an intravenous patient-controlled approach or thoracic epidural analgesia, has proved suboptimal following a minimally invasive repair of pectus excavatum. Considering its postulated mechanism of action, we encouraged cryoanalgesia as an effective method for postrepair pain management and a possibly superior alternative.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">&#x2003;A randomized, single-blind clinical trial was tested on patients undergoing pectus excavatum (PE) repair in March and December 2022. Among 101 patients, consenting study participants were randomly assigned to one of two groups: cryoanalgesia (group C, <i>n</i>&#x2009;=&#x2009;24) or noncryoanalgesia (group N, <i>n</i>&#x2009;=&#x2009;24). Group N received conventional pain management. Comparing the results, pain levels were measured using the visual analog scale (VAS-R for resting and VAS-D for dynamic) and the total rescue analgesic consumption was determined. Intrathoracic cryoablation was performed bilaterally on the fourth and seventh intercostal nerves using a cryoprobe at -80&#xb0;C for 2&#x2009;minutes.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">&#x2003;The two groups had similar baseline-patient characteristics; however, group C had a longer mean operative time (159 vs. 125&#x2009;minutes, <i>p</i>&#x2009;&lt;&#x2009;0.01) and experienced significantly less pain throughout the postoperative course, with VAS at 6&#x2009;hours (5.38 vs. 7.04, <i>p</i>&#x2009;&lt;&#x2009;0.01) and 48&#x2009;hours (3.17 vs. 5.67, <i>p</i>&#x2009;&lt;&#x2009;0.01).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">&#x2003;Cryoanalgesia improved postoperative pain control at rest and during movement following PE repair. However, the outcome was less favorable than expected because the VAS was greater than 4 (moderate pain), although after a day or two, it decreased to lower levels (VAS&#x2009;&lt;&#x2009;4) in the cyro group. Considering its extra invasiveness and instrumentation, a routine cryoanalgesia procedure for pectus surgery is yet to be determined.</AbstractText><CopyrightInformation>Thieme. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rim</LastName><ForeName>Gong Min</ForeName><Initials>GM</Initials><Identifier Source="ORCID">0000-0002-0982-7851</Identifier><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Nanoori Hospitals, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Hee Kyung</ForeName><Initials>HK</Initials><AffiliationInfo><Affiliation>Department of Thoracic and Cardiovascular Surgery-Cardiothoracic Surgery, Seoul St. Mary's Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koo</LastName><ForeName>Jung Min</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, College of Medicine, The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Hyung Joo</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Department of Thoracic and Cardiovascular Surgery, Seoul St. Mary's Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Eur J Pediatr Surg</MedlineTA><NlmUniqueID>9105263</NlmUniqueID><ISSNLinking>0939-7248</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005660" MajorTopicYN="Y">Funnel Chest</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016037" MajorTopicYN="N">Single-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010149" MajorTopicYN="Y">Pain, Postoperative</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003452" MajorTopicYN="Y">Cryosurgery</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010147" MajorTopicYN="Y">Pain Measurement</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059408" MajorTopicYN="Y">Pain Management</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017679" MajorTopicYN="N">Cryotherapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>6</Day><Hour>10</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>27</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>26</Day><Hour>19</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37364610</ArticleId><ArticleId IdType="doi">10.1055/a-2117-4628</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36075369</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>20</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1439-359X</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie</Title><ISOAbbreviation>Eur J Pediatr Surg</ISOAbbreviation></Journal><ArticleTitle>Rhabdomyolysis following Nuss Procedure: A Prospective Study in Children.</ArticleTitle><Pagination><StartPage>35</StartPage><EndPage>40</EndPage><MedlinePgn>35-40</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1055/a-1939-3891</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">&#x2003;Postoperative rhabdomyolysis (RML) has been documented after several surgical procedures in adults. Musculoskeletal remodeling after Nuss procedure for pectus excavatum (PE) could cause RML. We evaluated the incidence of RML after Nuss procedure in children.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">&#x2003;This study was a prospective study from 2018 to 2021. We enrolled all otherwise healthy patients who underwent PE correction with only one bar. Studied variables included demographic and clinical data, duration of surgery, complications, and length of hospitalization. The patients included underwent serial measurements of serum creatine kinase (CK), troponin I, N terminal pro B-type natriuretic peptide (NT-proBNP), serum creatinine, urea, and glomerular filtration rate at 6 and 48&#x2009;hours postoperatively, and hospital discharge.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">&#x2003;Forty-six patients met criteria (40 males/6 females), with a mean age of 15.1&#x2009;&#xb1;&#x2009;1.4 years. Mean duration of surgery was 74&#x2009;&#xb1;&#x2009;28&#x2009;minutes, and length of hospitalization was 4.6&#x2009;&#xb1;&#x2009;1.6 days. RML was diagnosed in 30.4% of patients at 6&#x2009;hours, 91.3% at 48&#x2009;hours, and 21.7% at hospital discharge. Mean preoperative CK value was 181.1&#x2009;&#xb1;&#x2009;141.6&#x2009;IU/L, and postoperative values were 863.3&#x2009;&#xb1;&#x2009;302.6&#x2009;IU/L at 6&#x2009;hours, 1,675.2&#x2009;&#xb1;&#x2009;561&#x2009;IU/L at 48&#x2009;hours, and 850&#x2009;&#xb1;&#x2009;683.7&#x2009;IU/L at hospital discharge, with statistically significant differences (<i>p</i>&#x2009;=&#x2009;0.001). High-sensitivity troponin I and NT-proBNP levels increased significantly during the postoperative time (<i>p</i>&#x2009;=&#x2009;0.001). Renal function remained stable (<i>p</i>&#x2009;=&#x2009;0.55).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">&#x2003;Nuss technique produces RML without kidney injury in healthy patients. This knowledge should be considered for patients at increased risk of developing acute kidney injury and other complications.</AbstractText><CopyrightInformation>Thieme. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Estefan&#xed;a</LastName><ForeName>Karla</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pediatric Surgery, Hospital Universitario La Paz, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serradilla</LastName><ForeName>Javier</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pediatric Surgery, Hospital Universitario La Paz, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramirez</LastName><ForeName>Carla</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pediatric Surgery, Hospital Universitario La Paz, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Velayos</LastName><ForeName>Maria</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-3997-2291</Identifier><AffiliationInfo><Affiliation>Department of Pediatric Surgery, Hospital Universitario La Paz, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mu&#xf1;oz-Serrano</LastName><ForeName>Antonio Jesus</ForeName><Initials>AJ</Initials><Identifier Source="ORCID">0000-0002-0073-9425</Identifier><AffiliationInfo><Affiliation>Department of Pediatric Surgery, Hospital Universitario La Paz, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dur&#xe1;n</LastName><ForeName>Pilar</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anestesiolog&#xed;a, Hospital La Paz, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fern&#xe1;ndez</LastName><ForeName>Carlota</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pediatric Nephrology, Hospital La Paz, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hernandez</LastName><ForeName>Francisco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Pediatric Surgery, Hospital Universitario La Paz, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De la Torre</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pediatric Surgery, Hospital Universitario La Paz, Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Eur J Pediatr Surg</MedlineTA><NlmUniqueID>9105263</NlmUniqueID><ISSNLinking>0939-7248</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019210">Troponin I</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005660" MajorTopicYN="Y">Funnel Chest</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012206" MajorTopicYN="Y">Rhabdomyolysis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019210" MajorTopicYN="N">Troponin I</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>8</Day><Hour>19</Hour><Minute>24</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36075369</ArticleId><ArticleId IdType="doi">10.1055/a-1939-3891</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39360910</PMID><DateCompleted><Year>2025</Year><Month>02</Month><Day>26</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2035-648X</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>European journal of paediatric dentistry</Title><ISOAbbreviation>Eur J Paediatr Dent</ISOAbbreviation></Journal><ArticleTitle>Laser and remineralising agents in dental erosion: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>37</StartPage><EndPage>46</EndPage><MedlinePgn>37-46</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.23804/ejpd.2024.2158</ELocationID><Abstract><AbstractText Label="AIM">This systematic review aimed to evaluate, by means of statistical comparison between selected studies, the effectiveness of laser irradiation on dental erosion applied alone or in combination with anti-erosive agents (fluoride, Acidulated phosphate fluoride APF and CPP-amorphous calcium fluoride phosphate CPP-ACFP), through optical profilometry and microhardness measurement.</AbstractText><AbstractText Label="METHODS">The searching strategy was conducted according to the International PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines, to answer research ques-tions regarding the effectiveness of lasers used in the context of dental erosion (such as Nd:YAG, CO2, Er:YAG, Er,Cr:YSGG, Diode, and Argon Ion lasers). A comprehensive and unrestricted sys-tematic searching was performed using the electronic databases of PubMed and Cochrane Library, for all articles published up to the end of January 2023. The review record was registered by the International prospective register of systematic reviews (PROSPERO) under the identification number CRD408639.</AbstractText><AbstractText Label="CONCLUSION">Change in microhardness for the lasers group, irrespective of the type of laser used in the sample, was significantly greater compared with the one in the control group. Regards microhardness, the combination of Laser and APF gel showed promising results compared to APF gel agent.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pardo</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Dentistry and Maxillofacial Surgery Section, Department of Surgery, Dentistry, Pediatrics and Gy-necology, University of Verona, Verona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butera</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Unit of Dental Hygiene, Section of Dentistry, Department of Clinical, Surgical, Diagnostic and Pe-diatric Sciences, University of Pavia, 27100, Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Signoriello</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Dentistry and Maxillofacial Surgery Section, Department of Surgery, Dentistry, Pediatrics and Gy-necology, University of Verona, Verona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marchiori</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Dentistry and Maxillofacial Surgery Section, Department of Surgery, Dentistry, Pediatrics and Gy-necology, University of Verona, Verona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fiorini</LastName><ForeName>V</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Dentistry and Maxillofacial Surgery Section, Department of Surgery, Dentistry, Pediatrics and Gy-necology, University of Verona, Verona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Branz</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Dentistry and Maxillofacial Surgery Section, Department of Surgery, Dentistry, Pediatrics and Gy-necology, University of Verona, Verona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scribante</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Unit of Dental Hygiene, Section of Dentistry, Department of Clinical, Surgical, Diagnostic and Pe-diatric Sciences, University of Pavia, 27100, Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lombardo</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Dentistry and Maxillofacial Surgery Section, Department of Surgery, Dentistry, Pediatrics and Gy-necology, University of Verona, Verona, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Eur J Paediatr Dent</MedlineTA><NlmUniqueID>101121881</NlmUniqueID><ISSNLinking>1591-996X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>39456-59-2</RegistryNumber><NameOfSubstance UI="D000149">Acidulated Phosphate Fluoride</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C447032">casein phosphopeptide-amorphous calcium phosphate nanocomplex</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002364">Caseins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014077" MajorTopicYN="Y">Tooth Erosion</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014089" MajorTopicYN="Y">Tooth Remineralization</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000149" MajorTopicYN="N">Acidulated Phosphate Fluoride</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D028022" MajorTopicYN="Y">Low-Level Light Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006244" MajorTopicYN="N">Hardness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002364" MajorTopicYN="N" AutoHM="Y">Caseins</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>2</Month><Day>26</Day><Hour>12</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>16</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>9</Hour><Minute>38</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39360910</ArticleId><ArticleId IdType="doi">10.23804/ejpd.2024.2158</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">23685349</PMID><DateCompleted><Year>2014</Year><Month>04</Month><Day>10</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1941-2444</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>5</Issue><PubDate><Year>2013</Year><Month>Sep</Month></PubDate></JournalIssue><Title>JPEN. Journal of parenteral and enteral nutrition</Title><ISOAbbreviation>JPEN J Parenter Enteral Nutr</ISOAbbreviation></Journal><ArticleTitle>A.S.P.E.N. clinical guidelines: nutrition support of neonatal patients at risk for metabolic bone disease.</ArticleTitle><Pagination><StartPage>570</StartPage><EndPage>598</EndPage><MedlinePgn>570-98</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/0148607113487216</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Premature infants are at increased risk for metabolic bone disease, with resulting delayed bone growth, osteopenia, and rickets.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">A systematic review of the best available evidence to answer a series of questions regarding neonatal patients at risk of metabolic bone disease receiving parenteral or enteral nutrition was undertaken and evaluated using concepts adopted from the Grading of Recommendations, Assessment, Development and Evaluation working group. A consensus process was used to develop the clinical guideline recommendations prior to external and internal review and approval by the American Society for Parenteral and Enteral Nutrition Board of Directors.</AbstractText><AbstractText Label="QUESTIONS" NlmCategory="OBJECTIVE">(1) What maternal risk factors predispose the neonate to metabolic bone disease? (2) What is the optimal type of feeding to promote neonatal bone health? (3) When and how should vitamin D supplements be administered? (4) Does parenteral nutrition (PN) predispose a neonate to metabolic bone disease, and if so, are there PN formulation recommendations to minimize this risk?</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nehra</LastName><ForeName>Deepika</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Surgery and The Vascular Biology Program, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carlson</LastName><ForeName>Sarah J</ForeName><Initials>SJ</Initials></Author><Author ValidYN="Y"><LastName>Fallon</LastName><ForeName>Erica M</ForeName><Initials>EM</Initials></Author><Author ValidYN="Y"><LastName>Kalish</LastName><ForeName>Brian</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Potemkin</LastName><ForeName>Alexis K</ForeName><Initials>AK</Initials></Author><Author ValidYN="Y"><LastName>Gura</LastName><ForeName>Kathleen M</ForeName><Initials>KM</Initials></Author><Author ValidYN="Y"><LastName>Simpser</LastName><ForeName>Edwin</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Compher</LastName><ForeName>Charlene</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Puder</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><CollectiveName>American Society for Parenteral and Enteral Nutrition</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017065">Practice Guideline</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>05</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JPEN J Parenter Enteral Nutr</MedlineTA><NlmUniqueID>7804134</NlmUniqueID><ISSNLinking>0148-6071</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018977">Micronutrients</NameOfSubstance></Chemical><Chemical><RegistryNumber>1406-16-2</RegistryNumber><NameOfSubstance UI="D014807">Vitamin D</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001851" MajorTopicYN="N">Bone Diseases, Metabolic</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019587" MajorTopicYN="N">Dietary Supplements</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007234" MajorTopicYN="N">Infant, Premature</DescriptorName><QualifierName UI="Q000254" MajorTopicYN="Y">growth &amp; development</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018977" MajorTopicYN="N">Micronutrients</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018529" MajorTopicYN="N">Nutritional Support</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014807" MajorTopicYN="N">Vitamin D</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">minerals/trace elements</Keyword><Keyword MajorTopicYN="N">neonates</Keyword><Keyword MajorTopicYN="N">parenteral nutrition</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>5</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>5</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23685349</ArticleId><ArticleId IdType="doi">10.1177/0148607113487216</ArticleId><ArticleId IdType="pii">0148607113487216</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37693640</PMID><DateRevised><Year>2023</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-875X</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in surgery</Title><ISOAbbreviation>Front Surg</ISOAbbreviation></Journal><ArticleTitle>Intercostal nerve cryoablation therapy for the repair of pectus excavatum: a systematic review.</ArticleTitle><Pagination><StartPage>1235120</StartPage><MedlinePgn>1235120</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1235120</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fsurg.2023.1235120</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">The minimally invasive repair of pectus excavatum (PE) is a painful procedure that can result in long-term hospitalization and opioid use. To mitigate the length of stay and opioid consumption, many different analgesia strategies have been implemented. The aim of this study is to review the use and patient outcomes of intercostal nerve cryoablation (INC) during PE repair reported in the literature.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">An unfunded literature search using PubMed identifying articles discussing INC during PE repair from 1946 to 1 July 2023 was performed. Articles were included if they discussed patient outcomes with INC use during PE repair. Articles were excluded if they were reviews/meta-analyses, editorials, or not available in English. Each article was reviewed for bias by analyzing the study methods, data analysis, patient selection, and patient follow-up. Articles comparing outcomes of INC were considered significant if <i>p</i>-value was &lt;0.05.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 34 articles were included in this review that described INC use during pectus repair. Most supported a decreased hospital length of stay and opioid use with INC. Overall, INC was associated with fewer short-term and long-term complications. However, the researchers reported varied results of total hospital costs with the use of INC.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">The review was limited by a paucity of prospective studies and low number of patients who received INC. Despite this, the present data support INC as a safe and effective analgesic strategy during the repair of PE.</AbstractText><CopyrightInformation>&#xa9; 2023 Eldredge and McMahon.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Eldredge</LastName><ForeName>R Scott</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Pediatric Surgery, Phoenix Children's Hospital, Phoenix, AZ, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McMahon</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Pediatric Surgery, Phoenix Children's Hospital, Phoenix, AZ, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Surg</MedlineTA><NlmUniqueID>101645127</NlmUniqueID><ISSNLinking>2296-875X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Nuss</Keyword><Keyword MajorTopicYN="N">cryoablation</Keyword><Keyword MajorTopicYN="N">cryoanalgesia</Keyword><Keyword MajorTopicYN="N">minimally invasive repair of pectus excavatum</Keyword><Keyword MajorTopicYN="N">pectus excavatum</Keyword></KeywordList><CoiStatement>LM is an educational consultant for AtriCure. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>11</Day><Hour>4</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37693640</ArticleId><ArticleId IdType="pmc">PMC10484532</ArticleId><ArticleId IdType="doi">10.3389/fsurg.2023.1235120</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Biavati M, Kozlitina J, Alder AC, Foglia R, McColl RW, Peshock RM, et al. Prevalence of pectus excavatum in an adult population-based cohort estimated from radiographic indices of chest wall shape. PLoS One. (2020) 15(5):e0232575. 10.1371/journal.pone.0232575</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0232575</ArticleId><ArticleId IdType="pmc">PMC7205298</ArticleId><ArticleId IdType="pubmed">32379835</ArticleId></ArticleIdList></Reference><Reference><Citation>Obermeyer RJ, Goretsky MJ. Chest wall deformities in pediatric surgery. Surg Clin North Am. (2012) 92(3):669&#x2013;84. 10.1016/j.suc.2012.03.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.suc.2012.03.001</ArticleId><ArticleId IdType="pubmed">22595715</ArticleId></ArticleIdList></Reference><Reference><Citation>Frawley G, Frawley J, Crameri J. A review of anesthetic techniques and outcomes following minimally invasive repair of pectus excavatum (Nuss procedure). Paediatr Anaesth. (2016) 26(11):1082&#x2013;90. 10.1111/pan.12988</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pan.12988</ArticleId><ArticleId IdType="pubmed">27510834</ArticleId></ArticleIdList></Reference><Reference><Citation>Fokin AA, Steuerwald NM, Ahrens WA, Allen KE. Anatomical, histologic, and genetic characteristics of congenital chest wall deformities. Semin Thorac Cardiovasc Surg. (2009) 21(1):44&#x2013;57. 10.1053/j.semtcvs.2009.03.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.semtcvs.2009.03.001</ArticleId><ArticleId IdType="pubmed">19632563</ArticleId></ArticleIdList></Reference><Reference><Citation>Brochhausen C, Turial S, M&#xfc;ller FKP, Schmitt VH, Coerdt W, Wihlm JM, et al. Pectus excavatum: history, hypotheses and treatment options. Interact Cardiovasc Thorac Surg. (2012) 14(6):801&#x2013;6. 10.1093/icvts/ivs045</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivs045</ArticleId><ArticleId IdType="pmc">PMC3352718</ArticleId><ArticleId IdType="pubmed">22394989</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuss D, Obermeyer RJ, Kelly RE. Pectus excavatum from a pediatric surgeon's perspective. Ann Cardiothorac Surg. (2016) 5(5):493&#x2013;500. 10.21037/acs.2016.06.04</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/acs.2016.06.04</ArticleId><ArticleId IdType="pmc">PMC5056929</ArticleId><ArticleId IdType="pubmed">27747183</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao YZ, Tang ST, Li S. Comparison of the Nuss versus Ravitch procedure for pectus excavatum repair: an updated meta-analysis. J Pediatr Surg. (2017) 52(10):1545&#x2013;52. 10.1016/j.jpedsurg.2017.05.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2017.05.028</ArticleId><ArticleId IdType="pubmed">28606386</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly RE, Shamberger RC, Mellins RB, Mitchell KK, Lawson ML, Oldham K, et al. Prospective multicenter study of surgical correction of pectus excavatum: design, perioperative complications, pain, and baseline pulmonary function facilitated by internet-based data collection. J Am Coll Surg. (2007) 205(2):205&#x2013;16. 10.1016/j.jamcollsurg.2007.03.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2007.03.027</ArticleId><ArticleId IdType="pubmed">17660066</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroud AM, Tulanont DD, Coates TE, Goodney PP, Croitoru DP. Epidural analgesia versus intravenous patient-controlled analgesia following minimally invasive pectus excavatum repair: a systematic review and meta-analysis. J Pediatr Surg. (2014) 49(5):798&#x2013;806. 10.1016/j.jpedsurg.2014.02.072</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2014.02.072</ArticleId><ArticleId IdType="pmc">PMC5315444</ArticleId><ArticleId IdType="pubmed">24851774</ArticleId></ArticleIdList></Reference><Reference><Citation>St. Peter SD, Weesner KA, Weissend EE, Sharp SW, Valusek PA, Sharp RJ, et al. Epidural vs. patient-controlled analgesia for postoperative pain after pectus excavatum repair: a prospective, randomized trial. J Pediatr Surg. (2012) 47(1):148&#x2013;53. 10.1016/j.jpedsurg.2011.10.040</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2011.10.040</ArticleId><ArticleId IdType="pubmed">22244408</ArticleId></ArticleIdList></Reference><Reference><Citation>Burton DMH, Boretsky KR. A comparison of paravertebral nerve block catheters and thoracic epidural catheters for postoperative analgesia following the Nuss procedure for pectus excavatum repair. Paediatr Anaesth. (2014) 24(5):516&#x2013;20. 10.1111/pan.12369</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pan.12369</ArticleId><ArticleId IdType="pubmed">24612096</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhry DK, Brenn BR, Sacks K, Reichard K, Lonnqvist PA. Continuous chest wall ropivacaine infusion for analgesia in children undergoing Nuss procedure: a comparison with thoracic epidural. Paediatr Anaesth. (2016) 26(6):582&#x2013;9. 10.1111/pan.12904</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pan.12904</ArticleId><ArticleId IdType="pubmed">27061848</ArticleId></ArticleIdList></Reference><Reference><Citation>Graves CE, Moyer J, Zobel MJ, Mora R, Smith D, O&#x2019;Day M, et al. Intraoperative intercostal nerve cryoablation during the Nuss procedure reduces length of stay and opioid requirement: a randomized clinical trial. J Pediatr Surg. (2019) 54(11):2250&#x2013;6. 10.1016/j.jpedsurg.2019.02.057</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2019.02.057</ArticleId><ArticleId IdType="pmc">PMC6920013</ArticleId><ArticleId IdType="pubmed">30935731</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller BA, Kabagambe SK, Becker JC, Chen YJ, Goodman LF, Clark-Wronski JM, et al. Intercostal nerve cryoablation versus thoracic epidural catheters for postoperative analgesia following pectus excavatum repair: preliminary outcomes in twenty-six cryoablation patients. J Pediatr Surg. (2016) 51(12):2033&#x2013;8. 10.1016/j.jpedsurg.2016.09.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2016.09.034</ArticleId><ArticleId IdType="pubmed">27745867</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain HS. Three types of nerve injury. Brain. (1943) 66(4):237&#x2013;88. 10.1093/brain/66.4.237</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/66.4.237</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon T. Peripheral nerve regeneration and muscle reinnervation. Int J Mol Sci. (2020) 21(22):1&#x2013;24. 10.3390/ijms21228652</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21228652</ArticleId><ArticleId IdType="pmc">PMC7697710</ArticleId><ArticleId IdType="pubmed">33212795</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P, Xianhua P, Bonaldo P. Role of macrophages in Wallerian degeneration and axonal regeneration after peripheral nerve injury. Acta Neuropathol. (2015) 3:605&#x2013;18. 10.1007/s00401-015-1482-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1482-4</ArticleId><ArticleId IdType="pubmed">26419777</ArticleId></ArticleIdList></Reference><Reference><Citation>Shafiq M, Sethi J, Ali MS, Ghori UK, Saghaie T, Folch E. Pleural cryobiopsy: a systematic review and meta-analysis. Chest. (2020) 157(1):223&#x2013;30. 10.1016/j.chest.2019.09.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2019.09.023</ArticleId><ArticleId IdType="pubmed">31610161</ArticleId></ArticleIdList></Reference><Reference><Citation>Talsma J, Kusakavitch M, Lee D, Niederhauser C, Palmer B, Ozgediz D, et al. Forgotten branch of the intercostal nerve: implication for cryoablation nerve block for pectus excavatum repair. J Pediatr Surg. (2023) S0022-3468(23):00294&#x2013;4. 10.1016/j.jpedsurg.2023.05.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2023.05.006</ArticleId><ArticleId IdType="pubmed">37286412</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen SY, Mack SJ, Stein JE, Kelley-Quon LI, Kim ES. Intercostal nerve cryoablation is associated with reduced opioid use in pediatric oncology patients. J Surg Res. (2023) 283:377&#x2013;84. 10.1016/j.jss.2022.11.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2022.11.004</ArticleId><ArticleId IdType="pmc">PMC10756229</ArticleId><ArticleId IdType="pubmed">36427448</ArticleId></ArticleIdList></Reference><Reference><Citation>Gologorsky R, Ewbank C, Idowu O, Kim S. Use of cryoanalgesia as a postoperative pain management for open pectus carinatum repair. Pediatr Surg Int. (2021) 37(1):179&#x2013;81. 10.1007/s00383-020-04768-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00383-020-04768-z</ArticleId><ArticleId IdType="pubmed">33112997</ArticleId></ArticleIdList></Reference><Reference><Citation>Das B, Sadhasivam S. Response to intercostal nerve cryoablation versus thoracic epidural catheters for postoperative analgesia following pectus excavatum repair. J Pediatr Surg. (2017) 52(6):1076. 10.1016/j.jpedsurg.2017.01.069</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2017.01.069</ArticleId><ArticleId IdType="pubmed">28302362</ArticleId></ArticleIdList></Reference><Reference><Citation>Chidambaran V, Garcia VF, Brown RL. Are we ready for cryoablation in children undergoing Nuss procedures? Anesth Analg. (2022) 134(4):881&#x2013;4. 10.1213/ANE.0000000000005857</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000005857</ArticleId><ArticleId IdType="pubmed">35299214</ArticleId></ArticleIdList></Reference><Reference><Citation>McCoy N, Hollinger L. Cryoanalgesia and lung isolation: a new challenge for the Nuss procedure made easier with the EZ-Blocker&#x2122;. Front Pediatr. (2021) 9:791607. 10.3389/fped.2021.791607</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2021.791607</ArticleId><ArticleId IdType="pmc">PMC8667069</ArticleId><ArticleId IdType="pubmed">34912765</ArticleId></ArticleIdList></Reference><Reference><Citation>Daemen JHT, de Loos ER, Vissers YLJ, Bakens MJAM, Maessen JG, Hulsew&#xe9; KWE. Intercostal nerve cryoablation versus thoracic epidural for postoperative analgesia following pectus excavatum repair: a systematic review and meta-analysis. Interact Cardiovasc Thorac Surg. (2020) 31(4):486&#x2013;98. 10.1093/icvts/ivaa151</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivaa151</ArticleId><ArticleId IdType="pubmed">32929487</ArticleId></ArticleIdList></Reference><Reference><Citation>Singhal NR, Jerman JD. A review of anesthetic considerations and postoperative pain control after the Nuss procedure. Semin Pediatr Surg. (2018) 27(3):156&#x2013;60. 10.1053/j.sempedsurg.2018.05.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.sempedsurg.2018.05.010</ArticleId><ArticleId IdType="pubmed">30078486</ArticleId></ArticleIdList></Reference><Reference><Citation>Pechetov AA, Lednev AN, Makov MA, Chlan TN. Intercostal nerve cryoablation in correction of pectus excavatum in adults. Khirurgiia (Sofiia). (2021) 5:14&#x2013;9. 10.17116/hirurgia202105114</Citation><ArticleIdList><ArticleId IdType="doi">10.17116/hirurgia202105114</ArticleId><ArticleId IdType="pubmed">33977693</ArticleId></ArticleIdList></Reference><Reference><Citation>Harbaugh CM, Johnson KN, Kein CE, Jarboe MD, Hirschl RB, Geiger JD, et al. Comparing outcomes with thoracic epidural and intercostal nerve cryoablation after Nuss procedure. J Surg Res. (2018) 231:217&#x2013;23. 10.1016/j.jss.2018.05.048</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2018.05.048</ArticleId><ArticleId IdType="pubmed">30278932</ArticleId></ArticleIdList></Reference><Reference><Citation>Morikawa N, Laferriere N, Koo S, Johnson S, Woo R, Puapong D. Cryoanalgesia in patients undergoing Nuss repair of pectus excavatum: technique modification and early results. J Laparoendosc Adv Surg Tech A. (2018) 28(9):1148&#x2013;51. 10.1089/lap.2017.0665</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/lap.2017.0665</ArticleId><ArticleId IdType="pubmed">29672193</ArticleId></ArticleIdList></Reference><Reference><Citation>Sujka J, Benedict LA, Fraser JD, Aguayo P, Millspaugh DL, St Peter SD. Outcomes using cryoablation for postoperative pain control in children following minimally invasive pectus excavatum repair. J Laparoendosc Adv Surg Tech A. (2018) 28(11):1383&#x2013;6. 10.1089/lap.2018.0111</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/lap.2018.0111</ArticleId><ArticleId IdType="pubmed">29927703</ArticleId></ArticleIdList></Reference><Reference><Citation>Parrado R, Lee J, McMahon LE, Clay C, Powell J, Kang P, et al. The use of cryoanalgesia in minimally invasive repair of pectus excavatum: lessons learned. J Laparoendosc Adv Surg Tech A. (2019) 29(10):1244&#x2013;51. 10.1089/lap.2019.0203</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/lap.2019.0203</ArticleId><ArticleId IdType="pubmed">31259649</ArticleId></ArticleIdList></Reference><Reference><Citation>Zobel MJ, Ewbank C, Mora R, Idowu O, Kim S, Padilla BE. The incidence of neuropathic pain after intercostal cryoablation during the Nuss procedure. Pediatr Surg Int. (2020) 36(3):317&#x2013;24. 10.1007/s00383-019-04602-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00383-019-04602-1</ArticleId><ArticleId IdType="pubmed">31760443</ArticleId></ArticleIdList></Reference><Reference><Citation>Dekonenko C, Dorman RM, Duran Y, Juang D, Aguayo P, Fraser JD, et al. Postoperative pain control modalities for pectus excavatum repair: a prospective observational study of cryoablation compared to results of a randomized trial of epidural vs. patient-controlled analgesia. J Pediatr Surg. (2020) 55(8):1444&#x2013;7. 10.1016/j.jpedsurg.2019.09.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2019.09.021</ArticleId><ArticleId IdType="pubmed">31699436</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilkington M, Harbaugh CM, Hirschl RB, Geiger JD, Gadepalli SK. Use of cryoanalgesia for pain management for the modified Ravitch procedure in children. J Pediatr Surg. (2020) 55(7):1381&#x2013;4. 10.1016/j.jpedsurg.2019.09.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2019.09.016</ArticleId><ArticleId IdType="pubmed">31672412</ArticleId></ArticleIdList></Reference><Reference><Citation>Rettig RL, Rudikoff AG, Lo HYA, Shaul DB, Banzali FM, Conte AH, et al. Cryoablation is associated with shorter length of stay and reduced opioid use in pectus excavatum repair. Pediatr Surg Int. (2021) 37(1):67&#x2013;75. 10.1007/s00383-020-04778-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00383-020-04778-x</ArticleId><ArticleId IdType="pubmed">33210165</ArticleId></ArticleIdList></Reference><Reference><Citation>Arshad SA, Hatton GE, Ferguson DM, Li LT, Austin MT, Tsao KJ. Cryoanalgesia enhances recovery from minimally invasive repair of pectus excavatum resulting in reduced length of stay: a case-matched analysis of NSQIP-pediatric patients. J Pediatr Surg. (2021) 56(7):1099&#x2013;102. 10.1016/j.jpedsurg.2021.03.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2021.03.017</ArticleId><ArticleId IdType="pubmed">33853733</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiken TJ, Stahl CC, Lemaster D, Casias TW, Walker BJ, Nichol PF, et al. Intercostal nerve cryoablation is associated with lower hospital cost during minimally invasive Nuss procedure for pectus excavatum. J Pediatr Surg. (2021) 56(10):1841&#x2013;5. 10.1016/j.jpedsurg.2020.10.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2020.10.009</ArticleId><ArticleId IdType="pmc">PMC8053720</ArticleId><ArticleId IdType="pubmed">33199059</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun RC, Mehl SC, Anbarasu CR, Portuondo JI, Espinoza AF, Whitlock R, et al. Intercostal cryoablation during Nuss procedure: a large volume single surgeon&#x2019;s experience and outcomes. J Pediatr Surg. (2021) 56(12):2229&#x2013;34. 10.1016/j.jpedsurg.2021.03.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2021.03.006</ArticleId><ArticleId IdType="pubmed">33853732</ArticleId></ArticleIdList></Reference><Reference><Citation>Velayos M, Alonso M, Delgado-Miguel C, Estefan&#xed;a-Fern&#xe1;ndez K, Mu&#xf1;oz-Serrano AJ, Santamar&#xed;a MVL, et al. Percutaneous cryoanalgesia: a new strategy for pain management in pectus excavatum surgery. Eur J Pediatr Surg. (2022) 32(1):73&#x2013;9. 10.1055/s-0041-1740555</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0041-1740555</ArticleId><ArticleId IdType="pubmed">34942673</ArticleId></ArticleIdList></Reference><Reference><Citation>DiFiore JW, Robertson JO, Chhabada S, DeRoss AL, Hossain MS, Rincon-Cruz L, et al. Next day discharge after the Nuss procedure using intercostal nerve cryoablation, intercostal nerve blocks, and a perioperative ERAS pain protocol. J Pediatr Surg. (2022) 57(2):213&#x2013;8. 10.1016/j.jpedsurg.2021.10.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2021.10.034</ArticleId><ArticleId IdType="pubmed">34823843</ArticleId></ArticleIdList></Reference><Reference><Citation>Song SH, Moon DH, Shim YH, Jung H, Lee S. Limited cryoablation reduces hospital stay and opioid consumption compared to thoracic epidural analgesia after minimally invasive repair of pectus excavatum. Medicine (Baltimore). (2022) 101(31):E29773. 10.1097/MD.0000000000029773</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000029773</ArticleId><ArticleId IdType="pmc">PMC9351910</ArticleId><ArticleId IdType="pubmed">35945758</ArticleId></ArticleIdList></Reference><Reference><Citation>Arshad SA, Ferguson DM, Garcia EI, Hebballi NB, Buchanan AC, Tsao KJ. Cryoanalgesia is associated with decreased postoperative opioid use in minimally invasive repair of pectus excavatum. J Surg Res. (2022) 271:1&#x2013;6. 10.1016/j.jss.2021.10.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2021.10.011</ArticleId><ArticleId IdType="pubmed">34814047</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark RA, Jacobson JC, Singhal A, Alder AC, Chung DH, Pandya SR. Impact of cryoablation on pectus excavatum repair in pediatric patients. J Am Coll Surg. (2022) 234(4):484&#x2013;92. 10.1097/XCS.0000000000000103</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/XCS.0000000000000103</ArticleId><ArticleId IdType="pubmed">35290267</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraser JA, Briggs KB, Svetanoff WJ, Aguayo P, Juang D, Fraser JD, et al. Short and long term outcomes of using cryoablation for postoperative pain control in patients after pectus excavatum repair. J Pediatr Surg. (2022) 57(6):1050&#x2013;5. 10.1016/j.jpedsurg.2022.01.051</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2022.01.051</ArticleId><ArticleId IdType="pubmed">35277249</ArticleId></ArticleIdList></Reference><Reference><Citation>Bundrant NT, Sayrs LW, Ostlie D, Lee J, Egan C, Molitor M, et al. Infectious complications of intercostal nerve cryoablation mediated by perioperative hypothermia during pediatric Nuss procedure. J Pediatr Surg. (2022) 57(6):1083&#x2013;6. 10.1016/j.jpedsurg.2022.01.044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2022.01.044</ArticleId><ArticleId IdType="pubmed">35232599</ArticleId></ArticleIdList></Reference><Reference><Citation>Cockrell HC, Hrachovec J, Schnuck J, Nchinda N, Meehan J. Implementation of a cryoablation-based pain management protocol for pectus excavatum. J Pediatr Surg. (2023) 58(7):1239&#x2013;45. 10.1016/j.jpedsurg.2023.01.059. Available at:
https://pubmed.ncbi.nlm.nih.gov/36894442/
(Accessed May 14, 2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2023.01.059</ArticleId><ArticleId IdType="pubmed">36894442</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai K, Eldredge RS, Nguyen M, Padilla BE, McMahon LE. Initial outcomes using cryoablation in surgical management of slipping rib syndrome. J Pediatr Surg. (2023) 58(8):1430&#x2013;4. 10.1016/j.jpedsurg.2022.12.031. Available at:
https://pubmed.ncbi.nlm.nih.gov/36737261/
(Accessed May 14, 2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2022.12.031</ArticleId><ArticleId IdType="pubmed">36737261</ArticleId></ArticleIdList></Reference><Reference><Citation>Downing L, Ramjist JK, Tyrrell A, Tsang M, Isaac L, Fecteau A. Development of a five point enhanced recovery protocol for pectus excavatum surgery. J Pediatr Surg. (2023) 58(5):822&#x2013;7. 10.1016/j.jpedsurg.2023.01.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2023.01.028</ArticleId><ArticleId IdType="pubmed">36788057</ArticleId></ArticleIdList></Reference><Reference><Citation>Akinboro S, John R, Reyna T, Davis R, Ayoub C, Sangster R, et al. A pilot study of multi-modal pain management for same-day discharge after minimally invasive repair of pectus excavatum (Nuss procedure) in children. Pediatr Surg Int. (2023) 39(1):159. 10.1007/s00383-023-05429-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00383-023-05429-7</ArticleId><ArticleId IdType="pmc">PMC10040230</ArticleId><ArticleId IdType="pubmed">36967421</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez Holguin RA, DeAngelo N, Sinha A, Shen C, Tsai AY. Cost and outcomes of intercostal nerve cryoablation versus thoracic epidural following the Nuss procedure. J Pediatr Surg. (2023) 58(4):608&#x2013;12. 10.1016/j.jpedsurg.2022.12.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2022.12.011</ArticleId><ArticleId IdType="pubmed">36646539</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeineddin S, Goldstein SD, Linton S, DeBoer C, Alayleh A, Ortiz I, et al. Effectiveness of one minute per level intercostal nerve cryoablation for postoperative analgesia after surgical correction of pectus excavatum. J Pediatr Surg. (2023) 58(1):34&#x2013;40. 10.1016/j.jpedsurg.2022.09.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2022.09.032</ArticleId><ArticleId IdType="pubmed">36283847</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaroszewski DE, Bostoros P, Farina JM, Botros MM, Aly MR, Peterson M, et al. Evolution of pain control for adult pectus excavatum repair. Ann Thorac Surg. (2023) S0003-4975(23):00570&#x2013;2. 10.1016/j.athoracsur.2023.04.044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2023.04.044</ArticleId><ArticleId IdType="pubmed">37279827</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai K, Lee J, Notrica DM, Egan JC, McMahon LE, Molitor MS, et al. Intercostal nerve cryoablation in minimally invasive repair of pectus excavatum: effect on pulmonary function. J Laparoendosc Adv Surg Tech A. (2022) 32(12):1244&#x2013;8. 10.1089/lap.2022.0242</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/lap.2022.0242</ArticleId><ArticleId IdType="pubmed">36350702</ArticleId></ArticleIdList></Reference><Reference><Citation>Rettig RL, Yang CJ, Ashfaq A, Sydorak RM. Cryoablation is associated with shorter length-of-stay and reduced opioid use after the Ravitch procedure. J Pediatr Surg. (2022) 57(7):1258&#x2013;63. 10.1016/j.jpedsurg.2022.02.040</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2022.02.040</ArticleId><ArticleId IdType="pubmed">35379492</ArticleId></ArticleIdList></Reference><Reference><Citation>Rettig RL, Rudikoff AG, Annie Lo HY, Lee CW, Vazquez WD, Rodriguez K, et al. Same-day discharge following the Nuss repair: a comparison. J Pediatr Surg. (2022) 57(1):135&#x2013;40. 10.1016/j.jpedsurg.2021.09.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2021.09.023</ArticleId><ArticleId IdType="pubmed">34670678</ArticleId></ArticleIdList></Reference><Reference><Citation>Cadaval Gallardo C, Mart&#xed;nez J, Bell&#xed;a-Munzon G, Nazar M, Sanjurjo D, Toselli L, et al. 
Thoracoscopic cryoanalgesia: a new strategy for postoperative pain control in minimally invasive pectus excavatum repair. Cir Pediatr. (2020) 33(1):11&#x2013;5. Available at:
https://pubmed.ncbi.nlm.nih.gov/32166917/
(Accessed May 14, 2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">32166917</ArticleId></ArticleIdList></Reference><Reference><Citation>Torre M, Mameli L, Bonfiglio R, Guerriero V, Derosas L, Palomba L, et al. A new device for thoracoscopic cryoanalgesia in pectus excavatum repair: preliminary single center experience. Front Pediatr. (2020) 8:614097. 10.3389/fped.2020.614097</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2020.614097</ArticleId><ArticleId IdType="pmc">PMC7874221</ArticleId><ArticleId IdType="pubmed">33585365</ArticleId></ArticleIdList></Reference><Reference><Citation>Rettig RL, Rudikoff AG, Lo HYA, Lee CW, Vazquez WD, Rodriguez K, et al. Same day discharge for pectus excavatum&#x2014;is it possible? J Pediatr Surg. (2022) 57(9):34&#x2013;8. 10.1016/j.jpedsurg.2021.02.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2021.02.007</ArticleId><ArticleId IdType="pubmed">33678403</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai K, Notrica DM, McMahon LE, Kang P, Molitor MS, Egan JC, et al. 
Cryoablation in 350 Nuss procedures: evolution of hospital length of stay and opioid use. J Pediatr Surg. (2022) 58(8):1435&#x2013;9. 10.1016/j.jpedsurg.2022.10.051. Available at:
https://pubmed.ncbi.nlm.nih.gov/36494205/
(Accessed May 14, 2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2022.10.051</ArticleId><ArticleId IdType="pubmed">36494205</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuru P, Bostanci K, Ermerak NO, Bahadir AT, Afacan C, Yuksel M. Quality of life improves after minimally invasive repair of pectus excavatum. Asian Cardiovasc Thorac Ann. (2015) 23(3):302&#x2013;7. 10.1177/0218492314553442</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0218492314553442</ArticleId><ArticleId IdType="pubmed">25293414</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuru P, Cakiroglu A, Er A, Ozbakir H, Cinel AE, Cangut B, et al. Pectus excavatum and pectus carinatum: associated conditions. Family history, and postoperative patient satisfaction. Korean J Thorac Cardiovasc Surg. (2016) 49(1):29&#x2013;34. 10.5090/kjtcs.2016.49.1.29</Citation><ArticleIdList><ArticleId IdType="doi">10.5090/kjtcs.2016.49.1.29</ArticleId><ArticleId IdType="pmc">PMC4757394</ArticleId><ArticleId IdType="pubmed">26889443</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawson ML, Cash TF, Akers R, Vasser E, Burke B, Tabangin M, et al. A pilot study of the impact of surgical repair on disease-specific quality of life among patients with pectus excavatum. J Pediatr Surg. (2003) 38(6):916&#x2013;8. 10.1016/S0022-3468(03)00123-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3468(03)00123-4</ArticleId><ArticleId IdType="pubmed">12778393</ArticleId></ArticleIdList></Reference><Reference><Citation>Jager KJ, Tripepi G, Chesnaye NC, Dekker FW, Zoccali C, Stel VS. Where to look for the most frequent biases? Nephrology. (2020) 25(6):435&#x2013;41. 10.1111/nep.13706</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nep.13706</ArticleId><ArticleId IdType="pmc">PMC7318122</ArticleId><ArticleId IdType="pubmed">32133725</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36143967</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>26</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1648-9144</ISSN><JournalIssue CitedMedium="Internet"><Volume>58</Volume><Issue>9</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>16</Day></PubDate></JournalIssue><Title>Medicina (Kaunas, Lithuania)</Title><ISOAbbreviation>Medicina (Kaunas)</ISOAbbreviation></Journal><ArticleTitle>Obesity as a Risk Factor for Venous Thromboembolism Recurrence: A Systematic Review.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1290</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/medicina58091290</ELocationID><Abstract><AbstractText><i>Background and Objectives:</i> Venous thromboembolism (VTE) encompasses Deep Venous Thrombosis (DVT) and Pulmonary Embolism (PE). The duration of anticoagulant therapy following a VTE event partly relies on the risk of recurrent VTE which depends on the clinical setting where VTE occurred and the VTE risk factors present. Obesity is considered a minor risk factor and studies in the literature have provided conflicting results on whether obesity influences the development of recurrences. The aim of the present study is to assess the effect of obesity on VTE recurrence in patients that suffered from a previous VTE event. <i>Materials and Methods:</i> We conducted systematic research for English language studies in Medline, Scopus and ProQuest databases in order to identify publications that assess the risk of VTE recurrence in obesity. Inclusion criteria were: 1. Diagnosis of VTE, 2. Definition of obesity as a body mass index &#x2265;30 kg/m<sup>2</sup>, 3. Report of the risk of obesity on VTE recurrence, 4. Adult human population. We did not include case reports, review studies or studies that assessed other forms of thrombosis and/or used other definitions of obesity. We used the Newcastle-Ottawa scale to address the quality of the studies. <i>Results:</i> Twenty studies were included in the analysis, of which 11 where prospective cohort studies, 6 were retrospective cohort studies, 1 was a cross-sectional study, and 2 were post-hoc analysis of randomized clinical trials. Obesity was significantly associated with recurrences in 9 studies and in 3 of them the association was significant only in females. <i>Conclusions:</i> There is heterogeneity between the studies both in their design and results, therefore the effect of obesity on VTE recurrence cannot be adequately estimated. Future randomized clinical studies with appropriately selected population are needed in order to streamline the effect of obesity on VTE recurrence.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ntinopoulou</LastName><ForeName>Pinelopi</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Laikon General Hospital, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ntinopoulou</LastName><ForeName>Erato</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Yverdon-les-Bains Hospital, 1400 Yverdon-les-Bains, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papathanasiou</LastName><ForeName>Ioanna V</ForeName><Initials>IV</Initials><Identifier Source="ORCID">0000-0002-8874-8085</Identifier><AffiliationInfo><Affiliation>Community Nursing Lab, Faculty of Nursing, University of Thessaly, 41500 Larissa, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fradelos</LastName><ForeName>Evangelos C</ForeName><Initials>EC</Initials><Identifier Source="ORCID">0000-0003-0244-9760</Identifier><AffiliationInfo><Affiliation>Community Nursing Lab, Faculty of Nursing, University of Thessaly, 41500 Larissa, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kotsiou</LastName><ForeName>Ourania</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0001-5219-6971</Identifier><AffiliationInfo><Affiliation>Faculty of Nursing, School of Health Sciences, University of Thessaly, 41500 Larissa, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roussas</LastName><ForeName>Nikolaos</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, Faculty of Medicine, University Hospital of Larissa, University of Thessaly, 41500 Larissa, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raptis</LastName><ForeName>Dimitrios G</ForeName><Initials>DG</Initials><AffiliationInfo><Affiliation>Respiratory Disorders Lab, Faculty of Nursing, University of Thessaly, 41500 Larissa, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gourgoulianis</LastName><ForeName>Konstantinos I</ForeName><Initials>KI</Initials><Identifier Source="ORCID">0000-0001-9541-1010</Identifier><AffiliationInfo><Affiliation>Respiratory Medicine Department, Faculty of Medicine, University Hospital of Larissa, University of Thessaly, 41500 Larissa, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malli</LastName><ForeName>Foteini</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-7595-6715</Identifier><AffiliationInfo><Affiliation>Respiratory Disorders Lab, Faculty of Nursing, University of Thessaly, 41500 Larissa, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Respiratory Medicine Department, Faculty of Medicine, University Hospital of Larissa, University of Thessaly, 41500 Larissa, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Medicina (Kaunas)</MedlineTA><NlmUniqueID>9425208</NlmUniqueID><ISSNLinking>1010-660X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="Y">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">deep venous thrombosis</Keyword><Keyword MajorTopicYN="N">obesity</Keyword><Keyword MajorTopicYN="N">pulmonary embolism</Keyword><Keyword MajorTopicYN="N">recurrence</Keyword><Keyword MajorTopicYN="N">risk factor</Keyword><Keyword MajorTopicYN="N">venous thromboembolism</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>23</Day><Hour>1</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36143967</ArticleId><ArticleId IdType="pmc">PMC9503246</ArticleId><ArticleId IdType="doi">10.3390/medicina58091290</ArticleId><ArticleId IdType="pii">medicina58091290</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Khan F., Tritschler T., Kahn S.R., Rodger M.A. Venous thromboembolism. Lancet. 2021;398:64&#x2013;77. doi: 10.1016/S0140-6736(20)32658-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32658-1</ArticleId><ArticleId IdType="pubmed">33984268</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar D.R., Hanlin E., Glurich I., Mazza J.J., Yale S.H. Virchow&#x2019;s contribution to the understanding of thrombosis and cellular biology. Clin. Med. Res. 2010;8:168&#x2013;172. doi: 10.3121/cmr.2009.866.</Citation><ArticleIdList><ArticleId IdType="doi">10.3121/cmr.2009.866</ArticleId><ArticleId IdType="pmc">PMC3006583</ArticleId><ArticleId IdType="pubmed">20739582</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#x115;lohl&#xe1;vek J., Dytrych V., Linhart A. Pulmonary embolism, part I: Epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism. Exp. Clin. Cardiol. 2013;18:129&#x2013;138.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3718593</ArticleId><ArticleId IdType="pubmed">23940438</ArticleId></ArticleIdList></Reference><Reference><Citation>Konstantinides S.V., Meyer G., Becattini C., Bueno H., Geersing G.J., Harjola V.P., Huisman M.V., Humbert M., Jennings C.S., Jim&#xe9;nez D., et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) Eur. Heart J. 2020;41:543&#x2013;603. doi: 10.1093/eurheartj/ehz405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehz405</ArticleId><ArticleId IdType="pubmed">31504429</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortel T.L., Neumann I., Ageno W., Beyth R., Clark N.P., Cuker A., Hutten B.A., Jaff M.R., Manja V., Schulman S., et al. American Society of Hematology 2020 guidelines for management of venous thromboembolism: Treatment of deep vein thrombosis and pulmonary embolism. Blood Adv. 2020;4:4693&#x2013;4738. doi: 10.1182/bloodadvances.2020001830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2020001830</ArticleId><ArticleId IdType="pmc">PMC7556153</ArticleId><ArticleId IdType="pubmed">33007077</ArticleId></ArticleIdList></Reference><Reference><Citation>Elmi G., Pizzini A.M., Silingardi M. The secondary prevention of venous thromboembolism: Towards an individual therapeutic strategy. Vascular. 2018;26:670&#x2013;682. doi: 10.1177/1708538118776896.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1708538118776896</ArticleId><ArticleId IdType="pubmed">29966487</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO.  [(accessed on 21 January 2022)].  Available online:  https://www.who.int/en/news-room/fact-sheets/detail/obesity-and-overweight.</Citation></Reference><Reference><Citation>Samama M.M. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: The Sirius study. Arch. Intern. Med. 2000;60:3415&#x2013;3420. doi: 10.1001/archinte.160.22.3415.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.160.22.3415</ArticleId><ArticleId IdType="pubmed">11112234</ArticleId></ArticleIdList></Reference><Reference><Citation>Page M.J., McKenzie J.E., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D., Shamseer L., Tetzlaff J.M., Akl E.A., Brennan S.E., et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Downess M.J., Brennan M.L., Williams H.C., Dean R.S. Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS) BMJ Open. 2016;6:6e011458. doi: 10.1136/bmjopen-2016-011458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2016-011458</ArticleId><ArticleId IdType="pmc">PMC5168618</ArticleId><ArticleId IdType="pubmed">27932337</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells G.A., Shea B., O&#x2019;Connell D., Peterson J., Welch V., Losos M., Tugwell P. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses.  [(accessed on 4 April 2022)].  Available online:  http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.</Citation></Reference><Reference><Citation>Higgins J.P.T., Altman D.G., G&#xf8;tzsche P.C., J&#xfc;ni P., Moher D., Oxman A.D., Savovi&#x107; J., Schulz K.F., Weeks L., Sterne J.A. The Cochrane Collaboration&#x2019;s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. doi: 10.1136/bmj.d5928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d5928</ArticleId><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Kearon C., Ageno W., Cannegieter S.C., Cosmi B., Geersing G.J., Kyrle P.A., Subcommittees on Control of Anticoagulation. Predictive and Diagnostic Variables in Thrombotic Disease Categorization of patients as having provoked or unprovoked venous thromboembolism: Guidance from the SSC of ISTH. J. Thromb. Haemost. 2016;14:1480&#x2013;1483. doi: 10.1111/jth.13336.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.13336</ArticleId><ArticleId IdType="pubmed">27428935</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Fuster M.J., Forner M.J., Fern&#xe1;ndez C., Gil J., Vaya A., Maldonado L. Long-term prospective study of recurrent venous thromboembolism in patients younger than 50 years. Pathophysiol. Haemost. Thromb. 2005;34:6&#x2013;12. doi: 10.1159/000088541.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000088541</ArticleId><ArticleId IdType="pubmed">16293979</ArticleId></ArticleIdList></Reference><Reference><Citation>Linnemann B., Zgouras D., Schindewolf M., Schwonberg J., Jarosch-Preusche M., Lindhoff-Last E. Impact of sex and traditional cardiovascular risk factors on the risk of recurrent venous thromboembolism: Results from the German MAISTHRO Registry. Blood Coagul. Fibrinolysis. 2008;19:159&#x2013;165. doi: 10.1097/MBC.0b013e3282f54558.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MBC.0b013e3282f54558</ArticleId><ArticleId IdType="pubmed">18277138</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodger M.A., Kahn S.R., Wells P.S., Anderson D.A., Chagnon I., Le Gal G., Solymoss S., Crowther M., Perrier A., White R., et al. Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy. CMAJ. 2008;179:417&#x2013;426. doi: 10.1503/cmaj.080493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.080493</ArticleId><ArticleId IdType="pmc">PMC2518177</ArticleId><ArticleId IdType="pubmed">18725614</ArticleId></ArticleIdList></Reference><Reference><Citation>Eichinger S., Hron G., Bialonczyk C., Hirschl M., Minar E., Wagner O., Heinze G., Kyrle P.A. Overweight, obesity, and the risk of recurrent venous thromboembolism. Arch. Intern. Med. 2008;168:1678&#x2013;1683. doi: 10.1001/archinte.168.15.1678.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.168.15.1678</ArticleId><ArticleId IdType="pubmed">18695082</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Nisio M., Di Iorio A., Porreca E., Abate M., Ferrante N., Bandinelli S., Guralnik J., Molino-Lova R., Cuccurullo F., Ferrucci L. Obesity, poor muscle strength, and venous thromboembolism in older persons: The InCHIANTI study. J. Gerontol. A Biol. Sci. Med. Sci. 2011;66:320&#x2013;325. doi: 10.1093/gerona/glq207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/glq207</ArticleId><ArticleId IdType="pmc">PMC3041471</ArticleId><ArticleId IdType="pubmed">21112964</ArticleId></ArticleIdList></Reference><Reference><Citation>Farzamnia H., Rabiei K., Sadeghi M., Roghani F. The predictive factors of recurrent deep vein thrombosis. ARYA Atheroscler. 2011;7:123&#x2013;128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3347857</ArticleId><ArticleId IdType="pubmed">22577459</ArticleId></ArticleIdList></Reference><Reference><Citation>Oli&#xe9; V., Zhu T., Martinez I., Scarabin P.Y., Emmerich J. Sex-specific risk factors for recurrent venous thromboembolism. Thromb. Res. 2012;130:16&#x2013;20. doi: 10.1016/j.thromres.2011.10.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2011.10.026</ArticleId><ArticleId IdType="pubmed">22100316</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodger M.A., Scarvelis D., Kahn S.R., Wells P.S., Anderson D.A., Chagnon I., Le Gal G., Gandara E., Solymoss S., Sabri E., et al. Long-term risk of venous thrombosis after stopping anticoagulants for a first unprovoked event: A multi-national cohort. Thromb. Res. 2016;143:152&#x2013;158. doi: 10.1016/j.thromres.2016.03.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2016.03.028</ArticleId><ArticleId IdType="pubmed">27086275</ArticleId></ArticleIdList></Reference><Reference><Citation>Franco Moreno A.I., Garc&#xed;a Navarro M.J., Ortiz S&#xe1;nchez J., Mart&#xed;n D&#xed;az R.M., Madro&#xf1;al Cerezo E., de Ancos Aracil C.L., Clotet N.C., Fraile I.P., Garc&#xed;a S.G., Hern&#xe1;ndez C.M., et al. A risk score for prediction of recurrence in patients with unprovoked venous thromboembolism (DAMOVES) Eur. J. Intern. Med. 2016;29:59&#x2013;64. doi: 10.1016/j.ejim.2015.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2015.12.010</ArticleId><ArticleId IdType="pubmed">26775136</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang W., Goldberg R.J., Anderson F.A., Cohen A.T., Spencer F.A. Occurrence and predictors of recurrence after a first episode of acute venous thromboembolism: Population-based Worcester Venous Thromboembolism Study. J. Thromb. Thrombolysis. 2016;41:525&#x2013;538. doi: 10.1007/s11239-015-1301-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-015-1301-8</ArticleId><ArticleId IdType="pubmed">26847621</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Nisio M., Vedovati M.C., Riera-Mestre A., Prins M.H., Mueller K., Cohen A.T., Wells P.S., Beyer-Westendorf J., Prandoni P., Bounameaux H., et al. Treatment of venous thromboembolism with rivaroxaban in relation to body weight. A sub-analysis of the EINSTEIN DVT/PE studies. Thromb. Haemost. 2016;116:739&#x2013;746.</Citation><ArticleIdList><ArticleId IdType="pubmed">27535349</ArticleId></ArticleIdList></Reference><Reference><Citation>Asim M., Al-Thani H., El-Menyar A. Recurrent Deep Vein Thrombosis After the First Venous Thromboembolism Event: A Single-Institution Experience. Med. Sci. Monit. 2017;23:2391&#x2013;2399. doi: 10.12659/MSM.901924.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.901924</ArticleId><ArticleId IdType="pmc">PMC5446976</ArticleId><ArticleId IdType="pubmed">28527240</ArticleId></ArticleIdList></Reference><Reference><Citation>Vu&#x10d;kovi&#x107; B.A., Cannegieter S.C., van Hylckama Vlieg A., Rosendaal F.R., Lijfering W.M. Recurrent venous thrombosis related to overweight and obesity: Results from the MEGA follow-up study. J. Thromb. Haemost. 2017;15:1430&#x2013;1435. doi: 10.1111/jth.13710.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.13710</ArticleId><ArticleId IdType="pubmed">28439955</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller C., Limacher A., M&#xe9;an M., Rodondi N., Aujesky D. Obesity is not associated with recurrent venous thromboembolism in elderly patients: Results from the prospective SWITCO65+ cohort study. PLoS ONE. 2017;12:e0184868. doi: 10.1371/journal.pone.0184868.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0184868</ArticleId><ArticleId IdType="pmc">PMC5600372</ArticleId><ArticleId IdType="pubmed">28915260</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart L.K., Kline J.A. Metabolic Syndrome Increases Risk of Venous Thromboembolism Recurrence after Acute Pulmonary Embolism. Ann. Am. Thorac. Soc. 2020;17:821&#x2013;828. doi: 10.1513/AnnalsATS.201907-518OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.201907-518OC</ArticleId><ArticleId IdType="pmc">PMC7328175</ArticleId><ArticleId IdType="pubmed">32187500</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart L.K., Kline J.A. Metabolic syndrome increases risk of venous thromboembolism recurrence after acute deep vein thrombosis. Blood Adv. 2020;4:127&#x2013;135. doi: 10.1182/bloodadvances.2019000561.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2019000561</ArticleId><ArticleId IdType="pmc">PMC6960475</ArticleId><ArticleId IdType="pubmed">31917844</ArticleId></ArticleIdList></Reference><Reference><Citation>Beenen L.F.M., Scheres L.J.J., Stoker J., Middeldorp S. Prognostic characteristics and body mass index in patients with pulmonary embolism: Does size matter? ERJ Open Res. 2020;6:00163&#x2013;02019. doi: 10.1183/23120541.00163-2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00163-2019</ArticleId><ArticleId IdType="pmc">PMC6955440</ArticleId><ArticleId IdType="pubmed">31956657</ArticleId></ArticleIdList></Reference><Reference><Citation>Giorgi-Pierfranceschi M., L&#xf3;pez-N&#xfa;&#xf1;ez J.J., Monreal M., Cattabiani C., Lodigiani C., Di Micco P. Morbid Obesity and Mortality in Patients With VTE: Findings from Real-Life Clinical Practice. Chest. 2020;157:1617&#x2013;1625. doi: 10.1016/j.chest.2019.12.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2019.12.040</ArticleId><ArticleId IdType="pubmed">32004553</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardinal R.M., D&#x2019;Amico F., D&#x2019;Addezio A., Dakers K., Castelli G. Safety and efficacy of direct oral anticoagulants across body mass index groups in patients with venous thromboembolism: A retrospective cohort design. J. Thromb. Thrombolysis. 2021;52:567&#x2013;576. doi: 10.1007/s11239-020-02361-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-020-02361-8</ArticleId><ArticleId IdType="pubmed">33387202</ArticleId></ArticleIdList></Reference><Reference><Citation>Weitz J.I., Farjat A.E., Ageno W., Turpie A.G.G., Haas S., Goto S. Influence of body mass index on clinical outcomes in venous thromboembolism: Insights from GARFIELD-VTE. J. Thromb. Haemost. 2021;19:3031&#x2013;3043. doi: 10.1111/jth.15520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15520</ArticleId><ArticleId IdType="pubmed">34487616</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin K., Beyer-Westendorf J., Davidson B.L., Huisman M.V., Sandset P.M. Use of the direct oral anticoagulants in obese patients: Guidance from the SSC of the ISTH. J. Thromb. Haemost. 2016;14:1308&#x2013;1313. doi: 10.1111/jth.13323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.13323</ArticleId><ArticleId IdType="pmc">PMC4936273</ArticleId><ArticleId IdType="pubmed">27299806</ArticleId></ArticleIdList></Reference><Reference><Citation>Baskin M.L., Ard J., Franklin F., Allison D.B. Prevalence of obesity in the United States. Obes. Rev. 2005;6:5&#x2013;7. doi: 10.1111/j.1467-789X.2005.00165.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1467-789X.2005.00165.x</ArticleId><ArticleId IdType="pubmed">15655032</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO   [(accessed on 13 July 2022)].  Available online:  https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.</Citation></Reference><Reference><Citation>Lampropoulos I.C., Raptis D.G., Daniil Z., Tasoulis S.K., Plagianakos V.P., Malli F., Gourgoulianis K.I. Temporal trends in pulmonary embolism prevalence in Greece during 2013&#x2013;2017. BMC Public Health. 2021;21:559. doi: 10.1186/s12889-021-10621-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-021-10621-2</ArticleId><ArticleId IdType="pmc">PMC7981863</ArticleId><ArticleId IdType="pubmed">33743643</ArticleId></ArticleIdList></Reference><Reference><Citation>Movahed M.R., Khoubyari R., Hashemzadeh M., Hashemzadeh M. Obesity is strongly and independently associated with a higher prevalence of pulmonary embolism. Respir Investig. 2019;57:376&#x2013;379. doi: 10.1016/j.resinv.2019.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resinv.2019.01.003</ArticleId><ArticleId IdType="pubmed">30770232</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannegieter S.C., van Hylckama Vlieg A. Venous thrombosis: Understanding the paradoxes of recurrence. J. Thromb. Haemost. 2013;11((Suppl. 1)):161&#x2013;169. doi: 10.1111/jth.12263.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.12263</ArticleId><ArticleId IdType="pubmed">23809120</ArticleId></ArticleIdList></Reference><Reference><Citation>Ageno W., Becattini C., Brighton T., Selby R., Kamphuisen P.W. Cardiovascular risk factors and venous thromboembolism: A meta-analysis. Circulation. 2008;117:93&#x2013;102. doi: 10.1161/CIRCULATIONAHA.107.709204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.107.709204</ArticleId><ArticleId IdType="pubmed">18086925</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Menyar A., Asim M., Al-Thani H. Obesity Paradox in Patients With Deep Venous Thrombosis. Clin. Appl. Thromb. Hemost. 2018;24:986&#x2013;992. doi: 10.1177/1076029617727858.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1076029617727858</ArticleId><ArticleId IdType="pmc">PMC6714731</ArticleId><ArticleId IdType="pubmed">28877605</ArticleId></ArticleIdList></Reference><Reference><Citation>Sartori M., Migliaccio L., Favaretto E., Palareti G., Cosmi B. Two years outcome of isolated distal deep vein thrombosis. Thromb. Res. 2014;134:36&#x2013;40. doi: 10.1016/j.thromres.2014.03.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2014.03.033</ArticleId><ArticleId IdType="pubmed">24713107</ArticleId></ArticleIdList></Reference><Reference><Citation>Allman-Farinelli M.A. Obesity and venous thrombosis: A review. Semin. Thromb. Hemost. 2011;37:903&#x2013;907. doi: 10.1055/s-0031-1297369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0031-1297369</ArticleId><ArticleId IdType="pubmed">22198855</ArticleId></ArticleIdList></Reference><Reference><Citation>Samad F., Ruf W. Inflammation, obesity, and thrombosis. Blood. 2013;122:3415&#x2013;3422. doi: 10.1182/blood-2013-05-427708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2013-05-427708</ArticleId><ArticleId IdType="pmc">PMC3829115</ArticleId><ArticleId IdType="pubmed">24092932</ArticleId></ArticleIdList></Reference><Reference><Citation>Blokhin I.O., Lentz S.R. Mechanisms of thrombosis in obesity. Curr. Opin. Hematol. 2013;20:437&#x2013;444. doi: 10.1097/MOH.0b013e3283634443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOH.0b013e3283634443</ArticleId><ArticleId IdType="pmc">PMC4445633</ArticleId><ArticleId IdType="pubmed">23817170</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross R., Neeland I.J., Yamashita S., Shai I., Seidell J., Magni P., Santos R.D., Arsenault B., Cuevas A., Hu F.B., et al. Waist circumference as a vital sign in clinical practice: A Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity. Nat. Rev. Endocrinol. 2020;16:177&#x2013;189. doi: 10.1038/s41574-019-0310-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-019-0310-7</ArticleId><ArticleId IdType="pmc">PMC7027970</ArticleId><ArticleId IdType="pubmed">32020062</ArticleId></ArticleIdList></Reference><Reference><Citation>Borch K.H., Braekkan S.K., Mathiesen E.B., Nj&#xf8;lstad I., Wilsgaard T., St&#xf8;rmer J., Hansen J.B. Anthropometric measures of obesity and risk of venous thromboembolism: The Tromso study. Arterioscler. Thromb. Vasc Biol. 2010;30:121&#x2013;127. doi: 10.1161/ATVBAHA.109.188920.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.109.188920</ArticleId><ArticleId IdType="pubmed">19834110</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosy-Westphal A., Booke C.A., Bl&#xf6;cker T., Kossel E., Goele K., Later W., Hitze B., Heller M., Gl&#xfc;er C.C., M&#xfc;ller M.J. Measurement site for waist circumference affects its accuracy as an index of visceral and abdominal subcutaneous fat in a Caucasian population. J. Nutr. 2010;140:954&#x2013;961. doi: 10.3945/jn.109.118737.</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/jn.109.118737</ArticleId><ArticleId IdType="pubmed">20335625</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30178727</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>02</Day></DateCompleted><DateRevised><Year>2020</Year><Month>06</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1469-8978</ISSN><JournalIssue CitedMedium="Internet"><Volume>49</Volume><Issue>10</Issue><PubDate><Year>2019</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Psychological medicine</Title><ISOAbbreviation>Psychol Med</ISOAbbreviation></Journal><ArticleTitle>Can brief alcohol interventions in general hospital inpatients improve mental and general health over 2 years? Results from a randomized controlled trial.</ArticleTitle><Pagination><StartPage>1722</StartPage><EndPage>1730</EndPage><MedlinePgn>1722-1730</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1017/S0033291718002453</ELocationID><Abstract><AbstractText Label="BACKGROUND">Little is known about the impact of brief alcohol interventions on mental and general health. The aim was to investigate whether brief interventions for general hospital inpatients with at-risk drinking can improve mental and general health over 2 years; and whether effects are dependent on how they are delivered: in-person or through computer-generated feedback letters (CO).</AbstractText><AbstractText Label="METHODS">Three-arm randomized controlled trial with 6-, 12-, 18-, and 24-month follow-ups. Data were collected on 13 general hospital wards from four medical departments (internal medicine, surgical medicine, trauma surgery, and ear-nose-throat) of one university hospital in northeastern rural Germany. A consecutive sample of 961 18- to 64-year-old general hospital inpatients with at-risk alcohol use was recruited through systematic screening. Inpatients with particularly severe alcohol problems were excluded. Participants were allocated to: in-person counseling (PE), CO, and assessment only (AO). PE and CO included three contacts: on the ward, 1, and 3 months later. Mental and general health were assessed using the five-item mental health inventory (0-100) and a one-item general health measure (0, poor - 4, excellent).</AbstractText><AbstractText Label="RESULTS">Latent growth models including all participants revealed: after 24 months and in contrast to AO, mental and general health were improved in PE (change in mean difference, &#x394;Mmental = 5.13, p = 0.002, Cohen's d = 0.51; &#x394;Mgeneral = 0.20, p = 0.005, d = 0.71) and CO (&#x394;Mmental = 6.98, p &amp;lt; 0.001, d = 0.69; &#x394;Mgeneral = 0.24, p = 0.001, d = 0.86). PE and CO did not differ significantly.</AbstractText><AbstractText Label="CONCLUSIONS">Beyond drinking reduction, PE and CO can improve general hospital inpatients' self-reported mental and general health over 2 years.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Freyer-Adam</LastName><ForeName>Jennis</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute for Medical Psychology, University Medicine Greifswald,Greifswald,Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baumann</LastName><ForeName>Sophie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>German Center for Cardiovascular Research,Site Greifswald,Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haberecht</LastName><ForeName>Katja</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>German Center for Cardiovascular Research,Site Greifswald,Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bischof</LastName><ForeName>Gallus</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy,Medical University of Luebeck,Luebeck,Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meyer</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>German Center for Cardiovascular Research,Site Greifswald,Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rumpf</LastName><ForeName>Hans-J&#xfc;rgen</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy,Medical University of Luebeck,Luebeck,Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>John</LastName><ForeName>Ulrich</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>German Center for Cardiovascular Research,Site Greifswald,Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaertner</LastName><ForeName>Beate</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Health Monitoring,Robert Koch Institute Berlin,Berlin,Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>09</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Psychol Med</MedlineTA><NlmUniqueID>1254142</NlmUniqueID><ISSNLinking>0033-2917</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000428" MajorTopicYN="Y">Alcohol Drinking</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000437" MajorTopicYN="N">Alcoholism</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003376" MajorTopicYN="N">Counseling</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006304" MajorTopicYN="Y">Health Status</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006748" MajorTopicYN="Y">Hospital Departments</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006769" MajorTopicYN="Y">Hospitals, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007297" MajorTopicYN="Y">Inpatients</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008603" MajorTopicYN="Y">Mental Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="Y">Outcome Assessment, Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Brief alcohol intervention</Keyword><Keyword MajorTopicYN="N">computer-generated feedback</Keyword><Keyword MajorTopicYN="N">efficacy</Keyword><Keyword MajorTopicYN="N">motivational interviewing</Keyword><Keyword MajorTopicYN="N">public mental health</Keyword><Keyword MajorTopicYN="N">randomized controlled trial</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30178727</ArticleId><ArticleId IdType="doi">10.1017/S0033291718002453</ArticleId><ArticleId IdType="pii">S0033291718002453</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33009095</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>03</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-4798</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>9</Issue><PubDate><Year>2021</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>Cornea</Title><ISOAbbreviation>Cornea</ISOAbbreviation></Journal><ArticleTitle>Long-Term Results of P.E.R.F.E.C.T. for PTERYGIUM.</ArticleTitle><Pagination><StartPage>1141</StartPage><EndPage>1146</EndPage><MedlinePgn>1141-1146</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/ICO.0000000000002545</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To identify the recurrence rate, complication rate, cosmetic results, and patient satisfaction after P.E.R.F.E.C.T. for PTERYGIUM more than 10 years after surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This is a prospective cohort study with 312 patients (351 surgeries). All patients underwent pterygium removal using P.E.R.F.E.C.T. for PTERYGIUM in 1 eye or both eyes by the author. The main parameters studied were recurrence rate, complication rate, esthetic outcomes, and patient satisfaction.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Two hundred twenty-nine patients (77% of surviving cohort group) were able to be followed up with 16 patients deceased. The basic biographical data of the group followed up and those lost to follow-up were not different. The follow-up period was 153 &#xb1; 20 months. Twenty-five percent of the surgeries were for recurrent pterygia. The recurrence rate was zero, and there were no serious complications. Ninety-four percent of patients were graded as having normal or excellent cosmetic appearance by the surgeon, and 95% of the patients graded the appearance of their eye as greater than 8 of 10. Ninety-four percent of the patients gave more than 8 of 10 as their satisfaction with the service and surgery.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">P.E.R.F.E.C.T. for PTERYGIUM provides long-term and stable results for primary and recurrent pterygium patients with a zero recurrence rate and excellent cosmetic appearance of the eye and no serious complications. P.E.R.F.E.C.T. for PTERYGIUM should be considered as the standard by which other pterygium surgeries should be compared. Cosmetic outcomes after pterygium surgeries are now a more sensitive measure of success than recurrence rate alone.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Wolters Kluwer Health, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hirst</LastName><ForeName>Lawrence</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>The Australian Pterygium Centre, Brisbane, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Queensland Eye Institute, Brisbane, Australia; and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, University of Queensland, Brisbane, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cornea</MedlineTA><NlmUniqueID>8216186</NlmUniqueID><ISSNLinking>0277-3740</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003228" MajorTopicYN="N">Conjunctiva</DescriptorName><QualifierName UI="Q000637" MajorTopicYN="Y">transplantation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004954" MajorTopicYN="N">Esthetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013508" MajorTopicYN="Y">Ophthalmologic Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017060" MajorTopicYN="N">Patient Satisfaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011625" MajorTopicYN="N">Pterygium</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014182" MajorTopicYN="N">Transplantation, Autologous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The author has no funding or conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>3</Day><Hour>5</Hour><Minute>27</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33009095</ArticleId><ArticleId IdType="doi">10.1097/ICO.0000000000002545</ArticleId><ArticleId IdType="pii">00003226-202109000-00013</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hirst LW. The treatment of pterygium. Surv Ophthalmol. 2003;48:145&#x2013;180.</Citation></Reference><Reference><Citation>Kenyon KR, Wagoner MD, Hettinger ME. Conjunctival autograft transplantation for advanced and recurrent pterygium. Ophthalmology. 1985;92:1461&#x2013;1470.</Citation></Reference><Reference><Citation>Kaufman SC, Jacobs DS, Lee WB, et al. Options and adjuvants in surgery for pterygium: a report by the American Academy of Ophthalmology. Ophthalmology. 2013;120:201&#x2013;208.</Citation></Reference><Reference><Citation>Levine DJ. Beta irradiation of pterygium. Ophthalmology. 1992;99:841.</Citation></Reference><Reference><Citation>Murakami M, Mori S, Kunitomo N. Studies on the pterygium. V. Follow-up information of mitomycin C treatment [in Japanese]. Nippon Ganka Gakkai Zasshi. 1967;71:351&#x2013;358.</Citation></Reference><Reference><Citation>MacKenzie F, Hirst LW, Kynaston B. Recurrence rate and complications after beta irradiation for pterygia. Ophthalmology. 1991;98:1776&#x2013;1780.</Citation></Reference><Reference><Citation>Rubinfeld RS, Pfister RR, Stein RM, et al. Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology. 1992;99:1647&#x2013;1654.</Citation></Reference><Reference><Citation>Hirst LW. New pterygium surgical techniques require standardization of outcome measures. Cornea. 2018;37:1&#x2013;2.</Citation></Reference><Reference><Citation>Hirst LW. Recurrence and complications after 1,000 surgeries using pterygium extended removal followed by extended conjunctival transplant. Ophthalmology. 2012;119:2205&#x2013;2210.</Citation></Reference><Reference><Citation>Hirst LW. Cosmesis after pterygium extended removal followed by extended conjunctival transplant as assessed by a new, web-based grading system. Ophthalmology. 2011;118:1739&#x2013;1746.</Citation></Reference><Reference><Citation>Hirst LW. Pterygium extended removal followed by extended conjunctival transplant: but on which eye? Cornea. 2013;32:799&#x2013;802.</Citation></Reference><Reference><Citation>Singh G, Wilson MR, Foster CS. Long-term follow-up study of mitomycin eye drops as adjunctive treatment of pterygia and its comparison with conjunctival autograft transplantation. Cornea. 1990;9:331&#x2013;334.</Citation></Reference><Reference><Citation>Mastropasqua L, Carpineto P, Ciancaglini M, et al. Long term results of intraoperative mitomycin C in the treatment of recurrent pterygium. Br J Ophthalmol. 1996;80:288&#x2013;291.</Citation></Reference><Reference><Citation>Sharma A, Gupta A, Ram J, et al. Low-dose intraoperative mitomycin-C versus conjunctival autograft in primary pterygium surgery: long term follow-up. Ophthalmic Surg Lasers. 2000;31:301&#x2013;307.</Citation></Reference><Reference><Citation>Nishimura Y, Nakai A, Yoshimasu T, et al. Long-term results of fractionated strontium-90 radiation therapy for pterygia. Int J Radiat Oncol Biol Phys. 2000;46:137&#x2013;141.</Citation></Reference><Reference><Citation>Raiskup F, Solomon A, Landau D, et al. Mitomycin C for pterygium: long term evaluation. Br J Ophthalmol. 2004;88:1425&#x2013;1428.</Citation></Reference><Reference><Citation>Solomon A, Kaiserman I, Raiskup FD, et al. Long-term effects of mitomycin C in pterygium surgery on scleral thickness and the conjunctival epithelium. Ophthalmology. 2004;111:1522&#x2013;1527.</Citation></Reference><Reference><Citation>Pajic B, Greiner RH. Long term results of non-surgical, exclusive strontium-/yttrium-90 beta-irradiation of pterygia. Radiother Oncol. 2005;74:25&#x2013;29.</Citation></Reference><Reference><Citation>Koranyi G, Seregard S, Kopp ED. The cut-and-paste method for primary pterygium surgery: long-term follow-up. Acta Ophthalmol Scand. 2005;83:298&#x2013;301.</Citation></Reference><Reference><Citation>Walkow T, Daniel J, Meyer CH, et al. Long-term results after bare sclera pterygium resection with excimer smoothing and local application of mitomycin C. Cornea. 2005;24:378&#x2013;381.</Citation></Reference><Reference><Citation>Mourits MP, Wyrdeman HK, Jurgenliemk-Schulz IM, et al. Favorable long-term results of primary pterygium removal by bare sclera extirpation followed by a single 90Strontium application. Eur J Ophthalmol. 2008;18:327&#x2013;331.</Citation></Reference><Reference><Citation>Bahar I, Weinberger D, Gaton DD, et al. Fibrin glue versus vicryl sutures for primary conjunctival closure in pterygium surgery: long-term results. Curr Eye Res. 2007;32:399&#x2013;405.</Citation></Reference><Reference><Citation>Vastardis I, Pajic B, Greiner RH, et al. Prospective study of exclusive strontium-/yttrium-90 beta-irradiation of primary and recurrent pterygia with no prior surgical excision. Clinical outcome of long-term follow-up. Strahlenther Onkol. 2009;185:808&#x2013;814.</Citation></Reference><Reference><Citation>Ozer A, Yildirim N, Erol N, et al. Long-term results of bare sclera, limbal-conjunctival autograft and amniotic membrane graft techniques in primary pterygium excisions. Ophthalmologica. 2009;223:269&#x2013;273.</Citation></Reference><Reference><Citation>Nieuwendaal CP, van der Meulen IJ, Mourits M, et al. Long-term follow-up of pterygium surgery using a conjunctival autograft and Tissucol. Cornea. 2011;30:34&#x2013;36.</Citation></Reference><Reference><Citation>Huerva V, March A, Martinez-Alonso M, et al. Pterygium surgery by means of conjunctival autograft: long term follow-up. Arq Bras Oftalmol. 2012;75:251&#x2013;255.</Citation></Reference><Reference><Citation>Young AL, Ho M, Jhanji V, et al. Ten-year results of a randomized controlled trial comparing 0.02% mitomycin C and limbal conjunctival autograft in pterygium surgery. Ophthalmology. 2013;120:2390&#x2013;2395.</Citation></Reference><Reference><Citation>Cagatay HH, Gokce G, Ekinci M, et al. Long-term comparison of fibrin tissue glue and vicryl suture in conjunctival autografting for pterygium surgery. Postgrad Med. 2014;126:97&#x2013;103.</Citation></Reference><Reference><Citation>Jiang J, Gong J, Li W, et al. Comparison of intra-operative 0.02% mitomycin C and sutureless limbal conjunctival autograft fixation in pterygium surgery: five-year follow-up. Acta Ophthalmol. 2015;93:e568&#x2013;e572.</Citation></Reference><Reference><Citation>Tsim NC, Young AL, Jhanji V, et al. Combined conjunctival rotational autograft with 0.02% mitomycin C in primary pterygium surgery: a long-term follow-up study. Br J Ophthalmol. 2015;99:1396&#x2013;1400.</Citation></Reference><Reference><Citation>Chan TC, Wong RL, Li EY, et al. Twelve-year outcomes of pterygium excision with conjunctival autograft versus intraoperative mitomycin C in double-head pterygium surgery. J Ophthalmol. 2015;2015:891582.</Citation></Reference><Reference><Citation>Masters JS, Harris DJ Jr. Low recurrence rate of pterygium after excision with conjunctival limbal autograft: a retrospective study with long-term follow-up. Cornea. 2015;34:1569&#x2013;1572.</Citation></Reference><Reference><Citation>Ono T, Mori Y, Nejima R, et al. Long-term follow-up of transplantation of preserved limbal allograft and amniotic membrane for recurrent pterygium. Graefes Arch Clin Exp Ophthalmol. 2016;254:2425&#x2013;2430.</Citation></Reference><Reference><Citation>Zloto O, Rosen N, Leshno A, et al. Very long term success of pterygium surgery with conjunctival graft. Cont Lens Anterior Eye. 2017;40:267&#x2013;269.</Citation></Reference><Reference><Citation>Daponte PL, Cigna A, Lescano O, et al. Conjunctival autograft with fibrin glue for pterygium: a long term recurrence assessment. Med Hypothesis Discov Innov Ophthalmol. 2019;8:272&#x2013;277.</Citation></Reference><Reference><Citation>Kam KW, Young AL. Fifteen-year results of a randomized controlled trial comparing 0.02% mitomycin C, limbal conjunctival autograft, and combined mitomycin C with limbal conjunctival autograft in recurrent pterygium surgery. Graefes Arch Clin Exp Ophthalmol. 2019;257:2683&#x2013;2690.</Citation></Reference><Reference><Citation>Kodavoor SK, Ramamurthy D, Tiwari NN, et al. Double-head pterygium excision with modified vertically split-conjunctival autograft: six-year long-term retrospective analysis. Indian J Ophthalmol. 2017;65:700&#x2013;704.</Citation></Reference><Reference><Citation>Hirst LW, Sebban A, Chant D. Pterygium recurrence time. Ophthalmology. 1994;101:755&#x2013;758.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40129404</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>11</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0260-1060</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>3</Issue><PubDate><Year>2025</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Nutrition and health</Title><ISOAbbreviation>Nutr Health</ISOAbbreviation></Journal><ArticleTitle>Management of adolescent obesity in developing countries: A systematic review.</ArticleTitle><Pagination><StartPage>891</StartPage><EndPage>906</EndPage><MedlinePgn>891-906</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/02601060251330027</ELocationID><Abstract><AbstractText><b>Background:</b> Adolescent obesity is a menace that demands a multi-factorial approach to its management and prevention. <b>Aim:</b> The purpose of this review was to assess interventions used in the management of adolescent obesity in developing countries. <b>Methods:</b> Electronic search were conducted between January 2000 and December 2022 on six databases: Pubmed, GoogleScholar, CINAHL, SCOPUS, Cochrane Library and Science Direct and three clinical trial registries: Pan African Clinical Trial, World Health Organization and clinicalTrial.gov. The quality of the included studies was assessed using the Effective Public Health Practice Project. <b>Results:</b> Eighteen studies met the inclusion criteria. The studies were conducted in Africa (<i>N</i>&#x2009;=&#x2009;7), Asia (<i>N</i>&#x2009;=&#x2009;6) and South America (<i>N</i>&#x2009;=&#x2009;5). The sample size ranged from 10 to 4003 at baseline. The studies were carried out in schools (<i>N</i>&#x2009;=&#x2009;13) and hospitals (<i>N</i>&#x2009;=&#x2009;5) with four main varied designs: controlled trial (<i>N</i>&#x2009;=&#x2009;7), quasi-experimental (<i>N</i>&#x2009;=&#x2009;3), cohort (<i>N</i>&#x2009;=&#x2009;3) and longitudinal (<i>N</i>&#x2009;=&#x2009;4). The duration of the interventions ranged from six weeks to three years. The interventions were nutrition education (NE) and physical education (PE) (<i>N</i>&#x2009;=&#x2009;11), PE only (<i>N</i>&#x2009;=&#x2009;3), Surgery/NE (<i>N</i>&#x2009;=&#x2009;1), Surgery/NE/PE (<i>N</i>&#x2009;=&#x2009;1) and psychotherapy/NE/PE (<i>N</i>&#x2009;=&#x2009;2). Three studies that used NE and PE and five studies that used same reported significant differences in body mass index for-age z score (zBMI) and waist circumference, respectively. Studies that included surgeries in the interventions reported significant differences in weight, zBMI and waist-to-hip ratio. <b>Conclusions:</b> Few intervention studies have been done on management of adolescent obesity in developing countries and largely effective. All interventions prioritized nutrition and/or PE. The studies were largely school-based.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wiafe</LastName><ForeName>Michael Akenteng</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0003-3756-3037</Identifier><AffiliationInfo><Affiliation>Department of Dietetics, University for Development Studies, Tamale, Ghana.</Affiliation><Identifier Source="RINGGOLD">128415</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ayensu</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Clinical Nutrition and Dietetics, School of Allied Health Sciences, College of Health and Allied Sciences, University of Cape Coast, Cape Coast, Ghana.</Affiliation><Identifier Source="RINGGOLD">606725</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yeboah</LastName><ForeName>Georgina Benewaa</ForeName><Initials>GB</Initials><AffiliationInfo><Affiliation>School of Food and Health Sciences, Anglican University College of Technology, Nkoranza, Ghana.</Affiliation><Identifier Source="RINGGOLD">593501</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eli-Cophie</LastName><ForeName>Divine</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-8954-5917</Identifier><AffiliationInfo><Affiliation>Department of Sport Nutrition, School of Sports and Exercise Medicine University of Health and Allied Sciences, Ho, Ghana.</Affiliation><Identifier Source="RINGGOLD">549574</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benewaa</LastName><ForeName>Anita</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Nursing and Midwifery, Christian Service University, Kumasi, Ghana.</Affiliation><Identifier Source="RINGGOLD">446016</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>03</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nutr Health</MedlineTA><NlmUniqueID>8306569</NlmUniqueID><ISSNLinking>0260-1060</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003906" MajorTopicYN="Y">Developing Countries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063766" MajorTopicYN="Y">Pediatric Obesity</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adolescents</Keyword><Keyword MajorTopicYN="N">developing countries</Keyword><Keyword MajorTopicYN="N">intervention</Keyword><Keyword MajorTopicYN="N">management of obesity</Keyword><Keyword MajorTopicYN="N">obesity</Keyword><Keyword MajorTopicYN="N">prevention of obesity</Keyword></KeywordList><CoiStatement>Declaration of conflicting interestsThe authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>11</Day><Hour>12</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>3</Month><Day>25</Day><Hour>4</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40129404</ArticleId><ArticleId IdType="doi">10.1177/02601060251330027</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39437476</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>27</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-7654</ISSN><JournalIssue CitedMedium="Internet"><Volume>303</Volume><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>European journal of obstetrics, gynecology, and reproductive biology</Title><ISOAbbreviation>Eur J Obstet Gynecol Reprod Biol</ISOAbbreviation></Journal><ArticleTitle>Efficacy and safety of norepinephrine versus phenylephrine for post-spinal hypotension in preeclamptic patients: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>91</StartPage><EndPage>98</EndPage><MedlinePgn>91-98</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejogrb.2024.10.012</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0301-2115(24)00550-5</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We conducted a systematic review and meta-analysis to evaluate the fetomaternal outcomes after the administration of norepinephrine or phenylephrine for the treatment of post spinal hypotension in preeclamptic women undergoing a cesarean section.</AbstractText><AbstractText Label="DATA SOURCES" NlmCategory="METHODS">We searched on PubMed, Embase, Scopus, Cochrane CENTRAL, and clinicaltrials.gov from inception till June 2024.</AbstractText><AbstractText Label="STUDY SELECTION" NlmCategory="METHODS">Randomized controlled trials of preeclamptic women receiving norepinephrine or phenylephrine for post spinal hypotension were included.</AbstractText><AbstractText Label="DATA EXTRACTION AND SYNTHESIS" NlmCategory="METHODS">Two reviewers extracted data onto an Excel spreadsheet. R version 4.4 was used for statistical analysis. Risk ratios (RR) and their 95% confidence intervals (CIs) were calculated and pooled using the random effects model. Cochrane's risk of bias (RoB 2) tool was used for quality assessment. This review has been registered with PROSPERO (CRD42024532740).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 4 trials, comprising 413 participants, were included in this review. 206 patients received norepinephrine, while 207 received phenylephrine. The incidence of maternal bradycardia was significantly lower in the norepinephrine group compared with the phenylephrine group (RR = 0.25, 95&#xa0;% CI = 0.16 to 0.39, p&#xa0;&lt;&#xa0;0.01). There were no statistical differences in other maternal outcomes or in the umbilical artery and umbilical vein blood gas analysis values. We also analyzed adverse events such as nausea (RR = 1.00, 95&#xa0;% CI: 0.62 to 1.60, p&#xa0;=&#xa0;1.00) and vomiting (RR = 0.99, 95&#xa0;% CI: 0.89 to 1.11, p&#xa0;=&#xa0;0.61), but they did not show a significant association with any group. All the trials had a moderate or low risk of bias.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Bolus doses of NE and PE for the treatment of post-spinal hypotension in preeclamptic women undergoing cesarean sections were found to exhibit comparable neonatal outcomes. However, NE provided superior maternal safety due to a lower incidence of bradycardia compared to PE.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Author(s). Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Shahzaib</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, Fatima Memorial Hospital College of Medicine and Dentistry, Lahore, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmad</LastName><ForeName>Eeman</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Medicine, Fatima Memorial Hospital College of Medicine and Dentistry, Lahore, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fatima</LastName><ForeName>Eeshal</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Medicine, Services Institute of Medical Sciences, Lahore, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akram</LastName><ForeName>Umar</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Medicine, Allama Iqbal Medical College, Lahore, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ur Rehman</LastName><ForeName>Obaid</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Surgery, Services Institute of Medical Sciences, Lahore, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harikrishna</LastName><ForeName>Arya</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>European University Cyprus, Nicosia, Cyprus.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharif</LastName><ForeName>Shaiza</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Gynaecology, Sir Ganga Ram Hospital, Lahore, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akmal</LastName><ForeName>Noreen</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Obstetrics and Gynaecology, Fatima Jinnah Medical University, Lahore, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nashwan</LastName><ForeName>Abdulqadir J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Nursing &amp; Midwifery Research Department (NMRD), Hamad Medical Corporation, Doha, Qatar; Department of Public Health, College of Health Sciences, QU Health, Qatar University, Doha, Qatar. Electronic address: anashwan@hamad.qa.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Eur J Obstet Gynecol Reprod Biol</MedlineTA><NlmUniqueID>0375672</NlmUniqueID><ISSNLinking>0301-2115</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>1WS297W6MV</RegistryNumber><NameOfSubstance UI="D010656">Phenylephrine</NameOfSubstance></Chemical><Chemical><RegistryNumber>X4W3ENH1CV</RegistryNumber><NameOfSubstance UI="D009638">Norepinephrine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014662">Vasoconstrictor Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="Y">Hypotension</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010656" MajorTopicYN="Y">Phenylephrine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011225" MajorTopicYN="Y">Pre-Eclampsia</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009638" MajorTopicYN="Y">Norepinephrine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002585" MajorTopicYN="Y">Cesarean Section</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014662" MajorTopicYN="Y">Vasoconstrictor Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000775" MajorTopicYN="Y">Anesthesia, Spinal</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Hypotension</Keyword><Keyword MajorTopicYN="N">Norepinephrine</Keyword><Keyword MajorTopicYN="N">Phenylephrine</Keyword><Keyword MajorTopicYN="N">Preeclampsia</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>28</Day><Hour>0</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>4</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>18</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39437476</ArticleId><ArticleId IdType="doi">10.1016/j.ejogrb.2024.10.012</ArticleId><ArticleId IdType="pii">S0301-2115(24)00550-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40165857</PMID><DateRevised><Year>2025</Year><Month>04</Month><Day>02</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1179-1411</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><PubDate><Year>2025</Year></PubDate></JournalIssue><Title>International journal of women's health</Title><ISOAbbreviation>Int J Womens Health</ISOAbbreviation></Journal><ArticleTitle>Endometriosis Severity and Risk of Preeclampsia: A Combined Mendelian Randomization and Observational Study.</ArticleTitle><Pagination><StartPage>923</StartPage><EndPage>935</EndPage><MedlinePgn>923-935</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2147/IJWH.S508174</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="UNASSIGNED">Endometriosis has been hypothesized to increase the risk of preeclampsia (PE) and eclampsia, although the exact mechanism of this relationship is not clear. This study aimed to further explore the potential association between endometriosis and PE/eclampsia through Mendelian randomization (MR) and confirm these findings in a retrospective cohort study.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A two-sample MR study was performed using genetic variants associated with endometriosis from the Finnish database, with outcome data for PE and eclampsia from the UK Biobank. Subgroup analyses were conducted based on endometriosis severity (American society of reproductive Medicine (ASRM) stages I-II and III-IV) and anatomical location (uterus, ovary, deep infiltrating endometriosis). Additionally, a retrospective cohort study was conducted to further assess the association, adjusting for confounding factors such as age, Body Mass Index (BMI), dysmenorrhea, history of uterine surgery, and adenomyosis. Multivariate logistic regression was used to analyze the risk of PE/eclampsia based on endometriosis severity.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">MR using the Inverse Variance Weighted method found a meaningful association between advanced endometriosis (ASRM stages III-IV) and PE/eclampsia (p = 0.008), while no significant associations were observed for lower stages or endometriosis in the uterus and ovary. In the retrospective cohort, the initial association between the revised American Fertility Society (r-AFS) score and PE/eclampsia (OR: 1.02, 95% CI: 1.01-1.03, p &lt; 0.001) weakened after adjusting for confounders. Significant risk factors identified included age (OR: 1.20, 95% CI: 1.10-1.30, p &lt; 0.001), dysmenorrhea (OR: 2.72, 95% CI: 1.31-5.76, p = 0.008) and adenomyosis showing the strongest association (OR: 9.96, 95% CI: 5.00-20.06, p &lt; 0.001).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">The findings suggest a potential relationship between advanced endometriosis and the risk of PE/eclampsia. However, other clinical factors such as age, dysmenorrhea, and adenomyosis appear to contribute more significantly to the risk. Further studies are needed to confirm these findings and clarify the underlying mechanisms.</AbstractText><CopyrightInformation>&#xa9; 2025 Zu et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Zu</LastName><ForeName>Yizheng</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-3030-987X</Identifier><AffiliationInfo><Affiliation>College of Clinical Medicine for Obstetrics &amp; Gynecology and Pediatrics, Fujian Medical University Fujian Maternity and Child Health Hospital, Fuzhou, Fujian Province, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fujian Clinical Research Center for Maternal-Fetal Medicine, Fuzhou, Fujian Province, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Maternal-Fetal Medicine, Fujian Maternity and Child Health Hospital, Fuzhou, Fujian Province, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Key Obstetric Clinical Specialty Construction Institution of China, Fuzhou, Fujian Province, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Xie</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>College of Clinical Medicine for Obstetrics &amp; Gynecology and Pediatrics, Fujian Medical University Fujian Maternity and Child Health Hospital, Fuzhou, Fujian Province, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fujian Clinical Research Center for Maternal-Fetal Medicine, Fuzhou, Fujian Province, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Maternal-Fetal Medicine, Fujian Maternity and Child Health Hospital, Fuzhou, Fujian Province, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Key Obstetric Clinical Specialty Construction Institution of China, Fuzhou, Fujian Province, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhang</LastName><ForeName>Huale</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>College of Clinical Medicine for Obstetrics &amp; Gynecology and Pediatrics, Fujian Medical University Fujian Maternity and Child Health Hospital, Fuzhou, Fujian Province, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fujian Clinical Research Center for Maternal-Fetal Medicine, Fuzhou, Fujian Province, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Maternal-Fetal Medicine, Fujian Maternity and Child Health Hospital, Fuzhou, Fujian Province, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Key Obstetric Clinical Specialty Construction Institution of China, Fuzhou, Fujian Province, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Lichun</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>College of Clinical Medicine for Obstetrics &amp; Gynecology and Pediatrics, Fujian Medical University Fujian Maternity and Child Health Hospital, Fuzhou, Fujian Province, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fujian Clinical Research Center for Maternal-Fetal Medicine, Fuzhou, Fujian Province, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Maternal-Fetal Medicine, Fujian Maternity and Child Health Hospital, Fuzhou, Fujian Province, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Key Obstetric Clinical Specialty Construction Institution of China, Fuzhou, Fujian Province, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Shihan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>College of Clinical Medicine for Obstetrics &amp; Gynecology and Pediatrics, Fujian Medical University Fujian Maternity and Child Health Hospital, Fuzhou, Fujian Province, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zhenna</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>College of Clinical Medicine for Obstetrics &amp; Gynecology and Pediatrics, Fujian Medical University Fujian Maternity and Child Health Hospital, Fuzhou, Fujian Province, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fang</LastName><ForeName>Zhuanji</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>College of Clinical Medicine for Obstetrics &amp; Gynecology and Pediatrics, Fujian Medical University Fujian Maternity and Child Health Hospital, Fuzhou, Fujian Province, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fujian Clinical Research Center for Maternal-Fetal Medicine, Fuzhou, Fujian Province, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Maternal-Fetal Medicine, Fujian Maternity and Child Health Hospital, Fuzhou, Fujian Province, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Key Obstetric Clinical Specialty Construction Institution of China, Fuzhou, Fujian Province, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Shunhe</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>College of Clinical Medicine for Obstetrics &amp; Gynecology and Pediatrics, Fujian Medical University Fujian Maternity and Child Health Hospital, Fuzhou, Fujian Province, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Jianying</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>College of Clinical Medicine for Obstetrics &amp; Gynecology and Pediatrics, Fujian Medical University Fujian Maternity and Child Health Hospital, Fuzhou, Fujian Province, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fujian Clinical Research Center for Maternal-Fetal Medicine, Fuzhou, Fujian Province, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Maternal-Fetal Medicine, Fujian Maternity and Child Health Hospital, Fuzhou, Fujian Province, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Key Obstetric Clinical Specialty Construction Institution of China, Fuzhou, Fujian Province, People's Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>03</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Int J Womens Health</MedlineTA><NlmUniqueID>101531698</NlmUniqueID><ISSNLinking>1179-1411</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Mendelian randomization</Keyword><Keyword MajorTopicYN="N">adenomyosis</Keyword><Keyword MajorTopicYN="N">dysmenorrhea</Keyword><Keyword MajorTopicYN="N">endometriosis</Keyword><Keyword MajorTopicYN="N">preeclampsia</Keyword><Keyword MajorTopicYN="N">retrospective cohort</Keyword></KeywordList><CoiStatement>The authors declare that there are no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>1</Day><Hour>4</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>3</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40165857</ArticleId><ArticleId IdType="pmc">PMC11956705</ArticleId><ArticleId IdType="doi">10.2147/IJWH.S508174</ArticleId><ArticleId IdType="pii">508174</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lamceva J, Uljanovs R, Strumfa I. The main theories on the pathogenesis of endometriosis. Int J mol Sci. 2023;24(5):4254. doi:10.3390/ijms24054254</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24054254</ArticleId><ArticleId IdType="pmc">PMC10001466</ArticleId><ArticleId IdType="pubmed">36901685</ArticleId></ArticleIdList></Reference><Reference><Citation>Pirtea P, de Ziegler D, Ayoubi JM. Endometrial receptivity in adenomyosis and/or endometriosis. Fertil Steril. 2023;119(5):741&#x2013;745. doi:10.1016/j.fertnstert.2023.03.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fertnstert.2023.03.004</ArticleId><ArticleId IdType="pubmed">36914148</ArticleId></ArticleIdList></Reference><Reference><Citation>Shim JY, Laufer MR, King CR, Lee T, Einarsson JI, Tyson N. Evaluation and management of endometriosis in the adolescent. Obstet Gynecol. 2024;143(1):44&#x2013;51. doi:10.1097/AOG.0000000000005448</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AOG.0000000000005448</ArticleId><ArticleId IdType="pubmed">37944153</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M, Sun F, Zhang S, et al. NEK2 promotes the development of ovarian endometriosis and impairs decidualization by phosphorylating FOXO1. Cell mol Life Sci. 2024;81(1):237. doi:10.1007/s00018-024-05270-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-024-05270-8</ArticleId><ArticleId IdType="pmc">PMC11127904</ArticleId><ArticleId IdType="pubmed">38795132</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharifipour F, Mohaghegh Z, Javanbakht Z, Siahkal SF, Azizi F. The relationship between hypertensive disorders in pregnancy and endometriosis: a systematic review and meta-analysis. Reprod Health. 2024;21(1):91. doi:10.1186/s12978-024-01833-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12978-024-01833-x</ArticleId><ArticleId IdType="pmc">PMC11201780</ArticleId><ArticleId IdType="pubmed">38926850</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee HJ, Park YM, Jee BC, Kim YB, Suh CS. Various anatomic locations of surgically proven endometriosis: a single-center experience. Obstet Gynecol Sci. 2015;58(1):53&#x2013;58. doi:10.5468/ogs.2015.58.1.53</Citation><ArticleIdList><ArticleId IdType="doi">10.5468/ogs.2015.58.1.53</ArticleId><ArticleId IdType="pmc">PMC4303753</ArticleId><ArticleId IdType="pubmed">25629019</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee GJ, Porreca F, Navratilova E. Prolactin and pain of endometriosis. Pharmacol Ther. 2023;247:108435. doi:10.1016/j.pharmthera.2023.108435</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2023.108435</ArticleId><ArticleId IdType="pubmed">37169264</ArticleId></ArticleIdList></Reference><Reference><Citation>Maddern J, Grundy L, Castro J, Brierley SM. Pain in endometriosis. Front Cell Neurosci. 2020;14:590823. doi:10.3389/fncel.2020.590823</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2020.590823</ArticleId><ArticleId IdType="pmc">PMC7573391</ArticleId><ArticleId IdType="pubmed">33132854</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenberg EA, Seely EW. Update on preeclampsia and hypertensive disorders of pregnancy. Endocrinol Metab Clin North Am. 2024;53(3):377&#x2013;389. doi:10.1016/j.ecl.2024.05.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ecl.2024.05.012</ArticleId><ArticleId IdType="pubmed">39084814</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu P, Green M, Myers JE. Hypertensive disorders of pregnancy. BMJ. 2023;381:e071653. doi:10.1136/bmj-2022-071653</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-071653</ArticleId><ArticleId IdType="pubmed">37391211</ArticleId></ArticleIdList></Reference><Reference><Citation>Metoki H, Iwama N, Hamada H, et al. Hypertensive disorders of pregnancy: definition, management, and out-of-office blood pressure measurement. Hypertens Res. 2022;45(8):1298&#x2013;1309. doi:10.1038/s41440-022-00965-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41440-022-00965-6</ArticleId><ArticleId IdType="pmc">PMC9207424</ArticleId><ArticleId IdType="pubmed">35726086</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein SA, Pagidipati NJ. Hypertensive disorders of pregnancy and heart failure risk. Curr Hypertens Rep. 2022;24(7):205&#x2013;213. doi:10.1007/s11906-022-01189-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11906-022-01189-2</ArticleId><ArticleId IdType="pubmed">35347569</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinkey RG, Battarbee AN, Bello NA, Ives CW, Oparil S, Tita A. Prevention, diagnosis, and management of hypertensive disorders of pregnancy: a comparison of international guidelines. Curr Hypertens Rep. 2020;22(9):66. doi:10.1007/s11906-020-01082-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11906-020-01082-w</ArticleId><ArticleId IdType="pmc">PMC7773049</ArticleId><ArticleId IdType="pubmed">32852691</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L, Tang K, Magee LA, et al. A global view of hypertensive disorders and diabetes mellitus during pregnancy. Nat Rev Endocrinol. 2022;18(12):760&#x2013;775. doi:10.1038/s41574-022-00734-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-022-00734-y</ArticleId><ArticleId IdType="pmc">PMC9483536</ArticleId><ArticleId IdType="pubmed">36109676</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan ML, Chen LR, Tsao HM, Chen KH. Risk of gestational hypertension-preeclampsia in women with preceding endometriosis: a nationwide population-based study. PLoS One. 2017;12(7):e0181261. doi:10.1371/journal.pone.0181261</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0181261</ArticleId><ArticleId IdType="pmc">PMC5513453</ArticleId><ArticleId IdType="pubmed">28715497</ArticleId></ArticleIdList></Reference><Reference><Citation>Deer E, Herrock O, Campbell N, et al. The role of immune cells and mediators in preeclampsia. Nat Rev Nephrol. 2023;19(4):257&#x2013;270. doi:10.1038/s41581-022-00670-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-022-00670-0</ArticleId><ArticleId IdType="pmc">PMC10038936</ArticleId><ArticleId IdType="pubmed">36635411</ArticleId></ArticleIdList></Reference><Reference><Citation>Brosens IA, De Sutter P, Hamerlynck T, et al. Endometriosis is associated with a decreased risk of pre-eclampsia. Hum Reprod. 2007;22(6):1725&#x2013;1729. doi:10.1093/humrep/dem072</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/humrep/dem072</ArticleId><ArticleId IdType="pubmed">17452394</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsson SC, Butterworth AS, Burgess S. Mendelian randomization for cardiovascular diseases: principles and applications. Eur Heart J. 2023;44(47):4913&#x2013;4924. doi:10.1093/eurheartj/ehad736</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehad736</ArticleId><ArticleId IdType="pmc">PMC10719501</ArticleId><ArticleId IdType="pubmed">37935836</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmioglu N, Mortlock S, Ghiasi M, et al. The genetic basis of endometriosis and comorbidity with other pain and inflammatory conditions. Nat Genet. 2023;55(3):423&#x2013;436. doi:10.1038/s41588-023-01323-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-023-01323-z</ArticleId><ArticleId IdType="pmc">PMC10042257</ArticleId><ArticleId IdType="pubmed">36914876</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapkota Y, Steinthorsdottir V, Morris AP, et al. Meta-analysis identifies five novel loci associated with endometriosis highlighting key genes involved in hormone metabolism. Nat Commun. 2017;8:15539. doi:10.1038/ncomms15539</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms15539</ArticleId><ArticleId IdType="pmc">PMC5458088</ArticleId><ArticleId IdType="pubmed">28537267</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker CM, Bokor A, Heikinheimo O, et al. ESHRE guideline: endometriosis. Hum Reprod Open. 2022;2022(2):hoac009. doi:10.1093/hropen/hoac009</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hropen/hoac009</ArticleId><ArticleId IdType="pmc">PMC8951218</ArticleId><ArticleId IdType="pubmed">35350465</ArticleId></ArticleIdList></Reference><Reference><Citation>Harada T, Taniguchi F, Guo SW, et al. The Asian Society of endometriosis and adenomyosis guidelines for managing adenomyosis. Reprod Med Biol. 2023;22(1):e12535. doi:10.1002/rmb2.12535</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmb2.12535</ArticleId><ArticleId IdType="pmc">PMC10493363</ArticleId><ArticleId IdType="pubmed">37701076</ArticleId></ArticleIdList></Reference><Reference><Citation>Kho KA, Chen JS, Halvorson LM. Diagnosis, evaluation, and treatment of adenomyosis. JAMA. 2021;326(2):177&#x2013;178. doi:10.1001/jama.2020.26436</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.26436</ArticleId><ArticleId IdType="pubmed">34255015</ArticleId></ArticleIdList></Reference><Reference><Citation>Farland LV, Prescott J, Sasamoto N, et al. Endometriosis and risk of adverse pregnancy outcomes. Obstet Gynecol. 2019;134(3):527&#x2013;536. doi:10.1097/AOG.0000000000003410</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AOG.0000000000003410</ArticleId><ArticleId IdType="pmc">PMC6922084</ArticleId><ArticleId IdType="pubmed">31403584</ArticleId></ArticleIdList></Reference><Reference><Citation>Vercellini P, Vigan&#xf2; P, Bandini V, Buggio L, Berlanda N, Somigliana E. Association of endometriosis and adenomyosis with pregnancy and infertility. Fertil Steril. 2023;119(5):727&#x2013;740. doi:10.1016/j.fertnstert.2023.03.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fertnstert.2023.03.018</ArticleId><ArticleId IdType="pubmed">36948440</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi H, Kawahara N, Ogawa K, Yoshimoto C. Shared molecular features linking endometriosis and obstetric complications. Reprod Sci. 2020;27(5):1089&#x2013;1096. doi:10.1007/s43032-019-00119-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s43032-019-00119-z</ArticleId><ArticleId IdType="pubmed">32046439</ArticleId></ArticleIdList></Reference><Reference><Citation>Nirgianakis K, Gasparri ML, Radan AP, et al. Obstetric complications after laparoscopic excision of posterior deep infiltrating endometriosis: a case-control study. Fertil Steril. 2018;110(3):459&#x2013;466. doi:10.1016/j.fertnstert.2018.04.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fertnstert.2018.04.036</ArticleId><ArticleId IdType="pubmed">30098698</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Wei H. Role of decidual natural killer cells in human pregnancy and related pregnancy complications. Front Immunol. 2021;12:728291. doi:10.3389/fimmu.2021.728291</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.728291</ArticleId><ArticleId IdType="pmc">PMC8426434</ArticleId><ArticleId IdType="pubmed">34512661</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahajan D, Sharma NR, Kancharla S, et al. Role of natural killer cells during pregnancy and related complications. Biomolecules. 2022;12(1):68. doi:10.3390/biom12010068</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom12010068</ArticleId><ArticleId IdType="pmc">PMC8773865</ArticleId><ArticleId IdType="pubmed">35053216</ArticleId></ArticleIdList></Reference><Reference><Citation>Szczuko M, Kikut J, Komorniak N, Bilicki J, Celewicz Z, Zi&#x119;tek M. The role of arachidonic and linoleic acid derivatives in pathological pregnancies and the human reproduction process. Int J mol Sci. 2020;21(24):9628. doi:10.3390/ijms21249628</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21249628</ArticleId><ArticleId IdType="pmc">PMC7766587</ArticleId><ArticleId IdType="pubmed">33348841</ArticleId></ArticleIdList></Reference><Reference><Citation>Zullo F, Spagnolo E, Saccone G, et al. Endometriosis and obstetrics complications: a systematic review and meta-analysis. Fertil Steril. 2017;108(4):667&#x2013;672.e5. doi:10.1016/j.fertnstert.2017.07.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fertnstert.2017.07.019</ArticleId><ArticleId IdType="pubmed">28874260</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorrentino F, De Padova M, Falagario M, et al. Endometriosis and adverse pregnancy outcome. Minerva Obstet Gynecol. 2022;74(1):31&#x2013;44. doi:10.23736/S2724-606X.20.04718-8</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S2724-606X.20.04718-8</ArticleId><ArticleId IdType="pubmed">34096691</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34039477</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>29</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1531-5037</ISSN><JournalIssue CitedMedium="Internet"><Volume>56</Volume><Issue>12</Issue><PubDate><Year>2021</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of pediatric surgery</Title><ISOAbbreviation>J Pediatr Surg</ISOAbbreviation></Journal><ArticleTitle>Association between pectus excavatum and congenital genetic disorders: A systematic review and practical guide for the treating physician.</ArticleTitle><Pagination><StartPage>2239</StartPage><EndPage>2252</EndPage><MedlinePgn>2239-2252</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jpedsurg.2021.04.016</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0022-3468(21)00326-2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Pectus excavatum (PE) could be part of a genetic disorder, which then has implications regarding comorbidity, the surgical correction of PE, and reproductive choices. However, referral of a patient presenting with PE for genetic analysis is often delayed because additional crucial clinical signs may be subtle or even missed in syndromic patients. We reviewed the literature to inventory known genetic disorders associated with PE and create a standardized protocol for clinical evaluation.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic literature search was performed in electronic databases. Genetic disorders were considered associated with PE if studies reported at least five cases with PE. Characteristics of each genetic disorder were extracted from the literature and the OMIM database in order to create a practical guide for the clinician.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">After removal of duplicates from the initial search, 1632 citations remained. Eventually, we included 119 full text articles, representing 20 different genetic disorders. Relevant characteristics and important clinical signs of each genetic disorder were summarized providing a standardized protocol in the form of a scoring list. The most important clinical sign was a positive family history for PE and/or congenital heart defect.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Twenty unique genetic disorders have been found associated with PE. We have created a scoring list for the clinician that systematically evaluates crucial clinical signs, thereby facilitating decision making for referral to a clinical geneticist.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Billar</LastName><ForeName>Ryan J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Erasmus University Medical Center - Sophia Children's Hospital, department of Paediatric Surgery Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manoubi</LastName><ForeName>Wiem</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Erasmus University Medical Centre, department of Neuroscience, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kant</LastName><ForeName>Sarina G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Erasmus University Medical Centre, department of Clinical Genetics, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wijnen</LastName><ForeName>Ren&#xe9; M H</ForeName><Initials>RMH</Initials><AffiliationInfo><Affiliation>Erasmus University Medical Center - Sophia Children's Hospital, department of Paediatric Surgery Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Demirdas</LastName><ForeName>Serwet</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Erasmus University Medical Centre, department of Clinical Genetics, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schnater</LastName><ForeName>Johannes M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Erasmus University Medical Center - Sophia Children's Hospital, department of Paediatric Surgery Rotterdam, Netherlands. Electronic address: j.schnater@erasmusmc.nl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Pediatr Surg</MedlineTA><NlmUniqueID>0052631</NlmUniqueID><ISSNLinking>0022-3468</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005660" MajorTopicYN="Y">Funnel Chest</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006330" MajorTopicYN="Y">Heart Defects, Congenital</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008403" MajorTopicYN="N">Mass Screening</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010820" MajorTopicYN="Y">Physicians</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Chest anomaly</Keyword><Keyword MajorTopicYN="N">Genetics</Keyword><Keyword MajorTopicYN="N">Surgery</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest All authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>4</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>27</Day><Hour>5</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34039477</ArticleId><ArticleId IdType="doi">10.1016/j.jpedsurg.2021.04.016</ArticleId><ArticleId IdType="pii">S0022-3468(21)00326-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32063522</PMID><DateCompleted><Year>2020</Year><Month>12</Month><Day>21</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-3348</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of vascular surgery. Venous and lymphatic disorders</Title><ISOAbbreviation>J Vasc Surg Venous Lymphat Disord</ISOAbbreviation></Journal><ArticleTitle>Network meta-analysis to compare VenaSeal with other superficial venous therapies for chronic venous insufficiency.</ArticleTitle><Pagination><StartPage>472</StartPage><EndPage>481.e3</EndPage><MedlinePgn>472-481.e3</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jvsv.2019.12.061</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2213-333X(19)30702-4</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Several randomized controlled trials (RCTs) have compared different interventions for chronic venous insufficiency (CVI) management, but mixed comparison of these interventions is lacking. The aim of this network meta-analysis was to compare VenaSeal closure system (Medtronic, Minneapolis, Minn) with endovenous laser ablation (EVLA), radiofrequency ablation (RFA), mechanochemical ablation, sclerotherapy, and surgery for management of CVI to achieve anatomic success (complete closure of treated vein within 6&#xa0;months after intervention) as the primary outcome and health-related quality of life (HRQoL; EuroQol-5 Dimension, Aberdeen Varicose Vein Questionnaire), Venous Clinical Severity Score (VCSS), pain scores, and adverse events as secondary outcomes.</AbstractText><AbstractText Label="METHODS">A systematic review of journal databases was undertaken, and RCTs between January 1996 and September 2018 comparing different treatment options were included. Risk of bias and quality of publications were assessed using the Cochrane bias tool; Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were used for study selection and reporting. Twenty RCTs comprising 4570 patients were analyzed. Data for anatomic success, VCSS, HRQoL, pain score, and adverse events were extracted and analyzed using mixed treatment comparison in a network meta-analysis. A Bayesian fixed or random effects model was selected for analysis. Rank probability graphs were generated for various treatments and corresponding ranks obtained to estimate their probability of being best. Relative treatment effects were calculated in terms of log odds ratios for anatomic success and adverse events. Mean difference was calculated for VCSS, HRQoL, and pain score.</AbstractText><AbstractText Label="RESULTS">For the primary outcome measure (anatomic success), VenaSeal system had the highest probability of being ranked first (P&#xa0;= .980); RFA was ranked second (P&#xa0;= .365), EVLA third (P&#xa0;= .397), surgery fourth (P&#xa0;= .290), mechanochemical ablation fifth (P&#xa0;= .695), and sclerotherapy sixth (P&#xa0;= .982). For secondary outcome measures, VenaSeal system ranked third for VCSS (P&#xa0;= .332), fifth for EuroQol-5 Dimension (P&#xa0;= .420), and third for Aberdeen Varicose Vein Questionnaire (P&#xa0;= .300). Although, VenaSeal system was slightly inferior to some of the other interventions for HRQoL, the 95% credible interval of log odds ratio indicated insufficient evidence for any concrete conclusion to be drawn. VenaSeal system ranked first in reduction of postoperative pain score from baseline (P&#xa0;= .690) and was lowest in occurrence of adverse events (P&#xa0;= .650). Odds of occurrence of adverse events was 3.3 times in the sclerotherapy arm, 2.7 times in the EVLA arm, 1.6 times with surgery, and 1.1 times with RFA vs VenaSeal system arm.</AbstractText><AbstractText Label="CONCLUSIONS">VenaSeal system is a promising therapeutic option for anatomic success at 6&#xa0;months, with fewer occurrences of adverse events (wound and groin infection, pulmonary embolism) in CVI patients compared with other interventions in this study. Additional economic analysis including cost-effectiveness analysis would provide interesting perspectives on real-world insights to patients, payers, and providers.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kolluri</LastName><ForeName>Raghu</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Ohio Health &amp; Riverside Methodist Hospital, Columbus, Ohio. Electronic address: raghu.kolluri@ohiohealth.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Janice</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Medtronic, Minneapolis, Minn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Sue</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Medtronic, Minneapolis, Minn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nath</LastName><ForeName>Nibir</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Indegene Pvt Ltd, Bengaluru, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhalla</LastName><ForeName>Bhoomika Bajaj</ForeName><Initials>BB</Initials><AffiliationInfo><Affiliation>Indegene Pvt Ltd, Bengaluru, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jain</LastName><ForeName>Tarun</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Indegene Pvt Ltd, Bengaluru, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zygmunt</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Medtronic, Minneapolis, Minn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davies</LastName><ForeName>Alun</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgery, Imperial College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D000099094">Network Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>02</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Vasc Surg Venous Lymphat Disord</MedlineTA><NlmUniqueID>101607771</NlmUniqueID><ISSNLinking>2213-333X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004621" MajorTopicYN="N">Embolization, Therapeutic</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="Y">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053685" MajorTopicYN="Y">Laser Therapy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010149" MajorTopicYN="N">Pain, Postoperative</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000078703" MajorTopicYN="Y">Radiofrequency Ablation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012501" MajorTopicYN="N">Saphenous Vein</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015911" MajorTopicYN="Y">Sclerotherapy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014689" MajorTopicYN="N">Venous Insufficiency</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CVI</Keyword><Keyword MajorTopicYN="N">Cyanoacrylate</Keyword><Keyword MajorTopicYN="N">Varicose veins</Keyword><Keyword MajorTopicYN="N">Venous insufficiency</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>12</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32063522</ArticleId><ArticleId IdType="doi">10.1016/j.jvsv.2019.12.061</ArticleId><ArticleId IdType="pii">S2213-333X(19)30702-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26994132</PMID><DateCompleted><Year>2016</Year><Month>12</Month><Day>13</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2047-9980</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>3</Issue><PubDate><Year>2016</Year><Month>Mar</Month><Day>18</Day></PubDate></JournalIssue><Title>Journal of the American Heart Association</Title><ISOAbbreviation>J Am Heart Assoc</ISOAbbreviation></Journal><ArticleTitle>Off-Hour Admission and Mortality Risk for 28 Specific Diseases: A Systematic Review and Meta-Analysis of 251 Cohorts.</ArticleTitle><Pagination><StartPage>e003102</StartPage><MedlinePgn>e003102</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e003102</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1161/JAHA.115.003102</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">A considerable amount of studies have examined the relationship between off-hours (weekends and nights) admission and mortality risk for various diseases, but the results remain equivocal.</AbstractText><AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">Through a search of EMBASE, PUBMED, Web of Science, and Cochrane Database of Systematic Reviews, we identified cohort studies that evaluated the association between off-hour admission and mortality risk for disease. In a random effects meta-analysis of 140 identified articles (251 cohorts), off-hour admission was strongly associated with increased mortality for aortic aneurysm (odds ratio, 1.52; 95% CI, 1.30-1.77), breast cancer (1.50, 1.21-1.86), leukemia (1.45, 1.17-1.79), respiratory neoplasm (1.32, 1.20-1.26), pancreatic cancer (1.32, 1.12-1.56), malignant neoplasm of genitourinary organs (1.27, 1.08-1.49), colorectal cancer (1.26, 1.07-1.49), pulmonary embolism (1.20, 1.13-1.28), arrhythmia and cardiac arrest (1.19, 1.09-1.29), and lymphoma (1.19, 1.06-1.34). Weaker (odds ratio &lt;1.19) but statistically significant association was noted for renal failure, traumatic brain injury, heart failure, intracerebral hemorrhage, subarachnoid hemorrhage, stroke, gastrointestinal bleeding, myocardial infarction, chronic obstructive pulmonary disease, and bloodstream infections. No association was found for hip fracture, pneumonia, intestinal obstruction, aspiration pneumonia, peptic ulcer, trauma, diverticulitis, and neonatal mortality. Overall, off-hour admission was associated with increased mortality for 28 diseases combined (odds ratio, 1.11; 95% CI, 1.10-1.13).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Off-hour admission is associated with increased mortality risk, and the associations varied substantially for different diseases. Specialists, nurses, as well as hospital administrators and health policymakers can take these findings into consideration to improve the quality and continuity of medical services.</AbstractText><CopyrightInformation>&#xa9; 2016 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Yanfeng</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Social Medicine and Health Management, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Wenzhen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Social Medicine and Health Management, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herath</LastName><ForeName>Chulani</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Social Medicine and Health Management, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Jiahong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Fujian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Norwich Medical School, Faculty of Medicine and Health Science, University of East Anglia, Norwich, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Shiyi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Social Medicine and Health Management, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China zuxunlu@yahoo.com hai_tao_cao@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Zuxun</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Social Medicine and Health Management, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China zuxunlu@yahoo.com hai_tao_cao@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>03</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Heart Assoc</MedlineTA><NlmUniqueID>101580524</NlmUniqueID><ISSNLinking>2047-9980</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D039602" MajorTopicYN="Y">After-Hours Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="N">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002423" MajorTopicYN="N">Cause of Death</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016009" MajorTopicYN="N">Chi-Square Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003141" MajorTopicYN="N">Communicable Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005767" MajorTopicYN="N">Gastrointestinal Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007674" MajorTopicYN="N">Kidney Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010343" MajorTopicYN="Y">Patient Admission</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012044" MajorTopicYN="N">Regression Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012140" MajorTopicYN="N">Respiratory Tract Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">disease</Keyword><Keyword MajorTopicYN="N">meta&#x2010;analysis</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">off&#x2010;hour</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>3</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26994132</ArticleId><ArticleId IdType="pmc">PMC4943279</ArticleId><ArticleId IdType="doi">10.1161/JAHA.115.003102</ArticleId><ArticleId IdType="pii">JAHA.115.003102</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Worni M, Schudel IM, &#xd8;stbye T, Shah A, Khare A, Pietrobon R, Thacker JK, Guller U. Worse outcomes in patients undergoing urgent surgery for left&#x2010;sided diverticulitis admitted on weekends vs weekdays: a population&#x2010;based study of 31&#xa0;832 patients. Arch Surg. 2012;147:649&#x2013;655.</Citation><ArticleIdList><ArticleId IdType="pubmed">22802061</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostis WJ, Demissie K, Marcella SW, Shao YH, Wilson AC, Moreyra AE. Weekend versus weekday admission and mortality from myocardial infarction. N Engl J Med. 2007;356:1099&#x2013;1109.</Citation><ArticleIdList><ArticleId IdType="pubmed">17360988</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricciardi R, Roberts PL, Read TE, Baxter NN, Marcello PW, Schoetz DJ. Mortality rate after nonelective hospital admission. Arch Surg. 2011;146:545&#x2013;551.</Citation><ArticleIdList><ArticleId IdType="pubmed">21576609</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell CM, Redelmeier DA. Mortality among patients admitted to hospitals on weekends as compared with weekdays. N Engl J Med. 2001;345:663&#x2013;668.</Citation><ArticleIdList><ArticleId IdType="pubmed">11547721</ArticleId></ArticleIdList></Reference><Reference><Citation>Needleman J, Buerhaus P, Mattke S, Stewart M, Zelevinsky K. Nurse&#x2010;staffing levels and the quality of care in hospitals. N Engl J Med. 2002;346:1715&#x2013;1722.</Citation><ArticleIdList><ArticleId IdType="pubmed">12037152</ArticleId></ArticleIdList></Reference><Reference><Citation>Magid DJ, Wang Y, Herrin J, McNamara RL, Bradley EH, Curtis JP, Pollack CV Jr, French WJ, Blaney ME, Krumholz HM. Relationship between time of day, day of week, timeliness of reperfusion, and in&#x2010;hospital mortality for patients with acute ST&#x2010;segment elevation myocardial infarction. JAMA. 2005;294:803&#x2013;812.</Citation><ArticleIdList><ArticleId IdType="pubmed">16106005</ArticleId></ArticleIdList></Reference><Reference><Citation>McDowell MM, Kellner CP, Sussman ES, Bruce SS, Bruce RA, Heuts SG, Sander Connolly E. The role of admission timing in the outcome of intracerebral hemorrhage patients at a specialized stroke center. Neurol Res. 2014;36:95&#x2013;101.</Citation><ArticleIdList><ArticleId IdType="pubmed">24410059</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang GM, Tung YC. Factors associated with pneumonia outcomes: a nationwide population&#x2010;based study over the 1997&#x2013;2008 period. J Gen Intern Med. 2012;27:527&#x2013;533.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3326101</ArticleId><ArticleId IdType="pubmed">22095573</ArticleId></ArticleIdList></Reference><Reference><Citation>
Agency for Health care Research and Quality
. Guide to inpatient quality indicators: quality of care in hospital&#x2010;volume, mortality, and utilization. Available at: http://qualityindicators.ahrq.gov/downloads/modules/iqi/v31/iqi_guide_v31.pdf. Accessed March 12, 2007.</Citation></Reference><Reference><Citation>MacFarlane A. Variations in number of births and perinatal mortality by day of week in England and Wales. Br Med J. 1978;2:1670&#x2013;1673.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1609011</ArticleId><ArticleId IdType="pubmed">737435</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendry RA. The weekend&#x2014;a dangerous time to be born? Br J Obstet Gynaecol. 1981;88:1200&#x2013;1203.</Citation><ArticleIdList><ArticleId IdType="pubmed">7306474</ArticleId></ArticleIdList></Reference><Reference><Citation>Cram P, Hillis SL, Barnett M, Rosenthal GE. Effects of weekend admission and hospital teaching status on in&#x2010;hospital mortality. Am J Med. 2004;117:151&#x2013;157.</Citation><ArticleIdList><ArticleId IdType="pubmed">15276592</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorita A, Ahmed A, Starr SR, Thompson KM, Reed DA, Prokop L, Shah ND, Murad MH, Ting HH. Off&#x2010;hour presentation and outcomes in patients with acute myocardial infarction: systematic review and meta&#x2010;analysis. BMJ. 2014;348:f7393.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3898160</ArticleId><ArticleId IdType="pubmed">24452368</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorita A, Ahmed A, Starr SR, Thompson KM, Reed DA, Dabrh AM, Prokop L, Kent DM, Shah ND, Murad MH, Ting HH. Off&#x2010;hour presentation and outcomes in patients with acute ischemic stroke: a systematic review and meta&#x2010;analysis. Eur J Intern Med. 2014;25:394&#x2013;400.</Citation><ArticleIdList><ArticleId IdType="pubmed">24721584</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta&#x2010;analysis of observational studies in epidemiology: a proposal for reporting. Meta&#x2010;analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008&#x2013;2012.</Citation><ArticleIdList><ArticleId IdType="pubmed">10789670</ArticleId></ArticleIdList></Reference><Reference><Citation>Stang A. Critical evaluation of the Newcastle&#x2010;Ottawa scale for the assessment of the quality of nonrandomized studies in meta&#x2010;analyses. Eur J Epidemiol. 2010;25:603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pubmed">20652370</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf HT, Owe KM, Juhl M, Hegaard HK. Leisure time physical activity and the risk of pre&#x2010;eclampsia: a systematic review. Matern Child Health J. 2014;18:899&#x2013;910.</Citation><ArticleIdList><ArticleId IdType="pubmed">23836014</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta&#x2010;analyses. BMJ. 2003;327:557&#x2013;560.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>DerSimonian R, Laird N. Meta&#x2010;analysis in clinical trials. Control Clin Trials. 1986;7:177&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088&#x2013;1101.</Citation><ArticleIdList><ArticleId IdType="pubmed">7786990</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarnow&#x2010;Mordi WO, Hau C, Warden A, Shearer AJ. Hospital mortality in relation to staff workload: a 4&#x2010;year study in an adult intensive&#x2010;care unit. Lancet. 2000;356:185&#x2013;189.</Citation><ArticleIdList><ArticleId IdType="pubmed">10963195</ArticleId></ArticleIdList></Reference><Reference><Citation>Meltzer D, Manning WG, Morrison J, Shah MN, Jin L, Guth T, Levinson W. Effects of physician experience on costs and outcomes on an academic general medicine service: results of a trial of hospitalists. Ann Intern Med. 2002;137:866&#x2013;874.</Citation><ArticleIdList><ArticleId IdType="pubmed">12458986</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallerani M, Volpato S, Boari B, Pala M, De Giorgi A, Fabbian F, Gasbarro V, Bossone E, Eagle KA, Carle F, Manfredini R. Outcomes of weekend versus weekday admission for acute aortic dissection or rupture: a retrospective study on the Italian National Hospital Database. Int J Cardiol. 2013;168:3117&#x2013;3119.</Citation><ArticleIdList><ArticleId IdType="pubmed">23642591</ArticleId></ArticleIdList></Reference><Reference><Citation>Jneid H, Fonarow GC, Cannon CP, Palacios IF, Kilic T, Moukarbel GV, Maree AO, LaBresh KA, Liang L, Newby LK, Fletcher G, Wexler L, Peterson E. Impact of time of presentation on the care and outcomes of acute myocardial infarction. Circulation. 2008;117:2502&#x2013;2509.</Citation><ArticleIdList><ArticleId IdType="pubmed">18427127</ArticleId></ArticleIdList></Reference><Reference><Citation>Bejanyan N, Fu AZ, Lazaryan A, Fu R, Kalaycio M, Advani A, Sobecks R, Copelan E, Maciejewski JP, Sekeres MA. Impact of weekend admissions on quality of care and outcomes in patients with acute myeloid leukemia. Cancer. 2010;116:3614&#x2013;3620.</Citation><ArticleIdList><ArticleId IdType="pubmed">20564070</ArticleId></ArticleIdList></Reference><Reference><Citation>Aujesky D, Jim&#xe9;nez D, Mor MK, Geng M, Fine MJ, Ibrahim SA. Weekend versus weekday admission and mortality after acute pulmonary embolism. Circulation. 2009;119:962&#x2013;968.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2746886</ArticleId><ArticleId IdType="pubmed">19204300</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorn SD, Shah ND, Berg BP, Naessens JM. Effect of weekend hospital admission on gastrointestinal hemorrhage outcomes. Dig Dis Sci. 2010;55:1658&#x2013;1666.</Citation><ArticleIdList><ArticleId IdType="pubmed">19672711</ArticleId></ArticleIdList></Reference><Reference><Citation>Abougergi MS, Travis AC, Saltzman JR. Impact of day of admission on mortality and other outcomes in upper GI hemorrhage: a nationwide analysis. Gastrointest Endosc. 2014;80:228&#x2013;235.</Citation><ArticleIdList><ArticleId IdType="pubmed">24674354</ArticleId></ArticleIdList></Reference><Reference><Citation>Peberdy MA, Ornato JP, Larkin GL, Braithwaite RS, Kashner TM, Carey SM, Meaney PA, Cen L, Nadkarni VM, Praestqaard AH, Berg RA. Survival from in&#x2010;hospital cardiac arrest during nights and weekends. JAMA. 2008;299:785&#x2013;792.</Citation><ArticleIdList><ArticleId IdType="pubmed">18285590</ArticleId></ArticleIdList></Reference><Reference><Citation>Koike S, Tanabe S, Ogawa T, Akahane M, Yasunaga H, Horiguchi H, Matsumoto S, Imamura T. Effect of time and day of admission on 1&#x2010;month survival and neurologically favourable 1&#x2010;month survival in out&#x2010;of&#x2010;hospital cardiopulmonary arrest patients. Resuscitation. 2011;82:863&#x2013;868.</Citation><ArticleIdList><ArticleId IdType="pubmed">21397380</ArticleId></ArticleIdList></Reference><Reference><Citation>Daugaard CL, Jorgensen HL, Riis T, Lauritzen JB, Duus BR, van der Mark S. Is mortality after hip fracture associated with surgical delay or admission during weekends and public holidays? A retrospective study of 38,020 patients. Acta Orthop. 2012;83:609&#x2013;613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3555458</ArticleId><ArticleId IdType="pubmed">23140106</ArticleId></ArticleIdList></Reference><Reference><Citation>Foss NB, Kehlet H. Short&#x2010;term mortality in hip fracture patients admitted during weekends and holidays. Br J Anaesth. 2006;96:450&#x2013;454.</Citation><ArticleIdList><ArticleId IdType="pubmed">16443639</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahsberg K, Ye W, Lu Y, Zheng Z, Sta&#xeb;l von Holstein C. Hospitalisation of and mortality from bleeding peptic ulcer in Sweden: a nationwide time&#x2010;trend analysis. Aliment Pharmacol Ther. 2011;33:578&#x2013;584.</Citation><ArticleIdList><ArticleId IdType="pubmed">21210831</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr BG, Jenkins P, Branas CC, Wiebe DJ, Kim P, Schwab CW, Reilly PM. Does the trauma system protect against the weekend effect? J Trauma. 2010;69:1042&#x2013;1047.</Citation><ArticleIdList><ArticleId IdType="pubmed">21068609</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr BG, Reilly PM, Schwab CW, Branas CC, Geiger J, Wiebe DJ. Weekend and night outcomes in a statewide trauma system. Arch Surg. 2011;146:810&#x2013;817.</Citation><ArticleIdList><ArticleId IdType="pubmed">21422328</ArticleId></ArticleIdList></Reference><Reference><Citation>MacKenzie EJ, Rivara FP, Jurkovich GJ, Nathens AB, Frey KP, Egleston BL, Salkever DS, Scharfstein DO. A national evaluation of the effect of trauma&#x2010;center care on mortality. N Engl J Med. 2006;354:366&#x2013;378.</Citation><ArticleIdList><ArticleId IdType="pubmed">16436768</ArticleId></ArticleIdList></Reference><Reference><Citation>Concha OP, Gallego B, Hillman K, Delaney GP, Coiera E. Do variations in hospital mortality patterns after weekend admission reflect reduced quality of care or different patient cohorts? A population&#x2010;based study BMJ Qual Saf. 2014;23:215&#x2013;222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3933164</ArticleId><ArticleId IdType="pubmed">24163392</ArticleId></ArticleIdList></Reference><Reference><Citation>Gould JB, Qin C, Marks AR, Chavez G. Neonatal mortality in weekend vs weekday births. JAMA. 2003;289:2958&#x2013;2962.</Citation><ArticleIdList><ArticleId IdType="pubmed">12799403</ArticleId></ArticleIdList></Reference><Reference><Citation>Laupland KB, Ball CG, Kirkpatrick AW. Hospital mortality among major trauma victims admitted on weekends and evenings: a cohort study. J Trauma Manag Outcomes. 2009;3:8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2731032</ArticleId><ArticleId IdType="pubmed">19635157</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke MS, Wills RA, Bowman RV, Zimmerman PV, Fong KM, Coory MD, Yang IA. Exploratory study of the &#x2018;weekend effect&#x2019; for acute medical admissions to public hospitals in Queensland, Australia. Intern Med J. 2010;40:777&#x2013;783.</Citation><ArticleIdList><ArticleId IdType="pubmed">19811554</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibrahimou B, Salihu HM, English G, Anozie C, Lartey G, Dagne G. Twins born over weekends: are they at risk for elevated infant mortality? Arch Gynecol Obstet. 2012;286:1349&#x2013;1355.</Citation><ArticleIdList><ArticleId IdType="pubmed">22797696</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen XK, Wen SW, Fleming N, Demissie K, Rhoads GG, Walker M. Teenage pregnancy and adverse birth outcomes: a large population based retrospective cohort study. Int J Epidemiol. 2007;36:368&#x2013;373.</Citation><ArticleIdList><ArticleId IdType="pubmed">17213208</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo ZC, Liu S, Wilkins R, Kramer MS. Risks of stillbirth and early neonatal death by day of week. CMAJ. 2004;170:337&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC331383</ArticleId><ArticleId IdType="pubmed">14757669</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell EF, Hansen NI, Morriss FH Jr, Stoll BJ, Ambalavanan N, Gould JB, Laptook AR, Walsh MC, Carlo WA, Shankaran S, Das A, Hiqqins RD. Impact of timing of birth and resident duty&#x2010;hour restrictions on outcomes for small preterm infants. Pediatrics. 2010;126:222&#x2013;231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2924191</ArticleId><ArticleId IdType="pubmed">20643715</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton P, Restrepo E. Weekend birth and higher neonatal mortality: a problem of patient acuity or quality of care? J Obstet Gynecol Neonatal Nurs. 2003;32:724&#x2013;733.</Citation><ArticleIdList><ArticleId IdType="pubmed">14649592</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33881602</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>22</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1433-3023</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>10</Issue><PubDate><Year>2021</Year><Month>Oct</Month></PubDate></JournalIssue><Title>International urogynecology journal</Title><ISOAbbreviation>Int Urogynecol J</ISOAbbreviation></Journal><ArticleTitle>Adult female urinary incontinence guidelines: a systematic review of evaluation guidelines across clinical specialties.</ArticleTitle><Pagination><StartPage>2671</StartPage><EndPage>2691</EndPage><MedlinePgn>2671-2691</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00192-021-04777-z</ELocationID><Abstract><AbstractText Label="INTRODUCTION AND HYPOTHESIS" NlmCategory="OBJECTIVE">To systematically review evaluation guidelines of uncomplicated urinary incontinence (UI) in community-dwelling adult women to assess guidance available to the full range of providers treating UI.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Systematic literature search of eight bibliographic databases. We included UI evaluation guidelines written for medical providers in English after January 1, 2008.</AbstractText><AbstractText Label="EXCLUSION CRITERIA" NlmCategory="METHODS">guidelines for children, men, institutionalized women, peripartum- and neurologic-related UI. A quantitative scoring system included assessed components and associated recommendation level and clarity.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twenty-two guidelines met the criteria. All guidelines included: history taking, UI characterization, physical examination (PE) performance, urinalysis, and post-void residual volume assessment. At least 75% included medical and surgical history assessment, other disease process exclusion, medication review, impact on quality of life ascertainment, observing stress UI, mental status assessment, performing a pelvic examination, urine culture, bladder diary, and limiting more invasive diagnostics procedures. Fifty to 75% included other important evaluation components (i.e., assessing obstetric history, bowel symptoms, fluid intake, patient expectations/preferences/values, obesity, physical functioning/mobility, other PE [abdominal, rectal, pelvic muscle, and neurologic], urethral hypermobility, and pad testing. Less than 50% of guidelines included discussing patient treatment goals. Guidelines varied in level of detail and clarity, with several instances of unclear or inconsistent recommendations within the same guideline and evaluation components identified only by inference from treatment recommendations. Non-specialty guidelines reported fewer components with a lesser degree of clarity, but this difference was not statistically significant (p&#xa0;=&#x2009;0.20).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">UI evaluation guidelines varied in level of comprehensiveness, detail, and clarity. This variability may lead to inconsistent evaluations in the work-up of UI, contributing to missed opportunities for individualized care.</AbstractText><CopyrightInformation>&#xa9; 2021. The International Urogynecological Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lenger</LastName><ForeName>Stacy M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Obstetrics, Gynecology, and Women's Health, Division of Female Pelvic Medicine and Reconstructive Surgery, The University of Louisville School of Medicine, Louisville, KY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Division of Female Pelvic Medicine and Reconstructive Surgery, Washington University School of Medicine, St. Louis Center for Outpatient Health, 9th floor, Campus, Box 8064, St. Louis, MO, 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chu</LastName><ForeName>Christine M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Division of Female Pelvic Medicine and Reconstructive Surgery, Washington University School of Medicine, St. Louis Center for Outpatient Health, 9th floor, Campus, Box 8064, St. Louis, MO, 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghetti</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Division of Female Pelvic Medicine and Reconstructive Surgery, Washington University School of Medicine, St. Louis Center for Outpatient Health, 9th floor, Campus, Box 8064, St. Louis, MO, 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hardi</LastName><ForeName>Angela C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Washington University School of Medicine, Becker Medical Library, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>H Henry</ForeName><Initials>HH</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Urologic Surgery, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pakpahan</LastName><ForeName>Ratna</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Public Health Sciences, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lowder</LastName><ForeName>Jerry L</ForeName><Initials>JL</Initials><Identifier Source="ORCID">0000-0003-1065-4537</Identifier><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Division of Female Pelvic Medicine and Reconstructive Surgery, Washington University School of Medicine, St. Louis Center for Outpatient Health, 9th floor, Campus, Box 8064, St. Louis, MO, 63110, USA. lowderj@wustl.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sutcliffe</LastName><ForeName>Siobhan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Public Health Sciences, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int Urogynecol J</MedlineTA><NlmUniqueID>101567041</NlmUniqueID><ISSNLinking>0937-3462</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014549" MajorTopicYN="Y">Urinary Incontinence</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014550" MajorTopicYN="Y">Urinary Incontinence, Stress</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Evaluation</Keyword><Keyword MajorTopicYN="N">Guidelines</Keyword><Keyword MajorTopicYN="N">Personalized medicine</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword><Keyword MajorTopicYN="N">Urinary incontinence</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>21</Day><Hour>12</Hour><Minute>20</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33881602</ArticleId><ArticleId IdType="doi">10.1007/s00192-021-04777-z</ArticleId><ArticleId IdType="pii">10.1007/s00192-021-04777-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Irwin DE, Milsom I, Hunskaar S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006;50(6):1306&#x2013;14 discussion 1314-1305.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eururo.2006.09.019</ArticleId></ArticleIdList></Reference><Reference><Citation>Markland AD, Richter HE, Fwu CW, Eggers P, Kusek JW. Prevalence and trends of urinary incontinence in adults in the United States, 2001 to 2008. J Urol. 2011;186(2):589&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.juro.2011.03.114</ArticleId></ArticleIdList></Reference><Reference><Citation>Minassian VA, Stewart WF, Wood GC. Urinary incontinence in women: variation in prevalence estimates and risk factors. Obstet Gynecol. 2008;111(2 Pt 1):324&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.AOG.0000267220.48987.17</ArticleId></ArticleIdList></Reference><Reference><Citation>Dovey S, McNaughton T, Tilyard M, Gurr E, Jolleys J, Wilson D. General practitioners' opinions of continence care training. N Z Med J. 1996;109(1029):340&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">8862354</ArticleId></ArticleIdList></Reference><Reference><Citation>Lose G, Jacobsen AT, Madsen H, Thorsen P, Tibaek S, Johansen B. General practitioners' knowledge of and attitude to assessment and treatment of women with urinary incontinence. A questionnaire among general practitioners in Denmark. Ugeskr Laeger. 2001;163(38):5183&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">11577524</ArticleId></ArticleIdList></Reference><Reference><Citation>McFall S, Yerkes AM, Bernard M, LeRud T. Evaluation and treatment of urinary incontinence. Report of a physician survey. Arch Fam Med. 1997;6(2):114&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archfami.6.2.114</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandvik H, Hunskaar S, Eriksen BC. Management of urinary incontinence in women in general practice: actions taken at the first consultation. Scand J Prim Health Care. 1990;8(1):3&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/02813439008994922</ArticleId></ArticleIdList></Reference><Reference><Citation>Swanson JG, Skelly J, Hutchison B, Kaczorowski J. Urinary incontinence in Canada. National survey of family physicians' knowledge, attitudes, and practices. Can Fam Physician. 2002;48:86&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">11852616</ArticleId><ArticleId IdType="pmc">2213918</ArticleId></ArticleIdList></Reference><Reference><Citation>Norton JM, Bradley CS, Brady SS, et al. Individualizing urinary incontinence treatment: research needs identified at NIDDK workshop. J Urol. 2018;199(6):1405&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.juro.2017.11.118</ArticleId></ArticleIdList></Reference><Reference><Citation>Syan R, Brucker BM. Guideline of guidelines: urinary incontinence. BJU Int. 2016;117(1):20&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bju.13187</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical Practice Guidelines We Can Trust. Institute of medicine (US) committee on standards for developing trustworthy clinical Practice guidelines. Washington, DC: National Academies Press; 2011.</Citation></Reference><Reference><Citation>Lian WQ, Li FJ, Huang HX, Zheng YQ, Chen LH. Constipation and risk of urinary incontinence in women: a meta-analysis. Int Urogynecol J. 2019;30(10):1629&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00192-019-03941-w</ArticleId></ArticleIdList></Reference><Reference><Citation>Subak LL, Whitcomb E, Shen H, Saxton J, Vittinghoff E, Brown JS. Weight loss: a novel and effective treatment for urinary incontinence. J Urol. 2005;174(1):190&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ju.0000162056.30326.83</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson K. A guide to assessing bladder function and urinary incontinence in older people. Nurs Times. 2009;105(40):20&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">19908660</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrams P, Andersson KE, Birder L, et al. Fourth international consultation on incontinence recommendations of the international scientific committee: evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn. 2010;29(1):213&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nau.20870</ArticleId></ArticleIdList></Reference><Reference><Citation>Committee opinion. Evaluation of uncomplicated stress urinary incontinence in women before surgical treatment. Female Pelvic Med Reconstruct Surg. 2014;20(5):248&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SPV.0000000000000113</ArticleId></ArticleIdList></Reference><Reference><Citation>Practice Bulletin No ACOG. 155: urinary incontinence in women. Obstet Gynecol. 2015;126(5):e66&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AOG.0000000000001148</ArticleId></ArticleIdList></Reference><Reference><Citation>Becher K, Oelke M, Grass-Kapanke B, et al. Improving the health care of geriatric patients: management of urinary incontinence: a position paper. Zeitschrift fur Gerontologie und Geriatrie. 2013;46(5):456&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00391-013-0491-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Bettez M, Tu LM, Carlson K, et al. Update: guidelines for adult urinary incontinence collaborative consensus document for the Canadian urological association. Can Urol Assoc J = J de l'Association des urologues du Canada. 2012;6(5):354&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="doi">10.5489/cuaj.12248</ArticleId></ArticleIdList></Reference><Reference><Citation>Burkhard FCea. Urinary Incontinence. 2018; https://uroweb.org/guideline/urinary-incontinence/ . Accessed June 13, 2018, 2018.</Citation></Reference><Reference><Citation>Chung E, Lee D, Gani J, et al. Position statement: a clinical approach to the management of adult non-neurogenic overactive bladder. Med J Aust. 2018;208(1):41&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="doi">10.5694/mja16.01097</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcos J, Przydacz M, Campeau L, et al. CUA guideline on adult overactive bladder. Can Urol Assoc J = J de l'Association des urologues du Canada. 2017;11(5):E142&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="doi">10.5489/cuaj.4586</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrell SA. No. 127-the evaluation of stress incontinence prior to primary surgery. J Obstetrics Gynaecol Canada. 2018;40(2):e45&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jogc.2017.11.034</ArticleId></ArticleIdList></Reference><Reference><Citation>Frank C, Szlanta A. Office management of urinary incontinence among older patients. Can Family Phys. 2010;56(11):1115&#x2013;20.</Citation></Reference><Reference><Citation>Fritel X, Fauconnier A, Bader G, et al. Diagnosis and management of adult female stress urinary incontinence: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians. European J Obstetrics Gynecol Reproduct Biol. 2010;151(1):14&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejogrb.2010.02.041</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghoniem G, Stanford E, Kenton K, et al. Evaluation and outcome measures in the treatment of female urinary stress incontinence: international Urogynecological association (IUGA) guidelines for research and clinical practice. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(1):5&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00192-007-0495-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Gormley EA, Lightner DJ, Burgio KL, et al. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. J Urol. 2012;188(6 Suppl):2455&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.juro.2012.09.079</ArticleId></ArticleIdList></Reference><Reference><Citation>Gormley EA, Lightner DJ, Faraday M, Vasavada SP. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment. J Urol. 2015;193(5):1572&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.juro.2015.01.087</ArticleId></ArticleIdList></Reference><Reference><Citation>Kammerer-Doak D, Rizk DEE, Sorinola O, Agur W, Ismail S, Bazi T. Mixed urinary incontinence: international urogynecological association research and development committee opinion. Int Urogynecol J Pelvic Floor Dysfunct. 2014;25(10):1303&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00192-014-2485-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobashi KC, Albo ME, Dmochowski RR, et al. Surgical treatment of female stress urinary incontinence: AUA/SUFU guideline. J Urol. 2017;198(4):875&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.juro.2017.06.061</ArticleId></ArticleIdList></Reference><Reference><Citation>Medina CA, Costantini E, Petri E, et al. Evaluation and surgery for stress urinary incontinence: a FIGO working group report. Neurourol Urodynam. 2017;36(2):518&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nau.22960</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence. Urinary incontinence in women: management. 2013; nice.org.uk/guidance/cg171 . Accessed June 6, 2018, 2018.</Citation></Reference><Reference><Citation>Nishizawa O, Ishizuka O, Okamura K, Gotoh M, Hasegawa T, Hirao Y. Guidelines for management of urinary incontinence. Int J Urol. 2008;15(10):857&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1442-2042.2008.02117.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha S, Agarwal MM, Vasudeva P, et al. The urological Society of India Guidelines for the evaluation and Management of Nonneurogenic Urinary Incontinence in adults (executive summary). Indian J Urol. 2019;35(3):185&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/iju.IJU_125_19</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi S, Takei M, Nishizawa O, et al. Clinical guideline for female lower urinary tract symptoms. LUTS: Lower Urinary Tract Sympt. 2016;8(1):5&#x2013;29.</Citation></Reference><Reference><Citation>Yamaguchi O, Nishizawa O, Takeda M, et al. Clinical guidelines for overactive bladder. Int J Urol: Off J Japanese Urol Assoc. 2009;16(2):126&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1442-2042.2008.02177.x</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">22753618</PMID><DateCompleted><Year>2013</Year><Month>01</Month><Day>03</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1941-2444</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>5</Issue><PubDate><Year>2012</Year><Month>Sep</Month></PubDate></JournalIssue><Title>JPEN. Journal of parenteral and enteral nutrition</Title><ISOAbbreviation>JPEN J Parenter Enteral Nutr</ISOAbbreviation></Journal><ArticleTitle>A.S.P.E.N. clinical guidelines: nutrition support of neonatal patients at risk for necrotizing enterocolitis.</ArticleTitle><Pagination><StartPage>506</StartPage><EndPage>523</EndPage><MedlinePgn>506-23</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/0148607112449651</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Necrotizing enterocolitis (NEC) is one of the most devastating diseases in the neonatal population, with extremely low birth weight and extremely preterm infants at greatest risk.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">A systematic review of the best available evidence to answer a series of questions regarding nutrition support of neonates at risk of NEC was undertaken and evaluated using concepts adopted from the Grading of Recommendations, Assessment, Development and Evaluation working group. A consensus process was used to develop the clinical guideline recommendations prior to external and internal review and approval by the A.S.P.E.N. Board of Directors. RESULTS/ CONCLUSIONS: (1) When and how should feeds be started in infants at high risk for NEC? We suggest that minimal enteral nutrition be initiated within the first 2 days of life and advanced by 30 mL/kg/d in infants &#x2265; 1, 000 g. (Weak) (2) Does the provision of mother's milk reduce the risk of developing NEC? We suggest the exclusive use of mother's milk rather than bovine-based products or formula in infants at risk for NEC. (Weak) (3) Do probiotics reduce the risk of developing NEC? There are insufficient data to recommend the use of probiotics in infants at risk for NEC. (Further research needed.) (4) Do nutrients either prevent or predispose to the development of NEC? We do not recommend glutamine supplementation for infants at risk for NEC (Strong). There is insufficient evidence to recommend arginine and/or long chain polyunsaturated fatty acid supplementation for infants at risk for NEC. (Further research needed.) (5) When should feeds be reintroduced to infants with NEC? There are insufficient data to make a recommendation regarding time to reintroduce feedings to infants after NEC. (Further research needed.).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fallon</LastName><ForeName>Erica M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Department of Surgery and The Vascular Biology Program, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nehra</LastName><ForeName>Deepika</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Potemkin</LastName><ForeName>Alexis K</ForeName><Initials>AK</Initials></Author><Author ValidYN="Y"><LastName>Gura</LastName><ForeName>Kathleen M</ForeName><Initials>KM</Initials></Author><Author ValidYN="Y"><LastName>Simpser</LastName><ForeName>Edwin</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Compher</LastName><ForeName>Charlene</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><CollectiveName>American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Board of Directors</CollectiveName></Author><Author ValidYN="Y"><LastName>Puder</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017065">Practice Guideline</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>06</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JPEN J Parenter Enteral Nutr</MedlineTA><NlmUniqueID>7804134</NlmUniqueID><ISSNLinking>0148-6071</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005231">Fatty Acids, Unsaturated</NameOfSubstance></Chemical><Chemical><RegistryNumber>0RH81L854J</RegistryNumber><NameOfSubstance UI="D005973">Glutamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>94ZLA3W45F</RegistryNumber><NameOfSubstance UI="D001120">Arginine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JPEN J Parenter Enteral Nutr. 2013 Jan;37(1):11. doi: 10.1177/0148607112459358.</RefSource><PMID Version="1">22972878</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>JPEN J Parenter Enteral Nutr. 2013 Jan;37(1):12. doi: 10.1177/0148607112461377.</RefSource><PMID Version="1">22990614</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>JPEN J Parenter Enteral Nutr. 2013 Jan;37(1):13. doi: 10.1177/0148607112463437.</RefSource><PMID Version="1">23070132</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>JPEN J Parenter Enteral Nutr. 2013 Jan;37(1):13-4. doi: 10.1177/0148607112466109.</RefSource><PMID Version="1">23169900</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001120" MajorTopicYN="N">Arginine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019587" MajorTopicYN="Y">Dietary Supplements</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004750" MajorTopicYN="N">Enteral Nutrition</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020345" MajorTopicYN="N">Enterocolitis, Necrotizing</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005231" MajorTopicYN="N">Fatty Acids, Unsaturated</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005973" MajorTopicYN="N">Glutamine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062071" MajorTopicYN="N">Infant, Extremely Premature</DescriptorName><QualifierName UI="Q000254" MajorTopicYN="N">growth &amp; development</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007230" MajorTopicYN="N">Infant, Low Birth Weight</DescriptorName><QualifierName UI="Q000254" MajorTopicYN="Y">growth &amp; development</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007235" MajorTopicYN="N">Infant, Premature, Diseases</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008892" MajorTopicYN="N">Milk</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008895" MajorTopicYN="N">Milk, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019936" MajorTopicYN="N">Probiotics</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><InvestigatorList><Investigator ValidYN="Y"><LastName>Mirtallo</LastName><ForeName>Jay M</ForeName><Initials>JM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ayers</LastName><ForeName>Phil</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goday</LastName><ForeName>Praveen S</ForeName><Initials>PS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ireton-Jones</LastName><ForeName>Carol</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jaksic</LastName><ForeName>Tom</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lyman</LastName><ForeName>Elizabeth M</ForeName><Initials>EM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Malone</LastName><ForeName>Ainsley M</ForeName><Initials>AM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Malone</LastName><ForeName>Ainsley M</ForeName><Initials>AM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Robinson</LastName><ForeName>Lawrence A</ForeName><Initials>LA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Teitelbaum</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Van Way</LastName><ForeName>Charles</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Compher</LastName><ForeName>Charlene</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Boullata</LastName><ForeName>Joseph</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Braunschweig</LastName><ForeName>Carol</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Druyan</LastName><ForeName>Mary Ellen</ForeName><Initials>ME</Initials></Investigator><Investigator ValidYN="Y"><LastName>George</LastName><ForeName>Donald</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Simpser</LastName><ForeName>Edwin</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Worthington</LastName><ForeName>Patricia</ForeName><Initials>P</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>7</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>7</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>1</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22753618</ArticleId><ArticleId IdType="doi">10.1177/0148607112449651</ArticleId><ArticleId IdType="pii">0148607112449651</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">23887247</PMID><DateCompleted><Year>2013</Year><Month>11</Month><Day>25</Day></DateCompleted><DateRevised><Year>2018</Year><Month>01</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>111</Volume><Issue>5</Issue><PubDate><Year>2013</Year><Month>Nov</Month></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Hypercapnia and surgical site infection: a randomized trial.</ArticleTitle><Pagination><StartPage>759</StartPage><EndPage>767</EndPage><MedlinePgn>759-67</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/bja/aet233</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Tissue oxygenation is a strong predictor of surgical site infection (SSI). Mild intraoperative hypercapnia increases peripheral, gastrointestinal, and splanchnic tissue oxygenation and perfusion. Hypercapnia also has anti-inflammatory effects. However, it is unknown whether hypercapnia reduces SSI risk. We tested the hypothesis that mild intraoperative hypercapnia reduces the risk of SSI in patients having colon resection surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">With institutional review board approval and subject consent, patients having elective colon resection (e.g. hemicolectomy and low-anterior resection) expected to last &gt;2 h were randomly assigned to intraoperative normocapnia (PE'CO2 &#x2248; 35 mm Hg; n=623) or hypercapnia ( PE'CO2 &#x2248; 50 mm Hg; n=592). Investigators blinded to group assignment evaluated perioperative SSI (Center for Disease Control criteria) for 30 postoperative days. SSI rates were compared.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Patient and surgical characteristics were comparable among the groups. The SSI rate for normocapnia was 13.3%, and for hypercapnia, it was 11.2% (P=0.29). The Executive Committee stopped the trial after the first a priori determined statistical assessment point because of much smaller actual effect compared with the projected. However, because the actual difference found in the SSI rates (15-16%) were within the 95% confidence intervals (CIs) of the projected relative difference of 33% (95% CI -43 to +24%), our results cannot be considered as 'no difference', and cannot exclude a Type II error. Time to first bowel movement was half-a-day shorter in the hypercapnia group.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Mild hypercapnia appears to have little or-possibly-no ability to prevent SSI after colon resection. Other strategies for reducing SSI risk should thus take priority.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ak&#xe7;a</LastName><ForeName>O</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Perioperative Medicine, Neuroscience ICU, University of Louisville, Louisville, KY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurz</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Fleischmann</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Buggy</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Herbst</LastName><ForeName>F</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Stocchi</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Galandiuk</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Iscoe</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Fisher</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Apfel</LastName><ForeName>C C</ForeName><Initials>CC</Initials></Author><Author ValidYN="Y"><LastName>Sessler</LastName><ForeName>D I</ForeName><Initials>DI</Initials></Author><Author ValidYN="Y"><CollectiveName>Hypercapnia Trial Investigators</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT00273377</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>07</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>142M471B3J</RegistryNumber><NameOfSubstance UI="D002245">Carbon Dioxide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001784" MajorTopicYN="N">Blood Gas Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002245" MajorTopicYN="N">Carbon Dioxide</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003106" MajorTopicYN="N">Colon</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003672" MajorTopicYN="N">Defecation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013505" MajorTopicYN="N">Digestive System Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006935" MajorTopicYN="N">Hypercapnia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013530" MajorTopicYN="N">Surgical Wound Infection</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">carbon dioxide, hypercapnia</Keyword><Keyword MajorTopicYN="N">complications, infections</Keyword><Keyword MajorTopicYN="N">infection</Keyword><Keyword MajorTopicYN="N">surgery, abdominal</Keyword><Keyword MajorTopicYN="N">surgery, gastrointestinal</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>Erdik</LastName><ForeName>Klaus</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eredics</LastName><ForeName>Erol</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kabon</LastName><ForeName>Barbara</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kazerounian</LastName><ForeName>Sara</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kimberger</LastName><ForeName>Oliver</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kugener</LastName><ForeName>Andre</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marschalek</LastName><ForeName>Corinna</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mikocki</LastName><ForeName>Pia</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Niedermayer</LastName><ForeName>Monika</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Obewegeser</LastName><ForeName>Eva</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ratzenbock</LastName><ForeName>Ina</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rozum</LastName><ForeName>Romana</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sindhuber</LastName><ForeName>Sonja</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schlemitz</LastName><ForeName>Katja</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schebesta</LastName><ForeName>Karl</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stift</LastName><ForeName>Anton</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Alvarez</LastName><ForeName>Adrian</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bala</LastName><ForeName>Endrit</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chen</LastName><ForeName>Samuel T</ForeName><Initials>ST</Initials></Investigator><Investigator ValidYN="Y"><LastName>Devarajan</LastName><ForeName>Jagan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maheshwari</LastName><ForeName>Ankit</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mahboobi</LastName><ForeName>Ramatia</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mascha</LastName><ForeName>Edward</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nagem</LastName><ForeName>Hassan</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rajogopalan</LastName><ForeName>Suman</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Reynolds</LastName><ForeName>Luke</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zirzow</LastName><ForeName>Erich</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hager</LastName><ForeName>Helmut</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Taguchi</LastName><ForeName>Akiko</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fleshman</LastName><ForeName>James W</ForeName><Initials>JW</Initials></Investigator><Investigator ValidYN="Y"><LastName>Read</LastName><ForeName>Thomas E</ForeName><Initials>TE</Initials></Investigator><Investigator ValidYN="Y"><LastName>DeLong</LastName><ForeName>Diane</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Doufas</LastName><ForeName>Anthony G</ForeName><Initials>AG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Govinda</LastName><ForeName>Raghavendra</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kasuya</LastName><ForeName>Yusuke</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Komatsu</LastName><ForeName>Ryu</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lenhardt</LastName><ForeName>Rainer</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Orhan-Sungur</LastName><ForeName>Mukadder</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sengupta</LastName><ForeName>Papiya</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wadhwa</LastName><ForeName>Anupama</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Arain</LastName><ForeName>Mujeeb</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Burke</LastName><ForeName>Siun</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>McGuire</LastName><ForeName>Barry</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ragheb</LastName><ForeName>Jackie</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Podranski</LastName><ForeName>Tobias</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Taguchi</LastName><ForeName>Akikio</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kimberger</LastName><ForeName>Oliver</ForeName><Initials>O</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>7</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>12</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23887247</ArticleId><ArticleId IdType="doi">10.1093/bja/aet233</ArticleId><ArticleId IdType="pii">S0007-0912(17)32019-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30569951</PMID><DateCompleted><Year>2019</Year><Month>05</Month><Day>01</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1809-4546</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>6</Issue><PubDate><Year>2018</Year><Month>Dec</Month><Day>13</Day></PubDate></JournalIssue><Title>Revista do Colegio Brasileiro de Cirurgioes</Title><ISOAbbreviation>Rev Col Bras Cir</ISOAbbreviation></Journal><ArticleTitle>Calcaneal lateral column lengthening osteotomy for symptomatic flexible flatfoot in children and adolescents: a systematic review.</ArticleTitle><Pagination><StartPage>e1969</StartPage><MedlinePgn>e1969</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1590/0100-6991e-20181969</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0100-69912018000600301</ELocationID><Abstract><AbstractText>Flexible flatfoot is a common condition in small children, which shows a strong tendency to spontaneously correct with their growth or to become moderate or mild in adults, which will not cause future problems. However, in a small number of cases, this condition is more severe, does not improve spontaneously, which may cause mechanical impairment, deformity, and, eventually, pain. In such cases, surgical treatment should be considered. The aim of this systematic review was to evaluate the literature results on the treatment of the symptomatic flexible flatfoot in children or adolescents through a very frequent procedure: calcaneal lateral column lengthening osteotomy, A systematic electronic search in PubMed, Web of Science, Cochrane, CINAHL, SciELO, SCOPUS and LILACS databases was performed. We searched articles published between March 1975 and September 2016. After applying the eligibility criteria, the selected publications were evaluated in relation to their clinical and radiographic results and complications. We found 341 articles in the mentioned databases, but selected only eight studies, according to the inclusion and exclusion criteria. These studies included a total of 105 patients and 167 treated feet. Only three authors performed prospective studies, but without case-control or randomization. The majority of publications were descriptive studies or case series (level of evidence III or IV), with great methodological variations, but with a high satisfaction rate on the part of both patients and surgeons in relation to the results. However, more prospective and randomized studies are required, with adequate control groups and validated evaluation criteria.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lima</LastName><ForeName>Thiago Coelho</ForeName><Initials>TC</Initials><AffiliationInfo><Affiliation>Universidade de S&#xe3;o Paulo, Faculdade de Medicina de Ribeir&#xe3;o Preto, Departamento de Biomec&#xe2;nica, Medicina e Reabilita&#xe7;&#xe3;o do Aparelho Locomotor, Ribeir&#xe3;o Preto, SP, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Volpon</LastName><ForeName>Jos&#xe9; Batista</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Universidade de S&#xe3;o Paulo, Faculdade de Medicina de Ribeir&#xe3;o Preto, Departamento de Biomec&#xe2;nica, Medicina e Reabilita&#xe7;&#xe3;o do Aparelho Locomotor, Ribeir&#xe3;o Preto, SP, Brasil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>por</Language><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><VernacularTitle>Osteotomia de alongamento da coluna lateral do calc&#xe2;neo para tratamento do p&#xe9; plano flex&#xed;vel sintom&#xe1;tico de crian&#xe7;as e adolescentes: revis&#xe3;o sistem&#xe1;tica.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2018</Year><Month>12</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Rev Col Bras Cir</MedlineTA><NlmUniqueID>7809515</NlmUniqueID><ISSNLinking>0100-6991</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001852" MajorTopicYN="N">Bone Lengthening</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002111" MajorTopicYN="N">Calcaneus</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005413" MajorTopicYN="N">Flatfoot</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010027" MajorTopicYN="N">Osteotomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011184" MajorTopicYN="N">Postoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="por"><AbstractText>O p&#xe9; plano flex&#xed;vel &#xe9; condi&#xe7;&#xe3;o frequente na crian&#xe7;a pequena e apresenta forte tend&#xea;ncia para corre&#xe7;&#xe3;o espont&#xe2;nea, ou tornar-se moderado ou leve no adulto, o que n&#xe3;o causar&#xe1; problemas futuros. Entretanto, em uma pequena propor&#xe7;&#xe3;o de casos a deformidade &#xe9; mais grave, n&#xe3;o melhora, o que pode levar ao comprometimento do desempenho mec&#xe2;nico, deformidade e, eventualmente, dor. Nestes casos o tratamento cir&#xfa;rgico deve ser considerado. O objetivo desta revis&#xe3;o sistem&#xe1;tica foi avaliar os resultados da literatura no tratamento do p&#xe9; plano flex&#xed;vel sintom&#xe1;tico da crian&#xe7;a ou adolescente por um procedimento bastante frequente que &#xe9; a osteotomia de alongamento da coluna lateral do calc&#xe2;neo. Foi realizada busca sistem&#xe1;tica eletr&#xf4;nica nas bases de dados PubMed, Web of Science, Cochrane, CINAHL, SciELO, SCOPUS e LILACS por artigos publicados entre mar&#xe7;o de 1975 e setembro de 2016. Ap&#xf3;s aplica&#xe7;&#xe3;o dos crit&#xe9;rios de elegibilidade, os artigos selecionados foram avaliados quanto aos resultados cl&#xed;nicos, radiogr&#xe1;ficos e complica&#xe7;&#xf5;es. Dos 341 artigos encontrados nas bases de dados, apenas oito estudos foram selecionados, segundo os crit&#xe9;rios de inclus&#xe3;o e exclus&#xe3;o, com um total de 105 pacientes e 167 p&#xe9;s tratados. Somente tr&#xea;s autores realizaram estudo prospectivo, mas sem caso controle ou aleatoriza&#xe7;&#xe3;o. A maioria das publica&#xe7;&#xf5;es no per&#xed;odo avaliado &#xe9; composta por estudos descritivos ou s&#xe9;rie de casos (n&#xed;vel de evid&#xea;ncia III ou IV), com grandes varia&#xe7;&#xf5;es metodol&#xf3;gicas, mas com alto &#xed;ndice de satisfa&#xe7;&#xe3;o dos pacientes e cirurgi&#xf5;es, em rela&#xe7;&#xe3;o aos resultados. Entretanto, s&#xe3;o necess&#xe1;rias pesquisas com desenho prospectivo, aleatorizado, grupo controle adequado e crit&#xe9;rios de avalia&#xe7;&#xe3;o validados.</AbstractText></OtherAbstract></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>8</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>5</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30569951</ArticleId><ArticleId IdType="doi">10.1590/0100-6991e-20181969</ArticleId><ArticleId IdType="pii">S0100-69912018000600301</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">17560891</PMID><DateCompleted><Year>2007</Year><Month>09</Month><Day>06</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0002-9149</ISSN><JournalIssue CitedMedium="Print"><Volume>99</Volume><Issue>12</Issue><PubDate><Year>2007</Year><Month>Jun</Month><Day>15</Day></PubDate></JournalIssue><Title>The American journal of cardiology</Title><ISOAbbreviation>Am J Cardiol</ISOAbbreviation></Journal><ArticleTitle>Cardiac function before and after surgery for pectus excavatum.</ArticleTitle><Pagination><StartPage>1762</StartPage><EndPage>1764</EndPage><MedlinePgn>1762-4</MedlinePgn></Pagination><Abstract><AbstractText>A 2006 meta-analysis concluded that thoracic surgery for pectus excavatum (PE) significantly improves cardiovascular function. However, that analysis was flawed by a high level of heterogeneity in the outcomes and inappropriate methods in 5 of the 8 publications analyzed. Therefore, a search of the published research from 1965 to the present was conducted, and only 5 publications were found that reported studies of cardiac function before and after operation, including 118 patients and 82 unoperated controls. Cardiac function was studied most frequently by echocardiography, despite the limitations imposed by the abnormal anatomy of pectus excavatum, but only studies that did not report cardiac or left ventricular dimensions or output were excluded. Studies using indirect estimates on the basis of oxygen pulse, which depends on several other variables, were not included. No improvements were found in left ventricular size, stroke volume, and cardiac output after surgery in 4 of 5 studies, using radionuclides, 2-dimensional echocardiography, radiographic planimetry, and cardiac output by the Fick method. Only a single study, with volumes calculated by squaring the diameter of the left ventricle from M-mode echocardiography, reported an increase (22%) in left ventricular stroke volume after operation, but that increased (17%) in the investigators' unoperated controls. This and 2 other studies used in this meta-analysis were also included in a meta-analysis conducted by Malek et al. In a fourth study, Malek et al included only the first study that found an improvement, but the final study reported no improvement. In conclusion, there is no reliable documentation of improved cardiac function from thoracic surgery for pectus excavatum.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Guntheroth</LastName><ForeName>Warren G</ForeName><Initials>WG</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Cardiology, University of Washington School of Medicine, Seattle, Washington, USA. wgg@u.washington.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spiers</LastName><ForeName>Philip S</ForeName><Initials>PS</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2007</Year><Month>04</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Cardiol</MedlineTA><NlmUniqueID>0207277</NlmUniqueID><ISSNLinking>0002-9149</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Am J Cardiol. 2008 Feb 1;101(3):415-7. doi: 10.1016/j.amjcard.2007.07.010.</RefSource><PMID Version="1">18237612</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D005660" MajorTopicYN="N">Funnel Chest</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006321" MajorTopicYN="N">Heart</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006334" MajorTopicYN="N">Heart Function Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015201" MajorTopicYN="N">Meta-Analysis as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>19</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2006</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2007</Year><Month>1</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2007</Year><Month>1</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>6</Month><Day>15</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>9</Month><Day>7</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2007</Year><Month>6</Month><Day>15</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17560891</ArticleId><ArticleId IdType="doi">10.1016/j.amjcard.2007.01.064</ArticleId><ArticleId IdType="pii">S0002-9149(07)00513-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38985038</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>24</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1809-4546</ISSN><JournalIssue CitedMedium="Internet"><Volume>51</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Revista do Colegio Brasileiro de Cirurgioes</Title><ISOAbbreviation>Rev Col Bras Cir</ISOAbbreviation></Journal><ArticleTitle>Preoperative hypovitaminosis D and complications in plastic surgery: a pilot study.</ArticleTitle><Pagination><StartPage>e20243719</StartPage><MedlinePgn>e20243719</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e20243719</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1590/0100-6991e-20243719-en</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0100-69912024000100212</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Vitamin D plays a crucial role in various biological processes, including the well-known regulation of the immune system and calcium metabolism. While its involvement in the surgical outcomes of various medical specialties is recognized, there is a lack of consistent data regarding plastic surgery. This study aimed to assess preoperative serum levels of 25-hydroxyvitamin D and its relationship with complications in patients undergoing reconstructive and aesthetic plastic surgeries.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">prospective and observational cohort study, conducted from October 2021 to August 2023 at the Hospital das Cl&#xed;nicas, Universidade Federal de Pernambuco, involving 83 patients.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">vitamin D levels were deemed deficient in 7 (8,4%) patients, insufficient in 36 (43,4%), and sufficient in 40 (48,2%). No direct association was demonstrated between deficient or insufficient serum levels of 25-hydroxyvitamin D and the incidence of complications in plastic surgery, even when considering comorbidities.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">preoperative hypovitaminosis D was not associated with complications in plastic surgery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Motta</LastName><ForeName>Fl&#xe1;vio Jos&#xe9; Teixeira Rocha Ata&#xed;de DA</ForeName><Initials>FJTRAD</Initials><Identifier Source="ORCID">0000-0002-6931-584X</Identifier><AffiliationInfo><Affiliation>- Universidade Federal de Pernambuco, Servi&#xe7;o de Cirurgia Pl&#xe1;stica - Recife - PE - Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luna</LastName><ForeName>Igor Chaves Gomes</ForeName><Initials>ICG</Initials><Identifier Source="ORCID">0000-0002-0077-9451</Identifier><AffiliationInfo><Affiliation>- Universidade Federal de Pernambuco, Servi&#xe7;o de Cirurgia Pl&#xe1;stica - Recife - PE - Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fabiani</LastName><ForeName>Isadora Moscardini</ForeName><Initials>IM</Initials><Identifier Source="ORCID">0009-0005-3550-5011</Identifier><AffiliationInfo><Affiliation>- Faculdade de Medicina do ABC, Servi&#xe7;o de Cirurgia Pl&#xe1;stica - Santo Andr&#xe9; - SP - Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Souza</LastName><ForeName>J&#xfa;lia Cibely DA Silva</ForeName><Initials>JCDS</Initials><Identifier Source="ORCID">0000-0002-7372-6609</Identifier><AffiliationInfo><Affiliation>- Universidade Federal de Pernambuco, Centro de Ci&#xea;ncias M&#xe9;dicas - Recife - PE - Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amorim</LastName><ForeName>Vinicyus Eduardo Melo</ForeName><Initials>VEM</Initials><Identifier Source="ORCID">0000-0003-4541-690X</Identifier><AffiliationInfo><Affiliation>- Faculdade Pernambucana de Sa&#xfa;de, Curso de Medicina - Recife - PE - Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xe1;</LastName><ForeName>Jairo Zacch&#xea; DE</ForeName><Initials>JZ</Initials><Identifier Source="ORCID">0000-0002-2312-2268</Identifier><AffiliationInfo><Affiliation>- Universidade Federal de Pernambuco, Servi&#xe7;o de Cirurgia Pl&#xe1;stica - Recife - PE - Brasil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>por</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Rev Col Bras Cir</MedlineTA><NlmUniqueID>7809515</NlmUniqueID><ISSNLinking>0100-6991</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>1406-16-2</RegistryNumber><NameOfSubstance UI="D014807">Vitamin D</NameOfSubstance></Chemical><Chemical><RegistryNumber>A288AR3C9H</RegistryNumber><NameOfSubstance UI="C104450">25-hydroxyvitamin D</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014808" MajorTopicYN="Y">Vitamin D Deficiency</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014807" MajorTopicYN="Y">Vitamin D</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019651" MajorTopicYN="N">Plastic Surgery Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057234" MajorTopicYN="N">Preoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="por"><AbstractText Label="INTRODU&#xc7;&#xc3;O:">a vitamina D &#xe9; parte constituinte de diversos processos biol&#xf3;gicos. Al&#xe9;m da conhecida regula&#xe7;&#xe3;o do sistema imunol&#xf3;gico e do metabolismo do c&#xe1;lcio, est&#xe1; envolvida no desfecho cir&#xfa;rgico de diversas especialidades, por&#xe9;m n&#xe3;o h&#xe1; dados consistentes sobre cirurgia pl&#xe1;stica. Este estudo teve como objetivo avaliar os n&#xed;veis s&#xe9;ricos pr&#xe9;-operat&#xf3;rios de 25-hidroxivitamina D e sua rela&#xe7;&#xe3;o com complica&#xe7;&#xf5;es em pacientes submetidos a cirurgias pl&#xe1;sticas reparadoras e est&#xe9;ticas.</AbstractText><AbstractText Label="M&#xc9;TODOS:">coorte prospectiva e observacional, conduzida de outubro de 2021 a agosto de 2023 no Hospital das Cl&#xed;nicas da Universidade Federal de Pernambuco, em 83 pacientes.</AbstractText><AbstractText Label="RESULTADOS:">os n&#xed;veis de vitamina D foram considerados deficientes em 7 (8,4%) dos pacientes, insuficientes em 36 (43,4%) e suficientes em 40 (48,2%). N&#xe3;o se demonstrou associa&#xe7;&#xe3;o direta entre n&#xed;veis s&#xe9;ricos deficientes ou insuficientes de 25-hidroxivitamina D e a incid&#xea;ncia de complica&#xe7;&#xf5;es em cirurgia pl&#xe1;stica, nem mesmo quando associado a comorbidades</AbstractText><AbstractText Label="CONCLUS&#xc3;O:">a hipovitaminose D pr&#xe9;-operat&#xf3;ria n&#xe3;o foi associada a complica&#xe7;&#xf5;es em cirurgia pl&#xe1;stica.</AbstractText></OtherAbstract><CoiStatement>Conflict of interest: no.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>10</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>10</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>10</Day><Hour>10</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38985038</ArticleId><ArticleId IdType="pmc">PMC11449515</ArticleId><ArticleId IdType="doi">10.1590/0100-6991e-20243719-en</ArticleId><ArticleId IdType="pii">S0100-69912024000100212</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Burkievcz CJC, Skare TL, Malafaia O, Nassif PAN, Ribas CSG, Santos LRP. Preval&#xea;ncia de defici&#xea;ncia de vitamina D em pacientes com &#xfa;lceras de perna de etiologia venosa. Rev Col Bras Cir. 2012;39(1):60&#x2013;63. doi: 10.1590/S0100-69912012000100012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0100-69912012000100012</ArticleId><ArticleId IdType="pubmed">22481708</ArticleId></ArticleIdList></Reference><Reference><Citation>Pazirandeh S, Burns D.  Overview of vitamin D. UpToDate; 2023. https://www.uptodate.com/contents/overview-of-vitamin-d</Citation></Reference><Reference><Citation>Souza JR, Brand&#xe3;o NA, Souza LMS, Coutinho-Lima CRO, Almeida VF, Silva LF, et al. A influ&#xea;ncia da suplementa&#xe7;&#xe3;o de vitamina D no tratamento da s&#xed;ndrome metab&#xf3;lica: uma revis&#xe3;o sistem&#xe1;tica. Res Soc Dev. 2023;12(4) doi: 10.33448/rsd-v12i4.33692..</Citation><ArticleIdList><ArticleId IdType="doi">10.33448/rsd-v12i4.33692.</ArticleId></ArticleIdList></Reference><Reference><Citation>Knackstedt R, Oliver J, Gatherwright J. Evidence-based perioperative nutrition recommendations optimizing results and minimizing risks. Plast Reconstr Surg. 2020;146(2):423&#x2013;435. doi: 10.1097/PRS.0000000000007004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PRS.0000000000007004</ArticleId><ArticleId IdType="pubmed">32740600</ArticleId></ArticleIdList></Reference><Reference><Citation>Misra M.  Vitamin D insufficiency and deficiency in children and adolescents. UpToDate; 2022. https://www.uptodate.com/contents/vitamin-d-insufficiency-and-deficiency-in-children-and-adolescents</Citation></Reference><Reference><Citation>Bouillon R.  Vitamin D and extraskeletal health. UpToDate; 2022. https://www.uptodate.com/contents/vitamin-d-and-extraskeletal-health</Citation></Reference><Reference><Citation>C&#xe2;mara JL, Vilas Boas RR, Nascimento LFC, Neto, Santos SDG. Vitamina D uma revis&#xe3;o narrativa. Braz J Health Rev. 2021;4(2):5904&#x2013;5920. doi: 10.34119/bjhrv4n2-152.</Citation><ArticleIdList><ArticleId IdType="doi">10.34119/bjhrv4n2-152</ArticleId></ArticleIdList></Reference><Reference><Citation>DeFontes III K, Smith JT. Surgical considerations for vitamin D deficiency in foot and ankle surgery. Orthop Clin North Am. 2019;50(2):259&#x2013;267. doi: 10.1016/j.ocl.2018.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ocl.2018.10.008</ArticleId><ArticleId IdType="pubmed">30850083</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawson-Hughes B.  Vitamin D deficiency in adults: definition, clinical manifestations, and treatment. UpToDate; 2023. https://www.uptodate.com/contents/vitamin-d-deficiency-in-adults-definition-clinical-manifestations-and-treatment</Citation></Reference><Reference><Citation>Matthews LR, Ahmed Y, Wilson KL, Griggs DD, Danner OK. Worsening severity of vitamin D deficiency is associated with increased length of stay, surgical intensive care unit cost, and mortality rate in surgical intensive care unit patients. Am J Surg. 2012;204:37&#x2013;43. doi: 10.1016/j.amjsurg.2011.07.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjsurg.2011.07.021</ArticleId><ArticleId IdType="pmc">PMC3992708</ArticleId><ArticleId IdType="pubmed">22325335</ArticleId></ArticleIdList></Reference><Reference><Citation>Bottura C. Avalia&#xe7;&#xe3;o da fragilidade em indiv&#xed;duos submetidos &#xe0; cirurgia card&#xed;aca. Universidade de S&#xe3;o Paulo; Ribeir&#xe3;o Preto: 2017. Mestrado.</Citation><ArticleIdList><ArticleId IdType="doi">10.11606/D.17.2018.tde-06042018-095710.</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciccone IMI. Novas perspectivas no papel da vitamina D e sua influ&#xea;ncia com a qualidade do s&#xea;men e horm&#xf4;nios sexuais em homens. Universidade de S&#xe3;o Paulo; S&#xe3;o Paulo: 2018. Mestrado.</Citation><ArticleIdList><ArticleId IdType="doi">10.11606/D.5.2019.tde-20032019-163542.</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa FMM.  A defici&#xea;ncia de vitamina D como fator de risco para a doen&#xe7;a cardiovascular. Universidade da Madeira; Funchal: 2016. http://hdl.handle.net/10400.13/1523 Mestrado.</Citation></Reference><Reference><Citation>Gumieiro DN, Pereira GJC, Miniucci MF, Ricciardi CEI, Damasceno ER, Funayama BS. Associa&#xe7;&#xe3;o da defici&#xea;ncia de vitamina D com mortalidade e marcha p&#xf3;s-operat&#xf3;ria em paciente com fratura de f&#xea;mur proximal. Rev Bras Ortop. 2015;50(2):153&#x2013;158. doi: 10.1016/j.rbo.2014.05.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rbo.2014.05.010</ArticleId><ArticleId IdType="pmc">PMC4519647</ArticleId><ArticleId IdType="pubmed">26229909</ArticleId></ArticleIdList></Reference><Reference><Citation>Nirujogi VL, Zopfi K. Considera&#xe7;&#xf5;es nutricionais para cirurgia pl&#xe1;stica em paciente ap&#xf3;s cirurgia bari&#xe1;trica. Rev Bras Cir Pl&#xe1;st. 2015;30(2):295&#x2013;302. doi: 10.5935/2177-1235.2015RBCP0158.</Citation><ArticleIdList><ArticleId IdType="doi">10.5935/2177-1235.2015RBCP0158</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva MQS, Esteves VF, Pinto LZF, Couto AC, Cardoso C, Netto, Vieira R, et al. N&#xed;veis s&#xe9;ricos de vitamina D e c&#xe2;ncer de mama no climat&#xe9;rio um estudo caso-controle. Rev Bras Mastologia. 2012;22(3):77&#x2013;82.</Citation></Reference><Reference><Citation>Soares CSP, Tagliarini JV, Mazeto GMFS. N&#xed;vel pr&#xe9;-operat&#xf3;rio de vitamina D como preditor de hipocalcemia p&#xf3;s-tireoidectomia total estudo prospectivo. Braz J Otorhinolaryngol. 2021;87:85&#x2013;89. doi: 10.1016/j.bjorl.2019.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bjorl.2019.07.001</ArticleId><ArticleId IdType="pmc">PMC9422554</ArticleId><ArticleId IdType="pubmed">31492617</ArticleId></ArticleIdList></Reference><Reference><Citation>Agha-Mohammadi S, Hurwitz DJ. Nutritional deficiency of post-bariatric surgery body contouring patients what every plastic surgeon should know. Plast Reconstr Surg. 2008;122(2):604&#x2013;613. doi: 10.1097/PRS.0b013e31817d6023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PRS.0b013e31817d6023</ArticleId><ArticleId IdType="pubmed">18626380</ArticleId></ArticleIdList></Reference><Reference><Citation>Dindo D, Demartines N, Clavien PA. Classification of surgical complications a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205&#x2013;213. doi: 10.1097/01.sla.0000133083.54934.ae.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.sla.0000133083.54934.ae</ArticleId><ArticleId IdType="pmc">PMC1360123</ArticleId><ArticleId IdType="pubmed">15273542</ArticleId></ArticleIdList></Reference><Reference><Citation>Cole AJ, Beckman LM, Earthman CP. Vitamin D status following bariatric surgery implications and recommendations. Nutr Clin Pract. 2014;20(10):1&#x2013;8. doi: 10.1177/0884533614546888.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0884533614546888</ArticleId><ArticleId IdType="pubmed">25190686</ArticleId></ArticleIdList></Reference><Reference><Citation>Schafer AL. The Vitamin D and Intestinal Calcium Transport After Bariatric Surgery. J Steroid Biochem Mol Biol. 2017;173:202&#x2013;210. doi: 10.1016/j.jsbmb.2016.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsbmb.2016.12.012</ArticleId><ArticleId IdType="pmc">PMC5483209</ArticleId><ArticleId IdType="pubmed">28027914</ArticleId></ArticleIdList></Reference><Reference><Citation>Burkievcz CJC, Guadagnin FA, Skare TL, Nascimento MM, Servin SCN, Souza GD. Vitamina D e cicatriza&#xe7;&#xe3;o de pele estudo prospectivo, duplo-cego, placebo controlado na cicatriza&#xe7;&#xe3;o de &#xfa;lceras de perna. Rev Col Bras Cir. 2012;39(5):401&#x2013;407. doi: 10.1590/S0100-69912012000500011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0100-69912012000500011</ArticleId><ArticleId IdType="pubmed">23174792</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeg F, Orazi R, Bowers GM, Janis JE. Evidence-based nutritional interventions in wound care. Plast Reconstr Surg. 2021;148(1):226&#x2013;238. doi: 10.1097/PRS.0000000000008061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PRS.0000000000008061</ArticleId><ArticleId IdType="pubmed">34181622</ArticleId></ArticleIdList></Reference><Reference><Citation>Guido GC, Negretti CMH. Tratamento de queloide. BWS J. 2022;5:1&#x2013;13. https://bwsjournal.emnuvens.com.br/bwsj/article/view/339/172</Citation></Reference><Reference><Citation>Freire MDM, Freire SM, Cas&#xe9; MLS, Freire SDM, Guedes A, Del Pozo FA, et al. Inflama&#xe7;&#xe3;o e cirurgia. Rev Cient Hosp Santa Izabel. 2022;6(3) doi: 10.35753/rchsi.v6i3.328..</Citation><ArticleIdList><ArticleId IdType="doi">10.35753/rchsi.v6i3.328.</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos MS. Estudo da reposi&#xe7;&#xe3;o da vitamina D na evolu&#xe7;&#xe3;o da inj&#xfa;ria renal aguda p&#xf3;s isqu&#xea;mica em ratos deficientes em vitamina D. Universidade de S&#xe3;o Paulo; S&#xe3;o Paulo: 2021. Mestrado.</Citation><ArticleIdList><ArticleId IdType="doi">10.11606/D.5.2021.tde-31032022-161401.</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartley J. Vitamin D emerging roles in infection and immunity. Expert Rev Anti Infect Ther. 2010;8(12):1359&#x2013;1369. doi: 10.1586/eri.10.102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/eri.10.102</ArticleId><ArticleId IdType="pubmed">21133662</ArticleId></ArticleIdList></Reference><Reference><Citation>Correia-S&#xe1; I, Serr&#xe3;o P, Marques M, Vieira-Coelho MA. Vitamin D and inflammatory biomarkers during wound-healing. Plast Reconstr Surg. 2014;134(4S-1):68&#x2013;69. doi: 10.1097/01.prs.0000455414.34615.b2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.prs.0000455414.34615.b2</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraga MSCB. Influ&#xea;ncia da nutri&#xe7;&#xe3;o na cicatriza&#xe7;&#xe3;o cir&#xfa;rgica. Universidade Atl&#xe2;ntica; Barcarena: 2015.</Citation></Reference><Reference><Citation>Quemel GKC, Sozinho MT, Costa JAP, Marinho CL, Quemel GKC, Moreira DR, et al. The role of vitamin D in immunity and coronavirus infection: a literature review. Res Soc Dev. 2021;10(7) doi: 10.33448/rsd-v10i7.16296..</Citation><ArticleIdList><ArticleId IdType="doi">10.33448/rsd-v10i7.16296.</ArticleId></ArticleIdList></Reference><Reference><Citation>Martins SM, Pratali RR, Barsotti CEG, Santos FPE, Oliveira CEAS. Correlation between nutritional status and clinical results in patients undergoing spinal surgery. Coluna/Columna. 2017;16(3):184&#x2013;187. doi: 10.1590/S1808-185120171603179057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S1808-185120171603179057</ArticleId></ArticleIdList></Reference><Reference><Citation>Zwiebel SJ, Lee M, Alleyne B, Guyuron B. The incidence of vitamin, mineral, herbal, and other supplement use in facial cosmetic patients. Plast Reconstr Surg. 2013;132(1):78&#x2013;82. doi: 10.1097/PRS.0b013e3182910cd9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PRS.0b013e3182910cd9</ArticleId><ArticleId IdType="pubmed">23806911</ArticleId></ArticleIdList></Reference><Reference><Citation>Bashutski JD, Eber RM, Kinney JS, Benavides E, Maitra S, Braun TM, et al. The impact of vitamin D status on periodontal surgery outcomes. J Dent Res. 2011;90(8):1007&#x2013;1012. doi: 10.1177/0022034511407771.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0022034511407771</ArticleId><ArticleId IdType="pmc">PMC3170167</ArticleId><ArticleId IdType="pubmed">21555774</ArticleId></ArticleIdList></Reference><Reference><Citation>Flynn L, Zimmerman LH, McNorton K, Dolman M, Tyburski J, Baylor A, et al. Effects of vitamin D deficiency in critically ill surgical patients. Am J Surg. 2012;203:379&#x2013;382. doi: 10.1016/j.amjsurg.2011.09.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjsurg.2011.09.012</ArticleId><ArticleId IdType="pubmed">22206852</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans RM, Lippman SM. Shining light on the COVID-19 pandemic a vitamin D receptor checkpoint in defense of unregulated wound healing. Cell Metab. 2020;32:1&#x2013;6. doi: 10.1016/j.cmet.2020.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2020.09.007</ArticleId><ArticleId IdType="pmc">PMC7486067</ArticleId><ArticleId IdType="pubmed">32941797</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorter EA, Hamdy NAT, Appelman-Dijkstra NM, Schipper IB. The role of vitamin D in human fracture healing a systematic review of the literature. Bone. 2014;64:288&#x2013;297. doi: 10.1016/j.bone.2014.04.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bone.2014.04.026</ArticleId><ArticleId IdType="pubmed">24792958</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27529702</PMID><DateCompleted><Year>2017</Year><Month>09</Month><Day>20</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1423-0151</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>6</Issue><PubDate><Year>2016</Year></PubDate></JournalIssue><Title>Medical principles and practice : international journal of the Kuwait University, Health Science Centre</Title><ISOAbbreviation>Med Princ Pract</ISOAbbreviation></Journal><ArticleTitle>Costal Cartilages Do Not Overgrow in Patients with Pectus Excavatum.</ArticleTitle><Pagination><StartPage>533</StartPage><EndPage>538</EndPage><MedlinePgn>533-538</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The purpose of this study was to determine whether or not patients with pectus excavatum (PE) exhibit costal cartilage overgrowth compared to normal subjects.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">The computed tomography acquisitions of 32 patients with PE and 35 normal controls were analyzed. On axial images the length of the 4th-7th costal cartilages was measured to calculate the Haller index. The ratio between the length of the cartilages and the median of the transverse and longitudinal thorax diameters were recorded to account for anatomical variability. The length of the cartilages was compared between the PE and control subjects using the independent-samples t test. For patients with asymmetric PE the length of the 4th-7th costal cartilages was compared between the rotated and nonrotated sides.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The mean transverse and coronal thorax diameters were 233.29 &#xb1; 24.47 and 231.69 &#xb1; 22.47 mm for PE patients and 252.67 &#xb1; 37.25 and 238.64 &#xb1; 27.40 mm for controls, respectively, with no significant differences between the two groups (p = 0.816 and 0.145). The mean sagittal diameter (59.30 &#xb1; 14.21 mm) and Haller index (4.02 &#xb1; 1.34) in the PE group were significantly different from the controls (107.34 &#xb1; 19.59 and 2.2 &#xb1; 0.54 mm, respectively; p = 0.00). Actual and relative lengths of costal cartilages were similar in both PE subjects and controls for all 4 costal cartilages measured. In subjects with asymmetric PE, both relative and absolute costal cartilage lengths were similar on the rotated and nonrotated side.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The length of the 4th, 5th, 6th and 7th costal cartilages was similar in PE patients and the control subjects. These was also similar between the rotated and nonrotated sides of the sternum in patients with asymmetric PE.</AbstractText><CopyrightInformation>&#xa9; 2016 S. Karger AG, Basel.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>David</LastName><ForeName>Vlad-Laurentiu</ForeName><Initials>VL</Initials><AffiliationInfo><Affiliation>Department of Pediatric Surgery, 'Victor Babes' University of Medicine and Pharmacy, Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cerbu</LastName><ForeName>Simona</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Haragus</LastName><ForeName>Horia</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Popoiu</LastName><ForeName>Marius-Calin</ForeName><Initials>MC</Initials></Author><Author ValidYN="Y"><LastName>Stanciulescu</LastName><ForeName>Corina-Maria</ForeName><Initials>CM</Initials></Author><Author ValidYN="Y"><LastName>Cozma</LastName><ForeName>Gabriel</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Burlacu</LastName><ForeName>Ovidiu</ForeName><Initials>O</Initials></Author><Author ValidYN="Y"><LastName>Boia</LastName><ForeName>Eugen-Sorin</ForeName><Initials>ES</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>08</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Med Princ Pract</MedlineTA><NlmUniqueID>8901334</NlmUniqueID><ISSNLinking>1011-7571</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066186" MajorTopicYN="N">Costal Cartilage</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005660" MajorTopicYN="N">Funnel Chest</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015898" MajorTopicYN="N">Tomography Scanners, X-Ray Computed</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>6</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>8</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>8</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>8</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>8</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27529702</ArticleId><ArticleId IdType="pmc">PMC5588508</ArticleId><ArticleId IdType="doi">10.1159/000449133</ArticleId><ArticleId IdType="pii">000449133</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sweet RH. Pectus excavatum. Ann Surg. 1944;119:922&#x2013;934.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1617978</ArticleId><ArticleId IdType="pubmed">17858419</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly RE., Jr Pectus excavatum: historical background, clinical picture, preoperative evaluation and criteria for operation. Semin Pediatr Surg. 2008;17:181&#x2013;193.</Citation><ArticleIdList><ArticleId IdType="pubmed">18582824</ArticleId></ArticleIdList></Reference><Reference><Citation>Fokin AA, Steuerwald NM, Ahrens WA, et al. Anatomical, histologic, and genetic characteristics of congenital chest wall deformities. Semin Thorac Cardiovasc Surg. 2009;21:44&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">19632563</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng J, Hu T, Liu W, et al. The biomechanical, morphologic, and histochemical properties of the costal cartilages in children with pectus excavatum. J Pediatr Surg. 2001;36:1770&#x2013;1776.</Citation><ArticleIdList><ArticleId IdType="pubmed">11733904</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakaoka T, Uemura S, Yoshida T, et al. Overgrowth of costal cartilage is not the etiology of pectus excavatum. J Pediatr Surg. 2010;45:2015&#x2013;2018.</Citation><ArticleIdList><ArticleId IdType="pubmed">20920721</ArticleId></ArticleIdList></Reference><Reference><Citation>Park CH, Kim TH, Haam SJ, et al. The etiology of pectus carinatum involves overgrowth of costal cartilage and undergrowth of ribs. J Pediatr Surg. 2014;49:1252&#x2013;1258.</Citation><ArticleIdList><ArticleId IdType="pubmed">25092085</ArticleId></ArticleIdList></Reference><Reference><Citation>Park CH, Kim TH, Haam SJ, et al. Does overgrowth of costal cartilage cause pectus carinatum? A three-dimensional computed tomography evaluation of rib length and costal cartilage length in patients with asymmetric pectus carinatum. Interact Cardiovasc Thorac Surg. 2013;17:757&#x2013;763.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3805208</ArticleId><ArticleId IdType="pubmed">23868604</ArticleId></ArticleIdList></Reference><Reference><Citation>Benhamed L, Hysi I, Wurtz AJ. eComment: is overgrowth of costal cartilages the unique cause of pectus deformities? Interact Cardiovasc Thorac Surg. 2013;17:763.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3805224</ArticleId><ArticleId IdType="pubmed">24150045</ArticleId></ArticleIdList></Reference><Reference><Citation>Cubuk S, Yucel O. eComment: dilemma of the costal cartilage overgrowth in chest wall deformities. Interact Cardiovasc Thorac Surg. 2013;17:763.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3805227</ArticleId><ArticleId IdType="pubmed">24150046</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakaoka T, Uemura S, Yano T, et al. Does overgrowth of costal cartilage cause pectus excavatum? A study on the lengths of ribs and costal cartilages in asymmetric patients. J Pediatr Surg. 2009;44:1333&#x2013;1336.</Citation><ArticleIdList><ArticleId IdType="pubmed">19573657</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">28150165</PMID><DateCompleted><Year>2017</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-0711</ISSN><JournalIssue CitedMedium="Internet"><Volume>295</Volume><Issue>3</Issue><PubDate><Year>2017</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Archives of gynecology and obstetrics</Title><ISOAbbreviation>Arch Gynecol Obstet</ISOAbbreviation></Journal><ArticleTitle>Elective delivery versus expectant management for pre-eclampsia: a meta-analysis of RCTs.</ArticleTitle><Pagination><StartPage>607</StartPage><EndPage>622</EndPage><MedlinePgn>607-622</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00404-016-4281-9</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To evaluate the effectiveness and safety of elective delivery versus expectant management for women with pre-eclampsia (PE) and to assess neonatal outcomes before and after 34&#xa0;weeks gestation.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched Biomed Central, CINAHL, Cochrane Library, Embase, HMIC, Medline, and WHO trial registry, British Nursing Index, ClinicalTrials.gov, Current Controlled Trials, and Web of Science on 16 March, 2016. 1704 citations were identified. Randomised controlled trials comparing elective delivery with expectant management for women with PE were included. Seven studies were included (n&#x2009;=&#x2009;1501). There were no maternal deaths.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Elective delivery lowered incidence of complications in women with PE or hypertension greater than 34&#xa0;weeks gestation (n&#x2009;=&#x2009;756; RR, 0.64; 95% CI 0.51-0.80). For women with severe PE less than 34&#xa0;weeks gestation, elective delivery lowered the incidence of placental abruption (n&#x2009;=&#x2009;483, 5 RCTs; RR, 0.43; 95% CI 0.19-0.98). For women with PE or hypertension greater than 34&#xa0;weeks gestation, elective delivery also reduced the need for antihypertensive drug therapy. The need for ventilatory support and the risk of developing neonatal intraventricular hemorrhage or hypoxic ischemic encephalopathy may be increased in infants whose mothers undergo elective delivery for severe PE at less than 34&#xa0;weeks gestation. However, there was no relevant evidence for women with severe PE over 34&#xa0;weeks.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In women with PE or gestational hypertension beyond 34&#xa0;weeks gestation, elective delivery can decrease the incidence of complications, severe hypertension and the need for antihypertensive drug therapy. Elective delivery can also lower the risk of placental abruption in women before 34&#xa0;weeks gestation with severe PE, however, may be associated with increased risk of neonatal complications.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yonghong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Second Hospital of Shanxi Medical University, 382 WuYi Road, TaiYuan City, Shanxi Province, 030001, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hao</LastName><ForeName>Min</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The Second Hospital of Shanxi Medical University, 382 WuYi Road, TaiYuan City, Shanxi Province, 030001, China. 2yuanhaomin@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sampson</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Systematic Review Solutions. Ltd, Yan Tai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Psychiatry Department, The University of Nottingham, Nottingham, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>02</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Arch Gynecol Obstet</MedlineTA><NlmUniqueID>8710213</NlmUniqueID><ISSNLinking>0932-0067</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005865" MajorTopicYN="N">Gestational Age</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D046110" MajorTopicYN="N">Hypertension, Pregnancy-Induced</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011225" MajorTopicYN="N">Pre-Eclampsia</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011256" MajorTopicYN="N">Pregnancy Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Deliver</Keyword><Keyword MajorTopicYN="N">Expectant management</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Obstetric</Keyword><Keyword MajorTopicYN="N">Pre-eclampsia</Keyword></KeywordList><CoiStatement>CONFLICT OF INTEREST: Authors declare no conflict of interest with respect to the authorship and/or publication of this article. ETHICAL APPROVAL: This article does not contain any studies with human participants or animals performed by any of the authors.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>2</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28150165</ArticleId><ArticleId IdType="pmc">PMC5315725</ArticleId><ArticleId IdType="doi">10.1007/s00404-016-4281-9</ArticleId><ArticleId IdType="pii">10.1007/s00404-016-4281-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rylander R. Pre-eclampsia during pregnancy and cardiovascular disease later in life: the case for a risk group. Arch Gynecol Obstet. 2015;3:519&#x2013;521. doi: 10.1007/s00404-015-3676-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00404-015-3676-3</ArticleId><ArticleId IdType="pubmed">25721023</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthys LA, Coppage KH, Lambers DS, Barton JR, Sibai BM. Delayed postpartum preeclampsia: an experience of 151 cases. Am J Obstet Gynecol. 2004;190:1464&#x2013;1466. doi: 10.1016/j.ajog.2004.02.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2004.02.037</ArticleId><ArticleId IdType="pubmed">15167870</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeyabalan A. Epidemiology of preeclampsia: impact of obesity. Nutr Rev. 2013;71(Suppl1):S18&#x2013;25. doi: 10.1111/nure.12055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nure.12055</ArticleId><ArticleId IdType="pmc">PMC3871181</ArticleId><ArticleId IdType="pubmed">24147919</ArticleId></ArticleIdList></Reference><Reference><Citation>Abalos E, Cuesta C, Carroli G, Qureshi Z, Widmer M, Vogel JP, et al. WHO Multicountry Survey on Maternal and Newborn Health Research Network. Pre-eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health. BJOG. 2014;121(Suppl 1):14&#x2013;24. doi: 10.1111/1471-0528.12629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1471-0528.12629</ArticleId><ArticleId IdType="pubmed">24641531</ArticleId></ArticleIdList></Reference><Reference><Citation>Uzan J, Carbonnel M, Piconne O, Asmar R, Ayoubi JM. Pre-eclampsia: pathophysiology, diagnosis, and management. Vasc Health Risk Manag. 2011;7:467&#x2013;474.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3148420</ArticleId><ArticleId IdType="pubmed">21822394</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H, Yang Z, Ding X, Wang Y, Han Y. Effects of serum from patients with early-onset pre-eclampsia, HELLP syndrome, and antiphospholipid syndrome on fatty acid oxidation in trophoblast cells. Arch Gynecol Obset. 2015;3:559&#x2013;567. doi: 10.1007/s00404-015-3669-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00404-015-3669-2</ArticleId><ArticleId IdType="pubmed">25740297</ArticleId></ArticleIdList></Reference><Reference><Citation>Odeg&#xe5;rd RA, Vatten LJ, Nilsen ST, Salvesen KA, Austgulen R. Preeclampsia and fetal growth. Obstet Gynecol. 2000;6:950&#x2013;955.</Citation><ArticleIdList><ArticleId IdType="pubmed">11084184</ArticleId></ArticleIdList></Reference><Reference><Citation>Royal College of Obstetricians and Gynaecologists: The management of severe pre-eclampsia/eclampsia, 2006. http://isshp.org/wp-content/uploads/2014/05/rcog.pdf. Accessed 26 Jan 2017</Citation></Reference><Reference><Citation>National Institute for Health and Clinical Excellence, Hypertension in Pregnancy: the management of hypertensive disorders during pregnancy; 2010. http://guidance.nice.org.uk/cg107. Accessed 26 Jan 2017</Citation></Reference><Reference><Citation>American College of Obstetricians and Gynecologists. &#x2019;. (ACOG) American College of Obstetricians and Gynecologists&#x2019; Task Force on Hypertension in Pregnancy: hypertension in pregnancy. Obstet Gynecol. 2013;122:1122&#x2013;1131. doi: 10.1097/01.AOG.0000437382.03963.88.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.AOG.0000437382.03963.88</ArticleId><ArticleId IdType="pubmed">24150027</ArticleId></ArticleIdList></Reference><Reference><Citation>Churchill D, Duley L, Thornton Jim G, Jones L (2013) Interventionist versus expectant care for severe pre-eclampsia between 24 and 34 weeks&#x2019; gestation. Cochrane Database Syst Rev [Internet]. (7). Available from: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD003106.pub2/abstract. Accessed 26 Jan 2017</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD003106.pub2/abstract</ArticleId><ArticleId IdType="pubmed">23888485</ArticleId></ArticleIdList></Reference><Reference><Citation>Yonghong Wang, Min Hao (2013) Interventionist versus expectant care for severe pre-eclampsia before term. PROSPERO CRD42013004741. Available from: http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42013004741. Accessed 26 Jan 2017</Citation></Reference><Reference><Citation>American College of Obstetricians and Gynecologists. Task Force on Hypertension in Pregnancy Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists&#x2019; Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122:1122&#x2013;1131. doi: 10.1097/01.AOG.0000437382.03963.88.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.AOG.0000437382.03963.88</ArticleId><ArticleId IdType="pubmed">24150027</ArticleId></ArticleIdList></Reference><Reference><Citation>Churchill D, Duley L, Thornton JG, Jones L. Interventionist versus expectant care for severe pre-eclampsia between 24 and 34 weeks&#x2019; gestation. Cochrane Database Syst Rev. 2013;7:CD003106.</Citation><ArticleIdList><ArticleId IdType="pubmed">23888485</ArticleId></ArticleIdList></Reference><Reference><Citation>Anjum S, Rajaram GP, Bano I. Short-course postpartum (6-h) magnesium sulfate therapy in severe preeclampsia. Arch Gynecol Obstet. 2016;5:983&#x2013;986. doi: 10.1007/s00404-015-3903-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00404-015-3903-y</ArticleId><ArticleId IdType="pubmed">26498603</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xfc;nemann H, Bro&#x17c;ek J, Oxman A (eds.) (2009) GRADE handbook for Grading quality of evidence and strength of recommendation. 3.2. Section 6. [updated March 2009]</Citation></Reference><Reference><Citation>Higgins JPT, Green S (eds.) (2011) Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0 The Cochrane Collaboration. http://www.cochrane-handbook.org. [updated March 2011]</Citation></Reference><Reference><Citation>Koopmans CM, Bijlenga D, Aarnoudse JG, van Beek E, Bekedam DJ, van den Berg PP, et al. Induction of labor versus expectant monitoring in women with pregnancy induced hypertension or mild preeclampsia at term: the HYPITAT trial. BMC Pregnancy Childbirth. 2007;7:14. doi: 10.1186/1471-2393-7-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2393-7-14</ArticleId><ArticleId IdType="pmc">PMC1950708</ArticleId><ArticleId IdType="pubmed">17662114</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijgen SMC, Koopmans CM, Opmeer BC, Groen H, Bijlenga D, Aarnoudse JG, et al. An economic analysis of induction of labor and expectant monitoring in women with gestational hypertension or pre-eclampsia at term (HYPITAT trial) BJOG. 2010;117:1577&#x2013;1585. doi: 10.1111/j.1471-0528.2010.02710.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-0528.2010.02710.x</ArticleId><ArticleId IdType="pubmed">20840526</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijgen S, Opmeer B, Mol BW, Bijlenga D, Burggraaff J, Loon A (2008) ISPOR 11th Annual European Congress: 8&#x2013;11th November, Athens</Citation></Reference><Reference><Citation>Mesbah EMM. Severe preterm preeclampsia: aggressive or expectant management? Med J Cairo Univ. 2003;71:175&#x2013;182.</Citation></Reference><Reference><Citation>Vigil-De Gracia P, Reyes Tejada O, Calle Mi&#xf1;aca A, Tellez G, Chon VY, Herrarte E, et al. Expectant management of severe preeclampsia remote from term: the MEXPRE Latin Study, a randomized, multicenter clinical trial. Am J Obstet Gynecol. 2013;209:425.e1e8. doi: 10.1016/j.ajog.2013.08.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2013.08.016</ArticleId><ArticleId IdType="pubmed">23954534</ArticleId></ArticleIdList></Reference><Reference><Citation>Odendaal HJ, Pattinson RC, Bam R, Grove D, TJVW Kotze. Aggressive or Expectant Management for Patients With Severe Preeclampsia Between 28&#x2013;34 Weeks&#x2019; Gestation: a randomized controlled trial. Obstet Gynecol. 1990;76:1070&#x2013;1075.</Citation><ArticleIdList><ArticleId IdType="pubmed">2234715</ArticleId></ArticleIdList></Reference><Reference><Citation>Sibai BM, Mercer BM, Schiff E, Friedman SA. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks&#x2019; gestation: as randomized controlled trial. Am J Obstet Gynecol. 1994;171:818&#x2013;822. doi: 10.1016/0002-9378(94)90104-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9378(94)90104-X</ArticleId><ArticleId IdType="pubmed">8092235</ArticleId></ArticleIdList></Reference><Reference><Citation>Duvekot J, Bax C, Bloemenkamp K (2015) Temporizing management versus termination of pregnancy in women with severe preeclampsia at 28&#x2013;34 weeks (TOTEM-Trial). Am J Obstet Gynecol 212:S246.</Citation></Reference><Reference><Citation>Koopmans CM, Bijlenga D, Groen H, Vijgen SMC, Aarnoudse JG, et al. Induction of labor versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks&#x2019; gestation (HYPITAT): a multi-centre, open-label randomised controlled trial. Lancet. 2009;374(9694):979&#x2013;988. doi: 10.1016/S0140-6736(09)60736-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(09)60736-4</ArticleId><ArticleId IdType="pubmed">19656558</ArticleId></ArticleIdList></Reference><Reference><Citation>GRIT Study Group A randomised trial of timed delivery for the compromised preterm fetus: short term outcomes and bayesian interpretation. BJOG. 2003;110:27&#x2013;32. doi: 10.1046/j.1471-0528.2003.02014.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-0528.2003.02014.x</ArticleId><ArticleId IdType="pubmed">12504932</ArticleId></ArticleIdList></Reference><Reference><Citation>Chappell LC, Milne F, Shennan A. Is early induction or expectant management more beneficial in women with late preterm pre-eclampsia? BMJ. 2015;350:h191. doi: 10.1136/bmj.h191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.h191</ArticleId><ArticleId IdType="pubmed">25861796</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. Rating quality of evidence and strength of recommendations: GRADE. BMJ. 2008;336:924&#x2013;926. doi: 10.1136/bmj.39489.470347.AD.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39489.470347.AD</ArticleId><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27483479</PMID><DateCompleted><Year>2018</Year><Month>07</Month><Day>09</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2385-2070</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>4</Issue><PubDate><Year>2017</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Blood transfusion = Trasfusione del sangue</Title><ISOAbbreviation>Blood Transfus</ISOAbbreviation></Journal><ArticleTitle>Anticoagulants for the prevention and treatment of catheter-related thrombosis in adults and children on parenteral nutrition: a systematic review and critical appraisal.</ArticleTitle><Pagination><StartPage>369</StartPage><EndPage>377</EndPage><MedlinePgn>369-377</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2450/2016.0031-16</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Patients on parenteral nutrition require a central venous access and are at risk of catheter-related thrombosis, pulmonary embolism, and vena cava syndrome. Parenteral nutrition guidelines suggest anticoagulation for the primary prevention of catheter-related thrombosis during long-term parenteral nutrition. We conducted a systematic review of the efficacy, safety and feasibility of anticoagulant use for preventing and treating catheter-related thrombosis during parenteral nutrition.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">We searched for interventional and observational studies on adults and children receiving systemic anticoagulants during either short- or long-term parenteral nutrition delivered via central venous access. Primary outcomes were: objectively-confirmed catheter-related thrombosis, pulmonary embolism and bleeding. Secondary outcomes were: heparin-induced thrombocytopenia, prevalence of anticoagulation, and quality of International Normalised Ratio management in vitamin K antagonist-treated patients.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified 1,199 studies, of which 23 were included. Seven interventional studies of short-term parenteral nutrition (adult population, n=5) were classified as low-quality: in those, intravenous unfractionated heparin did not prevent catheter-related thrombosis if compared to saline. No interventional studies were conducted in patients on long-term parenteral nutrition. Observational data were sparse, rarely focusing on anticoagulation, and overall of low quality. The reported use of anticoagulants was between 22 and 66% in recent multicentre cohorts.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">The amount and quality of data in this area are very suboptimal: most studies are outdated and involved heterogeneous populations. Currently, there is insufficient evidence to allow conclusions to be reached regarding the efficacy and safety of anticoagulants in this setting.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Barco</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Vascular Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Thrombosis and Haemostasis, Johannes Gutenberg University, Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Atema</LastName><ForeName>Jasper J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Surgery, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coppens</LastName><ForeName>Michiel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Vascular Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serlie</LastName><ForeName>Mireille J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Endocrinology and Metabolism, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Middeldorp</LastName><ForeName>Saskia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Vascular Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>07</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Blood Transfus</MedlineTA><NlmUniqueID>101237479</NlmUniqueID><ISSNLinking>1723-2007</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057785" MajorTopicYN="N">Catheters</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010288" MajorTopicYN="N">Parenteral Nutrition</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013927" MajorTopicYN="Y">Thrombosis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Disclosure of conflicts of interest</b>. SB received an educational travel grant from Daiichi Sankyo; his work has been supported by the German Federal Ministry of Education and Research (BMBF 01EO1003 and 01EO1503) since August 01, 2015, and by the University of Pavia (Italy) before May 15, 2015. JJA has no relevant conflicts to disclose. MC received consulting and lecturing fees from Boehringer Ingelheim, Daiichi Sankyo, the alliance of Bristol-Myers Squibb and Pfizer and Sanquin Blood Supply, and research support from Boehringer Ingelheim and Sanquin Blood Supply. MJS received consulting fees from Fresenius Kabi and research support from Baxter and TEFA Mediq. SM received consulting fees from Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Pfizer, Daiichi-Sankyo, and research support from Glaxo SmithKline, Aspen, Bristol-Meyers Squibb/Pfizer and Sanquin Blood Supply. The present work was not funded.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>2</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>5</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>8</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>8</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>7</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27483479</ArticleId><ArticleId IdType="pmc">PMC5490734</ArticleId><ArticleId IdType="doi">10.2450/2016.0031-16</ArticleId><ArticleId IdType="pii">2016.0031-16</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dudley J, Rogers R, Sealy L. Renal consequences of parenteral nutrition. Pediatr Nephrol. 2014;29:375&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">23624823</ArticleId></ArticleIdList></Reference><Reference><Citation>Staun M, Pironi L, Bozzetti F, et al. ESPEN Guidelines on Parenteral Nutrition: home parenteral nutrition (HPN) in adult patients. Clin Nutr. 2009;28:467&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pubmed">19464089</ArticleId></ArticleIdList></Reference><Reference><Citation>Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr. 2002;26:1SA&#x2013;138SA.</Citation><ArticleIdList><ArticleId IdType="pubmed">11841046</ArticleId></ArticleIdList></Reference><Reference><Citation>Dreesen M, Foulon V, Vanhaecht K, et al. Guidelines recommendations on care of adult patients receiving home parenteral nutrition: a systematic review of global practices. Clin Nutr. 2012;31:602&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">22424704</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillanders L, Angstmann K, Ball P, et al. AuSPEN clinical practice guideline for home parenteral nutrition patients in Australia and New Zealand. Nutrition. 2008;24:998&#x2013;1012.</Citation><ArticleIdList><ArticleId IdType="pubmed">18708279</ArticleId></ArticleIdList></Reference><Reference><Citation>Koletzko B, Jauch KW, Verwied-Jorky S, et al. Guidelines on Parenteral Nutrition from the German Society for Nutritional Medicine (DGEM) - overview. Ger Med Sci. 2009;7 Doc27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2795376</ArticleId><ArticleId IdType="pubmed">20049076</ArticleId></ArticleIdList></Reference><Reference><Citation>Pittiruti M, Hamilton H, Biffi R, et al. ESPEN Guidelines on Parenteral Nutrition: central venous catheters (access, care, diagnosis and therapy of complications) Clin Nutr. 2009;28:365&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">19464090</ArticleId></ArticleIdList></Reference><Reference><Citation>National Collaborating Centre for Acute Care-NICE Clincial Guideline. Nutrition Support for Adults Oral Nutrition Support, Enteral Tube Feeding and Parenteral Nutrition. 2006.  [Accessed on 05/02/2016].  Available at:  https://www.nice.org.uk/guidance/cg32/resources/guidance-nutrition-support-in-adults-pdf.</Citation><ArticleIdList><ArticleId IdType="pubmed">21309138</ArticleId></ArticleIdList></Reference><Reference><Citation>SINPE. [Complications of central venous access for parenteral nutrition]. Riv Ital Nutr Parenter Enterale. 2002;S5:29&#x2013;33. [In Italian.]</Citation></Reference><Reference><Citation>Zwicker JI, Connolly G, Carrier M, et al. Catheter-associated deep vein thrombosis of the upper extremity in cancer patients: guidance from the SSC of the ISTH. J Thromb Haemost. 2014;12:796&#x2013;800.</Citation><ArticleIdList><ArticleId IdType="pubmed">24548519</ArticleId></ArticleIdList></Reference><Reference><Citation>Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e419S&#x2013;94S.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3278049</ArticleId><ArticleId IdType="pubmed">22315268</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn SR, Lim W, Dunn AS, et al. Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e195S&#x2013;226S.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3278052</ArticleId><ArticleId IdType="pubmed">22315261</ArticleId></ArticleIdList></Reference><Reference><Citation>Debourdeau P, Farge D, Beckers M, et al. International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer. J Thromb Haemost. 2013;11:71&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">23217208</ArticleId></ArticleIdList></Reference><Reference><Citation>Brismar B, Hardstedt C, Jacobson S, et al. Reduction of catheter-associated thrombosis in parenteral nutrition by intravenous heparin therapy. Arch Surg. 1982;117:1196&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">6810843</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabri PJ, Mirtallo JM, Ruberg RL, et al. Incidence and prevention of thrombosis of the subclavian vein during total parenteral nutrition. Surg Gynecol Obstet. 1982;155:238&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">6808679</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabri PJ, Mirtallo JM, Ebbert ML, et al. Clinical effect of nonthrombotic total parenteral nutrition catheters. JPEN J Parenter Enteral Nutr. 1984;8:705&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">6441014</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamala F, Boo NY, Cheah FC, Birinder K. Randomized controlled trial of heparin for prevention of blockage of peripherally inserted central catheters in neonates. Acta Paediatr. 2002;91:1350&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">12578294</ArticleId></ArticleIdList></Reference><Reference><Citation>Macoviak JA, Melnik G, McLean G, et al. The effect of low-dose heparin on the prevention of venous thrombosis in patients receiving short-term parenteral nutrition. Curr Surg. 1984;41:98&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pubmed">6426864</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruggiero RP, Aisenstein TJ. Central catheter fibrin sleeve--heparin effect. JPEN J Parenter Enteral Nutr. 1983;7:270&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">6408274</ArticleId></ArticleIdList></Reference><Reference><Citation>Uslu S, Ozdemir H, Comert S, et al. The effect of low-dose heparin on maintaining peripherally inserted percutaneous central venous catheters in neonates. J Perinatol. 2010;30:794&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">20376059</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrew M, Marzinotto V, Pencharz P, et al. A cross-sectional study of catheter-related thrombosis in children receiving total parenteral nutrition at home. J Pediatr. 1995;126:358&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">7869192</ArticleId></ArticleIdList></Reference><Reference><Citation>Bern MM, Bothe A, Bistrian B, et al. Prophylaxis against central vein thrombosis with low-dose warfarin. Surgery. 1986;99:216&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">3080818</ArticleId></ArticleIdList></Reference><Reference><Citation>Cowl CT, Weinstock JV, Al-Jurf A, et al. Complications and cost associated with parenteral nutrition delivered to hospitalized patients through either subclavian or peripherally-inserted central catheters. Clin Nutr. 2000;19:237&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">10952794</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuerda C, Joly F, Corcos O, et al. Prospective study of catheter-related central vein thrombosis in home parenteral nutrition patients with benign disease using serial venous Doppler ultrasound. Clin Nutr. 2016;35:153&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">25660318</ArticleId></ArticleIdList></Reference><Reference><Citation>Dollery CM, Sullivan ID, Bauraind O, et al. Thrombosis and embolism in long-term central venous access for parenteral nutrition. Lancet. 1994;344:1043&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">7934444</ArticleId></ArticleIdList></Reference><Reference><Citation>Duerksen DR, Ahmad A, Doweiko J, et al. Risk of symptomatic central venous thrombotic complications in AIDS patients receiving home parenteral nutrition. JPEN J Parenter Enteral Nutr. 1996;20:302&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">8865114</ArticleId></ArticleIdList></Reference><Reference><Citation>Imperial J, Bistrian BR, Bothe A, et al. Limitation of central vein thrombosis in total parenteral nutrition by continuous infusion of low-dose heparin. J Am Coll Nutr. 1983;2:63&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">6411793</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladefoged K, Efsen F, Krogh CJ, Jarnum S. Long-term parenteral nutrition. II. Catheter-related complications. Scand J Gastroenterol. 1981;16:913&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">6798688</ArticleId></ArticleIdList></Reference><Reference><Citation>Newall F, Barnes C, Savoia H, et al. Warfarin therapy in children who require long-term total parenteral nutrition. Pediatrics. 2003;112:e386.</Citation><ArticleIdList><ArticleId IdType="pubmed">14595081</ArticleId></ArticleIdList></Reference><Reference><Citation>Olthof ED, Versleijen MW, Huisman-de WG, et al. Taurolidine lock is superior to heparin lock in the prevention of catheter related bloodstream infections and occlusions. PLoS One. 2014;9:e111216.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4224385</ArticleId><ArticleId IdType="pubmed">25379781</ArticleId></ArticleIdList></Reference><Reference><Citation>Puiggros C, Cuerda C, Virgili N, et al. [Catheter occlusion and venous thrombosis prevention and incidence in adult home parenteral nutrition (HPN) programme patients]. Nutr Hosp. 2012;27:256&#x2013;61. [In Spanish.]</Citation><ArticleIdList><ArticleId IdType="pubmed">22566330</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt-Sommerfeld E, Snyder G, Rossi TM, Lebenthal E. Catheter-related complications in 35 children and adolescents with gastrointestinal disease on home parenteral nutrition. JPEN J Parenter Enteral Nutr. 1990;14:148&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">2112622</ArticleId></ArticleIdList></Reference><Reference><Citation>Toure A, Duchamp A, Peraldi C, et al. A comparative study of peripherally-inserted and Broviac catheter complications in home parenteral nutrition patients. Clin Nutr. 2015;34:49&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">24439240</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Gossum A, Vahedi K, Abdel M, et al. Clinical, social and rehabilitation status of long-term home parenteral nutrition patients: results of a European multicentre survey. Clin Nutr. 2001;20:205&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">11407866</ArticleId></ArticleIdList></Reference><Reference><Citation>Veerabagu MP, Tuttle-Newhall J, Maliakkal R, et al. Warfarin and reduced central venous thrombosis in home total parenteral nutrition patients. Nutrition. 1995;11:142&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">7647477</ArticleId></ArticleIdList></Reference><Reference><Citation>Vegting IL, Tabbers MM, Benninga MA, et al. Prophylactic anticoagulation decreases catheter-related thrombosis and occlusion in children with home parenteral nutrition. JPEN J Parenter Enteral Nutr. 2012;36:456&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">22245761</ArticleId></ArticleIdList></Reference><Reference><Citation>Bigsby E, Chaudhuri A, Whiteway A. Mesenteric and coeliac occlusions following heparin-induced thrombocytopenia after aortobiprofunda bypass surgery. Ann R Coll Surg Engl. 2010;92:W15&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5696817</ArticleId><ArticleId IdType="pubmed">20056052</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun F, Platz KP, Faendrich F, et al. Management of venous access problems before and after intestinal transplantation: case reports. Transplant Proc. 2004;36:392&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">15050170</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee E, Lee JO, Lim Y, et al. Thrombocytopenia caused by low-dose heparin supplementation of parenteral nutrition solution. Blood Res. 2013;48:160&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3698407</ArticleId><ArticleId IdType="pubmed">23826591</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranze O, Ranze P, Magnani HN, Greinacher A. Heparin-induced thrombocytopenia in paediatric patients--a review of the literature and a new case treated with danaparoid sodium. Eur J Pediatr. 1999;158:S130&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">10650852</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranze O, Rakow A, Ranze P, et al. Low-dose danaparoid sodium catheter flushes in an intensive care infant suffering from heparin-induced thrombocytopenia. Pediatr Crit Care Med. 2001;2:175&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">12797878</ArticleId></ArticleIdList></Reference><Reference><Citation>Kearns PJ, Jr, O&#x2019;Reilly RA. Bioavailability of warfarin in a patient with severe short bowel syndrome. JPEN J Parenter Enteral Nutr. 1986;10:100&#x2013;1.</Citation><ArticleIdList><ArticleId IdType="pubmed">3945042</ArticleId></ArticleIdList></Reference><Reference><Citation>Cotogni P, Barbero C, Garrino C, et al. Peripherally inserted central catheters in non-hospitalized cancer patients: 5-year results of a prospective study. Support Care Cancer. 2015;23:403&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4289011</ArticleId><ArticleId IdType="pubmed">25120012</ArticleId></ArticleIdList></Reference><Reference><Citation>Akl EA, Ramly EP, Kahale LA, et al. Anticoagulation for people with cancer and central venous catheters. Cochrane Database Syst Rev. 2014;7:CD006468.</Citation><ArticleIdList><ArticleId IdType="pubmed">25318061</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah PS, Shah VS. Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters. Cochrane Database Syst Rev. 2008;2:CD002772.</Citation><ArticleIdList><ArticleId IdType="pubmed">18425882</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandao LR, Shah N, Shah PS. Low molecular weight heparin for prevention of central venous catheterization-related thrombosis in children. Cochrane Database Syst Rev. 2014;3:CD005982.</Citation><ArticleIdList><ArticleId IdType="pubmed">24615288</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoot RA, Kremer LC, van de Wetering MD, van Ommen CH. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters. Cochrane Database Syst Rev. 2013;9:CD009160.</Citation><ArticleIdList><ArticleId IdType="pubmed">24026801</ArticleId></ArticleIdList></Reference><Reference><Citation>Christensen LD, Vinter-Jensen L, Rasmussen HH, et al. Rivaroxaban as anticoagulant therapy in short bowel syndrome. Report of three cases. Thromb Res. 2015;135:568&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">25592650</ArticleId></ArticleIdList></Reference><Reference><Citation>Douros A, Schlemm L, Bolbrinker J, et al. Insufficient anticoagulation with dabigatran in a patient with short bowel syndrome. Thromb Haemost. 2014;112:419&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">24695752</ArticleId></ArticleIdList></Reference><Reference><Citation>Monagle P, Chan AK, Goldenberg NA, et al. Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e737S&#x2013;801S.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3278066</ArticleId><ArticleId IdType="pubmed">22315277</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">26993478</PMID><DateCompleted><Year>2017</Year><Month>08</Month><Day>22</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1569-9285</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2016</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Interactive cardiovascular and thoracic surgery</Title><ISOAbbreviation>Interact Cardiovasc Thorac Surg</ISOAbbreviation></Journal><ArticleTitle>Cardiac and arterial elastance and myocardial wall stress in children with pectus excavatum.</ArticleTitle><Pagination><StartPage>4</StartPage><EndPage>8</EndPage><MedlinePgn>4-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/icvts/ivw054</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Pectus excavatum (PE) is one of the most common skeletal deformities of childhood. The study was undertaken to assess cardiac functions in children with PE.</AbstractText><AbstractText Label="METHODS">Echocardiography was performed on 32 children with PE and 40 age-matched healthy controls. The following parameters were monitored: meridional left ventricular (LV) wall stress (WSM), arterial elastance (Ea), LV elastance at end-systole derived by single beat (Ees(sb)), LV circumferential end-systolic wall stress (ESWSc), midwall shortening fraction (SFmid), predicted midwall fiber shortening for a measured fiber stress (midwall VCFc), myocardial fiber stress (MFS), LV end-systolic dimension (LVES), LV end-diastolic dimension (LVED) and end-systolic blood pressure (Pes), LV wall thickness at end-systole (hes). To assess the severity of PE, Haller index (HI) was calculated by computed tomography of the thorax.</AbstractText><AbstractText Label="RESULTS">SFmid, ESWSc, midwall VCFc and MFS were lower in PE children than in controls. The degree to which the parameters SFmid, ESWSc, midwall VCFc and MFS were altered in PE children was 14.9, 27.5, 20.3 and 20.3%, respectively. The minimum HI value of children with PE was 2.00, the maximum value was 4.93 and the arithmetic mean was 2.62 &#xb1; 0.56. Of the 32 children, 14 (43.75%) demonstrated mild deformity, 15 (46.88%) showed moderate and only 3 (9.37%) had severe deformity. In children with PE, there was no statistically significant correlation between the cardiac data (ESWSc, midwall VCFc, MFS, Ea, Ees(sb), LVES, LVED, Pes, hes) and HI.</AbstractText><AbstractText Label="CONCLUSION">We found ESWSc, MFS, midwall VCFc and SFmid to be lower in children with PE than in controls. We concluded that the myocardial contractility and afterload is affected in children with PE.</AbstractText><CopyrightInformation>&#xa9; The Author 2016. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aky&#xfc;z &#xd6;zkan</LastName><ForeName>Esra</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Bozok University Medical Faculty, Yozgat, Turkey uzdresra@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khosrashahi</LastName><ForeName>Hashem E</ForeName><Initials>HE</Initials><AffiliationInfo><Affiliation>Department of Pediatric Cardiology, Bozok University Medical Faculty, Yozgat, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serin</LastName><ForeName>Halil &#x130;brahim</ForeName><Initials>H&#x130;</Initials><AffiliationInfo><Affiliation>Department of Radiology, Bozok University Medical Faculty, Yozgat, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Metin</LastName><ForeName>Bayram</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Thoracic Surgery, Bozok University Medical Faculty, Yozgat, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>K&#x131;l&#x131;&#xe7;</LastName><ForeName>Mahmut</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Public Health, Bozok University Medical Faculty, Yozgat, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ge&#xe7;it</LastName><ForeName>U Aliye</ForeName><Initials>UA</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Bozok University Medical Faculty, Yozgat, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>03</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Interact Cardiovasc Thorac Surg</MedlineTA><NlmUniqueID>101158399</NlmUniqueID><ISSNLinking>1569-9285</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001158" MajorTopicYN="N">Arteries</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001794" MajorTopicYN="N">Blood Pressure</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004452" MajorTopicYN="N">Echocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004548" MajorTopicYN="N">Elasticity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005660" MajorTopicYN="N">Funnel Chest</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006352" MajorTopicYN="N">Heart Ventricles</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009200" MajorTopicYN="N">Myocardial Contraction</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009206" MajorTopicYN="N">Myocardium</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="N">Stroke Volume</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016277" MajorTopicYN="N">Ventricular Function, Left</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiac function</Keyword><Keyword MajorTopicYN="N">Children</Keyword><Keyword MajorTopicYN="N">Pectus excavatum</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>11</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>2</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>7</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26993478</ArticleId><ArticleId IdType="pmc">PMC4986733</ArticleId><ArticleId IdType="doi">10.1093/icvts/ivw054</ArticleId><ArticleId IdType="pii">ivw054</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Molik KA, Engum SA, Rescorla FJ, West KW, Scherer LR, Grosfeld JL. Pectus excavatum repair: experience with standard and minimal invasive techniques. J Pediatr Surg 2001;36:324&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">11172426</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams AM, Crabbe DC. Pectus deformities of the anterior chest wall. Paediatr Respir Rev 2003;4:237&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">12880759</ArticleId></ArticleIdList></Reference><Reference><Citation>Shamberger RC. Cardiopulmonary effects of anterior chest wall deformities. Chest Surg Clin N Am 2000;10:245&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">10803331</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao L, Fenberg MS, Gaides M, Ben-Dov I. Why is exercise capacity reduced in subjects with pectus excavatum? J Pediatr 2000;136:163&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">10657820</ArticleId></ArticleIdList></Reference><Reference><Citation>Haller JA Jr, Peters GN, Mazur D, White JJ. Pectus excavatum: a 20-year surgical experience. J Thorac Cardiovasc Surg 1970;60:375&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">5451734</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaroszewski DE, Warsame TA, Chandrasekaran K, Chaliki H. Right ventricular compression observed in echocardiography from pectus excavatum deformity. J Cardiovasc Ultrasound 2011;19:192&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3259543</ArticleId><ArticleId IdType="pubmed">22259662</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosteller RD. Simplified calculation of body-surface area. N Engl J Med 1987;22:1098.</Citation><ArticleIdList><ArticleId IdType="pubmed">3657876</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen DH, Driscoll DJ, Shaddy ER, Feltes FT. Echocardiography. In: Driscoll DJ, Shaddy RE, Timothy F (eds) Moss and Adams&#x2019; Heart Disease in Infants, Children and Adolescents. Wlaters Kluwer/Lippincott, Williams &amp; Wilkins, 2008, 128&#x2013;31.</Citation></Reference><Reference><Citation>Regen DM. Calculation of left ventricular wall stress. Circ Res 1990;67:245&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">2198115</ArticleId></ArticleIdList></Reference><Reference><Citation>Grossman W, Jones D, McLaurin LP. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 1975;56:56&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC436555</ArticleId><ArticleId IdType="pubmed">124746</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen CH, Fetics B, Nevo E, Rochitte CE, Chiou KR, Ding PA et al. . Noninvasive single-beat determination of left ventricular end-systolic elastance in humans. J Am Coll Cardiol 2001;38:2028&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">11738311</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly RP, Ting CT, Yang TM, Liu CP, Maughan WL, Chang MS et al. . Effective arterial elastance as index of arterial vascular load in humans. Circulation 1992;86:513&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">1638719</ArticleId></ArticleIdList></Reference><Reference><Citation>Y&#xfc;ksel M, Bostanc&#x131; K. Minimally invasive repair of pectus excavatum. T&#xfc;rkiye Klinikleri J Thor Surg-Special Topics 2009;2:70&#x2013;7.</Citation></Reference><Reference><Citation>Jaroszewski DE, Fonkalsrud EW. Repair of pectus chest deformities in 320 adult patients: 21 year experience. Ann Thorac Surg 2007;84:429&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">17643611</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar UK, Sahasranam KV. Mitral valve prolapse syndrome and associated thoracic skeletal abnormalities. J Assoc Phys India 1991;39:536&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">1800499</ArticleId></ArticleIdList></Reference><Reference><Citation>Seliem MA, Duffy CE, Gidding SS, Berdusis K, Benson DW Jr. Echocardiographic evaluation of the aortic root and mitral valve in children and adolescents with isolated pectus excavatum: comparison with Marfan patients. Pediatr Cardiol 1992;13:20&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">1736263</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim&#x15f;ek Z, G&#xfc;nay E, Aksakal E, Kutucularo&#x11f;lu MG, G&#xfc;neren G. Evaluation of cardiopulmonary findings of young adult patients with isolated pectus excavatum. Anadolu Kardiyol Derg 2011;11:77&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">21220244</ArticleId></ArticleIdList></Reference><Reference><Citation>Bleeker GB, Steendijk P, Holman ER, Yu CM, Breithardt OA, Kaandorp TA et al. . Assessing right ventricular function: the role of echocardiography and complementary technologies. Heart 2006;92(Suppl 1):19&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1860734</ArticleId><ArticleId IdType="pubmed">16543597</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu T, Feng J, Liu W, Jiang X, Wei F, Tang Y et al. . Modified sternal elevation for children with pectus excavatum. Chin Med J (Engl) 2000;113:451&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">11776104</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;rsu AH, Karag&#xfc;n BS, Korkmaz O, G&#xfc;rsu SS, U&#xe7;ar MA. Correlation between Haller index and echocardiographic and spirometric findings in children with pectus excavatum. Turk Kardiyol Dern Ars 2014;42:259&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">24769818</ArticleId></ArticleIdList></Reference><Reference><Citation>Krueger T, Chassot PG, Christodoulou M, Cheng C, Ris HB, Magnusson L. Cardiac function assessed by transesophageal echocardiography during pectus excavatum repair. Ann Thorac Surg 2010;89:240&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">20103244</ArticleId></ArticleIdList></Reference><Reference><Citation>Bawazir OA, Montgomery M, Harder J, Sigalet DL. Mid-term evaluation of cardiopulmonary effects of closed repair for pectus excavatum. J Pediatr Surg 2005;40:863&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">15937832</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson RJ, Young WG Jr, Godwin JD, Sabiston DC Jr, Jones RH. Noninvasive assessment of exercise cardiac function before and after pectus excavatum repair. J Thorac Cardiovasc Surg 1985;90:251&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">4021526</ArticleId></ArticleIdList></Reference><Reference><Citation>Saleh RS, Finn JP, Fenchel M, Moghadam AN, Krishnam M, Abrazado M et al. . Cardiovascular magnetic resonance in patients with pectus excavatum compared with normal controls. J Cardiovasc Magn Reson 2010;12:73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3022801</ArticleId><ArticleId IdType="pubmed">21144053</ArticleId></ArticleIdList></Reference><Reference><Citation>Crepaz R, Cemin R, Pedron C, Gentili L, Trevisan D, Pitscheider W. Age-related variations of left ventricular endocardial and midwall function in healthy infants, children, and adolescents. Ital Heart J 2005;6:634&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">16161496</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38010536</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>20</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1179-1985</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Nov</Month></PubDate></JournalIssue><Title>High blood pressure &amp; cardiovascular prevention : the official journal of the Italian Society of Hypertension</Title><ISOAbbreviation>High Blood Press Cardiovasc Prev</ISOAbbreviation></Journal><ArticleTitle>First Trimester CD93 as a Novel Marker of Preeclampsia and Its Complications: A Pilot Study.</ArticleTitle><Pagination><StartPage>591</StartPage><EndPage>594</EndPage><MedlinePgn>591-594</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40292-023-00608-y</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">CD93 plays a crucial role in endothelial homeostasis and angiogenesis. Recently its role in hypertension has been investigated, holding promise for novel targeted diagnostic and therapeutic strategies.</AbstractText><AbstractText Label="AIM" NlmCategory="OBJECTIVE">We assessed for the first time differences in first trimester serum CD93 levels in women who lately developed preeclampsia (PE) vs. normotensive pregnancy (NP).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">First trimester serum CD93 concentrations were assessed in a multicenter cohort of 83 women (34 PE and 49 NP) by ELISA Immunoassay.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Serum CD93 was lower in women who developed PE vs. NP (111.8 &#xb1; 24.4 vs. 137.5 &#xb1; 22.3 ng/ml; p&#x2009;&lt;&#x2009;0.001). Serum CD93 was associated with a decreased risk of developing PE (OR 0.950, 95% CI 0.922-0.978) and composite neonatal outcome (OR 0.952, CI 0.923-0.982), after adjustment for confounders.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">PE is accompanied by decreased serum CD93 levels. CD93 might play a role during placentation leading to defective angiogenesis, vascular dysfunction, and PE development.</AbstractText><CopyrightInformation>&#xa9; 2023. Italian Society of Hypertension.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Piani</LastName><ForeName>Federica</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-3338-1172</Identifier><AffiliationInfo><Affiliation>Hypertension and Cardiovascular Risk Research Center, Medical and Surgical Sciences Department, Alma Mater Studiorum University of Bologna, Bologna, Italy. federica.piani@unibo.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiovascular Medicine Unit, Heart, Chest and Vascular Deptartment, IRCCS Azienda-Ospedaliero Universitaria Di Bologna, Bologna, Italy. federica.piani@unibo.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Tossetta</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Experimental and Clinical Medicine, Universit&#xe0; Politecnica delle Marche, Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fantone</LastName><ForeName>Sonia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Experimental and Clinical Medicine, Universit&#xe0; Politecnica delle Marche, Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agostinis</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute for Maternal and Child Health, IRCCS Burlo Garofolo, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Simone</LastName><ForeName>Nicoletta</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20072, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IRCCS Humanitas Research Hospital, Via Manzoni 56; Rozzano, 20089, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mandal&#xe0;</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biology, Ecology and Earth Science, University of Calabria, Rende, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bulla</LastName><ForeName>Roberta</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Life Sciences, University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Marzioni</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Experimental and Clinical Medicine, Universit&#xe0; Politecnica delle Marche, Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Borghi</LastName><ForeName>Claudio</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hypertension and Cardiovascular Risk Research Center, Medical and Surgical Sciences Department, Alma Mater Studiorum University of Bologna, Bologna, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiovascular Medicine Unit, Heart, Chest and Vascular Deptartment, IRCCS Azienda-Ospedaliero Universitaria Di Bologna, Bologna, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>High Blood Press Cardiovasc Prev</MedlineTA><NlmUniqueID>9421087</NlmUniqueID><ISSNLinking>1120-9879</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C032402">complement 1q receptor</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001794" MajorTopicYN="N">Blood Pressure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="Y">Hypertension</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011225" MajorTopicYN="Y">Pre-Eclampsia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011261" MajorTopicYN="N">Pregnancy Trimester, First</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Angiogenic marker</Keyword><Keyword MajorTopicYN="N">C1qR</Keyword><Keyword MajorTopicYN="N">CD93</Keyword><Keyword MajorTopicYN="N">Hypertension</Keyword><Keyword MajorTopicYN="N">Preeclampsia</Keyword><Keyword MajorTopicYN="N">Pregnancy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>17</Day><Hour>9</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>27</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>27</Day><Hour>11</Hour><Minute>18</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38010536</ArticleId><ArticleId IdType="doi">10.1007/s40292-023-00608-y</ArticleId><ArticleId IdType="pii">10.1007/s40292-023-00608-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wang W, Xie X, Yuan T, Wang Y, Zhao F, Zhou Z, Zhang H. Epidemiological trends of maternal hypertensive disorders of pregnancy at the global, regional, and national levels: a population-based study. BMC Pregnancy Childbirth. 2021;21(1):364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12884-021-03809-2</ArticleId><ArticleId IdType="pubmed">33964896</ArticleId><ArticleId IdType="pmc">8106862</ArticleId></ArticleIdList></Reference><Reference><Citation>C&#xed;fkov&#xe1; R. Hypertension in pregnancy: a diagnostic and therapeutic overview. High Blood Press Cardiovasc Prev. 2023;30(4):289&#x2013;303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40292-023-00582-5</ArticleId><ArticleId IdType="pubmed">37308715</ArticleId><ArticleId IdType="pmc">10403432</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, Hall DR, Warren CE, Adoyi G, Ishaku S. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension. 2018;72(1):24&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.117.10803</ArticleId><ArticleId IdType="pubmed">29899139</ArticleId></ArticleIdList></Reference><Reference><Citation>Borghi C, Ferri C, Sechi L. Clinical management of hypertension in pregnancy. Practical recommendations from the Italian Society of Hypertension (SIIA). [corrected]. High Blood Press Cardiovasc Prev. 2013;20(3):123&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40292-013-0019-y</ArticleId><ArticleId IdType="pubmed">23918155</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomimatsu T, Mimura K, Endo M, Kumasawa K, Kimura T. Pathophysiology of preeclampsia: an angiogenic imbalance and long-lasting systemic vascular dysfunction. Hypertens Res. 2017;40(4):305&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/hr.2016.152</ArticleId><ArticleId IdType="pubmed">27829661</ArticleId></ArticleIdList></Reference><Reference><Citation>Chourdakis E, Oikonomou N, Fouzas S, Hahalis G, Karatza AA. Preeclampsia emerging as a risk factor of cardiovascular disease in women. High Blood Press Cardiovasc Prev. 2021;28(2):103&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40292-020-00425-7</ArticleId><ArticleId IdType="pubmed">33660234</ArticleId></ArticleIdList></Reference><Reference><Citation>Tossetta G, Piani F, Borghi C, Marzioni D. Role of CD93 in health and disease. Cells. 2023;12(13):1778.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells12131778</ArticleId><ArticleId IdType="pubmed">37443812</ArticleId><ArticleId IdType="pmc">10340406</ArticleId></ArticleIdList></Reference><Reference><Citation>Piani F, Tossetta G, Cara-Fuentes G, Agnoletti D, Marzioni D, Borghi C. Diagnostic and prognostic role of CD93 in cardiovascular disease: a systematic review. Biomolecules. 2023;13(6):910.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom13060910</ArticleId><ArticleId IdType="pubmed">37371490</ArticleId><ArticleId IdType="pmc">10296080</ArticleId></ArticleIdList></Reference><Reference><Citation>Opichka MA, Rappelt MW, Gutterman DD, Grobe JL, McIntosh JJ. Vascular dysfunction in preeclampsia. Cells. 2021;10(11):3055.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10113055</ArticleId><ArticleId IdType="pubmed">34831277</ArticleId><ArticleId IdType="pmc">8616535</ArticleId></ArticleIdList></Reference><Reference><Citation>Fantone S, Tossetta G, Di Simone N, Tersigni C, Scambia G, Marcheggiani F, Giannubilo SR, Marzioni D. CD93 a potential player in cytotrophoblast and endothelial cell migration. Cell Tissue Res. 2022;387(1):123&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-021-03543-3</ArticleId><ArticleId IdType="pubmed">34674045</ArticleId></ArticleIdList></Reference><Reference><Citation>Strawbridge RJ, Hilding A, Silveira A, &#xd6;sterholm C, Sennblad B, McLeod O, Tsikrika P, Foroogh F, Tremoli E, Baldassarre D, Veglia F, Rauramaa R, Smit AJ, Giral P, Kurl S, Mannarino E, Grossi E, Syv&#xe4;nen AC, Humphries SE, de Faire U, &#xd6;stenson CG, Maegdefessel L, Hamsten A, B&#xe4;cklund A. Soluble CD93 is involved in metabolic dysregulation but does not influence carotid intima-media thickness. Diabetes. 2016;65(10):2888&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db15-1333</ArticleId><ArticleId IdType="pubmed">27659228</ArticleId><ArticleId IdType="pmc">5033267</ArticleId></ArticleIdList></Reference><Reference><Citation>Flint EJ, Cerdeira AS, Redman CW, Vatish M. The role of angiogenic factors in the management of preeclampsia. Acta Obstet Gynecol Scand. 2019;98(6):700&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aogs.13540</ArticleId><ArticleId IdType="pubmed">30667052</ArticleId></ArticleIdList></Reference><Reference><Citation>Abplanalp WT, Fischer A, John D, Zeiher AM, Gosgnach W, Darville H, Montgomery R, Pestano L, All&#xe9;e G, Paty I, Fougerousse F, Dimmeler S. Efficiency and target derepression of anti-miR-92a: results of a first in human study. Nucleic Acid Ther. 2020;30(6):335&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/nat.2020.0871</ArticleId><ArticleId IdType="pubmed">32707001</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinkel R, Penzkofer D, Z&#xfc;hlke S, Fischer A, Husada W, Xu QF, Baloch E, van Rooij E, Zeiher AM, Kupatt C, Dimmeler S. Inhibition of microRNA-92a protects against ischemia/reperfusion injury in a large-animal model. Circulation. 2013;128(10):1066&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.113.001904</ArticleId><ArticleId IdType="pubmed">23897866</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellera N, Barba I, Rodriguez-Sinovas A, Ferret E, As&#xed;n MA, Gonzalez-Alujas MT, P&#xe9;rez-Rodon J, Esteves M, Fonseca C, Toran N, Garcia Del Blanco B, P&#xe9;rez A, Garcia-Dorado D. Single intracoronary injection of encapsulated antagomir-92a promotes angiogenesis and prevents adverse infarct remodeling. J Am Heart Assoc. 2014;3(5): e000946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.114.000946</ArticleId><ArticleId IdType="pubmed">25240056</ArticleId><ArticleId IdType="pmc">4323815</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37337399</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1752-8062</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Clinical and translational science</Title><ISOAbbreviation>Clin Transl Sci</ISOAbbreviation></Journal><ArticleTitle>Remimazolam versus propofol in combination with esketamine for surgical abortion: A double-blind randomized controlled trial.</ArticleTitle><Pagination><StartPage>1606</StartPage><EndPage>1616</EndPage><MedlinePgn>1606-1616</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/cts.13572</ELocationID><Abstract><AbstractText>Remimazolam is a new benzodiazepine with a short half-life, good efficacy, and safety profiles in general anesthesia. Combining esketamine with propofol (P&#x2009;+&#x2009;E) could reduce propofol consumption and injection pain. It is, however, unclear if a low dose of remimazolam co-administrated with esketamine (R&#x2009;+&#x2009;E) is comparable to the increasingly used P&#x2009;+&#x2009;E for surgical abortion with general anesthetic. We conducted a double-blind randomized controlled trial to compare the efficacy and safety of R&#x2009;+&#x2009;E and P&#x2009;+&#x2009;E. Two hundred patients scheduled for a surgical abortion were randomized to receive remimazolam 0.3&#x2009;mg/kg plus esketamine 0.3&#x2009;mg/kg (R&#x2009;+&#x2009;E), and propofol 2&#x2009;mg/kg plus esketamine 0.3&#x2009;mg/kg (P&#x2009;+&#x2009;E). Sedative effectiveness was evaluated by measuring the time to lose consciousness (LOC), recovery time, and successful sedation rate. Safety was assessed by hemodynamics and adverse events during and postoperation. The time to LOC and recovery time in R&#x2009;+&#x2009;E was 5&#x2009;s shorter and 1&#x2009;min longer than that in P&#x2009;+&#x2009;E, respectively (both p&#x2009;&lt;&#x2009;0.001). Success sedation rate did not differ between groups (p&#x2009;=&#x2009;0.73). Bradycardia incidence and injection site pain were less frequent in the R&#x2009;+&#x2009;E group than that in the P&#x2009;+&#x2009;E group. More rash was observed in the R&#x2009;+&#x2009;E group compared with the P&#x2009;+&#x2009;E group (32% vs. 5%, p&#x2009;&lt;&#x2009;0.001), but all were mild (only chest rash) and resolved subsequently. Low dose of remimazolam when combined with esketamine has favorable profiles with rapid onset and recovery, but mild hemodynamic side effects and adverse events. It can be used as an alternative for surgical abortion with general anesthetic.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Clinical and Translational Science published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yue</LastName><ForeName>Linli</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Maternal and Child Health Hospital of Hubei Province, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Xiaoling</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Maternal and Child Health Hospital of Hubei Province, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Na</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-4221-6075</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesiology, Maternal and Child Health Hospital of Hubei Province, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Nursing, Hong Kong Polytechnic University, Hong Kong, SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Maternal and Child Health Hospital of Hubei Province, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wan</LastName><ForeName>Zhenzhen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Maternal and Child Health Hospital of Hubei Province, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Nursing, Hong Kong Polytechnic University, Hong Kong, SAR, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Transl Sci</MedlineTA><NlmUniqueID>101474067</NlmUniqueID><ISSNLinking>1752-8054</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>50LFG02TXD</RegistryNumber><NameOfSubstance UI="C000629870">Esketamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>YI7VU623SF</RegistryNumber><NameOfSubstance UI="D015742">Propofol</NameOfSubstance></Chemical><Chemical><RegistryNumber>7V4A8U16MB</RegistryNumber><NameOfSubstance UI="C522201">remimazolam</NameOfSubstance></Chemical><Chemical><RegistryNumber>12794-10-4</RegistryNumber><NameOfSubstance UI="D001569">Benzodiazepines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018681">Anesthetics, General</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015742" MajorTopicYN="Y">Propofol</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001569" MajorTopicYN="N">Benzodiazepines</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018681" MajorTopicYN="Y">Anesthetics, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010146" MajorTopicYN="N">Pain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005076" MajorTopicYN="Y">Exanthema</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declared no competing interests for this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>20</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>20</Day><Hour>1</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37337399</ArticleId><ArticleId IdType="pmc">PMC10499404</ArticleId><ArticleId IdType="doi">10.1111/cts.13572</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization . Safe Abortion: Technical and Policy Guidance for Health Systems. 2nd ed. WHO Press, World Health Organization; 2012.</Citation><ArticleIdList><ArticleId IdType="pubmed">23700650</ArticleId></ArticleIdList></Reference><Reference><Citation>Bearak J, Popinchalk A, Ganatra B, et al. Unintended pregnancy and abortion by income, region, and the legal status of abortion: estimates from a comprehensive model for 1990&#x2010;2019. Lancet Glob Health. 2020;8(9):e1152&#x2010;e1161. doi:10.1016/S2214-109X(20)30315-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(20)30315-6</ArticleId><ArticleId IdType="pubmed">32710833</ArticleId></ArticleIdList></Reference><Reference><Citation>Renner RM, Jensen JT, Nichols MD, Edelman AB. Pain control in first&#x2010;trimester surgical abortion: a systematic review of randomized controlled trials. Contraception. 2010;81(5):372&#x2010;388. doi:10.1016/j.contraception.2009.12.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.contraception.2009.12.008</ArticleId><ArticleId IdType="pubmed">20399943</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie H, Chen W, Liu J, Li J, Li S. Changes of analgesia/nociception index under different surgical steps in abortion under general anesthesia: a prospective clinical study. J Clin Anesth. 2020;66:109898. doi:10.1016/j.jclinane.2020.109898</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2020.109898</ArticleId><ArticleId IdType="pubmed">32590195</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu X, He X, Fan B, et al. Effect of propofol intravenous anesthesia combined with press&#x2010;needle therapy on analgesic effect during painless abortion. Comput Math Methods Med. 2022;2022:6543211. doi:10.1155/2022/6543211</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/6543211</ArticleId><ArticleId IdType="pmc">PMC9377957</ArticleId><ArticleId IdType="pubmed">35979057</ArticleId></ArticleIdList></Reference><Reference><Citation>Frank LR, Strote J, Hauff SR, Bigelow SK, Fay K. Propofol by infusion protocol for ED procedural sedation. Am J Emerg Med. 2006;24(5):599&#x2010;602. doi:10.1016/j.ajem.2006.02.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2006.02.008</ArticleId><ArticleId IdType="pubmed">16938600</ArticleId></ArticleIdList></Reference><Reference><Citation>Wadhwa V, Vargo JJ. Sedation and monitoring in endoscopy. In: Chandrasekhara V, Elmunzer BJ, Khashab M, Muthusamy VR, eds. Clinical Gastrointestinal Endoscopy. 3rd ed. Elsevier; 2019:81&#x2010;90.e2:chap 7.</Citation></Reference><Reference><Citation>Ebert TJ. Sympathetic and hemodynamic effects of moderate and deep sedation with propofol in humans. Anesthesiology. 2005;103(1):20&#x2010;24. doi:10.1097/00000542-200507000-00007</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200507000-00007</ArticleId><ArticleId IdType="pubmed">15983452</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang Y, Xu Y, Cao S, et al. Incidence and risk factors for hypoxia in deep sedation of propofol for artificial abortion patients. Front Med (Lausanne). 2022;9:763275. doi:10.3389/fmed.2022.763275</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.763275</ArticleId><ArticleId IdType="pmc">PMC9092022</ArticleId><ArticleId IdType="pubmed">35572953</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia Guzzo ME, Fernandez MS, Sanchez Novas D, et al. Deep sedation using propofol target&#x2010;controlled infusion for gastrointestinal endoscopic procedures: a retrospective cohort study. BMC Anesthesiol. 2020;20(1):195. doi:10.1186/s12871-020-01103-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-020-01103-w</ArticleId><ArticleId IdType="pmc">PMC7418437</ArticleId><ArticleId IdType="pubmed">32778055</ArticleId></ArticleIdList></Reference><Reference><Citation>Egan TD. Is anesthesiology going soft?: trends in fragile pharmacology. Anesthesiology. 2009;111(2):229&#x2010;230. doi:10.1097/ALN.0b013e3181ae8460</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3181ae8460</ArticleId><ArticleId IdType="pubmed">19625797</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilpatrick GJ, McIntyre MS, Cox RF, et al. CNS 7056: a novel ultra&#x2010;short&#x2010;acting benzodiazepine. Anesthesiology. 2007;107(1):60&#x2010;66. doi:10.1097/01.anes.0000267503.85085.c0</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.anes.0000267503.85085.c0</ArticleId><ArticleId IdType="pubmed">17585216</ArticleId></ArticleIdList></Reference><Reference><Citation>Keam SJ. Remimazolam: first approval. Drugs. 2020;80(6):625&#x2010;633. doi:10.1007/s40265-020-01299-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40265-020-01299-8</ArticleId><ArticleId IdType="pubmed">32274703</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers WK, McDowell TS. Remimazolam, a short&#x2010;acting GABA(a) receptor agonist for intravenous sedation and/or anesthesia in day&#x2010;case surgical and non&#x2010;surgical procedures. IDrugs. 2010;13:929&#x2010;937.</Citation><ArticleIdList><ArticleId IdType="pubmed">21154153</ArticleId></ArticleIdList></Reference><Reference><Citation>Saari TI, Uusi&#x2010;Oukari M, Ahonen J, Olkkola KT. Enhancement of GABAergic activity: neuropharmacological effects of benzodiazepines and therapeutic use in anesthesiology. Pharmacol Rev. 2011;63(1):243&#x2010;267. doi:10.1124/pr.110.002717</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/pr.110.002717</ArticleId><ArticleId IdType="pubmed">21245208</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilpatrick GJ. Remimazolam: non&#x2010;clinical and clinical profile of a new sedative/anesthetic agent. Front Pharmacol. 2021;12:690875. doi:10.3389/fphar.2021.690875</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.690875</ArticleId><ArticleId IdType="pmc">PMC8329483</ArticleId><ArticleId IdType="pubmed">34354587</ArticleId></ArticleIdList></Reference><Reference><Citation>Noor N, Legendre R, Cloutet A, Chitneni A, Varrassi G, Kaye AD. A comprehensive review of remimazolam for sedation. Health Psychol Res. 2021;9(1):24514. doi:10.52965/001c.24514</Citation><ArticleIdList><ArticleId IdType="doi">10.52965/001c.24514</ArticleId><ArticleId IdType="pmc">PMC8567764</ArticleId><ArticleId IdType="pubmed">34746482</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai G, Pei L, Duan F, et al. Safety and efficacy of remimazolam compared with propofol in induction of general anesthesia. Minerva Anestesiol. 2021;87(10):1073&#x2010;1079. doi:10.23736/S0375-9393.21.15517-8</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S0375-9393.21.15517-8</ArticleId><ArticleId IdType="pubmed">34263581</ArticleId></ArticleIdList></Reference><Reference><Citation>Doi M, Morita K, Takeda J, Sakamoto A, Yamakage M, Suzuki T. Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single&#x2010;blind, randomized, parallel&#x2010;group, phase IIb/III trial. J Anesth. 2020;34(4):543&#x2010;553. doi:10.1007/s00540-020-02788-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-020-02788-6</ArticleId><ArticleId IdType="pubmed">32417976</ArticleId></ArticleIdList></Reference><Reference><Citation>Pastis NJ, Yarmus LB, Schippers F, et al. Safety and efficacy of Remimazolam compared with placebo and midazolam for moderate sedation during bronchoscopy. Chest. 2019;155(1):137&#x2010;146. doi:10.1016/j.chest.2018.09.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2018.09.015</ArticleId><ArticleId IdType="pubmed">30292760</ArticleId></ArticleIdList></Reference><Reference><Citation>Jhuang BJ, Yeh BH, Huang YT, Lai PC. Efficacy and safety of remimazolam for procedural sedation: a meta&#x2010;analysis of randomized controlled trials with trial sequential analysis. Front Med (Lausanne). 2021;8:641866. doi:10.3389/fmed.2021.641866</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.641866</ArticleId><ArticleId IdType="pmc">PMC8353129</ArticleId><ArticleId IdType="pubmed">34386505</ArticleId></ArticleIdList></Reference><Reference><Citation>Ul&#x2010;Haque I, Shaikh TG, Ahmed SH, et al. Efficacy of remimazolam for procedural sedation in American Society of Anesthesiologists (ASA) I to IV patients undergoing colonoscopy: a systematic review and meta&#x2010;analysis. Cureus. 2022;14(3):e22881. doi:10.7759/cureus.22881</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.22881</ArticleId><ArticleId IdType="pmc">PMC8982285</ArticleId><ArticleId IdType="pubmed">35399486</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan X, Jiao Z, Gong X, et al. Efficacy of pre&#x2010;treatment with remimazolam on prevention of propofol&#x2010;induced injection pain in patients undergoing abortion or curettage: a prospective, double&#x2010;blinded, randomized and placebo&#x2010;controlled clinical trial. Drug Des Devel Ther. 2021;15:4551&#x2010;4558. doi:10.2147/DDDT.S334100</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DDDT.S334100</ArticleId><ArticleId IdType="pmc">PMC8576108</ArticleId><ArticleId IdType="pubmed">34764637</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu G, Xiong Y. Analysis of stress response and analgesic effect of remazolam combined with etomidate in painless gastroenteroscopy. Contrast Media Mol Imaging. 2022;2022:4863682. doi:10.1155/2022/4863682</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/4863682</ArticleId><ArticleId IdType="pmc">PMC9365612</ArticleId><ArticleId IdType="pubmed">35992545</ArticleId></ArticleIdList></Reference><Reference><Citation>Domino EF, Chodoff P, Corssen G. Pharmacologic effects of ci&#x2010;581, a new dissociative anesthetic, in man. Clin Pharmacol Ther. 1965;6:279&#x2010;291. doi:10.1002/cpt196563279</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpt196563279</ArticleId><ArticleId IdType="pubmed">14296024</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowdle TA, Radant AD, Cowley DS, et al. Psychedelic effects of ketamine in healthy volunteers: relationship to steady&#x2010;state plasma concentrations. Anesthesiology. 1998;88(1):82&#x2010;88. doi:10.1097/00000542-199801000-00015</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-199801000-00015</ArticleId><ArticleId IdType="pubmed">9447860</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Huang J, Yang S, et al. Pharmacokinetics and safety of esketamine in Chinese patients undergoing painless gastroscopy in comparison with ketamine: a randomized, open&#x2010;label clinical study. Drug Des Devel Ther. 2019;13:4135&#x2010;4144. doi:10.2147/DDDT.S224553</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DDDT.S224553</ArticleId><ArticleId IdType="pmc">PMC6902860</ArticleId><ArticleId IdType="pubmed">31827320</ArticleId></ArticleIdList></Reference><Reference><Citation>Peltoniemi MA, Hagelberg NM, Olkkola KT, Saari TI. Ketamine: a review of clinical pharmacokinetics and pharmacodynamics in anesthesia and pain therapy. Clin Pharmacokinet. 2016;55(9):1059&#x2010;1077. doi:10.1007/s40262-016-0383-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40262-016-0383-6</ArticleId><ArticleId IdType="pubmed">27028535</ArticleId></ArticleIdList></Reference><Reference><Citation>Azab M, Bharadwaj S, Jayaraj M, et al. Safety of endoscopic retrograde cholangiopancreatography (ERCP) in pregnancy: a systematic review and meta&#x2010;analysis. Saudi J Gastroenterol. 2019;25(6):341&#x2010;354. doi:10.4103/sjg.SJG_92_19</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/sjg.SJG_92_19</ArticleId><ArticleId IdType="pmc">PMC6941455</ArticleId><ArticleId IdType="pubmed">31744939</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu D, Wang D, Li W, Han Y, Jia J. Pretreatment with low&#x2010;dose esketamine for reduction of propofol injection pain: a randomized controlled trial. Pain Res Manag. 2022;2022:4289905. doi:10.1155/2022/4289905</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/4289905</ArticleId><ArticleId IdType="pmc">PMC9363235</ArticleId><ArticleId IdType="pubmed">35958679</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H, Zhao Q, Chen HY, et al. The median effective concentration of propofol with different doses of esketamine during gastrointestinal endoscopy in elderly patients: a randomized controlled trial. Br J Clin Pharmacol. 2022;88(3):1279&#x2010;1287. doi:10.1111/bcp.15072</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bcp.15072</ArticleId><ArticleId IdType="pubmed">34496448</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhan Y, Liang S, Yang Z, et al. Efficacy and safety of subanesthetic doses of esketamine combined with propofol in painless gastrointestinal endoscopy: a prospective, double&#x2010;blind, randomized controlled trial. BMC Gastroenterol. 2022;22(1):391. doi:10.1186/s12876-022-02467-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12876-022-02467-8</ArticleId><ArticleId IdType="pmc">PMC9392938</ArticleId><ArticleId IdType="pubmed">35987996</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu C, Wei X, Zhang C, et al. Esketamine prevents propofol&#x2010;induced injection pain: randomized controlled trial. Front Pharmacol. 2022;13:991559. doi:10.3389/fphar.2022.991559</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.991559</ArticleId><ArticleId IdType="pmc">PMC9530822</ArticleId><ArticleId IdType="pubmed">36204223</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu C, Ren J, Guo X, Qian J. Effects of remimazolam combined with esketamine anesthesia on circulatory and respiratory function during painless gastroenteroscopy. Contrast Media Mol Imaging. 2022;2022:1079099. doi:10.1155/2022/1079099</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/1079099</ArticleId><ArticleId IdType="pmc">PMC9581615</ArticleId><ArticleId IdType="pubmed">36304777</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi X, Xu W, Li A. The clinical application of remimazolam benzenesulfonate combined with esketamine intravenous anesthesia in endoscopic retrograde cholangiopancreatography. Biomed Res Int. 2022;2022:5628687. doi:10.1155/2022/5628687</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/5628687</ArticleId><ArticleId IdType="pmc">PMC9262575</ArticleId><ArticleId IdType="pubmed">35813222</ArticleId></ArticleIdList></Reference><Reference><Citation>Chernik DA, Gillings D, Laine H, et al. Validity and reliability of the observer's assessment of alertness/sedation scale: study with intravenous midazolam. J Clin Psychopharmacol. 1990;10(4):244&#x2010;251.</Citation><ArticleIdList><ArticleId IdType="pubmed">2286697</ArticleId></ArticleIdList></Reference><Reference><Citation>StataCorp . Stata Statistical Software: Release 14. StataCorp LP; 2015.</Citation></Reference><Reference><Citation>Bayoumi AM. STDDIFF: stata module to compute standardized differences for continuous and categorical variables. Statistical Software Components S458275 . 2016. revised 17 Dec 2022.</Citation></Reference><Reference><Citation>Chen S, Wang J, Xu X, et al. The efficacy and safety of remimazolam tosylate versus propofol in patients undergoing colonoscopy: a multicentered, randomized, positive&#x2010;controlled, phase III clinical trial. Am J Transl Res. 2020;12(8):4594&#x2010;4603.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7476156</ArticleId><ArticleId IdType="pubmed">32913533</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen SH, Yuan TM, Zhang J, et al. Remimazolam tosilate in upper gastrointestinal endoscopy: a multicenter, randomized, non&#x2010;inferiority, phase III trial. J Gastroenterol Hepatol. 2021;36(2):474&#x2010;481. doi:10.1111/jgh.15188</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgh.15188</ArticleId><ArticleId IdType="pubmed">32677707</ArticleId></ArticleIdList></Reference><Reference><Citation>Rex DK, Bhandari R, Desta T, et al. A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy. Gastrointest Endosc. 2018;88(3):427&#x2010;437 e6. doi:10.1016/j.gie.2018.04.2351</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gie.2018.04.2351</ArticleId><ArticleId IdType="pubmed">29723512</ArticleId></ArticleIdList></Reference><Reference><Citation>Rex DK, Bhandari R, Lorch DG, Meyers M, Schippers F, Bernstein D. Safety and efficacy of remimazolam in high risk colonoscopy: a randomized trial. Dig Liver Dis. 2021;53(1):94&#x2010;101. doi:10.1016/j.dld.2020.10.039</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dld.2020.10.039</ArticleId><ArticleId IdType="pubmed">33243567</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S, Wang J, Ran R, Peng Y, Xiao Y. Efficacy and safety of remimazolam tosylate in hysteroscopy: a randomized, single&#x2010;blind, parallel controlled trial. J Clin Pharm Ther. 2022;47(1):55&#x2010;60. doi:10.1111/jcpt.13525</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcpt.13525</ArticleId><ArticleId IdType="pubmed">34655087</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Li S, Liu J. Efficacy and safety of remimazolam besylate versus propofol during hysteroscopy: single&#x2010;centre randomized controlled trial. BMC Anesthesiol. 2021;21(1):156. doi:10.1186/s12871-021-01373-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-021-01373-y</ArticleId><ArticleId IdType="pmc">PMC8135983</ArticleId><ArticleId IdType="pubmed">34016045</ArticleId></ArticleIdList></Reference><Reference><Citation>Borkett KM, Riff DS, Schwartz HI, et al. A phase IIa, randomized, double&#x2010;blind study of remimazolam (CNS 7056) versus midazolam for sedation in upper gastrointestinal endoscopy. Anesth Analg. 2015;120(4):771&#x2010;780. doi:10.1213/ANE.0000000000000548</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000000548</ArticleId><ArticleId IdType="pubmed">25502841</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo J, Qian Y, Zhang X, Han S, Shi Q, Xu J. Remimazolam tosilate compared with propofol for gastrointestinal endoscopy in elderly patients: a prospective, randomized and controlled study. BMC Anesthesiol. 2022;22(1):180. doi:10.1186/s12871-022-01713-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-022-01713-6</ArticleId><ArticleId IdType="pmc">PMC9185932</ArticleId><ArticleId IdType="pubmed">35689208</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasushita Y, Nagao M, Miyazawa Y, Yunoki K, Mima H. Cardiac arrest following remimazolam&#x2010;induced anaphylaxis: a case report. A A Pract. 2022;16(9):e01616. doi:10.1213/XAA.0000000000001616</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/XAA.0000000000001616</ArticleId><ArticleId IdType="pmc">PMC9521581</ArticleId><ArticleId IdType="pubmed">36149988</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsurumi K, Takahashi S, Hiramoto Y, Nagumo K, Takazawa T, Kamiyama Y. Remimazolam anaphylaxis during anesthesia induction. J Anesth. 2021;35(4):571&#x2010;575. doi:10.1007/s00540-021-02934-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-021-02934-8</ArticleId><ArticleId IdType="pubmed">34050439</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchida S, Takekawa D, Kitayama M, Hirota K. Two cases of circulatory collapse due to suspected remimazolam anaphylaxis. JA Clin Rep. 2022;8(1):18. doi:10.1186/s40981-022-00508-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40981-022-00508-5</ArticleId><ArticleId IdType="pmc">PMC8898805</ArticleId><ArticleId IdType="pubmed">35249154</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38082386</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2474</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Dec</Month><Day>11</Day></PubDate></JournalIssue><Title>BMC musculoskeletal disorders</Title><ISOAbbreviation>BMC Musculoskelet Disord</ISOAbbreviation></Journal><ArticleTitle>Body height and spinal pain in adolescence: a cohort study from the Danish National Birth Cohort.</ArticleTitle><Pagination><StartPage>958</StartPage><MedlinePgn>958</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">958</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12891-023-07077-3</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To investigate how body height and trajectories of height from infancy through childhood and adolescence were associated with spinal pain in pre- and late adolescence.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This prospective study included 43,765 individuals born into The Danish National Birth Cohort (DNBC) from 1996 to 2003. DNBC-data were linked with health and social data identified from Statistics Denmark registers. Spinal pain was self-reported in both the 11-year- and 18-year follow-up of DNBC and classified according to severity. Body height was measured from birth and onwards and further modelled as distinct developmental height trajectories by using latent growth curve modelling. Associations were estimated by using multinomial logistic regression models.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Taller body height in childhood and adolescence was associated with approximately 20% increased likelihood of spinal pain in pre- and late adolescence among girls compared to their peers in the normal height group. For boys, taller body height was associated with spinal pain by late adolescence only. Spinal pain in pre-adolescence almost doubled the likelihood of spinal pain in late adolescence regardless of body height at age 18. Height trajectories confirmed the relationship for girls with the tall individuals being most likely to have spinal pain in both pre- and late adolescence.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Tall body height during childhood and adolescence predisposes to spinal pain among girls in both pre-and late adolescence, and among boys in late adolescence. Body height is a contributing factor to the pathogenesis of spinal pain in adolescence; however, the mechanisms may be related to growth velocity, but for now uncertain.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Falch-Joergensen</LastName><ForeName>Anne Cathrine</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Section of Epidemiology, Department of Public Health, Faculty of Health and Medical Science, University of Copenhagen, Oster Farimagsgade 5, Box 2099, Copenhagen K, DK-1014, Denmark. acjo@sund.ku.dk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andersen</LastName><ForeName>Per Kragh</ForeName><Initials>PK</Initials><AffiliationInfo><Affiliation>Section of Biostatistics, Department of Public Health, Faculty of Health and Medical Science, University of Copenhagen, Copenhagen K, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Budtz-Jorgensen</LastName><ForeName>Esben</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Section of Biostatistics, Department of Public Health, Faculty of Health and Medical Science, University of Copenhagen, Copenhagen K, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hestbaek</LastName><ForeName>Lise</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Sport Science and Clinical Biomechanics, University of Southern Denmark, Odense, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strandberg-Larsen</LastName><ForeName>Katrine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Section of Epidemiology, Department of Public Health, Faculty of Health and Medical Science, University of Copenhagen, Oster Farimagsgade 5, Box 2099, Copenhagen K, DK-1014, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nybo Andersen</LastName><ForeName>Anne-Marie</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Section of Epidemiology, Department of Public Health, Faculty of Health and Medical Science, University of Copenhagen, Oster Farimagsgade 5, Box 2099, Copenhagen K, DK-1014, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>(DFF-7016-00344)</GrantID><Agency>The Danish Council for Independent Research</Agency><Country/></Grant><Grant><GrantID>(European Commission, Grant Agreement No 824989).</GrantID><Agency>EUCAN-connect</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Musculoskelet Disord</MedlineTA><NlmUniqueID>100968565</NlmUniqueID><ISSNLinking>1471-2474</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001827" MajorTopicYN="Y">Body Height</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000089822" MajorTopicYN="Y">Birth Cohort</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010146" MajorTopicYN="N">Pain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003718" MajorTopicYN="N" Type="Geographic">Denmark</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adolescence</Keyword><Keyword MajorTopicYN="N">Back pain</Keyword><Keyword MajorTopicYN="N">Body height</Keyword><Keyword MajorTopicYN="N">Epidemiology</Keyword><Keyword MajorTopicYN="N">Growth</Keyword><Keyword MajorTopicYN="N">Spinal pain</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>17</Day><Hour>9</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>12</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>12</Day><Hour>0</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38082386</ArticleId><ArticleId IdType="pmc">PMC10712045</ArticleId><ArticleId IdType="doi">10.1186/s12891-023-07077-3</ArticleId><ArticleId IdType="pii">10.1186/s12891-023-07077-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hurwitz EL, Randhawa K, Yu H, C&#xf4;t&#xe9; P, Haldeman S. The global spine care initiative: a summary of the global burden of low back and neck pain studies. Eur Spine J. 2018;27(6):796&#x2013;801. doi: 10.1007/s00586-017-5432-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00586-017-5432-9</ArticleId><ArticleId IdType="pubmed">29480409</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassebaum NA, Barber M, Bjertness RM, Hailu E, Knudsen A, Norheim AK, Skogen OF, Savic JC, Skirbekk M, Steiner V, Stovner TJ, S&#xf8;reide LJ, Vollset K, Weiderpass SEE. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990&#x2013;2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1603&#x2013;1658. doi: 10.1016/S0140-6736(16)31460-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(16)31460-X</ArticleId><ArticleId IdType="pmc">PMC5388857</ArticleId><ArticleId IdType="pubmed">27733283</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunn KM, Hestbaek L, Cassidy JD. Low back pain across the life course. Best Pract Res Clin Rheumatol. 2013;27(5):591&#x2013;600. doi: 10.1016/j.berh.2013.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.berh.2013.09.007</ArticleId><ArticleId IdType="pubmed">24315141</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeffries LJ, Milanese SF, Grimmer-Somers KA. Epidemiology of adolescent spinal pain: a systematic overview of the research literature. Spine. 2007;32(23):2630&#x2013;2637. doi: 10.1097/BRS.0b013e318158d70b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BRS.0b013e318158d70b</ArticleId><ArticleId IdType="pubmed">17978666</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvo-Munoz I, Gomez-Conesa A, Sanchez-Meca J. Prevalence of low back pain in children and adolescents: a meta-analysis. BMC Pediatr. 2013;13:14. doi: 10.1186/1471-2431-13-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2431-13-14</ArticleId><ArticleId IdType="pmc">PMC3571904</ArticleId><ArticleId IdType="pubmed">23351394</ArticleId></ArticleIdList></Reference><Reference><Citation>MacDonald J, Stuart E, Rodenberg R. Musculoskeletal low back pain in school-aged children: a review. JAMA Pediatr. 2017;171(3):280&#x2013;287. doi: 10.1001/jamapediatrics.2016.3334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2016.3334</ArticleId><ArticleId IdType="pubmed">28135365</ArticleId></ArticleIdList></Reference><Reference><Citation>Lardon A, Leboeuf-Yde C, Le Scanff C, Wedderkopp N. Is puberty a risk factor for back pain in the young? A systematic critical literature review. Chiropr Man Ther. 2014;22(1):27. doi: 10.1186/s12998-014-0027-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12998-014-0027-6</ArticleId><ArticleId IdType="pmc">PMC4200222</ArticleId><ArticleId IdType="pubmed">25328668</ArticleId></ArticleIdList></Reference><Reference><Citation>Diepenmaat AC, van der Wal MF, de Vet HC, Hirasing RA. Neck/shoulder, low back, and arm pain in relation to computer use, physical activity, stress, and depression among Dutch adolescents. Pediatrics. 2006;117(2):412&#x2013;416. doi: 10.1542/peds.2004-2766.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2004-2766</ArticleId><ArticleId IdType="pubmed">16452360</ArticleId></ArticleIdList></Reference><Reference><Citation>Myrtveit SM, Sivertsen B, Skogen JC, Frostholm L, Stormark KM, Hysing M. Adolescent neck and shoulder pain&#x2013;the association with depression, physical activity, screen-based activities, and use of health care services. J Adolesc Health. 2014;55(3):366&#x2013;372. doi: 10.1016/j.jadohealth.2014.02.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jadohealth.2014.02.016</ArticleId><ArticleId IdType="pubmed">24746679</ArticleId></ArticleIdList></Reference><Reference><Citation>Stallknecht SE, Strandberg-Larsen K, Hestbaek L, Nybo Andersen A. Spinal pain and co-occurrence with stress and general well-being among young adolescents: a study within the Danish National Birth Cohort. Eur J Pediatrics. 2017;176(6):807&#x2013;814. doi: 10.1007/s00431-017-2915-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-017-2915-y</ArticleId><ArticleId IdType="pubmed">28470441</ArticleId></ArticleIdList></Reference><Reference><Citation>Joergensen AC, Hestbaek L, Andersen PK, Nybo Andersen AM. Epidemiology of spinal pain in children: a study within the Danish National Birth Cohort. Eur J Pediatrics. 2019;178(5):695&#x2013;706. doi: 10.1007/s00431-019-03326-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-019-03326-7</ArticleId><ArticleId IdType="pmc">PMC6459805</ArticleId><ArticleId IdType="pubmed">30788593</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones GT, Macfarlane GJ. Epidemiology of low back pain in children and adolescents. Arch Dis Child. 2005;90(3):312&#x2013;316. doi: 10.1136/adc.2004.056812.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/adc.2004.056812</ArticleId><ArticleId IdType="pmc">PMC1720304</ArticleId><ArticleId IdType="pubmed">15723927</ArticleId></ArticleIdList></Reference><Reference><Citation>Hershkovich O, Friedlander A, Gordon B, Arzi H, Derazne E, Tzur D, et al. Associations of body mass index and body height with low back pain in 829,791 adolescents. Am J Epidemiol. 2013;178(4):603&#x2013;609. doi: 10.1093/aje/kwt019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwt019</ArticleId><ArticleId IdType="pubmed">23690249</ArticleId></ArticleIdList></Reference><Reference><Citation>Jelenkovic A, Sund R, Hur YM, Yokoyama Y, Hjelmborg JB, M&#xf6;ller S, et al. Genetic and environmental influences on height from infancy to early adulthood: an individual-based pooled analysis of 45 twin cohorts. Sci Rep. 2016;6(1):1&#x2013;13. doi: 10.1038/srep28496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep28496</ArticleId><ArticleId IdType="pmc">PMC4917845</ArticleId><ArticleId IdType="pubmed">27333805</ArticleId></ArticleIdList></Reference><Reference><Citation>Heuch I, Heuch I, Hagen K, Zwart JA. Association between body height and chronic low back pain: a follow-up in the Nord-Tr&#xf8;ndelag Health Study. BMJ Open. 2015;5(6):e006983&#x2013;e. doi: 10.1136/bmjopen-2014-006983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2014-006983</ArticleId><ArticleId IdType="pmc">PMC4480023</ArticleId><ArticleId IdType="pubmed">26078308</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L, Nicholson P, Wang Q, Al&#xe9;n M, Cheng S. Bone and muscle development during puberty in girls: a seven-year longitudinal study. J Bone Miner Res. 2009;24(10):1693&#x2013;1698. doi: 10.1359/jbmr.090405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1359/jbmr.090405</ArticleId><ArticleId IdType="pubmed">19419294</ArticleId></ArticleIdList></Reference><Reference><Citation>Gualdi-Russo E, Toselli S, Masotti S, Marzouk D, Sundquist K, Sundquist J. Health, growth and psychosocial adaptation of immigrant children. Eur J Pub Health. 2014;24 Suppl 1(suppl 1):16&#x2013;25. doi: 10.1093/eurpub/cku107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurpub/cku107</ArticleId><ArticleId IdType="pubmed">25107994</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen J, Meder I. Better health for mother and child - the Danish National Birth Cohort (DNBC), its structure, history and aims. Nor Epidemiol. 2014;24(1&#x2013;2):37&#x2013;38.</Citation></Reference><Reference><Citation>Jensen VM, Rasmussen AW. Danish education registers. Scand J Public Health. 2011;39(7 Suppl):91&#x2013;94. doi: 10.1177/1403494810394715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1403494810394715</ArticleId><ArticleId IdType="pubmed">21775362</ArticleId></ArticleIdList></Reference><Reference><Citation>Bliddal M, Broe A, Pottegard A, Olsen J, Langhoff-Roos J. The Danish medical birth register. Eur J Epidemiol. 2018;33(1):27&#x2013;36. doi: 10.1007/s10654-018-0356-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-018-0356-1</ArticleId><ArticleId IdType="pubmed">29349587</ArticleId></ArticleIdList></Reference><Reference><Citation>Freedman DS, Lawman HG, Skinner AC, McGuire LC, Allison DB, Ogden CL. Validity of the WHO cutoffs for biologically implausible values of weight, height, and BMI in children and adolescents in NHANES from 1999 through 2012. Am J Clin Nutr. 2015;102(5):1000&#x2013;1006. doi: 10.3945/ajcn.115.115576.</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/ajcn.115.115576</ArticleId><ArticleId IdType="pmc">PMC4631693</ArticleId><ArticleId IdType="pubmed">26377160</ArticleId></ArticleIdList></Reference><Reference><Citation>Vidmar SI, Cole TJ, Pan H. Standardizing anthropometric measures in children and adolescents with functions for egen: update. Stata J. 2013;13(2):366&#x2013;378. doi: 10.1177/1536867X1301300211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1536867X1301300211</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauridsen HH, Hestbaek L. Development of the young spine questionnaire. BMC Musculoskelet Disord. 2013;14:185. doi: 10.1186/1471-2474-14-185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2474-14-185</ArticleId><ArticleId IdType="pmc">PMC3689606</ArticleId><ArticleId IdType="pubmed">23758965</ArticleId></ArticleIdList></Reference><Reference><Citation>Hicks CL, von Baeyer CL, Spafford PA, van Korlaar I, Goodenough B. The faces pain scale-revised: toward a common metric in pediatric pain measurement. Pain. 2001;93(2):173&#x2013;183. doi: 10.1016/S0304-3959(01)00314-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0304-3959(01)00314-1</ArticleId><ArticleId IdType="pubmed">11427329</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones KR, Vojir CP, Hutt E, Fink R. Determining mild, moderate, and severe pain equivalency across pain-intensity tools in nursing home residents. J Rehabil Res Dev. 2007;44(2):305&#x2013;314. doi: 10.1682/JRRD.2006.05.0051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1682/JRRD.2006.05.0051</ArticleId><ArticleId IdType="pubmed">17551881</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenland S, Pearl J, Robins JM. Causal diagrams for epidemiologic research. Epidemiology. 1999;10(1):37&#x2013;48. doi: 10.1097/00001648-199901000-00008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001648-199901000-00008</ArticleId><ArticleId IdType="pubmed">9888278</ArticleId></ArticleIdList></Reference><Reference><Citation>ISCED . International Standard Classification of Education ISCED 2011. Montreal: UNESCO Institute for Statistics; 2012.</Citation></Reference><Reference><Citation>Baadsgaard M, Quitzau J. Danish registers on personal income and transfer payments. Scand J Public Health. 2011;39(7 Suppl):103&#x2013;105. doi: 10.1177/1403494811405098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1403494811405098</ArticleId><ArticleId IdType="pubmed">21775365</ArticleId></ArticleIdList></Reference><Reference><Citation>OECD. OECD Project on Income Distribution and Poverty. What are the equivalence scales? : Organization for Economic Cooperation and Development. Available from: http://www.oecd.org/eco/growth/OECD-Note-EquivalenceScales.pdf. Cited 2018 19 September.</Citation></Reference><Reference><Citation>Aksglaede L, Olsen LW, S&#xf8;rensen TIA, Juul A. Forty years trends in timing of pubertal growth spurt in 157,000 Danish school children. PLoS One. 2008;3(7):e2728&#x2013;e. doi: 10.1371/journal.pone.0002728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0002728</ArticleId><ArticleId IdType="pmc">PMC2443288</ArticleId><ArticleId IdType="pubmed">18628945</ArticleId></ArticleIdList></Reference><Reference><Citation>Vach W. Regression models as a tool in medical statistics. Boca Raton: Chapman and Hall/CRC; 2013.</Citation></Reference><Reference><Citation>Seaman SR, White IR. Review of inverse probability weighting for dealing with missing data. Stat Methods Med Res. 2013;22(3):278&#x2013;295. doi: 10.1177/0962280210395740.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0962280210395740</ArticleId><ArticleId IdType="pubmed">21220355</ArticleId></ArticleIdList></Reference><Reference><Citation>Molenberghs G, Fitzmaurice G, Kenward MG, Tsiatis A, Verbeke G. Handbook of Missing Data Methodology. 1st edition. Chapman and Hall/CRC; 2014. 10.1201/b17622.</Citation></Reference><Reference><Citation>Tu YK, Tilling K, Sterne JAC, Gilthorpe MS. A critical evaluation of statistical approaches to examining the role of growth trajectories in the developmental origins of health and disease. Int J Epidemiol. 2013;42(5):1327&#x2013;1339. doi: 10.1093/ije/dyt157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyt157</ArticleId><ArticleId IdType="pubmed">24038715</ArticleId></ArticleIdList></Reference><Reference><Citation>Huguet A, Tougas ME, Hayden J, McGrath PJ, Stinson JN, Chambers CT. Systematic review with meta-analysis of childhood and adolescent risk and prognostic factors for musculoskeletal pain. Pain. 2016;157(12):2640&#x2013;2656. doi: 10.1097/j.pain.0000000000000685.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000000685</ArticleId><ArticleId IdType="pubmed">27525834</ArticleId></ArticleIdList></Reference><Reference><Citation>Hebert JJ, Leboeuf-Yde C, Franz C, Lardon A, Hestb&#xe6;k L, Manson N, et al. Pubertal development and growth are prospectively associated with spinal pain in young people (CHAMPS study-DK) Eur Spine J. 2019;28(7):1565&#x2013;1571. doi: 10.1007/s00586-019-05905-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00586-019-05905-6</ArticleId><ArticleId IdType="pubmed">30740638</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhee H. Relationships between physical symptoms and pubertal development. J Pediatr Health care. 2005;19(2):95&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pubmed">15750554</ArticleId></ArticleIdList></Reference><Reference><Citation>Wedderkopp N, Andersen LB, Froberg K, Leboeuf-Yde C. Back pain reporting in young girls appears to be puberty-related. BMC Musculoskelet Disord. 2005;6(1):52. doi: 10.1186/1471-2474-6-52.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2474-6-52</ArticleId><ArticleId IdType="pmc">PMC1291369</ArticleId><ArticleId IdType="pubmed">16262898</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundblad GMB, Saartok T, Engstrom LM. Prevalence and co-occurrence of self-rated pain and perceived health in school-children: age and gender differences. Eur J Pain. 2007;11(2):171&#x2013;180. doi: 10.1016/j.ejpain.2006.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejpain.2006.02.006</ArticleId><ArticleId IdType="pubmed">16542860</ArticleId></ArticleIdList></Reference><Reference><Citation>Janssens KA, Rosmalen JG, Ormel J, Verhulst FC, Hunfeld JA, Mancl LA, et al. Pubertal status predicts back pain, overtiredness, and dizziness in American and Dutch adolescents. Pediatrics. 2011;128(3):553&#x2013;559. doi: 10.1542/peds.2010-2364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2010-2364</ArticleId><ArticleId IdType="pmc">PMC3164091</ArticleId><ArticleId IdType="pubmed">21807699</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry M, Straker L, O&#x2019;Sullivan P, Smith A, Hands B. Fitness, motor competence, and body composition are weakly associated with adolescent back pain. J Orthop Sports Phys Ther. 2009;39(6):439&#x2013;449. doi: 10.2519/jospt.2009.3011.</Citation><ArticleIdList><ArticleId IdType="doi">10.2519/jospt.2009.3011</ArticleId><ArticleId IdType="pubmed">19487825</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi I, Kikuchi SI, Sato K, Iwabuchi M. Effects of the mechanical load on forward bending motion of the trunk: comparison between patients with motion-induced intermittent low back pain and healthy subjects. Spine (Phila Pa 1976) 2007;32(2):E73&#x2013;E78. doi: 10.1097/01.brs.0000252203.16357.9a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.brs.0000252203.16357.9a</ArticleId><ArticleId IdType="pubmed">17224802</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyrrell J, Jones SE, Beaumont R, Astley CM, Lovell R, Yaghootkar H, et al. Height, body mass index, and socioeconomic status: mendelian randomisation study in UK Biobank. BMJ. 2016;352:i582&#x2013;i. doi: 10.1136/bmj.i582.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.i582</ArticleId><ArticleId IdType="pmc">PMC4783516</ArticleId><ArticleId IdType="pubmed">26956984</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitley E, Martin RM, Davey Smith G, Holly JMP, Gunnell D. The association of childhood height, leg length and other measures of skeletal growth with adult cardiovascular disease: the Boyd-Orr cohort. J Epidemiol Community Health. 2012;66(1):18&#x2013;23. doi: 10.1136/jech.2009.104216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jech.2009.104216</ArticleId><ArticleId IdType="pubmed">20736489</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith GD, Hart C, Upton M, Hole D, Gillis C, Watt G, et al. Height and risk of death among men and women: aetiological implications of associations with cardiorespiratory disease and cancer mortality. J Epidemiol Community Health. 2000;54(2):97&#x2013;103. doi: 10.1136/jech.54.2.97.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jech.54.2.97</ArticleId><ArticleId IdType="pmc">PMC1731616</ArticleId><ArticleId IdType="pubmed">10715741</ArticleId></ArticleIdList></Reference><Reference><Citation>Lash T, VanderWeele T, Rothman K. Measurement and measurement error. In: Zinner S, editor. Modern epidemiology. 4. Mexico: Wolters Kluwer; 2021. pp. 287&#x2013;314.</Citation></Reference><Reference><Citation>Aksglaede L, Juul A, Olsen LW, S&#xf8;rensen TIA. Age at puberty and the emerging obesity epidemic. PLoS One. 2009;4(12):e8450&#x2013;e. doi: 10.1371/journal.pone.0008450.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0008450</ArticleId><ArticleId IdType="pmc">PMC2793517</ArticleId><ArticleId IdType="pubmed">20041184</ArticleId></ArticleIdList></Reference><Reference><Citation>Heuch I, Heuch I, Hagen K, Zwart J-A. Body mass index as a risk factor for developing chronic low back pain: a follow-up in the Nord-Tr&#xf8;ndelag Health Study. Spine. 2013;38(2):133&#x2013;139. doi: 10.1097/BRS.0b013e3182647af2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BRS.0b013e3182647af2</ArticleId><ArticleId IdType="pubmed">22718225</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobsen T, Nohr E, Frydenberg M. Selection by socioeconomic factors into the Danish National Birth Cohort. Eur J Epidemiol. 2010;25(5):349&#x2013;355. doi: 10.1007/s10654-010-9448-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-010-9448-2</ArticleId><ArticleId IdType="pubmed">20349116</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizzi C, De Stavola B, Merletti F, Bellocco R, dos Santos Silva I, Pearce N, et al. Sample selection and validity of exposure-disease association estimates in cohort studies. J Epidemiol Commun Health. 2011;65(5):407&#x2013;411. doi: 10.1136/jech.2009.107185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jech.2009.107185</ArticleId><ArticleId IdType="pubmed">20881022</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33956562</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>03</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1525-6065</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Hypertension in pregnancy</Title><ISOAbbreviation>Hypertens Pregnancy</ISOAbbreviation></Journal><ArticleTitle>Interleukin-1&#x3b2; and uric acid as potential second-trimester predictive biomarkers of preeclampsia.</ArticleTitle><Pagination><StartPage>186</StartPage><EndPage>192</EndPage><MedlinePgn>186-192</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/10641955.2021.1921793</ELocationID><Abstract><AbstractText><b>Methods:</b> The prospective study was conducted at the University Hospital from February 2020 to December 2020. The study population (n = 88) included women who later developed PE (n = 42), as well as women who were healthy at birth (n = 46) in the second trimester of pregnancy. Serum levels of CRP, IL-1&#x3b2;, uric acid, creatinine, AST, ALT, MPV, Hb, PC, vitamin D, Ca, and Mg were compared between the groups.<b>Results:</b> Serum IL-1&#x3b2; and uric acid levels were significantly higher in subjects who eventually developed PE compared with those who did not.<b>Conclusions:</b> IL-1&#x3b2; and uric acid may be a predictive markers for PE. Maternal serum IL-1&#x3b2; and uric acid levels in the second trimester of pregnancy may be a predictive markers for PE.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dogan</LastName><ForeName>Keziban</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>University of Health Sciences, Bakirk&#xf6;y Dr. Sadi Konuk Training and Research Hospital, Department of Obstetrics and Gynecology, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kural</LastName><ForeName>Alev</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Health Sciences, Bakirk&#xf6;y Dr. Sadi Konuk Training and Research Hospital, Department of Biochemistry, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oztoprak</LastName><ForeName>Yasin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>University of Health Sciences, Bakirk&#xf6;y Dr. Sadi Konuk Training and Research Hospital, Department of Obstetrics and Gynecology, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dogan</LastName><ForeName>Murat</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Health Sciences, Bakirk&#xf6;y Dr. Sadi Konuk Training and Research Hospital, Department of Anesthesia and Reanimation Clinics, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Hypertens Pregnancy</MedlineTA><NlmUniqueID>9421297</NlmUniqueID><ISSNLinking>1064-1955</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053583">Interleukin-1beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>1406-16-2</RegistryNumber><NameOfSubstance UI="D014807">Vitamin D</NameOfSubstance></Chemical><Chemical><RegistryNumber>268B43MJ25</RegistryNumber><NameOfSubstance UI="D014527">Uric Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-41-4</RegistryNumber><NameOfSubstance UI="D002097">C-Reactive Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>I38ZP9992A</RegistryNumber><NameOfSubstance UI="D008274">Magnesium</NameOfSubstance></Chemical><Chemical><RegistryNumber>SY7Q814VUP</RegistryNumber><NameOfSubstance UI="D002118">Calcium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002097" MajorTopicYN="N">C-Reactive Protein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002118" MajorTopicYN="N">Calcium</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053583" MajorTopicYN="N">Interleukin-1beta</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008274" MajorTopicYN="N">Magnesium</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011225" MajorTopicYN="N">Pre-Eclampsia</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011262" MajorTopicYN="N">Pregnancy Trimester, Second</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014527" MajorTopicYN="N">Uric Acid</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014807" MajorTopicYN="N">Vitamin D</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRP</Keyword><Keyword MajorTopicYN="N">MPV</Keyword><Keyword MajorTopicYN="N">Preeclampsia</Keyword><Keyword MajorTopicYN="N">calcium</Keyword><Keyword MajorTopicYN="N">interleukin-1&#x3b2;</Keyword><Keyword MajorTopicYN="N">magnesium</Keyword><Keyword MajorTopicYN="N">uric acid</Keyword><Keyword MajorTopicYN="N">vitamin D</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>6</Day><Hour>17</Hour><Minute>46</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33956562</ArticleId><ArticleId IdType="doi">10.1080/10641955.2021.1921793</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37829955</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Discussing the Prognosis and Complications of Transvenous Lead Extraction in Patients With Cardiac Implantable Electronic Devices (CIED): A Systematic Review.</ArticleTitle><Pagination><StartPage>e45048</StartPage><MedlinePgn>e45048</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e45048</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.45048</ELocationID><Abstract><AbstractText>An increase in cardiovascular implantable electronic devices (CIEDs) and undoubtedly the complications brought on by these devices coincide with an increase in cardiovascular disorders, particularly heart rhythm abnormalities. The safest procedure to extract these devices is transvenous lead extraction (TLE). Thus, this systematic review aimed to summarize the possibility of success rates and the common complications that could arise during the surgery. Full-text publications in PubMed, MEDLINE, PubMed Central (PMC), and ScienceDirect were used in this study, which was conducted using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Seventeen studies were reviewed for this systematic review after being screened by title, abstract, full-text availability, and quality appraisal assessment. Heart and vascular tears, along with tricuspid regurgitation (TR), are common adverse events. Pulmonary embolism, hemothorax, hemopericardium, and ghost appearance in echo are less common consequences. In addition, the longer the dwelling time of the leads, the greater the chance of infection due to an increase in lead adhesions and fibrous tissue that has made the procedure unsafe as time passes. However, we concluded that TLE is a successful method across all age groups with an excellent probability of clinical and procedural success&#xa0;in a majority of studies.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023, Salib et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Salib</LastName><ForeName>Korlos</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Internal Medicine, California Institute of Behavioral Neurosciences &amp; Psychology, Fairfield, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dardari</LastName><ForeName>Lana</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Internal Medicine, California Institute of Behavioral Neurosciences &amp; Psychology, Fairfield, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taha</LastName><ForeName>Maher</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Internal Medicine, California Institute of Behavioral Neurosciences &amp; Psychology, Fairfield, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dahat</LastName><ForeName>Purva</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Internal Medicine, California Institute of Behavioral Neurosciences &amp; Psychology, Fairfield, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toriola</LastName><ForeName>Stacy</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Pathology, California Institute of Behavioral Neurosciences &amp; Psychology, Fairfield, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Satnarine</LastName><ForeName>Travis</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Pediatrics, California Institute of Behavioral Neurosciences &amp; Psychology, Fairfield, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zohara</LastName><ForeName>Zareen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Internal Medicine, California Institute of Behavioral Neurosciences &amp; Psychology, Fairfield, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adelekun</LastName><ForeName>Ademiniyi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Family Medicine, California Institute of Behavioral Neurosciences &amp; Psychology, Fairfield, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seffah</LastName><ForeName>Kofi D</ForeName><Initials>KD</Initials><AffiliationInfo><Affiliation>Internal Medicine, California Institute of Behavioral Neurosciences &amp; Psychology, Fairfield, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Internal Medicine, Piedmont Athens Regional Medical, Athens, GRC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Safeera</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Internal Medicine, California Institute of Behavioral Neurosciences &amp; Psychology, Fairfield, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiac implantable electronic devices</Keyword><Keyword MajorTopicYN="N">complications</Keyword><Keyword MajorTopicYN="N">defibrillator</Keyword><Keyword MajorTopicYN="N">implantable pacemakers</Keyword><Keyword MajorTopicYN="N">prognosis</Keyword><Keyword MajorTopicYN="N">transvenous lead extraction</Keyword></KeywordList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>13</Day><Hour>6</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>13</Day><Hour>6</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>13</Day><Hour>4</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37829955</ArticleId><ArticleId IdType="pmc">PMC10565517</ArticleId><ArticleId IdType="doi">10.7759/cureus.45048</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Predictors of long-term survival free from relapses after extraction of infected CIED. Diemberger I, Biffi M, Lorenzetti S, et al. Europace. 2018;20:1018&#x2013;1027.</Citation><ArticleIdList><ArticleId IdType="pubmed">29016771</ArticleId></ArticleIdList></Reference><Reference><Citation>From lead management to implanted patient management: indications to lead extraction in pacemaker and cardioverter-defibrillator systems. Diemberger I, Biffi M, Martignani C, Boriani G. Expert Rev Med Devices. 2011;8:235&#x2013;255.</Citation><ArticleIdList><ArticleId IdType="pubmed">21381913</ArticleId></ArticleIdList></Reference><Reference><Citation>Efficacy and safety of transvenous lead extraction in 108 consecutive patients: a single-centre experience. Monsefi N, Waraich HS, Vamos M, Erath J, Sirat S, Moritz A, Hohnloser SH. Interact Cardiovasc Thorac Surg. 2019;28:704&#x2013;708.</Citation><ArticleIdList><ArticleId IdType="pubmed">30597017</ArticleId></ArticleIdList></Reference><Reference><Citation>Experience of cardiac implantable electronic device lead removal from a South African tertiary referral centre. Mkoko P, Mdakane NX, Govender G, Scherman J, Chin A. Cardiovasc J Afr. 2021;32:193&#x2013;197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8756057</ArticleId><ArticleId IdType="pubmed">33950067</ArticleId></ArticleIdList></Reference><Reference><Citation>2018 EHRA expert consensus statement on lead extraction: recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries: endorsed by APHRS/HRS/LAHRS. Bongiorni MG, Burri H, Deharo JC, et al. Europace. 2018;20:1217.</Citation><ArticleIdList><ArticleId IdType="pubmed">29566158</ArticleId></ArticleIdList></Reference><Reference><Citation>[Removal of infected entrapped pacemaker electrodes by continuous traction (author's transl)] Schmidt G, Wirtzfeld A, Himmler FC, Klein G, Alt E, Seidl KF, Pr&#xe4;uer HW. Dtsch Med Wochenschr. 1980;105:1609&#x2013;1614.</Citation><ArticleIdList><ArticleId IdType="pubmed">7439041</ArticleId></ArticleIdList></Reference><Reference><Citation>Risk factors predicting complications of transvenous lead extraction. Jache&#x107; W, Polewczyk A, Polewczyk M, Tomasik A, Janion M, Kutarski A. Biomed Res Int. 2018;2018:8796704.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6312591</ArticleId><ArticleId IdType="pubmed">30662917</ArticleId></ArticleIdList></Reference><Reference><Citation>Extraction of pacemaker and implantable cardioverter defibrillator leads: a single-centre study of electrosurgical and laser extraction. Scott PA, Chow W, Ellis E, Morgan JM, Roberts PR. Europace. 2009;11:1501&#x2013;1504.</Citation><ArticleIdList><ArticleId IdType="pubmed">19797252</ArticleId></ArticleIdList></Reference><Reference><Citation>Advanced techniques for chronic lead extraction: heading from the laser towards the evolution system. Mazzone P, Tsiachris D, Marzi A, et al. Europace. 2013;15:1771&#x2013;1776.</Citation><ArticleIdList><ArticleId IdType="pubmed">23645529</ArticleId></ArticleIdList></Reference><Reference><Citation>Initial experience with the TightRail&#x2122; Rotating Mechanical Dilator Sheath for transvenous lead extraction. Aytemir K, Yorgun H, Canpolat U, &#x15e;ahiner ML, Kaya EB, Evranos B, &#xd6;zer N. Europace. 2016;18:1043&#x2013;1048.</Citation><ArticleIdList><ArticleId IdType="pubmed">26467403</ArticleId></ArticleIdList></Reference><Reference><Citation>A 37-year-old woman with hypertrophic cardiomyopathy with a dual-chamber implantable cardioverter-defibrillator requiring percutaneous transvenous lead extraction and multidisciplinary management. Dhawan R, Khan F, Samant S, Asawaeer M, Merritt Genore H, Erickson CC. Am J Case Rep. 2021;22:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8546269</ArticleId><ArticleId IdType="pubmed">34675166</ArticleId></ArticleIdList></Reference><Reference><Citation>Safety and in-hospital outcomes of transvenous lead extraction for cardiac implantable device-related infections: analysis of 13 years of inpatient data in the United States. Hosseini SM, Rozen G, Kaadan MI, Galvin J, Ruskin JN. JACC Clin Electrophysiol. 2019;5:1450&#x2013;1458.</Citation><ArticleIdList><ArticleId IdType="pubmed">31857046</ArticleId></ArticleIdList></Reference><Reference><Citation>Analysis of outcomes in 8304 patients undergoing lead extraction for infection. Aleong RG, Zipse MM, Tompkins C, Aftab M, Varosy P, Sauer W, Kao D. J Am Heart Assoc. 2020;9:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7428595</ArticleId><ArticleId IdType="pubmed">32192410</ArticleId></ArticleIdList></Reference><Reference><Citation>Efficacy and safety of transvenous lead extraction in the Chinese octogenarian patients. Zhou X, Ze F, Li X, Wang B. Clin Cardiol. 2021;44:971&#x2013;977.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8259144</ArticleId><ArticleId IdType="pubmed">34137040</ArticleId></ArticleIdList></Reference><Reference><Citation>Transvenous laser lead extraction in patients with congenital complete heart block. Darden D, Boateng BA, Tseng AS, Alshawabkeh L, Pollema T, Cha YM, Birgersdotter-Green U. Heart Rhythm. 2022;19:1158&#x2013;1164.</Citation><ArticleIdList><ArticleId IdType="pubmed">35257976</ArticleId></ArticleIdList></Reference><Reference><Citation>Infections and associated costs following cardiovascular implantable electronic device implantations: a nationwide cohort study. Cl&#xe9;menty N, Carion PL, L&#xe9;otoing L, et al. Europace. 2018;20:1974&#x2013;1980.</Citation><ArticleIdList><ArticleId IdType="pubmed">29672690</ArticleId></ArticleIdList></Reference><Reference><Citation>Real-world costs of transvenous lead extraction: the challenge for reimbursement. Brough CE, Rao A, Haycox AR, Cowie MR, Wright DJ. Europace. 2019;21:290&#x2013;297.</Citation><ArticleIdList><ArticleId IdType="pubmed">30590458</ArticleId></ArticleIdList></Reference><Reference><Citation>The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Page MJ, McKenzie JE, Bossuyt PM, et al. BMJ. 2021;372:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8008539</ArticleId><ArticleId IdType="pubmed">33781348</ArticleId></ArticleIdList></Reference><Reference><Citation>A study of major and minor complications of 1500 transvenous lead extraction procedures performed with optimal safety at two high-volume referral centers. Tu&#x142;ecki &#x141;, Polewczyk A, Jache&#x107; W, et al. Int J Environ Res Public Health. 2021;18</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8508178</ArticleId><ArticleId IdType="pubmed">34639716</ArticleId></ArticleIdList></Reference><Reference><Citation>Atrial fibrillation and transvenous lead extraction-a comprehensive subgroup analysis of the GermAn Laser Lead Extraction RegistrY (GALLERY) Chung DU, Pecha S, Burger H, et al. Medicina (Kaunas) 2022;58</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9697767</ArticleId><ArticleId IdType="pubmed">36422224</ArticleId></ArticleIdList></Reference><Reference><Citation>Safety and efficacy of transvenous lead extraction in octogenarians using powered extraction sheaths. Burger H, Hakmi S, Petersen J, et al. Pacing Clin Electrophysiol. 2021;44:601&#x2013;606.</Citation><ArticleIdList><ArticleId IdType="pubmed">33594705</ArticleId></ArticleIdList></Reference><Reference><Citation>Mechanical extraction of implantable cardioverter-defibrillator leads with a dwell time of more than 10 years: insights from a single high-volume centre. Z&#x105;bek A, Boczar K, Ulman M, et al. Europace. 2023;25:1100&#x2013;1109.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10062326</ArticleId><ArticleId IdType="pubmed">36660771</ArticleId></ArticleIdList></Reference><Reference><Citation>Procedural outcomes associated with transvenous lead extraction in patients with abandoned leads: an ESC-EHRA ELECTRa (European Lead Extraction ConTRolled) Registry Sub-Analysis. Segreti L, Rinaldi CA, Claridge S, et al. Europace. 2019;21:645&#x2013;654.</Citation><ArticleIdList><ArticleId IdType="pubmed">30624715</ArticleId></ArticleIdList></Reference><Reference><Citation>Indications for transvenous lead extraction and its procedural and early outcomes in elderly patients: a single-center experience. Z&#x105;bek A, Boczar K, D&#x119;bski M, et al. Pol Arch Intern Med. 2020;130:216&#x2013;224.</Citation><ArticleIdList><ArticleId IdType="pubmed">32041927</ArticleId></ArticleIdList></Reference><Reference><Citation>Transvenous extraction of pacemaker and defibrillator leads and the risk&#xa0;of&#xa0;tricuspid valve regurgitation. Park SJ, Gentry JL 3rd, Varma N, et al. JACC Clin Electrophysiol. 2018;4:1421&#x2013;1428.</Citation><ArticleIdList><ArticleId IdType="pubmed">30466846</ArticleId></ArticleIdList></Reference><Reference><Citation>Tricuspid valve damage related to transvenous lead extraction. Polewczyk A, Jache&#x107; W, Nowosielecka D, et al. Int J Environ Res Public Health. 2022;19</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9566121</ArticleId><ArticleId IdType="pubmed">36231579</ArticleId></ArticleIdList></Reference><Reference><Citation>"Ghost", a well-known but not fully explained echocardiographic finding during transvenous lead extraction: clinical significance. Nowosielecka D, Jache&#x107; W, Polewczyk A, Tu&#x142;ecki &#x141;, Stefa&#x144;czyk P, Kutarski A. Int J Environ Res Public Health. 2022;19</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9565986</ArticleId><ArticleId IdType="pubmed">36231841</ArticleId></ArticleIdList></Reference><Reference><Citation>Safety and efficacy of transvenous lead extraction of very old leads. Pecha S, Ziegelhoeffer T, Yildirim Y, et al. Interact Cardiovasc Thorac Surg. 2021;32:402&#x2013;407.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8906697</ArticleId><ArticleId IdType="pubmed">33257960</ArticleId></ArticleIdList></Reference><Reference><Citation>Rare complications of pseudoaneurysms of the superior vena cava after transvenous lead extraction. Hayashi T, Tobita K, Miyashita H, Moriyama N, Murakami M, Saito S. JACC Case Rep. 2022;4:443&#x2013;448.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9175205</ArticleId><ArticleId IdType="pubmed">35693895</ArticleId></ArticleIdList></Reference><Reference><Citation>Disseminated intravascular coagulation as a complication after transvenous lead extraction for defibrillator-associated endocarditis: a case report. Dunn H, Foreman BW. HeartRhythm Case Rep. 2022;8:330&#x2013;334.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9123309</ArticleId><ArticleId IdType="pubmed">35607341</ArticleId></ArticleIdList></Reference><Reference><Citation>A ghost left behind after transvenous lead extraction: a finding to be feared. El-Zein RS, Stelzer M, Hatanelas J, Goodlive TW, Amin AK. Am J Case Rep. 2020;21:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7414831</ArticleId><ArticleId IdType="pubmed">32713936</ArticleId></ArticleIdList></Reference><Reference><Citation>Long-term mortality after transvenous lead extraction. Maytin M, Jones SO, Epstein LM. Circ Arrhythm Electrophysiol. 2012;5:252&#x2013;257.</Citation><ArticleIdList><ArticleId IdType="pubmed">22362891</ArticleId></ArticleIdList></Reference><Reference><Citation>Major cardiac and vascular complications after transvenous lead extraction: acute outcome and predictive factors from the ESC-EHRA ELECTRa (European Lead Extraction ConTRolled) registry. Zucchelli G, Di Cori A, Segreti L, et al. Europace. 2019;21:771&#x2013;780.</Citation><ArticleIdList><ArticleId IdType="pubmed">30590520</ArticleId></ArticleIdList></Reference><Reference><Citation>Risk of venous occlusion after lead laser extraction preventing future lead implantation. Al-Maisary S, Kremer J, Romano G, Karck M, De Simone R. J Cardiothorac Surg. 2021;16:321.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8557546</ArticleId><ArticleId IdType="pubmed">34717698</ArticleId></ArticleIdList></Reference><Reference><Citation>The encapsulation of polyurethane-insulated transvenous cardiac pacemaker leads. Stokes K, Anderson J, McVenes R, McClay C. Cardiovasc Pathol. 1995;4:163&#x2013;171.</Citation><ArticleIdList><ArticleId IdType="pubmed">25851004</ArticleId></ArticleIdList></Reference><Reference><Citation>Morphologic and immunohistochemical observations of tissues surrounding retrieved transvenous pacemaker leads. Esposito M, Kennergren C, Holmstr&#xf6;m N, Nilsson S, Eckerdal J, Thomsen P. J Biomed Mater Res. 2002;63:548&#x2013;558.</Citation><ArticleIdList><ArticleId IdType="pubmed">12209900</ArticleId></ArticleIdList></Reference><Reference><Citation>The prognostic value of transesophageal echocardiography after transvenous lead extraction: landscape after battle. Nowosielecka D, Jache&#x107; W, Polewczyk A, Kleinrok A, Tu&#x142;ecki &#x141;, Kutarski A. Cardiovasc Diagn Ther. 2021;11:394&#x2013;410.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8102270</ArticleId><ArticleId IdType="pubmed">33968618</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35189949</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>13</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>24</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1750-1172</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Feb</Month><Day>21</Day></PubDate></JournalIssue><Title>Orphanet journal of rare diseases</Title><ISOAbbreviation>Orphanet J Rare Dis</ISOAbbreviation></Journal><ArticleTitle>Natural history of respiratory muscle strength in spinal muscular atrophy: a prospective national cohort study.</ArticleTitle><Pagination><StartPage>70</StartPage><MedlinePgn>70</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">70</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13023-022-02227-7</ELocationID><Abstract><AbstractText Label="BACKGROUND">Respiratory complications are the most important cause of morbidity and mortality in spinal muscular atrophy (SMA). Respiratory muscle weakness results in impaired cough, recurrent respiratory tract infections and eventually can cause respiratory failure. We assessed longitudinal patterns of respiratory muscle strength in a national cohort of treatment-na&#xef;ve children and adults with SMA, hypothesizing a continued decline throughout life.</AbstractText><AbstractText Label="METHODS">We measured maximal expiratory and inspiratory pressure (PE<sub>max</sub> and PI<sub>max</sub>), Sniff Nasal inspiratory pressure (SNIP), peak expiratory flow (PEF), and peak cough flow (PCF) in treatment-na&#xef;ve patients with SMA. We used mixed-models to analyze natural history patterns.</AbstractText><AbstractText Label="RESULTS">We included 2172 measurements of respiratory muscle function from 80 treatment-na&#xef;ve patients with SMA types 1c-3b. All outcomes were lower in the more severe phenotypes. Significant differences in PEF were present between SMA types from early ages onwards. PEF decline was linear (1-2%/year). PEF reached values below 80% during early childhood in types 1c-2, and during adolescence in type 3a. PE<sub>max</sub> and PI<sub>max</sub> were severely lowered in most patients throughout life, with PE<sub>max</sub> values abnormally low (i.e. &lt;&#x2009;80 cmH<sub>2</sub>O) in virtually all patients. The PE<sub>max</sub>/PI<sub>max</sub> ratio was &lt;&#x2009;1 throughout life in all SMA types, indicating that expiratory muscles were most affected. All but SMA type 3b patients had a lowered PCF. Patients with types 2b and 3a had PCF levels between 160 and 270&#xa0;L/min, those with type 2a around 160&#xa0;L/min and patients with type 1c well below 160&#xa0;L/min. Finally, SNIP was low in nearly all patients, most pronounced in more severely affected patients.</AbstractText><AbstractText Label="CONCLUSIONS">There are clear differences in respiratory muscle strength and its progressive decline between SMA types. We observed lower outcomes in more severe SMA types. Particularly PEF may be a suitable outcome measure for the follow-up of respiratory strength in patients with SMA. PEF declines in a rather linear pattern in all SMA types, with clear differences at baseline. These natural history data may serve as a reference for longer-term treatment efficacy assessments.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Veldhoen</LastName><ForeName>Esther S</ForeName><Initials>ES</Initials><Identifier Source="ORCID">0000-0003-2918-9989</Identifier><AffiliationInfo><Affiliation>Department of Pediatric Intensive Care, University Medical Center Utrecht, Wilhelmina Children's Hospital, Utrecht University, PO box 85090, 3508 AB, Utrecht, The Netherlands. E.S.Veldhoen@umcutrecht.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Wijngaarde</LastName><ForeName>Camiel A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hulzebos</LastName><ForeName>Erik H J</ForeName><Initials>EHJ</Initials><AffiliationInfo><Affiliation>Child Development and Exercise Center, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>W&#xf6;sten-van Asperen</LastName><ForeName>Roelie M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Department of Pediatric Intensive Care, University Medical Center Utrecht, Wilhelmina Children's Hospital, Utrecht University, PO box 85090, 3508 AB, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wadman</LastName><ForeName>Renske I</ForeName><Initials>RI</Initials><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Eijk</LastName><ForeName>Ruben P A</ForeName><Initials>RPA</Initials><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biostatistics and Research Support, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asselman</LastName><ForeName>Fay Lynn</ForeName><Initials>FL</Initials><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stam</LastName><ForeName>Marloes</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Otto</LastName><ForeName>Louise A M</ForeName><Initials>LAM</Initials><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cuppen</LastName><ForeName>Inge</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scheijmans</LastName><ForeName>Feline E V</ForeName><Initials>FEV</Initials><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>den Oudenrijn</LastName><ForeName>Laura P Verweij-van</ForeName><Initials>LPV</Initials><AffiliationInfo><Affiliation>Department of Pediatric Intensive Care, University Medical Center Utrecht, Wilhelmina Children's Hospital, Utrecht University, PO box 85090, 3508 AB, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bartels</LastName><ForeName>Bart</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Child Development and Exercise Center, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaytant</LastName><ForeName>Michael A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, Center of Home Mechanical Ventilation, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Ent</LastName><ForeName>Cornelis K</ForeName><Initials>CK</Initials><AffiliationInfo><Affiliation>Department of Pediatric Pulmonology, Wilhelmina Children's Hospital, Member of ERN-LUNG, University Medical Center Utrecht, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Pol</LastName><ForeName>W Ludo</ForeName><Initials>WL</Initials><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Orphanet J Rare Dis</MedlineTA><NlmUniqueID>101266602</NlmUniqueID><ISSNLinking>1750-1172</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003371" MajorTopicYN="N">Cough</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053580" MajorTopicYN="N">Muscle Strength</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009134" MajorTopicYN="Y">Muscular Atrophy, Spinal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012131" MajorTopicYN="Y">Respiratory Insufficiency</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012132" MajorTopicYN="N">Respiratory Muscles</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Lung function</Keyword><Keyword MajorTopicYN="N">Natural history</Keyword><Keyword MajorTopicYN="N">Neuromuscular</Keyword><Keyword MajorTopicYN="N">Respiratory muscle strength</Keyword><Keyword MajorTopicYN="N">Spinal muscular atrophy</Keyword></KeywordList><CoiStatement>W. Ludo van der Pol was member of the scientific advisory boards of Biogen and Avexis.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>22</Day><Hour>5</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>2</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35189949</ArticleId><ArticleId IdType="pmc">PMC8862532</ArticleId><ArticleId IdType="doi">10.1186/s13023-022-02227-7</ArticleId><ArticleId IdType="pii">10.1186/s13023-022-02227-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Finkel RS, Mercuri E, Meyer OH, Simonds AK, Schroth MK, Graham RJ, et al. Diagnosis and management of spinal muscular atrophy: Part 2: pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics. Neuromuscul Disord. 2018;28(3):197&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pubmed">29305137</ArticleId></ArticleIdList></Reference><Reference><Citation>Mercuri E, Bertini E, Iannaccone ST. Childhood spinal muscular atrophy: controversies and challenges. Lancet Neurol. 2012;11(5):443&#x2013;452.</Citation><ArticleIdList><ArticleId IdType="pubmed">22516079</ArticleId></ArticleIdList></Reference><Reference><Citation>Finkel RS, Mercuri E, Darras BT, Connolly AM, Kuntz NL, Kirschner J, et al. Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N Engl J Med. 2017;377(18):1723&#x2013;1732.</Citation><ArticleIdList><ArticleId IdType="pubmed">29091570</ArticleId></ArticleIdList></Reference><Reference><Citation>Mercuri E, Darras BT, Chiriboga CA, Day JW, Campbell C, Connolly AM, et al. Nusinersen versus sham control in later-onset spinal muscular atrophy. N Engl J Med. 2018;378(7):625&#x2013;635.</Citation><ArticleIdList><ArticleId IdType="pubmed">29443664</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendell JR, Al-Zaidy S, Shell R, Arnold WD, Rodino-Klapac LR, Prior TW, et al. Single-dose gene-replacement therapy for spinal muscular atrophy. N Engl J Med. 2017;377(18):1713&#x2013;1722.</Citation><ArticleIdList><ArticleId IdType="pubmed">29091557</ArticleId></ArticleIdList></Reference><Reference><Citation>Mercuri E, Finkel RS, Muntoni F, Wirth B, Montes J, Main M, et al. Diagnosis and management of spinal muscular atrophy: Part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscul Disord. 2018;28(2):103&#x2013;115.</Citation><ArticleIdList><ArticleId IdType="pubmed">29290580</ArticleId></ArticleIdList></Reference><Reference><Citation>Darras BT, De Vivo DC. Precious SMA natural history data: a benchmark to measure future treatment successes. Neurology. 2018;91(8):337&#x2013;339.</Citation><ArticleIdList><ArticleId IdType="pubmed">30045956</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijngaarde CA, Veldhoen ES, Van Eijk RPA, Stam M, Otto LAM, Asselman FL, et al. Natural history of lung function in spinal muscular atrophy. Orphanet J Rare Dis. 2020;15(1):88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7149916</ArticleId><ArticleId IdType="pubmed">32276635</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicot F, Hart N, Forin V, Le Boul&#xe9; M, Cl&#xe9;ment A, Polkey MI, et al. Respiratory muscle testing: a valuable tool for children with neuromuscular disorders. Am J Respir Crit Care Med. 2006;174(1):67&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">16574932</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroth MK. Special considerations in the respiratory management of spinal muscular atrophy. Pediatrics. 2009;123(S4):S245&#x2013;249.</Citation><ArticleIdList><ArticleId IdType="pubmed">19420154</ArticleId></ArticleIdList></Reference><Reference><Citation>Lissoni A, Aliverti A, Molteni F, Bach JR. Spinal muscular atrophy: kinematic breathing analysis. Am J Phys Med Rehabil. 1996;75:332&#x2013;339.</Citation><ArticleIdList><ArticleId IdType="pubmed">8873699</ArticleId></ArticleIdList></Reference><Reference><Citation>Fauroux B, Khirani S. Neuromuscular disease and respiratory physiology in children: putting lung function into perspective. Respirology. 2014;19(6):782&#x2013;791.</Citation><ArticleIdList><ArticleId IdType="pubmed">24975704</ArticleId></ArticleIdList></Reference><Reference><Citation>Iannaccone ST, Rabb K, Carman D, Gordon J, Harris K, Morton A, et al. Outcome measures for pediatric spinal muscular atrophy. Arch Neurol. 2002;59(9):1445&#x2013;1450.</Citation><ArticleIdList><ArticleId IdType="pubmed">12223032</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufmann P, Iannaccone ST. Clinical trials in spinal muscular atrophy. Phys Med Rehabil Clin N Am. 2008;19(3):653&#x2013;660.</Citation><ArticleIdList><ArticleId IdType="pubmed">18625422</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenninger S, Stahl K, Wirner C, Einvag K, Thiele S, Walter MC, et al. Utility of maximum inspiratory and expiratory pressures as a screening method for respiratory insufficiency in slowly progressive neuromuscular disorders. Neuromuscul Disord. 2020;30(8):640&#x2013;648.</Citation><ArticleIdList><ArticleId IdType="pubmed">32690350</ArticleId></ArticleIdList></Reference><Reference><Citation>Wadman RI, Stam M, Gijzen M, Lemmink HH, Snoeck IN, Wijngaarde CA, et al. Association of motor milestones, SMN2 copy and outcome in spinal muscular atrophy types 0&#x2013;4. J Neurol Neurosurg Psychiatry. 2017;88(4):365&#x2013;367.</Citation><ArticleIdList><ArticleId IdType="pubmed">28108522</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijngaarde CA, Stam M, Otto LAM, Bartels B, Asselman FL, van Eijk RPA, et al. Muscle strength and motor function in adolescents and adults with spinal muscular atrophy. Neurology. 2020;95(14):e1988&#x2013;1998.</Citation><ArticleIdList><ArticleId IdType="pubmed">32732299</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E, Altman DG, Egger M, Pocock SJ, G&#xf8;tzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344&#x2013;349.</Citation><ArticleIdList><ArticleId IdType="pubmed">18313558</ArticleId></ArticleIdList></Reference><Reference><Citation>Zerres K, Sch&#xf6;neborn SR. Natural history in proximal spinal muscular atrophy: clinical analysis of 445 patients and suggestions for a modification of existing classifications. Arch Neurol. 1995;52(5):518&#x2013;523.</Citation><ArticleIdList><ArticleId IdType="pubmed">7733848</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson SH, Cooke NT, Edwards RHT, Spiro SG. Predicted normal values for maximal respiratory pressures in caucasian adults and children. Thorax. 1984;39(7):535&#x2013;538.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC459855</ArticleId><ArticleId IdType="pubmed">6463933</ArticleId></ArticleIdList></Reference><Reference><Citation>Carter GT, Abresch RT, Fowler WM, Johnson ER, Kilmer DD, McDonald CM. Spinal muscular atrophy. Am J Phys Med Rehabil. 1995;74(5 Suppl):S150&#x2013;159.</Citation><ArticleIdList><ArticleId IdType="pubmed">7576422</ArticleId></ArticleIdList></Reference><Reference><Citation>Fregonezi GAF, Resqueti VR, G&#xfc;ell R, Pradas J, Casan P, Augusto De Freitas Fregonezi G, et al. Effects of 8-week, interval-based inspiratory muscle training and breathing retraining in patients with generalized myasthenia gravis. Chest. 2005;128(3):1524&#x2013;1530.</Citation><ArticleIdList><ArticleId IdType="pubmed">16162753</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe9;ritier F, Rahm F, Pasche P, Fitting JW. Sniff nasal inspiratory pressure: a noninvasive assessment of inspiratory muscle strength. Am J Respir Crit Care Med. 1994;150(6 Pt 1):1678&#x2013;1683.</Citation><ArticleIdList><ArticleId IdType="pubmed">7952632</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanutti D, Fitting JW. Sniff nasal inspiratory pressure: reference values in Caucasian children. Am J Respir Crit Care Med. 1999;159(1):107&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="pubmed">9872826</ArticleId></ArticleIdList></Reference><Reference><Citation>Koopman M, Zanen P, Kruitwagen CLJJ, Van Der Ent CK, Arets HGM. Reference values for paediatric pulmonary function testing: the Utrecht dataset. Respir Med. 2011;105(1):15&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">20889322</ArticleId></ArticleIdList></Reference><Reference><Citation>Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Eur Respir J. 1993;6(Suppl 16):5&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">24576915</ArticleId></ArticleIdList></Reference><Reference><Citation>Bianchi C, Baiardi P. Cough peak flows: standard values for children and adolescents. Am J Phys Med Rehabil. 2008;87(6):461&#x2013;467.</Citation><ArticleIdList><ArticleId IdType="pubmed">18496248</ArticleId></ArticleIdList></Reference><Reference><Citation>Hull J, Aniapravan R, Chan E, Chatwin M, Forton J, Gallagher J, et al. Guideline for respiratory management of children with neuromuscular disease. Thorax. 2012;67:1&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">22730428</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson GJ, Whitelaw W, Siafakas N, Supinski GS, Fitting JW, Bellemare F, et al. American thoracic society/European respiratory society ats/ers statement on respiratory muscle testing. Am J Respir Crit Care Med. 2002;166:518&#x2013;624.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319&#x2013;338.</Citation><ArticleIdList><ArticleId IdType="pubmed">16055882</ArticleId></ArticleIdList></Reference><Reference><Citation>Kano H, Nakata H, Martin CF. Optimal curve fitting and smoothing using normalized uniform B-splines: a tool for studying complex systems. Appl Math Comput. 2005;169:96&#x2013;128.</Citation></Reference><Reference><Citation>Hull J, Aniapravan R, Chan E, Chatwin M, Forton J, Gallagher J, et al. British Thoracic Society guideline for respiratory management of children with neuromuscular weakness. Thorax. 2012;67:i1&#x2013;i40.</Citation><ArticleIdList><ArticleId IdType="pubmed">22730428</ArticleId></ArticleIdList></Reference><Reference><Citation>Hautmann H, Hefele S, Schotten K, Huber RM. Maximal inspiratory mouth pressures (PIMAX) in healthy subjects&#x2014;What is the lower limit of normal? Respir Med. 2000;94:689&#x2013;693.</Citation><ArticleIdList><ArticleId IdType="pubmed">10926341</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijngaarde CA, Stam M, Otto LAM, Van Eijk RPA, Cuppen I, Veldhoen ES, et al. Population-based analysis of survival in spinal muscular atrophy. Neurology. 2020;94(15):e1634&#x2013;e1644.</Citation><ArticleIdList><ArticleId IdType="pubmed">32217777</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagenacker T, Wurster CD, G&#xfc;nther R, Schreiber-Katz O, Osmanovic A, Petri S, et al. Nusinersen in adults with 5q spinal muscular atrophy: a non-interventional, multicentre, observational cohort study. Lancet Neurol. 2020;19(4):317&#x2013;325.</Citation><ArticleIdList><ArticleId IdType="pubmed">32199097</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoser B, Fong E, Geberhiwot T, Hughes D, Kissel JT, Madathil SC, et al. Maximum inspiratory pressure as a clinically meaningful trial endpoint for neuromuscular diseases: a comprehensive review of the literature. Orphanet J Rare Dis. 2017;12(1):52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5353799</ArticleId><ArticleId IdType="pubmed">28302142</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapur N, Deegan S, Parakh A, Gauld L. Relationship between respiratory function and need for NIV in childhood SMA. Pediatr Pulmonol. 2019;54(11):1174&#x2013;1180.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6852082</ArticleId><ArticleId IdType="pubmed">31328439</ArticleId></ArticleIdList></Reference><Reference><Citation>Fauroux B, Aubertin G, Cohen E, Cl&#xe9;ment A, Lofaso F. Sniff nasal inspiratory pressure in children with muscular, chest wall or lung disease. Eur Respir J. 2009;33(1):113&#x2013;117.</Citation><ArticleIdList><ArticleId IdType="pubmed">18799509</ArticleId></ArticleIdList></Reference><Reference><Citation>Su&#xe1;rez AA, Pessolano FA, Monteiro SG, Ferreyra G, Capria ME, Mesa L, et al. Peak flow and peak cough flow in the evaluation of expiratory muscle weakness and bulbar impairment in patients with neuromuscular disease. Am J Phys Med Rehabil. 2002;81(7):506&#x2013;511.</Citation><ArticleIdList><ArticleId IdType="pubmed">12131177</ArticleId></ArticleIdList></Reference><Reference><Citation>Buyse GM, Goemans N, Van Den Hauwe M, Meier T. Effects of glucocorticoids and idebenone on respiratory function in patients with duchenne muscular dystrophy. Pediatr Pulmonol. 2013;48(9):912&#x2013;920.</Citation><ArticleIdList><ArticleId IdType="pubmed">23129412</ArticleId></ArticleIdList></Reference><Reference><Citation>Steier J, Kaul S, Seymour J, Jolley C, Rafferty G, Man W, et al. The value of multiple tests of respiratory muscle strength. Thorax. 2007;62(11):975&#x2013;980.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2117126</ArticleId><ArticleId IdType="pubmed">17557772</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29296254</PMID><DateRevised><Year>2020</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2001-3078</ISSN><JournalIssue CitedMedium="Print"><Volume>6</Volume><Issue>1</Issue><PubDate><Year>2017</Year></PubDate></JournalIssue><Title>Journal of extracellular vesicles</Title><ISOAbbreviation>J Extracell Vesicles</ISOAbbreviation></Journal><ArticleTitle>Extracellular vesicles yield predictive pre-eclampsia biomarkers.</ArticleTitle><Pagination><StartPage>1408390</StartPage><MedlinePgn>1408390</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1408390</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1080/20013078.2017.1408390</ELocationID><Abstract><AbstractText>Circulating extracellular vesicles (EVs) such as cholera toxin B chain (CTB)- or annexin V (AV)-binding EVs were previously shown to be rich sources of biomarkers. Here we test if previously identified pre-eclampsia (PE) candidate biomarkers, TIMP-1 in CTB-EVs (CTB-TIMP) and PAI-1 in AV-EVs (AV-PAI) complement plasma PlGF in predicting PE in a low-risk obstetric population. Eight hundred and forty-three prospectively banked plasma samples collected at 28&#xa0;+&#xa0;0 to 32&#xa0;+&#xa0;0 gestation weeks in the Neonatal and Obstetrics Risk Assessment (NORA) cohort study were assayed by sandwich ELISAs for plasma PlGF, CTB-TIMP1 and AV-PAI1. Nineteen patients subsequently developed PE 7.3 (&#xb1;2.9) weeks later at a mean gestational age of 36.1&#xa0;&#xb1;&#xa0;3.5&#xa0;weeks. The biomarkers were assessed for their predictive accuracy for PE using stepwise multivariate logistic regression analysis with Firth correction and Areas under the curve (AUC). To achieve 100% sensitivity in predicting PE, the cut-off for plasma PlGF, CTB-TIMP1 &amp; AV-PAI1 were set at &lt;1235, &#x2264;300 or &gt;1300 and &lt;10,550&#xa0;pg/mL plasma, respectively. The corresponding AUCs, specificity and PPV at a 95% confidence interval were 0.92, 52.1% and 4.7%; 0.72, 44.5% and 4.0%; and 0.69, 21.5% and 2.9%, respectively. At 100% sensitivity, the three biomarkers had a combined AUC of 0.96, specificity of 78.6%, and PPV of 9.9%. This is the first large cohort validation of the utility of EV-associated analytes as disease biomarkers. Specifically, EV biomarkers enhanced the predictive robustness of an existing PE biomarker sufficiently to justify PE screening in a low-risk general obstetric population.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Kok Hian</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>Department of Maternal Fetal Medicine, KK Women's and Children's Hospital, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Soon Sim</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Paracrine Therapeutics Pte Ltd, Singapore, Republic of Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Mor Jack</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Division of Obstetrics &amp; Gynaecology, KK Women's and Children's Hospital, Singapore, Republic of Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tey</LastName><ForeName>Wan Shi</ForeName><Initials>WS</Initials><AffiliationInfo><Affiliation>Division of Obstetrics &amp; Gynaecology, KK Women's and Children's Hospital, Singapore, Republic of Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sim</LastName><ForeName>Wei Kian</ForeName><Initials>WK</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, ASTAR, Singapore, Republic of Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allen</LastName><ForeName>John Carson</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Centre for Quantitative Medicine, Duke-NUS Medical School, Singapore, Republic of Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Sai Kiang</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, ASTAR, Singapore, Republic of Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Yong Loo Lin School of Medicine, Singapore, Republic of Singapore.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>12</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Extracell Vesicles</MedlineTA><NlmUniqueID>101610479</NlmUniqueID><ISSNLinking>2001-3078</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Exosomes</Keyword><Keyword MajorTopicYN="N">PAI1</Keyword><Keyword MajorTopicYN="N">PIGF</Keyword><Keyword MajorTopicYN="N">TIMP1</Keyword><Keyword MajorTopicYN="N">annexin V</Keyword><Keyword MajorTopicYN="N">biomarkers</Keyword><Keyword MajorTopicYN="N">cholera toxin B chain</Keyword><Keyword MajorTopicYN="N">pre-eclampsia</Keyword></KeywordList><CoiStatement>No potential conflict of interest was reported by the authors.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>11</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>4</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>12</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29296254</ArticleId><ArticleId IdType="pmc">PMC5738645</ArticleId><ArticleId IdType="doi">10.1080/20013078.2017.1408390</ArticleId><ArticleId IdType="pii">1408390</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Villar J, Say L, Gulmezoglu AM, et al. Eclampsia and pre-eclampsia: a health problem for 2000 years In: Critchly H, MacLean A, Poston L, et al, editors. Pre-eclampsia. London: RCOG Press; 2003. p. 189&#x2013;9.</Citation></Reference><Reference><Citation>Tan KH, Tan SS, Sze SK, et al. Plasma biomarker discovery in preeclampsia using a novel differential isolation technology for circulating extracellular vesicles. Am J Obstet Gynecol. 2014. October;211(4):380.e1&#x2013;380.e13.</Citation><ArticleIdList><ArticleId IdType="pubmed">24657793</ArticleId></ArticleIdList></Reference><Reference><Citation>Y&#xe1;&#xf1;ez-M&#xf3; M, Siljander PR-M, Andreu Z, et al. Biological properties of extracellular vesicles and their physiological functions [physiology]. J Extracell Vesicles. 2015;4:27066.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4433489</ArticleId><ArticleId IdType="pubmed">25979354</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai RC, Tan SS, Yeo RWY, et al. MSC secretes at least 3 EV types each with a unique permutation of membrane lipid, protein and RNA. J Extracell Vesicles. 2016;5:29828.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4770866</ArticleId><ArticleId IdType="pubmed">26928672</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan SS, Yin Y, Lee T, et al. Therapeutic MSC exosomes are derived from lipid raft microdomains in the plasma membrane. J Extracell Vesicles. 2013;2 [pii]. PubMed PMID: 24371518; PubMed Central PMCID: PMC3873122. eng DOI:10.3402/jev.v2i0.22614.</Citation><ArticleIdList><ArticleId IdType="doi">10.3402/jev.v2i0.22614</ArticleId><ArticleId IdType="pmc">PMC3873122</ArticleId><ArticleId IdType="pubmed">24371518</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim WY, Saw SM, Tan KH, et al. A cohort evaluation on arterial stiffness and hypertensive disorders in pregnancy. BMC Pregnancy Childbirth. 2012;12:160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3574024</ArticleId><ArticleId IdType="pubmed">23268774</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan KH, Kwek K, Yeo GS.. Epidemiology of pre-eclampsia and eclampsia at the KK Women&#x2019;s and Children&#x2019;s Hospital, Singapore. Singapore Med J. 2006. January;47(1):48&#x2013;53. PubMed PMID: 16397721; eng.</Citation><ArticleIdList><ArticleId IdType="pubmed">16397721</ArticleId></ArticleIdList></Reference><Reference><Citation>Lobb RJ, Becker M, Wen Wen S, et al. Optimized exosome isolation protocol for cell culture supernatant and human plasma [exosomes; cancer; plasma; cell culture; isolation; purification]. J Extracell Vesicles. 2015;4:27031.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4507751</ArticleId><ArticleId IdType="pubmed">26194179</ArticleId></ArticleIdList></Reference><Reference><Citation>Witwer KW, Buz&#xe1;s EI, Bemis LT, et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research [Extracellular vesicle; RNA; isolation; characterization; biomarker; intercellular communication; biofluid; immunology; methodology]. J Extracell Vesicles. 2013;2:20360.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3760646</ArticleId><ArticleId IdType="pubmed">24009894</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiner AT, Tan S, Agreiter C, et al. EV-associated MMP9 in high-grade serous ovarian cancer is preferentially localized to annexin V-binding EVs. Dis Markers. 2017;2017:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5451862</ArticleId><ArticleId IdType="pubmed">28607529</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J-Y, Pang Z-J, Yu Y-H.. Regulation of trophoblast invasion: the role of matrix metalloproteinases. Rev Obstet Gynecol. 2012;5(3&#x2013;4):e137&#x2013;e143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3594863</ArticleId><ArticleId IdType="pubmed">23483768</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolben M, Lopens A, Bl&#xe4;ser J, et al. Proteases and their inhibitors are indicative in gestational disease. Eur J Obstetrics Gynecol Reprod Biol. 1996;68:59&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">8886683</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeisler H, Llurba E, Chantraine F, et al. Predictive value of the sFlt-1: plGFRatio in women with suspected preeclampsia. New Engl J Med. 2016;374(1):13&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">26735990</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37000238</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>18</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1068</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>European journal of orthopaedic surgery &amp; traumatology : orthopedie traumatologie</Title><ISOAbbreviation>Eur J Orthop Surg Traumatol</ISOAbbreviation></Journal><ArticleTitle>The use of pre-operative Inferior Vena Cava filters for thromboprophylaxis in ultra-high-risk patients undergoing total hip and knee arthroplasty: a systematic review and narrative analysis.</ArticleTitle><Pagination><StartPage>2749</StartPage><EndPage>2764</EndPage><MedlinePgn>2749-2764</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00590-023-03531-z</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Patients undergoing total hip (THA) or knee (TKA) arthroplasty are at high risk of venous thromboembolism (VTE). As the number performed annually increases, the population at risk of fatal pulmonary embolism (PE) also grows. Ultra-high-risk arthroplasty patients (UHRAPs) include those with additional comorbidities, or a history of VTE, for many of whom routine prophylaxis will previously have failed. Pre-operative insertion of Inferior Vena Cava filters (IVCFs) has been recommended for thromboprophylaxis in UHRAPs, and this review was performed to establish their results.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic search of MEDLINE and Embase databases was performed for studies reporting the use of Inferior Vena Cava filters in hip and knee arthroplasty patients.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Ten studies met the inclusion criteria, containing 718 IVCFs in Orthopaedic patients, 343 of which were permanent (47.8%), 369 potentially retrievable (51.4%), 5 absorbable (0.6%) and one of unknown design (0.1%). Patient age averaged 64.7yrs (17-95) and 56% were female. Pre-operatively, 415 prophylactic IVCFs were inserted in 409 UHRAPs, undergoing a total of 438 total joint arthroplasties (TJA). There were 11 cases of PE in the entire series (1.5%) only one of which was fatal (0.01%), with four non-fatal PE in the UHRAP group (0.96%). Removal was attempted for 283 of the retrievable filters (76.7%) and was successful in 280 (98.9%).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The use of IVCFs eliminated fatal PE in UHRAPs, but larger, high-quality studies, with standardised reporting, are still required to determine their absolute indications for use, complication profile, efficacy and optimum design.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer-Verlag France SAS, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sochart</LastName><ForeName>Sarita</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hyperacute Stroke Unit, Frimley Park Hospital, Portsmouth Rd, Frimley, Camberley, GU16 7UJ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baryeh</LastName><ForeName>Kwaku</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-2807-1965</Identifier><AffiliationInfo><Affiliation>Postgraduate Medical Education Department, West Middlesex University Hospital, Twickenham Road, Middlesex, TW7 6AF, UK. Kwaku.baryeh1@nhs.net.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sochart</LastName><ForeName>David H</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>The Academic Surgical Unit, South West London Elective Orthopaedic Centre (SWLEOC), Dorking Road, Epsom, Surrey, KT18 7EG, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The School of Health and Society, The University of Salford, Salford, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Eur J Orthop Surg Traumatol</MedlineTA><NlmUniqueID>9518037</NlmUniqueID><ISSNLinking>1633-8065</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016306" MajorTopicYN="Y">Vena Cava Filters</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="Y">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019645" MajorTopicYN="Y">Arthroplasty, Replacement, Knee</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Deep vein thrombosis</Keyword><Keyword MajorTopicYN="N">Hip and knee arthroplasty</Keyword><Keyword MajorTopicYN="N">Inferior Vena Cava filter</Keyword><Keyword MajorTopicYN="N">Pulmonary embolism</Keyword><Keyword MajorTopicYN="N">Thromboprophylaxis</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>18</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>31</Day><Hour>11</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37000238</ArticleId><ArticleId IdType="pmc">PMC10063930</ArticleId><ArticleId IdType="doi">10.1007/s00590-023-03531-z</ArticleId><ArticleId IdType="pii">10.1007/s00590-023-03531-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>N&#xe6;ss IA, Christiansen SC, Romundstad P, et al. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost. 2007;5:692&#x2013;699. doi: 10.1111/j.1538-7836.2007.02450.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2007.02450.x</ArticleId><ArticleId IdType="pubmed">17367492</ArticleId></ArticleIdList></Reference><Reference><Citation>Ks V, Stefano B, Mareike L, Guy M. Management of pulmonary embolism. J Am Coll Cardiol. 2016;67:976&#x2013;990. doi: 10.1016/j.jacc.2015.11.061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2015.11.061</ArticleId><ArticleId IdType="pubmed">26916489</ArticleId></ArticleIdList></Reference><Reference><Citation>Prandoni P, Lensing AWA, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med. 1996;125:1&#x2013;7. doi: 10.7326/0003-4819-125-1-199607010-00001.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-125-1-199607010-00001</ArticleId><ArticleId IdType="pubmed">8644983</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiff RL, Kahn SR, Shrier I, et al. Identifying orthopedic patients at high risk for venous thromboembolism despite thromboprophylaxis. Chest. 2005;128:3364&#x2013;3371. doi: 10.1378/chest.128.5.3364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.128.5.3364</ArticleId><ArticleId IdType="pubmed">16304285</ArticleId></ArticleIdList></Reference><Reference><Citation>White RH, Gettner S, Newman JM, et al. Predictors of rehospitalization for symptomatic venous thromboembolism after total hip arthroplasty. N Engl J Med. 2000;343:1758&#x2013;1764. doi: 10.1056/NEJM200012143432403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200012143432403</ArticleId><ArticleId IdType="pubmed">11114314</ArticleId></ArticleIdList></Reference><Reference><Citation>Poultsides LA, Gonzalez Della Valle A, Memtsoudis SG, et al. Meta-analysis of cause of death following total joint replacement using different thromboprophylaxis regimens. J Bone Joint Surg Br. 2012;94-B:113&#x2013;121. doi: 10.1302/0301-620X.94B1.27301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/0301-620X.94B1.27301</ArticleId><ArticleId IdType="pubmed">22219258</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunt LP, Ben-Shlomo Y, Clark EM, et al. 90-day mortality after 409&#x2008;096 total hip replacements for osteoarthritis, from the national joint registry for England and Wales: a retrospective analysis. Lancet. 2013;382:1097&#x2013;1104. doi: 10.1016/S0140-6736(13)61749-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(13)61749-3</ArticleId><ArticleId IdType="pubmed">24075049</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunt LP, Ben-Shlomo Y, Clark EM, et al. 45-day mortality after 467&#x2008;779 knee replacements for osteoarthritis from the national joint registry for England and Wales: an observational study. Lancet. 2014;384:1429&#x2013;1436. doi: 10.1016/S0140-6736(14)60540-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)60540-7</ArticleId><ArticleId IdType="pubmed">25012118</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayley E, Brown S, Bhamber NS, Howard PW. Fatal pulmonary embolism following elective total hip arthroplasty. Bone Joint J. 2016;98-B:585&#x2013;588. doi: 10.1302/0301-620X.98B5.34996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/0301-620X.98B5.34996</ArticleId><ArticleId IdType="pubmed">27143726</ArticleId></ArticleIdList></Reference><Reference><Citation>Quah C, Bayley E, Bhamber N, Howard P. Fatal pulmonary embolism following elective total knee replacement using aspirin in multi-modal prophylaxis &amp; #x2014; A 12&#x2005;year study. Knee. 2017;24:1187&#x2013;1190. doi: 10.1016/j.knee.2017.05.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.knee.2017.05.021</ArticleId><ArticleId IdType="pubmed">28622843</ArticleId></ArticleIdList></Reference><Reference><Citation>Januel J-M, Chen G, Ruffieux C, et al. Symptomatic in-hospital deep vein thrombosis and pulmonary embolism following hip and knee arthroplasty among patients receiving recommended prophylaxis: a systematic review. JAMA. 2012;307:294&#x2013;303. doi: 10.1001/jama.2011.2029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2011.2029</ArticleId><ArticleId IdType="pubmed">22253396</ArticleId></ArticleIdList></Reference><Reference><Citation>Nam D, Nunley RM, Johnson SR, et al. The effectiveness of a risk stratification protocol for thromboembolism prophylaxis after hip and knee arthroplasty. J Arthroplast. 2016;31:1299&#x2013;1306. doi: 10.1016/j.arth.2015.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2015.12.007</ArticleId><ArticleId IdType="pubmed">26777547</ArticleId></ArticleIdList></Reference><Reference><Citation>Nemeth B, Nelissen R, Arya R, Cannegieter S. Preventing VTE following total hip and knee arthroplasty: is prediction the future? J Thromb Haemost. 2021;19:41&#x2013;45. doi: 10.1111/jth.15132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15132</ArticleId><ArticleId IdType="pmc">PMC7839761</ArticleId><ArticleId IdType="pubmed">33043553</ArticleId></ArticleIdList></Reference><Reference><Citation>Parvizi J, Huang R, Rezapoor M, et al. Individualized risk model for venous thromboembolism after total joint arthroplasty. J Arthroplast. 2016;31:180&#x2013;186. doi: 10.1016/j.arth.2016.02.077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2016.02.077</ArticleId><ArticleId IdType="pubmed">27094244</ArticleId></ArticleIdList></Reference><Reference><Citation>Warren JA, Sundaram K, Kamath AF, et al. Venous thromboembolism rates did not decrease in lower extremity revision total joint arthroplasty from 2008 to 2016. J Arthroplast. 2019;34:2774&#x2013;2779. doi: 10.1016/j.arth.2019.05.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2019.05.012</ArticleId><ArticleId IdType="pubmed">31153709</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Chen Z, Zheng J, et al. Risk factors for venous thromboembolism after total hip and total knee arthroplasty: a meta-analysis. Arch Orthop Trauma Surg. 2015;135:759&#x2013;772. doi: 10.1007/s00402-015-2208-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00402-015-2208-8</ArticleId><ArticleId IdType="pubmed">25854654</ArticleId></ArticleIdList></Reference><Reference><Citation>Registry NJ (2020) National Joint Registry-17th Annual Report 2020. Natl Jt Regist</Citation><ArticleIdList><ArticleId IdType="pubmed">33439585</ArticleId></ArticleIdList></Reference><Reference><Citation>Matharu GS, Culliford DJ, Blom AW, Judge A. Projections for primary hip and knee replacement surgery up to the year 2060: an analysis based on data from the national joint registry for England, Wales, Northern Ireland and the Isle of Man. Ann R Coll Surg Engl. 2022;104:443&#x2013;448. doi: 10.1308/rcsann.2021.0206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1308/rcsann.2021.0206</ArticleId><ArticleId IdType="pmc">PMC9157920</ArticleId><ArticleId IdType="pubmed">34939832</ArticleId></ArticleIdList></Reference><Reference><Citation>Penfold CM, Judge A, Sayers A, et al. Temporal trends in comorbidity in adult elective hip and knee arthroplasty patients in England. Bone Joint J. 2022;104-B:1052&#x2013;1059. doi: 10.1302/0301-620X.104B9.BJJ-2022-0013.R1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/0301-620X.104B9.BJJ-2022-0013.R1</ArticleId><ArticleId IdType="pubmed">36047019</ArticleId></ArticleIdList></Reference><Reference><Citation>Menendez ME, Neuhaus V, van Dijk NC, Ring D. The elixhauser comorbidity method outperforms the charlson index in predicting inpatient death after orthopaedic surgery. Clin Orthop Relat Res. 2014;472(2878):2886.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4117875</ArticleId><ArticleId IdType="pubmed">24867450</ArticleId></ArticleIdList></Reference><Reference><Citation>Garland A, B&#xfc;low E, Lenguerrand E, et al. Prediction of 90-day mortality after total hip arthroplasty. Bone Joint J. 2021;103-B:469&#x2013;478. doi: 10.1302/0301-620X.103B3.BJJ-2020-1249.R1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/0301-620X.103B3.BJJ-2020-1249.R1</ArticleId><ArticleId IdType="pubmed">33641419</ArticleId></ArticleIdList></Reference><Reference><Citation>Sloan M, Premkumar A, Sheth NP. Projected volume of primary total joint arthroplasty in the U.S., 2014 to 2030. JBJS. 2018;100:1455&#x2013;1460. doi: 10.2106/JBJS.17.01617.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.17.01617</ArticleId><ArticleId IdType="pubmed">30180053</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurtz S, Ong K, Lau E, et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. JBJS. 2007;89:780&#x2013;785. doi: 10.2106/00004623-200704000-00012.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/00004623-200704000-00012</ArticleId><ArticleId IdType="pubmed">17403800</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackerman IN, Bohensky MA, Zomer E, et al. The projected burden of primary total knee and hip replacement for osteoarthritis in Australia to the year 2030. BMC Musculoskelet Disord. 2019;20:90. doi: 10.1186/s12891-019-2411-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12891-019-2411-9</ArticleId><ArticleId IdType="pmc">PMC6387488</ArticleId><ArticleId IdType="pubmed">30797228</ArticleId></ArticleIdList></Reference><Reference><Citation>Klug A, Gramlich Y, Rudert M, et al. The projected volume of primary and revision total knee arthroplasty will place an immense burden on future health care systems over the next 30 years. Knee Surg Sport Traumatol Arthrosc. 2021;29:3287&#x2013;3298. doi: 10.1007/s00167-020-06154-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00167-020-06154-7</ArticleId><ArticleId IdType="pmc">PMC7362328</ArticleId><ArticleId IdType="pubmed">32671435</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesko DR, Nikkole Haines MD, Sadauskas A, Sporer SM. Inferior vena cava filter use and risk of DVT/PE post arthroplasty. Orthop Rheumatol Open Access J. 2018;12:45&#x2013;49. doi: 10.19080/OROAJ.2018.12.555836.</Citation><ArticleIdList><ArticleId IdType="doi">10.19080/OROAJ.2018.12.555836</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenfield LJ. Evolution of venous interruption for pulmonary thromboembolism. Arch Surg. 1992;127:622&#x2013;626. doi: 10.1001/archsurg.1992.01420050150020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archsurg.1992.01420050150020</ArticleId><ArticleId IdType="pubmed">1575633</ArticleId></ArticleIdList></Reference><Reference><Citation>Moser KM, Harsany PG, Harvey-Smith W, et al. Reversible interruption of inferior vena cava by means of a balloon catheter: preliminary report. J Thorac Cardiovasc Surg. 1971;62:205&#x2013;212. doi: 10.1016/S0022-5223(19)42072-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-5223(19)42072-2</ArticleId><ArticleId IdType="pubmed">5560502</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunter JA, Sessions R, Buenger R. Experimental balloon obstruction of the inferior vena cava. Ann Surg. 1970;171:315. doi: 10.1097/00000658-197002000-00023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000658-197002000-00023</ArticleId><ArticleId IdType="pmc">PMC1396660</ArticleId><ArticleId IdType="pubmed">5413467</ArticleId></ArticleIdList></Reference><Reference><Citation>Mobin-Uddin K, Callard GM, Bolooki H, et al. Transvenous caval interruption with umbrella filter. N Engl J Med. 1972;286:55&#x2013;58. doi: 10.1056/NEJM197201132860202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM197201132860202</ArticleId><ArticleId IdType="pubmed">5006878</ArticleId></ArticleIdList></Reference><Reference><Citation>Dripps RD. New classification of physical status. Anesthesiology. 1963;24:111.</Citation></Reference><Reference><Citation>Muscatelli SR, Charters MA, Hallstrom BR. Time for an update? A look at current guidelines for venous thromboembolism prophylaxis after hip and knee arthroplasty and hip fracture. Arthroplast Today. 2021;10:105&#x2013;107. doi: 10.1016/j.artd.2021.06.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.artd.2021.06.015</ArticleId><ArticleId IdType="pmc">PMC8318891</ArticleId><ArticleId IdType="pubmed">34337116</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuy S, Dua A, Lee CJ, et al. National trends in utilization of inferior vena cava filters in the United States, 2000&#x2013;2009. J Vasc Surg Venous Lymphat Disord. 2014;2:15&#x2013;20. doi: 10.1016/j.jvsv.2013.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvsv.2013.08.007</ArticleId><ArticleId IdType="pubmed">26992963</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidane B, Madani AM, Vogt K, et al. The use of prophylactic inferior vena cava filters in trauma patients: a systematic review. Injury. 2012;43:542&#x2013;547. doi: 10.1016/j.injury.2012.01.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2012.01.020</ArticleId><ArticleId IdType="pubmed">22386925</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowland SP, Dharmarajah B, Moore HM, et al. Inferior vena cava filters for prevention of venous thromboembolism in obese patients undergoing bariatric surgery: a systematic review. Ann Surg. 2015;261:35&#x2013;45. doi: 10.1097/SLA.0000000000000621.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000000621</ArticleId><ArticleId IdType="pubmed">25599325</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Slim K, Nini E, Forestier D, et al. Methodological index for non-randomized studies (MINORS): development and validation of a new instrument. ANZ J Surg. 2003;73:712&#x2013;716. doi: 10.1046/j.1445-2197.2003.02748.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1445-2197.2003.02748.x</ArticleId><ArticleId IdType="pubmed">12956787</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed O, Kim YJ, Patel MV, et al. Efficacy and safety of mechanical IVC filtration for preventing pulmonary embolism in high-risk orthopedic patients undergoing total hip or knee arthroplasty. J Arthroplast. 2021;36:2586&#x2013;2590. doi: 10.1016/j.arth.2021.02.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2021.02.042</ArticleId><ArticleId IdType="pubmed">33741245</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin MS, Parvizi J, Grossman S, et al. The inferior vena cava filter is effective in preventing fatal pulmonary embolus after hip and knee arthroplasties. J Arthroplast. 2007;22:343&#x2013;348. doi: 10.1016/j.arth.2006.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2006.10.008</ArticleId><ArticleId IdType="pubmed">17400088</ArticleId></ArticleIdList></Reference><Reference><Citation>Bass AR, Mattern CJ, Voos JE, et al. Inferior vena cava filter placement in orthopedic surgery. Am J Orthop. 2010;39:435.</Citation><ArticleIdList><ArticleId IdType="pubmed">21290021</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhand S, David Stulberg S, Puri L, et al. The role of potentially retrievable inferior vena cava filters in high-risk patients undergoing joint arthroplasty. J Clin Diagn Res. 2015;9:TC01&#x2013;TC03. doi: 10.7860/JCDR/2015/11397.6890.</Citation><ArticleIdList><ArticleId IdType="doi">10.7860/JCDR/2015/11397.6890</ArticleId><ArticleId IdType="pmc">PMC4717762</ArticleId><ArticleId IdType="pubmed">26816965</ArticleId></ArticleIdList></Reference><Reference><Citation>Elizondo G, Eggers M, Falcon M, et al. First-in-human study with eight patients using an absorbable vena cava filter for the prevention of pulmonary embolism. J Vasc Interv Radiol. 2020;31:1817&#x2013;1824. doi: 10.1016/j.jvir.2020.07.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvir.2020.07.021</ArticleId><ArticleId IdType="pubmed">33008719</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerson RH, Cross R, Head WC. Prophylactic and early therapeutic use of the greenfield filter in hip and knee joint arthroplasty. J Arthroplast. 1991;6:129&#x2013;135. doi: 10.1016/S0883-5403(11)80007-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0883-5403(11)80007-0</ArticleId><ArticleId IdType="pubmed">1875203</ArticleId></ArticleIdList></Reference><Reference><Citation>Golueke PJ, Garrett WV, Thompson JE, et al. Interruption of the vena cava by means of the Greenfield filter: expanding the indications. Surgery. 1988;103:111&#x2013;117.</Citation><ArticleIdList><ArticleId IdType="pubmed">3336860</ArticleId></ArticleIdList></Reference><Reference><Citation>Strauss EJ, Egol KA, Alaia M, et al. The use of retrievable inferior vena cava filters in orthopaedic patients. J Bone Jt Surg Ser B. 2008;90:662&#x2013;667. doi: 10.1302/0301-620X.90B5.19743.</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/0301-620X.90B5.19743</ArticleId><ArticleId IdType="pubmed">18450637</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaughn BK, Knezevich S, Lombardi AV, Jr, Mallory TH. Use of the greenfield filter to prevent fatal pulmonary embolism associated with total hip and knee arthroplasty. J Bone Joint Surg Am. 1989;71:1542&#x2013;1548. doi: 10.2106/00004623-198971100-00013.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/00004623-198971100-00013</ArticleId><ArticleId IdType="pubmed">2592395</ArticleId></ArticleIdList></Reference><Reference><Citation>Angel LF, Tapson V, Galgon RE, et al. Systematic review of the use of retrievable inferior vena cava filters. J Vasc Interv Radiol. 2011 doi: 10.1016/j.jvir.2011.08.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvir.2011.08.024</ArticleId><ArticleId IdType="pubmed">22024114</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Haddadin I, McLennan G, et al. Inferior vena cava filter &#x2013; comprehensive overview of current indications, techniques, complications and retrieval rates. Vasa. 2020;49:449&#x2013;462. doi: 10.1024/0301-1526/a000887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1024/0301-1526/a000887</ArticleId><ArticleId IdType="pubmed">32660360</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufman JA, Kinney TB, Streiff MB, et al. Special communications-guidelines for the use of retrievable and convertible vena cava filters: report from the society of interventional radiology multidisciplinary consensus conference. J Vasc Interv Radiol. 2006;17:449&#x2013;459. doi: 10.1097/01.RVI.0000203418-39769.0D.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.RVI.0000203418-39769.0D</ArticleId><ArticleId IdType="pubmed">16567669</ArticleId></ArticleIdList></Reference><Reference><Citation>Morales JP, Li X, Irony TZ, et al. Decision analysis of retrievable inferior vena cava filters in patients without pulmonary embolism. J Vasc Surg Venous Lymphat Disord. 2013;1:376&#x2013;384. doi: 10.1016/j.jvsv.2013.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvsv.2013.04.005</ArticleId><ArticleId IdType="pubmed">26992759</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed O, Wadhwa V, Patel K, et al. Rising retrieval rates of inferior vena cava filters in the united states: insights from the 2012 to 2016 summary medicare claims data. J Am Coll Radiol. 2018;15:1553&#x2013;1557. doi: 10.1016/j.jacr.2018.01.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacr.2018.01.037</ArticleId><ArticleId IdType="pubmed">29606636</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs JJ, Mont MA, Bozic KJ, et al. American academy of orthopaedic surgeons clinical practice guideline on: preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty. JBJS. 2012;94:746. doi: 10.2106/JBJS.9408.ebo746.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.9408.ebo746</ArticleId><ArticleId IdType="pmc">PMC3326685</ArticleId><ArticleId IdType="pubmed">22517391</ArticleId></ArticleIdList></Reference><Reference><Citation>Group BC for S in HW. Baglin TP, Brush J, Streiff M. Guidelines on use of vena cava filters. Br J Haematol. 2006;134:590&#x2013;595. doi: 10.1111/j.1365-2141.2006.06226.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2141.2006.06226.x</ArticleId><ArticleId IdType="pubmed">16869824</ArticleId></ArticleIdList></Reference><Reference><Citation>Young T, Sriram KB. Vena caval filters for the prevention of pulmonary embolism. Cochrane Database Syst Rev. 2020 doi: 10.1002/14651858.CD006212.pub5/full.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD006212.pub5/full</ArticleId><ArticleId IdType="pmc">PMC8971091</ArticleId><ArticleId IdType="pubmed">33027844</ArticleId></ArticleIdList></Reference><Reference><Citation>Decousus H, Leizorovicz A, Parent F, et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N Engl J Med. 1998;338:409&#x2013;416. doi: 10.1056/nejm199802123380701.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejm199802123380701</ArticleId><ArticleId IdType="pubmed">9459643</ArticleId></ArticleIdList></Reference><Reference><Citation>Fullen WD, Miller EH, Steele WF, McDonough JJ. Prophylactic vena caval interruption in hip fractures. J Trauma Acute Care Surg. 1973;13:403&#x2013;410. doi: 10.1097/00005373-197305000-00001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005373-197305000-00001</ArticleId><ArticleId IdType="pubmed">4540786</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38233940</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>19</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1742-4755</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month><Day>17</Day></PubDate></JournalIssue><Title>Reproductive health</Title><ISOAbbreviation>Reprod Health</ISOAbbreviation></Journal><ArticleTitle>Maternal and fetal/neonatal outcomes in pregnancy, delivery and postpartum following bariatric surgery and comparison with pregnant women with obesity: a study protocol for a prospective cohort.</ArticleTitle><Pagination><StartPage>8</StartPage><MedlinePgn>8</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">8</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12978-023-01736-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Being obese can lead to various complications during pregnancy, such as Gestational Diabetes Mellitus (GDM), pregnancy induced hypertension (PIH), Pre-Eclampsia (PE), and Large Gestational Age (LGA). Although bariatric surgery is an effective way to treat obesity, it can also result in complications and may be linked to having small for gestational age (SGA) babies. This cohort study protocol aims to compare the maternal and fetal/neonatal outcomes of two groups of Iranian pregnant women: those who have undergone bariatric surgery and those who are obese but have not had bariatric surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this study Pregnant women (&lt;&#x2009;14 weeks' gestation) (n&#x2009;=&#x2009;38 per group) are recruited either from one of the obesity clinic (exposure group&#x2009;=&#x2009;with a history of bariatric surgery) or primary healthcare clinics in Tehran city (comparison group&#x2009;=&#x2009;pregnant women with obesity and and no history of bariatric surgery). Dietary intake and nutrient status are assessed at&#x2009;&lt;&#x2009;14, 28, and 36&#xa0;weeks. Maternal and fetal/neonatal outcomes are compared between the two groups, including gestational diabetes, preeclampsia, preterm labor, intrauterine growth restriction, severe nausea and vomiting, abortion, placenta previa and abruption, venous thrombosis, vaginal bleeding, cesarean delivery, meconium aspiration, and respiratory distress. Maternal serum levels of ferritin, albumin, zinc, calcium, magnesium, selenium, copper, vitamins A, B9, B12, and 25-hydroxy Vit D are checked during 24th to 28th weeks. Maternal and neonatal outcomes, including height, weight, head circumference, fetal abnormality, infection, small or large fetus, low birth weight, macrosomia, NICU admission, and total weight gain during pregnancy, are measured at birth. Maternal and offspring outcomes, including weight, height, head circumference, total weight gain during pregnancy, newborn diseases, postpartum bleeding, breastfeeding, and related problems, are assessed 6 weeks after delivery. Child's weight, height, and head circumference are followed at 2, 4, 6, 8, 10, and 12 months after birth. Maternal stress, anxiety, and depression are assessed with the DASS-21 questionnaire, and physical activity is evaluated using the PPAQ questionnaire in the first and third trimesters.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">By assessing the levels of micronutrients in the blood of pregnant women along with the evaluation of pregnancy outcomes, it is feasible to gain a more accurate understanding of how bariatric surgery affects the health and potential complications for both the mother and the fetus/newborn. This information can help specialists and patients make more informed decisions about the surgery. Additionally, by examining issues such as stress, anxiety, and depression in women undergoing surgery, this study can contribute to recognizing these problems, which can also affect pregnancy outcomes.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Navaee</LastName><ForeName>Maryam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Minimally Invasive Surgery Research Center, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kashanian</LastName><ForeName>Maryam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Minimally Invasive Surgery Research Center, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kabir</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Minimally Invasive Surgery Research Center, Iran University of Medical Sciences, Tehran, Iran. aikabir@yahoo.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zamaninour</LastName><ForeName>Negar</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Minimally Invasive Surgery Research Center, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chamari</LastName><ForeName>Maryam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pazouki</LastName><ForeName>Abdolreza</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Minimally Invasive Surgery Research Center, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Excellence of European Branch of International Federation for Surgery of Obesity, Tehran, Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Reprod Health</MedlineTA><NlmUniqueID>101224380</NlmUniqueID><ISSNLinking>1742-4755</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D037841" MajorTopicYN="N">Pregnant People</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007492" MajorTopicYN="N" Type="Geographic">Iran</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008471" MajorTopicYN="Y">Meconium Aspiration Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011256" MajorTopicYN="N">Pregnancy Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049590" MajorTopicYN="N">Postpartum Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016640" MajorTopicYN="Y">Diabetes, Gestational</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050110" MajorTopicYN="Y">Bariatric Surgery</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011225" MajorTopicYN="Y">Pre-Eclampsia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015430" MajorTopicYN="N">Weight Gain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005333" MajorTopicYN="N">Fetus</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anxiety</Keyword><Keyword MajorTopicYN="N">Bariatric surgery</Keyword><Keyword MajorTopicYN="N">Depression</Keyword><Keyword MajorTopicYN="N">Micronutrients</Keyword><Keyword MajorTopicYN="N">Obesity</Keyword><Keyword MajorTopicYN="N">Perinatal outcomes</Keyword><Keyword MajorTopicYN="N">Postpartum</Keyword><Keyword MajorTopicYN="N">Stress</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>19</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>18</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>17</Day><Hour>23</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38233940</ArticleId><ArticleId IdType="pmc">PMC10795358</ArticleId><ArticleId IdType="doi">10.1186/s12978-023-01736-3</ArticleId><ArticleId IdType="pii">10.1186/s12978-023-01736-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mabhout Moghadam T, Mosaferi Ziaaldini M, Fathi M, Attarzadeh Hoseini SR. Review the effect of high intensity interval training on obesity-related hormones. Res Sport Sci Med Plants. 2020;1(1):1&#x2013;18.</Citation></Reference><Reference><Citation>World Health Organization (2018) Obesity and Overweight Fact Sheet, World Health Organization. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.</Citation></Reference><Reference><Citation>Lobstein T, Brinsden H, Neveux M. World obesity atlas 2022. 2022.</Citation></Reference><Reference><Citation>Senobari M, Azmoude E, Mousavi M. The relationship between body mass index, body image, and sexual function: a survey on Iranian pregnant women. Int J Reprod Biomed. 2019;17(7):503.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6718881</ArticleId><ArticleId IdType="pubmed">31508576</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilmore LA, Redman LM. Weight gain in pregnancy and application of the 2009 IOM guidelines: toward a uniform approach. Obesity. 2015;23(3):507&#x2013;511. doi: 10.1002/oby.20951.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/oby.20951</ArticleId><ArticleId IdType="pmc">PMC4340812</ArticleId><ArticleId IdType="pubmed">25521748</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao L, Ding G, Vinturache A, Xu J, Ding Y, Guo J, et al. Associations of maternal pre-pregnancy body mass index and gestational weight gain with birth outcomes in Shanghai, China. Sci Rep. 2017;7(1):41073. doi: 10.1038/srep41073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep41073</ArticleId><ArticleId IdType="pmc">PMC5264385</ArticleId><ArticleId IdType="pubmed">28120879</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoorsan H, Majd HA, Chaichian S, Mehdizadehkashi A, Hoorsan R, Akhlaqghdoust M, Moradi Y. Maternal anthropometric characteristics and adverse pregnancy outcomes in iranian women: a confirmation analysis. Arch Iran Med. 2018;21(2):61&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">29664656</ArticleId></ArticleIdList></Reference><Reference><Citation>Omani-Samani R, Sepidarkish M, Safiri S, Esmailzadeh A, Vesali S, Farzaneh F, Almasi-Hashiani A. Impact of gestational weight gain on cesarean delivery risk, perinatal birth weight and gestational age in women with normal pre-pregnancy BMI. J Obstet Gynecol India. 2018;68:258&#x2013;263. doi: 10.1007/s13224-017-1023-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13224-017-1023-2</ArticleId><ArticleId IdType="pmc">PMC6046671</ArticleId><ArticleId IdType="pubmed">30065539</ArticleId></ArticleIdList></Reference><Reference><Citation>Amini P, Moghimbeigi A, Zayeri F, Mahjub H, Maroufizadeh S, Samani R-O. Evaluating the impact of risk factors on birth weight and gestational age: a multilevel joint modeling approach. Int J Fertil Steril. 2018;12(2):106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5936606</ArticleId><ArticleId IdType="pubmed">29707925</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacamon A-S, Merviel P, Herrmann S, Pan-Petesch B, Lacut K, Thereaux JJ. Outcomes of pregnancy after bariatric surgery: results of a French matched-cohort study. Surg Obes Relat Dis. 2020;16(9):1275&#x2013;82. doi: 10.1016/j.soard.2020.04.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.soard.2020.04.047</ArticleId><ArticleId IdType="pubmed">32654896</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik S, Teh JL, Lomanto D, Kim G, So JB-Y, Shabbir AJ. Maternal and fetal outcomes of Asian pregnancies after bariatric surgery. Surg Obes Relat Dis. 2020;16(4):529&#x2013;35. doi: 10.1016/j.soard.2020.01.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.soard.2020.01.017</ArticleId><ArticleId IdType="pubmed">32085937</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xf3;&#x17c;a&#x144;ska-Wal&#x119;dziak A, Bartnik P, Kacperczyk-Bartnik J, Czajkowski K, Wal&#x119;dziak M, Kwiatkowski AJV, Techniques OM. Pregnancy after bariatric surgery&#x2013;a narrative literature review. Videosurg Other Miniinvasive Tech. 2021;16(1):30. doi: 10.5114/wiitm.2020.99281.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/wiitm.2020.99281</ArticleId><ArticleId IdType="pmc">PMC7991924</ArticleId><ArticleId IdType="pubmed">33786114</ArticleId></ArticleIdList></Reference><Reference><Citation>Chilelli NC, Burlina S, Dalfr&#xe0; MG, Lapolla A. A focus on the impact of bariatric surgery on pregnancy outcome: effectiveness, safety and clinical management. J Obes Weight Loss Ther. 2014;4:210.</Citation></Reference><Reference><Citation>Chu D-T, Nguyet NTM, Nga VT, Lien NVT, Vo DD, Lien N, et al. An update on obesity: mental consequences and psychological interventions. Diabetes Metab Syndr. 2019;13(1):155&#x2013;160. doi: 10.1016/j.dsx.2018.07.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2018.07.015</ArticleId><ArticleId IdType="pubmed">30641689</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghanbari Z, Darvizeh Z, Khosravi ZJ. The role of anxiety and depression in the success of sleeve gastrectomy surgery. Quart J Health Psychol. 2018;7(27):7&#x2013;30.</Citation></Reference><Reference><Citation>Arterburn DE, Telem DA, Kushner RF, Courcoulas AP. Benefits and risks of bariatric surgery in adults: a review. Jama Surg. 2020;324(9):879&#x2013;87. doi: 10.1001/jama.2020.12567.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12567</ArticleId><ArticleId IdType="pubmed">32870301</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheiner E, Willis K, Yogev YJ. Bariatric surgery: impact on pregnancy outcomes. Curr Diab Rep. 2013;13(1):19&#x2013;26. doi: 10.1007/s11892-012-0329-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11892-012-0329-9</ArticleId><ArticleId IdType="pubmed">23065365</ArticleId></ArticleIdList></Reference><Reference><Citation>Collazo-Clavell ML, Shah MJE, Clinics M. Common and rare complications of bariatric surgery. Endocrinol Metab Clin. 2020;49(2):329&#x2013;346. doi: 10.1016/j.ecl.2020.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ecl.2020.02.003</ArticleId><ArticleId IdType="pubmed">32418594</ArticleId></ArticleIdList></Reference><Reference><Citation>Xanthakos SA, Khoury JC, Inge TH, Jenkins TM, Modi AC, Michalsky MP, et al. Nutritional risks in adolescents after bariatric surgery. Clin Gastroenterol Hepatol. 2020;18(5):1070&#x2013;81. doi: 10.1016/j.cgh.2019.10.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2019.10.048</ArticleId><ArticleId IdType="pmc">PMC7166172</ArticleId><ArticleId IdType="pubmed">31706057</ArticleId></ArticleIdList></Reference><Reference><Citation>Harreiter J, Schindler K, Bancher-Todesca D, G&#xf6;bl C, Langer A, Kautzky-Willer A, Prager G. Management of pregnant women after bariatric surgery. J Obes. 2018;2018:4587064. doi: 10.1155/2018/4587064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/4587064</ArticleId><ArticleId IdType="pmc">PMC6008727</ArticleId><ArticleId IdType="pubmed">29973985</ArticleId></ArticleIdList></Reference><Reference><Citation>Courcoulas AP, Yanovski SZ, Bonds D, Eggerman TL, Horlick M, Staten MA, Arterburn DE. Long-term outcomes of bariatric surgery: a National Institutes of Health symposium. JAMA surg. 2014;149(12):1323&#x2013;9. doi: 10.1001/jamasurg.2014.2440.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2014.2440</ArticleId><ArticleId IdType="pmc">PMC5570469</ArticleId><ArticleId IdType="pubmed">25271405</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephansson O, Johansson K, S&#xf6;derling J, N&#xe4;slund I, Neovius MJ. Delivery outcomes in term births after bariatric surgery: population-based matched cohort study. PLoS medicin. 2018;15(9):e1002656. doi: 10.1371/journal.pmed.1002656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1002656</ArticleId><ArticleId IdType="pmc">PMC6157842</ArticleId><ArticleId IdType="pubmed">30256796</ArticleId></ArticleIdList></Reference><Reference><Citation>Young B, Drew S, Ibikunle C, Sanni A. Maternal and fetal delivery outcomes in pregnancies following bariatric surgery: a meta-analysis of the literature. Mini-invasive Surg. 2018;2:16. doi: 10.20517/2574-1225.2017.50.</Citation><ArticleIdList><ArticleId IdType="doi">10.20517/2574-1225.2017.50</ArticleId></ArticleIdList></Reference><Reference><Citation>Galazis N, Docheva N, Simillis C, Nicolaides, Maternal and neonatal outcomes in women undergoing bariatric surgery: a systematic review and meta-analysis. Eur J Obstet Gynecol Reproduct Biol. 2014;181:45&#x2013;53. doi: 10.1016/j.ejogrb.2014.07.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejogrb.2014.07.015</ArticleId><ArticleId IdType="pubmed">25126981</ArticleId></ArticleIdList></Reference><Reference><Citation>Balestrin BUA, Barbieri MM, Paes A, Fujie J. Pregnancy after bariatric surgery: a comparative study of post-bariatric pregnant women versus non-bariatric obese pregnant women. Obes Surg. 2019;29:3142&#x2013;3148. doi: 10.1007/s11695-019-03961-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11695-019-03961-x</ArticleId><ArticleId IdType="pubmed">31129885</ArticleId></ArticleIdList></Reference><Reference><Citation>De Carolis S, Botta A, Del Sordo G, Guerrisi R, Salvi S, De Carolis M, et al. Influence of biliopancreatic diversion on pregnancy outcomes in comparison to other bariatric surgery procedures. Obes Surg. 2018;28(10):3284&#x2013;3292. doi: 10.1007/s11695-018-3350-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11695-018-3350-5</ArticleId><ArticleId IdType="pubmed">29909515</ArticleId></ArticleIdList></Reference><Reference><Citation>Yogev Y, Visser GH. Obesity, gestational diabetes and pregnancy outcome. Semin Fetal Neonatal Med. 2009 doi: 10.1016/j.siny.2008.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.siny.2008.09.002</ArticleId><ArticleId IdType="pubmed">18926784</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuart A, K&#xe4;llen KJ. Risk of abdominal surgery in pregnancy among women who have undergone bariatric surgery. Obstet Gynecol. 2017;129(5):887&#x2013;95. doi: 10.1097/AOG.0000000000001975.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AOG.0000000000001975</ArticleId><ArticleId IdType="pubmed">28383368</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultes B, Ernst B, Thurnheer M. Bariatrische chirurgie und schwangerschaft. Swiss Med Forum. 2010;10(17):304&#x2013;307. doi: 10.4414/smf.2010.07160.</Citation><ArticleIdList><ArticleId IdType="doi">10.4414/smf.2010.07160</ArticleId></ArticleIdList></Reference><Reference><Citation>Ducarme G, Planche L, Abet E, Desroys du Roure V, Ducet-Boiffard AJ. A prospective study of association of micronutrients deficiencies during pregnancy and neonatal outcome among women after bariatric surgery. J Clin Med. 2021;10(2):204. doi: 10.3390/jcm10020204.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10020204</ArticleId><ArticleId IdType="pmc">PMC7826626</ArticleId><ArticleId IdType="pubmed">33429966</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalaj A, Ghadimi F, Valizadeh M, Barzin MJ. Successful pregnancy and weight loss management in a woman unknowingly pregnant at the time of bariatric surgery: a case report. BMC Pregnancy Childbirth. 2020;20(1):1&#x2013;4. doi: 10.1186/s12884-020-2794-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12884-020-2794-5</ArticleId><ArticleId IdType="pmc">PMC7011514</ArticleId><ArticleId IdType="pubmed">32041556</ArticleId></ArticleIdList></Reference><Reference><Citation>Weintraub A, Levy A, Levi I, Mazor M, Wiznitzer A, Sheiner EJ. Effect of bariatric surgery on pregnancy outcome. Obstet Anesthesia Digest. 2009;29(4):210&#x2013;1. doi: 10.1097/01.aoa.0000362098.41451.b0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.aoa.0000362098.41451.b0</ArticleId><ArticleId IdType="pubmed">18768177</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke AE, Bennett WL, Jamshidi RM, Gilson MM, Clark JM, Segal JB, et al. Reduced incidence of gestational diabetes with bariatric surgery. J Am Coll Surg. 2010;211(2):169&#x2013;175. doi: 10.1016/j.jamcollsurg.2010.03.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2010.03.029</ArticleId><ArticleId IdType="pubmed">20670854</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi X-y, Li Q-f, Zhang J, Wang Z. A meta-analysis of maternal and fetal outcomes of pregnancy after bariatric surgery. Int J Gynecol Obstet. 2015;130(1):3&#x2013;9. doi: 10.1016/j.ijgo.2015.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijgo.2015.01.011</ArticleId><ArticleId IdType="pubmed">25863541</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwong W, Tomlinson G, Feig DS. Maternal and neonatal outcomes after bariatric surgery; a systematic review and meta-analysis: do the benefits outweigh the risks? Am J Obstet Gynecol. 2018;218(6):573&#x2013;80. doi: 10.1016/j.ajog.2018.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2018.02.003</ArticleId><ArticleId IdType="pubmed">29454871</ArticleId></ArticleIdList></Reference><Reference><Citation>Sesilia K, Susanna P, Virve K, Mika G, Veli-Matti U, Marja K. The outcome of pregnancies after bariatric surgery: an observational study of pregnancies during 2004&#x2013;2016 in Finland. Arch Gynecol Obstet. 2023;307(5):1599&#x2013;1606. doi: 10.1007/s00404-023-06935-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00404-023-06935-8</ArticleId><ArticleId IdType="pmc">PMC10110663</ArticleId><ArticleId IdType="pubmed">36703011</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheiner E, Balaban E, Dreiher J, Levi I, Levy A. Pregnancy outcome in patients following different types of bariatric surgeries. Obes Surg. 2009;19:1286&#x2013;1292. doi: 10.1007/s11695-009-9920-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11695-009-9920-9</ArticleId><ArticleId IdType="pubmed">19618246</ArticleId></ArticleIdList></Reference><Reference><Citation>Mousa A, Naqash A, Lim S. Macronutrient and micronutrient intake during pregnancy: an overview of recent evidence. Nutrients. 2019;11(2):443. doi: 10.3390/nu11020443.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11020443</ArticleId><ArticleId IdType="pmc">PMC6413112</ArticleId><ArticleId IdType="pubmed">30791647</ArticleId></ArticleIdList></Reference><Reference><Citation>Shawe J, Ceulemans D, Akhter Z, Neff K, Hart K, Heslehurst N, et al. Pregnancy after bariatric surgery: consensus recommendations for periconception, antenatal and postnatal care. Obes Rev. 2019;20(11):1507&#x2013;1522. doi: 10.1111/obr.12927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/obr.12927</ArticleId><ArticleId IdType="pmc">PMC6852078</ArticleId><ArticleId IdType="pubmed">31419378</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa MM, Belo S, Souteiro P, Neves JS, Magalh&#xe3;es D, Silva RB, et al. Pregnancy after bariatric surgery: Maternal and fetal outcomes of 39 pregnancies and a literature review. J Obstet Gynaecol Res. 2018;44(4):681&#x2013;690. doi: 10.1111/jog.13574.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jog.13574</ArticleId><ArticleId IdType="pubmed">29349843</ArticleId></ArticleIdList></Reference><Reference><Citation>Kominiarek MA. Preparing for and managing a pregnancy after bariatric surgery. Semin Perinatol. 2011;35(6):356&#x2013;361. doi: 10.1053/j.semperi.2011.05.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.semperi.2011.05.022</ArticleId><ArticleId IdType="pmc">PMC3345131</ArticleId><ArticleId IdType="pubmed">22108087</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaska L, Kobiela J, Abacjew-Chmylko A, Chmylko L, Wojanowska-Pindel M, Kobiela P, et al. Nutrition and pregnancy after bariatric surgery. Int Sch Res Notices. 2013;2013:492060. doi: 10.1155/2013/492060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/492060</ArticleId><ArticleId IdType="pmc">PMC3901983</ArticleId><ArticleId IdType="pubmed">24555146</ArticleId></ArticleIdList></Reference><Reference><Citation>Kareem O, Nisar S, Tanvir M, Muzaffer U, Bader GN. Thiamine deficiency in pregnancy and lactation: implications and present perspectives. Front Nutr. 2023;10:1080611. doi: 10.3389/fnut.2023.1080611.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2023.1080611</ArticleId><ArticleId IdType="pmc">PMC10158844</ArticleId><ArticleId IdType="pubmed">37153911</ArticleId></ArticleIdList></Reference><Reference><Citation>Amaral-Moreira CFA, Redezuk G, Pereira BG, Borovac-Pinheiro A, Rehder PM. Iron Deficiency Anemia in Pregnancy after Bariatric Surgery: Etiology, Risk Factors, and How to Manage It. Rev Bras Ginecol Obstet. 2023;45(10):e562&#x2013;e567. doi: 10.1055/s-0043-1776026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0043-1776026</ArticleId><ArticleId IdType="pmc">PMC10635785</ArticleId><ArticleId IdType="pubmed">37944922</ArticleId></ArticleIdList></Reference><Reference><Citation>Sen S, Iyer C, Meydani S. Obesity during pregnancy alters maternal oxidant balance and micronutrient status. J Perinatol. 2014;34(2):105&#x2013;111. doi: 10.1038/jp.2013.153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jp.2013.153</ArticleId><ArticleId IdType="pubmed">24355940</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Maternal Mental Health. https://www.who.int/mental_health/maternal-child/maternal_mental_health/en/. Accessed on 14 Mar 2019.</Citation></Reference><Reference><Citation>Tang X, Lu Z, Hu D, Zhong X. Influencing factors for prenatal stress, anxiety and depression in early pregnancy among women in Chongqing, China. J Affect Disord. 2019;253:292&#x2013;302. doi: 10.1016/j.jad.2019.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2019.05.003</ArticleId><ArticleId IdType="pubmed">31077972</ArticleId></ArticleIdList></Reference><Reference><Citation>Biaggi A, Conroy S, Pawlby S, Pariante CM. Identifying the women at risk of antenatal anxiety and depression: a systematic review. J Affect Disord. 2016;191:62&#x2013;77. doi: 10.1016/j.jad.2015.11.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2015.11.014</ArticleId><ArticleId IdType="pmc">PMC4879174</ArticleId><ArticleId IdType="pubmed">26650969</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezaee R, Framarzi M. Predictors of mental health during pregnancy. Iran J Nurs Midwifery Res. 2014;19(7 Suppl1):S45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4402987</ArticleId><ArticleId IdType="pubmed">25949251</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocha AC, Cunha AC, Silva JF. Prevalence of depression in pregnant women with bariatric surgery history and associated factors. Rev Bras Ginecol Obstet. 2022;44:109&#x2013;17. doi: 10.1055/s-0042-1742682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0042-1742682</ArticleId><ArticleId IdType="pmc">PMC10032054</ArticleId><ArticleId IdType="pubmed">35213908</ArticleId></ArticleIdList></Reference><Reference><Citation>Dachew BA, Ayano G, Betts K, Alati R. The impact of pre-pregnancy BMI on maternal depressive and anxiety symptoms during pregnancy and the postpartum period: a systematic review and meta-analysis. J Affect Disord. 2021;281:321&#x2013;330. doi: 10.1016/j.jad.2020.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2020.12.010</ArticleId><ArticleId IdType="pubmed">33341015</ArticleId></ArticleIdList></Reference><Reference><Citation>Seyed Amini B, Malek A, Moradi A, Ebrahimi M. Overweight and obesity associated with internalizing behavior problems in elementary school girls. Med J Tabriz Uni Med Sci. 2010;31(4):40&#x2013;44.</Citation></Reference><Reference><Citation>Rabiei S, Tabesh MR, Jahromi SR, Abolhasani M. The association between depression, obesity and body composition in Iranian women. Clin Nutr Open Sci. 2023;47:44&#x2013;52. doi: 10.1016/j.nutos.2022.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nutos.2022.11.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharafi SE, Garmaroudi G, Ghafouri M, Bafghi SA, Ghafouri M, Tabesh MR, Alizadeh Z. Prevalence of anxiety and depression in patients with overweight and obesity. Obes Med. 2020;17:100169. doi: 10.1016/j.obmed.2019.100169.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.obmed.2019.100169</ArticleId></ArticleIdList></Reference><Reference><Citation>Gon&#xe7;alves S, Freitas F, Freitas-Rosa MA, Machado BC. Dysfunctional eating behaviour, psychological well-being and adaptation to pregnancy: a study with women in the third trimester of pregnancy. J Health Psychol. 2015;20(5):535&#x2013;542. doi: 10.1177/1359105315573432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1359105315573432</ArticleId><ArticleId IdType="pubmed">25903241</ArticleId></ArticleIdList></Reference><Reference><Citation>Gravani S, Matiatou M, Nikolaidis PT, Menenakos E, Zografos CG, Zografos G, Albanopoulos K. Anxiety and depression affect early postoperative pain dimensions after bariatric surgery. J Clin Med. 2020;10(1):53. doi: 10.3390/jcm10010053.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10010053</ArticleId><ArticleId IdType="pmc">PMC7801948</ArticleId><ArticleId IdType="pubmed">33375765</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood L, Williams C, Billings J, Johnson S. The therapeutic needs of psychiatric in-patients with psychosis: a qualitative exploration of patient and staff perspectives. BJPsych open. 2019;5(3):e45. doi: 10.1192/bjo.2019.33.</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjo.2019.33</ArticleId><ArticleId IdType="pmc">PMC6537445</ArticleId><ArticleId IdType="pubmed">31530314</ArticleId></ArticleIdList></Reference><Reference><Citation>Monte SV, Russo KM, Mustafa E, Caruana JA. Impact of Sleeve Gastrectomy on Psychiatric Medication Use and Symptoms. J Obes. 2018;2018:8532602. 10.1155/2018/8532602.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6205308</ArticleId><ArticleId IdType="pubmed">30410796</ArticleId></ArticleIdList></Reference><Reference><Citation>Paczkowska A, Hoffmann K, Raakow J, Pross M, Berghaus R, Michalak M, et al. Impact of bariatric surgery on depression, anxiety and stress symptoms among patients with morbid obesity: International multicentre study in Poland and Germany. BJPsych Open. 2022;8(1):e32. doi: 10.1192/bjo.2021.1084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjo.2021.1084</ArticleId><ArticleId IdType="pmc">PMC8811782</ArticleId><ArticleId IdType="pubmed">35074027</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J, Kelley J, Davidson L, Richards N, Adams T. Depression and anxiety incidence during pregnancy between bariatric surgery patients and matched control subjects. Obes Surg. 2022;32(6):1962&#x2013;1968. doi: 10.1007/s11695-022-06037-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11695-022-06037-5</ArticleId><ArticleId IdType="pubmed">35352268</ArticleId></ArticleIdList></Reference><Reference><Citation>Komorniak N, Martynova-Van Kley A, Nalian A, Wro&#x144;ski M, Kaseja K, Kowalewski B, et al. Association between fecal microbiota, SCFA, gut integrity markers and depressive symptoms in patients treated in the past with bariatric surgery&#x2014;the cross-sectional study. Nutrients. 2022;14(24):5372. doi: 10.3390/nu14245372.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14245372</ArticleId><ArticleId IdType="pmc">PMC9781380</ArticleId><ArticleId IdType="pubmed">36558532</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulker I, Yildiran H. The effects of bariatric surgery on gut microbiota in patients with obesity: a review of the literature. Biosci Microbiota Food Health. 2019;38(1):3&#x2013;9. doi: 10.12938/bmfh.18-018.</Citation><ArticleIdList><ArticleId IdType="doi">10.12938/bmfh.18-018</ArticleId><ArticleId IdType="pmc">PMC6343052</ArticleId><ArticleId IdType="pubmed">30705797</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xe1;sica A. Minist&#xe9;rio da sa&#xfa;de secretaria de aten&#xe7;&#xe3;o &#xe0; sa&#xfa;de departamento de aten&#xe7;&#xe3;o b&#xe1;sica. Bras&#xed;lia; 2013.</Citation></Reference><Reference><Citation>Swanson JM, Entringer S, Buss C, Wadhwa PD. Developmental origins of health and disease: environmental exposures. Semin Reprod Med. 2009;27(5):391&#x2013;402. doi: 10.1055/s-0029-1237427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0029-1237427</ArticleId><ArticleId IdType="pmc">PMC2862627</ArticleId><ArticleId IdType="pubmed">19711249</ArticleId></ArticleIdList></Reference><Reference><Citation>Armitage JA, Poston L, Taylor PD. Developmental origins of obesity and the metabolic syndrome: the role of maternal obesity. Obes Metab. 2008;36:73&#x2013;84. doi: 10.1159/000115355.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000115355</ArticleId><ArticleId IdType="pubmed">18230895</ArticleId></ArticleIdList></Reference><Reference><Citation>Jans G, Matthys C, Bogaerts A, Lannoo M, Verhaeghe J, Van der Schueren B, Devlieger R. Maternal micronutrient deficiencies and related adverse neonatal outcomes after bariatric surgery: a systematic review. Adv Nutr. 2015;6(4):420&#x2013;429. doi: 10.3945/an.114.008086.</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/an.114.008086</ArticleId><ArticleId IdType="pmc">PMC4496736</ArticleId><ArticleId IdType="pubmed">26178026</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyake Y, Tanaka K, Okubo H, Sasaki S, Furukawa S, Arakawa M. Manganese intake is inversely associated with depressive symptoms during pregnancy in Japan: baseline data from the Kyushu Okinawa maternal and child health study. J Affect Disord. 2017;211:124&#x2013;129. doi: 10.1016/j.jad.2017.01.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2017.01.016</ArticleId><ArticleId IdType="pubmed">28110159</ArticleId></ArticleIdList></Reference><Reference><Citation>Chasan-Taber L, Marcus BH, Stanek E, III, Ciccolo JT, Marquez DX, Solomon CG, Markenson GJ. A randomized controlled trial of prenatal physical activity to prevent gestational diabetes: design and methods. J Womens Health. 2009;18(6):851&#x2013;9. doi: 10.1089/jwh.2008.1006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jwh.2008.1006</ArticleId><ArticleId IdType="pmc">PMC2851124</ArticleId><ArticleId IdType="pubmed">19514827</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahan LK, Escott-Stump S. Krause's food, nutrition, and diet therapy. Philadelphia: Saunders Philadelphia; 2004.</Citation></Reference><Reference><Citation>Kazemi AF, Hajian S, Sharifi NJ. The psychometric properties of the persian version of the pregnancy physical activity questionnaire. Int J Womens Health Reprod Sci. 2019;7(1):54&#x2013;60. doi: 10.15296/ijwhr.2019.09.</Citation><ArticleIdList><ArticleId IdType="doi">10.15296/ijwhr.2019.09</ArticleId></ArticleIdList></Reference><Reference><Citation>Samani S, Jokar B. Validity and reliability short-form version of the depression, anxiety and stress. J Soc Sci Humanit Univ Shiraz. 2008;26:65&#x2013;77.</Citation></Reference><Reference><Citation>Vayssi&#xe8;re C, Haumonte J-B, Chantry A, Coatleven F, Debord MP, Gomez C, et al. Prolonged and post-term pregnancies: guidelines for clinical practice from the French College of Gynecologists and Obstetricians (CNGOF) Eur J Obstet Gynecolx Reprod Biol. 2013;169(1):10&#x2013;16. doi: 10.1016/j.ejogrb.2013.01.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejogrb.2013.01.026</ArticleId><ArticleId IdType="pubmed">23434325</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasir M, Sohail I, Siraj N. Estimated fetal weight; a comparison between clinical and ultrasonographical measurements. J Soc Obstet Gynaecol Pak. 2019;9(3):135&#x2013;140.</Citation></Reference><Reference><Citation>Stewart ZA. Gestational diabetes. Obstet Gynaecol Reprod Med. 2020;30(3):79&#x2013;83. doi: 10.1016/j.ogrm.2019.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ogrm.2019.12.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Iriye BK, Gregory KD, Saade GR, Grobman WA, Brown HL. Quality measures in high-risk pregnancies: executive summary of a cooperative workshop of the Society for Maternal-Fetal Medicine, National Institute of Child Health and Human Development, and the American College of Obstetricians and Gynecologists. Amer J Obstetr Gynecol. 2017;217(4):B2&#x2013;5. doi: 10.1016/j.ajog.2017.07.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2017.07.018</ArticleId><ArticleId IdType="pubmed">28735702</ArticleId></ArticleIdList></Reference><Reference><Citation>International Association of Diabetes Pregnancy Study Groups Recommendations on the diagnosis and classification of hyperglycaemia in pregnancy. Diab Care. 2010;33:676&#x2013;82. doi: 10.2337/dc09-1848.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc09-1848</ArticleId><ArticleId IdType="pmc">PMC2827530</ArticleId><ArticleId IdType="pubmed">20190296</ArticleId></ArticleIdList></Reference><Reference><Citation>Lockwood CJ. ACOG task force on hypertension in pregnancy. Contemp OB/GYN. 2013;58(12):10.</Citation></Reference><Reference><Citation>Salomon LJ, Bernard JP, De Stavola B, Kenward M, Ville Y. Birth weight and size: charts and equations. J Gynecol Obstetr Biol Reprod. 2007;36(1):50&#x2013;56. doi: 10.1016/j.jgyn.2006.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jgyn.2006.09.001</ArticleId><ArticleId IdType="pubmed">17254718</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28248851</PMID><DateCompleted><Year>2017</Year><Month>03</Month><Day>24</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>96</Volume><Issue>9</Issue><PubDate><Year>2017</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Acute kidney injury in patients with pulmonary embolism: A population-based cohort study.</ArticleTitle><Pagination><StartPage>e5822</StartPage><MedlinePgn>e5822</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e5822</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000005822</ELocationID><Abstract><AbstractText>Acute kidney injury (AKI) is overlooked in patients with pulmonary embolism (PE). Risk factors for and long-term outcomes of this complication remain unknown. This study evaluated the predictors and prognosis of AKI in patients with PE.This retrospective cohort study used Taiwan's National Health Insurance Research Database. We enrolled a total of 7588 patients who were admitted to a hospital for PE from January1997 to December 2011 and administered anticoagulation or thrombolytic agents. All demographic data, risk factors, and outcomes were analyzed.AKI was diagnosed in 372 (4.9%) patients. Multivariate logistic regression analysis revealed pre-existing chronic kidney disease, hypertension, diabetes mellitus, massive PE, anemia, and sepsis as independent risk factors for AKI. In the long-term follow-up, the survival rate was similar in the AKI and non-AKI groups.Careful risk factor screening and intensive intervention in patients with AKI might yield outcomes similar to those in patients without AKI.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Chih-Hsiang</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Kidney Research Center, Chang Gung Memorial Hospital, Linkou Medical Center Department of Nephrology, Chang Gung Memorial Hospital, Kaohsiung Medical Center Division of Thoracic and Cardiovascular Surgery, Department of Surgery, Chang Gung Memorial Hospital, Linkou Medical Center, Chang Gung University, Taoyuan City Department of Cardiology, Chang Gung Memorial Hospital, Linkou Medical Center Clinical Informatics and Medical Statistics Research Center, Chang Gung University, Taoyuan City Department of Cardiology, Chang Gung Memorial Hospital, Keelung Branch Division of Allergy, Asthma, and Rheumatology, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Chung-Ming</ForeName><Initials>CM</Initials></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Pei-Chun</ForeName><Initials>PC</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Shao-Wei</ForeName><Initials>SW</Initials></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Su-Wei</ForeName><Initials>SW</Initials></Author><Author ValidYN="Y"><LastName>Mao</LastName><ForeName>Chun-Tai</ForeName><Initials>CT</Initials></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Ya-Chung</ForeName><Initials>YC</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yung-Chang</ForeName><Initials>YC</Initials></Author><Author ValidYN="Y"><LastName>Chu</LastName><ForeName>Pao-Hsien</ForeName><Initials>PH</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Tien-Hsing</ForeName><Initials>TH</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013624" MajorTopicYN="N">Taiwan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>3</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28248851</ArticleId><ArticleId IdType="pmc">PMC5340424</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000005822</ArticleId><ArticleId IdType="pii">00005792-201703030-00002</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chertow GM, Burdick E, Honour M, et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005;16:3365&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">16177006</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YC, Tsai FC, Chang CH, et al. Prognosis of patients on extracorporeal membrane oxygenation: the impact of acute kidney injury on mortality. Ann Thorac Surg 2011;91:137&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">21172502</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang CH, Chang CH, Chen TH, et al. Combination of urinary biomarkers improves early detection of acute kidney injury in ppatients With heart failure. Circ J 2016;80:1017&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">26888148</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen TH, Chang CH, Lin CY, et al. Acute kidney injury biomarkers for patients in a coronary care unit: a prospective cohort study. PloS One 2012;7:e32328.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3285210</ArticleId><ArticleId IdType="pubmed">22384218</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang CH, Lee CC, Chen SW, et al. Predicting acute kidney injury following mitral valve repair. Int J Med Sci 2016;13:19&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4716816</ArticleId><ArticleId IdType="pubmed">26816491</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostrubiec M, Pruszczyk P, Bochowicz A, et al. Biomarker-based risk assessment model in acute pulmonary embolism. Eur Heart J 2005;26:2166&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">15911566</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999;353:1386&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">10227218</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostrubiec M, Labyk A, Pedowska-Wloszek J, et al. Neutrophil gelatinase-associated lipocalin, cystatin C and eGFR indicate acute kidney injury and predict prognosis of patients with acute pulmonary embolism. Heart 2012;98:1221&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">22705926</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsing AW, Ioannidis JP. Nationwide population science: lessons from the Taiwan National Health Insurance Research Database. JAMA Int Med 2015;175:1527&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">26192815</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen DY, Mao CT, Tsai ML, et al. Clinical outcomes of drug-eluting stents versus bare-metal stents in patients with cardiogenic shock complicating acute myocardial infarction. Int J Cardiol 2016;215:98&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pubmed">27111168</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiener RS, Schwartz LM, Woloshin S. Time trends in pulmonary embolism in the United States: evidence of overdiagnosis. Arch Int Med 2011;171:831&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3140219</ArticleId><ArticleId IdType="pubmed">21555660</ArticleId></ArticleIdList></Reference><Reference><Citation>Tagalakis V, Patenaude V, Kahn SR, et al. Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE Study Cohort. Am J Med 2013;126: 832.e813-821.</Citation><ArticleIdList><ArticleId IdType="pubmed">23830539</ArticleId></ArticleIdList></Reference><Reference><Citation>Schrier RW, Bansal S. Pulmonary hypertension, right ventricular failure, and kidney: different from left ventricular failure? Clin J Am Soc Nephrol 2008;3:1232&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4571151</ArticleId><ArticleId IdType="pubmed">18614776</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Dorzi HM, Al-Heijan A, Tamim HM, et al. Renal failure as a risk factor for venous thromboembolism in critically Ill patients: a cohort study. Thrombosis Res 2013;132:671&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">24144445</ArticleId></ArticleIdList></Reference><Reference><Citation>Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int 2012;81:442&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3788581</ArticleId><ArticleId IdType="pubmed">22113526</ArticleId></ArticleIdList></Reference><Reference><Citation>James MT, Ghali WA, Tonelli M, et al. Acute kidney injury following coronary angiography is associated with a long-term decline in kidney function. Kidney Int 2010;78:803&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">20686453</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39594154</PMID><DateRevised><Year>2024</Year><Month>11</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-4418</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>22</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>07</Day></PubDate></JournalIssue><Title>Diagnostics (Basel, Switzerland)</Title><ISOAbbreviation>Diagnostics (Basel)</ISOAbbreviation></Journal><ArticleTitle>Prevalence of Mitral Valve Prolapse Among Individuals with Pectus Excavatum: A Systematic Review and Meta-Analysis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2488</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/diagnostics14222488</ELocationID><Abstract><AbstractText><b>Background</b>: During the last decades, a small number of studies reported a wide range of variability in the estimated prevalence of mitral valve prolapse (MVP) among individuals with pectus excavatum (PE). The present systematic review and meta-analysis has been primarily designed to summarize the main findings of these studies and to estimate the overall prevalence of MVP among PE individuals. <b>Methods</b>: All imaging studies assessing the prevalence of MVP in PE individuals vs. healthy controls, selected from PubMed and EMBASE databases, were included. The risk of bias was assessed by using the National Institutes of Health (NIH) Quality Assessment of Case-Control Studies. Events (presence of MVP) and nonevents (absence of MVP) in PE individuals and control groups were recorded. The main outcome was the measure of odds ratio (OR) for MVP presence pooled with 95% confidence intervals, using a fixed-effects model. <b>Results</b>: The full texts of eight studies with 303 PE patients (mean age 25.7 yrs) and 498 healthy controls (mean age 31 yrs) were analyzed. Three studies assessed MVP prevalence in children and early adolescents, whereas the remaining five studies examined PE adults. The prevalence of MVP in PE individuals and healthy controls was 40.6% and 12.8%, respectively. In the pooled sample, the OR for MVP presence was significantly higher in PE individuals compared to controls (OR = 5.80, 95%CI = 3.83-8.78, Z = 8.30, <i>p</i> &lt; 0.001). Subgroup analysis revealed that MVP prevalence was approximately three-fold higher among PE children and early adolescents compared with PE adults. Overall, high consistency was observed in the pooled effect sizes, due to the low statistical heterogeneity among the included studies (I<sup>2</sup> = 22.7%, <i>p</i> = 0.25). Egger's test for a regression intercept gave a <i>p</i>-value of 0.07, indicating no publication bias. The sensitivity analysis supported the robustness of the results. <b>Conclusions</b>: PE individuals are nearly six times more likely to have MVP than controls. MVP prevalence is three-fold higher in PE individuals during childhood and early adolescence, compared to PE adults. Given the strong association between MVP and PE, MVP should be suspected in all individuals with anterior chest wall deformity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sonaglioni</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Cardiology, IRCCS MultiMedica, 20123 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bruno</LastName><ForeName>Antonino</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4790-0861</Identifier><AffiliationInfo><Affiliation>Laboratory of Innate Immunity, IRCCS MultiMedica, 20138 Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Immunology and General Pathology, Department of Biotechnology and Life Sciences, University of Insubria, 21100 Varese, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Polymeropoulos</LastName><ForeName>Alessio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-2652-3964</Identifier><AffiliationInfo><Affiliation>Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicolosi</LastName><ForeName>Gian Luigi</ForeName><Initials>GL</Initials><Identifier Source="ORCID">0000-0002-2218-2808</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Policlinico San Giorgio, 33170 Pordenone, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lombardo</LastName><ForeName>Michele</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Cardiology, IRCCS MultiMedica, 20123 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muti</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Biomedical, Surgical and Dental Sciences, University of Milan, 20122 Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IRCCS MultiMedica, 20138 Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>N/A.</GrantID><Agency>Ministero della Salute</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Diagnostics (Basel)</MedlineTA><NlmUniqueID>101658402</NlmUniqueID><ISSNLinking>2075-4418</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Haller index</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">mitral valve prolapse</Keyword><Keyword MajorTopicYN="N">pectus excavatum</Keyword><Keyword MajorTopicYN="N">prevalence</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>10</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>11</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>27</Day><Hour>6</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>27</Day><Hour>6</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>27</Day><Hour>1</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39594154</ArticleId><ArticleId IdType="pmc">PMC11592659</ArticleId><ArticleId IdType="doi">10.3390/diagnostics14222488</ArticleId><ArticleId IdType="pii">diagnostics14222488</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Janssen N., Coorens N.A., Franssen A.J.P.M., Daemen J.H.T., Michels I.L., Hulsew&#xe9; K.W.E., Vissers Y.L.J., de Loos E.R. Pectus excavatum and carinatum: A narrative review of epidemiology, etiopathogenesis, clinical features, and classification. J. Thorac. Dis. 2024;16:1687&#x2013;1701. doi: 10.21037/jtd-23-957.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd-23-957</ArticleId><ArticleId IdType="pmc">PMC10944748</ArticleId><ArticleId IdType="pubmed">38505013</ArticleId></ArticleIdList></Reference><Reference><Citation>Biavati M., Kozlitina J., Alder A.C., Foglia R., McColl R.W., Peshock R.M., Kelly R.E., Jr., Garcia C.K. Prevalence of pectus excavatum in an adult population-based cohort estimated from radiographic indices of chest wall shape. PLoS ONE. 2020;15:e0232575. doi: 10.1371/journal.pone.0232575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0232575</ArticleId><ArticleId IdType="pmc">PMC7205298</ArticleId><ArticleId IdType="pubmed">32379835</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaroszewski D.E., Farina J.M., Gotway M.B., Stearns J.D., Peterson M.A., Pulivarthi V.S.K.K., Bostoros P., Abdelrazek A.S., Gotimukul A., Majdalany D.S., et al. Cardiopulmonary Outcomes After the Nuss Procedure in Pectus Excavatum. J. Am. Heart Assoc. 2022;11:e022149. doi: 10.1161/JAHA.121.022149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.121.022149</ArticleId><ArticleId IdType="pmc">PMC9075480</ArticleId><ArticleId IdType="pubmed">35377159</ArticleId></ArticleIdList></Reference><Reference><Citation>Fonkalsrud E.W., Dunn J.C., Atkinson J.B. Repair of pectus excavatum deformities: 30 years of experience with 375 patients. Ann. Surg. 2000;231:443&#x2013;448. doi: 10.1097/00000658-200003000-00019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000658-200003000-00019</ArticleId><ArticleId IdType="pmc">PMC1421017</ArticleId><ArticleId IdType="pubmed">10714639</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly R.E., Goretsky M.J., Obermeyer R., Kuhn M.A., Redlinger R., Haney T.S., Moskowitz A., Nuss D. Twenty-one years of experience with minimally invasive repair of pectus excavatum by the Nuss procedure in 1215 patients. Ann. Surg. 2010;252:1072&#x2013;1081. doi: 10.1097/SLA.0b013e3181effdce.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0b013e3181effdce</ArticleId><ArticleId IdType="pubmed">21107118</ArticleId></ArticleIdList></Reference><Reference><Citation>Haller J.A., Jr., Kramer S.S., Lietman S.A. Use of CT scans in selection of patients for pectus excavatum surgery: A preliminary report. J. Pediatr. Surg. 1987;22:904&#x2013;906. doi: 10.1016/S0022-3468(87)80585-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3468(87)80585-7</ArticleId><ArticleId IdType="pubmed">3681619</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuss D. Minimally invasive surgical repair of pectus excavatum. Semin. Pediatr. Surg. 2008;17:209&#x2013;217. doi: 10.1053/j.sempedsurg.2008.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.sempedsurg.2008.03.003</ArticleId><ArticleId IdType="pubmed">18582827</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao C.J., Jaroszewski D., Gotway M., Ewais M., Wilansky S., Lester S., Unzek S., Appleton C.P., Chaliki H.P., Gaitan B.D., et al. Effects of Pectus Excavatum Repair on Right and Left Ventricular Strain. Ann. Thorac. Surg. 2018;105:294&#x2013;301. doi: 10.1016/j.athoracsur.2017.08.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2017.08.017</ArticleId><ArticleId IdType="pubmed">29162223</ArticleId></ArticleIdList></Reference><Reference><Citation>Raggio I.M., Mart&#xed;nez-Ferro M., Bell&#xed;a-Munz&#xf3;n G., Capunay C., Mun&#xed;n M., Toselli L., Carrascosa P., Rodr&#xed;guez-Granillo G.A. Diastolic and Systolic Cardiac Dysfunction in Pectus Excavatum: Relationship to Exercise and Malformation Severity. Radiol. Cardiothorac. Imaging. 2020;2:e200011. doi: 10.1148/ryct.2020200011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/ryct.2020200011</ArticleId><ArticleId IdType="pmc">PMC7978017</ArticleId><ArticleId IdType="pubmed">33778619</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonaglioni A., Nicolosi G.L., Lombardo M. The relationship between mitral valve prolapse and thoracic skeletal abnormalities in clinical practice: A systematic review. J. Cardiovasc. Med. 2024;25:353&#x2013;363. doi: 10.2459/JCM.0000000000001614.</Citation><ArticleIdList><ArticleId IdType="doi">10.2459/JCM.0000000000001614</ArticleId><ArticleId IdType="pubmed">38526955</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilbert B.W., Schatz R.A., VonRamm O.T., Behar V.S., Kisslo J.A. Mitral valve prolapse. Two-dimensional echocardiographic and angiographic correlation. Circulation. 1976;54:716&#x2013;723. doi: 10.1161/01.CIR.54.5.716.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.54.5.716</ArticleId><ArticleId IdType="pubmed">975465</ArticleId></ArticleIdList></Reference><Reference><Citation>Morganroth J., Jones R.H., Chen C.C., Naito M. Two dimensional echocardiography in mitral, aortic and tricuspid valve prolapse. The clinical problem, cardiac nuclear imaging considerations and a proposed standard for diagnosis. Am. J. Cardiol. 1980;46:1164&#x2013;1177. doi: 10.1016/0002-9149(80)90287-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9149(80)90287-8</ArticleId><ArticleId IdType="pubmed">7006361</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine R.A., Stathogiannis E., Newell J.B., Harrigan P., Weyman A.E. Reconsideration of echocardiographic standards for mitral valve prolapse: Lack of association between leaflet displacement isolated to the apical four chamber view and independent echocardiographic evidence of abnormality. J. Am. Coll. Cardiol. 1988;11:1010&#x2013;1019. doi: 10.1016/S0735-1097(98)90059-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0735-1097(98)90059-6</ArticleId><ArticleId IdType="pubmed">3281989</ArticleId></ArticleIdList></Reference><Reference><Citation>Freed L.A., Levy D., Levine R.A., Larson M.G., Evans J.C., Fuller D.L., Lehman B., Benjamin E.J. Prevalence and clinical outcome of mitral-valve prolapse. N. Engl. J. Med. 1999;341:1&#x2013;7. doi: 10.1056/NEJM199907013410101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199907013410101</ArticleId><ArticleId IdType="pubmed">10387935</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D., Liberati A., Tetzlaff J., Altman D.G., PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 2009;6:e1000097. doi: 10.1371/journal.pmed.1000097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1000097</ArticleId><ArticleId IdType="pmc">PMC2707599</ArticleId><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma L.L., Wang Y.Y., Yang Z.H., Huang D., Weng H., Zeng X.T. Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: What are they and which is better? Mil. Med. Res. 2020;7:7. doi: 10.1186/s40779-020-00238-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40779-020-00238-8</ArticleId><ArticleId IdType="pmc">PMC7049186</ArticleId><ArticleId IdType="pubmed">32111253</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochran W.G. The comparison of percentages in matched samples. Biometrika. 1950;37:256&#x2013;266. doi: 10.1093/biomet/37.3-4.256.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/biomet/37.3-4.256</ArticleId><ArticleId IdType="pubmed">14801052</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 2002;21:1539&#x2013;1558. doi: 10.1002/sim.1186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1186</ArticleId><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>Borenstein M., Hedges L.V., Higgins J.P., Rothstein H.R. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res. Synth. Methods. 2010;1:97&#x2013;111. doi: 10.1002/jrsm.12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrsm.12</ArticleId><ArticleId IdType="pubmed">26061376</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee C.H., Cook S., Lee J.S., Han B. Comparison of Two Meta-Analysis Methods: Inverse-Variance-Weighted Average and Weighted Sum of Z-Scores. Genom. Inform. 2016;14:173&#x2013;180. doi: 10.5808/GI.2016.14.4.173.</Citation><ArticleIdList><ArticleId IdType="doi">10.5808/GI.2016.14.4.173</ArticleId><ArticleId IdType="pmc">PMC5287121</ArticleId><ArticleId IdType="pubmed">28154508</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629&#x2013;634. doi: 10.1136/bmj.315.7109.629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.315.7109.629</ArticleId><ArticleId IdType="pmc">PMC2127453</ArticleId><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference><Reference><Citation>Thabane L., Mbuagbaw L., Zhang S., Samaan Z., Marcucci M., Ye C., Thabane M., Giangregorio L., Dennis B., Kosa D., et al. A tutorial on sensitivity analyses in clinical trials: The what, why, when and how. BMC Med. Res. Methodol. 2013;13:92. doi: 10.1186/1471-2288-13-92.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-13-92</ArticleId><ArticleId IdType="pmc">PMC3720188</ArticleId><ArticleId IdType="pubmed">23855337</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J.M., Varma S.K. Pectus excavatum in children: Diagnostic significance for mitral valve prolapse. Indian J. Pediatr. 1990;57:219&#x2013;222. doi: 10.1007/BF02722092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02722092</ArticleId><ArticleId IdType="pubmed">2246020</ArticleId></ArticleIdList></Reference><Reference><Citation>Mocchegiani R., Badano L., Lestuzzi C., Nicolosi G.L., Zanuttini D. Relation of right ventricular morphology and function in pectus excavatum to the severity of the chest wall deformity. Am. J. Cardiol. 1995;76:941&#x2013;946. doi: 10.1016/S0002-9149(99)80266-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9149(99)80266-5</ArticleId><ArticleId IdType="pubmed">7484836</ArticleId></ArticleIdList></Reference><Reference><Citation>Nomura K., Ajiro Y., Nakano S., Matsushima M., Yamaguchi Y., Hatakeyama N., Ohata M., Sakuma M., Nonaka T., Harii M., et al. Characteristics of mitral valve leaflet length in patients with pectus excavatum: A single center cross-sectional study. PLoS ONE. 2019;14:e0212165. doi: 10.1371/journal.pone.0212165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0212165</ArticleId><ArticleId IdType="pmc">PMC6370242</ArticleId><ArticleId IdType="pubmed">30742685</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonaglioni A., Nicolosi G.L., Granato A., Lombardo M., Anz&#xe0; C., Ambrosio G. Reduced Myocardial Strain Parameters in Subjects with Pectus Excavatum: Impaired Myocardial Function or Methodological Limitations Due to Chest Deformity? Semin. Thorac. Cardiovasc. Surg. 2021;33:251&#x2013;262. doi: 10.1053/j.semtcvs.2020.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.semtcvs.2020.05.003</ArticleId><ArticleId IdType="pubmed">32442666</ArticleId></ArticleIdList></Reference><Reference><Citation>Karabulut M. Increased incidence of mitral valve prolapse in children with pectus chest wall deformity. Pediatr. Int. 2023;65:e15582. doi: 10.1111/ped.15582.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ped.15582</ArticleId><ArticleId IdType="pubmed">37518971</ArticleId></ArticleIdList></Reference><Reference><Citation>Acipayam A., G&#xfc;ll&#xfc; U.U., G&#xfc;ng&#xf6;r &#x15e;. Cardiac anomalies in pediatric patients with pectus excavatum. Rev. Assoc. Med. Bras. (1992) 2023;69:e20221301. doi: 10.1590/1806-9282.20221301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1806-9282.20221301</ArticleId><ArticleId IdType="pmc">PMC10352011</ArticleId><ArticleId IdType="pubmed">37466586</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohneck A., Ansari U., Natale M., Wittig K., Overhoff D., Riffel P., Boettcher M., Akin I., Duerschmied D., Papavassiliu T. Description of a new clinical syndrome: Thoracic constriction without evidence of the typical funnel-shaped depression-the &#x201c;invisible&#x201d; pectus excavatum. Sci. Rep. 2023;13:12036. doi: 10.1038/s41598-023-38739-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-38739-w</ArticleId><ArticleId IdType="pmc">PMC10368685</ArticleId><ArticleId IdType="pubmed">37491452</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdulmonem L., Hashem D., Chan V.S.H., Hanneman K., Wald R.M., Thavendiranathan P., Ouzounian M., Oechslin E., Karur G.R. Association of Pectus Excavatum with Ventricular Remodelling and Mitral Valve Abnormalities in Marfan Syndrome. Can. Assoc. Radiol. J. 2023;74:446&#x2013;454. doi: 10.1177/08465371221127236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/08465371221127236</ArticleId><ArticleId IdType="pubmed">36164999</ArticleId></ArticleIdList></Reference><Reference><Citation>Freed L.A., Benjamin E.J., Levy D., Larson M.G., Evans J.C., Fuller D.L., Lehman B., Levine R.A. Mitral valve prolapse in the general population: The benign nature of echocardiographic features in the Framingham Heart Study. J. Am. Coll. Cardiol. 2002;40:1298&#x2013;1304. doi: 10.1016/S0735-1097(02)02161-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0735-1097(02)02161-7</ArticleId><ArticleId IdType="pubmed">12383578</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugimoto T., Dulgheru R., Bernard A., Ilardi F., Contu L., Addetia K., Caballero L., Akhaladze N., Athanassopoulos G.D., Barone D., et al. Echocardiographic reference ranges for normal left ventricular 2D strain: Results from the EACVI NORRE study. Eur. Heart J. Cardiovasc. Imaging. 2017;18:833&#x2013;840. doi: 10.1093/ehjci/jex140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jex140</ArticleId><ArticleId IdType="pubmed">28637227</ArticleId></ArticleIdList></Reference><Reference><Citation>Muraru D., Onciul S., Peluso D., Soriani N., Cucchini U., Aruta P., Romeo G., Cavalli G., Iliceto S., Badano L.P. Sex- and Method-Specific Reference Values for Right Ventricular Strain by 2-Dimensional Speckle-Tracking Echocardiography. Circ. Cardiovasc. Imaging. 2016;9:e003866. doi: 10.1161/CIRCIMAGING.115.003866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCIMAGING.115.003866</ArticleId><ArticleId IdType="pubmed">26860970</ArticleId></ArticleIdList></Reference><Reference><Citation>Fokin A.A., Steuerwald N.M., Ahrens W.A., Allen K.E. Anatomical, histologic, and genetic characteristics of congenital chest wall deformities. Semin. Thorac. Cardiovasc. Surg. 2009;21:44&#x2013;57. doi: 10.1053/j.semtcvs.2009.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.semtcvs.2009.03.001</ArticleId><ArticleId IdType="pubmed">19632563</ArticleId></ArticleIdList></Reference><Reference><Citation>Hetzer R., Siegel G., Delmo Walter E.M. Cardiomyopathy in Marfan syndrome. Eur. J. Cardiothorac. Surg. 2016;49:561&#x2013;567. doi: 10.1093/ejcts/ezv073. discussion 567&#x2013;568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezv073</ArticleId><ArticleId IdType="pubmed">25755184</ArticleId></ArticleIdList></Reference><Reference><Citation>Parwani P., Avierinos J.F., Levine R.A., Delling F.N. Mitral Valve Prolapse: Multimodality Imaging and Genetic Insights. Prog. Cardiovasc. Dis. 2017;60:361&#x2013;369. doi: 10.1016/j.pcad.2017.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pcad.2017.10.007</ArticleId><ArticleId IdType="pmc">PMC5805573</ArticleId><ArticleId IdType="pubmed">29122631</ArticleId></ArticleIdList></Reference><Reference><Citation>Delling F.N., Vasan R.S. Epidemiology and pathophysiology of mitral valve prolapse: New insights into disease progression, genetics, and molecular basis. Circulation. 2014;129:2158&#x2013;2170. doi: 10.1161/CIRCULATIONAHA.113.006702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.113.006702</ArticleId><ArticleId IdType="pmc">PMC4052751</ArticleId><ArticleId IdType="pubmed">24867995</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayek E., Gring C.N., Griffin B.P. Mitral valve prolapse. Lancet. 2005;365:507&#x2013;518. doi: 10.1016/S0140-6736(05)17869-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(05)17869-6</ArticleId><ArticleId IdType="pubmed">15705461</ArticleId></ArticleIdList></Reference><Reference><Citation>Turker Y., Ozaydin M., Acar G., Ozgul M., Hoscan Y., Varol E., Dogan A., Erdogan D. Predictors of atrial arrhythmias in patients with mitral valve prolapse. Acta Cardiol. 2009;64:755&#x2013;760. doi: 10.2143/AC.64.6.2044739.</Citation><ArticleIdList><ArticleId IdType="doi">10.2143/AC.64.6.2044739</ArticleId><ArticleId IdType="pubmed">20128151</ArticleId></ArticleIdList></Reference><Reference><Citation>Bon Tempo C.P., Ronan J.A., Jr., de Leon A.C., Jr., Twigg H.L. Radiographic appearance of the thorax in systolic click-late systolic murmur syndrome. Am. J. Cardiol. 1975;36:27&#x2013;31. doi: 10.1016/0002-9149(75)90863-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9149(75)90863-2</ArticleId><ArticleId IdType="pubmed">1146694</ArticleId></ArticleIdList></Reference><Reference><Citation>Udoshi M.B., Shah A., Fisher V.J., Dolgin M. Incidence of mitral valve prolapse in subjects with thoracic skeletal abnormalities&#x2014;A prospective study. Am. Heart J. 1979;97:303&#x2013;311. doi: 10.1016/0002-8703(79)90429-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-8703(79)90429-0</ArticleId><ArticleId IdType="pubmed">420069</ArticleId></ArticleIdList></Reference><Reference><Citation>Goretsky M.J., Kelly R.E., Jr., Croitoru D., Nuss D. Chest wall anomalies: Pectus excavatum and pectus carinatum. Adolesc. Med. Clin. 2004;15:455&#x2013;471. doi: 10.1016/j.admecli.2004.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.admecli.2004.06.002</ArticleId><ArticleId IdType="pubmed">15625987</ArticleId></ArticleIdList></Reference><Reference><Citation>Koumbourlis A.C. Chest wall abnormalities and their clinical significance in childhood. Paediatr. Respir. Rev. 2014;15:246&#x2013;254. doi: 10.1016/j.prrv.2013.12.003. quiz 254&#x2013;255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.prrv.2013.12.003</ArticleId><ArticleId IdType="pubmed">24462760</ArticleId></ArticleIdList></Reference><Reference><Citation>Boudoulas K.D., Pitsis A.A., Mazzaferri E.L., Gumina R.J., Triposkiadis F., Boudoulas H. Floppy mitral valve/mitral valve prolapse: A complex entity with multiple genotypes and phenotypes. Prog. Cardiovasc. Dis. 2020;63:308&#x2013;326. doi: 10.1016/j.pcad.2020.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pcad.2020.03.004</ArticleId><ArticleId IdType="pubmed">32201287</ArticleId></ArticleIdList></Reference><Reference><Citation>Oezcan S., Attenhofer Jost C.H., Pfyffer M., Kellenberger C., Jenni R., Binggeli C., Faeh-Gunz A., Seifert B., Scharf C., Kretschmar O., et al. Pectus excavatum: Echocardiography and cardiac MRI reveal frequent pericardial effusion and right-sided heart anomalies. Eur. Heart J. Cardiovasc. Imaging. 2012;13:673&#x2013;679. doi: 10.1093/ehjci/jer284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jer284</ArticleId><ArticleId IdType="pubmed">22298154</ArticleId></ArticleIdList></Reference><Reference><Citation>Malev E., Zemtsovsky E., Pshepiy A., Timofeev E., Reeva S., Prokudina M. Evaluation of left ventricular systolic function in young adults with mitral valve prolapse. Exp. Clin. Cardiol. 2012;17:165&#x2013;168.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3627267</ArticleId><ArticleId IdType="pubmed">23592928</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda S., Song J.K., Mahara K., Kuwaki H., Jang J.Y., Takeuchi M., Sun B.J., Kim Y.J., Miyamoto T., Oginosawa Y., et al. Basal Left Ventricular Dilatation and Reduced Contraction in Patients with Mitral Valve Prolapse Can Be Secondary to Annular Dilatation: Preoperative and Postoperative Speckle-Tracking Echocardiographic Study on Left Ventricle and Mitral Valve Annulus Interaction. Circ. Cardiovasc. Imaging. 2016;9:e005113.</Citation><ArticleIdList><ArticleId IdType="pubmed">27729364</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonaglioni A., Nicolosi G.L., Lombardo M., Gensini G.F., Ambrosio G. Influence of chest conformation on myocardial strain parameters in healthy subjects with mitral valve prolapse. Int. J. Cardiovasc. Imaging. 2021;37:1009&#x2013;1022. doi: 10.1007/s10554-020-02085-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10554-020-02085-z</ArticleId><ArticleId IdType="pubmed">33128156</ArticleId></ArticleIdList></Reference><Reference><Citation>Morganroth J., Mardelli T.J., Naito M., Chen C.C. Apical cross-sectional echocardiography. Standard for the diagnosis of idiopathic mitral valve prolapse syndrome. Chest. 1981;79:23&#x2013;28. doi: 10.1378/chest.79.1.23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.79.1.23</ArticleId><ArticleId IdType="pubmed">7449501</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura R.A., Otto C.M., Bonow R.O., Carabello B.A., Erwin J.P., 3rd, Fleisher L.A., Jneid H., Mack M.J., McLeod C.J., O&#x2019;Gara P.T., et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients with Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;135:e1159&#x2013;e1195. doi: 10.1161/CIR.0000000000000503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000503</ArticleId><ArticleId IdType="pubmed">28298458</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonaglioni A., Baravelli M., Vincenti A., Trevisan R., Zompatori M., Nicolosi G.L., Lombardo M., Anz&#xe0; C. A New modified anthropometric haller index obtained without radiological exposure. Int. J. Cardiovasc. Imaging. 2018;34:1505&#x2013;1509. doi: 10.1007/s10554-018-1366-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10554-018-1366-5</ArticleId><ArticleId IdType="pubmed">29766334</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonaglioni A., Nicolosi G.L., Rigamonti E., Lombardo M. Modified Haller index is inversely correlated with true positive exercise stress echocardiographic results. J. Cardiovasc. Med. 2022;23:524&#x2013;534. doi: 10.2459/JCM.0000000000001344.</Citation><ArticleIdList><ArticleId IdType="doi">10.2459/JCM.0000000000001344</ArticleId><ArticleId IdType="pubmed">35905007</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonaglioni A., Rigamonti E., Nicolosi G.L., Lombardo M. Prognostic Value of Modified Haller Index in Patients with Suspected Coronary Artery Disease Referred for Exercise Stress Echocardiography. J. Cardiovasc. Echogr. 2021;31:85&#x2013;95. doi: 10.4103/jcecho.jcecho_141_20.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jcecho.jcecho_141_20</ArticleId><ArticleId IdType="pmc">PMC8388326</ArticleId><ArticleId IdType="pubmed">34485034</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonaglioni A., Rigamonti E., Nicolosi G.L., Lombardo M. Appropriate use criteria implementation with modified Haller index for predicting stress echocardiographic results and outcome in a population of patients with suspected coronary artery disease. Int. J. Cardiovasc. Imaging. 2021;37:2917&#x2013;2930. doi: 10.1007/s10554-021-02274-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10554-021-02274-4</ArticleId><ArticleId IdType="pubmed">33961159</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura R.A., Carabello B.A., Faxon D.P., Freed M.D., Lytle B.W., O&#x2019;Gara P.T., O&#x2019;Rourke R.A., Shah P.M. ACC/AHA 2008 Guideline update on valvular heart disease: Focused update on infective endocarditis: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J. Am. Coll. Cardiol. 2008;52:676&#x2013;685.</Citation><ArticleIdList><ArticleId IdType="pubmed">18702976</ArticleId></ArticleIdList></Reference><Reference><Citation>Basso C., Iliceto S., Thiene G., Perazzolo Marra M. Mitral Valve Prolapse, Ventricular Arrhythmias, and Sudden Death. Circulation. 2019;140:952&#x2013;964. doi: 10.1161/CIRCULATIONAHA.118.034075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.118.034075</ArticleId><ArticleId IdType="pubmed">31498700</ArticleId></ArticleIdList></Reference><Reference><Citation>Hourdain J., Clavel M.A., Deharo J.C., Asirvatham S., Avierinos J.F., Habib G., Franceschi F., Probst V., Sadoul N., Martins R., et al. Common Phenotype in Patients with Mitral Valve Prolapse Who Experienced Sudden Cardiac Death. Circulation. 2018;138:1067&#x2013;1069. doi: 10.1161/CIRCULATIONAHA.118.033488.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.118.033488</ArticleId><ArticleId IdType="pubmed">30354542</ArticleId></ArticleIdList></Reference><Reference><Citation>Haugaa K. Improving the imaging diagnosis of mitral annular disjunction. Heart. 2021;107:4&#x2013;5. doi: 10.1136/heartjnl-2020-317667.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2020-317667</ArticleId><ArticleId IdType="pubmed">32928893</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">25047161</PMID><DateCompleted><Year>2014</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1434-3916</ISSN><JournalIssue CitedMedium="Internet"><Volume>134</Volume><Issue>11</Issue><PubDate><Year>2014</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Archives of orthopaedic and trauma surgery</Title><ISOAbbreviation>Arch Orthop Trauma Surg</ISOAbbreviation></Journal><ArticleTitle>Complications after arthroscopic knee surgery.</ArticleTitle><Pagination><StartPage>1561</StartPage><EndPage>1564</EndPage><MedlinePgn>1561-4</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00402-014-2054-0</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To examine the complications of arthroscopic knee surgeries conducted in the Sports Medicine and Knee Center of our hospital.</AbstractText><AbstractText Label="SUBJECTS AND METHODS" NlmCategory="METHODS">In this prospective study, a total of 2,623 patients (1,396 men and 1,227 women) who underwent arthroscopic knee surgeries in our center between January 2006 and March 2013 (7&#xa0;years and 3&#xa0;months) were studied. The ages at surgery ranged 7-96&#xa0;years (mean 33.5&#xa0;years). Arthroscopy was conducted because of sports injuries in 1,653 patients (63.0&#xa0;%). The main diagnoses included meniscal injury in 920 patients, discoid meniscus in 64 patients, anterior cruciate ligament injury in 580 knees, posterior cruciate ligament injury in 30 knees, loose body in 61 knees, and intraarticular fracture in 33 knees. Arthroscopic procedures included meniscectomy in 987 knees, meniscal suture repair in 262 knees, and anterior cruciate ligament reconstruction in 508 knees. Intraoperative and postoperative complications in these cases were investigated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The rate of complication was 7 in 2,623 cases (0.27&#xa0;%). Intraoperative complications comprised three cases of intraarticular instrument breakage and one case of meniscal injury. Postoperative complications consisted of two cases of septic arthritis and one case of superficial infection, and reoperation was necessary in the two cases of septic arthritis. There were no neural, vascular and ligament injuries during surgery, and no complex regional pain syndrome, symptomatic deep vein thrombosis, and pulmonary embolism were observed.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Arthroscopic knee surgeries are considered to be minimally invasive, and are conducted relatively safe with low complication rates. In this series, however, seven cases of complications occurred, including two cases (0.08&#xa0;%) of septic arthritis. Furthermore, symptomatic thromboembolism has been reported to occur also in arthroscopic surgery. The risk of severe complications has to be acknowledged.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hagino</LastName><ForeName>Tetsuo</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>The Sports Medicine and Knee Center, Kofu National Hospital, 11-35 Tenjin-cho, Kofu, Yamanashi, 400-8533, Japan, tmhagino@amber.plala.or.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ochiai</LastName><ForeName>Satoshi</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Watanabe</LastName><ForeName>Yoshiyuki</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Senga</LastName><ForeName>Shinya</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Wako</LastName><ForeName>Masanori</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Ando</LastName><ForeName>Takashi</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Sato</LastName><ForeName>Eiichi</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Haro</LastName><ForeName>Hirotaka</ForeName><Initials>H</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>07</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Arch Orthop Trauma Surg</MedlineTA><NlmUniqueID>9011043</NlmUniqueID><ISSNLinking>0936-8051</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001182" MajorTopicYN="N">Arthroscopy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="N">Intraoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007718" MajorTopicYN="N">Knee Injuries</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007719" MajorTopicYN="N">Knee Joint</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016119" MajorTopicYN="N">Posterior Cruciate Ligament</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012086" MajorTopicYN="N">Reoperation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017695" MajorTopicYN="N">Soft Tissue Injuries</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>2</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>12</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25047161</ArticleId><ArticleId IdType="doi">10.1007/s00402-014-2054-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39274190</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>17</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>23</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Circulating Endothelin 1 but Not Transforming Growth Factor-&#x3b2; Levels Are Reduced after Pulmonary Endarterectomy in Subjects Affected by Chronic Thromboembolic Pulmonary Hypertension: A Prospective Cohort Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">4977</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm13174977</ELocationID><Abstract><AbstractText><b>Background and objectives:</b> Endothelin-1 (ET-1) and transforming growth factor-&#x3b2; (TGF-&#x3b2;) play a pivotal role in the pathophysiology and vascular remodeling of chronic thromboembolic pulmonary hypertension (CTEPH) which is an under-diagnosed complication of acute pulmonary embolism (PE). Currently, pulmonary endarterectomy (PEA) is still the treatment of choice for selected patients suffering from CTEPH. The aim of this study was to evaluate the preoperative and postoperative circulating levels of ET-1 and TGF-&#x3b2; in subjects affected by CTEPH undergoing successful surgical treatment by PEA. <b>Methods:</b> The data from patients diagnosed with CTEPH who underwent PEA at the Foundation IRCCS Policlinico San Matteo Hospital (Pavia, Italy) were prospectively recorded in the Institutional database. Circulating ET-1 and TGF-&#x3b2; levels were assessed by an ELISA commercial kit before PEA, at 3 months and 1 year after PEA. The demographic data, preoperatory mean pulmonary arterial pressure (mPAP), cardiac output (CO), and pulmonary vascular resistance (PVR) were also recorded. Univariate and multivariate analyses were performed. <b>Results:</b> The analysis included 340 patients with complete ET-1 measurements and 206 patients with complete TGF-&#x3b2; measurements. ET-1 significantly decreased both at 3 months (<i>p</i> &lt; 0.001) and at 1 year (<i>p</i> = 0.009) after PEA. On the other hand, preoperatory TGF-&#x3b2; levels did not significantly change after PEA. Furthermore, ET-1, but not TGF-&#x3b2;, was a good predictor for increased mPAP in multivariate analyses (<i>p</i> &lt; 0.05). <b>Conclusions:</b> ET-1 but not TGF &#x3b2; was significantly modulated by PEA in subjects affected by CTEPH up to 1 year after surgery. The mechanisms leading to prolonged elevated circulating TGF-&#x3b2; levels and their clinical significance have to be further elucidated.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Totaro</LastName><ForeName>Pasquale</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-5403-6274</Identifier><AffiliationInfo><Affiliation>Division of Cardiac Surgery 2,Pulmonary Hypertension Center, Foundation I.R.C.C.S. Policlinico San Matteo, 27100 Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tirelli</LastName><ForeName>Claudio</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-4502-9902</Identifier><AffiliationInfo><Affiliation>Respiratory Unit, ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20142 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Amici</LastName><ForeName>Mara</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Immuno-Allergology Laboratory of Clinical Chemistry, Foundation I.R.C.C.S. Policlinico San Matteo, 27100 Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grosjean</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Unit of Nephrology, Dialysis-Transplantation, Foundation I.R.C.C.S. Policlinico San Matteo, 27100 Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Testa</LastName><ForeName>Giorgia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Pediatrics Clinic, Foundation I.R.C.C.S. Policlinico San Matteo, 27100 Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sacchi</LastName><ForeName>Lucia</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-1390-9825</Identifier><AffiliationInfo><Affiliation>Department of Electrical, Computer and Biomedical Engineering, University of Pavia, 27100 Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Silvestri</LastName><ForeName>Annalisa</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-3128-8441</Identifier><AffiliationInfo><Affiliation>Scientific Direction, Clinical Epidemiology &amp; Biometric Unit, Foundation I.R.C.C.S. Policlinico San Matteo, 27100 Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alloni</LastName><ForeName>Alessia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Unit of Nephrology, Dialysis-Transplantation, Foundation I.R.C.C.S. Policlinico San Matteo, 27100 Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kushta</LastName><ForeName>Eraldo</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery 2,Pulmonary Hypertension Center, Foundation I.R.C.C.S. Policlinico San Matteo, 27100 Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albertini</LastName><ForeName>Riccardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Immuno-Allergology Laboratory of Clinical Chemistry, Foundation I.R.C.C.S. Policlinico San Matteo, 27100 Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rampino</LastName><ForeName>Teresa</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-5311-9174</Identifier><AffiliationInfo><Affiliation>Unit of Nephrology, Dialysis-Transplantation, Foundation I.R.C.C.S. Policlinico San Matteo, 27100 Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Armini</LastName><ForeName>Andrea Maria</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery 2,Pulmonary Hypertension Center, Foundation I.R.C.C.S. Policlinico San Matteo, 27100 Pavia, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">chronic thromboembolic pulmonary hypertension</Keyword><Keyword MajorTopicYN="N">endothelin 1</Keyword><Keyword MajorTopicYN="N">mean pulmonary arterial pressure</Keyword><Keyword MajorTopicYN="N">pulmonary endarterectomy</Keyword><Keyword MajorTopicYN="N">transforming growth factor-&#x3b2;</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>1</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39274190</ArticleId><ArticleId IdType="pmc">PMC11396395</ArticleId><ArticleId IdType="doi">10.3390/jcm13174977</ArticleId><ArticleId IdType="pii">jcm13174977</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Morrell N.W., Yang X., Upton P.D., Jourdan K.B., Morgan N., Sheares K.K., Trembath R.C. Altered Growth Responses of Pulmonary Artery Smooth Muscle Cells From Pa-tients With Primary Pulmonary Hypertension to Transforming Growth Factor-1 and Bone Morphogenetic Proteins. Circulation. 2001;104:790&#x2013;795. doi: 10.1161/hc3201.094152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/hc3201.094152</ArticleId><ArticleId IdType="pubmed">11502704</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannon J.E., Jenkins D.P., Hoole S.P. Chronic thromboembolic pulmonary hypertension: A review of risk factors, management and current challenges. Expert. Rev. Cardiovasc. Ther. 2022;20:35&#x2013;43. doi: 10.1080/14779072.2022.2034499.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14779072.2022.2034499</ArticleId><ArticleId IdType="pubmed">35081846</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang I.M., Campean I.A., Sadushi-Kolici R., Badr-Eslam R., Gerges C., Skoro-Sajer N. Chronic Thromboembolic Disease and Chronic Thromboembolic Pulmonary Hypertension. Clin. Chest Med. 2021;42:81&#x2013;90. doi: 10.1016/j.ccm.2020.11.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccm.2020.11.014</ArticleId><ArticleId IdType="pubmed">33541619</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamieson S.W., Kapelanski D.P. Pulmonary endarterectomy. Curr. Probl. Surg. 2000;37:165&#x2013;252. doi: 10.1016/S0011-3840(00)80005-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0011-3840(00)80005-2</ArticleId><ArticleId IdType="pubmed">10723452</ArticleId></ArticleIdList></Reference><Reference><Citation>Madani M.M., Jamieson S.W. Pulmonary endarterectomy for chronic thromboembolic disease. Oper. Tech. Thorac. Cardiovasc. Surg. 2006;11:264&#x2013;274. doi: 10.1053/j.optechstcvs.2006.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.optechstcvs.2006.10.002</ArticleId><ArticleId IdType="pubmed">17185187</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;armini A.M., Celentano A., Alloni A., Silvaggio G., Monterosso C., Pellegrini C., Ghio S. Surgical management of pulmonary endarterectomy avoiding deep hypo-thermia: The Pavia experience. Ann. Cardiothorac. Surg. 2022;11:177&#x2013;179. doi: 10.21037/acs-2021-pte-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/acs-2021-pte-22</ArticleId><ArticleId IdType="pmc">PMC9012201</ArticleId><ArticleId IdType="pubmed">35433356</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkins D., Madani M., Fadel E., D&#x2019;Armini A.M., Mayer E. Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension. Eur. Respir. Rev. 2017;26:160111. doi: 10.1183/16000617.0111-2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/16000617.0111-2016</ArticleId><ArticleId IdType="pmc">PMC9489144</ArticleId><ArticleId IdType="pubmed">28298388</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411&#x2013;415. doi: 10.1038/332411a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/332411a0</ArticleId><ArticleId IdType="pubmed">2451132</ArticleId></ArticleIdList></Reference><Reference><Citation>Davenport A.P., Hyndman K.A., Dhaun N., Southan C., Kohan D.E., Pollock J.S., Pollock D.M., Webb D.J., Maguire J.J. Endothelin. Pharmacol. Rev. 2016;68:357&#x2013;418. doi: 10.1124/pr.115.011833.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/pr.115.011833</ArticleId><ArticleId IdType="pmc">PMC4815360</ArticleId><ArticleId IdType="pubmed">26956245</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito Y., Nakao K., Mukoyama M., Imura H. Increased plasma endothelin level in patients with essential hypertension. N. Engl. J. Med. 1990;322:205.</Citation><ArticleIdList><ArticleId IdType="pubmed">2403657</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart D.J., Levy R.D., Cernacek P., Langleben D. Increased plasma endothelin-1 in pulmonary hypertension: Marker or mediator of disease? Ann. Intern. Med. 1991;114:464&#x2013;469. doi: 10.7326/0003-4819-114-6-464.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-114-6-464</ArticleId><ArticleId IdType="pubmed">1994793</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerman A., Edwards B.S., Hallett J.W., Heublein D.M., Sandberg S.M., Burnett J.C. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N. Engl. J. Med. 1991;325:997&#x2013;1001. doi: 10.1056/NEJM199110033251404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199110033251404</ArticleId><ArticleId IdType="pubmed">1886637</ArticleId></ArticleIdList></Reference><Reference><Citation>Jankowich M., Choudhary G. Endothelin-1 levels and cardiovascular events. Trends Cardiovasc. Med. 2020;30:1&#x2013;8. doi: 10.1016/j.tcm.2019.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcm.2019.01.007</ArticleId><ArticleId IdType="pubmed">30765295</ArticleId></ArticleIdList></Reference><Reference><Citation>Reesink H.J., Meijer R.C., Lutter R., Boomsma F., Jansen H.M., Kloek J.J., Bresser P. Hemodynamic and clinical correlates of endothelin-1 in chronic thromboembolic pulmonary hypertension. Circ. J. 2006;70:1058&#x2013;1063. doi: 10.1253/circj.70.1058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.70.1058</ArticleId><ArticleId IdType="pubmed">16864942</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xfc;ger M., Karakurt G., Seyhan E.C., Bolatkale M. Endothelin-1 Gene Polymorphism in Chronic Obstructive Pulmonary Disease: A Case-Control Study. New Trend Med. Sci. 2023;4:143&#x2013;148. doi: 10.56766/ntms.1331707.</Citation><ArticleIdList><ArticleId IdType="doi">10.56766/ntms.1331707</ArticleId></ArticleIdList></Reference><Reference><Citation>Tirelli C., Mira S., Belmonte L.A., De Filippi F., De Grassi M., Italia M., Maggioni S., Guido G., Mondoni M., Canonica G.W., et al. Exploring the Potential Role of Metabolomics in COPD: A Concise Review. Cells. 2024;13:475. doi: 10.3390/cells13060475.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells13060475</ArticleId><ArticleId IdType="pmc">PMC10969696</ArticleId><ArticleId IdType="pubmed">38534319</ArticleId></ArticleIdList></Reference><Reference><Citation>Tirelli C., Arbustini E., Meloni F. Bilateral Cystic Bronchiectasis as Novel Phenotype of Niemann-Pick Disease Type B Successfully Treated With Double Lung Transplantation. Chest. 2021;159:e293&#x2013;e297. doi: 10.1016/j.chest.2020.11.074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2020.11.074</ArticleId><ArticleId IdType="pubmed">33965151</ArticleId></ArticleIdList></Reference><Reference><Citation>Tirelli C., Rondinone O., Italia M., Mira S., Belmonte L.A., De Grassi M., Guido G., Maggioni S., Mondoni M., Miozzo M.R., et al. The Genetic Basis, Lung Involvement, and Therapeutic Options in Niemann-Pick Disease: A Comprehensive Review. Biomolecules. 2024;14:211. doi: 10.3390/biom14020211.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom14020211</ArticleId><ArticleId IdType="pmc">PMC10886890</ArticleId><ArticleId IdType="pubmed">38397448</ArticleId></ArticleIdList></Reference><Reference><Citation>Grosjean F., De Amici M., Klersy C., Marchi G., Sciortino A., Spaltini F., Pin M., Grazioli V., Celentano A., Vanini B., et al. High preoperative plasma endothelin-1 levels are associated with increased acute kidney injury risk after pulmonary endarterectomy. J. Nephrol. 2018;31:881&#x2013;888. doi: 10.1007/s40620-018-0538-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40620-018-0538-7</ArticleId><ArticleId IdType="pubmed">30229506</ArticleId></ArticleIdList></Reference><Reference><Citation>Bochenek M.L., Leidinger C., Rosinus N.S., Gogiraju R., Guth S., Hobohm L., Jurk K., Mayer E., M&#xfc;nzel T., Lankeit M., et al. Activated Endothelial TGF&#x3b2;1 Signaling Promotes Venous Thrombus Nonresolution in Mice Via Endothelin-1: Potential Role for Chronic Thromboembolic Pulmonary Hypertension. Circ. Res. 2020;126:162&#x2013;181. doi: 10.1161/CIRCRESAHA.119.315259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.119.315259</ArticleId><ArticleId IdType="pmc">PMC7101077</ArticleId><ArticleId IdType="pubmed">31747868</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito A., Horie M., Nagase T. TGF-&#x3b2; Signaling in Lung Health and Disease. Int. J. Mol. Sci. 2018;19:2460. doi: 10.3390/ijms19082460.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19082460</ArticleId><ArticleId IdType="pmc">PMC6121238</ArticleId><ArticleId IdType="pubmed">30127261</ArticleId></ArticleIdList></Reference><Reference><Citation>Tirelli C., Pesenti C., Miozzo M., Mondoni M., Fontana L., Centanni S. The Genetic and Epigenetic Footprint in Idiopathic Pulmonary Fibrosis and Familial Pulmonary Fibrosis: A State-of-the-Art Review. Diagnostics. 2022;12:3107. doi: 10.3390/diagnostics12123107.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics12123107</ArticleId><ArticleId IdType="pmc">PMC9777399</ArticleId><ArticleId IdType="pubmed">36553114</ArticleId></ArticleIdList></Reference><Reference><Citation>Tirelli C., De Amici M., Albrici C., Mira S., Nalesso G., Re B., Corsico A.G., Mondoni M., Centanni S. Exploring the Role of Immune System and Inflammatory Cytokines in SARS-CoV-2 Induced Lung Disease: A Narrative Review. Biology. 2023;12:177. doi: 10.3390/biology12020177.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology12020177</ArticleId><ArticleId IdType="pmc">PMC9953200</ArticleId><ArticleId IdType="pubmed">36829456</ArticleId></ArticleIdList></Reference><Reference><Citation>Melazzini F., Colaneri M., Fumoso F., Freddi G., Lenti M.V., Pieri T.C., Piloni D., Noris P., Pieresca C., Preti P.S., et al. Venous thromboembolism and COVID-19: A single center experience from an academic tertiary referral hospital of Northern Italy. Intern. Emerg. Med. 2021;16:1141&#x2013;1152. doi: 10.1007/s11739-020-02550-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-020-02550-6</ArticleId><ArticleId IdType="pmc">PMC7648897</ArticleId><ArticleId IdType="pubmed">33161478</ArticleId></ArticleIdList></Reference><Reference><Citation>Valerio L., Mavromanoli A.C., Barco S., Abele C., Becker D., Bruch L., Ewert R., Faehling M., Fistera D., Gerhardt F., et al. FOCUS Investigators. Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism: The FOCUS study. Eur. Heart J. 2022;43:3387&#x2013;3398. doi: 10.1093/eurheartj/ehac206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac206</ArticleId><ArticleId IdType="pmc">PMC9492241</ArticleId><ArticleId IdType="pubmed">35484821</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyder S.N., Chatterjee S., Aggarwal V. Percutaneous treatments for pulmonary hypertension: Reviewing the growing procedural role for interventional cardiology. Interv. Cardiol. Clin. 2022;11:293&#x2013;305. doi: 10.1016/j.iccl.2022.01.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.iccl.2022.01.006</ArticleId><ArticleId IdType="pubmed">35710284</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelava M., Koprivanac M., Smedira N., Mihaljevic T., Alfirevic A. Extracorporeal Membrane Oxygenation in Pulmonary Endarterectomy Patients. J. Cardiothorac. Vasc. Anesth. 2019;33:60&#x2013;69. doi: 10.1053/j.jvca.2018.06.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2018.06.025</ArticleId><ArticleId IdType="pubmed">30145074</ArticleId></ArticleIdList></Reference><Reference><Citation>Mago&#x144; W., St&#x119;pniewski J., Walig&#xf3;ra M., Jonas K., Przybylski R., Podolec P., Kope&#x107; G. Changes in Inflammatory Markers in Patients with Chronic Thromboem-bolic Pulmonary Hypertension Treated with Balloon Pulmonary Angioplasty. Cells. 2022;11:1491. doi: 10.3390/cells11091491.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11091491</ArticleId><ArticleId IdType="pmc">PMC9102042</ArticleId><ArticleId IdType="pubmed">35563797</ArticleId></ArticleIdList></Reference><Reference><Citation>Aggarwal V., Giri J., Visovatti S.H., Mahmud E., Matsubara H., Madani M., Rogers F., Gopalan D., Rosenfield K., McLaughlin V.V. American Heart Association Council on Clinical Cardiology; Council on Peripheral Vascular Disease; Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; and Council on Cardiovas-cular and Stroke Nursing. Status and Future Directions for Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease With and Without Pulmonary Hypertension: A Scientific Statement From the American Heart Associa-tion. Circulation. 2024;149:e1090&#x2013;e1107. doi: 10.1161/CIR.0000000000001197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000001197</ArticleId><ArticleId IdType="pubmed">38450477</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogo T., Chowdhury H.M., Yang J., Long L., Li X., Cleuren Y.N.T., Morrell N.W., Schermuly R.T., Trembath R.C., Nasim T. Inhibition of Overactive Transforming Growth Factor-b Signaling by Prostacy-clin Analogs in Pulmonary Arterial Hypertension CLINICAL RELEVANCE. Am. J. Respir. Cell Mol. Biol. 2013;48:733&#x2013;741. doi: 10.1165/rcmb.2012-0049OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2012-0049OC</ArticleId><ArticleId IdType="pubmed">23418342</ArticleId></ArticleIdList></Reference><Reference><Citation>Markewitz B.A., Farrukh I.S., Chen Y., Li Y., Michael J.R. Regulation of endothelin-1 synthesis in human pulmonary arterial smooth muscle cells: Effects of transforming growth factor-b and hypoxia. Cardiovasc. Res. 2001;49:200&#x2013;206. doi: 10.1016/S0008-6363(00)00221-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0008-6363(00)00221-2</ArticleId><ArticleId IdType="pubmed">11121812</ArticleId></ArticleIdList></Reference><Reference><Citation>Casta&#xf1;ares C., Redondo-Horcajo M., Mag&#xe1;n-Marchal N., Dijke P.T., Lamas S., Rodr&#xed;guez-Pascual F. Signaling by ALK5 mediates TGF-beta-induced ET-1 ex-pression in endothelial cells: A role for migration and proliferation. J. Cell Sci. 2007;120:1256&#x2013;1266. doi: 10.1242/jcs.03419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.03419</ArticleId><ArticleId IdType="pubmed">17376964</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambers C., Roth M., Zhong J., Campregher C., Binder P., Burian B., Petkov V., Block L.-H. The Interaction of Endothelin-1 and TGF-&#x3b2;1 Mediates Vascular Cell Remodeling. PLoS ONE. 2013;8:e73399. doi: 10.1371/journal.pone.0073399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0073399</ArticleId><ArticleId IdType="pmc">PMC3756002</ArticleId><ArticleId IdType="pubmed">24015303</ArticleId></ArticleIdList></Reference><Reference><Citation>Wermuth P.J., Li Z., Mendoza F.A., Jimenez S.A. Stimulation of Transforming Growth Factor-&#x3b2;1-Induced Endotheli-al-To-Mesenchymal Transition and Tissue Fibrosis by Endothelin-1 (ET-1): A Novel Profibrotic Effect of ET-1. PLoS ONE. 2016;11:e0161988. doi: 10.1371/journal.pone.0161988.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0161988</ArticleId><ArticleId IdType="pmc">PMC5008786</ArticleId><ArticleId IdType="pubmed">27583804</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogino H. Recent advances of pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension in-cluding Japanese experiences. Gen. Thorac. Cardiovasc. Surg. 2014;62:9&#x2013;18. doi: 10.1007/s11748-013-0323-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11748-013-0323-4</ArticleId><ArticleId IdType="pubmed">24068659</ArticleId></ArticleIdList></Reference><Reference><Citation>Corsico A.G., D&#x2019;armini A.M., Conio V., Sciortino A., Pin M., Grazioli V., Di Vincenzo G., Di Domenica R., Celentano A., Vanini B., et al. Persistent exercise limitation after successful pulmonary endoarterectomy: Fre-quency and determinants. Respir. Res. 2019;20:34. doi: 10.1186/s12931-019-1002-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-019-1002-5</ArticleId><ArticleId IdType="pmc">PMC6376724</ArticleId><ArticleId IdType="pubmed">30764853</ArticleId></ArticleIdList></Reference><Reference><Citation>Bochenek M.L., Saar K., Nazari-Jahantigh M., Gogiraju R., Wiedenroth C.B., M&#xfc;nzel T., Mayer E., Fink L., Schober A., H&#xfc;bner N., et al. Endothelial Overexpression of TGF-&#x3b2;-Induced Protein Impairs Venous Thrombus Resolution: Possible Role in CTEPH. JACC Basic. Transl. Sci. 2023;9:100&#x2013;116. doi: 10.1016/j.jacbts.2023.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacbts.2023.08.005</ArticleId><ArticleId IdType="pmc">PMC10864968</ArticleId><ArticleId IdType="pubmed">38362348</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29738629</PMID><DateCompleted><Year>2019</Year><Month>03</Month><Day>11</Day></DateCompleted><DateRevised><Year>2019</Year><Month>03</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1600-0714</ISSN><JournalIssue CitedMedium="Internet"><Volume>47</Volume><Issue>8</Issue><PubDate><Year>2018</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of oral pathology &amp; medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology</Title><ISOAbbreviation>J Oral Pathol Med</ISOAbbreviation></Journal><ArticleTitle>Calcifying odontogenic cyst, dentinogenic ghost cell tumor, and ghost cell odontogenic carcinoma: A systematic review.</ArticleTitle><Pagination><StartPage>721</StartPage><EndPage>730</EndPage><MedlinePgn>721-730</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jop.12727</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The aim of this study was to integrate the available data published on calcifying odontogenic cyst (COC), dentinogenic ghost cell tumor (DGCT), and ghost cell odontogenic carcinomas (GCOCs) into a comprehensive analysis of their clinicoradiological features, treatment, and recurrence.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">An electronic search with no publication date restriction was undertaken in October 2017 in the following databases: PubMed, Medline Ovid, Web of Science, and Scopus. Eligibility criteria included publications containing enough clinical, radiological, and histopathological information to confirm a definite diagnosis of these lesions. Data were evaluated descriptively.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The literature review indicated a total of 234 publications reporting 367 COCs, 55 DGCTs and 44 GCOCs. These lesions have a predilection for Asian males. COCs mainly affect the mandible and patients in the second decade of life, DGCTs mostly affect the mandible and patients in the fourth decade of life, and GCOCs mostly affect the maxilla and patients in the fifth decade of life.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Conservative surgery was the most common therapy for COCs and DGCTs, while radical surgery was most common for GCOCs. This study provides important and interesting data that could help clinicians and surgeons as well as oral and maxillofacial pathologists with the diagnosis and management of these lesions.</AbstractText><CopyrightInformation>&#xa9; 2018 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>de Arruda</LastName><ForeName>Jos&#xe9; Alcides Almeida</ForeName><Initials>JAA</Initials><Identifier Source="ORCID">0000-0002-6599-3950</Identifier><AffiliationInfo><Affiliation>Department of Oral Surgery, Pathology and Clinical Dentistry, School of Dentistry, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monteiro</LastName><ForeName>Jo&#xe3;o Luiz Gomes Carneiro</ForeName><Initials>JLGC</Initials><AffiliationInfo><Affiliation>Department of Oral and Maxillofacial Surgery and Pathology, School of Dentistry, Universidade de Pernambuco, Camaragibe, PE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abreu</LastName><ForeName>Lucas Guimar&#xe3;es</ForeName><Initials>LG</Initials><AffiliationInfo><Affiliation>Department of Pediatric Dentistry, School of Dentistry, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Oliveira Silva</LastName><ForeName>Leni Ver&#xf4;nica</ForeName><Initials>LV</Initials><AffiliationInfo><Affiliation>Department of Oral Surgery, Pathology and Clinical Dentistry, School of Dentistry, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuch</LastName><ForeName>Lauren Frenzel</ForeName><Initials>LF</Initials><AffiliationInfo><Affiliation>Department of Oral Surgery, Pathology and Clinical Dentistry, School of Dentistry, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Noronha</LastName><ForeName>Mariana Saturnino</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Oral Surgery, Pathology and Clinical Dentistry, School of Dentistry, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Callou</LastName><ForeName>Gerhilde</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Oral and Maxillofacial Surgery and Pathology, School of Dentistry, Universidade de Pernambuco, Camaragibe, PE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreno</LastName><ForeName>Am&#xe1;lia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Oral Surgery, Pathology and Clinical Dentistry, School of Dentistry, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mesquita</LastName><ForeName>Ricardo Alves</ForeName><Initials>RA</Initials><Identifier Source="ORCID">0000-0003-3207-4007</Identifier><AffiliationInfo><Affiliation>Department of Oral Surgery, Pathology and Clinical Dentistry, School of Dentistry, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>#309322/2015-4</GrantID><Agency>Brazilian National Council for Scientific and Technological Development</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>05</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>J Oral Pathol Med</MedlineTA><NlmUniqueID>8911934</NlmUniqueID><ISSNLinking>0904-2512</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017677" MajorTopicYN="N">Age Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016206" MajorTopicYN="N">Databases, Bibliographic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008339" MajorTopicYN="N">Mandibular Neoplasms</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008441" MajorTopicYN="N">Maxillary Neoplasms</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009364" MajorTopicYN="N">Neoplasm Recurrence, Local</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018333" MajorTopicYN="Y">Odontogenic Cyst, Calcifying</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009808" MajorTopicYN="Y">Odontogenic Tumors</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019647" MajorTopicYN="N">Oral Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">calcifying odontogenic cyst</Keyword><Keyword MajorTopicYN="N">clinical features</Keyword><Keyword MajorTopicYN="N">dentinogenic ghost cell tumor</Keyword><Keyword MajorTopicYN="N">ghost cell odontogenic carcinoma</Keyword><Keyword MajorTopicYN="N">recurrence rate</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>5</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>5</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29738629</ArticleId><ArticleId IdType="doi">10.1111/jop.12727</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">29723672</PMID><DateCompleted><Year>2018</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1743-9159</ISSN><JournalIssue CitedMedium="Internet"><Volume>54</Volume><Issue>Pt A</Issue><PubDate><Year>2018</Year><Month>Jun</Month></PubDate></JournalIssue><Title>International journal of surgery (London, England)</Title><ISOAbbreviation>Int J Surg</ISOAbbreviation></Journal><ArticleTitle>Tranexamic acid versus aminocaproic acid for blood management after total knee and total hip arthroplasty: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>105</StartPage><EndPage>112</EndPage><MedlinePgn>105-112</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijsu.2018.04.042</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1743-9191(18)30729-5</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To compare the efficacy and safety of tranexamic acid and aminocaproic acid for reducing blood loss and transfusion requirements after total knee and total hip arthroplasty.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conduct electronic searches of Medline (1966-2017.11), PubMed (1966-2017.11), Embase (1980-2017.11), ScienceDirect (1985-2017.11) and the Cochrane Library (1900-2017.11). The primary outcomes, including total blood loss, hemoglobin decline and transfusion requirements. Secondary outcomes include length of hospital stay and postoperative complications such as the incidence of deep vein thrombosis and pulmonary embolism. Each outcome is combined and calculated using the statistical software STATA 12.0. Fixed/random effect model is adopted based on the heterogeneity tested by I<sup>2</sup> statistic.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 1714 patients are analyzed across three randomized controlled trials (RCTs) and one non-RCT. The present meta-analysis reveals that TXA is associated with a significantly reduction of total blood loss and postoperative hemoglobin drop compared with EACA. No significant differences are identified in terms of transfusion rates, length of hospital stay, and the incidence of postoperative complications.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Although total blood loss and postoperative hemoglobin drop are significant greater in EACA groups, there is no significant difference between TXA and EACA groups in terms of transfusion rates. Based on the current evidence available, higher quality RCTs are still required for further research.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 IJS Publishing Group Ltd. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Qiuliang</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Pediatric Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China. Electronic address: liuqiuliang1919@sina.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geng</LastName><ForeName>Peishuo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Pediatric Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Longyan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pediatric Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Qi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Pediatric Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Pengliang</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Pediatric Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>05</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Surg</MedlineTA><NlmUniqueID>101228232</NlmUniqueID><ISSNLinking>1743-9159</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000933">Antifibrinolytic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006454">Hemoglobins</NameOfSubstance></Chemical><Chemical><RegistryNumber>6T84R30KC1</RegistryNumber><NameOfSubstance UI="D014148">Tranexamic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>U6F3787206</RegistryNumber><NameOfSubstance UI="D015119">Aminocaproic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015119" MajorTopicYN="N">Aminocaproic Acid</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000933" MajorTopicYN="N">Antifibrinolytic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019644" MajorTopicYN="N">Arthroplasty, Replacement, Hip</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019645" MajorTopicYN="N">Arthroplasty, Replacement, Knee</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016063" MajorTopicYN="N">Blood Loss, Surgical</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001803" MajorTopicYN="N">Blood Transfusion</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006454" MajorTopicYN="N">Hemoglobins</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017713" MajorTopicYN="N">Platelet Transfusion</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011184" MajorTopicYN="N">Postoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014148" MajorTopicYN="N">Tranexamic Acid</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aminocaproic acid</Keyword><Keyword MajorTopicYN="N">Blood loss</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Total hip arthroplasty</Keyword><Keyword MajorTopicYN="N">Total knee arthroplasty</Keyword><Keyword MajorTopicYN="N">Tranexamic acid</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>4</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>4</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>5</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>10</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>5</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29723672</ArticleId><ArticleId IdType="doi">10.1016/j.ijsu.2018.04.042</ArticleId><ArticleId IdType="pii">S1743-9191(18)30729-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29549559</PMID><DateCompleted><Year>2018</Year><Month>09</Month><Day>25</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1573-742X</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>4</Issue><PubDate><Year>2018</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of thrombosis and thrombolysis</Title><ISOAbbreviation>J Thromb Thrombolysis</ISOAbbreviation></Journal><ArticleTitle>No effectiveness of anticoagulants for thromboprophylaxis after non-major knee arthroscopy: a systemic review and meta-analysis of randomized controlled trials.</ArticleTitle><Pagination><StartPage>562</StartPage><EndPage>570</EndPage><MedlinePgn>562-570</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11239-018-1638-x</ELocationID><Abstract><AbstractText>Arthroscopic knee surgery is the most commonly performed orthopedic procedure worldwide and whether thromboprophylaxis should be undertaken after knee arthroscopy is still controversial. To evaluate the efficacy of thromboprophylaxis for deep venous thrombosis (DVT) and venous thromboembolism (VTE) after knee arthroscopic surgery. A meta-analysis was conducted using data from eight randomized trials (4148 patients) to compare thromboprophylaxis with placebo or no prophylactic treatment in patients undergoing knee arthroscopy. The benefits and harms of thromboprophylaxis were evaluated, including the incidence of asymptomatic DVT, symptomatic VTE, pulmonary embolism and anti-coagulation related adverse events. Thromboprophylaxis significantly decreased the incidence of DVT (95% CI 0.07-0.64, P&#x2009;=&#x2009;0.006) and symptomatic VTE in patients undergoing knee arthroscopy (95% CI 0.23-0.76, P&#x2009;=&#x2009;0.004), but not significantly decreased the incidence of pulmonary embolism (n.s.). Regarding to non-major knee arthroscopy surgery (simple surgical procedures without ligament reconstruction), no significant difference of the incidence of DVT or symptomatic VTE was noted between thromboprophylactic group and control group (n.s.). Thromboprophylactic treatment showed higher incidence rate of anti-coagulation related adverse events compared with the control group (95% CI 1.12-1.90, P&#x2009;=&#x2009;0.005). There was no significant difference of the incidence of clinically relevant major bleeding between the two groups (n.s.). This meta-analysis indicates no effectiveness of thromboprophylaxis for preventing DVT or symptomatic VTE in patients undergoing non-major knee arthroscopy. Regarding to patient undergoing knee ligament construction, the thromboprophylactic strategy should mainly take into account the patient's risk factors.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Gang</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, 109 Xueyuanxi Road, Wenzhou, 325027, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Qian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, 109 Xueyuanxi Road, Wenzhou, 325027, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shang</LastName><ForeName>Ping</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, 109 Xueyuanxi Road, Wenzhou, 325027, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Xiao-Yun</ForeName><Initials>XY</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, 109 Xueyuanxi Road, Wenzhou, 325027, China. xiaoyunpan@126.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Hai-Xiao</ForeName><Initials>HX</Initials><Identifier Source="ORCID">0000-0003-0994-2005</Identifier><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, 109 Xueyuanxi Road, Wenzhou, 325027, China. spineliu@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>81501869</GrantID><Agency>National Natural Science Foundation of China (CN)</Agency><Country/></Grant><Grant><GrantID>81601983</GrantID><Agency>National Natural Science Foundation of China (CN)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Thromb Thrombolysis</MedlineTA><NlmUniqueID>9502018</NlmUniqueID><ISSNLinking>0929-5305</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001182" MajorTopicYN="N">Arthroscopy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007719" MajorTopicYN="N">Knee Joint</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="N">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Knee arthroscopy</Keyword><Keyword MajorTopicYN="N">Thromboembolism</Keyword><Keyword MajorTopicYN="N">Thromboprophylaxis</Keyword><Keyword MajorTopicYN="N">Thrombosis</Keyword><Keyword MajorTopicYN="N">Venous</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>9</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29549559</ArticleId><ArticleId IdType="doi">10.1007/s11239-018-1638-x</ArticleId><ArticleId IdType="pii">10.1007/s11239-018-1638-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Knee Surg Sports Traumatol Arthrosc. 2017 Feb;25(2):335-346</Citation><ArticleIdList><ArticleId IdType="pubmed">28210788</ArticleId></ArticleIdList></Reference><Reference><Citation>Sports Health. 2015 May;7(3):261-6</Citation><ArticleIdList><ArticleId IdType="pubmed">26131305</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thromb Haemost. 2004 Nov;2(11):1901-2</Citation><ArticleIdList><ArticleId IdType="pubmed">15550019</ArticleId></ArticleIdList></Reference><Reference><Citation>Z Orthop Unfall. 2010 May;148(3):282-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20135619</ArticleId></ArticleIdList></Reference><Reference><Citation>Knee Surg Sports Traumatol Arthrosc. 2017 Feb;25(2):347-354</Citation><ArticleIdList><ArticleId IdType="pubmed">27650529</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Orthop Relat Res. 2014 Sep;472(9):2705-11</Citation><ArticleIdList><ArticleId IdType="pubmed">24696048</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Orthop Traumatol Turc. 2008 Nov-Dec;42(5):322-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19158452</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thromb Haemost. 2015 Aug;13(8):1441-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25940206</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthroscopy. 2001 Apr;17 (4):393-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11288011</ArticleId></ArticleIdList></Reference><Reference><Citation>Thromb Haemost. 2016 Aug 1;116(2):349-55</Citation><ArticleIdList><ArticleId IdType="pubmed">27075710</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Sports Med. 2000 Jul;19(3):519-43</Citation><ArticleIdList><ArticleId IdType="pubmed">10918964</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Joint Surg Br. 2011 Jan;93(1):47-51</Citation><ArticleIdList><ArticleId IdType="pubmed">21196542</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthroscopy. 2002 Mar;18(3):257-63</Citation><ArticleIdList><ArticleId IdType="pubmed">11877611</ArticleId></ArticleIdList></Reference><Reference><Citation>Medicine (Baltimore). 2017 Jun;96(22):e7074</Citation><ArticleIdList><ArticleId IdType="pubmed">28562574</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull Hosp Jt Dis (2013). 2015 Dec;73(4):243-8</Citation><ArticleIdList><ArticleId IdType="pubmed">26630467</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthroscopy. 2014 Mar;30(3):406-12</Citation><ArticleIdList><ArticleId IdType="pubmed">24581264</ArticleId></ArticleIdList></Reference><Reference><Citation>Knee Surg Sports Traumatol Arthrosc. 2015 Dec;23(12):3540-4</Citation><ArticleIdList><ArticleId IdType="pubmed">25362246</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2017 Feb 9;376(6):580-583</Citation><ArticleIdList><ArticleId IdType="pubmed">28177874</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Joint Surg Am. 2012 Apr 18;94(8):714-20</Citation><ArticleIdList><ArticleId IdType="pubmed">22517387</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Orthop. 2016 Sep 18;7(9):604-17</Citation><ArticleIdList><ArticleId IdType="pubmed">27672574</ArticleId></ArticleIdList></Reference><Reference><Citation>Chest. 2012 Feb;141(2 Suppl):e278S-e325S</Citation><ArticleIdList><ArticleId IdType="pubmed">22315265</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthroscopy. 2007 Jul;23(7):696-702</Citation><ArticleIdList><ArticleId IdType="pubmed">17637403</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthroscopy. 2015 Nov;31(11):2112-8</Citation><ArticleIdList><ArticleId IdType="pubmed">26105091</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2008 Jul 15;149(2):73-82</Citation><ArticleIdList><ArticleId IdType="pubmed">18626046</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2017 Feb 9;376(6):515-525</Citation><ArticleIdList><ArticleId IdType="pubmed">27959702</ArticleId></ArticleIdList></Reference><Reference><Citation>Sports Med. 2014 Mar;44(3):331-43</Citation><ArticleIdList><ArticleId IdType="pubmed">24190733</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thromb Haemost. 2010 Apr;8(4):678-83</Citation><ArticleIdList><ArticleId IdType="pubmed">20040041</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2015 Jun 16;350:h2747</Citation><ArticleIdList><ArticleId IdType="pubmed">26080045</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thromb Haemost. 2013 Jul;11(7):1279-86</Citation><ArticleIdList><ArticleId IdType="pubmed">23648016</ArticleId></ArticleIdList></Reference><Reference><Citation>Orthopedics. 2000 Jun;23(6 Suppl):s629-32</Citation><ArticleIdList><ArticleId IdType="pubmed">10875426</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthroscopy. 2013 Jul;29(7):1211-6</Citation><ArticleIdList><ArticleId IdType="pubmed">23809456</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Joint Surg Am. 2013 Jul 17;95(14):e98 1-10</Citation><ArticleIdList><ArticleId IdType="pubmed">23864189</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthroscopy. 2013 Apr;29(4):716-25</Citation><ArticleIdList><ArticleId IdType="pubmed">23395251</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">27529379</PMID><DateCompleted><Year>2017</Year><Month>04</Month><Day>07</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-9034</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>9</Issue><PubDate><Year>2016</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of laparoendoscopic &amp; advanced surgical techniques. Part A</Title><ISOAbbreviation>J Laparoendosc Adv Surg Tech A</ISOAbbreviation></Journal><ArticleTitle>Scoliosis and Pectus Excavatum in Adolescents: Does the Nuss Procedure Affect the Scoliotic Curvature?</ArticleTitle><Pagination><StartPage>734</StartPage><EndPage>739</EndPage><MedlinePgn>734-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1089/lap.2016.0168</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Pectus excavatum (PE) is known to be associated with adolescent idiopathic scoliosis (AIS). The correction of severe PE requires a mini-invasive procedure (MIRPE), with a metal bar positioned and left in the chest for 3 years. Adolescence seems to be the more appropriate time not only for MIRPE but also for AIS peak progression. This study was designed to answer the question whether, in adolescents, MIRPE could affect mild/moderate AIS.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We carried out a meta-analysis focused on defining the natural progression of untreated AIS. Inclusion criteria were as follows: AIS patients -age 10-18 years old -Cobb angle &lt;40&#xb0;-none treated as orthotics/electrostimulation/surgery. The expected outcome was the percentage of patients who improved, worsened, or hold steady of their condition at follow-up. Between 2008 and 2014, we followed up a cohort of 67 adolescents with severe PE treated with MIRPE, assessing whether AIS underwent a modification in the period between bar insertion and removal.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Meta-analysis included 9 studies with 1641 AIS patients. Although heterogeneous (I(2)&#x2009;=&#x2009;99.5%, P&#x2009;&lt;&#x2009;.0001), the overall percentage of progression for untreated AIS was 42.5% (CI 18.2%-72.2%). In our follow-up group who underwent MIRPE, 34 out of 67 patients had concurrent AIS with a Cobb angle &gt;10&#xb0; (range 10&#xb0;-45&#xb0;). We demonstrated that MIRPE had a favorable effect on AIS, with a mean improvement of 1.5&#xb0; (CI 0.64-2.44; P&#x2009;=&#x2009;.0011).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In our PE patients with AIS, MIRPE had a beneficial effect also on the spine. From our preliminary results, it seems that MIRPE should be offered during puberty as a timely option for treating PE and stabilizing mild/moderate scoliosis progression, when concurrent.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ghionzoli</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>1 Department of Emergency, Critical Area and Pediatric Surgery, University of Florence and Children's University Hospital "A. Meyer," Florence, Italy .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>1 Department of Emergency, Critical Area and Pediatric Surgery, University of Florence and Children's University Hospital "A. Meyer," Florence, Italy .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bongini</LastName><ForeName>Martina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>1 Department of Emergency, Critical Area and Pediatric Surgery, University of Florence and Children's University Hospital "A. Meyer," Florence, Italy .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bongini</LastName><ForeName>Ubaldo</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>1 Department of Emergency, Critical Area and Pediatric Surgery, University of Florence and Children's University Hospital "A. Meyer," Florence, Italy .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciuti</LastName><ForeName>Gastone</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>2 The BioRobotics Institute , Scuola Superiore Sant'Anna, Pontedera, Pisa, Italy .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grisotto</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>1 Department of Emergency, Critical Area and Pediatric Surgery, University of Florence and Children's University Hospital "A. Meyer," Florence, Italy .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monaco</LastName><ForeName>Vito</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>2 The BioRobotics Institute , Scuola Superiore Sant'Anna, Pontedera, Pisa, Italy .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Menciassi</LastName><ForeName>Arianna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>2 The BioRobotics Institute , Scuola Superiore Sant'Anna, Pontedera, Pisa, Italy .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Defilippi</LastName><ForeName>Claudio</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>1 Department of Emergency, Critical Area and Pediatric Surgery, University of Florence and Children's University Hospital "A. Meyer," Florence, Italy .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Messineo</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>1 Department of Emergency, Critical Area and Pediatric Surgery, University of Florence and Children's University Hospital "A. Meyer," Florence, Italy .</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>08</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Laparoendosc Adv Surg Tech A</MedlineTA><NlmUniqueID>9706293</NlmUniqueID><ISSNLinking>1092-6429</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="Y">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005660" MajorTopicYN="N">Funnel Chest</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012600" MajorTopicYN="N">Scoliosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>8</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>8</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27529379</ArticleId><ArticleId IdType="doi">10.1089/lap.2016.0168</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39179954</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>23</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2415</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>23</Day></PubDate></JournalIssue><Title>BMC ophthalmology</Title><ISOAbbreviation>BMC Ophthalmol</ISOAbbreviation></Journal><ArticleTitle>Effect of capsular tension ring implantation on intraocular lens calculation formula selection for long axial myopia.</ArticleTitle><Pagination><StartPage>368</StartPage><MedlinePgn>368</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">368</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12886-024-03602-7</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The study investigated the effect of capsular tension ring (CTR) implantation on postoperative refractive stability and accuracy of intraocular lens (IOL) formulas for axial length (AL)&#x2009;&#x2265;&#x2009;27.0&#xa0;mm patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Prospective case series. The eyes of patients underwent phacoemulsification extraction combined with IOL implantation were classified as CTR implantation (A-CTR) and without CTR implantation (B-CON) groups. Refractive outcome and anterior chamber depth (ACD) were recorded at 1&#xa0;week, 1&#xa0;month, and 3&#xa0;months post-operation. Prediction refractive error (PE) and absolute refractive error (AE) of each formula were calculated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 89 eyes (63 patients)&#xa0;were included and randomized into the CTR (A-CTR) and control groups (B-CON). Comparison of refraction at different postoperative times of the CTR group showed no statistical difference (all P&#x2009;&gt;&#x2009;0.05). The ACD in the A-CTR group gradually deepened, and that in the B-CON group gradually shallowed (all P&#x2009;&gt;&#x2009;0.05). The formulas' AE showed statistically significant differences in CTR and CON groups (P&#x2009;&lt;&#x2009;0.001). The PE of Hill-RBF 2.0 and EVO formulas in the A-CTR group were more hyperopic than that in the B-CON group (all P&#x2009;&gt;&#x2009;0.05), the other five formulas were more myopic in A-CTR group than that in the B-CON group (all P&#x2009;&gt;&#x2009;0.05).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Patients with 13&#xa0;mm diameter CTR implantation tended to have stable refraction at 1&#xa0;week post-surgery and 1&#xa0;month for those without it. CTR of the 13&#xa0;mm diameter had no effect on the selection of formulas. Additionally, it is found that Kane and EVO formulas were more accurate for patients with AL&#x2009;&#x2265;&#x2009;27.0&#xa0;mm.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Jiaojiao</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Shaanxi Eye Hospital, Xi'an People's Hospital (Xi'an Fourth Hospital), Affiliated People's Hospital of Northwest University, Xi'an, Shaanxi Province, 710004, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Xi'an Children's Hospital, Xi'an, Shaanxi Province, 710003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Shaanxi Eye Hospital, Xi'an People's Hospital (Xi'an Fourth Hospital), Affiliated People's Hospital of Northwest University, Xi'an, Shaanxi Province, 710004, China. yan2128ts@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Xue</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Shaanxi Eye Hospital, Xi'an People's Hospital (Xi'an Fourth Hospital), Affiliated People's Hospital of Northwest University, Xi'an, Shaanxi Province, 710004, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Xi'an Children's Hospital, Xi'an, Shaanxi Province, 710003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi Province, 710068, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yaping</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Shaanxi Eye Hospital, Xi'an People's Hospital (Xi'an Fourth Hospital), Affiliated People's Hospital of Northwest University, Xi'an, Shaanxi Province, 710004, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qu</LastName><ForeName>Laiqiang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Shaanxi Eye Hospital, Xi'an People's Hospital (Xi'an Fourth Hospital), Affiliated People's Hospital of Northwest University, Xi'an, Shaanxi Province, 710004, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Ophthalmol</MedlineTA><NlmUniqueID>100967802</NlmUniqueID><ISSNLinking>1471-2415</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007910" MajorTopicYN="Y">Lenses, Intraocular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012029" MajorTopicYN="Y">Refraction, Ocular</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018918" MajorTopicYN="Y">Phacoemulsification</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009216" MajorTopicYN="Y">Myopia</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019654" MajorTopicYN="Y">Lens Implantation, Intraocular</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014792" MajorTopicYN="Y">Visual Acuity</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019736" MajorTopicYN="N">Prostheses and Implants</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058452" MajorTopicYN="N">Axial Length, Eye</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001699" MajorTopicYN="N">Biometry</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019919" MajorTopicYN="N">Prosthesis Implantation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Capsular tension ring</Keyword><Keyword MajorTopicYN="N">Cataract</Keyword><Keyword MajorTopicYN="N">IOL calculation formula</Keyword><Keyword MajorTopicYN="N">Long axial myopia</Keyword><Keyword MajorTopicYN="N">Refraction</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>24</Day><Hour>16</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>24</Day><Hour>16</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>23</Day><Hour>23</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39179954</ArticleId><ArticleId IdType="pmc">PMC11344288</ArticleId><ArticleId IdType="doi">10.1186/s12886-024-03602-7</ArticleId><ArticleId IdType="pii">10.1186/s12886-024-03602-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pan CW, Ramamurthy D, Saw SM. Worldwide prevalence and risk factors for myopia. Ophthalmic Physiol Opt. 2012;32(1):3&#x2013;16. 10.1111/j.1475-1313.2011.00884.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1475-1313.2011.00884.x</ArticleId><ArticleId IdType="pubmed">22150586</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S, Zhang K, He W, et al. Quantitative phosphoproteomic comparison of lens proteins in highly myopic cataract and age-related cataract. Biomed Res Int. 2021;10:6668845.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8130905</ArticleId><ArticleId IdType="pubmed">34055996</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Wei L, He W, et al. Comparison of kane, hill-RBF 2.0, barrett universal II, and emmetropia verifying optical formulas in eyes with extreme myopia. J Refract Surg. 2021;37(10):680&#x2013;5. 10.3928/1081597X-20210712-03</Citation><ArticleIdList><ArticleId IdType="doi">10.3928/1081597X-20210712-03</ArticleId><ArticleId IdType="pubmed">34661474</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong EW, Mehta JS. High myopia and cataract surgery. Curr Opin Ophthalmol. 2016;27(1):45&#x2013;50. 10.1097/ICU.0000000000000217</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ICU.0000000000000217</ArticleId><ArticleId IdType="pubmed">26569522</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu TX, Luo X. Stability of axis and patient satisfaction after toric implantable collamer lens implantation for myopic astigmatism. Pak J Med Sci. 2013;29(6):1371&#x2013;4. 10.12669/pjms.296.3986</Citation><ArticleIdList><ArticleId IdType="doi">10.12669/pjms.296.3986</ArticleId><ArticleId IdType="pmc">PMC3905361</ArticleId><ArticleId IdType="pubmed">24550956</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber CH, Cionni RJ. All about capsular tension rings. Curr Opin Ophthalmol. 2015;26(1):10&#x2013;5. 10.1097/ICU.0000000000000118</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ICU.0000000000000118</ArticleId><ArticleId IdType="pubmed">25390861</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Li J, Yang K, et al. Combined special capsular tension ring and toric IOL implantation for management of astigmatism and high axial myopia with cataracts. Semin Ophthalmol. 2018;33(3):389&#x2013;94. 10.1080/08820538.2016.1247181</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08820538.2016.1247181</ArticleId><ArticleId IdType="pubmed">28005433</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia T, Martinez CE, Tsai LM. Update on intraocular lens formulas and calculations. Asia Pac J Ophthalmol. 2020;9(3):186&#x2013;93.10.1097/APO.0000000000000293</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/APO.0000000000000293</ArticleId><ArticleId IdType="pmc">PMC7299214</ArticleId><ArticleId IdType="pubmed">32501896</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett GD. Barrett Universal II Formula. Singapore, Asia-Pacific Association of Cataract and Refractive Surgeons. Available at: https://www.apacrs.org/barrett_universal2/. Accessed 25 Feb 2019.</Citation></Reference><Reference><Citation>Melles RB, Kane JX, Olsen T, et al. Update on intraocular lens calculation formulas. Ophthalmology. 2019;126(9):1334&#x2013;5. 10.1016/j.ophtha.2019.04.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ophtha.2019.04.011</ArticleId><ArticleId IdType="pubmed">30980854</ArticleId></ArticleIdList></Reference><Reference><Citation>Rong X, He W, Zhu Q, et al. Intraocular lens power calculation in eyes with extreme myopia: comparison of barrett universal II, haigis, and olsen formulas. J Cataract Refract Surg. 2019;45(6):732&#x2013;7. 10.1016/j.jcrs.2018.12.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrs.2018.12.025</ArticleId><ArticleId IdType="pubmed">30876784</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill WE. Hill-RBF calculator version 2.0. Hill-RBF calculator version 2.0. Available at: http://rbfcalculator.com/online/index.html. Accessed 25 Feb 2019.</Citation></Reference><Reference><Citation>EVO Formula.&#xa0;https://www.evoiolformula.com. Accessed 1 Apr 2021.</Citation></Reference><Reference><Citation>Kane Formula.&#xa0;https://www.iolformula.com.&#xa0;Accessed 15 Oct 2020.</Citation></Reference><Reference><Citation>Khatib ZI, Haldipurkar SS, Shetty V, et al. Comparison of three newer generation freely available intraocular lens power calculation formulae across all axial lengths. Indian J Ophthalmol. 2021;69(3):580&#x2013;4. 10.4103/ijo.IJO_943_20</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijo.IJO_943_20</ArticleId><ArticleId IdType="pmc">PMC7942088</ArticleId><ArticleId IdType="pubmed">33595478</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts TV, Hodge C, Sutton G, et al. Comparison of hillradial basis function, barrett universal and current third generation formulas for the calculation of intraocular lens power during cataract surgery. Clin Exp Ophthalmol. 2018;46(3):240&#x2013;6. 10.1111/ceo.13034</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ceo.13034</ArticleId><ArticleId IdType="pubmed">28778114</ArticleId></ArticleIdList></Reference><Reference><Citation>User Group for Laser Interference Biometry. Available at: 
http://ocusoft.de/ulib.&#xa0;Accessed 14 Jan 2018.</Citation></Reference><Reference><Citation>McNamara P, Hutchinson I, Thornell E, et al. Refractive stability following uncomplicated cataract surgery. Clin Exp Optom. 2019;102(2):154&#x2013;9. 10.1111/cxo.12837</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cxo.12837</ArticleId><ArticleId IdType="pubmed">30380588</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao HY, Zhang JS, Li M, et al. Effect of capsular tension ring on the refractive outcomes of patients with extreme high axial myopia after phacoemulsification. Eur J Med Res. 2024;29(1):142. 10.1186/s40001-024-01726-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40001-024-01726-6</ArticleId><ArticleId IdType="pmc">PMC10893688</ArticleId><ArticleId IdType="pubmed">38402171</ArticleId></ArticleIdList></Reference><Reference><Citation>Findl O, Drexler W, Menapace R, et al. Accurate determination of effective lens position and lens-capsule distance with 4 intraocular lenses. J Cataract Refract Surg. 1998;24(8):1094&#x2013;8. 10.1016/S0886-3350(98)80103-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0886-3350(98)80103-X</ArticleId><ArticleId IdType="pubmed">9719969</ArticleId></ArticleIdList></Reference><Reference><Citation>Gimbel HV, Sun R, Heston JP. Management of zonular dialysis in phacoemulsification and IOL implantation using the capsular tension ring. Ophthalmic Surg Lasers. 1997;28(4):273&#x2013;81. 10.3928/1542-8877-19970401-03</Citation><ArticleIdList><ArticleId IdType="doi">10.3928/1542-8877-19970401-03</ArticleId><ArticleId IdType="pubmed">9101564</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S, Hu Y, Guo R, et al. The effects of different shapes of capsulorrhexis on postoperative refractive outcomes and the effective position of the intraocular lens in cataract surgery. BMC Ophthalmol. 2019;19(1):59. 10.1186/s12886-019-1068-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12886-019-1068-3</ArticleId><ArticleId IdType="pmc">PMC6385455</ArticleId><ArticleId IdType="pubmed">30791880</ArticleId></ArticleIdList></Reference><Reference><Citation>Ning X, Yang Y, Yan H, et al. Anterior chamber depth-a predictor of refractive outcomes after age-related cataract surgery[J]. BMC Ophthalmol. 2019;19(1):134. 10.1186/s12886-019-1144-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12886-019-1144-8</ArticleId><ArticleId IdType="pmc">PMC6591866</ArticleId><ArticleId IdType="pubmed">31238910</ArticleId></ArticleIdList></Reference><Reference><Citation>Melles RB, Holladay JT, Chang WJ. Accuracy of untraocular lens calculation formulas. Ophthalmology. 2018;125(2):169&#x2013;78. 10.1016/j.ophtha.2017.08.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ophtha.2017.08.027</ArticleId><ArticleId IdType="pubmed">28951074</ArticleId></ArticleIdList></Reference><Reference><Citation>Kane JX, Van Heerden A, Atik A, et al. Accuracy of 3 new methods for intraocular lens power selection. J Cataract Refract Surg. 2017;43(10):333&#x2013;9. 10.1016/j.jcrs.2016.12.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrs.2016.12.021</ArticleId><ArticleId IdType="pubmed">28410714</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Jiang W, Lin T, et al. Accuracy of intraocular lens power calculation formulas in long eyes: a systematic review and meta-analysis. Clin Exp Ophthalmol. 2018;46(7):738&#x2013;49. 10.1111/ceo.13184</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ceo.13184</ArticleId><ArticleId IdType="pubmed">29498180</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Wang L, Chai F, et al. Comparison of intraocular lens power calculation formulas in Chinese eyes with axial myopia. J Cataract Refract Surg. 2019;45(6):725&#x2013;31. 10.1016/j.jcrs.2019.01.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrs.2019.01.018</ArticleId><ArticleId IdType="pubmed">31146930</ArticleId></ArticleIdList></Reference><Reference><Citation>Connell BJ, Kane JX. Comparison of the Kane formula with existing formulas for intraocular lens power selection. BMJ Open Ophthalmol. 2019;4(1):e000251. 10.1136/bmjophth-2018-000251</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjophth-2018-000251</ArticleId><ArticleId IdType="pmc">PMC6528763</ArticleId><ArticleId IdType="pubmed">31179396</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira A, Popovic MM, Ahmed Y, et al. A comparative analysis of 12 intraocular lens power formulas. Int Ophthalmol. 2021;41(12):4137&#x2013;50. 10.1007/s10792-021-01966-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10792-021-01966-z</ArticleId><ArticleId IdType="pubmed">34318369</ArticleId></ArticleIdList></Reference><Reference><Citation>Darcy K, Gunn D, Tavassoli S, Sparrow J, Kane JX. Assessment of the accuracy of new and updated intraocular lens power calculation formulas in 10930 eyes from the UK National Health Service. J Cataract Refract Surg. 2020;46(1):2&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">32050225</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan KH, Lam TCH, Yu MCY, et al. Accuracy and precision of intraocular lens calculations using the new Hill-RBF version 2.0 in eyes with high axial myopia. Am J Ophthalmol. 2019;205:66&#x2013;73. 10.1016/j.ajo.2019.04.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajo.2019.04.019</ArticleId><ArticleId IdType="pubmed">31078534</ArticleId></ArticleIdList></Reference><Reference><Citation>Boomer JA, Jackson DW. Effect of the morcher capsular tension ring on refractive outcome. J Cataract Refract Surg. 2006;32(7):1180&#x2013;3. 10.1016/j.jcrs.2006.06.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrs.2006.06.009</ArticleId><ArticleId IdType="pubmed">16857506</ArticleId></ArticleIdList></Reference><Reference><Citation>Saadet GI, Fatih &#xd6;. Effect of the capsular tension ring on refractive outcome after phacoemulsification. Rom J Ophthalmol. 2021;65(1):59&#x2013;63. 10.22336/rjo.2021.11</Citation><ArticleIdList><ArticleId IdType="doi">10.22336/rjo.2021.11</ArticleId><ArticleId IdType="pmc">PMC7995511</ArticleId><ArticleId IdType="pubmed">33817435</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33448032</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>19</Day></DateCompleted><DateRevised><Year>2025</Year><Month>02</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1469-493X</ISSN><JournalIssue CitedMedium="Internet"><Volume>1</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jan</Month><Day>15</Day></PubDate></JournalIssue><Title>The Cochrane database of systematic reviews</Title><ISOAbbreviation>Cochrane Database Syst Rev</ISOAbbreviation></Journal><ArticleTitle>Indomethacin for symptomatic patent ductus arteriosus in preterm infants.</ArticleTitle><Pagination><StartPage>CD013133</StartPage><MedlinePgn>CD013133</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">CD013133</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/14651858.CD013133.pub2</ELocationID><Abstract><AbstractText Label="BACKGROUND">Symptomatic patent ductus arteriosus (PDA) is associated with mortality and morbidity in preterm infants. In these infants, prophylactic use of indomethacin, a non-selective cyclooxygenase inhibitor, has demonstrated short-term clinical benefits. The effect of indomethacin in preterm infants with a symptomatic PDA remains unexplored.</AbstractText><AbstractText Label="OBJECTIVES">To determine the effectiveness and safety of indomethacin (given by any route) compared to placebo or no treatment in reducing mortality and morbidity in preterm infants with a symptomatic PDA.</AbstractText><AbstractText Label="SEARCH METHODS">We used the standard search strategy of Cochrane Neonatal to search Cochrane Central Register of Controlled Trials (CENTRAL; 2020, Issue 7), in the Cochrane Library; Ovid MEDLINE(R) and Epub Ahead of Print, In-Process &amp; Other Non-Indexed Citations, Daily and Versions(R); and Cumulative Index to Nursing and Allied Health Literature (CINAHL), on 31 July 2020. We also searched clinical trials databases and the reference lists of retrieved articles for randomized controlled trials (RCTs) and quasi-RCTs.</AbstractText><AbstractText Label="SELECTION CRITERIA">We included RCTs and quasi-RCTs that compared indomethacin (any dose, any route) versus placebo or no treatment in preterm infants.</AbstractText><AbstractText Label="DATA COLLECTION AND ANALYSIS">We used the standard methods of Cochrane Neonatal, with separate evaluation of trial quality and data extraction by at least two review authors. We used the GRADE approach to assess the certainty of evidence for the following outcomes: failure of PDA closure within one week of administration of the first dose of indomethacin; bronchopulmonary dysplasia (BPD) at 28 days' postnatal age and at 36 weeks' postmenstrual age; proportion of infants requiring surgical ligation or transcatheter occlusion; all-cause neonatal mortality; necrotizing enterocolitis (NEC) (&#x2265; Bell stage 2); and mucocutaneous or gastrointestinal bleeding.</AbstractText><AbstractText Label="MAIN RESULTS">We included 14 RCTs (880 preterm infants). Four out of the 14 included studies were judged to have high risk of bias in one or more domains. Indomethacin administration was associated with a large reduction in failure of PDA closure within one week of administration of the first dose (risk ratio (RR) 0.30, 95% confidence interval (CI) 0.23 to 0.38; risk difference (RD) -0.52, 95% CI -0.58 to -0.45; 10 studies, 654 infants; high-certainty evidence). There may be little to no difference in the incidence of BPD (BPD defined as supplemental oxygen need at 28 days' postnatal age: RR 1.45, 95% CI 0.60 to 3.51; 1 study, 55 infants; low-certainty evidence; BPD defined as supplemental oxygen need at 36 weeks' postmenstrual age: RR 0.80, 95% CI 0.41 to 1.55; 1 study, 92 infants; low-certainty evidence) and probably little to no difference in mortality (RR 0.78, 95% CI 0.46 to 1.33; 8 studies, 314 infants; moderate-certainty evidence) with use of indomethacin for symptomatic PDA. No differences were demonstrated in the need for surgical PDA ligation (RR 0.66, 95% CI 0.33 to 1.29; 7 studies, 275 infants; moderate-certainty evidence), in NEC (RR 1.27, 95% CI 0.36 to 4.55; 2 studies, 147 infants; low-certainty evidence), or in mucocutaneous or gastrointestinal bleeding (RR 0.33, 95% CI 0.01 to 7.58; 2 studies, 119 infants; low-certainty evidence) with use of indomethacin compared to placebo or no treatment. Certainty of evidence for BPD, surgical PDA ligation, NEC, and mucocutaneous or gastrointestinal bleeding was downgraded for very serious or serious imprecision.</AbstractText><AbstractText Label="AUTHORS' CONCLUSIONS">High-certainty evidence shows that indomethacin is effective in closing a symptomatic PDA compared to placebo or no treatment in preterm infants. Evidence is insufficient regarding effects of indomethacin on other clinically relevant outcomes and medication-related adverse effects.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Evans</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Reilly</LastName><ForeName>Deirdre</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Neonatal-Perinatal Medicine, Department of Pediatrics, Larner College of Medicine at the University of Vermont, Burlington, Vermont, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flyer</LastName><ForeName>Jonathan N</ForeName><Initials>JN</Initials><AffiliationInfo><Affiliation>Division of Pediatric Cardiology, Department of Pediatrics, Larner College of Medicine at the University of Vermont, Burlington, Vermont, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soll</LastName><ForeName>Roger</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Neonatal-Perinatal Medicine, Department of Pediatrics, Larner College of Medicine at the University of Vermont, Burlington, Vermont, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mitra</LastName><ForeName>Souvik</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Departments of Pediatrics, Community Health &amp; Epidemiology, Dalhousie University &amp; IWK Health Centre, Halifax, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cochrane Database Syst Rev</MedlineTA><NlmUniqueID>100909747</NlmUniqueID><ISSNLinking>1361-6137</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016861">Cyclooxygenase Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010919">Placebos</NameOfSubstance></Chemical><Chemical><RegistryNumber>XXE1CET956</RegistryNumber><NameOfSubstance UI="D007213">Indomethacin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>doi: 10.1002/14651858.CD013133</RefSource></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D015982" MajorTopicYN="N">Bias</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001997" MajorTopicYN="N">Bronchopulmonary Dysplasia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002423" MajorTopicYN="N">Cause of Death</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016861" MajorTopicYN="N">Cyclooxygenase Inhibitors</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004374" MajorTopicYN="N">Ductus Arteriosus, Patent</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020345" MajorTopicYN="N">Enterocolitis, Necrotizing</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006471" MajorTopicYN="N">Gastrointestinal Hemorrhage</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007213" MajorTopicYN="N">Indomethacin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007230" MajorTopicYN="N">Infant, Low Birth Weight</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007234" MajorTopicYN="N">Infant, Premature</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008026" MajorTopicYN="N">Ligation</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010102" MajorTopicYN="N">Oxygen Inhalation Therapy</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010919" MajorTopicYN="N">Placebos</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>PE is a Pediatric Resident at the Children's Hospital of Philadelphia. As a pediatric resident, he participated in the care of patients with PDA on his neonatology rotations. DO has no interest to declare. JNF is a Paediatric Cardiologist at the University of Vermont Medical Center. RS is a Professor of Neonatology at the University of Vermont Medical Center. He needs to make the decisions detailed in the review on a daily basis. SM is a neonatologist at a tertiary care neonatal intensive care unit in Halifax, Nova Scotia, Canada, where he attends to preterm infants diagnosed with a PDA. He has published review articles on PDA management in preterm infants.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>15</Day><Hour>6</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33448032</ArticleId><ArticleId IdType="pmc">PMC8095061</ArticleId><ArticleId IdType="doi">10.1002/14651858.CD013133.pub2</ArticleId></ArticleIdList><ReferenceList><Title>References to studies included in this review</Title><ReferenceList><Title>Cotton 1980 {published data only}</Title><Reference><Citation>Cotton RB, Hickey DE, Graham TP, Stahlman MT. Effect of early indomethacin (I) on ventilatory status of preterm infants with symptomatic patent ductus arteriosus (sPDA). Pediatric Research 1980;14:442.</Citation></Reference></ReferenceList><ReferenceList><Title>Gersony 1983 {published data only}</Title><Reference><Citation>Gersony WM, Peckham GJ, Ellison RC, Miettinen OS, Nadas AS. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. Journal of Pediatrics 1983;102(6):895-906. [DOI: 10.1016/s0022-3476(83)80022-5] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-3476(83)80022-5</ArticleId><ArticleId IdType="pubmed">6343572</ArticleId></ArticleIdList></Reference><Reference><Citation>Peckham GJ, Miettinen OS, Ellison RC, Kraybill EN, Gersony WM, Zierler S, et al. Clinical course to 1 year of age in premature infants with patent ductus arteriosus: results of a multicenter randomized trial of indomethacin. Journal of Pediatrics 1984;105(2):285-91. [DOI: 10.1016/s0022-3476(84)80134-1] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-3476(84)80134-1</ArticleId><ArticleId IdType="pubmed">6379136</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kluckow 2014 {published data only}</Title><Reference><Citation>Kluckow M, Evans N, Gill A, Jeffery M. Ductal echocardiographic targeting and early closure trial (DETECT): a pilot randomised controlled trial. In: Journal of Paediatrics and Child Health. Vol. 48. 2012:43-4.</Citation></Reference><Reference><Citation>Kluckow M, Jeffery M, Gill A, Evans N. A randomised placebo-controlled trial of early treatment of the patent ductus arteriosus. Archives of Disease in Childhood: Fetal &amp; Neonatal Edition 2014;99(2):F99&#x2013;F104. [DOI: 10.1136/archdischild-2013-304695] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2013-304695</ArticleId><ArticleId IdType="pubmed">24317704</ArticleId></ArticleIdList></Reference><Reference><Citation>Varghese J, Gill A, McMichael J, Evans NJ, Rieger I, Bowen J, et al. Follow up at 2 years of an early ductal targeted treatment (DETECT) trial. Journal of Paediatrics and Child Health 2016;52(Suppl 2):102.</Citation></Reference></ReferenceList><ReferenceList><Title>Knight 2011 {published data only}</Title><Reference><Citation>Knight D, Alkindi S, Buksh M, Kuschel C, Skinner J. Placebo-controlled pilot trial of indomethacin in preterm infants with a patent ductus arteriosus. Journal of Paediatrics and Child Health 2011;47:88.</Citation></Reference></ReferenceList><ReferenceList><Title>Krauss 1989 {published data only}</Title><Reference><Citation>Krauss AN, Fatica N, Lewis BS, Cooper R, Thaler HT, Cirrincione C, et al. Pulmonary function in preterm infants following treatment with intravenous indomethacin. American Journal of Diseases of Children 1989;143(1):78&#x2013;81. [DOI: 10.1001/archpedi.1989.02150130088021] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archpedi.1989.02150130088021</ArticleId><ArticleId IdType="pubmed">2910050</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Merritt 1981 {published data only}</Title><Reference><Citation>Merritt TA, Harris JP, Roghmann K, Wood B, Campanella V, Alexson C, et al. Early closure of the patent ductus arteriosus in very low-birth-weight infants: a controlled trial. Journal of Pediatrics 1981;99(2):281-6. [DOI: 10.1016/s0022-3476(81)80479-9] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-3476(81)80479-9</ArticleId><ArticleId IdType="pubmed">7019406</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Monset&#x2010;Couchard 1983 {published data only}</Title><Reference><Citation>Monset-Couchard M, Dias-Man&#xe7;ano D, Murat I, Relier JP. [Controlled trial of intravenous lyophilized indomethacin in the treatment of persistent ductus arteriosus in premature infants]. Pediatrie 1983;38(6):365-77. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">6364030</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Nestrud 1980 {published data only}</Title><Reference><Citation>Nestrud RM, Hill DE, Arrington RW, Beard AG, Dungan WT, Lau PY, et al. Indomethacin treatment in patent ductus arteriosus. A double-blind study utilizing indomethacin plasma levels. Developmental Pharmacology and Therapeutics 1980;1(2-3):125-36. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">6765467</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Neu 1981 {published data only}</Title><Reference><Citation>Neu J, Ariagno RL, Johnson JD, Pitlick PT, Cohen RS, Beets CL, et al. A double blind study of the effects of oral indomethacin in preterm infants with patent ductus arteriosus who failed medical management. Pediatric Pharmacology (New York) 1981;1(3):245-9. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">7346744</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Osborn 2003 {published data only}</Title><Reference><Citation>Osborn DA, Evans N, Kluckow M. Effect of early targeted indomethacin on the ductus arteriosus and blood flow to the upper body and brain in the preterm infant. Archives of Disease in Childhood: Fetal &amp; Neonatal Edition 2003;88(6):F477-82. [DOI: 10.1136/fn.88.6.f477] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/fn.88.6.f477</ArticleId><ArticleId IdType="pmc">PMC1763239</ArticleId><ArticleId IdType="pubmed">14602694</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Rudd 1983 {published data only}</Title><Reference><Citation>Rudd P, Montanez P, Hallidie-Smith K, Silverman M. Indomethacin treatment for patent ductus arteriosus in very low birthweight infants: double blind trial. Archives of Disease in Childhood 1983;58(4):267-70. [DOI: 10.1136/adc.58.4.267] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/adc.58.4.267</ArticleId><ArticleId IdType="pmc">PMC1627935</ArticleId><ArticleId IdType="pubmed">6342542</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Valaes 1980 {published data only}</Title><Reference><Citation>Valaes T, Moylan FM, Cohn H, Chung K, Nagpaul K, Chrenoff HL, et al. Incidence and significance of PDA in preterm infants (PTI) and controlled blind trial of indomethacin (IND). Pediatric Research 1980;14:452.</Citation></Reference></ReferenceList><ReferenceList><Title>Yanagi 1981 {published data only}</Title><Reference><Citation>Yanagi RM, Wilson A, Newfeld EA, Aziz KU, Hunt CE. Indomethacin treatment for symptomatic patent ductus arteriosus: a double-blind control study. Pediatrics 1981;67(5):647-52. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">7019841</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Yeh 1981a {published data only}</Title><Reference><Citation>Betkerur MV, Yeh TF, Miller K, Glasser RJ, Pildes RS. Indomethacin and its effect on renal function and urinary kallikrein excretion in premature infants with patent ductus arteriosus. Pediatrics 1981;68(1):99-102. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">6909683</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh TF, Goldbarg HR, Henek T, Thalji A, Pildes RS. Intravenous indomethacin therapy in premature infants with patent ductus arteriosus. Causes of death and one year follow&#x2010;up. American Journal of Diseases of Children 1982;136(9):803&#x2010;7. [DOI: 10.1001/archpedi.1982.03970450045012] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archpedi.1982.03970450045012</ArticleId><ArticleId IdType="pubmed">7114004</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh TF, Luken JA, Thalji A, Raval D, Carr I, Pildes RS. Intravenous indomethacin therapy in premature infants with persistent ductus arteriosus &#x2010; a double blind controlled study. Journal of Pediatrics 1981;98(1):137-45. [DOI: 10.1016/s0022-3476(81)80560-4] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-3476(81)80560-4</ArticleId><ArticleId IdType="pubmed">7005415</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh TF, Raval D, Lilien LD, Srinivasan G, Pildes RS. Decreased plasma glucose following indomethacin therapy in premature infants with patent ductus arteriosus. Pediatric Pharmacology (New York) 1982;2(3):171-7. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">6761637</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh TF, Raval D, Pyati S, Pildes RS. Retinopathy of prematurity (ROP) and indomethacin therapy in premature infants with patent ductus arteriosus (PDA). Prostaglandins 1983;25(3):385-91. [DOI: 10.1016/0090-6980(83)90041-2] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0090-6980(83)90041-2</ArticleId><ArticleId IdType="pubmed">6346399</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh TF, Thalji A, Luken L, Lilien L, Carr I, Pildes RS. Improved lung compliance following indomethacin therapy in premature infants with patent ductus arteriosus. Chest 1981;80(6):698-700. [DOI: 10.1378/chest.80.6.698] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.80.6.698</ArticleId><ArticleId IdType="pubmed">7307591</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to studies excluded from this review</Title><ReferenceList><Title>Carmo 2009 {published data only}</Title><Reference><Citation>Carmo K, Evans N, Paradisis M. Duration of indomethacin treatment of the preterm patent ductus arteriosus as directed by echocardiography. Journal of Pediatrics 2009;155(6):819-22. [DOI: 10.1016/j.jpeds.2009.06.013] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2009.06.013</ArticleId><ArticleId IdType="pubmed">19643435</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mardoum 1991 {published data only}</Title><Reference><Citation>Mardoum R, Bejar R, Merritt T, Berry C. Controlled study of the effects of indomethacin on cerebral blood flow velocities in newborn infants. Journal of Paediatrics 1991;118(1):112-5. [DOI: 10.1016/s0022-3476(05)81860-8] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-3476(05)81860-8</ArticleId><ArticleId IdType="pubmed">1986076</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mullett 1982 {published data only}</Title><Reference><Citation>Mullett M, Croghan T, Myerberg D, Krall J, Neal W. Indomethacin for closure of patent ductus arteriosus in prematures. Clinical Pediatrics 1982;21(4):217-20. [DOI: 10.1177/000992288202100404] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/000992288202100404</ArticleId><ArticleId IdType="pubmed">7039927</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Nair 1986 {published data only}</Title><Reference><Citation>Nair P, Karan S. Indomethacin for closure of patent ductus arteriosous in preterm neonates. Indian Journal of Pediatrics 1986;53(4):499-503. [DOI: 10.1007/BF02749534] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02749534</ArticleId><ArticleId IdType="pubmed">28391570</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Nuntnarumit 2011 {published data only}</Title><Reference><Citation>Nuntnarumit P, Chongkongkiat P, Khositseth A. N-terminal-pro-brain natriuretic peptide: a guide for early targeted indomethacin therapy for patent ductus arteriosus in preterm infants. Acta P&#xe6;diatrica 2011;100(9):1217-21. [DOI: 10.1111/j.1651-2227.2011.02304.x] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1651-2227.2011.02304.x</ArticleId><ArticleId IdType="pubmed">21457304</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Yeh 1982a {published data only}</Title><Reference><Citation>Yeh TF, Wilks A, Singh J, Betkerur M, Lilien L, Pildes RS. Furosemide prevents the renal side effects of indomethacin therapy in premature infants with patent ductus arteriosus. Journal of Pediatrics 1982;101(3):433-7. [DOI: 10.1016/s0022-3476(82)80079-6] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-3476(82)80079-6</ArticleId><ArticleId IdType="pubmed">7108667</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to studies awaiting assessment</Title><ReferenceList><Title>Clyman 2019 {published and unpublished data}</Title><Reference><Citation>Clyman RI, Liebowitz M, Kaempf J, Erdeve O, Bulbul A, H&#xe5;kansson S, et al, PDA-TOLERATE (PDA: TO LEave it alone or Respond And Treat Early) Trial Investigators. PDA-TOLERATE trial: an exploratory randomized controlled trial of treatment of moderate-to-large patent ductus arteriosus at 1 week of age. Journal of Pediatrics 2019;205:41-8.e6. [DOI: 10.1016/j.jpeds.2018.09.012] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2018.09.012</ArticleId><ArticleId IdType="pmc">PMC6502709</ArticleId><ArticleId IdType="pubmed">30340932</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to ongoing studies</Title><ReferenceList><Title>NCT03456336 {published data only}</Title><Reference><Citation>NCT03456336. Management of the PDA Trial (PDA) [Management of the patent ductus arteriosus in premature infants trial (PDA Trial)]. clinicaltrials.gov/ct2/show/NCT03456336 (first received 7 March 2018).</Citation></Reference></ReferenceList></ReferenceList><ReferenceList><Title>Additional references</Title><ReferenceList><Title>Ballabh 2010</Title><Reference><Citation>Ballabh P. Intraventricular hemorrhage in premature infants: mechanism of disease. Pediatric Research 2010;67(1):1-8. [DOI: 10.1203/PDR.0b013e3181c1b176] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1203/PDR.0b013e3181c1b176</ArticleId><ArticleId IdType="pmc">PMC2799187</ArticleId><ArticleId IdType="pubmed">19816235</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bancalari 1979</Title><Reference><Citation>Bancalari E, Abdenour GE, Feller R, Gannon J. Bronchopulmonary dysplasia: clinical presentation. Journal of Pediatrics 1979;95(5 Pt 2):819-23. [DOI: 10.1016/s0022-3476(79)80442-4] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-3476(79)80442-4</ArticleId><ArticleId IdType="pubmed">385815</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bayley 2006</Title><Reference><Citation>Bayley N. Bayley Scales of Infant and Toddler Development: Administration Manual. Third edition. San Antonio, TX: Harcourt, 2006.</Citation></Reference></ReferenceList><ReferenceList><Title>Bell 1978</Title><Reference><Citation>Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Annals of Surgery 1978;187(1):1-7. [DOI: 10.1097/00000658-197801000-00001] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000658-197801000-00001</ArticleId><ArticleId IdType="pmc">PMC1396409</ArticleId><ArticleId IdType="pubmed">413500</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bell 1980</Title><Reference><Citation>Bell EF, Warburton D, Stonestreet BS, Oh W. Effect of fluid administration on the development of symptomatic patent ductus arteriosus and congestive heart failure in premature infants. New England Journal of Medicine 1980;302(11):598-604. [DOI: 10.1056/NEJM198003133021103] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM198003133021103</ArticleId><ArticleId IdType="pubmed">7351906</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Benitz 2010</Title><Reference><Citation>Benitz WE. Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis? Journal of Perinatology 2010;30(4):241-52. [DOI: 10.1038/jp.2010.3] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jp.2010.3</ArticleId><ArticleId IdType="pubmed">20182439</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Brown 1979</Title><Reference><Citation>Brown ER. Increased risk of bronchopulmonary dysplasia in infants with patent ductus arteriosus. Journal of Pediatrics 1979;95(5 Pt 2):865-6. [DOI: 10.1016/s0022-3476(79)80454-0] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-3476(79)80454-0</ArticleId><ArticleId IdType="pubmed">490263</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Cifuentes 1979</Title><Reference><Citation>Cifuentes RF, Olley PM, Balfe JW, Radde IC, Soldin SJ. Indomethacin and renal function in premature infants with persistent patent ductus arteriosus. Journal of Pediatrics 1979;95(4):583-7. [DOI: 10.1016/s0022-3476(79)80775-1] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-3476(79)80775-1</ArticleId><ArticleId IdType="pubmed">480039</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Clyman 1977</Title><Reference><Citation>Clyman RI, Heymann MA, Rudolph AM. Ductus arteriosus responses to prostaglandin E1 at high and low oxygen concentrations. Prostaglandins 1977;13(2):219-23. [DOI: 10.1016/0090-6980(77)90003-x] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0090-6980(77)90003-x</ArticleId><ArticleId IdType="pubmed">847229</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Clyman 1996</Title><Reference><Citation>Clyman RI. Recommendations for the postnatal use of indomethacin: an analysis of four separate treatment strategies. Journal of Pediatrics 1996;128(5 Pt 1):601-7. [DOI: 10.1016/s0022-3476(96)80123-5] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-3476(96)80123-5</ArticleId><ArticleId IdType="pubmed">8627430</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Clyman 2000</Title><Reference><Citation>Clyman RI. Ibuprofen and patent ductus arteriosus. New England Journal of Medicine 2000;343(10):728-30. [DOI: 10.1056/NEJM200009073431009] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200009073431009</ArticleId><ArticleId IdType="pubmed">10974138</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Coombs 1990</Title><Reference><Citation>Coombs RC, Morgan ME, Durbin GM, Booth IW, McNeish AS. Gut blood flow velocities in the newborn: effects of patent ductus arteriosus and parenteral indomethacin. Archives of Disease in Childhood 1990;65(10 Spec No):1067-71. [DOI: 10.1136/adc.65.10_spec_no.1067] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/adc.65.10_spec_no.1067</ArticleId><ArticleId IdType="pmc">PMC1590251</ArticleId><ArticleId IdType="pubmed">2241229</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Cotton 1978</Title><Reference><Citation>Cotton RB, Stahlman MT, Kovar I, Catterton WZ. Medical management of small preterm infants with symptomatic patent ductus arteriosus. Journal of Pediatrics 1978;92(3):467-73. [DOI: 10.1016/s0022-3476(78)80451-x] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-3476(78)80451-x</ArticleId><ArticleId IdType="pubmed">632994</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Cotton 1981</Title><Reference><Citation>Cotton RB, Lindstrom DP, Stahlman MT. Early prediction of symptomatic patent ductus arteriosus from perinatal risk factors: a discriminant analysis model. Acta Paediatrica Scandinavica 1981;70(5):723-7. [DOI: 10.1111/j.1651-2227.1981.tb05775.x] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1651-2227.1981.tb05775.x</ArticleId><ArticleId IdType="pubmed">7324921</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Davis 1990</Title><Reference><Citation>Davis JM, Hendricks-Munoz KD, Hagberg D, Manning JA. The effects of indomethacin on renal function and intracranial hemorrhage in infants with patent ductus arteriosus. Developmental Pharmacology and Therapeutics 1990;14(1):15-9. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">2311476</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Davis 1995</Title><Reference><Citation>Davis P, Turner-Gomes S, Cunningham K, Way C, Roberts R, Schmidt B. Precision and accuracy of clinical and radiological signs in premature infants at risk of patent ductus arteriosus. Archives of Pediatrics &amp; Adolescent Medicine 1995;149(10):1136-41. [DOI: 10.1001/archpedi.1995.02170230090013] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archpedi.1995.02170230090013</ArticleId><ArticleId IdType="pubmed">7550818</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Dice 2007</Title><Reference><Citation>Dice JE, Bhatia J. Patent ductus arteriosus: an overview. Journal of Pediatric Pharmacology and Therapeutics 2007;12(3):138-46. [DOI: 10.5863/1551-6776-12.3.138] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.5863/1551-6776-12.3.138</ArticleId><ArticleId IdType="pmc">PMC3462096</ArticleId><ArticleId IdType="pubmed">23055849</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Dollberg 2005</Title><Reference><Citation>Dollberg S, Lusky A, Reichman B. Patent ductus arteriosus, indomethacin and necrotizing enterocolitis in very low birth weight infants: a population-based study. Journal of Pediatric Gastroenterology and Nutrition 2005;40(2):184-8. [DOI: 10.1097/00005176-200502000-00019] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005176-200502000-00019</ArticleId><ArticleId IdType="pubmed">15699694</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Edwards 1990</Title><Reference><Citation>Edwards AD, Wyatt JS, Richardson C, Potter A, Cope M, Delpy DT, et al. Effects of indomethacin on cerebral haemodynamics in very preterm infants. Lancet 1990;335(8704):1491-5. [DOI: 10.1016/0140-6736(90)93030-s] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0140-6736(90)93030-s</ArticleId><ArticleId IdType="pubmed">1972434</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ellison 1983</Title><Reference><Citation>Ellison RC, Peckham GJ, Lang P, Talner NS, Lerer TJ, Lin L, et al. Evaluation of the preterm infant for patent ductus arteriosus. Pediatrics 1983;71(3):364-72. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">6338474</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Fowlie 2010</Title><Reference><Citation>Fowlie PW, Davis PG, McGuire W. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database of Systematic Reviews 2010, Issue 7. Art. No: CD000174. [DOI: 10.1002/14651858.CD000174.pub2]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD000174.pub2</ArticleId><ArticleId IdType="pmc">PMC7045285</ArticleId><ArticleId IdType="pubmed">20614421</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Friedman 1976</Title><Reference><Citation>Friedman WF, Hirschklau MJ, Printz MP, Pitlick PT, Kirkpatrick SE. Pharmacologic closure of patent ductus arteriosus in the premature infant. New England Journal of Medicine 1976;295(10):526-9. [DOI: 10.1056/NEJM197609022951003] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM197609022951003</ArticleId><ArticleId IdType="pubmed">820994</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Fujii 2002</Title><Reference><Citation>Fujii AM, Brown E, Mirochnick M, O'Brien S, Kaufman G. Neonatal necrotizing enterocolitis with intestinal perforation in extremely premature infants receiving early indomethacin treatment for patent ductus arteriosus. Journal of Perinatology 2002;22(7):535-40. [DOI: 10.1038/sj.jp.7210795] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.jp.7210795</ArticleId><ArticleId IdType="pubmed">12368968</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>GRADEpro GDT [Computer program]</Title><Reference><Citation>GRADEpro GDT. Version accessed 9 November 2018. Hamilton (ON): McMaster University (developed by Evidence Prime). Available at gradepro.org.</Citation></Reference></ReferenceList><ReferenceList><Title>Grosfeld 1996</Title><Reference><Citation>Grosfeld JL, Chaet M, Molinari F, Engle W, Engum SA, West KW, et al. Increased risk of necrotizing enterocolitis in premature infants with patent ductus arteriosus treated with indomethacin. Annals of Surgery 1996;224(3):350-5; discussion 355-7. [DOI: 10.1097/00000658-199609000-00011] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000658-199609000-00011</ArticleId><ArticleId IdType="pmc">PMC1235380</ArticleId><ArticleId IdType="pubmed">8813263</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Hammerman 1986</Title><Reference><Citation>Hammerman C, Strates E, Valaitis S. The silent ductus: its precursors and its aftermath. Pediatric Cardiology 1986;7(3):121-7. [DOI: 10.1007/BF02424985] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02424985</ArticleId><ArticleId IdType="pubmed">3468491</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Hammerman 1995</Title><Reference><Citation>Hammerman C. Patent ductus arteriosus. Clinical relevance of prostaglandins and prostaglandin inhibitors in PDA pathophysiology and treatment. Clinics in Perinatology 1995;22(2):457-79. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">7671547</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Herrera 2007</Title><Reference><Citation>Herrera C, Holberton J, Davis P. Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants. Cochrane Database of Systematic Reviews 2007, Issue 2. Art. No: CD003480. [DOI: 10.1002/14651858.CD003480.pub3]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD003480.pub3</ArticleId><ArticleId IdType="pmc">PMC8715534</ArticleId><ArticleId IdType="pubmed">17443527</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Heymann 1976</Title><Reference><Citation>Heymann MA, Rudolph AM, Silverman NH. Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. New England Journal of Medicine 1976;295(10):530-3. [DOI: 10.1056/NEJM197609022951004] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM197609022951004</ArticleId><ArticleId IdType="pubmed">950959</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Higgins 2011</Title><Reference><Citation>Higgins JP, Altman DG, Sterne JA, on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group. Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). Cochrane, 2011. Available from handbook.cochrane.org.</Citation></Reference></ReferenceList><ReferenceList><Title>Higgins 2019</Title><Reference><Citation>Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 6.1 (updated September 2020). Cochrane, 2020. Available from www.training.cochrane.org/handbook.</Citation></Reference></ReferenceList><ReferenceList><Title>ICROP 2005</Title><Reference><Citation>International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Archives of Ophthalmology 2005;123(7):991-9. [DOI: 10.1001/archopht.123.7.991] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archopht.123.7.991</ArticleId><ArticleId IdType="pubmed">16009843</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Jacob 1980</Title><Reference><Citation>Jacob J, Gluck L, DiSessa T, Edwards D, Kulovich M, Kurlinski J, et al. The contribution of PDA in the neonate with severe RDS. Journal of Pediatrics 1980;96(1):79-87. [DOI: 10.1016/s0022-3476(80)80336-2] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-3476(80)80336-2</ArticleId><ArticleId IdType="pubmed">6892514</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Jones 2011</Title><Reference><Citation>Jones LJ, Craven PD, Attia J, Thakkinstian A, Wright I. Network meta-analysis of indomethacin versus ibuprofen versus placebo for PDA in preterm infants. Archives of Disease in Childhood. Fetal &amp; Neonatal Edition 2011;96(1):F45-52. [DOI: 10.1136/adc.2009.168682] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/adc.2009.168682</ArticleId><ArticleId IdType="pubmed">20876595</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kitterman 1972</Title><Reference><Citation>Kitterman JA, Edmunds LH Jr, Gregory GA, Heymann MA, Tooley WH, Rudolph AM. Patent ducts arteriosus in premature infants. Incidence, relation to pulmonary disease and management. New England Journal of Medicine 1972;287(10):473-7. [DOI: 10.1056/NEJM197209072871001] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM197209072871001</ArticleId><ArticleId IdType="pubmed">5048708</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lago 2002</Title><Reference><Citation>Lago P, Bettiol T, Salvadori S, Pitassi I, Vianello A, Chiandetti L, et al. Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial. European Journal of Pediatrics 2002;161(4):202-7. [DOI: 10.1007/s00431-002-0915-y] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-002-0915-y</ArticleId><ArticleId IdType="pubmed">12014386</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Malviya 2013</Title><Reference><Citation>Malviya MN, Ohlsson A, Shah SS. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. Cochrane Database of Systematic Reviews 2013, Issue 3. Art. No: CD003951. [DOI: 10.1002/14651858.CD003951.pub3]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD003951.pub3</ArticleId><ArticleId IdType="pmc">PMC7027388</ArticleId><ArticleId IdType="pubmed">23543527</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Matthew 1998</Title><Reference><Citation>Mathew R. Development of the pulmonary circulation: metabolic aspects. In: Polin RA, Fox WW, editors(s). Fetal and Neonatal Physiology. 2nd edition. Philadelphia (PA): WB Saunders, 1998:924-9.</Citation></Reference></ReferenceList><ReferenceList><Title>Mitra 2018</Title><Reference><Citation>Mitra S, Florez ID, Tamayo ME, Mbuagbaw L, Vanniyasingam T, Angeliki Veroniki A, et al. Association of placebo, indomethacin, ibuprofen, and acetaminophen with closure of hemodynamically significant patent ductus arteriosus in preterm infants: a systematic review and meta-analysis. JAMA 2018;319(12):1221-38. [DOI: 10.1001/jama.2018.1896] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2018.1896</ArticleId><ArticleId IdType="pmc">PMC5885871</ArticleId><ArticleId IdType="pubmed">29584842</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mitra 2020</Title><Reference><Citation>Mitra S, McNamara PJ. Patent ductus arteriosus &#x2013; time for a definitive trial. Clinics in Perinatology 2020;47(3):617-39. [DOI: 10.1016/j.clp.2020.05.007] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clp.2020.05.007</ArticleId><ArticleId IdType="pubmed">32713454</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Moher 1998</Title><Reference><Citation>Moher D. CONSORT: an evolving tool to help improve the quality of reports of randomized controlled trials. Consolidated standards of reporting trials. JAMA 1998;279:1489-91. [DOI: 10.1001/jama.279.18.1489] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.279.18.1489</ArticleId><ArticleId IdType="pubmed">9600488</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Moher 2009</Title><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Journal of Clinical Epidemiology 2009;62(10):1006-12. [DOI: 10.1016/j.jclinepi.2009.06.005] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2009.06.005</ArticleId><ArticleId IdType="pubmed">19631508</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Nehgme 1992</Title><Reference><Citation>Nehgme RA, O'Connor TZ, Lister G, Bracken MB. Patent ductus arteriosus. In: Sinclair JC, Bracken MB, editors(s). Effective Care of the Newborn Infant. Oxford: Oxford University Press, 1992:281-324.</Citation></Reference></ReferenceList><ReferenceList><Title>Noori 2009</Title><Reference><Citation>Noori S, Seri I. Treatment of the patent ductus arteriosus: when, how, and for how long? Journal of Pediatrics 2009;155(6):774-6. [DOI: 10.1016/j.jpeds.2009.07.053] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2009.07.053</ArticleId><ArticleId IdType="pubmed">19914428</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ohlsson 2020</Title><Reference><Citation>Ohlsson A, Walia R, Shah SS. Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants. Cochrane Database of Systematic Reviews 2020, Issue 2. Art. No: CD003481. [DOI: 10.1002/14651858.CD003481.pub8]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD003481.pub8</ArticleId><ArticleId IdType="pmc">PMC7012639</ArticleId><ArticleId IdType="pubmed">32045960</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Papile 1978</Title><Reference><Citation>Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. Journal of Pediatrics 1978;92(4):529-34. [DOI: 10.1016/s0022-3476(78)80282-0] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-3476(78)80282-0</ArticleId><ArticleId IdType="pubmed">305471</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Review Manager 2020 [Computer program]</Title><Reference><Citation>Review Manager 5 (RevMan 5). Version 5.4. Copenhagen: The Cochrane Collaboration, 2020.</Citation></Reference></ReferenceList><ReferenceList><Title>Sch&#xfc;nemann 2013</Title><Reference><Citation>Sch&#xfc;nemann H, Bro&#x17c;ek J, Guyatt G, Oxman A, editor(s). Handbook for Grading the Quality of Evidence and the Strength of Recommendations Using the GRADE Approach (updated October 2013). GRADE Working Group, 2013. Available from gdt.guidelinedevelopment.org/app/handbook/handbook.html.</Citation></Reference></ReferenceList><ReferenceList><Title>Semberova 2017</Title><Reference><Citation>Semberova J, Sirc J, Miletin J, Kucera J, Berka I, Sebkova S, et al. Spontaneous closure of patent ductus arteriosus in infants &lt;/=1500 g. Pediatrics 2017;140(2):e20164258. [DOI: 10.1542/peds.2016-4258] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2016-4258</ArticleId><ArticleId IdType="pubmed">28701390</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Shennan 1988</Title><Reference><Citation>Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics 1988;82(4):527-32. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">3174313</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Stavel 2017</Title><Reference><Citation>Stavel M, Wong J, Cieslak Z, Sherlock R, Claveau M, Shah PS. Effect of prophylactic indomethacin administration and early feeding on spontaneous intestinal perforation in extremely low-birth-weight infants. Journal of Perinatology 2017;37(2):188-93. [DOI: 10.1038/jp.2016.196] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jp.2016.196</ArticleId><ArticleId IdType="pubmed">27763630</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Thibeault 1975</Title><Reference><Citation>Thibeault DW, Emmanouilides GC, Nelson RJ, Lachman RS, Rosengart RM, Oh W. Patent ductus arteriosus complicating the respiratory distress syndrome in preterm infants. Journal of Pediatrics 1975;86(1):120-6. [DOI: 10.1016/s0022-3476(75)80722-0] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-3476(75)80722-0</ArticleId><ArticleId IdType="pubmed">122840</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Webbe 2020</Title><Reference><Citation>Webbe JW, Duffy JM, Afonso E, Al-Muzaffar I, Brunton G, Greenough A, et al. Core outcomes in neonatology: development of a core outcome set for neonatal research. Archives of Disease in Childhood. Fetal &amp; Neonatal Edition 2020;105(4):425-31. [DOI: 10.1136/archdischild-2019-317501] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2019-317501</ArticleId><ArticleId IdType="pmc">PMC7363790</ArticleId><ArticleId IdType="pubmed">31732683</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Weir 1999</Title><Reference><Citation>Weir FJ, Ohlsson A, Myhr TL, Fong K, Ryan ML. A patent ductus arteriosus is associated with reduced middle cerebral artery blood flow velocity. European Journal of Pediatrics 1999;158(6):484-7. [DOI: 10.1007/s004310051125] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004310051125</ArticleId><ArticleId IdType="pubmed">10378397</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Weisz 2014</Title><Reference><Citation>Weisz DE, More K, McNamara PJ, Shah PS. PDA ligation and health outcomes: a meta-analysis. Pediatrics 2014;133(4):e1024-46. [DOI: 10.1542/peds.2013-3431] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2013-3431</ArticleId><ArticleId IdType="pubmed">24639268</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Yeh 1981b</Title><Reference><Citation>Yeh TF, Thalji A, Luken L, Lilien L, Carr I, Pildes RS. Improved lung compliance following indomethacin therapy in premature infants with patent ductus arteriosus. Chest 1981;80(6):698-700. [DOI: 10.1378/chest.80.6.698] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.80.6.698</ArticleId><ArticleId IdType="pubmed">7307591</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Yeh 1982b</Title><Reference><Citation>Yeh TF, Goldbarg HR, Henek T, Thalji A, Pildes RS. Intravenous indomethacin therapy in premature infants with patent ductus arteriosus. Causes of death and one-year follow-up. American Journal of Diseases of Children 1982;136(9):803-7. [DOI: 10.1001/archpedi.1982.03970450045012] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archpedi.1982.03970450045012</ArticleId><ArticleId IdType="pubmed">7114004</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Yeh 1982c</Title><Reference><Citation>Yeh TF, Raval D, Lilien LD, Srinivasan G, Pildes RS. Decreased plasma glucose following indomethacin therapy in premature infants with patent ductus arteriosus. Pediatric Pharmacology (New York) 1982;2(3):171-7. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">6761637</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Yeh 1983</Title><Reference><Citation>Yeh TF, Raval D, Pyati S, Pildes RS. Retinopathy of prematurity (ROP) and indomethacin therapy in premature infants with patent ductus arteriosus (PDA). Prostaglandins 1983;25(3):385-91. [DOI: 10.1016/0090-6980(83)90041-2] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0090-6980(83)90041-2</ArticleId><ArticleId IdType="pubmed">6346399</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to other published versions of this review</Title><ReferenceList><Title>Evans 2018</Title><Reference><Citation>Evans P, O'Reilly D, Flyer JN, Mitra S, Soll R. Indomethacin for symptomatic patent ductus arteriosus in preterm infants. Cochrane Database of Systematic Reviews 2018, Issue 9. Art. No: CD013133. [DOI: 10.1002/14651858.CD013133]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD013133</ArticleId><ArticleId IdType="pmc">PMC8095061</ArticleId><ArticleId IdType="pubmed">33448032</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">26451667</PMID><DateRevised><Year>2022</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1547-5646</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>2</Issue><PubDate><Year>2016</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of neurosurgery. Spine</Title><ISOAbbreviation>J Neurosurg Spine</ISOAbbreviation></Journal><ArticleTitle>Causes of 30-day readmission after neurosurgery of the spine.</ArticleTitle><Pagination><StartPage>281</StartPage><EndPage>290</EndPage><MedlinePgn>281-290</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3171/2015.4.SPINE15445</ELocationID><Abstract><AbstractText>OBJECT Thirty-day readmission has been cited as an important indicator of the quality of care in several fields of medicine. The aim of this systematic review was to examine rate of readmission and factors relevant to readmission after neurosurgery of the spine. METHODS The authors carried out a systematic review using several databases, searches of cited reference lists, and a manual search of the JNS Publishing Group journals (Journal of Neurosurgery; Journal of Neurosurgery: Spine; Journal of Neurosurgery: Pediatrics; and Neurosurgical Focus), Neurosurgery, Acta Neurochirurgica, and Canadian Journal of Neurological Sciences. A quality review was performed using STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) criteria and reported according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. RESULTS A systematic review of 1136 records published between 1947 and 2014 revealed 31 potentially eligible studies, and 5 studies met inclusion criteria for content and quality. Readmission rates varied from 2.54% to 14.7%. Sequelae that could be traced back to complications that arose during neurosurgery of the spine were a prime reason for readmission after discharge. Increasing age, poor physical status, and comorbid illnesses were also important risk factors for 30-day readmission. CONCLUSIONS Readmission rates have predictable factors that can be addressed. Strategies to reduce readmission that relate to patient-centered factors, complication avoidance during neurosurgery, standardization with system-wide protocols, and moving toward a culture of nonpunitive system-wide error and "near miss" investigations and quality improvement are discussed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cusimano</LastName><ForeName>Michael D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Division of Neurosurgery, Keenan Research Centre and Li Ka Shing Knowledge Institute, St. Michael's Hospital; and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dalla Lana School of Public Health and Department of Surgery, University of Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pshonyak</LastName><ForeName>Iryna</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Division of Neurosurgery, Keenan Research Centre and Li Ka Shing Knowledge Institute, St. Michael's Hospital; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Michael Y</ForeName><Initials>MY</Initials><AffiliationInfo><Affiliation>Division of Neurosurgery, Keenan Research Centre and Li Ka Shing Knowledge Institute, St. Michael's Hospital; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ilie</LastName><ForeName>Gabriela</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Neurosurgery, Keenan Research Centre and Li Ka Shing Knowledge Institute, St. Michael's Hospital; and.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>10</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurosurg Spine</MedlineTA><NlmUniqueID>101223545</NlmUniqueID><ISSNLinking>1547-5646</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ASA = American Society of Anesthesiologists</Keyword><Keyword MajorTopicYN="N">CPT = Current Procedural Terminology</Keyword><Keyword MajorTopicYN="N">DVT = deep vein thrombosis</Keyword><Keyword MajorTopicYN="N">LOS = length of stay</Keyword><Keyword MajorTopicYN="N">PCI = percutaneous coronary intervention</Keyword><Keyword MajorTopicYN="N">PE = pulmonary embolism</Keyword><Keyword MajorTopicYN="N">PRISMA = Preferred Reporting Items for Systematic Reviews and Meta-Analyses</Keyword><Keyword MajorTopicYN="N">SSI = surgical site infection</Keyword><Keyword MajorTopicYN="N">UTI = urinary tract infection</Keyword><Keyword MajorTopicYN="N">neurosurgery</Keyword><Keyword MajorTopicYN="N">outcomes</Keyword><Keyword MajorTopicYN="N">readmission</Keyword><Keyword MajorTopicYN="N">spine</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>10</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>10</Month><Day>10</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>10</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26451667</ArticleId><ArticleId IdType="doi">10.3171/2015.4.SPINE15445</ArticleId></ArticleIdList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30177072</PMID><DateCompleted><Year>2018</Year><Month>11</Month><Day>14</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2210-7797</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2018</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Pregnancy hypertension</Title><ISOAbbreviation>Pregnancy Hypertens</ISOAbbreviation></Journal><ArticleTitle>Maternal Serum B Cell activating factor in hypertensive and normotensive pregnancies.</ArticleTitle><Pagination><StartPage>58</StartPage><EndPage>61</EndPage><MedlinePgn>58-61</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.preghy.2018.05.001</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2210-7789(17)30488-9</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The objective of this study was the analysis of B-Cell Activating Factor (BAFF) levels in pregnancies affected by PE, and in pregnancies affected by fetal growth restriction without Hypertensive disorders and its possible correlation with pulse wave velocity and cardiac output.</AbstractText><AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">Prospective study of 69 women at 24-40&#x202f;weeks gestation. Haemodynamic function was assessed in those with Pre-eclampsia (PE, n&#x202f;=&#x202f;19), fetal growth restriction (FGR, n&#x202f;=&#x202f;10) and healthy pregnancies (n&#x202f;=&#x202f;40). Maternal venous BAFF levels at recruitment were measured using ELISA. We analysed the relationship between BAFF and cardiac output (CO), and BAFF and PWV (pulse wave velocity); the gold standard for assessing arterial stiffness. PWV was measured with an oscillometric device and CO using inert gas rebreathing technique. PWV and CO were converted to gestation adjusted indices (z scores).</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">The association between BAFF levels in PE and FGR, and the relationship of BAFF with PWV and CO.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">BAFF was higher in PE (p&#x202f;=&#x202f;0.03) but not in FGR (p&#x202f;=&#x202f;0.83) when compared to healthy pregnancies. There was a positive correlation between BAFF levels and z score PWV (r&#x202f;=&#x202f;0.25, p&#x202f;=&#x202f;0.04), but not CO (r&#x202f;=&#x202f;-0.01, p&#x202f;=&#x202f;0.91). BAFF levels did not change with gestational age. (r&#x202f;=&#x202f;0.012, p&#x202f;=&#x202f;0.925).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These findings provide evidence of a possible contribution of BAFF to both maternal inflammation and arterial dysfunction associated with PE. Though no relationship was found with another disorder of placentation: normotensive FGR, this condition is not thought to be associated with maternal inflammation.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018. Published by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tay</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centre for Fetal Care, Queen Charlotte's and Chelsea Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costanzi</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cryolab University of Rome Tor Vergata, Via Montpellier, 1 - 00133 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Basello</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Cryolab University of Rome Tor Vergata, Via Montpellier, 1 - 00133 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piuri</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Inflammation Society, 18 Woodlands Park, Bexley DA52EL, Kent, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrazzi</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>IRCCS Fondazione C&#xe0; Granda, Ospedale Maggiore Policlinico, Department of Woman, Child and Neonate, Milan, Italy; Department of Biomedical and Clinical Sciences, University of Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Speciani</LastName><ForeName>A F</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Cryolab University of Rome Tor Vergata, Via Montpellier, 1 - 00133 Rome, Italy; Inflammation Society, 18 Woodlands Park, Bexley DA52EL, Kent, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lees</LastName><ForeName>C C</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Centre for Fetal Care, Queen Charlotte's and Chelsea Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom; Department of Surgery and Cancer, Imperial College London, London, United Kingdom; Department of Development and Regeneration, KU Leuven, Leuven, Belgium. Electronic address: christoph.lees@nhs.net.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>05</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Pregnancy Hypertens</MedlineTA><NlmUniqueID>101552483</NlmUniqueID><ISSNLinking>2210-7789</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053264">B-Cell Activating Factor</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053264" MajorTopicYN="N">B-Cell Activating Factor</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002302" MajorTopicYN="N">Cardiac Output</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005317" MajorTopicYN="N">Fetal Growth Retardation</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005865" MajorTopicYN="N">Gestational Age</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011225" MajorTopicYN="N">Pre-Eclampsia</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011296" MajorTopicYN="N">Prenatal Diagnosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063177" MajorTopicYN="N">Pulse Wave Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012039" MajorTopicYN="N">Regional Blood Flow</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Arterial function</Keyword><Keyword MajorTopicYN="N">BAFF</Keyword><Keyword MajorTopicYN="N">Fetal growth restriction</Keyword><Keyword MajorTopicYN="N">Pre-eclampsia</Keyword><Keyword MajorTopicYN="N">Pulse wave velocity</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>4</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30177072</ArticleId><ArticleId IdType="doi">10.1016/j.preghy.2018.05.001</ArticleId><ArticleId IdType="pii">S2210-7789(17)30488-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31855876</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>06</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1528-1140</ISSN><JournalIssue CitedMedium="Internet"><Volume>274</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>Dec</Month><Day>01</Day></PubDate></JournalIssue><Title>Annals of surgery</Title><ISOAbbreviation>Ann Surg</ISOAbbreviation></Journal><ArticleTitle>Long-term Impact of Bariatric Surgery on Venous Thromboembolic Risk: A Matched Cohort Study.</ArticleTitle><Pagination><StartPage>1017</StartPage><EndPage>1024</EndPage><MedlinePgn>1017-1024</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/SLA.0000000000003750</ELocationID><Abstract><AbstractText Label="OBJECTIVE">The aim of this study is to evaluate the effect of bariatric surgery on long-term risk of VTEs in a large cohort of patients with obesity.</AbstractText><AbstractText Label="BACKGROUND">Obesity is a well-established risk factor for VTEs, such as pulmonary embolism and deep vein thrombosis. The rising prevalence of obesity and its associated co-morbidities, including VTE, represent a growing public health issue.</AbstractText><AbstractText Label="METHODS">A nested, retrospective matched cohort study was designed and conducted on prospectively collected national electronic healthcare records data from the Clinical Practice Research Datalink. Eight thousand, one hundred twelve patients were included in the study: the 4056 patients on the database who had undergone bariatric surgery, and equal numbers of age, sex, and body mass index matched controls. The primary endpoint was the occurrence of VTEs; secondary endpoints were the occurrence of deep vein thrombosis alone, pulmonary embolism alone.</AbstractText><AbstractText Label="RESULTS">Patients were followed up for a median of 10.7 years. The bariatric surgery cohort had a significantly lower occurrence of the primary outcome [hazard ratio (HR) 0.601; 95% confidence interval (CI) 0.430-0.841, P = 0.003]; mainly driven by a reduction in deep vein thrombosis (HR 0.523; 95% CI 0.349-0.783, P = 0&#xb7;002) and not in pulmonary embolism (HR 0.882; 95% CI 0.511-1.521, P = 0.651).</AbstractText><AbstractText Label="CONCLUSIONS">The results of this nation-wide study set out to characterize the impact of bariatric surgery on long-term risk of thromboembolic events outline a significant reduction in thromboembolic events, driven by a reduction in deep vein thrombosis.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Wolters Kluwer Health, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Moussa</LastName><ForeName>Osama</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>St Mary's Academic Unit, Imperial College London, London W2 1NY, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ardissino</LastName><ForeName>Maddalena</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Imperial College London, London SW7 2AZ, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Magill Department of Anaesthesia, Intensive Care and Pain Management, Chelsea and Westminster Hospital, London SW10 9NH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Alice</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Imperial College London, London SW7 2AZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lazzari</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Imperial College London, London SW7 2AZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Millar</LastName><ForeName>Ophelia</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Imperial College London, London SW7 2AZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ziprin</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>St Mary's Academic Unit, Imperial College London, London W2 1NY, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Darzi</LastName><ForeName>Ara</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>St Mary's Academic Unit, Imperial College London, London W2 1NY, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Omar</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Upper GI and Bariatric Surgery, St George's University of London, London SW17 0RE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Collins</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Royal Brompton Hospital and National Heart and Lung Institute, Imperial College London, London SW3 6NP, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Purkayastha</LastName><ForeName>Sanjay</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>St Mary's Academic Unit, Imperial College London, London W2 1NY, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Surg</MedlineTA><NlmUniqueID>0372354</NlmUniqueID><ISSNLinking>0003-4932</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050110" MajorTopicYN="Y">Bariatric Surgery</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="N">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors report no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31855876</ArticleId><ArticleId IdType="doi">10.1097/SLA.0000000000003750</ArticleId><ArticleId IdType="pii">00000658-202112000-00021</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cohen AT, Agnelli G, Anderson FA, et al. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost 2007; 98:756&#x2013;764.</Citation></Reference><Reference><Citation>Zhu T, Martinez I, Emmerich J. Venous thromboembolism: risk factors for recurrence. Arterioscler Thromb Vasc Biol 2009; 29:298&#x2013;310.</Citation></Reference><Reference><Citation>White RH. The epidemiology of venous thromboembolism. Circulation 2003; 107:4&#x2013;8.</Citation></Reference><Reference><Citation>Heit JA, Silverstein MD, Mohr DN, et al. Risk factors for deep vein thrombosis and pulmonary embolism. Arch Intern Med 2003; 160:809&#x2013;815.</Citation></Reference><Reference><Citation>Martinelli I, De Stefano V, Mannucci PM. Inherited risk factors for venous thromboembolism. Nat Rev Cardiol 2014; 11:140&#x2013;156.</Citation></Reference><Reference><Citation>Stein PD, Beemath A, Olson RE. Obesity as a risk factor in venous thromboembolism. Am J Med 2005; 118:978&#x2013;980.</Citation></Reference><Reference><Citation>WHO. Obesity and overweight. World Heal Organ Media Cent Fact Sheet No 311. 2011:1-2. Available at: 10.3233/978-1-61499-438-1-372</Citation></Reference><Reference><Citation>Douglas IJ, Bhaskaran K, Batterham RL, et al. Bariatric surgery in the united kingdom: a cohort study of weight loss and clinical outcomes in routine clinical care. PLoS Med 2015; 12:1&#x2013;18.</Citation></Reference><Reference><Citation>Pareek M, Schauer PR, Kaplan LM, et al. Metabolic surgery: weight loss, diabetes, and beyond. J Am Coll Cardiol 2018; 71:670&#x2013;687.</Citation></Reference><Reference><Citation>Chang SH, Stoll CRT, Song J, et al. The effectiveness and risks of bariatric surgery an updated systematic review and meta-analysis. JAMA Surg 2014; 149:275&#x2013;287.</Citation></Reference><Reference><Citation>Sj&#xf6;str&#xf6;m L, Peltonen M, Jacobson P, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA 2014; 311:2297&#x2013;2304.</Citation></Reference><Reference><Citation>Sj&#xf6;str&#xf6;m L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA 2012; 307:56&#x2013;65.</Citation></Reference><Reference><Citation>Mistry P, Currie V, Super P, et al. Changes in glycaemic control, blood pressure and lipids 5 years following laparoscopic adjustable gastric banding combined with medical care in patients with type 2 diabetes: a longitudinal analysis. Clin Obes 2018; 8:151&#x2013;158.</Citation></Reference><Reference><Citation>Adams TD, Arterburn DE, Nathan DM, et al. Clinical outcomes of metabolic surgery: microvascular and macrovascular complications. Diabetes Care 2016; 39:912&#x2013;923.</Citation></Reference><Reference><Citation>Fisher DP, Johnson E, Haneuse S, et al. Association between bariatric surgery and macrovascular disease outcomes in patients with type 2 diabetes and severe obesity. JAMA 2018; 320:1570&#x2013;1582.</Citation></Reference><Reference><Citation>Hamad GG, Bergqvist D. Venous thromboembolism in bariatric surgery patients: an update of risk and prevention. Surg Obes Relat Dis 2007; 3:97&#x2013;102.</Citation></Reference><Reference><Citation>Steele KE, Schweitzer MA, Prokopowicz G, et al. The long-term risk of venous thromboembolism following bariatric surgery. Obes Surg 2011; 21:1371&#x2013;1376.</Citation></Reference><Reference><Citation>Jamal MH, Corcelles R, Shimizu H, et al. Thromboembolic events in bariatric surgery: a large multi-institutional referral center experience. Surg Endosc 2015; 29:376&#x2013;380.</Citation></Reference><Reference><Citation>Herrett E, Gallagher AM, Bhaskaran K, et al. Data resource profile: clinical practice research datalink (CPRD). Int J Epidemiol 2015; 44:827&#x2013;836.</Citation></Reference><Reference><Citation>Clinical Practice Research Datalink. CPRD Governance. Clinical Practice Research Datalink website. Published 2016. Available at: https://www.cprd.com/governance/ Accessed 18 September, 2019</Citation></Reference><Reference><Citation>Dafni U. Primer on statistical interpretation and methods landmark analysis at the 25-year landmark point background. Circ Cardiovasc Qual Outcomes 2011; 4:363&#x2013;371.</Citation></Reference><Reference><Citation>Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. J Am Med Assoc 2004; 292:1724&#x2013;1737.</Citation></Reference><Reference><Citation>Vest AR, Heneghan HM, Agarwal S, et al. Bariatric surgery and cardiovascular outcomes: a systematic review. Heart 2012; 98:1763&#x2013;1777.</Citation></Reference><Reference><Citation>Sj&#xf6;str&#xf6;m L. Review of the key results from the Swedish Obese Subjects (SOS) trial &#x2013; a prospective controlled intervention study of bariatric surgery. J Intern Med 2013; 273:219&#x2013;234.</Citation></Reference><Reference><Citation>Booth H, Khan O, Prevost AT, et al. Impact of bariatric surgery on clinical depression. Interrupted time series study with matched controls. J Affect Disord 2015; 174:644&#x2013;649.</Citation></Reference><Reference><Citation>Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg 2004; 240:416&#x2013;424.</Citation></Reference><Reference><Citation>Stein PD, Matta F. Pulmonary embolism and deep venous thrombosis following bariatric surgery. Obes Surg 2013; 23:663&#x2013;668.</Citation></Reference><Reference><Citation>Hutter MM, Randall S, Khuri SF, et al. Laparoscopic versus open gastric bypass for morbid obesity: a multicenter, prospective, risk-adjusted analysis from the National Surgical Quality Improvement Program. Ann Surg 2006; 243:657&#x2013;662.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29019557</PMID><DateCompleted><Year>2018</Year><Month>07</Month><Day>09</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2317-6326</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>3</Issue><PubDate><Year>2017</Year><Season>Jul-Sep</Season></PubDate></JournalIssue><Title>Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery</Title><ISOAbbreviation>Arq Bras Cir Dig</ISOAbbreviation></Journal><ArticleTitle>COLONOSCOPY: RANDOMIZED COMPARATIVE STUDY OF INSUFFLATION WITH CARBON DIOXIDE VERSUS AIR.</ArticleTitle><Pagination><StartPage>177</StartPage><EndPage>181</EndPage><MedlinePgn>177-181</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1590/0102-6720201700030004</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0102-67202017000300177</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">In Brazil, an increasing number of people are submitted to colonoscopy, either for screening or for therapeutic purposes.</AbstractText><AbstractText Label="AIM" NlmCategory="OBJECTIVE">To evaluate whether there are advantages of using carbon dioxide (CO2) over air for insufflation.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Two hundred and ten of 219 patients were considered eligible for this study and were randomized into two groups according to the gas insufflation used: Air Group (n=104) and CO2 Group (n=97). The study employed a double-blind design.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The Air and CO2 Groups were similar in respect to bowel preparation evaluated using the Boston scale, age, gender, previous surgery, maneuvers necessary for the advancement of the device, and presence of polyps, tumors or signs of diverticulitis. However, "waking up with pain" and "pain at discharge" were more prevalent in the Air Group, albeit not statistically significant, with post-exam bloating seen only in the Air Group. The responses to a questionnaire, applied to analyze the late post-exam period, showed more comfort with the use of CO2.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The use of CO2 is better than air as it avoids post-examination bloating, thereby providing greater comfort to patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>DE-Quadros</LastName><ForeName>Luiz Gustavo</ForeName><Initials>LG</Initials><AffiliationInfo><Affiliation>Kaiser Clinic and Hospital, Colonoscopy and Endoscopy Service, S&#xe3;o Jos&#xe9; do Rio Preto, SP, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Federal University of Pernambuco, Department of Bariatric Surgery, Recife, PE, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine of the ABC, Department of Endoscopy, Santo Andr&#xe9;, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaiser-J&#xfa;nior</LastName><ForeName>Roberto Luiz</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Kaiser Clinic and Hospital, Colonoscopy and Endoscopy Service, S&#xe3;o Jos&#xe9; do Rio Preto, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Felix</LastName><ForeName>Valter Nilton</ForeName><Initials>VN</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of S&#xe3;o Paulo, Department of Endoscopy and Bariatric Surgery, S&#xe3;o Paulo, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villar</LastName><ForeName>Lucio</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Federal University of Pernambuco, Department of Bariatric Surgery, Recife, PE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campos</LastName><ForeName>Josemberg Marins</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Federal University of Pernambuco, Department of Bariatric Surgery, Recife, PE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nogueira</LastName><ForeName>Vinicius Quintiliano Moutinho</ForeName><Initials>VQM</Initials><AffiliationInfo><Affiliation>Kaiser Clinic and Hospital, Colonoscopy and Endoscopy Service, S&#xe3;o Jos&#xe9; do Rio Preto, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teixeira</LastName><ForeName>Andr&#xe9;</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Clinical Health, Endoscopy and Bariatric Surgery Service, Orlando, Florida, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zotarelli-Filho</LastName><ForeName>Idiberto Jos&#xe9;</ForeName><Initials>IJ</Initials><AffiliationInfo><Affiliation>Kaiser Clinic and Hospital, Colonoscopy and Endoscopy Service, S&#xe3;o Jos&#xe9; do Rio Preto, SP, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>por</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Arq Bras Cir Dig</MedlineTA><NlmUniqueID>9100283</NlmUniqueID><ISSNLinking>0102-6720</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>142M471B3J</RegistryNumber><NameOfSubstance UI="D002245">Carbon Dioxide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000388" MajorTopicYN="Y">Air</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002245" MajorTopicYN="Y">Carbon Dioxide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003113" MajorTopicYN="N">Colonoscopy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007327" MajorTopicYN="N">Insufflation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="por"><AbstractText Label="RACIONAL:">No Brasil, estima-se crescente aumento da popula&#xe7;&#xe3;o submetida &#xe0; colonoscopia, apesar do desconforto do exame, decorrente sobretudo da insufla&#xe7;&#xe3;o col&#xf4;nica.</AbstractText><AbstractText Label="OBJETIVO:">Verificar se h&#xe1; vantagens do uso de CO<sub>2</sub> sobre o ar como elemento de insufla&#xe7;&#xe3;o.</AbstractText><AbstractText Label="M&#xc9;TODOS:">Um total de 219 participantes foram submetidos &#xe0; an&#xe1;lise de elegibilidade e dele extra&#xed;ram-se 210 eleitos, que foram randomizados em dois grupos, de acordo com o elemento utilizado: ar, n=104 e CO<sub>2,</sub> n=97. O ensaio seguiu o modelo duplo-cego.</AbstractText><AbstractText Label="RESULTADOS:">Os grupos demonstraram-se similares quando cotejados preparo intestinal avaliado pela Escala de Boston, idade, g&#xea;nero, opera&#xe7;&#xe3;o pr&#xe9;via, manobras necess&#xe1;rias para progress&#xe3;o do aparelho, presen&#xe7;a de p&#xf3;lipo, tumor ou sinais de diverticulite, valorizando a compara&#xe7;&#xe3;o entre eles quanto ao elemento de insufla&#xe7;&#xe3;o. Ent&#xe3;o, observou-se que &#x201c;acordar com dor&#x201d; e a presen&#xe7;a de dor na ocasi&#xe3;o da alta foram bem mais prevalentes no &#x201c;Grupo Ar&#x201d;, embora sem diferen&#xe7;a estatisticamente significante, sendo a distens&#xe3;o p&#xf3;s-exame observada apenas no &#x201c;Grupo Ar&#x201d;. De acordo com o question&#xe1;rio cl&#xed;nico aplicado para an&#xe1;lise do per&#xed;odo tardio p&#xf3;s-exame, as respostas apontaram muito mais conforto com o uso do CO<sub>2</sub>. Os elementos de insufla&#xe7;&#xe3;o n&#xe3;o pareceram modificar substancialmente os aspectos t&#xe9;cnicos do exame nem provocar &#xed;ndices expressivos de enantema da mucosa.</AbstractText><AbstractText Label="CONCLUS&#xc3;O:">O uso do di&#xf3;xido de carbono &#xe9; superior ao ar, pois evita a distens&#xe3;o abdominal p&#xf3;s-exame conferindo maior conforto aos pacientes no per&#xed;odo p&#xf3;s-exame.</AbstractText></OtherAbstract><CoiStatement><b>Conflict of interest: </b>none.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>3</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>7</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29019557</ArticleId><ArticleId IdType="pmc">PMC5630209</ArticleId><ArticleId IdType="doi">10.1590/0102-6720201700030004</ArticleId><ArticleId IdType="pii">S0102-67202017000300177</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Akan B, Sahora K, St Riss, Al-Mufti H, Karner-Hanusch J, Weiser FA. Cirurgia Europeia. 2011;43(1):30&#x2013;33.</Citation></Reference><Reference><Citation>Becker GL. Prevention of gas explosions in the large bowel during electrosurgery. Surg Gynecol Obstet. 1953;97:463&#x2013;467.</Citation><ArticleIdList><ArticleId IdType="pubmed">13102174</ArticleId></ArticleIdList></Reference><Reference><Citation>Bretthauer M, Hoff G, Thiis-Evensen E, et al. Carbon dioxide insufflation reduces discomfort due to flexible sigmoidoscopy in colorectal cancer screening. Scand J Gastroenterol. 2002;37:1103&#x2013;1107.</Citation><ArticleIdList><ArticleId IdType="pubmed">12374237</ArticleId></ArticleIdList></Reference><Reference><Citation>Bretthauer M, Seip B, Aasen S, et al. Carbon dioxide insufflation for more comfortable endoscopic retrograde cholangiopancreatography: a randomized, controlled, double-blind trial. Endoscopy. 2007;39:58&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">17252462</ArticleId></ArticleIdList></Reference><Reference><Citation>Bretthauer M, Thiis-Evense E, Huppertz-Hauss G, et al. NORCCAP (Norwegian colorectal cancer prevention): a randomized trial to assess the safety and efficacy of carbon dioxide versus air insufflation in colonoscopy. Gut. 2002;50:604&#x2013;607.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1773222</ArticleId><ArticleId IdType="pubmed">11950803</ArticleId></ArticleIdList></Reference><Reference><Citation>Calderwood AH, Jacobson BC. Comprehensive validation of the Boston Bowel Preparation Scale. Gastrointestinal Endoscopy. 2010;72(4):686&#x2013;692.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2951305</ArticleId><ArticleId IdType="pubmed">20883845</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho PHB, Otoch JP, Khan MA, Sakai P, Guedes HG, Artifon EL de A. Sedation in colonoscopy by using three different propofol infusion methods and analysis of plasma concentration levels: a prospective comparative study. ABCD. 2016;29(4):264&#x2013;268. doi: 10.1590/0102-6720201600040012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0102-6720201600040012</ArticleId><ArticleId IdType="pmc">PMC5225868</ArticleId><ArticleId IdType="pubmed">28076483</ArticleId></ArticleIdList></Reference><Reference><Citation>Church J, Delaney C. Diseases of the Colon &amp; Rectum March. 2003;46(3):322&#x2013;326.</Citation><ArticleIdList><ArticleId IdType="pubmed">12626906</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen CD, Keuneke C, Schiemann U, et al. Hyponatraemia as a complication of colonoscopy. Lancet. 2001;357:282&#x2013;283.</Citation><ArticleIdList><ArticleId IdType="pubmed">11214135</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellon ES, Velayudham A, Clarke BW, et al. A randomized, controlled, double-blind trial of air insufflation versus carbon dioxide insufflation during ERCP. Gastrointest Endosc. 2010;72:68&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2902617</ArticleId><ArticleId IdType="pubmed">20493485</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussein AM, Bartram CI, Williams CB. Carbon dioxide insufflation for more comfortable colonoscopy. Gastrointest Endosc. 1984;30:68&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">6425108</ArticleId></ArticleIdList></Reference><Reference><Citation>Janssens F, Deviere J, Eisendrath P, et al. Carbon dioxide for gut distension during digestive endoscopy: technique and practice survey. World J Gastroenterology. 2009;15:1475&#x2013;1479.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2665142</ArticleId><ArticleId IdType="pubmed">19322921</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuwatani M, Kawakami H, Hayashi T, et al. Carbon dioxide insufflation during endoscopic retrograde cholangiopancreatography reduces bowel gas volume but does not affect visual analogue scale scores of suffering: a prospective, double-blind, randomized, controlled trial. Surg Endosc. 2011;25:3784&#x2013;3790.</Citation><ArticleIdList><ArticleId IdType="pubmed">21656068</ArticleId></ArticleIdList></Reference><Reference><Citation>Luigiano C, Ferrara F, Pellicano R, et al. Carbon dioxide insufflation versus air insufflation during endoscopic retrograde cholangiopancreatography under general anesthesia. Minerva Med. 2011;102:261&#x2013;269.</Citation><ArticleIdList><ArticleId IdType="pubmed">21959700</ArticleId></ArticleIdList></Reference><Reference><Citation>Maeda Y, Hirasawa D, Fujita N, et al. A prospective, randomized, double-blind, controlled trial on the efficacy of carbon dioxide insufflation in gastric endoscopic submucosal dissection. Endoscopy. 2013;45:335&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pubmed">23468193</ArticleId></ArticleIdList></Reference><Reference><Citation>Maple JT, Keswani RN, Hovis RM, et al. Carbon dioxide insufflation during ERCP for reduction of postprocedure pain: a randomized, doubleblind, controlled trial. Gastrointest Endosc. 2009;70:278&#x2013;283.</Citation><ArticleIdList><ArticleId IdType="pubmed">19523621</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer C, Rohr S, Iderne A, et al. The value of peroperative colonic lavage in urgent colonic surgery. Apropos of 54 patients [in French] J Chir (Paris) 1997;134:271&#x2013;274.</Citation><ArticleIdList><ArticleId IdType="pubmed">9772987</ArticleId></ArticleIdList></Reference><Reference><Citation>Noveroske RJ. Intracolonic pressures during barium enema examination. Am J Roentgenol Radium Ther Nucl Med. 1964;91:852&#x2013;863.</Citation><ArticleIdList><ArticleId IdType="pubmed">14139913</ArticleId></ArticleIdList></Reference><Reference><Citation>Phaosawasdi K, Cooley W, Wheeler J, et al. Carbon dioxide-insufflated colonoscopy: an ignored superior technique. Gastrointest Endosc. 1986;32:330&#x2013;333.</Citation><ArticleIdList><ArticleId IdType="pubmed">3095169</ArticleId></ArticleIdList></Reference><Reference><Citation>Pohl J, Halphen M, Kloess HR, Fischbach W. Impact of the Quality of Bowel Cleansing on the Efficacy of Colonic Cancer Screening: A Prospective, Randomized, Blinded Study. PLoS ONE. 2015;10(5):e0126067. doi: 10.1371/journal.pone.0126067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0126067</ArticleId><ArticleId IdType="pmc">PMC4423835</ArticleId><ArticleId IdType="pubmed">25950434</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers BH. The safety of carbon dioxide insufflation during colonoscopic electrosurgical polypectomy. Gastrointest Endosc. 1974;20:115&#x2013;117.</Citation><ArticleIdList><ArticleId IdType="pubmed">4815026</ArticleId></ArticleIdList></Reference><Reference><Citation>Sajid MS, Caswell J, Bhatti MI, Sains P, Baig MK, Miles WF. Carbon dioxide insufflation vs conventional air insufflation for colonoscopy: a systematic review and meta-analysis of published randomized controlled trials. Colorectal Dis. 2015;17(2):111&#x2013;123.</Citation><ArticleIdList><ArticleId IdType="pubmed">25393051</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiwach RS. Hyponatremia from colonic lavage presenting as an acute confusional state. Am J Psychiatry. 1996;153:1367&#x2013;1367.</Citation><ArticleIdList><ArticleId IdType="pubmed">8831454</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevenson GW, Wilson JA, Wilkinson J, et al. Pain following colonoscopy: elimination with carbon dioxide. Gastrointest Endosc. 1992;38:564&#x2013;567.</Citation><ArticleIdList><ArticleId IdType="pubmed">1397911</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumanac K, Zealiey I, Fox BM, et al. Minimizing post colonoscopy abdominal pain by using CO2 insufflation: a prospective, randomized, double blind, controlled trial evaluating a new commercially available CO2 delivery system. Gastrointest Endosc. 2002;562:190&#x2013;194.</Citation><ArticleIdList><ArticleId IdType="pubmed">12145595</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamano H., Yoshikawa K., Kimura T. Carbon dioxide insufflation for colonoscopy: evaluation of gas volume, abdominal pain, examination time and transcutaneous partial CO2pressure. J Gastroenterol. 2010;45:1235&#x2013;1235. doi: 10.1007/s00535-010-0286-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00535-010-0286-5</ArticleId><ArticleId IdType="pubmed">20635100</ArticleId></ArticleIdList></Reference><Reference><Citation>Warren JL, Klabunde CN, Mariotto AB, et al. Adverse events after outpatient colonoscopy in the Medicare population. Ann Intern Med. 2009;150:849&#x2013;857.</Citation><ArticleIdList><ArticleId IdType="pubmed">19528563</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37237335</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>29</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2393</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>26</Day></PubDate></JournalIssue><Title>BMC pregnancy and childbirth</Title><ISOAbbreviation>BMC Pregnancy Childbirth</ISOAbbreviation></Journal><ArticleTitle>Incremental predictive value of platelet parameters for preeclampsia: results from a large prospective cohort study.</ArticleTitle><Pagination><StartPage>387</StartPage><MedlinePgn>387</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">387</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12884-023-05661-y</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Platelet parameters during pregnancy were associated with the risk of preeclampsia (PE), but the predictive value of these parameters for PE remained unclear. Our aim was to clarify the individual and incremental predictive value of platelet parameters, including platelet count (PC), mean platelet volume (MPV), plateletcrit (PCT), and platelet distribution width (PDW) for PE.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This study was based on the Born in Guangzhou Cohort Study in China. Data on platelet parameters were extracted from medical records of routine prenatal examinations. Receiver operating characteristic (ROC) curve was performed to analyze the predictive ability of platelet parameters for PE. Maternal characteristic factors proposed by NICE and ACOG were used to develop the base model. Detection rate (DR), integrated discrimination improvement (IDI) and continuous net reclassification improvement (NRI) were calculated compared with the base model to assess the incremental predictive value of platelet parameters.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 30,401 pregnancies were included in this study, of which 376 (1.24%) were diagnosed with PE. Higher levels of PC and PCT were observed at 12-19 gestational weeks in women who developed PE later. However, no platelet parameters before 20&#xa0;weeks of gestation reliably distinguished between PE complicated pregnancy and non-PE complicated pregnancy, with all values of the areas under the ROC curves (AUC) below 0.70. The addition of platelet parameters at 16-19 gestational weeks to the base model increased the DR for preterm PE from 22.9 to 31.4% at a fixed false positive rate of 5%, improved the AUC from 0.775 to 0.849 (p&#x2009;=&#x2009;0.015), and yielded a NRI of 0.793 (p&#x2009;&lt;&#x2009;0.001), and an IDI of 0.0069 (p&#x2009;=&#x2009;0.035). Less but significant improvement in prediction performance was also observed for term PE and total PE when all the four platelet parameters were added to the base model.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Although no single platelet parameter at the early stage of pregnancy identified PE with high accuracy, the addition of platelet parameters to known independent risk factors could improve the prediction of PE.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Shan-Shan</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Division of Birth Cohort Study, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Cheng-Rui</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Department of Women and Child Health Care, Provincial Key Clinical Specialty of Woman and Child Health, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Dong-Mei</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Division of Birth Cohort Study, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Women and Child Health Care, Provincial Key Clinical Specialty of Woman and Child Health, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Jin-Hua</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Division of Birth Cohort Study, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Women and Child Health Care, Provincial Key Clinical Specialty of Woman and Child Health, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xiao-Juan</ForeName><Initials>XJ</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Qiao-Zhu</ForeName><Initials>QZ</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Xiao-Yan</ForeName><Initials>XY</Initials><AffiliationInfo><Affiliation>Division of Birth Cohort Study, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Women and Child Health Care, Provincial Key Clinical Specialty of Woman and Child Health, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Jian-Rong</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Division of Birth Cohort Study, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, China. jianrong.he@bigcs.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Women and Child Health Care, Provincial Key Clinical Specialty of Woman and Child Health, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, China. jianrong.he@bigcs.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qiu</LastName><ForeName>Xiu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Division of Birth Cohort Study, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, China. xiu.qiu@bigcs.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Women's Health, Guangdong Provincial Key Clinical Specialty of Woman and Child Health, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, 510623, China. xiu.qiu@bigcs.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangdong Provincial Clinical Research Center for Child Health, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, 510623, China. xiu.qiu@bigcs.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Provincial Key Laboratory of Research in Structure Birth Defect Disease and Department of Pediatric Surgery, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, 510623, China. xiu.qiu@bigcs.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>31900608</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>2019B030316014</GrantID><Agency>Guangdong Science and Technology Department</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Pregnancy Childbirth</MedlineTA><NlmUniqueID>100967799</NlmUniqueID><ISSNLinking>1471-2393</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011225" MajorTopicYN="Y">Pre-Eclampsia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010976" MajorTopicYN="N">Platelet Count</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063847" MajorTopicYN="N">Mean Platelet Volume</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Platelet parameter</Keyword><Keyword MajorTopicYN="N">Predictive value</Keyword><Keyword MajorTopicYN="N">Preeclampsia</Keyword><Keyword MajorTopicYN="N">Pregnancy</Keyword><Keyword MajorTopicYN="N">Risk factor</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>27</Day><Hour>9</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>26</Day><Hour>23</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37237335</ArticleId><ArticleId IdType="pmc">PMC10214644</ArticleId><ArticleId IdType="doi">10.1186/s12884-023-05661-y</ArticleId><ArticleId IdType="pii">10.1186/s12884-023-05661-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. Pregnancy Hypertens. 2014;4(2):105&#x2013;145. doi: 10.1016/j.preghy.2014.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.preghy.2014.01.003</ArticleId><ArticleId IdType="pubmed">26104418</ArticleId></ArticleIdList></Reference><Reference><Citation>Lisonkova S, Joseph KS. Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. Am J Obstet Gynecol. 2013;209(6):544.e1&#x2013;e12. doi: 10.1016/j.ajog.2013.08.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2013.08.019</ArticleId><ArticleId IdType="pubmed">23973398</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol BWJ, Roberts CT, Thangaratinam S, Magee LA, de Groot CJM, Hofmeyr GJ. Pre-eclampsia. Lancet. 2016;387(10022):999&#x2013;1011. doi: 10.1016/S0140-6736(15)00070-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(15)00070-7</ArticleId><ArticleId IdType="pubmed">26342729</ArticleId></ArticleIdList></Reference><Reference><Citation>Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009;33(3):130&#x2013;137. doi: 10.1053/j.semperi.2009.02.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.semperi.2009.02.010</ArticleId><ArticleId IdType="pubmed">19464502</ArticleId></ArticleIdList></Reference><Reference><Citation>Bokslag A, Teunissen PW, Franssen C, van Kesteren F, Kamp O, Ganzevoort W, et al. Effect of early-onset preeclampsia on cardiovascular risk in the fifth decade of life. Am J Obstet Gynecol. 2017;216(5):523.e1&#x2013;e7. doi: 10.1016/j.ajog.2017.02.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2017.02.015</ArticleId><ArticleId IdType="pubmed">28209494</ArticleId></ArticleIdList></Reference><Reference><Citation>Jim B, Karumanchi SA. Preeclampsia: pathogenesis, prevention, and long-term complications. Semin Nephrol. 2017;37(4):386&#x2013;397. doi: 10.1016/j.semnephrol.2017.05.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semnephrol.2017.05.011</ArticleId><ArticleId IdType="pubmed">28711078</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu P, Haththotuwa R, Kwok CS, Babu A, Kotronias RA, Rushton C, et al. Preeclampsia and future cardiovascular health: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes. 2017;10(2):e003497. doi: 10.1161/CIRCOUTCOMES.116.003497.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCOUTCOMES.116.003497</ArticleId><ArticleId IdType="pubmed">28228456</ArticleId></ArticleIdList></Reference><Reference><Citation>Fields JA, Garovic VD, Mielke MM, Kantarci K, Jayachandran M, White WM, et al. Preeclampsia and cognitive impairment later in life. Am J Obstet Gynecol. 2017;217(1):74.e1&#x2013;e11. doi: 10.1016/j.ajog.2017.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2017.03.008</ArticleId><ArticleId IdType="pmc">PMC5615406</ArticleId><ArticleId IdType="pubmed">28322777</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE Clinical Guidelines, No. 107. National Collaborating Centre for Women's and Children's Health (UK). Hypertension in Pregnancy: The Management of Hypertensive Disorders During Pregnancy. updated in June 2019. London: RCOG Press; 2010 Aug. Available from: 
https://www.ncbi.nlm.nih.gov/books/NBK62652/.</Citation><ArticleIdList><ArticleId IdType="pubmed">22220321</ArticleId></ArticleIdList></Reference><Reference><Citation>Committee Opinion No 638: First-Trimester Risk Assessment for Early-Onset Preeclampsia. Obstet Gynecol. 2015;126(3):e25&#x2013;e27. doi: 10.1097/AOG.0000000000001049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AOG.0000000000001049</ArticleId><ArticleId IdType="pubmed">26287789</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright D, Syngelaki A, Akolekar R, Poon LC, Nicolaides KH. Competing risks model in screening for preeclampsia by maternal characteristics and medical history. Am J Obstet Gynecol. 2015;213(1):62.e1&#x2013;e10. doi: 10.1016/j.ajog.2015.02.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2015.02.018</ArticleId><ArticleId IdType="pubmed">25724400</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Gorman N, Wright D, Syngelaki A, Akolekar R, Wright A, Poon LC, et al. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11&#x2013;13 weeks gestation. Am J Obstet Gynecol. 2016;214(1):103.e1&#x2013;e12. doi: 10.1016/j.ajog.2015.08.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2015.08.034</ArticleId><ArticleId IdType="pubmed">26297382</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeisler H, Llurba E, Chantraine F, Vatish M, Staff AC, Sennstr&#xf6;m M, et al. Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia. N Engl J Med. 2016;374(1):13&#x2013;22. doi: 10.1056/NEJMoa1414838.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1414838</ArticleId><ArticleId IdType="pubmed">26735990</ArticleId></ArticleIdList></Reference><Reference><Citation>Plasencia W, Maiz N, Bonino S, Kaihura C, Nicolaides KH. Uterine artery Doppler at 11 + 0 to 13 + 6 weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol. 2007;30(5):742&#x2013;749. doi: 10.1002/uog.5157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/uog.5157</ArticleId><ArticleId IdType="pubmed">17899573</ArticleId></ArticleIdList></Reference><Reference><Citation>Rolnik DL, Wright D, Poon LC, O'Gorman N, Syngelaki A, de Paco MC, et al. Aspirin versus Placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017;377(7):613&#x2013;622. doi: 10.1056/NEJMoa1704559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1704559</ArticleId><ArticleId IdType="pubmed">28657417</ArticleId></ArticleIdList></Reference><Reference><Citation>Stubbs TM, Lazarchick J, Van Dorsten JP, Cox J, Loadholt CB. Evidence of accelerated platelet production and consumption in nonthrombocytopenic preeclampsia. Am J Obstet Gynecol. 1986;155(2):263&#x2013;265. doi: 10.1016/0002-9378(86)90803-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9378(86)90803-3</ArticleId><ArticleId IdType="pubmed">3740135</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutt R, Ogunniyi SO, Sullivan MH, Elder MG. Increased platelet volume and aggregation precede the onset of preeclampsia. Obstet Gynecol. 1994;83(1):146&#x2013;149.</Citation><ArticleIdList><ArticleId IdType="pubmed">8272297</ArticleId></ArticleIdList></Reference><Reference><Citation>AlSheeha MA, Alaboudi RS, Alghasham MA, Iqbal J, Adam I. Platelet count and platelet indices in women with preeclampsia. Vasc Health Risk Manag. 2016;12:477&#x2013;480. doi: 10.2147/VHRM.S120944.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/VHRM.S120944</ArticleId><ArticleId IdType="pmc">PMC5123587</ArticleId><ArticleId IdType="pubmed">27920548</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin S, Zhang L, Shen S, Wei D, Lu J, Chen X, et al. Platelet parameters and risk of hypertension disorders of pregnancy: a propensity score adjusted analysis. Platelets. 2022;33(4):543&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">34223796</ArticleId></ArticleIdList></Reference><Reference><Citation>Vilchez G, Lagos M, Kumar K, Argoti P. Is mean platelet volume a better biomarker in pre-eclampsia? J Obstet Gynaecol Res. 2017;43(6):982&#x2013;990. doi: 10.1111/jog.13312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jog.13312</ArticleId><ArticleId IdType="pubmed">28422358</ArticleId></ArticleIdList></Reference><Reference><Citation>Mannaerts D, Heyvaert S, De Cordt C, Macken C, Loos C, Jacquemyn Y. Are neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), and/or mean platelet volume (MPV) clinically useful as predictive parameters for preeclampsia? J Matern Fetal Neonatal Med. 2019;32(9):1412&#x2013;1419. doi: 10.1080/14767058.2017.1410701.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14767058.2017.1410701</ArticleId><ArticleId IdType="pubmed">29179639</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezk M, Gaber W, Shaheen A, Nofal A, Emara M, Gamal A, et al. First versus second trimester mean platelet volume and uric acid for prediction of preeclampsia in women at moderate and low risk. Hypertens Pregnancy. 2018;37(3):111&#x2013;117. doi: 10.1080/10641955.2018.1483508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10641955.2018.1483508</ArticleId><ArticleId IdType="pubmed">29893156</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim MA, Han GH, Kwon JY, Kim YH. Clinical significance of platelet-to-lymphocyte ratio in women with preeclampsia. Am J Reprod Immunol. 2018;80(1):e12973. doi: 10.1111/aji.12973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aji.12973</ArticleId><ArticleId IdType="pubmed">29781540</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang SW, Cho SH, Kwon HS, Sohn IS, Hwang HS. Significance of the platelet distribution width as a severity marker for the development of preeclampsia. Eur J Obstet Gynecol Reprod Biol. 2014;175:107&#x2013;111. doi: 10.1016/j.ejogrb.2013.12.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejogrb.2013.12.036</ArticleId><ArticleId IdType="pubmed">24502873</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Z, Ji Y, Zhou S, Su T, Yuan Z, Han N, et al. Development and validation of multi-stage prediction models for pre-eclampsia: a retrospective cohort study on Chinese women. Front Public Health. 2022;10:911975. doi: 10.3389/fpubh.2022.911975.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.911975</ArticleId><ArticleId IdType="pmc">PMC9195617</ArticleId><ArticleId IdType="pubmed">35712289</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu X, Lu JH, He JR, Lam KH, Shen SY, Guo Y, et al. The Born in Guangzhou Cohort Study (BIGCS) Eur J Epidemiol. 2017;32(4):337&#x2013;346. doi: 10.1007/s10654-017-0239-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-017-0239-x</ArticleId><ArticleId IdType="pubmed">28321694</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP) Hypertens Pregnancy. 2001;20(1):Ix&#x2013;xiv. doi: 10.3109/10641950109152635.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/10641950109152635</ArticleId><ArticleId IdType="pubmed">12044323</ArticleId></ArticleIdList></Reference><Reference><Citation>Pencina MJ, D'Agostino RB, Sr, D'Agostino RB, Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27(2):157&#x2013;72. doi: 10.1002/sim.2929.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.2929</ArticleId><ArticleId IdType="pubmed">17569110</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickering JW, Endre ZH. New metrics for assessing diagnostic potential of candidate biomarkers. Clin J Am Soc Nephrol. 2012;7(8):1355&#x2013;1364. doi: 10.2215/CJN.09590911.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.09590911</ArticleId><ArticleId IdType="pubmed">22679181</ArticleId></ArticleIdList></Reference><Reference><Citation>Reese JA, Peck JD, Deschamps DR, McIntosh JJ, Knudtson EJ, Terrell DR, et al. Platelet counts during pregnancy. N Engl J Med. 2018;379(1):32&#x2013;43. doi: 10.1056/NEJMoa1802897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1802897</ArticleId><ArticleId IdType="pmc">PMC6049077</ArticleId><ArticleId IdType="pubmed">29972751</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayer-Pickel K, Stern C, Eberhard K, Lang U, Obermayer-Pietsch B, Cervar-Zivkovic M. Comparison of mean platelet volume (MPV) and sFlt-1/PlGF ratio as predictive markers for preeclampsia. J Matern Fetal Neonatal Med. 2021;34(9):1407&#x2013;1414. doi: 10.1080/14767058.2019.1638356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14767058.2019.1638356</ArticleId><ArticleId IdType="pubmed">31257953</ArticleId></ArticleIdList></Reference><Reference><Citation>Dundar O, Yoruk P, Tutuncu L, Erikci AA, Muhcu M, Ergur AR, et al. Longitudinal study of platelet size changes in gestation and predictive power of elevated MPV in development of pre-eclampsia. Prenat Diagn. 2008;28(11):1052&#x2013;1056. doi: 10.1002/pd.2126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pd.2126</ArticleId><ArticleId IdType="pubmed">18973157</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Lin L. Potential value of coagulation parameters for suggesting preeclampsia during the third trimester of pregnancy. Am J Med Sci. 2017;354(1):39&#x2013;43. doi: 10.1016/j.amjms.2017.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjms.2017.03.012</ArticleId><ArticleId IdType="pubmed">28755731</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy SG, Rajendra Prasad CSB. Significance of platelet indices as severity marker in nonthrombocytopenic preeclampsia cases. J Lab Physicians. 2019;11(3):186&#x2013;191. doi: 10.4103/JLP.JLP_161_18.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/JLP.JLP_161_18</ArticleId><ArticleId IdType="pmc">PMC6771321</ArticleId><ArticleId IdType="pubmed">31579247</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao D, Chen L, Li Q, Liu G, Wang W, Li J, et al. Predictive value of the peripheral blood parameters for preeclampsia. Clin Lab 2022;68(3).</Citation><ArticleIdList><ArticleId IdType="pubmed">35254028</ArticleId></ArticleIdList></Reference><Reference><Citation>Han L, Liu X, Li H, Zou J, Yang Z, Han J, et al. Blood coagulation parameters and platelet indices: changes in normal and preeclamptic pregnancies and predictive values for preeclampsia. PLoS ONE. 2014;9(12):e114488. doi: 10.1371/journal.pone.0114488.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0114488</ArticleId><ArticleId IdType="pmc">PMC4252147</ArticleId><ArticleId IdType="pubmed">25464515</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanat-Pektas M, Yesildager U, Tuncer N, Arioz DT, Nadirgil-Koken G, Yilmazer M. Could mean platelet volume in late first trimester of pregnancy predict intrauterine growth restriction and pre-eclampsia? J Obstet Gynaecol Res. 2014;40(7):1840&#x2013;1845. doi: 10.1111/jog.12433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jog.12433</ArticleId><ArticleId IdType="pubmed">25056460</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Sun L, Zheng X, Liu J, Zheng R, Lv Y. The clinical value of platelet parameters combined with sFlt-1/PlGF in predicting preeclampsia. Ann Palliat Med. 2021;10(7):7619&#x2013;7626. doi: 10.21037/apm-21-1244.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/apm-21-1244</ArticleId><ArticleId IdType="pubmed">34353049</ArticleId></ArticleIdList></Reference><Reference><Citation>Wataganara T, Leetheeragul J, Pongprasobchai S, Sutantawibul A, Phatihattakorn C, Angsuwathana S. Prediction and prevention of pre-eclampsia in Asian subpopulation. J Obstet Gynaecol Res. 2018;44(5):813&#x2013;830. doi: 10.1111/jog.13599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jog.13599</ArticleId><ArticleId IdType="pubmed">29442407</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallo DM, Wright D, Casanova C, Campanero M, Nicolaides KH. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19&#x2013;24 weeks' gestation. Am J Obstet Gynecol. 2016;214(5):619.e1&#x2013;e17. doi: 10.1016/j.ajog.2015.11.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2015.11.016</ArticleId><ArticleId IdType="pubmed">26627730</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsiakkas A, Saiid Y, Wright A, Wright D, Nicolaides KH. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 30&#x2013;34 weeks' gestation. Am J Obstet Gynecol. 2016;215(1):87.e1&#x2013;e17. doi: 10.1016/j.ajog.2016.02.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2016.02.016</ArticleId><ArticleId IdType="pubmed">26875953</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonek J, Krantz D, Carmichael J, Downing C, Jessup K, Haidar Z, et al. First-trimester screening for early and late preeclampsia using maternal characteristics, biomarkers, and estimated placental volume. Am J Obstet Gynecol. 2018;218(1):126.e1&#x2013;e13. doi: 10.1016/j.ajog.2017.10.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2017.10.024</ArticleId><ArticleId IdType="pubmed">29097177</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallo D, Poon LC, Fernandez M, Wright D, Nicolaides KH. Prediction of preeclampsia by mean arterial pressure at 11&#x2013;13 and 20&#x2013;24 weeks' gestation. Fetal Diagn Ther. 2014;36(1):28&#x2013;37. doi: 10.1159/000360287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000360287</ArticleId><ArticleId IdType="pubmed">24752037</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Y, Leung TY, Law LW, Ting YH, Law KM, Sahota DS. First trimester screening for pre-eclampsia in Chinese pregnancies: case-control study. BJOG. 2018;125(4):442&#x2013;449. doi: 10.1111/1471-0528.14970.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1471-0528.14970</ArticleId><ArticleId IdType="pubmed">29032578</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaemsaithong P, Pooh RK, Zheng M, Ma R, Chaiyasit N, Tokunaka M, et al. Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population. Am J Obstet Gynecol. 2019;221(6):650.e1&#x2013;e16. doi: 10.1016/j.ajog.2019.09.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2019.09.041</ArticleId><ArticleId IdType="pubmed">31589866</ArticleId></ArticleIdList></Reference><Reference><Citation>Moons KG, de Groot JA, Linnet K, Reitsma JB, Bossuyt PM. Quantifying the added value of a diagnostic test or marker. Clin Chem. 2012;58(10):1408&#x2013;1417. doi: 10.1373/clinchem.2012.182550.</Citation><ArticleIdList><ArticleId IdType="doi">10.1373/clinchem.2012.182550</ArticleId><ArticleId IdType="pubmed">22952348</ArticleId></ArticleIdList></Reference><Reference><Citation>Pencina MJ, D'Agostino RB. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med. 2004;23(13):2109&#x2013;2123. doi: 10.1002/sim.1802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1802</ArticleId><ArticleId IdType="pubmed">15211606</ArticleId></ArticleIdList></Reference><Reference><Citation>Egbor M, Ansari T, Morris N, Green CJ, Sibbons PD. Morphometric placental villous and vascular abnormalities in early- and late-onset pre-eclampsia with and without fetal growth restriction. BJOG. 2006;113(5):580&#x2013;589. doi: 10.1111/j.1471-0528.2006.00882.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-0528.2006.00882.x</ArticleId><ArticleId IdType="pubmed">16579806</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Anna R, Baviera G, Corrado F, Giordano D, De Vivo A, Nicocia G, et al. Adiponectin and insulin resistance in early- and late-onset pre-eclampsia. BJOG. 2006;113(11):1264&#x2013;1269. doi: 10.1111/j.1471-0528.2006.01078.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-0528.2006.01078.x</ArticleId><ArticleId IdType="pubmed">17010118</ArticleId></ArticleIdList></Reference><Reference><Citation>Melchiorre K, Wormald B, Leslie K, Bhide A, Thilaganathan B. First-trimester uterine artery Doppler indices in term and preterm pre-eclampsia. Ultrasound Obstet Gynecol. 2008;32(2):133&#x2013;137. doi: 10.1002/uog.5400.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/uog.5400</ArticleId><ArticleId IdType="pubmed">18615872</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38597549</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>11</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>30</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1807-3107</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Brazilian oral research</Title><ISOAbbreviation>Braz Oral Res</ISOAbbreviation></Journal><ArticleTitle>Systemic benefits of periodontal therapy in patients with obesity and periodontitis: a systematic review.</ArticleTitle><Pagination><StartPage>e031</StartPage><MedlinePgn>e031</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e031</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1590/1807-3107bor-2024.vol38.0031</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1806-83242024000108700</ELocationID><Abstract><AbstractText>This systematic review aimed to answer the focused question: "What are the benefits of subgingival periodontal therapy on blood hematological and biochemical index, biomarkers of inflammation and oxidative stress, quality of life, and periodontal pathogen counts in patients with obesity and periodontitis?". A systematic literature search was performed in six databases: PubMed, Embase, LILACS, Web of Science, Cochrane and SCOPUS and other sources, and a manual search was conducted as well. Inclusion criteria were randomized and non-randomized clinical trials, and before-and-after studies on patients with obesity subjected to periodontal therapy. The results were synthesized qualitatively. Risk of bias within studies was assessed using RoB 2 and ROBINS-I tools. The certainty of evidence was evaluated following the GRADE approach. Three randomized controlled trials and 15 before-and-after studies were included. Randomized controlled trials were considered to have a low risk of bias, as compared to before-and-after studies assessed as having low, serious, and critical risks of bias. Non-surgical periodontal therapy plus azithromycin, chlorhexidine, and cetylpyridinium chloride reduced blood pressure and decreased serum levels of HbA1c, hsCRP, IL-1&#x3b2;, and TNF-&#x3b1;. Salivary resistin level also decreased in patients with obesity and periodontitis after therapy and chlorhexidine mouth rinse. Before-and-after data suggest an improvement in total cholesterol, LDL, triglycerides, insulin resistance, C3, GCF levels of TNF-&#x3b1;, chemerin, vaspin, omentin-1, visfatin, 8-OHdG, and periodontal pathogen counts after therapy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Menezes</LastName><ForeName>Cl&#xe1;udia Callegaro de</ForeName><Initials>CC</Initials><Identifier Source="ORCID">0000-0002-2589-7366</Identifier><AffiliationInfo><Affiliation>Universidade Federal do Rio de Janeiro - UFRJ, Dental School, Division of Periodontics, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbirato</LastName><ForeName>Davi da Silva</ForeName><Initials>DDS</Initials><Identifier Source="ORCID">0000-0003-0527-6092</Identifier><AffiliationInfo><Affiliation>Universidade Federal do Rio de Janeiro - UFRJ, Dental School, Division of Periodontics, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fogacci</LastName><ForeName>Mariana Fampa</ForeName><Initials>MF</Initials><Identifier Source="ORCID">0000-0003-3765-2152</Identifier><AffiliationInfo><Affiliation>Universidade Federal de Pernambuco - UFPE, Department of Clinical and Preventive Dentistry, Recife, PE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mara&#xf1;&#xf3;n-V&#xe1;squez</LastName><ForeName>Guido Artemio</ForeName><Initials>GA</Initials><Identifier Source="ORCID">0000-0001-7029-0347</Identifier><AffiliationInfo><Affiliation>Universidade Federal do Rio de Janeiro - UFRJ, Department of Pediatric Dentistry, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carneiro</LastName><ForeName>Jo&#xe3;o R&#xe9;gis Ivar</ForeName><Initials>JRI</Initials><Identifier Source="ORCID">0000-0002-2085-8130</Identifier><AffiliationInfo><Affiliation>Universidade Federal do Rio de Janeiro - UFRJ, Clementino Fraga Filho Hospital University, Department of Nutrology/Bariatric Surgery, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maia</LastName><ForeName>Lucianne Copple</ForeName><Initials>LC</Initials><Identifier Source="ORCID">0000-0003-1026-9401</Identifier><AffiliationInfo><Affiliation>Universidade Federal do Rio de Janeiro - UFRJ, Department of Pediatric Dentistry and Orthodontics, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barros</LastName><ForeName>Maria Cyn&#xe9;sia Medeiros de</ForeName><Initials>MCM</Initials><Identifier Source="ORCID">0000-0002-2284-3581</Identifier><AffiliationInfo><Affiliation>Universidade Federal do Rio de Janeiro - UFRJ, Dental School, Division of Periodontics, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Braz Oral Res</MedlineTA><NlmUniqueID>101307187</NlmUniqueID><ISSNLinking>1806-8324</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>R4KO0DY52L</RegistryNumber><NameOfSubstance UI="D002710">Chlorhexidine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002710" MajorTopicYN="N">Chlorhexidine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010518" MajorTopicYN="Y">Periodontitis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055113" MajorTopicYN="Y">Chronic Periodontitis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Declaration of Interests:</b> The authors certify that they have no commercial or
associative interest that represents a conflict of interest in connection
with the manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>10</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>10</Day><Hour>8</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38597549</ArticleId><ArticleId IdType="pmc">PMC11376685</ArticleId><ArticleId IdType="doi">10.1590/1807-3107bor-2024.vol38.0031</ArticleId><ArticleId IdType="pii">S1806-83242024000108700</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kim S, Popkin BM. Commentary: understanding the epidemiology of overweight and obesity-a real global public health concern. Int J Epidemiol. 2006;35:60&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">16339598</ArticleId></ArticleIdList></Reference><Reference><Citation>Akram Z, Abduljabbar T, Abu Hassan MI, Javed F, Vohra F. Cytokine Profile in Chronic Periodontitis Patients with and without Obesity: A Systematic Review and Meta-Analysis. Dis Markers. 2016a doi: 10.1155/2016/4801418.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/4801418</ArticleId><ArticleId IdType="pmc">PMC5067315</ArticleId><ArticleId IdType="pubmed">27795608</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO - World Health Organization  
 https://www.euro.who.int/en/health-topics/disease-prevention/nutrition/a-healthy-lifestyle/body-mass-index-bmi
.  [Accessed in May 27
2021]. </Citation></Reference><Reference><Citation>Akram Z, Safii SH, Vaithilingam RD, Baharuddin NA, Javed F, Vohra F. Efficacy of non-surgical periodontal therapy in the management of chronic periodontitis among obese and non-obese patients: a systematic review and meta-analysis. Clin Oral Investig. 2016b;20(5):903&#x2013;914. doi: 10.1007/s00784-016-1793-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00784-016-1793-4</ArticleId><ArticleId IdType="pubmed">27005812</ArticleId></ArticleIdList></Reference><Reference><Citation>Suresh S, Mahendra J. Multifactorial relationship of obesity and periodontal disease. J Clin Diagn Res. 2014;8(4):ZE01&#x2013;ZZE3. doi: 10.7860/JCDR/2014/7071.4227.</Citation><ArticleIdList><ArticleId IdType="doi">10.7860/JCDR/2014/7071.4227</ArticleId><ArticleId IdType="pmc">PMC4064865</ArticleId><ArticleId IdType="pubmed">24959524</ArticleId></ArticleIdList></Reference><Reference><Citation>Polak D, Sanui T, Nishimura F, Shapira L. Diabetes as a risk factor for periodontal disease-plausible mechanisms. Periodontol 2000. 2020 Jun;83(1):46&#x2013;58. doi: 10.1111/prd.12298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/prd.12298</ArticleId><ArticleId IdType="pubmed">32385872</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanz M, Ceriello A, Buysschaert M, et al. Scientific evidence on the links between periodontal diseases and diabetes: Consensus report and guidelines of the joint workshop on periodontal diseases and diabetes by the International Diabetes Federation and the European Federation of Periodontology. J Clin Periodontol. 2018;45(2):138&#x2013;149. doi: 10.1111/jcpe.12808.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcpe.12808</ArticleId><ArticleId IdType="pubmed">29280174</ArticleId></ArticleIdList></Reference><Reference><Citation>Liccardo D, Cannavo A, Spagnuolo G, et al. Periodontal Disease: A Risk Factor for Diabetes and Cardiovascular Disease. Int J Mol Sci. 2019;20(6):1414. doi: 10.3390/ijms20061414.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20061414</ArticleId><ArticleId IdType="pmc">PMC6470716</ArticleId><ArticleId IdType="pubmed">30897827</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapellas K, Singh A, Bertotti M, Nascimento GG, Jamieson LM, Perio-CKD collaboration Periodontal and chronic kidney disease association: A systematic review and meta-analysis. Nephrology (Carlton) 2019;24(2):202&#x2013;212. doi: 10.1111/nep.13225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nep.13225</ArticleId><ArticleId IdType="pubmed">29359889</ArticleId></ArticleIdList></Reference><Reference><Citation>Moliner-S&#xe1;nchez CA, Iranzo-Cort&#xe9;s JE, Almerich-Silla JM, et al. Effect of per Capita Income on the Relationship between Periodontal Disease during Pregnancy and the Risk of Preterm Birth and Low Birth Weight Newborn. Systematic Review and Meta-Analysis. 8015Int J Environ Res Public Health. 2020;17(21) doi: 10.3390/ijerph17218015.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17218015</ArticleId><ArticleId IdType="pmc">PMC7662804</ArticleId><ArticleId IdType="pubmed">33143275</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Zahrani MS, Alghamdi HS. Effect of periodontal treatment on serum C-reactive protein level in obese and normal-weight women affected with chronic periodontitis. Saudi Med J. 2012;33(3):309&#x2013;314.</Citation><ArticleIdList><ArticleId IdType="pubmed">22426913</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Herrera M, Silvestre-Rangil J, Silvestre FJ. Association between obesity and periodontal disease. A systematic review of epidemiological studies and controlled clinical trials. Med Oral Patol Oral Cir Bucal. 2017;22(6):e708&#x2013;e715. doi: 10.4317/medoral.21786.</Citation><ArticleIdList><ArticleId IdType="doi">10.4317/medoral.21786</ArticleId><ArticleId IdType="pmc">PMC5813989</ArticleId><ArticleId IdType="pubmed">29053651</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlstein MI, Bissada NF. Influence of obesity and hypertension on the severity of periodontitis in rats. Oral Surg Oral Med Oral Pathol. 1977;43(5):707&#x2013;719. doi: 10.1016/0030-4220(77)90055-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0030-4220(77)90055-x</ArticleId><ArticleId IdType="pubmed">266151</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuza EP, Barroso EM, Carrareto ALV, et al. The role of obesity as a modifying factor in patients undergoing non-surgical periodontal therapy. J Periodontol. 2011;82(5):676&#x2013;682. doi: 10.1902/jop.2010.100545.</Citation><ArticleIdList><ArticleId IdType="doi">10.1902/jop.2010.100545</ArticleId><ArticleId IdType="pubmed">21073330</ArticleId></ArticleIdList></Reference><Reference><Citation>Kose O, Canakci V, Canakci CF, et al. The effects of obesity on local and circulating levels of tumor necrosis factor-a and interleukin-6 in patients with chronic periodontitis. J Periodontol Imp Dent. 2015;7(1):7&#x2013;14. doi: 10.15171/jpid.2015.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.15171/jpid.2015.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Papageorgiou SN, Reichert C, J&#xe4;ger A, Deschner J. Effect of overweight/obesity on response to periodontal treatment: systematic review and a meta-analysis. J Clin Periodontol. 2015;42(3):247&#x2013;261. doi: 10.1111/jcpe.12365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcpe.12365</ArticleId><ArticleId IdType="pubmed">25580635</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerber FA, Sahrmann P, Schmidlin OA, Heumann C, Beer JH, Schmidlin PR. Influence of obesity on the outcome of non-surgical periodontal therapy - a systematic review. 90BMC Oral Health. 2016;16(1) doi: 10.1186/s12903-016-0272-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12903-016-0272-2</ArticleId><ArticleId IdType="pmc">PMC5010690</ArticleId><ArticleId IdType="pubmed">27590050</ArticleId></ArticleIdList></Reference><Reference><Citation>Nascimento GG, Leite FR, Correa MB, Peres MA, Demarco FF. Does periodontal treatment have an effect on clinical and immunological parameters of periodontal disease in obese subjects? A systematic review and meta-analysis. Clin Oral Investig. 2016;20(4):639&#x2013;647. doi: 10.1007/s00784-015-1678-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00784-015-1678-y</ArticleId><ArticleId IdType="pubmed">26620732</ArticleId></ArticleIdList></Reference><Reference><Citation>Artese HP, Foz AM, Rabelo M de S, et al. Periodontal therapy and systemic inflammation in type 2 diabetes mellitus: a meta-analysis. PLoS One. 2015;10(5):e0128344. doi: 10.1371/journal.pone.0128344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0128344</ArticleId><ArticleId IdType="pmc">PMC4444100</ArticleId><ArticleId IdType="pubmed">26010492</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372(71) doi: 10.1136/bmj.n71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell M, McKenzie JE, Sowden A, et al. Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. BMJ. 2020;368 doi: 10.1136/bmj.l6890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l6890</ArticleId><ArticleId IdType="pmc">PMC7190266</ArticleId><ArticleId IdType="pubmed">31948937</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xfc;nemann H, Brozek J, Guyatt G, Oxman A, editors, editors. GRADE handbook for grading quality of evidence and strength of
recommendations. 2013.  [Cited 2021 Sep 9]. guidelinedevelopment.org/handbook Updated October 2013. The GRADE Working Group.</Citation></Reference><Reference><Citation>GRADEpro GDT: GRADEpro Guideline Development Tool. McMaster University; 2020.  [Cited 2021 Sep 9]. gradepro.org Software. developed by Evidence Prime, Inc.</Citation></Reference><Reference><Citation>Murad MH, Mustafa RA, Sch&#xfc;nemann HJ, Sultan S, Santesso N. Rating the certainty in evidence in the absence of a single estimate of effect. Evid Based Med. 2017;22(3):85&#x2013;87. doi: 10.1136/ebmed-2017-110668.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ebmed-2017-110668</ArticleId><ArticleId IdType="pmc">PMC5502230</ArticleId><ArticleId IdType="pubmed">28320705</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd6;ng&#xf6;z Dede F, Bozkurt Dogan S, Balli U, Avci B, Durmuslar MC, Baratzade T. Glutathione levels in plasma, saliva and gingival crevicular fluid after periodontal therapy in obese and normal weight individuals. J Periodontal Res. 2016a;51(6):726&#x2013;734. doi: 10.1111/jre.12349.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jre.12349</ArticleId><ArticleId IdType="pubmed">26740476</ArticleId></ArticleIdList></Reference><Reference><Citation>Vohra F, Akram Z, Bukhari IA, Sheikh SA, Javed F. Short-term effects of adjunctive antimicrobial photodynamic therapy in obese patients with chronic periodontitis: A randomized controlled clinical trial. Photodiagnosis Photodyn Ther. 2018;21:10&#x2013;15. Epub 2017 Oct 27. PMID: 29111391.</Citation><ArticleIdList><ArticleId IdType="pubmed">29111391</ArticleId></ArticleIdList></Reference><Reference><Citation>Varghese T, Prashant MC, Dodani K, Nagpal N, Khare N, Singh V. Resistin and Plasma-reactive Oxygen Metabolite Levels in Obese and Non-obese Individuals with Chronic Periodontitis in Response to Non-surgical Periodontal Therapy. J Contemp Dent Pract. 2018;19(12):1525&#x2013;1530.</Citation><ArticleIdList><ArticleId IdType="pubmed">30713184</ArticleId></ArticleIdList></Reference><Reference><Citation>Z&#xfa;&#xf1;iga Curz CA, Calzada Mendoza CC, Miranda Mondrag&#xf3;n ID, Bustamante Bacame A, Portilla Robertson J, Ochar&#xe1;n Hern&#xe1;ndez E. Efecto del manejo de la obesidad clase I con metformina sobre actividad de metaloproteinasas en pacientes con periodontitis cr&#xf3;nica. Nutr Hosp. 2019;36(5):1095&#x2013;1100. doi: 10.20960/nh.02602.. Effect of the management of class I obesity with metformin on metalloproteinase activity in patients with chronic periodontitis.</Citation><ArticleIdList><ArticleId IdType="doi">10.20960/nh.02602.</ArticleId><ArticleId IdType="pubmed">31516010</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez NJ, Quintero A, Casanova PA, Ibieta CI, Baelum V, L&#xf3;pez R. Effects of periodontal therapy on systemic markers of inflammation in patients with metabolic syndrome: a controlled clinical trial. J Periodontol. 2012;83(3):267&#x2013;278. doi: 10.1902/jop.2011.110227.</Citation><ArticleIdList><ArticleId IdType="doi">10.1902/jop.2011.110227</ArticleId><ArticleId IdType="pubmed">21749167</ArticleId></ArticleIdList></Reference><Reference><Citation>Bunjaku V, Popovska M, Grcev A, et al. Non-surgical periodontal treatment and Low-Level Laser Therapy (LLLT) outcomes for patients suffering from type 2 diabetes mellitus, obesity and chronic periodontitis. J Int Dent Med Res. 2017;10(2):214&#x2013;221.</Citation></Reference><Reference><Citation>Al-Hamoudi N, Abduljabbar T, Mirza S, et al. Non-surgical periodontal therapy reduces salivary adipocytokines in chronic periodontitis patients with and without obesity. J Investig Clin Dent. 2018;9(2):e12314. doi: 10.1111/jicd.12314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jicd.12314</ArticleId><ArticleId IdType="pubmed">29322684</ArticleId></ArticleIdList></Reference><Reference><Citation>Suresh S, Mahendra J, Singh G, Pradeep Kumar AR, Thilagar S, Rao N. Effect of nonsurgical periodontal therapy on plasma-reactive oxygen metabolite and gingival crevicular fluid resistin and serum resistin levels in obese and normal weight individuals with chronic periodontitis. J Indian Soc Periodontol. 2018;22(4):310&#x2013;316. doi: 10.4103/jisp.jisp_108_18.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jisp.jisp_108_18</ArticleId><ArticleId IdType="pmc">PMC6077962</ArticleId><ArticleId IdType="pubmed">30131622</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanichkittikul N, Laohapand P, Mansa-Nguan C, Thanakun S. Periodontal Treatment Improves Serum Levels of Leptin, Adiponectin, and C-Reactive Protein in Thai Patients with Overweight or Obesity. Int J Dent. 2021 doi: 10.1155/2021/6660097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/6660097</ArticleId><ArticleId IdType="pmc">PMC7872757</ArticleId><ArticleId IdType="pubmed">33603787</ArticleId></ArticleIdList></Reference><Reference><Citation>Eldin AM, Nasr SA, Hassan NE. Effect of Non-Surgical Periodontal Therapy on Interleukin-8 (il-8) Level in Gingival Crevicular Fluid in Overweight and Obese Subjects with Chronic Periodontitis. W J Med Sci. 2013;9(3):173&#x2013;179.</Citation></Reference><Reference><Citation>Basher SS, Saub R, Vaithilingam RD, et al. Impact of non-surgical periodontal therapy on OHRQoL in an obese population, a randomized control trial. 225Health Qual Life Outcomes. 2017;15(1) doi: 10.1186/s12955-017-0793-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-017-0793-7</ArticleId><ArticleId IdType="pmc">PMC5696769</ArticleId><ArticleId IdType="pubmed">29157276</ArticleId></ArticleIdList></Reference><Reference><Citation>Montero E, L&#xf3;pez M, Vidal H, et al. Impact of periodontal therapy on systemic markers of inflammation in patients with metabolic syndrome: A randomized clinical trial. Diabetes Obes Metab. 2020;22(11):2120&#x2013;2132. doi: 10.1111/dom.14131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dom.14131</ArticleId><ArticleId IdType="pubmed">32613714</ArticleId></ArticleIdList></Reference><Reference><Citation>Altay U, G&#xfc;rgan CA, Agbaht K. Changes in inflammatory and metabolic parameters after periodontal treatment in patients with and without obesity. J Periodontol. 2013;84(1):13&#x2013;23. doi: 10.1902/jop.2012.110646.</Citation><ArticleIdList><ArticleId IdType="doi">10.1902/jop.2012.110646</ArticleId><ArticleId IdType="pubmed">22348694</ArticleId></ArticleIdList></Reference><Reference><Citation>Gon&#xe7;alves TE, Feres M, Zimmermann GS, et al. Effects of scaling and root planing on clinical response and serum levels of adipocytokines in patients with obesity and chronic periodontitis. J Periodontol. 2015a;86(1):53&#x2013;61. doi: 10.1902/jop.2014.140266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1902/jop.2014.140266</ArticleId><ArticleId IdType="pubmed">25119561</ArticleId></ArticleIdList></Reference><Reference><Citation>Gon&#xe7;alves TE, Zimmermann GS, Figueiredo LC, et al. Local and serum levels of adipokines in patients with obesity after periodontal therapy: one-year follow-up. J Clin Periodontol. 2015b;42(5):431&#x2013;439. doi: 10.1111/jcpe.12396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcpe.12396</ArticleId><ArticleId IdType="pubmed">25858047</ArticleId></ArticleIdList></Reference><Reference><Citation>Balli U, &#xd6;ng&#xf6;z Dede F, Bozkurt Dogan S, Gulsoy Z, Sertoglu E. Chemerin and interleukin-6 levels in obese individuals following periodontal treatment. Oral Dis. 2016a;22(7):673&#x2013;680. doi: 10.1111/odi.12520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/odi.12520</ArticleId><ArticleId IdType="pubmed">27265537</ArticleId></ArticleIdList></Reference><Reference><Citation>Balli U, Bozkurt Dogan S, &#xd6;ng&#xf6;z Dede F, Sertoglu E, Keles GC. The levels of visceral adipose tissue-derived serpin, omentin-1 and tumor necrosis factor-a in the gingival crevicular fluid of obese patients following periodontal therapy. J Oral Sci. 2016b;58(4):465&#x2013;473. doi: 10.2334/josnusd.16-0212.</Citation><ArticleIdList><ArticleId IdType="doi">10.2334/josnusd.16-0212</ArticleId><ArticleId IdType="pubmed">28025429</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd6;ng&#xf6;z Dede F, Bozkurt Dogan S, Balli U, Avci B, Durmuslar MC. The effect of initial periodontal treatment on plasma, gingival crevicular fluid and salivary levels of 8-hydroxy-deoxyguanosine in obesity. Arch Oral Biol. 2016b;62:80&#x2013;85. doi: 10.1016/j.archoralbio.2015.11.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.archoralbio.2015.11.014</ArticleId><ArticleId IdType="pubmed">26655951</ArticleId></ArticleIdList></Reference><Reference><Citation>Tasdemir Z, &#xd6;zsari Tasdemir F, Ko&#xe7;yigit I, Yazici C, G&#xfc;rgan CA. The clinical and systemic effects of periodontal treatment in diabetic and non-diabetic obese patients. J Oral Sci. 2016;58(4):523&#x2013;531. doi: 10.2334/josnusd.16-0163.</Citation><ArticleIdList><ArticleId IdType="doi">10.2334/josnusd.16-0163</ArticleId><ArticleId IdType="pubmed">28025436</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuza EP, Barroso EM, Fabricio M, Carrareto AL, Toledo BE, R Pires J. Lipid profile and high-sensitivity C-reactive protein levels in obese and non-obese subjects undergoing non-surgical periodontal therapy. J Oral Sci. 2016;58(3):423&#x2013;430. doi: 10.2334/josnusd.16-0173.</Citation><ArticleIdList><ArticleId IdType="doi">10.2334/josnusd.16-0173</ArticleId><ArticleId IdType="pubmed">27665983</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xc7;etiner D, Uraz A, &#xd6;ztoprak S, Ak&#xe7;a G. The role of visfatin levels in gingival crevicular fluid as a potential biomarker in the relationship between obesity and periodontal disease. J Appl Oral Sci. 2019;27:e20180365. doi: 10.1590/1678-7757-2018-0365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1678-7757-2018-0365</ArticleId><ArticleId IdType="pmc">PMC6690727</ArticleId><ArticleId IdType="pubmed">31365708</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Herrera M, Silvestre FJ, Silvestre-Rangil J, L&#xf3;pez-Dom&#xe8;nech S, Ba&#xf1;uls C, Rocha M. Levels of serum retinol-binding protein 4 before and after non-surgical periodontal treatment in lean and obese subjects: An interventional study. J Clin Periodontol. 2018a;45(3):336&#x2013;344. doi: 10.1111/jcpe.12840.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcpe.12840</ArticleId><ArticleId IdType="pubmed">29150947</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Herrera M, L&#xf3;pez-Dom&#xe8;nech S, Silvestre FJ, et al. Dietary therapy and non-surgical periodontal treatment in obese patients with chronic periodontitis. J Clin Periodontol. 2018b;45(12):1448&#x2013;1457. doi: 10.1111/jcpe.13030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcpe.13030</ArticleId><ArticleId IdType="pubmed">30362611</ArticleId></ArticleIdList></Reference><Reference><Citation>Peralta FDS, Cortelli SC, Rovai ES, et al. Clinical and microbiological evaluation of non-surgical periodontal therapy in obese and non-obese individuals with periodontitis: a 9-month prospective longitudinal study. J Appl Oral Sci. 2020;28:e20190694. doi: 10.1590/1678-7757-2019-0694.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1678-7757-2019-0694</ArticleId><ArticleId IdType="pmc">PMC7213783</ArticleId><ArticleId IdType="pubmed">32428060</ArticleId></ArticleIdList></Reference><Reference><Citation>Md Tahir K, Ab Malek AH, Vaithilingam RD, et al. Impact of non-surgical periodontal therapy on serum Resistin and periodontal pathogen in periodontitis patients with obesity. 52BMC Oral Health. 2020;20(1) doi: 10.1186/s12903-020-1039-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12903-020-1039-3</ArticleId><ArticleId IdType="pmc">PMC7023789</ArticleId><ArticleId IdType="pubmed">32059714</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortelli SC, Peralta FS, Nogueira LMR, et al. Periodontal therapy on the oral health-related quality of life of obese and non-obese individuals. Odontology. 2021;109(4):956&#x2013;964. doi: 10.1007/s10266-021-00617-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10266-021-00617-0</ArticleId><ArticleId IdType="pubmed">34023952</ArticleId></ArticleIdList></Reference><Reference><Citation>Quirynen M, Bollen CM, Vandekerckhove BN, Dekeyser C, Papaioannou W, Eyssen H. Full- vs. partial-mouth disinfection in the treatment of periodontal infections: short-term clinical and microbiological observations. J Dent Res. 1995;74(8):1459&#x2013;1467. doi: 10.1177/00220345950740080501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00220345950740080501</ArticleId><ArticleId IdType="pubmed">7560400</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagishengallis G. Interconnection of periodontal disease and comorbidities: evidence, mechanisms, and implications. Periodontol 2000. 2022;89(1):9&#x2013;18. doi: 10.1111/prd.12430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/prd.12430</ArticleId><ArticleId IdType="pmc">PMC9018559</ArticleId><ArticleId IdType="pubmed">35244969</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva-Boghossian MC, Dezonne RS. What Are the Clinical and Systemic Results of Periodontitis Treatment in Obese Individuals? Cur Oral Health Rep. 2021;8(3):48&#x2013;65. doi: 10.1007/s40496-021-00295-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40496-021-00295-5</ArticleId><ArticleId IdType="pmc">PMC8327900</ArticleId><ArticleId IdType="pubmed">34367878</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu&#xf1;oz Aguilera E, Suvan J, Buti J, et al. Periodontitis is associated with hypertension: a systematic review and meta-analysis. Cardiovasc Res. 2020;116(1):28&#x2013;39. doi: 10.1093/cvr/cvz201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvz201</ArticleId><ArticleId IdType="pubmed">31549149</ArticleId></ArticleIdList></Reference><Reference><Citation>Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomized trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665. doi: 10.1136/bmj.b1665.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b1665</ArticleId><ArticleId IdType="pmc">PMC2684577</ArticleId><ArticleId IdType="pubmed">19454737</ArticleId></ArticleIdList></Reference><Reference><Citation>Joffres M, Falaschetti E, Gillespie C, et al. Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischemic heart disease mortality: a cross-sectional study. BMJ Open. 2013;3(8):e003423. doi: 10.1136/bmjopen-2013-003423.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2013-003423</ArticleId><ArticleId IdType="pmc">PMC3758966</ArticleId><ArticleId IdType="pubmed">23996822</ArticleId></ArticleIdList></Reference><Reference><Citation>Esk&#xe5;s PA, Heimark S, Eek Mariampillai J, Larstorp AC, Fadl Elmula FE, H&#xf8;ieggen A. Adherence to medication and drug monitoring in apparent treatment-resistant hypertension. Blood Press. 2016;25(4):199&#x2013;205. doi: 10.3109/08037051.2015.1121706.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/08037051.2015.1121706</ArticleId><ArticleId IdType="pubmed">26729283</ArticleId></ArticleIdList></Reference><Reference><Citation>Burnier M. Drug adherence in hypertension. Pharmacol Res. 2017;125(Pt B):142&#x2013;149.</Citation><ArticleIdList><ArticleId IdType="pubmed">28870498</ArticleId></ArticleIdList></Reference><Reference><Citation>Burnier M, Egan BM. Adherence in hypertension. A review of prevalence, risk factors, impact, and management. Circ Res. 2019;124:1124&#x2013;1140. doi: 10.1161/CIRCRESAHA.118.313220.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.118.313220</ArticleId><ArticleId IdType="pubmed">30920917</ArticleId></ArticleIdList></Reference><Reference><Citation>Tonetti MS, D'Aiuto F, Nibali L, et al. Treatment of periodontitis and endothelial function. N Engl J Med. 2007;356(9):911&#x2013;920. doi: 10.1056/NEJMoa063186. Erratum in: N Engl J Med. 2018 Jun 13;:null.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa063186</ArticleId><ArticleId IdType="pubmed">17329698</ArticleId></ArticleIdList></Reference><Reference><Citation>Teeuw WJ, Slot DE, Susanto H, et al. Treatment of periodontitis improves the atherosclerotic profile: a systematic review and meta-analysis. J Clin Periodontol. 2014;41(1):70&#x2013;79. doi: 10.1111/jcpe.12171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcpe.12171</ArticleId><ArticleId IdType="pubmed">24111886</ArticleId></ArticleIdList></Reference><Reference><Citation>Koromantzos PA, Makrilakis K, Dereka X, Katsilambros N, Vrotsos IA, Madianos PN. A randomized, controlled trial on the effect of non-surgical periodontal therapy in patients with type 2 diabetes. Part I: effect on periodontal status and glycemic control. J Clin Periodontol. 2011;38(2):142&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pubmed">21114680</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Aiuto F, Gkranias N, Bhowruth D, et al. Systemic effects of periodontitis treatment in patients with type 2 diabetes: a 12 month, single-centre, investigator-masked, randomised trial. Lancet Diabetes Endocrinol. 2018;6(12):954&#x2013;965. doi: 10.1016/S2213-8587(18)30038-X. Epub 2018 Oct 24. Erratum in: Lancet Diabetes Endocrinol. 2019 Mar;7(3):e3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(18)30038-X</ArticleId><ArticleId IdType="pubmed">30472992</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridker PM, MacFadyen JG, Everett BM, Libby P, Thuren T, Glynn RJ, CANTOS Trial Group Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial. Lancet. 2018;391(10118):319&#x2013;328. doi: 10.1016/S0140-6736(17)32814-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)32814-3</ArticleId><ArticleId IdType="pubmed">29146124</ArticleId></ArticleIdList></Reference><Reference><Citation>Bokhari SA, Khan AA, Butt AK, et al. Non-surgical periodontal therapy reduces coronary heart disease risk markers: a randomized controlled trial. J Clin Periodontol. 2012;39(11):1065&#x2013;1074.</Citation><ArticleIdList><ArticleId IdType="pubmed">22966824</ArticleId></ArticleIdList></Reference><Reference><Citation>Offenbacher S, Beck JD, Moss K, et al. Results from the Periodontitis and Vascular Events (PAVE) Study: a pilot multicentered, randomized, controlled trial to study effects of periodontal therapy in a secondary prevention model of cardiovascular disease. J Periodontol. 2009;80(2):190&#x2013;201. doi: 10.1902/jop.2009.080007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1902/jop.2009.080007</ArticleId><ArticleId IdType="pmc">PMC2778200</ArticleId><ArticleId IdType="pubmed">19186958</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann GS, Bastos MF, Dias Gon&#xe7;alves TE, Chambrone L, Duarte PM. Local and circulating levels of adipocytokines in obese and normal weight individuals with chronic periodontitis. J Periodontol. 2013;84(5):624&#x2013;633. doi: 10.1902/jop.2012.120254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1902/jop.2012.120254</ArticleId><ArticleId IdType="pubmed">22839694</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller A, Rohde JF, Raymond K, Heitmann BL. Association between periodontal disease and overweight and obesity: a systematic review. J Periodontol. 2015;86(6):766&#x2013;776.</Citation><ArticleIdList><ArticleId IdType="pubmed">25672656</ArticleId></ArticleIdList></Reference><Reference><Citation>Akram Z, Baharuddin NA, Vaithilingam RD, et al. Effect of nonsurgical periodontal treatment on clinical periodontal variables and salivary resistin levels in obese Asians. J Oral Sci. 2017;59(1):93&#x2013;102. doi: 10.2334/josnusd.16-0127.</Citation><ArticleIdList><ArticleId IdType="doi">10.2334/josnusd.16-0127</ArticleId><ArticleId IdType="pubmed">28049964</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergstr&#xf6;m J. Tobacco smoking and chronic destructive periodontal disease. Odontology. 2004;92(1):1&#x2013;8. doi: 10.1007/s10266-004-0043-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10266-004-0043-4</ArticleId><ArticleId IdType="pubmed">15490298</ArticleId></ArticleIdList></Reference><Reference><Citation>Genco RJ, Borgnakke WS. Risk factors for periodontal disease. Periodontol 2000. 2013;62(1):59&#x2013;94. doi: 10.1111/j.1600-0757.2012.00457.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0757.2012.00457.x</ArticleId><ArticleId IdType="pubmed">23574464</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapple ILC, Mealey BL, Van Dyke TE, et al. Periodontal health and gingival diseases and conditions on an intact and a reduced periodontium: Consensus report of workgroup 1 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Periodontol. 2018;89(Suppl 1):S74&#x2013;S84. doi: 10.1002/JPER.17-0719.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JPER.17-0719</ArticleId><ArticleId IdType="pubmed">29926944</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel SP, Raju PA. Gingival crevicular fluid and serum levels of resistin in obese and non-obese subjects with and without periodontitis and association with single nucleotide polymorphism at -420. J Indian Soc Periodontol. 2014;18(5):555&#x2013;559. doi: 10.4103/0972-124X.142438.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0972-124X.142438</ArticleId><ArticleId IdType="pmc">PMC4239742</ArticleId><ArticleId IdType="pubmed">25425814</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Lu C, Qiu J, et al. Correlation of serum adipocytokine levels with glycolipid metabolism and inflammatory factors in obese patients with periodontal disease. Int J Clin Exp Pathol. 2018;11(3):1620&#x2013;1628.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6958146</ArticleId><ArticleId IdType="pubmed">31938261</ArticleId></ArticleIdList></Reference><Reference><Citation>Paredes-S&#xe1;nchez E, Montiel-Company JM, Iranzo-Cort&#xe9;s JE, Almerich-Torres T, Bellot-Arc&#xed;s C, Almerich-Silla JM. Meta-Analysis of the Use of 8-OHdG in Saliva as a Marker of Periodontal Disease. Dis Markers. 2018 doi: 10.1155/2018/7916578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/7916578</ArticleId><ArticleId IdType="pmc">PMC5954896</ArticleId><ArticleId IdType="pubmed">29854026</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993;259(5091):87&#x2013;91. doi: 10.1126/science.7678183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.7678183</ArticleId><ArticleId IdType="pubmed">7678183</ArticleId></ArticleIdList></Reference><Reference><Citation>Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999;282(22):2131&#x2013;2135. doi: 10.1001/jama.282.22.2131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.282.22.2131</ArticleId><ArticleId IdType="pubmed">10591334</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444(7121):860&#x2013;867. doi: 10.1038/nature05485.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05485</ArticleId><ArticleId IdType="pubmed">17167474</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006;116(7):1793&#x2013;1801. doi: 10.1172/JCI29069. Erratum in: J Clin Invest., 116, (8), 2308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI29069</ArticleId><ArticleId IdType="pmc">PMC1483173</ArticleId><ArticleId IdType="pubmed">16823477</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011;11(2):85&#x2013;97. doi: 10.1038/nri2921.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2921</ArticleId><ArticleId IdType="pmc">PMC3518031</ArticleId><ArticleId IdType="pubmed">21252989</ArticleId></ArticleIdList></Reference><Reference><Citation>Czech MP. Obesity Notches up fatty liver. Nat Med. 2013;19(8):969&#x2013;971. doi: 10.1038/nm.3293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.3293</ArticleId><ArticleId IdType="pubmed">23921741</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibata R, Ouchi N, Ohashi K, Murohara T. The role of adipokines in cardiovascular disease. J Cardiol. 2017;70(4):329&#x2013;334. doi: 10.1016/j.jjcc.2017.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jjcc.2017.02.006</ArticleId><ArticleId IdType="pubmed">28325521</ArticleId></ArticleIdList></Reference><Reference><Citation>Oikonomou EK, Antoniades C. The role of adipose tissue in cardiovascular health and disease. Nat Rev Cardiol. 2019;16(2):83&#x2013;99. doi: 10.1038/s41569-018-0097-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-018-0097-6</ArticleId><ArticleId IdType="pubmed">30287946</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez LM, de Lucas B, Bernal A, G&#xe1;lvez BG. Adipokines disrupt cardiac differentiation and cardiomyocyte survival. Int J Obes (Lond) 2020;44(4):908&#x2013;919. doi: 10.1038/s41366-019-0455-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41366-019-0455-4</ArticleId><ArticleId IdType="pubmed">31548573</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2021;286(3):327&#x2013;334. doi: 10.1001/jama.286.3.327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.286.3.327</ArticleId><ArticleId IdType="pubmed">11466099</ArticleId></ArticleIdList></Reference><Reference><Citation>Samaras K, Botelho NK, Chisholm DJ, Lord RV. Subcutaneous and visceral adipose tissue gene expression of serum adipokines that predict type 2 diabetes. Obesity (Silver Spring) 2010;18(5):884&#x2013;889. doi: 10.1038/oby.2009.443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/oby.2009.443</ArticleId><ArticleId IdType="pubmed">20019678</ArticleId></ArticleIdList></Reference><Reference><Citation>Maciel SS, Feres M, Gon&#xe7;alves TE, et al. Does obesity influence the subgingival microbiota composition in periodontal health and disease? J Clin Periodontol. 2016;43(12):1003&#x2013;1012. doi: 10.1111/jcpe.12634.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcpe.12634</ArticleId><ArticleId IdType="pubmed">27717180</ArticleId></ArticleIdList></Reference><Reference><Citation>Cugini MA, Haffajee AD, Smith C, Kent RL, Jr, Socransky SS. The effect of scaling and root planing on the clinical and microbiological parameters of periodontal diseases: 12-month results. J Clin Periodontol. 2000;27(1):30&#x2013;36. doi: 10.1034/j.1600-051x.2000.027001030.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1600-051x.2000.027001030.x</ArticleId><ArticleId IdType="pubmed">10674959</ArticleId></ArticleIdList></Reference><Reference><Citation>Predin T, Djuric M, Nikolic N, et al. Clinical and microbiological effects of quadrant versus full-mouth root planning--A randomized study. J Dent Sci. 2014 doi: 10.1016/j.jds.2013.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jds.2013.06.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Christgau M, Palitzsch KD, Schmalz G, Kreiner U, Frenzel S. Healing response to non-surgical periodontal therapy in patients with diabetes mellitus: clinical, microbiological, and immunologic results. J Clin Periodontol. 1998;25(2):112&#x2013;124. doi: 10.1111/j.1600-051x.1998.tb02417.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-051x.1998.tb02417.x</ArticleId><ArticleId IdType="pubmed">9495610</ArticleId></ArticleIdList></Reference><Reference><Citation>Buzinin SM, Alabsi AM, Tan AT, Vincent-Chong VK, Swaminathan D. Effects of nonsurgical periodontal therapy on clinical response, microbiological profile, and glycemic control in Malaysian subjects with type 1 diabetes. Scientific World Journal. 2014 doi: 10.1155/2014/232535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/232535</ArticleId><ArticleId IdType="pmc">PMC4132400</ArticleId><ArticleId IdType="pubmed">25147841</ArticleId></ArticleIdList></Reference><Reference><Citation>Quirynen M, De Soete M, Boschmans G, et al. Benefit of "one-stage full-mouth disinfection" is explained by disinfection and root planing within 24 hours: a randomized controlled trial. J Clin Periodontol. 2006;33(9):639&#x2013;647.</Citation><ArticleIdList><ArticleId IdType="pubmed">16856902</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao H, Hu J, Zhao L. Adjunctive subgingival application of Chlorhexidine gel in nonsurgical periodontal treatment for chronic periodontitis: a systematic review and meta-analysis. 34BMC Oral Health. 2020;20(1) doi: 10.1186/s12903-020-1021-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12903-020-1021-0</ArticleId><ArticleId IdType="pmc">PMC6995104</ArticleId><ArticleId IdType="pubmed">32005169</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiloah J, Patters MR. Repopulation of periodontal pockets by microbial pathogens in the absence of supportive therapy. J Periodontol. 1996;67(2):130&#x2013;139. doi: 10.1902/jop.1996.67.2.130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1902/jop.1996.67.2.130</ArticleId><ArticleId IdType="pubmed">8667133</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos S, Herrera D, L&#xf3;pez E, O'Connor A, Gonz&#xe1;lez I, Sanz M. A randomized clinical trial on the short-term clinical and microbiological effects of the adjunctive use of a 0.05% chlorhexidine mouth rinse for patients in supportive periodontal care. J Clin Periodontol. 2004;31(1):45&#x2013;51. doi: 10.1111/j.0303-6979.2004.00438.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.0303-6979.2004.00438.x</ArticleId><ArticleId IdType="pubmed">15058374</ArticleId></ArticleIdList></Reference><Reference><Citation>Haffajee AD, Roberts C, Murray L, et al. Effect of herbal, essential oil, and chlorhexidine mouthrinses on the composition of the subgingival microbiota and clinical periodontal parameters. J Clin Dent. 2009;20(7):211&#x2013;217.</Citation><ArticleIdList><ArticleId IdType="pubmed">20128317</ArticleId></ArticleIdList></Reference><Reference><Citation>Swierkot K, Nonnenmacher CI, Mutters R, Flores-de-Jacoby L, Mengel R. One-stage full-mouth disinfection versus quadrant and full-mouth root planing. J Clin Periodontol. 2009;36(3):240&#x2013;249.</Citation><ArticleIdList><ArticleId IdType="pubmed">19236536</ArticleId></ArticleIdList></Reference><Reference><Citation>Fonseca DC, Cortelli JR, Cortelli SC, et al. Clinical and Microbiologic Evaluation of Scaling and Root Planing per Quadrant and One-Stage Full-Mouth Disinfection Associated With Azithromycin or Chlorhexidine: A Clinical Randomized Controlled Trial. J Periodontol. 2015;86(12):1340&#x2013;1351. doi: 10.1902/jop.2015.150227.</Citation><ArticleIdList><ArticleId IdType="doi">10.1902/jop.2015.150227</ArticleId><ArticleId IdType="pubmed">26252751</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenstein G. Full-mouth therapy versus individual quadrant root planning: a critical commentary. J Periodontol. 2002;73(7):797&#x2013;812. doi: 10.1902/jop.2002.73.7.797.</Citation><ArticleIdList><ArticleId IdType="doi">10.1902/jop.2002.73.7.797</ArticleId><ArticleId IdType="pubmed">12146540</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartold PM, du Bois AH, Gannon S, Haynes DR, Hirsch RS. Antibacterial and immunomodulatory properties of azithromycin treatment implications for periodontitis. Inflammopharmacology. 2013;21(4):321&#x2013;338. doi: 10.1007/s10787-012-0165-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-012-0165-1</ArticleId><ArticleId IdType="pubmed">23446952</ArticleId></ArticleIdList></Reference><Reference><Citation>Culic O, Erakovic V, Parnham MJ. Anti-inflammatory effects of macrolide antibiotics. Eur J Pharmacol. 2001 1-3;429:209&#x2013;229.</Citation><ArticleIdList><ArticleId IdType="pubmed">11698042</ArticleId></ArticleIdList></Reference><Reference><Citation>Ianaro A, Ialenti A, Maffia P, et al. Anti-inflammatory activity of macrolide antibiotics. J Pharmacol Exp Ther. 2000;292(1):156&#x2013;163.</Citation><ArticleIdList><ArticleId IdType="pubmed">10604943</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodge P, Michalowicz B. Genetic predisposition to periodontitis in children and young adults. Periodontol 2000. 2001;26:113&#x2013;134.</Citation><ArticleIdList><ArticleId IdType="pubmed">11452901</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurdowska A, Noble JM, Griffith DE. The effect of azithromycin and clarithromycin on ex vivo interleukin-8 (IL-8) release from whole blood and IL-8 production by human alveolar macrophages. J Antimicrob Chemother. 2001;47(6):867&#x2013;870. doi: 10.1093/jac/47.6.867.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/47.6.867</ArticleId><ArticleId IdType="pubmed">11389120</ArticleId></ArticleIdList></Reference><Reference><Citation>Culic O, Erakovic V, Cepelak I, et al. Azithromycin modulates neutrophil function and circulating inflammatory mediators in healthy human subjects. Eur J Pharmacol. 2002;450(3):277&#x2013;289. doi: 10.1016/s0014-2999(02)02042-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0014-2999(02)02042-3</ArticleId><ArticleId IdType="pubmed">12208321</ArticleId></ArticleIdList></Reference><Reference><Citation>Shinkai M, Foster GH, Rubin BK. Macrolide antibiotics modulate ERK phosphorylation and IL-8 and GM-CSF production by human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2006;290(1):L75&#x2013;L85.</Citation><ArticleIdList><ArticleId IdType="pubmed">16085674</ArticleId></ArticleIdList></Reference><Reference><Citation>Shinkai M, Henke MO, Rubin BK. Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action. Pharmacol Ther. 2008;117(3):393&#x2013;405. doi: 10.1016/j.pharmthera.2007.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2007.11.001</ArticleId><ArticleId IdType="pubmed">18289694</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenland P, Alpert JS, Beller GA, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2010;122(25):e584&#x2013;e636. doi: 10.1161/CIR.0b013e3182051b4c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0b013e3182051b4c</ArticleId><ArticleId IdType="pubmed">21098428</ArticleId></ArticleIdList></Reference><Reference><Citation>Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): Developed with the special contribution of the European Association for Cardiovascular Prevention &amp; Rehabilitation (EACPR) Eur J Prev Cardiol. 2016;23(11):NP1&#x2013;NP96. doi: 10.1177/2047487316653709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2047487316653709</ArticleId><ArticleId IdType="pubmed">27353126</ArticleId></ArticleIdList></Reference><Reference><Citation>Yousuf O, Mohanty BD, Martin SS, et al. High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link? J Am Coll Cardiol. 2013;62(5):397&#x2013;408. doi: 10.1016/j.jacc.2013.05.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2013.05.016</ArticleId><ArticleId IdType="pubmed">23727085</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajishengallis G, Liang S, Payne MA, et al. Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. Cell Host Microbe. 2011;10(5):497&#x2013;506. doi: 10.1016/j.chom.2011.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2011.10.006</ArticleId><ArticleId IdType="pmc">PMC3221781</ArticleId><ArticleId IdType="pubmed">22036469</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricklin D, Hajishengallis G, Yang K, Lambris JD. Complement: a key system for immune surveillance and homeostasis. Nat Immunol. 2010;11(9):785&#x2013;797. doi: 10.1038/ni.1923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.1923</ArticleId><ArticleId IdType="pmc">PMC2924908</ArticleId><ArticleId IdType="pubmed">20720586</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajishengallis G. Complement and periodontitis. Biochem Pharmacol. 2010;80(12):1992&#x2013;2001. doi: 10.1016/j.bcp.2010.06.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2010.06.017</ArticleId><ArticleId IdType="pmc">PMC2955993</ArticleId><ArticleId IdType="pubmed">20599785</ArticleId></ArticleIdList></Reference><Reference><Citation>Sischo L, Broder HL. Oral health-related quality of life: what, why, how, and future implications. J Dent Res. 2011;90(11):1264&#x2013;1270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3318061</ArticleId><ArticleId IdType="pubmed">21422477</ArticleId></ArticleIdList></Reference><Reference><Citation>Thornton A, Lee P. Publication bias in meta-analysis: its causes and consequences. J Clin Epidemiol. 2000;53(2):207&#x2013;216. doi: 10.1016/s0895-4356(99)00161-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0895-4356(99)00161-4</ArticleId><ArticleId IdType="pubmed">10729693</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35696708</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>30</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2380-0194</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>01</Day></PubDate></JournalIssue><Title>Clinical spine surgery</Title><ISOAbbreviation>Clin Spine Surg</ISOAbbreviation></Journal><ArticleTitle>Comparison of Relative Value Units and 30-Day Outcomes Between Primary and Revision Pediatric Spinal Deformity Surgery.</ArticleTitle><Pagination><StartPage>E40</StartPage><EndPage>E44</EndPage><MedlinePgn>E40-E44</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/BSD.0000000000001352</ELocationID><Abstract><AbstractText Label="STUDY DESIGN">Retrospective cohort study.</AbstractText><AbstractText Label="OBJECTIVE">The aim of this study was to compare the relative value units (RVUs) and 30-day outcomes between primary and revision pediatric spinal deformity (PSD) surgery.</AbstractText><AbstractText Label="SUMMARY OF BACKGROUND DATA">PSD surgery is frequently complicated by the need for reoperation. However, there is limited literature on physician reimbursement rates and short-term outcomes following primary versus revision spinal deformity surgery in the pediatric population.</AbstractText><AbstractText Label="MATERIALS AND METHODS">This study utilizes data obtained from the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) Pediatric database. Patients between 10 and 18 years of age who underwent posterior spinal deformity surgery between 2012 and 2018 were included. Univariate and multivariate regression were used to assess the independent impact of revision surgery on RVUs and postoperative outcomes, including 30-day readmission, reoperation, morbidity, and complications.</AbstractText><AbstractText Label="RESULTS">The study cohort included a total of 15,055 patients, with 358 patients who underwent revision surgery. Patients in the revision group were more likely to be younger and male sex. Revision surgery more commonly required osteotomy (13.7% vs. 8.3%, P =0.002).Univariate analysis revealed higher total RVUs (71.09 vs. 60.51, P &lt;0.001), RVUs per minute (0.27 vs. 0.23, P &lt;0.001), readmission rate (6.7% vs. 4.0%, P =0.012), and reoperation rate (7.5% vs. 3.3%, P &lt;0.001) for the revision surgery group. Morbidity rates were found to be statistically similar. In addition, deep surgical site infection, pulmonary embolism, and urinary tract infection were more common in the revision group. After controlling for baseline differences in multivariate regression, the differences in total RVUs, RVUs per minute, reoperation rate, and rate of pulmonary embolism between primary and revision surgery remained statistically significant.</AbstractText><AbstractText Label="CONCLUSIONS">Revision PSD surgery was found to be assigned appropriately higher mean total RVUs and RVUs per minute corresponding to the higher operative complexity compared with primary surgery. Revision surgery was also associated with poorer 30-day outcomes, including higher frequencies of reoperation and pulmonary embolism.</AbstractText><AbstractText Label="LEVEL OF EVIDENCE">Level III.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Wolters Kluwer Health, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Junho</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Northwell Health Long Island Jewish Medical Center, Queens, NY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital for Special Surgery, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katz</LastName><ForeName>Austen D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Northwell Health Long Island Jewish Medical Center, Queens, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalal</LastName><ForeName>Sidhant</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hospital for Special Surgery, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silber</LastName><ForeName>Jeff</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Northwell Health Long Island Jewish Medical Center, Queens, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Essig</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Northwell Health Long Island Jewish Medical Center, Queens, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qureshi</LastName><ForeName>Sheeraz</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hospital for Special Surgery, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Virk</LastName><ForeName>Sohrab</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Northwell Health Long Island Jewish Medical Center, Queens, NY.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Spine Surg</MedlineTA><NlmUniqueID>101675083</NlmUniqueID><ISSNLinking>2380-0186</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012086" MajorTopicYN="N">Reoperation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D024162" MajorTopicYN="N">Second-Look Surgery</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013123" MajorTopicYN="Y">Spinal Fusion</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>J.S.: teaching fees: Stryker. D.E.: paid consultant: Stryker, DePuy. S.Q.: editorial or governing board: Clinical Orthopaedics and Related Research , Contemporary Spine Surgery , Global Spine Journal , Spine Journal , Annals of Translational Medicine . Paid consultant: Globus Medical, Paradigm Spine, Stryker. IP royalties: Globus Medical, Stryker. Paid presenter or speaker: Globus Medical. Stock or stock options: Avaz Surgical, Vital 5 (past). Board or committee member: Association of Bone and Joint Surgeons, Cervical Spine Research Society, Healthgrades, International Society for the Advancement of Spine Surgery (ISASS), Lifelink.com, Minimally Invasive Spine Study Group, North American Spine Society, Society of Minimally Invasive Spine Surgery (SMISS), Spinal Simplicity. The remaining authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>13</Day><Hour>17</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35696708</ArticleId><ArticleId IdType="doi">10.1097/BSD.0000000000001352</ArticleId><ArticleId IdType="pii">01933606-202302000-00012</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Weinstein SL, Dolan LA, Spratt KF, et al. Health and function of patients with untreated idiopathic scoliosis: a 50-year natural history study. JAMA. 2003;289:559&#x2013;567.</Citation></Reference><Reference><Citation>Garrido E, Tome-Bermejo F, Tucker SK, et al. Short anterior instrumented fusion and posterior convex non-instrumented fusion of hemivertebra for congenital scoliosis in very young children. Eur Spine J. 2008;17:1507&#x2013;1514.</Citation></Reference><Reference><Citation>Geck MJ, Macagno A, Ponte A, et al. The Ponte procedure: posterior only treatment of Scheuermann&#x2019;s kyphosis using segmental posterior shortening and pedicle screw instrumentation. J Spinal Disord Tech. 2007;20:586&#x2013;593.</Citation></Reference><Reference><Citation>Wessell NM, Martus JE, Halanski MA, et al. What&#x2019;s new in pediatric spine growth modulation and implant technology for early-onset scoliosis? J Pediatr Orthop. 2018;38:e3&#x2013;e13.</Citation></Reference><Reference><Citation>Jalanko T, Helenius I, Remes V, et al. Operative treatment of isthmic spondylolisthesis in children: a long-term, retrospective comparative study with matched cohorts. Eur Spine J. 2011;20:766&#x2013;775.</Citation></Reference><Reference><Citation>Kim HJ, Cunningham ME, Boachie-Adjei O. Revision spine surgery to manage pediatric deformity. J Am Acad Orthop Surg. 2010;18:739&#x2013;748.</Citation></Reference><Reference><Citation>Coe JD, Smith JS, Berven S, et al. Complications of spinal fusion for scheuermann kyphosis: a report of the scoliosis research society morbidity and mortality committee. Spine (Phila Pa 1976). 2010;35:99&#x2013;103.</Citation></Reference><Reference><Citation>Sponseller PD. Pediatric revision spinal deformity surgery: issues and complications. Spine (Phila Pa 1976). 2010;35:2205&#x2013;2210.</Citation></Reference><Reference><Citation>Fruergaard S, Ohrt-Nissen S, Pitter FT, et al. Revision risk after pediatric spinal deformity surgery: a nationwide study with 2-year follow-up. Spine J. 2021;21:642&#x2013;652.</Citation></Reference><Reference><Citation>Ahmed SI, Bastrom TP, Yaszay B, et al. Five-year reoperation risk and causes for revision after idiopathic scoliosis surgery. Spine (Phila Pa 1976). 2017;42:999&#x2013;1005.</Citation></Reference><Reference><Citation>Song Z, McMahon LF Jr. Rethinking physician payment. J Gen Intern Med. 2015;30:152&#x2013;154.</Citation></Reference><Reference><Citation>Nurok M, Gewertz B. Relative value units and the measurement of physician performance. JAMA. 2019;322:1139&#x2013;1140.</Citation></Reference><Reference><Citation>Di Guida S, Gyrd-Hansen D, Oxholm AS. Testing the myth of fee-for-service and overprovision in health care. Health Econ. 2019;28:717&#x2013;722.</Citation></Reference><Reference><Citation>Ramirez JL, Gasper WJ, Seib CD, et al. Patient complexity by surgical specialty does not correlate with work relative value units. Surgery. 2020;168:371&#x2013;378.</Citation></Reference><Reference><Citation>Peterson J, Sodhi N, Khlopas A, et al. A comparison of relative value units in primary versus revision total knee arthroplasty. J Arthroplasty. 2018;33:S39&#x2013;S42.</Citation></Reference><Reference><Citation>Sodhi N, Piuzzi NS, Khlopas A, et al. Are we appropriately compensated by relative value units for primary vs revision total hip arthroplasty? J Arthroplasty. 2018;33:340&#x2013;344.</Citation></Reference><Reference><Citation>ACS-NSQIP. ACS NSQIP Participant Use Data File. 2021. Available at: https://www.facs.org/quality-programs/data-and-registries/acs-nsqip/participant-use-data-file/ . Accessed December 27, 2021.</Citation></Reference><Reference><Citation>Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159:702&#x2013;706.</Citation></Reference><Reference><Citation>Zou GY, Donner A. Extension of the modified Poisson regression model to prospective studies with correlated binary data. Stat Methods Med Res. 2013;22:661&#x2013;670.</Citation></Reference><Reference><Citation>DePasse JM, Durand W, Daniels AH. Predictors of nonneurologic complications and increased length of stay after cervical spine osteotomy. World Neurosurg. 2018;118:e727&#x2013;e730.</Citation></Reference><Reference><Citation>Song Z, Rose S, Safran DG, et al. Changes in health care spending and quality 4 years into global payment. N Engl J Med. 2014;371:1704&#x2013;1714.</Citation></Reference><Reference><Citation>Gan ZS, Wood CM, Hayon S, et al. Correlation of relative value units with surgical complexity and physician workload in urology. Urology. 2020;139:71&#x2013;77.</Citation></Reference><Reference><Citation>Jiang DD, Chakiryan NH, Gillis KA, et al. Relative value units do not adequately account for operative time in pediatric urology. J Pediatr Surg. 2021;56:883&#x2013;887.</Citation></Reference><Reference><Citation>Shah DR, Bold RJ, Yang AD, et al. Relative value units poorly correlate with measures of surgical effort and complexity. J Surg Res. 2014;190:465&#x2013;470.</Citation></Reference><Reference><Citation>Gupta MC, Ferrero E, Mundis G, et al. Pedicle subtraction osteotomy in the revision versus primary adult spinal deformity patient: is there a difference in correction and complications? Spine (Phila Pa 1976). 2015;40:E1169&#x2013;E1175.</Citation></Reference><Reference><Citation>Little DC, Peter SD St, Calkins CM, et al. Relative value units correlate with pediatric surgeons&#x2019; operating time: when perceived myth becomes reality. J Pediatr Surg. 2006;41:234&#x2013;238; discussion 8.</Citation></Reference><Reference><Citation>Richards BS, Hasley BP, Casey VF. Repeat surgical interventions following &#x201c;definitive&#x201d; instrumentation and fusion for idiopathic scoliosis. Spine (Phila Pa 1976). 2006;31:3018&#x2013;3026.</Citation></Reference><Reference><Citation>Yagi M, King AB, Kim HJ, et al. Outcome of revision surgery in pediatric spine deformity patients. Spine Deform. 2013;1:59&#x2013;67.</Citation></Reference><Reference><Citation>Bick RL, Kaplan H. Syndromes of thrombosis and hypercoagulability. Congenital and acquired causes of thrombosis. Med Clin North Am. 1998;82:409&#x2013;458.</Citation></Reference><Reference><Citation>Della Valle CJ, Steiger DJ, Di Cesare PE. Thromboembolism after hip and knee arthroplasty: diagnosis and treatment. J Am Acad Orthop Surg. 1998;6:327&#x2013;336.</Citation></Reference><Reference><Citation>West JL III, Anderson LD. Incidence of deep vein thrombosis in major adult spinal surgery. Spine (Phila Pa 1976). 1992;17:S254&#x2013;S257.</Citation></Reference><Reference><Citation>Patel SA, McDonald CL, Reid DBC, et al. Complications of thoracolumbar adult spinal deformity surgery. JBJS Rev. 2020;8:e0214.</Citation></Reference><Reference><Citation>Erkilinc M, Clarke A, Poe-Kochert C, et al. Is there value in venous thromboembolism chemoprophylaxis after pediatric scoliosis surgery? A 28-year single center study. J Pediatr Orthop. 2021;41:138&#x2013;142.</Citation></Reference><Reference><Citation>Pateder DB, Gonzales RA, Kebaish KM, et al. Pulmonary embolism after adult spinal deformity surgery. Spine (Phila Pa 1976). 2008;33:301&#x2013;305.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32080078</PMID><DateCompleted><Year>2020</Year><Month>03</Month><Day>09</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>99</Volume><Issue>8</Issue><PubDate><Year>2020</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Cemented versus uncemented hemi-arthroplasty for femoral neck fractures in elderly patients: A systematic review and meta-analysis of randomized controlled trials.</ArticleTitle><Pagination><StartPage>e19039</StartPage><MedlinePgn>e19039</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e19039</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000019039</ELocationID><Abstract><AbstractText Label="AIM" NlmCategory="OBJECTIVE">To compare the efficacy and safety of cemented and uncemented hemiarthroplasty in elderly patients with femoral neck fracture.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">We searched PubMed, EMBASE, and Cochrane Library databases for published randomized clinical trials comparing cemented hemiarthroplasty with uncemented hemiarthroplasty in elderly patients with a femoral neck fracture. The search was not limited to language, time, or other factors. The quality of each study was assessed using the revised Jadad scale. Two researchers independently extracted data from all selected studies, including the following base line data: study period, fracture stage, number of patients, male female ratio, average age, and per-protocol (PP) or intent-to-treat (ITT), and the interest outcomes: the mortality at 12 months, operative time, hospital stay, common complications, prosthetic-related complications, blood loss and Harris Hip Score (HHS). Fixed-effects or random-effects models with mean differences and odds ratios were used to pool the continuous and dichotomous variables to determine heterogeneity of the included studies.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 8 studies involving 1577 hips (782 uncemented and 795 cemented) were included in this meta-analysis. The meta-analysis is indicated that the operation time of cemented hemiarthroplasty was longer than uncemented hemiarthroplasty and there was statistical significance between two groups (OR&#x200a;=&#x200a;-7.30, 95%CI, -13.13, -1.46; P&#x200a;=&#x200a;.01). However, there was no significant difference between the two methods of fixation in mortality at 12 months (OR&#x200a;=&#x200a;1.22, 95%CI, 0.94-1.59; P&#x200a;=&#x200a;.14), hospital stay (OR&#x200a;=&#x200a;0.26, 95%CI, -0.41, 0.93; P&#x200a;=&#x200a;.44), blood loss (OR&#x200a;=&#x200a;-17.94, 95%CI, -65.83, 29.95; P&#x200a;=&#x200a;.46), and HHS score. There were significant differences in the common complications of pulmonary embolism between the two groups, but there were no differences in the other five common complications. The results showed that uncemented hemiarthroplasty could reduce the incidence of pulmonary embolism after operation. Moreover, the outcomes of prosthetic-related complications showed that there were significant differences between the two groups in periprosthetic fracture (OR&#x200a;=&#x200a;8.32, 95%CI, 3.85-17.98; P&#x200a;&lt;&#x200a;.00001) and prosthetic subsidence and loosening (OR&#x200a;=&#x200a;5.33, 95%CI, 2.18-13.00; P&#x200a;=&#x200a;.0002).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our study shows that uncemented prosthesis can shorten the operation time and reduce the incidence of pulmonary embolism, but it does not reduce mortality, blood loss, and hospital stay. Most importantly, the incidence of prosthetic-related complications was higher in uncemented patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Na</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, The Second Hospital of Jilin University.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Applied Statistical Research and College of Mathematics, Jilin University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, The Second Hospital of Jilin University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Chang</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center for Applied Statistical Research and College of Mathematics, Jilin University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Meng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, The Second Hospital of Jilin University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, The First Hospital of Jilin University, Changchun, Jilin, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001843">Bone Cements</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016063" MajorTopicYN="N">Blood Loss, Surgical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001843" MajorTopicYN="N">Bone Cements</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005265" MajorTopicYN="N">Femoral Neck Fractures</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062785" MajorTopicYN="N">Hemiarthroplasty</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006622" MajorTopicYN="N">Hip Prosthesis</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061646" MajorTopicYN="N">Operative Time</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>2</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32080078</ArticleId><ArticleId IdType="pmc">PMC7034642</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000019039</ArticleId><ArticleId IdType="pii">00005792-202002210-00008</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Burge R, Dawson-Hughes B, Solomon DH, et al. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005&#x2013;2025. J Bone Miner Res 2007;22:465&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">17144789</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhandari M, Devereaux PJ, Tornetta IIIP, et al. Operative management of displaced femoral neck fractures in elderly patients. An international survey. J Bone Joint Surg Am 2005;87:2122&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">16140828</ArticleId></ArticleIdList></Reference><Reference><Citation>Crossman PT, Khan RJ, MacDowell A, et al. A survey of the treatment of displaced intracapsular femoral neck fractures in the UK. Injury 2002;33:383&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">12095715</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T, Zhuang Q, Weng X, et al. Cemented versus uncemented hemiarthroplasty for femoral neck fractures in elderly patients: a meta-analysis. PLoS One 2013;8:68903.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3720851</ArticleId><ArticleId IdType="pubmed">23935902</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo X, He S, Li Z, et al. Systematic review of cemented versus uncemented hemiarthroplasty for displaced femoral neck fractures in older patients. Arch Orthop Trauma Surg 2012;132:455&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">22160512</ArticleId></ArticleIdList></Reference><Reference><Citation>Ning GZ, Li YL, Wu Q, et al. Cemented versus uncemented hemiarthroplasty for displaced femoral neck fractures: an updated meta-analysis. Eur J Orthop Surg Traumatol 2014;24:7&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">23412274</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker MJ, Gurusamy KS, Azegami S. Arthroplasties (with and without bone cement) for proximal femoral fractures in adults. Cochrane Database Syst Rev 2010;6:CD001706.</Citation><ArticleIdList><ArticleId IdType="pubmed">20556753</ArticleId></ArticleIdList></Reference><Reference><Citation>Skyrme AD, Jeer PJ, Berry J, et al. Intravenous polymethyl methacrylate after cemented hemiarthroplasty of the hip. J Arthroplasty 2001;16:521&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">11402421</ArticleId></ArticleIdList></Reference><Reference><Citation>Fallon KM, Fuller JG, Morley-Forster P. Fat embolization and fatal cardiac arrest during hip arthroplasty with methylmethacrylate. Can J Anaesth 2001;48:626&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">11495867</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen SK, Brix M, Birkelund L, et al. Can introduction of an uncemented, hydroxyapatite coated hemiarthroplasty for displaced femoral neck fractures be recommended. Hip Int 2010;20:109&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">20235070</ArticleId></ArticleIdList></Reference><Reference><Citation>Figved W, Opland V, Frihagen F, et al. Cemented versus uncemented hemiarthroplasty for displaced femoral neck fractures. Clin Orthop Relat Res 2009;467:2426&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2866935</ArticleId><ArticleId IdType="pubmed">19130162</ArticleId></ArticleIdList></Reference><Reference><Citation>Deangelis JP, Ademi A, Staff I, et al. Cemented versus uncemented hemiarthroplasty for displaced femoral neck fractures: a prospective randomized trial with early follow-up. J Orthop Trauma 2012;26:135&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">22198652</ArticleId></ArticleIdList></Reference><Reference><Citation>Moerman S, Mathijssen NMC, Niesten DD, et al. More complications in uncemented compared to cemented hemiarthroplasty for displaced femoral neck fractures: a randomized controlled trial of 201 patients, with one year follow-up. BMC Musculoskelet Disord 2017;18:169.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5399836</ArticleId><ArticleId IdType="pubmed">28431543</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2707599</ArticleId><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference><Reference><Citation>Vidovic D, Matejcic A, Punda M, et al. Periprosthetic bone loss following hemiarthroplasty: a comparison between cemented and cementless hip prosthesis. Injury 2013;44: Suppl 3: S62&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">24060022</ArticleId></ArticleIdList></Reference><Reference><Citation>Langslet E, Frihagen F, Opland V, et al. Cemented versus uncemented hemiarthroplasty for displaced femoral neck fractures: 5-year followup of a randomized trial. Clin Orthop Relat Res 2014;472:1291&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3940758</ArticleId><ArticleId IdType="pubmed">24081667</ArticleId></ArticleIdList></Reference><Reference><Citation>Emery RJ, Broughton NS, Desai K, et al. Bipolar hemiarthroplasty for subcapital fracture of the femoral neck: a prospective randomised trial of cemented Thompson and uncemented Moore stems. J Bone Joint Surg Br 1991;73:322&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">2005165</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor F, Wright M, Zhu M. Hemiarthroplasty of the hip with and without cement: a randomized clinical trial. J Bone Joint Surg [Am] 2012;94-A:577&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">22488613</ArticleId></ArticleIdList></Reference><Reference><Citation>DeAngelis JP, Ademi A, Staff I, et al. Cemented versus uncemented hemiarthroplasty for displaced femoral neck fractures: a prospective randomized trial with early follow-up. J Orthop Trauma 2012;26:135&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">22198652</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker MI, Pryor G, Gurusamy K. Cemented versus uncemented hemiarthroplasty for intracapsular hip fractures: a randomised controlled trial in 400 patients. J Bone Joint Surg Br 2010;92:116&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">20044689</ArticleId></ArticleIdList></Reference><Reference><Citation>Talsnes O, Hjelmstedt F, Pripp AH. No difference in mortality between cemented and uncemented hemiprosthesis for elderly patients with cervical hip fracture. A prospective randomized study on 334 patients over 75 years. Arch Orthop Trauma Surg 2013;133:805&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">23532371</ArticleId></ArticleIdList></Reference><Reference><Citation>Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">8721797</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan RJK, MacDowell A, Crossman P, et al. Cemented or uncemented hemiarthroplasty for displaced intracapsular fractures of the hip&#x2014;a systematic review. Injury 2002;33:13&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">11879826</ArticleId></ArticleIdList></Reference><Reference><Citation>Azegami S, Gurusamy KS, Parker MJ. Cemented versus uncemented hemiarthroplasty for hip fractures: a systematic review of randomised controlled trials. Hip Int 2011;21:509&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">21948035</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo WH, Chen WM, Huang CK, et al. Bateman bipolar hemiarthroplasty for displaced interacapsular femoral neck fracture: uncemented versus cemented. Clin Orthop Relat Res 1994;302:75&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">8168326</ArticleId></ArticleIdList></Reference><Reference><Citation>Faraj AA, Branfoot T. Cemented versus uncemented Thompson prostheses: a functional outcome study. Injury 1999;30:671&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">10707241</ArticleId></ArticleIdList></Reference><Reference><Citation>Santini S, Rebeccato A, Bolgan I, et al. Hip fractures in elderly patients treated with bipolar hemiarthroplasty: comparison between cemented and cementless implants. J Orthopaed Traumatol 2005;6:80&#x2013;7.</Citation></Reference><Reference><Citation>Harper WMGP. The treatment of intracapsular proximal femoral fractures: a randomized prospective trial. J Bone Joint Surg Br 1992;74-B:282.</Citation></Reference><Reference><Citation>Jameson SS, Jensen CD, Elson DW, et al. Cemented versus cementless hemiarthroplasty for intracapsular neck of femur fracture&#x2014;a comparison of 60848 matched patients using national data. Injury 2012;44:730&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">23206920</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao Li, Qianyu Z, Xisheng W. Cemented versus uncemented hemiarthroplasty for femoral neck fractures in elderly patients: a meta-analysis. PLoS One 2014;8:e68903.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3720851</ArticleId><ArticleId IdType="pubmed">23935902</ArticleId></ArticleIdList></Reference><Reference><Citation>Talsnes O, Vinje T, Gjertsen JE, et al. Perioperative mortality in hip fracture patients treated with cemented and uncemented hemiprosthesis: a register study of 11,210 patients. Int Orthop 2013;37:1135&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3664168</ArticleId><ArticleId IdType="pubmed">23508867</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh U, Singh K, Waikhom S, et al. A comparative study between cemented and uncemented bipolar hemiarthroplasty in the treatment of fresh fracture of femoral neck in the elderly patients. JMS 2011;1:19&#x2013;23.</Citation></Reference><Reference><Citation>Veldman HD, Heyligers IC, Grimm B. Cemented versus cementless hemiarthroplasty for a displaced fracture of the femoral neck. A systematic review and meta-analysis of current generation hip stems. Bone Joint J 2017;99-B:421&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">28385929</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark DI, Ahmed AB, Baxendale BR, et al. Cardiac output during hemiarthroplasty of the hip&#x2014;a prospective, controlled trial of cemented and uncemented prostheses. J Bone Joint Surg Br 2001;83:414&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">11341430</ArticleId></ArticleIdList></Reference><Reference><Citation>Christie J, Burnett R, Potts HR, et al. Echocardiography of transatrial embolism during cemented and uncemented hemiarthroplasty of the hip. J Bone Joint Surg Br 1994;76:409&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">8175843</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker MJ, Gurusamy K. Arthroplasties (with and without bone cement) for proximal femoral fractures in adults. Cochrane Database Syst Rev 2006;CD001706.</Citation><ArticleIdList><ArticleId IdType="pubmed">16855974</ArticleId></ArticleIdList></Reference><Reference><Citation>Parvizi J, Holiday AD, Ereth MH, et al. Sudden death during primary hip arthroplasty. Clin Orthop Relat Res 1999;369:39&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">10611859</ArticleId></ArticleIdList></Reference><Reference><Citation>Holt EM, Evans RA, Hindley CJ, et al. 1000 femoral neck fractures: the effect of pre-injury mobility and surgical experience on outcome. Injury 1994;25:91&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">8138305</ArticleId></ArticleIdList></Reference><Reference><Citation>Donaldson AJ, Thomson HE, Harper NJ, et al. Bone cement implantation syndrome. Br J Anaesth 2009;102:12&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">19059919</ArticleId></ArticleIdList></Reference><Reference><Citation>Garellick G, Malchau H, Herberts P. The Charnley versus the Spectron hip prosthesis: clinical evaluation of a randomized, prospective study of 2 different hip implants. J Arthroplasty 1999;14:407&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">10428220</ArticleId></ArticleIdList></Reference><Reference><Citation>Grammatopoulos G, Wilson HA, Kendrick BJ, et al. Hemiarthroplasty using cemented or uncemented stems of proven design: a comparative study. Bone Joint J 2015;97-B:94&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">25568420</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris K, Davies H, Wronka K. Implant-related complications following hip hemiarthroplasty: a comparison of modern cemented and uncemented prostheses. Eur J Orthop Surg 2015;25:1161&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">26174416</ArticleId></ArticleIdList></Reference><Reference><Citation>Yli-Kyyny T, Ojanper&#xe4; J, Venesmaa P, et al. Perioperative complications after cemented or uncemented hemiarthroplasty in hip fracture patients. Scand J Surg 2013;102:124&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">23820689</ArticleId></ArticleIdList></Reference><Reference><Citation>Gjertsen JE, Lie SA, Vinje T, et al. More re-operations after uncemented than cemented hemiarthroplasty used in the treatment of displaced fractures of the femoral neck: an observational study of 11,116 hemiarthroplasties from a national register. J Bone Joint Surg Br 2012;94:1113&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">22844055</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26266339</PMID><DateCompleted><Year>2016</Year><Month>09</Month><Day>26</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2164-554X</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>12</Issue><PubDate><Year>2015</Year></PubDate></JournalIssue><Title>Human vaccines &amp; immunotherapeutics</Title><ISOAbbreviation>Hum Vaccin Immunother</ISOAbbreviation></Journal><ArticleTitle>The usefulness of immunotherapy in pediatric neurodegenerative disorders: A systematic review of literature data.</ArticleTitle><Pagination><StartPage>2749</StartPage><EndPage>2763</EndPage><MedlinePgn>2749-63</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/21645515.2015.1061161</ELocationID><Abstract><AbstractText>Immunotherapeutic strategies to treat neurodegenerative disorders have inspired the scientific community. The aim of our review is to address the translational aspects of neuroimmunology to describe the efficacy of immunotherapy in the treatment of pediatric neurodegenerative disorders. In the studies we analyzed IVIG were found to be efficient in the treatment of post-streptococcal neurodegenerative disorders, even if in PANDAS, plasma-exchange (PE) showed a higher efficiency. IVIG were also successfully used in ADEM and Guillan-Barr&#xe9; syndrome. In Sydenham Chorea the use of methylprednisolone was found in most cases as efficient as IVIG, while in Tourette's Syndrome, Colecoxib was successfully used in one patient. Pediatric Multiple Sclerosis seems to respond better to immunosuppressant agents (Mitoxantrone, Cyclophosphamide, Natalizumab), as well as Neuromyelitis optica (Rituximab, Mycofenolate). The importance of this review relies in the attempt to draw standardized guidelines for immunotherapy in pediatric neurodegeneratve disorders.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vitaliti</LastName><ForeName>Giovanna</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>a Acute and Emergency Paediatric and General Paediatric Operative Unit; Policlinico-Vittorio Emanuele Hospital; University of Catania ; Catania , Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tabatabaie</LastName><ForeName>Omidreza</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>b School of Medicine; Tehran University of Medical Sciences ; Tehran , Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matin</LastName><ForeName>Nassim</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>b School of Medicine; Tehran University of Medical Sciences ; Tehran , Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ledda</LastName><ForeName>Caterina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>c Hygiene and Public Health; Department of Medical, Surgical Sciences and Advanced Technologies "G.F. Ingrassia"; University of Catania ; Catania , Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pavone</LastName><ForeName>Piero</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>a Acute and Emergency Paediatric and General Paediatric Operative Unit; Policlinico-Vittorio Emanuele Hospital; University of Catania ; Catania , Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lubrano</LastName><ForeName>Riccardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>d Pediatric Department ; Pediatric Nephrology Operative Unit of the Sapienza University of Rome ; Rome , Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serra</LastName><ForeName>Agostino</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>e ENT Department G.F. Ingrassia ; Policlinico-Vittorio Emanuele University Hospital; University of Catania ; Catania , Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Mauro</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>e ENT Department G.F. Ingrassia ; Policlinico-Vittorio Emanuele University Hospital; University of Catania ; Catania , Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cocuzza</LastName><ForeName>Salvatore</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>e ENT Department G.F. Ingrassia ; Policlinico-Vittorio Emanuele University Hospital; University of Catania ; Catania , Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falsaperla</LastName><ForeName>Raffaele</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>a Acute and Emergency Paediatric and General Paediatric Operative Unit; Policlinico-Vittorio Emanuele Hospital; University of Catania ; Catania , Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Hum Vaccin Immunother</MedlineTA><NlmUniqueID>101572652</NlmUniqueID><ISSNLinking>2164-5515</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016756">Immunoglobulins, Intravenous</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000069442">Natalizumab</NameOfSubstance></Chemical><Chemical><RegistryNumber>4F4X42SYQ6</RegistryNumber><NameOfSubstance UI="D000069283">Rituximab</NameOfSubstance></Chemical><Chemical><RegistryNumber>8N3DW7272P</RegistryNumber><NameOfSubstance UI="D003520">Cyclophosphamide</NameOfSubstance></Chemical><Chemical><RegistryNumber>BZ114NVM5P</RegistryNumber><NameOfSubstance UI="D008942">Mitoxantrone</NameOfSubstance></Chemical><Chemical><RegistryNumber>X4W7ZR7023</RegistryNumber><NameOfSubstance UI="D008775">Methylprednisolone</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C537163">Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="N">Autoimmune Diseases</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002819" MajorTopicYN="N">Chorea</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003520" MajorTopicYN="N">Cyclophosphamide</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020275" MajorTopicYN="N">Guillain-Barre Syndrome</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016756" MajorTopicYN="N">Immunoglobulins, Intravenous</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007167" MajorTopicYN="N">Immunotherapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008775" MajorTopicYN="N">Methylprednisolone</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008942" MajorTopicYN="N">Mitoxantrone</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069442" MajorTopicYN="N">Natalizumab</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009420" MajorTopicYN="N">Nervous System</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009471" MajorTopicYN="N">Neuromyelitis Optica</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009771" MajorTopicYN="N">Obsessive-Compulsive Disorder</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010951" MajorTopicYN="N">Plasma Exchange</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069283" MajorTopicYN="N">Rituximab</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013290" MajorTopicYN="N">Streptococcal Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005879" MajorTopicYN="N">Tourette Syndrome</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">childhood</Keyword><Keyword MajorTopicYN="N">immunotherapy-systematic review</Keyword><Keyword MajorTopicYN="N">neurodegenerative disorders</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>8</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>8</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>9</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>12</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26266339</ArticleId><ArticleId IdType="pmc">PMC5391617</ArticleId><ArticleId IdType="doi">10.1080/21645515.2015.1061161</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Amor S, Puentes F, Baker D, van der Valk P. Inflammation in neurodegenerative diseases. Immunology 2010; 129:154-69; PMID:20561356; http://dx.doi.org/10.1111/j.1365-2567.2009.03225.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2567.2009.03225.x</ArticleId><ArticleId IdType="pmc">PMC2814458</ArticleId><ArticleId IdType="pubmed">20561356</ArticleId></ArticleIdList></Reference><Reference><Citation>Bsibsi M, Ravid R, Gveric D, van Noort JM. Broad expression of Toll&#x2010;like receptors in the human central nervous system. J Neuropathol Exp Neurol 2002; 61:1013-21; PMID:12430718</Citation><ArticleIdList><ArticleId IdType="pubmed">12430718</ArticleId></ArticleIdList></Reference><Reference><Citation>Koedel U, Merbt UM, Schmidt C, Angele B, Popp B, Wagner H, Pfister HW, Kirschning CJ. Acute brain injury triggers MyD88-dependent, TLR2/4-independent inflammatory responses. Am J Pathol 2007; 171:200-13; PMID:17591966; http://dx.doi.org/10.2353/ajpath.2007.060821</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2007.060821</ArticleId><ArticleId IdType="pmc">PMC1941591</ArticleId><ArticleId IdType="pubmed">17591966</ArticleId></ArticleIdList></Reference><Reference><Citation>Letiembre M, Liu Y, Walter S, Hao W, Pfander T, Wrede A, Schulz-Schaeffer W, Fassbender K. Screening of innate immune receptors in neurodegenerative diseases: a similar pattern. Neurobiol Aging 2009; 30:759-68; PMID:17905482; http://dx.doi.org/10.1016/j.neurobiolaging.2007.08.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2007.08.018</ArticleId><ArticleId IdType="pubmed">17905482</ArticleId></ArticleIdList></Reference><Reference><Citation>Okun E, Griffioen KJ, Lathia JD, Tang SC, Mattson MP, Arumugam TV. Toll-like receptors in neurodegeneration. Brain Res Rev 2009; 59:278-92; PMID:18822314; http://dx.doi.org/10.1016/j.brainresrev.2008.09.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresrev.2008.09.001</ArticleId><ArticleId IdType="pmc">PMC2679904</ArticleId><ArticleId IdType="pubmed">18822314</ArticleId></ArticleIdList></Reference><Reference><Citation>Marta M, Meier UC, Lobell A. Regulation of autoimmune encephalomyelitis by toll-like receptors. Autoimmun Rev 2009; 8:506-9; PMID:19211042; http://dx.doi.org/10.1016/j.autrev.2009.01.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2009.01.006</ArticleId><ArticleId IdType="pubmed">19211042</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin J, Goswami R, Dawson S, Dawson G. Expression of the receptor for advanced glycation end products in oligodendrocytes in response to oxidative stress. J Neurosci Res 2008; 86:2414-22; PMID:18438937; http://dx.doi.org/10.1002/jnr.21692</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.21692</ArticleId><ArticleId IdType="pmc">PMC2671024</ArticleId><ArticleId IdType="pubmed">18438937</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersson &#x212b;, Covacu R, Sunnemark D, Danilov AI, Dal Bianco A, Khademi M, Khademi M, Wallstr&#xf6;m E, Lobell A, Brundin L, et&#xa0;al.. Pivotal advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis. J Leukoc Biol 2008; 84:1248-55; PMID:18644848; http://dx.doi.org/10.1189/jlb.1207844</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.1207844</ArticleId><ArticleId IdType="pubmed">18644848</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonifati DM, Kishore U. Role of complement in neurodegeneration and neuroinflammation. Mol Immunol 2007; 44:999-1010; PMID:16698083; http://dx.doi.org/10.1016/j.molimm.2006.03.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2006.03.007</ArticleId><ArticleId IdType="pubmed">16698083</ArticleId></ArticleIdList></Reference><Reference><Citation>Huizinga R, Linington C, Amor S. Resistance is futile: antineuronal autoimmunity in multiple sclerosis. Trends Immunol 2008; 29:54-60; PMID:18182323; http://dx.doi.org/10.1016/j.it.2007.11.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2007.11.002</ArticleId><ArticleId IdType="pubmed">18182323</ArticleId></ArticleIdList></Reference><Reference><Citation>Martino D, Giovannoni G. Antibasal ganglia antibodies and their relevance to movement disorders. Curr Opin Neurol 2004; 17:425-32; PMID:15247537; http://dx.doi.org/10.1097/01.wco.0000137532.76491.19</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.wco.0000137532.76491.19</ArticleId><ArticleId IdType="pubmed">15247537</ArticleId></ArticleIdList></Reference><Reference><Citation>Huizinga R, Hintzen RQ, Assink K, van Meurs M, Amor S. T-cell responses to neurofilament light protein are part of the normal immune repertoire. Int Immunol 2009:21:433-41; PMID:19240089; http://dx.doi.org/10.1093/intimm/dxp011</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxp011</ArticleId><ArticleId IdType="pubmed">19240089</ArticleId></ArticleIdList></Reference><Reference><Citation>Larbi A, Pawelec G, Witkowski JM, Schipper HM, Derhovanessian E, Goldeck D, Fulop T. Dramatic shifts in circulating CD4 but not CD8 T cell subsets in mild Alzheimer's disease. J Alzheimer's Dis 2009; 17:91-103; PMID:19494434</Citation><ArticleIdList><ArticleId IdType="pubmed">19494434</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantovani S, Garbelli S, Pasini A, Alimonti D, Perotti C, Melazzini M, Bendotti C, Mora G. Immune system alterations in sporadic amyotrophic lateral sclerosis patients suggest an ongoing neuroinflammatory process. J Neuroimmunol 2009; 210:73-9; PMID:19307024; http://dx.doi.org/10.1016/j.jneuroim.2009.02.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2009.02.012</ArticleId><ArticleId IdType="pubmed">19307024</ArticleId></ArticleIdList></Reference><Reference><Citation>Ankeny DP, Popovich PG. Mechanisms and implications of adaptive immune responses after traumatic spinal cord injury. Neuroscience 2009; 158:1112-21; PMID:18674593; http://dx.doi.org/10.1016/j.neuroscience.2008.07.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2008.07.001</ArticleId><ArticleId IdType="pmc">PMC2661571</ArticleId><ArticleId IdType="pubmed">18674593</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann H, Medana IM, Bauer J, Lassmann H. Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. Trends Neurosci 2002; 25:313-9; PMID:12086750; http://dx.doi.org/10.1016/S0166-2236(02)02154-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0166-2236(02)02154-9</ArticleId><ArticleId IdType="pubmed">12086750</ArticleId></ArticleIdList></Reference><Reference><Citation>Seksenyan A, Ron-Harel N, Azoulay D, Cahalon L, Cardon M, Rogeri P, Ko MK, Weil M, Bulvik S, Rechavi G, et&#xa0;al.. Thymic involution, a co&#x2010;morbidity factor in amyotrophic lateral sclerosis. J Cell Mol Med 2010; 14:2470-82; PMID:19650830; http://dx.doi.org/10.1111/j.1582-4934.2009.00863.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1582-4934.2009.00863.x</ArticleId><ArticleId IdType="pmc">PMC3823164</ArticleId><ArticleId IdType="pubmed">19650830</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohlfeld R. Neurotrophic cross-talk between the nervous and immune systems: relevance for repair strategies in multiple sclerosis? J Neurol Scie 2008; 265:93-6; PMID:17459415; http://dx.doi.org/10.1016/j.jns.2007.03.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2007.03.012</ArticleId><ArticleId IdType="pubmed">17459415</ArticleId></ArticleIdList></Reference><Reference><Citation>Jummani RR, Okun MS. SYdenham chorea. Arch Neurol 2001; 58:311-3; PMID:11176972; http://dx.doi.org/10.1001/archneur.58.2.311</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.58.2.311</ArticleId><ArticleId IdType="pubmed">11176972</ArticleId></ArticleIdList></Reference><Reference><Citation>Martino D, Tanner A, Defazio G, Church AJ, Bhatia KP, Giovannoni G, Dale RC. Tracing Sydenham's chorea: historical documents from a British paediatric hospital. Arch Dis Child 2005; 90:507-11; PMID:15851434; http://dx.doi.org/10.1136/adc.2004.057679</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/adc.2004.057679</ArticleId><ArticleId IdType="pmc">PMC1720385</ArticleId><ArticleId IdType="pubmed">15851434</ArticleId></ArticleIdList></Reference><Reference><Citation>Osler W. ON chorea and choreiform: affections. Am J Med Sci 1895; 109:316-317; http://dx.doi.org/10.1097/00000441-189503000-00011</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000441-189503000-00011</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon N. Sydenham's chorea, and its complications affecting the nervous system. Brain and Development 2009; 31:11-14; PMID:18558468; http://dx.doi.org/10.1016/j.braindev.2008.05.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.braindev.2008.05.001</ArticleId><ArticleId IdType="pubmed">18558468</ArticleId></ArticleIdList></Reference><Reference><Citation>Swedo SE, Leonard HL, Garvey M, Mittleman B, Allen AJ, Perlmutter S, Lougee L, Dow S, Zamkoff J, Dubbert BK. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry 1998; 155:264-71; PMID:9464208</Citation><ArticleIdList><ArticleId IdType="pubmed">9464208</ArticleId></ArticleIdList></Reference><Reference><Citation>Swedo SE, Leonard HL, Kiessling LS. Speculations on antineuronal antibody-mediated neuropsychiatric disorders of childhood. Pediatrics 1994; 93:323-6; PMID:8121747</Citation><ArticleIdList><ArticleId IdType="pubmed">8121747</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiessling LS, Marcotte AC, Culpepper L. Antineuronal antibodies in movement disorders. Pediatrics 1993; 92:39-43; PMID:8516083</Citation><ArticleIdList><ArticleId IdType="pubmed">8516083</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirvan CA, Swedo SE, Heuser JS, Cunningham MW. Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med 2003; 9:914-20; PMID:12819778; http://dx.doi.org/10.1038/nm892</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm892</ArticleId><ArticleId IdType="pubmed">12819778</ArticleId></ArticleIdList></Reference><Reference><Citation>Church A, Dale R, Giovannoni G. Anti-basal ganglia antibodies: a possible diagnostic utility in idiopathic movement disorders? Arch Dis Child 2004; 89:611-4; PMID:15210488; http://dx.doi.org/10.1136/adc.2003.031880</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/adc.2003.031880</ArticleId><ArticleId IdType="pmc">PMC1719969</ArticleId><ArticleId IdType="pubmed">15210488</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavone P, Bianchini R, Parano E, Incorpora G, Rizzo R, Mazzone L, Trifiletti RR. Anti-brain antibodies in PANDAS versus uncomplicated streptococcal infection. Pediatr Neurol 2004; 30:107-10; PMID:14984902; http://dx.doi.org/10.1016/S0887-8994(03)00413-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0887-8994(03)00413-2</ArticleId><ArticleId IdType="pubmed">14984902</ArticleId></ArticleIdList></Reference><Reference><Citation>Gause C, Morris C, Vernekar S, Pardo-Villamizar C, Grados MA, Singer HS. Antineuronal antibodies in OCD: comparisons in children with OCD-only, OCD+ chronic tics and OCD+ PANDAS. J Neuroimmunol 2009; 214:118-24; PMID:19628285; http://dx.doi.org/10.1016/j.jneuroim.2009.06.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2009.06.015</ArticleId><ArticleId IdType="pubmed">19628285</ArticleId></ArticleIdList></Reference><Reference><Citation>Morer A, L&#xe1;zaro L, Sabater L, Massana J, Castro J, Graus F. Antineuronal antibodies in a group of children with obsessive&#x2013;compulsive disorder and Tourette syndrome. J Psychiatr Res 2008; 42:64-8; PMID:17113107; http://dx.doi.org/10.1016/j.jpsychires.2006.09.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2006.09.010</ArticleId><ArticleId IdType="pubmed">17113107</ArticleId></ArticleIdList></Reference><Reference><Citation>Asbahr FR, Negr&#xe3;o AB, Gentil V, Zanetta DM, da Paz JA, Marques-Dias MJ, Kiss MH. Obsessive-compulsive and related symptoms in children and adolescents with rheumatic fever with and without chorea: a prospective 6-month study. Am J Psychiatry 1998; 155:1122-4; PMID:9699708; http://dx.doi.org/10.1176/ajp.155.8.1122</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/ajp.155.8.1122</ArticleId><ArticleId IdType="pubmed">9699708</ArticleId></ArticleIdList></Reference><Reference><Citation>Dale RC, Heyman I, Giovannoni G, Church AW. Incidence of anti-brain antibodies in children with obsessive&#x2013;compulsive disorder. Br J Psychiatry 2005; 187:314-9; PMID:16199788; http://dx.doi.org/10.1192/bjp.187.4.314</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjp.187.4.314</ArticleId><ArticleId IdType="pubmed">16199788</ArticleId></ArticleIdList></Reference><Reference><Citation>Leckman JF, Katsovich L, Kawikova I, Lin H, Zhang H, Kr&#xf6;nig H, Morshed S, Parveen S, Grantz H, Lombroso PJ, et&#xa0;al.. Increased serum levels of interleukin-12 and tumor necrosis factor-alpha in Tourette's syndrome. Biol Psychiatry 2005; 57:667-73; PMID:15780855; http://dx.doi.org/10.1016/j.biopsych.2004.12.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2004.12.004</ArticleId><ArticleId IdType="pubmed">15780855</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabbay V, Coffey BJ, Guttman LE, Gottlieb L, Katz Y, Babb JS, Hamamoto MM, Gonzalez CJ. A cytokine study in children and adolescents with Tourette's disorder. Progress Neuro-Psychopharmacol Biol Psychiatry 2009; 33:967-71; PMID:19427348; http://dx.doi.org/10.1016/j.pnpbp.2009.05.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pnpbp.2009.05.001</ArticleId><ArticleId IdType="pmc">PMC2770728</ArticleId><ArticleId IdType="pubmed">19427348</ArticleId></ArticleIdList></Reference><Reference><Citation>Morer A, Chae W, Henegariu O, Bothwell AL, Leckman JF, Kawikova I. Elevated expression of MCP-1, IL-2 and PTPR-N in basal ganglia of Tourette syndrome cases. Brain Behav Immun 2010; 24:1069-73; PMID:20193755; http://dx.doi.org/10.1016/j.bbi.2010.02.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2010.02.007</ArticleId><ArticleId IdType="pubmed">20193755</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng YH, Zheng Y, He F, Yang JH, Li WB, Wang ML, Cui DY, Chen Y. Detection of autoantibodies and increased concentrations of interleukins in plasma from patients with Tourette's syndrome. J Mol Neurosci 2012; 48:219-24; PMID:22638859; http://dx.doi.org/10.1007/s12031-012-9811-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-012-9811-8</ArticleId><ArticleId IdType="pubmed">22638859</ArticleId></ArticleIdList></Reference><Reference><Citation>Matz J, Krause DL, Dehning S, Riedel M, Gruber R, Schwarz MJ, M&#xfc;ller N. Altered monocyte activation markers in Tourette's syndrome: a case&#x2013;control study. BMC Psychiatry 2012; 12:29; PMID:22471395; http://dx.doi.org/10.1186/1471-244X-12-29</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-244X-12-29</ArticleId><ArticleId IdType="pmc">PMC3356225</ArticleId><ArticleId IdType="pubmed">22471395</ArticleId></ArticleIdList></Reference><Reference><Citation>Paz JA, Silva CA, Marques-Dias MJ. Randomized double-blind study with prednisone in Sydenham's chorea. Pediatr Neurol 2006; 34:264-9; PMID:16638499; http://dx.doi.org/10.1016/j.pediatrneurol.2005.08.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pediatrneurol.2005.08.028</ArticleId><ArticleId IdType="pubmed">16638499</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker AR, Tani LY, Thompson JA, Firth SD, Veasy LG, Bale JF Jr. Rheumatic chorea: relationship to systemic manifestations and response to corticosteroids. J Pediatr 2007; 151:679-83; PMID:18035153; http://dx.doi.org/10.1016/j.jpeds.2007.04.059</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2007.04.059</ArticleId><ArticleId IdType="pubmed">18035153</ArticleId></ArticleIdList></Reference><Reference><Citation>Fusco C, Ucchino V, Frattini D, Pisani F, Della Giustina E. Acute and chronic corticosteroid treatment of ten patients with paralytic form of Sydenham's chorea. Eur J Paediatr Neurol 2012; 16:373-8; PMID:22197452; http://dx.doi.org/10.1016/j.ejpn.2011.12.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejpn.2011.12.005</ArticleId><ArticleId IdType="pubmed">22197452</ArticleId></ArticleIdList></Reference><Reference><Citation>Garvey MA, Snider LA, Leitman SF, Werden R, Swedo SE. Treatment of Sydenham's chorea with intravenous immunoglobulin, plasma exchange, or prednisone. J Child Neurol 2005; 20:424-9; PMID:15968928; http://dx.doi.org/10.1177/08830738050200050601</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/08830738050200050601</ArticleId><ArticleId IdType="pubmed">15968928</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Immerzeel TD, Van Gilst RM, Hartwig NG. Beneficial use of immunoglobulins in the treatment of Sydenham chorea. Eur J Pediatr 2010; 169:1151-4; PMID:20349351; http://dx.doi.org/10.1007/s00431-010-1172-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-010-1172-0</ArticleId><ArticleId IdType="pmc">PMC2908459</ArticleId><ArticleId IdType="pubmed">20349351</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker K, Brink A, Lawrenson J, Mathiassen W, Wilmshurst JM. Treatment of sydenham chorea with intravenous immunoglobulin. J Child Neurol 2012; 27:147-55; PMID:21868369; http://dx.doi.org/10.1177/0883073811414058</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0883073811414058</ArticleId><ArticleId IdType="pubmed">21868369</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortese I, Chaudhry V, So YT, Cantor F, Cornblath DR, Rae-Grant A. Evidence-based guideline update: plasmapheresis in neurologic disorders: report of the therapeutics and technology assessment subcommittee of the american academy of neurology. Neurology 2011; 76:294-300; PMID:21242498; http://dx.doi.org/10.1212/WNL.0b013e318207b1f6</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e318207b1f6</ArticleId><ArticleId IdType="pmc">PMC3034395</ArticleId><ArticleId IdType="pubmed">21242498</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlmutter SJ, Leitman SF, Garvey MA, Hamburger S, Feldman E, Leonard HL, Swedo SE. Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet 1999; 354:1153-8; PMID:10513708; http://dx.doi.org/10.1016/S0140-6736(98)12297-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(98)12297-3</ArticleId><ArticleId IdType="pubmed">10513708</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolson R, Swedo SE, Lenane M, Bedwell J, Wudarsky M, Gochman P. An open trial of plasma exchange in childhood-onset obsessive-compulsive disorder without poststreptococcal exacerbations. J Am Acad Child Adolesc Psychiatry 2000; 39:1313-5; PMID:11026187; http://dx.doi.org/10.1097/00004583-200010000-00020</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00004583-200010000-00020</ArticleId><ArticleId IdType="pubmed">11026187</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen AJ, Leonard HL, Swedo SE. Case study: a new infection-triggered, autoimmune subtype of pediatric OCD and Tourette's syndrome. J Am Acad Child Adolesc Psychiatry 1995; 34:307-11; PMID:7896671; http://dx.doi.org/10.1097/00004583-199503000-00015</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00004583-199503000-00015</ArticleId><ArticleId IdType="pubmed">7896671</ArticleId></ArticleIdList></Reference><Reference><Citation>Giedd JN, Rapoport JL, Leonard HL, Richter D, Swedo SE. Case study: acute basal ganglia enlargement and obsessive-compulsive symptoms in an adolescent boy. J Am Acad Child Adolesc Psychiatry 1996; 35:913-5; PMID:8768351; http://dx.doi.org/10.1097/00004583-199607000-00017</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00004583-199607000-00017</ArticleId><ArticleId IdType="pubmed">8768351</ArticleId></ArticleIdList></Reference><Reference><Citation>Zykov V, Shcherbina AY, Novikova EB, Shvabrina TV. Neuroimmune aspects of the pathogenesis of Tourette's syndrome and experience in the use of immunoglobulins in children. Neurosci Behav Physiol 2009; 39:635-8; PMID:19621268; http://dx.doi.org/10.1007/s11055-009-9184-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11055-009-9184-9</ArticleId><ArticleId IdType="pubmed">19621268</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoekstra PJ, Minderaa RB, Kallenberg C. Lack of effect of intravenous immunoglobulins on tics: a double-blind placebo-controlled study. J Clin Psychiatry 2004; 65:537-42; PMID:15119917; http://dx.doi.org/10.4088/JCP.v65n0413</Citation><ArticleIdList><ArticleId IdType="doi">10.4088/JCP.v65n0413</ArticleId><ArticleId IdType="pubmed">15119917</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller N. Anti-inflammatory therapy with a COX-2 inhibitor in Tourette's syndrome. Inflammopharmacology 2004; 12:271-5; PMID:15527551; http://dx.doi.org/10.1163/1568560042342338</Citation><ArticleIdList><ArticleId IdType="doi">10.1163/1568560042342338</ArticleId><ArticleId IdType="pubmed">15527551</ArticleId></ArticleIdList></Reference><Reference><Citation>Dale RC, Yin K, Ding A, Merheb V, Varadkhar S, McKay D, Singh-Grewal D, Brilot F. Antibody binding to neuronal surface in movement disorders associated with lupus and antiphospholipid antibodies. Dev Med Child Neurol 2011; 53:522-8; PMID:21574989; http://dx.doi.org/10.1111/j.1469-8749.2011.03922.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-8749.2011.03922.x</ArticleId><ArticleId IdType="pubmed">21574989</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso S, Antenora A, De Rosa A, Roca A, Maddaluno G, Brescia Morra V, De Michele G. Antiphospholipid-related chorea. Front Neurol 2012; 3:150; PMID:23097646; http://dx.doi.org/10.3389/fneur.2012.00150</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2012.00150</ArticleId><ArticleId IdType="pmc">PMC3477765</ArticleId><ArticleId IdType="pubmed">23097646</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazurova I, Macejova Z, Benhatchi K, Oetterov&#xe1; M, Antolov&#xe1; E, Asherson RA, Rovensky J. Efficacy of intravenous immunoglobulin treatment in lupus erythematosus chorea. Clin Rheumatol 2007; 26:2145-7; PMID:17487450; http://dx.doi.org/10.1007/s10067-007-0627-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-007-0627-9</ArticleId><ArticleId IdType="pubmed">17487450</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertsias G, Ioannidis JP, Aringer M, Bollen E, Bombardieri S, Bruce IN, Cervera R, Dalakas M, Doria A, Hanly JG, et&#xa0;al.. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis 2010; 69:2074-82; PMID:20724309; http://dx.doi.org/10.1136/ard.2010.130476</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.2010.130476</ArticleId><ArticleId IdType="pubmed">20724309</ArticleId></ArticleIdList></Reference><Reference><Citation>Brogna C, Mariotti P, Manna R. Conventional and intravenous immunoglobulin therapy in paediatric antiphospholipid antibodies-related chorea. Lupus 2014; 23:1449-51; PMID:25237169; http://dx.doi.org/10.1177/0961203314551084</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203314551084</ArticleId><ArticleId IdType="pubmed">25237169</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandvig I, Barlinn J, Nedregaard B. Skjeldal OH An important differential diagnosis of acute neurological disease. Eur J Paediatr Neurol 2015; 19:211-7; PMID:25596063; http://dx.doi.org/10.1016/j.ejpn.2014.12.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejpn.2014.12.004</ArticleId><ArticleId IdType="pubmed">25596063</ArticleId></ArticleIdList></Reference><Reference><Citation>Brinar VV, Habek M. Monophasic acute, recurrent, and multiphasic disseminated encephalomyelitis and multiple sclerosis. Arch Neurol 2008; 65:672-7; PMID:18474748; http://dx.doi.org/10.1001/archneur.65.5.675</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.65.5.675</ArticleId><ArticleId IdType="pubmed">18474750</ArticleId></ArticleIdList></Reference><Reference><Citation>Wingerchuk DM, Lucchinetti CF. Comparative immunopathogenesis of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis. Curr Opin Neurol 2007; 20:343-50; PMID:17495631; http://dx.doi.org/10.1097/WCO.0b013e3280be58d8</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0b013e3280be58d8</ArticleId><ArticleId IdType="pubmed">17495631</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishizu T, Minohara M, Ichiyama T, Kira R, Tanaka M, Osoegawa M, Hara T, Furukawa S, Kira J. CSF cytokine and chemokine profiles in acute disseminated encephalomyelitis. J Neuroimmunol 2006; 175:52-8; PMID:16697050; http://dx.doi.org/10.1016/j.jneuroim.2006.03.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2006.03.020</ArticleId><ArticleId IdType="pubmed">16697050</ArticleId></ArticleIdList></Reference><Reference><Citation>Javed A, Khan O. Acute disseminated encephalomyelitis. Handb Clin Neurol 2014; 123:705-17; PMID:25015513</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7151857</ArticleId><ArticleId IdType="pubmed">25015513</ArticleId></ArticleIdList></Reference><Reference><Citation>Anlar B, Basaran C, Kose G, Guven A, Haspolat S, Yakut A, Serdaroglu A, Senbil N, Tan H, Karaagaoglu E, et&#xa0;al.. Acute disseminated encephalomyelitis in children: outcome and prognosis. Neuropediatrics 2003; 34:194-9; PMID:12973660; http://dx.doi.org/10.1055/s-2003-42208</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2003-42208</ArticleId><ArticleId IdType="pubmed">12973660</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander M, Murthy J. Acute disseminated encephalomyelitis: Treatment guidelines. Ann Indian Acad Neurol 2011; 14:S60; PMID:21847331; http://dx.doi.org/10.4103/0972-2327.83095</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0972-2327.83095</ArticleId><ArticleId IdType="pmc">PMC3152158</ArticleId><ArticleId IdType="pubmed">21847331</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishikawa M, Ichiyama T, Hayashi T, Ouchi K, Furukawa S. Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis. Pediatr Neurol 1999; 21:583-6; PMID:10465150; http://dx.doi.org/10.1016/S0887-8994(99)00042-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0887-8994(99)00042-9</ArticleId><ArticleId IdType="pubmed">10465150</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradhan S, Gupta RP, Shashank S, Pandey N. Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis. J Neurol Sci 1999; 165:56-61; PMID:10426148; http://dx.doi.org/10.1016/S0022-510X(99)00072-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(99)00072-6</ArticleId><ArticleId IdType="pubmed">10426148</ArticleId></ArticleIdList></Reference><Reference><Citation>Feasby T, Banwell B, Benstead T, Bril V, Brouwers M, Freedman M, Hahn A, Hume H, Freedman J, Pi D, et&#xa0;al.. Guidelines on the use of intravenous immune globulin for neurologic conditions. Transfus Med Rev 2007; 21:S57-107; PMID:17397768; http://dx.doi.org/10.1016/j.tmrv.2007.01.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tmrv.2007.01.002</ArticleId><ArticleId IdType="pubmed">17397768</ArticleId></ArticleIdList></Reference><Reference><Citation>Imataka G, Arisaka O. An infant with steroid-refractory cytomegalovirus-associated ADEM who responded to immunoglobulin therapy. Eur Rev Med Pharmacol Sci 2014; 18:2148-51; PMID:25070820</Citation><ArticleIdList><ArticleId IdType="pubmed">25070820</ArticleId></ArticleIdList></Reference><Reference><Citation>Hahn JS, Siegler DJ, Enzmann D. Intravenous gammaglobulin therapy in recurrent acute disseminated encephalomyelitis. Neurology 1996; 46:1173-4; PMID:8780119; http://dx.doi.org/10.1212/WNL.46.4.1173</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.46.4.1173</ArticleId><ArticleId IdType="pubmed">8780119</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariotti P, Batocchi AP, Colosimo C, Lo Monaco M, Caggiula M, Colitto F, Tonali PA, Guzzetta F. Multiphasic demyelinating disease involving central and peripheral nervous system in a child. Neurology 2003; 60:348-9; PMID:12552065; http://dx.doi.org/10.1212/01.WNL.0000044051.79305.DD</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000044051.79305.DD</ArticleId><ArticleId IdType="pubmed">12552065</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanter D, Horensky D, Sperling RA, Kaplan JD, Malachowski ME, Churchill WH Jr. Plasmapheresis in fulminant acute disseminated encephalomyelitis. Neurology 1995; 45:824-7; PMID:7723979; http://dx.doi.org/10.1212/WNL.45.4.824</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.45.4.824</ArticleId><ArticleId IdType="pubmed">7723979</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinshenker BG, O'Brien PC, Petterson TM, Noseworthy JH, Lucchinetti CF, Dodick DW, Pineda AA, Stevens LN, Rodriguez M. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol 1999; 46:878-86; PMID:10589540; http://dx.doi.org/10.1002/1531-8249(199912)46:6%3c878::AID-ANA10%3e3.0.CO;2-Q</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1531-8249(199912)46:6%3c878::AID-ANA10%3e3.0.CO;2-Q</ArticleId><ArticleId IdType="pubmed">10589540</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinshenker BG. Plasma exchange for severe attacks of inflammatory demyelinating diseases of the central nervous system. J Clin Apher 2001; 16:39-42; PMID:11309833; http://dx.doi.org/10.1002/jca.1010</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jca.1010</ArticleId><ArticleId IdType="pubmed">11309833</ArticleId></ArticleIdList></Reference><Reference><Citation>Keegan M, Pineda AA, McClelland RL, Darby CH, Rodriguez M, Weinshenker BG. Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology 2002; 58(1):143-6; PMID:11781423; http://dx.doi.org/10.1212/WNL.58.1.143</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.58.1.143</ArticleId><ArticleId IdType="pubmed">11781423</ArticleId></ArticleIdList></Reference><Reference><Citation>Llufriu S, Castillo J, Blanco Y, Rami&#xf3;-Torrent&#xe0; L, R&#xed;o J, Vall&#xe8;s M, Lozano M, Castell&#xe0; MD, Calabia J, Horga A, et&#xa0;al.. Plasma exchange for acute attacks of CNS demyelination Predictors of improvement at 6 months. Neurology 2009; 73:949-53; PMID:19770470; http://dx.doi.org/10.1212/WNL.0b013e3181b879be</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181b879be</ArticleId><ArticleId IdType="pubmed">19770470</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunot S, Vukusic S, Fromont A, Couvreur G, Mousson C, Giroud M, Confavreux C, Moreau T. [Plasma exchanges in severe and acute inflammatory demyelinating attacks of the central nervous system]. Presse Med 2011; 40:e271-8; PMID:21353760; http://dx.doi.org/10.1016/j.lpm.2010.11.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lpm.2010.11.022</ArticleId><ArticleId IdType="pubmed">21353760</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyazawa R, Hikima A, Takano Y, Arakawa H, Tomomasa T, Morikawa A. Plasmapheresis in fulminant acute disseminated encephalomyelitis. Brain Dev 2001; 23:424-6; PMID:11578855; http://dx.doi.org/10.1016/S0387-7604(01)00256-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0387-7604(01)00256-X</ArticleId><ArticleId IdType="pubmed">11578855</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennetto L, Totham A, Healy P, Massey E, Scolding N. Plasma exchange in episodes of severe inflammatory demyelination of the central nervous system. A report of six cases. J Neurol 2004; 251:1515-21; PMID:15645353; http://dx.doi.org/10.1007/s00415-004-0588-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-004-0588-8</ArticleId><ArticleId IdType="pubmed">15645353</ArticleId></ArticleIdList></Reference><Reference><Citation>RamachandranNair R, Parameswaran M, Girija A. Acute disseminated encephalomyelitis treated with plasmapheresis. Singapore Med J 2005; 46:561; PMID:16172778</Citation><ArticleIdList><ArticleId IdType="pubmed">16172778</ArticleId></ArticleIdList></Reference><Reference><Citation>Khurana DS, Melvin JJ, Kothare SV, Valencia I, Hardison HH, Yum S, Faerber EN, Legido A. Acute disseminated encephalomyelitis in children: discordant neurologic and neuroimaging abnormalities and response to plasmapheresis. Pediatrics 2005; 116:431-6; PMID:16061599; http://dx.doi.org/10.1542/peds.2004-2038</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2004-2038</ArticleId><ArticleId IdType="pubmed">16061599</ArticleId></ArticleIdList></Reference><Reference><Citation>Koziolek M, M&#xfc;hlhausen J, Friede T, Ellenberger D, Sigler M, Huppke B, G&#xe4;rtner J, M&#xfc;ller GA, Huppke P. Therapeutic apheresis in pediatric patients with acute CNS inflammatory demyelinating disease. Blood Purif 2013; 36:92-7; PMID:24021839</Citation><ArticleIdList><ArticleId IdType="pubmed">24021839</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarz S, Mohr A, Knauth M, Wildemann B, Storch-Hagenlocher B. Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients. Neurology 2001; 56:1313-8; PMID:11376180; http://dx.doi.org/10.1212/WNL.56.10.1313</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.56.10.1313</ArticleId><ArticleId IdType="pubmed">11376180</ArticleId></ArticleIdList></Reference><Reference><Citation>Waldman A, Ghezzi A, Bar-Or A, Mikaeloff Y, Tardieu M, Banwell B. Multiple sclerosis in children: an update on clinical diagnosis, therapeutic strategies, and research. Lancet Neurol 2014; 13:936-48; PMID:25142460; http://dx.doi.org/10.1016/S1474-4422(14)70093-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70093-6</ArticleId><ArticleId IdType="pmc">PMC4443918</ArticleId><ArticleId IdType="pubmed">25142460</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh EA, Chitnis T, Krupp L, Ness J, Chabas D, Kuntz N, Waubant E; US Network of Pediatric Multiple Sclerosis Centers of Excellence . Pediatric multiple sclerosis. Nat Revi Neurol 2009; 5:621-31; PMID:19826402; http://dx.doi.org/10.1038/nrneurol.2009.158</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2009.158</ArticleId><ArticleId IdType="pubmed">19826402</ArticleId></ArticleIdList></Reference><Reference><Citation>Spalice A, Parisi P, Papetti L, Nicita F, Ursitti F, Del Balzo F, Properzi E, Verrotti A, Ruggieri M, Iannetti P. Clinical and pharmacological aspects of inflammatory demyelinating diseases in childhood: an update. Curr Neuropharmacol 2010; 8:135-48; PMID:21119885; http://dx.doi.org/10.2174/157015910791233141</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/157015910791233141</ArticleId><ArticleId IdType="pmc">PMC2923368</ArticleId><ArticleId IdType="pubmed">21119885</ArticleId></ArticleIdList></Reference><Reference><Citation>Narula S, Banwell B. Treatment of multiple sclerosis in children and its challenges. Presse Med; 2015; 44(4 Pt 2):e153-8; http://dx.doi.org/10.1016/j.lpm.2014.10.018; Epub 2015 Mar 3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lpm.2014.10.018</ArticleId><ArticleId IdType="pubmed">25744946</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemmer B, Nessler S, Zhou D, Kieseier B, Hartung HP. Immunopathogenesis and immunotherapy of multiple sclerosis. Nat Clin Pract Neurol 2006; 2:201-11; PMID:16932551; http://dx.doi.org/10.1038/ncpneuro0154</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncpneuro0154</ArticleId><ArticleId IdType="pubmed">16932551</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombo M, Dono M, Gazzola P, Roncella S, Valetto A, Chiorazzi N, Mancardi GL, Ferrarini M. Accumulation of clonally related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients. J Immunol 2000; 164:2782-9; PMID:10679121; http://dx.doi.org/10.4049/jimmunol.164.5.2782</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.164.5.2782</ArticleId><ArticleId IdType="pubmed">10679121</ArticleId></ArticleIdList></Reference><Reference><Citation>Chabas D, Green AJ, Waubant E. Pediatric multiple sclerosis. NeuroRx 2006; 3(2):264-75; PMID:16554264; http://dx.doi.org/10.1016/j.nurx.2006.01.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nurx.2006.01.011</ArticleId><ArticleId IdType="pmc">PMC3593440</ArticleId><ArticleId IdType="pubmed">16554264</ArticleId></ArticleIdList></Reference><Reference><Citation>Chitnis T, Green AJ, Waubant E. Consensus statement: evaluation of new and existing therapeutics for pediatric multiple sclerosis. Mult Scler J 2012; 18:116-27; PMID:22146610; http://dx.doi.org/10.1177/1352458511430704</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1352458511430704</ArticleId><ArticleId IdType="pubmed">22146610</ArticleId></ArticleIdList></Reference><Reference><Citation>Iannetti P, Marciani MG, Spalice A, Spanedda F, Raucci U, Trasimeni G, Gualdi GF, Bernardi G. Primary CNS demyelinating diseases in childhood: multiple sclerosis. Childs Nerv Syst 1996; 12:149-54; PMID:8697458; http://dx.doi.org/10.1007/BF00266819</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00266819</ArticleId><ArticleId IdType="pubmed">8697458</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh EA, Waubant E, Krupp LB, Ness J, Chitnis T, Kuntz N, Ramanathan M, Belman A, Chabas D, Gorman MP, et&#xa0;al.. Multiple sclerosis therapies in pediatric patients with refractory multiple sclerosis. Arch Neurol 2011; 68(4):437-44; PMID:21149803; http://dx.doi.org/10.1001/archneurol.2010.325</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2010.325</ArticleId><ArticleId IdType="pubmed">21149803</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston J, So TY. First-line disease-modifying therapies in paediatric multiple sclerosis. Drugs 2012; 72:1195-211; PMID:22642799; http://dx.doi.org/10.2165/11634010-000000000-00000</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/11634010-000000000-00000</ArticleId><ArticleId IdType="pubmed">22642799</ArticleId></ArticleIdList></Reference><Reference><Citation>Marriott JJ, Miyasaki JM, Gronseth G, O'Connor PW. Evidence report: the efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis report of the therapeutics and technology assessment subcommittee of the American academy of neurology. Neurology 2010; 74:1463-70; PMID:20439849; http://dx.doi.org/10.1212/WNL.0b013e3181dc1ae0</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181dc1ae0</ArticleId><ArticleId IdType="pmc">PMC2871006</ArticleId><ArticleId IdType="pubmed">20439849</ArticleId></ArticleIdList></Reference><Reference><Citation>Kornek B, Bernert G, Rostasy K, Mlczoch E, Feucht M, Prayer D, Vass K, Seidl R. Long-term follow-up of pediatric patients treated with mitoxantrone for multiple sclerosis. Neuropediatrics 2011; 42:7-12; PMID:21557144; http://dx.doi.org/10.1055/s-0031-1275345</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0031-1275345</ArticleId><ArticleId IdType="pubmed">21557144</ArticleId></ArticleIdList></Reference><Reference><Citation>Etemadifar M, Afzali P, Abtahi SH, Ramagopalan SV, Nourian SM, Murray RT, Fereidan-Esfahani M. Safety and efficacy of mitoxantrone in pediatric patients with aggressive multiple sclerosis. Eur J Paediatr Neurol 2014; 18:119-25; PMID:24139067; http://dx.doi.org/10.1016/j.ejpn.2013.09.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejpn.2013.09.001</ArticleId><ArticleId IdType="pubmed">24139067</ArticleId></ArticleIdList></Reference><Reference><Citation>Makhani N, Gorman MP, Branson HM, Stazzone L, Banwell BL, Chitnis T. Cyclophosphamide therapy in pediatric multiple sclerosis. Neurology 2009; 72:2076-82; PMID:19439723; http://dx.doi.org/10.1212/WNL.0b013e3181a8164c</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181a8164c</ArticleId><ArticleId IdType="pmc">PMC2923592</ArticleId><ArticleId IdType="pubmed">19439723</ArticleId></ArticleIdList></Reference><Reference><Citation>Huppke P, Stark W, Z&#xfc;rcher C, Huppke B, Br&#xfc;ck W, G&#xe4;rtner J. Natalizumab use in pediatric multiple sclerosis. Arch Neurol 2008; 65:1655-8; PMID:19064754; http://dx.doi.org/10.1001/archneur.65.12.1655</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.65.12.1655</ArticleId><ArticleId IdType="pubmed">19064754</ArticleId></ArticleIdList></Reference><Reference><Citation>Borriello G, Prosperini L, Luchetti A, Pozzilli C. Natalizumab treatment in pediatric multiple sclerosis: a case report. Eur J Paediatr Neurol 2009; 13:67-71; PMID:18406645; http://dx.doi.org/10.1016/j.ejpn.2008.01.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejpn.2008.01.007</ArticleId><ArticleId IdType="pubmed">18406645</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghezzi A, Pozzilli C, Grimaldi LM, Brescia Morra V, Bortolon F, Capra R, Filippi M, Moiola L, Rocca MA, Rottoli M, et&#xa0;al.. Safety and efficacy of natalizumab in children with multiple sclerosis. Neurology 2010; 75:912-7; PMID:20820002; http://dx.doi.org/10.1212/WNL.0b013e3181f11daf</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181f11daf</ArticleId><ArticleId IdType="pubmed">20820002</ArticleId></ArticleIdList></Reference><Reference><Citation>Torisu H, Hara T. [Clinical features of pediatric multiple sclerosis: epidemiology and treatment]. Nihon Rinsho 2014; 72:2061-6; PMID:25518393</Citation><ArticleIdList><ArticleId IdType="pubmed">25518393</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh EA, Weinstock-Guttman B. Natalizumab in pediatric multiple sclerosis patients. Ther Adv Neurol disorders 2010; 3:293-9; PMID:21179619; http://dx.doi.org/10.1177/1756285610381526</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1756285610381526</ArticleId><ArticleId IdType="pmc">PMC3002661</ArticleId><ArticleId IdType="pubmed">21179619</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloomgren G, Richman S, Hotermans C, Subramanyam M, Goelz S, Natarajan A, Lee S, Plavina T, Scanlon JV, Sandrock A, et&#xa0;al.. Risk of natalizumab-associated progressive multifocal leukoencephalopathy. N Engl J Med 2012; 366:1870-80; PMID:22591293; http://dx.doi.org/10.1056/NEJMoa1107829</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1107829</ArticleId><ArticleId IdType="pubmed">22591293</ArticleId></ArticleIdList></Reference><Reference><Citation>Zettl UK, St&#xfc;ve O, Patejdl R. Immune-mediated CNS diseases: a review on nosological classification and clinical features. Autoimmun Rev 2012; 11:167-73; PMID:21619943; http://dx.doi.org/10.1016/j.autrev.2011.05.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2011.05.008</ArticleId><ArticleId IdType="pubmed">21619943</ArticleId></ArticleIdList></Reference><Reference><Citation>Absoud M, Lim MJ, Appleton R, Jacob A3, Kitley J, Leite MI, Pike MG, Vincent A, Wassmer E, Waters P, Woodhall M, Hemingway C, Palace J.. Paediatric neuromyelitis optica: clinical, MRI of the brain and prognostic features. J Neurol Neurosurg Psychiatry 2015; 86(4):470-2; http://dx.doi.org/10.1136/jnnp-2014-308550; Epub 2014 Aug 4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2014-308550</ArticleId><ArticleId IdType="pubmed">25091363</ArticleId></ArticleIdList></Reference><Reference><Citation>Cree BA, Lamb S, Morgan K, Chen A, Waubant E, Genain C. An open label study of the effects of rituximab in neuromyelitis optica. Neurology 2005; 64:1270-2; PMID:15824362; http://dx.doi.org/10.1212/01.WNL.0000159399.81861.D5</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000159399.81861.D5</ArticleId><ArticleId IdType="pubmed">15824362</ArticleId></ArticleIdList></Reference><Reference><Citation>Cree B. Acute inflammatory myelopathies. Handbook Clin Neurol 2013; 122:613-67</Citation><ArticleIdList><ArticleId IdType="pubmed">24507538</ArticleId></ArticleIdList></Reference><Reference><Citation>Longoni G, Banwell B, Filippi M, Yeh EA. Rituximab as a first-line preventive treatment in pediatric NMOSDs: Preliminary results in 5 children. Neurol Neuroimmunol Neuroinflamm 2014; 1:e46; PMID:25520954; http://dx.doi.org/10.1212/NXI.0000000000000046</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000046</ArticleId><ArticleId IdType="pmc">PMC4268036</ArticleId><ArticleId IdType="pubmed">25520954</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabre P, Olindo S, Marignier R, Jeannin S, Merle H, Smadja D; Aegis of French National Observatory of Multiple Sclerosis . Efficacy of mitoxantrone in neuromyelitis optica spectrum: clinical and neuroradiological study. J Neurol Neurosurg Psychiatry 2013; 84:511-6; PMID:23138769; http://dx.doi.org/10.1136/jnnp-2012-303121</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2012-303121</ArticleId><ArticleId IdType="pubmed">23138769</ArticleId></ArticleIdList></Reference><Reference><Citation>Papeix C, Vidal JS, de Seze J, Pierrot-Deseilligny C, Tourbah A, Stankoff B, Lebrun C, Moreau T, Vermersch P, Fontaine B, et&#xa0;al.. Immunosuppressive therapy is more effective than interferon in neuromyelitis optica. Mult Scler 2007; 13:256-9; PMID:17439893; http://dx.doi.org/10.1177/1352458506070732</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1352458506070732</ArticleId><ArticleId IdType="pubmed">17439893</ArticleId></ArticleIdList></Reference><Reference><Citation>Winer J. An Update in Guillain-Barr&#xe9; Syndrome. Autoimmune Dis 2014; 2014:793024; PMID:24511391; http://dx.doi.org/10.1155/2014/793024</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/793024</ArticleId><ArticleId IdType="pmc">PMC3910670</ArticleId><ArticleId IdType="pubmed">24511391</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartung HP, Willison HJ, Kieseier BC. Acute immunoinflammatory neuropathy: update on Guillain-Barr&#xe9; syndrome. Curr Opin Neurol 2002; 15:571-7; PMID:12352001; http://dx.doi.org/10.1097/00019052-200210000-00008</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00019052-200210000-00008</ArticleId><ArticleId IdType="pubmed">12352001</ArticleId></ArticleIdList></Reference><Reference><Citation>Group G.B.S.S.T Double-blind trial of intravenous methylprednisolone in Guillain-Barr&#xe9; syndrome. Lancet 1993; 341:586-90; PMID:8094828</Citation><ArticleIdList><ArticleId IdType="pubmed">8094828</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes RA, van Doorn PA. Corticosteroids for Guillain-Barre syndrome. Cochrane Database Syst Rev 2012; 8:Cd001446; PMID:22895921</Citation><ArticleIdList><ArticleId IdType="pubmed">22895921</ArticleId></ArticleIdList></Reference><Reference><Citation>Mark B, et&#xa0;al.. Plasmapheresis in idiopathic inflammatory polyradiculoneuropathy. in Waubant. 1980. LIPPINCOTT-RAVEN PUBL 227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106.</Citation></Reference><Reference><Citation>Schooneman F, et&#xa0;al.. Plasma exchange in Guillain-Barr&#xe9; syndrome: Ten cases. Plasma Ther 1981; 2:117-21</Citation></Reference><Reference><Citation>Valbonesi M. Garelli S, Mosconi L, Zerbi D, Celano I.. Plasma Exchange as a Therapy for Guillain&#x2010;Barr&#xe9; Syndrome with Immune Complexes. Vox Sang 1981; 41:74-8; PMID:7331282; http://dx.doi.org/10.1111/j.1423-0410.1981.tb01017.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1423-0410.1981.tb01017.x</ArticleId><ArticleId IdType="pubmed">7331282</ArticleId></ArticleIdList></Reference><Reference><Citation>The Guillain-Barre syndrome Study Group Plasmapheresis and acute Guillain-Barre syndrome. Neurology 1985; 35:1096-104; PMID:4022342; http://dx.doi.org/10.1212/WNL.35.8.1096</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.35.8.1096</ArticleId><ArticleId IdType="pubmed">4022342</ArticleId></ArticleIdList></Reference><Reference><Citation>McKhann G, Griffin JW, Cornblath DR, Mellits ED, Fisher RS, Quaskey SA. Plasmapheresis and guillain&#x2010;barr&#xe9; syndrome: Analysis of prognostic factors and the effect of plasmapheresis. Ann Neurol 1988; 23:347-53; PMID:3382169; http://dx.doi.org/10.1002/ana.410230406</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410230406</ArticleId><ArticleId IdType="pubmed">3382169</ArticleId></ArticleIdList></Reference><Reference><Citation>Van der Mech&#xe9; F, Schmitz P. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barr&#xe9; syndrome. N Engl J Med 1992; 326:1123-9; PMID:1552913; http://dx.doi.org/10.1056/NEJM199204233261705</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199204233261705</ArticleId><ArticleId IdType="pubmed">1552913</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravasio A, Pasquinelli M, Curr&#x222b; Dossi B, Neri W, Guidi C, Gessaroli M, Rasi F, Fabbri R, Mazzini G, et&#xa0;al.. High dose intravenous immune globulins and plasma exchange in Guillain-Barre Syndrome. Ital J Neurol Sci 1995; 16:487-92; PMID:8749707; http://dx.doi.org/10.1007/BF02229327</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02229327</ArticleId><ArticleId IdType="pubmed">8749707</ArticleId></ArticleIdList></Reference><Reference><Citation>Latov N. Practice parameter: immunotherapy for Guillain-Barr&#xe9; syndrome: report of the quality standards subcommittee of the American academy of neurology. Neurology 2004; 62:1653-4; PMID:15136711; http://dx.doi.org/10.1212/WNL.62.9.1653-a</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.62.9.1653-a</ArticleId><ArticleId IdType="pubmed">15136711</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;rses N, Uysal S, Cetinkaya F, I&#x15f;lek I, Kalayci AG. Intravenous immunoglobulin treatment in children with Guillain-Barr&#xe9; syndrome. Scand J Infect Dis 1995; 27:241-3; PMID:8539548; http://dx.doi.org/10.3109/00365549509019016</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00365549509019016</ArticleId><ArticleId IdType="pubmed">8539548</ArticleId></ArticleIdList></Reference><Reference><Citation>Singhi SC, Jayshree M, Singhi P, Banerjee S, Prabhakar S. Intravenous immunoglobulin in very severe childhood Guillain-Barre syndrome. Ann Trop Paediatr 1999; 19:167-74; PMID:10690257; http://dx.doi.org/10.1080/02724939992491</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02724939992491</ArticleId><ArticleId IdType="pubmed">10690257</ArticleId></ArticleIdList></Reference><Reference><Citation>Korinthenberg R, Schessl J, Kirschner J, M&#xf6;nting JS. Intravenously administered immunoglobulin in the treatment of childhood Guillain-Barre syndrome: a randomized trial. Pediatrics 2005; 116:8-14; PMID:15995024; http://dx.doi.org/10.1542/peds.2004-1324</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2004-1324</ArticleId><ArticleId IdType="pubmed">15995024</ArticleId></ArticleIdList></Reference><Reference><Citation>Abd-Allah SA, Jansen PW, Ashwal S, Perkin RM. Intravenous immunoglobulin as therapy for pediatric Guillain-Barre syndrome. J Child Neurol 1997; 12:376-80; PMID:9309521; http://dx.doi.org/10.1177/088307389701200607</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/088307389701200607</ArticleId><ArticleId IdType="pubmed">9309521</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Bayoumi MA, El-Refaey AM, Abdelkader AM, El-Assmy MM, Alwakeel AA, El-Tahan HM. Comparison of intravenous immunoglobulin and plasma exchange in treatment of mechanically ventilated children with Guillain Barre syndrome: a randomized study. Crit Care 2011; 15:R164; PMID:21745374; http://dx.doi.org/10.1186/cc10305</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc10305</ArticleId><ArticleId IdType="pmc">PMC3387601</ArticleId><ArticleId IdType="pubmed">21745374</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes RA, Pritchard J, Hadden RD. Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain&#x2010;Barr&#xe9; syndrome. Cochrane Library 2013; 2:CD008630; PMID:23450584</Citation><ArticleIdList><ArticleId IdType="pubmed">23450584</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Doorn PA. Treatment of Guillain&#x2010;Barr&#xe9; syndrome and CIDP. J Peripher Nerv Sys 2005; 10:113-27; PMID:15958124; http://dx.doi.org/10.1111/j.1085-9489.2005.0010203.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1085-9489.2005.0010203.x</ArticleId><ArticleId IdType="pubmed">15958124</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36823666</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>27</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1750-1172</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>23</Day></PubDate></JournalIssue><Title>Orphanet journal of rare diseases</Title><ISOAbbreviation>Orphanet J Rare Dis</ISOAbbreviation></Journal><ArticleTitle>Lung function decline preceding chronic respiratory failure in spinal muscular atrophy: a national prospective cohort study.</ArticleTitle><Pagination><StartPage>40</StartPage><MedlinePgn>40</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">40</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13023-023-02634-4</ELocationID><Abstract><AbstractText Label="BACKGROUND">Progressive lung function decline, resulting in respiratory failure, is an important complication of spinal muscular atrophy (SMA). The ability to predict the need for mechanical ventilation is important. We assessed longitudinal patterns of lung function prior to chronic respiratory failure in a national cohort of treatment-na&#xef;ve children and adults with SMA, hypothesizing an accelerated decline prior to chronic respiratory failure.</AbstractText><AbstractText Label="METHODS">We included treatment-na&#xef;ve SMA patients participating in a prospective national cohort study if they required mechanical ventilation because of chronic respiratory failure and if lung function test results were available from the years prior to initiation of ventilation. We analyzed Forced Vital Capacity (FVC), Forced Expiratory Volume in 1&#xa0;s (FEV<sub>1</sub>), Peak Expiratory Flow (PEF) and Maximum Expiratory Pressure (PE<sub>max</sub>). We studied the longitudinal course using linear mixed-effects models. We compared patients who electively started mechanical ventilation compared to patients who could not be weaned after acute respiratory failure.</AbstractText><AbstractText Label="RESULTS">We analyzed 385 lung function tests from 38 patients with SMA types 1c-3a. At initiation of ventilation median age was 18.8&#xa0;years (IQR: 13.2-30.1) and median standardized FVC, FEV<sub>1</sub> and PEF were 28.8% (95% CI: 23.5; 34.2), 28.8% (95% CI: 24.0; 33.7) and 30.0% (95% CI: 23.4; 36.7), with an average annual decline of 1.75% (95% CI: 0.86; 2.66), 1.72% (95% CI: 1.04; 2.40) and 1.65% (95% CI: 0.71; 2.59), respectively. Our data did not support the hypothesis of an accelerated decline prior to initiation of mechanical ventilation. Median PE<sub>max</sub> was 35.3&#xa0;cmH<sub>2</sub>O (95% CI: 29.4; 41.2) at initiation of mechanical ventilation and relatively stable in the years preceding ventilation. Median FVC, FEV<sub>1,</sub> PEF and PE<sub>max</sub> were lower in patients who electively started mechanical ventilation (p&#x2009;&lt;&#x2009;0.001).</AbstractText><AbstractText Label="CONCLUSIONS">Patterns of lung function decline cannot predict impending respiratory failure: SMA is characterized by a gradual decline of lung function. We found no evidence for an accelerated deterioration. In addition, PE<sub>max</sub> remains low and stable in the years preceding initiation of ventilation. Patients who electively started mechanical ventilation had more restrictive lung function at initiation of ventilation, compared to patients who could not be weaned after surgery or a respiratory tract infection.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Veldhoen</LastName><ForeName>Esther S</ForeName><Initials>ES</Initials><Identifier Source="ORCID">0000-0003-2918-9989</Identifier><AffiliationInfo><Affiliation>Department of Pediatric Intensive Care, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht University, PO Box 85090, 3508 AB, Utrecht, The Netherlands. E.S.Veldhoen@umcutrecht.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wijngaarde</LastName><ForeName>Camiel A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Eijk</LastName><ForeName>Ruben P A</ForeName><Initials>RPA</Initials><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biostatistics and Research Support, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asselman</LastName><ForeName>Fay-Lynn</ForeName><Initials>FL</Initials><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seddiqi</LastName><ForeName>Negina</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pediatric Intensive Care, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht University, PO Box 85090, 3508 AB, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Otto</LastName><ForeName>Louise A M</ForeName><Initials>LAM</Initials><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stam</LastName><ForeName>Marloes</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cuppen</LastName><ForeName>Inge</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wadman</LastName><ForeName>Renske I</ForeName><Initials>RI</Initials><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Asperen</LastName><ForeName>Roelie M W&#xf6;sten</ForeName><Initials>RMW</Initials><AffiliationInfo><Affiliation>Department of Pediatric Intensive Care, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht University, PO Box 85090, 3508 AB, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hulzebos</LastName><ForeName>Erik H J</ForeName><Initials>EHJ</Initials><AffiliationInfo><Affiliation>Child Development and Exercise Center, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van den Oudenrijn</LastName><ForeName>Laura P Verweij</ForeName><Initials>LPV</Initials><AffiliationInfo><Affiliation>Department of Pediatric Intensive Care, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht University, PO Box 85090, 3508 AB, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bartels</LastName><ForeName>Bart</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Child Development and Exercise Center, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boezer</LastName><ForeName>Jasmijn</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pediatric Intensive Care, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht University, PO Box 85090, 3508 AB, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaytant</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center of Home Mechanical Ventilation, Department of Pulmonology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Ent</LastName><ForeName>Cornelis K</ForeName><Initials>CK</Initials><AffiliationInfo><Affiliation>Department of Pediatric Pulmonology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Pol</LastName><ForeName>W Ludo</ForeName><Initials>WL</Initials><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Orphanet J Rare Dis</MedlineTA><NlmUniqueID>101266602</NlmUniqueID><ISSNLinking>1750-1172</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009134" MajorTopicYN="Y">Muscular Atrophy, Spinal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014797" MajorTopicYN="N">Vital Capacity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012131" MajorTopicYN="Y">Respiratory Insufficiency</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005541" MajorTopicYN="N">Forced Expiratory Volume</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Lung function</Keyword><Keyword MajorTopicYN="N">Natural history</Keyword><Keyword MajorTopicYN="N">Neuromuscular</Keyword><Keyword MajorTopicYN="N">Respiratory failure</Keyword><Keyword MajorTopicYN="N">Spinal muscular atrophy</Keyword></KeywordList><CoiStatement>WLP received fee for service to employer for ad hoc consultancy as member of scientific advisory boards of Biogen and Avexis. All other authors report no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>24</Day><Hour>1</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36823666</ArticleId><ArticleId IdType="pmc">PMC9951433</ArticleId><ArticleId IdType="doi">10.1186/s13023-023-02634-4</ArticleId><ArticleId IdType="pii">10.1186/s13023-023-02634-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Finkel RS, Mercuri E, Meyer OH, Simonds AK, Schroth MK, Graham RJ, et al. Diagnosis and management of spinal muscular atrophy: Part 2: pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics. Neuromuscul Disord. 2018;28:197&#x2013;207. doi: 10.1016/j.nmd.2017.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2017.11.004</ArticleId><ArticleId IdType="pubmed">29305137</ArticleId></ArticleIdList></Reference><Reference><Citation>Mercuri E, Bertini E, Iannaccone ST. Childhood spinal muscular atrophy: controversies and challenges. Lancet Neurol. 2012;11:443&#x2013;452. doi: 10.1016/S1474-4422(12)70061-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(12)70061-3</ArticleId><ArticleId IdType="pubmed">22516079</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioos C, Leclair-Richard D, Mrad S, Barois A, Estournet-Mathiaud B. Respiratory capacity course in patients with infantile spinal muscular atrophy. Chest. 2004;126:831&#x2013;837. doi: 10.1378/chest.126.3.831.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.126.3.831</ArticleId><ArticleId IdType="pubmed">15364763</ArticleId></ArticleIdList></Reference><Reference><Citation>Khirani S, Colella M, Caldarelli V, Aubertin G, Boul&#xe9; M, Forin V, et al. Longitudinal course of lung function and respiratory muscle strength in spinal muscular atrophy type 2 and 3. Eur J Paediatr Neurol. 2013;17:552&#x2013;60. doi: 10.1016/j.ejpn.2013.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejpn.2013.04.004</ArticleId><ArticleId IdType="pubmed">23672834</ArticleId></ArticleIdList></Reference><Reference><Citation>Trucco F, Ridout D, Scoto M, Coratti G, Main ML, Muni Lofra R, et al. Respiratory trajectories in type 2 and 3 spinal muscular atrophy in the iSMAC cohort study. Neurology. 2021;96:e587&#x2013;e599. doi: 10.1212/WNL.0000000000011051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000011051</ArticleId><ArticleId IdType="pmc">PMC7905794</ArticleId><ArticleId IdType="pubmed">33067401</ArticleId></ArticleIdList></Reference><Reference><Citation>Veldhoen ES, Wijngaarde CA, Hulzebos EHJ, van Asperen RMW, Wadman RI, van Eijk RPA, et al. Natural history of respiratory muscle strength in spinal muscular atrophy: a prospective national cohort study. Orphanet J Rare Dis. 2022;17:70. doi: 10.1186/s13023-022-02227-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13023-022-02227-7</ArticleId><ArticleId IdType="pmc">PMC8862532</ArticleId><ArticleId IdType="pubmed">35189949</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijngaarde CA, Veldhoen ES, Van Eijk RPA, Stam M, Otto LAM, Asselman FL, et al. Natural history of lung function in spinal muscular atrophy. Orphanet J Rare Dis. 2020;15:88. doi: 10.1186/s13023-020-01367-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13023-020-01367-y</ArticleId><ArticleId IdType="pmc">PMC7149916</ArticleId><ArticleId IdType="pubmed">32276635</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijngaarde CA, Stam M, Otto LAM, Van Eijk RPA, Cuppen I, Veldhoen ES, et al. Population-based analysis of survival in spinal muscular atrophy. Neurology. 2020;94:e1634&#x2013;e1644. doi: 10.1212/WNL.0000000000009248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000009248</ArticleId><ArticleId IdType="pubmed">32217777</ArticleId></ArticleIdList></Reference><Reference><Citation>Hull J, Aniapravan R, Chan E, Chatwin M, Forton J, Gallagher J, et al. Guideline for respiratory management of children with neuromuscular disease. Thorax. 2012;67:1&#x2013;40. doi: 10.1136/thoraxjnl-2012-201964.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2012-201964</ArticleId><ArticleId IdType="pubmed">22730428</ArticleId></ArticleIdList></Reference><Reference><Citation>Darras BT, De Vivo DC. Precious SMA natural history data: a benchmark to measure future treatment successes. Neurology. 2018;91:337&#x2013;339. doi: 10.1212/WNL.0000000000006026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000006026</ArticleId><ArticleId IdType="pubmed">30045956</ArticleId></ArticleIdList></Reference><Reference><Citation>Veldhoen ES, Wijngaarde CA, Van Den Oudenrijn LPV, Asselman FL, Van Asperen RMW, Hulzebos EHJ, et al. Relative hyperventilation in non-ventilated patients with spinal muscular atrophy. Eur Respir J. 2020;56:2000162. doi: 10.1183/13993003.00162-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00162-2020</ArticleId><ArticleId IdType="pmc">PMC7674775</ArticleId><ArticleId IdType="pubmed">32586880</ArticleId></ArticleIdList></Reference><Reference><Citation>VSCA. Veldnorm chronische beademing: https://www.vsca.nl/wp-content/uploads/Rapport_Veldnorm_Chronische_beademing_def.pdf. Accessed 10 January 2023.</Citation></Reference><Reference><Citation>Wadman RI, Stam M, Gijzen M, Lemmink HH, Snoeck IN, Wijngaarde CA, et al. Association of motor milestones, SMN2 copy and outcome in spinal muscular atrophy types 0&#x2013;4. J Neurol Neurosurg Psychiatry. 2017;88:365&#x2013;367. doi: 10.1136/jnnp-2016-314292.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-314292</ArticleId><ArticleId IdType="pubmed">28108522</ArticleId></ArticleIdList></Reference><Reference><Citation>Zerres K, Sch&#xf6;neborn SR. Natural history in proximal spinal muscular atrophy: clinical analysis of 445 patients and suggestions for a modification of existing classifications. Arch Neurol. 1995;52:518&#x2013;523. doi: 10.1001/archneur.1995.00540290108025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1995.00540290108025</ArticleId><ArticleId IdType="pubmed">7733848</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijngaarde CA, Stam M, Otto LAM, Bartels B, Asselman FL, van Eijk RPA, et al. Muscle strength and motor function in adolescents and adults with spinal muscular atrophy. Neurology. 2020;95:e1988&#x2013;1998. doi: 10.1212/WNL.0000000000010540.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010540</ArticleId><ArticleId IdType="pubmed">32732299</ArticleId></ArticleIdList></Reference><Reference><Citation>Mercuri E, Finkel RS, Muntoni F, Wirth B, Montes J, Main M, et al. Diagnosis and management of spinal muscular atrophy: Part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscul Disord. 2018;28:103&#x2013;115. doi: 10.1016/j.nmd.2017.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2017.11.005</ArticleId><ArticleId IdType="pubmed">29290580</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicot F, Hart N, Forin V, Le BM, Cl&#xe9;ment A, Polkey MI, et al. Respiratory muscle testing: a valuable tool for children with neuromuscular disorders. Am J Respir Crit Care Med. 2006;174:67&#x2013;74. doi: 10.1164/rccm.200512-1841OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200512-1841OC</ArticleId><ArticleId IdType="pubmed">16574932</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroth MK. Special considerations in the respiratory management of spinal muscular atrophy. Pediatrics. 2009;123:S245&#x2013;249. doi: 10.1542/peds.2008-2952K.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2008-2952K</ArticleId><ArticleId IdType="pubmed">19420154</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319&#x2013;338. doi: 10.1183/09031936.05.00034805.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.05.00034805</ArticleId><ArticleId IdType="pubmed">16055882</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham BL, Steenbruggen I, Barjaktarevic IZ, Cooper BG, Hall GL, Hallstrand TS, et al. Standardization of spirometry 2019 update an official American Thoracic Society and European Respiratory Society technical statement. Am J Respir Crit Care Med. 2019;200:e70&#x2013;88. doi: 10.1164/rccm.201908-1590ST.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201908-1590ST</ArticleId><ArticleId IdType="pmc">PMC6794117</ArticleId><ArticleId IdType="pubmed">31613151</ArticleId></ArticleIdList></Reference><Reference><Citation>Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, et al. Multi-ethnic reference values for spirometry for the 3&#x2013;95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40:1324&#x2013;1343. doi: 10.1183/09031936.00080312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00080312</ArticleId><ArticleId IdType="pmc">PMC3786581</ArticleId><ArticleId IdType="pubmed">22743675</ArticleId></ArticleIdList></Reference><Reference><Citation>Hibbert ME, Lanigan A, Raven J, Phelan PD. Relation of armspan to height and the prediction of lung function. Thorax. 1988;43:657&#x2013;659. doi: 10.1136/thx.43.8.657.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.43.8.657</ArticleId><ArticleId IdType="pmc">PMC461410</ArticleId><ArticleId IdType="pubmed">3175981</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E, Altman DG, Egger M, Pocock SJ, G&#xf8;tzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61:344&#x2013;349. doi: 10.1016/j.jclinepi.2007.11.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2007.11.008</ArticleId><ArticleId IdType="pubmed">18313558</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team. R Foundation for Statistical Computing. R A Lang. Environ. Stat. Comput. 2020. Available from: https://www.r-project.org/</Citation></Reference><Reference><Citation>Bates D, M&#xe4;chler M, Bolker BM, Walker SC. Fitting linear mixed-effects models using lme4. J Stat Softw. 2015;67:1&#x2013;48. doi: 10.18637/jss.v067.i01.</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v067.i01</ArticleId></ArticleIdList></Reference><Reference><Citation>Wickham H. ggplot2: elegant graphics for data analysis. 2016.</Citation></Reference><Reference><Citation>Bach JR, Tuccio MC, Khan U, Saporito LR. Vital capacity in spinal muscular atrophy. Am J Phys Med Rehabil. 2012;91:487&#x2013;493. doi: 10.1097/PHM.0b013e31824fa5dd.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PHM.0b013e31824fa5dd</ArticleId><ArticleId IdType="pubmed">22469873</ArticleId></ArticleIdList></Reference><Reference><Citation>Chabanon A, Seferian AM, Daron A, P&#xe9;r&#xe9;on Y, Cances C, Vuillerot C, et al. Prospective and longitudinal natural history study of patients with type 2 and 3 spinal muscular atrophy: baseline data NatHis-SMA study. PLoS ONE. 2018;13:e0201004. doi: 10.1371/journal.pone.0201004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0201004</ArticleId><ArticleId IdType="pmc">PMC6062049</ArticleId><ArticleId IdType="pubmed">30048507</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin LC, Jong YJ. Pulmonary function assessment in patients with spinal muscular atrophy type II and type III. Acta Paediatr Taiwanica. 2004;45:15&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">15264700</ArticleId></ArticleIdList></Reference><Reference><Citation>Samaha FJ, Buncher CR, Russman BS, White ML, Iannaccone ST, Barker L, et al. Pulmonary function in spinal muscular atrophy. J Child Neurol. 1994;9:326&#x2013;329. doi: 10.1177/088307389400900321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/088307389400900321</ArticleId><ArticleId IdType="pubmed">7930415</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilgoff IS, Kahlstrom E, MacLaughlin E, Keens TG. Long-term ventilatory support in spinal muscular atrophy. J Pediatr. 1989;115:904&#x2013;909. doi: 10.1016/S0022-3476(89)80740-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3476(89)80740-1</ArticleId><ArticleId IdType="pubmed">2585226</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyager S, Steffensen B, Juhl B. Indicators of need for mechanical ventilation in Duchenne muscular dystrophy and spinal muscular atrophy. Chest. 1995;108:779&#x2013;785. doi: 10.1378/chest.108.3.779.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.108.3.779</ArticleId><ArticleId IdType="pubmed">7656633</ArticleId></ArticleIdList></Reference><Reference><Citation>Kant-Smits K, Hulzebos EH, Habets LE, Asselman F-L, Veldhoen ES, van Eijk R, de Groot JF, van der Pol WL, Bartels B. Respiratory muscle fatigability in patients with spinal muscular atrophy. Pediatr Pulmonol. 2022;57:3050&#x2013;3059. doi: 10.1002/ppul.26133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.26133</ArticleId><ArticleId IdType="pmc">PMC9826393</ArticleId><ArticleId IdType="pubmed">36039838</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26448633</PMID><DateCompleted><Year>2016</Year><Month>11</Month><Day>02</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1538-7836</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>12</Issue><PubDate><Year>2015</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of thrombosis and haemostasis : JTH</Title><ISOAbbreviation>J Thromb Haemost</ISOAbbreviation></Journal><ArticleTitle>Bemiparin for thromboprophylaxis after benign gynecologic surgery: a randomized clinical trial.</ArticleTitle><Pagination><StartPage>2161</StartPage><EndPage>2167</EndPage><MedlinePgn>2161-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jth.13164</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Venous thromboembolism (VTE) is the leading cause of mortality and morbidity in women following gynecologic surgery.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To determine the efficacy of a second-generation low molecular weight heparin (bemiparin) for thromboprophylaxis after benign gynecologic surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We performed a single-blind randomized controlled trial including women in the moderate-risk, high-risk and highest-risk groups for developing VTE after benign gynecologic surgery. Participants were randomized at a 1&#xa0;:&#xa0;1 ratio into parallel groups to receive either seven daily doses of 3500&#xa0;IU of subcutaneous bemiparin or to a non-intervention group receiving standard rehydration and advice on ambulation. Participants were followed up for 7&#xa0;days and 30&#xa0;days postoperatively for symptomatic VTE, which was confirmed by compression Doppler ultrasound, magnetic resonance imaging, or computed tomographic pulmonary angiography, according to the type of VTE.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, 387 participants were randomized to the bemiparin group and 387 to the non-intervention group. The incidence of symptomatic VTE (deep vein thrombosis and pulmonary embolism) events was lower (0/377) in participants who received bemiparin than in those who received no pharmacologic intervention (12/380, 3.2%; 95% confidence interval [CI]&#xa0;0.002-0.6). Logistic regression analysis showed significant associations between VTE and immobility (odds ratio [OR]&#xa0;7.1; 95%&#xa0;CI&#xa0;1.3-36.2), varicose veins (OR&#xa0;16.8; 95%&#xa0;CI&#xa0;3.1-76.2), and thrombophilia (OR&#xa0;39.3; 95%&#xa0;CI&#xa0;1.5-1006.7). There were no major bleeding events or side effects related to the use of bemiparin.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Bemiparin was an effective thromboprophylactic agent for preventing venous thrombosis after benign gynecologic surgery.</AbstractText><CopyrightInformation>&#xa9; 2015 International Society on Thrombosis and Haemostasis.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alalaf</LastName><ForeName>S K</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, College of Medicine, Hawler Medical University, Erbil City, Kurdistan Region, Iraq.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jawad</LastName><ForeName>A K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, College of Medicine, Hawler Medical University, Erbil City, Kurdistan Region, Iraq.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jawad</LastName><ForeName>R K</ForeName><Initials>RK</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, College of Medicine, Hawler Medical University, Erbil City, Kurdistan Region, Iraq.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ali</LastName><ForeName>M S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Maternity Teaching Hospital, Hawler Ministry of Health, Erbil City, Kurdistan Region, Iraq.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al Tawil</LastName><ForeName>N G</ForeName><Initials>NG</Initials><AffiliationInfo><Affiliation>Department of Community Medicine, College of Medicine, Hawler Medical University, Erbil City, Kurdistan Region, Iraq.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>10</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Thromb Haemost</MedlineTA><NlmUniqueID>101170508</NlmUniqueID><ISSNLinking>1538-7836</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006495">Heparin, Low-Molecular-Weight</NameOfSubstance></Chemical><Chemical><RegistryNumber>PUE0TO3XDR</RegistryNumber><NameOfSubstance UI="C411345">bemiparin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013509" MajorTopicYN="N">Gynecologic Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006495" MajorTopicYN="N">Heparin, Low-Molecular-Weight</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007493" MajorTopicYN="N">Iraq</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016037" MajorTopicYN="N">Single-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018608" MajorTopicYN="N">Ultrasonography, Doppler</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="N">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">bemiparin</Keyword><Keyword MajorTopicYN="N">clinical trial</Keyword><Keyword MajorTopicYN="N">gynecologic surgery</Keyword><Keyword MajorTopicYN="N">pulmonary embolism</Keyword><Keyword MajorTopicYN="N">venous thromboembolism</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>6</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>10</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>10</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26448633</ArticleId><ArticleId IdType="doi">10.1111/jth.13164</ArticleId><ArticleId IdType="pii">S1538-7836(22)08774-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39812802</PMID><DateCompleted><Year>2025</Year><Month>01</Month><Day>15</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1433-0350</ISSN><JournalIssue CitedMedium="Internet"><Volume>41</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jan</Month><Day>15</Day></PubDate></JournalIssue><Title>Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery</Title><ISOAbbreviation>Childs Nerv Syst</ISOAbbreviation></Journal><ArticleTitle>Comparative analysis of treatment modalities for pediatric spinal cord glioblastoma: insights from a meta-analysis.</ArticleTitle><Pagination><StartPage>91</StartPage><MedlinePgn>91</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00381-024-06729-6</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Glioblastomas (GBM) are aggressive tumors that make up about 7% of central nervous system tumors in children. Spinal GBMs (sGBMs) are extremely rare, accounting for less than 1% of pediatric spinal tumors. sGBMs are difficult to treat due to their infiltrative nature and cause significant morbidity. While there is extensive literature on treatment outcomes for cranial GBMs, there is limited research on pediatric sGBMs. This meta-analysis aims to assess the impact of available treatments on overall survival (OS) and progression-free survival (PFS) in pediatric sGBM patients and to identify prognostic factors.</AbstractText><AbstractText Label="METHODOLOGY" NlmCategory="METHODS">A comprehensive review of pediatric sGBM cases up to June 2024 was conducted using PubMed and Mendeley. Inclusion criteria were case series and case reports of pediatric sGBM, excluding those with metastatic sGBM or aggregated patient data. A total of 2202 articles were identified, with 46 meeting the inclusion criteria. Data on demographics, tumor characteristics, extent of resection, and treatments were collected. Kaplan-Meier and Cox proportional hazards models were used for statistical analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The data was collected from 81 patients, 43 females and 38 males, with an average age of 10.7&#xa0;years. The majority of tumors were found in the cervical region (32%). Subtotal resection (STR) was performed in 53% of cases, and 59% of patients received both chemotherapy (QT) and radiotherapy (RT). The average progression-free survival (PFS) was 10.95&#xa0;months, with RT significantly improving PFS (15.2&#xa0;months vs. 2.1&#xa0;months, p&#x2009;=&#x2009;0.001). The average OS was 13.4&#xa0;months, with RT and QT being significant protective factors (p&#x2009;&lt;&#x2009;0.05). Age over seven years and cervical tumor location were associated with worse OS.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study highlights the significance of radiation therapy and chemotherapy in enhancing overall survival and progression-free survival in pediatric patients with spinal cord glioblastoma. Specifically, RT significantly improves PFS, while advanced age and tumor location in the cervical region are associated with worse outcomes. These findings can help shape treatment approaches and ultimately enhance the quality of life for pediatric sGBM patients.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Da Cunha</LastName><ForeName>Artur Henrique Galvao Bruno</ForeName><Initials>AHGB</Initials><Identifier Source="ORCID">0000-0002-8589-8563</Identifier><AffiliationInfo><Affiliation>Department of Neurosurgery, Hospital da Restaura&#xe7;&#xe3;o, Avenida Agamenon Magalh&#xe3;es, S/N, Derby, Recife, PE, 52171-011, Brazil. arturdacunha@hotmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidade Federal de Pernambuco, PosNeuro, Recife, Brazil. arturdacunha@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guerra</LastName><ForeName>Pedro Lucas Negromonte</ForeName><Initials>PLN</Initials><Identifier Source="ORCID">0000-0003-0221-5585</Identifier><AffiliationInfo><Affiliation>Department of Neurosurgery, Hospital da Restaura&#xe7;&#xe3;o, Avenida Agamenon Magalh&#xe3;es, S/N, Derby, Recife, PE, 52171-011, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Silva</LastName><ForeName>Ina&#xea; Carolline Silveira</ForeName><Initials>ICS</Initials><Identifier Source="ORCID">0000-0003-3132-772X</Identifier><AffiliationInfo><Affiliation>Department of Neurosurgery, Hospital da Restaura&#xe7;&#xe3;o, Avenida Agamenon Magalh&#xe3;es, S/N, Derby, Recife, PE, 52171-011, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>J&#xfa;nior</LastName><ForeName>Deoclides Lima Bezerra</ForeName><Initials>DLB</Initials><Identifier Source="ORCID">0000-0002-6493-350X</Identifier><AffiliationInfo><Affiliation>Department of Neurosurgery, Hospital da Restaura&#xe7;&#xe3;o, Avenida Agamenon Magalh&#xe3;es, S/N, Derby, Recife, PE, 52171-011, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Carvalho J&#xfa;nior</LastName><ForeName>Eduardo Vieira</ForeName><Initials>EV</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Hospital da Restaura&#xe7;&#xe3;o, Avenida Agamenon Magalh&#xe3;es, S/N, Derby, Recife, PE, 52171-011, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>01</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Childs Nerv Syst</MedlineTA><NlmUniqueID>8503227</NlmUniqueID><ISSNLinking>0256-7040</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013120" MajorTopicYN="Y">Spinal Cord Neoplasms</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005909" MajorTopicYN="Y">Glioblastoma</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anastomotic ulcers</Keyword><Keyword MajorTopicYN="N">Bariatric Surgery</Keyword><Keyword MajorTopicYN="N">Laparoscopic Roux-en-Y Gastric Bypass</Keyword></KeywordList><CoiStatement>Declarations. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>10</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>12</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>1</Month><Day>15</Day><Hour>12</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>1</Month><Day>15</Day><Hour>12</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>1</Month><Day>15</Day><Hour>11</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39812802</ArticleId><ArticleId IdType="doi">10.1007/s00381-024-06729-6</ArticleId><ArticleId IdType="pii">10.1007/s00381-024-06729-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Behmanesh B, Setzer M, Konczalla J, Harter P, Quick-Weller J, Imoehl L, Franz K, Gessler F, Seifert V, Marquardt G (2017) Management of patients with primary intramedullary spinal cord glioblastoma. World Neurosurg 98:198&#x2013;202</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wneu.2016.10.075</ArticleId></ArticleIdList></Reference><Reference><Citation>States CBTRotU (2010) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in. Central Brain Tumor Registry of the United States, Hinsdale, IL, pp 2004&#x2013;2006</Citation></Reference><Reference><Citation>Lober R, Sharma S, Bell B, Free A, Figueroa R, Sheils CW et al (2010) Pediatric primary intramedullary spinal cord glioblastoma. Rare Tumors 2:e48</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/rt.2010.e48</ArticleId><ArticleId IdType="pmc">2994522</ArticleId></ArticleIdList></Reference><Reference><Citation>Konar SK, Bir SC, Maiti TK, Nanda A (2017) A systematic review of overall survival in pediatric primary glioblastoma multiforme of the spinal cord. J Neurosurg Pediatr 19(2):239&#x2013;248. https://doi.org/10.3171/2016.8.PEDS1631</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/2016.8.PEDS1631</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang R, Isaacs AM, Cadieux M et al (2021) Primary and metastatic glioblastoma of the spine in the pediatric population: a systematic review. Childs Nerv Syst 37:1849&#x2013;1858. https://doi.org/10.1007/s00381-021-05098-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00381-021-05098-8</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31902124</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>07</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1573-742X</ISSN><JournalIssue CitedMedium="Internet"><Volume>50</Volume><Issue>2</Issue><PubDate><Year>2020</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of thrombosis and thrombolysis</Title><ISOAbbreviation>J Thromb Thrombolysis</ISOAbbreviation></Journal><ArticleTitle>The efficacy and safety of tranexamic acid in the treatment of intertrochanteric fracture: an updated meta-analysis of 11 randomized controlled trials.</ArticleTitle><Pagination><StartPage>243</StartPage><EndPage>257</EndPage><MedlinePgn>243-257</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11239-019-02034-1</ELocationID><Abstract><AbstractText>This meta-analysis was performed to investigate the efficacy and safety of tranexamic acid (TXA) in the elderly patients undergoing intertrochanteric fracture surgery from the current literatures. The electronic literature database of PubMed, Embase and Cochrane library were searched in October 2019. The intraoperative blood loss, hidden blood loss, postoperative drainage and total blood loss, postoperative hemoglobin, length of stay, transfusion rate, mortality rate, thromboembolic events and wound complications were extracted. Stata 14.0 software was used for our meta-analysis. A total of 11 RCTs (3 new RCTs in 2019) with 1202 patients met our inclusion criteria. This meta-analysis showed that administration of TXA can reduce intraoperative blood loss (P&#x2009;=&#x2009;0.009), hidden blood loss (P&#x2009;=&#x2009;0.000), total blood loss (P&#x2009;=&#x2009;0.000), length of stay (P&#x2009;=&#x2009;0.003), transfusion rate (P&#x2009;=&#x2009;0.000) and the occurrence of wound complications (P&#x2009;=&#x2009;0.006). Furthermore, administration of TXA was associated with an increase in the postoperative Hb level at day 1, 2 and 3 (P&#x2009;=&#x2009;0.000, P&#x2009;=&#x2009;0.000 and P&#x2009;=&#x2009;0.000, respectively) after surgery. However, no significant difference was found between the TXA group and control group regarding the occurrence of thromboembolic events (P&#x2009;=&#x2009;0.978, including deep vein thrombosis, P&#x2009;=&#x2009;0.850; pulmonary embolism, P&#x2009;=&#x2009;0.788; cerebrovascular accident, P&#x2009;=&#x2009;0.549; myocardial infarction, P&#x2009;=&#x2009;0.395) and mortality rate (P&#x2009;=&#x2009;0. 338). Our meta-analysis suggested that administration of TXA is effective in reducing intraoperative blood loss, hidden blood loss, total blood loss, length of stay, transfusion rate, wound complications and enhancing postoperative Hb without increasing the risk of thromboembolic events and mortality rate in intertrochanteric fracture surgery. More large multi-center and high-quality RCTs are required for further research.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Xianbin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, 109 Xueyuan Xi Road, Wenzhou, 325000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jinwu</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, 109 Xueyuan Xi Road, Wenzhou, 325000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xingyu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, 109 Xueyuan Xi Road, Wenzhou, 325000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Linzhen</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, 109 Xueyuan Xi Road, Wenzhou, 325000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Chunhui</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, 109 Xueyuan Xi Road, Wenzhou, 325000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Wenhao</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, 109 Xueyuan Xi Road, Wenzhou, 325000, China. zhengwenhao@wmu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Thromb Thrombolysis</MedlineTA><NlmUniqueID>9502018</NlmUniqueID><ISSNLinking>0929-5305</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000933">Antifibrinolytic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>6T84R30KC1</RegistryNumber><NameOfSubstance UI="D014148">Tranexamic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000933" MajorTopicYN="N">Antifibrinolytic Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016063" MajorTopicYN="N">Blood Loss, Surgical</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005592" MajorTopicYN="Y">Fracture Fixation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006620" MajorTopicYN="N">Hip Fractures</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019106" MajorTopicYN="N">Postoperative Hemorrhage</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014148" MajorTopicYN="N">Tranexamic Acid</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Blood loss</Keyword><Keyword MajorTopicYN="N">Intertrochanteric fracture</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">RCT</Keyword><Keyword MajorTopicYN="N">Tranexamic acid</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31902124</ArticleId><ArticleId IdType="doi">10.1007/s11239-019-02034-1</ArticleId><ArticleId IdType="pii">10.1007/s11239-019-02034-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">19569978</PMID><DateCompleted><Year>2009</Year><Month>12</Month><Day>11</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1744-764X</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>5</Issue><PubDate><Year>2009</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Expert opinion on drug safety</Title><ISOAbbreviation>Expert Opin Drug Saf</ISOAbbreviation></Journal><ArticleTitle>Risk of venous thromboembolism due to antipsychotic drug therapy.</ArticleTitle><Pagination><StartPage>537</StartPage><EndPage>547</EndPage><MedlinePgn>537-47</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1517/14740330903117271</ELocationID><Abstract><AbstractText>An increasing number of reports suggest a link between venous thromboembolism (VTE) and the use of antipsychotics. To better understand this association the available body of evidence has been critically scrutinised. Relevant articles were identified in the databases Scopus and PubMed. Several observational studies using different methodologies show an increased risk of VTE in psychiatric patients. This elevated risk seems to be related to the use of antipsychotic medication and in particular to the use of clozapine and low-potency first-generation drugs. Many studies investigating the association have, however, methodological limitations. The biological mechanisms involved in the pathogenesis of this possible adverse reaction are largely unknown but several hypotheses have been suggested such as drug-induced sedation, obesity, increased levels of antiphospholipid antibodies, enhanced platelet aggregation, hyperhomocysteinemia and hyperprolactinemia. The association may also be related to underlying risk factors present in psychotic patients. Physicians need to be aware of this possible adverse drug reaction. Although supporting evidence has not been published they should consider discontinuing or switching the antipsychotic treatment in patients experiencing VTE. In addition, although data is lacking, the threshold for considering prophylactic antithrombotic treatment should be low when risk situations for VTE arise, such as immobilisation, surgery and so on.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>H&#xe4;gg</LastName><ForeName>Staffan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Link&#xf6;ping University, Department of Drug Research, Section of Clinical Pharmacology, S-581 83 Link&#xf6;ping, Sweden. staffan.hagg@liu.se</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>J&#xf6;nsson</LastName><ForeName>Anna K</ForeName><Initials>AK</Initials></Author><Author ValidYN="Y"><LastName>Spigset</LastName><ForeName>Olav</ForeName><Initials>O</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Expert Opin Drug Saf</MedlineTA><NlmUniqueID>101163027</NlmUniqueID><ISSNLinking>1474-0338</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014150">Antipsychotic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>J60AR2IKIC</RegistryNumber><NameOfSubstance UI="D003024">Clozapine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014150" MajorTopicYN="N">Antipsychotic Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002389" MajorTopicYN="N">Catatonia</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003024" MajorTopicYN="N">Clozapine</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003645" MajorTopicYN="N">Death, Sudden</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003681" MajorTopicYN="N">Dehydration</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010974" MajorTopicYN="N">Platelet Aggregation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012149" MajorTopicYN="N">Restraint, Physical</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019851" MajorTopicYN="N">Thrombophilia</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="N">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>93</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>7</Month><Day>3</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>7</Month><Day>3</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>12</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19569978</ArticleId><ArticleId IdType="doi">10.1517/14740330903117271</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">24745310</PMID><DateCompleted><Year>2014</Year><Month>07</Month><Day>01</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1532-6500</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>5</Issue><PubDate><Year>2014</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of shoulder and elbow surgery</Title><ISOAbbreviation>J Shoulder Elbow Surg</ISOAbbreviation></Journal><ArticleTitle>Venous thromboembolism after elective shoulder surgery: a prospective cohort study of 175 patients.</ArticleTitle><Pagination><StartPage>605</StartPage><EndPage>612</EndPage><MedlinePgn>605-12</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jse.2014.01.054</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1058-2746(14)00121-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The purpose of this study was to investigate the incidence of venous thromboembolism (VTE) after elective arthroscopic shoulder surgery.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">One hundred seventy-five consecutive patients who underwent arthroscopic shoulder surgery were enrolled (mean age, 61&#xa0;years). Patients who had VTE preoperatively and underwent trauma surgery or arthroplasty were excluded. All the patients used foot pumps or elastic stockings after surgery for deep venous thrombosis (DVT) prophylaxis. DVT in the 4 limbs was assessed by ultrasound before and after surgery. Pulmonary embolism was diagnosed by computed tomography pulmonary angiography. Risk factors related to DVT were assessed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The overall incidence of DVT was 10 of 175 patients (5.7%). Most of the DVT cases were detected at 1 to 2&#xa0;days after surgery. All patients were asymptomatic. There were no patients who had symptomatic pulmonary embolism. However, an asymptomatic pulmonary embolus developed in 1 patient during the 3-month follow-up period. There were no significant differences between the DVT and non-DVT groups regarding the risk factors.</AbstractText><AbstractText Label="DISCUSSION AND CONCLUSION" NlmCategory="CONCLUSIONS">Our data have shown that symptomatic VTE is rare after elective arthroscopic shoulder surgery. However, asymptomatic VTE may occur even with DVT preventive measures. Because most of the DVTs were found in the calf veins, we recommend that surgeons pay attention to the possibility of DVT in the lower extremities even after arthroscopic shoulder surgery. The incidence of asymptomatic VTE after elective arthroscopic shoulder surgery was 5.7%. All patients were asymptomatic, and most of the DVTs occurred 1 or 2&#xa0;days after surgery.</AbstractText><CopyrightInformation>Copyright &#xa9; 2014 Journal of Shoulder and Elbow Surgery Board of Trustees. Published by Mosby, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Takahashi</LastName><ForeName>Hiroyuki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Tohoku University School of Medicine, Sendai, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamamoto</LastName><ForeName>Nobuyuki</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Tohoku University School of Medicine, Sendai, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagamoto</LastName><ForeName>Hideaki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Tohoku University School of Medicine, Sendai, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sano</LastName><ForeName>Hirotaka</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Tohoku University School of Medicine, Sendai, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanaka</LastName><ForeName>Minoru</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Tohoku Rosai Hospital, Sendai, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Itoi</LastName><ForeName>Eiji</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Tohoku University School of Medicine, Sendai, Japan. Electronic address: itoi-eiji@med.tohoku.ac.jp.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Shoulder Elbow Surg</MedlineTA><NlmUniqueID>9206499</NlmUniqueID><ISSNLinking>1058-2746</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001182" MajorTopicYN="N">Arthroscopy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012785" MajorTopicYN="N">Shoulder Joint</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="N">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Venous thromboembolism</Keyword><Keyword MajorTopicYN="N">arthroscopy</Keyword><Keyword MajorTopicYN="N">asymptomatic</Keyword><Keyword MajorTopicYN="N">deep venous thrombosis</Keyword><Keyword MajorTopicYN="N">pulmonary embolism</Keyword><Keyword MajorTopicYN="N">shoulder surgery</Keyword><Keyword MajorTopicYN="N">ultrasonography</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>1</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>1</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>7</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24745310</ArticleId><ArticleId IdType="doi">10.1016/j.jse.2014.01.054</ArticleId><ArticleId IdType="pii">S1058-2746(14)00121-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">25586971</PMID><DateCompleted><Year>2015</Year><Month>01</Month><Day>15</Day></DateCompleted><DateRevised><Year>2018</Year><Month>08</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1758-8103</ISSN><JournalIssue CitedMedium="Print"><Volume>1</Volume><Issue>1</Issue><PubDate><Year>2011</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Clinical obesity</Title><ISOAbbreviation>Clin Obes</ISOAbbreviation></Journal><ArticleTitle>Effectiveness and cost-effectiveness of paediatric bariatric surgery: a systematic review.</ArticleTitle><Pagination><StartPage>12</StartPage><EndPage>25</EndPage><MedlinePgn>12-25</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/j.1758-8111.2010.00003.x</ELocationID><Abstract><AbstractText>Strong evidence for successful and cost-effective obesity management strategies is still generally lacking, leading the medical profession to rely increasingly on surgical options to treat obesity in children and adolescents. We performed a systematic review to examine the effectiveness of surgical interventions to treat obese children and adolescents, and whether they are cost-effective. We searched PubMed, ISI Web of Science, Embase and the Cochrane Library to 6 September 2010, and hand-searched bibliographies. We included articles with English abstracts if they examined subjects &#x2264;19 years of age, reported at least one postoperative weight loss measure and at least 1 year of postoperative follow-up. Thirty-seven relevant papers on bariatric surgery effectiveness in 831 children or adolescents were included, spanning 36 years. Thirteen studies examined gastric banding, with mean body mass index (BMI) reductions ranging from 8.5 to 43&#x2003;kg&#x2003;m(-2) . Weight gain was reported in one case study. Eight papers examined Roux-en-Y gastric bypass, with mean BMI reductions ranging from 9 to 25&#x2003;kg&#x2003;m(-2) . Fourteen publications studied other forms of bariatric surgery: sleeve gastrectomies, vertical banded gastroplasty, biliopancreatic diversion or a combination of procedures. Mean BMI reductions ranged from 9 to 24&#x2003;kg&#x2003;m(-2) . Three surgery-related mortalities were reported, as was weight regain in several cases. The majority of studies reported resolution or improvement of comorbid conditions. A range of postoperative complications were identified across surgery types, including: ulcers, intestinal leakage, wound infection, anastomotic stricture, nutritional deficiencies, bowel obstruction, pulmonary embolism, disrupted staple lines, band slippage, psychological intolerance and repeated vomiting. Evidence on cost-effectiveness was limited to one Australian modelling project, which deemed laparoscopic adjustable gastric banding cost-effective for adolescents. Existing evidence - although based generally on underpowered, retrospective studies - suggests that bariatric surgery in older children results in significant weight loss and improvements in comorbidities and quality of life. However, postoperative complications, compliance and follow-up may be more problematic in adolescents than adults, and availability of long-term data on safety, effectiveness and cost-effectiveness remains largely unknown. Pending an improvement in the quality of available evidence, a cautious approach to child and adolescent bariatric surgery is warranted, and reversible techniques are advisable compared to approaches that permanently alter anatomy.</AbstractText><CopyrightInformation>&#xa9; 2011 IASO. Clinical Obesity &#xa9; 2011 International Association for the Study of Obesity.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aikenhead</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>International Association for the Study of Obesity, London, UKLondon School of Hygiene and Tropical Medicine, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knai</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>International Association for the Study of Obesity, London, UKLondon School of Hygiene and Tropical Medicine, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lobstein</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>International Association for the Study of Obesity, London, UKLondon School of Hygiene and Tropical Medicine, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>03</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Clin Obes</MedlineTA><NlmUniqueID>101560587</NlmUniqueID><ISSNLinking>1758-8103</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">bariatric</Keyword><Keyword MajorTopicYN="N">obesity</Keyword><Keyword MajorTopicYN="N">paediatric</Keyword><Keyword MajorTopicYN="N">surgery</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>1</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>2</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>2</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25586971</ArticleId><ArticleId IdType="doi">10.1111/j.1758-8111.2010.00003.x</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38850067</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>25</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1939-3806</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>7</Issue><PubDate><Year>2024</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Autism research : official journal of the International Society for Autism Research</Title><ISOAbbreviation>Autism Res</ISOAbbreviation></Journal><ArticleTitle>Comparison of propofol-esketamine versus propofol-sufentanil for deep sedation and analgesia in children with autism: A randomized double-blind clinical trial.</ArticleTitle><Pagination><StartPage>1356</StartPage><EndPage>1364</EndPage><MedlinePgn>1356-1364</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/aur.3172</ELocationID><Abstract><AbstractText>Propofol sedation, routinely used for endoscopic procedures, is safe and acceptable for children. Adjuvants, such as esketamine or sufentanil, are commonly added to improve the efficacy and safety of propofol sedation. This study aimed to compare the clinical efficacy and safety of propofol-esketamine (PE) versus propofol-sufentanil (PS) for deep sedation and analgesia in children with autism undergoing colonoscopy procedure. One hundred and twenty-four children with autism undergoing colonoscopy procedure were included in the study. Patients were randomly assigned to receive one of the two adjuvants: esketamine (0.3&#x2009;mg/kg) or sufentanil (0.2&#x2009;&#x3bc;g/kg), subsequently administered propofol 2.0&#x2009;mg/kg to induce anesthesia. Additional doses of propofol (0.5-1.0&#x2009;mg/kg) were administered as needed to ensure patient tolerance for the remaining duration of the procedure. Movement during the procedure, hemodynamic variables, the total dose of propofol, recovery time, and adverse events were recorded. The PE group exhibited a significantly lower incidence of severe movement during the procedure compared with the PS group (14.52% vs. 32.26%, p&#x2009;=&#x2009;0.020). The PE group showed significantly lower incidence of respiratory depression, hypotension, and severe injection pain of propofol than the PS group during the procedure (all p&#x2009;&lt;&#x2009;0.05). The mean arterial pressure (MAP) decreased significantly after anesthesia induction in the PS group and remained lower than baseline (all p&#x2009;&lt;&#x2009;0.05). Compared with the combination of low-dose sufentanil (0.2&#x2009;&#x3bc;g/mg) with propofol, the low-dose esketamine (0.3&#x2009;mg/kg) combined with propofol provided more stable hemodynamics, higher quality of sedation, and fewer adverse events in children with autism undergoing colonoscopy procedure.</AbstractText><CopyrightInformation>&#xa9; 2024 The Author(s). Autism Research published by International Society for Autism Research and Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Miao</LastName><ForeName>Yanxiang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Sir Run Run Hospital, Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Minghui</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Microbiota Medicine and Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Qing</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Sir Run Run Hospital, Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiong</LastName><ForeName>Lixia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Microbiota Medicine and Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Microbiotherapy, Sir Run Run Hospital, Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Jinxiang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Sir Run Run Hospital, Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xiaoyu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Sir Run Run Hospital, Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Guoxiang</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Sir Run Run Hospital, Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaturvedi</LastName><ForeName>Rupesh</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine, School of International Education, Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Faming</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Microbiota Medicine and Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Microbiotherapy, Sir Run Run Hospital, Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Ning</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-7139-3399</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Sir Run Run Hospital, Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>YKK23200</GrantID><Agency>Nanjing Health Technology Project</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Autism Res</MedlineTA><NlmUniqueID>101461858</NlmUniqueID><ISSNLinking>1939-3806</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>690G0D6V8H</RegistryNumber><NameOfSubstance UI="D007649">Ketamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>YI7VU623SF</RegistryNumber><NameOfSubstance UI="D015742">Propofol</NameOfSubstance></Chemical><Chemical><RegistryNumber>AFE2YW0IIZ</RegistryNumber><NameOfSubstance UI="D017409">Sufentanil</NameOfSubstance></Chemical><Chemical><RegistryNumber>50LFG02TXD</RegistryNumber><NameOfSubstance UI="C000629870">Esketamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006993">Hypnotics and Sedatives</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007649" MajorTopicYN="Y">Ketamine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015742" MajorTopicYN="Y">Propofol</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017409" MajorTopicYN="Y">Sufentanil</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001321" MajorTopicYN="Y">Autistic Disorder</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054810" MajorTopicYN="Y">Deep Sedation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006993" MajorTopicYN="N">Hypnotics and Sedatives</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003113" MajorTopicYN="N">Colonoscopy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000698" MajorTopicYN="N">Analgesia</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">anesthesia</Keyword><Keyword MajorTopicYN="N">autism</Keyword><Keyword MajorTopicYN="N">colonoscopy</Keyword><Keyword MajorTopicYN="N">esketamine</Keyword><Keyword MajorTopicYN="N">propofol</Keyword><Keyword MajorTopicYN="N">sufentanil</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>26</Day><Hour>12</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>8</Day><Hour>10</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>8</Day><Hour>4</Hour><Minute>42</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38850067</ArticleId><ArticleId IdType="doi">10.1002/aur.3172</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Aghadavoudi, O., Shetabi, H., &amp; Dezfouli, Z. S. (2020). Comparison of the analgesic and sedative effects of midazolam&#x2010;ketamine and propofol&#x2010;sufentanil combinations in painful procedures of children with haematologic malignancy. Turkish Journal of Anaesthesiology and Reanimation, 48, 120&#x2013;126. https://doi.org/10.5152/TJAR.2019.42402</Citation></Reference><Reference><Citation>Akhondzadeh, R., Ghomeishi, A., Nesioonpour, S., &amp; Nourizade, S. (2016). A comparison between the effects of propofol&#x2010;fentanyl with propofol&#x2010;ketamine for sedation in patients undergoing endoscopic retrograde cholangiopancreatography outside the operating room. Biomedical Journal, 39, 145&#x2013;149. https://doi.org/10.1016/j.bj.2015.11.002</Citation></Reference><Reference><Citation>Akin, A., Guler, G., Esmaoglu, A., Bedirli, N., &amp; Boyaci, A. (2005). A comparison of fentanyl&#x2010;propofol with a ketamine&#x2010;propofol combination for sedation during endometrial biopsy. Journal of Clinical Anesthesia, 17, 187&#x2013;190.</Citation></Reference><Reference><Citation>Brown, J. J., Gray, J. M., Roback, M. G., Sethuraman, U., Farooqi, A., &amp; Kannikeswaran, N. (2019). Procedural sedation in children with autism spectrum disorders in the emergency department. The American Journal of Emergency Medicine, 37, 1404&#x2013;1408. https://doi.org/10.1016/j.ajem.2018.10.025</Citation></Reference><Reference><Citation>Elitsur, Y., Blankenship, P., &amp; Lawrence, Z. (2000). Propofol sedation for endoscopic procedures in children. Endoscopy, 32, 788&#x2013;791.</Citation></Reference><Reference><Citation>Hayes, J., Matava, C., Pehora, C., El&#x2010;Beheiry, H., Jarvis, S., &amp; Finkelstein, Y. (2018). Determination of the median effective dose of propofol in combination with different doses of ketamine during gastro&#x2010;duodenoscopy in children: A randomised controlled trial. British Journal of Anaesthesia, 121, 453&#x2013;461. https://doi.org/10.1016/j.bja.2018.03.037</Citation></Reference><Reference><Citation>Hentgen, E., Houfani, M., Billard, V., Capron, F., Ropars, J.&#x2010;M., &amp; Travagli, J. P. (2002). Propofol&#x2010;sufentanil anesthesia for thyroid surgery: Optimal concentrations for hemodynamic and electroencephalogram stability, and recovery features. Anesthesia and Analgesia, 95, 597&#x2013;605.</Citation></Reference><Reference><Citation>Izgi, M., Basaran, B., Muderrisoglu, A., Ankay Yilbas, A., Uluer, M. S., &amp; Celebioglu, B. (2018). Evaluation of the stability and stratification of propofol and ketamine mixtures for pediatric anesthesia. Paediatric Anaesthesia, 28, 275&#x2013;280. https://doi.org/10.1111/pan.13318</Citation></Reference><Reference><Citation>Jalili, M., Bahreini, M., Doosti&#x2010;Irani, A., Masoomi, R., Arbab, M., &amp; Mirfazaelian, H. (2016). Ketamine&#x2010;propofol combination (ketofol) vs propofol for procedural sedation and analgesia: Systematic review and meta&#x2010;analysis. The American Journal of Emergency Medicine, 34, 558&#x2013;569. https://doi.org/10.1016/j.ajem.2015.12.074</Citation></Reference><Reference><Citation>Kamat, P. P., Bryan, L. N., McCracken, C. E., Simon, H. K., Berkenbosch, J. W., &amp; Grunwell, J. R. (2018). Procedural sedation in children with autism spectrum disorders: A survey of current practice patterns of the society for pediatric sedation members. Paediatric Anaesthesia, 28, 552&#x2013;557. https://doi.org/10.1111/pan.13387</Citation></Reference><Reference><Citation>Kwak, H. J., Min, S. K., Kim, J. S., &amp; Kim, J. Y. (2009). Prevention of propofol&#x2010;induced pain in children: Combination of alfentanil and lidocaine vs alfentanil or lidocaine alone. British Journal of Anaesthesia, 103, 410&#x2013;412. https://doi.org/10.1093/bja/aep163</Citation></Reference><Reference><Citation>Lai, M.&#x2010;C., Lombardo, M. V., &amp; Baron&#x2010;Cohen, S. (2014). Autism. Lancet (London, England), 383, 896&#x2013;910. https://doi.org/10.1016/S0140-6736(13)61539-1</Citation></Reference><Reference><Citation>Li, B. L., Yuen, V. M.&#x2010;Y., Zhang, N., Zhang, H. H., Huang, J. X., Yang, S. Y., Miller, J. W., &amp; Song, X. R. (2019). A comparison of intranasal dexmedetomidine and dexmedetomidine plus buccal midazolam for non&#x2010;painful procedural sedation in children with autism. Journal of Autism and Developmental Disorders, 49, 3798&#x2013;3806. https://doi.org/10.1007/s10803-019-04095-w</Citation></Reference><Reference><Citation>Martorano, P. P., Aloj, F., Baietta, S., Fiorelli, A., Munari, M., Paccagnella, F., Rosa, G., Scafuro, M., Zei, E., Falzetti, G., &amp; Pelaia, P. (2008). Sufentanil&#x2010;propofol vs remifentanil&#x2010;propofol during total intravenous anesthesia for neurosurgery. A multicentre study. Minerva Anestesiologica, 74, 233&#x2013;243.</Citation></Reference><Reference><Citation>McBride, G. R., Stephenson, K. A. J., Comer, G., &amp; Flanagan, O. (2021). The use of oral midazolam to facilitate the ophthalmic examination of children with autism and developmental disorders. Journal of Autism and Developmental Disorders, 51, 1678&#x2013;1682. https://doi.org/10.1007/s10803-020-04658-2</Citation></Reference><Reference><Citation>Monk, J. P., Beresford, R., &amp; Ward, A. (1988). Sufentanil. A review of its pharmacological properties and therapeutic use. Drugs, 36, 286&#x2013;313.</Citation></Reference><Reference><Citation>Morice, V. (2012). RandoWeb, an online randomization tool for clinical trials. Computer Methods and Programs in Biomedicine, 107, 308&#x2013;314. https://doi.org/10.1016/j.cmpb.2011.10.003</Citation></Reference><Reference><Citation>Nikayin, S., Murphy, E., Krystal, J. H., &amp; Wilkinson, S. T. (2022). Long&#x2010;term safety of ketamine and esketamine in treatment of depression. Expert Opinion on Drug Safety, 21, 777&#x2013;787. https://doi.org/10.1080/14740338.2022.2066651</Citation></Reference><Reference><Citation>Peng, Z., Xiang, J., He, Z., Zhang, T., Xu, L., Cui, B., Li, P., Huang, G., Ji, G., Nie, Y., Wu, K., Fan, D., &amp; Zhang, F. (2016). Colonic transendoscopic enteral tubing: A novel way of transplanting fecal microbiota. Endoscopy International Open, 4, E610&#x2013;E613. https://doi.org/10.1055/s-0042-105205</Citation></Reference><Reference><Citation>Seol, T.&#x2010;K., Lim, J.&#x2010;K., Yoo, E.&#x2010;K., Min, S.&#x2010;W., Kim, C.&#x2010;S., &amp; Hwang, J.&#x2010;Y. (2015). Propofol&#x2010;ketamine or propofol&#x2010;remifentanil for deep sedation and analgesia in pediatric patients undergoing burn dressing changes: A randomized clinical trial. Paediatric Anaesthesia, 25, 560&#x2013;566. https://doi.org/10.1111/pan.12592</Citation></Reference><Reference><Citation>Singh, R., Arora, M., &amp; Vajifdar, H. (2011). Randomized double&#x2010;blind comparison of ketamine&#x2010;propofol and fentanyl&#x2010;propofol for the insertion of laryngeal mask airway in children. Journal of Anaesthesiology Clinical Pharmacology, 27, 91&#x2013;96.</Citation></Reference><Reference><Citation>Singh, S. A., Prakash, K., Sharma, S., Dhakate, G., &amp; Bhatia, V. (2018). Comparison of propofol alone and in combination with ketamine or fentanyl for sedation in endoscopic ultrasonography. Korean Journal of Anesthesiology, 71, 43&#x2013;47. https://doi.org/10.4097/kjae.2018.71.1.43</Citation></Reference><Reference><Citation>Wang, Y., Zhang, S., Borody, T. J., &amp; Zhang, F. (2022). Encyclopedia of fecal microbiota transplantation: A review of effectiveness in the treatment of 85 diseases. Chinese Medical Journal, 135, 1927&#x2013;1939. https://doi.org/10.1097/CM9.0000000000002339</Citation></Reference><Reference><Citation>Yin, S., Hong, J., Sha, T., Chen, Z., Guo, Y., Li, C., &amp; Liu, Y. (2019). Efficacy and tolerability of sufentanil, dexmedetomidine, or ketamine added to propofol&#x2010;based sedation for gastrointestinal endoscopy in elderly patients: A prospective, randomized, controlled trial. Clinical Therapeutics, 41, 1864&#x2013;1877.e0. https://doi.org/10.1016/j.clinthera.2019.06.011</Citation></Reference><Reference><Citation>Yu, J., Xiang, B., Song, Y., Chen, H., Li, Y., &amp; Liu, C. (2019). ED50 of propofol in combination with low&#x2010;dose sufentanil for intravenous anaesthesia in hysteroscopy. Basic &amp; Clinical Pharmacology &amp; Toxicology, 125, 460&#x2013;465. https://doi.org/10.1111/bcpt.13280</Citation></Reference><Reference><Citation>Yu, Y., Qi, S.&#x2010;L., &amp; Zhang, Y. (2017). Role of combined propofol and sufentanil anesthesia in endoscopic injection sclerotherapy for esophageal varices. World Journal of Gastroenterology, 23, 7875&#x2013;7880. https://doi.org/10.3748/wjg.v23.i44.7875</Citation></Reference><Reference><Citation>Zeidan, J., Fombonne, E., Scorah, J., Ibrahim, A., Durkin, M. S., Saxena, S., Yusuf, A., Shih, A., &amp; Elsabbagh, M. (2022). Global prevalence of autism: A systematic review update. Autism Research: Official Journal of the International Society for Autism Research, 15, 778&#x2013;790. https://doi.org/10.1002/aur.2696</Citation></Reference><Reference><Citation>Zhan, Y., Liang, S., Yang, Z., Luo, Q., Li, S., Li, J., Liang, Z., &amp; Li, Y. (2022). Efficacy and safety of subanesthetic doses of esketamine combined with propofol in painless gastrointestinal endoscopy: A prospective, double&#x2010;blind, randomized controlled trial. BMC Gastroenterology, 22, 391. https://doi.org/10.1186/s12876-022-02467-8</Citation></Reference><Reference><Citation>Zhang, T., Lu, G., Zhao, Z., Liu, Y., Shen, Q., Li, P., Chen, Y., Yin, H., Wang, H., Marcella, C., Cui, B., Cheng, L., Ji, G., &amp; Zhang, F. (2020). Washed microbiota transplantation vs. manual fecal microbiota transplantation: Clinical findings, animal studies and in vitro screening. Protein &amp; Cell, 11, 251&#x2013;266. https://doi.org/10.1007/s13238-019-00684-8</Citation></Reference><Reference><Citation>Zhao, G.&#x2010;y., Guo, Y., Bao, S.&#x2010;m., Meng, L.&#x2010;x., &amp; Zhang, L.&#x2010;h. (2012). Prevention of propofol&#x2010;induced pain in children: Pretreatment with small doses of ketamine. Journal of Clinical Anesthesia, 24, 284&#x2013;288. https://doi.org/10.1016/j.jclinane.2011.08.013</Citation></Reference><Reference><Citation>Zheng, X.&#x2010;S., Shen, Y., Yang, Y.&#x2010;Y., He, P., Wang, Y. T., Tao, Y. Y., Zheng, J. J., &amp; Sun, Y. (2022). ED50 and ED95 of propofol combined with different doses of esketamine for children undergoing upper gastrointestinal endoscopy: A prospective dose&#x2010;finding study using up&#x2010;and&#x2010;down sequential allocation method. Journal of Clinical Pharmacy and Therapeutics, 47, 1002&#x2013;1009. https://doi.org/10.1111/jcpt.13635</Citation></Reference><Reference><Citation>Zheng, Y., Xu, Y., Huang, B., Mai, Y., Zhang, Y., &amp; Zhang, Z. (2022). Effective dose of propofol combined with a low&#x2010;dose esketamine for gastroscopy in elderly patients: A dose finding study using dixon's up&#x2010;and&#x2010;down method. Frontiers in Pharmacology, 13, 956392. https://doi.org/10.3389/fphar.2022.956392</Citation></Reference><Reference><Citation>Zhong, M., Buch, H., Wen, Q., Long, C., Cui, B., &amp; Zhang, F. (2021). Colonic transendoscopic enteral tubing: Route for a novel, safe, and convenient delivery of washed microbiota transplantation in children. Gastroenterology Research and Practice, 2021, 6676962. https://doi.org/10.1155/2021/6676962</Citation></Reference><Reference><Citation>Zhong, Y., Jiang, M., Wang, Y., Su, T., Lv, Y., Fan, Z., Ning, H., Yang, Y., Chen, Y., &amp; Xie, Y. (2023). Evaluating efficacy and safety of sub&#x2010;anesthetic dose esketamine as an adjuvant to propofol/remifentanil analgosedation and spontaneous respiration for children flexible fibreoptic bronchoscopy: A prospective, double&#x2010;blinded, randomized, and placebo&#x2010;controlled clinical trial. Frontiers in Pharmacology, 14, 1184663. https://doi.org/10.3389/fphar.2023.1184663</Citation></Reference><Reference><Citation>Zhou, S., Zhu, Z., Dai, W., Qi, S., Tian, W., Zhang, Y., Zhang, X., Huang, L., Tian, J., Yu, W., &amp; Su, D. (2021). National survey on sedation for gastrointestinal endoscopy in 2758 Chinese hospitals. British Journal of Anaesthesia, 127, 56&#x2013;64. https://doi.org/10.1016/j.bja.2021.01.028</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26702484</PMID><DateCompleted><Year>2016</Year><Month>10</Month><Day>24</Day></DateCompleted><DateRevised><Year>2017</Year><Month>09</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-2472</ISSN><JournalIssue CitedMedium="Internet"><Volume>138</Volume><PubDate><Year>2016</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Thrombosis research</Title><ISOAbbreviation>Thromb Res</ISOAbbreviation></Journal><ArticleTitle>Risk factors and clinical features of acute pulmonary embolism in children from the community.</ArticleTitle><Pagination><StartPage>86</StartPage><EndPage>90</EndPage><MedlinePgn>86-90</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.thromres.2015.12.005</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0049-3848(15)30220-6</ELocationID><Abstract><AbstractText Label="BACKGROUND AND AIMS" NlmCategory="OBJECTIVE">Current clinical decision rules for pulmonary embolism are based on adult populations and have not been validated in children. The objective was to identify and evaluate clinical features for a first lifetime episode of pulmonary embolism in children presenting to the emergency department.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">We present a case-control study of children (&#x2264;18years) presenting to the emergency department of the Royal Children's Hospital, Melbourne between November 2007 and February 2015. Children with radiologically proven pulmonary embolism formed the case group, whilst children in whom there was a clinical suspicion of pulmonary embolism but negative diagnostic imaging formed the control group. Charts, electronic medical and imaging records of both cases and controls were reviewed and analysed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">There were a total of 50 patients in this study (11 cases and 39 controls). Current or recent (within three months) use of the oral contraceptive pill was the most significant risk factor in our study (odds ratio 14.667, 95% confidence interval 3.001-71.678, P&lt;0.001). Most other features failed to discriminate between cases and controls, although there was a trend towards increased heart rate in cases.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Pulmonary embolism is perhaps the most common presenting spontaneous venous thromboembolism in the community and teenage girls on the oral contraceptive pill are most at-risk amongst children. The clinical signs and symptoms are often non-specific. Additional larger studies are required to determine the significance and magnitude of potential clinical predictors identified in this study. This may lead to derivation of a paediatric-specific pre-test probability tool.</AbstractText><CopyrightInformation>Copyright &#xa9; 2015 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Charlie Yue</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Department of Surgery, Monash University, Clayton, Victoria 3168, Australia; School of Clinical Sciences, Monash Health, Clayton, Victoria 3168, Australia. Electronic address: cywan14@student.monash.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ignjatovic</LastName><ForeName>Vera</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Haematology Research Group, Murdoch Children's Research Institute, Clayton, Victoria 3052, Australia; Department of Paediatrics, The University of Melbourne, Parkville, Victoria 3052, Australia. Electronic address: verai@unimelb.edu.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Francis</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Emergency Department, The Royal Children's Hospital Melbourne, Parkville, Victoria 3052, Australia. Electronic address: peter.francis@rch.org.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cain</LastName><ForeName>Timothy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Emergency Department, The Royal Children's Hospital Melbourne, Parkville, Victoria 3052, Australia. Electronic address: tim.cain@rch.org.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Babl</LastName><ForeName>Franz</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>The Cardiology Department, The Royal Children's Hospital Melbourne, Parkville, Victoria 3052, Australia. Electronic address: franz.babl@rch.org.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kowalski</LastName><ForeName>Remi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Medical Imaging, The Royal Children's Hospital Melbourne, Parkville, Victoria 3052, Australia. Electronic address: remi.kowalski@rch.org.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cochrane</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgery, Monash University, Clayton, Victoria 3168, Australia; Department of Cardiothoracic Surgery, Monash Health, Clayton, Victoria 3168, Australia. Electronic address: andrew.cochrane@monashhealth.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monagle</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Haematology Research Group, Murdoch Children's Research Institute, Clayton, Victoria 3052, Australia; Department of Paediatrics, The University of Melbourne, Parkville, Victoria 3052, Australia; Clinical Haematology Group, The Royal Children's Hospital Melbourne, Parkville, Victoria 3052, Australia. Electronic address: paul.monagle@rch.org.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>12</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Thromb Res</MedlineTA><NlmUniqueID>0326377</NlmUniqueID><ISSNLinking>0049-3848</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003277">Contraceptives, Oral, Combined</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003277" MajorTopicYN="N">Contraceptives, Oral, Combined</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004636" MajorTopicYN="N">Emergency Service, Hospital</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011651" MajorTopicYN="N">Pulmonary Artery</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Child</Keyword><Keyword MajorTopicYN="N">Hospital emergency service</Keyword><Keyword MajorTopicYN="N">Pulmonary embolism</Keyword><Keyword MajorTopicYN="N">Risk factors</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>9</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>12</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>12</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26702484</ArticleId><ArticleId IdType="doi">10.1016/j.thromres.2015.12.005</ArticleId><ArticleId IdType="pii">S0049-3848(15)30220-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32495037</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>23</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1279-8517</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>11</Issue><PubDate><Year>2020</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Surgical and radiologic anatomy : SRA</Title><ISOAbbreviation>Surg Radiol Anat</ISOAbbreviation></Journal><ArticleTitle>The effect of pectus excavatum deformity on lung volume: fact or myth?</ArticleTitle><Pagination><StartPage>1287</StartPage><EndPage>1292</EndPage><MedlinePgn>1287-1292</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00276-020-02512-9</ELocationID><Abstract><AbstractText Label="BACKGROUND AND PURPOSE" NlmCategory="OBJECTIVE">Most of the previous studies evaluating lung volume of pectus excavatum (PE) patients were based on spirometric measurements. We aimed to calculate lung volume of patients with PE and compare them with lung volume of patients without chest wall deformity using CT volumetry.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">After institutional review board approval, preoperative chest CT of PE patients who underwent minimal invasive procedure between January 2012 and February 2018, were evaluated retrospectively. As a control group, age and sex matched patients who underwent chest CT scan in the same period were enrolled. Total, right and left lung volumes were calculated using an automated software. Haller indexes were measured for both groups. Lung volumes and Haller indexes compared between the two groups. We also compared left and right lung volumes in both groups. We evaluated whether there is a correlation across the Haller index and total lung volume.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Total, right and left lung volumes were not statistically different between the two groups. While left lung volumes were significantly smaller in PE group (p&#x2009;=&#x2009;0.041), there was no significant difference between the left and right lung volume in the control group (p&#x2009;=&#x2009;0.12). Haller index and total lung volume showed no significant correlation between patients with the same age and gender (p&#x2009;=&#x2009;0.14, R&#x2009;=&#x2009;-0.3).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">PE deformity does not reduce lung volume when compared to age and sex matched control group. Quantitative CT volumetric evaluation of lung gives valuable data about lung volume.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cebeci</LastName><ForeName>Hakan</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-2017-3166</Identifier><AffiliationInfo><Affiliation>Department of Radiology, Faculty of Medicine, Sel&#xe7;uk University, 42130, Konya, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>K&#x131;l&#x131;n&#xe7;er</LastName><ForeName>Abidin</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-6027-874X</Identifier><AffiliationInfo><Affiliation>Department of Radiology, Faculty of Medicine, Sel&#xe7;uk University, 42130, Konya, Turkey. akilincer@yahoo.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xd6;zl&#xfc;</LastName><ForeName>Mustafa Yasir</ForeName><Initials>MY</Initials><Identifier Source="ORCID">0000-0003-4940-7592</Identifier><AffiliationInfo><Affiliation>Department of Radiology, Faculty of Medicine, Sel&#xe7;uk University, 42130, Konya, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xd6;zt&#xfc;rk</LastName><ForeName>Mehmet</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-5585-1476</Identifier><AffiliationInfo><Affiliation>Department of Radiology, Faculty of Medicine, Sel&#xe7;uk University, 42130, Konya, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xd6;ncel</LastName><ForeName>Murat</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8381-7961</Identifier><AffiliationInfo><Affiliation>Department of Thoracic Surgery, Faculty of Medicine, Sel&#xe7;uk University, Konya, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sunam</LastName><ForeName>G&#xfc;ven Sadi</ForeName><Initials>GS</Initials><Identifier Source="ORCID">0000-0001-9655-0012</Identifier><AffiliationInfo><Affiliation>Department of Thoracic Surgery, Faculty of Medicine, Sel&#xe7;uk University, Konya, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Surg Radiol Anat</MedlineTA><NlmUniqueID>8608029</NlmUniqueID><ISSNLinking>0930-1038</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005660" MajorTopicYN="N">Funnel Chest</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000033" MajorTopicYN="Y">anatomy &amp; histology</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008176" MajorTopicYN="N">Lung Volume Measurements</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057234" MajorTopicYN="N">Preoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CT</Keyword><Keyword MajorTopicYN="N">Haller index</Keyword><Keyword MajorTopicYN="N">Lung CT volumetry</Keyword><Keyword MajorTopicYN="N">Lung volume</Keyword><Keyword MajorTopicYN="N">Pectus excavatum</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>2</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>5</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32495037</ArticleId><ArticleId IdType="doi">10.1007/s00276-020-02512-9</ArticleId><ArticleId IdType="pii">10.1007/s00276-020-02512-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24696095</PMID><DateCompleted><Year>2015</Year><Month>10</Month><Day>08</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1941-2444</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>5</Issue><PubDate><Year>2014</Year><Month>Jul</Month></PubDate></JournalIssue><Title>JPEN. Journal of parenteral and enteral nutrition</Title><ISOAbbreviation>JPEN J Parenter Enteral Nutr</ISOAbbreviation></Journal><ArticleTitle>A.S.P.E.N. clinical guidelines: support of pediatric patients with intestinal failure at risk of parenteral nutrition-associated liver disease.</ArticleTitle><Pagination><StartPage>538</StartPage><EndPage>557</EndPage><MedlinePgn>538-57</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/0148607114527772</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Children with severe intestinal failure and prolonged dependence on parenteral nutrition are susceptible to the development of parenteral nutrition-associated liver disease (PNALD). The purpose of this clinical guideline is to develop recommendations for the care of children with PN-dependent intestinal failure that have the potential to prevent PNALD or improve its treatment.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">A systematic review of the best available evidence to answer a series of questions regarding clinical management of children with intestinal failure receiving parenteral or enteral nutrition was undertaken and evaluated using concepts adopted from the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) Working Group. A consensus process was used to develop the clinical guideline recommendations prior to external and internal review and approval by the American Society for Parenteral and Enteral Nutrition Board of Directors.</AbstractText><AbstractText Label="QUESTIONS" NlmCategory="OBJECTIVE">(1) Is ethanol lock effective in preventing bloodstream infection and catheter removal in children at risk of PNALD? (2) What fat emulsion strategies can be used in pediatric patients with intestinal failure to reduce the risk of or treat PNALD? (3) Can enteral ursodeoxycholic acid improve the treatment of PNALD in pediatric patients with intestinal failure? (4) Are PNALD outcomes improved when patients are managed by a multidisciplinary intestinal rehabilitation team?</AbstractText><CopyrightInformation>&#xa9; 2014 American Society for Parenteral and Enteral Nutrition.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wales</LastName><ForeName>Paul W</ForeName><Initials>PW</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Toronto, Toronto, Ontario, Canada The Hospital for Sick Children, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allen</LastName><ForeName>Nancy</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Children's Mercy Hospital, Kansas City, Missouri.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Worthington</LastName><ForeName>Patricia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Thomas Jefferson University Hospital, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>George</LastName><ForeName>Donald</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Nemours Children's Clinic, Jacksonville, Florida.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Compher</LastName><ForeName>Charlene</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University of Pennsylvania School of Nursing, Philadelphia, Pennsylvania compherc@nursing.upenn.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>American Society for Parenteral and Enteral Nutrition</CollectiveName></Author><Author ValidYN="Y"><LastName>Teitelbaum</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University of Michigan, Ann Arbor, Michigan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017065">Practice Guideline</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>04</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JPEN J Parenter Enteral Nutr</MedlineTA><NlmUniqueID>7804134</NlmUniqueID><ISSNLinking>0148-6071</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007410" MajorTopicYN="Y">Intestinal Diseases</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008107" MajorTopicYN="Y">Liver Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010288" MajorTopicYN="Y">Parenteral Nutrition</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">home nutrition support</Keyword><Keyword MajorTopicYN="N">life cycle</Keyword><Keyword MajorTopicYN="N">lipids</Keyword><Keyword MajorTopicYN="N">nutrition</Keyword><Keyword MajorTopicYN="N">parenteral nutrition</Keyword><Keyword MajorTopicYN="N">pediatrics</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>Malone</LastName><ForeName>Ainsley</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jaksic</LastName><ForeName>Tom</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ayers</LastName><ForeName>Phil</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baroccas</LastName><ForeName>Albert</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goday</LastName><ForeName>Praveen S</ForeName><Initials>PS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ireton-Jones</LastName><ForeName>Carol</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sacks</LastName><ForeName>Gordon</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mirtallo</LastName><ForeName>Jay</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Robinson</LastName><ForeName>Lawrence A</ForeName><Initials>LA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Van Way</LastName><ForeName>Charles W</ForeName><Initials>CW</Initials><Suffix>3rd</Suffix></Investigator><Investigator ValidYN="Y"><LastName>Compher</LastName><ForeName>Charlene</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Allen</LastName><ForeName>Nancy</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Boullata</LastName><ForeName>Joseph I</ForeName><Initials>JI</Initials></Investigator><Investigator ValidYN="Y"><LastName>Braunschweig</LastName><ForeName>Carol L</ForeName><Initials>CL</Initials></Investigator><Investigator ValidYN="Y"><LastName>George</LastName><ForeName>Donald E</ForeName><Initials>DE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Simpser</LastName><ForeName>Edwin</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Worthington</LastName><ForeName>Patricia A</ForeName><Initials>PA</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>10</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24696095</ArticleId><ArticleId IdType="doi">10.1177/0148607114527772</ArticleId><ArticleId IdType="pii">0148607114527772</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33219527</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>20</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1600-0528</ISSN><JournalIssue CitedMedium="Internet"><Volume>49</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Community dentistry and oral epidemiology</Title><ISOAbbreviation>Community Dent Oral Epidemiol</ISOAbbreviation></Journal><ArticleTitle>Caries experience among children born after a complicated pregnancy.</ArticleTitle><Pagination><StartPage>225</StartPage><EndPage>231</EndPage><MedlinePgn>225-231</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/cdoe.12593</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Behavioural and lifestyle factors, as oral hygiene and diet, are well-established risk factors in the pathogenesis of dental caries, though displaying large differences in susceptibility across individuals. Since enamel formation already starts in utero, pregnancy course and outcome may eventually play a role in enamel strength and caries susceptibility. Therefore, we studied the association between history of pregnancy complications and the caries experience in their six-year-old children. The pregnancy complications included small for gestational age (SGA), spontaneous preterm birth (sPTB), gestational hypertension (GH), pre-eclampsia (PE), individually, and a combination of those, designated as placental syndrome.</AbstractText><AbstractText Label="METHODS">This study was embedded in Generation R, a prospective longitudinal Dutch multiethnic pregnancy cohort study. Information about pregnancy complications was obtained from questionnaires completed by midwives and obstetricians with cross-validation in medical records. These included SGA, sPTB, GH and PE. Caries experience was assessed with the decayed, missing and filled teeth (dmft) index at a mean age of six years. The association between dental caries experience and a history of pregnancy complications was studied by using hurdle negative binomial (HNB) models.</AbstractText><AbstractText Label="RESULTS">We were able to assess the dmft index in 5323 six-year-old children (mean age 6.2&#xa0;years, SD 0.5). We did not find an association between the different pregnancy complications and dental caries experience in childhood, whether for SGA, sPTB, GH, PE, or for the combined outcome placental syndrome (HNB estimates: OR 1.02, 95%CI 0.87 - 1.19; RR 0.90, 95%CI 0.78 - 1.04). Further adjustment of the models with different confounders did not alter the outcome.</AbstractText><AbstractText Label="CONCLUSIONS">Although it is expected that prenatal stress can be a risk factor for caries development later in life, our findings do not support this hypothesis. Therefore, we believe disparities in caries experience between children are probably not explained by early life events during a critical intrauterine period of development.</AbstractText><CopyrightInformation>&#xa9; 2020 The Authors. Community Dentistry and Oral Epidemiology published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>van der Tas</LastName><ForeName>Justin T</ForeName><Initials>JT</Initials><Identifier Source="ORCID">0000-0003-4624-6447</Identifier><AffiliationInfo><Affiliation>The Generation R Study Group, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Oral &amp; Maxillofacial Surgery, Special Dental Care and Orthodontics, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wolvius</LastName><ForeName>Eppo B</ForeName><Initials>EB</Initials><AffiliationInfo><Affiliation>The Generation R Study Group, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Oral &amp; Maxillofacial Surgery, Special Dental Care and Orthodontics, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kragt</LastName><ForeName>Lea</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-4223-429X</Identifier><AffiliationInfo><Affiliation>The Generation R Study Group, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Oral &amp; Maxillofacial Surgery, Special Dental Care and Orthodontics, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rivadeneira</LastName><ForeName>Fernando</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>The Generation R Study Group, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Oral &amp; Maxillofacial Surgery, Special Dental Care and Orthodontics, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moll</LastName><ForeName>Henri&#xeb;tte A</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>The Generation R Study Group, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steegers</LastName><ForeName>Eric A P</ForeName><Initials>EAP</Initials><AffiliationInfo><Affiliation>The Generation R Study Group, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schalekamp-Timmermans</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>The Generation R Study Group, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>Community Dent Oral Epidemiol</MedlineTA><NlmUniqueID>0410263</NlmUniqueID><ISSNLinking>0301-5661</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004245" MajorTopicYN="N">DMF Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003731" MajorTopicYN="Y">Dental Caries</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003733" MajorTopicYN="N">Dental Caries Susceptibility</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D047928" MajorTopicYN="Y">Premature Birth</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">dental caries</Keyword><Keyword MajorTopicYN="N">epidemiology</Keyword><Keyword MajorTopicYN="N">paediatric dentistry</Keyword><Keyword MajorTopicYN="N">pregnancy complications</Keyword></KeywordList><CoiStatement>All authors declare to have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>10</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>10</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>21</Day><Hour>5</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>7</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33219527</ArticleId><ArticleId IdType="pmc">PMC8246927</ArticleId><ArticleId IdType="doi">10.1111/cdoe.12593</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Vos T, Lozano R, Naghavi M, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990&#x2013;2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743&#x2010;800.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4561509</ArticleId><ArticleId IdType="pubmed">26063472</ArticleId></ArticleIdList></Reference><Reference><Citation>Selwitz RH, Ismail AI, Pitts NB. Dental caries. Lancet. 2007;369:51&#x2010;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">17208642</ArticleId></ArticleIdList></Reference><Reference><Citation>Americano GC, Jacobsen PE, Soviero VM, Haubek D. A systematic review on the association between molar incisor hypomineralization and dental caries. Int J Paediatr Dent. 2017;27:11&#x2010;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">27098755</ArticleId></ArticleIdList></Reference><Reference><Citation>Elfrink ME, Schuller AA, Veerkamp JS, Poorterman JH, Moll HA, ten Cate JM. Factors increasing the caries risk of second primary molars in 5&#x2010;year&#x2010;old Dutch children. Int J Paediatr Dent. 2010;20:151&#x2010;157.</Citation><ArticleIdList><ArticleId IdType="pubmed">20384830</ArticleId></ArticleIdList></Reference><Reference><Citation>Barker DJ. The foetal and infant origins of adult disease. BMJ. 1990;301:1111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1664286</ArticleId><ArticleId IdType="pubmed">2252919</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith CE. Cellular and chemical events during enamel maturation. Crit Rev Oral Biol Med. 1998;9:128&#x2010;161.</Citation><ArticleIdList><ArticleId IdType="pubmed">9603233</ArticleId></ArticleIdList></Reference><Reference><Citation>Eli I, Sarnat H, Talmi E. Effect of the birth process on the neonatal line in primary tooth enamel. Pediatr Dent. 1989;11:220&#x2010;223.</Citation><ArticleIdList><ArticleId IdType="pubmed">2638008</ArticleId></ArticleIdList></Reference><Reference><Citation>Canturk N, Atsu SS, Aka PS, Dagalp R. Neonatal line on fetus and infant teeth: An indicator of live birth and mode of delivery. Early Hum Dev. 2014;90:393&#x2010;397.</Citation><ArticleIdList><ArticleId IdType="pubmed">24951074</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurnanen J, Visnapuu V, Sillanp&#xe4;&#xe4; M, L&#xf6;yttyniemi E, Rautava J. Deciduous neonatal line: Width is associated with duration of delivery. Forensic Sci Int. 2017;271:87&#x2010;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">28073052</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabel N, Johansson C, K&#xfc;hnisch J, et al. Neonatal lines in the enamel of primary teeth&#x2014;a morphological and scanning electron microscopic investigation. Arch Oral Biol. 2008;53:954&#x2010;963.</Citation><ArticleIdList><ArticleId IdType="pubmed">18589400</ArticleId></ArticleIdList></Reference><Reference><Citation>FitzGerald CM, Saunders SR. Test of histological methods of determining chronology of accentuated striae in deciduous teeth. Am J Phys Anthropol. 2005;127:277&#x2010;290.</Citation><ArticleIdList><ArticleId IdType="pubmed">15584065</ArticleId></ArticleIdList></Reference><Reference><Citation>FitzGerald C, Saunders S, Bondioli L, Macchiarelli R. Health of infants in an imperial roman skeletal sample: Perspective from dental microstructure. Am J Phys Anthropol. 2006;130:179&#x2010;189.</Citation><ArticleIdList><ArticleId IdType="pubmed">16365859</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmer JP, Papagerakis P, Smith CE, et al. Regulation of dental enamel shape and hardness. J Dent Res. 2010;89:1024&#x2010;1038.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3086535</ArticleId><ArticleId IdType="pubmed">20675598</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobsen PE, Haubek D, Henriksen TB, &#xd8;stergaard JR, Poulsen S. Developmental enamel defects in children born preterm: A systematic review. Eur J Oral Sci. 2014;122:7&#x2010;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">24164573</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa FS, Silveira ER, Pinto GS, Nascimento GG, Thomson WM, Demarco FF. Developmental defects of enamel and dental caries in the primary dentition: A systematic review and meta&#x2010;analysis. J Dent. 2017;60:1&#x2010;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">28347809</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolau B, Thomson WM, Steele JG, Allison PJ. Life&#x2010;course epidemiology: Concepts and theoretical models and its relevance to chronic oral conditions. Community Dent Oral Epidemiol. 2007;35:241&#x2010;249.</Citation><ArticleIdList><ArticleId IdType="pubmed">17615010</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokomichi H, Tanaka T, Suzuki K, Akiyama T, Yamagata Z. Macrosomic Neonates Carry Increased Risk of Dental Caries in Early Childhood: Findings from a Cohort Study, the Okinawa Child Health Study, Japan. PLoS One. 2015;10:e0133872.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4514765</ArticleId><ArticleId IdType="pubmed">26207737</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernab&#xe9; E, MacRitchie H, Longbottom C, Pitts NB, Sabbah W. Birth weight, breastfeeding, maternal smoking and caries trajectories. J Dent Res. 2016;96:171&#x2010;178.</Citation><ArticleIdList><ArticleId IdType="pubmed">27834298</ArticleId></ArticleIdList></Reference><Reference><Citation>Nirunsittirat A, Pitiphat W, McKinney C, et al. Adverse birth outcomes and childhood caries: A cohort study. Community Dent Oral Epidemiol. 2016;44:239&#x2010;247.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4833576</ArticleId><ArticleId IdType="pubmed">26750102</ArticleId></ArticleIdList></Reference><Reference><Citation>Saraiva MC, Bettiol H, Barbieri MA, Silva AA. Are intrauterine growth restriction and preterm birth associated with dental caries? Community Dent Oral Epidemiol. 2007;35:364&#x2010;376.</Citation><ArticleIdList><ArticleId IdType="pubmed">17822485</ArticleId></ArticleIdList></Reference><Reference><Citation>Shulman JD. Is there an association between low birth weight and caries in the primary dentition? Caries Res. 2005;39:161&#x2010;167.</Citation><ArticleIdList><ArticleId IdType="pubmed">15914975</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka K, Miyake Y. Low birth weight, preterm birth or small&#x2010;for&#x2010;gestational&#x2010;age are not associated with dental caries in young Japanese children. BMC Oral Health. 2014;14:38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3989784</ArticleId><ArticleId IdType="pubmed">24731399</ArticleId></ArticleIdList></Reference><Reference><Citation>Kooijman MN, Kruithof CJ, van Duijn CM, et al. The generation R study: Design and cohort update 2017. Eur J Epidemiol. 2016;31:1243&#x2010;1264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5233749</ArticleId><ArticleId IdType="pubmed">28070760</ArticleId></ArticleIdList></Reference><Reference><Citation>Coolman M, de Groot CJM, Jaddoe VW, Hofman A, Raat H, Steegers EAP. Medical record validation of maternally reported history of preeclampsia. J Clin Epidemiol. 2010;63:932&#x2010;937.</Citation><ArticleIdList><ArticleId IdType="pubmed">20189760</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaillard R, de Ridder MAJ, Verburg BO, et al. Individually customised foetal weight charts derived from ultrasound measurements: The generation R study. Eur J Epidemiol. 2011;26:919&#x2010;926.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3253277</ArticleId><ArticleId IdType="pubmed">22083366</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol BWJ, Roberts CT, Thangaratinam S, Magee LA, de Groot CJM, Hofmeyr GJ. Pre&#x2010;eclampsia. Lancet. 2016;387:999&#x2010;1011.</Citation><ArticleIdList><ArticleId IdType="pubmed">26342729</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohn W, Burt B, Sowers M. Carbonated soft drinks and dental caries in the primary dentition. J Dent Res. 2006;85:262&#x2010;266.</Citation><ArticleIdList><ArticleId IdType="pubmed">16498075</ArticleId></ArticleIdList></Reference><Reference><Citation>Brosens I, Pijnenborg R, Vercruysse L, Romero R. The, &#x201c;great obstetrical syndromes&#x201d; are associated with disorders of deep placentation. Am J Obstet Gynecol. 2011;204:193&#x2010;201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3369813</ArticleId><ArticleId IdType="pubmed">21094932</ArticleId></ArticleIdList></Reference><Reference><Citation>Elfrink ME, Veerkamp JS, Aartman IH, Moll HA, Ten Cate JM. Validity of scoring caries and primary molar hypomineralization (DMH) on intraoral photographs. JM Eur Arch Paediatr Dent. 2009;10:5&#x2010;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">19863892</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Tas JT, Kragt L, Veerkamp JJS, et al. Ethnic disparities in dental caries among six&#x2010;year&#x2010;old children in the netherlands. Caries Res. 2016;50:489&#x2010;497.</Citation><ArticleIdList><ArticleId IdType="pubmed">27595263</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofstetter H, Dusseldorp E, Zeileis A, Schuller AA. Modeling caries experience: Advantages of the use of the hurdle model. Caries Res. 2016;50:517&#x2010;526.</Citation><ArticleIdList><ArticleId IdType="pubmed">27639918</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeileis A, Kleiber C, Jackman S. Regression models for count data in R. J Stat Softw. 2008;27:1&#x2010;25.</Citation></Reference><Reference><Citation>van Buuren S, Groothuis&#x2010;Oudshoorn K. Mice: Multivariate imputation by chained equations in r. J Stat Softw. 2011;45:1&#x2010;67.</Citation></Reference><Reference><Citation>
Openepi: Open source epidemiologic statistics for public health [online]. 2012. http://www.openepi.com/SampleSize/SSCohort.htm Accessed 05/05/2020</Citation></Reference><Reference><Citation>von Elm E, Altman DG, Egger M, Pocock SJ, G&#xf8;tzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. J Clin Epidemiol. 2008;61:344&#x2010;349.</Citation><ArticleIdList><ArticleId IdType="pubmed">18313558</ArticleId></ArticleIdList></Reference><Reference><Citation>Elfrink MEC, Moll HA, Kiefte&#x2010;de Jong JC, et al. Pre&#x2010; and Postnatal Determinants of Deciduous Molar Hypomineralisation in 6&#x2010;Year&#x2010;Old Children. The Generation R Study. PLoS One. 2014;9:e91057.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4079596</ArticleId><ArticleId IdType="pubmed">24988443</ArticleId></ArticleIdList></Reference><Reference><Citation>Sayyed T, Kandil M, Bashir O, Alnaser H. The relationship between term pre&#x2010;eclampsia and the risk of early childhood caries. J Matern Fetal Neonatal Med. 2014;27:62&#x2010;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">23679897</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwendicke F, D&#xf6;rfer CE, Schlattmann P, Page LF, Thomson WM, Paris S. Socioeconomic inequality and caries: A systematic review and meta&#x2010;analysis. J Dent Res. 2014;94:10&#x2010;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">25394849</ArticleId></ArticleIdList></Reference><Reference><Citation>Aktoren O, Tuna EB, Guven Y, Gokcay G. A study on neonatal factors and eruption time of primary teeth. Community Dent Health. 2010;27:52&#x2010;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">20426262</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda JT, Sonis AL, Platt OS, Kurth S. Acquisition of mutans streptococci and caries prevalence in pediatric sickle cell anemia patients receiving long&#x2010;term antibiotic therapy. Pediatr Dent. 2005;27:186&#x2010;190.</Citation><ArticleIdList><ArticleId IdType="pubmed">16173221</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39588393</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>26</Day></DateCompleted><DateRevised><Year>2025</Year><Month>04</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1177-8881</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Drug design, development and therapy</Title><ISOAbbreviation>Drug Des Devel Ther</ISOAbbreviation></Journal><ArticleTitle>Comparative Analysis of Hemodynamic Effects of Remimazolam and Propofol Combined with Esketamine in Colonoscopic Procedures in the Elderly.</ArticleTitle><Pagination><StartPage>5269</StartPage><EndPage>5280</EndPage><MedlinePgn>5269-5280</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2147/DDDT.S490179</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="UNASSIGNED">The debate continues over the differential impact of remimazolam vs propofol on hemodynamic stability. This study aims to elucidate the effects of a combination of remimazolam and esketamine vs propofol and esketamine on hemodynamic parameters in elderly patients undergoing painless colonoscopies.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="UNASSIGNED">We conducted a randomized controlled trial involving 754 patients, divided equally between two treatment groups. The remimazolam-esketamine group (RE group) received 0.15 mg/kg of remimazolam and 0.3 mg/kg of esketamine. Conversely, the propofol-esketamine group (PE group) was administered 1.5 mg/kg of propofol with 0.3 mg/kg of esketamine. Primary outcomes focused on the incidence of hypotension. Secondary outcomes assessed were other hemodynamic adverse events, intraoperative blood pressure and heart rate fluctuations, usage of vasoactive agents, sedation efficacy, and additional adverse reactions.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Hypotension occurred significantly less frequently in the RE group (9.78%, 95% confidence interval[CI]: 6.67-12.87%) compared to the PE group (23.57%, 95% CI: 21.22-30.52%), <i>P</i>&lt;0.001. The RE group also showed lower incidences of sinus tachycardia, sinus bradycardia, and required less support from vasoactive agents (<i>P</i>&lt;0.001). Additionally, the RE group experienced smaller fluctuations in blood pressure and heart rate (<i>P</i>&lt;0.05). Both groups achieved a 100% sedation success rate. Notably, the RE group had a longer induction period but a quicker recovery time (<i>P</i>&lt;0.001), and lower rates of respiratory depression (<i>P</i>=0.006) and injection pain (<i>P</i>&lt;0.001).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Remimazolam combined with esketamine offers superior hemodynamic stability and significantly reduces adverse event rates compared to propofol plus esketamine in elderly patients undergoing painless colonoscopies, while maintaining effective sedation.</AbstractText><CopyrightInformation>&#xa9; 2024 Deng et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Deng</LastName><ForeName>Bo-Ran</ForeName><Initials>BR</Initials><Identifier Source="ORCID">0009-0002-6361-917X</Identifier><AffiliationInfo><Affiliation>Surgical Anesthesia Center, Zigong Hospital of TCM, Zigong, 643000, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhang</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Da'an District Maternal and Child Health Hospital, Zigong, 643000, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Xie</LastName><ForeName>Zi-Feng</ForeName><Initials>ZF</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, 121000, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Wang</LastName><ForeName>Ding-Ding</ForeName><Initials>DD</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, EYE &amp; ENT Hospital of Fudan University, Shanghai, 200031, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Surgical Anesthesia Center, Zigong Hospital of TCM, Zigong, 643000, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Dong-Bo</ForeName><Initials>DB</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, 121000, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Surgical Anesthesia Center, Zigong Hospital of TCM, Zigong, 643000, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Qi-Yan</ForeName><Initials>QY</Initials><AffiliationInfo><Affiliation>Surgical Anesthesia Center, Zigong Hospital of TCM, Zigong, 643000, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Tu</ForeName><Initials>T</Initials><Identifier Source="ORCID">0009-0001-6003-2966</Identifier><AffiliationInfo><Affiliation>Department of Anesthesia, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, 121000, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Qiao-Ling</ForeName><Initials>QL</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, 121000, People's Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Drug Des Devel Ther</MedlineTA><NlmUniqueID>101475745</NlmUniqueID><ISSNLinking>1177-8881</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>YI7VU623SF</RegistryNumber><NameOfSubstance UI="D015742">Propofol</NameOfSubstance></Chemical><Chemical><RegistryNumber>690G0D6V8H</RegistryNumber><NameOfSubstance UI="D007649">Ketamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>7V4A8U16MB</RegistryNumber><NameOfSubstance UI="C522201">remimazolam</NameOfSubstance></Chemical><Chemical><RegistryNumber>50LFG02TXD</RegistryNumber><NameOfSubstance UI="C000629870">Esketamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>12794-10-4</RegistryNumber><NameOfSubstance UI="D001569">Benzodiazepines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006993">Hypnotics and Sedatives</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015742" MajorTopicYN="Y">Propofol</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007649" MajorTopicYN="Y">Ketamine</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003113" MajorTopicYN="Y">Colonoscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="Y">Hemodynamics</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001569" MajorTopicYN="N">Benzodiazepines</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006993" MajorTopicYN="N">Hypnotics and Sedatives</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">colonoscopy</Keyword><Keyword MajorTopicYN="N">elderly patients</Keyword><Keyword MajorTopicYN="N">esketamine</Keyword><Keyword MajorTopicYN="N">hemodynamic effects</Keyword><Keyword MajorTopicYN="N">remimazolam</Keyword></KeywordList><CoiStatement>The authors report no conflicts of interest in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>11</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>26</Day><Hour>11</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>26</Day><Hour>11</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>26</Day><Hour>4</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39588393</ArticleId><ArticleId IdType="pmc">PMC11586265</ArticleId><ArticleId IdType="doi">10.2147/DDDT.S490179</ArticleId><ArticleId IdType="pii">490179</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Isoldi S, Cucchiara S, Repici A, et al. Gastrointestinal endoscopy in children and adults: how do they differ? Dig Liver Dis. 2021;53(6):697&#x2013;705. doi:10.1016/j.dld.2021.02.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dld.2021.02.016</ArticleId><ArticleId IdType="pubmed">33692010</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang L, Ye C, Wang N, et al. The median effective doses of propofol combined with two different doses of nalbuphine for adult patients during painless gastroscopy. Front Pharmacol. 2022;13:1014486. doi:10.3389/fphar.2022.1014486</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.1014486</ArticleId><ArticleId IdType="pmc">PMC9531776</ArticleId><ArticleId IdType="pubmed">36204238</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Giles J, Yao Y, et al. The path to healthy ageing in China: a Peking University-Lancet Commission. Lancet. 2022;400(10367):1967&#x2013;2006. doi:10.1016/S0140-6736(22)01546-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01546-X</ArticleId><ArticleId IdType="pmc">PMC9801271</ArticleId><ArticleId IdType="pubmed">36423650</ArticleId></ArticleIdList></Reference><Reference><Citation>Sneyd JR, Absalom AR, Barends CRM, et al. Hypotension during propofol sedation for colonoscopy: a retrospective exploratory analysis and meta-analysis. Br J Anaesth. 2022;128(4):610&#x2013;622. doi:10.1016/j.bja.2021.10.044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2021.10.044</ArticleId><ArticleId IdType="pmc">PMC9008870</ArticleId><ArticleId IdType="pubmed">34916051</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao L, Hu X, Zhu B, et al. Clinical observation of the combined use of propofol and etomidate in painless gastroscopy. Medicine. 2020;99(45):e23061. doi:10.1097/MD.0000000000023061</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000023061</ArticleId><ArticleId IdType="pmc">PMC7647540</ArticleId><ArticleId IdType="pubmed">33157963</ArticleId></ArticleIdList></Reference><Reference><Citation>Jelen LA, Young AH, Stone JM. Ketamine: a tale of two enantiomers. J Psychopharmacol. 2021;35(2):109&#x2013;123. doi:10.1177/0269881120959644</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0269881120959644</ArticleId><ArticleId IdType="pmc">PMC7859674</ArticleId><ArticleId IdType="pubmed">33155503</ArticleId></ArticleIdList></Reference><Reference><Citation>Lian X, Lin Y, Luo T, et al. Efficacy and safety of esketamine for sedation among patients undergoing gastrointestinal endoscopy: a systematic review and meta-analysis. BMC Anesthesiol. 2023;23(1):204. doi:10.1186/s12871-023-02167-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-023-02167-0</ArticleId><ArticleId IdType="pmc">PMC10262466</ArticleId><ArticleId IdType="pubmed">37312027</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H, Zhao Q, Chen HY, et al. The median effective concentration of propofol with different doses of esketamine during gastrointestinal endoscopy in elderly patients: a randomized controlled trial. Br J Clin Pharmacol. 2022;88(3):1279&#x2013;1287. doi:10.1111/bcp.15072</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bcp.15072</ArticleId><ArticleId IdType="pubmed">34496448</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Q, Liu X, Wen C, et al. Remimazolam: an updated review of a new sedative and anaesthetic. Drug Des Devel Ther. 2022;16:3957&#x2013;3974. doi:10.2147/DDDT.S384155</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DDDT.S384155</ArticleId><ArticleId IdType="pmc">PMC9675580</ArticleId><ArticleId IdType="pubmed">36411859</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B, Jiang K, Shi W, et al. Effect of remimazolam tosilate on respiratory depression in elderly patients undergoing gastroscopy: a multicentered, prospective, and randomized study. Drug Des Devel Ther. 2022;16:4151&#x2013;4159. doi:10.2147/DDDT.S391147</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DDDT.S391147</ArticleId><ArticleId IdType="pmc">PMC9733689</ArticleId><ArticleId IdType="pubmed">36506792</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Zhao J, Hao R, et al. The efficacy and safety of remimazolam besylate combined with esketamine for outpatient colonoscopy: a prospective, randomized, controlled clinical trial. Drug Des Devel Ther. 2023;17:2875&#x2013;2887. doi:10.2147/DDDT.S425860</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DDDT.S425860</ArticleId><ArticleId IdType="pmc">PMC10516197</ArticleId><ArticleId IdType="pubmed">37746114</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu C, Ren J, Guo X, et al. Effects of remimazolam combined with esketamine anesthesia on circulatory and respiratory function during painless gastroenteroscopy. Contrast Media Mol Imaging. 2022;2022:1079099. doi:10.1155/2022/1079099</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/1079099</ArticleId><ArticleId IdType="pmc">PMC9581615</ArticleId><ArticleId IdType="pubmed">36304777</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo J, Qian Y, Zhang X, et al. Remimazolam tosilate compared with propofol for gastrointestinal endoscopy in elderly patients: a prospective, randomized and controlled study. BMC Anesthesiol. 2022;22(1):180. doi:10.1186/s12871-022-01713-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-022-01713-6</ArticleId><ArticleId IdType="pmc">PMC9185932</ArticleId><ArticleId IdType="pubmed">35689208</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y, Xu Y, Huang B, et al. Effective dose of propofol combined with a low-dose esketamine for gastroscopy in elderly patients: a dose finding study using dixon&#x2019;s up-and-down method. Front Pharmacol. 2022;13:956392. doi:10.3389/fphar.2022.956392</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.956392</ArticleId><ArticleId IdType="pmc">PMC9530901</ArticleId><ArticleId IdType="pubmed">36204220</ArticleId></ArticleIdList></Reference><Reference><Citation>Xin Y, Chu T, Wang J, et al. Sedative effect of remimazolam combined with alfentanil in colonoscopic polypectomy: a prospective, randomized, controlled clinical trial. BMC Anesthesiol. 2022;22(1):262. doi:10.1186/s12871-022-01805-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-022-01805-3</ArticleId><ArticleId IdType="pmc">PMC9380378</ArticleId><ArticleId IdType="pubmed">35974309</ArticleId></ArticleIdList></Reference><Reference><Citation>Yue L, Ma X, Li N, et al. Remimazolam versus propofol in combination with esketamine for surgical abortion: a double-blind randomized controlled trial. Clin Transl Sci. 2023;16(9):1606&#x2013;1616. doi:10.1111/cts.13572</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cts.13572</ArticleId><ArticleId IdType="pmc">PMC10499404</ArticleId><ArticleId IdType="pubmed">37337399</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa G, Hirata N, Yoshikawa Y, et al. Differential effects of remimazolam and propofol on heart rate variability during anesthesia induction. J Anesth. 2022;36(2):239&#x2013;245. doi:10.1007/s00540-022-03037-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-022-03037-8</ArticleId><ArticleId IdType="pubmed">35028756</ArticleId></ArticleIdList></Reference><Reference><Citation>Hristova TS, Keating SC, McCoy AM, et al. Heart rate, arterial pressure and propofol-sparing effects of guaifenesin in dogs. Vet Anaesth Analg. 2023;50(1):50&#x2013;56. doi:10.1016/j.vaa.2022.10.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaa.2022.10.001</ArticleId><ArticleId IdType="pubmed">36344374</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan Y, Ouyang W, Tang Y, et al. Effect of remimazolam tosilate on early cognitive function in elderly patients undergoing upper gastrointestinal endoscopy. J Gastroenterol Hepatol. 2022;37(3):576&#x2013;583. doi:10.1111/jgh.15761</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgh.15761</ArticleId><ArticleId IdType="pmc">PMC9303590</ArticleId><ArticleId IdType="pubmed">34907594</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei A, Ma S, Dou Y, et al. The safety and efficacy of remimazolam tosylate combined with propofol in upper gastrointestinal endoscopy: a multicenter, randomized clinical trial. PLoS One. 2023;18(8):e0282930. doi:10.1371/journal.pone.0282930</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0282930</ArticleId><ArticleId IdType="pmc">PMC10399878</ArticleId><ArticleId IdType="pubmed">37535618</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Zhang Y, Fang X, et al. Comparison of remimazolam and propofol for drug-induced sleep endoscopy: a randomized clinical trial. Otolaryngol Head Neck Surg. 2023;169(5):1356&#x2013;1365. doi:10.1002/ohn.387</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ohn.387</ArticleId><ArticleId IdType="pubmed">37264980</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Xiao Q, Zhuang S. Comparison of propofol-esketamine versus propofol for anesthesia in gastroscopy: a double-blind, randomized controlled clinical trial. Front Med. 2023;10:1184709. doi:10.3389/fmed.2023.1184709</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1184709</ArticleId><ArticleId IdType="pmc">PMC10442552</ArticleId><ArticleId IdType="pubmed">37614948</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37271740</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>05</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-0528</ISSN><JournalIssue CitedMedium="Internet"><Volume>131</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month></PubDate></JournalIssue><Title>BJOG : an international journal of obstetrics and gynaecology</Title><ISOAbbreviation>BJOG</ISOAbbreviation></Journal><ArticleTitle>Adverse pregnancy outcomes in women at increased risk of preterm pre-eclampsia on first-trimester combined screening.</ArticleTitle><Pagination><StartPage>81</StartPage><EndPage>87</EndPage><MedlinePgn>81-87</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/1471-0528.17560</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Uteroplacental dysfunction may not only result in pre-eclampsia (PE) but also in preterm birth (PTB), small-for-gestational-age (SGA) birth and stillbirth. The aim of this study is to evaluate the positive predictive value (PPV) of first-trimester combined PE screening for all of these placenta-mediated adverse pregnancy outcomes.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Retrospective cohort study.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Tertiary referral maternity unit.</AbstractText><AbstractText Label="SAMPLE" NlmCategory="METHODS">A total of 13&#x2009;211 singleton pregnancies.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">First-trimester combined screening for preterm PE using the Fetal Medicine Foundation (FMF) algorithm.</AbstractText><AbstractText Label="MAIN OUTCOMES MEASURES" NlmCategory="METHODS">Hypertensive disorders of pregnancy (HDP), PTB, SGA birth and stillbirth were combined to assess composite adverse and severe adverse pregnancy outcomes (CAPO and CAPO-S). The PPVs for CAPO and CAPO-S were calculated for women with a combined risk for preterm PE of &#x2265;1 in 50 and &#x2265;1 in 100.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">First-trimester combined screening identified 2215 women (16.8%) with a risk of &#x2265;1 in 100 for preterm PE. The PPVs for a risk of &#x2265;1 in 100 for CAPO and CAPO-S were 38.8% and 18.2%, respectively. The equivalent PPVs for a risk of &#x2265;1 in 50 were 45.1% and 21.1%, respectively.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Women identified at high risk of preterm PE are also at increased risk of other placenta-mediated adverse pregnancy outcomes, such as PTB, SGA birth and stillbirth. Women at high risk for preterm PE after first-trimester screening may benefit from a higher surveillance care pathway, with interventions to mitigate all the adverse outcomes associated with placental dysfunction.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Minopoli</LastName><ForeName>Monica</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-8681-4501</Identifier><AffiliationInfo><Affiliation>Fetal Medicine Unit, St George's University Hospitals NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine and Surgery, Obstetrics and Gynaecology Unit, Universit&#xe0; degli Study di Parma, Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>No&#xeb;l</LastName><ForeName>Laure</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Centre Hospitalier Universitaire de Li&#xe8;ge, Li&#xe8;ge, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meroni</LastName><ForeName>Anna</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-8428-7162</Identifier><AffiliationInfo><Affiliation>Fetal Medicine Unit, St George's University Hospitals NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine and Surgery, Obstetrics and Gynaecology Unit, Universit&#xe0; degli Studi di Pavia, Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mascherpa</LastName><ForeName>Margaret</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Fetal Medicine Unit, St George's University Hospitals NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine and Surgery, Obstetrics and Gynaecology Unit, Universit&#xe0; degli Studi di Brescia, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frick</LastName><ForeName>Alex</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Fetal Medicine Unit, St George's University Hospitals NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thilaganathan</LastName><ForeName>Basky</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Fetal Medicine Unit, St George's University Hospitals NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vascular Biology Research Centre, Molecular and Clinical Sciences Research Institute, St George's University of London, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BJOG</MedlineTA><NlmUniqueID>100935741</NlmUniqueID><ISSNLinking>1470-0328</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011256" MajorTopicYN="N">Pregnancy Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011261" MajorTopicYN="N">Pregnancy Trimester, First</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011225" MajorTopicYN="Y">Pre-Eclampsia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050497" MajorTopicYN="N">Stillbirth</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D047928" MajorTopicYN="Y">Premature Birth</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010920" MajorTopicYN="N">Placenta</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005317" MajorTopicYN="N">Fetal Growth Retardation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">composite adverse outcomes of pregnancy</Keyword><Keyword MajorTopicYN="N">first trimester</Keyword><Keyword MajorTopicYN="N">pre-eclampsia</Keyword><Keyword MajorTopicYN="N">preterm birth</Keyword><Keyword MajorTopicYN="N">screening</Keyword><Keyword MajorTopicYN="N">small for gestational age</Keyword><Keyword MajorTopicYN="N">stillbirth</Keyword><Keyword MajorTopicYN="N">uteroplacental dysfunction</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>5</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>5</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>4</Day><Hour>22</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37271740</ArticleId><ArticleId IdType="doi">10.1111/1471-0528.17560</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Abalos E, Cuesta C, Grosso AL, Chou D, Say L. Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2013;170(1):1-7.</Citation></Reference><Reference><Citation>Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009;33(3):130-7.</Citation></Reference><Reference><Citation>Geographic variation in the incidence of hypertension in pregnancy. World Health Organization international collaborative study of hypertensive disorders of pregnancy. Am J Obstet Gynecol. 1988;158(1):80-3.</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention. Pregnancy-related mortality surveillance. 1987-2018.</Citation></Reference><Reference><Citation>Melchiorre K, Giorgione V, Thilaganathan B. The placenta and preeclampsia: villain or victim? Am J Obstet Gynecol. 2022;226(2s):S954-s62.</Citation></Reference><Reference><Citation>Poon LC, Wright D, Thornton S, Akolekar R, Brocklehurst P, Nicolaides KH. Mini-combined test compared with NICE guidelines for early risk-assessment for pre-eclampsia: the SPREE diagnostic accuracy study. Southampton: NIHR Journals Library; 2020.</Citation></Reference><Reference><Citation>Akolekar R, Syngelaki A, Poon L, Wright D, Nicolaides KH. Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. Fetal Diagn Ther. 2013;33(1):8-15.</Citation></Reference><Reference><Citation>National Collaborating Centre for Women's and Children's Health. Hypertension in Pregnancy: The Management of Hypertensive Disorders During Pregnancy. London: RCOG Press; 2010.</Citation></Reference><Reference><Citation>Rolnik DL, Wright D, Poon LC, O'Gorman N, Syngelaki A, de Paco Matallana C, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017;377(7):613-22.</Citation></Reference><Reference><Citation>Giorgione V, Quintero Mendez O, Pinas A, Ansley W, Thilaganathan B. Routine first-trimester pre-eclampsia screening and risk of preterm birth. Ultrasound Obstet Gynecol. 2022;60(2):185-91.</Citation></Reference><Reference><Citation>Hoffman MK, Goudar SS, Kodkany BS, Metgud M, Somannavar M, Okitawutshu J, et al. Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial. Lancet. 2020;395(10220):285-93.</Citation></Reference><Reference><Citation>Guy GP, Leslie K, Diaz Gomez D, Forenc K, Buck E, Bhide A, et al. Effect of routine first-trimester combined screening for pre-eclampsia on small-for-gestational-age birth: secondary interrupted time series analysis. Ultrasound Obstet Gynecol. 2022;59(1):55-60.</Citation></Reference><Reference><Citation>Phipps EA, Thadhani R, Benzing T, Karumanchi SA. Pre-eclampsia: pathogenesis, novel diagnostics and therapies. Nat Rev Nephrol. 2019;15(5):275-89.</Citation></Reference><Reference><Citation>Aplin JD, Myers JE, Timms K, Westwood M. Tracking placental development in health and disease. Nat Rev Endocrinol. 2020;16(9):479-94.</Citation></Reference><Reference><Citation>Liu B, Nadeem U, Frick A, Alakaloko M, Bhide A, Thilaganathan B. Reducing health inequality in black, Asian and other minority ethnic pregnant women: impact of first trimester combined screening for placental dysfunction on perinatal mortality. BJOG. 2022;129(10):1750-6.</Citation></Reference><Reference><Citation>Kupka E, Hesselman S, Hastie R, Lomartire R, Wikstr&#xf6;m AK, Bergman L. Low-dose aspirin use in pregnancy and the risk of preterm birth: a Swedish register-based cohort study. Am J Obstet Gynecol. 2023; 228(3): 336.e1-e9.</Citation></Reference><Reference><Citation>Plasencia W, Maiz N, Bonino S, Kaihura C, Nicolaides KH. Uterine artery doppler at 11 + 0 to 13 + 6&#x2009;weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol. 2007;30(5):742-9.</Citation></Reference><Reference><Citation>Poon LC, Zymeri NA, Zamprakou A, Syngelaki A, Nicolaides KH. Protocol for measurement of mean arterial pressure at 11-13&#x2009;weeks' gestation. Fetal Diagn Ther. 2012;31(1):42-8.</Citation></Reference><Reference><Citation>No&#xeb;l L, Guy GP, Jones S, Forenc K, Buck E, Papageorghiou AT, et al. Routine&#x2009;first-trimester&#x2009;combined&#x2009;screening for pre-eclampsia: pregnancy-associated plasma protein-a or placental growth factor? Ultrasound Obstet Gynecol. 2021;58(4):540-5.</Citation></Reference><Reference><Citation>Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, et al. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis &amp; management recommendations for international practice. Pregnancy Hypertens. 2018;13:291-310.</Citation></Reference><Reference><Citation>WHO. Preterm birth. 2018.</Citation></Reference><Reference><Citation>Villar J, Cheikh Ismail L, Victora CG, Ohuma EO, Bertino E, Altman DG, et al. International standards for newborn weight, length, and head circumference by gestational age and sex: the newborn cross-sectional study of the INTERGROWTH-21st project. Lancet. 2014;384(9946):857-68.</Citation></Reference><Reference><Citation>Guy GP, Leslie K, Diaz Gomez D, Forenc K, Buck E, Khalil A, et al. Implementation of routine first trimester combined screening for pre-eclampsia: a clinical effectiveness study. BJOG. 2021;128(2):149-56.</Citation></Reference><Reference><Citation>Tan MY, Syngelaki A, Poon LC, Rolnik DL, O'Gorman N, Delgado JL, et al. Screening for pre-eclampsia by maternal factors and biomarkers at 11-13&#x2009;weeks' gestation. Ultrasound Obstet Gynecol. 2018;52(2):186-95.</Citation></Reference><Reference><Citation>Tan MY, Poon LC, Rolnik DL, Syngelaki A, de Paco Matallana C, Akolekar R, et al. Prediction and prevention of small-for-gestational-age neonates: evidence from SPREE and ASPRE. Ultrasound Obstet Gynecol. 2018;52(1):52-9.</Citation></Reference><Reference><Citation>Mastrodima S, Akolekar R, Yerlikaya G, Tzelepis T, Nicolaides KH. Prediction of stillbirth from biochemical and biophysical markers at 11-13&#x2009;weeks. Ultrasound Obstet Gynecol. 2016;48(5):613-7.</Citation></Reference><Reference><Citation>Boutin A, Guerby P, Gasse C, Tapp S, Bujold E. Pregnancy outcomes in nulliparous women with positive first-trimester preterm preeclampsia screening test: the great obstetrical syndromes cohort study. Am J Obstet Gynecol. 2021;224(2):204.e1-7.</Citation></Reference><Reference><Citation>Rolnik DL, Selvaratnam RJ, Wertaschnigg D, Meagher S, Wallace E, Hyett J, et al. Routine first trimester combined screening for preterm preeclampsia in Australia: a multicenter clinical implementation cohort study. Int J Gynaecol Obstet. 2022;158(3):634-42.</Citation></Reference><Reference><Citation>Gordijn SJ, Beune IM, Thilaganathan B, Papageorghiou A, Baschat AA, Baker PN, et al. Consensus definition of fetal growth restriction: a Delphi procedure. Ultrasound Obstet Gynecol. 2016;48(3):333-9.</Citation></Reference><Reference><Citation>Mecacci F, Avagliano L, Lisi F, Clemenza S, Serena C, Vannuccini S, et al. Fetal growth restriction: does an integrated maternal hemodynamic-placental model fit better? Reprod Sci. 2021;28(9):2422-35.</Citation></Reference><Reference><Citation>Arias F, Victoria A, Cho K, Kraus F. Placental histology and clinical characteristics of patients with preterm premature rupture of membranes. Obstet Gynecol. 1997;89(2):265-71.</Citation></Reference><Reference><Citation>Arias F, Rodriquez L, Rayne SC, Kraus FT. Maternal placental vasculopathy and infection: two distinct subgroups among patients with preterm labor and preterm ruptured membranes. Am J Obstet Gynecol. 1993;168(2):585-91.</Citation></Reference><Reference><Citation>Brosens I, Pijnenborg R, Vercruysse L, Romero R. The "great obstetrical syndromes" are associated with disorders of deep placentation. Am J Obstet Gynecol. 2011;204(3):193-201.</Citation></Reference><Reference><Citation>Costello Medical. Screening for the Prevention and Prediction of Pre-eclampsia. External review against programme appraisal criteria for the UK National Screening Committee. UK NSC Recommendations 2023.</Citation></Reference><Reference><Citation>van Vliet EOG, Askie LA, Mol BWJ, Oudijk MA. Antiplatelet agents and the prevention of spontaneous preterm birth: a systematic review and meta-analysis. Obstet Gynecol. 2017;129(2):327-36.</Citation></Reference><Reference><Citation>Wilson JMG, Jungner G, World Health Organization. Principles and practice of screening for disease. Geneva: World Health Organization; 1968.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35411272</PMID><DateRevised><Year>2024</Year><Month>08</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Venous Thromboembolism Rate in Patients With Bladder Cancer According to the Type of Treatment: A Systematic Review.</ArticleTitle><Pagination><StartPage>e22945</StartPage><MedlinePgn>e22945</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e22945</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.22945</ELocationID><Abstract><AbstractText>Bladder cancer (BC) is classified as a high-risk tumour type for venous thromboembolism (VTE). VTE presents an extra challenge in the management of patients with cancer, given the increase in morbidity and mortality on having both conditions. To summarise the contemporary evidence on the VTE rate in patients with BC according to the stage, type of anti-cancer treatment and highlight VTE rate in the UK and other countries. A systematic review was carried out, and an electronic search for publications between January 2000 and November 2021 was done. Studies recording VTE in BC patients were included, whilst paediatric patients, case reports, studies reporting on a mix of arterial and venous thrombosis, studies reporting DVT or PE only and recorded hospitalised VTE only were excluded. The rate of VTE, country of origin, risk factors and thromboprophylaxis duration for VTE in BC patients were identified. A total of 38 papers met the search criteria. All publications were original research papers (cohort studies). The overall VTE rate in patients with BC was estimated at 1.9% to 4.7%. For those patients undergoing cystectomy, the VTE rate ranged from 3% to 17.6%; however, the VTE rate in the metastatic stage of BC patients ranged from 3.1% to 5.1%. The rates of VTE in BC patients are high, further increased by interventions such as surgery and chemotherapy. Thromboprophylaxis measures should be optimised. This review highlighted the fact that the VTE rate in BC varies between studies due to the heterogeneity of risk factors reported.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022, Abdullah et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Abdullah</LastName><ForeName>Omar</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Warwick Medical School, University of Warwick, Coventry, GBR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parashar</LastName><ForeName>Deepak</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Warwick Medical School, University of Warwick, Coventry, GBR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mustafa</LastName><ForeName>Israa J</ForeName><Initials>IJ</Initials><AffiliationInfo><Affiliation>Mosul Cancer Control Centre, Nineveh Health Directorate, Mosul, IRQ.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Young</LastName><ForeName>Annie M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Warwick Medical School, University of Warwick, Coventry, GBR.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">bladder cancer</Keyword><Keyword MajorTopicYN="N">cancer</Keyword><Keyword MajorTopicYN="N">chemotherapy</Keyword><Keyword MajorTopicYN="N">cystectomy</Keyword><Keyword MajorTopicYN="N">thrombosis</Keyword><Keyword MajorTopicYN="N">venous thromboembolism</Keyword></KeywordList><CoiStatement>The authors have declared financial relationships, which are detailed in the next section.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>12</Day><Hour>5</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>13</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>3</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35411272</ArticleId><ArticleId IdType="pmc">PMC8987908</ArticleId><ArticleId IdType="doi">10.7759/cureus.22945</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Assessing risk of venous thromboembolism in the patient with cancer. Khorana AA, Connolly GC. J Clin Oncol. 2009;27:4839&#x2013;4847.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2764392</ArticleId><ArticleId IdType="pubmed">19720906</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer-associated thrombosis: an overview. Elyamany G, Alzahrani AM, Bukhary E. Clin Med Insights Oncol. 2014;8:129&#x2013;137.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4259501</ArticleId><ArticleId IdType="pubmed">25520567</ArticleId></ArticleIdList></Reference><Reference><Citation>Venous thromboembolism in cancer patients: an underestimated major health problem. Khalil J, Bensaid B, Elkacemi H, Afif M, Bensaid Y, Kebdani T, Benjaafar N. World J Surg Oncol. 2015;13:204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4486121</ArticleId><ArticleId IdType="pubmed">26092573</ArticleId></ArticleIdList></Reference><Reference><Citation>Venous thromboembolic disease and cancer. Fennerty A. Postgrad Med J. 2006;82:642&#x2013;648.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2653906</ArticleId><ArticleId IdType="pubmed">17068274</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer and venous thromboembolism. Prandoni P, Falanga A, Piccioli A. Lancet Oncol. 2005;6:401&#x2013;410.</Citation><ArticleIdList><ArticleId IdType="pubmed">15925818</ArticleId></ArticleIdList></Reference><Reference><Citation>Venous thromboembolism in metastatic urothelial carcinoma or variant histologies: incidence, associative factors, and effect on survival. Ramos JD, Casey MF, Crabb SJ, et al. Cancer Med. 2017;6:186&#x2013;194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5269690</ArticleId><ArticleId IdType="pubmed">28000388</ArticleId></ArticleIdList></Reference><Reference><Citation>Venous thromboembolism and effect of comorbidity in bladder cancer: A Danish nationwide cohort study of 13,809 patients diagnosed between 1995 and 2011. Ording AG, Nielsen ME, Smith AB, Horv&#xe1;th-Puh&#xf3; E, S&#xf8;rensen HT. https://www.sciencedirect.com/science/article/abs/pii/S1078143916000478 Urol Oncol. 2016;34:292&#x2013;298.</Citation><ArticleIdList><ArticleId IdType="pubmed">26971189</ArticleId></ArticleIdList></Reference><Reference><Citation>Extended outpatient chemoprophylaxis reduces venous thromboembolism after radical cystectomy. Schomburg J, Krishna S, Soubra A, Cotter K, Fan Y, Brown G, Konety B. Urol Oncol. 2018;36:77.</Citation><ArticleIdList><ArticleId IdType="pubmed">29097086</ArticleId></ArticleIdList></Reference><Reference><Citation>Procedure-specific risks of thrombosis and bleeding in urological cancer surgery: systematic review and meta-analysis. Tikkinen KA, Craigie S, Agarwal A, et al. Eur Urol. 2018;73:242&#x2013;251.</Citation><ArticleIdList><ArticleId IdType="pubmed">28342641</ArticleId></ArticleIdList></Reference><Reference><Citation>Reporting bias leading to discordant venous thromboembolism rates in the United States versus Non-US countries following radical cystectomy: a systematic review and meta-analysis. Fantony JJ, Gopalakrishna A, Van Noord M, Inman BA. https://www.sciencedirect.com/science/article/abs/pii/S2405456915001406 Eur Urol Focus. 2016;2:189&#x2013;196.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4941825</ArticleId><ArticleId IdType="pubmed">27430026</ArticleId></ArticleIdList></Reference><Reference><Citation>Systematic reviews of observational studies of risk of thrombosis and bleeding in urological surgery (ROTBUS): introduction and methodology. Tikkinen KA, Agarwal A, Craigie S, et al. Syst Rev. 2014;3:150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4307154</ArticleId><ArticleId IdType="pubmed">25540016</ArticleId></ArticleIdList></Reference><Reference><Citation>Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Moher D, Liberati A, Tetzlaff J, Altman DG. BMJ. 2009;339:2535.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3090117</ArticleId><ArticleId IdType="pubmed">21603045</ArticleId></ArticleIdList></Reference><Reference><Citation>Risk factors and timing of venous thromboembolism after radical cystectomy in routine clinical practice: a population-based study. Doiron RC, Booth CM, Wei X, Siemens DR. BJU Int. 2016;118:714&#x2013;722.</Citation><ArticleIdList><ArticleId IdType="pubmed">26950039</ArticleId></ArticleIdList></Reference><Reference><Citation>Neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer and its impact on surgical morbidity and oncological outcomes: a real-world experience. Nguyen TT, Huillard O, Dabi Y, Anract J, Sibony M, Zerbib M, Xylinas E. Front Surg. 2018;5:58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6156362</ArticleId><ArticleId IdType="pubmed">30283787</ArticleId></ArticleIdList></Reference><Reference><Citation>Venous thromboembolism and peri-operative chemotherapy for muscle-invasive bladder cancer: a population-based study. Brennan K, Karim S, Doiron RC, Siemens DR, Booth CM. Bladder Cancer. 2018;4:419&#x2013;428.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6218104</ArticleId><ArticleId IdType="pubmed">30417053</ArticleId></ArticleIdList></Reference><Reference><Citation>Radical cystectomy in patients with disseminated disease: an assessment of perioperative outcomes using the National Surgical Quality Improvement Program database. Wallis C, Khana S, Hajiha M, Nam RK, Satkunasivam R. Can Urol Assoc J. 2017;11:244&#x2013;248.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5542830</ArticleId><ArticleId IdType="pubmed">28798823</ArticleId></ArticleIdList></Reference><Reference><Citation>Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States. Khorana AA, Dalal M, Lin J, Connolly GC. Cancer. 2013;119:648&#x2013;655.</Citation><ArticleIdList><ArticleId IdType="pubmed">22893596</ArticleId></ArticleIdList></Reference><Reference><Citation>Extended duration enoxaparin decreases the rate of venous thromboembolic events after radical cystectomy compared to inpatient only subcutaneous heparin. Pariser JJ, Pearce SM, Anderson BB, Packiam VT, Prachand VN, Smith ND, Steinberg GD. J Urol. 2017;197:302&#x2013;307.</Citation><ArticleIdList><ArticleId IdType="pubmed">27569434</ArticleId></ArticleIdList></Reference><Reference><Citation>Incidence and risk factors for venous thromboembolism after transurethral resection of bladder tumor: a population-based analysis. Zaffuto E, Pompe R, Moschini M, et al. Eur Urol Suppl. 2017;16:468&#x2013;469.</Citation></Reference><Reference><Citation>The incidence of venous thromboembolism and its effect on survival among patients with primary bladder cancer. Sandhu R, Pan CX, Wun T, Harvey D, Zhou H, White RH, Chew HK. Cancer. 2010;116:2596&#x2013;2603.</Citation><ArticleIdList><ArticleId IdType="pubmed">20336780</ArticleId></ArticleIdList></Reference><Reference><Citation>Incidence of venous thromboembolism in patients with cancer - a cohort study using linked United Kingdom databases. Walker AJ, Card TR, West J, Crooks C, Grainge MJ. Eur J Cancer. 2013;49:1404&#x2013;1413.</Citation><ArticleIdList><ArticleId IdType="pubmed">23146958</ArticleId></ArticleIdList></Reference><Reference><Citation>Hospital Episode Statistics data analysis of postoperative venous thromboembolus in patients undergoing urological surgery: a review of 126,891 cases. Dyer J, Wyke S, Lynch C. Ann R Coll Surg Engl. 2013;95:65&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3964643</ArticleId><ArticleId IdType="pubmed">23317732</ArticleId></ArticleIdList></Reference><Reference><Citation>A dual-centre, cohort comparison of open, laparoscopic and robotic-assisted radical cystectomy. Khan MS, Challacombe B, Elhage O, et al. Int J Clin Pract. 2012;66:656&#x2013;662.</Citation><ArticleIdList><ArticleId IdType="pubmed">22507234</ArticleId></ArticleIdList></Reference><Reference><Citation>Variation in thromboembolic complications among patients undergoing commonly performed cancer operations. De Martino RR, Goodney PP, Spangler EL, et al. J Vasc Surg. 2012;55:1035&#x2013;1040.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3339376</ArticleId><ArticleId IdType="pubmed">22409858</ArticleId></ArticleIdList></Reference><Reference><Citation>Venous thromboembolism after major urologic oncology surgery: a focus on the incidence and timing of thromboembolic events after 27,455 operations. Alberts BD, Woldu SL, Weinberg AC, Danzig MR, Korets R, Badani KK. Urology. 2014;84:799&#x2013;806.</Citation><ArticleIdList><ArticleId IdType="pubmed">25156513</ArticleId></ArticleIdList></Reference><Reference><Citation>Mp49-07 the risk of postoperative venous thromboembolism according to the circulating tumor cell status in patients with urothelial carcinoma of the bladder treated with radical cystectomy. Soave A, Riethdorf S, Dahlem R, et al. J Urol. 2016;195:0&#x2013;7.</Citation></Reference><Reference><Citation>MP2-15 identifying incidence and risk factors for VTE among cystectomy patients for bladder cancer. Vukina J, McBride A, McKibben M, et al. J Urol. 2014;191:0.</Citation></Reference><Reference><Citation>PD18-09 comparative effectiveness of prophylactic anticoagulation in patients undergoing radical cystectomy for bladder cancer. Mossanen M, Holt S, James A, Calvert J, Wright J, Gore J. J Urol. 2014;191:0.</Citation></Reference><Reference><Citation>Incidence and risk factors of venous thromboembolism after pelvic uro-oncologic surgery - a single center experience. Chen EC, Papa N, Lawrentschuk N, Bolton D, Sengupta S. BJU Int. 2016;117 Suppl 4:50&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">26486818</ArticleId></ArticleIdList></Reference><Reference><Citation>Temporal trends in venous thromboembolism after radical cystectomy. Lyon TD, Tollefson MK, Shah PH, et al. Urol Oncol. 2018;36:361&#x2013;321.</Citation><ArticleIdList><ArticleId IdType="pubmed">29885792</ArticleId></ArticleIdList></Reference><Reference><Citation>MP50-05 identifying practice patterns for thromboprophylaxis after radical cystectomy. Van Dlac A, Cowan N. J Urol. 2014;191:0.</Citation></Reference><Reference><Citation>Enhanced recovery protocol after radical cystectomy for bladder cancer. Daneshmand S, Ahmadi H, Schuckman AK, Mitra AP, Cai J, Miranda G, Djaladat H. J Urol. 2014;192:50&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">24518775</ArticleId></ArticleIdList></Reference><Reference><Citation>Complications of radical cystectomy for nonmuscle invasive disease: comparison with muscle invasive disease. Cookson MS, Chang SS, Wells N, Parekh DJ, Smith JA, Jr Jr. https://pubmed.ncbi.nlm.nih.gov/12478113/ J Urol. 2003;169:101&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pubmed">12478113</ArticleId></ArticleIdList></Reference><Reference><Citation>MP60-20 adverse outcomes following radical cystectomy. Breau R, Lavallee L, Witiuk K, et al. J Urol. 2014;191:0.</Citation></Reference><Reference><Citation>Venous thromboembolism after urological surgery. Tyson MD, Castle EP, Humphreys MR, Andrews PE. https://doi.org/10.1016/j.juro.2014.02.092. J Urol. 2014;192:793&#x2013;797.</Citation><ArticleIdList><ArticleId IdType="pubmed">24594402</ArticleId></ArticleIdList></Reference><Reference><Citation>Short-term outcome after cystectomy: comparison of two different perioperative protocols. de Vries RR, Kauer P, van Tinteren H, et al. Urol Int. 2012;88:383&#x2013;389.</Citation><ArticleIdList><ArticleId IdType="pubmed">22433508</ArticleId></ArticleIdList></Reference><Reference><Citation>Does extended lymphadenectomy increase the morbidity of radical cystectomy? Br&#xf6;ssner C, Pycha A, Toth A, Mian C, Kuber W. BJU Int. 2004;93:64&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">14678370</ArticleId></ArticleIdList></Reference><Reference><Citation>Pd36-10 venous thromboembolism rates following radical cystectomy stratified by method of prophylaxis. Hugen C, Stern A, Cai J, et al. J Urol. 2017;197:0.</Citation></Reference><Reference><Citation>Venous thromboembolism following radical cystectomy: significant predictors, comparison of different anticoagulants and timing of events. Sun AJ, Djaladat H, Schuckman A, Miranda G, Cai J, Daneshmand S. J Urol. 2015;193:565&#x2013;569.</Citation><ArticleIdList><ArticleId IdType="pubmed">25150642</ArticleId></ArticleIdList></Reference><Reference><Citation>Associations among age, comorbidity and clinical outcomes after radical cystectomy: results from the Alberta Urology Institute radical cystectomy database. Fairey A, Chetner M, Metcalfe J, et al. J Urol. 2008;180:128&#x2013;134.</Citation><ArticleIdList><ArticleId IdType="pubmed">18485375</ArticleId></ArticleIdList></Reference><Reference><Citation>J: 1442 burden of venothrombotic events in patients undergoing radical cystectomy for bladder cancer. James A, Wright J, Porter M, Holt S, Gore J. J Urol. 2013;189:0.</Citation><ArticleIdList><ArticleId IdType="pubmed">24837010</ArticleId></ArticleIdList></Reference><Reference><Citation>Venous thromboembolism after radical cystectomy and urinary diversion: a single-center experience with 1737 consecutive patients. Laymon M, Harraz A, Elshal A, et al. Scand J Urol. 2019;53:392&#x2013;397.</Citation><ArticleIdList><ArticleId IdType="pubmed">31830847</ArticleId></ArticleIdList></Reference><Reference><Citation>Ileocaecal vs ileal neobladder after radical cystectomy in patients with bladder cancer: a comparative study. Khafagy M, Shaheed FA, Moneim TA. BJU Int. 2006;97:799&#x2013;804.</Citation><ArticleIdList><ArticleId IdType="pubmed">16536777</ArticleId></ArticleIdList></Reference><Reference><Citation>Morbidity and mortality of octogenarians following open radical cystectomy using a standardized reporting system. Berneking AD, Rosevear HM, Askeland EJ, Newton MR, O'Donnell MA, Brown JA. https://pubmed.ncbi.nlm.nih.gov/23930606/ Can J Urol. 2013;20:6826&#x2013;6831.</Citation><ArticleIdList><ArticleId IdType="pubmed">23930606</ArticleId></ArticleIdList></Reference><Reference><Citation>Cystectomy in the ninth decade: operative results and long-term survival outcomes. Mendiola FP, Zorn KC, Gofrit ON, Mikhail AA, Orvieto MA, Msezane LP, Steinberg GD. https://pubmed.ncbi.nlm.nih.gov/17784983/ Can J Urol. 2007;14:3628&#x2013;3634.</Citation><ArticleIdList><ArticleId IdType="pubmed">17784983</ArticleId></ArticleIdList></Reference><Reference><Citation>Incidence, risk profile and morphological pattern of lower extremity venous thromboembolism after urological cancer surgery. Cl&#xe9;ment C, Rossi P, Aissi K, et al. J Urol. 2011;186:2293&#x2013;2297.</Citation><ArticleIdList><ArticleId IdType="pubmed">22014814</ArticleId></ArticleIdList></Reference><Reference><Citation>Gender and age differences in blood utilization and length of stay in radical cystectomy: a population-based study. C&#xe1;rdenas-Turanzas M, Cooksley C, Kamat AM, Pettaway CA, Elting LS. Int Urol Nephrol. 2008;40:893&#x2013;899.</Citation><ArticleIdList><ArticleId IdType="pubmed">18317944</ArticleId></ArticleIdList></Reference><Reference><Citation>Effects of neoadjuvant chemotherapy on pathological parameters and survival in patients undergoing radical cystectomy for muscle-invasive bladder cancer. Caglayan A, Akbulut Z, Atmaca AF, Altinova S, Kilic M, Balbay MD. Turk J Med Sci. 2012;42:623&#x2013;629.</Citation></Reference><Reference><Citation>MP04-02 long-term incidence of venous thromboembolic events following cystectomy: a population-based analysis. Wallis CJD, Magee DE, Satkunasivam R, Nam RK. Can Urol Assoc J. 2017;197:0&#x2013;9.</Citation></Reference><Reference><Citation>Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study. Blom JW, Vanderschoot JP, Oostindi&#xeb;r MJ, Osanto S, van der Meer FJ, Rosendaal FR. J Thromb Haemost. 2006;4:529&#x2013;535.</Citation><ArticleIdList><ArticleId IdType="pubmed">16460435</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer-associated venous thromboembolic disease, version 1.2015. Streiff MB, Holmstrom B, Ashrani A, et al.  https://jnccn.org/view/journals/jnccn/13/9/article-p1079.xml?print. J Natl Compr Canc Netw. 2015;13:1079&#x2013;1095.</Citation><ArticleIdList><ArticleId IdType="pubmed">26358792</ArticleId></ArticleIdList></Reference><Reference><Citation>Venous thromboembolism prophylaxis in patients undergoing abdominal and pelvic cancer surgery: adherence and compliance to ACCP guidelines in DIONYS registry. Geahchan N, Basile M, Tohmeh M. https://springerplus.springeropen.com/articles/10.1186/s40064-016-3057-9. SpringerPlus. 2016;5:1541.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5020030</ArticleId><ArticleId IdType="pubmed">27652114</ArticleId></ArticleIdList></Reference><Reference><Citation>High rates of venous thromboembolic events in patients undergoing systemic therapy for urothelial carcinoma: a systematic review and meta-analysis. Gopalakrishna A, Longo TA, Fantony JJ, Doshi U, Harrison MR, Van Noord M, Inman BA. Urol Oncol. 2016;34:407&#x2013;414.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4996725</ArticleId><ArticleId IdType="pubmed">27267581</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33678403</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1531-5037</ISSN><JournalIssue CitedMedium="Internet"><Volume>57</Volume><Issue>9</Issue><PubDate><Year>2022</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of pediatric surgery</Title><ISOAbbreviation>J Pediatr Surg</ISOAbbreviation></Journal><ArticleTitle>Same day discharge for pectus excavatum-is it possible?</ArticleTitle><Pagination><StartPage>34</StartPage><EndPage>38</EndPage><MedlinePgn>34-38</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jpedsurg.2021.02.007</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0022-3468(21)00114-7</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The use of intercostal nerve cryoablation (INC) has been an effective modality for treating pain in patients undergoing pectus excavatum (PE) repair. This study sought to evaluate if PE patients undergoing Nuss procedures with INC and intercostal nerve block (INB) could safely be discharged the same day of surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A prospective study with IRB approval of 15 consecutive patients undergoing PE Nuss repair with INC, INB, and an enhanced recovery after surgery (ERAS) protocol was conducted. The primary outcome measure was hospital length of stay (LOS) in hours. Secondary variables included same day discharge, postoperative complications, emergency department (ED) visits, urgent care (UC) visits, opioid use, and return to the operating room (OR).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">LOS averaged 11.9&#xa0;h amongst 15 patients. Ten patients (66.7%) went home on postoperative day (POD) 0, and the rest went home on POD 1. No patients stayed in the hospital due to pain. Reasons for failure to discharge included urinary retention, drowsiness, vomiting, and anxiety, but not pain. No patients were readmitted to the ED. One patient visited UC for constipation. One patient had bar migration requiring return to the OR for revision. Ten (66.7%) patients did not use opioids after discharge.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Same day discharge is feasible and safe in PE patients undergoing Nuss procedure with INC and INB. INC with INB can adequately control pain without significant complications. Same day discharge can be safely considered for PE patients undergoing Nuss procedure with INC with INB.</AbstractText><AbstractText Label="TYPE OF STUDY" NlmCategory="METHODS">Prognosis study LEVEL-OF-EVIDENCE RATING: Level II.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rettig</LastName><ForeName>R Luke</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Department of Pediatric Surgery, Kaiser Permanente Los Angeles Medical Center, 4867 Sunset Blvd. Los Angeles 90027, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rudikoff</LastName><ForeName>Andrew G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Kaiser Permanente Los Angeles Medical Center, 4867 Sunset Blvd. Los Angeles 90027, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lo</LastName><ForeName>Hoi Yee Annie</ForeName><Initials>HYA</Initials><AffiliationInfo><Affiliation>Department of Pediatric Surgery, Kaiser Permanente Los Angeles Medical Center, 4867 Sunset Blvd. Los Angeles 90027, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Constance W</ForeName><Initials>CW</Initials><AffiliationInfo><Affiliation>Department of Pediatric Surgery, Kaiser Permanente Los Angeles Medical Center, 4867 Sunset Blvd. Los Angeles 90027, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vazquez</LastName><ForeName>Walter D</ForeName><Initials>WD</Initials><AffiliationInfo><Affiliation>Department of Pediatric Surgery, Kaiser Permanente San Diego Medical Center, 9455 Clairemont Mesa Blvd, San Diego 92123, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodriguez</LastName><ForeName>Karen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pediatric Surgery, Kaiser Permanente Los Angeles Medical Center, 4867 Sunset Blvd. Los Angeles 90027, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaul</LastName><ForeName>Donald B</ForeName><Initials>DB</Initials><AffiliationInfo><Affiliation>Department of Pediatric Surgery, Kaiser Permanente Los Angeles Medical Center, 4867 Sunset Blvd. Los Angeles 90027, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conte</LastName><ForeName>Antonio Hernandez</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Kaiser Permanente Los Angeles Medical Center, 4867 Sunset Blvd. Los Angeles 90027, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banzali</LastName><ForeName>Franklin M</ForeName><Initials>FM</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Kaiser Permanente Los Angeles Medical Center, 4867 Sunset Blvd. Los Angeles 90027, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sydorak</LastName><ForeName>Roman M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Department of Pediatric Surgery, Kaiser Permanente Los Angeles Medical Center, 4867 Sunset Blvd. Los Angeles 90027, CA, United States. Electronic address: roman.m.sydorak@kp.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Pediatr Surg</MedlineTA><NlmUniqueID>0052631</NlmUniqueID><ISSNLinking>0022-3468</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005660" MajorTopicYN="Y">Funnel Chest</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010149" MajorTopicYN="N">Pain, Postoperative</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010351" MajorTopicYN="N">Patient Discharge</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Enhanced recovery after surgery (ERAS)</Keyword><Keyword MajorTopicYN="N">Intercostal nerve cryoablation</Keyword><Keyword MajorTopicYN="N">Pectus excavatum repair</Keyword><Keyword MajorTopicYN="N">Same day discharge</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>11</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>1</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>8</Day><Hour>5</Hour><Minute>35</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33678403</ArticleId><ArticleId IdType="doi">10.1016/j.jpedsurg.2021.02.007</ArticleId><ArticleId IdType="pii">S0022-3468(21)00114-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40287637</PMID><DateCompleted><Year>2025</Year><Month>04</Month><Day>27</Day></DateCompleted><DateRevised><Year>2025</Year><Month>04</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2431</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Apr</Month><Day>26</Day></PubDate></JournalIssue><Title>BMC pediatrics</Title><ISOAbbreviation>BMC Pediatr</ISOAbbreviation></Journal><ArticleTitle>Epidemiology and management of massive, sub-massive, and non-massive pediatric pulmonary embolism: a systematic reviews.</ArticleTitle><Pagination><StartPage>330</StartPage><MedlinePgn>330</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">330</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12887-025-05472-4</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To evaluate the current evidence on the diagnosis, management, and outcomes of pediatric pulmonary embolism (PE) across varying severity classifications, including massive, submassive, and non-massive presentations.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic review was conducted following PRISMA guidelines. Searches were performed in PubMed, Scopus, Web of Science, and Cochrane databases up to February 17, 2024. Eligible studies included pediatric and adolescent patients (&#x2264;&#x2009;21 years) with confirmed PE diagnoses. Risk of bias was assessed using the NIH tool.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Six studies involving 258 pediatric patients with massive, submassive, or non-massive PE were included. Most patients were adolescents, with a mean age of 14.1 years and a predominance of females (62-66%). Risk factors included obesity, oral contraceptive use, thrombophilia, and autoimmune conditions. Computed tomography pulmonary angiography (CTPA) was the most frequently used diagnostic modality, showing varied lobar, segmental, and subsegmental involvement. Management strategies ranged from anticoagulation to catheter-directed thrombolysis and surgical thrombectomy. Outcomes varied by severity, with massive PE cases showing higher mortality and complications compared to submassive and non-massive cases.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Pediatric PE requires tailored risk stratification and management strategies to optimize outcomes. Delays in diagnosis and severe disease presentations contribute to higher morbidity and mortality. Future research should focus on standardized severity classifications, novel diagnostic modalities, and comparative assessments of therapeutic interventions to enhance outcomes in this population.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alsabri</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Emergency Department, Al-thawara Modern General Hospital, Sana'a, Yemen. Alsabri5000@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatric Emergency Department, Department of Pediatrics, St. Christopher's Hospital, Philadelphia, PA, USA. Alsabri5000@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abo-Elnour</LastName><ForeName>Dina Essam</ForeName><Initials>DE</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Zagazig University, Zagazig, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ayyad</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Al-Quds University, Jerusalem, Palestine.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Rutgers New Jersey Medical School, Newark, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdelgalil</LastName><ForeName>Mahmoud Shaaban</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Ain- Shams University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alqeeq</LastName><ForeName>Basel F</ForeName><Initials>BF</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Islamic University of Gaza, Gaza, Palestine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shahid</LastName><ForeName>Muhammad Azan</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>CUNY Brooklyn College, Brooklyn, NY, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Pediatr</MedlineTA><NlmUniqueID>100967804</NlmUniqueID><ISSNLinking>1471-2431</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015912" MajorTopicYN="N">Thrombolytic Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072226" MajorTopicYN="N">Computed Tomography Angiography</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Massive pulmonary embolism</Keyword><Keyword MajorTopicYN="N">Non-massive pulmonary embolism</Keyword><Keyword MajorTopicYN="N">Pediatric pulmonary embolism</Keyword><Keyword MajorTopicYN="N">Severity classification</Keyword><Keyword MajorTopicYN="N">Submassive pulmonary embolism</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword></KeywordList><CoiStatement>Declarations. Ethical approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>1</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>4</Month><Day>27</Day><Hour>13</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>27</Day><Hour>3</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>26</Day><Hour>23</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>4</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40287637</ArticleId><ArticleId IdType="pmc">PMC12032742</ArticleId><ArticleId IdType="doi">10.1186/s12887-025-05472-4</ArticleId><ArticleId IdType="pii">10.1186/s12887-025-05472-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zaidi AU, Hutchins KK, Rajpurkar M. Pulmonary embolism in children. Front Pediatr. 2017;5:170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5554122</ArticleId><ArticleId IdType="pubmed">28848725</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan RW, Stinson HR, Wolfe H, Lindell RB, Topjian AA, Nadkarni VM, et al. Pediatric In-hospital Cardiac arrest secondary to Acute Pulmonary Embolism. Crit Care Med. 2018;46:e229&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5825246</ArticleId><ArticleId IdType="pubmed">29261563</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross CE, Shih JA, Kleinman ME, Donnino MW. Pediatric massive and submassive pulmonary embolism: a single-center experience. Hosp Pediatr. 2020;10:272&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7041554</ArticleId><ArticleId IdType="pubmed">32047028</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopes de Bragan&#xe7;a R, Gorito V, Cibele DG, Ricca Gon&#xe7;alves L, Ribeiro A, Baptista MJ, et al. Pulmonary embolism in pediatric age: a retrospective study from a tertiary center. Pediatr Pulmonol. 2021;56:2751&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">34133850</ArticleId></ArticleIdList></Reference><Reference><Citation>Lassandro G, Palmieri VV, Palladino V, Amoruso A, Faienza MF, Giordano P. Venous thromboembolism in children: from diagnosis to management. Int J Environ Res Public Health. 2020;17:4993.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7400059</ArticleId><ArticleId IdType="pubmed">32664502</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts LN, Patel RK, Arya R. Venous thromboembolism and ethnicity. Br J Haematol. 2009;146:369&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">19552721</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal S, Shrivastava Y, Bolia R, Panda PK, Sharawat IK, Bhat NK. Pulmonary embolism in children: a Case Series. Indian J Crit Care Med. 2020;24:1272&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7775944</ArticleId><ArticleId IdType="pubmed">33446985</ArticleId></ArticleIdList></Reference><Reference><Citation>Akam-Venkata J, Forbes TJ, Schreiber T, Kaki A, Elder M, Turner DR, et al. Catheter-directed therapy for acute pulmonary embolism in children. Cardiol Young. 2019;29:263&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">30572968</ArticleId></ArticleIdList></Reference><Reference><Citation>Belsky J, Warren P, Stanek J, Kumar R. Catheter-directed thrombolysis for submassive pulmonary embolism in children: a case series. Pediatr Blood Cancer. 2020;67:e28144.</Citation><ArticleIdList><ArticleId IdType="pubmed">31876109</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji D, Gill AE, Durrence WW, Shah JH, Paden ML, Patel KN, et al. Catheter-Directed Pharmacologic Thrombolysis for Acute Submassive and massive pulmonary emboli in children and Adolescents-An exploratory report. Pediatr Crit Care Med. 2020;21:e15&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">31688811</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelland-Marcotte M-C, Tucker C, Klaassen A, Avila ML, Amid A, Amiri N, et al. Outcomes and risk factors of massive and submassive pulmonary embolism in children: a retrospective cohort study. Lancet Haematol. 2019;6:e144&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">30772417</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Study Quality Assessment Tools| NHLBI. NIH n.d. https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools (accessed April 21, 2024).</Citation></Reference><Reference><Citation>Konstantinides SV, Meyer G, Becattini C, et al. ESC guidelines on acute pulmonary embolism. Eur Heart J. 2020;41(4):543&#x2013;603. 10.1093/eurheartj/ehz405.</Citation><ArticleIdList><ArticleId IdType="pubmed">31504429</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">19726018</PMID><DateCompleted><Year>2009</Year><Month>12</Month><Day>29</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2046-4924</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>41</Issue><PubDate><Year>2009</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Health technology assessment (Winchester, England)</Title><ISOAbbreviation>Health Technol Assess</ISOAbbreviation></Journal><ArticleTitle>The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>iv</EndPage><MedlinePgn>1-190, 215-357, iii-iv</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3310/hta13410</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To assess the clinical effectiveness and cost-effectiveness of bariatric surgery for obesity.</AbstractText><AbstractText Label="DATA SOURCES" NlmCategory="METHODS">Seventeen electronic databases were searched [MEDLINE; EMBASE; PreMedline In-Process &amp; Other Non-Indexed Citations; The Cochrane Library including the Cochrane Systematic Reviews Database, Cochrane Controlled Trials Register, DARE, NHS EED and HTA databases; Web of Knowledge Science Citation Index (SCI); Web of Knowledge ISI Proceedings; PsycInfo; CRD databases; BIOSIS; and databases listing ongoing clinical trials] from inception to August 2008. Bibliographies of related papers were assessed and experts were contacted to identify additional published and unpublished references.</AbstractText><AbstractText Label="REVIEW METHODS" NlmCategory="METHODS">Two reviewers independently screened titles and abstracts for eligibility. Inclusion criteria were applied to the full text using a standard form. Interventions investigated were open and laparoscopic bariatric surgical procedures in widespread current use compared with one another and with non-surgical interventions. Population comprised adult patients with body mass index (BMI) &gt; or = 30 and young obese people. Main outcomes were at least one of the following after at least 12 months follow-up: measures of weight change; quality of life (QoL); perioperative and postoperative mortality and morbidity; change in obesity-related comorbidities; cost-effectiveness. Studies eligible for inclusion in the systematic review for comparisons of Surgery versus Surgery were RCTs. For comparisons of Surgery versus Non-surgical procedures eligible studies were RCTs, controlled clinical trials and prospective cohort studies (with a control cohort). Studies eligible for inclusion in the systematic review of cost-effectiveness were full cost-effectiveness analyses, cost-utility analyses, cost-benefit analyses and cost-consequence analyses. One reviewer performed data extraction, which was checked by two reviewers independently. Two reviewers independently applied quality assessment criteria and differences in opinion were resolved at each stage. Studies were synthesised through a narrative review with full tabulation of the results of all included studies. In the economic model the analysis was developed for three patient populations, those with BMI &gt; or = 40; BMI &gt; or = 30 and &lt; 40 with Type 2 diabetes at baseline; and BMI &gt; or = 30 and &lt; 35. Models were applied with assumptions on costs and comorbidity.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 5386 references were identified of which 26 were included in the clinical effectiveness review: three randomised controlled trials (RCTs) and three cohort studies compared surgery with non-surgical interventions and 20 RCTs compared different surgical procedures. Bariatric surgery was a more effective intervention for weight loss than non-surgical options. In one large cohort study weight loss was still apparent 10 years after surgery, whereas patients receiving conventional treatment had gained weight. Some measures of QoL improved after surgery, but not others. After surgery statistically fewer people had metabolic syndrome and there was higher remission of Type 2 diabetes than in non-surgical groups. In one large cohort study the incidence of three out of six comorbidities assessed 10 years after surgery was significantly reduced compared with conventional therapy. Gastric bypass (GBP) was more effective for weight loss than vertical banded gastroplasty (VBG) and adjustable gastric banding (AGB). Laparoscopic isolated sleeve gastrectomy (LISG) was more effective than AGB in one study. GBP and banded GBP led to similar weight loss and results for GBP versus LISG and VBG versus AGB were equivocal. All comparisons of open versus laparoscopic surgeries found similar weight losses in each group. Comorbidities after surgery improved in all groups, but with no significant differences between different surgical interventions. Adverse event reporting varied; mortality ranged from none to 10%. Adverse events from conventional therapy included intolerance to medication, acute cholecystitis and gastrointestinal problems. Major adverse events following surgery, some necessitating reoperation, included anastomosis leakage, pneumonia, pulmonary embolism, band slippage and band erosion. Bariatric surgery was cost-effective in comparison to non-surgical treatment in the reviewed published estimates of cost-effectiveness. However, these estimates are likely to be unreliable and not generalisable because of methodological shortcomings and the modelling assumptions made. Therefore a new economic model was developed. Surgical management was more costly than non-surgical management in each of the three patient populations analysed, but gave improved outcomes. For morbid obesity, incremental cost-effectiveness ratios (ICERs) (base case) ranged between 2000 pounds and 4000 pounds per QALY gained. They remained within the range regarded as cost-effective from an NHS decision-making perspective when assumptions for deterministic sensitivity analysis were changed. For BMI &gt; or = 30 and 40, ICERs were 18,930 pounds at two years and 1397 pounds at 20 years, and for BMI &gt; or = 30 and &lt; 35, ICERs were 60,754 pounds at two years and 12,763 pounds at 20 years. Deterministic and probabilistic sensitivity analyses produced ICERs which were generally within the range considered cost-effective, particularly at the long twenty year time horizons, although for the BMI 30-35 group some ICERs were above the acceptable range.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Bariatric surgery appears to be a clinically effective and cost-effective intervention for moderately to severely obese people compared with non-surgical interventions. Uncertainties remain and further research is required to provide detailed data on patient QoL; impact of surgeon experience on outcome; late complications leading to reoperation; duration of comorbidity remission; resource use. Good-quality RCTs will provide evidence on bariatric surgery for young people and for adults with class I or class II obesity. New research must report on the resolution and/or development of comorbidities such as Type 2 diabetes and hypertension so that the potential benefits of early intervention can be assessed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Picot</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Southampton Health Technology Assessments Centre, University of Southampton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Colquitt</LastName><ForeName>J L</ForeName><Initials>JL</Initials></Author><Author ValidYN="Y"><LastName>Gospodarevskaya</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Loveman</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Baxter</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Clegg</LastName><ForeName>A J</ForeName><Initials>AJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Health Technol Assess</MedlineTA><NlmUniqueID>9706284</NlmUniqueID><ISSNLinking>1366-5278</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050110" MajorTopicYN="N">Bariatric Surgery</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003362" MajorTopicYN="N">Cost-Benefit Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="Y">Outcome Assessment, Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>197</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>12</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19726018</ArticleId><ArticleId IdType="doi">10.3310/hta13410</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38131366</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2239-253X</ISSN><JournalIssue CitedMedium="Internet"><Volume>94</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Annali italiani di chirurgia</Title><ISOAbbreviation>Ann Ital Chir</ISOAbbreviation></Journal><ArticleTitle>The impact of multimodal analgesia timing on postoperative pain in cesarean delivery. A prospective randomized study.</ArticleTitle><Pagination><StartPage>617</StartPage><EndPage>622</EndPage><MedlinePgn>617-622</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0003469X23038769</ELocationID><Abstract><AbstractText Label="AIM" NlmCategory="OBJECTIVE">The issue of preemptive or preventive use of paracetamol still raises questions in terms of multimodal analgesia in cesarean delivery. A combination of paracetamol and opioid is commonly used for pain management after cesarean delivery. This study aims to compare postoperative pain level and analgesic consumption when using paracetamol at two different perioperative times in cesarean section.</AbstractText><AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">Sixty patients recruited for elective cesarean section under general anesthesia were included in this prospective study. Patients were randomly assigned to receive iv 1 g paracetamol 15 minutes before incision (Group PE) or after delivery of newborn (Group PV). Visual analog scale (VAS) values, 24-hour morphine consumption, additional analgesic requirement, side effects, and patient and surgeons' satisfaction were recorded.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Demographic data and hemodynamic values of the patients were similar in both groups. There was no differences between groups in terms of VAS scores at rest and during movement, additional analgesic requirement during the postoperative 1st hour, and 24-hour total morphine consumption. There was no difference in side effects, and patient and surgeon satisfaction scores postoperatively.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Preemptive and preventive use of paracetamol provides the same quality of analgesia and opioid sparing effect without increasing the frequency of adverse effects.</AbstractText><AbstractText Label="KEY WORDS" NlmCategory="BACKGROUND">Analgesia, Cesarean Section, General Anesthesia, Preemptive, Preventive.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ozmete</LastName><ForeName>Ozlem</ForeName><Initials>O</Initials></Author><Author ValidYN="Y"><LastName>Sener</LastName><ForeName>Mesut</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Bali</LastName><ForeName>Cagla</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Cal&#x131;gan</LastName><ForeName>Esla</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Durdag</LastName><ForeName>Gulsen Dorgan</ForeName><Initials>GD</Initials></Author><Author ValidYN="Y"><LastName>Aribogan</LastName><ForeName>Anis</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Ann Ital Chir</MedlineTA><NlmUniqueID>0372343</NlmUniqueID><ISSNLinking>0003-469X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>362O9ITL9D</RegistryNumber><NameOfSubstance UI="D000082">Acetaminophen</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000700">Analgesics</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000701">Analgesics, Opioid</NameOfSubstance></Chemical><Chemical><RegistryNumber>76I7G6D29C</RegistryNumber><NameOfSubstance UI="D009020">Morphine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000082" MajorTopicYN="Y">Acetaminophen</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000698" MajorTopicYN="Y">Analgesia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000700" MajorTopicYN="N">Analgesics</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000701" MajorTopicYN="N">Analgesics, Opioid</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002585" MajorTopicYN="N">Cesarean Section</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009020" MajorTopicYN="N">Morphine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059408" MajorTopicYN="N">Pain Management</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010149" MajorTopicYN="N">Pain, Postoperative</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="ita"><AbstractText Label="UNLABELLED">La questione dell&#x2019;uso preventivo o preventivo del paracetamolo solleva ancora interrogativi in termini di analgesia multimodale, e comunemente, si usa una combinazione di paracetamolo e oppioidi per la gestione del dolore dopo il parto cesareo. Questo studio mira a confrontare il livello di dolore postoperatorio e il consumo di analgesici quando si utilizza il paracetamolo in due diversi tempi perioperatori nel taglio cesareo.</AbstractText><AbstractText Label="MATERIALI E METODI" NlmCategory="UNASSIGNED">&#x130;n questo studio prospettico sono stati incluse sessanta pazienti reclutate per taglio cesareo elettivo in anestesia generale. Alle pazienti sono stati assegnati in modo casuale a ricevere 1g di paracetamolo 15 minuti prima dell&#x2019;incisione (Gruppo PE) o dopo il parto del neonato (Gruppo PV). Sono stati registrati i valori della scala analogica visiva (VAS), il consumo di morfina nelle 24 ore, il fabbisogno di analgesici aggiuntivi, gli effetti collaterali e la soddisfazione del paziente e dei chirurghi.</AbstractText><AbstractText Label="RISULTATI" NlmCategory="UNASSIGNED">I dati demografici e i valori emodinamici delle pazienti erano simili in entrambi i gruppi. Non c&#x2019;erano differenze tra i gruppi in termini di punteggi VAS a riposo e durante il movimento, ulteriore fabbisogno di analgesici durante la prima ora postoperatoria e consumo totale di morfina nelle 24 ore. Non c&#x2019;era alcuna differenza negli effetti collaterali e nei punteggi di soddisfazione del paziente e del chirurgo dopo l&#x2019;intervento.</AbstractText><AbstractText Label="CONCLUSIONI" NlmCategory="CONCLUSIONS">L&#x2019;uso preventivo e preventivo del paracetamolo fornisce la stessa qualit&#xe0; di analgesia e l&#x2019;effetto di risparmio di oppioidi senza aumentare la frequenza degli effetti avversi.</AbstractText></OtherAbstract></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>25</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>22</Day><Hour>12</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>22</Day><Hour>7</Hour><Minute>44</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38131366</ArticleId><ArticleId IdType="pii">S0003469X23038769</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">16490088</PMID><DateCompleted><Year>2006</Year><Month>08</Month><Day>29</Day></DateCompleted><DateRevised><Year>2006</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1155-5645</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>3</Issue><PubDate><Year>2006</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Paediatric anaesthesia</Title><ISOAbbreviation>Paediatr Anaesth</ISOAbbreviation></Journal><ArticleTitle>Randomized controlled trial comparing the laryngeal tube and the laryngeal mask in pediatric patients.</ArticleTitle><Pagination><StartPage>251</StartPage><EndPage>257</EndPage><MedlinePgn>251-7</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The laryngeal tube (LT) is a supraglottic ventilatory device used in adults. However, there is limited information about LT use in pediatric patients. This randomized controlled study compares LT with laryngeal mask (LMA) for airway management during spontaneous or assisted ventilation and during fiberoptic laryngoscopy in children.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Thirty children under 10-years old, ASA I-II, scheduled for minor general surgery, Mallampati score I-II, fasted and premedicated were included. Patients with upper respiratory infection, craniofacial malformation, intracranial hypertension, emergency surgery were excluded. The primary outcome measure was the proportion of patients in whom effective spontaneous or assisted ventilation [Vt &gt; or = 4 ml.kg(-1), SpO2 &gt; or = 95% with FiO2 0.4, P(E)CO2 &lt; or = 7.2 kPa (55 mmHg)] was achieved after 3 min of LT or LMA cuff inflation. The secondary endpoint was the proportion of patients in whom fiberoptic laryngoscopy resulted in identification of the vocal cords.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Eleven children with LMA and two children in LT group had adequate spontaneous or assisted ventilation after initial positioning (P &lt; 0.01). After head extension or device repositioning 15 of 15 patients in LMA group had adequate ventilation compared with 11 of 15 patients in LT group (P &lt; 0.05). The vocal cords could be observed with fiberoptic laryngoscopy in 11 LMA group patients compared with no patients in the LT group (P &lt; 0.001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The LT is less effective than the LMA to allow adequate spontaneous or assisted ventilation and for fiberoptic evaluation of the airway in children under 10 years old.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bortone</LastName><ForeName>Luciano</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Azienda Ospedaliera di Parma, Parma, Italy. lbortone@ao.pr.it</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ingelmo</LastName><ForeName>Pablo M</ForeName><Initials>PM</Initials></Author><Author ValidYN="Y"><LastName>De Ninno</LastName><ForeName>Ges&#xf9;</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Tosi</LastName><ForeName>Michela</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Caffini</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Trenchi</LastName><ForeName>Juna</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Mergoni</LastName><ForeName>Mario</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Martorana</LastName><ForeName>Fabio</ForeName><Initials>F</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Paediatr Anaesth</MedlineTA><NlmUniqueID>9206575</NlmUniqueID><ISSNLinking>1155-5645</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007442" MajorTopicYN="Y">Intubation, Intratracheal</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017214" MajorTopicYN="Y">Laryngeal Masks</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007828" MajorTopicYN="N">Laryngoscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012119" MajorTopicYN="N">Respiration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>2</Month><Day>24</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2006</Year><Month>8</Month><Day>30</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>2</Month><Day>24</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16490088</ArticleId><ArticleId IdType="doi">10.1111/j.1460-9592.2005.01756.x</ArticleId><ArticleId IdType="pii">PAN1756</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38530453</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>15</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1438-8359</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of anesthesia</Title><ISOAbbreviation>J Anesth</ISOAbbreviation></Journal><ArticleTitle>Multisystem inflammatory syndrome in children: an Umbrella review.</ArticleTitle><Pagination><StartPage>309</StartPage><EndPage>320</EndPage><MedlinePgn>309-320</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00540-024-03323-7</ELocationID><Abstract><AbstractText>We conducted an Umbrella review of eligible studies to evaluate what patient features have been investigated in the multisystem inflammatory syndrome in children (MIS-C) population, in order to guide future investigations. We comprehensively searched MEDLINE, EMBASE, and Cochrane Database of Systematic Reviews from December 1, 2019 to the May 6, 2022. The time period was limited to cover the coronavirus disease-2019 (COVID-19) pandemic period. The protocol was registered in the PROSPERO registry (CRD42022340228). Eligible studies included (1) a study population of pediatric patients &#x2264;21&#xa0;years of age diagnosed with MIS-C; (2) an original Systematic review or Mata-analysis; (3) published 2020 afterward; and (4) was published in English. A total of 41 studies met inclusion criteria and underwent qualitative analysis. 28 studies reported outcome data of MIS-C. 22 studies selected clinical features of MIS-C, and 6 studies chose demographic data as a main topic. The mortality rate for children with MIS-C was 1.9% (interquartile range (IQR) 0.48), the ICU admission rate was 72.6% (IQR 8.3), and the extracorporeal membrane oxygenation rate was 4.7% (IQR 2.0). A meta-analysis of eligible studies found that cerebral natriuretic peptide in children with MIS-C was higher than that in children with COVID-19, and that the use of intravenous immunoglobulin (IVIG) in combination with glucocorticoids to treat MIS-C compared to IVIG alone was associated with lower treatment failure. In the future, for patients with MIS-C, studies focused on safety of surgery requiring general anesthesia, risk factors, treatment, and long-term outcomes are warranted.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s) under exclusive licence to Japanese Society of Anesthesiologists.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shioji</LastName><ForeName>Naohiro</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, National Cancer Center Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sumie</LastName><ForeName>Makoto</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Medicine, The Hospital for Sick Children, 555 University Ave, #2211, Toronto, ON, M5G 1X8, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Program in Child Health Evaluative Sciences, SickKids Research Institute, Toronto, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, St. Mary's Hospital, Fukuoka, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Englesakis</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Library and Information Services, University Health Network, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gilfoyle</LastName><ForeName>Elaine</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, The Hospital for Sick Children, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maynes</LastName><ForeName>Jason T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Medicine, The Hospital for Sick Children, 555 University Ave, #2211, Toronto, ON, M5G 1X8, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Program in Molecular Medicine, SickKids Research Institute, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aoyama</LastName><ForeName>Kazuyoshi</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-7502-0896</Identifier><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Medicine, The Hospital for Sick Children, 555 University Ave, #2211, Toronto, ON, M5G 1X8, Canada. kazu.aoyama@utoronto.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Program in Child Health Evaluative Sciences, SickKids Research Institute, Toronto, Canada. kazu.aoyama@utoronto.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Perioperative Services Facilitator Grant Program 2020-2021</GrantID><Agency>Hospital for Sick Children</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>J Anesth</MedlineTA><NlmUniqueID>8905667</NlmUniqueID><ISSNLinking>0913-8668</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018746" MajorTopicYN="Y">Systemic Inflammatory Response Syndrome</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015199" MajorTopicYN="N">Extracorporeal Membrane Oxygenation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016756" MajorTopicYN="N">Immunoglobulins, Intravenous</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">MIS-C</Keyword><Keyword MajorTopicYN="N">Umbrella review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>15</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>26</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>26</Day><Hour>12</Hour><Minute>17</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38530453</ArticleId><ArticleId IdType="doi">10.1007/s00540-024-03323-7</ArticleId><ArticleId IdType="pii">10.1007/s00540-024-03323-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Feldstein LR, Rose EB, Horwitz SM, Collins JP, Newhams MM, Son MBF, Newburger JW, Kleinman LC, Heidemann SM, Martin AA, Singh AR, Li S, Tarquinio KM, Jaggi P, Oster ME, Zackai SP, Gillen J, Ratner AJ, Walsh RF, Fitzgerald JC, Keenaghan MA, Alharash H, Doymaz S, Clouser KN, Giuliano JS Jr, Gupta A, Parker RM, Maddux AB, Havalad V, Ramsingh S, Bukulmez H, Bradford TT, Smith LS, Tenforde MW, Carroll CL, Riggs BJ, Gertz SJ, Daube A, Lansell A, Coronado Munoz A, Hobbs CV, Marohn KL, Halasa NB, Patel MM, Randolph AG, Overcoming COVID-19 Investigators, CDC COVID-19 Response Team. Multisystem inflammatory syndrome in us children and adolescents. N Engl J Med. 2020;383:334&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021680</ArticleId><ArticleId IdType="pubmed">32598831</ArticleId></ArticleIdList></Reference><Reference><Citation>Dufort EM, Koumans EH, Chow EJ, Rosenthal EM, Muse A, Rowlands J, Barranco MA, Maxted AM, Rosenberg ES, Easton D, Udo T, Kumar J, Pulver W, Smith L, Hutton B, Blog D, Zucker H, New York State and Centers for Disease Control and Prevention Multisystem Inflammatory Syndrome in Children Investigation Team. Multisystem inflammatory syndrome in children in New York State. N Engl J Med. 2020;383:347&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021756</ArticleId><ArticleId IdType="pubmed">32598830</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies P, Evans C, Kanthimathinathan HK, Lillie J, Brierley J, Waters G, Johnson M, Griffiths B, du Pr&#xe9; P, Mohammad Z, Deep A, Playfor S, Singh D, Inwald D, Jardine M, Ross O, Shetty N, Worrall M, Sinha R, Koul A, Whittaker E, Vyas H, Scholefield BR, Ramnarayan P. Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study. Lancet Child Adolesc Health. 2020;4:669&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(20)30215-7</ArticleId><ArticleId IdType="pubmed">32653054</ArticleId><ArticleId IdType="pmc">7347350</ArticleId></ArticleIdList></Reference><Reference><Citation>Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE, Shah P, Ramnarayan P, Fraisse A, Miller O, Davies P, Kucera F, Brierley J, McDougall M, Carter M, Tremoulet A, Shimizu C, Herberg J, Burns JC, Lyall H, Levin M, PIMS-TS Study Group and EUCLIDS and PERFORM Consortia. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA. 2020;21(324):259&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.10369</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandes DM, Oliveira CR, Guerguis S, Eisenberg R, Choi J, Kim M, Abdelhemid A, Agha R, Agarwal S, Aschner JL, Avner JR, Ballance C, Bock J, Bhavsar SM, Campbell M, Clouser KN, Gesner M, Goldman DL, Hammerschlag MR, Hymes S, Howard A, Jung HJ, Kohlhoff S, Kojaoghlanian T, Lewis R, Nachman S, Naganathan S, Paintsil E, Pall H, Sy S, Wadowski S, Zirinsky E, Cabana MD, Herold BC, Tri-State Pediatric COVID-19 Research Consortium. Severe acute respiratory syndrome coronavirus 2 clinical syndromes and predictors of disease severity in hospitalized children and youth. J Pediatr. 2021;230:23&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2020.11.016</ArticleId><ArticleId IdType="pubmed">33197493</ArticleId></ArticleIdList></Reference><Reference><Citation>Ant&#xfa;nez-Montes OY, Escamilla MI, Figueroa-Uribe AF, Arteaga-Menchaca E, Lavariega-Sar&#xe1;chaga M, Salcedo-Lozada P, Melchior P, de Oliveira RB, Tirado Caballero JC, Redondo HP, Montes Fontalvo LV, Hernandez R, Chavez C, Campos F, Uribe F, Del Aguila O, Rios Aida JA, Buitrago AP, Betancur Londo&#xf1;o LM, Mendoza Vega LF, Hern&#xe1;ndez CA, Sali M, Higuita Palacio JE, Gomez-Vargas J, Yock-Corrales A, Buonsenso D. COVID-19 and multisystem inflammatory syndrome in Latin American children: a multinational study. Pediatr Infect Dis J. 2021;40:e1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000002949</ArticleId><ArticleId IdType="pubmed">33055501</ArticleId></ArticleIdList></Reference><Reference><Citation>Gai N, Maynes JT, Aoyama K. Unique challenges in pediatric anesthesia created by COVID-19. J Anesth. 2021;35:345&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-020-02837-0</ArticleId><ArticleId IdType="pubmed">32770277</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoyama K, Heath A, Yang A, Maynes JT, Petroz G, Robertson J, Mc Donnell C, Velummailum R, Bond E, Pechlivanoglou P. Estimating the risk of SARS-CoV-2 transmission to pediatric anesthesiologists: a microsimulation model. Can J Anaesth. 2020;67:1694&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12630-020-01771-9</ArticleId><ArticleId IdType="pubmed">32720258</ArticleId><ArticleId IdType="pmc">7384724</ArticleId></ArticleIdList></Reference><Reference><Citation>Shioji N, Aoyama K, Englesakis M, Annich G, Maynes JT. Multisystem inflammatory syndrome in children during the coronavirus disease pandemic of 2019: a review of clinical features and acute phase management. J Anesth. 2021;35:563&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-021-02952-6</ArticleId><ArticleId IdType="pubmed">34052944</ArticleId><ArticleId IdType="pmc">8164829</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane handbook for systematic reviews of interventions | cochrane training. Available from: https://training.cochrane.org/handbook . Cited 14 May 2022.</Citation></Reference><Reference><Citation>Eden J, Levit L, Berg A, Morton S. Finding what works in health care: standards for systematic reviews. 2011. Available from: http://www.nap.edu/catalog.php?record_id=13059 . Cited 14 May 2022.</Citation></Reference><Reference><Citation>Centre for Reviews and Dissemination U of Y. CRD&#x2019;s guidance on systematic reviews. Centre for Reviews Dissemination, University of York, 2008. 2009. p 294. Available from: https://gate2.library.lse.ac.uk/login?url=http://onlinelibrary.wiley.com . Cited 21 Apr 2023.</Citation></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr&#xf3;bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId><ArticleId IdType="pmc">8005924</ArticleId></ArticleIdList></Reference><Reference><Citation>Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19. Available from: https://www.who.int/news-room/commentaries/detail/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19 . Cited 21 Apr 2023.</Citation></Reference><Reference><Citation>Information for healthcare providers about multisystem inflammatory syndrome in children (MIS-C) | CDC. Available from: https://www.cdc.gov/mis-c/hcp/ . Cited 12 Jan 2021.</Citation></Reference><Reference><Citation>Paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (spring 2021 update) | Canadian Paediatric Society. Available from: https://cps.ca/en/documents/position/pims . Cited 21 Apr 2023.</Citation></Reference><Reference><Citation>Paediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS)&#x2014;guidance for clinicians | RCPCH. Available from: https://www.rcpch.ac.uk/resources/paediatric-multisystem-inflammatory-syndrome-temporally-associated-covid-19-pims-guidance . Cited 12 Jan 2021.</Citation></Reference><Reference><Citation>Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, Moher D, Tugwell P, Welch V, Kristjansson E, Henry DA. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358: j4008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.j4008</ArticleId><ArticleId IdType="pubmed">28935701</ArticleId><ArticleId IdType="pmc">5833365</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiting P, Savovi&#x107; J, Higgins JP, Caldwell DM, Reeves BC, Shea B, Davies P, Kleijnen J, Churchill R. ROBIS: a new tool to assess risk of bias in systematic reviews was developed. J Clin Epidemiol. 2016;69:225&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2015.06.005</ArticleId><ArticleId IdType="pubmed">26092286</ArticleId><ArticleId IdType="pmc">4687950</ArticleId></ArticleIdList></Reference><Reference><Citation>Harwood R, Yan H, Talawila Da Camara N, Smith C, Ward J, Tudur-Smith C, Linney M, Clark M, Whittaker E, Saatci D, Davis PJ, Luyt K, Draper ES, Kenny SE, Fraser LK, Viner RM. Which children and young people are at higher risk of severe disease and death after hospitalisation with SARS-CoV-2 infection in children and young people: a systematic review and individual patient meta-analysis. eClinicalMedicine. 2022;44:101287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101287</ArticleId><ArticleId IdType="pubmed">35169689</ArticleId><ArticleId IdType="pmc">8832134</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Gonzalez M, Castellano-Martinez A, Cascales-Poyatos HM, Perez-Reviriego AA. Cardiovascular impact of COVID-19 with a focus on children: a systematic review. World J Clin Cases. 2020;8:5250&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="doi">10.12998/wjcc.v8.i21.5250</ArticleId><ArticleId IdType="pubmed">33269260</ArticleId><ArticleId IdType="pmc">7674714</ArticleId></ArticleIdList></Reference><Reference><Citation>Haghighi Aski B, Manafi Anari A, Abolhasan Choobdar F, Zareh Mahmoudabadi R, Sakhaei M. Cardiac abnormalities due to multisystem inflammatory syndrome temporally associated with Covid-19 among children: a systematic review and meta-analysis. Int J Cardiol Heart Vasc. 2021;33: 100764.</Citation><ArticleIdList><ArticleId IdType="pubmed">33778151</ArticleId><ArticleId IdType="pmc">7983575</ArticleId></ArticleIdList></Reference><Reference><Citation>Henrina J, Putra ICS, Lawrensia S, Marta DS, Wijaya E, Saboe A, Cool CJ, Suciadi LP. Cardiac manifestations, treatment characteristics, and outcomes of paediatric inflammatory multisystem syndrome temporally associated with severe acute respiratory syndrome coronavirus-2: a systematic review. Prog Pediatr Cardiol. 2021;63: 101365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ppedcard.2021.101365</ArticleId><ArticleId IdType="pubmed">33584087</ArticleId><ArticleId IdType="pmc">7871802</ArticleId></ArticleIdList></Reference><Reference><Citation>Nepal G, Shrestha GS, Rehrig JH, Gajurel BP, Ojha R, Agrawal A, Panthi S, Khatri B, Adhikari I. Neurological Manifestations of COVID-19 Associated multi-system inflammatory syndrome in children: a systematic review and meta-analysis. J Nepal Health Res Counc. 2021;19:10&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="doi">10.33314/jnhrc.v19i1.3410</ArticleId><ArticleId IdType="pubmed">33934126</ArticleId></ArticleIdList></Reference><Reference><Citation>Rouva G, Vergadi E, Galanakis E. Acute abdomen in multisystem inflammatory syndrome in children: a systematic review. Acta Paediatr. 2022;111:467&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.16178</ArticleId><ArticleId IdType="pubmed">34751972</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo TC, Chen YY. Ocular and systemic manifestations in paediatric multisystem inflammatory syndrome associated with COVID-19. J Clin Med. 2021;10:2953.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10132953</ArticleId><ArticleId IdType="pubmed">34209269</ArticleId><ArticleId IdType="pmc">8269386</ArticleId></ArticleIdList></Reference><Reference><Citation>Nascimento RB, Araujo NS, Silva JC, Xavier FCA. Oral manifestations of multisystemic inflammatory syndrome in children (MIS-C) and Kawasaki disease associated to COVID-19: a systematic review. Spec Care Dentist. 2022;42:266&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/scd.12669</ArticleId><ArticleId IdType="pubmed">34792813</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasuhara J, Watanabe K, Takagi H, Sumitomo N, Kuno T. COVID-19 and multisystem inflammatory syndrome in children: a systematic review and meta-analysis. Pediatr Pulmonol. 2021;56:837&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.25245</ArticleId><ArticleId IdType="pubmed">33428826</ArticleId><ArticleId IdType="pmc">8013394</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrams JY, Godfred-Cato SE, Oster ME, Chow EJ, Koumans EH, Bryant B, Leung JW, Belay ED. Multisystem inflammatory syndrome in children associated with severe acute respiratory syndrome coronavirus 2: a systematic review. J Pediatr. 2020;226:45&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2020.08.003</ArticleId><ArticleId IdType="pubmed">32768466</ArticleId><ArticleId IdType="pmc">7403869</ArticleId></ArticleIdList></Reference><Reference><Citation>Guimar&#xe3;es D, Pissarra R, Reis-Melo A, Guimar&#xe3;es H. Multisystem inflammatory syndrome in children (MISC): a systematic review. Int J Clin Pract. 2021;75: e14450.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14450</ArticleId><ArticleId IdType="pubmed">34105843</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoste L, Van Paemel R, Haerynck F. Multisystem inflammatory syndrome in children related to COVID-19: a systematic review. Eur J Pediatr. 2021;180:2019&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-021-03993-5</ArticleId><ArticleId IdType="pubmed">33599835</ArticleId><ArticleId IdType="pmc">7890544</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhar D, Dey T, Samim MM, Padmanabha H, Chatterjee A, Naznin P, Chandra SR, Mallesh K, Shah R, Siddiqui S, Pratik K, Ameya P, Abhishek G. Systemic inflammatory syndrome in COVID-19-SISCoV study: systematic review and meta-analysis. Pediatr Res. 2022;91:1334&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41390-021-01545-z</ArticleId><ArticleId IdType="pubmed">34006982</ArticleId></ArticleIdList></Reference><Reference><Citation>Mardi P, Esmaeili M, Iravani P, Abdar ME, Pourrostami K, Qorbani M. Characteristics of children With Kawasaki disease-like signs in COVID-19 pandemic: a systematic review. Front Pediatr. 2021;9: 625377.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2021.625377</ArticleId><ArticleId IdType="pubmed">33816398</ArticleId><ArticleId IdType="pmc">8012548</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Yin L, Patel J, Tang L, Huang Y. The inflammatory markers of multisystem inflammatory syndrome in children (MIS-C) and adolescents associated with COVID-19: a meta-analysis. J Med Virol. 2021;93:4358&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26951</ArticleId><ArticleId IdType="pubmed">33739452</ArticleId><ArticleId IdType="pmc">8250955</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Patel J, Huang Y, Yin L, Tang L. Cardiac markers of multisystem inflammatory syndrome in children (MIS-C) in COVID-19 patients: a meta-analysis. Am J Emerg Med. 2021;49:62&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2021.05.044</ArticleId><ArticleId IdType="pubmed">34082189</ArticleId><ArticleId IdType="pmc">8129790</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou C, Zhao Y, Wang X, Huang Y, Tang X, Tang L. Laboratory parameters between multisystem inflammatory syndrome in children and Kawasaki disease. Pediatr Pulmonol. 2021;56:3688&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.25687</ArticleId><ArticleId IdType="pubmed">34583417</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Zhao S, Tang Y, Wang Z, Shi Q, Dang X, Gan L, Peng S, Li W, Zhou Q, Li Q, Mafiana JJ, Cort&#xe9;s RG, Luo Z, Liu E, Chen Y. Potentially effective drugs for the treatment of COVID-19 or MIS-C in children: a systematic review. Eur J Pediatr. 2022;181:2135&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-022-04388-w</ArticleId><ArticleId IdType="pubmed">35192051</ArticleId><ArticleId IdType="pmc">8861482</ArticleId></ArticleIdList></Reference><Reference><Citation>Rauniyar R, Mishra A, Kharel S, Giri S, Rauniyar R, Yadav S, Chaudhary G. IVIG plus glucocorticoids versus IVIG alone in multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19: a systematic review and meta-analysis. Can J Infect Dis Med Microbiol. 2022;2022:9458653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/9458653</ArticleId><ArticleId IdType="pubmed">35368517</ArticleId><ArticleId IdType="pmc">8965733</ArticleId></ArticleIdList></Reference><Reference><Citation>Llin&#xe1;s-Caballero K, Rodr&#xed;guez Y, Fern&#xe1;ndez-Sarmiento J, Rodr&#xed;guez-Jim&#xe9;nez M, Anaya JM. Kawasaki disease in Colombia: a systematic review and contrast with multisystem inflammatory syndrome in children associated with COVID-19. Rev Colomb Reumatol. 2022;29:S66&#x2013;76.</Citation></Reference><Reference><Citation>De Rose DU, Pugnaloni F, Cal&#xec; M, Ronci S, Caoci S, Maddaloni C, Martini L, Santisi A, Dotta A, Auriti C. Multisystem inflammatory syndrome in neonates born to mothers with SARS-CoV-2 infection (MIS-N) and in neonates and infants younger than 6 months with acquired COVID-19 (MIS-C): a systematic review. Viruses. 2022;14:750.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14040750</ArticleId><ArticleId IdType="pubmed">35458480</ArticleId><ArticleId IdType="pmc">9024762</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma D, Bhaskar SMM. Prevalence of paediatric hyperinflammatory conditions in paediatric and adolescent hospitalized COVID-19 patients: a systematic review and meta-analysis. APMIS. 2022;130:101&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apm.13199</ArticleId><ArticleId IdType="pubmed">34894016</ArticleId></ArticleIdList></Reference><Reference><Citation>Karimi A, Ghafouri P, Alilou S, Rezaei N, Talesh SA, Ashraf H. Echocardiographic findings in multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19: a systematic review. Iran J Pediatr. 2022;32:e119001.</Citation><ArticleIdList><ArticleId IdType="doi">10.5812/ijp.119001</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;loughlin L, Toledo NA, Budrie L, Waechter R, Rayner J. A systematic review of severe neurological manifestations in pediatric patients with coexisting sars-cov-2 infection. Neurol Int. 2021;13:410&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/neurolint13030041</ArticleId><ArticleId IdType="pubmed">34449704</ArticleId><ArticleId IdType="pmc">8396020</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaffanello M, Piacentini G, Nosetti L, Ganzarolli S, Franchini M. Thrombotic risk in children with COVID-19 infection: a systematic review of the literature. Thromb Res. 2021;205:92&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2021.07.011</ArticleId><ArticleId IdType="pubmed">34293539</ArticleId><ArticleId IdType="pmc">8284063</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison SL, Buckley BJR, Rivera-Caravaca JM, Zhang J, Lip GYH. Cardiovascular risk factors, cardiovascular disease, and COVID-19: an umbrella review of systematic reviews. Eur Hear J Qual Care Clin Outcomes. 2021;7:330&#x2013;9.</Citation></Reference><Reference><Citation>Treskova-Schwarzbach M, Haas L, Reda S, Pilic A, Borodova A, Karimi K, Koch J, Nygren T, Scholz S, Sch&#xf6;nfeld V, Vygen-Bonnet S, Wichmann O, Harder T. Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence. BMC Med. 2021;19:212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02058-6</ArticleId><ArticleId IdType="pubmed">34446016</ArticleId><ArticleId IdType="pmc">8390115</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L, Li J, Wei W, Yi C, Pu Y, Zhang L, Cui T, Ma L, Zhang J, Koyner J, Zhao Y, Fu P. Kidney health in the COVID-19 pandemic: an umbrella review of meta-analyses and systematic reviews. Front Public Health. 2022;10: 963667.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.963667</ArticleId><ArticleId IdType="pubmed">36172213</ArticleId><ArticleId IdType="pmc">9511113</ArticleId></ArticleIdList></Reference><Reference><Citation>Shioji N, Sumie M, Aoyama K. How long elective surgery should be delayed from COVID-19 infection in pediatric patients? J Anesth. 2023. https://doi.org/10.1007/s00540-023-03284-3 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-023-03284-3</ArticleId><ArticleId IdType="pubmed">37975914</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">40917545</PMID><DateRevised><Year>2025</Year><Month>09</Month><Day>10</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2475-0379</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>6</Issue><PubDate><Year>2025</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Research and practice in thrombosis and haemostasis</Title><ISOAbbreviation>Res Pract Thromb Haemost</ISOAbbreviation></Journal><ArticleTitle>High- and intermediate-risk pulmonary embolism in pediatric tertiary care centers in the Netherlands.</ArticleTitle><Pagination><StartPage>102972</StartPage><MedlinePgn>102972</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">102972</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.rpth.2025.102972</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Pulmonary embolism (PE) response teams are increasingly used in adult care to improve severe PE management. Understanding the epidemiology, treatment, and outcomes of severe PE in children is crucial to assessing the need for pediatric PE response teams in the Netherlands.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">To evaluate the incidence, management, and short-term outcomes of severe PE in Dutch pediatric patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This retrospective cohort study included children (0-18 years) diagnosed with high- and intermediate-risk PE between 2012 and 2022 across 6 pediatric tertiary care centers in the Netherlands.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Among 172 PE patients, 17 (10%) had high-risk PE and 19 (11%) had intermediate-risk PE. The annual PE incidence was estimated at 1.0 case per million children, predominantly affecting adolescents. Common symptoms included dyspnea (90%) and tachypnea (75%). Major risk factors were oral contraceptive use (57%) and congenital thrombophilia (39%). In the high-risk group, 100% underwent reperfusion therapy, including systemic thrombolysis (<i>n</i> = 13), surgical thrombectomy (<i>n</i> = 3), and catheter-directed therapy (CDT; <i>n</i> = 1). Four systemic thrombolysis failures required further intervention (3 CDT and 1 surgical thrombectomy). Major bleeding occurred in 2 patients (12%), and 2 (12%) suffered PE-related deaths. Among intermediate-risk patients, 42% received reperfusion therapy (7 systemic thrombolysis and 1 CDT), with major bleeding in 2 (11%) and no deaths. Postdischarge treatment included low-molecular-weight heparin (<i>n</i> = 10), vitamin K antagonists (<i>n</i> = 7), and direct oral anticoagulants (<i>n</i> = 17).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Severe PE is rare in Dutch children. The variation in indications and reperfusion strategies highlights the need for national, multidisciplinary care pathways to standardize management and improve outcomes.</AbstractText><CopyrightInformation>&#xa9; 2025 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>van Balkom</LastName><ForeName>C A M Karlijn</ForeName><Initials>CAMK</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Zaans Medical Centre, Zaandam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klaassen</LastName><ForeName>Irene L M</ForeName><Initials>ILM</Initials><AffiliationInfo><Affiliation>Department of Pediatric Hematology, Amsterdam University Medical Center, Emma Children's Hospital, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diender</LastName><ForeName>Marije</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatric Hematology, Radboud University Medical Center, Amalia Children's Hospital, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hovinga</LastName><ForeName>Idske Kremer</ForeName><Initials>IK</Initials><AffiliationInfo><Affiliation>Department of Pediatric Hematology, Center for Benign Haematology, Thrombosis and Haemostasis, Van Creveldkliniek, University Medical Center Utrecht, Utrecht University, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stein-Wit</LastName><ForeName>Marjet A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Pediatric Hematology, University Medical Center Groningen Beatrix Children's Hospital, Groningen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smiers</LastName><ForeName>Frans J W</ForeName><Initials>FJW</Initials><AffiliationInfo><Affiliation>Department of Pediatric Hematology, Leiden University Medical Center, Willem-Alexander Children's Hospital, Leiden, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heleen van Ommen</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pediatric Hematology, Erasmus Medical Center, Sophia Children's Hospital, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Res Pract Thromb Haemost</MedlineTA><NlmUniqueID>101703775</NlmUniqueID><ISSNLinking>2475-0379</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">PERT</Keyword><Keyword MajorTopicYN="N">high risk</Keyword><Keyword MajorTopicYN="N">intermediate risk</Keyword><Keyword MajorTopicYN="N">pediatrics</Keyword><Keyword MajorTopicYN="N">pulmonary embolism</Keyword><Keyword MajorTopicYN="N">rapid response team</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>3</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>6</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>8</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>9</Month><Day>8</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>9</Month><Day>8</Day><Hour>7</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40917545</ArticleId><ArticleId IdType="pmc">PMC12410197</ArticleId><ArticleId IdType="doi">10.1016/j.rpth.2025.102972</ArticleId><ArticleId IdType="pii">S2475-0379(25)00296-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Huisman M.V., Barco S., Cannegieter S.C., Le Gal G., Konstantinides S.V., Reitsma P.H., et al. Pulmonary embolism. Nat Rev Dis Primers. 2018;4 doi: 10.1038/nrdp.2018.28.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2018.28</ArticleId><ArticleId IdType="pubmed">29770793</ArticleId></ArticleIdList></Reference><Reference><Citation>Konstantinides S.V., Meyer G. The 2019 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2019;40:3453&#x2013;3455.</Citation><ArticleIdList><ArticleId IdType="pubmed">31697840</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosovsky R., Chang Y., Rosenfield K., Channick R., Jaff M.R., Weinberg I., et al. Changes in treatment and outcomes after creation of a pulmonary embolism response team (PERT), a 10-year analysis. J Thromb Thrombolysis. 2019;47:31&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">30242551</ArticleId></ArticleIdList></Reference><Reference><Citation>Annabathula R., Dugan A., Bhalla V., Davis G.A., Smyth S.S., Gupta V.A. Value-based assessment of implementing a pulmonary embolism response team (PERT) J Thromb Thrombolysis. 2021;51:217&#x2013;225.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8325945</ArticleId><ArticleId IdType="pubmed">32542527</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandya V., Chandra A.A., Scotti A., Assafin M., Schenone A.L., Latib A., et al. Evolution of pulmonary embolism response teams in the United States: a review of the literature. J Clin Med. 2024;13:3984.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11242386</ArticleId><ArticleId IdType="pubmed">38999548</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelland-Marcotte M.C., Tucker C., Klaassen A., Avila M.L., Amid A., Amiri N., et al. Outcomes and risk factors of massive and submassive pulmonary embolism in children: a retrospective cohort study. Lancet Haematol. 2019;6:e144&#x2013;e153.</Citation><ArticleIdList><ArticleId IdType="pubmed">30772417</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf S., Valerio L., Kucher N., Konstantinides S.V., Klaassen I.L.M., van Ommen C.H., et al. Acute pulmonary embolism in children and adolescents in the USA (2016 and 2019): a nationwide retrospective cohort study. Lancet Respir Med. 2025;13:393&#x2013;402.</Citation><ArticleIdList><ArticleId IdType="pubmed">39919780</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpenter S.L., Richardson T., Hall M. Increasing rate of pulmonary embolism diagnosed in hospitalized children in the United States from 2001 to 2014. Blood Adv. 2018;2:1403&#x2013;1408.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6020809</ArticleId><ArticleId IdType="pubmed">29907635</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajpurkar M., Biss T., Amankwah E.K., Martinez D., Williams S., Van Ommen C.H., et al. Pulmonary embolism and in situ pulmonary artery thrombosis in paediatrics. A systematic review. Thromb Haemost. 2017;117:1199&#x2013;1207.</Citation><ArticleIdList><ArticleId IdType="pubmed">28331932</ArticleId></ArticleIdList></Reference><Reference><Citation>Biss T.T., Brandao L.R., Kahr W.H., Chan A.K., Williams S. Clinical probability score and D-dimer estimation lack utility in the diagnosis of childhood pulmonary embolism. J Thromb Haemost. 2009;7:1633&#x2013;1638.</Citation><ArticleIdList><ArticleId IdType="pubmed">19682234</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajpurkar M., Warrier I., Chitlur M., Sabo C., Frey M.J., Hollon W., et al. Pulmonary embolism-experience at a single children&#x2019;s hospital. Thromb Res. 2007;119:699&#x2013;703.</Citation><ArticleIdList><ArticleId IdType="pubmed">16879861</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross C., Kumar R., Pelland-Marcotte M.C., Mehta S., Kleinman M.E., Thiagarajan R.R., et al. Acute management of high-risk and intermediate-risk pulmonary embolism in children: a review. Chest. 2022;161:791&#x2013;802.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8941619</ArticleId><ArticleId IdType="pubmed">34587483</ArticleId></ArticleIdList></Reference><Reference><Citation>Monagle P., Cuello C.A., Augustine C., Bonduel M., Brandao L.R., Capman T., et al. American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism. Blood Adv. 2018;2:3292&#x2013;3316.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6258911</ArticleId><ArticleId IdType="pubmed">30482766</ArticleId></ArticleIdList></Reference><Reference><Citation>Akam-Venkata J., Forbes T.J., Schreiber T., Kaki A., Elder M., Turner D.R., et al. Catheter-directed therapy for acute pulmonary embolism in children. Cardiol Young. 2019;29:263&#x2013;269.</Citation><ArticleIdList><ArticleId IdType="pubmed">30572968</ArticleId></ArticleIdList></Reference><Reference><Citation>Bavare A.C., Naik S.X., Lin P.H., Poi M.J., Yee D.L., Bronicki R.A., et al. Catheter-directed thrombolysis for severe pulmonary embolism in pediatric patients. Ann Vasc Surg. 2014;28:1794.e1&#x2013;1794.e7.</Citation><ArticleIdList><ArticleId IdType="pubmed">24698774</ArticleId></ArticleIdList></Reference><Reference><Citation>Belsky J., Warren P., Stanek J., Kumar R. Catheter-directed thrombolysis for submassive pulmonary embolism in children: a case series. Pediatr Blood Cancer. 2020;67 doi: 10.1002/pbc.28144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pbc.28144</ArticleId><ArticleId IdType="pubmed">31876109</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolovos N.S., Gill J., Michelson P.H., Doctor A., Hartman M.E. Reduction in mortality following pediatric rapid response team implementation. Pediatr Crit Care Med. 2018;19:477&#x2013;482.</Citation><ArticleIdList><ArticleId IdType="pubmed">29528975</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandquist M., Tegtmeyer K. No more pediatric code blues on the floor: evolution of pediatric rapid response teams and situational awareness plans. Transl Pediatr. 2018;7:291&#x2013;298.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6212387</ArticleId><ArticleId IdType="pubmed">30460181</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajpurkar M., Rosovsky R.P., Williams S., Chan A.K.C., van Ommen C.H., Faustino E.V.S., et al. Considerations for instituting pediatric pulmonary embolism response teams: a tool kit. Thromb Res. 2024;236:97&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pubmed">38417301</ArticleId></ArticleIdList></Reference><Reference><Citation>Bashir D.A., Cargill J.C., Gowda S., Musick M., Coleman R., Chartan C.A., et al. Implementing a pediatric pulmonary embolism response team model: an institutional experience. Chest. 2024;165:192&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="pubmed">38199732</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang M.P., Cheng A., Garcia J., Lee Y., Parikh M., McMichael A.B.V., et al. Bringing PERT to pediatrics: initial experience and outcomes of a pediatric multidisciplinary pulmonary embolism response team (PERT) Chest. 2025;167:851&#x2013;862.</Citation><ArticleIdList><ArticleId IdType="pubmed">39368735</ArticleId></ArticleIdList></Reference><Reference><Citation>Cole T.J., Bellizzi M.C., Flegal K.M., Dietz W.H. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ. 2000;320:1240&#x2013;1243.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC27365</ArticleId><ArticleId IdType="pubmed">10797032</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitworth H., Amankwah E.K., Betensky M., Castellucci L.A., Cuker A., Goldenberg N.A., et al. Updated guidance for efficacy and safety outcomes for clinical trials in venous thromboembolism in children: communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis. J Thromb Haemost. 2023;21:1666&#x2013;1673.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10472337</ArticleId><ArticleId IdType="pubmed">36921919</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Ommen C.H., Peters M. Acute pulmonary embolism in childhood. Thromb Res. 2006;118:13&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">15992866</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein P.D., Kayali F., Olson R.E. Incidence of venous thromboembolism in infants and children: data from the National Hospital Discharge Survey. J Pediatr. 2004;145:563&#x2013;565.</Citation><ArticleIdList><ArticleId IdType="pubmed">15480387</ArticleId></ArticleIdList></Reference><Reference><Citation>Krmpotic K., Ramsay L., McMullen S., Chan A.K.C., Plint A.C., Moorehead P. Pediatric pulmonary thromboembolism: a 3-year Canadian Pediatric Surveillance Program study. J Thromb Haemost. 2024;22:1366&#x2013;1371.</Citation><ArticleIdList><ArticleId IdType="pubmed">38266677</ArticleId></ArticleIdList></Reference><Reference><Citation>van Ommen C.H., Heijboer H., Buller H.R., Hirasing R.A., Heijmans H.S., Peters M. Venous thromboembolism in childhood: a prospective two-year registry in the Netherlands. J Pediatr. 2001;139:676&#x2013;681.</Citation><ArticleIdList><ArticleId IdType="pubmed">11713446</ArticleId></ArticleIdList></Reference><Reference><Citation>Lira L.A.S., Celeste D.M., Garanito M.P., Carneiro J.D.A. Pulmonary embolism in pediatrics: a 10-year experience from a tertiary center in Brazil. Hematol Transfus Cell Ther. 2023;45:S85&#x2013;S90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10433301</ArticleId><ArticleId IdType="pubmed">35400623</ArticleId></ArticleIdList></Reference><Reference><Citation>Biss T.T., Rajpurkar M., Williams S., van Ommen C.H., Chan A.K.C., Goldenberg N.A., et al. Recommendations for future research in relation to pediatric pulmonary embolism: communication from the SSC of the ISTH. J Thromb Haemost. 2018;16:405&#x2013;408.</Citation><ArticleIdList><ArticleId IdType="pubmed">29197153</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendelson J. Emergency department management of pediatric shock. Emerg Med Clin North Am. 2018;36:427&#x2013;440.</Citation><ArticleIdList><ArticleId IdType="pubmed">29622332</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner K., Raffini L.J., Whitworth H. Clinical characteristics and acute management of pediatric pulmonary embolism. Blood. 2022;140:2801&#x2013;2802.</Citation></Reference><Reference><Citation>Jimenez D., Lobo J.L., Barrios D., Prandoni P., Yusen R.D. Risk stratification of patients with acute symptomatic pulmonary embolism. Intern Emerg Med. 2016;11:11&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">26768476</ArticleId></ArticleIdList></Reference><Reference><Citation>White R.H. The epidemiology of venous thromboembolism. Circulation. 2003;107:I4&#x2013;I8.</Citation><ArticleIdList><ArticleId IdType="pubmed">12814979</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein P.D., Matta F., Hughes P.G., Hughes M.J. Mortality in pulmonary embolism according to risk category at presentation in emergency department: impact of cardiac arrest. Am J Cardiol. 2021;157:125&#x2013;127.</Citation><ArticleIdList><ArticleId IdType="pubmed">34373080</ArticleId></ArticleIdList></Reference><Reference><Citation>Dijk F.N., Curtin J., Lord D., Fitzgerald D.A. Pulmonary embolism in children. Paediatr Respir Rev. 2012;13:112&#x2013;122.</Citation><ArticleIdList><ArticleId IdType="pubmed">22475258</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross C.E., Shih J.A., Kleinman M.E., Donnino M.W. Pediatric massive and submassive pulmonary embolism: a single-center experience. Hosp Pediatr. 2020;10:272&#x2013;276.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7041554</ArticleId><ArticleId IdType="pubmed">32047028</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37301238</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>20</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8406</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>12</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>The Journal of arthroplasty</Title><ISOAbbreviation>J Arthroplasty</ISOAbbreviation></Journal><ArticleTitle>Total Hip Arthroplasty Outcomes in Patients Who Have a History of Prior Radiation.</ArticleTitle><Pagination><StartPage>2644</StartPage><EndPage>2649</EndPage><MedlinePgn>2644-2649</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.arth.2023.05.066</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0883-5403(23)00609-5</ELocationID><Abstract><AbstractText Label="BACKGROUND">The purpose of this study was to assess the odds of developing medical and surgical adverse events following total hip arthroplasty (THA) in patients who have a history of radiation therapy (RT) for cancer.</AbstractText><AbstractText Label="METHODS">A retrospective cohort study was conducted using a national database to identify patients who underwent primary THA (Current Procedural Terminology code 27130) from 2002 to 2022. Patients who had a prior RT were identified by International Classification of Diseases, Tenth Revision, Clinical Modification codes Z51.0 (encounter for antineoplastic RT), Z92.3 (personal history of irradiation), or Current Procedural Terminology code 101843 (radiation oncology treatment). One-to-one propensity score matching was conducted to generate 3 pairs of cohorts: 1) THA with/without a history of RT; 2) THA with/without a history of cancer; and 3) THA patients who have a history of cancer treated with/without RT. Surgical and medical complications were assessed at the 30-day, 90-day, and 1-year postoperative periods.</AbstractText><AbstractText Label="RESULTS">Patients who have a history of RT had higher odds of developing anemia, deep vein thrombosis, pneumonia, pulmonary embolism, and prosthetic joint infection at all intervals. When controlling for a history of cancer, RT was associated with an increased risk of pulmonary embolism, heterotrophic ossification, prosthetic joint infection, and periprosthetic fracture at all postoperative time points. There was additionally an increased risk of aseptic loosening at 1 year (odds ratio: 2.0, 95% confidence interval: 1.2 to 3.1).</AbstractText><AbstractText Label="CONCLUSION">These findings suggest that patients who have a history of antineoplastic RT are at an increased risk of developing various surgical and medical complications following THA.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lavu</LastName><ForeName>Monish S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Case Western Reserve University School of Medicine, Cleveland, Ohio; Department of Orthopaedic Surgery, Cleveland Clinic Foundation, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hecht</LastName><ForeName>Christian J</ForeName><Initials>CJ</Initials><Suffix>2nd</Suffix><AffiliationInfo><Affiliation>Case Western Reserve University School of Medicine, Cleveland, Ohio; Department of Orthopaedic Surgery, Cleveland Clinic Foundation, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rizk</LastName><ForeName>Adam A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Case Western Reserve University School of Medicine, Cleveland, Ohio; Department of Orthopaedic Surgery, Cleveland Clinic Foundation, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Acu&#xf1;a</LastName><ForeName>Alexander J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, Rush University Medical Center, Chicago, Illinois.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaelber</LastName><ForeName>David C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Departments of Internal Medicine, Pediatrics, and Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, Ohio; The Center for Clinical Informatics Research and Education, The MetroHealth System, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamath</LastName><ForeName>Atul F</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Cleveland Clinic Foundation, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR002548</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Arthroplasty</MedlineTA><NlmUniqueID>8703515</NlmUniqueID><ISSNLinking>0883-5403</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019644" MajorTopicYN="Y">Arthroplasty, Replacement, Hip</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="Y">Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000970" MajorTopicYN="Y">Antineoplastic Agents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012086" MajorTopicYN="N">Reoperation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">adverse events</Keyword><Keyword MajorTopicYN="N">complications</Keyword><Keyword MajorTopicYN="N">radiation therapy</Keyword><Keyword MajorTopicYN="N">radiotherapy</Keyword><Keyword MajorTopicYN="N">total hip arthroplasty</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>11</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>10</Day><Hour>19</Hour><Minute>24</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37301238</ArticleId><ArticleId IdType="doi">10.1016/j.arth.2023.05.066</ArticleId><ArticleId IdType="pii">S0883-5403(23)00609-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27888743</PMID><DateCompleted><Year>2017</Year><Month>03</Month><Day>03</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2688</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><PubDate><Year>2016</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Seizure</Title><ISOAbbreviation>Seizure</ISOAbbreviation></Journal><ArticleTitle>Plasmapheresis for refractory status epilepticus Part II: A scoping systematic review of the pediatric literature.</ArticleTitle><Pagination><StartPage>61</StartPage><EndPage>68</EndPage><MedlinePgn>61-68</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.seizure.2016.11.010</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1059-1311(16)30233-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Our goal was to perform a scoping systematic review of the literature on the use of plasmapheresis or plasma exchange (PE) for refractory status epilepticus (RSE) in children.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Articles from MEDLINE, BIOSIS, EMBASE, Global Health, Healthstar, Scopus, Cochrane Library, the International Clinical Trials Registry Platform, clinicaltrials.gov (inception to May 2016), reference lists of relevant articles, and gray literature were searched. The strength of evidence was adjudicated using both the Oxford and GRADE methodology by two independent reviewers.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twenty-two original articles were identified, with 37 pediatric patients. The mean age of the patients was 8.3 years (age median: 8.5, range: 0.6 years-17 years). Seizure response to PE therapy occurred in 9 of the 37 patients (24.3%) included in the review, with 7 patients (18.9%) displaying resolution of seizures and 2 patients (5.4%) displaying a partial reduction in seizure volume. Twenty-eight of the 37 patients (75.7%) had no response to PE therapy. No adverse events were recorded.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Oxford level 4, GRADE D evidence exists to suggest little to no benefit of PE in pediatric RSE. Routine application of PE for pediatric RSE cannot be recommended at this time.</AbstractText><CopyrightInformation>Copyright &#xa9; 2016 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zeiler</LastName><ForeName>F A</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Clinician Investigator Program, University of Manitoba, Winnipeg, Canada. Electronic address: umzeiler@myumanitoba.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matuszczak</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Undergraduate Medicine, University of Manitoba, Winnipeg, MB R3A 1R9, Canada. Electronic address: matuszcm@myumanitoba.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teitelbaum</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Section of Neurology, Montreal Neurological Institute, 3801 Rue University, McGill, Montreal, QC, H3A 2B4, Canada. Electronic address: jteitelbaum@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kazina</LastName><ForeName>C J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Clinician Investigator Program, University of Manitoba, Winnipeg, Canada. Electronic address: ckazina@exchange.hsc.mb.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gillman</LastName><ForeName>L M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Section of Critical Care Medicine, Dept of Medicine, University of Manitoba, Winnipeg, Canada; Section of General Surgery, Dept of Surgery, University of Manitoba, Winnipeg, Canada. Electronic address: gillmanlm@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000098583">Scoping Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>11</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Seizure</MedlineTA><NlmUniqueID>9306979</NlmUniqueID><ISSNLinking>1059-1311</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016206" MajorTopicYN="N">Databases, Bibliographic</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010956" MajorTopicYN="N">Plasmapheresis</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013226" MajorTopicYN="N">Status Epilepticus</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Children</Keyword><Keyword MajorTopicYN="N">PLEX</Keyword><Keyword MajorTopicYN="N">Plasma exchange</Keyword><Keyword MajorTopicYN="N">Plasmapheresis</Keyword><Keyword MajorTopicYN="N">Refractory seizures</Keyword><Keyword MajorTopicYN="N">Status epilepticus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>8</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>11</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>11</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>11</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27888743</ArticleId><ArticleId IdType="doi">10.1016/j.seizure.2016.11.010</ArticleId><ArticleId IdType="pii">S1059-1311(16)30233-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39685739</PMID><DateRevised><Year>2025</Year><Month>01</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>23</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>29</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Pregnancy Outcomes in Women with Biventricular Circulation and a Systemic Right Ventricle: A Systematic Review.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">7281</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm13237281</ELocationID><Abstract><AbstractText><b>Background:</b> Pregnancy in women with biventricular circulation and a systemic right ventricle (sRV) is considered high risk, with limited data available on pregnancy outcomes. This study aimed to investigate pregnancy outcomes in this population. <b>Materials and Methods:</b> A systematic review was conducted using four major electronic databases. Pregnant women with a complete transposition of great arteries (d-TGA) after an atrial switch operation or a congenitally corrected transposition of the great arteries (ccTGA) were included. <b>Results:</b> In total, 15 studies including 632 pregnancies in 415 women with an sRV and biventricular circulation were identified, of whom 299 (72%) had d-TGA and 116 (28%) ccTGA. Maternal mortality or cardiac transplantation occurred in 0.8% of pregnancies. The most frequent maternal complications were the worsening of systemic atrioventricular valve regurgitation [pooled estimate (PE): 16%, 95% CI: 5;26], the deterioration of sRV function (PE: 15%, 95% CI: 2;27), the worsening of the NYHA class (PE: 13%, 95% CI: 6;20), all-cause hospitalization (PE): 10%, 95% CI: 7;12), arrhythmias (PE: 8%, 95% CI: 5;11), and symptomatic heart failure (PE: 6%, 95% CI: 3;10). Stillbirth occurred in 0.7% of pregnancies and neonatal death in 0.4%. Small-for-gestational-age neonates were encountered in 36% (95% CI: 21;52) of pregnancies and preterm delivery in 22% (95% CI: 14;30). A subgroup analysis showed no significant difference in outcomes between women with d-TGA and those with ccTGA, except for the worsening of the NYHA class, which occurred more often in d-TGA (18%, 95% CI: 12;27 vs. 6%, 95% CI: 3;15, respectively, <i>p</i> = 0.03). <b>Conclusions:</b> Maternal and fetal/neonatal mortality are low among pregnant women with biventricular circulation and an sRV. However, significant maternal morbidity and poor neonatal outcomes are frequently encountered, rendering management in specialized centers imperative.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Grantza</LastName><ForeName>Triantafyllia</ForeName><Initials>T</Initials><Identifier Source="ORCID">0009-0009-1248-1212</Identifier><AffiliationInfo><Affiliation>First Department of Cardiology, AHEPA University General Hospital, School of Medicine, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arvanitaki</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-3180-7280</Identifier><AffiliationInfo><Affiliation>First Department of Cardiology, AHEPA University General Hospital, School of Medicine, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton and Harefield Hospitals, Guy's and St Thomas's NHS Foundation Trust, Imperial College, London SW3 5NP, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baroutidou</LastName><ForeName>Amalia</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-0182-8259</Identifier><AffiliationInfo><Affiliation>First Department of Cardiology, AHEPA University General Hospital, School of Medicine, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsakiridis</LastName><ForeName>Ioannis</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0003-4337-7871</Identifier><AffiliationInfo><Affiliation>Third Department of Obstetrics and Gynecology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54642 Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mamopoulos</LastName><ForeName>Apostolos</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-2605-0765</Identifier><AffiliationInfo><Affiliation>Third Department of Obstetrics and Gynecology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54642 Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giannopoulos</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Pediatric Department, AHEPA University General Hospital, School of Medicine, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ziakas</LastName><ForeName>Antonios</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>First Department of Cardiology, AHEPA University General Hospital, School of Medicine, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giannakoulas</LastName><ForeName>George</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-7491-6319</Identifier><AffiliationInfo><Affiliation>First Department of Cardiology, AHEPA University General Hospital, School of Medicine, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">congenitally corrected transposition of the great arteries</Keyword><Keyword MajorTopicYN="N">d-transposition of the great arteries</Keyword><Keyword MajorTopicYN="N">fetal</Keyword><Keyword MajorTopicYN="N">maternal</Keyword><Keyword MajorTopicYN="N">outcomes</Keyword><Keyword MajorTopicYN="N">pregnancy</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>10</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>11</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>11</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>12</Month><Day>17</Day><Hour>11</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>12</Month><Day>17</Day><Hour>11</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>12</Month><Day>17</Day><Hour>1</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39685739</ArticleId><ArticleId IdType="pmc">PMC11642114</ArticleId><ArticleId IdType="doi">10.3390/jcm13237281</ArticleId><ArticleId IdType="pii">jcm13237281</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Greutmann M., Pieper Petronella G. Pregnancy in women with congenital heart disease. Eur. Heart J. 2015;36:2491&#x2013;2499. doi: 10.1093/eurheartj/ehv288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehv288</ArticleId><ArticleId IdType="pubmed">26112887</ArticleId></ArticleIdList></Reference><Reference><Citation>Canobbio M.M., Warnes C.A., Aboulhosn J., Connolly H.M., Khanna A., Koos B.J., Mital S., Rose C., Silversides C., Stout K. Management of Pregnancy in Patients with Complex Congenital Heart Disease: A Scientific Statement for Healthcare Professionals from the American Heart Association. Circulation. 2017;135:e50&#x2013;e87. doi: 10.1161/CIR.0000000000000458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000458</ArticleId><ArticleId IdType="pubmed">28082385</ArticleId></ArticleIdList></Reference><Reference><Citation>Bevilacqua F., Pasqualin G., Ferrero P., Micheletti A., Negura D.G., D&#x2019;Aiello A.F., Giamberti A., Chessa M. Overview of Long-Term Outcome in Adults with Systemic Right Ventricle and Transposition of the Great Arteries: A Review. Diagnostics. 2023;13:2205. doi: 10.3390/diagnostics13132205.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics13132205</ArticleId><ArticleId IdType="pmc">PMC10340263</ArticleId><ArticleId IdType="pubmed">37443599</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramlakhan K.P., Ahmed I., Johnson M.R., Roos-Hesselink J.W. Congenital heart disease and family planning: Preconception care, reproduction, contraception and maternal health. Int. J. Cardiol. Congenit. Heart Dis. 2020;1:100049. doi: 10.1016/j.ijcchd.2020.100049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcchd.2020.100049</ArticleId></ArticleIdList></Reference><Reference><Citation>the European Society of Gynecology (ESG) the Association for European Paediatric Cardiology (AEPC) the German Society for Gender Medicine (DGesGM) ESC Guidelines on the management of cardiovascular diseases during pregnancy the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC) Eur. Heart J. 2011;32:3147&#x2013;3197. doi: 10.1093/eurheartj/ehr218.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehr218</ArticleId><ArticleId IdType="pubmed">21873418</ArticleId></ArticleIdList></Reference><Reference><Citation>Page M.J., McKenzie J.E., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D., Shamseer L., Tetzlaff J.M., Akl E.A., Brennan S.E., et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsakiridis I., Giouleka S., Mamopoulos A., Athanasiadis A., Dagklis T. Investigation and management of stillbirth: A descriptive review of major guidelines. J. Perinat. Med. 2022;50:796&#x2013;813. doi: 10.1515/jpm-2021-0403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/jpm-2021-0403</ArticleId><ArticleId IdType="pubmed">35213798</ArticleId></ArticleIdList></Reference><Reference><Citation>American College of Obstetricians and Gynecologists&#x2019; Committee on Practice Bulletins&#x2014;Obstetrics Practice Bulletin No. 171: Management of Preterm Labor. Obs. Gynecol. 2016;128:e155&#x2013;e164. doi: 10.1097/AOG.0000000000001711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AOG.0000000000001711</ArticleId><ArticleId IdType="pubmed">27661654</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassett R., Sabatier B., Savoldelli V., Mair A., Hanley J., Dima A., Paterson R. ochrane EPOC Protocol: Providing medication adherence feedback to healthcare providers. The effect on care and outcomes. Protoc. Cochrane Rev. Update. 2017 doi: 10.5281/zenodo.7009215.</Citation><ArticleIdList><ArticleId IdType="doi">10.5281/zenodo.7009215</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan X., Wang W., Liu J., Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med. Res. Methodol. 2014;14:135. doi: 10.1186/1471-2288-14-135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-14-135</ArticleId><ArticleId IdType="pmc">PMC4383202</ArticleId><ArticleId IdType="pubmed">25524443</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J.P.T., Green S. Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration; Melbourne, VIC, Australia: 2008. pp. 151&#x2013;185. (Cochrane Book Series).</Citation></Reference><Reference><Citation>Wells G.A., Shea B., O&#x2019;Connell D., Peterson J., Welch V., Losos M., Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses; Proceedings of the 3rd Symposium on Systematic Reviews: Beyond the Basics; Oxford, UK. 3&#x2013;5 July 2000.</Citation></Reference><Reference><Citation>Egger M., Smith G.D., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629&#x2013;634. doi: 10.1136/bmj.315.7109.629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.315.7109.629</ArticleId><ArticleId IdType="pmc">PMC2127453</ArticleId><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters J.L., Sutton A.J., Jones D.R., Abrams K.R., Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA. 2006;295:676&#x2013;680. doi: 10.1001/jama.295.6.676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.295.6.676</ArticleId><ArticleId IdType="pubmed">16467236</ArticleId></ArticleIdList></Reference><Reference><Citation>Connolly H.M., Grogan M., Warnes C.A. Pregnancy Among Women with Congenitally Corrected Transposition of Great Arteries. J. Am. Coll. Cardiol. 1999;33:1692&#x2013;1695. doi: 10.1016/S0735-1097(99)00046-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0735-1097(99)00046-7</ArticleId><ArticleId IdType="pubmed">10334444</ArticleId></ArticleIdList></Reference><Reference><Citation>Therrien J., Barnes I., Somerville J. Outcome of Pregnancy in Patients with Congenitally Corrected Transposition of the Great Arteries. Am. J. Cardiol. 1999;84:820&#x2013;824. doi: 10.1016/S0002-9149(99)00444-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9149(99)00444-0</ArticleId><ArticleId IdType="pubmed">10513781</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu&#xe9;d&#xe8;s A., Mercier L.A., Leduc L., B&#xe9;rub&#xe9; L., Marcotte F., Dore A. Impact of pregnancy on the systemic right ventricle after a Mustard operation for transposition of the great arteries. J. Am. Coll. Cardiol. 2004;44:433&#x2013;437. doi: 10.1016/j.jacc.2004.04.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2004.04.037</ArticleId><ArticleId IdType="pubmed">15261944</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannobio M.M., Morris C.D., Graham T.P., Landzberg M.J. Pregnancy Outcomes After Atrial Repair for Transposition of the Great Arteries. Am. J. Cardiol. 2006;98:668&#x2013;672. doi: 10.1016/j.amjcard.2006.03.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2006.03.050</ArticleId><ArticleId IdType="pubmed">16923459</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelson E., Curry R., Gatzoulis M.A., Swan L., Lupton M., Durbridge J., Deans C., Steer P., Johnson M.R. Pregnancy in women with a systemic right ventricle after surgically and congenitally corrected transposition of the great arteries. Eur. J. Obs. Gynecol. Reprod. Biol. 2011;155:146&#x2013;149. doi: 10.1016/j.ejogrb.2010.12.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejogrb.2010.12.021</ArticleId><ArticleId IdType="pubmed">21276649</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain V.D., Moghbeli N., Webb G., Srinivas S.K., Elovitz M.A., Par&#xe9; E. Pregnancy in Women with Congenital Heart Disease: The Impact of a Systemic Right Ventricle. Congenit. Heart Dis. 2011;6:147&#x2013;156. doi: 10.1111/j.1747-0803.2011.00497.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1747-0803.2011.00497.x</ArticleId><ArticleId IdType="pubmed">21418534</ArticleId></ArticleIdList></Reference><Reference><Citation>Zentner D., Wheeler M., Grigg L. Does Pregnancy Contribute to Systemic Right Ventricular Dysfunction in Adults with an Atrial Switch Operation? Heart Lung Circ. 2012;21:433&#x2013;438. doi: 10.1016/j.hlc.2012.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hlc.2012.04.009</ArticleId><ArticleId IdType="pubmed">22578588</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowater S.E., Selman T.J., Hudsmith L.E., Clift P.F., Thompson P.J., Thorne S.A. Long-term outcome following pregnancy in women with a systemic right ventricle: Is the deterioration due to pregnancy or a consequence of time? Congenit. Heart Dis. 2013;8:302&#x2013;307. doi: 10.1111/chd.12001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/chd.12001</ArticleId><ArticleId IdType="pubmed">22967110</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowalik E., Klisiewicz A., Biernacka E.K., Hoffman P. Pregnancy and long-term cardiovascular outcomes in women with congenitally corrected transposition of the great arteries. Int. J. Gynecol. Obstet. 2014;125:154&#x2013;157. doi: 10.1016/j.ijgo.2013.10.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijgo.2013.10.022</ArticleId><ArticleId IdType="pubmed">24568958</ArticleId></ArticleIdList></Reference><Reference><Citation>Cataldo S., Doohan M., Rice K., Trinder J., Stuart A.G., Curtis S.L. Pregnancy following Mustard or Senning correction of transposition of the great arteries: A retrospective study. BJOG. 2016;123:807&#x2013;813. doi: 10.1111/1471-0528.13508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1471-0528.13508</ArticleId><ArticleId IdType="pubmed">26138245</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipczy&#x144;ska M., Szyma&#x144;ski P., Trojnarska O., Tomkiewicz-Paj&#x105;k L., Pietrzak B., Klisiewicz A., Kumor M., Podolec P., Hoffman P. Pregnancy in women with complete transposition of the great arteries following the atrial switch procedure. A study from three of the largest Adult Congenital Heart Disease centers in Poland. J. Matern. Fetal Neonatal Med. 2017;30:563&#x2013;567.</Citation><ArticleIdList><ArticleId IdType="pubmed">27072884</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabre-Gray A., Curtis S., Trinder J. Obstetric outcomes following atrial and arterial switch procedures for transposition of the great arteries (TGA)&#x2013;A single, tertiary referral centre experience over 20 years. Obs. Med. 2020;13:125&#x2013;131. doi: 10.1177/1753495X19825964.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1753495X19825964</ArticleId><ArticleId IdType="pmc">PMC7543168</ArticleId><ArticleId IdType="pubmed">33093864</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang D., Zhang H.F., Liu Q., Li Y.N., Zhang J., Zheng T. Pregnancy outcomes in women with congenitally corrected transposition of the great arteries. Clin. Exp. Obstet. Gynecol. 2020;47:291&#x2013;295. doi: 10.31083/j.ceog.2020.02.5235.</Citation><ArticleIdList><ArticleId IdType="doi">10.31083/j.ceog.2020.02.5235</ArticleId></ArticleIdList></Reference><Reference><Citation>Tutarel O., Baris L., Budts W., Abd-El Aziz M.G., Liptai C., Majdalany D., Jovanova S., Frogoudaki A., Connolly H.M., Johnson M.R., et al. Pregnancy outcomes in women with a systemic right ventricle and transposition of the great arteries results from the ESC-EORP Registry of Pregnancy and Cardiac disease (ROPAC) Heart. 2022;108:117&#x2013;123. doi: 10.1136/heartjnl-2020-318685.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2020-318685</ArticleId><ArticleId IdType="pmc">PMC8717477</ArticleId><ArticleId IdType="pubmed">33911009</ArticleId></ArticleIdList></Reference><Reference><Citation>Harada G., Inai K., Shimada E., Ishido M., Shinohara T., Ogawa M. Management of pregnancy and delivery in women with transposition of the great arteries after atrial switch operation: A 16-year single-center experience. J. Obs. Gynaecol. Res. 2022;48:351&#x2013;359. doi: 10.1111/jog.15111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jog.15111</ArticleId><ArticleId IdType="pubmed">34897895</ArticleId></ArticleIdList></Reference><Reference><Citation>Winter M.M., Bouma B.J., Groenink M., Konings T.C., Tijssen J.G.P., Van Veldhuisen D.J., Mulder B.J.M. Latest insights in therapeutic options for systemic right ventricular failure: A comparison with left ventricular failure. Heart. 2009;95:960&#x2013;963. doi: 10.1136/hrt.2008.156265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/hrt.2008.156265</ArticleId><ArticleId IdType="pubmed">19033293</ArticleId></ArticleIdList></Reference><Reference><Citation>Derrick G.P., Narang I., White P.A., Kelleher A., Bush A., Penny D.J., Redington A.N. Failure of stroke volume augmentation during exercise and dobutamine stress is unrelated to load-independent indexes of right ventricular performance after the Mustard operation. Circulation. 2000;102((Suppl. 3)):III154-9. doi: 10.1161/circ.102.suppl_3.III-154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circ.102.suppl_3.III-154</ArticleId><ArticleId IdType="pubmed">11082379</ArticleId></ArticleIdList></Reference><Reference><Citation>Broberg C.S., van Dissel A., Minnier J., Aboulhosn J., Kauling R.M., Ginde S., Krieger E.V., Rodriguez F., Gupta T., Shah S., et al. Long-Term Outcomes After Atrial Switch Operation for Transposition of the Great Arteries. J. Am. Coll. Cardiol. 2022;80:951&#x2013;963. doi: 10.1016/j.jacc.2022.06.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2022.06.020</ArticleId><ArticleId IdType="pubmed">36049802</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabbah B., Arabi T.Z., Shafqat A., Rab S.A., Razak A., Albert-Brotons D.C. Heart failure in systemic right ventricle: Mechanisms and therapeutic options. Front. Cardiovasc. Med. 2022;9:1064196. doi: 10.3389/fcvm.2022.1064196.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.1064196</ArticleId><ArticleId IdType="pmc">PMC9871570</ArticleId><ArticleId IdType="pubmed">36704462</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouzounian J.G., Elkayam U. Physiologic Changes During Normal Pregnancy and Delivery. Cardiol. Clin. 2012;30:317&#x2013;329. doi: 10.1016/j.ccl.2012.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccl.2012.05.004</ArticleId><ArticleId IdType="pubmed">22813360</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardee I., Wrigh L., McCracken C., Lawson E., Oster M.E. Maternal and Neonatal Outcomes of Pregnancies in Women with Congenital Heart Disease: A Meta-Analysis. J. Am. Heart Assoc. 2021;10:e017834. doi: 10.1161/JAHA.120.017834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.120.017834</ArticleId><ArticleId IdType="pmc">PMC8174159</ArticleId><ArticleId IdType="pubmed">33821681</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S., Chien D., Huang C., Shih S., Lee W., Chang W. Dyspnea in pregnancy. Taiwan J. Obs. Gynecol. 2017;56:432&#x2013;436. doi: 10.1016/j.tjog.2017.04.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tjog.2017.04.035</ArticleId><ArticleId IdType="pubmed">28805596</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamirisa K.P., Elkayam U., Briller J.E., Mason P.K., Pillarisetti J., Merchant F.M., Patel H., Lakkireddy D.R., Russo A.M., Volgman A.S., et al. Arrhythmias in Pregnancy. State-of-the-Art Review. J. Am. Coll. Cardiol. EP. 2022;8:120&#x2013;135.</Citation><ArticleIdList><ArticleId IdType="pubmed">35057977</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannakoulas G., Baroutidou A. Predicting antepartum arrhythmias in congenital heart disease: A step forward? Int. J. Cardiol. 2023;392:131287. doi: 10.1016/j.ijcard.2023.131287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2023.131287</ArticleId><ArticleId IdType="pubmed">37625484</ArticleId></ArticleIdList></Reference><Reference><Citation>Roos-Hesselink J., Baris L., Johnson M., De Backer J., Otto C., Marelli A., Jondeau G., Budts W., Grewal J., Sliwa K., et al. Pregnancy outcomes in women with cardiovascular disease: Evolving trends over 10 years in the ESC Registry Of Pregnancy And Cardiac disease (ROPAC) Eur. Heart J. 2019;40:3848&#x2013;3855. doi: 10.1093/eurheartj/ehz136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehz136</ArticleId><ArticleId IdType="pubmed">30907409</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizula J., Devera J., Ng T.M.H., Yeung S.L., Thangathurai J., Herrick N., Chatfield A.J., Mehra A., Elkayam U. Outcome of Pregnancy in Women with D-Transposition of the Great Arteries: A Systematic Review. J. Am. Heart Assoc. 2022;11:e026862. doi: 10.1161/JAHA.122.026862.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.122.026862</ArticleId><ArticleId IdType="pmc">PMC9851445</ArticleId><ArticleId IdType="pubmed">36444833</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubota K., Inai K., Shimada E., Shinohara T. &#x3b1;/&#x3b2;- and &#x3b2;-Blocker Exposure in Pregnancy and the Risk of Neonatal Hypoglycemia and Small for Gestational Age. Circ. J. 2023;87:569&#x2013;577. doi: 10.1253/circj.CJ-22-0647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.CJ-22-0647</ArticleId><ArticleId IdType="pubmed">36823100</ArticleId></ArticleIdList></Reference><Reference><Citation>Regitz-Zagrosek V., Roos-Hesselink J.W., Bauersachs J., Blomstr&#xf6;m-Lundqvist C., C&#xed;fkov&#xe1; R., De Bonis M., Iung B., Johnson M.R., Kintscher U., Kranke P., et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy: The Task Force for the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC) Eur. Heart J. 2018;39:3165&#x2013;3241. doi: 10.1093/eurheartj/ehy340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehy340</ArticleId><ArticleId IdType="pubmed">30165544</ArticleId></ArticleIdList></Reference><Reference><Citation>Baroutidou A., Ntiloudi D., Kasinos N., Nyktari E., Giannakoulas G. Multi-modality imaging of the systemic right ventricle in congenital heart disease. Echocardiography. 2024;41:e15749. doi: 10.1111/echo.15749.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/echo.15749</ArticleId><ArticleId IdType="pubmed">38284684</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24755850</PMID><DateCompleted><Year>2015</Year><Month>01</Month><Day>15</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1473-5865</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>4</Issue><PubDate><Year>2014</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of pediatric orthopedics. Part B</Title><ISOAbbreviation>J Pediatr Orthop B</ISOAbbreviation></Journal><ArticleTitle>Risk factors for venous thromboembolism in hospitalized children and adolescents: a systemic review and pooled analysis.</ArticleTitle><Pagination><StartPage>389</StartPage><EndPage>393</EndPage><MedlinePgn>389-93</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/BPB.0000000000000053</ELocationID><Abstract><AbstractText>We performed a systematic review of published studies that evaluated the potential risk factors and outcomes of venous thromboembolism (VTE) in hospitalized children. A total of 761 VTE patients from six published studies were identified. The mean prevalence of VTE in children admitted to the hospital was 9.7/10 000 admissions. The presence of a central venous catheter was found to be the single most important predisposing cause of VTE, with a pooled percentage of 29%. Infection was the second most common cause of the disease (20%). Pulmonary embolism occurred in 15% (113/745) of the patients. The overall recurrence rate of VTE was 16% (74/464) and the mortality rate was 8% (59/704). Although uncommon, orthopedic surgeons need to be aware of the unique risk factors for VTE among pediatric inpatients. Hospitalized children and adolescents with known risk factors for VTE should be considered candidates for VTE screening or prophylaxis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Seung-Ju</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>aDepartment of Orthopedic Surgery, KEPCO Medical Foundation, KEPCO Medical Center, Seoul, Korea bDepartment of Orthopaedics, New Jersey Medical School, Newark, New Jersey, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sabharwal</LastName><ForeName>Sanjeev</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Pediatr Orthop B</MedlineTA><NlmUniqueID>9300904</NlmUniqueID><ISSNLinking>1060-152X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="N">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>1</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24755850</ArticleId><ArticleId IdType="doi">10.1097/BPB.0000000000000053</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">22959496</PMID><DateCompleted><Year>2013</Year><Month>03</Month><Day>08</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0267</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>11</Issue><PubDate><Year>2012</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Injury</Title><ISOAbbreviation>Injury</ISOAbbreviation></Journal><ArticleTitle>Clinical outcomes after repair of quadriceps tendon rupture: a systematic review.</ArticleTitle><Pagination><StartPage>1931</StartPage><EndPage>1938</EndPage><MedlinePgn>1931-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.injury.2012.08.044</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0020-1383(12)00355-5</ELocationID><Abstract><AbstractText>The existing evidence regarding the management of quadriceps tendon rupture remains obscure. The aim of the current review is to investigate the characteristics, the different techniques employed and to analyse the clinical outcomes following surgical repair of quadriceps tendon rupture. An Internet based search of the English literature of the last 25 years was carried out. Case reports and non-clinical studies were excluded. The methodological quality of the included studies was assessed using the Coleman Methodology Score. All data regarding mechanism and site of rupture, type of treatment, time elapsed between diagnosis and repair, patients' satisfaction, clinical outcome, return to pre-injury activities, complications and recurrence rates were extracted and analysed. Out of 474 studies identified, 12 met the inclusion criteria. The average of Coleman Methodology Score was 50.46/100. In total 319 patients were analysed with a mean age of 57 years (16-85). The mean time of follow-up was 47.5 months (3 months to 24 years). The most common mechanism of injury was simple fall (61.5%). Spontaneous ruptures were reported in 3.2% of cases. The most common sites of tear were noted between 1cm and 2 cm of the superior pole of the patella and, in the older people, at the osseotendinous junction. The most frequently used repair technique was patella drill holes (50% of patients). Simple sutures were used in mid-substance ruptures. Several reinforcement techniques were employed in case of poor quality or retraction of the torn ends of tendon. The affected limb was immobilised in a cast for a period of 3-10 weeks. Quadriceps muscular atrophy and muscle strength deficit were present in most of the cases. Worst results were noted in delayed repairs. Reported complications included heterotopic ossifications in 6.9% of patients, deep venous thrombosis or pulmonary embolism in 2.5%, superficial infection in 1.2% and deep infection in 1.1%. It appears that the type of surgical repair does not influence the clinical results. The majority of the studies reported good or excellent ROM and return to the pre-injury activities. The overall rate of re-rupture was 2%.</AbstractText><CopyrightInformation>Copyright &#xa9; 2012 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ciriello</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Academic Department of Trauma &amp; Orthopaedic Surgery, Clarendon Wing, Floor A, Great George Street, Leeds General Infirmary, LS1 3EX Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gudipati</LastName><ForeName>Suribabu</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Tosounidis</LastName><ForeName>Theodoros</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Soucacos</LastName><ForeName>P N</ForeName><Initials>PN</Initials></Author><Author ValidYN="Y"><LastName>Giannoudis</LastName><ForeName>Peter V</ForeName><Initials>PV</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>09</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Injury</MedlineTA><NlmUniqueID>0226040</NlmUniqueID><ISSNLinking>0020-1383</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017060" MajorTopicYN="N">Patient Satisfaction</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D052097" MajorTopicYN="N">Quadriceps Muscle</DescriptorName><QualifierName UI="Q000293" MajorTopicYN="Y">injuries</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012421" MajorTopicYN="N">Rupture</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012422" MajorTopicYN="N">Rupture, Spontaneous</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013708" MajorTopicYN="N">Tendon Injuries</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22959496</ArticleId><ArticleId IdType="doi">10.1016/j.injury.2012.08.044</ArticleId><ArticleId IdType="pii">S0020-1383(12)00355-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">28642669</PMID><DateRevised><Year>2022</Year><Month>03</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1413-7852</ISSN><JournalIssue CitedMedium="Print"><Volume>25</Volume><Issue>3</Issue><PubDate><Year>2017</Year><Season>May-Jun</Season></PubDate></JournalIssue><Title>Acta ortopedica brasileira</Title><ISOAbbreviation>Acta Ortop Bras</ISOAbbreviation></Journal><ArticleTitle>Concordance for curve type in idiopathic scoliosis among family members.</ArticleTitle><Pagination><StartPage>90</StartPage><EndPage>94</EndPage><MedlinePgn>90-94</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1590/1413-785220172503172684</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To evaluate the concordance for the curve pattern, side and levels of the superior apical vertebrae, apex and inferior apical vertebrae of curves in patients and their relatives with idiopathic scoliosis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Concordance according to the Lenke classification for curve pattern, side and levels of the superior apical vertebrae, apex and inferior apical vertebrae were evaluated comparative and prospectively in 243 pairs of patients and respective relatives with idiopathic scoliosis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The family concordance for the curve pattern and side was 51.4% (125 pairs). Among these pairs, the concordance of the levels of the vertebrae was 91.2% (114 pairs). The concordance rate for the curve pattern and side between parents/children was 51.6% and between siblings was 50.0% (p-value= 0.411). The concordance rates of the levels of vertebrae were 86.8% and 95.1%, respectively (p-value = 0.219).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Curve shape in idiopathic scoliosis is related to family and degree of kinship, since the data showed a high concordance for the curve pattern, side and levels of the apical vertebrae and apex between patients and relatives with this deformity. The concordance was higher in those with a closer degree of kinship. <b><i>Level of Evidence II, Lesser Quality Prospective Study.</i></b></AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Olbertz</LastName><ForeName>Clarissa Miranda Carneiro de Albuquerque</ForeName><Initials>CMCA</Initials><Identifier Source="ORCID">0000-0002-3321-8255</Identifier><AffiliationInfo><Affiliation>Universidade Federal de Pernambuco, Hospital das Cl&#xed;nicas, Surgery of Department, Recife, PE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Gauzy</LastName><ForeName>J&#xe9;r&#xf4;me Sales</ForeName><Initials>JS</Initials><Identifier Source="ORCID">0000-0001-6206-514X</Identifier><AffiliationInfo><Affiliation>Centre Hospitalier Universitaire de Toulouse, H&#xf4;pital des Enfants, Department of Pediatric Orthopedic Surgery, Toulouse, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Albuquerque</LastName><ForeName>Paulo Cezar Vidal Carneiro</ForeName><Initials>PCVC</Initials><Identifier Source="ORCID">0000-00031898-9139</Identifier><AffiliationInfo><Affiliation>Universidade Federal de Pernambuco, Hospital das Cl&#xed;nicas, Surgery of Department, Recife, PE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Accadbled</LastName><ForeName>Frank</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-5366-3885</Identifier><AffiliationInfo><Affiliation>Centre Hospitalier Universitaire de Toulouse, H&#xf4;pital des Enfants, Department of Pediatric Orthopedic Surgery, Toulouse, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Albuquerque</LastName><ForeName>Paula Eduarda Miranda Carneiro</ForeName><Initials>PEMC</Initials><Identifier Source="ORCID">0000-0002-92382303</Identifier><AffiliationInfo><Affiliation>Faculdade Pernambucana de Sa&#xfa;de, Instituto de Medicina Integral Professor Fernando Figueira, Recife, PE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aguiar</LastName><ForeName>Jos&#xe9; Lamartine de Andrade</ForeName><Initials>JLA</Initials><Identifier Source="ORCID">0000-0002-12065368</Identifier><AffiliationInfo><Affiliation>Universidade Federal de Pernambuco, Hospital das Cl&#xed;nicas, Surgery of Department, Recife, PE, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Acta Ortop Bras</MedlineTA><NlmUniqueID>9804509</NlmUniqueID><ISSNLinking>1413-7852</ISSNLinking></MedlineJournalInfo><OtherAbstract Type="Publisher" Language="por"><AbstractText Label="OBJETIVO" NlmCategory="OBJECTIVE">Avaliar a concord&#xe2;ncia para o padr&#xe3;o de curva, lado e <i>n&#xed;veis das v&#xe9;rtebras apical superior, &#xe1;pex</i> e apical inferior das curvas de pacientes e respectivos familiares com escoliose idiop&#xe1;tica.</AbstractText><AbstractText Label="M&#xc9;TODOS" NlmCategory="UNASSIGNED">A concord&#xe2;ncia, pela classifica&#xe7;&#xe3;o de Lenke, para o padr&#xe3;o de curva, lado e n&#xed;veis das v&#xe9;rtebras apical superior, &#xe1;pex e apical inferior foi avaliada em 243 pares de pacientes e respectivos familiares com escoliose idiop&#xe1;tica.</AbstractText><AbstractText Label="RESULTADOS" NlmCategory="RESULTS">A concord&#xe2;ncia familiar para o padr&#xe3;o de curva e lado foi de 51,4% (125 pares). Entre esses pares, a concord&#xe2;ncia dos n&#xed;veis das v&#xe9;rtebras foi de 91,2% (114 pares). A taxa de concord&#xe2;ncia para o padr&#xe3;o de curva e lado entre pais/filhos foi de 51,6% e entre irm&#xe3;os foi de 50,0% (p= 0,411). As taxas de concord&#xe2;ncia dos n&#xed;veis das v&#xe9;rtebras foram respectivamente de 86,8% e 95,1% (p-valor = 0,219).</AbstractText><AbstractText Label="CONCLUS&#xc3;O" NlmCategory="UNASSIGNED">O formato das curvas na escoliose idiop&#xe1;tica tem rela&#xe7;&#xe3;o familiar e com o grau de parentesco, uma vez que se reportou alta concord&#xe2;ncia para o padr&#xe3;o de curva, lado e n&#xed;veis das v&#xe9;rtebras apicais e &#xe1;pex entre pacientes e familiares com a deformidade. A concord&#xe2;ncia foi maior entre aqueles com grau de parentesco mais pr&#xf3;ximo. N&#xed;vel de Evid&#xea;ncia Ii, Estudo Prospectivo de Menor Qualidade.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Genetics</Keyword><Keyword MajorTopicYN="N">Scoliosis</Keyword><Keyword MajorTopicYN="N">Spine</Keyword></KeywordList><CoiStatement>All authors declare no potential conflict of interest related to this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>5</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28642669</ArticleId><ArticleId IdType="pmc">PMC5474411</ArticleId><ArticleId IdType="doi">10.1590/1413-785220172503172684</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Carr AJ, Jefferson RJ, Turner-Smith AR. Familial back shape in adolescent scoliosis. A photogrammetric population study. Acta Orthop Scand. 1991;62(2):131&#x2013;135.</Citation><ArticleIdList><ArticleId IdType="pubmed">2014722</ArticleId></ArticleIdList></Reference><Reference><Citation>Veldhuizen AG, Wever DJ, Webb PJ. The aetiology of idiopathic scoliosis: biomechanical and neuromuscular factors. Eur Spine J. 2000;9(3):178&#x2013;184.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3611388</ArticleId><ArticleId IdType="pubmed">10905433</ArticleId></ArticleIdList></Reference><Reference><Citation>Sales de Gauzy J, Ballouhey Q, Arnaud C, Grandjean H, Accadbled F. Concordance for curve type in familial idiopathic scoliosis: a survey of one hundred families. Spine (Phila Pa 1976) 2010;35(17):1602&#x2013;1606.</Citation><ArticleIdList><ArticleId IdType="pubmed">20453726</ArticleId></ArticleIdList></Reference><Reference><Citation>Grauers A, Danielsson A, Karlsson M, Ohlin A, Gerdhem P. amily history and its association to curve size and treatment in 1,463 patients with idiopathic scoliosis. Eur Spine J. 2013;22(11):2421&#x2013;2426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3886503</ArticleId><ArticleId IdType="pubmed">23801015</ArticleId></ArticleIdList></Reference><Reference><Citation>Riseborough EJ, Wynne-Davies R. A genetic survey of idiopathic scoliosis in Boston, Massachusetts. J Bone Joint Surg Am. 1973;55(5):974&#x2013;982.</Citation><ArticleIdList><ArticleId IdType="pubmed">4760104</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr AJ. Adolescent idiopathic scoliosis in identical twins. J Bone Joint Surg Br. 1990;72(6):1077&#x2013;1077.</Citation><ArticleIdList><ArticleId IdType="pubmed">2246294</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue M, Minami S, Kitahara H, Otsuka Y, Nakata Y, Takaso M, et al. Idiopathic scoliosis in twins studied by DNA fingerprinting: the incidence and type of scoliosis. J Bone Joint Surg Br. 1998;80(2):212&#x2013;217.</Citation><ArticleIdList><ArticleId IdType="pubmed">9546446</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponseti IV, Friedman B. Prognosis in idiopathic scoliosis. J Bone Joint Surg Am. 1950;32A(2):381&#x2013;395.</Citation><ArticleIdList><ArticleId IdType="pubmed">15412180</ArticleId></ArticleIdList></Reference><Reference><Citation>Kesling KL, Reinker KA. oliosis in twins. A meta-analysis of the literature and report of six cases. Spine (Phila Pa 1976) 1997;22(17):2009&#x2013;2014.</Citation><ArticleIdList><ArticleId IdType="pubmed">9306532</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rhijn LW, Jansen EJ, Plasmans CM, Veraart BE. Curve characteristics in monozygotic twins with adolescent idiopathic scoliosis: 3 new twin pairs and a review of the literature. Acta Orthop Scand. 2001;72(6):621&#x2013;625.</Citation><ArticleIdList><ArticleId IdType="pubmed">11817878</ArticleId></ArticleIdList></Reference><Reference><Citation>Cowell HR, Hall JN, MacEwen GD. Genetic aspects of idiopathic scoliosis. A Nicholas Andry Award essay, 1970. Clin Orthop Relat Res. 1972;86:121&#x2013;131.</Citation><ArticleIdList><ArticleId IdType="pubmed">5047777</ArticleId></ArticleIdList></Reference><Reference><Citation>Cobb JR. Outline for the study of scoliosis. Instr Course Lect. 1948;5:261&#x2013;275.</Citation></Reference><Reference><Citation>Rose PS, Lenke LG. Classification of operative adolescent idiopathic scoliosis: treatment guidelines. Orthop Clin North Am. 2007;38(4):521&#x2013;529.</Citation><ArticleIdList><ArticleId IdType="pubmed">17945131</ArticleId></ArticleIdList></Reference><Reference><Citation>Warner WC, Sawyer JR, Kelly DM. Scoliosis and kyphosis. In: Canale ST, Beaty JH, editors. Campbell's operative orthopaedics. 12th ed. Philadelphia: Elsevier-Mosby; 2013. pp. 1691&#x2013;1895.</Citation></Reference><Reference><Citation>Aulisa AG, Guzzanti V, Galli M, Bottaro G, Vitelli O, Ferrara P, et al., editors. The familiarity of idiopathic scoliosis: statistical analysis and clinical considerations. Eur J Orthop Surg Traumatol. 2012;23(7):781&#x2013;784.</Citation><ArticleIdList><ArticleId IdType="pubmed">23412192</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickson RA, Lawton JO, Archer IA, Butt WP. The pathogenesis of idiopathic scoliosis. Biplanar spinal asymmetry. J Bone Joint Surg Br. 1984;66(1):8&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">6693483</ArticleId></ArticleIdList></Reference><Reference><Citation>MM . Janssen, Vincken KL, van Raak SM, Vrtovec T, Kemp B, Viergever MA, et al. Sagittal spinal profile and spinopelvic balance in parents of scoliotic children. Spine J. 2013;13(12):1789&#x2013;1800.</Citation><ArticleIdList><ArticleId IdType="pubmed">23819971</ArticleId></ArticleIdList></Reference><Reference><Citation>Janssen MM, Kouwenhoven JW, Schl&#xf6;sser TP, Viergever MA, Bartels LW, Castelein RM, et al. Analysis of preexistent vertebral rotation in the normal infantile, juvenile and adolescent spine. Spine (Phila Pa 1976) 2011;36(7):E486&#x2013;E491.</Citation><ArticleIdList><ArticleId IdType="pubmed">21240053</ArticleId></ArticleIdList></Reference><Reference><Citation>Robin GC, Cohen T. Familial scoliosis. A clinical report. J Bone Joint Surg Br. 1975;57(2):146&#x2013;148.</Citation><ArticleIdList><ArticleId IdType="pubmed">1141280</ArticleId></ArticleIdList></Reference><Reference><Citation>Dryden IL, Oxborrow N, Dickson R. Familial relationships of normal spine shape. Stat Med. 2008;27(11):1993&#x2013;2003.</Citation><ArticleIdList><ArticleId IdType="pubmed">18167631</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24657793</PMID><DateCompleted><Year>2014</Year><Month>11</Month><Day>21</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-6868</ISSN><JournalIssue CitedMedium="Internet"><Volume>211</Volume><Issue>4</Issue><PubDate><Year>2014</Year><Month>Oct</Month></PubDate></JournalIssue><Title>American journal of obstetrics and gynecology</Title><ISOAbbreviation>Am J Obstet Gynecol</ISOAbbreviation></Journal><ArticleTitle>Plasma biomarker discovery in preeclampsia using a novel differential isolation technology for circulating extracellular vesicles.</ArticleTitle><Pagination><StartPage>380.e1</StartPage><EndPage>380.e3813</EndPage><MedlinePgn>380.e1-13</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajog.2014.03.038</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0002-9378(14)00248-8</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To circumvent the complex protein milieu of plasma and discover robust predictive biomarkers for preeclampsia (PE), we investigate if phospholipid-binding ligands can reduce the milieu complexity by extracting plasma extracellular vesicles for biomarker discovery.</AbstractText><AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">Cholera toxin B chain (CTB) and annexin V (AV) which respectively binds GM1 ganglioside and phosphatidylserine were used to isolate extracellular vesicles from plasma of PE patients and healthy pregnant women. The proteins in the vesicles were identified using enzyme-linked immunosorbent assay, antibody array, and mass spectrometry.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">CTB and AV were found to bind 2 distinct groups of extracellular vesicles. Antibody array and enzyme-linked immunosorbent assay revealed that PE patients had elevated levels of CD105, interleukin-6, placental growth factor, tissue inhibitor of metallopeptidase 1, and atrial natriuretic peptide in cholera toxin B- but not AV-vesicles, and elevated levels of plasminogen activator inhibitor-1, pro-calcitonin, S100b, tumor growth factor &#x3b2;, vascular endothelial growth factor receptor 1, brain natriuretic peptide, and placental growth factor in both cholera toxin B- and AV-vesicles. CD9 level was elevated in cholera toxin B-vesicles but reduced in AV vesicles of PE patients. Proteome analysis revealed that in cholera toxin B-vesicles, 87 and 222&#xa0;proteins were present only in PE patients and healthy pregnant women respectively while in AV-vesicles, 104 and 157 proteins were present only in PE and healthy pregnant women, respectively.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study demonstrated for the first time that CTB and AV bind unique extracellular vesicles, and their protein cargo reflects the disease state of the patient. The successful use of these 2 ligands to isolate circulating plasma extracellular vesicles for biomarker discovery in PE represents a novel technology for biomarker discovery that can be applied to other specialties.</AbstractText><CopyrightInformation>Copyright &#xa9; 2014 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Kok Hian</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>Department of Maternal-Fetal Medicine, KK Women's and Children's Hospital, Republic of Singapore; Duke-NUS Graduate Medical School Singapore, Republic of Singapore. Electronic address: tan.kok.hian@kkh.com.sg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Soon Sim</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>A&#x2217;STAR Institute of Medical Biology, Republic of Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sze</LastName><ForeName>Siu Kwan</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>School of Biological Sciences, Nanyang Technological University, Republic of Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Wai Kheong Ryan</ForeName><Initials>WK</Initials><AffiliationInfo><Affiliation>Department of Maternal-Fetal Medicine, KK Women's and Children's Hospital, Republic of Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Mor Jack</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Maternal-Fetal Medicine, KK Women's and Children's Hospital, Republic of Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Sai Kiang</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>A&#x2217;STAR Institute of Medical Biology, Republic of Singapore; Department of Surgery, YLL School of Medicine, NUS, Republic of Singapore.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>03</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Obstet Gynecol</MedlineTA><NlmUniqueID>0370476</NlmUniqueID><ISSNLinking>0002-9378</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017304">Annexin A5</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020543">Proteome</NameOfSubstance></Chemical><Chemical><RegistryNumber>9012-63-9</RegistryNumber><NameOfSubstance UI="D002772">Cholera Toxin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017304" MajorTopicYN="Y">Annexin A5</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002772" MajorTopicYN="Y">Cholera Toxin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004591" MajorTopicYN="N">Electrophoresis, Polyacrylamide Gel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055354" MajorTopicYN="N">Exosomes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013058" MajorTopicYN="N">Mass Spectrometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011225" MajorTopicYN="N">Pre-Eclampsia</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011263" MajorTopicYN="N">Pregnancy Trimester, Third</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020543" MajorTopicYN="N">Proteome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">annexin V</Keyword><Keyword MajorTopicYN="N">biomarker discovery</Keyword><Keyword MajorTopicYN="N">cholera toxin B chain</Keyword><Keyword MajorTopicYN="N">extracellular vesicles</Keyword><Keyword MajorTopicYN="N">preeclampsia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>1</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>3</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24657793</ArticleId><ArticleId IdType="doi">10.1016/j.ajog.2014.03.038</ArticleId><ArticleId IdType="pii">S0002-9378(14)00248-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">19005649</PMID><DateCompleted><Year>2009</Year><Month>04</Month><Day>16</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0301-0449</ISSN><JournalIssue CitedMedium="Print"><Volume>39</Volume><Issue>1</Issue><PubDate><Year>2009</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Pediatric radiology</Title><ISOAbbreviation>Pediatr Radiol</ISOAbbreviation></Journal><ArticleTitle>Evaluation of pulmonary embolism in a pediatric population with high clinical suspicion.</ArticleTitle><Pagination><StartPage>35</StartPage><EndPage>41</EndPage><MedlinePgn>35-41</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00247-008-1037-0</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Pulmonary embolism (PE) is an underdiagnosed entity in the pediatric population in part because of the low level of suspicion and awareness in the clinical world.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To examine its relative prevalence, associated risk factors and imaging features in our pediatric population.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">A total of 92 patients age 21 years and younger with a high clinical suspicion of PE and who had available radiographic studies were identified from January 2003 to September 2006. Patients with a positive CT scan or a high probability ventilation/perfusion scan formed the case group; patients with a high clinical suspicion of PE and no radiographic evidence of PE or deep venous thrombosis (DVT), randomly matched in age and sex, became the matched control group. We reviewed the charts of both groups and analyzed the imaging studies.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In our hospital, the prevalence of PE in patients with a strong suspicion of PE was 14%. The overall prevalence of thromboembolic disease (PE and/or DVT) was 25%. Recent surgery or orthopedic procedure, blood dyscrasias and contraceptive use were more common in patients with PE. No child died of PE in our study. The youngest child with PE in our study was 13 years. Girls were twice as likely to develop PE as boys.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">PE is a relatively common diagnosis in our tertiary care pediatric population when the clinical suspicion is high. We suggest increased awareness and index of suspicion in order to initiate prompt diagnostic imaging and treatment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Victoria</LastName><ForeName>Teresa</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Radiology, Children's Hospital of Philadelphia, 34th Street and Civic Center Boulevard, Philadelphia, PA 19103, USA. victoria@email.chop.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mong</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Altes</LastName><ForeName>Talissa</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Jawad</LastName><ForeName>Abbas F</ForeName><Initials>AF</Initials></Author><Author ValidYN="Y"><LastName>Hernandez</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Gonzalez</LastName><ForeName>Leonardo</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Raffini</LastName><ForeName>Leslie</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Kramer</LastName><ForeName>Sandra S</ForeName><Initials>SS</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2008</Year><Month>11</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Pediatr Radiol</MedlineTA><NlmUniqueID>0365332</NlmUniqueID><ISSNLinking>0301-0449</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018579" MajorTopicYN="N">Patient Selection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013902" MajorTopicYN="N">Radiography, Thoracic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014463" MajorTopicYN="N">Ultrasonography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2007</Year><Month>12</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2008</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2008</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2008</Year><Month>11</Month><Day>14</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>4</Month><Day>17</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>11</Month><Day>14</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19005649</ArticleId><ArticleId IdType="doi">10.1007/s00247-008-1037-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Thromb Haemost. 2003 Jul;1(7):1443-55</Citation><ArticleIdList><ArticleId IdType="pubmed">12871279</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Radiol. 2005 Mar;35(3):258-74</Citation><ArticleIdList><ArticleId IdType="pubmed">15635472</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2008 Mar 6;358(10):1037-52</Citation><ArticleIdList><ArticleId IdType="pubmed">18322285</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiology. 2007 Nov;245(2):315-29</Citation><ArticleIdList><ArticleId IdType="pubmed">17848685</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiographics. 2006 Jan-Feb;26(1):23-39; discussion 39-40</Citation><ArticleIdList><ArticleId IdType="pubmed">16418240</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiographics. 2004 Sep-Oct;24(5):1219-38</Citation><ArticleIdList><ArticleId IdType="pubmed">15371604</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pediatr. 2004 Oct;145(4):563-5</Citation><ArticleIdList><ArticleId IdType="pubmed">15480387</ArticleId></ArticleIdList></Reference><Reference><Citation>AJR Am J Roentgenol. 2005 Jul;185(1):135-49</Citation><ArticleIdList><ArticleId IdType="pubmed">15972414</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36515945</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2574-3805</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>12</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA network open</Title><ISOAbbreviation>JAMA Netw Open</ISOAbbreviation></Journal><ArticleTitle>Association of Time to Surgery After COVID-19 Infection With Risk of Postoperative Cardiovascular Morbidity.</ArticleTitle><Pagination><StartPage>e2246922</StartPage><MedlinePgn>e2246922</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e2246922</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2022.46922</ELocationID><Abstract><AbstractText Label="IMPORTANCE">The time interval between COVID-19 infection and surgery is a potentially modifiable but understudied risk factor for postoperative complications.</AbstractText><AbstractText Label="OBJECTIVE">To examine the association between time to surgery after COVID-19 diagnosis and the risk of a composite of major postoperative cardiovascular morbidity events within 30 days of surgery.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">This single-center, retrospective cohort study was conducted among 3997 adult patients (aged &#x2265;18 years) with a previous diagnosis of COVID-19, as documented by a positive polymerase chain reaction test result, who were undergoing surgery from January 1, 2020, to December 6, 2021. Data were obtained through Structured Query Language access of an existing perioperative data warehouse. Statistical analysis was performed March 29, 2022.</AbstractText><AbstractText Label="EXPOSURE">The time interval between COVID-19 diagnosis and surgery.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">The primary outcome was the composite occurrence of major cardiovascular comorbidity, defined as deep vein thrombosis, pulmonary embolism, cerebrovascular accident, myocardial injury, acute kidney injury, and death within 30 days after surgery, using multivariable logistic regression.</AbstractText><AbstractText Label="RESULTS">A total of 3997 patients (2223 [55.6%]; median age, 51.3 years [IQR, 35.1-64.4 years]; 667 [16.7%] African American or Black; 2990 [74.8%] White; and 340 [8.5%] other race) were included in the study. The median time from COVID-19 diagnosis to surgery was 98 days (IQR, 30-225 days). Major postoperative adverse cardiovascular events were identified in 485 patients (12.1%). Increased time from COVID-19 diagnosis to surgery was associated with a decreased rate of the composite outcome (adjusted odds ratio, 0.99 [per 10 days]; 95% CI, 0.98-1.00; P&#x2009;=&#x2009;.006). This trend persisted for the 1552 patients who had received at least 1 dose of COVID-19 vaccine (adjusted odds ratio, 0.98 [per 10 days]; 95% CI, 0.97-1.00; P&#x2009;=&#x2009;.04).</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">This study suggests that increased time from COVID-19 diagnosis to surgery was associated with a decreased odds of experiencing major postoperative cardiovascular morbidity. This information should be used to better inform risk-benefit discussions concerning optimal surgical timing and perioperative outcomes for patients with a history of COVID-19 infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bryant</LastName><ForeName>John M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boncyk</LastName><ForeName>Christina S</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rengel</LastName><ForeName>Kimberly F</ForeName><Initials>KF</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doan</LastName><ForeName>Vivian</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Snarskis</LastName><ForeName>Connor</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McEvoy</LastName><ForeName>Matthew D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCarthy</LastName><ForeName>Karen Y</ForeName><Initials>KY</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Gen</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sandberg</LastName><ForeName>Warren S</ForeName><Initials>WS</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freundlich</LastName><ForeName>Robert E</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 HL148640</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR000445</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002243</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Netw Open</MedlineTA><NlmUniqueID>101729235</NlmUniqueID><ISSNLinking>2574-3805</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086742" MajorTopicYN="N">COVID-19 Testing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="Y">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr Boncyk reported receiving personal fees from Sedana Medical outside the submitted work. Dr Rengel reported receiving grants from Vanderbilt Faculty Research Scholars outside the submitted work. Mr Li reported holding stock in Johnson &amp; Johnson and Roche Holding AG outside the submitted work. Dr Freundlich reported receiving grants from the National Heart, Lung, and Blood Institute and the National Center for Advancing Translational Sciences during the conduct of the study and personal fees from Phillips Healthcare, University of Massachusetts, and Oak Hill Clinical Informatics and holding stock in 3M outside the submitted work. No other disclosures were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>14</Day><Hour>11</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36515945</ArticleId><ArticleId IdType="pmc">PMC9856239</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.46922</ArticleId><ArticleId IdType="pii">2799548</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>COVIDSurg Collaborative . Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans. Br J Surg. 2020;107(11):1440-1449.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7272903</ArticleId><ArticleId IdType="pubmed">32395848</ArticleId></ArticleIdList></Reference><Reference><Citation>COVIDSurg Collaborative; GlobalSurg Collaborative. Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study. Anaesthesia. 2021;76(6):748-758. doi:10.1111/anae.15458</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.15458</ArticleId><ArticleId IdType="pmc">PMC8206995</ArticleId><ArticleId IdType="pubmed">33690889</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesthesia Patient Safety Foundation . American Society of Anesthesiologists and Anesthesia Patient Safety Foundation joint statement on elective surgery and anesthesia for patients after COVID-19 infection. Updated February 22, 2022. Accessed September 27, 2022. https://www.apsf.org/news-updates/asa-and-apsf-joint-statement-on-elective-surgery-and-anesthesia-for-patients-after-covid-19-infection/</Citation></Reference><Reference><Citation>Sridharan GK, Vegunta R, Rokkam VRP, et al. . Venous thromboembolism in hospitalized COVID-19 patients. Am J Ther. 2020;27(6):e599-e610. doi:10.1097/MJT.0000000000001295</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MJT.0000000000001295</ArticleId><ArticleId IdType="pubmed">33156016</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadim MK, Forni LG, Mehta RL, et al. . COVID-19&#x2013;associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup. Nat Rev Nephrol. 2020;16(12):747-764. doi:10.1038/s41581-020-00356-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-020-00356-5</ArticleId><ArticleId IdType="pmc">PMC7561246</ArticleId><ArticleId IdType="pubmed">33060844</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E, Altman DG, Egger M, Pocock SJ, G&#xf8;tzsche PC, Vandenbroucke JP; STROBE Initiative . The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344-349. doi:10.1016/j.jclinepi.2007.11.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2007.11.008</ArticleId><ArticleId IdType="pubmed">18313558</ArticleId></ArticleIdList></Reference><Reference><Citation>Botto F, Alonso-Coello P, Chan MT, et al. ; Vascular events In noncardiac Surgery patIents cOhort evaluatioN (VISION) Writing Group, on behalf of The Vascular events In noncardiac Surgery patIents cOhort evaluatioN (VISION) Investigators . Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes. Anesthesiology. 2014;120(3):564-578. doi:10.1097/ALN.0000000000000113</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000113</ArticleId><ArticleId IdType="pubmed">24534856</ArticleId></ArticleIdList></Reference><Reference><Citation>Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179-c184. doi:10.1159/000339789</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000339789</ArticleId><ArticleId IdType="pubmed">22890468</ArticleId></ArticleIdList></Reference><Reference><Citation>Levey AS, Coresh J, Greene T, et al. ; Chronic Kidney Disease Epidemiology Collaboration . Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem. 2007;53(4):766-772. doi:10.1373/clinchem.2006.077180</Citation><ArticleIdList><ArticleId IdType="doi">10.1373/clinchem.2006.077180</ArticleId><ArticleId IdType="pubmed">17332152</ArticleId></ArticleIdList></Reference><Reference><Citation>Palevsky PM, Molitoris BA, Okusa MD, et al. . Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodology. Clin J Am Soc Nephrol. 2012;7(5):844-850. doi:10.2215/CJN.12791211</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.12791211</ArticleId><ArticleId IdType="pubmed">22442182</ArticleId></ArticleIdList></Reference><Reference><Citation>Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8-27. doi:10.1097/00005650-199801000-00004</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005650-199801000-00004</ArticleId><ArticleId IdType="pubmed">9431328</ArticleId></ArticleIdList></Reference><Reference><Citation>Vascular Events in Noncardiac Surgery Patients Cohort Evaluation (VISION) Study Investigators; Spence J, LeManach Y, Chan MTV, et al. Association between complications and death within 30 days after noncardiac surgery. CMAJ. 2019;191(30):E830-E837. doi:10.1503/cmaj.190221</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.190221</ArticleId><ArticleId IdType="pmc">PMC6663503</ArticleId><ArticleId IdType="pubmed">31358597</ArticleId></ArticleIdList></Reference><Reference><Citation>Meersch M, Schmidt C, Zarbock A. Perioperative acute kidney injury: an under-recognized problem. Anesth Analg. 2017;125(4):1223-1232. doi:10.1213/ANE.0000000000002369</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000002369</ArticleId><ArticleId IdType="pubmed">28787339</ArticleId></ArticleIdList></Reference><Reference><Citation>Aleligne YK, Appiah D, Ebong IA. Racial disparities in coronavirus disease 2019 (COVID-19) outcomes. Curr Opin Cardiol. 2021;36(3):360-366. doi:10.1097/HCO.0000000000000847</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HCO.0000000000000847</ArticleId><ArticleId IdType="pubmed">33657019</ArticleId></ArticleIdList></Reference><Reference><Citation>Novick TK, Rizzolo K, Cervantes L. COVID-19 and kidney disease disparities in the United States. Adv Chronic Kidney Dis. 2020;27(5):427-433. doi:10.1053/j.ackd.2020.06.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ackd.2020.06.005</ArticleId><ArticleId IdType="pmc">PMC7309916</ArticleId><ArticleId IdType="pubmed">33308509</ArticleId></ArticleIdList></Reference><Reference><Citation>Koh HK, Geller AC, VanderWeele TJ. Deaths from COVID-19. JAMA. 2021;325(2):133-134. doi:10.1001/jama.2020.25381</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.25381</ArticleId><ArticleId IdType="pubmed">33331884</ArticleId></ArticleIdList></Reference><Reference><Citation>Woolf SH, Chapman DA, Lee JH. COVID-19 as the leading cause of death in the United States. JAMA. 2021;325(2):123-124. doi:10.1001/jama.2020.24865</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.24865</ArticleId><ArticleId IdType="pmc">PMC8553021</ArticleId><ArticleId IdType="pubmed">33331845</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Gennaro F, Pizzol D, Marotta C, et al. . Coronavirus diseases (COVID-19) current status and future perspectives: a narrative review. Int J Environ Res Public Health. 2020;17(8):2690. doi:10.3390/ijerph17082690</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17082690</ArticleId><ArticleId IdType="pmc">PMC7215977</ArticleId><ArticleId IdType="pubmed">32295188</ArticleId></ArticleIdList></Reference><Reference><Citation>Haffner MR, Le HV, Saiz AM, et al. . Postoperative in-hospital morbidity and mortality of patients with COVID-19 infection compared with patients without COVID-19 infection. JAMA Netw Open. 2021;4(4):e215697. doi:10.1001/jamanetworkopen.2021.5697</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.5697</ArticleId><ArticleId IdType="pmc">PMC8042521</ArticleId><ArticleId IdType="pubmed">33844002</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson C, Ozrazgat-Baslanti T, Kuxhausen A, et al. . Cost and mortality associated with postoperative acute kidney injury. Ann Surg. 2015;261(6):1207-1214. doi:10.1097/SLA.0000000000000732</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000000732</ArticleId><ArticleId IdType="pmc">PMC4247993</ArticleId><ArticleId IdType="pubmed">24887982</ArticleId></ArticleIdList></Reference><Reference><Citation>Viterbo JF, Tavares MJ. Prevention and treatment of perioperative pulmonary thromboembolism. Article in Portuguese. Acta Med Port. 2005;18(3):209-220.</Citation><ArticleIdList><ArticleId IdType="pubmed">16207457</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger A, Simpson A, Bhagnani T, et al. . Incidence and cost of major adverse cardiovascular events and major adverse limb events in patients with chronic coronary artery disease or peripheral artery disease. Am J Cardiol. 2019;123(12):1893-1899. doi:10.1016/j.amjcard.2019.03.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2019.03.022</ArticleId><ArticleId IdType="pubmed">31014542</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hader R, Al-Robaidi K, Jovin T, Jadhav A, Wechsler LR, Thirumala PD. The incidence of perioperative stroke: estimate using state and national databases and systematic review. J Stroke. 2019;21(3):290-301. doi:10.5853/jos.2019.00304</Citation><ArticleIdList><ArticleId IdType="doi">10.5853/jos.2019.00304</ArticleId><ArticleId IdType="pmc">PMC6780011</ArticleId><ArticleId IdType="pubmed">31590473</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. . More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. medRxiv. Preprint posted January 30, 2021. doi:10.1101/2021.01.27.21250617</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.01.27.21250617</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohatgi N, Smilowitz NR, Reejhsinghani R. Perioperative cardiovascular considerations prior to elective noncardiac surgery in patients with a history of COVID-19. JAMA Surg. 2022;157(3):187-188. doi:10.1001/jamasurg.2021.6953</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2021.6953</ArticleId><ArticleId IdType="pubmed">35019990</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsoularis I, Fonseca-Rodr&#xed;guez O, Farrington P, et al. . Risks of deep vein thrombosis, pulmonary embolism, and bleeding after COVID-19: nationwide self-controlled cases series and matched cohort study. BMJ. 2022;377:e069590. doi:10.1136/bmj-2021-069590</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069590</ArticleId><ArticleId IdType="pmc">PMC8984137</ArticleId><ArticleId IdType="pubmed">35387772</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieberman N, Racine A, Nair S, et al. . Should asymptomatic patients testing positive for SARS-CoV-2 wait for elective surgical procedures? Br J Anaesth. 2022;128(5):e311-e314. doi:10.1016/j.bja.2022.02.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2022.02.005</ArticleId><ArticleId IdType="pmc">PMC8847097</ArticleId><ArticleId IdType="pubmed">35277245</ArticleId></ArticleIdList></Reference><Reference><Citation>Nahshon C, Bitterman A, Haddad R, Hazzan D, Lavie O. Hazardous postoperative outcomes of unexpected COVID-19 infected patients: a call for global consideration of sampling all asymptomatic patients before surgical treatment. World J Surg. 2020;44(8):2477-2481. doi:10.1007/s00268-020-05575-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-020-05575-2</ArticleId><ArticleId IdType="pmc">PMC7229873</ArticleId><ArticleId IdType="pubmed">32418028</ArticleId></ArticleIdList></Reference><Reference><Citation>American Society of Anesthesiologists. ASA and APSF joint statement on elective surgery and anesthesia for patients after COVID-19 infection. Updated March 9, 2021. Accessed March 29, 2022. https://www.asahq.org/about-asa/newsroom/news-releases/2021/03/asa-and-apsf-joint-statement-on-elective-surgery-and-anesthesia-for-patients-after-covid-19-infection-rv</Citation></Reference><Reference><Citation>Weitzner ZN, Schumm MA, Hu T, Wu JX. Short-term perioperative outcomes among patients with concurrent asymptomatic and mild SARS-CoV-2 infection: a retrospective, multicenter study. Surgery. 2022;171(6):1500-1504. doi:10.1016/j.surg.2021.12.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.surg.2021.12.024</ArticleId><ArticleId IdType="pmc">PMC8716176</ArticleId><ArticleId IdType="pubmed">35109982</ArticleId></ArticleIdList></Reference><Reference><Citation>COVIDSurg Collaborative. Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study. Lancet. 2020;396(10243):27-38. doi:10.1016/S0140-6736(20)31182-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31182-X</ArticleId><ArticleId IdType="pmc">PMC7259900</ArticleId><ArticleId IdType="pubmed">32479829</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandoval Y, Januzzi JL Jr, Jaffe AS. Cardiac troponin for assessment of myocardial injury in COVID-19: JACC review topic of the week. J Am Coll Cardiol. 2020;76(10):1244-1258. doi:10.1016/j.jacc.2020.06.068</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.06.068</ArticleId><ArticleId IdType="pmc">PMC7833921</ArticleId><ArticleId IdType="pubmed">32652195</ArticleId></ArticleIdList></Reference><Reference><Citation>Lala A, Johnson KW, Januzzi JL, et al. ; Mount Sinai COVID Informatics Center . Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection. J Am Coll Cardiol. 2020;76(5):533-546. doi:10.1016/j.jacc.2020.06.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.06.007</ArticleId><ArticleId IdType="pmc">PMC7279721</ArticleId><ArticleId IdType="pubmed">32517963</ArticleId></ArticleIdList></Reference><Reference><Citation>deFilippi CR, Herzog CA. Interpreting cardiac biomarkers in the setting of chronic kidney disease. Clin Chem. 2017;63(1):59-65. doi:10.1373/clinchem.2016.254748</Citation><ArticleIdList><ArticleId IdType="doi">10.1373/clinchem.2016.254748</ArticleId><ArticleId IdType="pubmed">27811207</ArticleId></ArticleIdList></Reference><Reference><Citation>Kip KE, Hollabaugh K, Marroquin OC, Williams DO. The problem with composite end points in cardiovascular studies: the story of major adverse cardiac events and percutaneous coronary intervention. J Am Coll Cardiol. 2008;51(7):701-707. doi:10.1016/j.jacc.2007.10.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2007.10.034</ArticleId><ArticleId IdType="pubmed">18279733</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40245162</PMID><DateCompleted><Year>2025</Year><Month>06</Month><Day>04</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1535-1386</ISSN><JournalIssue CitedMedium="Internet"><Volume>107</Volume><Issue>11</Issue><PubDate><Year>2025</Year><Month>Jun</Month><Day>04</Day></PubDate></JournalIssue><Title>The Journal of bone and joint surgery. American volume</Title><ISOAbbreviation>J Bone Joint Surg Am</ISOAbbreviation></Journal><ArticleTitle>Risk of Venous Thromboembolism in Pediatric Patients with Surgically Treated Lower-Extremity Fractures: A Propensity-Matched Cohort Study.</ArticleTitle><Pagination><StartPage>1171</StartPage><EndPage>1179</EndPage><MedlinePgn>1171-1179</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2106/JBJS.24.00810</ELocationID><Abstract><AbstractText Label="BACKGROUND">Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is a substantial cause of morbidity and mortality among hospitalized patients. Although rare in the general pediatric population, VTE remains a potential concern in hospitalized children, particularly those with lower-extremity (LE) fractures. With this study, we aimed to determine the risk of VTE in pediatric patients with surgically treated LE fractures through a retrospective, propensity-matched, cohort analysis.</AbstractText><AbstractText Label="METHODS">The TriNetX Research Network, encompassing data from &gt;80 health-care organizations and &gt;120 million patient records, was utilized for this retrospective cohort study comparing 3 age-based cohorts (children [age of &lt;14 years], adolescents [age of 14 to 17 years], and adults [age of &#x2265;18 years]) who underwent surgical treatment of LE fractures between January 1, 2003, and January 1, 2023.</AbstractText><AbstractText Label="RESULTS">A total of 634,880 patients with surgically treated LE fractures were included; 13.3% were children, 5.6% were adolescents, and 81.1% were adults. Propensity-score matching was used to compare VTE incidence across cohorts, resulting in 3 independent matched comparisons. Overall, the incidence of VTE (either DVT or PE) was 0.2% in children, 1.0% in adolescents, and 4.1% in adults. Adults had a significantly higher risk of developing DVT (risk ratio [RR]: 17.0; 95% confidence interval [CI]: 14.5 to 20.0) and PE (RR: 21.8; 95% CI: 17.0 to 28.1) compared with children. Similarly, adolescents had a higher risk of DVT (RR: 3.5; 95% CI: 2.7 to 4.4) and PE (RR: 3.1; 95% CI: 2.2 to 4.4) compared with children. The incidence of VTE varied by fracture location, with femoral and knee joint (incidence: 0.5% in children, 2.5% in adolescents) and pelvic and hip joint (incidence: 1.2% in children, 2.8% in adolescents) fractures presenting the highest risk across all age groups.</AbstractText><AbstractText Label="CONCLUSIONS">The incidence of VTE in a large cohort of pediatric patients undergoing surgical treatment of LE fractures was higher in adolescents than in children. These findings may warrant prophylactic VTE measures in adolescents undergoing surgical treatment of femoral or pelvic fractures.</AbstractText><AbstractText Label="LEVEL OF EVIDENCE">Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 by The Journal of Bone and Joint Surgery, Incorporated.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mittal</LastName><ForeName>Mehul M</ForeName><Initials>MM</Initials><Identifier Source="ORCID">0000-0001-8837-0396</Identifier><AffiliationInfo><Affiliation>Department of Orthopaedics, University of Texas Southwestern Medical Center, Dallas, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Acevedo</LastName><ForeName>Katalina V</ForeName><Initials>KV</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, University of Texas Southwestern Medical Center, Dallas, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hosseinzadeh</LastName><ForeName>Pooya</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-7146-664</Identifier><AffiliationInfo><Affiliation>Department of Orthopaedics, Washington University School of Medicine, St. Louis, Missouri.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Bone Joint Surg Am</MedlineTA><NlmUniqueID>0014030</NlmUniqueID><ISSNLinking>0021-9355</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="Y">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057216" MajorTopicYN="N">Propensity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050723" MajorTopicYN="Y">Fractures, Bone</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035002" MajorTopicYN="N">Lower Extremity</DescriptorName><QualifierName UI="Q000293" MajorTopicYN="N">injuries</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Disclosure: No external funding was received for this work. The Disclosure of Potential Conflicts of Interest forms are provided with the online version of the article ( http://links.lww.com/JBJS/I549 ).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>4</Day><Hour>12</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>17</Day><Hour>18</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>17</Day><Hour>14</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40245162</ArticleId><ArticleId IdType="doi">10.2106/JBJS.24.00810</ArticleId><ArticleId IdType="pii">00004623-202506040-00001</ArticleId></ArticleIdList><ReferenceList><Title/><Reference><Citation>Heit JA, Spencer FA, White RH. The epidemiology of venous thromboembolism. J Thromb Thrombolysis. 2016 Jan;41(1):3-14.</Citation></Reference><Reference><Citation>Falck-Ytter Y, Francis CW, Johanson NA, Curley C, Dahl OE, Schulman S, Ortel TL, Pauker SG, Colwell CW Jr. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb;141(2)(Suppl):e278S-325S.</Citation></Reference><Reference><Citation>Murphy RF, Naqvi M, Miller PE, Feldman L, Shore BJ. Pediatric orthopaedic lower extremity trauma and venous thromboembolism. J Child Orthop. 2015 Oct;9(5):381-4.</Citation></Reference><Reference><Citation>O&#x2019;Brien SH, Haley K, Kelleher KJ, Wang W, McKenna C, Gaines BA. Variation in DVT prophylaxis for adolescent trauma patients: a survey of the Society of Trauma Nurses. J Trauma Nurs. 2008 Apr-Jun;15(2):53-7.</Citation></Reference><Reference><Citation>Mulpuri N, Sanborn RM, Pradhan P, Miller PE, Canizares MF, Shore BJ. Pediatric Orthopaedic Venous Thromboembolism: A Systematic Review Investigating Incidence, Risk Factors, and Outcome. JBJS Open Access. 2024 Jan 5;9(1):e23.00107.</Citation></Reference><Reference><Citation>Allen CJ, Murray CR, Meizoso JP, Ray JJ, Neville HL, Schulman CI, Namias N, Sola JE, Proctor KG. Risk factors for venous thromboembolism after pediatric trauma. J Pediatr Surg. 2016 Jan;51(1):168-71.</Citation></Reference><Reference><Citation>Naranje SM, Erali RA, Warner WCJ Jr, Sawyer JR, Kelly DM. Epidemiology of Pediatric Fractures Presenting to Emergency Departments in the United States. J Pediatr Orthop. 2016 Jun;36(4):e45-8.</Citation></Reference><Reference><Citation>Nakaniida A, Sakuraba K, Hurwitz EL. Pediatric orthopaedic injuries requiring hospitalization: epidemiology and economics. J Orthop Trauma. 2014 Mar;28(3):167-72.</Citation></Reference><Reference><Citation>TriNetX. Linked EHR and Claims. Accessed 2024 May 29. https://trinetx.com/real-world-data/linked/</Citation></Reference><Reference><Citation>TriNetX. Publication Guidelines. Accessed 2024 Mar 10. https://trinetx.com/real-world-resources/publications/trinetx-publication-guidelines/</Citation></Reference><Reference><Citation>Tenny S, Hoffman MR. Relative Risk. In: StatPearls. StatPearls Publishing; 2024.</Citation></Reference><Reference><Citation>TrinetX Help Center. In compare outcomes, how are patients matched when balancing cohorts? 2024. Accessed 2024 Oct 9. https://support.trinetx.com/hc/en-us/articles/360011978033-In-compare-outcomes-how-are-patients-matched-when-balancing-cohorts</Citation></Reference><Reference><Citation>Sandoval JA, Sheehan MP, Stonerock CE, Shafique S, Rescorla FJ, Dalsing MC. Incidence, risk factors, and treatment patterns for deep venous thrombosis in hospitalized children: an increasing population at risk. J Vasc Surg. 2008 Apr;47(4):837-43.</Citation></Reference><Reference><Citation>Biss TT, Brand&#xe3;o LR, Kahr WH, Chan AK, Williams S. Clinical features and outcome of pulmonary embolism in children. Br J Haematol. 2008 Sep;142(5):808-18.</Citation></Reference><Reference><Citation>Guzman D, Sabharwal S, Zhao C, Sabharwal S. Venous thromboembolism among pediatric orthopedic trauma patients: a database analysis. J Pediatr Orthop B. 2018 Mar;27(2):93-8.</Citation></Reference><Reference><Citation>Anderson FA Jr, Wheeler HB, Goldberg RJ, Hosmer DW, Patwardhan NA, Jovanovic B, Forcier A, Dalen JE. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med. 1991 May;151(5):933-8.</Citation></Reference><Reference><Citation>Andrew M, David M, Adams M, Ali K, Anderson R, Barnard D, Bernstein M, Brisson L, Cairney B, DeSai D, et al. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood. 1994 Mar 1;83(5):1251-7.</Citation></Reference><Reference><Citation>Stein PD, Kayali F, Olson RE. Incidence of venous thromboembolism in infants and children: data from the National Hospital Discharge Survey. J Pediatr. 2004 Oct;145(4):563-5.</Citation></Reference><Reference><Citation>Vu LT, Nobuhara KK, Lee H, Farmer DL. Determination of risk factors for deep venous thrombosis in hospitalized children. J Pediatr Surg. 2008 Jun;43(6):1095-9.</Citation></Reference><Reference><Citation>Van Arendonk KJ, Schneider EB, Haider AH, Colombani PM, Stewart FD, Haut ER. Venous Thromboembolism after Trauma: When Do Children Become Adults? J Emerg Med. 2014;46(6):874-5.</Citation></Reference><Reference><Citation>Kuhle S, Massicotte P, Chan A, Adams M, Abdolell M, de Veber G, Mitchell L. Systemic thromboembolism in children. Data from the 1-800-NO-CLOTS Consultation Service. Thromb Haemost. 2004 Oct;92(4):722-8.</Citation></Reference><Reference><Citation>Andrew M, Vegh P, Johnston M, Bowker J, Ofosu F, Mitchell L. Maturation of the hemostatic system during childhood. Blood. 1992 Oct 15;80(8):1998-2005.</Citation></Reference><Reference><Citation>Mitchell L, Piovella F, Ofosu F, Andrew M. Alpha-2-macroglobulin may provide protection from thromboembolic events in antithrombin III-deficient children. Blood. 1991 Nov 1;78(9):2299-304.</Citation></Reference><Reference><Citation>Monagle P, Chan AKC, Albisetti M, Vegh P, Andrew M, Mitchell L. Fibrinolytic system in adolescents: response to venous occlusion stress tests. Pediatr Res. 2003 Feb;53(2):333-7.</Citation></Reference><Reference><Citation>Paffrath T, Wafaisade A, Lefering R, Simanski C, Bouillon B, Spanholtz T, Wutzler S, Maegele M; Trauma Registry of DGU. Venous thromboembolism after severe trauma: incidence, risk factors and outcome. Injury. 2010 Jan;41(1):97-101.</Citation></Reference><Reference><Citation>Azu MC, McCormack JE, Scriven RJ, Brebbia JS, Shapiro MJ, Lee TK. Venous thromboembolic events in pediatric trauma patients: is prophylaxis necessary? J Trauma. 2005 Dec;59(6):1345-9.</Citation></Reference><Reference><Citation>Curwin J, MacNevin W, El-Hawary R, Kulkarni K. Venous Thromboembolism Prophylaxis Use by Pediatric Orthopedic Surgeons in Canada for the Pediatric Orthopedic Surgical Population. Cureus. 2022 Oct 5;14(10):e29933.</Citation></Reference><Reference><Citation>Greenwald LJ, Yost MT, Sponseller PD, Abdullah F, Ziegfeld SM, Ain MC. The role of clinically significant venous thromboembolism and thromboprophylaxis in pediatric patients with pelvic or femoral fractures. J Pediatr Orthop. 2012 Jun;32(4):357-61.</Citation></Reference><Reference><Citation>Bosch A, Albisetti M. Management of Venous Thromboembolism in Children: Current Recommendations and Therapeutic Options. Ther Clin Risk Manag. 2020 Jul 28;16:673-9.</Citation></Reference><Reference><Citation>Meier KA, Clark E, Tarango C, Chima RS, Shaughnessy E. Venous thromboembolism in hospitalized adolescents: an approach to risk assessment and prophylaxis. Hosp Pediatr. 2015 Jan;5(1):44-51.</Citation></Reference><Reference><Citation>Murphy RF, Williams D, Hogue GD, Spence DD, Epps H, Chambers HG, Shore BJ. Prophylaxis for Pediatric Venous Thromboembolism: Current Status and Changes Across Pediatric Orthopaedic Society of North America From 2011. J Am Acad Orthop Surg. 2020 May 1;28(9):388-94.</Citation></Reference><Reference><Citation>Barbar S, Noventa F, Rossetto V, Ferrari A, Brandolin B, Perlati M, De Bon E, Tormene D, Pagnan A, Prandoni P. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost. 2010 Nov;8(11):2450-7.</Citation></Reference><Reference><Citation>Rothberg MB, Lahti M, Pekow PS, Lindenauer PK. Venous thromboembolism prophylaxis among medical patients at US hospitals. J Gen Intern Med. 2010 Jun;25(6):489-94.</Citation></Reference><Reference><Citation>Le P, Martinez KA, Pappas MA, Rothberg MB. A decision model to estimate a risk threshold for venous thromboembolism prophylaxis in hospitalized medical patients. J Thromb Haemost. 2017 Jun;15(6):1132-41.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31409532</PMID><DateCompleted><Year>2020</Year><Month>11</Month><Day>12</Day></DateCompleted><DateRevised><Year>2020</Year><Month>11</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1479-666X</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Feb</Month></PubDate></JournalIssue><Title>The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland</Title><ISOAbbreviation>Surgeon</ISOAbbreviation></Journal><ArticleTitle>The effect of tranexamic acid on wound complications in primary total Hip Arthroplasty: A meta-analysis.</ArticleTitle><Pagination><StartPage>53</StartPage><EndPage>61</EndPage><MedlinePgn>53-61</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.surge.2019.05.003</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1479-666X(19)30090-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Allogeneic blood transfusion has been linked with an increase in the risk of surgical site infections (SSIs) through the mechanism of immunomodulation. However, no studies to date have investigated the direct relationship between blood conserving strategies including antifibrinolytics and wound complications after total hip arthroplasties (THA).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic review and meta-analysis of published randomised controlled trials (RCTs) to investigate the effect of tranexamic acid (TXA) on wound complications after THAs has been conducted.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified 25 clinical trials which were suitable for detailed data extraction. There were no trials which utilised TXA in revision THA. All studies reported on wound complications including a total of 1608 patients. Using TXA led to a 2% reduction in the risk of developing wound complications compared to the control group with no significant statistical heterogeneity among the study groups (Risk Difference -0.02, 95%, confidence interval CI -0.04 to -0.00, P&#xa0;=&#xa0;0.01, Heterogeneity I<sup>2</sup>&#xa0;=&#xa0;0%). However, there was no significant difference in clinical outcomes in terms of antibiotic treatment or surgical intervention among the study groups. TXA also reduced intraoperative, postoperative and total blood loss and led to a significant reduction in the proportion of patients requiring allogeneic blood transfusion with no significant differences in deep venous thrombosis, pulmonary embolisms, or other complications between the study groups.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">TXA reduced blood loss and transfusion rates after primary THA surgery. It also reduced wound complication rates but the clinical significance of this needs further investigation through well designed and adequately powered RCTs.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Royal College of Surgeons of Edinburgh (Scottish charity number SC005317) and Royal College of Surgeons in Ireland. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sukeik</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Trauma and Orthopaedics, Foothills Medical Centre, 1403 29 St NW, Calgary, AB T2N 2T9, Canada. Electronic address: msukeik@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alshryda</LastName><ForeName>Sattar</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Trauma and Orthopaedics, Royal Manchester Children's Hospital, Oxford Road, Manchester, M13 9WL, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Powell</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Trauma and Orthopaedics, Foothills Medical Centre, 1403 29 St NW, Calgary, AB T2N 2T9, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haddad</LastName><ForeName>Fares S</ForeName><Initials>FS</Initials><AffiliationInfo><Affiliation>Department of Trauma and Orthopaedics, University College London Hospital, 235 Euston Road London, NW1 2BU, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>08</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Scotland</Country><MedlineTA>Surgeon</MedlineTA><NlmUniqueID>101168329</NlmUniqueID><ISSNLinking>1479-666X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000933">Antifibrinolytic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>6T84R30KC1</RegistryNumber><NameOfSubstance UI="D014148">Tranexamic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000933" MajorTopicYN="N">Antifibrinolytic Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019644" MajorTopicYN="N">Arthroplasty, Replacement, Hip</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014148" MajorTopicYN="N">Tranexamic Acid</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Complications</Keyword><Keyword MajorTopicYN="N">Hip replacement</Keyword><Keyword MajorTopicYN="N">Tranexamic acid</Keyword><Keyword MajorTopicYN="N">Wound</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>1</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>4</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>5</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31409532</ArticleId><ArticleId IdType="doi">10.1016/j.surge.2019.05.003</ArticleId><ArticleId IdType="pii">S1479-666X(19)30090-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37147099</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>08</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2044-6055</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>05</Day></PubDate></JournalIssue><Title>BMJ open</Title><ISOAbbreviation>BMJ Open</ISOAbbreviation></Journal><ArticleTitle>Value of retrograde pulmonary vein perfusion combined with pulmonary artery thrombectomy in acute pulmonary embolism: a protocol for a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>e069685</StartPage><MedlinePgn>e069685</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e069685</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2022-069685</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Acute pulmonary embolism is a serious cardiovascular disease with high mortality. Surgery is an important therapeutic means. The traditional surgical method is pulmonary artery embolectomy with cardiopulmonary bypass, but there is a certain recurrence rate after surgery. Some scholars use retrograde pulmonary vein perfusion as an adjunct to conventional pulmonary artery embolectomy. However, whether this method can be used safely for acute pulmonary embolism and its long-term effects remains unclear. Therefore, we plan to conduct a systematic review and meta-analysis to investigate whether retrograde pulmonary vein perfusion combined with pulmonary artery thrombectomy can be safely used in acute pulmonary embolism.</AbstractText><AbstractText Label="METHODS AND ANALYSIS">We will search key databases (Ovid MEDLINE, PubMed, Web of Science, Cochrane Library, China Science and Technology Journals and Wanfang) for studies on acute pulmonary embolism treated with retrograde pulmonary vein perfusion from January 2002 to December 2022. The useful information will be consolidated into a piloting spreadsheet. The Cochrane Risk of Bias Tool will be used to assess the bias. Data will be synthesised and heterogeneity will be evaluated. The dichotomous variables will be determined by using risk ratio with 95% CI, and weighted mean differences (with 95%&#x2009;CI) or standardised mean differences (95%&#x2009;CI) will be used for continuous variables. &#x3a7;<sup>2</sup> test and I<sup>2</sup> test will be used to assess the statistical heterogeneity. Meta-analysis will be conducted when strong homogeneous data are accessible.</AbstractText><AbstractText Label="ETHICS AND DISSEMINATION">Approval of the ethics committee is not needed for this review. While results will be disseminated electronically, effective dissemination will be done through presentations and peer-reviewed publication.</AbstractText><AbstractText Label="PROSPERO REGISTRATION NUMBER">CRD42022345812; pre-results.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Xiang</LastName><ForeName>Jun</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-8049-2804</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>He</LastName><ForeName>Ling</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Tailuan</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Weiwei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Shuliang</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China shuliang_wei@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open</MedlineTA><NlmUniqueID>101552874</NlmUniqueID><ISSNLinking>2044-6055</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011651" MajorTopicYN="N">Pulmonary Artery</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011667" MajorTopicYN="Y">Pulmonary Veins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000078202" MajorTopicYN="N">Systematic Reviews as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015201" MajorTopicYN="N">Meta-Analysis as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017131" MajorTopicYN="N">Thrombectomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010477" MajorTopicYN="N">Perfusion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012196" MajorTopicYN="N">Review Literature as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiac surgery</Keyword><Keyword MajorTopicYN="N">Cardiology</Keyword><Keyword MajorTopicYN="N">Thoracic surgery</Keyword><Keyword MajorTopicYN="N">Vascular surgery</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>8</Day><Hour>10</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>6</Day><Hour>9</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>5</Day><Hour>21</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37147099</ArticleId><ArticleId IdType="pmc">PMC10163473</ArticleId><ArticleId IdType="doi">10.1136/bmjopen-2022-069685</ArticleId><ArticleId IdType="pii">bmjopen-2022-069685</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Konstantinides SV, Meyer G. The 2019 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2019;40:3453&#x2013;5. 10.1093/eurheartj/ehz726</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehz726</ArticleId><ArticleId IdType="pubmed">31697840</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez Licha CR, McCurdy CM, Maldonado SM, et al. . Current management of acute pulmonary embolism. ATCS 2020;26:65&#x2013;71. 10.5761/atcs.ra.19-00158</Citation><ArticleIdList><ArticleId IdType="doi">10.5761/atcs.ra.19-00158</ArticleId><ArticleId IdType="pmc">PMC7184035</ArticleId><ArticleId IdType="pubmed">31588070</ArticleId></ArticleIdList></Reference><Reference><Citation>RASKOB G, ANGCHAISUKSIRI P, BLANCO A. Thrombosis: a major contributor to global disease burden. Arteriosclerosis, thrombosis, and vascular biology 2014;34:2363&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">25304324</ArticleId></ArticleIdList></Reference><Reference><Citation>Wendelboe AM, Raskob GE. Global burden of thrombosis: epidemiologic aspects. Circ Res 2016;118:1340&#x2013;7. 10.1161/CIRCRESAHA.115.306841</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.115.306841</ArticleId><ArticleId IdType="pubmed">27126645</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsoularis I, Fonseca-Rodr&#xed;guez O, Farrington P, et al. . Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study. BMJ 2022;377:e069590. 10.1136/bmj-2021-069590</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069590</ArticleId><ArticleId IdType="pmc">PMC8984137</ArticleId><ArticleId IdType="pubmed">35387772</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruaro B, Confalonieri P, Santagiuliana M, et al. . Correlation between potential risk factors and pulmonary embolism in sarcoidosis patients timely treated. J Clin Med 2021;10:2462. 10.3390/jcm10112462</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10112462</ArticleId><ArticleId IdType="pmc">PMC8199598</ArticleId><ArticleId IdType="pubmed">34199396</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostura M, Smalley C, Koyfman A, et al. . Right heart failure: a narrative review for emergency clinicians. Am J Emerg Med 2022;58:106&#x2013;13. 10.1016/j.ajem.2022.05.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2022.05.030</ArticleId><ArticleId IdType="pubmed">35660367</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaptein FHJ, Kroft LJM, Hammerschlag G, et al. . Pulmonary infarction in acute pulmonary embolism. Thromb Res 2021;202:162&#x2013;9. 10.1016/j.thromres.2021.03.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2021.03.022</ArticleId><ArticleId IdType="pubmed">33862471</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy P-M, Douillet D, Penaloza A. Contemporary management of acute pulmonary embolism. Trends Cardiovasc Med 2022;32:259&#x2013;68. 10.1016/j.tcm.2021.06.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcm.2021.06.002</ArticleId><ArticleId IdType="pubmed">34214598</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul JD, Cifu AS. Management of acute pulmonary embolism. JAMA 2020;324:597&#x2013;8. 10.1001/jama.2020.3905</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.3905</ArticleId><ArticleId IdType="pubmed">32780129</ArticleId></ArticleIdList></Reference><Reference><Citation>Osho AA, Dudzinski DM. Interventional therapies for acute pulmonary embolism. Surg Clin North Am 2022;102:429&#x2013;47. 10.1016/j.suc.2022.02.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.suc.2022.02.004</ArticleId><ArticleId IdType="pubmed">35671765</ArticleId></ArticleIdList></Reference><Reference><Citation>Papakonstantinou NA, Kampaktsis PN, Rorris F-P, et al. . Surgical treatment of pulmonary embolism and chronic thromboembolic pulmonary hypertension. Curr Pharm Des 2022;28:521&#x2013;34. 10.2174/1381612827666210902152539</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612827666210902152539</ArticleId><ArticleId IdType="pubmed">34477511</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee T, Itagaki S, Chiang YP, et al. . Survival and recurrence after acute pulmonary embolism treated with pulmonary embolectomy or thrombolysis in New York state, 1999 to 2013 J. J Thorac Cardiovasc Surg 2018;155:1084&#x2013;90. 10.1016/j.jtcvs.2017.07.074</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2017.07.074</ArticleId><ArticleId IdType="pubmed">28942971</ArticleId></ArticleIdList></Reference><Reference><Citation>Konstantinides SV, Meyer G, Becattini C, et al. . 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European respiratory Society (ERS): the task force for the diagnosis and management of acute pulmonary embolism of the European Society of cardiology (ESC). Eur Respir J 2019;54:1901647. 10.1183/13993003.01647-2019</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01647-2019</ArticleId><ArticleId IdType="pubmed">31473594</ArticleId></ArticleIdList></Reference><Reference><Citation>Keeling WB, Sundt T, Leacche M, et al. . Outcomes after surgical pulmonary embolectomy for acute pulmonary embolus: a multi-institutional study. Ann Thorac Surg 2016;102:1498&#x2013;502. 10.1016/j.athoracsur.2016.05.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2016.05.004</ArticleId><ArticleId IdType="pubmed">27373187</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasrija C, Kronfli A, Rouse M, et al. . Outcomes after surgical pulmonary embolectomy for acute submassive and massive pulmonary embolism: a single-center experience. J Thorac Cardiovasc Surg 2018;155:1095&#x2013;106. 10.1016/j.jtcvs.2017.10.139</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2017.10.139</ArticleId><ArticleId IdType="pubmed">29452460</ArticleId></ArticleIdList></Reference><Reference><Citation>QiMin W, LiangWan C, DaoZhong C, et al. . Clinical outcomes of acute pulmonary embolectomy as the first-line treatment for massive and submassive pulmonary embolism: a single-centre study in China. J Cardiothorac Surg 2020;15:321. 10.1186/s13019-020-01364-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13019-020-01364-z</ArticleId><ArticleId IdType="pmc">PMC7576708</ArticleId><ArticleId IdType="pubmed">33087152</ArticleId></ArticleIdList></Reference><Reference><Citation>Azari A, Bigdelu L, Moravvej Z. Surgical embolectomy in the management of massive and sub-massive pulmonary embolism: the results of 30 consecutive ill patients. ARYA Atheroscler 2015;11:208&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4568195</ArticleId><ArticleId IdType="pubmed">26405455</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldberg JB, Spevack DM, Ahsan S, et al. . Survival and right ventricular function after surgical management of acute pulmonary embolism. J Am Coll Cardiol 2020;76:903&#x2013;11. 10.1016/j.jacc.2020.06.065</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.06.065</ArticleId><ArticleId IdType="pubmed">32819463</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J, Lim S-H, Hong YS, et al. . Acute pulmonary thromboembolism: 14 years of surgical experience. Korean J Thorac Cardiovasc Surg 2019;52:78&#x2013;84. 10.5090/kjtcs.2019.52.2.78</Citation><ArticleIdList><ArticleId IdType="doi">10.5090/kjtcs.2019.52.2.78</ArticleId><ArticleId IdType="pmc">PMC6493267</ArticleId><ArticleId IdType="pubmed">31089444</ArticleId></ArticleIdList></Reference><Reference><Citation>Gahagan T, Manzor A, Mathur AN, et al. . Removal of impacted pulmonary emboli by retrograde injection of fibrinolysin into the pulmonary veins. Report of three cases and experimental studies. Ann Surg 1966;164:315&#x2013;20. 10.1097/00000658-196608000-00019</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000658-196608000-00019</ArticleId><ArticleId IdType="pmc">PMC1477253</ArticleId><ArticleId IdType="pubmed">4223832</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvatore S, Maria Antonia G, Ugo Filippo T. Retrograde pulmonary perfusion improves results in pulmonary embolectomy for massive pulmonary embolism. Tex Heart Inst J 2006;33:473&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1764971</ArticleId><ArticleId IdType="pubmed">17215973</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarrabi K, Mollazadeh R, Ostovan MA, et al. . Retrograde pulmonary embolectomy in 11 patients. Ann Thorac Surg 2008;85:1471&#x2013;2. 10.1016/j.athoracsur.2007.09.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2007.09.005</ArticleId><ArticleId IdType="pubmed">18355564</ArticleId></ArticleIdList></Reference><Reference><Citation>Kj&#xe6;rgaard B, Honge JL, Magnusdottir SO, et al. . Retrograde lung perfusion in the treatment of massive pulmonary embolism. A randomised porcine study. Thromb Res 2015;135:410&#x2013;4. 10.1016/j.thromres.2014.12.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2014.12.003</ArticleId><ArticleId IdType="pubmed">25523344</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarrabi K, Zolghadrasli A, Ostovan MA, et al. . Short-Term results of retrograde pulmonary embolectomy in massive and submassive pulmonary embolism: a single-center study of 30 patients J. European Journal of Cardio-Thoracic Surgery 2011;40:890&#x2013;3. 10.1016/j.ejcts.2011.06.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcts.2011.06.004</ArticleId><ArticleId IdType="pubmed">21741854</ArticleId></ArticleIdList></Reference><Reference><Citation>Spagnolo S, Barbato L, Grasso MA, et al. . Retrograde pulmonary perfusion as an adjunct to standard pulmonary embolectomy for acute pulmonary embolism. Multimed Man Cardiothorac Surg 2014;2014:mmu019. 10.1093/mmcts/mmu019</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/mmcts/mmu019</ArticleId><ArticleId IdType="pubmed">25298365</ArticleId></ArticleIdList></Reference><Reference><Citation>Shamseer L, Moher D, Clarke M, et al. . Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 2015;350:g7647. 10.1136/bmj.g7647</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.g7647</ArticleId><ArticleId IdType="pubmed">25555855</ArticleId></ArticleIdList></Reference><Reference><Citation>Booth A, Clarke M, Dooley G, et al. . The nuts and bolts of Prospero: an international prospective register of systematic reviews. Syst Rev 2012;1:2. 10.1186/2046-4053-1-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2046-4053-1-2</ArticleId><ArticleId IdType="pmc">PMC3348673</ArticleId><ArticleId IdType="pubmed">22587842</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Altman DG, G&#xf8;tzsche PC, et al. . The Cochrane collaboration&#x2019;s tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928. 10.1136/bmj.d5928</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d5928</ArticleId><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Q, Yang Y, Zhang J, et al. . Laparoscopic versus open left hemicolectomy for left-sided colon cancer: protocol for a systematic review and meta-analysis. BMJ Open 2022;12:e062216. 10.1136/bmjopen-2022-062216</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-062216</ArticleId><ArticleId IdType="pmc">PMC9226930</ArticleId><ArticleId IdType="pubmed">35732400</ArticleId></ArticleIdList></Reference><Reference><Citation>Parmar MKB, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statist Med 1998;17:2815&#x2013;34. 10.1002/(SICI)1097-0258(19981230)17:24&lt;2815::AID-SIM110&gt;3.0.CO;2-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-0258(19981230)17:24&lt;2815::AID-SIM110&gt;3.0.CO;2-8</ArticleId><ArticleId IdType="pubmed">9921604</ArticleId></ArticleIdList></Reference><Reference><Citation>Tierney JF, Stewart LA, Ghersi D, et al. . Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007;8:16. 10.1186/1745-6215-8-16</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1745-6215-8-16</ArticleId><ArticleId IdType="pmc">PMC1920534</ArticleId><ArticleId IdType="pubmed">17555582</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Thompson SG, Deeks JJ, et al. . Measuring inconsistency in meta-analyses. BMJ 2003;327:557&#x2013;60. 10.1136/bmj.327.7414.557</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.327.7414.557</ArticleId><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Zhang D, Zhou C, et al. . Value of lung ultrasound for the diagnosis of covid-19 pneumonia: a protocol for a systematic review and meta-analysis. BMJ Open 2020;10:e039180. 10.1136/bmjopen-2020-039180</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-039180</ArticleId><ArticleId IdType="pmc">PMC7430339</ArticleId><ArticleId IdType="pubmed">32801207</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35150345</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>25</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-2568</ISSN><JournalIssue CitedMedium="Internet"><Volume>67</Volume><Issue>11</Issue><PubDate><Year>2022</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Digestive diseases and sciences</Title><ISOAbbreviation>Dig Dis Sci</ISOAbbreviation></Journal><ArticleTitle>Real-World Insurance Claims Analysis of Venous Thromboembolism in Japanese Patients with Inflammatory Bowel Disease.</ArticleTitle><Pagination><StartPage>5195</StartPage><EndPage>5205</EndPage><MedlinePgn>5195-5205</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10620-022-07388-w</ELocationID><Abstract><AbstractText Label="BACKGROUND">Inflammatory bowel disease (IBD), which encompasses both ulcerative colitis (UC) and Crohn's disease (CD), is a risk factor for venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE).</AbstractText><AbstractText Label="AIM">To investigate the incidence of, and risk factors for, VTE in patients with IBD in Japan.</AbstractText><AbstractText Label="METHODS">This was a retrospective, non-interventional study in patients with IBD from the Japan Medical Data Center claims database. Incidence rates (IRs; unique patients with events per 100 patient-years) were calculated for VTE, DVT, and PE among the IBD, UC, and CD cohorts. Odds ratios of potential risk factors were calculated by univariate and multivariate analyses in a nested case-control design.</AbstractText><AbstractText Label="RESULTS">Overall, 16&#xa0;273 patients with IBD were included: 13&#xa0;585 with UC and 3443 with CD. VTE events occurred in 1.3%, 1.2%, and 1.9% of patients with IBD, UC, and CD, respectively. In patients with IBD, UC, and CD, IRs of VTE were 0.45, 0.40, and 0.64, respectively, IRs of DVT were 0.42, 0.38, and 0.61, respectively, and IRs of PE were 0.07, 0.07, and 0.11, respectively. In patients with IBD, treatment history (immunomodulators), cardiovascular risk (hypertension, high-density lipoprotein or diabetes mellitus, and history of coronary artery disease or heart failure), malignancy, and undergoing major surgery were identified as potential risk factors for VTE in the multivariate analysis, with similar risk factors reported for patients with UC and CD.</AbstractText><AbstractText Label="CONCLUSIONS">This large study provides insight into the incidence and risk factors for VTE in patients with IBD from Japan.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fujiya</LastName><ForeName>Mikihiro</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4321-7774</Identifier><AffiliationInfo><Affiliation>Division of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical University, 2-1 Midorigaoka-Higashi, Asahikawa, 078-8510, Japan. fjym@asahikawa-med.ac.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kawaguchi</LastName><ForeName>Tsutomu</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Immunology &amp; Inflammation Medical Affairs, Pfizer Japan Inc, Shinjuku Culture Quint Bldg 3-22-7 Yoyogi Shibuya-ku, Tokyo, 151-8589, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arai</LastName><ForeName>Shoko</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Immunology &amp; Inflammation Medical Affairs, Pfizer Japan Inc, Shinjuku Culture Quint Bldg 3-22-7 Yoyogi Shibuya-ku, Tokyo, 151-8589, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Isogawa</LastName><ForeName>Naoki</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Biometrics &amp; Data Management, Pfizer R&amp;D Japan, Shinjuku Culture Quint Bldg 3-22-7 Yoyogi Shibuya-ku, Tokyo, 151-8589, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hiro</LastName><ForeName>Shintaro</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Biometrics &amp; Data Management, Pfizer R&amp;D Japan, Shinjuku Culture Quint Bldg 3-22-7 Yoyogi Shibuya-ku, Tokyo, 151-8589, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsumoto</LastName><ForeName>Fumihiro</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Immunology &amp; Inflammation Medical Affairs, Pfizer Japan Inc, Shinjuku Culture Quint Bldg 3-22-7 Yoyogi Shibuya-ku, Tokyo, 151-8589, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamaguchi</LastName><ForeName>Satoshi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Immunology &amp; Inflammation Medical Affairs, Pfizer Japan Inc, Shinjuku Culture Quint Bldg 3-22-7 Yoyogi Shibuya-ku, Tokyo, 151-8589, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>International University of Health and Welfare, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoshii</LastName><ForeName>Noritoshi</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Immunology &amp; Inflammation Medical Affairs, Pfizer Japan Inc, Shinjuku Culture Quint Bldg 3-22-7 Yoyogi Shibuya-ku, Tokyo, 151-8589, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakamura</LastName><ForeName>Mashio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Pediatrics and Cardiology, Hidamarinooka Nakamura Medical Clinic, 7-1510 Hidamarinooka, Kuwana, 511-0867, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsuoka</LastName><ForeName>Katsuyoshi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology and Hepatology, Department of Internal Medicine, Toho University Sakura Medical Center, Sakura City, Chiba, 285-0841, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dig Dis Sci</MedlineTA><NlmUniqueID>7902782</NlmUniqueID><ISSNLinking>0163-2116</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008075">Lipoproteins, HDL</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="Y">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007564" MajorTopicYN="N" Type="Geographic">Japan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007345" MajorTopicYN="N">Insurance Claim Review</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015212" MajorTopicYN="Y">Inflammatory Bowel Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003093" MajorTopicYN="Y">Colitis, Ulcerative</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003424" MajorTopicYN="Y">Crohn Disease</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008075" MajorTopicYN="N">Lipoproteins, HDL</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Incidence</Keyword><Keyword MajorTopicYN="N">Inflammatory bowel diseases</Keyword><Keyword MajorTopicYN="N">Japan</Keyword><Keyword MajorTopicYN="N">Risk factors</Keyword><Keyword MajorTopicYN="N">Venous thromboembolism</Keyword></KeywordList><CoiStatement>M.F. has received grants from Fuji Chemical Industries Co., Ltd., JIMRO Co., Ltd., Kamui Pharma Inc., Nobelpharma Co., Ltd., and Yakult Honsha Co., Ltd.; grants and personal fees from AbbVie Inc, AYUMI Pharmaceutical Corporation, Bristol-Myers Squibb, Daiichi Sankyo Co., Ltd., EA Pharma Co., Ltd., Janssen Pharmaceutical K.K., Kyorin Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Mochida Pharmaceutical Co., Ltd., Nippon Kayaku Co., Ltd., Pfizer Inc, Takeda Pharmaceutical Co., Ltd., and ZERIA Pharmaceutical Co., Ltd.; and personal fees from Aspen Japan K.K., AstraZeneca.co.jp, Boehringer Ingelheim GmbH, Celltrion Healthcare Japan Co., Ltd., Chugai Pharmaceutical Co., Ltd., Horii Pharmaceutical Ind., Ltd., Kissei Pharmaceutical Co., Ltd., Medical Tribune, Inc., Nobelpharma Co., Ltd., Olympus Co., Ltd., Sanofi K.K., Shionogi &amp; Co., Ltd., Taiho Pharmaceutical Co., Ltd., Technical Information Institute Co., Ltd., and Teijin Pharma Ltd. T.K. is a former employee and stockholder of Pfizer Inc, and is a current employee of Eli Lilly and Company. S.A., S.H., F.M., and S.Y. are employees and stockholders of Pfizer Inc. N.I. and N.Y. are former employees and stockholders of Pfizer Inc. M.N. has received lecture fees from Daiichi Sankyo Co., Ltd. K.M. has received grants and personal fees from AbbVie Inc, EA Pharma Co., Ltd., Kissei Pharmaceutical Co., Ltd., Kyorin Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Mochida Pharmaceutical Co., Ltd., Nipponn Kayaku Co., Ltd., Pfizer Inc, Sekisui Medical Co., Ltd., Takeda Pharmaceutical Co., Ltd.; and personal fees from Alfresa Pharma Corporation, Gilead Sciences, Inc., GlaxoSmithKline plc, Janssen Pharmaceutical K.K., JIMRO Co., Ltd., MIYARISAN Pharmaceutical Co., Ltd., Thermo Fisher Scientific Inc., and ZERIA Pharmaceutical Co., Ltd.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>2</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>12</Day><Hour>12</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>2</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35150345</ArticleId><ArticleId IdType="pmc">PMC9587926</ArticleId><ArticleId IdType="doi">10.1007/s10620-022-07388-w</ArticleId><ArticleId IdType="pii">10.1007/s10620-022-07388-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>McDowell C, Farooq U, Haseeb M. Inflammatory bowel disease (IBD). In: StatPearls [Internet], Treasure Island, FL; StatPearls Publishing;2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">29262182</ArticleId></ArticleIdList></Reference><Reference><Citation>Asakura K, Nishiwaki Y, Inoue N, Hibi T, Watanabe M, Takebayashi T. Prevalence of ulcerative colitis and Crohn's disease in Japan. J Gastroenterol. 2009;44:659&#x2013;665. doi: 10.1007/s00535-009-0057-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00535-009-0057-3</ArticleId><ArticleId IdType="pubmed">19424654</ArticleId></ArticleIdList></Reference><Reference><Citation>Murakami Y, Nishiwaki Y, Oba MS, et al. Estimated prevalence of ulcerative colitis and Crohn's disease in Japan in 2014: an analysis of a nationwide survey. J Gastroenterol. 2019;54:1070&#x2013;1077. doi: 10.1007/s00535-019-01603-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00535-019-01603-8</ArticleId><ArticleId IdType="pubmed">31309327</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuhara H, Steinmaus C, Corley D, et al. Meta-analysis: the risk of venous thromboembolism in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2013;37:953&#x2013;962. doi: 10.1111/apt.12294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apt.12294</ArticleId><ArticleId IdType="pubmed">23550660</ArticleId></ArticleIdList></Reference><Reference><Citation>Saibeni S, Saladino V, Chantarangkul V, et al. Increased thrombin generation in inflammatory bowel diseases. Thromb Res. 2010;125:278&#x2013;282. doi: 10.1016/j.thromres.2009.10.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2009.10.012</ArticleId><ArticleId IdType="pubmed">19914688</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen GC, Sam J. Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients. Am J Gastroenterol. 2008;103:2272&#x2013;2280. doi: 10.1111/j.1572-0241.2008.02052.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1572-0241.2008.02052.x</ArticleId><ArticleId IdType="pubmed">18684186</ArticleId></ArticleIdList></Reference><Reference><Citation>Office of the Surgeon General (US), National Heart Lung and Blood Institute (US). INTRODUCTION: Definitions of deep vein thrombosis and pulmonary embolism. In: The Surgeon General's call to action to prevent deep vein thrombosis and pulmonary embolism, Rockville, MD; Office of the Surgeon General (US);2008.</Citation><ArticleIdList><ArticleId IdType="pubmed">20669525</ArticleId></ArticleIdList></Reference><Reference><Citation>W&#x142;odarczyk M, Sobolewska A, Fichna J, Wi&#x15b;niewska-Jarosi&#x144;ska M. Prevention and therapeutic strategies of thromboembolic events in patients with inflammatory bowel diseases: a report of three cases. Curr Drug Targets. 2015;16:194&#x2013;198. doi: 10.2174/1389450115666141109213152.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389450115666141109213152</ArticleId><ArticleId IdType="pubmed">25382207</ArticleId></ArticleIdList></Reference><Reference><Citation>Alatri A, Schoepfer A, Fournier N, et al. Prevalence and risk factors for venous thromboembolic complications in the Swiss Inflammatory Bowel Disease Cohort. Scand J Gastroenterol. 2016;51:1200&#x2013;1205. doi: 10.1080/00365521.2016.1185464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00365521.2016.1185464</ArticleId><ArticleId IdType="pubmed">27211077</ArticleId></ArticleIdList></Reference><Reference><Citation>Purnak T, Yuksel O. Overview of venous thrombosis in inflammatory bowel disease. Inflamm Bowel Dis. 2015;21:1195&#x2013;1203. doi: 10.1097/MIB.0000000000000274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MIB.0000000000000274</ArticleId><ArticleId IdType="pubmed">25581828</ArticleId></ArticleIdList></Reference><Reference><Citation>Grainge MJ, West J, Card TR. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet. 2010;375:657&#x2013;663. doi: 10.1016/S0140-6736(09)61963-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(09)61963-2</ArticleId><ArticleId IdType="pubmed">20149425</ArticleId></ArticleIdList></Reference><Reference><Citation>Harbord M, Annese V, Vavricka SR, et al. The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease. J Crohns Colitis. 2016;10:239&#x2013;254. doi: 10.1093/ecco-jcc/jjv213.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ecco-jcc/jjv213</ArticleId><ArticleId IdType="pmc">PMC4957476</ArticleId><ArticleId IdType="pubmed">26614685</ArticleId></ArticleIdList></Reference><Reference><Citation>White RH, Keenan CR. Effects of race and ethnicity on the incidence of venous thromboembolism. Thromb Res. 2009;123(Suppl 4):S11&#x2013;17. doi: 10.1016/S0049-3848(09)70136-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0049-3848(09)70136-7</ArticleId><ArticleId IdType="pubmed">19303496</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernstein CN, Blanchard JF, Houston DS, Wajda A. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost. 2001;85:430&#x2013;434. doi: 10.1055/s-0037-1615600.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0037-1615600</ArticleId><ArticleId IdType="pubmed">11307809</ArticleId></ArticleIdList></Reference><Reference><Citation>Kappelman MD, Horvath-Puho E, Sandler RS, et al. Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study. Gut. 2011;60:937&#x2013;943. doi: 10.1136/gut.2010.228585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gut.2010.228585</ArticleId><ArticleId IdType="pubmed">21339206</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonoda K, Ikeda S, Mizuta Y, Miyahara Y, Kohno S. Evaluation of venous thromboembolism and coagulation-fibrinolysis markers in Japanese patients with inflammatory bowel disease. J Gastroenterol. 2004;39:948&#x2013;954. doi: 10.1007/s00535-004-1426-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00535-004-1426-6</ArticleId><ArticleId IdType="pubmed">15549447</ArticleId></ArticleIdList></Reference><Reference><Citation>Ando K, Fujiya M, Nomura Y, et al. The incidence and risk factors of venous thromboembolism in Japanese inpatients with inflammatory bowel disease: a retrospective cohort study. Intest Res. 2018;16:416&#x2013;425. doi: 10.5217/ir.2018.16.3.416.</Citation><ArticleIdList><ArticleId IdType="doi">10.5217/ir.2018.16.3.416</ArticleId><ArticleId IdType="pmc">PMC6077312</ArticleId><ArticleId IdType="pubmed">30090041</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng MT, Park SH, Matsuoka K, et al. Incidence and risk factor analysis of thromboembolic events in East Asian patients with inflammatory bowel disease, a multinational collaborative study. Inflamm Bowel Dis. 2018;24:1791&#x2013;1800. doi: 10.1093/ibd/izy058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ibd/izy058</ArticleId><ArticleId IdType="pubmed">29726897</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee LH, Gallus A, Jindal R, Wang C, Wu CC. Incidence of venous thromboembolism in Asian populations: a systematic review. Thromb Haemost. 2017;117:2243&#x2013;2260. doi: 10.1160/TH17-02-0134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH17-02-0134</ArticleId><ArticleId IdType="pubmed">29212112</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarlos P, Szemes K, Hegyi P, et al. Steroid but not biological therapy elevates the risk of venous thromboembolic events in inflammatory bowel disease: a meta-analysis. J Crohns Colitis. 2018;12:489&#x2013;498. doi: 10.1093/ecco-jcc/jjx162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ecco-jcc/jjx162</ArticleId><ArticleId IdType="pubmed">29220427</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocha AT, Paiva EF, Lichtenstein A, Milani R, Jr, Cavalheiro CF, Maffei FH. Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients. Vasc Health Risk Manag. 2007;3:533&#x2013;553.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2291339</ArticleId><ArticleId IdType="pubmed">17969384</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkim H, Koksal AR, Boga S, Sen I, Alkim C. Etiopathogenesis, prevention, and treatment of thromboembolism in inflammatory bowel disease. Clin Appl Thromb Hemost. 2017;23:501&#x2013;510. doi: 10.1177/1076029616632906.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1076029616632906</ArticleId><ArticleId IdType="pubmed">26893444</ArticleId></ArticleIdList></Reference><Reference><Citation>Ageno W, Becattini C, Brighton T, Selby R, Kamphuisen PW. Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation. 2008;117:93&#x2013;102. doi: 10.1161/CIRCULATIONAHA.107.709204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.107.709204</ArticleId><ArticleId IdType="pubmed">18086925</ArticleId></ArticleIdList></Reference><Reference><Citation>Eichinger S, Pecheniuk NM, Hron G, et al. High-density lipoprotein and the risk of recurrent venous thromboembolism. Circulation. 2007;115:1609&#x2013;1614. doi: 10.1161/CIRCULATIONAHA.106.649954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.106.649954</ArticleId><ArticleId IdType="pubmed">17372172</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahlich J, Matsuoka K, Sruamsiri R. Biologic treatment of Japanese patients with inflammatory bowel disease. BMC Gastroenterol. 2018;18:160. doi: 10.1186/s12876-018-0892-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12876-018-0892-x</ArticleId><ArticleId IdType="pmc">PMC6211510</ArticleId><ArticleId IdType="pubmed">30384833</ArticleId></ArticleIdList></Reference><Reference><Citation>Scoville EA, Konijeti GG, Nguyen DD, Sauk J, Yajnik V, Ananthakrishnan AN. Venous thromboembolism in patients with inflammatory bowel diseases: a case-control study of risk factors. Inflamm Bowel Dis. 2014;20:631&#x2013;636. doi: 10.1097/MIB.0000000000000007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MIB.0000000000000007</ArticleId><ArticleId IdType="pmc">PMC4116613</ArticleId><ArticleId IdType="pubmed">24552828</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25183697</PMID><DateCompleted><Year>2016</Year><Month>06</Month><Day>29</Day></DateCompleted><DateRevised><Year>2015</Year><Month>07</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1708-539X</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>4</Issue><PubDate><Year>2015</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Vascular</Title><ISOAbbreviation>Vascular</ISOAbbreviation></Journal><ArticleTitle>A single center experience with retrievable IVC filters.</ArticleTitle><Pagination><StartPage>350</StartPage><EndPage>357</EndPage><MedlinePgn>350-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/1708538114546713</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To evaluate retrievable IVC filters in our institution and assess their retrieval following a well-structured follow up program.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Retrospective cohort study.</AbstractText><AbstractText Label="MATERIALS" NlmCategory="METHODS">The medical records of patients implanted with retrievable IVC filters were reviewed.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">All retrievable filter insertions between July 2007 and August 2011 at our institution were reviewed. Data was analyzed for age, gender, indication, complications, retrieval rate, and brand of filter inserted. Statistical analysis was done using SPSS software v19. Chi-square was used to compare discrete data and t-test for continuous data. P&#x2009;&lt;&#x2009;0.05 was significant.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 484 patients were reviewed of which 258 (53.1%) had a complete medical record. And 96 (37.2%) filters were placed as permanent at the time of insertion. An additional 40 (15.5%) filters were converted to permanent (total permanent filters 136; 52.7%). Death was reported in 26 (10%) patients and 96 (37.2%) out of the remaining 232 patients presented for potential retrieval. Also, 73 (28.2%) had an attempt to retrieve the filters, 69 (94.5%) were successful and 4 (5.4%) failed to retrieve. The remaining 23 (8.9%) patients declined retrieval. Filters studied include Celect (38%), Bard (31.4%), Option (26.2%), Tulip (4.1%), and Recovery (0.2%). Bard was more commonly used as a retrievable filter (80.9%). Retrieval on the first attempt was 90.4% (n&#x2009;=&#x2009;66) successful. Of the remaining seven filters, three were successfully retrieved on a second attempt, and four failed to retrieve due to filter tilt. The success rates of retrieval for Celect and Tulip were significantly lower than for Bard (p&#x2009;=&#x2009;0.04 and 0.023, respectively).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our study showed that a variety of IVC filters can be retrieved successfully with minimal complication rates. In more than half of our patients, IVC filters were used as permanent. Failure of retrieval was most frequently due to filter tilting.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2014.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Renno</LastName><ForeName>Anas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Vascular and Endovascular Surgery, University of Toledo Medical Center, Toledo, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khateeb</LastName><ForeName>Faisal</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Division of Vascular and Endovascular Surgery, University of Toledo Medical Center, Toledo, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kazan</LastName><ForeName>Viviane</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Division of Vascular and Endovascular Surgery, University of Toledo Medical Center, Toledo, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qu</LastName><ForeName>Weikai</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Division of Vascular and Endovascular Surgery, University of Toledo Medical Center, Toledo, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gollapudi</LastName><ForeName>Anurekha</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Vascular and Endovascular Surgery, University of Toledo Medical Center, Toledo, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aplin</LastName><ForeName>Brett</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Division of Vascular and Endovascular Surgery, University of Toledo Medical Center, Toledo, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abbas</LastName><ForeName>Jihad</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Vascular and Endovascular Surgery, University of Toledo Medical Center, Toledo, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zelenock</LastName><ForeName>Gerald</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Vascular and Endovascular Surgery, University of Toledo Medical Center, Toledo, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nazzal</LastName><ForeName>Munier</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Vascular and Endovascular Surgery, University of Toledo Medical Center, Toledo, OH, USA Munier.Nazzal@utoledo.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>09</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Vascular</MedlineTA><NlmUniqueID>101196722</NlmUniqueID><ISSNLinking>1708-5381</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016009" MajorTopicYN="N">Chi-Square Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020878" MajorTopicYN="N">Device Removal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009820" MajorTopicYN="N" Type="Geographic">Ohio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011474" MajorTopicYN="N">Prosthesis Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019919" MajorTopicYN="N">Prosthesis Implantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="Y">instrumentation</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016306" MajorTopicYN="Y">Vena Cava Filters</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014682" MajorTopicYN="Y">Vena Cava, Inferior</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">IVC filter prophylaxis</Keyword><Keyword MajorTopicYN="N">Retrievable IVC filters</Keyword><Keyword MajorTopicYN="N">deep vein thrombosis</Keyword><Keyword MajorTopicYN="N">permanent filters</Keyword><Keyword MajorTopicYN="N">retrieval rate</Keyword><Keyword MajorTopicYN="N">trauma</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>6</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25183697</ArticleId><ArticleId IdType="doi">10.1177/1708538114546713</ArticleId><ArticleId IdType="pii">1708538114546713</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27457468</PMID><DateCompleted><Year>2018</Year><Month>04</Month><Day>17</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><PubDate><Year>2016</Year><Month>Jul</Month><Day>26</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Early intramedullary nailing of femoral shaft fracture on outcomes in patients with severe chest injury: A meta-analysis.</ArticleTitle><Pagination><StartPage>30566</StartPage><MedlinePgn>30566</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">30566</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/srep30566</ELocationID><Abstract><AbstractText>Early intramedullary nailing (IMN) within the first 24&#x2009;hours for multiply injured patients with femoral fracture and concomitant severe chest injury is still controversial. This review aimed to investigate the association between early IMN and pulmonary complications in such patients. We searched the literature up to Jan 2016 in the main electronic databases (PubMed, Web of Science, Cochrane library databases) to identify eligible studies. Data were extracted and analyzed using a Mantel-Haenszel method with random-effects model to estimate pooled odds ratio (OR) and 95% confidence intervals (CIs). Seven retrospective cohort studies were identified eventually. The pooled estimates demonstrated that the application of early IMN did not significantly increase the risk of adult respiratory distress syndrome (ARDS) (OR, 0.65; 95% CI: 0.38-1.13), mortality (OR, 0.79; 95% CI: 0.43-1.47), pneumonia (OR, 0.92; 95% CI: 0.55-1.54), multiple organ failure (MOF) (OR, 0.87; 95% CI: 0.45-1.71) and pulmonary embolism (OR, 1.81; 95% CI: 0.28-11.83). In subgroup analysis according to the type of IMN (reamed or undreamed), we did not find any significant difference either. Our results indicated that early IMN of femoral shaft fracture was not associated with increased rates of pulmonary complications in severe chest-injured patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Meng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatric Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Wuhan 430022, Hubei Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Changli</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Geratology, Hubei Provincial Hospital of Integrated Chinese and Western medicine, 11 Lingjiaohu Avenue, Wuhan 430015, Hubei Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yi</LastName><ForeName>Chengla</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Trauma Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan 430022, Hubei Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Shaotao</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pediatric Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Wuhan 430022, Hubei Province, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>07</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001858" MajorTopicYN="Y">Bone Nails</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005264" MajorTopicYN="Y">Femoral Fractures</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009102" MajorTopicYN="Y">Multiple Organ Failure</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011014" MajorTopicYN="Y">Pneumonia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012128" MajorTopicYN="Y">Respiratory Distress Syndrome</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013898" MajorTopicYN="Y">Thoracic Injuries</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015599" MajorTopicYN="N">Trauma Severity Indices</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>4</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>7</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>7</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>7</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27457468</ArticleId><ArticleId IdType="pmc">PMC4960546</ArticleId><ArticleId IdType="doi">10.1038/srep30566</ArticleId><ArticleId IdType="pii">srep30566</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bradford D. S., Foster R. R. &amp; Nossel H. L. Coagulation alterations, hypoxemia, and fat embolism in fracture patients. J Trauma 10, 307&#x2013;321 (1970).</Citation><ArticleIdList><ArticleId IdType="pubmed">5435842</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker S. P., O&#x2019;Neill B., Haddon W. J. &amp; Long W. B. The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma 14, 187&#x2013;196 (1974).</Citation><ArticleIdList><ArticleId IdType="pubmed">4814394</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone L. B., Johnson K. D., Weigelt J. &amp; Scheinberg R. Early versus delayed stabilization of femoral fractures. A prospective randomized study. J. Bone Joint Surg Am 71, 336&#x2013;340 (1989).</Citation><ArticleIdList><ArticleId IdType="pubmed">2925704</ArticleId></ArticleIdList></Reference><Reference><Citation>Goris R. J., Gimbrere J. S., van Niekerk J. L., Schoots F. J. &amp; Booy L. H. Early osteosynthesis and prophylactic mechanical ventilation in the multitrauma patient. J Trauma 22, 895&#x2013;903 (1982).</Citation><ArticleIdList><ArticleId IdType="pubmed">6754962</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson K. D., Cadambi A. &amp; Seibert G. B. Incidence of adult respiratory distress syndrome in patients with multiple musculoskeletal injuries: effect of early operative stabilization of fractures. J Trauma 25, 375&#x2013;384 (1985).</Citation><ArticleIdList><ArticleId IdType="pubmed">3999159</ArticleId></ArticleIdList></Reference><Reference><Citation>Meek R. N., Vivoda E. E. &amp; Pirani S. Comparison of mortality of patients with multiple injuries according to type of fracture treatment&#x2013;a retrospective age- and injury-matched series. Injury 17, 2&#x2013;4 (1986).</Citation><ArticleIdList><ArticleId IdType="pubmed">3770879</ArticleId></ArticleIdList></Reference><Reference><Citation>Nahm N. J. &amp; Vallier H. A. Timing of definitive treatment of femoral shaft fractures in patients with multiple injuries: A systematic review of randomized and nonrandomized trials. J. Trauma Acute Care 73, 1046&#x2013;1063 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">23117368</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramseier L. E., Janicki J. A., Weir S. &amp; Narayanan U. G. Femoral fractures in adolescents: a comparison of four methods of fixation. J. Bone Joint Surg Am 92, 1122&#x2013;1129 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20439657</ArticleId></ArticleIdList></Reference><Reference><Citation>Gansslen A., Gosling T., Hildebrand F., Pape H. C. &amp; Oestern H. J. Femoral shaft fractures in adults: treatment options and controversies. Acta Chir Orthop Traumatol Cech 81, 108&#x2013;117 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">25105784</ArticleId></ArticleIdList></Reference><Reference><Citation>Schult M. F. U. &amp; Pathophysiology F. S. E. B. of Fat Embolism after Intramedullary Reaming. J Trauma 29, 68&#x2013;73 (2003).</Citation></Reference><Reference><Citation>Carlson D. W., Rodman G. J., Kaehr D., Hage J. &amp; Misinski M. Femur fractures in chest-injured patients: is reaming contraindicated? J. Orthop Trauma 12, 164&#x2013;168 (1998).</Citation><ArticleIdList><ArticleId IdType="pubmed">9553856</ArticleId></ArticleIdList></Reference><Reference><Citation>Weninger P., Figl M., Spitaler R., Mauritz W. &amp; Hertz H. Early unreamed intramedullary nailing of femoral fractures is safe in patients with severe thoracic trauma. J Trauma 62, 692&#x2013;696 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17414349</ArticleId></ArticleIdList></Reference><Reference><Citation>Handolin L., Pajarinen J., Lassus J. &amp; Tulikoura I. Early intramedullary nailing of lower extremity fracture and respiratory function in polytraumatized patients with a chest injury: a retrospective study of 61 patients. Acta Orthop Scand 75, 477&#x2013;480 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15370594</ArticleId></ArticleIdList></Reference><Reference><Citation>Kutscha-Lissberg F., Hopf F. K., Kollig E. &amp; Muhr G. How risky is early intramedullary nailing of femoral fractures in polytraumatized patients? Injury 32, 289&#x2013;293 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11325364</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosse M. J. et al.. Adult respiratory distress syndrome, pneumonia, and mortality following thoracic injury and a femoral fracture treated either with intramedullary nailing with reaming or with a plate. A comparative study. J. Bone Joint Surg Am 79, 799&#x2013;809 (1997).</Citation><ArticleIdList><ArticleId IdType="pubmed">9199375</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Made W. J., Smit E. J., van Luyt P. A. &amp; van Vugt A. B. Intramedullary femoral osteosynthesis: an additional cause of ARDS in multiply injured patients? Injury 27, 391&#x2013;393 (1996).</Citation><ArticleIdList><ArticleId IdType="pubmed">8881133</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone L. B., Babikian G. &amp; Stegemann P. M. Femoral canal reaming in the polytrauma patient with chest injury. A clinical perspective. Clin Orthop Relat Res 318, 91&#x2013;94 (1995).</Citation><ArticleIdList><ArticleId IdType="pubmed">7671536</ArticleId></ArticleIdList></Reference><Reference><Citation>Aufmkolk M. et al.. Effect of primary femoral plate osteosynthesis on the course of polytrauma patients with or without thoracic trauma. Unfallchirurg 101, 433&#x2013;439 (1998).</Citation><ArticleIdList><ArticleId IdType="pubmed">9677841</ArticleId></ArticleIdList></Reference><Reference><Citation>Pape H. C. et al.. Primary intramedullary femur fixation in multiple trauma patients with associated lung contusion&#x2013;a cause of posttraumatic ARDS? J Trauma 34, 540&#x2013;547, 547&#x2013;548 (1993).</Citation><ArticleIdList><ArticleId IdType="pubmed">8487339</ArticleId></ArticleIdList></Reference><Reference><Citation>Pape H. C., Regel G., Dwenger A., Sturm J. A. &amp; Tscherne H. Influence of thoracic trauma and primary femoral intramedullary nailing on the incidence of ARDS in multiple trauma patients. Injury 24 Suppl 3, S82&#x2013;S103 (1993).</Citation><ArticleIdList><ArticleId IdType="pubmed">8168882</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray A. C. et al.. The stress response to bilateral femoral fractures: a comparison of primary intramedullary nailing and external fixation. J. Orthop Trauma 23, 90&#x2013;99 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19169099</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone L. B., Anders M. J. &amp; Rohrbacher B. J. Treatment of femoral fractures in the multiply injured patient with thoracic injury. Clin Orthop Relat Res 347, 57&#x2013;61 (1998).</Citation><ArticleIdList><ArticleId IdType="pubmed">9520875</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannoudis P. V. et al.. Growth factor release following femoral nailing. Bone 42, 751&#x2013;757 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18243089</ArticleId></ArticleIdList></Reference><Reference><Citation>Streubel P. N., Desai P. &amp; Suk M. Comparison of RIA and conventional reamed nailing for treatment of femur shaft fractures. Injury 41 Suppl 2, S51&#x2013;S56 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">21144929</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith P. N. et al.. Monitoring and controlling intramedullary pressure increase in long bone instrumentation: a study on sheep. J. Orthop Res 26, 1327&#x2013;1333 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18464262</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone L. B. &amp; Giannoudis P. Femoral shaft fracture fixation and chest injury after polytrauma. J. Bone Joint Surg Am 93, 311&#x2013;317 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21266645</ArticleId></ArticleIdList></Reference><Reference><Citation>Scalea T. M. et al.. External fixation as a bridge to intramedullary nailing for patients with multiple injuries and with femur fractures: damage control orthopedics. J Trauma 48, 613&#x2013;623 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10780592</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D., Liberati A., Tetzlaff J. &amp; Altman D. G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339, b2535 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2714657</ArticleId><ArticleId IdType="pubmed">19622551</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroup D. F. et al.. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283, 2008&#x2013;2012 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10789670</ArticleId></ArticleIdList></Reference><Reference><Citation>Duckitt K. &amp; Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 330, 565 (2005).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC554027</ArticleId><ArticleId IdType="pubmed">15743856</ArticleId></ArticleIdList></Reference><Reference><Citation>Taggart D. P., D&#x2019;Amico R. &amp; Altman D. G. Effect of arterial revascularisation on survival: a systematic review of studies comparing bilateral and single internal mammary arteries. Lancet 358, 870&#x2013;875 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11567701</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells G. A. et al.. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Ottawa Health Research Institute Web site (2016).</Citation></Reference><Reference><Citation>DerSimonian R. &amp; Laird N. Meta-analysis in clinical trials. Control Clin Trials 7, 177&#x2013;188 (1986).</Citation><ArticleIdList><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Begg C. B. &amp; Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 50, 1088&#x2013;1101 (1994).</Citation><ArticleIdList><ArticleId IdType="pubmed">7786990</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger M., Davey S. G., Schneider M. &amp; Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629&#x2013;634 (1997).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2127453</ArticleId><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D., Schulz K. F. &amp; Altman D. G. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 357, 1191&#x2013;1194 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11323066</ArticleId></ArticleIdList></Reference><Reference><Citation>Pogue J. M. &amp; Yusuf S. Cumulating evidence from randomized trials: utilizing sequential monitoring boundaries for cumulative meta-analysis. Control Clin Trials 18, 580&#x2013;593, 661&#x2013;666 (1997).</Citation><ArticleIdList><ArticleId IdType="pubmed">9408720</ArticleId></ArticleIdList></Reference><Reference><Citation>Brok J., Thorlund K., Gluud C. &amp; Wetterslev J. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. J. Clin Epidemiol 61, 763&#x2013;769 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18411040</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37240571</PMID><DateRevised><Year>2023</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>14</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Thromboembolic Complications in Adult Patients Following Fontan Procedure-A Multicenter Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">3465</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm12103465</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Morbidity and mortality following Fontan (FO) surgery are primarily thromboembolic in nature. However, follow-up data regarding thromboembolic complications (TECs) in adult patients after FO procedure are inconsistent. In this multicenter study, we investigated the incidence of TECs in FO patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We studied 91 patients who underwent FO procedure. Clinical data, laboratory, and imaging investigations were collected prospectively during the scheduled medical appointments in 3 Adult Congenital Heart Disease Departments in Poland. TECs were recorded during a median follow-up of 31 months.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Four patients (4.4%) were lost to follow-up. The mean age of patients was 25.3 (&#xb1;6.0) years at enrollment, and the mean time between FO operation and investigation was 22.1 (&#xb1;5.1) years. A total of 21 out of 91 patients (23.1%) had a history of 24 TECs since an FO procedure, mainly pulmonary embolism (PE; <i>n</i> = 12, 13.2%), including 4 (33.3%) silent PE. The mean time since FO operation to the first TEC was 17.8 (&#xb1;5.1) years. During follow-up, we documented 9 TECs in 7 (8.0%) patients, mainly PE (<i>n</i> = 5, 5.5%). Most patients with TEC had a left type of systemic ventricle (57.1%). Three patients (42.9%) were treated with aspirin, 3 (3.4%) with Vitamin K antagonists or novel oral anticoagulants, and 1 patient had no antithrombotic treatment at the time of TEC occurrence. Supraventricular tachyarrhythmias were present in 3 patients (42.9%).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This prospective study shows that TECs are common in FO patients, and a significant number of these events occur during adolescence and young adulthood. We also indicated how much TECs are underestimated in the growing adult FO population. The complexity of the problem requires more studies, especially to standardize the prevention of TECs in the whole FO population.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Skubera</LastName><ForeName>Maciej</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiac and Vascular Diseases, John Paul II Hospital, 31-202 Krakow, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Go&#x142;&#x105;b</LastName><ForeName>Aleksandra</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-4773-7512</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine and Dentistry, Pomeranian Medical University in Szczecin, 70-204 Szczecin, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Research and Innovative Technology, John Paul II Hospital, 31-202 Krakow, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sternalski</LastName><ForeName>Tomasz</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-6166-3460</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, Collegium Medicum Jagiellonian University, 31-008 Krakow, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trojnarska</LastName><ForeName>Olga</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>1st Department of Cardiology, Poznan University of Medical Sciences, 61-701 Poznan, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Plicner</LastName><ForeName>Dariusz</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-3687-512X</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery and Transplantation, John Paul II Hospital, 31-202 Krakow, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unit of Experimental Cardiology and Cardiac Surgery, Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski Krakow University, 30-705 Krakow, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sma&#x15b;-Suska</LastName><ForeName>Monika</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Liver Diseases, John Paul II Hospital, 31-202 Krakow, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazurek-Kula</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Polish Mother's Memorial Hospital, Research Institute, 93-338 Lodz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bartczak-Rutkowska</LastName><ForeName>Agnieszka</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-6607-9191</Identifier><AffiliationInfo><Affiliation>1st Department of Cardiology, Poznan University of Medical Sciences, 61-701 Poznan, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paj&#x105;k</LastName><ForeName>Jacek</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-0138-411X</Identifier><AffiliationInfo><Affiliation>Institute of Medical Sciences, Department of Surgery, Medical College of Rzeszow University, 35-025 Rzeszow, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Podolec</LastName><ForeName>Piotr</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Cardiac and Vascular Diseases, John Paul II Hospital, 31-202 Krakow, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Cardiology, Jagiellonian University Medical College, 31-008 Krakow, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomkiewicz-Paj&#x105;k</LastName><ForeName>Lidia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Cardiac and Vascular Diseases, John Paul II Hospital, 31-202 Krakow, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Liver Diseases, John Paul II Hospital, 31-202 Krakow, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Cardiology, Jagiellonian University Medical College, 31-008 Krakow, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Fontan procedure</Keyword><Keyword MajorTopicYN="N">follow-up</Keyword><Keyword MajorTopicYN="N">thromboembolic complications</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>27</Day><Hour>9</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>27</Day><Hour>9</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>27</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37240571</ArticleId><ArticleId IdType="pmc">PMC10219158</ArticleId><ArticleId IdType="doi">10.3390/jcm12103465</ArticleId><ArticleId IdType="pii">jcm12103465</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Firdouse M., Agarwal A., Chan A.K., Mondal T. Thrombosis and thromboembolic complications in fontan patients: A literature review. Clin. Appl. Thromb. Hemost. 2014;20:484&#x2013;492. doi: 10.1177/1076029613520464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1076029613520464</ArticleId><ArticleId IdType="pubmed">24463598</ArticleId></ArticleIdList></Reference><Reference><Citation>Monagle P., Cochrane A., Roberts R., Manlhiot C., Weintraub R., Szechtman B., Hughes M., Andrew M., McCrindle B.W., Fontan Anticoagulation Study Group Multicenter, randomized trial comparing heparin/warfarin and acetylsalicylic acid as primary thromboprophylaxis for 2 years after the Fontan procedure in children. J. Am. Coll. Cardiol. 2011;58:645&#x2013;651. doi: 10.1016/j.jacc.2011.01.061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2011.01.061</ArticleId><ArticleId IdType="pubmed">21798429</ArticleId></ArticleIdList></Reference><Reference><Citation>Khairy P., Fernandes S.M., MayerJr J.E., Triedman J.K., Walsh E.P., Lock J.E., Landzberg M.J. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation. 2008;117:85&#x2013;92. doi: 10.1161/CIRCULATIONAHA.107.738559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.107.738559</ArticleId><ArticleId IdType="pubmed">18071068</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs M.L., Pourmoghadam K.K. Thromboembolism and the role of anticoagulation in the Fontan patient. Pediatr. Cardiol. 2007;28:457&#x2013;464. doi: 10.1007/s00246-007-9006-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00246-007-9006-1</ArticleId><ArticleId IdType="pubmed">17762953</ArticleId></ArticleIdList></Reference><Reference><Citation>Gissel M., Tomkiewicz-Pajak L., Podolec P., Hoffman P., Trojnarska O., Lipczy&#x144;ska M., Undas A., Brummel-Ziedins K.E. In silico thrombin and factor Xa generation profiles in adult patients after Fontan operation. Blood Coagul. Fibrinolysis. 2018;29:236&#x2013;240. doi: 10.1097/MBC.0000000000000694.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MBC.0000000000000694</ArticleId><ArticleId IdType="pubmed">29406387</ArticleId></ArticleIdList></Reference><Reference><Citation>Egbe A.C., Connolly H.M., Niaz T., Yogeswaran V., Taggart N.W., Qureshi M.Y., Poterucha J.T., Khan A.R., Driscoll D.J. Prevalence and outcome of thrombotic and embolic complications in adults after Fontan operation. Am. Heart J. 2017;183:10&#x2013;17. doi: 10.1016/j.ahj.2016.09.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2016.09.014</ArticleId><ArticleId IdType="pubmed">27979032</ArticleId></ArticleIdList></Reference><Reference><Citation>McCrindle B.W., Manlhiot C., Cochrane A., Roberts R., Hughes M., Szechtman B., Weintraub R., Andrew M., Monagle P., Fontan Anticoagulation Study Group Factors associated with thrombotic complications after the Fontan procedure: A secondary analysis of a multicenter, randomized trial of primary thromboprophylaxis for 2 years after the Fontan procedure. J. Am. Coll. Cardiol. 2013;61:346&#x2013;353. doi: 10.1016/j.jacc.2012.08.1023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2012.08.1023</ArticleId><ArticleId IdType="pubmed">23246393</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomkiewicz-Pajak L., Hoffman P., Trojnarska O., Lipczy&#x144;ska M., Podolec P., Undas A. Abnormalities in blood coagulation, fibrinolysis, and platelet activation in adult patients after the Fontan procedure. J. Thorac. Cardiovasc. Surg. 2014;147:1284&#x2013;1290. doi: 10.1016/j.jtcvs.2013.06.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2013.06.011</ArticleId><ArticleId IdType="pubmed">23891464</ArticleId></ArticleIdList></Reference><Reference><Citation>Skubera M., Go&#x142;&#x105;b A., Plicner D., Natorska J., Z&#x105;bczyk M., Trojnarska O., Mazurek-Kula A., Sma&#x15b;-Suska M., Bartczak-Rutkowska A., Podolec P., et al. Properties of Plasma Clots in Adult Patients Following Fontan Procedure: Relation to Clot Permeability and Lysis Time&#x2014;Multicenter Study. J. Clin. Med. 2021;10:5976. doi: 10.3390/jcm10245976.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10245976</ArticleId><ArticleId IdType="pmc">PMC8709107</ArticleId><ArticleId IdType="pubmed">34945271</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono M., Boethig D., Goerler H., Lange M., Westhoff-Bleck M., Breymann T. Clinical outcome of patients 20 years after Fontan operation&#x2014;Effect of fenestration on late morbidity. Eur. J. Cardio-Thoracic Surg. 2006;30:923&#x2013;929. doi: 10.1016/j.ejcts.2006.08.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcts.2006.08.025</ArticleId><ArticleId IdType="pubmed">17074498</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Jazairi A.S., Al Alshaykh H.A., Di Salvo G., De Vol E.B., Alhalees Z.Y. Assessment of Late Thromboembolic Complications Post&#x2013;Fontan Procedure in Relation to Different Antithrombotic Regimens: 30-Years&#x2019; Follow-up Experience. Ann. Pharmacother. 2019;53:786&#x2013;793. doi: 10.1177/1060028019829860.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1060028019829860</ArticleId><ArticleId IdType="pubmed">30788973</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H., Bouma B., Dimopoulos K., Khairy P., Ladouceur M., Niwa K., Greutmann M., Schwerzmann M., Egbe A., Scognamiglio G., et al. Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide study. Int. J. Cardiol. 2020;299:123&#x2013;130. doi: 10.1016/j.ijcard.2019.06.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2019.06.014</ArticleId><ArticleId IdType="pubmed">31307847</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgekutty J., Kazerouninia A., Wang Y., Ermis P.R., Parekh D.R., Franklin W.J., Lam W.W. Novel oral anticoagulant use in adult Fontan patients: A single center experience. Congenit. Heart Dis. 2018;13:541&#x2013;547. doi: 10.1111/chd.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/chd.12603</ArticleId><ArticleId IdType="pubmed">29575675</ArticleId></ArticleIdList></Reference><Reference><Citation>Konstantinides S.V., Meyer G., Becattini C., Bueno H., Geersing G.J., Harjola V.-P., Huisman M.V., Humbert M., Jennings C.S., Jim&#xe9;nez D., et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) Eur. Heart J. 2020;41:543&#x2013;603. doi: 10.1093/eurheartj/ehz405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehz405</ArticleId><ArticleId IdType="pubmed">31504429</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleindorfer D.O., Towfighi A., Chaturvedi S., Cockroft K.M., Gutierrez J., Lombardi-Hill D., Kamel H., Kernan W.N., Kittner S.J., Leira E.C., et al. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association. Stroke. 2021;52:e364&#x2013;e467. doi: 10.1161/STR.0000000000000375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STR.0000000000000375</ArticleId><ArticleId IdType="pubmed">34024117</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathananthan G., Johal N., Verma T., Sandhu S., Chakrabarti S., Riahi M., Human D., Leipsic J., Grewal J. Clinical Importance of Fontan Circuit Thrombus in the Adult Population: Significant Association With Increased Risk of Cardiovascular Events. Can. J. Cardiol. 2019;35:1807&#x2013;1814. doi: 10.1016/j.cjca.2019.08.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2019.08.038</ArticleId><ArticleId IdType="pubmed">31813509</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzolai L., Aboyans V., Ageno W., Agnelli G., Alatri A., Bauersachs R., Brekelmans M.P., B&#xfc;ller H.R., Elias A., Farge D., et al. Diagnosis and management of acute deep vein thrombosis: A joint consensus document from the European Society of Cardiology working groups of aorta and peripheral vascular diseases and pulmonary circulation and right ventricular function. Eur. Heart J. 2018;39:4208&#x2013;4218. doi: 10.1093/eurheartj/ehx003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehx003</ArticleId><ArticleId IdType="pubmed">28329262</ArticleId></ArticleIdList></Reference><Reference><Citation>Hindricks G., Potpara T., Dagres N., Arbelo E., Bax J.J., Blomstr&#xf6;m-Lundqvist C., Boriani G., Castella M., Dan G.-A., Dilaveris P.E., et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur. Heart J. 2021;42:373&#x2013;498. doi: 10.1093/eurheartj/ehaa612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa612</ArticleId><ArticleId IdType="pubmed">32860505</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomkiewicz-Pajak L., Podolec P., Drabik L., Pajak J., Kolcz J., Plazak W. Single ventricle function and exercise tolerance in adult patients after Fontan operation. Acta Cardiol. 2014;69:155&#x2013;160. doi: 10.1080/AC.69.2.3017296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/AC.69.2.3017296</ArticleId><ArticleId IdType="pubmed">24783466</ArticleId></ArticleIdList></Reference><Reference><Citation>Kajimoto H., Nakazawa M., Murasaki K., Mori Y., Tanoue K., Kasanuki H., Nakanishi T. Increased Thrombogenesity in Patients With Cyanotic Congenital Heart Disease. Circ. J. 2007;71:948&#x2013;953. doi: 10.1253/circj.71.948.</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.71.948</ArticleId><ArticleId IdType="pubmed">17526995</ArticleId></ArticleIdList></Reference><Reference><Citation>Deshaies C., Hamilton R.M., Shohoudi A., Trottier H., Poirier N., Aboulhosn J., Broberg C.S., Cohen S., Cook S., Dore A., et al. Thromboembolic Risk After Atriopulmonary, Lateral Tunnel, and Extracardiac Conduit Fontan Surgery. J. Am. Coll. Cardiol. 2019;74:1071&#x2013;1081. doi: 10.1016/j.jacc.2019.06.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2019.06.051</ArticleId><ArticleId IdType="pubmed">31439217</ArticleId></ArticleIdList></Reference><Reference><Citation>Idorn L., Jensen A., Juul K., Reimers J.I., Johansson P.I., S&#xf8;rensen K.E., Ostrowski S.R., S&#xf8;ndergaard L. Thromboembolic Complications in Fontan Patients: Population-Based Prevalence and Exploration of the Etiology. Pediatr. Cardiol. 2013;34:262&#x2013;272. doi: 10.1007/s00246-012-0431-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00246-012-0431-4</ArticleId><ArticleId IdType="pubmed">22843202</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenthal D.N., Friedman A.H., Kleinman C.S., Kopf G.S., Rosenfeld L.E., Hellenbrand W.E. Thromboembolic complications after Fontan operations. Circulation. 1995;92((Suppl. 9)):287&#x2013;293. doi: 10.1161/01.CIR.92.9.287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.92.9.287</ArticleId><ArticleId IdType="pubmed">7586425</ArticleId></ArticleIdList></Reference><Reference><Citation>Potter B.J., Leong-Sit P., Fernandes S.M., Feifer A., Mayer J.E., Triedman J.K., Walsh E.P., Landzberg M.J., Khairy P. Effect of Aspirin and warfarin therapy on thromboembolic events in patients with univentricular hearts and Fontan palliation. Int. J. Cardiol. 2013;168:3940&#x2013;3943. doi: 10.1016/j.ijcard.2013.06.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2013.06.058</ArticleId><ArticleId IdType="pubmed">23870650</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H., Veldtman G.R., Bouma B.J., Budts W., Niwa K., Meijboom F., Scognamiglio G., Egbe A.C., Schwerzmann M., Broberg C., et al. Non-vitamin K antagonist oral anticoagulants in adults with a Fontan circulation: Are they safe. Open Heart. 2019;6:e000985. doi: 10.1136/openhrt-2018-000985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/openhrt-2018-000985</ArticleId><ArticleId IdType="pmc">PMC6560660</ArticleId><ArticleId IdType="pubmed">31245011</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomkiewicz-Pajak L., Wojcik T., Ch&#x142;opicki S., Olszowska M., Pajak J., Podolec J., Sitek B., Musia&#x142;ek P., Rubis P., Komar M., et al. Aspirin resistance in adult patients after Fontan surgery. Int. J. Cardiol. 2015;181:19&#x2013;26. doi: 10.1016/j.ijcard.2014.11.219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2014.11.219</ArticleId><ArticleId IdType="pubmed">25479533</ArticleId></ArticleIdList></Reference><Reference><Citation>Khairy P., Van Hare G.F., Balaji S., Berul C.I., Cecchin F., Cohen M.I., Daniels C.J., Deal B.J., Dearani J.A., de Groot N., et al. PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease: Developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD) Heart Rhythm. 2014;11:e102&#x2013;e165. doi: 10.1016/j.hrthm.2014.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2014.05.009</ArticleId><ArticleId IdType="pubmed">24814377</ArticleId></ArticleIdList></Reference><Reference><Citation>Stout K.K., Daniels C.J., Aboulhosn J.A., Bozkurt B., Broberg C.S., Colman J.M., Crumb S.R., Dearani J.A., Fuller S., Gurvitz M., et al. 2018 AHA/ACC Guideline for the Management of Adults with Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J. Am. Coll. Cardiol. 2019;73:e81&#x2013;e192. doi: 10.1016/j.jacc.2018.08.1029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.08.1029</ArticleId><ArticleId IdType="pubmed">30121239</ArticleId></ArticleIdList></Reference><Reference><Citation>Varma C., Warr M.R., Hendler A.L., Paul N.S., Webb G.D., Therrien J. Prevalence of &#x201c;silent&#x201d; pulmonary emboli in adults after the Fontan operation. J. Am. Coll. Cardiol. 2003;41:2252&#x2013;2258. doi: 10.1016/S0735-1097(03)00490-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0735-1097(03)00490-X</ArticleId><ArticleId IdType="pubmed">12821256</ArticleId></ArticleIdList></Reference><Reference><Citation>Grewal J., Al Hussein M., Feldstein J., Kiess M., Ellis J., Human D., Leipsic J. Evaluation of silent thrombus after the Fontan operation. Congenit. Heart Dis. 2013;8:40&#x2013;47. doi: 10.1111/j.1747-0803.2012.00699.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1747-0803.2012.00699.x</ArticleId><ArticleId IdType="pubmed">22897869</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan V.L., Graham T.P., Jr., Roselli R.J., Lorenz C.H. Alterations in pulmonary artery flow patterns and shear stress determined with three-dimensional phase-contrast magnetic resonance imaging in fontan patients. J. Thorac. Cardiovasc. Surg. 1998;116:294&#x2013;304. doi: 10.1016/S0022-5223(98)70130-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-5223(98)70130-8</ArticleId><ArticleId IdType="pubmed">9699583</ArticleId></ArticleIdList></Reference><Reference><Citation>Egbe A.C., Connolly H.M., McLeod C.J., Ammash N.M., Niaz T., Yogeswaran V., Poterucha J.T., Qureshi M.Y., Driscoll D.J. Thrombotic and Embolic Complications Associated with Atrial Arrhythmia After Fontan Operation: Role of Prophylactic Therapy. J. Am. Coll. Cardiol. 2016;68:1312&#x2013;1319. doi: 10.1016/j.jacc.2016.06.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2016.06.056</ArticleId><ArticleId IdType="pubmed">27634123</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinning C., Zengin E., Blankenberg S., Rickers C., von Kodolitsch Y., Diller G., Kirchhof P. Anticoagulation management in adult patients with congenital heart disease: A narrative review. Cardiovasc. Diagn. Ther. 2021;11:1324&#x2013;1333. doi: 10.21037/cdt-20-631.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/cdt-20-631</ArticleId><ArticleId IdType="pmc">PMC8748474</ArticleId><ArticleId IdType="pubmed">35070801</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen A., Idorn L., N&#xf8;rager B., Vejlstrup N., Sondergaard L. Anticoagulation in adults with congenital heart disease: The who, the when and the how? Heart. 2015;101:424&#x2013;429. doi: 10.1136/heartjnl-2014-305576.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2014-305576</ArticleId><ArticleId IdType="pubmed">25281599</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">29411068</PMID><DateCompleted><Year>2018</Year><Month>10</Month><Day>24</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1432-2323</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>8</Issue><PubDate><Year>2018</Year><Month>Aug</Month></PubDate></JournalIssue><Title>World journal of surgery</Title><ISOAbbreviation>World J Surg</ISOAbbreviation></Journal><ArticleTitle>Early Consequences of Pectus Excavatum Surgery on Self-Esteem and General Quality of Life.</ArticleTitle><Pagination><StartPage>2502</StartPage><EndPage>2506</EndPage><MedlinePgn>2502-2506</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00268-018-4526-9</ELocationID><Abstract><AbstractText Label="BACKGROUND">An early observation after chest wall correction is direct inspection from the PE patient of their "new" thorax. Changes in self-perception may give raise to other psychological adaptations. The aim of this study was to evaluate the early changes in the fields of self-esteem, body image and QoL.</AbstractText><AbstractText Label="METHODS">Prospective observational longitudinal multicenter cohort study. Self-esteem, emotional limitations and general health were assessed using the Child Health Questionnaire (CHQ) in patients under 18 and the World Health Organization Quality of Life Questionnaire-bref (WHOQOL-bref) was used for body image, psychological domain and overall QoL in patients over 16&#xa0;years of age. Measurements were taken before surgery (T1) and 6&#xa0;weeks (T2), and 6&#xa0;months thereafter (T3).</AbstractText><AbstractText Label="RESULTS">Scores on post-operative self-esteem were significantly higher compared with scores pre-operatively (p&#xa0;&lt;&#xa0;0.007). Also body image, psychological domain and emotional limitations showed significant improvement, respectively p&#xa0;&lt;&#xa0;0.001, p&#xa0;&lt;&#xa0;0.001, and p&#xa0;&lt;&#xa0;0.016. Significant improvement in the first three components was mainly achieved in the first 6&#xa0;weeks post-operative. In emotional limitation, however, the largest change was between 6&#xa0;weeks and 6&#xa0;months. Overall quality of life in the WHOQOL-bref and general health domain in the CHQ showed no significant improvement in relation to the pre-operative scores.</AbstractText><AbstractText Label="CONCLUSION">Post-operative PE patients after Nuss procedure showed an improved body image, increased self-esteem and increased psychological resilience in the first 6&#xa0;months, with the most marked change in the first 6&#xa0;weeks. Also emotional limitations changed significantly over time. The changes were not large enough to influence general QoL or general health significantly.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zuidema</LastName><ForeName>W P</ForeName><Initials>WP</Initials><AffiliationInfo><Affiliation>Pediatric Surgical Center Amsterdam, Emma Children's Hospital AMC, VU-University Medical Center, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands. w.zuidema@vumc.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oosterhuis</LastName><ForeName>J W A</ForeName><Initials>JWA</Initials><AffiliationInfo><Affiliation>Department of Surgery, Haaglanden Medical Center, The Hague, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zijp</LastName><ForeName>G W</ForeName><Initials>GW</Initials><AffiliationInfo><Affiliation>Pediatric Surgery, Juliana Children's Hospital/Haga-Hospital, The Hague, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Heide</LastName><ForeName>S M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Cardio-Thoracic Surgery, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Steeg</LastName><ForeName>A F W</ForeName><Initials>AFW</Initials><AffiliationInfo><Affiliation>Pediatric Surgical Center Amsterdam, Emma Children's Hospital AMC, VU-University Medical Center, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Research on Psychology in Somatic Disease (CoRPS), Tilburg University, Tilburg, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Heurn</LastName><ForeName>L W E</ForeName><Initials>LWE</Initials><AffiliationInfo><Affiliation>Pediatric Surgical Center Amsterdam, Emma Children's Hospital AMC, VU-University Medical Center, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>World J Surg</MedlineTA><NlmUniqueID>7704052</NlmUniqueID><ISSNLinking>0364-2313</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>World J Surg. 2019 Mar;43(3):963-964. doi: 10.1007/s00268-018-4704-9.</RefSource><PMID Version="1">29882100</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000223" MajorTopicYN="N">Adaptation, Psychological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001828" MajorTopicYN="Y">Body Image</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005660" MajorTopicYN="N">Funnel Chest</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012649" MajorTopicYN="Y">Self Concept</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflict of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>10</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>2</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29411068</ArticleId><ArticleId IdType="pmc">PMC6060811</ArticleId><ArticleId IdType="doi">10.1007/s00268-018-4526-9</ArticleId><ArticleId IdType="pii">10.1007/s00268-018-4526-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Shamberger RC. Congenital chest wall deformities. Curr Probl Surg. 1996;33:469&#x2013;552. doi: 10.1016/S0011-3840(96)80005-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0011-3840(96)80005-0</ArticleId><ArticleId IdType="pubmed">8641129</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam MWC, Klassen AF, Montgomery CJ, et al. Quality-of-life outcomes after surgical correction of pectus excavatum: a comparison of the Ravitch and Nuss procedures. J Ped Surg. 2008;43:819&#x2013;825. doi: 10.1016/j.jpedsurg.2007.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2007.12.020</ArticleId><ArticleId IdType="pubmed">18485946</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly RE, Cash TF, Shamberger RC, et al. Surgical repair of pectus excavatum markedly improves body image and perceived ability for physical activity: multicenter study. Pediatrics. 2008;122:1218&#x2013;1222. doi: 10.1542/peds.2007-2723.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2007-2723</ArticleId><ArticleId IdType="pubmed">19047237</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasopoulos G, Dusmet M, Ladas G, et al. Nuss procedure improves the quality of life in young male adults with pectus excavatum deformity. Eur J Cardiothorac Surg. 2006;29:1&#x2013;5. doi: 10.1016/j.ejcts.2005.09.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcts.2005.09.018</ArticleId><ArticleId IdType="pubmed">16337131</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang M, Nielsen HH, Lesbo M, et al. Improved cardiopulmonary exercise function after modified Nuss operation for pectus excavatum. Eur J Cardiothorac Surg. 2012;41:1063&#x2013;1067. doi: 10.1093/ejcts/ezr170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezr170</ArticleId><ArticleId IdType="pubmed">22219453</ArticleId></ArticleIdList></Reference><Reference><Citation>Maagaard M, Tang M, Ringgaard S, et al. Normalized cardiopulmonary exercise function in patients with pectus excavatum three years after operation. Ann Thorac Surg. 2013;96:272&#x2013;278. doi: 10.1016/j.athoracsur.2013.03.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2013.03.034</ArticleId><ArticleId IdType="pubmed">23684487</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta J, Bradley A, Raja V, et al. Exercise improvement after pectus excavatum repair is not related to chest wall function. Eur J Cardiothorac Surg. 2014;45:544&#x2013;548. doi: 10.1093/ejcts/ezt473.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezt473</ArticleId><ArticleId IdType="pubmed">24067751</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigalet DL, Montgomery M, Harder J. Cardiopulmonary effects of closed repair of pectus excavatum. J Pediatr Surg. 2003;38:380&#x2013;385. doi: 10.1053/jpsu.2003.50112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/jpsu.2003.50112</ArticleId><ArticleId IdType="pubmed">12632353</ArticleId></ArticleIdList></Reference><Reference><Citation>Maagaard M, Heiberg J. Improved cardiac function and exercise capacity following correction of pectus excavatum: review of current literature. Ann Cardiothorac Surg. 2016;5:485&#x2013;492. doi: 10.21037/acs.2016.09.03.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/acs.2016.09.03</ArticleId><ArticleId IdType="pmc">PMC5056930</ArticleId><ArticleId IdType="pubmed">27747182</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinmann C, Krille S, Mueller A, et al. Pectus excavatum and pectus carinatum patients suffer from lower quality of life and impaired body image: a control group comparison of psychological characteristics prior to surgical correction. Eur J Cardiothorac Surg. 2011;40:1138&#x2013;1145.</Citation><ArticleIdList><ArticleId IdType="pubmed">21440452</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaroszewski D, Notrica D, McMahon L, et al. Current management of pectus excavatum: a review and update of therapy and treatment recommendations. J Am Board Fam Med. 2010;23:230&#x2013;239. doi: 10.3122/jabfm.2010.02.090234.</Citation><ArticleIdList><ArticleId IdType="doi">10.3122/jabfm.2010.02.090234</ArticleId><ArticleId IdType="pubmed">20207934</ArticleId></ArticleIdList></Reference><Reference><Citation>WHOQOL group Development of the WHOQOL: rationale and current status. Int J Ment Health. 1994;23:24&#x2013;56. doi: 10.1080/00207411.1994.11449286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00207411.1994.11449286</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuidema WP, van der Steeg AFW, Oosterhuis JWA, et al. The influence of pain: quality of life after pectus excavatum correction. Open J Pediatr. 2014;4:216&#x2013;221. doi: 10.4236/ojped.2014.43028.</Citation><ArticleIdList><ArticleId IdType="doi">10.4236/ojped.2014.43028</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuss D, Kelly RE, Jr, Croitoru DP, et al. A 10-year review of a minimally invasive technique for the correction of pectus excavatum. J Pediatr Surg. 1998;33:545&#x2013;552. doi: 10.1016/S0022-3468(98)90314-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3468(98)90314-1</ArticleId><ArticleId IdType="pubmed">9574749</ArticleId></ArticleIdList></Reference><Reference><Citation>WHOQOL group Development of the world health organization WHOQOL-Bref quality of life assessment. Psychol Med. 1998;28:551&#x2013;558. doi: 10.1017/S0033291798006667.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033291798006667</ArticleId><ArticleId IdType="pubmed">9626712</ArticleId></ArticleIdList></Reference><Reference><Citation>Landgraf JM, Abetz L, Ware JA. The CHQ user manual. Boston: The Health Institute, New England Medical Center; 1996.</Citation></Reference><Reference><Citation>Raat H, Landgraf JM, Bonsel GJ, et al. Reliability and validity of the child health questionnaire-child form (CHQ-CF87) in a Dutch adolescent population. Qual Life Res. 2002;11:575&#x2013;581. doi: 10.1023/A:1016393311799.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1016393311799</ArticleId><ArticleId IdType="pubmed">12206578</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HK, Shim JH, Choi YH. The quality of life after bar removal in patients after the nuss procedure for pectus excavatum. World J Surg. 2011;35:1656&#x2013;1661. doi: 10.1007/s00268-011-1111-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-011-1111-x</ArticleId><ArticleId IdType="pubmed">21560000</ArticleId></ArticleIdList></Reference><Reference><Citation>Fricke A, Lehner GM, Stark GB, et al. Long-term follow-up of recurrence and patient satisfaction after surgical treatment of gynecomastia. Aesthet Plast Surg. 2017;41:491&#x2013;498. doi: 10.1007/s00266-017-0827-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00266-017-0827-x</ArticleId><ArticleId IdType="pubmed">28280898</ArticleId></ArticleIdList></Reference><Reference><Citation>Songu M, Kutlu A. Long-term psychosocial impact of otoplasty performed on children with prominent ears. J Laryngol Otol. 2014;128:768&#x2013;771. doi: 10.1017/S0022215114001662.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0022215114001662</ArticleId><ArticleId IdType="pubmed">25115321</ArticleId></ArticleIdList></Reference><Reference><Citation>Niemel&#xe4; BJ, Hedlund A, Andersson G, et al. Prominent ears: the effect of reconstructive surgery on self-esteem and social interaction in children with a minor defect compared to children with a major orthopedic defect. Plast Reconstr Surg. 2008;122:1390&#x2013;1398. doi: 10.1097/PRS.0b013e3181881fb0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PRS.0b013e3181881fb0</ArticleId><ArticleId IdType="pubmed">18971722</ArticleId></ArticleIdList></Reference><Reference><Citation>Frieson TC, Frieson CW. Relationship between hope and self-esteem in renal transplant recipients. J Transpl Coord. 1996;6:20&#x2013;23. doi: 10.7182/prtr.1.6.1.q52347756145h374.</Citation><ArticleIdList><ArticleId IdType="doi">10.7182/prtr.1.6.1.q52347756145h374</ArticleId><ArticleId IdType="pubmed">9157926</ArticleId></ArticleIdList></Reference><Reference><Citation>de Castro EK, Moreno-Jim&#xe9;nez B, Rodr&#xed;guez-Carvajal R. Psychological well-being in adults transplanted in childhood. Pediatr Transpl. 2007;11:272&#x2013;278. doi: 10.1111/j.1399-3046.2006.00648.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-3046.2006.00648.x</ArticleId><ArticleId IdType="pubmed">17430482</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">21462279</PMID><DateCompleted><Year>2011</Year><Month>10</Month><Day>13</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1099-1557</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>6</Issue><PubDate><Year>2011</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Pharmacoepidemiology and drug safety</Title><ISOAbbreviation>Pharmacoepidemiol Drug Saf</ISOAbbreviation></Journal><ArticleTitle>Non-steroidal anti-inflammatory drugs and risk of pulmonary embolism.</ArticleTitle><Pagination><StartPage>635</StartPage><EndPage>642</EndPage><MedlinePgn>635-42</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/pds.2130</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Non-steroidal anti-inflammatory drugs (NSAIDs) have been associated with an increased risk of arterial thrombosis, but their effect on venous thrombotic events is less well established. The study aimed to assess the risk of symptomatic pulmonary embolism (PE) in patients using NSAIDs and to evaluate any effect of type, dose, and duration of therapy.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A case-control study was conducted using the PHARMO Record Linkage System, a Dutch population-based registry. Cases were patients hospitalized with a primary diagnosis of PE and were matched to controls without a history of PE. To exclude confounding by indication, the effect of painkillers without known hemostatic effects was assessed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The study population consisted of 4433 cases and 16,802 controls. After adjustment for surgery, trauma, and malignancy, current use of NSAIDs was associated with PE (odds ratio (OR) 2.39, 95% confidence interval (CI) 2.06-2.77). The risk was highest for traditional NSAIDs, and the overall risk for NSAIDs was highest in the first 30 days of exposure (OR 4.77, 95%CI 3.92-5.81), as compared with chronic (&lt;1 year; OR 1.83, 95%CI 1.47-2.28) or long-term use (&gt;1 year; OR 2.14, 95%CI 1.48-3.09). Use of acetaminophen and tramadol also increased the risk of PE (OR 1.74, 95%CI 1.42-2.14 and OR 4.07, 95%CI 2.86-5.75, respectively) with a similar time trend.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Use of NSAIDs is associated with an increased risk of symptomatic PE. This association may be partially explained by underlying medical conditions, as suggested by a similarly increased thrombotic risk in patients receiving acetaminophen and tramadol.</AbstractText><CopyrightInformation>Copyright &#xa9; 2011 John Wiley &amp; Sons, Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Biere-Rafi</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands. s.rafi@amc.uva.nl</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Nisio</LastName><ForeName>Marcello</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Gerdes</LastName><ForeName>Victor</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Porreca</LastName><ForeName>Ettore</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Souverein</LastName><ForeName>Patrick</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Boer</LastName><ForeName>Anthonius</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>B&#xfc;ller</LastName><ForeName>Harry</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Kamphuisen</LastName><ForeName>Pieter</ForeName><Initials>P</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Pharmacoepidemiol Drug Saf</MedlineTA><NlmUniqueID>9208369</NlmUniqueID><ISSNLinking>1053-8569</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018712">Analgesics, Non-Narcotic</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000701">Analgesics, Opioid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000894">Anti-Inflammatory Agents, Non-Steroidal</NameOfSubstance></Chemical><Chemical><RegistryNumber>362O9ITL9D</RegistryNumber><NameOfSubstance UI="D000082">Acetaminophen</NameOfSubstance></Chemical><Chemical><RegistryNumber>39J1LGJ30J</RegistryNumber><NameOfSubstance UI="D014147">Tramadol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000082" MajorTopicYN="N">Acetaminophen</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018712" MajorTopicYN="N">Analgesics, Non-Narcotic</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000701" MajorTopicYN="N">Analgesics, Opioid</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000894" MajorTopicYN="N">Anti-Inflammatory Agents, Non-Steroidal</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008498" MajorTopicYN="N">Medical Record Linkage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009426" MajorTopicYN="N" Type="Geographic">Netherlands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014147" MajorTopicYN="N">Tramadol</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>10</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21462279</ArticleId><ArticleId IdType="doi">10.1002/pds.2130</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37665826</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>06</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-5476</ISSN><JournalIssue CitedMedium="Internet"><Volume>65</Volume><PubDate><Year>2023</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Psychology of sport and exercise</Title><ISOAbbreviation>Psychol Sport Exerc</ISOAbbreviation></Journal><ArticleTitle>How divergent are children's divergent movements? The role of cognition and expertise in a class-randomized cross-over trial.</ArticleTitle><Pagination><StartPage>102373</StartPage><MedlinePgn>102373</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.psychsport.2022.102373</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1469-0292(22)00241-2</ELocationID><Abstract><AbstractText>This study aimed at investigating (1) the cognitive and motor predictors of divergent movement ability (DMA) in childhood and (2) the role of sport and enriched physical education (PE) experience. Participants were 165 fifth graders, aged 10-11 years, with different histories (onset and duration) of participation in enriched PE. They were assessed in cognitive/attentional and motor/sport skills and active play/sport habits at baseline, and six months later in DMA. Results of regression analyses showed an overall prediction of DMA by sport practice and a nuanced prediction of individual DMA indices (fluency, flexibility, originality) by decision making and spatial attention ability. Linear mixed models revealed better DMA in children exposed to enriched PE, with differential effects on DMA indices depending on its duration and earlier/later onset. The results identify novel cognitive determinants of children's DMA and suggest that sport practice and experience of designed enrichment in PE may benefit DMA.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>De Fano</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Chieti and Pescara "G. d'Annunzio", Department of Neuroscience, Imaging and Clinical Sciences, Via dei Vestini 33, 66100, Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benzing</LastName><ForeName>Valentin</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>University of Bern, Institute of Sport Science, Bremgartenstrasse 145, 3012, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Condello</LastName><ForeName>Giancarlo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>University of Parma, Department of Medicine and Surgery, Via Gramsci 14, 43126, Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ballester</LastName><ForeName>Rafael</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Catholic University of Valencia "San Vicente Martir", Department of Athletic Training, Carrer de Quevedo, 2, 46001, Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tocci</LastName><ForeName>Nicoletta</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>University of Rome "Foro Italico", Department of Movement, Human and Health Sciences, Piazza Lauro De Bosis 6, 00135, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marchetti</LastName><ForeName>Rosalba</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University of Rome "Foro Italico", Department of Movement, Human and Health Sciences, Piazza Lauro De Bosis 6, 00135, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pesce</LastName><ForeName>Caterina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University of Rome "Foro Italico", Department of Movement, Human and Health Sciences, Piazza Lauro De Bosis 6, 00135, Rome, Italy. Electronic address: caterina.pesce@uniroma4.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmidt</LastName><ForeName>Mirko</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Bern, Institute of Sport Science, Bremgartenstrasse 145, 3012, Bern, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Psychol Sport Exerc</MedlineTA><NlmUniqueID>101088724</NlmUniqueID><ISSNLinking>1878-5476</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018592" MajorTopicYN="N">Cross-Over Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="Y">Cognition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006184" MajorTopicYN="Y">Habits</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016014" MajorTopicYN="N">Linear Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009048" MajorTopicYN="N">Motor Skills</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Constraint-led approach</Keyword><Keyword MajorTopicYN="N">Executive function</Keyword><Keyword MajorTopicYN="N">Motor creativity</Keyword><Keyword MajorTopicYN="N">Spatial attention</Keyword><Keyword MajorTopicYN="N">Sport</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: C.P., G.C. and R.M. received honoraria from Soremartec for developing and monitoring the enriched PE program and for training teachers. N.T. received honoraria for training teachers. However, their role in the research project granted by the corporate has not influenced the outcomes reported in this article. A.D.F., V.B., R.B. and M.S. had no involvement in securing the funding for this research and received no financial support for the research, authorship, and/or publication of this article. The funders had no role in the study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>6</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>4</Day><Hour>18</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>4</Day><Hour>15</Hour><Minute>37</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37665826</ArticleId><ArticleId IdType="doi">10.1016/j.psychsport.2022.102373</ArticleId><ArticleId IdType="pii">S1469-0292(22)00241-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38214744</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>15</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1437-2320</ISSN><JournalIssue CitedMedium="Internet"><Volume>47</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month><Day>12</Day></PubDate></JournalIssue><Title>Neurosurgical review</Title><ISOAbbreviation>Neurosurg Rev</ISOAbbreviation></Journal><ArticleTitle>Endovascular treatment of brain aneurysms under conscious sedation: a systematic review of procedural feasibility and safety.</ArticleTitle><Pagination><StartPage>42</StartPage><MedlinePgn>42</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10143-023-02272-1</ELocationID><Abstract><AbstractText>Over the last decades, minimally invasive techniques have revolutionized the endovascular treatment (EVT) of brain aneurysms. In parallel, the development of conscious sedation (CS), a potentially less harmful anesthetic protocol than general anesthesia (GA), has led to the course optimization of surgeries, patient outcomes, and healthcare costs. Nevertheless, the feasibility and safety of EVT of brain aneurysms under CS have yet to be assessed thoroughly. Herein, we systematically reviewed the medical literature about this procedure. In accordance with the PRISMA guidelines, four databases (PubMed, EMBASE, SCOPUS, and Cochrane Library) were queried to identify articles describing the EVT of brain aneurysms under CS. Successful procedural completion, complete aneurysm occlusion outcomes, intraoperative complications, clinical outcomes, and mortality rates assessed the feasibility and safety. Our search strategy yielded 567 records, of which 11 articles were included in the qualitative synthesis. These studies entailed a total of 1142 patients (40.7% females), 1183 intracranial aneurysms (78.4% in the anterior circulation and 60.9% unruptured at presentation), and 1391 endovascular procedures (91.9% performed under CS). EVT modalities under CS included coiling alone (63.2%), flow diversion (17.7%), stent-assisted coiling (10.6%), stenting alone (6.5%), onyx embolization alone (1.7%), onyx&#x2009;+&#x2009;stenting (0.2%), and onyx&#x2009;+&#x2009;coiling (0.2%). CS was achieved by combining two or more anesthetics, such as midazolam, fentanyl, and remifentanil. Selection criteria for CS were heterogenous and included patients' history of pulmonary and cardiovascular diseases, outweighing the benefits of CS versus GA, a Hunt and Hess score of I-II, a median score of 3 in the American Society of Anesthesiology scale, and patient's compliance with elective CS. Procedures were deemed successful or achieving complete aneurysm occlusion in 88.1% and 9.4% of reported cases, respectively. Good clinical outcomes were described in 90.4% of patients with available data at follow-up (mean time: 10.7&#xa0;months). The procedural complication rate was 16%, and the mortality rate was 2.8%. No complications or mortality were explicitly attributed to CS. On the other hand, procedure abortion and conversion from CS to GA were deemed necessary in 5% and 1% of cases, respectively. The present study highlights the feasibility of performing EVT of brain aneurysms under CS as an alternative anesthetic protocol to GA. However, the limited nature of observational studies, methodological quality, the predominant absence of a comparative GA group, and clinical data during follow-up restrict a conclusive statement about the safety of EVT under CS. Accordingly, further research endeavors are warranted toward a higher level of evidence that can be translated into surgical practice.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bocanegra-Becerra</LastName><ForeName>Jhon E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>School of Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru. jhon.bocanegra.b@upch.pe.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kersting</LastName><ForeName>Katharina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Charit&#xe9;-Universit&#xe4;tsmedzin Berlin, Corporate Member of Freie Universit&#xe4;t Berlin and Humboldt-Universtit&#xe4; Zu Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blega</LastName><ForeName>Alin Maximilian</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Nolan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University of California-Irvine, Orange, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliveira</LastName><ForeName>Leonardo de Barros</ForeName><Initials>LB</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, State University of Ponta Grossa, Paran&#xe1;, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alajarmeh</LastName><ForeName>Rnad</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Istiklal Hospital, Amman, Jordan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Batista</LastName><ForeName>S&#xe1;vio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wellington</LastName><ForeName>Jack</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Acha S&#xe1;nchez</LastName><ForeName>Jos&#xe9; Luis</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Hospital Nacional Dos de Mayo, Lima, Peru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertani</LastName><ForeName>Raphael</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University of S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Neurosurg Rev</MedlineTA><NlmUniqueID>7908181</NlmUniqueID><ISSNLinking>0344-5607</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000777">Anesthetics</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002532" MajorTopicYN="Y">Intracranial Aneurysm</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016292" MajorTopicYN="N">Conscious Sedation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005240" MajorTopicYN="N">Feasibility Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004621" MajorTopicYN="Y">Embolization, Therapeutic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000777" MajorTopicYN="Y">Anesthetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057510" MajorTopicYN="Y">Endovascular Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Brain aneurysm</Keyword><Keyword MajorTopicYN="N">Conscious sedation</Keyword><Keyword MajorTopicYN="N">Endovascular treatment</Keyword><Keyword MajorTopicYN="N">Intracranial aneurysm</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>15</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>12</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>12</Day><Hour>11</Hour><Minute>5</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38214744</ArticleId><ArticleId IdType="doi">10.1007/s10143-023-02272-1</ArticleId><ArticleId IdType="pii">10.1007/s10143-023-02272-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Connolly ES, Rabinstein AA, Carhuapoma JR et al (2012) Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association. Stroke 43(6):1711&#x2013;1737. https://doi.org/10.1161/STR.0b013e3182587839</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STR.0b013e3182587839</ArticleId><ArticleId IdType="pubmed">22556195</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson B, Brown R, Amin-Hanjani S et al (2015) Guidelines for the management of patients with unruptured intracranial aneurysms: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (1970) 46(8):2368&#x2013;2400. https://doi.org/10.1161/STR.0000000000000070</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STR.0000000000000070</ArticleId></ArticleIdList></Reference><Reference><Citation>Dumont TM, Eller JL, Mokin M, Sorkin GC, Levy EI (2014) Advances in endovascular approaches to cerebral aneurysms. Neurosurgery 74(Suppl 1):17. https://doi.org/10.1227/NEU.0000000000000217</Citation><ArticleIdList><ArticleId IdType="doi">10.1227/NEU.0000000000000217</ArticleId></ArticleIdList></Reference><Reference><Citation>Riina HA, Eskridge J, Berenstein A (1998) Future endovascular management of cerebral aneurysms. Neurosurg Clin N Am 9(4):917&#x2013;921</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1042-3680(18)30238-9</ArticleId><ArticleId IdType="pubmed">9738116</ArticleId></ArticleIdList></Reference><Reference><Citation>Waqas M, Monteiro A, Cappuzzo JM, Tutino VM, Levy EI (2022) Evolution of the patient-first approach: a dual-trained, single-neurosurgeon experience with 2002 consecutive intracranial aneurysm treatments. J Neurosurg 137(6):1751&#x2013;1757. https://doi.org/10.3171/2022.2.JNS22105</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/2022.2.JNS22105</ArticleId><ArticleId IdType="pubmed">35364567</ArticleId></ArticleIdList></Reference><Reference><Citation>Practice guidelines for sedation and analgesia by non-anesthesiologists: an updated report by the American Society of Anesthesiologists Task Force on Sedation and Analgesia by non-Anesthesiologists. Anesthesiology (Philadelphia). 2002;96(4):1004&#x2013;1017. https://doi.org/10.1097/00000542-200204000-00031</Citation></Reference><Reference><Citation>Esmaeeli S, Valencia J, Buhl LK et al (2021) Anesthetic management of unruptured intracranial aneurysms: a qualitative systematic review. Neurosurg Rev 44(5):2477&#x2013;2492. https://doi.org/10.1007/s10143-020-01441-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10143-020-01441-w</ArticleId><ArticleId IdType="pubmed">33415519</ArticleId><ArticleId IdType="pmc">9157460</ArticleId></ArticleIdList></Reference><Reference><Citation>Brinjikji W, Murad MH, Rabinstein AA, Cloft HJ, Lanzino G, Kallmes DF (2015) Conscious sedation versus general anesthesia during endovascular acute ischemic stroke treatment: a systematic review and meta-analysis. AJNR Am J Neuroradiol 36(3):525&#x2013;529. https://doi.org/10.3174/ajnr.A4159</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A4159</ArticleId><ArticleId IdType="pubmed">25395655</ArticleId><ArticleId IdType="pmc">8013063</ArticleId></ArticleIdList></Reference><Reference><Citation>Rangel-Castilla L, Cress M, Munich S et al (2015) Feasibility, safety, and periprocedural complications of pipeline embolization for intracranial aneurysm treatment under conscious sedation: University at Buffalo neurosurgery experience. Neurosurgery. 11(Suppl 3(3)):426&#x2013;430. https://doi.org/10.1227/NEU.0000000000000864</Citation><ArticleIdList><ArticleId IdType="doi">10.1227/NEU.0000000000000864</ArticleId><ArticleId IdType="pubmed">26284351</ArticleId></ArticleIdList></Reference><Reference><Citation>Murad MH, Sultan S, Haffar S, Bazerbachi F (2018) Methodological quality and synthesis of case series and case reports. BMJ Evid Based Med 23(2):60&#x2013;63. https://doi.org/10.1136/bmjebm-2017-110853</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjebm-2017-110853</ArticleId><ArticleId IdType="pubmed">29420178</ArticleId><ArticleId IdType="pmc">6234235</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells GA, Shea B, O'Connell D&#xa0;et al The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp . Accessed 1 Dec 2022</Citation></Reference><Reference><Citation>Tso MK, Dossani RH, Waqas M, Rajah GB, Vakharia K, Siddiqui AH (2021) Coil occlusion of right M2 fusiform aneurysm after balloon-test occlusion: 2-dimensional video. World Neurosurgery 146:45. https://doi.org/10.1016/j.wneu.2020.10.129</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wneu.2020.10.129</ArticleId><ArticleId IdType="pubmed">33130133</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhogal P, Chan N, Makalanda H, Wong K, Noblet J (2020) Transradial Woven EndoBridge device to treat a ruptured basilar tip aneurysm under conscious sedation. Interv Neuroradiol 26(6):779&#x2013;784. https://doi.org/10.1177/1591019920927243</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1591019920927243</ArticleId><ArticleId IdType="pubmed">32443960</ArticleId><ArticleId IdType="pmc">7724591</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorenson TJ, Lanzino G, Rangel Castilla L (2019) Novel endovascular neck reconstruction and coiling technique for the treatment of a large wide-necked basilar apex aneurysm through a radial artery approach: 2-dimensional operative video. Oper Neurosurg (Hagerstown, Md.) 17(4):E157. https://doi.org/10.1093/ons/opz025</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ons/opz025</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J, Lee C, Kim H (2018) Feasibility, safety, and periprocedural complications associated with endovascular treatment of ruptured intracranial aneurysms according to the depth of anesthesia. Am J Neuroradiol AJNR 39(9):1676&#x2013;1681. https://doi.org/10.3174/ajnr.A5753</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A5753</ArticleId><ArticleId IdType="pubmed">30115675</ArticleId></ArticleIdList></Reference><Reference><Citation>Griessenauer CJ, Shallwani H, Adeeb N et al (2017) Conscious sedation versus general anesthesia for the treatment of cerebral aneurysms with flow diversion: a matched cohort study. World Neurosurg. 102:1&#x2013;5. https://doi.org/10.1016/j.wneu.2017.02.111</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wneu.2017.02.111</ArticleId><ArticleId IdType="pubmed">28279774</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramaswamy R, Villwock MR, Shaw PM, Swarnkar A, Deshaies EM, Padalino DJ (2015) Open direct carotid artery access for coiling of an intracranial aneurysm under conscious sedation. Interv Neuroradiol 21(3):387&#x2013;389. https://doi.org/10.1177/1591019915583220</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1591019915583220</ArticleId><ArticleId IdType="pubmed">26015521</ArticleId><ArticleId IdType="pmc">4757269</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahme R, Grande A, Jimenez L, Abruzzo TA, Ringer AJ (2014) Onyx HD-500 embolization of intracranial aneurysms: modified technique using continuous balloon inflation under conscious sedation. J Clin Neurosci 21(8):1383&#x2013;1387. https://doi.org/10.1016/j.jocn.2014.01.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2014.01.004</ArticleId><ArticleId IdType="pubmed">24746443</ArticleId></ArticleIdList></Reference><Reference><Citation>Kan P, Jahshan S, Yashar P et al (2013) Feasibility, safety, and periprocedural complications associated with endovascular treatment of selected ruptured aneurysms under conscious sedation and local anesthesia. Neurosurgery 72(2):216&#x2013;220. https://doi.org/10.1227/NEU.0b013e31827b9183</Citation><ArticleIdList><ArticleId IdType="doi">10.1227/NEU.0b013e31827b9183</ArticleId><ArticleId IdType="pubmed">23149970</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogilvy CS, Yang X, Jamil OA et al (2011) Neurointerventional procedures for unruptured intracranial aneurysms under procedural sedation and local anesthesia: a large-volume, single-center experience. J Neurosurg 114(1):120&#x2013;128. https://doi.org/10.3171/2010.3.JNS091384</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/2010.3.JNS091384</ArticleId><ArticleId IdType="pubmed">20397895</ArticleId></ArticleIdList></Reference><Reference><Citation>Qureshi AI, Suri MFK, Khan J et al (2001) Endovascular treatment of intracranial aneurysms by using Guglielmi detachable coils in awake patients: safety and feasibility. J Neurosurg 94(6):880&#x2013;885. https://doi.org/10.3171/jns.2001.94.6.0880</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/jns.2001.94.6.0880</ArticleId><ArticleId IdType="pubmed">11409514</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee CZ, Gelb AW (2014) Anesthesia management for endovascular treatment. Curr Opin Anaesthesiol 27(5):484&#x2013;488. https://doi.org/10.1097/ACO.0000000000000103</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACO.0000000000000103</ArticleId><ArticleId IdType="pubmed">25014255</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald JS, Brinjikji W, Rabinstein AA, Cloft HJ, Lanzino G, Kallmes DF (2015) Conscious sedation versus general anaesthesia during mechanical thrombectomy for stroke: a propensity score analysis. J Neurointerv Surg 7(11):789&#x2013;794. https://doi.org/10.1136/neurintsurg-2014-011373</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/neurintsurg-2014-011373</ArticleId><ArticleId IdType="pubmed">25261440</ArticleId></ArticleIdList></Reference><Reference><Citation>Vatner SF (1978) Effects of anesthesia on cardiovascular control mechanisms. Environ Health Perspect 26:193&#x2013;206. https://doi.org/10.1289/ehp.7826193</Citation><ArticleIdList><ArticleId IdType="doi">10.1289/ehp.7826193</ArticleId><ArticleId IdType="pubmed">363416</ArticleId><ArticleId IdType="pmc">1637240</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris M, Chung F (2013) Complications of general anesthesia. Clin Plast Surg 40(4):503&#x2013;513. https://doi.org/10.1016/j.cps.2013.07.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cps.2013.07.001</ArticleId><ArticleId IdType="pubmed">24093647</ArticleId></ArticleIdList></Reference><Reference><Citation>Lone PA, Wani NA, Ain QU, Heer A, Devi R, Mahajan S (2021) Common postoperative complications after general anesthesia in oral and maxillofacial surgery. Natl J Maxillofac Surg 12(2):206&#x2013;210. https://doi.org/10.4103/njms.NJMS_66_20</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/njms.NJMS_66_20</ArticleId><ArticleId IdType="pubmed">34483578</ArticleId><ArticleId IdType="pmc">8386273</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu L, Zhao H, Weng H, Ma D (2019) Lasting effects of general anesthetics on the brain in the young and elderly: &#x201c;mixed picture&#x201d; of neurotoxicity, neuroprotection and cognitive impairment. J Anesth 33(2):321&#x2013;335. https://doi.org/10.1007/s00540-019-02623-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-019-02623-7</ArticleId><ArticleId IdType="pubmed">30859366</ArticleId><ArticleId IdType="pmc">6443620</ArticleId></ArticleIdList></Reference><Reference><Citation>Volovici V, Verploegh IS, Satoer D et al (2023) Outcomes associated with intracranial aneurysm treatments reported as safe, effective, or durable: a systematic review and meta-analysis. JAMA Netw Open 6(9):e2331798. https://doi.org/10.1001/jamanetworkopen.2023.31798</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.31798</ArticleId><ArticleId IdType="pubmed">37656458</ArticleId><ArticleId IdType="pmc">10474558</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33746973</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Survival and Pulmonary Injury After Neonatal Sepsis: PD1/PDL1's Contributions to Mouse and Human Immunopathology.</ArticleTitle><Pagination><StartPage>634529</StartPage><MedlinePgn>634529</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">634529</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2021.634529</ELocationID><Abstract><AbstractText>Morbidity and mortality associated with neonatal sepsis remains a healthcare crisis. PD1<sup>-/-</sup> neonatal mice endured experimental sepsis, in the form of cecal slurry (CS), and showed improved rates of survival compared to wildtype (WT) counterparts. End-organ injury, particularly of the lung, contributes to the devastation set forth by neonatal sepsis. PDL1<sup>-/-</sup> neonatal mice, in contrast to PD1<sup>-/-</sup> neonatal mice did not have a significant improvement in survival after CS. Because of this, we focused subsequent studies on the impact of PD1 gene deficiency on lung injury. Here, we observed that at 24 h post-CS (but not at 4 or 12 h) there was a marked increase in pulmonary edema (PE), neutrophil influx, myeloperoxidase (MPO) levels, and cytokine expression sham (Sh) WT mice. Regarding pulmonary endothelial cell (EC) adhesion molecule expression, we observed that Zona occludens-1 (ZO-1) within the cell shifted from a membranous location to a peri-nuclear location after CS in WT murine cultured ECs at 24hrs, but remained membranous among PD1<sup>-/-</sup> lungs. To expand the scope of this inquiry, we investigated human neonatal lung tissue. We observed that the lungs of human newborns exposed to intrauterine infection had significantly higher numbers of PD1<sup>+</sup> cells compared to specimens who died from non-infectious causes. Together, these data suggest that PD1/PDL1, a pathway typically thought to govern adaptive immune processes in adult animals, can modulate the largely innate neonatal pulmonary immune response to experimental septic insult. The potential future significance of this area of study includes that PD1/PDL1 checkpoint proteins may be viable therapeutic targets in the septic neonate.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Fallon, Chung, Heffernan, Chen, De Paepe and Ayala.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fallon</LastName><ForeName>Eleanor A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Division of Surgical Research, Department of Surgery, Alpert Medical School of Brown University, Rhode Island Hospital, Providence, RI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Chun-Shiang</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Division of Surgical Research, Department of Surgery, Alpert Medical School of Brown University, Rhode Island Hospital, Providence, RI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heffernan</LastName><ForeName>Daithi S</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Division of Surgical Research, Department of Surgery, Alpert Medical School of Brown University, Rhode Island Hospital, Providence, RI, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Providence Veterans Affairs Medical Center, Providence, RI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yaping</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Division of Surgical Research, Department of Surgery, Alpert Medical School of Brown University, Rhode Island Hospital, Providence, RI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Paepe</LastName><ForeName>Monique E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Department of Pathology, Women &amp; Infants Hospital and Alpert Medical School of Brown University, Providence, RI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ayala</LastName><ForeName>Alfred</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Surgical Research, Department of Surgery, Alpert Medical School of Brown University, Rhode Island Hospital, Providence, RI, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K08 GM110495</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 GM118097</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D060890">B7-H1 Antigen</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C423236">CD274 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C498919">Cd274 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C105992">PDCD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C491383">Pdcd1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000628805">Pecam1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019408">Platelet Endothelial Cell Adhesion Molecule-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D061026">Programmed Cell Death 1 Receptor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C569043">Tjp1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D062826">Zonula Occludens-1 Protein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000831" MajorTopicYN="N">Animals, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060890" MajorTopicYN="N">B7-H1 Antigen</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042783" MajorTopicYN="N">Endothelial Cells</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055370" MajorTopicYN="N">Lung Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071074" MajorTopicYN="N">Neonatal Sepsis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019408" MajorTopicYN="N">Platelet Endothelial Cell Adhesion Molecule-1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061026" MajorTopicYN="N">Programmed Cell Death 1 Receptor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011654" MajorTopicYN="N">Pulmonary Edema</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062826" MajorTopicYN="N">Zonula Occludens-1 Protein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">endothelial cell culture</Keyword><Keyword MajorTopicYN="N">immunopathology</Keyword><Keyword MajorTopicYN="N">innate immunity</Keyword><Keyword MajorTopicYN="N">lung injury</Keyword><Keyword MajorTopicYN="N">neonatal</Keyword><Keyword MajorTopicYN="N">programmed cell death receptor</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">survival</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>22</Day><Hour>8</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33746973</ArticleId><ArticleId IdType="pmc">PMC7965961</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2021.634529</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Desale M, Thinkhamrop J, Lumbiganon P, Qazi S, Anderson J. Ending preventable maternal and newborn deaths due to infection. Best Pract Res Clin Obstet Gynaecol. (2016) 36:116&#x2013;30. 10.1016/j.bpobgyn.2016.05.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpobgyn.2016.05.008</ArticleId><ArticleId IdType="pubmed">27450868</ArticleId></ArticleIdList></Reference><Reference><Citation>Epstein L, Dantes R, Magill S, Fiore A. Varying estimates of sepsis mortality using death certificates and administrative codes&#x2013;United States, 1999-2014. MMWR Morb Mortal Wkly Rep. (2016) 65:342&#x2013;5. 10.15585/mmwr.mm6513a2</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6513a2</ArticleId><ArticleId IdType="pubmed">27054476</ArticleId></ArticleIdList></Reference><Reference><Citation>Arefian H, Heublein S, Scherag A, Brunkhorst FM, Younis MZ, Moerer O, et al. . Hospital-related cost of sepsis: a systematic review. J Infect. (2016) 74:107&#x2013;17. 10.1016/j.jinf.2016.11.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2016.11.006</ArticleId><ArticleId IdType="pubmed">27884733</ArticleId></ArticleIdList></Reference><Reference><Citation>Farmer D, Tessier JM, Sanders JM, Sawyer RG, Rotstein OD, Dellinger EP, et al. . Age and its impact on outcomes with intra-abdominal infection. Surg Infect. (2017) 18:77&#x2013;82. 10.1089/sur.2016.184</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/sur.2016.184</ArticleId><ArticleId IdType="pubmed">28005468</ArticleId></ArticleIdList></Reference><Reference><Citation>Balamuth F. Pediatric severe sepsis in U.S. children's hospitals. Pediatr Crit Care Med. (2014) 15:798&#x2013;805. 10.1097/PCC.0000000000000225</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PCC.0000000000000225</ArticleId><ArticleId IdType="pmc">PMC4221502</ArticleId><ArticleId IdType="pubmed">25162514</ArticleId></ArticleIdList></Reference><Reference><Citation>Osterman MJ, Kochanek KD, MacDorman MF, Strobino DM, Guyer B. Annual summary of vital statistics: 2012-2013. Pediatrics. (2015) 135:1115&#x2013;25. 10.1542/peds.2015-0434</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2015-0434</ArticleId><ArticleId IdType="pmc">PMC4750477</ArticleId><ArticleId IdType="pubmed">25941306</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawn JE, Wilczynska-Ketende K, Cousens SN. Estimating the causes of 4 million neonatal deaths in the year 2000. Int J Epidemiol. (2006) 35:706&#x2013;18. 10.1093/ije/dyl043</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyl043</ArticleId><ArticleId IdType="pubmed">16556647</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynn JL, Wong HR, Shanley TP, Bizzarro MJ, Saiman L, Polin RA. Time for a neonatal-specific consensus definition for sepsis. Pediatr Crit Care Med. (2014) 15:523&#x2013;8. 10.1097/PCC.0000000000000157</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PCC.0000000000000157</ArticleId><ArticleId IdType="pmc">PMC4087075</ArticleId><ArticleId IdType="pubmed">24751791</ArticleId></ArticleIdList></Reference><Reference><Citation>Maddux AB Douglas IS . Is the developmentally immature immune response in paediatric sepsis a recapitulation of immune tolerance? Immunology. (2015) 145:1&#x2013;10. 10.1111/imm.12454</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.12454</ArticleId><ArticleId IdType="pmc">PMC4405319</ArticleId><ArticleId IdType="pubmed">25691226</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutchins NA, Unsinger J, Hotchkiss RS, Ayala A. The new normal: immunomodulatory agents against sepsis immune suppression. Trends Mol Med. (2014) 20:224&#x2013;33. 10.1016/j.molmed.2014.01.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2014.01.002</ArticleId><ArticleId IdType="pmc">PMC3976785</ArticleId><ArticleId IdType="pubmed">24485901</ArticleId></ArticleIdList></Reference><Reference><Citation>Buras JA, Holzmann B, Sitkovsky M. Animal models of sepsis: setting the stage. Nat Rev Drug Discov. (2005) 4:854&#x2013;65. 10.1038/nrd1854</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd1854</ArticleId><ArticleId IdType="pubmed">16224456</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakowitz M, Bruns B, McCunn M. Acute lung injury and the acute respiratory distress syndrome in the injured patient. Scand J Trauma Resusc Emerge Med. (2012) 20:54. 10.1186/1757-7241-20-54</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1757-7241-20-54</ArticleId><ArticleId IdType="pmc">PMC3518173</ArticleId><ArticleId IdType="pubmed">22883052</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang L, Bai J, Chung CS, Lomas-Neira J, Chen Y, Huang X, et al. . Active players in resolution of shock/sepsis induced indirect lung injury: immunomodulatory effects of Tregs and PD-1. J Leukoc Biol. (2014) 96:809&#x2013;20. 10.1189/jlb.4MA1213-647RR</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.4MA1213-647RR</ArticleId><ArticleId IdType="pmc">PMC4197571</ArticleId><ArticleId IdType="pubmed">25082151</ArticleId></ArticleIdList></Reference><Reference><Citation>Lomas-Neira J, Venet F, Chung CS, Thakkar R, Heffernan D, Ayala A. Neutrophil-endothelial interactions mediate angiopoietin-2-associated pulmonary endothelial cell dysfunction in indirect acute lung injury in mice. Am J Respir Cell Mol Biol. (2014) 50:193&#x2013;200. 10.1165/rcmb.2013-0148OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2013-0148OC</ArticleId><ArticleId IdType="pmc">PMC3930935</ArticleId><ArticleId IdType="pubmed">23980650</ArticleId></ArticleIdList></Reference><Reference><Citation>Gill SE, Taneja R, Rohan M, Wang L, Mehta S. Pulmonary microvascular albumin leak is associated with endothelial cell death in murine sepsis-induced lung injury in vivo. PLoS ONE. (2014) 9:e88501. 10.1371/journal.pone.0088501</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0088501</ArticleId><ArticleId IdType="pmc">PMC3917898</ArticleId><ArticleId IdType="pubmed">24516666</ArticleId></ArticleIdList></Reference><Reference><Citation>Monaghan SF, Thakkar RK, Heffernan DS, Huang X, Chung CS, Lomas-Neira J, et al. . Mechanisms of indirect acute lung injury: a novel role for the coinhibitory receptor, programmed death-1. Ann Surg. (2012) 255:158&#x2013;64. 10.1097/SLA.0b013e31823433ca</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0b013e31823433ca</ArticleId><ArticleId IdType="pmc">PMC3243770</ArticleId><ArticleId IdType="pubmed">21997806</ArticleId></ArticleIdList></Reference><Reference><Citation>Monaghan SF, Thakkar RK, Tran ML, Huang X, Cioffi WG, Ayala A, et al. . Programmed death 1 expression as a marker for immune and physiological dysfunction in the critically ill surgical patient. Shock. (2012) 38:117&#x2013;22. 10.1097/SHK.0b013e31825de6a3</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0b013e31825de6a3</ArticleId><ArticleId IdType="pubmed">22683728</ArticleId></ArticleIdList></Reference><Reference><Citation>Lomas-Neira J, Chung CS, Perl M, Gregory S, Biffl W, Ayala A. Role of alveolar macrophage and migrating neutrophils in hemorrhage-induced priming for ALI subsequent to septic challenge. Am J Physiol Lung Cell Mol Physiol. (2006) 290:L51&#x2013;8. 10.1152/ajplung.00028.2005</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00028.2005</ArticleId><ArticleId IdType="pubmed">16157517</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Zhu S, Zhang Y, Li J, Sama AE, Wang P, et al. . Use of animal model of sepsis to evaluate novel herbal therapies. J Vis Exp. (2012):3926. 10.3791/3926</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/3926</ArticleId><ArticleId IdType="pmc">PMC3466661</ArticleId><ArticleId IdType="pubmed">22525208</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu P, Sodhi CP, Jia H, Shaffiey S, Good M, Branca MF, et al. . Animal models of gastrointestinal and liver diseases. Animal models of necrotizing enterocolitis: pathophysiology, translational relevance, and challenges. Am J Physiol Gastrointest Liver Physiol. (2014) 306:G917&#x2013;28. 10.1152/ajpgi.00422.2013</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpgi.00422.2013</ArticleId><ArticleId IdType="pmc">PMC4042110</ArticleId><ArticleId IdType="pubmed">24763555</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin PW, Stoll BJ. Necrotising enterocolitis. Lancet. (2006) 368:1271&#x2013;83. 10.1016/S0140-6736(06)69525-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(06)69525-1</ArticleId><ArticleId IdType="pubmed">17027734</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazarian KK, Perdue PW, Lynch W, Dziki A, Nevola J, Lee CH, et al. . Porcine peritoneal sepsis: modeling for clinical relevance. Shock. (1994) 1:201&#x2013;12. 10.1097/00024382-199403000-00008</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00024382-199403000-00008</ArticleId><ArticleId IdType="pubmed">7735952</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynn JL, Scumpia PO, Delano MJ, O'Malley KA, Ungaro R, Abouhamze A, et al. . Increased mortality and altered immunity in neonatal sepsis produced by generalized peritonitis. Shock. (2007) 28:675&#x2013;83. 10.1097/SHK.0b013e3180556d09</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0b013e3180556d09</ArticleId><ArticleId IdType="pubmed">17621256</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishida Y, Agata Y, Shibahara K, Honjo T. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J. (1992) 11:3887&#x2013;95. 10.1002/j.1460-2075.1992.tb05481.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/j.1460-2075.1992.tb05481.x</ArticleId><ArticleId IdType="pmc">PMC556898</ArticleId><ArticleId IdType="pubmed">1396582</ArticleId></ArticleIdList></Reference><Reference><Citation>Thibult ML, Mamessier E, Gertner-Dardenne J, Pastor S, Just-Landi S, Xerri L, et al. . PD-1 is a novel regulator of human B-cell activation. Int Immunol. (2013) 25:129&#x2013;37. 10.1093/intimm/dxs098</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxs098</ArticleId><ArticleId IdType="pubmed">23087177</ArticleId></ArticleIdList></Reference><Reference><Citation>Monaghan SF, Chung CS, Chen Y, Lomas-Neira J, Fairbrother WG, Heffernan DS, et al. . Soluble programmed cell death receptor-1 (sPD-1): a potential biomarker with anti-inflammatory properties in human and experimental acute respiratory distress syndrome (ARDS). J Transl Med. (2016) 14:312. 10.1186/s12967-016-1071-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-016-1071-x</ArticleId><ArticleId IdType="pmc">PMC5106799</ArticleId><ArticleId IdType="pubmed">27835962</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang X, Venet F, Wang YL, Lepape A, Yuan Z, Chen Y, et al. . PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis. Proc Natl Acad Sci USA. (2009) 106:6303&#x2013;8. 10.1073/pnas.0809422106</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0809422106</ArticleId><ArticleId IdType="pmc">PMC2669369</ArticleId><ArticleId IdType="pubmed">19332785</ArticleId></ArticleIdList></Reference><Reference><Citation>Young WA, Fallon EA, Heffernan DS, Efron PA, Cioffi WG, Ayala A. Improved survival after induction of sepsis by cecal slurry in PD-1 knockout murine neonates. Surgery. (2016) 36:240&#x2013;. 10.1016/j.surg.2016.11.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.surg.2016.11.008</ArticleId><ArticleId IdType="pmc">PMC5404993</ArticleId><ArticleId IdType="pubmed">28012568</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Chung CS, Chen Y, Monaghan SF, Patel S, Huang X, et al. . A novel role for programmed cell death receptor ligand-1 (PD-L1) in sepsis-induced intestinal dysfunction. Mol Med. (2017) 22:830&#x2013;40. 10.2119/molmed.2016.00150</Citation><ArticleIdList><ArticleId IdType="doi">10.2119/molmed.2016.00150</ArticleId><ArticleId IdType="pmc">PMC5263053</ArticleId><ArticleId IdType="pubmed">27782294</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung CS, Venet F, Chen Y, Jones LN, Wilson DC, Ayala CA, et al. . Deficiency of Bid protein reduces sepsis-induced apoptosis and inflammation, while improving septic survival. Shock. (2010) 34:150&#x2013;61. 10.1097/SHK.0b013e3181cf70fb</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0b013e3181cf70fb</ArticleId><ArticleId IdType="pmc">PMC2909339</ArticleId><ArticleId IdType="pubmed">20023601</ArticleId></ArticleIdList></Reference><Reference><Citation>Perl M, Chung CS, Perl U, Biffl WL, Cioffi WG, Ayala A. Beneficial versus detrimental effects of neutrophils are determined by the nature of the insult. J Am Coll Surg. (2007) 204:840&#x2013;52; discussion 852&#x2013;43. 10.1016/j.jamcollsurg.2007.02.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2007.02.023</ArticleId><ArticleId IdType="pubmed">17481496</ArticleId></ArticleIdList></Reference><Reference><Citation>Song GY, Chung CS, Jarrar D, Cioffi WG, Ayala A. Mechanism of immune dysfunction in sepsis: inducible nitric oxide-meditated alterations in p38 MAPK activation. J Trauma. (2002) 53:276&#x2013;82; discussion 282&#x2013;73. 10.1097/00005373-200208000-00015</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005373-200208000-00015</ArticleId><ArticleId IdType="pubmed">12169934</ArticleId></ArticleIdList></Reference><Reference><Citation>Biron BM, Chung CS, O'Brien XM, Chen Y, Reichner JS, Ayala A. Cl-Amidine prevents histone 3 citrullination and neutrophil extracellular trap formation, and improves survival in a murine sepsis model. J Innate Immun. (2017) 9:22&#x2013;32. 10.1159/000448808</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000448808</ArticleId><ArticleId IdType="pmc">PMC5219946</ArticleId><ArticleId IdType="pubmed">27622642</ArticleId></ArticleIdList></Reference><Reference><Citation>Ventetuolo CE, Aliotta JM, Braza J, Chichger H, Dooner M, McGuirl, et al. . Culture of pulmonary artery endothelial cells from pulmonary artery catheter balloon tips: considerations for use in pulmonary vascular disease. Eur Respir J. (2020) 55:1901313. 10.1183/13993003.01313-2019</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01313-2019</ArticleId><ArticleId IdType="pmc">PMC7147989</ArticleId><ArticleId IdType="pubmed">31949110</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrington EO, Newton J, Morin N, Rounds S. Barrier dysfunction and RhoA activation are blunted by homocysteine and adenosine in pulmonary endothelium. Am J Physiol Lung Cell Mol Physiol. (2004) 287:L1091&#x2013;7. 10.1152/ajplung.00421.2003</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00421.2003</ArticleId><ArticleId IdType="pubmed">15286003</ArticleId></ArticleIdList></Reference><Reference><Citation>De Paepe ME, Mao Q, Powell J, Rubin SE, DeKoninck P, Appel N, et al. . Growth of pulmonary microvasculature in ventilated preterm infants. Am J Respir Crit Care Med. (2006) 173:204&#x2013;11. 10.1164/rccm.200506-927OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200506-927OC</ArticleId><ArticleId IdType="pmc">PMC2662989</ArticleId><ArticleId IdType="pubmed">16210670</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S, Yang Q, Bai J, Tao T, Tang L, Chen Y, et al. . Blockade of endothelial, but not epithelial, cell expression of PD-L1 following severe shock attenuates the development of indirect acute lung injury in mice. Am J Physiol Lung Cell Mol Physiol. (2020) 318:L801&#x2013;12. 10.1152/ajplung.00108.2019</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00108.2019</ArticleId><ArticleId IdType="pmc">PMC7191484</ArticleId><ArticleId IdType="pubmed">31994912</ArticleId></ArticleIdList></Reference><Reference><Citation>Lomas-Neira J, Monaghan SF, Huang X, Fallon EA, Chung CS, Ayala A. Novel role for PD-1:PD-L1 as mediator of pulmonary vascular endothelial cell functions in pathogenesis of indirect ARDS in mice. Front Immunol. (2018) 9:3030. 10.3389/fimmu.2018.03030</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.03030</ArticleId><ArticleId IdType="pmc">PMC6306416</ArticleId><ArticleId IdType="pubmed">30619369</ArticleId></ArticleIdList></Reference><Reference><Citation>De Paepe ME, Shapiro S, Hansen K, G&#xfc;ndogan F. Postmortem lung volume/body weight standards for term and preterm infants. Pediatr Pulmonol. (2014) 49:60&#x2013;6. 10.1002/ppul.22818</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.22818</ArticleId><ArticleId IdType="pubmed">24039222</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevenson BR, Siliciano JD, Mooseker MS, Goodenough DA. Identification of ZO-1: a high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia. J Cell Biol. (1986) 103:755&#x2013;66. 10.1083/jcb.103.3.755</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.103.3.755</ArticleId><ArticleId IdType="pmc">PMC2114282</ArticleId><ArticleId IdType="pubmed">3528172</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang I, An BS, Yang H, Kang HS, Jung EM, Jeung EB. Tissue-specific expression of occludin, zona occludens-1, and junction adhesion molecule A in the duodenum, ileum, colon, kidney, liver, lung, brain, and skeletal muscle of C57BL mice. J Physiol Pharmacol. (2013) 64:11&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">23568966</ArticleId></ArticleIdList></Reference><Reference><Citation>Demaret J, Venet F, Plassais J, Cazalis MA, Vallin H, Friggeri A, et al. . Identification of CD177 as the most dysregulated parameter in a microarray study of purified neutrophils from septic shock patients. Immunol Lett. (2016) 178:122&#x2013;30. 10.1016/j.imlet.2016.08.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imlet.2016.08.011</ArticleId><ArticleId IdType="pubmed">27568821</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai M, Grieshaber-Bouyer R, Wang J, Schmider AB, Wilson ZS, Zeng L, et al. . CD177 modulates human neutrophil migration through activation-mediated integrin and chemoreceptor regulation. Blood. (2017) 130:2092&#x2013;100. 10.1182/blood-2017-03-768507</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2017-03-768507</ArticleId><ArticleId IdType="pmc">PMC5680608</ArticleId><ArticleId IdType="pubmed">28807980</ArticleId></ArticleIdList></Reference><Reference><Citation>Raymond SL, Hawkins RB, Murphy TJ, Rincon JC, Stortz JA, L&#xf3;pez MC, Ungaro R, et al. . Impact of toll-like receptor 4 stimulation on human neonatal neutrophil spontaneous migration, transcriptomics, and cytokine production. J Mol Med. (2018) 96:673&#x2013;84. 10.1007/s00109-018-1646-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00109-018-1646-5</ArticleId><ArticleId IdType="pmc">PMC6091213</ArticleId><ArticleId IdType="pubmed">29808244</ArticleId></ArticleIdList></Reference><Reference><Citation>Raymond SL, Mathias BJ, Murphy TJ, Rincon JC, L&#xf3;pez MC, Ungaro R, et al. . Neutrophil chemotaxis and transcriptomics in term and preterm neonates. Transl Res. (2017) 190:4&#x2013;15. 10.1016/j.trsl.2017.08.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2017.08.003</ArticleId><ArticleId IdType="pmc">PMC5705589</ArticleId><ArticleId IdType="pubmed">28873345</ArticleId></ArticleIdList></Reference><Reference><Citation>Gentile LF, Nacionales DC, Lopez MC, Vanzant E, Cuenca A, Szpila BE, et al. . Host responses to sepsis vary in different low-lethality murine models. PLoS ONE. (2014) 9:e94404. 10.1371/journal.pone.0094404</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0094404</ArticleId><ArticleId IdType="pmc">PMC4006924</ArticleId><ArticleId IdType="pubmed">24788351</ArticleId></ArticleIdList></Reference><Reference><Citation>Zasada M, Lenart M, Rutkowska-Zapa&#x142;a M, Stec M, Durlak W, Grudzie&#x144; A, et al. . Analysis of PD-1 expression in the monocyte subsets from non-septic and septic preterm neonates. PLoS ONE. (2017) 12:e0186819. 10.1371/journal.pone.0186819</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0186819</ArticleId><ArticleId IdType="pmc">PMC5648248</ArticleId><ArticleId IdType="pubmed">29049359</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayala A, Chung CS, Lomas JL, Song GY, Doughty LA, Gregory SH, et al. . Shock-induced neutrophil mediated priming for acute lung injury in mice: divergent effects of TLR-4 and TLR-4/FasL deficiency. Am J Pathol. (2002) 161:2283&#x2013;94. 10.1016/S0002-9440(10)64504-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9440(10)64504-X</ArticleId><ArticleId IdType="pmc">PMC1850899</ArticleId><ArticleId IdType="pubmed">12466142</ArticleId></ArticleIdList></Reference><Reference><Citation>Guignant C, Lepape A, Huang X, Kherouf H, Denis L, Poitevin F, et al. . Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients. Crit Care. (2011) 15:R99. 10.1186/cc10112</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc10112</ArticleId><ArticleId IdType="pmc">PMC3219369</ArticleId><ArticleId IdType="pubmed">21418617</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Acharya G, Elahy M, Xin H, Khachigian LM. The anthelmintic flubendazole blocks human melanoma growth and metastasis and suppresses programmed cell death protein-1 and myeloid-derived suppressor cell accumulation. Cancer Lett. (2019) 459:268&#x2013;76. 10.1016/j.canlet.2019.05.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.canlet.2019.05.026</ArticleId><ArticleId IdType="pubmed">31128215</ArticleId></ArticleIdList></Reference><Reference><Citation>Fallon EA, Chun TT, Young WA, Gray C, Ayala A, Heffernan DS. Program cell death receptor-1-mediated invariant natural killer t-cell control of peritoneal macrophage modulates survival in neonatal sepsis. Front Immunol. (2017) 8:1469. 10.3389/fimmu.2017.01469</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01469</ArticleId><ArticleId IdType="pmc">PMC5701916</ArticleId><ArticleId IdType="pubmed">29209308</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolognese AC, Yang WL, Hansen LW, Sharma A, Nicastro JM, Coppa GF, et al. . Activation of invariant natural killer T cells redirects the inflammatory response in neonatal sepsis. Front Immunol. (2018) 9:833. 10.3389/fimmu.2018.00833</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00833</ArticleId><ArticleId IdType="pmc">PMC5922987</ArticleId><ArticleId IdType="pubmed">29720984</ArticleId></ArticleIdList></Reference><Reference><Citation>Shalish W, Lakshminrusimha S, Manzoni P, Keszler M, Sant'Anna GM. COVID-19 and Neonatal respiratory care: current evidence and practical approach. Am J Perinatol. (2020) 37:780&#x2013;91. 10.1055/s-0040-1710522</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1710522</ArticleId><ArticleId IdType="pmc">PMC7356086</ArticleId><ArticleId IdType="pubmed">32359226</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38595207</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1536-3732</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>5</Issue><PubDate><MedlineDate>2024 Jul-Aug 01</MedlineDate></PubDate></JournalIssue><Title>The Journal of craniofacial surgery</Title><ISOAbbreviation>J Craniofac Surg</ISOAbbreviation></Journal><ArticleTitle>Profile of Facial Trauma Victims of Motorcycle Accidents: A Prospective Study.</ArticleTitle><Pagination><StartPage>1342</StartPage><EndPage>1345</EndPage><MedlinePgn>1342-1345</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/SCS.0000000000010103</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To outline the profile of patients with facial trauma, victims of motorcycle accidents, treated at the Hospital da Restaura&#xe7;&#xe3;o, Recife/PE, Brazil, from December 2020 to July 2021.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The collection was carried out through questionnaire and analysis of medical records. Data were analyzed descriptively, as well as Pearson's chi-square test or Fisher's exact test.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among the patients, 88.6% were male, 47.5% were between 18 and 29 years old, and 59.6% lived in rural areas; 72.15% of the victims used the motorcycle for work and 43.52% were working at the time of the accident. Most victims did not have a national motorcycle license (62%) and were not wearing a helmet at the time of the accident (60%), with 37.6% wearing a full-face helmet, 16.5% an open helmet, and 5.9% an articulated full-face helmet. Soft tissue injuries were the most prevalent. Zygomatic complex fractures were the most common facial fractures and were significantly associated with helmet use and type.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Most victims of motorcycle accidents are young adult men, without a regular driver's license and residing in rural areas. Preventive and educational actions and continuous traffic inspections are necessary to minimize these accidents.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 by Mutaz B. Habal, MD.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aires</LastName><ForeName>Carolina Chaves Gama</ForeName><Initials>CCG</Initials><AffiliationInfo><Affiliation>Department of Oral and Maxillofacial Surgery, Dental School of Pernambuco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vasconcellos</LastName><ForeName>Ricardo Jos&#xe9; de Holanda</ForeName><Initials>RJH</Initials><AffiliationInfo><Affiliation>Department of Dentistry, University of Pernambuco, Recife, Pernambuco, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ara&#xfa;jo</LastName><ForeName>Heitor Tavares de</ForeName><Initials>HT</Initials><AffiliationInfo><Affiliation>Department of Dentistry, University of Pernambuco, Recife, Pernambuco, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pereira</LastName><ForeName>Rebeca Valeska Soares</ForeName><Initials>RVS</Initials><AffiliationInfo><Affiliation>Department of Oral and Maxillofacial Surgery, Dental School of Pernambuco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Souza</LastName><ForeName>Rosa Rayanne Lins de</ForeName><Initials>RRL</Initials><AffiliationInfo><Affiliation>Department of Oral and Maxillofacial Surgery, Dental School of Pernambuco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andrade</LastName><ForeName>Emanuel Savio de Souza</ForeName><Initials>ESS</Initials><AffiliationInfo><Affiliation>Department of Dentistry, University of Pernambuco, Recife, Pernambuco, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vasconcelos</LastName><ForeName>Belmiro Cavalcanti do Egito</ForeName><Initials>BCDE</Initials><AffiliationInfo><Affiliation>Department of Oral and Maxillofacial Surgery, Dental School of Pernambuco.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Craniofac Surg</MedlineTA><NlmUniqueID>9010410</NlmUniqueID><ISSNLinking>1049-2275</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000063" MajorTopicYN="Y">Accidents, Traffic</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009049" MajorTopicYN="Y">Motorcycles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006260" MajorTopicYN="Y">Head Protective Devices</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005151" MajorTopicYN="Y">Facial Injuries</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001938" MajorTopicYN="N" Type="Geographic">Brazil</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017695" MajorTopicYN="N">Soft Tissue Injuries</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors report no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>23</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>10</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>10</Day><Hour>3</Hour><Minute>37</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38595207</ArticleId><ArticleId IdType="doi">10.1097/SCS.0000000000010103</ArticleId><ArticleId IdType="pii">00001665-990000000-01443</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Venugopal MG, Sinha R, Menon PS, et al. Fractures in the maxillofacial region: a four year retrospective study. Med J Armed Forces India 2010;66:14&#x2013;17</Citation></Reference><Reference><Citation>Brasileiro BF, Passeri LA. Epidemiological analysis of maxillofacial fractures in Brazil&#x202f;: a 5-year prospective study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;102:28&#x2013;34</Citation></Reference><Reference><Citation>Hsieh CH, Hsu SY, Hsieh HY, et al. Differences between the sexes in motorcycle-related injuries and fatalities at a Taiwanese level I trauma center. Biomed J 2017;40:113&#x2013;120</Citation></Reference><Reference><Citation>Liang C, Liu H, Rau C, et al. Motorcycle-related hospitalization of adolescents in a level I trauma center in southern Taiwan&#x202f;: a cross-sectional study. BMC Pediatr 2015;15:105&#x2013;112</Citation></Reference><Reference><Citation>Agbor AM, Chinedu AC, Ebot-Tabil B, et al. Dentofacial injuries in commercial motorcycle accidents in Cameroon: pattern and cost implication of care. Afr Health Sci 2014;14:77&#x2013;82</Citation></Reference><Reference><Citation>Cini MA,&#xa0;Prado BG, Hinnig Pde F, et al. Influence of type of helmet on facial trauma in motorcycle accidents. Br J Oral Maxillofac Surg 2014;52:789&#x2013;792</Citation></Reference><Reference><Citation>Abiodun A, Atinuke A, Yvonne O. Computerized tomography assessment of cranial and mid-facial fractures in patients following road traffic accident in South-West Nigeria. Ann Afr Med 2012;11:131&#x2013;138</Citation></Reference><Reference><Citation>Arangio P, Vellone V, Torre U, et al. Maxillofacial fractures in the province of Latina, Lazio, Italy: review of 400 injuries and 83 cases. J Cranio-Maxillofacial Surg 2014;42:583&#x2013;587</Citation></Reference><Reference><Citation>Munante-Cardenas JL, Nunes PHF, Passeri LA. Etiology, treatment, and complications of mandibular fractures. J Craniofac Surg 2015;26:611&#x2013;615</Citation></Reference><Reference><Citation>Strong EB, Gary C. Management of zygomaticomaxillary complex fractures. Facial Plast Surg Clin North Am 2017;25:547&#x2013;562</Citation></Reference><Reference><Citation>Aires CCG, Vasconcelos BCDE, Da Silva ICG. Profile and costs associated with the use of osteosynthesis materials in victims of traffic accidents. Dent Traumatol 2020;36:151&#x2013;155</Citation></Reference><Reference><Citation>Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Int J Surg 2014;12:1500&#x2013;1524</Citation></Reference><Reference><Citation>da N&#xf3;brega LM, de Macedo Bernardino &#xcd;, Leal PM, et al. Traffic accidents, maxillofacial injuries and risk factors: a systematic review of observational studies. J Evid Based Med 2019;12:3&#x2013;8</Citation></Reference><Reference><Citation>Choi SH, Gu JH, Kang DH. Analysis of traffic accident-related facial trauma. J Craniofac Surg 2016;27:1682&#x2013;1685</Citation></Reference><Reference><Citation>Abosadegh MM, Saddki N, Al-Tayar B, et al. Epidemiology of maxillofacial fractures at a teaching hospital in Malaysia: a retrospective study. Biomed Res Int 2019;2019:9024763</Citation></Reference><Reference><Citation>Obimakinde O, Olajuyin O, Rabiu T, et al. Crash characteristics and pattern of motorcycle related facial bone fractures in a sub-urban Nigerian teaching hospital. Niger J Surg 2018;24:71&#x2013;75</Citation></Reference><Reference><Citation>Peltola EM, Koivikko MP, Koskinen SK. The spectrum of facial fractures in motor vehicle accidents: an MDCT study of 374 patients. Emerg Radiol 2014;21:165&#x2013;171</Citation></Reference><Reference><Citation>Barbosa KGN, Lucas-Neto A, Gama BD, et al. Injuries and absenteeism among motorcycle taxi drivers who are victims of traffic accidents. J Forensic Leg Med 2014;26:15&#x2013;18</Citation></Reference><Reference><Citation>Santos MESM, Silva &#xc9;KP da, Rocha WBSS, et al. Epidemiologic features of facial trauma victims caused by motorcycle accidents. Brazilian J Oral Maxillofac Surg 2016;16:29&#x2013;38</Citation></Reference><Reference><Citation>Souto RMCV, Corassa RB, de Lima CM, et al. Helmet use and injury severity among crashed motorcyclists in Brazilian state capitals: an analysis of the violence an accidents survey 2017. Rev Bras Epidemiol 2020;23:1&#x2013;12</Citation></Reference><Reference><Citation>Porto DE, Ara&#xfa;jo JMDN, J&#xfa;nior CL. Pattern of maxillofacial trauma and associated factors in traffic accident victims. J Craniofacial Surg 2021;32:1010&#x2013;1013</Citation></Reference><Reference><Citation>Silva MG, Silva VL, Vilela MR, et al. Factors associated with speech-language disorders in motorcycle accident victims. Codas 2016;28:745&#x2013;752</Citation></Reference><Reference><Citation>Christian JM, Thomas RF, Scarbecz M. The incidence and pattern of maxillofacial injuries in helmeted versus non-helmeted motorcycle accident patients. J Oral Maxillofac Surg 2014;72:2503&#x2013;2506</Citation></Reference><Reference><Citation>Pita Neto IC, Franco JMPL, Junior JL, et al. Factors associated with the complexity of facial trauma. J Craniofac Surg 2018;29:e562&#x2013;e566</Citation></Reference><Reference><Citation>Oginni FO, Oladejo T, Alake DP, et al. Facial bone fractures in Ile-Ife, Nigeria&#x202f;: an update on pattern of presentation and care. J Maxillofac Oral Surg 2016;15:184&#x2013;190</Citation></Reference><Reference><Citation>Cavalcante DKF, Veloso SRM, Dur&#xe3;o MA, et al. Do helmet use and type influence facial trauma occurrence and severity in motorcyclists? A systematic review and meta-analysis. J Oral Maxillofac Surg 2021;79:1492&#x2013;1506</Citation></Reference><Reference><Citation>Soares-Carneiro SC, Vasconcelos BC, Matos da-Silva GS, et al. Alcohol abusive use increases facial trauma&#x202f;? Med Oral Patol Oral Cir Bucal 2016;21:547&#x2013;553</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26230536</PMID><DateCompleted><Year>2016</Year><Month>08</Month><Day>23</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1528-1159</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>19</Issue><PubDate><Year>2015</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>Spine</Title><ISOAbbreviation>Spine (Phila Pa 1976)</ISOAbbreviation></Journal><ArticleTitle>Timing of Complications After Spinal Fusion Surgery.</ArticleTitle><Pagination><StartPage>1527</StartPage><EndPage>1535</EndPage><MedlinePgn>1527-35</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/BRS.0000000000001073</ELocationID><Abstract><AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">Retrospective cohort study.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To characterize the timing of complications after spinal fusion procedures.</AbstractText><AbstractText Label="SUMMARY OF BACKGROUND DATA" NlmCategory="BACKGROUND">Despite many publications on risk factors for complications after spine surgery, there are few publications on the timing at which such complications occur.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Patients undergoing anterior cervical decompression and fusion (ACDF) or posterior lumbar fusion (PLF; with or without interbody) procedures during 2011-2013 were identified in the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database. For each of 8 different complications, the median time from surgery until complication was determined, along with the interquartile range and middle 80%.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 12,067 patients undergoing ACDF and 11,807 patients undergoing PLF were identified. For ACDF, the median day of diagnosis (and interquartile range; middle 80%) for anemia requiring transfusion was 0 (0-1; 0-2), myocardial infarction 2 (1-5; 0-15), pneumonia 4 (2-9; 1-14), pulmonary embolism 5 (2-9; 1-10), deep vein thrombosis 10.5 (7-16.5; 5-21), sepsis 10.5 (4-18; 1-23), surgical site infection 13 (8-19; 5-25), and urinary tract infection 17 (8-22; 4-26). For PLF, the median day of diagnosis (and interquartile range; middle 80%) for anemia requiring transfusion was 0 (0-1; 0-2), myocardial infarction 2 (1-4; 1-8), pneumonia 4 (2-9; 1-17), pulmonary embolism 5 (3-11; 2-17), urinary tract infection 7 (4-14; 2-23), deep vein thrombosis 8 (5-16; 3-20), sepsis 9 (4-16; 2-22), and surgical site infection 17 (13-22; 9-27).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">These precisely described postoperative time periods enable heightened clinical awareness among spine surgeons. Spine surgeons should have the lowest threshold for testing for each complication during the time period of greatest risk. Authors, reviewers, and surgeons utilizing research on postoperative complications should carefully consider the impact that the duration of follow-up has on study results.</AbstractText><AbstractText Label="LEVEL OF EVIDENCE" NlmCategory="METHODS">3.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bohl</LastName><ForeName>Daniel D</ForeName><Initials>DD</Initials><AffiliationInfo><Affiliation>*Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL &#x2020;Department of Orthopaedics and Rehabilitation, Yale School of Medicine, New Haven, CT; and &#x2021;Departments of Orthopaedic Surgery and Neurological Surgery, Thomas Jefferson University and The Rothman Institute, Philadelphia, PA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Webb</LastName><ForeName>Matthew L</ForeName><Initials>ML</Initials></Author><Author ValidYN="Y"><LastName>Lukasiewicz</LastName><ForeName>Adam M</ForeName><Initials>AM</Initials></Author><Author ValidYN="Y"><LastName>Samuel</LastName><ForeName>Andre M</ForeName><Initials>AM</Initials></Author><Author ValidYN="Y"><LastName>Basques</LastName><ForeName>Bryce A</ForeName><Initials>BA</Initials></Author><Author ValidYN="Y"><LastName>Ahn</LastName><ForeName>Junyoung</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Kern</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Vaccaro</LastName><ForeName>Alexander R</ForeName><Initials>AR</Initials></Author><Author ValidYN="Y"><LastName>Grauer</LastName><ForeName>Jonathan N</ForeName><Initials>JN</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Spine (Phila Pa 1976)</MedlineTA><NlmUniqueID>7610646</NlmUniqueID><ISSNLinking>0362-2436</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019299" MajorTopicYN="N">Decompression, Surgical</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008159" MajorTopicYN="N">Lumbar Vertebrae</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013123" MajorTopicYN="N">Spinal Fusion</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066231" MajorTopicYN="Y">Surgeons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>8</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>8</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26230536</ArticleId><ArticleId IdType="doi">10.1097/BRS.0000000000001073</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">34107989</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>11</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1746-160X</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jun</Month><Day>09</Day></PubDate></JournalIssue><Title>Head &amp; face medicine</Title><ISOAbbreviation>Head Face Med</ISOAbbreviation></Journal><ArticleTitle>Panoramic prediction equations to estimate implant- to-mandibular canal dimensions in the mandibular posterior region: implications for dental implant treatment.</ArticleTitle><Pagination><StartPage>19</StartPage><MedlinePgn>19</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">19</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13005-021-00270-6</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">To develop and cross-validate site-specific panoramic radiography (PAN) analysis prediction equations of implant-to-mandibular canal dimensions (IMCD) in mandibular regions posterior to the mental foramen, and to help determine in which instances CBCT technology will be a justified adjunct in clinical practice.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">IMCD by PAN (Pan-D) from implant site-specific regions (first premolar, second premolar, first molar, and second molar sites) were collected from 40- to 70-year-old adolescents. They were randomly assigned to validation (n&#x2009;=&#x2009;144) and cross-validation (n&#x2009;=&#x2009;148) groups. The cone-beam computed tomography (CBCT) technique was used as the criterion method for the estimation of IMCD (CBCT-D). The PAN analysis equations were developed using stepwise multiple regression analysis and cross-validated using the Bland-Altman approach.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">There was a significant relationship between PAN-D and CBCT-D for both validation (R<sup>2</sup>&#x2009;=&#x2009;57.8&#x2009;%; p&#x2009;&lt;&#x2009;.001) and cross-validation groups (R<sup>2</sup>&#x2009;=&#x2009;52.5&#x2009;%; p&#x2009;&lt;&#x2009;.001). Root means-squared error (RMSE) and pure error (PE) were highest for the first molar (RMSE&#x2009;=&#x2009;1.116 mm, PE&#x2009;=&#x2009;1.01 mm) and the second molar region (RMSE&#x2009;=&#x2009;1.162 mm, PE&#x2009;=&#x2009;1.11 mm).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">PAN-D has the potential to be developed as an indirect measure of IMCD. However, the findings suggest to exclude scoring of the first and second molars when assessing IMCD via PAN. Use of CBCT may be justified for all IMCD estimations in the first and second molars regions.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">This study has been registered and approved by the Ethics Committee of the Martin-Luther University, Halle, Germany (2020-034).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bertram</LastName><ForeName>Annika</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Otto von Guericke University of Magdeburg, Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eckert</LastName><ForeName>Alexander W</ForeName><Initials>AW</Initials><AffiliationInfo><Affiliation>University Clinic of Oral and Maxillofacial Surgery, Martin-Luther University, Halle-Wittenberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kolk</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University Clinic of Oral and Maxillofacial Surgery, Medical University of Innsbruck, Anichstra&#xdf;e 35, A-6020, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Emshoff</LastName><ForeName>R&#xfc;diger</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University Clinic of Oral and Maxillofacial Surgery, Medical University of Innsbruck, Anichstra&#xdf;e 35, A-6020, Innsbruck, Austria. ruediger.emshoff@tirol-kliniken.at.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Private Practice Oral and Maxillofacial Surgery, Freilassing, Germany. ruediger.emshoff@tirol-kliniken.at.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Head Face Med</MedlineTA><NlmUniqueID>101245792</NlmUniqueID><ISSNLinking>1746-160X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015921">Dental Implants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054893" MajorTopicYN="N">Cone-Beam Computed Tomography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015921" MajorTopicYN="Y">Dental Implants</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008334" MajorTopicYN="N">Mandible</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008964" MajorTopicYN="N">Molar, Third</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011862" MajorTopicYN="N">Radiography, Panoramic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cone-beam computed tomography</Keyword><Keyword MajorTopicYN="N">Dental implants</Keyword><Keyword MajorTopicYN="N">Mandibular canal</Keyword><Keyword MajorTopicYN="N">Mandibular edentulousness</Keyword><Keyword MajorTopicYN="N">Panoramic radiography</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>5</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>10</Day><Hour>5</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>6</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34107989</ArticleId><ArticleId IdType="pmc">PMC8188713</ArticleId><ArticleId IdType="doi">10.1186/s13005-021-00270-6</ArticleId><ArticleId IdType="pii">10.1186/s13005-021-00270-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Goodacre CJ, Bernal G, Rungcharassaeng K, Kan JY. Clinical complications with implants and implant prostheses. J Prosthet Dent. 2003;90:121&#x2013;32. doi: 10.1016/S0022-3913(03)00212-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3913(03)00212-9</ArticleId><ArticleId IdType="pubmed">12886205</ArticleId></ArticleIdList></Reference><Reference><Citation>Quirynen M, De Soete M, van Steenberghe D. Infectious risks for oral implants: A review of the literature. Clin Oral Implants Res. 2002;13:1&#x2013;19. doi: 10.1034/j.1600-0501.2002.130101.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1600-0501.2002.130101.x</ArticleId><ArticleId IdType="pubmed">12005139</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark D, Barbu H, Lorean A, Mijiritsky E, Levin L. Incidental findings of implant complications on postimplantation CBCTs: a cross-sectional study. Clin Implant Dent Relat Res. 2017:19: 776&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">28631287</ArticleId></ArticleIdList></Reference><Reference><Citation>Misch K, Wang H-L. Implant surgery complications: etiology and treatment. Implant Dent. 2008;17:159&#x2013;68. doi: 10.1097/ID.0b013e3181752f61.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ID.0b013e3181752f61</ArticleId><ArticleId IdType="pubmed">18545047</ArticleId></ArticleIdList></Reference><Reference><Citation>Rios HF, Borgnakke WS, Benavides E. The Use of Cone-Beam Computed Tomography in Management of Patients Requiring Dental Implants: An American Academy of Periodontology Best Evidence Review. J Periodontol. 2017;88:946&#x2013;59. doi: 10.1902/jop.2017.160548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1902/jop.2017.160548</ArticleId><ArticleId IdType="pubmed">28967330</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyndall DA, Brooks SL. Selection criteria for dental implant site imaging: a position paper of the American Academy of Oral and Maxillofacial Radiology. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;89:630&#x2013;7. doi: 10.1067/moe.2000.106336.</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/moe.2000.106336</ArticleId><ArticleId IdType="pubmed">10807723</ArticleId></ArticleIdList></Reference><Reference><Citation>Frei C, Buser D, Dula K. Study on the necessity for cross-section imaging of the posterior mandible for treatment planning of standard cases in implant dentistry. Clin Oral Implants Res. 2004;15:490&#x2013;7. doi: 10.1111/j.1600-0501.2004.01032.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0501.2004.01032.x</ArticleId><ArticleId IdType="pubmed">15248885</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris D, Buser D, Dula K, et al. E.A.O. guidelines fo the use of diagnostic imaging in implant dentistry. A consensus workshop organized by the European Association for Osseointegration in Trinity College Dublin. Clin Oral Implants Res. 2002;13:566&#x2013;70. doi: 10.1034/j.1600-0501.2002.130518.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1600-0501.2002.130518.x</ArticleId><ArticleId IdType="pubmed">12674118</ArticleId></ArticleIdList></Reference><Reference><Citation>Dula K, Mini R, van der Stelt PF, Buser D. The radiographic assessment of implant patients: decision-making criteria. Int J Oral Maxillofac Implants. 2001;16:80&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">11280366</ArticleId></ArticleIdList></Reference><Reference><Citation>Bornstein MM, Scarfe WC, Vaughn VM, Jacobs R. Cone Beam Computed Tomography in implant dentistry: a systematic review focusing on guidelines, indications, and radiation dose risks. Int J Oral Maxillofac Implants. 2014;29 Suppl:55&#x2013;77. doi: 10.11607/jomi.2014suppl.g1.4.</Citation><ArticleIdList><ArticleId IdType="doi">10.11607/jomi.2014suppl.g1.4</ArticleId><ArticleId IdType="pubmed">24660190</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vos W, Casselman J, Swennen GR. Cone-beam computerized tomography (CBCT) imaging of the oral and maxillofacial region: a systematic review of the literature. Int J Oral Maxillofac Surg. 2009;38:609&#x2013;25. doi: 10.1016/j.ijom.2009.02.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijom.2009.02.028</ArticleId><ArticleId IdType="pubmed">19464146</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonton JD, Azevedo B, Schindler WG, Hargreaves KM. Age- and gender-related differences in the position of the inferior alveolar nerve by using cone beam computed tomography. J Endod. 2009;35:944&#x2013;49. doi: 10.1016/j.joen.2009.04.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joen.2009.04.032</ArticleId><ArticleId IdType="pubmed">19567312</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine MH, Goddard AL, Dodson TB. Inferior alveolar nerve canal position: a clinical and radiographic study. J Oral Maxillofac Surg. 2007;65:470&#x2013;4. doi: 10.1016/j.joms.2006.05.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joms.2006.05.056</ArticleId><ArticleId IdType="pubmed">17307595</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo SS, Chumle WC. Statistical methods for the development and testing of predictive equations. In: Roche AF, Heymsfield SB, Lohman TG, editors. Human Body Composition. Champaign: Human Kinetics; 1996. pp. 191&#x2013;202.</Citation></Reference><Reference><Citation>Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 198;61:307&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">2868172</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhassani AA, AlGhamdi AS. Inferior alveolar nerve injury in implant dentistry: diagnosis, causes, prevention, and management. J Oral Implantol. 2010;36:401&#x2013;7. doi: 10.1563/AAID-JOI-D-09-00059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1563/AAID-JOI-D-09-00059</ArticleId><ArticleId IdType="pubmed">20545547</ArticleId></ArticleIdList></Reference><Reference><Citation>Angelopoulous C, Thomas SL, Hechler S, Parissis N, Hlavacek M. Comparison between digital panoramic radiography and cone-beam computed tomography for the identification of the mandibular canal as part of presurgical dental implant assessment. J Oral Maxillofac Surg. 2008;66:2130&#x2013;5. doi: 10.1016/j.joms.2008.06.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joms.2008.06.021</ArticleId><ArticleId IdType="pubmed">18848113</ArticleId></ArticleIdList></Reference><Reference><Citation>Burstein J, Mastin C, Le B. Avoiding injury to the inferior alveolar nerve by routine use of intraoperative radiographs during implant placement. J Oral Implantol. 2008;34:34&#x2013;8. doi: 10.1563/1548-1336(2008)34[34:AITTIA]2.0.CO;2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1563/1548-1336(2008)34[34:AITTIA]2.0.CO;2</ArticleId><ArticleId IdType="pubmed">18390241</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellies LG, Hawker PB. The prevalence of altered sensation associated with implant surgery. Int J Oral Maxillofac Implants. 1993;8:674&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">8181830</ArticleId></ArticleIdList></Reference><Reference><Citation>Wismeijer D, van Waas MA, Vermeeren JI, Kalk W. Patients&#x2019; perception of sensory disturbances of the mental nerve before and after implant surgery: a prospective study of 110 patients. Br J Oral Maxillofac Surg. 1997;35:254&#x2013;9. doi: 10.1016/S0266-4356(97)90043-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0266-4356(97)90043-7</ArticleId><ArticleId IdType="pubmed">9291263</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindh C, Petersson A. Radiologic examination for location of the mandibular canal. a comparison between panoramic radiography and conventional tomography. Int J Oral Maxillofac Implants. 1989;4:249&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">2639123</ArticleId></ArticleIdList></Reference><Reference><Citation>Naitoh M, Katsumata A, Kubota Y, Hayashi M, et al. Relationship between cancellous bone density and mandibular canal depiction. Implant Dent. 2009;18:112&#x2013;18. doi: 10.1097/ID.0b013e318198da7e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ID.0b013e318198da7e</ArticleId><ArticleId IdType="pubmed">19359861</ArticleId></ArticleIdList></Reference><Reference><Citation>Tantanapornkul W, Okouchi K, Fujiwara Y, et al. A comparative study of cone-beam computed tomography and conventional panoramic radiography in assessing the topographic relationship between the mandibular canal and impacted third molars. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103:253&#x2013;9. doi: 10.1016/j.tripleo.2006.06.060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tripleo.2006.06.060</ArticleId><ArticleId IdType="pubmed">17234544</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi K, Shimoda S, Nakagawa Y, Yamamoto A. Accuracy in measurement of distance using limited cone-beam computerized tomography. Int J Oral Maxillofac Implants. 2004;19:228&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">15101594</ArticleId></ArticleIdList></Reference><Reference><Citation>Lou L, Lagravere MO, Compton S, Major PW, Flores-Mir C. Accuracy of measurements and reliability of landmark identification with computed tomography techniques in the maxillofacial area: a systematic review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;104:402&#x2013;11. doi: 10.1016/j.tripleo.2006.07.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tripleo.2006.07.015</ArticleId><ArticleId IdType="pubmed">17709072</ArticleId></ArticleIdList></Reference><Reference><Citation>Scarfe WC, Farman AG, Sukovic P. Clinical applications of cone-beam computed tomography in dental practice. J Can Dent Assoc. 2006;72:75&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">16480609</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertram F, Bertram S, Rudisch A, Emshoff R. Assessment of Location of the Mandibular Canal: Correlation Between Panoramic and Cone Beam Computed Tomography Measurements. Int J Prosthodont. 2018;31:129&#x2013;34. doi: 10.11607/ijp.5430.</Citation><ArticleIdList><ArticleId IdType="doi">10.11607/ijp.5430</ArticleId><ArticleId IdType="pubmed">29448262</ArticleId></ArticleIdList></Reference><Reference><Citation>Peltola JS, Mattila M. Cross-sectional tomograms obtained with four panoramic radiographic units in the assessment of implant site measurements. Dentomaxillofac Radiol. 2004;33:295&#x2013;300. doi: 10.1259/dmfr/14606317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1259/dmfr/14606317</ArticleId><ArticleId IdType="pubmed">15585805</ArticleId></ArticleIdList></Reference><Reference><Citation>Potter BJ, Shrout MK, Russell CM, Sharawy M. Implant site assessment using panoramic cross-sectional tomographic imaging. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997;114:436&#x2013;42. doi: 10.1016/S1079-2104(97)90045-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1079-2104(97)90045-7</ArticleId><ArticleId IdType="pubmed">9347511</ArticleId></ArticleIdList></Reference><Reference><Citation>Vazquez L, Saulacic L, Belser U, Bernard JP. Efficacy of panoramic radiographs in the preoperative planning of posterior mandibular implants: a prospective clinical study of 1,527 consecutively treated patients. Clin Oral Implants Res. 2008;19:81&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">17956572</ArticleId></ArticleIdList></Reference><Reference><Citation>Sghaireen MG, Srivastava KC, Shrivastava D, et al. A CBCT based three-dimensional assessment of mandibular posterior region for evaluating the possibility of bypassing the inferior alveolar nerve while placing dental implants. Diagnostics (Basel) 2020;10:E406. doi: 10.3390/diagnostics10060406.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics10060406</ArticleId><ArticleId IdType="pmc">PMC7344927</ArticleId><ArticleId IdType="pubmed">32545908</ArticleId></ArticleIdList></Reference><Reference><Citation>Juodzbalys G, Wang HL, Sabalys G. Anatomy of mandibular vital structures. Part I: mandibular canal and inferior alveolar neurovascular bundle in relation with dental implantology. J Oral Maxillofac Res. 2010;1:e2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3886040</ArticleId><ArticleId IdType="pubmed">24421958</ArticleId></ArticleIdList></Reference><Reference><Citation>Yim JH, Ryu DM, Lee BS, Kwon YD. Analysis of digitalized panorama and cone beam computed tomographic image distortion for the diagnosis of dental implant surgery. J Craniofac Surg. 2011;22:669&#x2013;73. doi: 10.1097/SCS.0b013e31820745a7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SCS.0b013e31820745a7</ArticleId><ArticleId IdType="pubmed">21415634</ArticleId></ArticleIdList></Reference><Reference><Citation>Halperin-Sternfeld M, Machtei EE, Horwitz J. Diagnostic accuracy of cone beam computed tomography for dimensional linear measurements in the mandible. Int J Oral Maxillofac Implants. 2014;29:593&#x2013;9. doi: 10.11607/jomi.3409.</Citation><ArticleIdList><ArticleId IdType="doi">10.11607/jomi.3409</ArticleId><ArticleId IdType="pubmed">24818197</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikneshan S, Aval SH, Bakhshalian N, Shahab S, et al. Accuracy of linear measurement using cone-beam computed tomography at different reconstruction angles. Imaging Sci Dent. 2014;44:257&#x2013;62. doi: 10.5624/isd.2014.44.4.257.</Citation><ArticleIdList><ArticleId IdType="doi">10.5624/isd.2014.44.4.257</ArticleId><ArticleId IdType="pmc">PMC4245466</ArticleId><ArticleId IdType="pubmed">25473632</ArticleId></ArticleIdList></Reference><Reference><Citation>Fokas G, Vaughn VM, Scarfe WC, Bornstein MM. Accuracy of linear measurements on CBCT images related to presurgical implant treatment planning: A systematic review. Clin Oral Implants Res. 2018;29:393&#x2013;415. doi: 10.1111/clr.13142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/clr.13142</ArticleId><ArticleId IdType="pubmed">30328204</ArticleId></ArticleIdList></Reference><Reference><Citation>Pauwels R, Stamatakis H, Bosmans H, et al. Quantification of metal artifacts on cone beam computed tomography images. Clin Oral Implants Res. 2013;24:94&#x2013;9. doi: 10.1111/j.1600-0501.2011.02382.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0501.2011.02382.x</ArticleId><ArticleId IdType="pubmed">22168574</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulze RK, Berndt D, d&#x2019;Hoedt B. On cone-beam computed tomography artifacts induced by titanium implants. Clin Oral Implants Res. 2010;21:100&#x2013;7. doi: 10.1111/j.1600-0501.2009.01817.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0501.2009.01817.x</ArticleId><ArticleId IdType="pubmed">19845706</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24589368</PMID><DateCompleted><Year>2014</Year><Month>08</Month><Day>25</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1741-7015</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2014</Year><Month>Mar</Month><Day>04</Day></PubDate></JournalIssue><Title>BMC medicine</Title><ISOAbbreviation>BMC Med</ISOAbbreviation></Journal><ArticleTitle>A cohort study on the incidence and outcome of pulmonary embolism in trauma and orthopedic patients.</ArticleTitle><Pagination><StartPage>39</StartPage><MedlinePgn>39</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/1741-7015-12-39</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">This study aims to determine the incidence of pulmonary embolism (PE) in trauma and orthopedic patients within a regional tertiary referral center and its association with the pattern of injury, type of treatment, co-morbidities, thromboprophylaxis and mortality.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">All patients admitted to our institution between January 2010 and December 2011, for acute trauma or elective orthopedic procedures, were eligible to participate in this study. Our cohort was formed by identifying all patients with clinical features of PE who underwent Computed Tomography-Pulmonary Angiogram (CT-PA) to confirm or exclude the clinical suspicion of PE, within six months after the injury or the surgical procedure.Case notes and electronic databases were reviewed retrospectively to identify each patient's venous thromboembolism (VTE) risk factors, type of treatment, thromboprophylaxis and mortality.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Out of 18,151 patients admitted during the study period only 85 (0.47%) patients developed PE (positive CT-PA) (24 underwent elective surgery and 61 sustained acute trauma). Of these, only 76% of the patients received thromboprophylaxis. Hypertension, obesity and cardiovascular disease were the most commonly identifiable risk factors. In 39% of the cases, PE was diagnosed during the in-hospital stay. The median time of PE diagnosis, from the date of injury or the surgical intervention was 23 days (range 1 to 312). The overall mortality rate was 0.07% (13/18,151), but for those who developed PE it was 15.29% (13/85). Concomitant deep venous thrombosis (DVT) was identified in 33.3% of patients. The presence of two or more co-morbidities was significantly associated with the incidence of mortality (unadjusted odds ratio (OR) = 3.52, 95% confidence interval (CI) (1.34, 18.99), P = 0.034). Although there was also a similar clinical effect size for polytrauma injury on mortality (unadjusted OR = 1.90 (0.38, 9.54), P = 0.218), evidence was not statistically significant for this factor.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The incidence of VTE was comparable to previously reported rates, whereas the mortality rate was lower. Our local protocols that comply with the National Institute for Health and Clinical Excellence (NICE) guidelines in the UK appear to be effective in preventing VTE and reducing mortality in trauma and orthopedic patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gudipati</LastName><ForeName>Suribabu</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Fragkakis</LastName><ForeName>Evangelos M</ForeName><Initials>EM</Initials></Author><Author ValidYN="Y"><LastName>Ciriello</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Harrison</LastName><ForeName>Simon J</ForeName><Initials>SJ</Initials></Author><Author ValidYN="Y"><LastName>Stavrou</LastName><ForeName>Petros Z</ForeName><Initials>PZ</Initials></Author><Author ValidYN="Y"><LastName>Kanakaris</LastName><ForeName>Nikolaos K</ForeName><Initials>NK</Initials></Author><Author ValidYN="Y"><LastName>West</LastName><ForeName>Robert M</ForeName><Initials>RM</Initials></Author><Author ValidYN="Y"><LastName>Giannoudis</LastName><ForeName>Peter V</ForeName><Initials>PV</Initials><AffiliationInfo><Affiliation>Academic Department of Trauma and Orthopaedics, School of Medicine, University of Leeds, Leeds General Infirmary, Clarendon Wing Level A, Great George Street, LS1 3EX Leeds, West Yorkshire, UK. pgiannoudi@aol.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>03</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med</MedlineTA><NlmUniqueID>101190723</NlmUniqueID><ISSNLinking>1741-7015</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009026" MajorTopicYN="N">Mortality</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019637" MajorTopicYN="N">Orthopedic Procedures</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015912" MajorTopicYN="N">Thrombolytic Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014947" MajorTopicYN="N">Wounds and Injuries</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>8</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>2</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>8</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2014</Year><Month>3</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24589368</ArticleId><ArticleId IdType="pmc">PMC3996019</ArticleId><ArticleId IdType="doi">10.1186/1741-7015-12-39</ArticleId><ArticleId IdType="pii">1741-7015-12-39</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Markovic-Denic L, Zivkovic K, Lesic A, Bumbasirevic V, Dubljanin-Raspopovic ER, Bumbasirevic M. Risk factors and distribution of symptomatic venous thromboembolism in total hip and knee replacements: prospective study. Int Orthop. 2012;36:1299&#x2013;1305. doi: 10.1007/s00264-011-1466-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00264-011-1466-5</ArticleId><ArticleId IdType="pmc">PMC3353084</ArticleId><ArticleId IdType="pubmed">22215369</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ, Kakkar AK, Deslandes B, Huang W, Zayaruzny M, Emery L, Anderson FA Jr. ENDORSE Investigators. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet. 2008;371:387&#x2013;394. doi: 10.1016/S0140-6736(08)60202-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(08)60202-0</ArticleId><ArticleId IdType="pubmed">18242412</ArticleId></ArticleIdList></Reference><Reference><Citation>Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, Ray JG. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:338S&#x2013;400S. doi: 10.1378/chest.126.3_suppl.338S.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.126.3_suppl.338S</ArticleId><ArticleId IdType="pubmed">15383478</ArticleId></ArticleIdList></Reference><Reference><Citation>Linblad B, Sternby NH, Bergqvist D. Incidence of venous thromboembolism verified by necropsy over 30&#xa0;years. BMJ. 1991;302:709&#x2013;711. doi: 10.1136/bmj.302.6778.709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.302.6778.709</ArticleId><ArticleId IdType="pmc">PMC1669118</ArticleId><ArticleId IdType="pubmed">2021744</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandler DA, Martin JF. Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis? J R Soc Med. 1989;82:203&#x2013;205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1292084</ArticleId><ArticleId IdType="pubmed">2716016</ArticleId></ArticleIdList></Reference><Reference><Citation>Alikhan R, Peters F, Wilmott R, Cohen AT. Fatal pulmonary embolism in hospitalized patients: a necropsy review. J Clin Pathol. 2004;57:1254&#x2013;1257. doi: 10.1136/jcp.2003.013581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jcp.2003.013581</ArticleId><ArticleId IdType="pmc">PMC1770519</ArticleId><ArticleId IdType="pubmed">15563663</ArticleId></ArticleIdList></Reference><Reference><Citation>Prandoni P, Villalta S, Bagatella P, Rossi L, Marchiori A, Piccioli A, Bernardi E, Girolami B, Simioni P, Girolami A. The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients. Haematologica. 1997;82:423&#x2013;428.</Citation><ArticleIdList><ArticleId IdType="pubmed">9299855</ArticleId></ArticleIdList></Reference><Reference><Citation>Pengo V, Lensing AW, Prins MH, Marchiori A, Davidson BL, Tiozzo F, Albanese P, Biasiolo A, Pegoraro C, Iliceto S, Prandoni P. Thromboembolic Pulmonary Hypertension Study Group. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med. 2004;350:2257&#x2013;2264. doi: 10.1056/NEJMoa032274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa032274</ArticleId><ArticleId IdType="pubmed">15163775</ArticleId></ArticleIdList></Reference><Reference><Citation>Paffrath T, Wafaisade A, Lefering R, Simanski C, Bouillon B, Spanholtz T, Wutzler S, Maegele M. Trauma Registry of DGU. Venous thromboembolism after severe trauma: incidence, risk factors and outcome. Injury. 2010;41:97&#x2013;101. doi: 10.1016/j.injury.2009.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2009.06.010</ArticleId><ArticleId IdType="pubmed">19608183</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho KM, Burrell M, Rao S, Baker R. Incidence and risk factors for fatal pulmonary embolism after major trauma: a nested cohort study. Br J Anaesth. 2010;105:596&#x2013;602. doi: 10.1093/bja/aeq254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aeq254</ArticleId><ArticleId IdType="pmc">PMC2955535</ArticleId><ArticleId IdType="pubmed">20861095</ArticleId></ArticleIdList></Reference><Reference><Citation>Poultsides LA, Gonzalez Della Valle A, Memtsoudis SG, Ma Y, Roberts T, Sharrock N, Salvati E. Meta-analysis of cause of death following total joint replacement using different thromboprophylaxis regimens. J Bone Joint Surg Br. 2012;94:113&#x2013;121.</Citation><ArticleIdList><ArticleId IdType="pubmed">22219258</ArticleId></ArticleIdList></Reference><Reference><Citation>Januel JM, Chen G, Ruffieux C, Quan H, Douketis JD, Crowther MA, Colin C, Ghali WA, Burnand B. IMECCHI Group. Symptomatic in-hospital deep vein thrombosis and pulmonary embolism following hip and knee arthroplasty among patients receiving recommended prophylaxis a systematic review. JAMA. 2012;307:294&#x2013;303.</Citation><ArticleIdList><ArticleId IdType="pubmed">22253396</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramaniam RM, Blair D, Gilbert K, Sleigh J, Karalus N. Computed tomography pulmonary angiogram diagnosis of pulmonary embolism. Australas Radiol. 2006;50:193&#x2013;200. doi: 10.1111/j.1440-1673.2006.01561.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1673.2006.01561.x</ArticleId><ArticleId IdType="pubmed">16732813</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein PD, Fowler SE, Goodman LR, Gottschalk A, Hales CA, Hull RD, Leeper KV Jr, Popovich J Jr, Quinn DA, Sos TA, Sostman HD, Tapson VF, Wakefield TW, Weg JG, Woodard PK. PIOPED II Investigators. Multidetector computed tomography for acute pulmonary embolism. N Engl J Med. 2006;354:2317&#x2013;2327. doi: 10.1056/NEJMoa052367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa052367</ArticleId><ArticleId IdType="pubmed">16738268</ArticleId></ArticleIdList></Reference><Reference><Citation>Pruszczyk P, Torbicki A, Pacho R, Chlebus M, Kuch-Wocial A, Pruszynski B, Gurba H. Noninvasive diagnosis of suspected severe pulmonary embolism: transesophageal echocardiography vs. spiral CT. Chest. 1997;112:722&#x2013;728. doi: 10.1378/chest.112.3.722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.112.3.722</ArticleId><ArticleId IdType="pubmed">9315806</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE guidelines.  Venous thromboembolism - reducing the risk (CG92). [http treatment protocol:  http://guidance.nice.org.uk/CG92] Venous thromboembolism (surgical) (CG46) (replaced by CG92) http treatment protocol:  http://guidance.nice.org.uk/CG46.</Citation></Reference><Reference><Citation>Jim&#xe9;nez D, Aujesky D, Moores L, G&#xf3;mez V, Lobo JL, Uresandi F, Otero R, Monreal M, Muriel A, Yusen RD. RIETE Investigators. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med. 2010;170:1383&#x2013;1389. doi: 10.1001/archinternmed.2010.199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinternmed.2010.199</ArticleId><ArticleId IdType="pubmed">20696966</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen AT, Edmondson RA, Phillips MJ, Ward VP, Kakkar VV. The changing pattern of venous thromboembolic disease. Haemostasis. 1996;26:65&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">9119284</ArticleId></ArticleIdList></Reference><Reference><Citation>MacDonald D, Hobson S. VTE Prophylaxis for Elective Knee Replacement, eClinical VTE Guidelines Template. Leeds Teaching Hospitals Trust; Publication date: 1 July 2010.</Citation></Reference><Reference><Citation>MacDonald D, Hobson S. VTE Prophylaxis for Elective Hip Replacement, eClinical VTE Guidelines Template. Leeds Teaching Hospitals Trust; Publication date: 1 July 2010.</Citation></Reference><Reference><Citation>Rao A, Monkhouse R, Gummerson N, Hobson S. VTE Prophylaxis for Hip Fracture, eClinical VTE Guidelines Template. Leeds Teaching Hospitals Trust; Publication date: 1 July 2010.</Citation></Reference><Reference><Citation>Rao A, Monkhouse R, Gummerson N, Hobson S. VTE Prophylaxis for Other Orthopedic Surgery, eClinical VTE Guidelines Template. Leeds Teaching Hospitals Trust; Publication date: 1 July 2010.</Citation></Reference><Reference><Citation>Rao A, Monkhouse R, Gummerson N, Hobson S. VTE Prophylaxis for Lower Limb Plaster Casts, eClinical VTE Guidelines Template. Leeds Teaching Hospitals Trust; Publication date: 1 July 2010.</Citation></Reference><Reference><Citation>R Core Team. R: A language and environment for statistical computing.  Vienna, Austria: Foundation for Statistical Computing; 2013. URL  http://www.R-project.org/</Citation></Reference><Reference><Citation>Heit JA. The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol. 2008;28:370&#x2013;372. doi: 10.1161/ATVBAHA.108.162545.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.108.162545</ArticleId><ArticleId IdType="pmc">PMC2873781</ArticleId><ArticleId IdType="pubmed">18296591</ArticleId></ArticleIdList></Reference><Reference><Citation>Falck-Ytter Y, Francis CW, Johanson NA, Curley C, Dahl OE, Schulman S, Ortel TL, Pauker SG, Colwell CW Jr. American College of Chest Physicians. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 suppl):e278S&#x2013;e325S.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3278063</ArticleId><ArticleId IdType="pubmed">22315265</ArticleId></ArticleIdList></Reference><Reference><Citation>Jawa RS, Warren K, Young D, Wagner M, Nelson L, Yetter D, Banks S, Shostrom V, Stothert J. Venous thromboembolic disease in trauma and surveillance ultrasonography. J Surg Res. 2011;167:24&#x2013;31. doi: 10.1016/j.jss.2010.09.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2010.09.046</ArticleId><ArticleId IdType="pubmed">21176915</ArticleId></ArticleIdList></Reference><Reference><Citation>Huseynova K, Xiong W, Ray JG, Ahmed N, Nathens AB. Venous thromboembolism as a marker of quality of care in trauma. J Am Coll Surg. 2009;208:547&#x2013;552. doi: 10.1016/j.jamcollsurg.2009.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2009.01.002</ArticleId><ArticleId IdType="pubmed">19476788</ArticleId></ArticleIdList></Reference><Reference><Citation>Menaker J, Stein DM, Scalea TM. Incidence of early pulmonary embolism after injury. J Trauma. 2007;63:620&#x2013;624. doi: 10.1097/TA.0b013e31812f60aa.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e31812f60aa</ArticleId><ArticleId IdType="pubmed">18073610</ArticleId></ArticleIdList></Reference><Reference><Citation>McNamara I, Sharma A, Prevost T, Parker M. Symptomatic venous thromboembolism following a hip fracture. Acta Orthop. 2009;80:687&#x2013;692. doi: 10.3109/17453670903448273.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17453670903448273</ArticleId><ArticleId IdType="pmc">PMC2823318</ArticleId><ArticleId IdType="pubmed">19968601</ArticleId></ArticleIdList></Reference><Reference><Citation>Estrada-Y-Martin RM, Oldham SA. CTPA as the gold standard for the diagnosis of pulmonary embolism. Int J Comput Assist Radiol Surg. 2011;6:557&#x2013;563. doi: 10.1007/s11548-010-0526-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11548-010-0526-4</ArticleId><ArticleId IdType="pubmed">20689999</ArticleId></ArticleIdList></Reference><Reference><Citation>Vedovati MC, Becattini C, Agnelli G, Kamphuisen PW, Masotti L, Pruszczyk P, Casazza F, Salvi A, Grifoni S, Carugati A, Konstantinides S, Schreuder M, Golebiowski M, Duranti M. Multidetector CT for acute pulmonary embolism: embolic burden and clinical outcome. Chest. 2012;142(6):1417&#x2013;1424. doi: 10.1378/chest.11-2739.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.11-2739</ArticleId><ArticleId IdType="pubmed">22628491</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen AB, Sorensen HT, Mehnert F, Overgaard S, Johnsen SP. Risk factors for venous thromboembolism in patients undergoing total hip replacement and receiving routine thromboprophylaxis. J Bone Joint Surg Am. 2010;92:2156&#x2013;2164. doi: 10.2106/JBJS.I.00882.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.I.00882</ArticleId><ArticleId IdType="pubmed">20844157</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen AB, Mehnert F, Johnsen SP, Husted S, Sorensen HT. Venous thromboembolism in patients having knee replacement and receiving thromboprophylaxis: a Danish population-based follow-up study. J Bone Joint Surg Am. 2011;93:1281&#x2013;1287.</Citation><ArticleIdList><ArticleId IdType="pubmed">21792493</ArticleId></ArticleIdList></Reference><Reference><Citation>Dy CJ, Wilkinson JD, Tamariz L, Scully SP. Influence of preoperative cardiovascular risk factor clusters on complications of total joint arthroplasty. Am J Orthop (Belle Mead, NJ) 2011;40:560&#x2013;565.</Citation><ArticleIdList><ArticleId IdType="pubmed">22263208</ArticleId></ArticleIdList></Reference><Reference><Citation>Haut ER, Chang DC, Pierce CA, Colantuoni E, Efron DT, Haider AH, Cornwell EE 3rd, Pronovost PJ. Predictors of posttraumatic deep vein thrombosis (DVT): hospital practice versus patient factors - an analysis of the National Trauma Data Bank (NTDB) J Trauma. 2009;66:994&#x2013;1001. doi: 10.1097/TA.0b013e3181991adc.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e3181991adc</ArticleId><ArticleId IdType="pubmed">19359905</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers MA, Levine DA, Blumberg N, Flanders SA, Chopra V, Langa KM. Triggers of hospitalization for venous thromboembolism. Circulation. 2012;2012:125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3342773</ArticleId><ArticleId IdType="pubmed">22474264</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibuya N, Frost CH, Campbell JD, Davis ML, Jupiter DC. Incidence of acute deep vein thrombosis and pulmonary embolism in foot and ankle trauma: analysis of the National Trauma Data Bank. J Foot Ankle Surg. 2012;51:63&#x2013;68. doi: 10.1053/j.jfas.2011.10.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jfas.2011.10.017</ArticleId><ArticleId IdType="pubmed">22196459</ArticleId></ArticleIdList></Reference><Reference><Citation>Knudson MM, Ikossi DG, Khaw L, Morabito D, Speetzen LS. Thromboembolism after trauma: an analysis of 1602 episodes from the American College of Surgeons National Trauma Data Bank. Ann Surg. 2004;240:490&#x2013;498. doi: 10.1097/01.sla.0000137138.40116.6c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.sla.0000137138.40116.6c</ArticleId><ArticleId IdType="pmc">PMC1356439</ArticleId><ArticleId IdType="pubmed">15319720</ArticleId></ArticleIdList></Reference><Reference><Citation>Turkstra F, Kuijer PM, van Beek EJ, Brandjes DP, ten Cate JW, B&#xfc;ller HR. Diagnostic utility of ultrasonography of leg veins in patients suspected of having pulmonary embolism. Ann Intern Med. 1997;126:775&#x2013;781. doi: 10.7326/0003-4819-126-10-199705150-00005.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-126-10-199705150-00005</ArticleId><ArticleId IdType="pubmed">9148650</ArticleId></ArticleIdList></Reference><Reference><Citation>Cipolle MD, Wojcik R, Seislove E, Wasser TE, Pasquale MD. The role of surveillance duplex scanning in preventing venous thromboembolism in trauma patients. J Trauma. 2002;52:453&#x2013;462. doi: 10.1097/00005373-200203000-00007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005373-200203000-00007</ArticleId><ArticleId IdType="pubmed">11901319</ArticleId></ArticleIdList></Reference><Reference><Citation>Velmahos GC, Spaniolas K, Tabbara M, Abujudeh HH, de Moya M, Gervasini A, Alam HB. Pulmonary embolism and deep venous thrombosis in trauma: are they related? Arch Surg. 2009;144:928&#x2013;932. doi: 10.1001/archsurg.2009.97.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archsurg.2009.97</ArticleId><ArticleId IdType="pubmed">19841360</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37847947</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>30</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2468-7812</ISSN><JournalIssue CitedMedium="Internet"><Volume>68</Volume><PubDate><Year>2023</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Musculoskeletal science &amp; practice</Title><ISOAbbreviation>Musculoskelet Sci Pract</ISOAbbreviation></Journal><ArticleTitle>Effectiveness of different percutaneous electrolysis protocols in the endogenous modulation of pain: A Double-Blinded Randomized Clinical Trial.</ArticleTitle><Pagination><StartPage>102872</StartPage><MedlinePgn>102872</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.msksp.2023.102872</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2468-7812(23)00157-1</ELocationID><Abstract><AbstractText Label="OBJECTIVE">This randomized clinical trial investigated if the application of percutaneous electrolysis (PE) enhances endogenous pain mechanisms (EPM) when compared with a simple needle application (acting as sham).</AbstractText><AbstractText Label="METHODS">Forty-six asymptomatic subjects, aged 18-40 years, were randomized into three groups receiving a single ultrasound-guided PE intervention consisting of a needle insertion on the lateral epicondyle: sham (without electrical current), low-intensity (0.3&#xa0;mA, 90s), or high-intensity (three pulses of 3&#xa0;mA, 3s) PE. Widespread pressure pain thresholds (PPT), conditioned pain modulation (CPM), and temporal summation (TS) were bilaterally assessed in the lateral epicondyle, bicipital groove, transverse process of C5 and tibialis anterior muscle. Outcomes were obtained by an assessor blinded to the treatment allocation of the subjects.</AbstractText><AbstractText Label="RESULTS">No significant changes in CPM were observed in either group (omnibus ANOVA all, P&#xa0;&gt;&#xa0;.05). A significant bilateral increase in PPT in the lateral epicondyle in the high intensity group as compared with the sham group was observed (P&#xa0;&lt;&#xa0;.01). A significant decrease of TS in both low (P&#xa0;=&#xa0;.002) and high (P&#xa0;=&#xa0;.049) intensity groups on the right, but not on the left, tibialis anterior was also observed when compared with the sham group.</AbstractText><AbstractText Label="CONCLUSIONS">One session of PE is able to slightly stimulate modulatory pathways related to nociceptive gain, particularly pressure pain sensitivity and temporal summation but not conditioning pain modulation, when compared with a sham needle intervention, with changes even contralaterally. No significant differences were found between low- and high-intensity doses of percutaneous electrolysis.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>S&#xe1;nchez-Gonz&#xe1;lez</LastName><ForeName>Juan L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Nursery and Physiotherapy, Faculty of Nursery and Physiotherapy, University of Salamanca, 37007, Salamanca, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Navarro-L&#xf3;pez</LastName><ForeName>V&#xed;ctor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>International Doctoral School, Faculty of Health Sciences, Rey Juan Carlos University, 28922, Madrid, Spain; Department of Physical Therapy, Occupational Therapy, Rehabilitation and Physical Medicine, Rey Juan Carlos University, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calder&#xf3;n-D&#xed;ez</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Nursery and Physiotherapy, Faculty of Nursery and Physiotherapy, University of Salamanca, 37007, Salamanca, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varela-Rodr&#xed;guez</LastName><ForeName>Sergio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Nursery and Physiotherapy, Faculty of Nursery and Physiotherapy, University of Salamanca, 37007, Salamanca, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-de-Las-Pe&#xf1;as</LastName><ForeName>C&#xe9;sar</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Physical Therapy, Occupational Therapy, Rehabilitation and Physical Medicine, Rey Juan Carlos University, Madrid, Spain; C&#xe1;tedra de Investigaci&#xf3;n y Docencia en Fisioterapia: Terapia Manual y Punci&#xf3;n Seca, Universidad Rey Juan Carlos, Alcorc&#xf3;n, Madrid, Spain. Electronic address: cesar.fernandez@urjc.es.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xe1;nchez-S&#xe1;nchez</LastName><ForeName>Jos&#xe9; L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Nursery and Physiotherapy, Faculty of Nursery and Physiotherapy, University of Salamanca, 37007, Salamanca, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04710992</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Musculoskelet Sci Pract</MedlineTA><NlmUniqueID>101692753</NlmUniqueID><ISSNLinking>2468-7812</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020393" MajorTopicYN="Y">Manipulation, Spinal</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010146" MajorTopicYN="Y">Pain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010147" MajorTopicYN="N">Pain Measurement</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017288" MajorTopicYN="N">Pain Threshold</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012782" MajorTopicYN="N">Shoulder</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Electrolysis percutaneous</Keyword><Keyword MajorTopicYN="N">Endogenous pain</Keyword><Keyword MajorTopicYN="N">Pain</Keyword><Keyword MajorTopicYN="N">Randomized controlled trial</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>27</Day><Hour>12</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>17</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>17</Day><Hour>18</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37847947</ArticleId><ArticleId IdType="doi">10.1016/j.msksp.2023.102872</ArticleId><ArticleId IdType="pii">S2468-7812(23)00157-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34584149</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>27</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Sep</Month><Day>28</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>A nested case-control study of risk for pulmonary embolism in the general trauma population using nationwide trauma registry data in Japan.</ArticleTitle><Pagination><StartPage>19192</StartPage><MedlinePgn>19192</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">19192</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-021-98692-4</ELocationID><Abstract><AbstractText>Post-trauma patients are at great risk of pulmonary embolism (PE), however, data assessing specific risk factors for post-traumatic PE are scarce. This was a nested case-control study using the Japan Trauma Data Bank between 2004 and 2017. We enrolled patients aged&#x2009;&#x2265;&#x2009;16&#xa0;years, Injury Severity Score&#x2009;&#x2265;&#x2009;9, and length of hospital stay&#x2009;&#x2265;&#x2009;2&#xa0;days, with PE and without PE, using propensity score matching. We conducted logistic regression analyses to examine risk factors for PE. We included 719 patients with PE and 3595 patients without PE. Of these patients, 1864 [43.2%] were male, and their median Interquartile Range (IQR) age was 73 [55-84] years. The major mechanism of injury was blunt (4282 [99.3%]). Median [IQR] Injury Severity Score (ISS) was 10 [9-18]. In the multivariate analysis, the variables spinal injury [odds ratio (OR), 1.40 (1.03-1.89)]; long bone open fracture in upper extremity and lower extremity [OR, 1.51 (1.06-2.15) and OR, 3.69 (2.89-4.71), respectively]; central vein catheter [OR, 2.17 (1.44-3.27)]; and any surgery [OR, 4.48 (3.46-5.81)] were independently associated with PE. Spinal injury, long bone open fracture in extremities, central vein catheter placement, and any surgery were risk factors for post-traumatic PE. Prompt initiation of prophylaxis is needed for patients with such trauma.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Iriyama</LastName><ForeName>Hiroki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Faculty of Medicine, Juntendo University, 2-1-2 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Komori</LastName><ForeName>Akira</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Faculty of Medicine, Juntendo University, 2-1-2 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kainoh</LastName><ForeName>Takako</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Faculty of Medicine, Juntendo University, 2-1-2 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kondo</LastName><ForeName>Yutaka</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu, Chiba, 270-0021, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naito</LastName><ForeName>Toshio</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Faculty of Medicine, Juntendo University, 2-1-2 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abe</LastName><ForeName>Toshikazu</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Health Services Research, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8577, Japan. abetoshi111@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Services Research and Development Center, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8577, Japan. abetoshi111@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, Tsukuba Memorial Hospital, 1187-299 Kaname, Tsukuba, Ibaraki, 300-2622, Japan. abetoshi111@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002405" MajorTopicYN="N">Catheterization, Central Venous</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007564" MajorTopicYN="N" Type="Geographic">Japan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057216" MajorTopicYN="N">Propensity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015599" MajorTopicYN="N">Trauma Severity Indices</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014947" MajorTopicYN="N">Wounds and Injuries</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>9</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34584149</ArticleId><ArticleId IdType="pmc">PMC8478977</ArticleId><ArticleId IdType="doi">10.1038/s41598-021-98692-4</ArticleId><ArticleId IdType="pii">10.1038/s41598-021-98692-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Knudson MM, Collins JA, Goodman SB, McCrory DW. Thromboembolism following multiple trauma. J. Trauma. 1992;32:2&#x2013;11. doi: 10.1097/00005373-199201000-00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005373-199201000-00002</ArticleId><ArticleId IdType="pubmed">1732568</ArticleId></ArticleIdList></Reference><Reference><Citation>Gudipati S, et al. A cohort study on the incidence and outcome of pulmonary embolism in trauma and orthopedic patients. BMC Med. 2014;12:39. doi: 10.1186/1741-7015-12-39.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1741-7015-12-39</ArticleId><ArticleId IdType="pmc">PMC3996019</ArticleId><ArticleId IdType="pubmed">24589368</ArticleId></ArticleIdList></Reference><Reference><Citation>Knudson MM, Ikossi DG, Khaw L, Morabito D, Speetzen LS. Thromboembolism after trauma: An analysis of 1602 episodes from the American College of Surgeons National Trauma Data Bank. Ann. Surg. 2004;240:490&#x2013;498. doi: 10.1097/01.sla.0000137138.40116.6c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.sla.0000137138.40116.6c</ArticleId><ArticleId IdType="pmc">PMC1356439</ArticleId><ArticleId IdType="pubmed">15319720</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultz DJ, et al. Incidence of asymptomatic pulmonary embolism in moderately to severely injured trauma patients. J. Trauma. 2004;56:727&#x2013;733. doi: 10.1097/01.TA.0000119687.23542.EC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.TA.0000119687.23542.EC</ArticleId><ArticleId IdType="pubmed">15187734</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuttle-Newhall JE, Rutledge R, Hultman CS, Fakhry SM. Statewide, population-based, time-series analysis of the frequency and outcome of pulmonary embolus in 318,554 trauma patients. J. Trauma. 1997;42:90&#x2013;99. doi: 10.1097/00005373-199701000-00016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005373-199701000-00016</ArticleId><ArticleId IdType="pubmed">9003264</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Malley KF, Ross SE. Pulmonary embolism in major trauma patients. J. Trauma. 1990;30:748&#x2013;750. doi: 10.1097/00005373-199006000-00018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005373-199006000-00018</ArticleId><ArticleId IdType="pubmed">2352304</ArticleId></ArticleIdList></Reference><Reference><Citation>Netto FS, et al. Pulmonary emboli after blunt trauma: Timing, clinical characteristics and natural history. Injury. 2012;43:1502&#x2013;1506. doi: 10.1016/j.injury.2010.12.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2010.12.028</ArticleId><ArticleId IdType="pubmed">21722897</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers FB, et al. Determining venous thromboembolic risk assessment for patients with trauma: The trauma embolic scoring system. J. Trauma Acute Care Surg. 2012;73:511&#x2013;515. doi: 10.1097/TA.0b013e3182588b54.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e3182588b54</ArticleId><ArticleId IdType="pubmed">23019680</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeremitsky E, Germain NS, Kao AH, Ong AW, Smith RS. Risk of pulmonary embolism in trauma patients: Not all created equal. Surgery. 2013;154:810&#x2013;815. doi: 10.1016/j.surg.2013.04.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.surg.2013.04.045</ArticleId><ArticleId IdType="pubmed">24074419</ArticleId></ArticleIdList></Reference><Reference><Citation>Meizoso JP, et al. A simplified stratification system for venous thromboembolism risk in severely injured trauma patients. J. Surg. Res. 2017;207:138&#x2013;144. doi: 10.1016/j.jss.2016.08.072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2016.08.072</ArticleId><ArticleId IdType="pubmed">27979470</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoyt DB, et al. A risk analysis of pulmonary complications following major trauma. J. Trauma. 1993;35:524&#x2013;531. doi: 10.1097/00005373-199310000-00005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005373-199310000-00005</ArticleId><ArticleId IdType="pubmed">8411274</ArticleId></ArticleIdList></Reference><Reference><Citation>Azu MC, McCormack JE, Huang EC, Lee TK, Shapiro MJ. Venous thromboembolic events in hospitalized trauma patients. Am. Surg. 2007;73:1228&#x2013;1231. doi: 10.1177/000313480707301206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/000313480707301206</ArticleId><ArticleId IdType="pubmed">18186377</ArticleId></ArticleIdList></Reference><Reference><Citation>Paffrath T, et al. Venous thromboembolism after severe trauma: Incidence, risk factors and outcome. Injury. 2010;41:97&#x2013;101. doi: 10.1016/j.injury.2009.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2009.06.010</ArticleId><ArticleId IdType="pubmed">19608183</ArticleId></ArticleIdList></Reference><Reference><Citation>Lichte P, et al. Post-traumatic thrombo-embolic complications in polytrauma patients. Int. Orthop. 2015;39:947&#x2013;954. doi: 10.1007/s00264-015-2698-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00264-015-2698-6</ArticleId><ArticleId IdType="pubmed">25690923</ArticleId></ArticleIdList></Reference><Reference><Citation>Brakenridge SC, et al. Comparing clinical predictors of deep venous thrombosis versus pulmonary embolus after severe injury: A new paradigm for posttraumatic venous thromboembolism? J. Trauma Acute Care Surg. 2013;74:1231&#x2013;1238.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3716365</ArticleId><ArticleId IdType="pubmed">23609272</ArticleId></ArticleIdList></Reference><Reference><Citation>Benns M, Reilly P, Kim P. Early pulmonary embolism after injury: A different clinical entity? Injury. 2014;45:241&#x2013;244. doi: 10.1016/j.injury.2013.02.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2013.02.026</ArticleId><ArticleId IdType="pubmed">23518042</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim KS, Brophy GM. Symptomatic venous thromboembolism: Incidence and risk factors in patients with spontaneous or traumatic intracranial hemorrhage. Neurocrit. Care. 2009;11:28&#x2013;33. doi: 10.1007/s12028-009-9201-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12028-009-9201-4</ArticleId><ArticleId IdType="pubmed">19238588</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe T, et al. Trauma complications and in-hospital mortality: Failure-to-rescue. Crit. Care. 2020;24:223. doi: 10.1186/s13054-020-02951-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-02951-1</ArticleId><ArticleId IdType="pmc">PMC7226721</ArticleId><ArticleId IdType="pubmed">32414401</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultz, D. J. et al. Incidence of asymptomatic pulmonary embolism in moderately to severely injured trauma patients. J. Trauma56, 727&#x2013;731; discussion 731&#x2013;723 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15187734</ArticleId></ArticleIdList></Reference><Reference><Citation>Selby R, et al. Hypercoagulability after trauma: Hemostatic changes and relationship to venous thromboembolism. Thromb. Res. 2009;124:281&#x2013;287. doi: 10.1016/j.thromres.2008.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2008.10.002</ArticleId><ArticleId IdType="pubmed">19041119</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrera, L. M. et al. Thromboprophylaxis for trauma patients. Cochrane Database Syst. Rev. CD008303 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23543562</ArticleId></ArticleIdList></Reference><Reference><Citation>Knudson MM, Gomez D, Haas B, Cohen MJ, Nathens AB. Three thousand seven hundred thirty-eight posttraumatic pulmonary emboli: A new look at an old disease. Ann. Surg. 2011;254:625&#x2013;632. doi: 10.1097/SLA.0b013e3182300209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0b013e3182300209</ArticleId><ArticleId IdType="pubmed">21869675</ArticleId></ArticleIdList></Reference><Reference><Citation>Geerts WH, Code KI, Jay RM, Chen E, Szalai JP. A prospective study of venous thromboembolism after major trauma. N. Engl. J. Med. 1994;331:1601&#x2013;1606. doi: 10.1056/NEJM199412153312401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199412153312401</ArticleId><ArticleId IdType="pubmed">7969340</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallier HA, Cureton BA, Ekstein C, Oldenburg FP, Wilber JH. Early definitive stabilization of unstable pelvis and acetabulum fractures reduces morbidity. J. Trauma. 2010;69:677&#x2013;684.</Citation><ArticleIdList><ArticleId IdType="pubmed">20838139</ArticleId></ArticleIdList></Reference><Reference><Citation>Haas B, Gomez D, Hemmila MR, Nathens AB. Prevention of complications and successful rescue of patients with serious complications: Characteristics of high-performing trauma centers. J. Trauma. 2011;70:575&#x2013;582.</Citation><ArticleIdList><ArticleId IdType="pubmed">21610345</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team. R: A Language and Environment for Statistical Computing. https://www.R-project.org (2019).</Citation></Reference><Reference><Citation>Blann AD. How a damaged blood vessel wall contibutes to thrombosis and hypertension. Pathophysiol. Haemost. Thromb. 2003;33:445&#x2013;448. doi: 10.1159/000083843.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000083843</ArticleId><ArticleId IdType="pubmed">15692258</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson PI, Stensballe J, Rasmussen LS, Ostrowski SR. A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients. Ann. Surg. 2011;254:194&#x2013;200. doi: 10.1097/SLA.0b013e318226113d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0b013e318226113d</ArticleId><ArticleId IdType="pubmed">21772125</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelman DT, Gabram SG, Allen L, Ens GE, Jacobs LM. Hypercoagulability following multiple trauma. World J. Surg. 1996;20:5&#x2013;10. doi: 10.1007/s002689900001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s002689900001</ArticleId><ArticleId IdType="pubmed">8588412</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowe GDO. Virchow&#x2019;s triad revisited: Abnormal flow. Pathophysiol. Haemost. Thromb. 2003;33:455&#x2013;457. doi: 10.1159/000083845.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000083845</ArticleId><ArticleId IdType="pubmed">15692260</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii Y, et al. Thrombosis in spinal cord injury. Thromb. Res. 1992;68:357&#x2013;368. doi: 10.1016/0049-3848(92)90094-Q.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0049-3848(92)90094-Q</ArticleId><ArticleId IdType="pubmed">1290164</ArticleId></ArticleIdList></Reference><Reference><Citation>Aito S, Pieri A, D'Andrea M, Marcelli F, Cominelli E. Primary prevention of deep venous thrombosis and pulmonary embolism in acute spinal cord injured patients. Spinal Cord. 2002;40:300&#x2013;303. doi: 10.1038/sj.sc.3101298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.sc.3101298</ArticleId><ArticleId IdType="pubmed">12037712</ArticleId></ArticleIdList></Reference><Reference><Citation>Merli GJ, Crabbe S, Paluzzi RG, Fritz D. Etiology, incidence, and prevention of deep vein thrombosis in acute spinal cord injury. Arch. Phys. Med. Rehabil. 1993;74:1199&#x2013;1205.</Citation><ArticleIdList><ArticleId IdType="pubmed">8239962</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahl V, et al. A validation study of a retrospective venous thromboembolism risk scoring method. Ann. Surg. 2010;251:344&#x2013;350. doi: 10.1097/SLA.0b013e3181b7fca6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0b013e3181b7fca6</ArticleId><ArticleId IdType="pubmed">19779324</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy MM, Albuquerque F, Pfeifer JD. Low incidence of pulmonary embolism associated with upper-extremity deep venous thrombosis. Ann. Vasc. Surg. 2012;26:964&#x2013;972. doi: 10.1016/j.avsg.2011.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.avsg.2011.12.016</ArticleId><ArticleId IdType="pubmed">22749742</ArticleId></ArticleIdList></Reference><Reference><Citation>Brakenridge SC, Toomay SM, Sheng JL, Gentilello LM, Shafi S. Predictors of early versus late timing of pulmonary embolus after traumatic injury. Am. J. Surg. 2011;201:209&#x2013;215. doi: 10.1016/j.amjsurg.2009.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjsurg.2009.12.005</ArticleId><ArticleId IdType="pmc">PMC5575912</ArticleId><ArticleId IdType="pubmed">20385370</ArticleId></ArticleIdList></Reference><Reference><Citation>Coleman JJ, et al. Factors associated with pulmonary embolism within 72 hours of admission after trauma: A multicenter study. J. Am. Coll. Surg. 2015;220:731&#x2013;736. doi: 10.1016/j.jamcollsurg.2014.12.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2014.12.032</ArticleId><ArticleId IdType="pubmed">25724603</ArticleId></ArticleIdList></Reference><Reference><Citation>Gambhir S, et al. Early versus late pulmonary embolism in trauma patients: Not all pulmonary embolisms are created similarly. J. Surg. Res. 2019;239:174&#x2013;179. doi: 10.1016/j.jss.2019.02.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2019.02.018</ArticleId><ArticleId IdType="pubmed">30836300</ArticleId></ArticleIdList></Reference><Reference><Citation>Brundage SI, McGhan R, Jurkovich GJ, Mack CD, Maier RV. Timing of femur fracture fixation: Effect on outcome in patients with thoracic and head injuries. J. Trauma. 2002;52:299&#x2013;307.</Citation><ArticleIdList><ArticleId IdType="pubmed">11834992</ArticleId></ArticleIdList></Reference><Reference><Citation>Nahm NJ, Como JJ, Wilber JH, Vallier HA. Early appropriate care: Definitive stabilization of femoral fractures within 24 hours of injury is safe in most patients with multiple injuries. J. Trauma. 2011;71:175&#x2013;185.</Citation><ArticleIdList><ArticleId IdType="pubmed">21336198</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvin JA, et al. Early femur fracture fixation is associated with a reduction in pulmonary complications and hospital charges: A decade of experience with 1,376 diaphyseal femur fractures. J. Trauma Acute Care Surg. 2012;73:1442&#x2013;1449. doi: 10.1097/TA.0b013e3182782696.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e3182782696</ArticleId><ArticleId IdType="pubmed">23188236</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne JP, Nathens AB, Gomez D, Pincus D, Jenkinson RJ. Timing of femoral shaft fracture fixation following major trauma: A retrospective cohort study of United States trauma centers. PLoS Med. 2017;14:e1002336. doi: 10.1371/journal.pmed.1002336.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1002336</ArticleId><ArticleId IdType="pmc">PMC5497944</ArticleId><ArticleId IdType="pubmed">28678793</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuroiwa M, et al. Changes in the incidence, case fatality rate, and characteristics of symptomatic perioperative pulmonary thromboembolism in Japan: Results of the 2002&#x2013;2011 Japanese Society of Anesthesiologists Perioperative Pulmonary Thromboembolism (JSA-PTE) study. J. Anesth. 2015;29:433&#x2013;441. doi: 10.1007/s00540-014-1939-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-014-1939-y</ArticleId><ArticleId IdType="pubmed">25412800</ArticleId></ArticleIdList></Reference><Reference><Citation>Gangireddy, C. et al. Risk factors and clinical impact of postoperative symptomatic venous thromboembolism. J. Vasc. Surg.45, 335&#x2013;341; discussion 341&#x2013;332 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17264013</ArticleId></ArticleIdList></Reference><Reference><Citation>Organisation for Economic Co-operation and Development. Computed Tomography (CT) Scanners (Indicator). https://data.oecd.org/healtheqt/computed-tomography-ct-scanners.htm#indicator-chart (2021).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25456730</PMID><DateCompleted><Year>2015</Year><Month>11</Month><Day>17</Day></DateCompleted><DateRevised><Year>2017</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-2472</ISSN><JournalIssue CitedMedium="Internet"><Volume>135</Volume><Issue>1</Issue><PubDate><Year>2015</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Thrombosis research</Title><ISOAbbreviation>Thromb Res</ISOAbbreviation></Journal><ArticleTitle>Prognostic role of heart-type fatty acid binding protein in pulmonary embolism: a meta-analysis.</ArticleTitle><Pagination><StartPage>20</StartPage><EndPage>25</EndPage><MedlinePgn>20-5</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.thromres.2014.10.007</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0049-3848(14)00531-3</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Pulmonary embolism (PE) has a high morbidity and mortality. Hence it is important to recognize factors associated with higher risk of adverse outcomes in hemodynamically stable patients. Heart-type fatty acid binding protein (H-FABP) is a novel marker evaluated in recent years for prognosis in acute PE. Our aim was to evaluate the available evidence on the accuracy of H-FABP for predicting the prognosis of adverse clinical outcomes (defined as the occurrence of any of the following: death, cardiopulmonary resuscitation, endotracheal intubation, use of vasopressors, thrombolysis, surgical embolectomy, or admission to the intensive care unit) or mortality in patients with acute PE.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Unrestricted searches of PubMed, the Cochrane Library, Web of Science and Science Direct were performed using the terms of "H-FABP" or "heart-type fatty acid binding protein" and ("pulmonary embolism" or "pulmonary thromboembolism"). A random-effect model was used to pool study results; &#x3c7;(2) and I(2) testing was used to test for heterogeneity. Data of six studies were included in this analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">34 of 119(28.57%; 95%CI, 20.42%-36.72%) patients with elevated H-FABP levels had adverse events during follow-up compared with 24 of 475 (5.05%; 95%CI, 3.08%-7.02%) patients with normal levels. High H-FABP levels were associated with a high risk of occurrence of adverse clinical outcome (pooled OR, 10.81; 95%CI, 3.92-29.83).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The results of this meta-analysis indicate that H-FABP is a good predictor for adverse outcomes in patients with acute PE.</AbstractText><CopyrightInformation>Copyright &#xa9; 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Mingjie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Shandong Provincial Hospital affiliated to Shandong University, Jinan 250021, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Xia</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Yankuang Group General Hospital, Jining 272000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qiu</LastName><ForeName>Xianming</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Unit, Zhongda Hospital Southeast University, Nanjing 210000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shan</LastName><ForeName>Xiaoxi</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Respiratory, Yuhuangding Hospital, Yantai 264000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Dianjie</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Shandong Provincial Hospital affiliated to Shandong University, Jinan 250021, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Ling</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Shandong Provincial Hospital affiliated to Shandong University, Jinan 250021, China. Electronic address: llqysys1114@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>10</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Thromb Res</MedlineTA><NlmUniqueID>0326377</NlmUniqueID><ISSNLinking>0049-3848</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C493408">FABP3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000074026">Fatty Acid Binding Protein 3</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050556">Fatty Acid-Binding Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000074026" MajorTopicYN="N">Fatty Acid Binding Protein 3</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050556" MajorTopicYN="N">Fatty Acid-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006321" MajorTopicYN="N">Heart</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009206" MajorTopicYN="N">Myocardium</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adverse clinical outcome</Keyword><Keyword MajorTopicYN="N">Heart-type fatty acid binding protein</Keyword><Keyword MajorTopicYN="N">Pulmonary embolism</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>10</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>12</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>12</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25456730</ArticleId><ArticleId IdType="doi">10.1016/j.thromres.2014.10.007</ArticleId><ArticleId IdType="pii">S0049-3848(14)00531-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37538392</PMID><DateRevised><Year>2023</Year><Month>08</Month><Day>05</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-875X</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in surgery</Title><ISOAbbreviation>Front Surg</ISOAbbreviation></Journal><ArticleTitle>Single Incision non-thoracoscopic Nuss procedure for children with pectus excavatum: protocol for a multicenter, non-masked, randomized controlled trial.</ArticleTitle><Pagination><StartPage>1210452</StartPage><MedlinePgn>1210452</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1210452</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fsurg.2023.1210452</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Nuss procedure is the most common method of surgical treatment to pectus excavatum (PE). A significant percentage of surgeons choose to use thoracoscopic assistance during the Nuss procedure (TNP) to avoid cardiac injury. However, our previous findings confirm the safety of single incision Non-thoracoscopic Nuss Procedure (SINTNP). Hence, Further studies, particularly prospective randomized controlled trials, are necessary to assess the value of SINTNP for PE.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This study is a prospective, superiority, multicenter, non-masked, randomized controlled trial that investigates the outcome and hospitalization medical expense of SINTNP compared to TNP for PE. A total of 320 eligible patients according to sample size calculation by retrospective data will be randomly assigned to the SINTNP group or the TNP group at a 1:1 ratio using stratified blocked randomization and the zone length was set as four. Patients aged between 3 and 18 years old for the first surgery and without combination of complex anomalies such as Marfan syndrome and congenital heart disease will be considered for the study. The co-primary endpoint is thoracic related complications and medical expense during hospitalization. Thoracic related complications were defined as pneumothorax, pleural effusion, pneumonia and incision infection. The secondary endpoints include surgery duration and length of hospital stay.The registration number for this study protocol is ChiCTR230073081 (Chinese Clinical Trial Registry, A Primary Registry of International Clinical Trial Registry Platform, World Health Organization).</AbstractText><CopyrightInformation>&#xa9; 2023 Wang, Pan, Wu, Li, Wang, Dai, Ren, Xie, Xiong, Zhang and Li.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Quan</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Ministry of Education Key Laboratory of Child Development and Disorders,National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chongqing Key Laboratory of Pediatrics, Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Zhengxia</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Ministry of Education Key Laboratory of Child Development and Disorders,National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Chun</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Ministry of Education Key Laboratory of Child Development and Disorders,National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yonggang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Ministry of Education Key Laboratory of Child Development and Disorders,National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Gang</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Ministry of Education Key Laboratory of Child Development and Disorders,National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Jiangtao</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Ministry of Education Key Laboratory of Child Development and Disorders,National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Chunnian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Ministry of Education Key Laboratory of Child Development and Disorders,National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chongqing Key Laboratory of Pediatrics, Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Yiming</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pediatric Surgery, Chongqing Three Gorges Central Hospital, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiong</LastName><ForeName>Liangjun</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pediatric Surgery, Qujing Maternal and Child Health Hospital, Qujing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Libing</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pediatric Surgery, Chengdu Women and Children's Central Hospital, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Hongbo</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Ministry of Education Key Laboratory of Child Development and Disorders,National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chongqing Key Laboratory of Pediatrics, Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Surg</MedlineTA><NlmUniqueID>101645127</NlmUniqueID><ISSNLinking>2296-875X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Nuss procedure</Keyword><Keyword MajorTopicYN="N">multicenter</Keyword><Keyword MajorTopicYN="N">pectus excavatum</Keyword><Keyword MajorTopicYN="N">randomized controlled trial</Keyword><Keyword MajorTopicYN="N">single incision</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>4</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>4</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>4</Day><Hour>4</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37538392</ArticleId><ArticleId IdType="pmc">PMC10394465</ArticleId><ArticleId IdType="doi">10.3389/fsurg.2023.1210452</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kelly RE, Jr., Obermeyer RJ, Goretsky MJ, Kuhn MA, Frantz FW, McGuire MM, et al. Recent modifications of the Nuss procedure: the pursuit of safety during the minimally invasive repair of pectus Excavatum. Ann Surg. (2022) 275:e496&#x2013;502. 10.1097/SLA.0000000000003877</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000003877</ArticleId><ArticleId IdType="pubmed">32224740</ArticleId></ArticleIdList></Reference><Reference><Citation>Scalise PN, Demehri FR. The management of pectus excavatum in pediatric patients: a narrative review. Transl Pediatr. (2023) 12:208&#x2013;20. 10.21037/tp-22-361</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/tp-22-361</ArticleId><ArticleId IdType="pmc">PMC9986778</ArticleId><ArticleId IdType="pubmed">36891368</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuss D, Kelly RE, Jr., Croitoru DP, Katz ME. A 10-year review of a minimally invasive technique for the correction of pectus excavatum. J Pediatr Surg. (1998) 33:545&#x2013;52. 10.1016/S0022-3468(98)90314-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3468(98)90314-1</ArticleId><ArticleId IdType="pubmed">9574749</ArticleId></ArticleIdList></Reference><Reference><Citation>Hebra A, Swoveland B, Egbert M, Tagge EP, Georgeson K, Othersen HB, Jr., et al. Outcome analysis of minimally invasive repair of pectus excavatum: review of 251 cases. J Pediatr Surg. (2000) 35:252&#x2013;7; discussion 57&#x2013;8. 10.1016/S0022-3468(00)90019-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3468(00)90019-8</ArticleId><ArticleId IdType="pubmed">10693675</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly RE, Goretsky MJ, Obermeyer R, Kuhn MA, Redlinger R, Haney TS, et al. Twenty-one years of experience with minimally invasive repair of pectus excavatum by the Nuss procedure in 1215 patients. Ann Surg. (2010) 252:1072&#x2013;81. 10.1097/SLA.0b013e3181effdce</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0b013e3181effdce</ArticleId><ArticleId IdType="pubmed">21107118</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacco-Casamassima MG, Goldstein SD, Gause CD, Karim O, Michailidou M, Stewart D, et al. Minimally invasive repair of pectus excavatum: analyzing contemporary practice in 50 ACS NSQIP-pediatric institutions. Pediatr Surg Int. (2015) 31:493&#x2013;9. 10.1007/s00383-015-3694-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00383-015-3694-z</ArticleId><ArticleId IdType="pubmed">25814003</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng YL, Lee SC, Huang TW, Wu CT. Efficacy and safety of modified bilateral thoracoscopy-assisted Nuss procedure in adult patients with pectus excavatum. Eur J Cardiothorac Surg. (2008) 34:1057&#x2013;61. 10.1016/j.ejcts.2008.07.068</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcts.2008.07.068</ArticleId><ArticleId IdType="pubmed">18774724</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi R, Xie L, Chen G, Zeng Q, Mo X, Tang J, et al. Surgical management of pectus excavatum in China: results of a survey amongst members of the Chinese association of thoracic surgeons. Ann Transl Med. (2019) 7:202. 10.21037/atm.2019.05.03</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm.2019.05.03</ArticleId><ArticleId IdType="pmc">PMC6545319</ArticleId><ArticleId IdType="pubmed">31205920</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Jin X, Fan S, Wang D, Wu C, Pan Z, et al. Behavioural disorders in children with pectus excavatum in China: a retrospective cohort study with propensity score matching and risk prediction model. Eur J Cardiothorac Surg. (2019) 56:596&#x2013;603. 10.1093/ejcts/ezz038</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezz038</ArticleId><ArticleId IdType="pubmed">30824916</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J, Wang Q, Pan Z, Wu C, Li Y, Wang G, et al. The safety and efficacy of the modified single incision non-thoracoscopic Nuss procedure for children with pectus Excavatum. Front Pediatr. (2022) 10:831617. 10.3389/fped.2022.831617</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2022.831617</ArticleId><ArticleId IdType="pmc">PMC8861268</ArticleId><ArticleId IdType="pubmed">35211432</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gotzsche PC, Krleza-Jeric K, et al. SPIRIT 2013 Statement: defining standard protocol items for clinical trials. Ann Intern Med. (2013) 158:200&#x2013;7. 10.7326/0003-4819-158-3-201302050-00583</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-158-3-201302050-00583</ArticleId><ArticleId IdType="pmc">PMC5114123</ArticleId><ArticleId IdType="pubmed">23295957</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly RE, Jr., Mellins RB, Shamberger RC, Mitchell KK, Lawson ML, Oldham KT, et al. Multicenter study of pectus excavatum, final report: complications, static/exercise pulmonary function, and anatomic outcomes. J Am Coll Surg. (2013) 217:1080&#x2013;9. 10.1016/j.jamcollsurg.2013.06.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2013.06.019</ArticleId><ArticleId IdType="pubmed">24246622</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuss D. Minimally invasive surgical repair of pectus excavatum. Semin Pediatr Surg. (2008) 17:209&#x2013;17. 10.1053/j.sempedsurg.2008.03.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.sempedsurg.2008.03.003</ArticleId><ArticleId IdType="pubmed">18582827</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo PC, Tzeng IS, Hsieh MS, Yang MC, Wei BC, Cheng YL. The Nuss procedure for pectus excavatum: an effective and safe approach using bilateral thoracoscopy and a selective approach to use multiple bars in 296 adolescent and adult patients. PLoS One. (2020) 15:e0233547. 10.1371/journal.pone.0233547</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0233547</ArticleId><ArticleId IdType="pmc">PMC7259695</ArticleId><ArticleId IdType="pubmed">32470011</ArticleId></ArticleIdList></Reference><Reference><Citation>Tetteh O, Rhee DS, Boss E, Alaish SM, Garcia AV. Minimally invasive repair of pectus excavatum: analysis of the NSQIP database and the use of thoracoscopy. J Pediatr Surg. (2018) 53:1230&#x2013;33. 10.1016/j.jpedsurg.2018.02.089</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2018.02.089</ArticleId><ArticleId IdType="pubmed">29602550</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Fan S, Kong X, Pan Z, Wu C, Li Y, et al. Academic performance in children with pectus excavatum: a real-world research with propensity score matching. Ther Adv Respir Dis. (2023) 17:17534666231155779. 10.1177/17534666231155779</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17534666231155779</ArticleId><ArticleId IdType="pmc">PMC9972046</ArticleId><ArticleId IdType="pubmed">36846947</ArticleId></ArticleIdList></Reference><Reference><Citation>de Loos ER, Daemen JHT, Pennings AJ, Heuts S, Maessen JG, Hulsewe KWE, et al. Minimally invasive repair of pectus excavatum by the Nuss procedure: the learning curve. J Thorac Cardiovasc Surg. (2022) 163:828&#x2013;37.e4. 10.1016/j.jtcvs.2020.11.154</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2020.11.154</ArticleId><ArticleId IdType="pubmed">33478832</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35804327</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>12</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2474</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jul</Month><Day>08</Day></PubDate></JournalIssue><Title>BMC musculoskeletal disorders</Title><ISOAbbreviation>BMC Musculoskelet Disord</ISOAbbreviation></Journal><ArticleTitle>Evaluation of the safety of tranexamic acid use in pediatric patients undergoing spinal fusion surgery: a retrospective comparative cohort study.</ArticleTitle><Pagination><StartPage>651</StartPage><MedlinePgn>651</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">651</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12891-022-05604-2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Pediatric spinal fusion may be associated with significant intraoperative blood loss, leading to complications from transfusion, hypoperfusion and coagulopathy. One emerging strategy to mediate these risks is by utilization of the anti-fibrinolytic agent tranexamic acid (TXA). However, concerns regarding potential adverse reactions, specifically postoperative seizures and thrombotic events, still exist. To assess these risks, we examined the perioperative morbidity of TXA use in a large national database.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Retrospective data from pediatric patients (age 18&#xa0;years or younger), discharged between January 2013 to December 2015, who underwent primary or revision posterior spinal fusions, was collected from the Premier Perspective database (Premier, Charlotte, NC). Patients were stratified by TXA use and records were assessed for complications of new onset seizures, strokes, pulmonary embolisms (PE) or deep vein thromboses (DVT) occurring during the perioperative period.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In this cohort of 2,633 pediatric patients undergoing posterior spinal fusions, most often to treat adolescent idiopathic scoliosis, 15% received TXA. Overall, adverse events were rare in this patient population. The incidence of seizure, stoke, PE, or DVT in the control group was 0.54% (95% CI, 0.31% to 0.94%) and not significantly different from the TXA group. There was no significant difference in the incidence of DVTs, and no incidences of stroke in either group. There were no new-onset seizures or PEs in patients who received TXA.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The use of TXA was not associated with an increased risk of adverse events including seizure, stroke, PE, and DVT. Our findings support the safety of TXA use in pediatric patients undergoing spinal fusion surgery.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ivasyk</LastName><ForeName>Iryna</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Weill Cornell Medical College, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chatterjee</LastName><ForeName>Abhinaba</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Weill Cornell Medical College, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jordan</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Psychology, Thompson Rivers University, Kamloops, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geiselmann</LastName><ForeName>Matthew T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>New York Institute of Technology College of Osteopathic Medicine, Old Westbury, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Peter S</ForeName><Initials>PS</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Washington University, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamel</LastName><ForeName>Hooman</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute and Department of Neurology, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khormaee</LastName><ForeName>Sariah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hospital for Special Surgery, New York, NY, USA. khormaees@hss.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Musculoskelet Disord</MedlineTA><NlmUniqueID>100968565</NlmUniqueID><ISSNLinking>1471-2474</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000933">Antifibrinolytic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>6T84R30KC1</RegistryNumber><NameOfSubstance UI="D014148">Tranexamic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000933" MajorTopicYN="Y">Antifibrinolytic Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016063" MajorTopicYN="N">Blood Loss, Surgical</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012600" MajorTopicYN="Y">Scoliosis</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012640" MajorTopicYN="N">Seizures</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013123" MajorTopicYN="Y">Spinal Fusion</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014148" MajorTopicYN="Y">Tranexamic Acid</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antifibrinolytic</Keyword><Keyword MajorTopicYN="N">Pediatric</Keyword><Keyword MajorTopicYN="N">Spinal fusion</Keyword><Keyword MajorTopicYN="N">Tranexamic acid</Keyword><Keyword MajorTopicYN="N">Txa</Keyword></KeywordList><CoiStatement>Ms. Ivasyk has no disclosures, Mr. Chatterjee has no disclosures, Ms. Jordan has no disclosures, Mr. Geiselmann has no disclosures, Dr. Chang has no disclosures, Dr. Kamel serves as a PI for the NIH-funded ARCADIA trial (NINDS U01NS095869) which receives in-kind study drug from the BMS-Pfizer Alliance for Eliquis&#xae; and ancillary study support from Roche Diagnostics, serves as Deputy Editor for JAMA Neurology, serves as a steering committee member of Medtronic&#x2019;s Stroke AF trial (uncompensated), and serves on an endpoint adjudication committee for a trial of empagliflozin for Boehringer-Ingelheim, Dr. Khormaee has no disclosures.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>8</Day><Hour>23</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35804327</ArticleId><ArticleId IdType="pmc">PMC9264589</ArticleId><ArticleId IdType="doi">10.1186/s12891-022-05604-2</ArticleId><ArticleId IdType="pii">10.1186/s12891-022-05604-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Oetgen ME, Litrenta J. Perioperative Blood Management in Pediatric Spine Surgery: J Am Acad Orthop Surg. 2017;25(7):480&#x2013;488. doi: 10.5435/JAAOS-D-16-00035.</Citation><ArticleIdList><ArticleId IdType="doi">10.5435/JAAOS-D-16-00035</ArticleId><ArticleId IdType="pubmed">28644187</ArticleId></ArticleIdList></Reference><Reference><Citation>Fletcher ND, Marks MC, Asghar JK, Hwang SW, Sponseller PD, Newton PO. Development of Consensus Based Best Practice Guidelines for Perioperative Management of Blood Loss in Patients Undergoing Posterior Spinal Fusion for Adolescent Idiopathic Scoliosis*. Spine Deform. 2018;6(4):424&#x2013;429. doi: 10.1016/j.jspd.2018.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jspd.2018.01.001</ArticleId><ArticleId IdType="pubmed">29886914</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoylaerts M, Lijnen HR, Collen D. Studies on the mechanism of the antifibrinolytic action of tranexamic acid. Biochim Biophys Acta. 1981;673(1):75&#x2013;85. doi: 10.1016/0304-4165(81)90312-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0304-4165(81)90312-3</ArticleId><ArticleId IdType="pubmed">7193484</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunn CJ, Goa KL. Tranexamic Acid: A Review of its Use in Surgery and Other Indications. Drugs. 1999;57(6):1005&#x2013;1032. doi: 10.2165/00003495-199957060-00017.</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/00003495-199957060-00017</ArticleId><ArticleId IdType="pubmed">10400410</ArticleId></ArticleIdList></Reference><Reference><Citation>Ker K, Prieto-Merino D, Roberts I. Systematic review, meta-analysis and meta-regression of the effect of tranexamic acid on surgical blood loss. Br J Surg. 2013;100(10):1271&#x2013;1279. doi: 10.1002/bjs.9193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.9193</ArticleId><ArticleId IdType="pubmed">23839785</ArticleId></ArticleIdList></Reference><Reference><Citation>Faraoni D, Rahe C, Cybulski KA. Use of antifibrinolytics in pediatric cardiac surgery: Where are we now? Pediatr Anesth. 2019;29(5):435&#x2013;440. doi: 10.1111/pan.13533.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pan.13533</ArticleId><ArticleId IdType="pubmed">30365221</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardy JF, Desroches J. Natural and synthetic antifibrinolytics in cardiac surgery. Can J Anaesth J Can Anesth. 1992;39(4):353&#x2013;365. doi: 10.1007/BF03009046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03009046</ArticleId><ArticleId IdType="pubmed">1373346</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrons RW, Jahr JS. A REVIEW OF POST-CARDIOPULMONARY BYPASS BLEEDING, AMINOCAPROIC ACID, TRANEXAMIC ACID, AND APROTININ. Am J Ther. 1996;3(12):821&#x2013;838. doi: 10.1097/00045391-199612000-00007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00045391-199612000-00007</ArticleId><ArticleId IdType="pubmed">11862245</ArticleId></ArticleIdList></Reference><Reference><Citation>Porter SB, White LJ, Osagiede O, Robards CB, Spaulding AC. Tranexamic Acid Administration Is Not Associated With an Increase in Complications in High-Risk Patients Undergoing Primary Total Knee or Total Hip Arthroplasty: A Retrospective Case-Control Study of 38,220 Patients. J Arthroplasty. 2020;35(1):45&#x2013;51.e3. doi: 10.1016/j.arth.2019.08.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2019.08.015</ArticleId><ArticleId IdType="pubmed">31522854</ArticleId></ArticleIdList></Reference><Reference><Citation>Veien M, S&#xf8;rensen JV, Madsen F, Juelsgaard P. Tranexamic acid given intraoperatively reduces blood loss after total knee replacement: a randomized, controlled study. Acta Anaesthesiol Scand. 2002;46(10):1206&#x2013;1211. doi: 10.1034/j.1399-6576.2002.461007.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1399-6576.2002.461007.x</ArticleId><ArticleId IdType="pubmed">12421192</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang F, Wu D, Ma G, Yin Z, Wang Q. The use of tranexamic acid to reduce blood loss and transfusion in major orthopedic surgery: a meta-analysis. J Surg Res. 2014;186(1):318&#x2013;327. doi: 10.1016/j.jss.2013.08.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2013.08.020</ArticleId><ArticleId IdType="pubmed">24075404</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwai T, Tsuji S, Tomita T, Sugamoto K, Hideki Y, Hamada M. Repeat-dose intravenous tranexamic acid further decreases blood loss in total knee arthroplasty. Int Orthop. 2013;37(3):441&#x2013;445. doi: 10.1007/s00264-013-1787-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00264-013-1787-7</ArticleId><ArticleId IdType="pmc">PMC3580084</ArticleId><ArticleId IdType="pubmed">23371424</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman RJ, Gordon E, Butler RB, Mock L, Dumas B. Tranexamic acid decreases blood loss after total shoulder arthroplasty. J Shoulder Elbow Surg. 2016;25(4):614&#x2013;618. doi: 10.1016/j.jse.2015.09.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jse.2015.09.014</ArticleId><ArticleId IdType="pubmed">26652697</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapiro F, Zurakowski D, Sethna NF. Tranexamic acid diminishes intraoperative blood loss and transfusion in spinal fusions for duchenne muscular dystrophy scoliosis. Spine. 2007;32(20):2278&#x2013;2283. doi: 10.1097/BRS.0b013e31814cf139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BRS.0b013e31814cf139</ArticleId><ArticleId IdType="pubmed">17873823</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Xi C, Xu W, Yan J. Role of tranexamic acid in blood loss control and blood transfusion management of patients undergoing multilevel spine surgery: A meta-analysis. Medicine (Baltimore) 2021;100(7):e24678. doi: 10.1097/MD.0000000000024678.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000024678</ArticleId><ArticleId IdType="pmc">PMC7899852</ArticleId><ArticleId IdType="pubmed">33607807</ArticleId></ArticleIdList></Reference><Reference><Citation>Lonner BS, Ren Y, Asghar J, Shah SA, Samdani AF, Newton PO. Antifibrinolytic Therapy in Surgery for Adolescent Idiopathic Scoliosis Does the Level 1 Evidence Translate to Practice? Bull Hosp Jt Dis 2013. 2018;76(3):165&#x2013;170.</Citation><ArticleIdList><ArticleId IdType="pubmed">31513519</ArticleId></ArticleIdList></Reference><Reference><Citation>McLeod LM, French B, Flynn JM, Dormans JP, Keren R. Antifibrinolytic Use and Blood Transfusions in Pediatric Scoliosis Surgeries Performed at US Children&#x2019;s Hospitals. J Spinal Disord Tech. 2015;28(8):E460&#x2013;E466. doi: 10.1097/BSD.0b013e3182a22a54.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BSD.0b013e3182a22a54</ArticleId><ArticleId IdType="pubmed">24091932</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasan MS, Yunus SN, Ng CC, Chan CYW, Chiu CK, Kwan MK. Tranexamic Acid in Pediatric Scoliosis Surgery: A Prospective Randomized Trial Comparing High-dose and Low-dose Tranexamic Acid in Adolescent Idiopathic Scoliosis Undergoing Posterior Spinal Fusion Surgery. Spine. 2021;46(22):E1170&#x2013;E1177. doi: 10.1097/BRS.0000000000004076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BRS.0000000000004076</ArticleId><ArticleId IdType="pubmed">33882541</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Wang LN, Yang X, et al. The effect of multiple-dose oral versus intravenous tranexamic acid in reducing postoperative blood loss and transfusion rate after adolescent scoliosis surgery: a randomized controlled trial. Spine J. 2021;21(2):312&#x2013;320. doi: 10.1016/j.spinee.2020.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.spinee.2020.10.011</ArticleId><ArticleId IdType="pubmed">33049411</ArticleId></ArticleIdList></Reference><Reference><Citation>Sethna NF, Zurakowski D, Brustowicz RM, Bacsik J, Sullivan LJ, Shapiro F. Tranexamic acid reduces intraoperative blood loss in pediatric patients undergoing scoliosis surgery. Anesthesiology. 2005;102(4):727&#x2013;732. doi: 10.1097/00000542-200504000-00006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200504000-00006</ArticleId><ArticleId IdType="pubmed">15791100</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong Y, Liang J, Tong B, Shen J, Zhao H, Li Q. Combined topical and intravenous administration of tranexamic acid further reduces postoperative blood loss in adolescent idiopathic scoliosis patients undergoing spinal fusion surgery: a randomized controlled trial. BMC Musculoskelet Disord. 2021;22(1):663. doi: 10.1186/s12891-021-04562-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12891-021-04562-5</ArticleId><ArticleId IdType="pmc">PMC8351088</ArticleId><ArticleId IdType="pubmed">34372818</ArticleId></ArticleIdList></Reference><Reference><Citation>Sui W yuan, Ye F, Yang J lin. Efficacy of tranexamic acid in reducing allogeneic blood products in adolescent idiopathic scoliosis surgery. BMC Musculoskelet Disord. 2016;17(1):187. doi:10.1186/s12891-016-1006-y</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4847368</ArticleId><ArticleId IdType="pubmed">27117696</ArticleId></ArticleIdList></Reference><Reference><Citation>Goobie SM, Zurakowski D, Glotzbecker MP, et al. Tranexamic Acid Is Efficacious at Decreasing the Rate of Blood Loss in Adolescent Scoliosis Surgery: A Randomized Placebo-Controlled Trial. J Bone Joint Surg Am. 2018;100(23):2024&#x2013;2032. doi: 10.2106/JBJS.18.00314.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.18.00314</ArticleId><ArticleId IdType="pubmed">30516625</ArticleId></ArticleIdList></Reference><Reference><Citation>Yagi M, Hasegawa J, Nagoshi N, et al. Does the Intraoperative Tranexamic Acid Decrease Operative Blood Loss During Posterior Spinal Fusion for Treatment of Adolescent Idiopathic Scoliosis?: Spine. 2012;37(21):E1336-E1342. doi:10.1097/BRS.0b013e318266b6e5</Citation><ArticleIdList><ArticleId IdType="pubmed">22772572</ArticleId></ArticleIdList></Reference><Reference><Citation>George S, Ramchandran S, Mihas A, George K, Mansour A, Errico T. Topical tranexemic acid reduces intra-operative blood loss and transfusion requirements in spinal deformity correction in patients with adolescent idiopathic scoliosis. Spine Deform. 2021;9(5):1387&#x2013;1393. doi: 10.1007/s43390-021-00337-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s43390-021-00337-z</ArticleId><ArticleId IdType="pubmed">33844193</ArticleId></ArticleIdList></Reference><Reference><Citation>Lecker I, Wang DS, Kaneshwaran K, Mazer CD, Orser BA. High Concentrations of Tranexamic Acid Inhibit Ionotropic Glutamate Receptors. Anesthesiology. 2017;127(1):89&#x2013;97. doi: 10.1097/ALN.0000000000001665.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000001665</ArticleId><ArticleId IdType="pubmed">28475556</ArticleId></ArticleIdList></Reference><Reference><Citation>Lecker I, Wang DS, Romaschin AD, Peterson M, Mazer CD, Orser BA. Tranexamic acid concentrations associated with human seizures inhibit glycine receptors. J Clin Invest. 2012;122(12):4654&#x2013;4666. doi: 10.1172/JCI63375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI63375</ArticleId><ArticleId IdType="pmc">PMC3533541</ArticleId><ArticleId IdType="pubmed">23187124</ArticleId></ArticleIdList></Reference><Reference><Citation>Kratzer S, Irl H, Mattusch C, et al. Tranexamic Acid Impairs &#x3b3;-Aminobutyric Acid Receptor Type A&#x2013;mediated Synaptic Transmission in the Murine Amygdala. Anesthesiology. 2014;120(3):639&#x2013;649. doi: 10.1097/ALN.0000000000000103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000103</ArticleId><ArticleId IdType="pubmed">24335749</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrini A, Giaretta D, Chemello R, Zanotto L, Testa G. Feline Generalized Epilepsy Induced by Tranexamic Acid (AMCA) Epilepsia. 1982;23(1):35&#x2013;45. doi: 10.1111/j.1528-1157.1982.tb05051.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1528-1157.1982.tb05051.x</ArticleId><ArticleId IdType="pubmed">7056249</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcha PS, Mohan CVR, Sharma RM. Death After an Inadvertent Intrathecal Injection of Tranexamic Acid: Anesth Analg. 2007;104(1):241&#x2013;242. doi: 10.1213/01.ane.0000250436.17786.72.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ane.0000250436.17786.72</ArticleId><ArticleId IdType="pubmed">17179315</ArticleId></ArticleIdList></Reference><Reference><Citation>de Leede-van der Maarl MGJ, Hilkens P, Bosch F. The epileptogenic effect of tranexamic acid. J Neurol. 1999;246(9):843&#x2013;843. doi:10.1007/s004150050466</Citation><ArticleIdList><ArticleId IdType="pubmed">10525986</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh HM, Lau HP, Lin PL, Sun WZ, Mok MS. Convulsions and Refractory Ventricular Fibrillation after Intrathecal Injection of a Massive Dose of Tranexamic Acid. Anesthesiology. 2003;98(1):270&#x2013;272. doi: 10.1097/00000542-200301000-00042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200301000-00042</ArticleId><ArticleId IdType="pubmed">12503009</ArticleId></ArticleIdList></Reference><Reference><Citation>Manji RA, Grocott HP, Leake J, et al. Seizures following cardiac surgery: the impact of tranexamic acid and other risk factors. Can J Anesth Can Anesth. 2012;59(1):6&#x2013;13. doi: 10.1007/s12630-011-9618-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12630-011-9618-z</ArticleId><ArticleId IdType="pubmed">22065333</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin K, Knorr J, Breuer T, et al. Seizures After Open Heart Surgery: Comparison of &#x3b5;-Aminocaproic Acid and Tranexamic Acid. J Cardiothorac Vasc Anesth. 2011;25(1):20&#x2013;25. doi: 10.1053/j.jvca.2010.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2010.10.007</ArticleId><ArticleId IdType="pubmed">21272777</ArticleId></ArticleIdList></Reference><Reference><Citation>Maeda T, Sasabuchi Y, Matsui H, Ohnishi Y, Miyata S, Yasunaga H. Safety of Tranexamic Acid in Pediatric Cardiac Surgery: A Nationwide Database Study. J Cardiothorac Vasc Anesth. 2017;31(2):549&#x2013;553. doi: 10.1053/j.jvca.2016.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2016.10.001</ArticleId><ArticleId IdType="pubmed">27988092</ArticleId></ArticleIdList></Reference><Reference><Citation>Lecker I, Wang D, Whissell PD, Avramescu S, Mazer CD, Orser BA. Tranexamic acid&#x2013;associated seizures: Causes and treatment. Ann Neurol. 2016;79(1):18&#x2013;26. doi: 10.1002/ana.24558.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24558</ArticleId><ArticleId IdType="pmc">PMC4738442</ArticleId><ArticleId IdType="pubmed">26580862</ArticleId></ArticleIdList></Reference><Reference><Citation>Deyo R. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613&#x2013;619. doi: 10.1016/0895-4356(92)90133-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0895-4356(92)90133-8</ArticleId><ArticleId IdType="pubmed">1607900</ArticleId></ArticleIdList></Reference><Reference><Citation>Neilipovitz DT, Murto K, Hall L, Barrowman NJ, Splinter WM. A randomized trial of tranexamic acid to reduce blood transfusion for scoliosis surgery. Anesth Analg. 2001;93(1):82&#x2013;87. doi: 10.1097/00000539-200107000-00018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000539-200107000-00018</ArticleId><ArticleId IdType="pubmed">11429344</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant JA, Howard J, Luntley J, Harder J, Aleissa S, Parsons D. Perioperative blood transfusion requirements in pediatric scoliosis surgery: the efficacy of tranexamic acid. J Pediatr Orthop. 2009;29(3):300&#x2013;304. doi: 10.1097/BPO.0b013e31819a85de.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BPO.0b013e31819a85de</ArticleId><ArticleId IdType="pubmed">19305284</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng BKW, Chau W, Hung ALH, Hui AC, Lam TP, Cheng JCY. Use of Tranexamic Acid (TXA) on reducing blood loss during scoliosis surgery in Chinese adolescents. Scoliosis. 2015;10(1):28. doi: 10.1186/s13013-015-0052-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13013-015-0052-9</ArticleId><ArticleId IdType="pmc">PMC4593193</ArticleId><ArticleId IdType="pubmed">26442124</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson DJ, Johnson CC, Goobie SM, et al. High-dose Versus Low-dose Tranexamic Acid to Reduce Transfusion Requirements in Pediatric Scoliosis Surgery. J Pediatr Orthop. 2017;37(8):e552&#x2013;e557. doi: 10.1097/BPO.0000000000000820.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BPO.0000000000000820</ArticleId><ArticleId IdType="pubmed">29120963</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones KE, Butler EK, Barrack T, et al. Tranexamic Acid Reduced the Percent of Total Blood Volume Lost During Adolescent Idiopathic Scoliosis Surgery. Int J Spine Surg. 2017;11(4):27. doi: 10.14444/4027.</Citation><ArticleIdList><ArticleId IdType="doi">10.14444/4027</ArticleId><ArticleId IdType="pmc">PMC5779269</ArticleId><ArticleId IdType="pubmed">29372131</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohashi N, Ohashi M, Endo N, Kohno T. Administration of tranexamic acid to patients undergoing surgery for adolescent idiopathic scoliosis evokes pain and increases the infusion rate of remifentanil during the surgery. Sumitani M, ed. PLOS ONE. 2017;12(3):e0173622. doi:10.1371/journal.pone.0173622</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5345863</ArticleId><ArticleId IdType="pubmed">28282425</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B, Li H, Wang D, He X, Zhang C, Yang P. Systematic Review and Meta-Analysis of Perioperative Intravenous Tranexamic Acid Use in Spinal Surgery. Landoni G, ed. PLoS ONE. 2013;8(2):e55436. doi:10.1371/journal.pone.0055436</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3570541</ArticleId><ArticleId IdType="pubmed">23424632</ArticleId></ArticleIdList></Reference><Reference><Citation>Soroceanu A, Oren JH, Smith JS, et al. Effect of Antifibrinolytic Therapy on Complications, Thromboembolic Events, Blood Product Utilization, and Fusion in Adult Spinal Deformity Surgery. Spine. 2016;41(14):E879&#x2013;E886. doi: 10.1097/BRS.0000000000001454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BRS.0000000000001454</ArticleId><ArticleId IdType="pubmed">27398796</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei T, Bingtao W, Zhaoqing G, Zhongqiang C, Xin L. The efficacy and safety of intravenous tranexamic acid in patients with posterior operation of multilevel thoracic spine stenosis: a prospective randomized controlled trial. BMC Musculoskelet Disord. 2022;23(1):410. doi: 10.1186/s12891-022-05361-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12891-022-05361-2</ArticleId><ArticleId IdType="pmc">PMC9063045</ArticleId><ArticleId IdType="pubmed">35501751</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko BS, Cho KJ, Kim YT, Park JW, Kim NC. Does Tranexamic Acid Increase the Incidence of Thromboembolism After Spinal Fusion Surgery? Clin Spine Surg Spine Publ. 2020;33(2):E71&#x2013;E75. doi: 10.1097/BSD.0000000000000860.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BSD.0000000000000860</ArticleId><ArticleId IdType="pubmed">31385850</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornelius B, Cummings Q, Assercq M, Rizzo E, Gennuso S, Cornelius A. Current Practices in Tranexamic Acid Administration for Pediatric Trauma Patients in the United States. J Trauma Nurs. 2021;28(1):21&#x2013;25. doi: 10.1097/JTN.0000000000000553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JTN.0000000000000553</ArticleId><ArticleId IdType="pubmed">33417398</ArticleId></ArticleIdList></Reference><Reference><Citation>Eckert MJ, Wertin TM, Tyner SD, Nelson DW, Izenberg S, Martin MJ. Tranexamic acid administration to pediatric trauma patients in a combat setting: The pediatric trauma and tranexamic acid study (PED-TRAX) J Trauma Acute Care Surg. 2014;77(6):852&#x2013;858. doi: 10.1097/TA.0000000000000443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0000000000000443</ArticleId><ArticleId IdType="pubmed">25423534</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts I, Shakur H, Coats T, et al. The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. Health Technol Assess. 2013;17(10). doi:10.3310/hta17100</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4780956</ArticleId><ArticleId IdType="pubmed">23477634</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29374780</PMID><DateCompleted><Year>2019</Year><Month>03</Month><Day>11</Day></DateCompleted><DateRevised><Year>2019</Year><Month>03</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1863-9941</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>6</Issue><PubDate><Year>2018</Year><Month>Dec</Month></PubDate></JournalIssue><Title>European journal of trauma and emergency surgery : official publication of the European Trauma Society</Title><ISOAbbreviation>Eur J Trauma Emerg Surg</ISOAbbreviation></Journal><ArticleTitle>Wound complications after ankle surgery. Does compression treatment work? A randomized, controlled trial.</ArticleTitle><Pagination><StartPage>947</StartPage><EndPage>956</EndPage><MedlinePgn>947-956</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00068-017-0892-5</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Infection rates following ankle fractures are as high as 19% in selected material and is the most common complication following this type of surgery, with potential catastrophic consequences. The purpose of this study was to test a regime of intermittent pneumatic compression, a compression bandage and a compression stocking and its effect on the rate of wound complications. The hypothesis was that compression could lower the infection rate from 20 to 5%.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We performed a randomized, controlled, non-blinded trial, including 153 adult patients with unstable ankle fractures. Patients were randomized to either compression (N&#x2009;=&#x2009;82) or elevation (N&#x2009;=&#x2009;71). Patients with open fracture, DVT, pulmonary embolism, dementia, no pedal pulse, or no Danish address were excluded. Primary endpoint was infection. Secondary endpoints were necrosis and wound dehiscence.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">After 2&#xa0;weeks, 1.4% (0.0;7.6) in the compression group had infection compared to 4.6% (1.0;12.9) in the control group, p&#x2009;=&#x2009;0.35. The rate of necrosis after 2&#xa0;weeks was 7.0% (95% CI 2.3;15.7) in the compression group compared with 26.2% (95% CI 16.0;38.5) in the elevation group, p&#x2009;=&#x2009;0.004. No difference was shown regarding wound dehiscence.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Based on this study, we cannot conclude if compression therapy prevents infection or not. This is mainly due to under-powering of the study. The effect on necrosis was in favor of compression, but the trial was not powered to show a difference regarding this endpoints and the result is thus hypothesis generating. Further research is needed before a thorough recommendation on the use of compression treatment that can be made.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Winge</LastName><ForeName>Rikke</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-0501-8192</Identifier><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Nordsj&#xe6;llands Hospital, Dyrehavevej 29, 3400, Hiller&#xf8;d, Denmark. rikkewinge@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryge</LastName><ForeName>Camilla</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Gentofte Hospital, Kildeg&#xe5;rdsvej 28, 2900, Hellerup, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bayer</LastName><ForeName>Lasse</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Nordsj&#xe6;llands Hospital, Dyrehavevej 29, 3400, Hiller&#xf8;d, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klausen</LastName><ForeName>Tobias Wirenfeldt</ForeName><Initials>TW</Initials><AffiliationInfo><Affiliation>Herlev Hospital, Herlev Ringvej 75, 2730, Herlev, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gottlieb</LastName><ForeName>Hans</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Herlev Hospital, Herlev Ringvej 75, 2730, Herlev, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NOH-431</GrantID><Agency>Nordsjaellands Hospital</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur J Trauma Emerg Surg</MedlineTA><NlmUniqueID>101313350</NlmUniqueID><ISSNLinking>1863-9933</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064386" MajorTopicYN="N">Ankle Fractures</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058128" MajorTopicYN="N">Compression Bandages</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003718" MajorTopicYN="N" Type="Geographic">Denmark</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005593" MajorTopicYN="N">Fracture Fixation, Internal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D048228" MajorTopicYN="N">Intermittent Pneumatic Compression Devices</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011187" MajorTopicYN="N">Posture</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011312" MajorTopicYN="N">Pressure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013530" MajorTopicYN="N">Surgical Wound Infection</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Ankle fracture</Keyword><Keyword MajorTopicYN="N">Compression treatment</Keyword><Keyword MajorTopicYN="N">Necrosis</Keyword><Keyword MajorTopicYN="N">Surgical site infection</Keyword><Keyword MajorTopicYN="N">Trauma</Keyword><Keyword MajorTopicYN="N">Wound complications</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>12</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29374780</ArticleId><ArticleId IdType="doi">10.1007/s00068-017-0892-5</ArticleId><ArticleId IdType="pii">10.1007/s00068-017-0892-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Eur J Vasc Endovasc Surg. 2000 Mar;19(3):250-60</Citation><ArticleIdList><ArticleId IdType="pubmed">10753688</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Joint Surg Br. 1991 May;73(3):511-3</Citation><ArticleIdList><ArticleId IdType="pubmed">1670461</ArticleId></ArticleIdList></Reference><Reference><Citation>Injury. 2001 Sep;32(7):559-63</Citation><ArticleIdList><ArticleId IdType="pubmed">11524089</ArticleId></ArticleIdList></Reference><Reference><Citation>J Orthop Res. 2007 Sep;25(9):1185-92</Citation><ArticleIdList><ArticleId IdType="pubmed">17469190</ArticleId></ArticleIdList></Reference><Reference><Citation>Injury. 2011 Oct;42(10):1125-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21329921</ArticleId></ArticleIdList></Reference><Reference><Citation>Foot Ankle Int. 2016 Apr;37(4):401-6</Citation><ArticleIdList><ArticleId IdType="pubmed">26830839</ArticleId></ArticleIdList></Reference><Reference><Citation>Hip Int. 2012 Sep-Oct;22(5):527-33</Citation><ArticleIdList><ArticleId IdType="pubmed">23112075</ArticleId></ArticleIdList></Reference><Reference><Citation>J Appl Physiol (1985). 2012 Jun;112(12):2099-109</Citation><ArticleIdList><ArticleId IdType="pubmed">22442025</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Joint Surg Am. 2014 Aug 6;96(15):1263-1271</Citation><ArticleIdList><ArticleId IdType="pubmed">25100773</ArticleId></ArticleIdList></Reference><Reference><Citation>J Orthop Surg (Hong Kong). 2015 Apr;23(1):59-61</Citation><ArticleIdList><ArticleId IdType="pubmed">25920646</ArticleId></ArticleIdList></Reference><Reference><Citation>J Appl Physiol (1985). 2002 Feb;92(2):559-66</Citation><ArticleIdList><ArticleId IdType="pubmed">11796664</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Vasc Endovasc Surg. 2015 Jun;49(6):678-737</Citation><ArticleIdList><ArticleId IdType="pubmed">25920631</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Phys Med Rehabil. 1992 May;73(5):482-5</Citation><ArticleIdList><ArticleId IdType="pubmed">1580778</ArticleId></ArticleIdList></Reference><Reference><Citation>Intern Med. 2006;45(2):93-4</Citation><ArticleIdList><ArticleId IdType="pubmed">16484746</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Joint Surg Br. 2005 Apr;87(4):489-95</Citation><ArticleIdList><ArticleId IdType="pubmed">15795198</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Orthop. 2005 Feb;76(1):89-94</Citation><ArticleIdList><ArticleId IdType="pubmed">15788314</ArticleId></ArticleIdList></Reference><Reference><Citation>PM R. 2012 Aug;4(8):580-601</Citation><ArticleIdList><ArticleId IdType="pubmed">22920313</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesthesiology. 2000 Mar;92(3):880-2</Citation><ArticleIdList><ArticleId IdType="pubmed">10719972</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Joint Surg Br. 1992 Sep;74(5):775-8</Citation><ArticleIdList><ArticleId IdType="pubmed">1527133</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Orthop Scand. 1998 Feb;69(1):48-50</Citation><ArticleIdList><ArticleId IdType="pubmed">9524518</ArticleId></ArticleIdList></Reference><Reference><Citation>Asian J Surg. 2008 Jul;31(3):124-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18658010</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Control Hosp Epidemiol. 1999 Apr;20(4):250-78; quiz 279-80</Citation><ArticleIdList><ArticleId IdType="pubmed">10219875</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Joint Surg Am. 2009 May;91(5):1042-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19411451</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Orthop. 2014 Sep;85(5):525-30</Citation><ArticleIdList><ArticleId IdType="pubmed">24694275</ArticleId></ArticleIdList></Reference><Reference><Citation>Foot Ankle Int. 2002 Nov;23(11):999-1002</Citation><ArticleIdList><ArticleId IdType="pubmed">12449403</ArticleId></ArticleIdList></Reference><Reference><Citation>Foot Ankle Surg. 2014 Mar;20(1):40-3</Citation><ArticleIdList><ArticleId IdType="pubmed">24480498</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Joint Surg Am. 2012 Nov 21;94(22):2047-52</Citation><ArticleIdList><ArticleId IdType="pubmed">23172322</ArticleId></ArticleIdList></Reference><Reference><Citation>Foot Ankle Int. 2011 Feb;32(2):120-30</Citation><ArticleIdList><ArticleId IdType="pubmed">21288410</ArticleId></ArticleIdList></Reference><Reference><Citation>Orthopedics. 1998 Jan;21(1):59-61</Citation><ArticleIdList><ArticleId IdType="pubmed">9474633</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone Joint J. 2014 Aug;96-B(8):1062-9</Citation><ArticleIdList><ArticleId IdType="pubmed">25086122</ArticleId></ArticleIdList></Reference><Reference><Citation>Yonsei Med J. 2013 May 1;54(3):801-2</Citation><ArticleIdList><ArticleId IdType="pubmed">23549834</ArticleId></ArticleIdList></Reference><Reference><Citation>Foot Ankle Surg. 2013 Sep;19(3):173-6</Citation><ArticleIdList><ArticleId IdType="pubmed">23830165</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaesthesia. 2005 Feb;60(2):207-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15644032</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Orthop. 2012 Jun;83(3):276-81</Citation><ArticleIdList><ArticleId IdType="pubmed">22401675</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Vasc Endovasc Surg. 2000 Mar;19(3):270-7</Citation><ArticleIdList><ArticleId IdType="pubmed">10753690</ArticleId></ArticleIdList></Reference><Reference><Citation>J Perioper Pract. 2014 Apr;24(4):84-6</Citation><ArticleIdList><ArticleId IdType="pubmed">24855719</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30611138</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>06</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">1933-0693</ISSN><JournalIssue CitedMedium="Internet"><Volume>132</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jan</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of neurosurgery</Title><ISOAbbreviation>J Neurosurg</ISOAbbreviation></Journal><ArticleTitle>Venous thromboembolic events in patients undergoing craniotomy for tumor resection: incidence, predictors, and review of literature.</ArticleTitle><Pagination><StartPage>10</StartPage><EndPage>21</EndPage><MedlinePgn>10-21</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3171/2018.7.JNS181175</ELocationID><Abstract><AbstractText Label="OBJECTIVE">The authors sought to investigate the incidence and predictors of venous thromboembolic events (VTEs) after craniotomy for tumor resection, which are not well established, and the efficacy of and risks associated with VTE chemoprophylaxis, which remains controversial.</AbstractText><AbstractText Label="METHODS">The authors investigated the incidence of VTEs in a consecutive series of patients presenting to the authors' institution for resection of an intracranial lesion between 2012 and 2017. Information on patient and tumor characteristics was collected and independent predictors of VTEs were determined using stepwise multivariate logistic regression analysis. Review of the literature was performed by searching MEDLINE using the keywords "venous thromboembolism," "deep venous thrombosis," "pulmonary embolism," "craniotomy," and "brain neoplasms."</AbstractText><AbstractText Label="RESULTS">There were 1622 patients included for analysis. A small majority of patients were female (52.6%) and the mean age of the cohort was 52.9 years (SD 15.8 years). A majority of intracranial lesions were intraaxial (59.3%). The incidence of VTEs was 3.0% and the rates of deep venous thromboses and pulmonary emboli were 2.3% and 0.9%, respectively. On multivariate analysis, increasing patient age (unit OR 1.02, 95% CI 1.00-1.05; p = 0.018), history of VTE (OR 7.26, 95% CI 3.24-16.27; p &lt; 0.001), presence of motor deficit (OR 2.64, 95% CI 1.43-4.88; p = 0.002), postoperative intracranial hemorrhage (OR 4.35, 95% CI 1.51-12.55; p &lt; 0.001), and prolonged intubation or reintubation (OR 3.27, 95% CI 1.28-8.32; p &lt; 0.001) were independently associated with increased odds of a VTE. There were 192 patients who received VTE chemoprophylaxis (11.8%); the mean postoperative day of chemoprophylaxis initiation was 4.6 (SD 3.8). The incidence of VTEs was higher in patients receiving chemoprophylaxis than in patients not receiving chemoprophylaxis (8.3% vs 2.2%; p &lt; 0.001). There were 30 instances of clinically significant postoperative hemorrhage (1.9%), with only 1 hemorrhage occurring after initiation of VTE chemoprophylaxis (0.1%).</AbstractText><AbstractText Label="CONCLUSIONS">The study results show the incidence and predictors of VTEs after craniotomy for tumor resection in this patient population. The incidence of VTE within this cohort appears low and comparable to that observed in other institutional series, despite the lack of routine prophylactic anticoagulation in the postoperative setting.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rinaldo</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>1Department of Neurological Surgery, Mayo Clinic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Desmond A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>1Department of Neurological Surgery, Mayo Clinic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhargav</LastName><ForeName>Adip G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>2Mayo Clinic College of Medicine and Science, Mayo Clinic; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rusheen</LastName><ForeName>Aaron E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>3Medical Scientist Training Program, Mayo Clinic College of Medicine and Science, Mayo Clinic, Rochester, Minnesota.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naylor</LastName><ForeName>Ryan M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>1Department of Neurological Surgery, Mayo Clinic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gilder</LastName><ForeName>Hannah E</ForeName><Initials>HE</Initials><AffiliationInfo><Affiliation>1Department of Neurological Surgery, Mayo Clinic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monie</LastName><ForeName>Dileep D</ForeName><Initials>DD</Initials><AffiliationInfo><Affiliation>3Medical Scientist Training Program, Mayo Clinic College of Medicine and Science, Mayo Clinic, Rochester, Minnesota.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Youssef</LastName><ForeName>Stephanie J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>2Mayo Clinic College of Medicine and Science, Mayo Clinic; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parney</LastName><ForeName>Ian F</ForeName><Initials>IF</Initials><AffiliationInfo><Affiliation>1Department of Neurological Surgery, Mayo Clinic.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32 GM065841</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>01</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurosurg</MedlineTA><NlmUniqueID>0253357</NlmUniqueID><ISSNLinking>0022-3085</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010975">Platelet Aggregation Inhibitors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001932" MajorTopicYN="N">Brain Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002543" MajorTopicYN="N">Cerebral Hemorrhage</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018890" MajorTopicYN="N">Chemoprevention</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003399" MajorTopicYN="Y">Craniotomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007442" MajorTopicYN="N">Intubation, Intratracheal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017567" MajorTopicYN="N">Karnofsky Performance Status</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010975" MajorTopicYN="N">Platelet Aggregation Inhibitors</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019106" MajorTopicYN="N">Postoperative Hemorrhage</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011292" MajorTopicYN="N">Premedication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019851" MajorTopicYN="N">Thrombophilia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="N">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DVT = deep venous thrombosis</Keyword><Keyword MajorTopicYN="N">ICH = intracranial hemorrhage</Keyword><Keyword MajorTopicYN="N">KPS = Karnofsky Performance Scale</Keyword><Keyword MajorTopicYN="N">LMWH = low-molecular-weight heparin</Keyword><Keyword MajorTopicYN="N">PE = pulmonary embolism</Keyword><Keyword MajorTopicYN="N">RCT = randomized controlled trial</Keyword><Keyword MajorTopicYN="N">VTE = venous thromboembolic event</Keyword><Keyword MajorTopicYN="N">brain neoplasms</Keyword><Keyword MajorTopicYN="N">chemoprevention</Keyword><Keyword MajorTopicYN="N">deep venous thrombosis</Keyword><Keyword MajorTopicYN="N">neurosurgery</Keyword><Keyword MajorTopicYN="N">pulmonary embolism</Keyword><Keyword MajorTopicYN="N">vascular disorders</Keyword><Keyword MajorTopicYN="N">venous thromboembolism</Keyword></KeywordList><CoiStatement>Disclosures. The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>4</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>7</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30611138</ArticleId><ArticleId IdType="mid">NIHMS1005218</ArticleId><ArticleId IdType="pmc">PMC6609511</ArticleId><ArticleId IdType="doi">10.3171/2018.7.JNS181175</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Agarwal N, Zenonos GA, Agarwal P, Walch FJ, Roach E, Stokes SJ, et al.: Risk-to-benefit ratio of venous thromboembolism prophylaxis for neurosurgical procedures at a quaternary referral center. Neurosurgery [epub ahead of print], 2018</Citation><ArticleIdList><ArticleId IdType="pubmed">29538700</ArticleId></ArticleIdList></Reference><Reference><Citation>Agnelli G, Piovella F, Buoncristiani P, Severi P, Pini M, D&#x2019;Angelo A, et al.: Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery. N Engl J Med 339:80&#x2013;85, 1998</Citation><ArticleIdList><ArticleId IdType="pubmed">9654538</ArticleId></ArticleIdList></Reference><Reference><Citation>Algattas H, Damania D, DeAndrea-Lazarus I, Kimmell KT, Marko NF, Walter KA, et al.: Systematic review of safety and cost-effectiveness of venous thromboembolism prophylaxis strategies in patients undergoing craniotomy for brain tumor. Neurosurgery 82:142&#x2013;154, 2018</Citation><ArticleIdList><ArticleId IdType="pubmed">28402497</ArticleId></ArticleIdList></Reference><Reference><Citation>Algattas H, Kimmell KT, Vates GE, Jahromi BS: Analysis of venous thromboembolism risk in patients undergoing craniotomy. World Neurosurg 84:1372&#x2013;1379, 2015</Citation><ArticleIdList><ArticleId IdType="pubmed">26117085</ArticleId></ArticleIdList></Reference><Reference><Citation>Alshehri N, Cote DJ, Hulou MM, Alghamdi A, Alshahrani A, Mekary RA, et al.: Venous thromboembolism prophylaxis in brain tumor patients undergoing craniotomy: a meta-analysis. J Neurooncol 130:561&#x2013;570, 2016</Citation><ArticleIdList><ArticleId IdType="pubmed">27591773</ArticleId></ArticleIdList></Reference><Reference><Citation>Auguste KI, Quinones-Hinojosa A, Gadkary C, Zada G, Lamborn KR, Berger MS: Incidence of venous thromboembolism in patients undergoing craniotomy and motor mapping for glioma without intraoperative mechanical prophylaxis to the contralateral leg. J Neurosurg 99:680&#x2013;684, 2003</Citation><ArticleIdList><ArticleId IdType="pubmed">14567603</ArticleId></ArticleIdList></Reference><Reference><Citation>Bucci MN, Papadopoulos SM, Chen JC, Campbell JA, Hoff JT: Mechanical prophylaxis of venous thrombosis in patients undergoing craniotomy: a randomized trial. Surg Neurol 32:285&#x2013;288, 1989</Citation><ArticleIdList><ArticleId IdType="pubmed">2675364</ArticleId></ArticleIdList></Reference><Reference><Citation>Cage TA, Lamborn KR, Ware ML, Frankfurt A, Chakalian L, Berger MS, et al.: Adjuvant enoxaparin therapy may decrease the incidence of postoperative thrombotic events though does not increase the incidence of postoperative intracranial hemorrhage in patients with meningiomas. J Neurooncol 93:151&#x2013;156, 2009</Citation><ArticleIdList><ArticleId IdType="pubmed">19430892</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerrato D, Ariano C, Fiacchino F: Deep vein thrombosis and low-dose heparin prophylaxis in neurosurgical patients. J Neurosurg 49:378&#x2013;381, 1978</Citation><ArticleIdList><ArticleId IdType="pubmed">681999</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaichana KL, Pendleton C, Jackson C, Martinez-Gutierrez JC, Diaz-Stransky A, Aguayo J, et al.: Deep venous thrombosis and pulmonary embolisms in adult patients undergoing craniotomy for brain tumors. Neurol Res 35:206&#x2013;211, 2013</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3991124</ArticleId><ArticleId IdType="pubmed">23336127</ArticleId></ArticleIdList></Reference><Reference><Citation>Cogo A, Lensing AWA, Prandoni P, Hirsh J: Distribution of thrombosis in patients with symptomatic deep vein thrombosis. Implications for simplifying the diagnostic process with compression ultrasound. Arch Intern Med 153:2777&#x2013;2780, 1993</Citation><ArticleIdList><ArticleId IdType="pubmed">8257253</ArticleId></ArticleIdList></Reference><Reference><Citation>Constantini S, Kanner A, Friedman A, Shoshan Y, Israel Z, Ashkenazi E, et al.: Safety of perioperative minidose heparin in patients undergoing brain tumor surgery: a prospective, randomized, double-blind study. J Neurosurg 94:918&#x2013;921, 2001</Citation><ArticleIdList><ArticleId IdType="pubmed">11409520</ArticleId></ArticleIdList></Reference><Reference><Citation>Cote DJ, Dubois HM, Karhade AV, Smith TR: Venous thromboembolism in patients undergoing craniotomy for brain tumors: a U.S. nationwide analysis. Semin Thromb Hemost 42:870&#x2013;876, 2016</Citation><ArticleIdList><ArticleId IdType="pubmed">27764877</ArticleId></ArticleIdList></Reference><Reference><Citation>Danish SF, Burnett MG, Ong JG, Sonnad SS, Maloney-Wilensky E, Stein SC: Prophylaxis for deep venous thrombosis in craniotomy patients: a decision analysis. Neurosurgery 56:1286&#x2013;1294, 2005</Citation><ArticleIdList><ArticleId IdType="pubmed">15918945</ArticleId></ArticleIdList></Reference><Reference><Citation>Dermody M, Alessi-Chinetti J, Iafrati MD, Estes JM: The utility of screening for deep venous thrombosis in asymptomatic, non-ambulatory neurosurgical patients. J Vasc Surg 53:1309&#x2013;1315, 2011</Citation><ArticleIdList><ArticleId IdType="pubmed">21215569</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickinson LD, Miller LD, Patel CP, Gupta SK: Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery 43:1074&#x2013;1081, 1998</Citation><ArticleIdList><ArticleId IdType="pubmed">9802851</ArticleId></ArticleIdList></Reference><Reference><Citation>Flinn WR, Sandager GP, Silva MB Jr, Benjamin ME, Cerullo LJ, Taylor M: Prospective surveillance for perioperative venous thrombosis. Experience in 2643 patients. Arch Surg 131:472&#x2013;480, 1996</Citation><ArticleIdList><ArticleId IdType="pubmed">8624191</ArticleId></ArticleIdList></Reference><Reference><Citation>Frim DM, Barker FG II, Poletti CE, Hamilton AJ: Postoperative low-dose heparin decreases thromboembolic complications in neurosurgical patients. Neurosurgery 30:830&#x2013;833, 1992</Citation><ArticleIdList><ArticleId IdType="pubmed">1614582</ArticleId></ArticleIdList></Reference><Reference><Citation>Frisius J, Ebeling M, Karst M, Fahlbusch R, Schedel I, Gerganov V, et al.: Prevention of venous thromboembolic complications with and without intermittent pneumatic compression in neurosurgical cranial procedures using intraoperative magnetic resonance imaging. A retrospective analysis. Clin Neurol Neurosurg 133:46&#x2013;54, 2015</Citation><ArticleIdList><ArticleId IdType="pubmed">25837574</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerber DE, Segal JB, Salhotra A, Olivi A, Grossman SA, Streiff MB: Venous thromboembolism occurs infrequently in meningioma patients receiving combined modality prophylaxis. Cancer 109:300&#x2013;305, 2007</Citation><ArticleIdList><ArticleId IdType="pubmed">17154163</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerlach R, Scheuer T, Beck J, Woszczyk A, Seifert V, Raabe A: Risk of postoperative hemorrhage after intracranial surgery after early nadroparin administration: results of a prospective study. Neurosurgery 53:1028&#x2013;1035, 2003</Citation><ArticleIdList><ArticleId IdType="pubmed">14580268</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldhaber SZ, Dunn K, Gerhard-Herman M, Park JK, Black PM: Low rate of venous thromboembolism after craniotomy for brain tumor using multimodality prophylaxis. Chest 122:1933&#x2013;1937, 2002</Citation><ArticleIdList><ArticleId IdType="pubmed">12475829</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo X, Zhang F, Wu Y, Gao L, Wang Q, Wang Z, et al.: Coagulation alteration and deep vein thrombosis in brain tumor patients during the perioperative period. World Neurosurg 114:e982&#x2013;e991, 2018</Citation><ArticleIdList><ArticleId IdType="pubmed">29588239</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton MG, Yee WH, Hull RD, Ghali WA: Venous thromboembolism prophylaxis in patients undergoing cranial neurosurgery: a systematic review and meta-analysis. Neurosurgery 68:571&#x2013;581, 2011</Citation><ArticleIdList><ArticleId IdType="pubmed">21311292</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirmerova J, Seidlerova J, Chudacek Z: The prevalence of concomitant deep vein thrombosis, symptomatic or asymptomatic, proximal or distal, in patients with symptomatic pulmonary embolism. Clin Appl Thromb Hemost 24:1352&#x2013;1357, 2018</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6714772</ArticleId><ArticleId IdType="pubmed">29848045</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoefnagel D, Kwee LE, van Putten EH, Kros JM, Dirven CM, Dammers R: The incidence of postoperative thromboembolic complications following surgical resection of intracranial meningioma. A retrospective study of a large single center patient cohort. Clin Neurol Neurosurg 123:150&#x2013;154, 2014</Citation><ArticleIdList><ArticleId IdType="pubmed">24956544</ArticleId></ArticleIdList></Reference><Reference><Citation>Joffe SN: Incidence of postoperative deep vein thrombosis in neurosurgical patients. J Neurosurg 42:201&#x2013;203, 1975</Citation><ArticleIdList><ArticleId IdType="pubmed">1113155</ArticleId></ArticleIdList></Reference><Reference><Citation>Kearon C: Natural history of venous thromboembolism. Circulation 107 (23 Suppl 1):I22&#x2013;I30, 2003</Citation><ArticleIdList><ArticleId IdType="pubmed">12814982</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimmell KT, Jahromi BS: Clinical factors associated with venous thromboembolism risk in patients undergoing craniotomy. J Neurosurg 122:1004&#x2013;1011, 2015</Citation><ArticleIdList><ArticleId IdType="pubmed">25495743</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar K, Tang KK, Thomas J, Chumpon C: Is postoperative deep vein thrombosis a problem in neurosurgical patients with brain tumours in Singapore? Singapore Med J 43:345&#x2013;349, 2002</Citation><ArticleIdList><ArticleId IdType="pubmed">12437041</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagerstedt CI, Olsson CG, Fagher BO, Oqvist BW, Albrechtsson U: Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis. Lancet 2:515&#x2013;518, 1985</Citation><ArticleIdList><ArticleId IdType="pubmed">2863541</ArticleId></ArticleIdList></Reference><Reference><Citation>Macdonald RL, Amidei C, Baron J, Weir B, Brown F, Erickson RK, et al.: Randomized, pilot study of intermittent pneumatic compression devices plus dalteparin versus intermittent pneumatic compression devices plus heparin for prevention of venous thromboembolism in patients undergoing craniotomy. Surg Neurol 59:363&#x2013;374, 2003</Citation><ArticleIdList><ArticleId IdType="pubmed">12765806</ArticleId></ArticleIdList></Reference><Reference><Citation>Macdonald RL, Amidei C, Lin G, Munshi I, Baron J, Weir BK, et al.: Safety of perioperative subcutaneous heparin for prophylaxis of venous thromboembolism in patients undergoing craniotomy. Neurosurgery 45:245&#x2013;252, 1999</Citation><ArticleIdList><ArticleId IdType="pubmed">10449068</ArticleId></ArticleIdList></Reference><Reference><Citation>Melon E, Keravel Y, Gaston A, Huet Y, Combes S, the NEURO-NOX Group: Deep venous thrombosis prophylaxis by low molecular weight heparin in neurosurgical patients. Anesthesiology 75:A214, 1991. (Abstract)</Citation></Reference><Reference><Citation>Nakano F, Matsubara T, Ishigaki T, Hatazaki S, Mouri G, Nakatsuka Y, et al.: Incidence and risk factor of deep venous thrombosis in patients undergoing craniotomy for brain tumors: A Japanese single-center, retrospective study. Thromb Res 165:95&#x2013;100, 2018</Citation><ArticleIdList><ArticleId IdType="pubmed">29605752</ArticleId></ArticleIdList></Reference><Reference><Citation>Natsumeda M, Uzuka T, Watanabe J, Fukuda M, Akaiwa Y, Hanzawa K, et al.: High incidence of deep vein thrombosis in the perioperative period of neurosurgical patients. World Neurosurg 112:e103&#x2013;e112, 2018</Citation><ArticleIdList><ArticleId IdType="pubmed">29294399</ArticleId></ArticleIdList></Reference><Reference><Citation>Nu&#xf1;o M, Carico C, Mukherjee D, Ly D, Ortega A, Black KL, et al.: Association between in-hospital adverse events and mortality for patients with brain tumors. J Neurosurg 123:1247&#x2013;1255, 2015</Citation><ArticleIdList><ArticleId IdType="pubmed">26053457</ArticleId></ArticleIdList></Reference><Reference><Citation>Nurmohamed MT, van Riel AM, Henkens CM, Koopman MM, Que GT, d&#x2019;Azemar P, et al.: Low molecular weight heparin and compression stockings in the prevention of venous thromboembolism in neurosurgery. Thromb Haemost 75:233&#x2013;238, 1996</Citation><ArticleIdList><ArticleId IdType="pubmed">8815566</ArticleId></ArticleIdList></Reference><Reference><Citation>Prell J, Rachinger J, Smaczny R, Taute BM, Rampp S, Illert J, et al.: D-dimer plasma level: a reliable marker for venous thromboembolism after elective craniotomy. J Neurosurg 119:1340&#x2013;1346, 2013</Citation><ArticleIdList><ArticleId IdType="pubmed">23915033</ArticleId></ArticleIdList></Reference><Reference><Citation>Prell J, Schenk G, Taute BM, Scheller C, Marquart C, Strauss C, et al.: Reduced risk of venous thromboembolism with the use of intermittent pneumatic compression after craniotomy: a randomized controlled prospective study. J Neurosurg [epub ahead of print March 30, 2018. DOI: 10.3171/2017.9.JNS17533]</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/2017.9.JNS17533</ArticleId><ArticleId IdType="pubmed">29600912</ArticleId></ArticleIdList></Reference><Reference><Citation>Raabe A, Gerlach R, Zimmermann M, Seifert V: The risk of haemorrhage associated with early postoperative heparin administration after intracranial surgery. Acta Neurochir (Wien) 143:1&#x2013;7, 2001</Citation><ArticleIdList><ArticleId IdType="pubmed">11345711</ArticleId></ArticleIdList></Reference><Reference><Citation>Rolston JD, Han SJ, Bloch O, Parsa AT: What clinical factors predict the incidence of deep venous thrombosis and pulmonary embolism in neurosurgical patients? J Neurosurg 121:908&#x2013;918, 2014</Citation><ArticleIdList><ArticleId IdType="pubmed">25084467</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruff RL, Posner JB: Incidence and treatment of peripheral venous thrombosis in patients with glioma. Ann Neurol 13:334&#x2013;336, 1983</Citation><ArticleIdList><ArticleId IdType="pubmed">6303201</ArticleId></ArticleIdList></Reference><Reference><Citation>Salmaggi A, Simonetti G, Trevisan E, Beecher D, Carapella CM, DiMeco F, et al.: Perioperative thromboprophylaxis in patients with craniotomy for brain tumours: a systematic review. J Neurooncol 113:293&#x2013;303, 2013</Citation><ArticleIdList><ArticleId IdType="pubmed">23543244</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheller C, Rachinger J, Strauss C, Alfieri A, Prell J, Koman G: Therapeutic anticoagulation after craniotomies: is the risk for secondary hemorrhage overestimated? J Neurol Surg A Cent Eur Neurosurg 75:2&#x2013;6, 2014</Citation><ArticleIdList><ArticleId IdType="pubmed">23959615</ArticleId></ArticleIdList></Reference><Reference><Citation>Senders JT, Goldhaber NH, Cote DJ, Muskens IS, Dawood HY, De Vos FYFL, et al.: Venous thromboembolism and intracranial hemorrhage after craniotomy for primary malignant brain tumors: a National Surgical Quality Improvement Program analysis. J Neurooncol 136:135&#x2013;145, 2018</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5754452</ArticleId><ArticleId IdType="pubmed">29039075</ArticleId></ArticleIdList></Reference><Reference><Citation>Sj&#xe5;vik K, Bartek J Jr, Solheim O, Ingebrigtsen T, Gulati S, Sagberg LM, et al.: Venous thromboembolism prophylaxis in meningioma surgery: a population-based comparative effectiveness study of routine mechanical prophylaxis with or without preoperative low-molecular-weight heparin. World Neurosurg 88:320&#x2013;326, 2016</Citation><ArticleIdList><ArticleId IdType="pubmed">26746334</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith TR, Lall RR, Graham RB, Mcclendon J Jr, Lall RR, Nanney AD, et al.: Venous thromboembolism in high grade glioma among surgical patients: results from a single center over a 10 year period. J Neurooncol 120:347&#x2013;352, 2014</Citation><ArticleIdList><ArticleId IdType="pubmed">25062669</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith TR, Nanney AD III, Lall RR, Graham RB, McClendon J Jr, Lall RR, et al.: Development of venous thromboembolism (VTE) in patients undergoing surgery for brain tumors: results from a single center over a 10 year period. J Clin Neurosci 22:519&#x2013;525, 2015</Citation><ArticleIdList><ArticleId IdType="pubmed">25533212</ArticleId></ArticleIdList></Reference><Reference><Citation>Ting AC, Cheng SW, Cheung GC, Wu LL, Hung KN, Fan YW: Perioperative deep vein thrombosis in Chinese patients undergoing craniotomy. Surg Neurol 58:274&#x2013;279, 2002</Citation><ArticleIdList><ArticleId IdType="pubmed">12480241</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34246658</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>18</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1549-4713</ISSN><JournalIssue CitedMedium="Internet"><Volume>129</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Ophthalmology</Title><ISOAbbreviation>Ophthalmology</ISOAbbreviation></Journal><ArticleTitle>Postoperative Endophthalmitis in Immediate Sequential Bilateral Cataract Surgery: A Nationwide Registry Study.</ArticleTitle><Pagination><StartPage>26</StartPage><EndPage>34</EndPage><MedlinePgn>26-34</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ophtha.2021.07.007</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0161-6420(21)00517-0</ELocationID><Abstract><AbstractText Label="PURPOSE">To report the incidence of postoperative endophthalmitis (PE) after immediate sequential bilateral cataract surgery (ISBCS) in Sweden.</AbstractText><AbstractText Label="DESIGN">Retrospective cohort registry study.</AbstractText><AbstractText Label="PARTICIPANTS">Patient data from 1&#x2009;457&#x2009;172 cataract extractions, including 1&#x2009;364&#x2009;934 unilateral surgeries and 92&#x2009;238 ISBCSs.</AbstractText><AbstractText Label="METHODS">Endophthalmitis cases reported to the Swedish National Cataract Register (NCR) during a 16-year period (2002-2017) were analyzed in comparison to all control cases with regard to patient characteristics, surgical technique, and capsule complication.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURE">Incidence and determinants for PE in ISBCS compared with unilateral surgeries.</AbstractText><AbstractText Label="RESULTS">A total of 422 cases of PE were identified in 1&#x2009;457&#x2009;172 cataract extractions, yielding an overall incidence of 0.029% (95% confidence interval [CI], 0.0262-0.0317). For unilateral procedures, the rate was 0.0299% (95% CI, 0.0270-0.0328) or 408 cases in 1&#x2009;364&#x2009;934 operations, whereas that for ISBCS was 0.0152% (95% CI, 0.0072-0.0231) or 14 incidents in 92&#x2009;238 operations (P&#xa0;= 0.01). In a logistic regression model including all cataract procedures, nonuse of intracameral (IC) antibiotics (ABs), capsule complication, age 85 years or more, male gender, and ocular comorbidity were found to be independent risk factors for PE. All these parameters were less frequent in ISBCS. Notwithstanding, in the same multivariate analysis, ISBCS in itself was associated with a&#xa0;significantly lower risk for PE. At follow-up, 5 of the 14 PE cases in the ISBCS cohort had a visual acuity (VA) of 20/200 or worse. Of these, one 93-year-old ISBCS patient developed bilateral infection.</AbstractText><AbstractText Label="CONCLUSIONS">After ISBCS in Sweden, PE occurred once in 6600 surgeries. The risk of sustaining a final VA of 20/200 or less was 1 incident in 18&#x2009;000 operated eyes. When counseling potential ISBCS patients about the risk of PE, it seems reasonable to state that the reported risk in the literature is lower than that with unilateral surgery but not negligible. Precautions remain necessary.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Friling</LastName><ForeName>Emma</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Stockholms &#xd6;gonklinik, Stockholm, Sweden. Electronic address: emma.friling@ki.se.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johansson</LastName><ForeName>Bj&#xf6;rn</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology in Link&#xf6;ping and Department of Biomedical and Clinical Sciences, Link&#xf6;ping University, Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lundstr&#xf6;m</LastName><ForeName>Mats</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical Sciences, Ophthalmology, Faculty of Medicine, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montan</LastName><ForeName>Per</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Department of Anterior Segment Surgery, St. Erik Eye Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ophthalmology</MedlineTA><NlmUniqueID>7802443</NlmUniqueID><ISSNLinking>0161-6420</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002387" MajorTopicYN="N">Cataract Extraction</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009877" MajorTopicYN="N">Endophthalmitis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015818" MajorTopicYN="N">Eye Infections, Bacterial</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007903" MajorTopicYN="N">Lens Capsule, Crystalline</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019654" MajorTopicYN="N">Lens Implantation, Intraocular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013548" MajorTopicYN="N" Type="Geographic">Sweden</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014792" MajorTopicYN="N">Visual Acuity</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Immediate sequential bilateral cataract surgery</Keyword><Keyword MajorTopicYN="N">Intracameral antibiotics</Keyword><Keyword MajorTopicYN="N">Postoperative endophthalmitis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>6</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>11</Day><Hour>20</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34246658</ArticleId><ArticleId IdType="doi">10.1016/j.ophtha.2021.07.007</ArticleId><ArticleId IdType="pii">S0161-6420(21)00517-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38734998</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>12</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-0711</ISSN><JournalIssue CitedMedium="Internet"><Volume>310</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Archives of gynecology and obstetrics</Title><ISOAbbreviation>Arch Gynecol Obstet</ISOAbbreviation></Journal><ArticleTitle>First-trimester serum biomarkers in twin pregnancies and adverse obstetric outcomes-a single center cohort study.</ArticleTitle><Pagination><StartPage>315</StartPage><EndPage>325</EndPage><MedlinePgn>315-325</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00404-024-07547-6</ELocationID><Abstract><AbstractText Label="PURPOSE">This study aimed to determine the association of first-trimester maternal serum biomarkers with preterm birth (PTB), fetal growth restriction (FGR) and hypertensive disorders of pregnancy (HDP) in twin pregnancies.</AbstractText><AbstractText Label="METHODS">This is a retrospective cohort study of twin pregnancies followed at Maternidade Dr. Alfredo da Costa, Lisbon, Portugal, between January 2010 and December 2022. We included women who completed first-trimester screening in our unit and had ongoing pregnancies with two live fetuses, and delivered after 24&#xa0;weeks. Maternal characteristics, pregnancy-associated plasma protein-A (PAPP-A) and &#x3b2;-human chorionic gonadotropin (&#x3b2;-hCG) levels were analyzed for different outcomes: small for gestational age (SGA), gestational hypertension (GH), early and late-onset pre-eclampsia (PE), as well as the composite outcome of PTB associated with FGR and/or HDP. Univariable, multivariable logistic regression analyses and receiver-operating characteristic curve were used.</AbstractText><AbstractText Label="RESULTS">466 twin pregnancies met the inclusion criteria. Overall, 185 (39.7%) pregnancies were affected by SGA&#x2009;&lt;&#x2009;5th percentile and/or HDP. PAPP-A demonstrated a linear association with gestational age at birth and mean birth weight. PAPP-A proved to be an independent risk factor for SGA and PTB (&lt;&#x2009;34 and&#x2009;&lt;&#x2009;36&#xa0;weeks) related to FGR and/or HDP. None of the women with PAPP-A MoM&#x2009;&gt;&#x2009;90th percentile developed early-onset PE or PTB&#x2009;&lt;&#x2009;34&#xa0;weeks.</AbstractText><AbstractText Label="CONCLUSION">A high serum PAPP-A (&gt;&#x2009;90th percentile) ruled out early-onset PE and PTB&#x2009;&lt;&#x2009;34&#xa0;weeks. Unless other major risk factors for hypertensive disorders are present, these women should not be considered candidates for aspirin prophylaxis. Nevertheless, close monitoring of all TwP for adverse obstetric outcomes is still recommended.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Queir&#xf3;s</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1736-1825</Identifier><AffiliationInfo><Affiliation>Fetal Medicine and Surgery Center, Maternidade Dr. Alfredo da Costa, Unidade Local de Sa&#xfa;de de S&#xe3;o Jos&#xe9;, Lisbon, Portugal. alexandra.queiros@ulssjose.min-saude.pt.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Maternal and Fetal Medicine Unit, Maternidade Dr. Alfredo da Costa, Unidade Local de Sa&#xfa;de de S&#xe3;o Jos&#xe9;, Lisbon, Portugal. alexandra.queiros@ulssjose.min-saude.pt.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nova Medical School, Universidade Nova de Lisboa, Lisbon, Portugal. alexandra.queiros@ulssjose.min-saude.pt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gomes</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Maternal and Fetal Medicine Unit, Maternidade Dr. Alfredo da Costa, Unidade Local de Sa&#xfa;de de S&#xe3;o Jos&#xe9;, Lisbon, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pereira</LastName><ForeName>In&#xea;s</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Maternal and Fetal Medicine Unit, Maternidade Dr. Alfredo da Costa, Unidade Local de Sa&#xfa;de de S&#xe3;o Jos&#xe9;, Lisbon, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Charepe</LastName><ForeName>N&#xe1;dia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Maternal and Fetal Medicine Unit, Maternidade Dr. Alfredo da Costa, Unidade Local de Sa&#xfa;de de S&#xe3;o Jos&#xe9;, Lisbon, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Plancha</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Maternal and Fetal Medicine Unit, Maternidade Dr. Alfredo da Costa, Unidade Local de Sa&#xfa;de de S&#xe3;o Jos&#xe9;, Lisbon, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodrigues</LastName><ForeName>Sofia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Maternal and Fetal Medicine Unit, Maternidade Dr. Alfredo da Costa, Unidade Local de Sa&#xfa;de de S&#xe3;o Jos&#xe9;, Lisbon, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cohen</LastName><ForeName>&#xc1;lvaro</ForeName><Initials>&#xc1;</Initials><AffiliationInfo><Affiliation>Fetal Medicine and Surgery Center, Maternidade Dr. Alfredo da Costa, Unidade Local de Sa&#xfa;de de S&#xe3;o Jos&#xe9;, Lisbon, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alves</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Nova Medical School, Universidade Nova de Lisboa, Lisbon, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology and Statistics Unit, Unidade Local de Sa&#xfa;de de S&#xe3;o Jos&#xe9;, Lisbon, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre of Statistics and Its Applications, Universidade de Lisboa, Lisbon, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papoila</LastName><ForeName>Ana Lu&#xed;sa</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Nova Medical School, Universidade Nova de Lisboa, Lisbon, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology and Statistics Unit, Unidade Local de Sa&#xfa;de de S&#xe3;o Jos&#xe9;, Lisbon, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre of Statistics and Its Applications, Universidade de Lisboa, Lisbon, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sim&#xf5;es</LastName><ForeName>Teresinha</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Maternal and Fetal Medicine Unit, Maternidade Dr. Alfredo da Costa, Unidade Local de Sa&#xfa;de de S&#xe3;o Jos&#xe9;, Lisbon, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nova Medical School, Universidade Nova de Lisboa, Lisbon, Portugal.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Arch Gynecol Obstet</MedlineTA><NlmUniqueID>8710213</NlmUniqueID><ISSNLinking>0932-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.24.-</RegistryNumber><NameOfSubstance UI="D011266">Pregnancy-Associated Plasma Protein-A</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018997">Chorionic Gonadotropin, beta Subunit, Human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059285" MajorTopicYN="Y">Pregnancy, Twin</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011261" MajorTopicYN="Y">Pregnancy Trimester, First</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="Y">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005317" MajorTopicYN="Y">Fetal Growth Retardation</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011266" MajorTopicYN="Y">Pregnancy-Associated Plasma Protein-A</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D047928" MajorTopicYN="Y">Premature Birth</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018997" MajorTopicYN="Y">Chorionic Gonadotropin, beta Subunit, Human</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D046110" MajorTopicYN="Y">Hypertension, Pregnancy-Induced</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007236" MajorTopicYN="N">Infant, Small for Gestational Age</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011225" MajorTopicYN="N">Pre-Eclampsia</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011256" MajorTopicYN="N">Pregnancy Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011174" MajorTopicYN="N" Type="Geographic">Portugal</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005865" MajorTopicYN="N">Gestational Age</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Fetal growth restriction</Keyword><Keyword MajorTopicYN="N">First trimester screening</Keyword><Keyword MajorTopicYN="N">Hypertensive disorders</Keyword><Keyword MajorTopicYN="N">Preterm birth</Keyword><Keyword MajorTopicYN="N">Serum biomarkers</Keyword><Keyword MajorTopicYN="N">Twin pregnancies</Keyword></KeywordList><CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>12</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>12</Day><Hour>12</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>12</Day><Hour>11</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38734998</ArticleId><ArticleId IdType="pmc">PMC11169060</ArticleId><ArticleId IdType="doi">10.1007/s00404-024-07547-6</ArticleId><ArticleId IdType="pii">10.1007/s00404-024-07547-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Santolaya J. Twins-twice more trouble? Clin Obstet Gynecol. 2012;55:296&#x2013;306. doi: 10.1097/GRF.0b013e3182446f51.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/GRF.0b013e3182446f51</ArticleId><ArticleId IdType="pubmed">22343246</ArticleId></ArticleIdList></Reference><Reference><Citation>Wainstock T, Yoles I, Sergienko R, Sheiner E. Twins vs singletons-long-term health outcomes. Acta Obstet Gynecol Scand. 2023;102(8):1000&#x2013;1006. doi: 10.1111/aogs.14579.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aogs.14579</ArticleId><ArticleId IdType="pmc">PMC10377983</ArticleId><ArticleId IdType="pubmed">37186304</ArticleId></ArticleIdList></Reference><Reference><Citation>Chauhan SP, Scardo JA, Hayes E, Abuhamad AZ, Berghella V. Twins: prevalence, problems, and preterm births. YMOB. 2010;203:305&#x2013;315.</Citation><ArticleIdList><ArticleId IdType="pubmed">20728073</ArticleId></ArticleIdList></Reference><Reference><Citation>Beta J, Akolekar R, Ventura W, Syngelaki A, Nicolaides KH. Prediction of spontaneous preterm delivery from maternal factors, obstetric history and placental perfusion and function at 11&#x2013;13&#xa0;weeks. Prenat Diagn. 2011;31:75&#x2013;83. doi: 10.1002/pd.2662.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pd.2662</ArticleId><ArticleId IdType="pubmed">21210482</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright A, Guerra L, Pellegrino M, Wright D, Nicolaides KH. Maternal serum PAPP-A and free &#x3b2;-hCG at 12, 22 and 32 weeks&#x2019; gestation in screening for pre-eclampsia. Ultrasound Obstet Gynecol. 2016;47(6):762&#x2013;767. doi: 10.1002/uog.15849.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/uog.15849</ArticleId><ArticleId IdType="pubmed">26726121</ArticleId></ArticleIdList></Reference><Reference><Citation>Giorgione V, Quintero Mendez O, Pinas A, Ansley W, Thilaganathan B. Routine first-trimester pre-eclampsia screening and risk of preterm birth. Ultrasound Obstet Gynecol. 2022;60:185&#x2013;191. doi: 10.1002/uog.24915.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/uog.24915</ArticleId><ArticleId IdType="pmc">PMC9545360</ArticleId><ArticleId IdType="pubmed">35441764</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu CPH, Feng Q, Chaemsaithong P, et al. Prediction of spontaneous preterm birth and preterm prelabor rupture of membranes using maternal factors, obstetric history and biomarkers of placental function at 11&#x2013;13&#xa0;weeks. Ultrasound Obstet Gynecol. 2022;60:192&#x2013;199. doi: 10.1002/uog.24917.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/uog.24917</ArticleId><ArticleId IdType="pubmed">35445767</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris RK, Bilagi A, Devani P, Kilby MD. Association of serum PAPP-A levels in first trimester with small for gestational age and adverse pregnancy outcomes: systematic review and meta-analysis. Prenat Diagn. 2017;37(3):253&#x2013;265. doi: 10.1002/pd.5001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pd.5001</ArticleId><ArticleId IdType="pubmed">28012202</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavoretto PI, Farina A, Salmeri N, Syngelaki A, Tan MY, Nicolaides KH. First trimester risk of preeclampsia and rate of spontaneous birth in patients without preeclampsia. Am J Obstet Gynecol. 2024 doi: 10.1016/j.ajog.2024.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2024.01.008</ArticleId><ArticleId IdType="pubmed">38244830</ArticleId></ArticleIdList></Reference><Reference><Citation>Svirsky R, Levinsohn-Tavor O, Feldman N, Klog E, Cuckle H, Maymon R. First- and second-trimester maternal serum markers of pre-eclampsia in twin pregnancy. Ultrasound Obstet Gynecol. 2016;47(5):560&#x2013;564. doi: 10.1002/uog.14873.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/uog.14873</ArticleId><ArticleId IdType="pubmed">25865365</ArticleId></ArticleIdList></Reference><Reference><Citation>Saletra-Bieli&#x144;ska A, Kosi&#x144;ska-Kaczy&#x144;ska K, Szymusik I, et al. Both low and high PAPP-A concentrations in the first trimester of pregnancy are associated with increased risk of delivery before 32&#xa0;weeks in twin gestation. J Clin Med. 2020;9(7):2099. doi: 10.3390/jcm9072099.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9072099</ArticleId><ArticleId IdType="pmc">PMC7408854</ArticleId><ArticleId IdType="pubmed">32635314</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown MA, Magee LA, Kenny LC, et al. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension. 2018;72:24&#x2013;43. doi: 10.1161/HYPERTENSIONAHA.117.10803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.117.10803</ArticleId><ArticleId IdType="pubmed">29899139</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalil A, Beune I, Hecher K, et al. Consensus definition and essential reporting parameters of selective fetal growth restriction in twin pregnancy: a delphi procedure. Ultrasound Obstet Gynecol. 2019;53(1):47&#x2013;54. doi: 10.1002/uog.19013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/uog.19013</ArticleId><ArticleId IdType="pubmed">29363848</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye C, Duan H, Liu M, Liu J, Xiang J, Yin Y, Zhou Q, Yang D, Yan R, Li R. The value of combined detailed first-trimester ultrasound-biochemical analysis for screening fetal aneuploidy in the era of non-invasive prenatal testing. Arch Gynecol Obstet. 2023 doi: 10.1007/s00404-023-07267-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00404-023-07267-3</ArticleId><ArticleId IdType="pmc">PMC11258060</ArticleId><ArticleId IdType="pubmed">37938359</ArticleId></ArticleIdList></Reference><Reference><Citation>Papastefanou I, Wright D, Syngelaki A, Souretis K, Chrysanthopoulou E, Nicolaides KH. Competing-risks model for prediction of small-for-gestational-age neonate from biophysical and biochemical markers at 11&#x2013;13&#xa0;weeks&#x2019; gestation. Ultrasound Obstet Gynecol. 2021;57(1):52&#x2013;61. doi: 10.1002/uog.23523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/uog.23523</ArticleId><ArticleId IdType="pubmed">33094535</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Gorman N, Wright D, Syngelaki A, Akolekar R, Wright A, Poon LC, Nicolaides KH. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11&#x2013;13&#xa0;weeks gestation. Am J Obstet Gynecol. 2016;214(1):103.e1&#x2013;103.e12. doi: 10.1016/j.ajog.2015.08.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2015.08.034</ArticleId><ArticleId IdType="pubmed">26297382</ArticleId></ArticleIdList></Reference><Reference><Citation>Benk&#x151; Z, Wright A, Rehal A, et al. Prediction of pre-eclampsia in twin pregnancy by maternal factors and biomarkers at 11&#x2013;13&#xa0;weeks&#x2019; gestation: data from EVENTS trial. Ultrasound Obstet Gynecol. 2021;57(2):257&#x2013;265. doi: 10.1002/uog.23531.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/uog.23531</ArticleId><ArticleId IdType="pubmed">33142361</ArticleId></ArticleIdList></Reference><Reference><Citation>Proctor LK, Kfouri J, Hiersch L, et al. Association between hypertensive disorders and fetal growth restriction in twin compared with singleton gestations. Am J Obstet Gynecol. 2019;221(3):251.e1&#x2013;251.e8. doi: 10.1016/j.ajog.2019.04.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2019.04.022</ArticleId><ArticleId IdType="pubmed">31029663</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang M, Wang M, Li N. Advances in pathogenesis of preeclampsia. Arch Gynecol Obstet. 2024;309(5):1815&#x2013;1823. doi: 10.1007/s00404-024-07393-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00404-024-07393-6</ArticleId><ArticleId IdType="pubmed">38421424</ArticleId></ArticleIdList></Reference><Reference><Citation>Vats H, Saxena R, Sachdeva MP, Walia GK, Gupta V. Impact of maternal pre-pregnancy body mass index on maternal, fetal and neonatal adverse outcomes in the worldwide populations: a systematic review and meta-analysis. Obes Res Clin Pract. 2021;15(6):536&#x2013;545. doi: 10.1016/j.orcp.2021.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.orcp.2021.10.005</ArticleId><ArticleId IdType="pubmed">34782256</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber E, Ram M, Mor L, Ganor Paz Y, Shmueli A, Bornstein S, Barda G, Schreiber L, Weiner E, Levy M. Pregnancy and placental outcomes according to maternal BMI in women with preeclampsia: a retrospective cohort study. Arch Gynecol Obstet. 2023 doi: 10.1007/s00404-023-07148-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00404-023-07148-9</ArticleId><ArticleId IdType="pubmed">37466689</ArticleId></ArticleIdList></Reference><Reference><Citation>Okby R, Harlev A, Sacks KN, Sergienko R, Sheiner E. Preeclampsia acts differently in in vitro fertilization versus spontaneous twins. Arch Gynecol Obstet. 2018;297(3):653&#x2013;658. doi: 10.1007/s00404-017-4635-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00404-017-4635-y</ArticleId><ArticleId IdType="pubmed">29302809</ArticleId></ArticleIdList></Reference><Reference><Citation>Funaki S, Ogawa K, Ozawa N, Hosoya S, Okamoto A, Urayama KY, Morisaki N, Sago H. Association between fetal sex and pregnancy outcomes among women with twin pregnancies: a multicenter cross-sectional study. Arch Gynecol Obstet. 2023;307(5):1397&#x2013;1405. doi: 10.1007/s00404-022-06623-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00404-022-06623-z</ArticleId><ArticleId IdType="pubmed">35624168</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RE, Noah AI, Hill AV, Taylor BD. Fetal sexual dimorphism and preeclampsia among twin pregnancies. Hypertension. 2024;81(3):614&#x2013;619. doi: 10.1161/HYPERTENSIONAHA.123.22380.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.123.22380</ArticleId><ArticleId IdType="pmc">PMC10922256</ArticleId><ArticleId IdType="pubmed">38152884</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirkegaard I, Uldbjerg N, Oxvig C. Biology of pregnancy-associated plasma protein-A in relation to prenatal diagnostics: an overview. Acta Obstet Gynecol Scand. 2010;89(9):1118&#x2013;1125. doi: 10.3109/00016349.2010.505639.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00016349.2010.505639</ArticleId><ArticleId IdType="pubmed">20804336</ArticleId></ArticleIdList></Reference><Reference><Citation>Brosens I, Pijnenborg R, Vercruysse L, Romero R. The, &#x201c;Great Obstetrical Syndromes&#x201d; are associated with disorders of deep placentation. Am J Obstet Gynecol. 2011;204(3):193&#x2013;201. doi: 10.1016/j.ajog.2010.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2010.08.009</ArticleId><ArticleId IdType="pmc">PMC3369813</ArticleId><ArticleId IdType="pubmed">21094932</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu P, van den Berg C, Alfirevic Z, O'Brien S, R&#xf6;thlisberger M, Baker PN, Kenny LC, Kublickiene K, Duvekot JJ. Early pregnancy biomarkers in pre-eclampsia: a systematic review and meta-analysis. Int J Mol Sci. 2015;16(9):23035&#x2013;23056. doi: 10.3390/ijms160923035.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms160923035</ArticleId><ArticleId IdType="pmc">PMC4613350</ArticleId><ArticleId IdType="pubmed">26404264</ArticleId></ArticleIdList></Reference><Reference><Citation>Poon LC, Shennan A, Hyett JA, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention. Int J Gynaecol Obstet. 2019;145(Suppl 1):1&#x2013;33. doi: 10.1002/ijgo.12802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijgo.12802</ArticleId><ArticleId IdType="pmc">PMC6944283</ArticleId><ArticleId IdType="pubmed">31111484</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan MY, Poon LC, Rolnik DL, Syngelaki A, de Paco MC, Nicolaides KH, et al. Prediction and prevention of small-for-gestational-age neonates: evidence from SPREE and ASPRE. Ultrasound Obstet Gynecol. 2018;52(1):52&#x2013;59. doi: 10.1002/uog.19077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/uog.19077</ArticleId><ArticleId IdType="pubmed">29704277</ArticleId></ArticleIdList></Reference><Reference><Citation>ACOG Committee Opinion No 743: low-dose aspirin use during pregnancy. Obstet Gynecol. 2018;132(1):e44&#x2013;e52. doi: 10.1097/AOG.0000000000002708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AOG.0000000000002708</ArticleId><ArticleId IdType="pubmed">29939940</ArticleId></ArticleIdList></Reference><Reference><Citation>Hypertension in pregnancy: diagnosis and management. NICE Guideline, No. 133. London: National Institute for Health and Care Excellence (NICE). ISBN-13: 978-1-4731-3434-8. (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31498578</ArticleId></ArticleIdList></Reference><Reference><Citation>Toussia-Cohen S, Zaslavsky-Paltiel I, et al. Reconsidering the effectiveness of low-dose aspirin in prevention of pre-eclampsia among otherwise low risk twin gestations: a historical cohort study. Int J Gynecol Obstet. 2023;162:964&#x2013;968. doi: 10.1002/ijgo.14754.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijgo.14754</ArticleId><ArticleId IdType="pubmed">37014367</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergeron TS, Roberge S, Carpentier C, Sibai B, McCaw-Binns A, Bujold E. Prevention of preeclampsia with aspirin in multiple gestations: a systematic review and meta-analysis. Am J Perinatol. 2016;33(6):605&#x2013;610. doi: 10.1055/s-0035-1570381.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0035-1570381</ArticleId><ArticleId IdType="pubmed">26731178</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Antonio F, Khalil A, Rizzo G, Fichera A, Herrera M, Prefumo F, et al. Aspirin for prevention of preeclampsia and adverse perinatal outcome in twin pregnancies: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2023;5(2):100803. doi: 10.1016/j.ajogmf.2022.100803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajogmf.2022.100803</ArticleId><ArticleId IdType="pubmed">36402356</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38425589</PMID><DateRevised><Year>2024</Year><Month>03</Month><Day>02</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Biomarkers of Pre-eclampsia in Pregnant Women With Gestational Diabetes and Pre-existing Type 2 Diabetes: A Systematic Review.</ArticleTitle><Pagination><StartPage>e53207</StartPage><MedlinePgn>e53207</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e53207</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.53207</ELocationID><Abstract><AbstractText>Pre-eclampsia (PE) is one of the leading causes of maternal and perinatal health morbidity, producing more than 4.6% of complications in pregnancy worldwide. This systematic review was conducted to determine the significance of specific biomarkers in predicting PE in gestational diabetes mellitus (GDM) and type 2 diabetes mellitus (DM). The review measured and explained the significant abnormalities in lipids, blood glucose, cytokines, inflammatory markers, placental proteins, urinary proteins, and other serum biomarkers that contribute to the development of PE in GDM and type 2 DM populations. We searched CINAHL, EMBASE, Medline, Maternity and Infant care, Scopus, and Web of Science.&#xa0;Studies were included if they had a measurable component in the blood serum or urine of women who developed PE and suffered from GDM or pre-existing type 2 DM.&#xa0;A narrative synthesis was conducted instead of a meta-analysis due to the high heterogeneity of data from the studies. A total of 2,593 studies were screened, producing eight relevant studies. Twenty-seven different biomarkers were investigated from the study group of 40 to 1,344 participants. No single biomarker was identified; however, there is a need for further research on specific biomarkers of PE, especially in CRP, FABP4, and microalbuminuria in the GDM-PE group and calprotectin in the type 2 DM population.&#xa0;Many biomarkers were identified as practical in predicting PE when combined with other biomarkers and more data are required to verify the predictability of the diagnostic markers in pregnant women.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024, Kabir et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kabir</LastName><ForeName>Yasmin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Medicine and Surgery, Royal College of Surgeons in Ireland, Manama, BHR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaykhon</LastName><ForeName>Norhan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Medicine and Surgery, Royal College of Surgeons in Ireland, Manama, BHR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Atkin</LastName><ForeName>Stephen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Medicine and Surgery, Royal College of Surgeons in Ireland, Manama, BHR.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">diabetes mellitus 2</Keyword><Keyword MajorTopicYN="N">diagnostic markers</Keyword><Keyword MajorTopicYN="N">gestational diabetes mellitus</Keyword><Keyword MajorTopicYN="N">hypertensive disorders of pregnancy</Keyword><Keyword MajorTopicYN="N">maternal morbidity</Keyword><Keyword MajorTopicYN="N">preeclampsia</Keyword><Keyword MajorTopicYN="N">pregnancy</Keyword><Keyword MajorTopicYN="N">serum biomarkers</Keyword></KeywordList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>1</Day><Hour>3</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38425589</ArticleId><ArticleId IdType="pmc">PMC10902745</ArticleId><ArticleId IdType="doi">10.7759/cureus.53207</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Global causes of maternal death: a WHO systematic analysis. Say L, Chou D, Gemmill A, et al. Lancet Glob Heal. 2014;2:0&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">25103301</ArticleId></ArticleIdList></Reference><Reference><Citation>Hypertensive Disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Brown MA, Magee LA, Kenny LC, et al. Hypertension. 2018;72:24&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">29899139</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardiovascular risk markers in pregnancies complicated by diabetes mellitus or preeclampsia. Sugulle M, Herse F, Seiler M, Dechend R, Staff AC. Pregnancy Hypertens. 2012;2:403&#x2013;410.</Citation><ArticleIdList><ArticleId IdType="pubmed">26105611</ArticleId></ArticleIdList></Reference><Reference><Citation>Pregnancy outcomes in type 2 diabetic patients as compared with type 1 diabetic patients and nondiabetic controls. Knight KM, Thornburg LL, Pressman EK. https://pubmed.ncbi.nlm.nih.gov/23091986/ J Reprod Med. 2012;57:397&#x2013;404.</Citation><ArticleIdList><ArticleId IdType="pubmed">23091986</ArticleId></ArticleIdList></Reference><Reference><Citation>Similar adverse pregnancy outcome in native and nonnative dutch women with pregestational type 2 diabetes: a multicentre retrospective study. Groen B, Links TP, van den Berg PP, et al. ISRN Obstet Gynecol. 2013;2013:361435.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3833010</ArticleId><ArticleId IdType="pubmed">24294525</ArticleId></ArticleIdList></Reference><Reference><Citation>Preeclampsia, gestational diabetes and later risk of cardiovascular disease: women's experiences and motivation for lifestyle changes explored in focus group interviews. Sands&#xe6;ter HL, Horn J, Rich-Edwards JW, Haugdahl HS. BMC Pregnancy Childbirth. 2019;19:448.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6882194</ArticleId><ArticleId IdType="pubmed">31775681</ArticleId></ArticleIdList></Reference><Reference><Citation>Hypertension in pregnancy: diagnosis and management.  [
Aug;
2023 
]. 2019. https://www.nice.org.uk/guidance/ng133 https://www.nice.org.uk/guidance/ng133</Citation></Reference><Reference><Citation>Early pregnancy biomarkers in pre-eclampsia: a systematic review and meta-analysis. Wu P, van den Berg C, Alfirevic Z, et al. Int J Mol Sci. 2015;16:23035&#x2013;23056.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4613350</ArticleId><ArticleId IdType="pubmed">26404264</ArticleId></ArticleIdList></Reference><Reference><Citation>Evaluation of biomarkers for the prediction of pre-eclampsia in women with type 1 diabetes mellitus: a systematic review. Wotherspoon AC, Young IS, McCance DR, Holmes VA. J Diabetes Complications. 2016;30:958&#x2013;966.</Citation><ArticleIdList><ArticleId IdType="pubmed">26900097</ArticleId></ArticleIdList></Reference><Reference><Citation>QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Whiting PF, Rutjes AW, Westwood ME, et al. Ann Intern Med. 2011;155:529&#x2013;536.</Citation><ArticleIdList><ArticleId IdType="pubmed">22007046</ArticleId></ArticleIdList></Reference><Reference><Citation>Factors predisposing to pre-eclampsia in women with gestational diabetes. Barden A, Singh R, Walters BN, Ritchie J, Roberman B, Beilin LJ. J Hypertens. 2004;22:2371&#x2013;2378.</Citation><ArticleIdList><ArticleId IdType="pubmed">15614032</ArticleId></ArticleIdList></Reference><Reference><Citation>Maternal lipids, BMI and IL-17/IL-35 imbalance in concurrent gestational diabetes mellitus and preeclampsia. Cao W, Wang X, Chen T, et al. Exp Ther Med. 2018;16:427&#x2013;435.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6030913</ArticleId><ArticleId IdType="pubmed">29977366</ArticleId></ArticleIdList></Reference><Reference><Citation>Urine albumin-creatinine ratio in women with gestational diabetes: its link with glycaemic status. Wong VW, Chong S, Jalaludin B, Russell H, Depczynski B. Aust N Z J Obstet Gynaecol. 2014;54:529&#x2013;533.</Citation><ArticleIdList><ArticleId IdType="pubmed">25308306</ArticleId></ArticleIdList></Reference><Reference><Citation>Insulin resistance and preeclampsia in gestational diabetes mellitus. Montoro MN, Kjos SL, Chandler M, Peters RK, Xiang AH, Buchanan TA. Diabetes Care. 2005;28:1995&#x2013;2000.</Citation><ArticleIdList><ArticleId IdType="pubmed">16043744</ArticleId></ArticleIdList></Reference><Reference><Citation>Plasma calprotectin as inflammation marker in pregnancies complicated by diabetes mellitus and superimposed preeclampsia. Sugulle M, Kvehaugen AS, Br&#xe6;kke K, Harsem NK, Staff AC. Pregnancy Hypertens. 2011;1:137&#x2013;142.</Citation><ArticleIdList><ArticleId IdType="pubmed">26104494</ArticleId></ArticleIdList></Reference><Reference><Citation>Correlation of tumor necrosis factor alpha, interleukin 6 and interleukin 10 with blood pressure, risk of preeclampsia and low birth weight in gestational diabetes. &#x17d;&#xe1;k P, Sou&#x10d;ek M. Physiol Res. 2019;68:395&#x2013;408.</Citation><ArticleIdList><ArticleId IdType="pubmed">30904009</ArticleId></ArticleIdList></Reference><Reference><Citation>Preterm birth, low birthweight, and small for gestational age among women with preeclampsia: does maternal age matter? Li X, Zhang W, Lin J, et al. Pregnancy Hypertens. 2018;13:260&#x2013;266.</Citation><ArticleIdList><ArticleId IdType="pubmed">30177063</ArticleId></ArticleIdList></Reference><Reference><Citation>Placental protein expression of kisspeptin-1 (KISS1) and the kisspeptin-1 receptor (KISS1R) in pregnancy complicated by diabetes mellitus or preeclampsia. Kapustin RV, Drobintseva AO, Alekseenkova EN, Onopriychuk AR, Arzhanova ON, Polyakova VO, Kvetnoy IM. Arch Gynecol Obstet. 2020;301:437&#x2013;445.</Citation><ArticleIdList><ArticleId IdType="pubmed">31811415</ArticleId></ArticleIdList></Reference><Reference><Citation>Dyslipidemia in early second trimester is mainly a feature of women with early onset pre-eclampsia. Clausen T, Djurovic S, Henriksen T. BJOG. 2001;108:1081&#x2013;1087.</Citation><ArticleIdList><ArticleId IdType="pubmed">11702841</ArticleId></ArticleIdList></Reference><Reference><Citation>Pre-pregnancy BMI, gestational weight gain and risk of preeclampsia: a birth cohort study in Lanzhou, China. Shao Y, Qiu J, Huang H, et al. BMC Pregnancy Childbirth. 2017;17:400.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5709979</ArticleId><ArticleId IdType="pubmed">29191156</ArticleId></ArticleIdList></Reference><Reference><Citation>Overweight and obesity are associated with clustering of metabolic risk factors in early pregnancy and the risk of GDM. Yen IW, Lee CN, Lin MW, et al.  http://10.1371/journal.pone.0225978. PLoS One. 2019;14:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6890240</ArticleId><ArticleId IdType="pubmed">31794594</ArticleId></ArticleIdList></Reference><Reference><Citation>Future of high-density lipoprotein infusion therapies: potential for clinical management of vascular disease. Kingwell BA, Chapman MJ. Circulation. 2013;128:1112&#x2013;1121.</Citation><ArticleIdList><ArticleId IdType="pubmed">24002713</ArticleId></ArticleIdList></Reference><Reference><Citation>Serum biomarkers for the prediction and diagnosis of preeclampsia: a&#xa0;meta-analysis. Shahid R, Bari MF, Hussain M. J Taibah Univ Med Sci. 2022;17:14&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8802864</ArticleId><ArticleId IdType="pubmed">35140561</ArticleId></ArticleIdList></Reference><Reference><Citation>Serum levels of adipocyte fatty acid binding protein are increased in gestational diabetes mellitus. Kralisch S, Stepan H, Kratzsch J, et al. Eur J Endocrinol. 2009;160:33&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">18849305</ArticleId></ArticleIdList></Reference><Reference><Citation>Serum adipocyte fatty acid-binding protein levels were independently associated with carotid atherosclerosis. Yeung DC, Xu A, Cheung CW, et al. Arterioscler Thromb Vasc Biol. 2007;27:1796&#x2013;1802.</Citation><ArticleIdList><ArticleId IdType="pubmed">17510463</ArticleId></ArticleIdList></Reference><Reference><Citation>Increased plasma fatty acid binding protein 4 concentration at the first prenatal visit and its relevance to preeclampsia. Qiao GH, Sun XZ. Hypertens Res. 2018;41:763&#x2013;769.</Citation><ArticleIdList><ArticleId IdType="pubmed">29946156</ArticleId></ArticleIdList></Reference><Reference><Citation>Free fatty acid profiles in preeclampsia. Villa PM, Laivuori H, Kajantie E, Kaaja R. Prostaglandins Leukot Essent Fatty Acids. 2009;81:17&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">19497719</ArticleId></ArticleIdList></Reference><Reference><Citation>A potential role for free fatty acids in the pathogenesis of preeclampsia. Robinson NJ, Minchell LJ, Myers JE, Hubel CA, Crocker IP. J Hypertens. 2009;27:1293&#x2013;1302.</Citation><ArticleIdList><ArticleId IdType="pubmed">19462499</ArticleId></ArticleIdList></Reference><Reference><Citation>[Glycemic control and the risk of preeclampsia in women with gestational diabetes mellitus] Starcevi&#x107; V, Djelmis J. https://pubmed.ncbi.nlm.nih.gov/15756801/ Acta Med Croatica. 2004;58:367&#x2013;371.</Citation><ArticleIdList><ArticleId IdType="pubmed">15756801</ArticleId></ArticleIdList></Reference><Reference><Citation>Associations of mid-pregnancy HbA1c with gestational diabetes and risk of adverse pregnancy outcomes in high-risk Taiwanese women. Ho YR, Wang P, Lu MC, Tseng ST, Yang CP, Yan YH. PLoS One. 2017;12:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5432166</ArticleId><ArticleId IdType="pubmed">28505205</ArticleId></ArticleIdList></Reference><Reference><Citation>Glycated haemoglobin A1c as a predictor of preeclampsia in type 1 diabetic pregnant women: a systematic review and meta-analysis. Cavero-Redondo I, Mart&#xed;nez-Vizca&#xed;no V, Soriano-Cano A, Mart&#xed;nez-Hortelano JA, Sanabria-Mart&#xed;nez G, &#xc1;lvarez-Bueno C. Pregnancy Hypertens. 2018;14:49&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">30527118</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemoglobin A1c as screening for gestational diabetes mellitus in Nordic Caucasian women. Ods&#xe6;ter IH, &#xc5;sberg A, Vanky E, M&#xf8;rkved S, Stafne SN, Salvesen K&#xc5;, Carlsen SM. Diabetol Metab Syndr. 2016;8:43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4957925</ArticleId><ArticleId IdType="pubmed">27453735</ArticleId></ArticleIdList></Reference><Reference><Citation>Maternal levels of prostacyclin, thromboxane, ICAM, and VCAM in normal and preeclamptic pregnancies. Lewis DF, Canzoneri BJ, Gu Y, Zhao S, Wang Y. Am J Reprod Immunol. 2010;64:376&#x2013;383.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3062267</ArticleId><ArticleId IdType="pubmed">20482519</ArticleId></ArticleIdList></Reference><Reference><Citation>Effects of free fatty acids found increased in women who develop pre-eclampsia on the ability of endothelial cells to produce prostacyclin, cGMP and inhibit platelet aggregation. Endresen MJ, T&#xf8;sti E, Heimli H, Lorentzen B, Henriksen T. Scand J Clin Lab Invest. 1994;54:549&#x2013;557.</Citation><ArticleIdList><ArticleId IdType="pubmed">7863232</ArticleId></ArticleIdList></Reference><Reference><Citation>Microalbuminuria as an early predictor of preeclampsia in the pre-gestational diabetic population: a prospective cohort study. Zen M, Padmanabhan S, Cheung NW, Kirby A, Jesudason S, Alahakoon TI, Lee VW. Pregnancy Hypertens. 2019;15:182&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pubmed">30825920</ArticleId></ArticleIdList></Reference><Reference><Citation>Prediction of proteinuria and microalbuminuria in diabetic pregnancies with a random single void. Eddib A, Allaf MB, Ogunleye O, Rodgers B. J Matern Fetal Neonatal Med. 2011;24:583&#x2013;586.</Citation><ArticleIdList><ArticleId IdType="pubmed">21375371</ArticleId></ArticleIdList></Reference><Reference><Citation>Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney. Ruiz-Ortega M, Ruperez M, Lorenzo O, Esteban V, Blanco J, Mezzano S, Egido J. Kidney Int Suppl. 2002:0&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">12410849</ArticleId></ArticleIdList></Reference><Reference><Citation>Determination of interleukin-6 and tumor necrosis factor-alpha concentrations in Iranian-Khorasanian patients with preeclampsia. Afshari JT, Ghomian N, Shameli A, et al. BMC Pregnancy Childbirth. 2005;5:14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1298308</ArticleId><ArticleId IdType="pubmed">16259641</ArticleId></ArticleIdList></Reference><Reference><Citation>Maternal serum levels of TNF-alpha and IL-6 long after delivery in preeclamptic and normotensive pregnant women. Vitoratos N, Economou E, Iavazzo C, Panoulis K, Creatsas G. Mediators Inflamm. 2010;2010:908649.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3021880</ArticleId><ArticleId IdType="pubmed">21253506</ArticleId></ArticleIdList></Reference><Reference><Citation>CD4+ T-helper cells stimulated in response to placental ischemia mediate hypertension during pregnancy. Wallace K, Richards S, Dhillon P, et al. Hypertension. 2011;57:949&#x2013;955.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3144629</ArticleId><ArticleId IdType="pubmed">21464392</ArticleId></ArticleIdList></Reference><Reference><Citation>Tumor necrosis factor-alpha in the placenta is not elevated in pre-eclamptic patients despite its elevation in peripheral blood. Hayashi M, Ueda Y, Yamaguchi T, Sohma R, Shibazaki M, Ohkura T, Inaba N. Am J Reprod Immunol. 2005;53:113&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pubmed">15727564</ArticleId></ArticleIdList></Reference><Reference><Citation>Preeclamptic women have decreased circulating IL-10 (interleukin-10) values at the time of preeclampsia diagnosis: systematic review and meta-analysis. Nath MC, Cubro H, McCormick DJ, Milic NM, Garovic VD. Hypertension. 2020;76:1817&#x2013;1827.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7666074</ArticleId><ArticleId IdType="pubmed">33100048</ArticleId></ArticleIdList></Reference><Reference><Citation>The concentrations of soluble HLA-G protein are elevated during mid-gestation and decreased in pre-eclampsia. Darmochwal-Kolarz D, Kolarz B, Rolinski J, Leszczynska-Gorzelak B, Oleszczuk J. Folia Histochem Cytobiol. 2012;50:286&#x2013;291.</Citation><ArticleIdList><ArticleId IdType="pubmed">22763960</ArticleId></ArticleIdList></Reference><Reference><Citation>Serum lipid levels in pregnancies complicated by preeclampsia. de Lima VJ, Andrade CR, Ruschi GE, Sass N. Sao Paulo Med J. 2011;129:73&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10896031</ArticleId><ArticleId IdType="pubmed">21603783</ArticleId></ArticleIdList></Reference><Reference><Citation>Predictive value of serum uric acid levels for adverse perinatal outcomes in preeclampsia. Ryu A, Cho NJ, Kim YS, Lee EY. Medicine (Baltimore) 2019;98:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6504307</ArticleId><ArticleId IdType="pubmed">31045822</ArticleId></ArticleIdList></Reference><Reference><Citation>Assessing the role of uric acid as a predictor of preeclampsia. Corominas AI, Medina Y, Balconi S, Casale R, Farina M, Mart&#xed;nez N, Damiano AE. Front Physiol. 2021;12:785219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8794766</ArticleId><ArticleId IdType="pubmed">35095555</ArticleId></ArticleIdList></Reference><Reference><Citation>Serum uric acid may not be involved in the development of preeclampsia. Chen Q, Lau S, Tong M, Wei J, Shen F, Zhao J, Zhao M. J Hum Hypertens. 2016;30:136&#x2013;140.</Citation><ArticleIdList><ArticleId IdType="pubmed">25994995</ArticleId></ArticleIdList></Reference><Reference><Citation>Endothelin-1: a key pathological factor in pre-eclampsia? Jain A. Reprod Biomed Online. 2012;25:443&#x2013;449.</Citation><ArticleIdList><ArticleId IdType="pubmed">22995748</ArticleId></ArticleIdList></Reference><Reference><Citation>The emerging role of endothelin-1 in the pathogenesis of pre-eclampsia. Saleh L, Verdonk K, Visser W, van den Meiracker AH, Danser AH. Ther Adv Cardiovasc Dis. 2016;10:282&#x2013;293.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5933567</ArticleId><ArticleId IdType="pubmed">26755746</ArticleId></ArticleIdList></Reference><Reference><Citation>C-reactive protein, marker for evaluation of systemic inflammatory response in preeclampsia. Mihu D, Costin N, Mihu CM, Blaga LD, Pop RB. https://pubmed.ncbi.nlm.nih.gov/20209780/ Rev Med Chir Soc Med Nat Iasi. 2008;112:1019&#x2013;1025.</Citation><ArticleIdList><ArticleId IdType="pubmed">20209780</ArticleId></ArticleIdList></Reference><Reference><Citation>C-reactive protein for prediction or early detection of pre-eclampsia: a systematic review. Hamadeh R, Mohsen A, Kobeissy F, Karouni A, Akoum H. Gynecol Obstet Invest. 2021;86:13&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">33902044</ArticleId></ArticleIdList></Reference><Reference><Citation>Serum PAPP-A and free beta-hCG are first-trimester screening markers for Down syndrome. Brambati B, Tului L, Bonacchi I, Shrimanker K, Suzuki Y, Grudzinskas JG. Prenat Diagn. 1994;14:1043&#x2013;1047.</Citation><ArticleIdList><ArticleId IdType="pubmed">7533285</ArticleId></ArticleIdList></Reference><Reference><Citation>Low maternal serum pregnancy-associated plasma protein-a as a risk factor of preeclampsia. Luewan S, Teja-Intr M, Sirichotiyakul S, Tongsong T. Singapore Med J. 2018;59:55&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5778261</ArticleId><ArticleId IdType="pubmed">28451695</ArticleId></ArticleIdList></Reference><Reference><Citation>Serum screening in first trimester to predict pre-eclampsia, small for gestational age and preterm delivery: systematic review and meta-analysis. Zhong Y, Zhu F, Ding Y. BMC Pregnancy Childbirth. 2015;15:191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4548561</ArticleId><ArticleId IdType="pubmed">26303460</ArticleId></ArticleIdList></Reference><Reference><Citation>Calprotectin, a marker of inflammation, is elevated in the maternal but not in the fetal circulation in preeclampsia. Braekke K, Holthe MR, Harsem NK, Fagerhol MK, Staff AC. Am J Obstet Gynecol. 2005;193:227&#x2013;233.</Citation><ArticleIdList><ArticleId IdType="pubmed">16021084</ArticleId></ArticleIdList></Reference><Reference><Citation>An evaluation of calprotectin as serum marker of preeclampsia: a systematic review of observational studies. Pergialiotis V, Prodromidou A, Pappa E, Vlachos GD, Perrea DN, Papantoniou N. Inflamm Res. 2016;65:95&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pubmed">26603731</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39150297</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1531-2291</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of orthopaedic trauma</Title><ISOAbbreviation>J Orthop Trauma</ISOAbbreviation></Journal><ArticleTitle>Effects of Obesity on Systemic Complications After Operative Pelvic Ring Fractures.</ArticleTitle><Pagination><StartPage>466</StartPage><EndPage>471</EndPage><MedlinePgn>466-471</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/BOT.0000000000002852</ELocationID><Abstract><AbstractText Label="OBJECTIVES">To determine the effect of obesity on systemic complications after operative pelvic ring injuries.</AbstractText><AbstractText Label="DESIGN">Retrospective cohort study.</AbstractText><AbstractText Label="SETTING">Single level 1 trauma center.</AbstractText><AbstractText Label="PATIENT SELECTION CRITERIA">All patients at a level 1 trauma center who underwent operative fixation of a pelvic ring injury from 2015 to 2022 were included. Patients were grouped based on body mass index (BMI) into 4 categories (normal = BMI &lt;25, overweight = BMI 25-30, obese = BMI 30-40, and morbidly obese BMI &gt;40).</AbstractText><AbstractText Label="OUTCOME MEASURES AND COMPARISONS">Systemic complications including acute respiratory distress syndrome, pneumonia, sepsis, deep venous thrombosis (DVT), pulmonary embolism, ileus, acute kidney injury (AKI), myocardial infarction, and mortality were recorded. Patients who developed a complication were compared with those who did not regarding demographic and clinical parameters to determine risk factors for each complication.</AbstractText><AbstractText Label="RESULTS">A total of 1056 patients underwent pelvic ring fixation including 388 normal BMI, 267 overweight, 289 obese, and 112 morbidly obese patients. The average age of all patients was 36.9 years, with a range from 16 to 85 years. Overall, 631 patients (59.8%) were male. The overall complication and mortality rates were 23.2% and 1.4%, respectively. BMI was a significant independent risk factor for all-cause complication with an odds ratio of 1.67 for overweight, 2.30 for obese, and 2.45 for morbidly obese patients. The risk of DVT and AKI was also significantly increased with every weight class above normal with ORs of 5.06 and 3.02, respectively, for morbidly obese patients (BMI &gt;40).</AbstractText><AbstractText Label="CONCLUSIONS">This study demonstrated that among patients undergoing pelvic ring fixation, higher BMI was associated with increased risks of overall complication, specifically DVT and AKI. As the prevalence of obesity continues to increase in the population, surgeons should be cognizant that these patients may be at higher risk of certain postoperative complications during the initial trauma admission.</AbstractText><AbstractText Label="LEVEL OF EVIDENCE">Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Wolters Kluwer Health, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Mihir</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, University of Alabama at Birmingham, Birmingham, AL; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fairburn</LastName><ForeName>Stevan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, University of Alabama at Birmingham, Birmingham, AL; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McGwin</LastName><ForeName>Gerald</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spitler</LastName><ForeName>Clay</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, University of Alabama at Birmingham, Birmingham, AL; and.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Orthop Trauma</MedlineTA><NlmUniqueID>8807705</NlmUniqueID><ISSNLinking>0890-5339</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010384" MajorTopicYN="Y">Pelvic Bones</DescriptorName><QualifierName UI="Q000293" MajorTopicYN="N">injuries</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050723" MajorTopicYN="Y">Fractures, Bone</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="Y">Obesity</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005593" MajorTopicYN="N">Fracture Fixation, Internal</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors report no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>16</Day><Hour>13</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>16</Day><Hour>13</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>16</Day><Hour>9</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39150297</ArticleId><ArticleId IdType="doi">10.1097/BOT.0000000000002852</ArticleId><ArticleId IdType="pii">00005131-202409000-00002</ArticleId></ArticleIdList><ReferenceList><Title/><Reference><Citation>Centers for Disease Control and Prevention. Overweight and Obesity. Available at: https://www.cdc.gov/obesity/index.html . Accessed June 10, 2023.</Citation></Reference><Reference><Citation>Fryar CD, Carroll MD, Afful J. Prevalence of Overweight, Obesity, and Severe Obesity Among Adults Aged 20 and over: United States, 1960&#x2013;1962 through 2017&#x2013;2018. NCHS Health E-Stats; 2020. Available at: https://www.cdc.gov/nchs/data/hestat/obesity-adult-17-18/obesity-adult.htm . Accessed June 10, 2023.</Citation></Reference><Reference><Citation>Manna P, Jain SK. Obesity, oxidative stress, adipose tissue dysfunction, and the associated health risks: causes and therapeutic strategies. Metab Syndr Relat Disord. 2015;13:423&#x2013;444.</Citation></Reference><Reference><Citation>Finkelstein EA, Chen H, Prabhu M, et al. The relationship between obesity and injuries among U.S. Adults. Am J Health Promot. 2007;21:460&#x2013;468.</Citation></Reference><Reference><Citation>Maheshwari R, Mack CD, Kaufman RP, et al. Severity of injury and outcomes among obese trauma patients with fractures of the femur and tibia: a crash injury research and engineering network study. J Orthop Trauma. 2009;23:634&#x2013;639.</Citation></Reference><Reference><Citation>Strauss EJ, Frank JB, Walsh M, et al. Does obesity influence the outcome after the operative treatment of ankle fractures? J Bone Joint Surg Br. 2007;89:794&#x2013;798.</Citation></Reference><Reference><Citation>Sabharwal S, Root MZ. Impact of obesity on orthopaedics. J Bone Joint Surg Am. 2012;94:1045&#x2013;1052.</Citation></Reference><Reference><Citation>Tucker MC, Schwappach JR, Leighton RK, et al. Results of femoral intramedullary nailing in patients who are obese versus those who are not obese: a prospective multicenter comparison study. J Orthop Trauma. 2007;21:523&#x2013;529.</Citation></Reference><Reference><Citation>Lameka M, Mabry S, Montgomery T, et al. Systemic complications of obesity in operative acetabular fractures. J Orthop Trauma. 2022;36:184&#x2013;188.</Citation></Reference><Reference><Citation>Baldwin KD, Matuszewski PE, Namdari S, et al. Does morbid obesity negatively affect the hospital course of patients undergoing treatment of closed, lower-extremity diaphyseal long-bone fractures? Orthopedics. 2011;34:18.</Citation></Reference><Reference><Citation>Robertson MJ, Lee RC, Bergin PF, et al. Complications of morbid obesity in the treatment of acetabular fractures: Re-evaluating outcomes a decade later. J Orthop Trauma. 2022;36:87&#x2013;92.</Citation></Reference><Reference><Citation>Karunakar MA, Shah SN, Jerabek S. Body mass index as a predictor of complications after operative treatment of acetabular fractures. J Bone Joint Surg Am. 2005;87:1498&#x2013;1502.</Citation></Reference><Reference><Citation>Werner BC, Rawles RB, Jobe JT, et al. Obesity is associated with increased postoperative complications after operative management of distal humerus fractures. J Shoulder Elbow Surg. 2015;24:1602&#x2013;1606.</Citation></Reference><Reference><Citation>Sems SA, Johnson M, Cole PA, et al. Elevated body mass index increases early complications of surgical treatment of pelvic ring injuries. J Orthop Trauma. 2010;24:309&#x2013;314.</Citation></Reference><Reference><Citation>Burrus MT, Werner BC, Yarboro SR. Obesity is associated with increased postoperative complications after operative management of tibial shaft fractures. Injury. 2016;47:465&#x2013;470.</Citation></Reference><Reference><Citation>Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8:R204&#x2013;R212.</Citation></Reference><Reference><Citation>Amin RM, Raad M, Rao SS, et al. Survival bias may explain the appearance of the obesity paradox in hip fracture patients. Osteoporos Int. 2021;32:2555&#x2013;2562.</Citation></Reference><Reference><Citation>Modig K, Erdefelt A, Mellner C, et al. Obesity paradox" holds true for patients with hip fracture: a registry-based cohort study. J Bone Joint Surg Am. 2019;101:888&#x2013;895.</Citation></Reference><Reference><Citation>Glance LG, Li Y, Osler TM, et al. Impact of obesity on mortality and complications in trauma patients. Ann Surg. 2014;259:576&#x2013;581.</Citation></Reference><Reference><Citation>Ditillo M, Pandit V, Rhee P, et al. Morbid obesity predisposes trauma patients to worse outcomes: a National Trauma Data Bank analysis. J Trauma Acute Care Surg. 2014;76:176&#x2013;179.</Citation></Reference><Reference><Citation>Childs BR, Nahm NJ, Dolenc AJ, et al. Obesity is associated with more complications and longer hospital stays after orthopaedic trauma. J Orthop Trauma. 2015;29:504&#x2013;509.</Citation></Reference><Reference><Citation>Winfield RD, Bochicchio GV. The critically injured obese patient: a review and a look ahead. J Am Coll Surg. 2013;216:1193&#x2013;1206.</Citation></Reference><Reference><Citation>Klovaite J, Benn M, Nordestgaard BG. Obesity as a causal risk factor for deep venous thrombosis: a Mendelian randomization study. J Intern Med. 2015;277:573&#x2013;584.</Citation></Reference><Reference><Citation>Ageno W, Becattini C, Brighton T, et al. Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation. 2008;117:93&#x2013;102.</Citation></Reference><Reference><Citation>B&#xfc;y&#xfc;ky&#x131;lmaz F, &#x15e;endir M, Autar R, et al. Risk level analysis for deep vein thrombosis (DVT): a study of Turkish patients undergoing major orthopedic surgery. J Vasc Nurs. 2015;33:100&#x2013;105.</Citation></Reference><Reference><Citation>Flancbaum L, Choban PS. Surgical implications of obesity. Annu Rev Med. 1998;49:215&#x2013;234.</Citation></Reference><Reference><Citation>Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of chest physicians evidence-based clinical practice guidelines. Chest. 2012;141:e278S&#x2013;e325S.</Citation></Reference><Reference><Citation>Major Extremity Trauma Research Consortium METRC, O'Toole RV, Stein DM, O'Hara NN, et al. Aspirin or low-molecular-weight heparin for thromboprophylaxis after a fracture. N Engl J Med. 2023;388:203&#x2013;213.</Citation></Reference><Reference><Citation>Walker CK, Sandmann EA, Horyna TJ, et al. Increased enoxaparin dosing for venous thromboembolism prophylaxis in general trauma patients. Ann Pharmacother. 2017;51:323&#x2013;331.</Citation></Reference><Reference><Citation>Danziger J, Chen KP, Lee J, et al. Obesity, acute kidney injury, and mortality in critical illness. Crit Care Med. 2016;44:328&#x2013;334.</Citation></Reference><Reference><Citation>Hennrikus MT, Hennrikus WP, Lehman E, et al. Obesity, angiotensin-blocking drugs, and acute kidney injury in orthopedic surgery. Orthopedics. 2021;44:e253&#x2013;e258.</Citation></Reference><Reference><Citation>James MT, Bhatt M, Pannu N, et al. Long-term outcomes of acute kidney injury and strategies for improved care. Nat Rev Nephrol. 2020;16:193&#x2013;205.</Citation></Reference><Reference><Citation>Joseph B, Zangbar B, Haider AA, et al. Hips don't lie: waist-to-hip ratio in trauma patients. J Trauma Acute Care Surg. 2015;79:1055&#x2013;1061.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">23845640</PMID><DateCompleted><Year>2014</Year><Month>03</Month><Day>14</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1531-5037</ISSN><JournalIssue CitedMedium="Internet"><Volume>48</Volume><Issue>6</Issue><PubDate><Year>2013</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of pediatric surgery</Title><ISOAbbreviation>J Pediatr Surg</ISOAbbreviation></Journal><ArticleTitle>Venous thromboembolism prophylaxis in the pediatric trauma population.</ArticleTitle><Pagination><StartPage>1413</StartPage><EndPage>1421</EndPage><MedlinePgn>1413-21</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jpedsurg.2013.02.059</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0022-3468(13)00191-7</ELocationID><Abstract><AbstractText Label="BACKGROUND/PURPOSE" NlmCategory="OBJECTIVE">The aim of this study was to review evidence-based literature addressing pertinent questions about venous thromboembolism (VTE) after traumatic injury in children.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Data were obtained from English-language articles identified through Pubmed published from 1995 until November 2012, and from bibliographies of relevant articles. Studies were included if they contributed evidence to one of the following questions. In the pediatric traumatic injury population: (1) What is the overall incidence of VTE? (2) Is age (adolescence versus pre-adolescence) associated with higher VTE incidence? (3) Which risk factors are associated with higher VTE incidence? (4) Does mechanical and/or pharmacological prophylaxis impact outcomes?</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Eighteen articles were included in this systematic review. The evidence regarding each question was evaluated, graded by author consensus, and summarized.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The overall incidence of VTE is low. Older (&gt;13years) and more severely injured patients are at higher VTE risk. Additional factors including injury type or presence of a central venous catheter also place a patient at higher VTE risk. Implementation of a risk-based clinical practice guideline for VTE prophylaxis has been associated with reduced symptomatic VTE at one institution. Randomized, prospective trials analyzing outcomes of VTE prophylaxis in pediatric trauma victims are needed.</AbstractText><CopyrightInformation>Copyright &#xa9; 2013 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>A Jill</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Department of Pharmacy Services, Medical University of South Carolina, Charleston, SC, USA. thompsam@musc.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McSwain</LastName><ForeName>S David</ForeName><Initials>SD</Initials></Author><Author ValidYN="Y"><LastName>Webb</LastName><ForeName>Sally A</ForeName><Initials>SA</Initials></Author><Author ValidYN="Y"><LastName>Stroud</LastName><ForeName>Melanie A</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Streck</LastName><ForeName>Christian J</ForeName><Initials>CJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Pediatr Surg</MedlineTA><NlmUniqueID>0052631</NlmUniqueID><ISSNLinking>0022-3468</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005343">Fibrinolytic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002405" MajorTopicYN="N">Catheterization, Central Venous</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005343" MajorTopicYN="N">Fibrinolytic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015601" MajorTopicYN="N">Injury Severity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D048228" MajorTopicYN="Y">Intermittent Pneumatic Compression Devices</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="N">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014947" MajorTopicYN="N">Wounds and Injuries</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CVC</Keyword><Keyword MajorTopicYN="N">Central venous catheter</Keyword><Keyword MajorTopicYN="N">DVT</Keyword><Keyword MajorTopicYN="N">ICU</Keyword><Keyword MajorTopicYN="N">IPC</Keyword><Keyword MajorTopicYN="N">ISS</Keyword><Keyword MajorTopicYN="N">KID</Keyword><Keyword MajorTopicYN="N">Kids&#x2019; Inpatient Database</Keyword><Keyword MajorTopicYN="N">LE</Keyword><Keyword MajorTopicYN="N">LMWH</Keyword><Keyword MajorTopicYN="N">Low molecular weight heparin</Keyword><Keyword MajorTopicYN="N">NPTR</Keyword><Keyword MajorTopicYN="N">NTDB</Keyword><Keyword MajorTopicYN="N">National Pediatric Trauma Registry</Keyword><Keyword MajorTopicYN="N">National Trauma Data Bank</Keyword><Keyword MajorTopicYN="N">PE</Keyword><Keyword MajorTopicYN="N">PHIS</Keyword><Keyword MajorTopicYN="N">PICU</Keyword><Keyword MajorTopicYN="N">Pediatric</Keyword><Keyword MajorTopicYN="N">Pediatric Health Information System</Keyword><Keyword MajorTopicYN="N">Pediatric intensive care unit</Keyword><Keyword MajorTopicYN="N">SCI</Keyword><Keyword MajorTopicYN="N">Trauma</Keyword><Keyword MajorTopicYN="N">VTE</Keyword><Keyword MajorTopicYN="N">Venous thromboembolism</Keyword><Keyword MajorTopicYN="N">central venous catheter</Keyword><Keyword MajorTopicYN="N">deep venous thrombosis</Keyword><Keyword MajorTopicYN="N">injury severity score</Keyword><Keyword MajorTopicYN="N">intensive care unit</Keyword><Keyword MajorTopicYN="N">intermittent pneumatic compression</Keyword><Keyword MajorTopicYN="N">low molecular weight heparin</Keyword><Keyword MajorTopicYN="N">lower extremity</Keyword><Keyword MajorTopicYN="N">pediatric intensive care unit</Keyword><Keyword MajorTopicYN="N">pulmonary embolism</Keyword><Keyword MajorTopicYN="N">spinal cord injury</Keyword><Keyword MajorTopicYN="N">venous thromboembolism</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>7</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2013</Year><Month>2</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>7</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>7</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23845640</ArticleId><ArticleId IdType="doi">10.1016/j.jpedsurg.2013.02.059</ArticleId><ArticleId IdType="pii">S0022-3468(13)00191-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33712253</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>25</Day></DateCompleted><DateRevised><Year>2022</Year><Month>08</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2352-2291</ISSN><JournalIssue CitedMedium="Internet"><Volume>71</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Season>Jan-Feb</Season></PubDate></JournalIssue><Title>Brazilian journal of anesthesiology (Elsevier)</Title><ISOAbbreviation>Braz J Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>Intraoperative clonidine to prevent postoperative emergence delirium following sevoflurane anesthesia in pediatric patients: a randomized clinical trial.</ArticleTitle><Pagination><StartPage>5</StartPage><EndPage>10</EndPage><MedlinePgn>5-10</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bjane.2020.12.003</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0104-0014(20)30203-7</ELocationID><Abstract><AbstractText Label="INTRODUCTION AND OBJECTIVE">Emergence Delirium (ED), particularly in children, is characterized by mental confusion, irritability, disorientation, and inconsolable crying. ED prolongs the time required in the Post-Anesthesia Care Unit (PACU) and increases concern and anxiety in parents. The present study aimed to determine the effectiveness and safety of low-dose clonidine in preventing ED in children receiving sevoflurane anesthesia for tonsillectomy/adenotonsillectomy.</AbstractText><AbstractText Label="METHODS">A randomized, double-blind clinical trial was conducted between November 2013 and January 2014. Sixty-two children aged 2-12 years, scheduled to undergo tonsillectomy/adenotonsillectomy, and classified as American Society of Anesthesiologists (ASA) physical status I/II were included, with 29 being randomized to receive 1&#xa0;&#x3bc;g.kg<sup>-1</sup> clonidine intravenously, and 33 allocated to a control group that received no clonidine. Anesthesia was induced and maintained with sevoflurane. Children with altered state of consciousness, neurological deficit, history of allergy to dipyrone, or receiving other drugs such as preanesthetic agents were excluded from the study. The primary outcome was the presence of ED in the initial 20&#xa0;minutes in the PACU according to the Pediatric Anesthesia Emergence Delirium (PAED) scale. The Chi-Square test and Fisher's two-tailed exact test were used for statistical analysis, as applicable. Significance level was set at 5%, and Risk Ratios (RR) and their 95% Confidence Intervals (95% CI) were calculated.</AbstractText><AbstractText Label="RESULTS">The frequency of ED was significantly decreased in the group of children who received clonidine (17.2% vs. 57.6%; RR&#xa0;=&#xa0;0.30; 95% CI 0.13-0.70; p&#xa0;=&#xa0; 0.001). There was no difference between groups with respect to the frequency of postoperative self-harm (falls and bruises), dislodged catheters, and for most of the other adverse events evaluated.</AbstractText><AbstractText Label="CONCLUSIONS">The use of 1&#xa0;&#x3bc;g.kg<sup>-1</sup> intravenous clonidine during anesthesia induction can effectively reduce the incidence of ED in children undergoing elective tonsillectomy/adenotonsillectomy under general inhalation anesthesia with sevoflurane. CLINICALTRIALS.</AbstractText><AbstractText Label="GOV IDENTIFIER">NCT02181543.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020. Published by Elsevier Editora Ltda.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sousa-J&#xfa;nior</LastName><ForeName>Fernando A</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Instituto de Medicina Integral Prof. Fernando Figueira (IMIP), Departamento de Anestesiologia, Recife, PE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Souza</LastName><ForeName>Alex S R</ForeName><Initials>ASR</Initials><AffiliationInfo><Affiliation>Instituto de Medicina Integral Prof. Fernando Figueira (IMIP), Recife, PE, Brazil; Universidade Federal de Pernambuco (UFPE), Departamento de Sa&#xfa;de da Mulher e da Crian&#xe7;a, Recife, PE, Brazil; Universidade Cat&#xf3;lica de Pernambuco (Unicap), Recife, PE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lima</LastName><ForeName>Luciana C</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Instituto de Medicina Integral Prof. Fernando Figueira (IMIP), Departamento de Anestesiologia, Recife, PE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos</LastName><ForeName>&#xcd;talo G M</ForeName><Initials>&#xcd;GM</Initials><AffiliationInfo><Affiliation>Faculdade Pernambucana de Sa&#xfa;de (FPS), Recife, PE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Menezes</LastName><ForeName>Leonardo A P</ForeName><Initials>LAP</Initials><AffiliationInfo><Affiliation>Faculdade Pernambucana de Sa&#xfa;de (FPS), Recife, PE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ratis</LastName><ForeName>Pedro A P L</ForeName><Initials>PAPL</Initials><AffiliationInfo><Affiliation>Faculdade Pernambucana de Sa&#xfa;de (FPS), Recife, PE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Couceiro</LastName><ForeName>Tania C M</ForeName><Initials>TCM</Initials><AffiliationInfo><Affiliation>Instituto de Medicina Integral Prof. Fernando Figueira (IMIP), Departamento de Anestesiologia, Recife, PE, Brazil. Electronic address: taniacouceiro@yahoo.com.br.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02181543</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>12</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Braz J Anesthesiol</MedlineTA><NlmUniqueID>101624623</NlmUniqueID><ISSNLinking>0104-0014</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018685">Anesthetics, Inhalation</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008738">Methyl Ethers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004364">Pharmaceutical Preparations</NameOfSubstance></Chemical><Chemical><RegistryNumber>38LVP0K73A</RegistryNumber><NameOfSubstance UI="D000077149">Sevoflurane</NameOfSubstance></Chemical><Chemical><RegistryNumber>MN3L5RMN02</RegistryNumber><NameOfSubstance UI="D003000">Clonidine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000762" MajorTopicYN="N">Anesthesia Recovery Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018685" MajorTopicYN="Y">Anesthetics, Inhalation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003000" MajorTopicYN="N">Clonidine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071257" MajorTopicYN="Y">Emergence Delirium</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008738" MajorTopicYN="Y">Methyl Ethers</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004364" MajorTopicYN="Y">Pharmaceutical Preparations</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077149" MajorTopicYN="N">Sevoflurane</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anesthesia</Keyword><Keyword MajorTopicYN="N">Children</Keyword><Keyword MajorTopicYN="N">Clonidine</Keyword><Keyword MajorTopicYN="N">Emergence delirium</Keyword><Keyword MajorTopicYN="N">Psychomotor agitation</Keyword><Keyword MajorTopicYN="N">Tonsillectomy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>5</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>13</Day><Hour>5</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>12</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33712253</ArticleId><ArticleId IdType="pmc">PMC9373338</ArticleId><ArticleId IdType="doi">10.1016/j.bjane.2020.12.003</ArticleId><ArticleId IdType="pii">S0104-0014(20)30203-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hudek K. Emergence delirium: a nursing perspective. AORN J. 2009;89:509&#x2013;516.</Citation><ArticleIdList><ArticleId IdType="pubmed">19326585</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlajkovic G.P., Sindjelic R.P. Emergence delirium in children: many questions, few answers. Anesth Analg. 2007;104:84&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">17179249</ArticleId></ArticleIdList></Reference><Reference><Citation>Lapin S.L., Auden S.M., Goldsmith L.J., et al. Effects of sevoflurane anaesthesia on recovery in children: a comparison with halothane. Paediatr Anaesth. 1999;9:299&#x2013;304.</Citation><ArticleIdList><ArticleId IdType="pubmed">10411764</ArticleId></ArticleIdList></Reference><Reference><Citation>Welborn L.G., Hannallah R.S., Norden J.M., Ruttimann U.E., Callan C.M. Comparison of emergence and recovery characteristics of sevoflurane, desflurane, and halothane in pediatric ambulatory patients. Anesth Analg. 1996;83:917&#x2013;920.</Citation><ArticleIdList><ArticleId IdType="pubmed">8895263</ArticleId></ArticleIdList></Reference><Reference><Citation>Aouad M.T., Nasr V.G. Emergence agitation in children: an update. Curr Opin Anaesthesiol. 2005;18:614&#x2013;619.</Citation><ArticleIdList><ArticleId IdType="pubmed">16534301</ArticleId></ArticleIdList></Reference><Reference><Citation>Silkich N., Lerman J. Development and psychometric evaluation of the pediatric anesthesia emergence delirium scale. Anesthesiol. 2004;100:1138&#x2013;1145.</Citation><ArticleIdList><ArticleId IdType="pubmed">15114210</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott G.M., Gold J.I. Emergence delirium: a re-emerging interest. Semin Anesth Perioperat Med Pain. 2006;25:100&#x2013;104.</Citation></Reference><Reference><Citation>Voepel-Lewis T., Malviya S., Tait A.R. A prospective cohort study of emergence agitation in the pediatric postanesthesia care unit. Anesth Analg. 2003;96:1625&#x2013;1630.</Citation><ArticleIdList><ArticleId IdType="pubmed">12760985</ArticleId></ArticleIdList></Reference><Reference><Citation>Veyckemans F. Excitation phenomena during sevoflurane anaesthesia in children. Curr Opin Anaesthesiol. 2001;14:339&#x2013;343.</Citation><ArticleIdList><ArticleId IdType="pubmed">17019113</ArticleId></ArticleIdList></Reference><Reference><Citation>Aouad M.T., Yazbeck-Karam V.G., Nasr V.G., El-Khatib M.F., Kanazi G.E., Bleik J.H. A single dose of propofol at the end of surgery for the prevention of emergence agitation in children undergoing strabismus surgery during sevoflurane anesthesia. Anesthesiol. 2007;107:733&#x2013;738.</Citation><ArticleIdList><ArticleId IdType="pubmed">18073548</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryan Y.F., Hoke L.K., Taghon T.A., et al. A randomized trial comparing sevoflurane and propofol in children undergoing MRI scans. Paediatr Anaesth. 2009;19:672&#x2013;681.</Citation><ArticleIdList><ArticleId IdType="pubmed">19638112</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulka P.J., Bressem M., Tryba M. Clonidine prevents sevoflurane-induced agitation in children. Anesth Analg. 2001;93:335&#x2013;338.</Citation><ArticleIdList><ArticleId IdType="pubmed">11473855</ArticleId></ArticleIdList></Reference><Reference><Citation>Fazi L.1, Jantzen E.C., Rose J.B., Kurth C.D., Watcha M.F. A comparison of oral clonidine and oral midazolam as preanesthetic medications in the pediatric tonsillectomy patient. Anesth Analg. 2001;92:56&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">11133600</ArticleId></ArticleIdList></Reference><Reference><Citation>Malviya S., Voepel-Lewis T., Ramamurthi R.J., Burke C., Tait A.R. Clonidine for the prevention of emergence agitation in young children: efficacy and recovery profile. Paediatr Anaesth. 2006;16:554&#x2013;559.</Citation><ArticleIdList><ArticleId IdType="pubmed">16677266</ArticleId></ArticleIdList></Reference><Reference><Citation>Ydemann M., Nielsen B.N., Henneberg S., et al. Prevent Agitation Research Group. Intraoperative clonidine for prevention of postoperative agitation in children anaesthetised with sevoflurane (PREVENT AGITATION): a randomised, placebo-controlled, double-blind trial. Lancet Child Adolesc Health. 2018;2:15&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">30169192</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickard A., Davies P., Birnie K., Beringer R. Systematic review and meta-analysis of the effect of intraoperative a2-adrenergic agonists on postoperative behaviour in children. Br J Anaesth. 2014;112:982&#x2013;990.</Citation><ArticleIdList><ArticleId IdType="pubmed">24727829</ArticleId></ArticleIdList></Reference><Reference><Citation>Daabiss M. American Society of Anaesthesiologists physical status classification. Indian J Anaesth. 2011;55:111&#x2013;115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3106380</ArticleId><ArticleId IdType="pubmed">21712864</ArticleId></ArticleIdList></Reference><Reference><Citation>Tazeroualti N., De Groote F., De Hert S., et al. Oral clonidine vs. midazolam in the prevention of sevoflurane-induced agitation in children: a prospective, randomized, controlled trial. Br J Anaesth. 2007;98:667&#x2013;671.</Citation><ArticleIdList><ArticleId IdType="pubmed">17416907</ArticleId></ArticleIdList></Reference><Reference><Citation>Bock M., Kunz P., Schreckenberger R., Graf B.M., Martin E., Motsch J. Comparison of caudal and intravenous clonidine in the prevention of agitation after sevoflurane in children. Br J Anaesth. 2002;88:790&#x2013;796.</Citation><ArticleIdList><ArticleId IdType="pubmed">12173195</ArticleId></ArticleIdList></Reference><Reference><Citation>Lankinen U., Avela R., Tarkkila P. The prevention of emergence agitation with tropisetron or clonidine after sevoflurane anesthesia in small children undergoing adenoidectomy. Anesth Analg. 2006;102:1383&#x2013;1386.</Citation><ArticleIdList><ArticleId IdType="pubmed">16632814</ArticleId></ArticleIdList></Reference><Reference><Citation>De Jonge A., Timmermans P.B.M.W.M., van Zweiten P.A. Participation of cardiac presynaptic &#x3b1;2-adrenoceptors in the bradycardic effects of clonidine and analogues. Naunyn Schmiedebergs Arch Pharmacol. 1981;317:8&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">6116198</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergendahl H.T., Lonnqvist P.A., Eksborg S., et al. Clonidine vs midazolam as premedication in children undergoing adenotonsillectomy: a prospective, randomized, controlled clinical trial. Acta Anaesthesiol Scand. 2004;48:1292&#x2013;1300.</Citation><ArticleIdList><ArticleId IdType="pubmed">15504191</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahmani S., Mantz J., Veyckemans F. Case scenario: severe emergence agitation after myringotomy in a 3-yr-old child. Anesthesiol. 2012;117:399&#x2013;406.</Citation><ArticleIdList><ArticleId IdType="pubmed">22722574</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28318926</PMID><DateCompleted><Year>2018</Year><Month>03</Month><Day>22</Day></DateCompleted><DateRevised><Year>2018</Year><Month>03</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-4119</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>5</Issue><PubDate><Year>2017</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery</Title><ISOAbbreviation>J Craniomaxillofac Surg</ISOAbbreviation></Journal><ArticleTitle>Effectiveness of tranexamic acid for reducing intraoperative bleeding in palatoplasties: A randomized clinical trial.</ArticleTitle><Pagination><StartPage>642</StartPage><EndPage>648</EndPage><MedlinePgn>642-648</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcms.2016.12.021</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1010-5182(16)30345-6</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Few data are available regarding blood loss during cleft palate surgery. This study assessed the effect of using tranexamic acid in the reduction of intraoperative bleeding.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A double-blind, randomized clinical trial compared intraoperative bleeding and the incidence of oronasal fistulas after palatoplasties in a control group that was given placebo and an intervention group that was given 10&#xa0;mg/kg tranexamic acid followed by a continuous infusion of 1&#xa0;mg/kg/h of the same until the end of surgery. Patients who underwent primary palatoplasty with no known or suspected coagulation disorders at our institution during the study period were included in the study.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">70 patients were allocated, 66 received the intervention. Blood loss was reduced by 11.9%, without statistical significance. The incidence of fistulas in the intervention and control groups was 12.9% and 18.75%, respectively. The reduction of 5.8% (CI 95%: 12%-23.8%) was not significant.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The reduction of intraoperative blood loss was lower than expected and not statistically significant; a larger sample is needed to confirm the observed reduction. The drug did not seem to have negative effects on flap viability.</AbstractText><CopyrightInformation>Copyright &#xa9; 2016. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Arantes</LastName><ForeName>Guilherme C</ForeName><Initials>GC</Initials><AffiliationInfo><Affiliation>Department of Plastic Surgery of the Professor Fernando Figueira Integral Medicine Institute (Instituto de Medicina Integral Prof. Fernando Figueira), Recife, Pernambuco (PE), Brazil. Electronic address: dr.guilherme.campelo@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pereira</LastName><ForeName>Rui Manoel R</ForeName><Initials>RMR</Initials><AffiliationInfo><Affiliation>Plastic Surgery of the Professor Fernando Figueira Integral Medicine Institute (Instituto de Medicina Integral Prof. Fernando Figueira) (Head: Prof. Rui Manoel R. Pereira), Recife, PE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Melo</LastName><ForeName>Daniela B</ForeName><Initials>DB</Initials><AffiliationInfo><Affiliation>Department of Plastic Surgery of the Professor Fernando Figueira Integral Medicine Institute (Instituto de Medicina Integral Prof. Fernando Figueira), Recife, PE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alonso</LastName><ForeName>Nivaldo</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Postgraduate Program Sensu Stricto of the University of Sao Paulo (Universidade de Sao Paulo - USP), Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duarte</LastName><ForeName>Maria do Carmo M B</ForeName><Initials>MDCMB</Initials><AffiliationInfo><Affiliation>Postgraduate Program Sensu Stricto of the Professor Fernando Figueira Integral Medicine Institute (Instituto de Medicina Integral Prof. Fernando Figueira), Recife, PE, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>12</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Scotland</Country><MedlineTA>J Craniomaxillofac Surg</MedlineTA><NlmUniqueID>8704309</NlmUniqueID><ISSNLinking>1010-5182</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000933">Antifibrinolytic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>6T84R30KC1</RegistryNumber><NameOfSubstance UI="D014148">Tranexamic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000933" MajorTopicYN="N">Antifibrinolytic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016063" MajorTopicYN="N">Blood Loss, Surgical</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002972" MajorTopicYN="N">Cleft Palate</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010159" MajorTopicYN="N">Palate</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014148" MajorTopicYN="N">Tranexamic Acid</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Blood loss</Keyword><Keyword MajorTopicYN="N">Cleft palate</Keyword><Keyword MajorTopicYN="N">Tranexamic acid</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28318926</ArticleId><ArticleId IdType="doi">10.1016/j.jcms.2016.12.021</ArticleId><ArticleId IdType="pii">S1010-5182(16)30345-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33984303</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>25</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-6868</ISSN><JournalIssue CitedMedium="Internet"><Volume>225</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Oct</Month></PubDate></JournalIssue><Title>American journal of obstetrics and gynecology</Title><ISOAbbreviation>Am J Obstet Gynecol</ISOAbbreviation></Journal><ArticleTitle>Racial and ethnic differences in reconstructive surgery for apical vaginal prolapse.</ArticleTitle><Pagination><StartPage>405.e1</StartPage><EndPage>405.e7</EndPage><MedlinePgn>405.e1-405.e7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajog.2021.05.002</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0002-9378(21)00545-7</ELocationID><Abstract><AbstractText Label="BACKGROUND">There is limited literature identifying racial and ethnic health disparities among surgical modalities and outcomes in the field of urogynecology and specifically pelvic organ prolapse surgery.</AbstractText><AbstractText Label="OBJECTIVE">This study aimed to evaluate the differences in surgical approach for apical vaginal prolapse and postoperative complications by race and ethnicity.</AbstractText><AbstractText Label="STUDY DESIGN">This is a retrospective cohort study of women undergoing surgical repair for apical vaginal prolapse between 2014 and 2017 using data from the American College of Surgeons National Surgical Quality Improvement Program. Patients were eligible for inclusion if they underwent either vaginal colpopexy or abdominal sacrocolpopexy. Abdominal sacrocolpopexy cases were further divided into those performed by laparotomy and those performed by laparoscopy. Multivariable logistic regression models that controlled for age, comorbidities, American Society of Anesthesiologists physical status classification, and concurrent surgery were used to determine whether race and ethnicity are associated with the type of colpopexy (vaginal vs abdominal) or the surgical route of abdominal sacrocolpopexy. Similar models that also controlled for surgical approach were used to assess 30-day complications by race and ethnicity.</AbstractText><AbstractText Label="RESULTS">A total of 22,861 eligible surgical cases were identified, of which 12,337 (54%) were vaginal colpopexy and 10,524 (46%) were abdominal sacrocolpopexy. Among patients who had an abdominal sacrocolpopexy, 2262 (21%) were performed via laparotomy and 8262 (79%) via laparoscopy. The study population was 70% White, 9% Latina, 6% African American, 3% Asian, 0.6% Native Hawaiian or Pacific Islander, 0.4% American Indian or Alaska Native, and 11% unknown. In multivariable analysis, Asian and Native Hawaiian or Pacific Islander women were less likely to undergo abdominal sacrocolpopexy compared with White women (odds ratio, 0.82; 95% confidence interval, 0.68-0.99, and odds ratio, 0.56; 95% confidence interval, 0.39-0.82, respectively). Among women who underwent an abdominal sacrocolpopexy, Latina women and Native Hawaiian or Pacific Islander women were less likely to undergo a laparoscopic approach compared with White women (odds ratio, 0.68; 95% confidence interval, 0.58-0.79, and odds ratio, 0.31; 95% confidence interval, 0.1-0.56, respectively). Complication rates also differed by race and ethnicity. After a colpopexy, African American women were more likely to need a blood transfusion (odds ratio, 3.04; 95% confidence interval, 1.95-4.73; P&#x2264;.001) and have a deep vein thrombosis or pulmonary embolus (odds ratio, 2.46; 95% confidence interval, 1.10-5.48; P=.028), but less likely to present with postoperative urinary tract infections (odds ratio, 0.68; 95% confidence interval, 0.49-0.96; P=.028) than White women in multivariable regression models. Using the Clavien-Dindo classification system, Latina women had higher odds of developing grade II complications than White women in multivariable models (odds ratio, 1.25; 95% confidence interval, 1.04-1.51; P=.02).</AbstractText><AbstractText Label="CONCLUSION">There are racial and ethnic differences in the type and route of surgical repair for apical vaginal prolapse. In particular, Latina and Pacific Islander women were less likely to undergo a laparoscopic approach to abdominal sacrocolpopexy compared with White women. Although complications were uncommon, there were several complications including blood transfusions that were higher among African American and Latina women. Additional studies are needed to better understand and describe associated factors for these differences in care and surgical outcomes.</AbstractText><CopyrightInformation>Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Boyd</LastName><ForeName>Brittni A J</ForeName><Initials>BAJ</Initials><AffiliationInfo><Affiliation>Department of Obstetrics, Gynecology, and Reproductive Science, University of California, San Francisco, CA. Electronic address: brittnij@hs.uci.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Winkelman</LastName><ForeName>William D</ForeName><Initials>WD</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Mount Auburn Hospital, Cambridge, MA; Department of Obstetrics, Gynecology, and Reproductive Biology, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mishra</LastName><ForeName>Kavita</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Women's Health Institute, Cleveland Clinic Foundation, Cleveland, OH.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vittinghoff</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacoby</LastName><ForeName>Vanessa L</ForeName><Initials>VL</Initials><AffiliationInfo><Affiliation>Department of Obstetrics, Gynecology, and Reproductive Science, University of California, San Francisco, CA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Obstet Gynecol</MedlineTA><NlmUniqueID>0370476</NlmUniqueID><ISSNLinking>0002-9378</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001741" MajorTopicYN="N">Black or African American</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001213" MajorTopicYN="N">Asian</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001803" MajorTopicYN="N">Blood Transfusion</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013509" MajorTopicYN="N">Gynecologic Surgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054625" MajorTopicYN="N">Healthcare Disparities</DescriptorName><QualifierName UI="Q000208" MajorTopicYN="Y">ethnology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006630" MajorTopicYN="N">Hispanic or Latino</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="N">Laparoscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007813" MajorTopicYN="N">Laparotomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044468" MajorTopicYN="N">Native Hawaiian or Pacific Islander</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000208" MajorTopicYN="Y">ethnology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000208" MajorTopicYN="Y">ethnology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019651" MajorTopicYN="N">Plastic Surgery Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012447" MajorTopicYN="N">Sacrum</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014552" MajorTopicYN="N">Urinary Tract Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014596" MajorTopicYN="N">Uterine Prolapse</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000208" MajorTopicYN="Y">ethnology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044465" MajorTopicYN="N">White People</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044467" MajorTopicYN="N">American Indian or Alaska Native</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">disparities</Keyword><Keyword MajorTopicYN="N">ethnicity</Keyword><Keyword MajorTopicYN="N">pelvic organ prolapse</Keyword><Keyword MajorTopicYN="N">pelvic reconstructive surgery</Keyword><Keyword MajorTopicYN="N">race</Keyword><Keyword MajorTopicYN="N">sacrocolpopexy</Keyword><Keyword MajorTopicYN="N">surgical trends</Keyword><Keyword MajorTopicYN="N">urogynecology</Keyword><Keyword MajorTopicYN="N">vaginal colpopexy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>2</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>5</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>13</Day><Hour>20</Hour><Minute>10</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33984303</ArticleId><ArticleId IdType="doi">10.1016/j.ajog.2021.05.002</ArticleId><ArticleId IdType="pii">S0002-9378(21)00545-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24780198</PMID><DateCompleted><Year>2015</Year><Month>05</Month><Day>11</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-3102</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>7</Issue><PubDate><Year>2014</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Placenta</Title><ISOAbbreviation>Placenta</ISOAbbreviation></Journal><ArticleTitle>JunB/cyclin-D1 imbalance in placental mesenchymal stromal cells derived from preeclamptic pregnancies with fetal-placental compromise.</ArticleTitle><Pagination><StartPage>483</StartPage><EndPage>490</EndPage><MedlinePgn>483-90</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.placenta.2014.04.001</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0143-4004(14)00153-2</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">In the present study, we characterized the expression of Activating Protein 1 (AP-1) factors, key cell cycle regulators, in primary placental mesenchymal stromal cells (PDMSCs) derived from normal and preeclamptic (PE) pregnancies with fetal-placental compromise.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">PDMSCs were isolated from control (n&#xa0;=&#xa0;20) and preeclamptic (n&#xa0;=&#xa0;24) placentae. AP-1 expression was determined by semi-quantitative RT-PCR (sqRT-PCR), Real Time PCR and Western Blot assay. PDMSCs were plated and JunB siRNA was performed. JunB and Cyclin-D1 expression were assessed by Real Time and Western Blot analyses.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">JunB expression was significantly increased while Cyclin-D1 expression was significantly down-regulated in PE relative to control PDMSCs. JunB siRNA was accompanied by JunB down-regulation and increased Cyclin-D1 in normal PDMSCs.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We described, for the first time, AP-1 expression in PDMSCs derived from physiological and PE placentae. Importantly, we demonstrated that JunB over-expression in PE-PDMSCs affects Cyclin-D1 regulation. Our data suggest a possible contribution of these pathological placental cells to the altered cell cycle regulation typical of preeclamptic placentae.</AbstractText><CopyrightInformation>Copyright &#xa9; 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nuzzo</LastName><ForeName>A M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Dept. of Surgical Sciences, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giuffrida</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Dept. of Surgical Sciences, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zenerino</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Dept. of Surgical Sciences, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piazzese</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Dept. of Surgical Sciences, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olearo</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Dept. of Surgical Sciences, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Todros</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Dept. of Surgical Sciences, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rolfo</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Dept. of Surgical Sciences, University of Turin, Turin, Italy. Electronic address: alessandro.rolfo@unito.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>04</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Placenta</MedlineTA><NlmUniqueID>8006349</NlmUniqueID><ISSNLinking>0143-4004</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C530104">CCND1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C497872">FOSL2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051921">Fos-Related Antigen-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C581727">JunB protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016760">Proto-Oncogene Proteins c-fos</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034741">RNA, Small Interfering</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018808">Transcription Factor AP-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C087271">fos-related antigen 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>136601-57-5</RegistryNumber><NameOfSubstance UI="D019938">Cyclin D1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002453" MajorTopicYN="N">Cell Cycle</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019938" MajorTopicYN="N">Cyclin D1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051921" MajorTopicYN="N">Fos-Related Antigen-2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059630" MajorTopicYN="N">Mesenchymal Stem Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010920" MajorTopicYN="N">Placenta</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011225" MajorTopicYN="N">Pre-Eclampsia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016760" MajorTopicYN="N">Proto-Oncogene Proteins c-fos</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034741" MajorTopicYN="N">RNA, Small Interfering</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018808" MajorTopicYN="N">Transcription Factor AP-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Activating protein 1</Keyword><Keyword MajorTopicYN="N">Cyclin D1</Keyword><Keyword MajorTopicYN="N">JunB</Keyword><Keyword MajorTopicYN="N">Placenta</Keyword><Keyword MajorTopicYN="N">Placental mesenchymal stromal cells</Keyword><Keyword MajorTopicYN="N">Preeclampsia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>4</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>5</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>5</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24780198</ArticleId><ArticleId IdType="doi">10.1016/j.placenta.2014.04.001</ArticleId><ArticleId IdType="pii">S0143-4004(14)00153-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37568381</PMID><DateRevised><Year>2023</Year><Month>08</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>15</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>28</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Preoperative Oral Carbohydrate (CHO) Supplementation Is Beneficial for Clinical and Biochemical Outcomes in Patients Undergoing Elective Cesarean Delivery under Spinal Anaesthesia-A Randomized Controlled Trial.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">4978</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm12154978</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Preoperative fasting and surgery cause metabolic stress, insulin resistance with ketosis, and postoperative nausea and vomiting (PONV). Oral carbohydrate loading strategy (CHO) improves outcomes in labor and general surgery. We aimed to compare the effectiveness of CHO with standard fasting in patients undergoing elective cesarean delivery (CD) under spinal anesthesia.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A single-center, parallel, prospective randomized controlled trial (RCT) was conducted in a tertiary university obstetrics department at Pomeranian Medical University in Szczecin, Poland. Patients were randomly assigned (1:1 ratio) to the CHO group (oral carbohydrate 2 h before elective CD, <i>n</i> = 75) or the SF group (control-standard fasting, <i>n</i> = 73). The main outcome measures were incidence and severity of PONV at 6 and 24 h after CD, time to the first peristalsis, time to first bowel movement, and biochemical parameters indicating ketosis in mothers and their children.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 148 adult females with singleton pregnancies undergoing elective CD under spinal anesthesia (ASA I and II) were included in the final analysis. At 24 h after CD, 8.0% from the CHO group vs. 20.55% reported three or more episodes of vomiting or dry retching as compared to patients in the SF group (<i>p</i> = 0.041). Preoperative CHO supplementation decreased preoperative feelings of hunger (<i>p</i> &lt; 0.001) and thirst (<i>p</i> &lt; 0.001). Laboratory results in the CHO group showed higher plasma pH (<i>p</i> = 0.001) and glucose (<i>p</i> &lt; 0.001), lower F2-isoprostane in plasma (<i>p</i> = 0.049) and urine (<i>p</i> = 0.018), lower urine F2-isoprostane/creatinine ratio (<i>p</i> = 0.045) than in the SF group. HOMA-IR (<i>p</i> &lt; 0.001) and lactate (<i>p</i> &lt; 0.001) were higher in the CHO group than in the control group.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">There was no significant difference in the incidence or severity of early PONV at 6 h. The incidence of vomiting or dry retching at 24 h after cesarean delivery was lower in the CHO group as compared to standard starvation, but the combined results of PONV frequency and severity on the Wengritzky scale did not differ between the two study groups. Preoperative CHO supplementation decreased preoperative feelings of hunger and thirst, enhancing the comfort of pregnant women.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">ClinicalTrials.gov identifier: NCT04069806.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kotfis</LastName><ForeName>Katarzyna</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Therapy and Acute Intoxications, Pomeranian Medical University in Szczecin, 70-111 Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wojciechowska</LastName><ForeName>Arleta</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Pomeranian Medical University in Szczecin, 70-111 Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zimny</LastName><ForeName>Ma&#x142;gorzata</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Pomeranian Medical University in Szczecin, 70-111 Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jamio&#x142;-Milc</LastName><ForeName>Dominika</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-0203-1823</Identifier><AffiliationInfo><Affiliation>Department of Human Nutrition and Metabolomics, Pomeranian Medical University, 71-460 Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szyli&#x144;ska</LastName><ForeName>Aleksandra</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-6105-5329</Identifier><AffiliationInfo><Affiliation>Department of Medical Rehabilitation and Clinical Physiotherapy, Pomeranian Medical University in Szczecin, 71-210 Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwiatkowski</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Pomeranian Medical University in Szczecin, 70-111 Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaim</LastName><ForeName>Karolina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Therapy and Acute Intoxications, Pomeranian Medical University in Szczecin, 70-111 Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Do&#x142;&#x119;gowska</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-3138-1013</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Laboratory Medicine, Pomeranian Medical University in Szczecin, 70-111 Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stachowska</LastName><ForeName>Ewa</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-4009-1977</Identifier><AffiliationInfo><Affiliation>Department of Human Nutrition and Metabolomics, Pomeranian Medical University, 71-460 Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zukowski</LastName><ForeName>Maciej</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Therapy and Acute Intoxications, Pomeranian Medical University in Szczecin, 70-111 Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pankowiak</LastName><ForeName>Maria</ForeName><Initials>M</Initials><Identifier Source="ORCID">0009-0008-6016-0176</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Therapy and Acute Intoxications, Pomeranian Medical University in Szczecin, 70-111 Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torb&#xe9;</LastName><ForeName>Andrzej</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Pomeranian Medical University in Szczecin, 70-111 Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wischmeyer</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Surgery, Duke University School of Medicine, Durham, NC 27710, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04069806</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ERAS</Keyword><Keyword MajorTopicYN="N">F2-isoprostane</Keyword><Keyword MajorTopicYN="N">OCH</Keyword><Keyword MajorTopicYN="N">PONV</Keyword><Keyword MajorTopicYN="N">cesarean section</Keyword><Keyword MajorTopicYN="N">fasting</Keyword><Keyword MajorTopicYN="N">nausea</Keyword><Keyword MajorTopicYN="N">obstetrics</Keyword><Keyword MajorTopicYN="N">oral carbohydrate</Keyword><Keyword MajorTopicYN="N">outcomes</Keyword><Keyword MajorTopicYN="N">vomiting</Keyword></KeywordList><CoiStatement>P.E.W. reports receiving investigator-initiated grant funding for nutrition, perioperative, and ICU research from the US National Institutes of Health, US Department of Defense, Canadian Institutes of Health Research, Abbott, Baxter, and Fresenius. P.E.W. has served as a consultant to Abbott, Fresenius, Baxter, Cardinal Health, and Nutricia. P.E.W. has received unrestricted gift donations for nutrition and perioperative research from Musclesound and DSM. P.E.W. has received honoraria or travel expenses for CME lectures on improving nutrition and perioperative care from Abbott, Baxter, Fresenius, Danone-Nutricia, DSM, and Nestle. All other authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>12</Day><Hour>10</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>12</Day><Hour>10</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>12</Day><Hour>1</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37568381</ArticleId><ArticleId IdType="pmc">PMC10419905</ArticleId><ArticleId IdType="doi">10.3390/jcm12154978</ArticleId><ArticleId IdType="pii">jcm12154978</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jelting Y., Klein C., Harlander T., Eberhart L., Roewer N., Kranke P. Preventing nausea and vomiting in women undergoing regional anesthesia for cesarean section: Challenges and solutions. Local Reg. Anesth. 2017;10:83&#x2013;90. doi: 10.2147/LRA.S111459.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/LRA.S111459</ArticleId><ArticleId IdType="pmc">PMC5558589</ArticleId><ArticleId IdType="pubmed">28860857</ArticleId></ArticleIdList></Reference><Reference><Citation>Balki M., Carvalho J.C. Intraoperative nausea and vomiting during cesarean section under regional anesthesia. Int. J. Obstet. Anesth. 2005;14:230&#x2013;241. doi: 10.1016/j.ijoa.2004.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijoa.2004.12.004</ArticleId><ArticleId IdType="pubmed">15935649</ArticleId></ArticleIdList></Reference><Reference><Citation>Batova R., Georgiev S. Impact of spinal needle design and approach to postdural puncture headache and spinal anesthesia failure in obstetrics. Anaesthesiol. Intensive Ther. 2019;51:81&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">31268266</ArticleId></ArticleIdList></Reference><Reference><Citation>Voigt M., Frolich C.W., Huttel C., Kranke P., Mennen J., Boessneck O., Lenz C., Erbes T., Ernst J., Kerger H. Prophylaxis of intra and postoperative nausea and vomiting in patients during cesarean section in spinal anesthesia. Med. Sci. Monit. 2013;19:993&#x2013;1000.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3852368</ArticleId><ArticleId IdType="pubmed">24226381</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendelson C. The aspiration of stomach contents into the lungs during obstetric anesthesia. Am. J. Obstet. Gynecol. 1946;52:191&#x2013;206. doi: 10.1016/S0002-9378(16)39829-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9378(16)39829-5</ArticleId><ArticleId IdType="pubmed">20993766</ArticleId></ArticleIdList></Reference><Reference><Citation>Maltby J.R. Fasting from midnight: The history behind the dogma. Best Pract. Res. Clin. Anaesthesiol. 2006;20:363&#x2013;378. doi: 10.1016/j.bpa.2006.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpa.2006.02.001</ArticleId><ArticleId IdType="pubmed">17080690</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouvet L., Cercueil E., Barnoud S., Lilot M., Desgranges F., Chassard D. Relationship between the regurgitated and the aspirated volume of water. A manikin study. Anaesthesiol. Intensive Ther. 2019;51:125&#x2013;129. doi: 10.5114/ait.2019.85953.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/ait.2019.85953</ArticleId><ArticleId IdType="pubmed">31268273</ArticleId></ArticleIdList></Reference><Reference><Citation>Horosz B., Nawrocka K., Malec-Milewska M. Anaesthetic perioperative management according to the enhanced recovery after surgery protocol. Anaesthesiol. Intensive Ther. 2016;48:49&#x2013;54. doi: 10.5603/AIT.2016.0006.</Citation><ArticleIdList><ArticleId IdType="doi">10.5603/AIT.2016.0006</ArticleId><ArticleId IdType="pubmed">26966110</ArticleId></ArticleIdList></Reference><Reference><Citation>Brady M.C., Kinn S., Stuart P., Ness V. Preoperative fasting for adults to prevent perioperative complications. Cochrane Database Syst. Rev. 2003;4:CD004423. doi: 10.1002/14651858.CD004423.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD004423</ArticleId><ArticleId IdType="pubmed">14584013</ArticleId></ArticleIdList></Reference><Reference><Citation>Wendling A.L., Byun S.Y., Koenig M., Vasipouloulos T. Impact of oral carbohydrate consumption prior to cesarean delivery on preoperative well-being: A randomized interventional study. Arch. Gynecol. Obstet. 2020;301:179&#x2013;187. doi: 10.1007/s00404-020-05455-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00404-020-05455-z</ArticleId><ArticleId IdType="pubmed">32025843</ArticleId></ArticleIdList></Reference><Reference><Citation>Nygren J. The metabolic effects of fasting and surgery. Best. Pract. Res. Clin. Anaesthesiol. 2006;20:429&#x2013;438. doi: 10.1016/j.bpa.2006.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpa.2006.02.004</ArticleId><ArticleId IdType="pubmed">17080694</ArticleId></ArticleIdList></Reference><Reference><Citation>Awad S., Constantin-Teodosiu D., Macdonald I.A., Lobo D.N. Short-term starvation and mitochondrial dysfunction&#x2014;a possible mechanism leading to postoperative insulin resistance. Clin. Nutr. 2009;28:497&#x2013;499. doi: 10.1016/j.clnu.2009.04.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2009.04.014</ArticleId><ArticleId IdType="pubmed">19446932</ArticleId></ArticleIdList></Reference><Reference><Citation>Toohill J., Soong B., Fleandy V. Interventions for ketosis in labour. Cochrane Database Syst. Rev. 2008;3:CD004230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8769494</ArticleId><ArticleId IdType="pubmed">18646103</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith I., Kranke P., Murat I., Smith A., O&#x2019;Sullivan G., S&#xf8;reide E., Spies C. European Society of Anaesthesiology. Perioperative fasting in adults and children: Guidelines from the European Society of Anaesthesiology. Eur. J. Anaesthesiol. 2011;28:556&#x2013;569. doi: 10.1097/EJA.0b013e3283495ba1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0b013e3283495ba1</ArticleId><ArticleId IdType="pubmed">21712716</ArticleId></ArticleIdList></Reference><Reference><Citation>American Society of Anesthesiologists Practice guidelines for preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration: Application to healthy patients undergoing elective procedures: An updated report by the American Society of Anesthesiologists Committee on Standards and Practice Parameters. Anesthesiology. 2011;114:495&#x2013;511.</Citation><ArticleIdList><ArticleId IdType="pubmed">21307770</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambert E., Carey S. Practice guideline recommendations on perioperative fasting: A systematic review. JPEN J. Parenter. Enter. Nutr. 2016;40:1158&#x2013;1165.</Citation><ArticleIdList><ArticleId IdType="pubmed">25575497</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson R.D., Caughey A.B., Wood S.L., Macones G.A., Wrench I.J., Huang J., Norman M., Pettersson K., Fawcett W.J., Shalabi M.M., et al. Guidelines for Antenatal and Preoperative care in Cesarean Delivery: Enhanced Recovery After Surgery Society Recommendations (Part 1) Am. J. Obstet. Gynecol. 2018;219:523.e1&#x2013;523.e15. doi: 10.1016/j.ajog.2018.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2018.09.015</ArticleId><ArticleId IdType="pubmed">30240657</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith M.D., McCall J., Plank L., Herbison P.G., Soop M., Nygren J. Preoperative carbohydrate treatment for enhancing recovery after elective surgery. Cochrane Database Syst. Rev. 2014;8:CD009161.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11060647</ArticleId><ArticleId IdType="pubmed">25121931</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison C.E., Ritchie-McLean S., Jha A., Mythen M. Two hours too long: Time to review fasting guidelines for clear fluids. Br. J. Anaesth. 2020;17:363&#x2013;366. doi: 10.1016/j.bja.2019.11.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2019.11.036</ArticleId><ArticleId IdType="pubmed">31959387</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotfis K., Jamio&#x142;-Milc D., Skonieczna-&#x17b;ydecka K., Folwarski M., Stachowska E. The Effect of Preoperative Carbohydrate Loading on Clinical and Biochemical Outcomes after Cardiac Surgery: A Systematic Review and Meta-Analysis of Randomized Trials. Nutrients. 2020;12:3105. doi: 10.3390/nu12103105.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12103105</ArticleId><ArticleId IdType="pmc">PMC7600335</ArticleId><ArticleId IdType="pubmed">33053694</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Sullivan G., Liu B., Hart D., Seed P., Shennan A. Effect of food intake during labour on obstetric outcome: Randomised controlled trial. BMJ. 2009;338:b784. doi: 10.1136/bmj.b784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b784</ArticleId><ArticleId IdType="pmc">PMC2660391</ArticleId><ArticleId IdType="pubmed">19318702</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmani R., Khakbazan Z., Yavari P., Granmayeh M., Yavari L. Effect of oral carbohydrate intake on labor progress: Randomized controlled trial. Iran. J. Public Health. 2012;41:59&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3521887</ArticleId><ArticleId IdType="pubmed">23304677</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheepers H.C., Thans M.C., de Jong P.A., Essed G.G., Kanhai H.H. The effects of oral carbohydrate administration on fetal acid base balance. J. Perinat. Med. 2002;30:400&#x2013;404. doi: 10.1515/JPM.2002.062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/JPM.2002.062</ArticleId><ArticleId IdType="pubmed">12442604</ArticleId></ArticleIdList></Reference><Reference><Citation>Malin G.L., Bugg G.J., Thornton J., Taylor M.A., Grauwen N., Devlieger R., Kardel K.R., Kubli M., Tranmer J.E., Jones N.W. Does oral carbohydrate supplementation improve labour outcome? A systematic review and individual patient data meta-analysis. BJOG. 2016;123:510&#x2013;517. doi: 10.1111/1471-0528.13728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1471-0528.13728</ArticleId><ArticleId IdType="pubmed">26914893</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark A., Litchfield K., Hannah S., Love C., Slade K., Lake K., Agaram R. Pre-operative carbohydrate loading prior to elective caesarean delivery: A randomised controlled trial. Int. J. Obstet. Anesth. 2021;45:21&#x2013;27. doi: 10.1016/j.ijoa.2020.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijoa.2020.10.008</ArticleId><ArticleId IdType="pubmed">33277162</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellwood H., Rozdarz K.M., Riordan J. Incidence of urinary ketosis and the effect of carbohydrate drink supplementation during fasting for elective caesarean section: Audit. J. Perioper. Pract. 2022;32:280&#x2013;285. doi: 10.1177/17504589211009099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17504589211009099</ArticleId><ArticleId IdType="pubmed">34315297</ArticleId></ArticleIdList></Reference><Reference><Citation>Awad S., Varadhan K.K., Ljungqvist O., Lobo D.N. A meta-analysis of randomized controlled trials on preoperative oral carbohydrate treatment in elective surgery. Clin. Nutr. 2013;32:34&#x2013;44. doi: 10.1016/j.clnu.2012.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2012.10.011</ArticleId><ArticleId IdType="pubmed">23200124</ArticleId></ArticleIdList></Reference><Reference><Citation>Faris M.A., Hussein R.N., Al-Kurd R.A., Al-Fararjeh M.A., Bustanji Y.K., Mohammad M.K. Impact of ramadan intermittent fasting on oxidative stress measured by urinary 15-f(2t)-isoprostane. J. Nutr. Metab. 2012;2012:802924. doi: 10.1155/2012/802924.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/802924</ArticleId><ArticleId IdType="pmc">PMC3485525</ArticleId><ArticleId IdType="pubmed">23150812</ArticleId></ArticleIdList></Reference><Reference><Citation>Greco A., Minghetti L., Puopolo M., Pietrobon B., Franzoi M., Chiandetti L., Suppiej A. Plasma levels of 15-F(2t)-isoprostane in newborn infants are affected by mode of delivery. Clin. Biochem. 2007;40:1420&#x2013;1422. doi: 10.1016/j.clinbiochem.2007.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinbiochem.2007.09.004</ArticleId><ArticleId IdType="pubmed">17949702</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y., Dong B., Dong Q., Zhao Z., Yu Y. Effect of Preoperative Oral Carbohydrate Administration on Patients Undergoing Cesarean Section with Epidural Anesthesia: A Pilot Study. J. Perianesth. Nurs. 2021;36:30&#x2013;35. doi: 10.1016/j.jopan.2020.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jopan.2020.05.006</ArticleId><ArticleId IdType="pubmed">33239219</ArticleId></ArticleIdList></Reference><Reference><Citation>He Y., Liu C., Han Y., Huang Y., Zhou J., Xie Q. The impact of oral carbohydrate-rich supplement taken two hours before caesarean delivery on maternal and neonatal perioperative outcomes&#x2014;A randomized clinical trial. BMC Pregnancy Childbirth. 2021;21:682. doi: 10.1186/s12884-021-04155-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12884-021-04155-z</ArticleId><ArticleId IdType="pmc">PMC8495981</ArticleId><ArticleId IdType="pubmed">34620123</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilku D.R., Dennison A.R., Hall T.C., Metcalfe M.S., Garcea G. Role of preoperative carbohydrate loading: A systematic review. Ann. R. Coll. Surg. Engl. 2014;96:15&#x2013;22. doi: 10.1308/003588414X13824511650614.</Citation><ArticleIdList><ArticleId IdType="doi">10.1308/003588414X13824511650614</ArticleId><ArticleId IdType="pmc">PMC5137663</ArticleId><ArticleId IdType="pubmed">24417824</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilcox G. Insulin and insulin resistance. Clin. Biochem. Rev. 2005;26:19&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1204764</ArticleId><ArticleId IdType="pubmed">16278749</ArticleId></ArticleIdList></Reference><Reference><Citation>Monti L.D., Genzano C.B., Fontana B., Galluccio E., Spadoni S., Magistro A., Bosi E., Piatti P. Association between new markers of cardiovascular risk and hepatic insulin resistance in those at high risk of developing type 2 diabetes. Endocrine. 2022;75:409&#x2013;417. doi: 10.1007/s12020-021-02868-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-021-02868-x</ArticleId><ArticleId IdType="pubmed">34546488</ArticleId></ArticleIdList></Reference><Reference><Citation>Akash M.S.H., Rehman K., Liaqat A. Tumor Necrosis Factor-Alpha: Role in Development of Insulin Resistance and Pathogenesis of Type 2 Diabetes Mellitus. J. Cell. Biochem. 2018;119:105&#x2013;110. doi: 10.1002/jcb.26174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.26174</ArticleId><ArticleId IdType="pubmed">28569437</ArticleId></ArticleIdList></Reference><Reference><Citation>Rehman K., Akash M.S.H. Mechanism of Generation of Oxidative Stress and Pathophysiology of Type 2 Diabetes Mellitus: How Are They Interlinked? J. Cell. Biochem. 2017;118:3577&#x2013;3585. doi: 10.1002/jcb.26097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.26097</ArticleId><ArticleId IdType="pubmed">28460155</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindsay K.L., Gyllenhammer L.E., Entringer S., Wadhwa P.D. Rate of Gestational Weight Gain and Glucose-Insulin Metabolism Among Hispanic Pregnant Women With Overweight and Obesity. J. Clin. Endocrinol. Metab. 2022;107:e734&#x2013;e744. doi: 10.1210/clinem/dgab655.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgab655</ArticleId><ArticleId IdType="pmc">PMC8764225</ArticleId><ArticleId IdType="pubmed">34468745</ArticleId></ArticleIdList></Reference><Reference><Citation>Tayanloo-Beik A., Roudsari P.P., Rezaei-Tavirani M., Biglar M., Tabatabaei-Malazy O., Arjmand B., Larijani B. Diabetes and Heart Failure: Multi-Omics Approaches. Front. Physiol. 2021;12:705424. doi: 10.3389/fphys.2021.705424.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2021.705424</ArticleId><ArticleId IdType="pmc">PMC8378451</ArticleId><ArticleId IdType="pubmed">34421642</ArticleId></ArticleIdList></Reference><Reference><Citation>McIntyre C., Johnston A., Foley D., Lawler J., Bucholc M., Flanagan L., Sugrue M. Readmission to hospital following laparoscopic cholecystectomy: A meta-analysis. Anaesthesiol. Intensive Ther. 2020;52:47&#x2013;55. doi: 10.5114/ait.2020.92967.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/ait.2020.92967</ArticleId><ArticleId IdType="pmc">PMC10173143</ArticleId><ArticleId IdType="pubmed">32090306</ArticleId></ArticleIdList></Reference><Reference><Citation>Fard R.K., Tabassi Z., Qorbani M., Hosseini S. The Effect of Preoperative Oral Carbohydrate on Breastfeeding After Cesarean Section: A Double-Blind, Randomized Controlled Clinical Trial. J. Diet. Suppl. 2018;15:445&#x2013;451. doi: 10.1080/19390211.2017.1353566.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19390211.2017.1353566</ArticleId><ArticleId IdType="pubmed">28937862</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson K.N., Cassady B.A., Hegazi R.A., Wischmeyer P.E. Preoperative carbohydrate loading in surgical patients with type 2 diabetes: Are concerns supported by data? Clin. Nutr. ESPEN. 2021;45:1&#x2013;8. doi: 10.1016/j.clnesp.2021.08.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnesp.2021.08.023</ArticleId><ArticleId IdType="pubmed">34620304</ArticleId></ArticleIdList></Reference><Reference><Citation>Lafflin M.R., Shuai L., Brisebois R., Senior P.A., Wang H. The use of a preoperative carbohydrate drink in patients with diabetes mellitus: A prospective, non-inferiority, cohort study. World J. Surg. 2018;42:1965&#x2013;1970. doi: 10.1007/s00268-017-4413-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-017-4413-9</ArticleId><ArticleId IdType="pubmed">29282506</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu N., Jin Y., Wang X., Xiang Z., Zhang L., Feng S. Safety, and feasibility of oral carbohydrate consumption before cesarean delivery on patients with gestational diabetes mellitus: A parallel, randomized controlled trial. J. Obstet. Gynaecol. Res. 2021;47:1272&#x2013;1280. doi: 10.1111/jog.14653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jog.14653</ArticleId><ArticleId IdType="pubmed">33403738</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37593933</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2648</ISSN><JournalIssue CitedMedium="Internet"><Volume>80</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Journal of advanced nursing</Title><ISOAbbreviation>J Adv Nurs</ISOAbbreviation></Journal><ArticleTitle>Digital tools for post-discharge surveillance of surgical site infection.</ArticleTitle><Pagination><StartPage>96</StartPage><EndPage>109</EndPage><MedlinePgn>96-109</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jan.15830</ELocationID><Abstract><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">Conduct a scoping review on the development and use of digital tools for post-discharge surgical site infection surveillance.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Scoping review.</AbstractText><AbstractText Label="DATA SOURCES" NlmCategory="METHODS">Science Direct, PubMed, Embase, Literatura Latino-Americana e do Caribe em Ci&#xea;ncias da Sa&#xfa;de and Cumulative Index to Nursing and Allied Health Literature were searched from 2013 to May 2022. Six intellectual property registries were reviewed from 2013 to 2022.</AbstractText><AbstractText Label="REVIEW METHODS" NlmCategory="METHODS">The review followed the Joanna Briggs Institute model, and included intellectual property records (applications, prototypes and software) and scientific articles published in any language on the development and/or testing of digital tools for post-discharge surveillance of surgical site infection among surgical patients aged 18 and over.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">One intellectual property record and 13 scientific articles were identified, covering 10 digital tools. The intellectual property record was developed and registered by a China educational institution in 2018. The majority of manuscripts were prospective cohort studies and randomized clinical trials, published between 2016 and 2022, and more than half were conducted in the United States. The population included adult patients undergoing cardiac, thoracic, vascular, abdominal, arthroplasty and caesarean surgery. The main functionalities of the digital tools were the previously prepared questionnaire, the attachment of a wound image, the integrated Web system and the evaluation of data by the health team, with post-discharge surgical site infection surveillance time between 14 and 30&#x2009;days after surgery.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Digital tools show promise for the surveillance of surgical site infection, collaborating with the early detection of wound infection.</AbstractText><AbstractText Label="IMPLICATIONS FOR THE PROFESSION AND/OR PATIENT CARE" NlmCategory="UNASSIGNED">Mobile technology was favourable for detecting surgical site infections, reducing unnecessary visits to the health service, and increasing patient satisfaction.</AbstractText><AbstractText Label="IMPACT" NlmCategory="CONCLUSIONS">Technological advances in the health area open new perspectives for post-discharge surveillance of surgical site infection. WHAT IS ALREADY KNOWN?: There is underreporting of surgical site infections due to difficulties related to traditional methods of post-discharge surveillance. The use of digital tools within surgical site infection surveillance is increasing. Benefits of using digital tools within surgical site infection surveillance have been reported. WHAT HAS THIS STUDY ADDED TO OUR KNOWLEDGE?: This scoping review is one of the first to analyse the development and use of digital tools for post-discharge surveillance of surgical site infection in different countries. The main functionalities of digital tools are: structured questionnaires; attachment of wound images; integrated web systems; and evaluation of data by professionals. The use of mobile technology is favourable for detecting surgical site infections with a reduction in costs from face-to-face consultations and increased patient satisfaction. WHERE AND ON WHOM WILL THE RESEARCH HAVE AN IMPACT?: Healthcare providers can successfully use digital tools for surgical site infection post-discharge surveillance. Remote monitoring can reduce unnecessary patient visits to healthcare facilities. Policy makers can study how to implement digital platforms for remote patient monitoring.</AbstractText><AbstractText Label="REPORTING METHOD" NlmCategory="UNASSIGNED">PRISMA statement for Scoping Reviews (PRISMA-ScR).</AbstractText><AbstractText Label="PATIENT OR PUBLIC CONTRIBUTION" NlmCategory="UNASSIGNED">No patient or public contribution.</AbstractText><AbstractText Label="TRIAL AND PROTOCOL REGISTRATION" NlmCategory="UNASSIGNED">The study protocol was registered in the OSF (https://doi.org/10.17605/OSF.IO/BA8D6).</AbstractText><CopyrightInformation>&#xa9; 2023 John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dalc&#xf3;l</LastName><ForeName>Camila</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-6224-0582</Identifier><AffiliationInfo><Affiliation>University of S&#xe3;o Paulo School of Nursing, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanner</LastName><ForeName>Judith</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-0023-3149</Identifier><AffiliationInfo><Affiliation>University of Nottingham, Nottingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Brito Poveda</LastName><ForeName>Vanessa</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-5839-7253</Identifier><AffiliationInfo><Affiliation>University of S&#xe3;o Paulo School of Nursing, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Finance Code 001</GrantID><Agency>Coordena&#xe7;&#xe3;o de Aperfei&#xe7;oamento de Pessoal de N&#xed;vel Superior - Brasil (CAPES)</Agency><Country/></Grant><Grant><GrantID>FAPESP2019/22306-0</GrantID><Agency>Funda&#xe7;&#xe3;o de Amparo &#xe0; Pesquisa do Estado de S&#xe3;o Paulo</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Adv Nurs</MedlineTA><NlmUniqueID>7609811</NlmUniqueID><ISSNLinking>0309-2402</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013530" MajorTopicYN="Y">Surgical Wound Infection</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010351" MajorTopicYN="Y">Patient Discharge</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000359" MajorTopicYN="N">Aftercare</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006282" MajorTopicYN="N">Health Personnel</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">mobile applications</Keyword><Keyword MajorTopicYN="N">patient discharge</Keyword><Keyword MajorTopicYN="N">perioperative nursing</Keyword><Keyword MajorTopicYN="N">public health surveillance</Keyword><Keyword MajorTopicYN="N">surgical wound infection</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>17</Day><Hour>9</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>18</Day><Hour>5</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37593933</ArticleId><ArticleId IdType="doi">10.1111/jan.15830</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Alwis, S., Asadi, N., Bagona, L., Bhudia, S. K., Birdsall, D. M., Brady, D., Brown, C., Siaw, C., Connolly, K., Derland, S., English, C., Fabroa, S., Ferrett, J., Giacobbe, M., Gondo, T., Hawkins, J., Hedley, V., Ildefonzo, G., Jawarchan, A., &amp; Jordan, S. (2022). Implementing smartphone technology in practice using the collaborative for surgical site infection surveillance (CASSIS) project: Preliminary findings. Wounds UK, 18(1), 34-41.</Citation></Reference><Reference><Citation>Bradbury-Jones, C., Aveyard, H., Herber, O. R., Isham, L., Taylor, J., &amp; O'Malley, L. (2022). Scoping reviews: The PAGER framework for improving the quality of reporting. International Journal of Social Research Methodology, 25(4), 457-470. https://doi.org/10.1080/13645579.2021.1899596</Citation></Reference><Reference><Citation>Castillo, E., McIsaac, C., MacDougall, B., Wilson, D., &amp; Kohr, R. (2017). Post-caesarean section surgical site infection surveillance using an online database and mobile phone technology. Journal of Obstetrics and Gynaecology Canada, 39(8), 645-651. https://doi.org/10.1016/j.jogc.2016.12.037</Citation></Reference><Reference><Citation>Clayphan, B., Dixon, L., Biggs, S., Jordan, L., &amp; Pullyblank, A. (2022). PreciSSIon Collaborators. PreciSSIon: A collaborative initiative to reduce surgical site infections after elective colorectal surgery. The Journal of Hospital Infection, 130, 131-137. https://doi.org/10.1016/j.jhin.2022.08.012</Citation></Reference><Reference><Citation>Contractor, U., Haas, W., Reed, P., Osborne, L., Tree, J., &amp; Bosanquet, D. C. (2022). Patient satisfaction with tele- and video-consultation in the COVID-19 era-A survey of vascular surgical patients. Annals of Vascular Surgery, 85, 105-109. https://doi.org/10.1016/j.avsg.2022.05.009</Citation></Reference><Reference><Citation>Evans, H. L., &amp; Lober, W. B. (2017). A pilot use of patient-generated wound data to improve postdischarge surgical site infection monitoring. JAMA Surgery, 152(6), 595-596. https://doi.org/10.1001/jamasurg.2017.0568</Citation></Reference><Reference><Citation>Evans, H. L., Lober, W. B., Lee, J. R., Lawrence, S. O., &amp; Lavallee, D. C. (2019). Assessing Surgical Site Infection Surveillance Technologies (ASSIST): Health technology assessment report. University of Washington Dispon&#xed;vel em www.cirg.washington.edu/assistHTAreport</Citation></Reference><Reference><Citation>Fernandes-Taylor, S., Gunter, R. L., Bennett, K. M., Awoyinka, L., Rahman, S., Greenberg, C. C., &amp; Kent, K. C. (2017). Feasibility of implementing a patient-centered postoperative wound monitoring program using smartphone images: A pilot protocol. JMIR Research Protocols, 6(2), e26. https://doi.org/10.2196/resprot.6819</Citation></Reference><Reference><Citation>Getachew, E., Adebeta, T., Muzazu, S. G. Y., Charlie, L., Said, B., Tesfahunei, H. A., Wanjiru, C. L., Acam, J., Kajogoo, V. D., Solomon, S., Atim, M. G., &amp; Manyazewal, T. (2023). Digital health in the era of COVID-19: Reshaping the next generation of healthcare. Frontiers in Public Health, 11, 942703. https://doi.org/10.3389/fpubh.2023.942703</Citation></Reference><Reference><Citation>Gunter, R., Fernandes-Taylor, S., Mahnke, A., Awoyinka, L., Schroeder, C., Wiseman, J., Sullivan, S., Bennett, K., Greenberg, C., &amp; Kent, K. C. (2016). Evaluating patient usability of an image-based mobile health platform for postoperative wound monitoring. JMIR mHealth and uHealth, 4(3), e113. https://doi.org/10.2196/mhealth.6023</Citation></Reference><Reference><Citation>Gunter, R. L., Fernandes-Taylor, S., Rahman, S., Awoyinka, L., Bennett, K. M., Weber, S. M., Greenberg, C. C., &amp; Kent, K. C. (2018). Feasibility of an image-based mobile health protocol for postoperative wound monitoring. Journal of the American College of Surgeons, 226(3), 277-286. https://doi.org/10.1016/j.jamcollsurg.2017.12.013</Citation></Reference><Reference><Citation>Gupta, N., Gupta, M. K., Joshi, N. K., Mantri, N., Sridevi, G., Patel, M., Goel, A. D., Singh, K., Garg, M. K., &amp; Brardwaj, P. (2023). Is telemedicine a holy grail in healthcare policy: Clinicians' and patients' perspectives from an Apex Institution in Western India. BMC Health Services Research, 23, 161. https://doi.org/10.1186/s12913-022-09013-y</Citation></Reference><Reference><Citation>Herrero, C. P., Bloom, D. A., Lin, C. C., Jazrawi, L. M., Strauss, E. J., Gonzalez-Lomas, G., Alaia, M. J., &amp; Campbell, K. A. (2021). Patient satisfaction is equivalent using telemedicine versus office-based follow-up after arthroscopic meniscal surgery. The Journal of Bone and Joint Surgery, 103(9), 771-777. https://doi.org/10.2106/JBJS.20.01413</Citation></Reference><Reference><Citation>Hutchings, R. (2020). The impact of Covid-19 on the use of digital technology in the NHS. Nuffield Trust, 27, 2002-2008.</Citation></Reference><Reference><Citation>Ke, C., Jin, Y., Evans, H., Lober, B., Qian, X., Liu, J., &amp; Huang, S. (2017). Prognostics of surgical site infections using dynamic health data. Journal of Biomedical Informatics, 65, 22-33. https://doi.org/10.1016/j.jbi.2016.10.021</Citation></Reference><Reference><Citation>Lavallee, D. C., Lee, J. R., Semple, J. L., Lober, W. B., &amp; Evans, H. L. (2019). Engaging patients in co-design of mobile health tools for surgical site infection surveillance: Implications for research and implementation. Surgical Infections, 20(7), 535-540. https://doi.org/10.1089/sur.2019.148</Citation></Reference><Reference><Citation>Macefield, R. C., Blazeby, J. M., Reeves, B. C., King, A., Rees, J., Pullyblank, A., &amp; Avery, K. (2023). Remote assessment of surgical site infection (SSI) using patient-taken wound images: Development and evaluation of a method for research and routine practice. Journal of Tissue Viability, 32(1), 94-101. https://doi.org/10.1016/j.jtv.2023.01.001</Citation></Reference><Reference><Citation>McLean, K. A., Montanha, K. E., Shaw, C. A., Drake, T. M., Pius, R., Knigth, R., Fairfield, C., Sgro, A., Bouamrane, M., Cambridge, W. A., Lyons, M., Riad, A., Skipworth, R. J. E., Wigmore, S. J., Potter, M. A., &amp; Harrison, E. M. (2021). Remote diagnosis of surgical-site infection using a mobile digital intervention: A randomised controlled trial in emergency surgery patients. NPJ Digital Medicine, 4, 160. https://doi.org/10.1038/s41746-021-00526-0</Citation></Reference><Reference><Citation>McLean, K. A., Mountain, K. E., Shaw, C. A., Drake, T. M., Ots, R., Knight, S. R., Fairfield, C., Sgro, A., Skipworth, R. J. E., Wigmore, S. J., Potter, M. A., &amp; Harrison, E. M. (2019). Can a smartphone-delivered tool facilitate the assessment of surgical site infection and result in earlier treatment? Tracking wound infection with smartphone technology (TWIST): Protocol for a randomised controlled trial in emergency surgery patients. BMJ Open, 9(10), e029620. https://doi.org/10.1136/bmjopen-2019-029620</Citation></Reference><Reference><Citation>Monahan, M., Jowett, S., Pinkney, T., Brocklehurst, P., Morton, D. G., Abdali, Z., &amp; Roberts, T. E. (2020). Surgical site infection and costs in low- and middle-income countries: A systematic review of the economic burden. PLoS ONE, 15(6), e0232960. https://doi.org/10.1371/journal.pone.0232960</Citation></Reference><Reference><Citation>Mousa, A. Y., Broce, M., Davis, E., McKee, B., &amp; Yacoub, M. (2017). Telehealth electronic monitoring to reduce post-discharge complications and surgical site infections after arterial revascularization with groin incision. Journal of Vascular Surgery, 66(6), 1902-1908. https://doi.org/10.1016/j.jvs.2017.07.063</Citation></Reference><Reference><Citation>National Wound Care Strategy Programme. (2021). Practical recommendations for the use of digital images in wound care. Dispon&#xed;vel em https://www.nationalwoundcarestrategy.net/wp-content/uploads/2021/09/Digital-Images-in-wound-care-17Sept21.pdf</Citation></Reference><Reference><Citation>Ohr, S. O., Giles, M., Munnoch, S., Hunter, M., Bolte, M., Ferguson, J., Deane, J., Cashman, P., &amp; Foureur, M. (2021). What gets measured gets noticed. Tracking surgical site infection post caesarean section through community surveillance: A post intervention study protocol. Journal of Advanced Nursing, 77(5), 2530-2538. https://doi.org/10.1111/jan.14796</Citation></Reference><Reference><Citation>Oliveira, L. P., Lucato, A. L. S., Fernandes, D. R., Vieira, L. G., Santos, B. N., &amp; Silveira, R. C. C. P. (2022). Use of technology for self-care in surgical wound infection surveillance: Integrative review. Revista Brasileira de Enfermagem, 3, e20210208. https://doi.org/10.1590/0034-7167-2021-0208</Citation></Reference><Reference><Citation>Peters, M. D. J., Godfrey, C., McInerney, P., Munn, Z., Tricco, A. C., &amp; Khalil, H. (2020). Scoping reviews. In E. Aromataris &amp; Z. Munn (Eds.), Joanna Briggs Institute manual for evidence synthesis [Internet] (p. 2020). JBI. Available from https://synthesismanual.jbi.global</Citation></Reference><Reference><Citation>Research2guidance. (2016). mHealth app developer economics. Available from http://branden.biz/wp-content/uploads/2017/10/r2g-mHealth-App-Developer-Economics-2016.pdf</Citation></Reference><Reference><Citation>Roess, A. (2017). The promise, growth, and reality of mobile health-Another data-free zone. The New England Journal of Medicine, 377, 2010-2011. https://doi.org/10.1056/NEJMp1713180</Citation></Reference><Reference><Citation>Russo, P. L., Saguil, E., Chakraarthy, M., Lee, K. Y., Ling, M. L., Morikane, K., Spencer, M., Danker, W., Yu, N. Y. C., &amp; Edmiston, C. E., Jr. (2021). Improving surgical site infection prevention in Asia-Pacific through appropriate surveillance programs: Challenges and recommendation. Infection, Disease &amp; Health, 26, 198-207. https://doi.org/10.1016/j.idh.2021.03.003</Citation></Reference><Reference><Citation>Sanger, P. C., Hartzler, A., Lordon, R. J., Armstrong, C. A., Lober, W. B., Evans, H. L., &amp; Pratt, W. (2016). A patient-centered system in a provider-centered world: Challenges of incorporating post-discharge wound data into practice. Journal of the American Medical Informatics Association, 23(3), 514-525. https://doi.org/10.1093/jamia/ocv183</Citation></Reference><Reference><Citation>Sawyer, R. G., Evans, H. L., &amp; Hedrick, T. L. (2019). Technological advances in clinical definition and surveillance methodology for surgical site infection incorporating surgical site imaging and patient-generated health data. Surgical Infections, 20(7), 541-545. https://doi.org/10.1089/sur.2019.153</Citation></Reference><Reference><Citation>Scheper, H., Derogee, R., Mahdad, R., van der Wal, R. J. P., Nelissen, R. G. H. H., Visser, L. G., &amp; de Boer, M. G. J. (2019). A mobile app for postoperative wound care after arthroplasty: Ease of use and perceived usefulness. International Journal of Medical Informatics, 129, 75-80. https://doi.org/10.1016/j.ijmedinf.2019.05.010</Citation></Reference><Reference><Citation>Semple, J. L., Sharpe, S., Murnaghan, M. L., Theodoropoulos, J., &amp; Metcalfe, K. A. (2015). Using a mobile app for monitoring postoperative quality of recovery of patients at home: A feasibility study. JMIR mHealth and uHealth, 3, e18. https://doi.org/10.2196/mhealth.3929</Citation></Reference><Reference><Citation>Sreedharan, S., Nemeth, L. S., Hirsch, J., &amp; Evans, H. L. (2022). Patient and provider preferences for monitoring surgical wounds using an mHealth app: A formative qualitative analysis. Surgical Infections, 23(2), 168-173. https://doi.org/10.1089/sur.2021.240</Citation></Reference><Reference><Citation>Totty, J. P., Harwood, A. E., Wallace, T., Smith, G. E., &amp; Chetter, I. C. (2018). Use of photograph-based telemedicine in postoperative wound assessment to diagnose or exclude surgical site infection. Journal of Wound Care, 27(3), 128-135. https://doi.org/10.12968/jowc.2018.27.3.128</Citation></Reference><Reference><Citation>Tricco, A. C., Lillie, E., Zarin, W., O'Brien, K. K., Colquhoun, H., Levac, D., Moher, D., Peters, M. D., Horsley, T., Weeks, L., Hempel, S., Akl, E. A., Chang, C., McGowan, J., Hartling, L., Aldcroft, A., Wilson, M. G., Garritty, C., Lewin, S., &#x2026; Straus, S. E. (2018). PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Annals of Internal Medicine, 169(7), 467-473. https://doi.org/10.7326/M18-0850</Citation></Reference><Reference><Citation>Wiseman, J. T., Fernades-taylor, S., Barnes, M. L., Tomsejova, A., Saunders, R. S., &amp; Kent, K. C. (2015). Conceptualizing smartphone use in outpatient wound assessment: Patients' and caregivers' willingness to use technology. Journal of the American College of Surgeons, 198(1), 245-251. https://doi.org/10.1016/j.jss.2015.05.011</Citation></Reference><Reference><Citation>Woelber, E., Schrick, E. J., Gessner, B. D., &amp; Evans, H. L. (2016). Proportion of surgical site infections occurring after hospital discharge: A systematic review. Surgical Infections, 17(5), 510-519. https://doi.org/10.1089/sur.2015.241</Citation></Reference><Reference><Citation>World Health Organization (WHO). (2016). Global diffusion of eHealth: Making universal health coverage achievable. Report of the third global survey on eHealth. WHO.</Citation></Reference><Reference><Citation>World Health Organization (WHO). (2018). Global guidelines for the prevention of surgical site infection. WHO. ISBN 978-92-4-155047-5.</Citation></Reference><Reference><Citation>Zhang, J., Dushaj, K., Rasquinha, V. J., Scuderi, G. R., &amp; Hepinstall, M. S. (2019). Monitoring surgical incision sites in orthopedic patients using an online physician-patient messaging platform. The Journal of Arthroplasty, 34(9), 1897-1900. https://doi.org/10.1016/j.arth.2019.05.003</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28637438</PMID><DateCompleted><Year>2018</Year><Month>04</Month><Day>05</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2474</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>Jun</Month><Day>21</Day></PubDate></JournalIssue><Title>BMC musculoskeletal disorders</Title><ISOAbbreviation>BMC Musculoskelet Disord</ISOAbbreviation></Journal><ArticleTitle>The efficacy and safety of tranexamic acid in revision total knee arthroplasty: a meta-analysis.</ArticleTitle><Pagination><StartPage>273</StartPage><MedlinePgn>273</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">273</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12891-017-1633-y</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">There is no consistent conclusion regarding the efficacy and safety of the intravenous administration of tranexamic acid (TXA) for reducing blood loss in revision total knee arthroplasty (TKA). We performed a meta-analysis of comparative trials to evaluate the efficacy and safety of TXA in revision TKA.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a search of PubMed, EMBASE, The Cochrane Library and Web of Science for randomized controlled trials (RCTs) and non-RCTs. Two authors selected the studies, extracted the data, and assessed the risk of bias independently. A pooled meta-analysis was performed using RevMan 5.3 software.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Four non-RCTs met the inclusion criteria. The meta-analysis indicated that the use of TXA was related to significantly less transfusion requirements (RD&#xa0;=&#xa0;-0.25; 95% CI: -0.43 to -0.08; P&#xa0;=&#xa0;0.005), drainage volume (MD&#xa0;=&#xa0;-321.07; 95% CI: -445.13 to -197.01, P&#xa0;=&#xa0;0.005), hemoglobin reduction (MD&#xa0;=&#xa0;-0.52; 95% CI: -0.79 to -0.25, P&#xa0;=&#xa0;0.0001), and length of hospital stay (MD&#xa0;=&#xa0;-2.36; 95% CI: -4.00 to -0.71, P&#xa0;=&#xa0;0.005). No significant differences in the incidence of deep venous thrombosis (DVT) or pulmonary embolism (PE) were noted.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The use of TXA for patients undergoing revision TKA may reduce blood loss and transfusion requirements without increasing the risk of postoperative venous thromboembolism. Due to the limited quality of the currently available evidence, more high-quality RCTs are required.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Peng</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, Tianjin Hospital, No. 406, Jiefang Nan Road, Tianjin, 300211, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Wen-Bin</ForeName><Initials>WB</Initials><AffiliationInfo><Affiliation>Department of Joint Surgery, Tianjin Hospital, No. 406, Jiefang Nan Road, Tianjin, 300211, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zhi-Jun</ForeName><Initials>ZJ</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, General Hospital of Tianjin Medical University, No. 154, Anshan Road, Tianjin, 300052, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Gui-Jun</ForeName><Initials>GJ</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, Tianjin Hospital, No. 406, Jiefang Nan Road, Tianjin, 300211, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yu-Ting</ForeName><Initials>YT</Initials><AffiliationInfo><Affiliation>Cancer &amp; Immunology Research, Children's Research Institute, Children's National Medical Center, 111 Michigan Avenue, NW, Washington, DC, 20010, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Xin-Long</ForeName><Initials>XL</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, Tianjin Hospital, No. 406, Jiefang Nan Road, Tianjin, 300211, People's Republic of China. maxinlong868686@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>06</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Musculoskelet Disord</MedlineTA><NlmUniqueID>100968565</NlmUniqueID><ISSNLinking>1471-2474</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000933">Antifibrinolytic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>6T84R30KC1</RegistryNumber><NameOfSubstance UI="D014148">Tranexamic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000933" MajorTopicYN="N">Antifibrinolytic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019645" MajorTopicYN="N">Arthroplasty, Replacement, Knee</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016063" MajorTopicYN="N">Blood Loss, Surgical</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012086" MajorTopicYN="N">Reoperation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014148" MajorTopicYN="N">Tranexamic Acid</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Arthroplasty</Keyword><Keyword MajorTopicYN="N">Knee</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Revision</Keyword><Keyword MajorTopicYN="N">Tranexamic acid</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>12</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>6</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>6</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>4</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>6</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28637438</ArticleId><ArticleId IdType="pmc">PMC5480129</ArticleId><ArticleId IdType="doi">10.1186/s12891-017-1633-y</ArticleId><ArticleId IdType="pii">10.1186/s12891-017-1633-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>De Martino I, D'Apolito R, Sculco PK, Poultsides LA, Gasparini G. Total knee Arthroplasty using Cementless porous tantalum Monoblock Tibial component: a minimum 10-year follow-up. J Arthroplast. 2016;31(10):2193&#x2013;2198. doi: 10.1016/j.arth.2016.03.057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2016.03.057</ArticleId><ArticleId IdType="pubmed">27172865</ArticleId></ArticleIdList></Reference><Reference><Citation>Keating EM, Meding JB, Faris PM, Ritter MA. Long-term followup of nonmodular total knee replacements. Clin Orthop Relat Res. 2002;404:34&#x2013;39. doi: 10.1097/00003086-200211000-00007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003086-200211000-00007</ArticleId><ArticleId IdType="pubmed">12439235</ArticleId></ArticleIdList></Reference><Reference><Citation>Maradit Kremers H, Larson DR, Crowson CS, Kremers WK, Washington RE, Steiner CA, et al. Prevalence of Total hip and knee replacement in the United States. J Bone Joint Surg Am. 2015;97(17):1386&#x2013;1397. doi: 10.2106/JBJS.N.01141.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.N.01141</ArticleId><ArticleId IdType="pmc">PMC4551172</ArticleId><ArticleId IdType="pubmed">26333733</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A, Pavlou G, Mujica-Mota RE, Toms AD. The epidemiology of revision total knee and hip arthroplasty in England and Wales: a comparative analysis with projections for the United States. A study using the National Joint Registry dataset. Bone Joint J. 2015;97-B(8):1076&#x2013;1081. doi: 10.1302/0301-620X.97B8.35170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/0301-620X.97B8.35170</ArticleId><ArticleId IdType="pubmed">26224824</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozic KJ, Kurtz SM, Lau E, Ong K, Chiu V, Vail TP, et al. The epidemiology of revision total knee arthroplasty in the United States. Clin Orthop Relat Res. 2010;468(1):45&#x2013;51. doi: 10.1007/s11999-009-0945-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11999-009-0945-0</ArticleId><ArticleId IdType="pmc">PMC2795838</ArticleId><ArticleId IdType="pubmed">19554385</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton DF, Howie CR, Burnett R, Simpson AH, Patton JT. Dealing with the predicted increase in demand for revision total knee arthroplasty: challenges, risks and opportunities. Bone Joint J. 2015;97-B(6):723&#x2013;728. doi: 10.1302/0301-620X.97B6.35185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/0301-620X.97B6.35185</ArticleId><ArticleId IdType="pubmed">26033049</ArticleId></ArticleIdList></Reference><Reference><Citation>Alshryda S, Sarda P, Sukeik M, Nargol A, Blenkinsopp J, Mason JM. Tranexamic acid in total knee replacement: a systematic review and meta-analysis. J Bone Joint Surg Br. 2011;93(12):1577&#x2013;1585. doi: 10.1302/0301-620X.93B12.26989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/0301-620X.93B12.26989</ArticleId><ArticleId IdType="pubmed">22161917</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan J, Chen H, Liu Q, Chen C, Huang W. A meta-analysis of the effectiveness and safety of using tranexamic acid in primary unilateral total knee arthroplasty. J Surg Res. 2013;184(2):880&#x2013;887. doi: 10.1016/j.jss.2013.03.099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2013.03.099</ArticleId><ArticleId IdType="pubmed">23643299</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang ZG, Chen WP, Wu LD. Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty: a meta-analysis. J Bone Joint Surg Am. 2012;94(13):1153&#x2013;1159. doi: 10.2106/JBJS.K.00873.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.K.00873</ArticleId><ArticleId IdType="pubmed">22623147</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguilera X, Videla S, Almenara M, Fernandez JA, Gich I, Celaya F. Effectiveness of tranexamic acid in revision total knee arthroplasty. Acta Orthop Belg. 2012;78(1):68&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">22523930</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega-Andreu M, Talavera G, Padilla-Eguiluz NG, Perez-Chrzanowska H, Figueredo-Galve R, Rodriguez-Merchan CE, et al. Tranexamic acid in a multimodal blood loss prevention protocol to decrease blood loss in revision Total knee Arthroplasty: a cohort study. Open Orthop J. 2016;10:439&#x2013;447. doi: 10.2174/1874325001610010439.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1874325001610010439</ArticleId><ArticleId IdType="pmc">PMC5039954</ArticleId><ArticleId IdType="pubmed">27708740</ArticleId></ArticleIdList></Reference><Reference><Citation>Samujh C, Falls TD, Wessel R, Smith L, Malkani AL. Decreased blood transfusion following revision total knee arthroplasty using tranexamic acid. J Arthroplast. 2014;29(9 Suppl):182&#x2013;185. doi: 10.1016/j.arth.2014.03.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2014.03.047</ArticleId><ArticleId IdType="pubmed">25015759</ArticleId></ArticleIdList></Reference><Reference><Citation>Smit KM, Naudie DD, Ralley FE, Berta DM, Howard JL. One dose of tranexamic acid is safe and effective in revision knee arthroplasty. J Arthroplast. 2013;28(8 Suppl):112&#x2013;115. doi: 10.1016/j.arth.2013.05.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2013.05.036</ArticleId><ArticleId IdType="pubmed">23953962</ArticleId></ArticleIdList></Reference><Reference><Citation>Li ZJ, Wang Y, Zhang HF, Ma XL, Tian P, Huang Y. Effectiveness of low-level laser on carpal tunnel syndrome: a meta-analysis of previously reported randomized trials. Medicine (Baltimore) 2016;95(31):e4424. doi: 10.1097/MD.0000000000004424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000004424</ArticleId><ArticleId IdType="pmc">PMC4979817</ArticleId><ArticleId IdType="pubmed">27495063</ArticleId></ArticleIdList></Reference><Reference><Citation>Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg. 2003;73(9):712&#x2013;716. doi: 10.1046/j.1445-2197.2003.02748.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1445-2197.2003.02748.x</ArticleId><ArticleId IdType="pubmed">12956787</ArticleId></ArticleIdList></Reference><Reference><Citation>Cankaya D, Della Valle CJ. Blood loss and transfusion rates in the revision of Unicompartmental knee Arthroplasty to Total knee Arthroplasty are similar to those of primary Total knee Arthroplasty but are lower compared with the revision Total knee Arthroplasty. J Arthroplast. 2016;31(1):339&#x2013;341. doi: 10.1016/j.arth.2015.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2015.08.002</ArticleId><ArticleId IdType="pubmed">26350261</ArticleId></ArticleIdList></Reference><Reference><Citation>Ralley FE, Berta D, Binns V, Howard J, Naudie DD. One intraoperative dose of tranexamic acid for patients having primary hip or knee arthroplasty. Clin Orthop Relat Res. 2010;468(7):1905&#x2013;1911. doi: 10.1007/s11999-009-1217-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11999-009-1217-8</ArticleId><ArticleId IdType="pmc">PMC2882010</ArticleId><ArticleId IdType="pubmed">20063079</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24170345</PMID><DateCompleted><Year>2014</Year><Month>07</Month><Day>23</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1932-8494</ISSN><JournalIssue CitedMedium="Internet"><Volume>296</Volume><Issue>12</Issue><PubDate><Year>2013</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Anatomical record (Hoboken, N.J. : 2007)</Title><ISOAbbreviation>Anat Rec (Hoboken)</ISOAbbreviation></Journal><ArticleTitle>Rib cartilage characterization in patients affected by pectus excavatum.</ArticleTitle><Pagination><StartPage>1813</StartPage><EndPage>1820</EndPage><MedlinePgn>1813-20</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/ar.22824</ELocationID><Abstract><AbstractText>Pectus excavatum (PE) is the most frequent anterior chest deformity which may be frequently associated with connective tissue disorders. We performed microscopic analyses to better understand cartilage behavior and obtain clues on its pathogenesis. In 37 PE patients, none with Marfan syndrome, we analyzed costal cartilage by light microscopy, immunohistochemistry and transmission electron microscopy. Control tissue specimens were harvested from four patients without any connective tissue disease. In both control and PE patients, chondrocytes were on the average &lt;15 &#xb5;m in diameter and occupied &lt;10% of tissue volume; in most cases the extracellular matrix was stained by alcian blue, instead of safranin; no difference between PE and control samples was significant. All samples showed an uneven collagen type II immunolabeling both within the cells and pericellular matrix, and occasionally of the territorial matrix. In all cases numerous cells underwent apoptosis accompanied by matrix condensation as shown by electron microscopy. Our results suggest that matrix composition and the cell number and size of costal cartilage are dependent on the subject and not on the disease; the microscopic organization of cartilage is correlated with the stabilization of the defective shape rather than with the onset of the deformity.</AbstractText><CopyrightInformation>Copyright &#xa9; 2013 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tocchioni</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Pediatric Surgery, University of Florence and Children's University Hospital A. Meyer, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghionzoli</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Calosi</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Guasti</LastName><ForeName>Daniele</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Romagnoli</LastName><ForeName>Paolo</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Messineo</LastName><ForeName>Antonio</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>10</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anat Rec (Hoboken)</MedlineTA><NlmUniqueID>101292775</NlmUniqueID><ISSNLinking>1932-8486</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002356" MajorTopicYN="N">Cartilage</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019902" MajorTopicYN="N">Chondrocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005660" MajorTopicYN="N">Funnel Chest</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007124" MajorTopicYN="N">Immunoenzyme Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D046529" MajorTopicYN="N">Microscopy, Electron, Transmission</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012272" MajorTopicYN="N">Ribs</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">fibrillin</Keyword><Keyword MajorTopicYN="N">fibrillinopathies</Keyword><Keyword MajorTopicYN="N">marfan</Keyword><Keyword MajorTopicYN="N">pectus excavatum</Keyword><Keyword MajorTopicYN="N">rib cartilage</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>5</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>10</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>10</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>7</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24170345</ArticleId><ArticleId IdType="doi">10.1002/ar.22824</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24374549</PMID><DateCompleted><Year>2014</Year><Month>06</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>12</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1528-1140</ISSN><JournalIssue CitedMedium="Internet"><Volume>259</Volume><Issue>6</Issue><PubDate><Year>2014</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Annals of surgery</Title><ISOAbbreviation>Ann Surg</ISOAbbreviation></Journal><ArticleTitle>Preoperative enoxaparin versus postoperative semuloparin thromboprophylaxis in major abdominal surgery: a randomized controlled trial.</ArticleTitle><Pagination><StartPage>1073</StartPage><EndPage>1079</EndPage><MedlinePgn>1073-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/SLA.0000000000000430</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To compare efficacy and safety of thromboprophylaxis with semuloparin started postoperatively versus enoxaparin started preoperatively in major abdominal surgery.</AbstractText><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Venous thromboembolism is an important complication following major abdominal surgery. Semuloparin is a novel ultra-low-molecular-weight heparin with high antifactor Xa and minimal antifactor IIa activity.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this double-blind noninferiority trial, adult patients undergoing major abdominal or pelvic operation under general anesthesia lasting more than 45 minutes were assigned to either daily enoxaparin 40 mg commenced preoperatively or daily semuloparin 20 mg commenced postoperatively, for 7 to 10 days. Patients underwent bilateral leg venography between 7 and 11 days postsurgery. The primary efficacy end point was the composite of any deep vein thrombosis, nonfatal pulmonary embolism, or all-cause death. The primary safety outcome was bleeding. Both were independently adjudicated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, 4413 patients were randomized; 3030 (1499 in the enoxaparin and 1531 in the semuloparin groups) were evaluable for the primary efficacy end point, which occurred in 97 patients (6.3%) in the semuloparin group and 82 patients (5.5%) in the enoxaparin group [odds ratio (OR) = 1.16, 95% confidence interval (CI): 0.84-1.59]. On the basis of a noninferiority margin of 1.25, postoperative semuloparin did not demonstrate noninferiority to preoperative enoxaparin. Major bleeding occurred in 63 of 2175 patients (2.9%) in the semuloparin group and 98 of 2177 patients (4.5%) in the enoxaparin group (OR = 0.63, 95% CI: 0.46-0.87).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Semuloparin commenced postoperatively did not demonstrate noninferiority to enoxaparin initiated preoperatively for thromboprophylaxis after major abdominal surgery. Study registered with clinicaltrials.gov: NCT00679588.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kakkar</LastName><ForeName>Ajay K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>*Thrombosis Research Institute and University College London, London, UK &#x2020;Stroke Unit and Division of Cardiovascular Medicine, Department of Internal Medicine, University of Perugia, Perugia, Italy &#x2021;Department of Orthopaedic Surgery, McGill University Health Centre, Montreal, QC, Canada &#xa7;Duke University Medical Center, Durham, NC &#xb6;Spine Center Copenhagen, Copenhagen University Hospital, Glostrup, Denmark &#x2016;University of Saint-&#xc9;tienne, Saint-&#xc9;tienne, France **Klinikum Frankfurt H&#xf6;echst, Frankfurt, Germany &#x2020;&#x2020;Sanofi, Bridgewater, NJ &#x2021;&#x2021;Hamilton Health Sciences General Hospital, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agnelli</LastName><ForeName>Giancarlo</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Fisher</LastName><ForeName>William</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>George</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Lassen</LastName><ForeName>Michael R</ForeName><Initials>MR</Initials></Author><Author ValidYN="Y"><LastName>Mismetti</LastName><ForeName>Patrick</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Mouret</LastName><ForeName>Patrick</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Murphy</LastName><ForeName>Judith</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Lawson</LastName><ForeName>Francesca</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Turpie</LastName><ForeName>Alexander G G</ForeName><Initials>AG</Initials></Author><Author ValidYN="Y"><CollectiveName>SAVE-ABDO Investigators</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT00679588</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Surg</MedlineTA><NlmUniqueID>0372354</NlmUniqueID><ISSNLinking>0003-4932</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017984">Enoxaparin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005343">Fibrinolytic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006495">Heparin, Low-Molecular-Weight</NameOfSubstance></Chemical><Chemical><RegistryNumber>4QW4AN84NQ</RegistryNumber><NameOfSubstance UI="C569346">semuloparin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000005" MajorTopicYN="N">Abdomen</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017984" MajorTopicYN="N">Enoxaparin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005343" MajorTopicYN="N">Fibrinolytic Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006495" MajorTopicYN="N">Heparin, Low-Molecular-Weight</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011184" MajorTopicYN="N">Postoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057234" MajorTopicYN="N">Preoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="N">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><InvestigatorList><Investigator ValidYN="Y"><LastName>Turpie</LastName><ForeName>A G G</ForeName><Initials>AG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Agnelli</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>George</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fisher</LastName><ForeName>W</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kakkar</LastName><ForeName>A K</ForeName><Initials>AK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lassen</LastName><ForeName>M R</ForeName><Initials>MR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mismetti</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mouret</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Levine</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leizorovicz</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Borris</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Buyse</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fisher</LastName><ForeName>M R</ForeName><Initials>MR</Initials></Investigator><Investigator ValidYN="Y"><LastName>White</LastName><ForeName>R H</ForeName><Initials>RH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Larrey</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bluguerman</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carlevaro</LastName><ForeName>O</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Damia</LastName><ForeName>O</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gaite</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hendler</LastName><ForeName>H</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kevorkian</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tatangelo</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Facello</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chong</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Coughlin</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Salem</LastName><ForeName>H</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carroll</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mischinger</LastName><ForeName>H-J</ForeName><Initials>HJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schauer</LastName><ForeName>W</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ceelen</LastName><ForeName>W</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Verhelst</LastName><ForeName>H</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Figueiredo</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Freire</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Genzini</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kato</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Paula</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pereira</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Robles</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Souza</LastName><ForeName>H</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wainstein</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Westphal</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Von Bahten</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brienze</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Giovanardi</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scarpelini</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lefterov</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ninov</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Petrov</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Platikanov</LastName><ForeName>V</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tcherveniakov</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grigorov</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Madjov</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Draganov</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Beliakouski</LastName><ForeName>V</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bordakov</LastName><ForeName>V</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dosta</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Erushevich</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kuzmin</LastName><ForeName>Y</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mikhailova</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shchastny</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shmak</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhu</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Woods</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Telang</LastName><ForeName>H</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>McFadyen</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Warriner</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dolan</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stein</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Farries</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bellolio</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guerra Castro</LastName><ForeName>J F</ForeName><Initials>JF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vigueras</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bainan</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhou</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lu</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shi</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wang</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhou</LastName><ForeName>Y</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Huang</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Li</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Li</LastName><ForeName>Y</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Peng</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhao</LastName><ForeName>Y</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gluhacic</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Horzic</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Simlesa</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Divis</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ryska</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mrazek</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baader</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Neumann</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Penka</LastName><ForeName>I</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Visokai</LastName><ForeName>V</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lajmar</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sauer</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meduna</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sakra</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stembera</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hendrych</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Buzek</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schnack</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ovist</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Soplepmann</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tein</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Teras</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Birth</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>B&#xfc;chler</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schilling</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schellong</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Uhl</LastName><ForeName>W</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Winkler</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schuhmacher</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kujath</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Boehner</LastName><ForeName>H</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ridwelski</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chalkiadakis</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sz&#xe1;nt&#xf3;</LastName><ForeName>Z</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Altorjay</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Damjanovich</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lazar</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Csap&#xf3;</LastName><ForeName>Z</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Augustine</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gupta</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kapoor</LastName><ForeName>V</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Behari</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kukreja</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mehta</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pitchamuthu</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hariharan</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mayakonda</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sudhir</LastName><ForeName>Rawal</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Venkat</LastName><ForeName>Rao</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rozario</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sastry</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dhar</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Menon</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Janaviculam</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chaitanvanand</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hemanth</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Devarajan</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yuvaraja</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harish</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Annamalai</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mathur</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kalambe</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vora</LastName><ForeName>H</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Abhijith</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chowdappa</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Srinivasalu</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mehta</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Samaiya</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Virk</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Voonna</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bertoglio</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Terranova</LastName><ForeName>O</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Silingardi</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Di Carlo</LastName><ForeName>V</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Liguori</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Quintavalla</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Belluco</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grossi</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Levkin</LastName><ForeName>Y</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baldini</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Imberti</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gianetta</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gvu-Seok</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chun</LastName><ForeName>H-K</ForeName><Initials>HK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Han</LastName><ForeName>S-Y</ForeName><Initials>SY</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hyung</LastName><ForeName>W J</ForeName><Initials>WJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Park</LastName><ForeName>Y J</ForeName><Initials>YJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>In</LastName><ForeName>H K</ForeName><Initials>HK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yu</LastName><ForeName>C S</ForeName><Initials>CS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Choi</LastName><ForeName>S K</ForeName><Initials>SK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yang</LastName><ForeName>H-K</ForeName><Initials>HK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pupelis</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Krievins</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Novikovs</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zelobovskis</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Endzinas</LastName><ForeName>Z</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gradauskas</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Venskutonis</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chavez-Michel</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Javer-Fernandez</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mark</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meffan</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smith</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gronbech</LastName><ForeName>J E</ForeName><Initials>JE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Arias</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Flores Mena</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Flores Yabar</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Colca Ccahuana</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Luque Vasquez</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Munoz</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Santillana</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dabrowiecki</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dziki</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jawien</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Krasnodebski</LastName><ForeName>I</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kulig</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sledzinski</LastName><ForeName>Z</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bednarz</LastName><ForeName>W</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grzebieniak</LastName><ForeName>Z</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Modzelewski</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wallner</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jackowski</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Karczewski</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kladny</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ciostek</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Starzewski</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Witkiewicz</LastName><ForeName>W</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Labza</LastName><ForeName>H</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Drop</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lesi</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Negrau</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sandesc</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ciuce</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Duse</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nadim</LastName><ForeName>A H</ForeName><Initials>AH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Muntean</LastName><ForeName>V</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rodoman</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shulutko</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ushakov</LastName><ForeName>I</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Karapetvan</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Isakov</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shevcova</LastName><ForeName>O</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parfeev</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shcherbakov</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Korolev</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lenskaya</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Staroverov</LastName><ForeName>I</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Agafina</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Matevosyan</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Oseshnuk</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Topuzov</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Medvedev</LastName><ForeName>V</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bychkova</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ruchkin</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Severtsev</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vyushkov</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hadzi Djokic</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marusic</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ivanovic</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hutan</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Osole</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Potrc</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pretorius</LastName><ForeName>C F</ForeName><Initials>CF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Van Zyl</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Warren</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rafecas</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tellado</LastName><ForeName>J M</ForeName><Initials>JM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Andr&#xe9;n-Sandberg</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mardani</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lundgren</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Edin</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Franz&#xe9;n</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kurtoglu</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aygun</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Karahan</LastName><ForeName>S R</ForeName><Initials>SR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cokmez</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dubovyi</LastName><ForeName>V</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Paramonov</LastName><ForeName>V</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cheshuk</LastName><ForeName>V</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shchepotin</LastName><ForeName>I</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sedakov</LastName><ForeName>I</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zaychuk</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Borota</LastName><ForeName>O</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Datsenko</LastName><ForeName>O</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cohen</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Touliatos</LastName><ForeName>J G</ForeName><Initials>JG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Berger</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wilson</LastName><ForeName>M A</ForeName><Initials>MA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lal</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wittgen</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Taylor</LastName><ForeName>W E</ForeName><Initials>WE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Waxman</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Moya</LastName><ForeName>M A</ForeName><Initials>MA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Velmahos</LastName><ForeName>G C</ForeName><Initials>GC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mancuso</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kerwin</LastName><ForeName>A J</ForeName><Initials>AJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Luchette</LastName><ForeName>F A</ForeName><Initials>FA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goodman</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maroni</LastName><ForeName>P D</ForeName><Initials>PD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Minkowitz</LastName><ForeName>H S</ForeName><Initials>HS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Williams</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Erickson</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Valenzuela</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Griswold</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ward</LastName><ForeName>J A</ForeName><Initials>JA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hassan</LastName><ForeName>I</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Koura</LastName><ForeName>F A</ForeName><Initials>FA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Murray</LastName><ForeName>R M</ForeName><Initials>RM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cassim</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Candiotti</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wood</LastName><ForeName>M T</ForeName><Initials>MT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bergese</LastName><ForeName>S D</ForeName><Initials>SD</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>12</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>1</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24374549</ArticleId><ArticleId IdType="doi">10.1097/SLA.0000000000000430</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38012761</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>29</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1745-6215</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Nov</Month><Day>27</Day></PubDate></JournalIssue><Title>Trials</Title><ISOAbbreviation>Trials</ISOAbbreviation></Journal><ArticleTitle>Analgesic effect of nitrous oxide during manual therapy after anterior cruciate ligament reconstruction: a study protocol for a randomized controlled trial.</ArticleTitle><Pagination><StartPage>764</StartPage><MedlinePgn>764</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">764</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13063-023-07732-z</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Many patients during manual therapy after anterior ligament reconstruction will experience severe pain, which has a negative impact on their rehabilitation. However, there is rarely an analgesic method for these patients during rehabilitation. Nitrous oxide with rapid analgesic and sedative effects is often used to relieve pain in minor procedures. The purpose of this study is to determine whether or not nitrous oxide analgesia decreases pain compared to oxygen during manual therapy after anterior ligament reconstruction.</AbstractText><AbstractText Label="METHODS/DESIGN" NlmCategory="METHODS">This single-center, randomized, double-blind and controlled trial will recruit 120 patients. Patients&#x2009;&#x2265;&#x2009;18&#xa0;years old undergoing manual therapy after anterior ligament reconstruction (1&#xa0;month post-operative) with acute pain (VAS&#x2009;&#x2265;&#x2009;4) are included. The main exclusion criteria included the following: pulmonary embolism, intestinal obstruction, pneumothorax. Patients will be randomly allocated to the intervention group (A) and the control group (B) in a ratio of 1:1. Doctors, therapists, patients, and data collectors are all blind to the study. The manual therapy will be performed by therapists. Nurses who implemented the intervention handed the doctors envelopes containing the patients' codes and allocation of A or B. Group A will receive a pre-prepared nitrous oxide/oxygen mixture plus conventional treatment (no analgesic) given as 30-min treatment sessions, once daily, and group B will receive oxygen plus conventional treatment (no analgesic) under the same conditions. Assessments will be taken 2&#xa0;min before the intervention (T0), 5&#xa0;min after the beginning of the intervention (T1), and 5&#xa0;min after the intervention finished (T2). The primary outcome is pain score. Secondary outcomes include vital signs, side effects, joint range of motion, adjuvant analgesia need, therapist and patient satisfaction, and whether willing to receive the same gas again.</AbstractText><AbstractText Label="EXPECTED OUTCOMES" NlmCategory="OBJECTIVE">We expect nitrous oxide inhalation to have a beneficial effect on the pain of patients who receive manual therapy after anterior ligament reconstruction.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">If this treatment appears beneficial, it could improve patients' satisfaction and quality of life potentially and even be implemented widely in hospital and rehabilitation settings.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">ClinicalTrials.gov identifier, ChiCTR2200061175 (Version 2.0 June 15, 2022), https://www.chictr.org.cn .</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Wang</LastName><ForeName>Ziyang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Stomatology, the 960th Hospital of People's Liberation Army of China (PLA), Jinan, Shandong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Nursing, Weifang Medical University, Weifang, Shandong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Wang</LastName><ForeName>Fei</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, the 960th Hospital of People's Liberation Army of China (PLA), Jinan, Shandong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Li</LastName><ForeName>Yuxiang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>School of Nursing, Ningxia Medical University, Ningxia, Yinchuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xing</LastName><ForeName>Yihui</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Stomatology, the 960th Hospital of People's Liberation Army of China (PLA), Jinan, Shandong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Nursing, Weifang Medical University, Weifang, Shandong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Xiaochen</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Stomatology, the 960th Hospital of People's Liberation Army of China (PLA), Jinan, Shandong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Nursing, Weifang Medical University, Weifang, Shandong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Cui</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation Medicine, the 960th Hospital of People's Liberation Army of China (PLA), Jinan, Shandong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Zhiguo</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Hepatopancreatobiliary Surgery, Qingdao Municipal Hospital, Qingdao, Shandong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Lu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Nursing, Weifang Medical University, Weifang, Shandong, China. tanglu_office@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>202019025</GrantID><Agency>Clinical medical science and technology innovation project of Jinan</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D000078325">Clinical Trial Protocol</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Trials</MedlineTA><NlmUniqueID>101263253</NlmUniqueID><ISSNLinking>1745-6215</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>K50XQU1029</RegistryNumber><NameOfSubstance UI="D009609">Nitrous Oxide</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000700">Analgesics</NameOfSubstance></Chemical><Chemical><RegistryNumber>S88TT14065</RegistryNumber><NameOfSubstance UI="D010100">Oxygen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009609" MajorTopicYN="N">Nitrous Oxide</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000700" MajorTopicYN="N">Analgesics</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059787" MajorTopicYN="Y">Acute Pain</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010100" MajorTopicYN="N">Oxygen</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059549" MajorTopicYN="Y">Anterior Cruciate Ligament Reconstruction</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D026201" MajorTopicYN="Y">Musculoskeletal Manipulations</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Analgesia</Keyword><Keyword MajorTopicYN="N">Manual therapy</Keyword><Keyword MajorTopicYN="N">Nitrous oxide</Keyword><Keyword MajorTopicYN="N">Rehabilitation</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>29</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>28</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>28</Day><Hour>0</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38012761</ArticleId><ArticleId IdType="pmc">PMC10683199</ArticleId><ArticleId IdType="doi">10.1186/s13063-023-07732-z</ArticleId><ArticleId IdType="pii">10.1186/s13063-023-07732-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yabroudi MA, Irrgang JJ. Rehabilitation and return to play after anatomic anterior cruciate ligament reconstruction. Clin Sports Med. 2013;32(1):165&#x2013;175. doi: 10.1016/j.csm.2012.08.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.csm.2012.08.016</ArticleId><ArticleId IdType="pubmed">23177470</ArticleId></ArticleIdList></Reference><Reference><Citation>Frobell RB, Roos EM, Roos HP, Ranstam J, Lohmander LS. A randomized trial of treatment for acute anterior cruciate ligament tears. N Engl J Med. 2010;363(4):331&#x2013;342. doi: 10.1056/NEJMoa0907797.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0907797</ArticleId><ArticleId IdType="pubmed">20660401</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai YL, Chai XM, Zhu N, Wang KB, Bao WQ, Zhang XS, et al. Analgesia effect of premixed nitrous oxide/oxygen during the rehabilitation after total knee arthroplasty: a study protocol for a randomized controlled trial. Trials. 2019;20(1):399. doi: 10.1186/s13063-019-3472-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-019-3472-7</ArticleId><ArticleId IdType="pmc">PMC6610947</ArticleId><ArticleId IdType="pubmed">31272502</ArticleId></ArticleIdList></Reference><Reference><Citation>Swirtun LR, Eriksson K, Renstr&#xf6;m P. Who chooses anterior cruciate ligament reconstruction and why? A 2-year prospective study. Scand J Med Sci Sports. 2006;16(6):441&#x2013;446. doi: 10.1111/j.1600-0838.2005.00505.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0838.2005.00505.x</ArticleId><ArticleId IdType="pubmed">17121647</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker MJ, Boyles RE, Young BA, Strunce JB, Garber MB, Whitman JM, et al. The effectiveness of manual physical therapy and exercise for mechanical neck pain: a randomized clinical trial. Spine (Phila Pa 1976) 2008;33(22):2371&#x2013;8. doi: 10.1097/BRS.0b013e318183391e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BRS.0b013e318183391e</ArticleId><ArticleId IdType="pubmed">18923311</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaborklu Argut S, Celik D, Kilicoglu OI. The combination of exercise and manual therapy versus exercise alone in total knee arthroplasty rehabilitation: a randomized controlled clinical trial. PM R. 2021;13(10):1069&#x2013;1078. doi: 10.1002/pmrj.12542.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmrj.12542</ArticleId><ArticleId IdType="pubmed">33352007</ArticleId></ArticleIdList></Reference><Reference><Citation>Bishop MD, Torres-Cueco R, Gay CW, Lluch-Girb&#xe9;s E, Beneciuk JM, Bialosky JE. What effect can manual therapy have on a patient&#x2019;s pain experience? Pain Manag. 2015;5(6):455&#x2013;464. doi: 10.2217/pmt.15.39.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/pmt.15.39</ArticleId><ArticleId IdType="pmc">PMC4976880</ArticleId><ArticleId IdType="pubmed">26401979</ArticleId></ArticleIdList></Reference><Reference><Citation>Chuaychoosakoon C, Parinyakhup W, Wiwatboworn A, Purngpiputtrakul P, Wanasitchaiwat P, Boonriong T. Comparing post-operative pain between single bundle and double bundle anterior cruciate ligament reconstruction: a retrospective study. BMC Musculoskelet Disord. 2021;22(1):753. doi: 10.1186/s12891-021-04635-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12891-021-04635-5</ArticleId><ArticleId IdType="pmc">PMC8418012</ArticleId><ArticleId IdType="pubmed">34479511</ArticleId></ArticleIdList></Reference><Reference><Citation>Forogh B, Aslanpour H, Fallah E, Babaei-Ghazani A, Ebadi S. Adding high-frequency transcutaneous electrical nerve stimulation to the first phase of post anterior cruciate ligament reconstruction rehabilitation does not improve pain and function in young male athletes more than exercise alone: a randomized single-blind clinical trial. Disabil Rehabil. 2019;41(5):514&#x2013;522. doi: 10.1080/09638288.2017.1399294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09638288.2017.1399294</ArticleId><ArticleId IdType="pubmed">29117738</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinbroum AA. Non-opioid IV adjuvants in the perioperative period: pharmacological and clinical aspects of ketamine and gabapentinoids. Pharmacol Res. 2012;65(4):411&#x2013;429. doi: 10.1016/j.phrs.2012.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2012.01.002</ArticleId><ArticleId IdType="pubmed">22311381</ArticleId></ArticleIdList></Reference><Reference><Citation>Buvanendran A, Kroin JS. Multimodal analgesia for controlling acute postoperative pain. Curr Opin Anaesthesiol. 2009;22(5):588&#x2013;593. doi: 10.1097/ACO.0b013e328330373a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACO.0b013e328330373a</ArticleId><ArticleId IdType="pubmed">19606021</ArticleId></ArticleIdList></Reference><Reference><Citation>Bang SR, Yu SK, Kim TH. Can gabapentin help reduce postoperative pain in arthroscopic rotator cuff repair? A prospective, randomized, double-blind study. Arthroscopy. 2010;26(9 Suppl):S106&#x2013;S111. doi: 10.1016/j.arthro.2009.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arthro.2009.11.010</ArticleId><ArticleId IdType="pubmed">20810085</ArticleId></ArticleIdList></Reference><Reference><Citation>Herres J, Chudnofsky CR, Manur R, Damiron K, Deitch K. The use of inhaled nitrous oxide for analgesia in adult ED patients: a pilot study. Am J Emerg Med. 2016;34(2):269&#x2013;73. doi: 10.1016/j.ajem.2015.10.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2015.10.038</ArticleId><ArticleId IdType="pubmed">26585197</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta PD, Mahajan P, Monga P, Thaman D, Khinda VIS, Gupta A. Evaluation of the efficacy of nitrous oxide inhalation sedation on anxiety and pain levels of patients undergoing endodontic treatment in a vital tooth: a prospective randomized controlled trial. J Conserv Dent. 2019;22(4):356&#x2013;361. doi: 10.4103/JCD.JCD_332_18.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/JCD.JCD_332_18</ArticleId><ArticleId IdType="pmc">PMC6873592</ArticleId><ArticleId IdType="pubmed">31802819</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao LL, Yu JQ, Liu Q, Gao HX, Dai YL, Zhang JJ, et al. Analgesic effect of nitrous oxide/oxygen mixture for traumatic pain in the emergency department: a randomized, double-blind study. J Emerg Med. 2019;57(4):444&#x2013;452. doi: 10.1016/j.jemermed.2019.06.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jemermed.2019.06.026</ArticleId><ArticleId IdType="pubmed">31514988</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheyklo SG, Hajebrahimi S, Moosavi A, Pournaghi-Azar F, Azami-Aghdash S, Ghojazadeh M. Effect of Entonox for pain management in labor: a systematic review and meta-analysis of randomized controlled trials. Electron Physician. 2017;9(12):6002&#x2013;6009. doi: 10.19082/6002.</Citation><ArticleIdList><ArticleId IdType="doi">10.19082/6002</ArticleId><ArticleId IdType="pmc">PMC5843427</ArticleId><ArticleId IdType="pubmed">29560153</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJoseph LM, Pou JD. Local anesthetic facelift. Facial Plast Surg Clin North Am. 2020;28(3):409&#x2013;418. doi: 10.1016/j.fsc.2020.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fsc.2020.03.012</ArticleId><ArticleId IdType="pubmed">32503722</ArticleId></ArticleIdList></Reference><Reference><Citation>Maslekar S, Balaji P, Gardiner A, Culbert B, Monson JR, Duthie GS. Randomized controlled trial of patient-controlled sedation for colonoscopy: entonox vs modified patient-maintained target-controlled propofol. Colorectal Dis. 2011;13(1):48&#x2013;57. doi: 10.1111/j.1463-1318.2009.01988.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1463-1318.2009.01988.x</ArticleId><ArticleId IdType="pubmed">19575742</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Wang Y, Luo XJ, Wang NJ, Chen P, Jin X, et al. A fixed inhaled nitrous oxide/oxygen mixture as an analgesic for adult cancer patients with breakthrough pain: study protocol for a randomized controlled trial. Trials. 2017;18(1):13. doi: 10.1186/s13063-016-1739-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-016-1739-9</ArticleId><ArticleId IdType="pmc">PMC5225628</ArticleId><ArticleId IdType="pubmed">28077162</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson H, Burke D, Plews C, Newell R, Parapia L. Improving the patient's experience of a bone marrow biopsy - an RCT. J Clin Nurs. 2008;17(6):717&#x2013;725. doi: 10.1111/j.1365-2702.2007.01991.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2702.2007.01991.x</ArticleId><ArticleId IdType="pubmed">18047576</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen A, Iversen C, St&#xf8;rdal K. Use of nitrous oxide in children. Tidsskr Nor Laegeforen. 2019;139(12).</Citation><ArticleIdList><ArticleId IdType="pubmed">31502800</ArticleId></ArticleIdList></Reference><Reference><Citation>Gall O, Annequin D, Benoit G, Glabeke E, Vrancea F, Murat I. Adverse events of 399 premixed nitrous oxide and oxygen for procedural sedation in children. Lancet. 2001;400(358):1514&#x2013;1515. doi: 10.1016/S0140-6736(01)06575-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(01)06575-8</ArticleId><ArticleId IdType="pubmed">11705568</ArticleId></ArticleIdList></Reference><Reference><Citation>Annequin D, Carbajal R, Chauvin P, Gall O, Tourniaire B, Murat I. Fixed 50% nitrous oxide oxygen mixture for painful procedures: a French survey. Pediatrics. 2000;105(4):e47. doi: 10.1542/peds.105.4.e47.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.105.4.e47</ArticleId><ArticleId IdType="pubmed">10742368</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), ShortForm McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP) Arthritis Care Res (Hoboken) 2011;63(Suppl 11):S240&#x2013;S252.</Citation><ArticleIdList><ArticleId IdType="pubmed">22588748</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuxiang L, Lu T, Jianqiang Y, Xiuying D, Wanfang Z, Wannian Z, et al. Analgesia effect of a fixed nitrous oxide/oxygen mixture on burn dressing pain: study protocol for a randomized controlled trial. Trials. 2012;13:67. doi: 10.1186/1745-6215-13-67.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1745-6215-13-67</ArticleId><ArticleId IdType="pmc">PMC3404913</ArticleId><ArticleId IdType="pubmed">22624697</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Zhao C, Hu J, Ma T, Yang J, Kang P. Efficacy of a modified cocktail for periarticular local infiltration analgesia in total knee arthroplasty: a prospective, double-blinded, randomized controlled trial. J Bone Joint Surg Am. 2023;105(5):354&#x2013;362. doi: 10.2106/JBJS.22.00614.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.22.00614</ArticleId><ArticleId IdType="pubmed">36856693</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumstarck K. Efficacy of lidocaine in patients receiving palliative care with opioid-refractory cancer pain with a neuropathic component: study protocol for a randomized controlled study. Trials. 2014;15:318. doi: 10.1186/1745-6215-15-318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1745-6215-15-318</ArticleId><ArticleId IdType="pmc">PMC4247742</ArticleId><ArticleId IdType="pubmed">25112302</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrazzano GF, Quaraniello M, Sangianantoni G, Ingenito A, Cantile T. Clinical effectiveness of inhalation conscious sedation with nitrous oxide and oxygen for dental treatment in uncooperative paediatric patients during COVID-19 outbreak. Eur J Paediatr Dent. 2020;21(4):277&#x2013;282.</Citation><ArticleIdList><ArticleId IdType="pubmed">33337902</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao LL, Yang LS, Zhang JJ, Wang YL, Feng K, Ma L, et al. A fixed nitrous oxide/oxygen mixture as an analgesic for trauma patients in emergency department: study protocol for a randomized, controlled trial. Trials. 2018;19(1):527. doi: 10.1186/s13063-018-2899-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-018-2899-6</ArticleId><ArticleId IdType="pmc">PMC6162929</ArticleId><ArticleId IdType="pubmed">30268163</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xc7;elik D, Kaya ME. Does adding mobilization to stretching improve outcomes for people with frozen shoulder? A randomized controlled clinical trial. Clin Rehabil. 2016;30(8):786&#x2013;794. doi: 10.1177/0269215515597294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0269215515597294</ArticleId><ArticleId IdType="pubmed">26229109</ArticleId></ArticleIdList></Reference><Reference><Citation>Delafontaine A, Presedo A, Mohamed D, Lopes D, Wood C, Alberti C. Equimolar mixture of nitroux oxyde and oxygen during post-operative physiotherapy in patients with cerebral palsy: a randomized, double-blind, placebo-controlled study. Eur J Pain. 2017;21(10):1657&#x2013;1667. doi: 10.1002/ejp.1071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejp.1071</ArticleId><ArticleId IdType="pubmed">28726270</ArticleId></ArticleIdList></Reference><Reference><Citation>Lovich-Sapola J, Smith CE, Brandt CP. Postoperative pain control. Surg Clin North Am. 2015;95(2):301&#x2013;318. doi: 10.1016/j.suc.2014.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.suc.2014.10.002</ArticleId><ArticleId IdType="pubmed">25814108</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Liqiong Wu, Bin HA, Chaofeng Xu, Zixin Z, Jun Li. Investigation on the current situation of postoperative acute pain. J Clin Anesthesiol. 2021;37(11):1200&#x2013;1203.</Citation></Reference><Reference><Citation>Tian F, Mi Y, Liu J, Zhang R, Zhang Z, Gui S, et al. Research on the current situation and influencing factors of pain management knowledge and attitude of emergency medical staff. J Nurs Further Educ. 2021;36(02):134&#x2013;8.</Citation></Reference><Reference><Citation>Xu Y, Zhao X, Zhu H, Gao F, Zhang L, Xu H. A multicenter survey of domestic rehabilitation medical staff&#x2019;s perception of pain in children with cerebral palsy. Chin J Phys Med Rehabil. 2021;43(01):60&#x2013;3.</Citation></Reference><Reference><Citation>Collins M. Nitrous oxide utility in labor and birth: a multipurpose modality. J Perinat Neonatal Nurs. 2017;31(2):137&#x2013;144. doi: 10.1097/JPN.0000000000000248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JPN.0000000000000248</ArticleId><ArticleId IdType="pubmed">28437304</ArticleId></ArticleIdList></Reference><Reference><Citation>Masood J, Shah N, Lane T, Andrews H, Simpson P, Barua JM. Nitrous oxide (Entonox) inhalation and tolerance of transrectal ultrasound guided prostate biopsy: a double-blind randomized controlled study. J Urol. 2002;168(1):116&#x2013;120. doi: 10.1016/S0022-5347(05)64842-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-5347(05)64842-2</ArticleId><ArticleId IdType="pubmed">12050503</ArticleId></ArticleIdList></Reference><Reference><Citation>Broughton K, Clark AG, Ray AP. Nitrous oxide for labor analgesia: what we know to date. Ochsner J. 2020;20(4):419&#x2013;421. doi: 10.31486/toj.19.0102.</Citation><ArticleIdList><ArticleId IdType="doi">10.31486/toj.19.0102</ArticleId><ArticleId IdType="pmc">PMC7755562</ArticleId><ArticleId IdType="pubmed">33408580</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33703863</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>23</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2724-5772</ISSN><JournalIssue CitedMedium="Internet"><Volume>70</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Minerva cardiology and angiology</Title><ISOAbbreviation>Minerva Cardiol Angiol</ISOAbbreviation></Journal><ArticleTitle>Chronic thromboembolic pulmonary hypertension risk score evaluation and validation (CTEPH SOLUTION): proposal of a study protocol aimed to realize a validated risk score for early diagnosis.</ArticleTitle><Pagination><StartPage>545</StartPage><EndPage>554</EndPage><MedlinePgn>545-554</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.23736/S2724-5683.21.05575-7</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Chronic thromboembolic pulmonary hypertension (CTEPH) is the most serious long-term complication of acute pulmonary embolism (PE) though it is the only potentially reversible form of pulmonary hypertension (PH). Its incidence is mainly limited to the first 2 years following the embolic event, however it is often underdiagnosed or misdiagnosed.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This is a multicenter observational cross-sectional and prospective study. Patients with a prior diagnosis of PE will be enrolled and undergo baseline evaluation for prevalent PH detection through a clinical examination and an echocardiogram as first screening exam. All cases of intermediate-high echocardiographic probability of PH will be confirmed by right heart catheterization and then identified as CTEPH through appropriate imaging and functional examinations in order to exclude other causes of PH. A CTEPH Risk Score will be created using retrospective data from this prevalent cohort of patients and will be then validated on an incident cohort of patients with acute PE.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">One thousand retrospective and 218 prospective patients are expected to be enrolled and the study is expected to be completed by the end of 2021. Up to now 841 patients (620 retrospective and 221 prospective) have been enrolled.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study is the first large prospective study for the prediction of CTEPH development in patients with PE. It aims to create a comprehensive scoring tool that includes echocardiographic data which may allow early detection of CTEPH and the application of targeted follow-up screening programs in patients with PE.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Miotti</LastName><ForeName>Cristiano</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular and Respiratory Sciences, Sapienza University, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Armini</LastName><ForeName>Andrea M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Section of Cardiac Surgery, Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, San Matteo Polyclinic Hospital, Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scardovi</LastName><ForeName>Beatrice</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Unit of Cardiology, Santo Spirito in Saxia Hospital, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghio</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>S. Matteo Plyclinic Hospital, Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sinagra</LastName><ForeName>Gianfranco</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Ospedali Riuniti Hospital, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serra</LastName><ForeName>Walter</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Unit of Cardiology, Maggiore Hospital, AOU Parma, Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romaniello</LastName><ForeName>Antonella</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Unit of Cardiology, Sant'Andrea Hospital, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galgano</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Unit of Cardiology and Intensive Care, Francesco Miulli Regional Hospital, Acquaviva delle Fonti, Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roncon</LastName><ForeName>Loris</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Cardiology, ULSS 18 Rovigo, Santa Maria della Misericordia Hospital, Rovigo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Alto</LastName><ForeName>Michele</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Monaldi Hospital, L. Vanvitelli University, Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giannazzo</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Ferrarotto Hospital, AOU Policlinico Vittorio Emanuele, Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vitulo</LastName><ForeName>Patrizio</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Pneumology, Mediterranean Institute of Trasplantation and Highly-Specialized Therapetics (ISMETT), Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bongarzoni</LastName><ForeName>Amedeo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology, San Carlo Borromeo Hospital, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruzzolini</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Unit of Cardiology and Intensiva Care, San Giovanni Calibita Fatebenefratelli Hospital, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albera</LastName><ForeName>Carlo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Service of Pneumology, Molinette Hospital, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casu</LastName><ForeName>Gavino</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Unit of Cardiology, San Francesco Hospital, Nuoro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perazzolo Marra</LastName><ForeName>Martina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiologic, Thoracic, and Vascular Sciences, AOU Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pierdomenico</LastName><ForeName>Sante D</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>Unit of Cardiovascular Diseases, Department of Medical and Oral Sciences and Biotechnologies, G. d'Annunzio University, Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luongo</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular and Respiratory Sciences, Sapienza University, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manzi</LastName><ForeName>Giovanna</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular and Respiratory Sciences, Sapienza University, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papa</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular and Respiratory Sciences, Sapienza University, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scoccia</LastName><ForeName>Gianmarco</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular and Respiratory Sciences, Sapienza University, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cedrone</LastName><ForeName>Nadia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular and Respiratory Sciences, Sapienza University, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Badagliacca</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular and Respiratory Sciences, Sapienza University, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vizza</LastName><ForeName>Carmine D</ForeName><Initials>CD</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular and Respiratory Sciences, Sapienza University, Rome, Italy - dario.vizza@uniroma1.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Minerva Cardiol Angiol</MedlineTA><NlmUniqueID>101776555</NlmUniqueID><ISSNLinking>2724-5683</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042241" MajorTopicYN="N">Early Diagnosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006976" MajorTopicYN="Y">Hypertension, Pulmonary</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015337" MajorTopicYN="N">Multicenter Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>11</Day><Hour>9</Hour><Minute>58</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33703863</ArticleId><ArticleId IdType="doi">10.23736/S2724-5683.21.05575-7</ArticleId><ArticleId IdType="pii">S2724-5683.21.05575-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">32810841</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>22</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1438-8871</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>9</Issue><PubDate><Year>2020</Year><Month>Sep</Month><Day>09</Day></PubDate></JournalIssue><Title>Journal of medical Internet research</Title><ISOAbbreviation>J Med Internet Res</ISOAbbreviation></Journal><ArticleTitle>Patient Satisfaction With Telemedicine During the COVID-19 Pandemic: Retrospective Cohort Study.</ArticleTitle><Pagination><StartPage>e20786</StartPage><MedlinePgn>e20786</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e20786</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/20786</ELocationID><Abstract><AbstractText Label="BACKGROUND">New York City was the international epicenter of the COVID-19 pandemic. Health care providers responded by rapidly transitioning from in-person to video consultations. Telemedicine (ie, video visits) is a potentially disruptive innovation; however, little is known about patient satisfaction with this emerging alternative to the traditional clinical encounter.</AbstractText><AbstractText Label="OBJECTIVE">This study aimed to determine if patient satisfaction differs between video and in-person visits.</AbstractText><AbstractText Label="METHODS">In this retrospective observational cohort study, we analyzed 38,609 Press Ganey patient satisfaction survey outcomes from clinic encounters (620 video visits vs 37,989 in-person visits) at a single-institution, urban, quaternary academic medical center in New York City for patients aged 18 years, from April 1, 2019, to March 31, 2020. Time was categorized as pre-COVID-19 and COVID-19 (before vs after March 4, 2020). Wilcoxon-Mann-Whitney tests and multivariable linear regression were used for hypothesis testing and statistical modeling, respectively.</AbstractText><AbstractText Label="RESULTS">We experienced an 8729% increase in video visit utilization during the COVID-19 pandemic compared to the same period last year. Video visit Press Ganey scores were significantly higher than in-person visits (94.9% vs 92.5%; P&lt;.001). In adjusted analyses, video visits (parameter estimate [PE] 2.18; 95% CI 1.20-3.16) and the COVID-19 period (PE 0.55; 95% CI 0.04-1.06) were associated with higher patient satisfaction. Younger age (PE -2.05; 95% CI -2.66 to -1.22), female gender (PE -0.73; 95% CI -0.96 to -0.50), and new visit type (PE -0.75; 95% CI -1.00 to -0.49) were associated with lower patient satisfaction.</AbstractText><AbstractText Label="CONCLUSIONS">Patient satisfaction with video visits is high and is not a barrier toward a paradigm shift away from traditional in-person clinic visits. Future research comparing other clinic visit quality indicators is needed to guide and implement the widespread adoption of telemedicine.</AbstractText><CopyrightInformation>&#xa9;Ashwin Ramaswamy, Miko Yu, Siri Drangsholt, Eric Ng, Patrick J Culligan, Peter N Schlegel, Jim C Hu. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 09.09.2020.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ramaswamy</LastName><ForeName>Ashwin</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-8816-7838</Identifier><AffiliationInfo><Affiliation>Department of Urology, Weill Cornell Medicine, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Miko</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-5491-0278</Identifier><AffiliationInfo><Affiliation>Department of Urology, Weill Cornell Medicine, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drangsholt</LastName><ForeName>Siri</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-8263-7897</Identifier><AffiliationInfo><Affiliation>Department of Urology, Weill Cornell Medicine, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Eric</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-8599-5451</Identifier><AffiliationInfo><Affiliation>Department of Urology, Weill Cornell Medicine, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Culligan</LastName><ForeName>Patrick J</ForeName><Initials>PJ</Initials><Identifier Source="ORCID">0000-0002-2982-8667</Identifier><AffiliationInfo><Affiliation>Department of Urology, Weill Cornell Medicine, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schlegel</LastName><ForeName>Peter N</ForeName><Initials>PN</Initials><Identifier Source="ORCID">0000-0002-7129-8137</Identifier><AffiliationInfo><Affiliation>Department of Urology, Weill Cornell Medicine, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Jim C</ForeName><Initials>JC</Initials><Identifier Source="ORCID">0000-0003-2562-8024</Identifier><AffiliationInfo><Affiliation>Department of Urology, Weill Cornell Medicine, New York, NY, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>09</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>J Med Internet Res</MedlineTA><NlmUniqueID>100959882</NlmUniqueID><ISSNLinking>1438-8871</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000046" MajorTopicYN="N">Academic Medical Centers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000553" MajorTopicYN="N">Ambulatory Care</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="Y">Betacoronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="Y">Coronavirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019538" MajorTopicYN="N">Health Care Surveys</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009519" MajorTopicYN="N" Type="Geographic">New York City</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017060" MajorTopicYN="Y">Patient Satisfaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="Y">Pneumonia, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017216" MajorTopicYN="Y">Telemedicine</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">disruptive technology</Keyword><Keyword MajorTopicYN="N">health care delivery</Keyword><Keyword MajorTopicYN="N">health care reform</Keyword><Keyword MajorTopicYN="N">health policy</Keyword><Keyword MajorTopicYN="N">health services research</Keyword><Keyword MajorTopicYN="N">medical informatics</Keyword><Keyword MajorTopicYN="N">medicine</Keyword><Keyword MajorTopicYN="N">pandemics</Keyword><Keyword MajorTopicYN="N">patient satisfaction</Keyword><Keyword MajorTopicYN="N">physicians</Keyword><Keyword MajorTopicYN="N">practice patterns</Keyword><Keyword MajorTopicYN="N">remote consultation</Keyword><Keyword MajorTopicYN="N">telemedicine</Keyword></KeywordList><CoiStatement>Conflicts of Interest: PJC is a stockholder in Origami Surgical and has received consulting fees from Intuitive Surgical, Hologic, Coloplast. JCH receives research support from the Frederick J and Theresa Dow Wallace Fund of the New York Community Trust. PNS reports consulting fees from Roman Health, Gilead Sciences, and Theralogix. The remaining authors report no further disclosures related to this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>5</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>8</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>9</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32810841</ArticleId><ArticleId IdType="pmc">PMC7511224</ArticleId><ArticleId IdType="doi">10.2196/20786</ArticleId><ArticleId IdType="pii">v22i9e20786</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Why New York is the epicenter of the American coronavirus outbreak. CNN. 2020. Mar,  [2020-05-10].   https://www.cnn.com/2020/03/26/us/new-york-coronavirus-explainer/index.html.</Citation></Reference><Reference><Citation>Johns Hopkins Coronavirus Resource Center. COVID-19 United States Cases by County.  [2020-05-09].   https://coronavirus.jhu.edu/us-map.</Citation></Reference><Reference><Citation>Hollander Judd E, Carr Brendan G. Virtually Perfect? Telemedicine for Covid-19. N Engl J Med. 2020 Apr 30;382(18):1679&#x2013;1681. doi: 10.1056/NEJMp2003539.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp2003539</ArticleId><ArticleId IdType="pubmed">32160451</ArticleId></ArticleIdList></Reference><Reference><Citation>Telehealth Parity Laws. Health Affairs.  [2020-05-07].   https://www.healthaffairs.org/do/10.1377/hpb20160815.244795/full/</Citation><ArticleIdList><ArticleId IdType="doi">10.1377/hpb20160815.244795/full/</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine SR, Gorman M. "Telestroke" : the application of telemedicine for stroke. Stroke. 1999 Feb;30(2):464&#x2013;9. doi: 10.1161/01.str.30.2.464.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.str.30.2.464?url_ver=Z39.88-2003&amp;rfr_id=ori%3Arid%3Acrossref.org&amp;rfr_dat=cr_pub++0pubmed&amp;</ArticleId><ArticleId IdType="doi">10.1161/01.str.30.2.464</ArticleId><ArticleId IdType="pubmed">9933289</ArticleId></ArticleIdList></Reference><Reference><Citation>Lurie N, Carr BG. The Role of Telehealth in the Medical Response to Disasters. JAMA Intern Med. 2018 Jun 01;178(6):745&#x2013;746. doi: 10.1001/jamainternmed.2018.1314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2018.1314</ArticleId><ArticleId IdType="pubmed">29710200</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross SW, Lauer CW, Miles WS, Green JM, Christmas AB, May AK, Matthews BD. Maximizing the Calm before the Storm: Tiered Surgical Response Plan for Novel Coronavirus (COVID-19) J Am Coll Surg. 2020 Jun;230(6):1080&#x2013;1091.e3. doi: 10.1016/j.jamcollsurg.2020.03.019.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2020.03.019</ArticleId><ArticleId IdType="pmc">PMC7128345</ArticleId><ArticleId IdType="pubmed">32240770</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloem BR, Dorsey ER, Okun MS. The Coronavirus Disease 2019 Crisis as Catalyst for Telemedicine for Chronic Neurological Disorders. JAMA Neurol. 2020 Apr 24;:e. doi: 10.1001/jamaneurol.2020.1452.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1452</ArticleId><ArticleId IdType="pubmed">32329796</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong Y, Lawrence J, Williams Dunc, Mainous III Arch. Population-Level Interest and Telehealth Capacity of US Hospitals in Response to COVID-19: Cross-Sectional Analysis of Google Search and National Hospital Survey Data. JMIR Public Health Surveill. 2020 Apr 07;6(2):e18961. doi: 10.2196/18961.  </Citation><ArticleIdList><ArticleId IdType="doi">10.2196/18961</ArticleId><ArticleId IdType="pmc">PMC7141249</ArticleId><ArticleId IdType="pubmed">32250963</ArticleId></ArticleIdList></Reference><Reference><Citation>President Trump Expands Telehealth Benefits for Medicare Beneficiaries During COVID-19 Outbreak. CMS. 2020. May,  [2020-05-06].   https://www.cms.gov/newsroom/press-releases/president-trump-expands-telehealth-benefits-medicare-beneficiaries-during-covid-19-outbreak.</Citation></Reference><Reference><Citation>Hopkins B, Patel M, Yamaguchi J, Cloney M, Dahdaleh N. Predictors of patient satisfaction and survey participation after spine surgery: a retrospective review of 17,853 consecutive spinal patients from a single academic institution. Part 1: Press Ganey. J Neurosurg Spine. 2019 Jan 04;30(3):382&#x2013;388. doi: 10.3171/2018.8.SPINE18594.</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/2018.8.SPINE18594</ArticleId><ArticleId IdType="pubmed">30611140</ArticleId></ArticleIdList></Reference><Reference><Citation>Avdalovic MV, Marcin JP. When Will Telemedicine Appear in the ICU? J Intensive Care Med. 2019 Apr 13;34(4):271&#x2013;276. doi: 10.1177/0885066618775956.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0885066618775956</ArticleId><ArticleId IdType="pubmed">29756527</ArticleId></ArticleIdList></Reference><Reference><Citation>Arora S, Thornton K, Murata G, Deming P, Kalishman S, Dion D, Parish B, Burke T, Pak W, Dunkelberg J, Kistin M, Brown J, Jenkusky S, Komaromy M, Qualls C. Outcomes of Treatment for Hepatitis C Virus Infection by Primary Care Providers. N Engl J Med. 2011 Jun 09;364(23):2199&#x2013;2207. doi: 10.1056/nejmoa1009370.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa1009370</ArticleId><ArticleId IdType="pmc">PMC3820419</ArticleId><ArticleId IdType="pubmed">21631316</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain S, Khera R, Lin Z, Ross JS, Krumholz HM. Availability of Telemedicine Services Across Hospitals in the United States in 2018: A Cross-sectional Study. Annals of Internal Medicine. 2020 Apr 30;:e. doi: 10.7326/m20-1201.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/m20-1201</ArticleId><ArticleId IdType="pmc">PMC7212823</ArticleId><ArticleId IdType="pubmed">32353106</ArticleId></ArticleIdList></Reference><Reference><Citation>Nochomovitz M, Sharma R. Is It Time for a New Medical Specialty?: The Medical Virtualist. JAMA. 2018 Feb 06;319(5):437&#x2013;438. doi: 10.1001/jama.2017.17094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.17094</ArticleId><ArticleId IdType="pubmed">29181539</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann DM, Chen J, Chunara R, Testa PA, Nov O. COVID-19 transforms health care through telemedicine: Evidence from the field. J Am Med Inform Assoc. 2020 Jul 01;27(7):1132&#x2013;1135. doi: 10.1093/jamia/ocaa072.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocaa072</ArticleId><ArticleId IdType="pmc">PMC7188161</ArticleId><ArticleId IdType="pubmed">32324855</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwamm LH, Erskine A, Licurse A. A digital embrace to blunt the curve of COVID19 pandemic. NPJ Digit Med. 2020 May 4;3(1):64. doi: 10.1038/s41746-020-0279-6.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-020-0279-6</ArticleId><ArticleId IdType="pmc">PMC7198549</ArticleId><ArticleId IdType="pubmed">32377575</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwamm LH. Telehealth: seven strategies to successfully implement disruptive technology and transform health care. Health Aff (Millwood) 2014 Feb;33(2):200&#x2013;6. doi: 10.1377/hlthaff.2013.1021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1377/hlthaff.2013.1021</ArticleId><ArticleId IdType="pubmed">24493761</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabesan S, Simcox K, Marr I. Medical oncology clinics through videoconferencing: an acceptable telehealth model for rural patients and health workers. Intern Med J. 2012 Jul;42(7):780&#x2013;5. doi: 10.1111/j.1445-5994.2011.02537.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1445-5994.2011.02537.x</ArticleId><ArticleId IdType="pubmed">21627743</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorsey ER, Venkataraman V, Grana MJ, Bull MT, George BP, Boyd CM, Beck CA, Rajan B, Seidmann A, Biglan KM. Randomized controlled clinical trial of "virtual house calls" for Parkinson disease. JAMA Neurol. 2013 May 01;70(5):565&#x2013;70. doi: 10.1001/jamaneurol.2013.123.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2013.123</ArticleId><ArticleId IdType="pmc">PMC3791511</ArticleId><ArticleId IdType="pubmed">23479138</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker LC, Johnson SJ, Macaulay D, Birnbaum H. Integrated telehealth and care management program for Medicare beneficiaries with chronic disease linked to savings. Health Aff (Millwood) 2011 Sep;30(9):1689&#x2013;97. doi: 10.1377/hlthaff.2011.0216.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1377/hlthaff.2011.0216</ArticleId><ArticleId IdType="pubmed">21900660</ArticleId></ArticleIdList></Reference><Reference><Citation>Nord G, Rising KL, Band RA, Carr BG, Hollander JE. On-demand synchronous audio video telemedicine visits are cost effective. Am J Emerg Med. 2019 May;37(5):890&#x2013;894. doi: 10.1016/j.ajem.2018.08.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2018.08.017</ArticleId><ArticleId IdType="pubmed">30100333</ArticleId></ArticleIdList></Reference><Reference><Citation>Jennett PA, Affleck Hall L, Hailey D, Ohinmaa A, Anderson C, Thomas R, Young B, Lorenzetti D, Scott RE. The socio-economic impact of telehealth: a systematic review. J Telemed Telecare. 2003 Dec;9(6):311&#x2013;20. doi: 10.1258/135763303771005207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1258/135763303771005207</ArticleId><ArticleId IdType="pubmed">14680514</ArticleId></ArticleIdList></Reference><Reference><Citation>Su D, Zhou J, Kelley MS, Michaud TL, Siahpush M, Kim J, Wilson F, Stimpson JP, Pag&#xe1;n Jos&#xe9; A. Does telemedicine improve treatment outcomes for diabetes? A meta-analysis of results from 55 randomized controlled trials. Diabetes Res Clin Pract. 2016 Jun;116:136&#x2013;48. doi: 10.1016/j.diabres.2016.04.019.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2016.04.019</ArticleId><ArticleId IdType="pubmed">27321329</ArticleId></ArticleIdList></Reference><Reference><Citation>de Jong MJ, van der Meulen-de Jong AE, Romberg-Camps MJ, Becx MC, Maljaars JP, Cilissen M, van Bodegraven AA, Mahmmod N, Markus T, Hameeteman WM, Dijkstra G, Masclee AA, Boonen A, Winkens B, van Tubergen A, Jonkers DM, Pierik MJ. Telemedicine for management of inflammatory bowel disease (myIBDcoach): a pragmatic, multicentre, randomised controlled trial. The Lancet. 2017 Sep;390(10098):959&#x2013;968. doi: 10.1016/s0140-6736(17)31327-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(17)31327-2</ArticleId><ArticleId IdType="pubmed">28716313</ArticleId></ArticleIdList></Reference><Reference><Citation>Fortney JC, Pyne JM, Kimbrell TA, Hudson TJ, Robinson DE, Schneider R, Moore WM, Custer PJ, Grubbs KM, Schnurr PP. Telemedicine-based collaborative care for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2015 Jan 01;72(1):58&#x2013;67. doi: 10.1001/jamapsychiatry.2014.1575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2014.1575</ArticleId><ArticleId IdType="pubmed">25409287</ArticleId></ArticleIdList></Reference><Reference><Citation>Portnoy JM, Waller M, De Lurgio S, Dinakar C. Telemedicine is as effective as in-person visits for patients with asthma. Ann Allergy Asthma Immunol. 2016 Sep;117(3):241&#x2013;5. doi: 10.1016/j.anai.2016.07.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anai.2016.07.012</ArticleId><ArticleId IdType="pubmed">27613456</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Wherton J, Shaw S, Morrison C. Video consultations for covid-19. BMJ. 2020 Mar 12;368:m998. doi: 10.1136/bmj.m998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m998</ArticleId><ArticleId IdType="pubmed">32165352</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancaster K, Abuzour A, Khaira M, Mathers A, Chan A, Bui V, Lok A, Thabane L, Dolovich L. The Use and Effects of Electronic Health Tools for Patient Self-Monitoring and Reporting of Outcomes Following Medication Use: Systematic Review. J Med Internet Res. 2018 Dec 18;20(12):e294. doi: 10.2196/jmir.9284.  </Citation><ArticleIdList><ArticleId IdType="doi">10.2196/jmir.9284</ArticleId><ArticleId IdType="pmc">PMC6315271</ArticleId><ArticleId IdType="pubmed">30563822</ArticleId></ArticleIdList></Reference><Reference><Citation>Mair F, Whitten P. Systematic review of studies of patient satisfaction with telemedicine. BMJ. 2000 Jun 03;320(7248):1517&#x2013;20. doi: 10.1136/bmj.320.7248.1517.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.320.7248.1517</ArticleId><ArticleId IdType="pmc">PMC27397</ArticleId><ArticleId IdType="pubmed">10834899</ArticleId></ArticleIdList></Reference><Reference><Citation>McLean S, Sheikh A, Cresswell K, Nurmatov U, Mukherjee M, Hemmi A, Pagliari C. The impact of telehealthcare on the quality and safety of care: a systematic overview. PLoS One. 2013 Aug 19;8(8):e71238. doi: 10.1371/journal.pone.0071238.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0071238</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0071238</ArticleId><ArticleId IdType="pmc">PMC3747134</ArticleId><ArticleId IdType="pubmed">23977001</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraai I, Luttik M, de Jong R, Jaarsma T, Hillege H. Heart failure patients monitored with telemedicine: patient satisfaction, a review of the literature. J Card Fail. 2011 Aug;17(8):684&#x2013;90. doi: 10.1016/j.cardfail.2011.03.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cardfail.2011.03.009</ArticleId><ArticleId IdType="pubmed">21807331</ArticleId></ArticleIdList></Reference><Reference><Citation>Granja C, Janssen W, Johansen MA. Factors Determining the Success and Failure of eHealth Interventions: Systematic Review of the Literature. J Med Internet Res. 2018 May 01;20(5):e10235. doi: 10.2196/10235.  </Citation><ArticleIdList><ArticleId IdType="doi">10.2196/10235</ArticleId><ArticleId IdType="pmc">PMC5954232</ArticleId><ArticleId IdType="pubmed">29716883</ArticleId></ArticleIdList></Reference><Reference><Citation>Kupfer JM, Bond EU. Patient satisfaction and patient-centered care: necessary but not equal. JAMA. 2012 Jul 11;308(2):139&#x2013;40. doi: 10.1001/jama.2012.7381.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2012.7381</ArticleId><ArticleId IdType="pubmed">22782413</ArticleId></ArticleIdList></Reference><Reference><Citation>Porter ME, Larsson S, Lee TH. Standardizing Patient Outcomes Measurement. N Engl J Med. 2016 Feb 11;374(6):504&#x2013;506. doi: 10.1056/nejmp1511701.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmp1511701</ArticleId><ArticleId IdType="pubmed">26863351</ArticleId></ArticleIdList></Reference><Reference><Citation>Zolnierek KBH, Dimatteo MR. Physician communication and patient adherence to treatment: a meta-analysis. Med Care. 2009 Aug;47(8):826&#x2013;34. doi: 10.1097/MLR.0b013e31819a5acc.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0b013e31819a5acc</ArticleId><ArticleId IdType="pmc">PMC2728700</ArticleId><ArticleId IdType="pubmed">19584762</ArticleId></ArticleIdList></Reference><Reference><Citation>Lobo Prabhu K, Cleghorn MC, Elnahas A, Tse A, Maeda A, Quereshy FA, Okrainec A, Jackson TD. Is quality important to our patients? The relationship between surgical outcomes and patient satisfaction. BMJ Qual Saf. 2018 Jan 03;27(1):48&#x2013;52. doi: 10.1136/bmjqs-2017-007071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjqs-2017-007071</ArticleId><ArticleId IdType="pubmed">29101291</ArticleId></ArticleIdList></Reference><Reference><Citation>Safran DG, Montgomery JE, Chang H, Murphy J, Rogers WH. Switching doctors: predictors of voluntary disenrollment from a primary physician's practice. J Fam Pract. 2001 Feb;50(2):130&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">11219560</ArticleId></ArticleIdList></Reference><Reference><Citation>Press Ganey Introduces New Telemedicine Solution for Medical Practices. Press Ganey. 2018. Apr,  [2020-05-07].   https://www.pressganey.com/about/news/press-ganey-introduces-new-telemedicine-solution-for-medical-practices.</Citation></Reference><Reference><Citation>Cleveland Clinic Orthopaedic Arthroplasty Group Press Ganey Administration of Hospital Consumer Assessment of Healthcare Providers and Systems Survey Result in a Biased Responder Sample for Hip and Knee Arthroplasties. J Arthroplasty. 2019 Nov;34(11):2538&#x2013;2543. doi: 10.1016/j.arth.2019.06.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2019.06.045</ArticleId><ArticleId IdType="pubmed">31331703</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang C, Lipman G, Kane M. Effect of an emergency department fast track on Press-Ganey patient satisfaction scores. West J Emerg Med. 2015 Jan 01;16(1):34&#x2013;8. doi: 10.5811/westjem.2014.11.21768.  </Citation><ArticleIdList><ArticleId IdType="doi">10.5811/westjem.2014.11.21768</ArticleId><ArticleId IdType="pmc">PMC4307722</ArticleId><ArticleId IdType="pubmed">25671005</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandra A, Sieck S, Hocker M, Gerardo CJ, Villani J, Harrison D, Boardwine A, Limkakeng A. An Observation Unit May Help Improve an Institution&#x2bc;s Press Ganey Satisfaction Score. Crit Pathw Cardiol. 2011;10(2):104&#x2013;106. doi: 10.1097/hpc.0b013e31821c5da8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/hpc.0b013e31821c5da8</ArticleId><ArticleId IdType="pubmed">21988951</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqui Z, Berry S, Bertram A, Allen L, Hoyer E, Durkin N, Qayyum R, Wick E, Pronovost P, Brotman DJ. Does Patient Experience Predict 30-Day Readmission? A Patient-Level Analysis of HCAHPS Data. J Hosp Med. 2018 Sep;13(10):681&#x2013;687. doi: 10.12788/jhm.3037.</Citation><ArticleIdList><ArticleId IdType="doi">10.12788/jhm.3037</ArticleId><ArticleId IdType="pubmed">30261085</ArticleId></ArticleIdList></Reference><Reference><Citation>Newgard CD, Fu R, Heilman J, Tanski M, Ma OJ, Lines A, Keith French L. Using Press Ganey Provider Feedback to Improve Patient Satisfaction: A Pilot Randomized Controlled Trial. Acad Emerg Med. 2017 Sep 16;24(9):1051&#x2013;1059. doi: 10.1111/acem.13248. doi: 10.1111/acem.13248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acem.13248</ArticleId><ArticleId IdType="doi">10.1111/acem.13248</ArticleId><ArticleId IdType="pubmed">28662281</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29653390</PMID><DateCompleted><Year>2018</Year><Month>10</Month><Day>22</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-2472</ISSN><JournalIssue CitedMedium="Internet"><Volume>166</Volume><PubDate><Year>2018</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Thrombosis research</Title><ISOAbbreviation>Thromb Res</ISOAbbreviation></Journal><ArticleTitle>Fondaparinux versus nadroparin for thromboprophylaxis following minimally invasive esophagectomy: A randomized controlled trial.</ArticleTitle><Pagination><StartPage>22</StartPage><EndPage>27</EndPage><MedlinePgn>22-27</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.thromres.2018.04.001</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0049-3848(18)30299-8</ELocationID><Abstract><AbstractText Label="BACKGROUND">The methodology of thromboprophylaxis post minimally invasive esophagectomy (MIE) is unclear. Thus, we compared the efficacy and safety of fondaparinux and nadroparin on the prophylaxis of venous thromboembolism (VTE) after MIE.</AbstractText><AbstractText Label="MATERIALS AND METHODS">We conducted a randomized, double-blind, treatment-controlled study. Consecutive patients undergoing MIE randomly received a single dose of either nadroparin 2850 AxaIU (Group H) or fondaparinux 2.5&#x202f;mg (Group F) daily. We used ultrasonography to identify deep vein thrombosis (DVT) on postoperative day 7. The coagulation status was examined using thromboelastography (TEG) prior to and at 0, 24, 48, and 72&#x202f;h after the operation. Bleeding events were recorded during anticoagulation therapy and analysis was performed on an intention-to-treat basis.</AbstractText><AbstractText Label="RESULTS">We randomly assigned the patients to Group H (n&#x202f;=&#x202f;57) or Group F (n&#x202f;=&#x202f;59). Symptomatic or asymptomatic DVT was identified in seven patients in Group H and one patient in Group F (12.28% vs. 1.69%, p&#x202f;=&#x202f;0.031). Pulmonary embolism developed in one patient in Group H, and the VTE incidence was significantly lower in Group F than Group H (1.69% vs. 14.04%, RR: 0.121, 95% CI: 0.016-0.935, p&#x202f;=&#x202f;0.016). TEG analysis showed a more inhibited coagulation profile of Group F compared with Group H reflected by the significantly prolonged R time at 48&#x202f;h and 72&#x202f;h after operation (6.8&#x202f;&#xb1;&#x202f;2.2&#x202f;min vs. 8.4&#x202f;&#xb1;&#x202f;2.7&#x202f;min, p&#x202f;=&#x202f;0.005; 7.1&#x202f;&#xb1;&#x202f;1.6&#x202f;min vs. 9.2&#x202f;&#xb1;&#x202f;3.7&#x202f;min, p&#x202f;=&#x202f;0.002). Bleeding events were not recorded in either group.</AbstractText><AbstractText Label="CONCLUSIONS">Fondaparinux could provide similar efficacy and safety in postoperative thromboprophylaxis following MIE compared with nadroparin.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Jieqiong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Zhongshan Hospital Fudan University, 180 Fenglin Road, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xuan</LastName><ForeName>Lizhen</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Zhongshan Hospital Fudan University, 180 Fenglin Road, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Zhongshan Hospital Fudan University, 180 Fenglin Road, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Yaxing</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Thoracic Surgery, Zhongshan Hospital Fudan University, 180 Fenglin Road, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Lijie</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Thoracic Surgery, Zhongshan Hospital Fudan University, 180 Fenglin Road, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Ming</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Zhongshan Hospital Fudan University, 180 Fenglin Road, Shanghai, China. Electronic address: zhong.ming@zs-hospital.sh.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>04</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Thromb Res</MedlineTA><NlmUniqueID>0326377</NlmUniqueID><ISSNLinking>0049-3848</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017762">Nadroparin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011134">Polysaccharides</NameOfSubstance></Chemical><Chemical><RegistryNumber>J177FOW5JL</RegistryNumber><NameOfSubstance UI="D000077425">Fondaparinux</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016629" MajorTopicYN="N">Esophagectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077425" MajorTopicYN="N">Fondaparinux</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017762" MajorTopicYN="N">Nadroparin</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011134" MajorTopicYN="N">Polysaccharides</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013916" MajorTopicYN="N">Thrombelastography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="N">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Esophagectomy</Keyword><Keyword MajorTopicYN="N">Fondaparinux</Keyword><Keyword MajorTopicYN="N">Low molecular weight heparin</Keyword><Keyword MajorTopicYN="N">Thrombelastography</Keyword><Keyword MajorTopicYN="N">Venous thromboembolism</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>1</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>3</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>10</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29653390</ArticleId><ArticleId IdType="doi">10.1016/j.thromres.2018.04.001</ArticleId><ArticleId IdType="pii">S0049-3848(18)30299-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>